PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Ariga, K				Ariga, Katsuhiko			From Nanotechnology to Nanoarchitectonics	JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS			English	Editorial Material									Natl Inst Mat Sci, World Premier Int WPI Res Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki, Japan	Ariga, K (reprint author), Natl Inst Mat Sci, World Premier Int WPI Res Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki, Japan.	ARIGA.Katsuhiko@nims.go.jp	ARIGA, Katsuhiko/H-2695-2011				[Anonymous], 1959, AM PHYS SOC M 1959; Ramanathan M, 2013, PHYS CHEM CHEM PHYS, V15, P10580, DOI 10.1039/c3cp50620g; Ariga K, 2013, CHEM SOC REV, V42, P6322, DOI 10.1039/c2cs35475f; Ariga K, 2014, NEW J CHEM, V38, P5149, DOI 10.1039/c4nj00864b; Aono M, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/4/040301; Nakanishi W, 2014, NANO TODAY, V9, P378, DOI 10.1016/j.nantod.2014.05.002; Ariga K, 2014, CHEM LETT, V43, P36, DOI 10.1246/cl.130987; Ariga K, 2012, B CHEM SOC JPN, V85, P1, DOI 10.1246/bcsj.20110162; Ariga K., 2014, NPG ASIA MATER, V4, pe17	9	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1574-1443	1574-1451		J INORG ORGANOMET P	J. Inorg. Organomet. Polym. Mater.	MAR	2015	25	2					177	178		10.1007/s10904-015-0170-0		2	Polymer Science	Polymer Science	CC4XX	WOS:000350360500001		
J	Cordier, S; Grasset, F; Molard, Y; Amela-Cortes, M; Boukherroub, R; Ravaine, S; Mortier, M; Ohashi, N; Saito, N; Haneda, H				Cordier, S.; Grasset, F.; Molard, Y.; Amela-Cortes, M.; Boukherroub, R.; Ravaine, S.; Mortier, M.; Ohashi, N.; Saito, N.; Haneda, H.			Inorganic Molybdenum Octahedral Nanosized Cluster Units, Versatile Functional Building Block for Nanoarchitectonics	JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS			English	Article						Nanoarchitectonics; Metal nanoclusters; Molybdenum; Near infra-red; Hybrids; Liquid crystal; Microemulsion	TRANSITION-METAL CLUSTERS; CORE-SHELL NANOPARTICLES; IN-OIL MICROEMULSION; ONE-POT SYNTHESIS; HEXANUCLEAR MOLYBDENUM; MO6S4.5I4.5 NANOWIRES; SILICA NANOPARTICLES; HALIDE CLUSTERS; LUMINESCENT MATERIALS; POWDER DIFFRACTION	Recently, Nanoarchitectonics has been introduced as a new concept that refers to a technology system for arranging nanoscale structural units in a required architecture. Multifunctional properties are achieved by a combination of several materials in a well-defined architecture. In the frame of this concept, composite nanoarchitectures represent a new class of nanostructured entities that integrate various dissimilar nanoscale building blocks including clusters, particles, wires and films. The heterogeneous composite nanostructured materials are composed by definition of multi-(nano)components, each tailored to address different requirements. As one of the nanocomponents, nanometer sized metal clusters (< 2 nm), which consist of less than a few dozens of metal atoms, could be defined as a link between atom and nanoparticle. In this paper, we will focus on our results on new nano-composites involving Mo-6 atom nanosized cluster units for optical, nanobiotechnology, energy and environmental applications.	[Cordier, S.; Grasset, F.; Molard, Y.; Amela-Cortes, M.] Univ Rennes 1, CNRS, UMR 6226, Inst Sci Chim Rennes, F-35042 Rennes, France; [Grasset, F.] Natl Inst Mat Sci, CNRS, UMI 3629, Lab Innovat Key Mat & Struct LINK, Tsukuba, Ibaraki 3050044, Japan; [Boukherroub, R.] Univ Lille 1, IRI, USR CNRS 3078, F-59658 Villeneuve Dascq, France; [Ravaine, S.] Univ Bordeaux, CNRS, CRPP, UPR 8641, F-33600 Pessac, France; [Mortier, M.] CNRS, Chim ParisTech, Inst Rech Chim Paris, F-75005 Paris, France; [Ohashi, N.; Saito, N.; Haneda, H.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan	Cordier, S (reprint author), Univ Rennes 1, CNRS, UMR 6226, Inst Sci Chim Rennes, Campus Beaulieu, F-35042 Rennes, France.	stephane.cordier@univ-rennes1.fr; fabien.grasset@univ-rennes1.fr; yann.molard@univ-rennes1.fr	Mortier, Michel/G-4417-2015; GRASSET, Fabien/A-7609-2008	Mortier, Michel/0000-0002-1288-7468; GRASSET, Fabien/0000-0002-4911-0214	YCIS-NIMS; UR1; CNRS; Region Bretagne; ANR [CLUSTOP-11-BS08-013-01, CLUSTOMESOGEN-13-BS07-0003-01]	We are grateful to T. Aubert, C. Neaime, N. Nerambourg, J.F. Dechezelles, M. A. Shestopalov, A. Y. Ledneva, O.A. Efremova and F. Dorson who made a part of their PhD or post-doc work on this research topic. The authors thank Dr. P. Gredin from University of Paris 6-France, Dr. G. Patriarche at Laboratoire de Photonique et de Nanostructures (LPN-CNRS), Prof. G. Ferey and Dr C. Serre from Institut Lavoisier Versailles, Prof. S. L. Jain from Chemical Sciences Division, CSIR-Indian Institute of Petroleum Mohkampur, Prof. K. Kimoto and Prof. Y. Bando from NIMS and MANA-NIMS, Prof. G. Saito and Dr Y. Yoshida from Faculty of Agriculture, Meijo University, Shiogamaguchi for very fruitful collaborations. These works have been supported by YCIS-NIMS, UR1, CNRS, Region Bretagne and ANR (CLUSTOP-11-BS08-013-01; CLUSTOMESOGEN-13-BS07-0003-01).	Amela-Cortes M., 2014, CHEM-EUR J, V20, P8561; Robinson LM, 1996, J COORD CHEM, V37, P119, DOI 10.1080/00958979608023545; Gross S, 2003, J NON-CRYST SOLIDS, V322, P154, DOI 10.1016/S0022-3093(03)00196-0; MAVERICK AW, 1981, J AM CHEM SOC, V103, P1298, DOI 10.1021/ja00395a088; Eastoe J, 2000, CHEM MATER, V12, P3533, DOI 10.1021/cm001096z; Vrbanic D, 2004, NANOTECHNOLOGY, V15, P635, DOI 10.1088/0957-4484/15/5/039; Naumov NG, 2003, SOLID STATE SCI, V5, P1359, DOI 10.1016/S1293-2558(03)00193-6; Dechezelles JF, 2010, PHYS CHEM CHEM PHYS, V12, P11993, DOI 10.1039/c0cp00129e; Tanaka K, 2014, ADV POWDER TECHNOL, V25, P101, DOI 10.1016/j.apt.2013.07.002; Naumov NG, 2005, SOLID STATE SCI, V7, P1517, DOI 10.1016/j.solidstatesciences.2005.08.022; Fontaine B, 2011, NEW J CHEM, V35, P2245, DOI 10.1039/c1nj20377k; Aubert T, 2013, PART PART SYST CHAR, V30, P90, DOI 10.1002/ppsc.201200047; Fabre B, 2009, J PHYS CHEM C, V113, P17437, DOI 10.1021/jp903205a; Duguet E, 2006, B MATER SCI, V29, P581, DOI 10.1007/s12034-006-0007-0; Kibsgaard J, 2014, NAT CHEM, V6, P248, DOI [10.1038/nchem.1853, 10.1038/NCHEM.1853]; Remskar M, 2007, ADV MATER, V19, P4276, DOI 10.1002/adma.200701784; Masse P, 2006, CHEM PHYS LETT, V422, P251, DOI 10.1016/j.cplett.2006.02.074; Bunzli JCG, 2010, J RARE EARTH, V28, P824, DOI 10.1016/S1002-0721(09)60208-8; Cordier S, 2009, J CLUST SCI, V20, P9, DOI 10.1007/s10876-008-0224-3; Naito M, 2012, ANGEW CHEM INT EDIT, V51, P10751, DOI 10.1002/anie.201203360; Nicolosi V, 2005, J PHYS CHEM B, V109, P7124, DOI 10.1021/jp045166r; Aubert T, 2013, J PHYS CHEM C, V117, P20154, DOI 10.1021/jp405836q; Saito G, 2012, J MATER CHEM, V22, P19774, DOI 10.1039/c2jm33086e; Vivero-Escoto JL, 2012, CHEM SOC REV, V41, P2673, DOI 10.1039/c2cs15229k; Zhang CM, 2012, CHEM SOC REV, V41, P7938, DOI 10.1039/c2cs35215j; Aubert T, 2010, LANGMUIR, V26, P18512, DOI 10.1021/la103784v; MacDonald WA, 2004, J MATER CHEM, V14, P4, DOI 10.1039/b310846p; CHEVREL R, 1971, J SOLID STATE CHEM, V3, P515, DOI 10.1016/0022-4596(71)90095-8; Adamenko OA, 2002, RUSS CHEM B+, V51, P994, DOI 10.1023/A:1019609601612; Ferey G, 2004, ANGEW CHEM INT EDIT, V43, P6296, DOI 10.1002/anie.200460592; Molard Y, 2013, ADV FUNCT MATER, V23, P4821, DOI 10.1002/adfm.201300417; Perrin A, 2012, CR CHIM, V15, P815, DOI 10.1016/j.crci.2012.07.004; Jin RC, 2010, NANOSCALE, V2, P343, DOI 10.1039/b9nr00160c; Grasset F, 2002, LANGMUIR, V18, P8209, DOI 10.1021/la020322b; Grasset F, 2008, ADV MATER, V20, P143, DOI 10.1002/adma.200701686; Cario L, 2010, ADV MATER, V22, P5193, DOI 10.1002/adma.201002521; Masse P, 2008, ADV MATER, V20, P584, DOI 10.1002/adma.200700628; Hemmer E, 2013, NANOSCALE, V5, P11339, DOI 10.1039/c3nr02286b; Joly-Pottuz L, 2005, TRIBOL LETT, V18, P385, DOI 10.1007/s11249-004-2769-0; Shang L, 2011, NANO TODAY, V6, P401, DOI 10.1016/j.nantod.2011.06.004; Li Z, 2014, J MATER CHEM B, V2, P2793, DOI 10.1039/c3tb21760d; Kamiguchi S, 2006, J MOL CATAL A-CHEM, V260, P43, DOI 10.1016/j.molcata.2006.06.050; Moraru B, 2002, CHEM MATER, V14, P2732, DOI 10.1021/cm021113f; Bisoyi HK, 2011, CHEM SOC REV, V40, P306, DOI 10.1039/b901793n; Domenici V, 2011, J MATER SCI, V46, P3639, DOI 10.1007/s10853-011-5280-7; Ferey G, 2005, SCIENCE, V309, P2040, DOI 10.1126/science.1116275; Wang JS, 2014, NANOSCALE, V6, P4418, DOI 10.1039/c3nr06025j; Binnemans K, 2009, CHEM REV, V109, P4283, DOI 10.1021/cr8003983; WESSEL GJ, 1957, ACTA CRYSTALLOGR, V10, P466, DOI 10.1107/S0365110X57001577; Feldmann C, 2003, ADV FUNCT MATER, V13, P511, DOI 10.1002/adfm.200301005; Amela-Cortes M, 2014, J MATER CHEM C, V2, P1545, DOI 10.1039/c3tc31309c; Ariga K, 2014, CHEM LETT, V43, P36, DOI 10.1246/cl.130987; Liu R, 2011, CHEM COMMUN, V47, P1384, DOI 10.1039/c0cc03158e; Dybtsev D, 2010, LANGMUIR, V26, P11283, DOI 10.1021/la100601a; Peric B, 2011, CHEM-EUR J, V17, P6263, DOI 10.1002/chem.201002332; Demont A, 2013, CHEM-EUR J, V19, P12711, DOI 10.1002/chem.201300777; Ghosh RN, 1999, APPL PHYS LETT, V75, P2885, DOI 10.1063/1.125180; Lopez-Quintela MA, 2003, CURR OPIN COLLOID IN, V8, P137, DOI 10.1016/S1359-0294(03)00019-0; POTEL M, 1980, J SOLID STATE CHEM, V35, P286, DOI 10.1016/0022-4596(80)90505-8; Masse P, 2009, J PHYS CHEM C, V113, P14487, DOI 10.1021/jp903651m; COTTON FA, 1964, INORG CHEM, V3, P1217, DOI 10.1021/ic50019a003; Barras A, 2012, APPL CATAL B-ENVIRON, V123, P1, DOI 10.1016/j.apcatb.2012.04.006; Guo ZQ, 2014, CHEM SOC REV, V43, P16, DOI 10.1039/c3cs60271k; Holder E, 2008, J MATER CHEM, V18, P1064, DOI 10.1039/b712176h; Mocanu AS, 2011, CHEM COMMUN, V47, P2056, DOI 10.1039/c0cc05012a; Adamenko OA, 2001, DOKL PHYS CHEM, V381, P275, DOI 10.1023/A:1012948111002; Kumar P, 2014, RSC ADV, V4, P10420, DOI 10.1039/c3ra47255h; Mihailovic D, 2009, PROG MATER SCI, V54, P309, DOI 10.1016/j.pmatsci.2008.09.001; Cordier S, 2004, INORG CHEM, V43, P219, DOI 10.1021/ic034443q; Roullier V, 2008, CHEM MATER, V20, P6657, DOI 10.1021/cm801423r; Turner M, 2008, NATURE, V454, P981, DOI 10.1038/nature07194; GOLDEN JH, 1995, SCIENCE, V268, P1463, DOI 10.1126/science.268.5216.1463; Nerambourg N, 2014, J COLLOID INTERF SCI, V424, P132, DOI 10.1016/j.jcis.2014.03.008; Barras A, 2013, APPL CATAL B-ENVIRON, V130, P270, DOI 10.1016/j.apcatb.2012.11.017; Lu YZ, 2012, CHEM SOC REV, V41, P3594, DOI 10.1039/c2cs15325d; MAVERICK AW, 1983, J AM CHEM SOC, V105, P1878, DOI 10.1021/ja00345a034; Weiss PS, 2007, ACS NANO, V1, P1, DOI 10.1021/nn700131b; Molard Y, 2010, ANGEW CHEM INT EDIT, V49, P3351, DOI 10.1002/anie.201000325; Pilet G, 2003, SOLID STATE SCI, V5, P1263, DOI 10.1016/S1293-2558(03)00143-2; Kirakci K, 2005, J SOLID STATE CHEM, V178, P3117, DOI 10.1016/j.jssc.2005.07.026; Cordier S, 2006, INORG CHIM ACTA, V359, P1705, DOI 10.1016/j.ica.2005.07.044; Ariga K., 2012, B CHEM SOC JPN, V85, P132; Aubert T., 2010, J COLLOID INTERF SCI, V341, P301; Barrier N, 2009, INORG CHEM, V48, P3848, DOI 10.1021/ic801942d; BRUCE DW, 1994, ADV MATER, V6, P699, DOI 10.1002/adma.19940060920; Contag CH, 2002, J MAGN RESON IMAGING, V16, P378, DOI 10.1002/jmri.10178; CONVERSE JG, 1970, INORG CHEM, V9, P1361, DOI 10.1021/ic50088a013; Cordier S, 2010, J PHYS CHEM C, V114, P18622, DOI 10.1021/jp1071007; Cordier S, 2015, J CLUST SCI, V26, P53, DOI 10.1007/s10876-014-0734-0; Dassenoy F, 2007, J EUR CERAM SOC, V27, P915, DOI [10.1016/j.jeurceramsoc.2006.04.137, 10.1016/j.jeureramsoc.2006.04.137]; Date RW, 2003, DALTON T, P1914, DOI 10.1039/b212610a; Doyle JJ, 2007, CHEM PHYS LETT, V435, P109, DOI 10.1016/j.cplett.2006.12.053; Gao L, 2010, CHEM MATER, V22, P6240, DOI 10.1021/cm101609p; Golubeva ND, 2004, INORG MATER+, V40, P306, DOI 10.1023/B:INMA.0000020534.96346.55; Grasset F, 2006, J COLLOID INTERF SCI, V299, P726, DOI 10.1016/j.jcis.2006.02.028; Grasset F, 2008, CHEM COMMUN, P4729, DOI 10.1039/b806919k; Jackson JA, 1996, CHEM MATER, V8, P558, DOI 10.1021/cm950443f; Kamiguchi S, 2003, CATAL LETT, V85, P97, DOI 10.1023/A:1022129126499; Kirakci K, 2006, J SOLID STATE CHEM, V179, P3628, DOI 10.1016/j.jssc.2006.07.030; Kramer KW, 2001, Z ANORG ALLG CHEM, V627, P2511, DOI 10.1002/1521-3749(200111)627:11<2511::AID-ZAAC2511>3.0.CO;2-J; KRUSIC PJ, 1991, J AM CHEM SOC, V113, P2322, DOI 10.1021/ja00006a072; Llusar R, 2010, COORDIN CHEM REV, V254, P1534, DOI 10.1016/j.ccr.2009.12.026; McCarthy DN, 2007, J APPL PHYS, V101, DOI 10.1063/1.2405322; Mery D, 2005, CR CHIM, V8, P1789, DOI 10.1016/j.crci.2005.02.023; MICHAS J, 1989, LIQ CRYST, V5, P1737, DOI 10.1080/02678298908045684; Murray R.W., 2008, CHEM REV, V108, P2705; Murugan P, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2920437; Nagarajan S, 2010, MED BIOL ENG COMPUT, V48, P1033, DOI 10.1007/s11517-010-0618-x; Nagashima S, 2013, APPL CATAL A-GEN, V450, P50, DOI 10.1016/j.apcata.2012.09.053; Neaime Chrystelle, 2014, Key Engineering Materials, V617, DOI 10.4028/www.scientific.net/KEM.617.174; Nicolosi V, 2005, CHEM PHYS LETT, V401, P13, DOI 10.1016/j.cplett.2004.11.006; NOCERA DG, 1984, J AM CHEM SOC, V106, P824, DOI 10.1021/ja00315a079; Perrin C., 1983, J CHEM RES S, V5, P38; Perrin C., 1997, J ALLOY COMPD, P263; Prabusankar G, 2009, EUR J INORG CHEM, P2153, DOI 10.1002/ejic.200900136; Saez IM, 2008, STRUCT BOND, V128, P1, DOI 10.1007/430_2007_077; Shestopalov MA, 2011, ANGEW CHEM INT EDIT, V50, P7300, DOI 10.1002/anie.201101986; Stranger R., 2001, INORG CHEM, V40, P17; Sun HT, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/1/014205; Tschierske C, 2013, ANGEW CHEM INT EDIT, V52, P8828, DOI 10.1002/anie.201300872; Vengust D, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075106; Xu H.X., 2010, ADV MATER, V22, P3209; Yoshida Y, 2014, EUR J INORG CHEM, P3871, DOI 10.1002/ejic.201400119; Yoshimura T, 2011, INORG CHEM, V50, P9918, DOI 10.1021/ic2010858	124	12	12	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1574-1443	1574-1451		J INORG ORGANOMET P	J. Inorg. Organomet. Polym. Mater.	MAR	2015	25	2					189	204		10.1007/s10904-014-0112-2		16	Polymer Science	Polymer Science	CC4XX	WOS:000350360500003		
J	Takada, K; Ohta, N; Tateyama, Y				Takada, Kazunori; Ohta, Narumi; Tateyama, Yoshitaka			Recent Progress in Interfacial Nanoarchitectonics in Solid-State Batteries	JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS			English	Article						Solid-state lithium battery; Interface; Nanoionics; Space-charge layer; Sulfide electrolyte	LITHIUM SECONDARY BATTERIES; IONIC-CONDUCTIVITY; CATHODE MATERIALS; SINGLE-CRYSTALS; TANTALUM OXIDE; ELECTROLYTE; TITANATE; GLASSES; DENSIFICATION; PERFORMANCE	Employing solid electrolytes in lithium-ion batteries is anticipated to be a solution to some issues originated from their organic electrolytes. However, solid-state lithium batteries had not been practicable, because ionic conductivities of lithium-ion conductive solid electrolytes had been very low. Therefore, many studies aiming at the development of solid-state lithium batteries have been focused on enhancement of ionic transport in solids. They have succeeded in enhancing the conductivity to be comparable to or even higher than that of liquids. At this stage, rate-determining step of the battery reactions is sometimes ionic transport at interface rather than bulk in the battery components. Since anomalous ionic conduction at the interface takes place in space-charge layers with ca. 10 nm in thickness, it will be controlled by "nanoarchitectonics". This paper reviews some interfacial nanoarchitectures that control the interfacial ionic conduction to enhance the performance of solid-state lithium batteries.	[Takada, Kazunori; Ohta, Narumi; Tateyama, Yoshitaka] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan	Takada, K (reprint author), Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan.	takada.kazunori@nims.go.jp	Ohta, Narumi/B-7239-2008	Ohta, Narumi/0000-0002-6353-4806			MERCIER R, 1981, SOLID STATE IONICS, V5, P663, DOI 10.1016/0167-2738(81)90341-6; Yada C, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301416; Sakuda A, 2013, J CERAM SOC JPN, V121, P946, DOI 10.2109/jcersj2.121.957; Song MK, 2011, MAT SCI ENG R, V72, P203, DOI 10.1016/j.mser.2011.06.001; Osada M, 2009, J MATER CHEM, V19, P2503, DOI 10.1039/b820160a; Wang YG, 2010, NANOSCALE, V2, P1294, DOI 10.1039/c0nr00068j; Seino Y, 2014, ENERG ENVIRON SCI, V7, P627, DOI 10.1039/c3ee41655k; Kobayashi Y, 1999, J POWER SOURCES, V81, P853, DOI 10.1016/S0378-7753(99)00121-4; Kanno R, 2001, J ELECTROCHEM SOC, V148, pA742, DOI 10.1149/1.1379028; Aatiq A, 2002, J MATER CHEM, V12, P2971, DOI 10.1039/b203652p; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; WHITTINGHAM MS, 1976, SCIENCE, V192, P1126, DOI 10.1126/science.192.4244.1126; Takada K, 2012, SOLID STATE IONICS, V225, P594, DOI 10.1016/j.ssi.2012.01.009; Ohta N, 2006, ADV MATER, V18, P2226, DOI 10.1002/adma.200502604; Kamaya N, 2011, NAT MATER, V10, P682, DOI [10.1038/nmat3066, 10.1038/NMAT3066]; MIZUSHIMA K, 1980, MATER RES BULL, V15, P783, DOI 10.1016/0025-5408(80)90012-4; Minami T, 2006, SOLID STATE IONICS, V177, P2715, DOI 10.1016/j.ssi.2006.07.017; ALPEN UV, 1977, APPL PHYS LETT, V30, P621, DOI 10.1063/1.89283; Takada K, 2008, SOLID STATE IONICS, V179, P1333, DOI 10.1016/j.ssi.2008.02.017; Ohta N, 2007, ELECTROCHEM COMMUN, V9, P1486, DOI 10.1016/j.elecom.2007.02.008; Tanaka T, 2003, CHEM MATER, V15, P3564, DOI 10.1021/cm034307j; Haruyama J, 2014, CHEM MATER, V26, P4248, DOI 10.1021/cm5016959; Ariga K, 2014, NEW J CHEM, V38, P5149, DOI 10.1039/c4nj00864b; Mizuno F, 2005, ADV MATER, V17, P918, DOI 10.1002/adma.200401286; Zheng NF, 2003, NATURE, V426, P428, DOI 10.1038/nature02159; AONO H, 1990, J ELECTROCHEM SOC, V137, P1023, DOI 10.1149/1.2086597; KENNEDY JH, 1989, MATER CHEM PHYS, V23, P29, DOI 10.1016/0254-0584(89)90015-1; Kumazaki S, 2011, ELECTROCHEM COMMUN, V13, P509, DOI 10.1016/j.elecom.2011.02.035; Kraytsberg A, 2012, ADV ENERGY MATER, V2, P922, DOI 10.1002/aenm.201200068; Nakanishi W, 2014, NANO TODAY, V9, P378, DOI 10.1016/j.nantod.2014.05.002; INAGUMA Y, 1993, SOLID STATE COMMUN, V86, P689, DOI 10.1016/0038-1098(93)90841-A; Ariga K, 2014, CHEM LETT, V43, P36, DOI 10.1246/cl.130987; Yu XH, 1997, J ELECTROCHEM SOC, V144, P524, DOI 10.1149/1.1837443; Li YQ, 2013, SOLID STATE IONICS, V253, P76, DOI 10.1016/j.ssi.2013.09.005; Miyazaki R, 2014, J POWER SOURCES, V272, P541, DOI 10.1016/j.jpowsour.2014.08.109; Klingler M, 1997, IONICS, V3, P289, DOI 10.1007/BF02375631; Cervera RB, 2014, ENERG ENVIRON SCI, V7, P662, DOI 10.1039/c3ee43306d; Inaguma Y, 2013, J POWER SOURCES, V228, P250, DOI 10.1016/j.jpowsour.2012.11.098; BOUKAMP BA, 1978, MATER RES BULL, V13, P23, DOI 10.1016/0025-5408(78)90023-5; Croguennec L, 2009, CHEM MATER, V21, P1051, DOI 10.1021/cm802954g; Fukuda K, 2007, INORG CHEM, V46, P4787, DOI 10.1021/ic7004002; MAIER J, 1995, PROG SOLID STATE CH, V23, P171, DOI 10.1016/0079-6786(95)00004-E; Ohzuku T, 1995, J ELECTROCHEM SOC, V142, P4033, DOI 10.1149/1.2048458; Pitchai R, 2011, J MATER CHEM, V21, P11040, DOI 10.1039/c1jm10857c; PRADEL A, 1989, MATER CHEM PHYS, V23, P121, DOI 10.1016/0254-0584(89)90021-7; Sakuda A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02261; Sakuda A., 2010, CHEM MATER, V22, P945; Takada K, 1998, IONICS, V4, P42, DOI 10.1007/BF02375778; Xu XX, 2011, ENERG ENVIRON SCI, V4, P3509, DOI 10.1039/c1ee01389k; Xu XX, 2011, CHEM MATER, V23, P3798, DOI 10.1021/cm103665w	50	3	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1574-1443	1574-1451		J INORG ORGANOMET P	J. Inorg. Organomet. Polym. Mater.	MAR	2015	25	2					205	213		10.1007/s10904-014-0127-8		9	Polymer Science	Polymer Science	CC4XX	WOS:000350360500004		
J	Wang, HJ; Imura, M; Malgras, V; Li, CL; Wang, L; Yamauchi, Y				Wang, Hongjing; Imura, Masataka; Malgras, Victor; Li, Cuiling; Wang, Liang; Yamauchi, Yusuke			A Solution Phase Synthesis of Dendritic Platinum Nanoelectrocatalysts with the Assistance of Polyoxyethylene Nonylphenyl Ether	JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS			English	Article						Mesoporous material; Platinum; Surfactant; Electrocatalyst; Dendrite	HIGH-INDEX FACETS; HIGHLY-ACTIVE ELECTROCATALYSTS; AQUEOUS SURFACTANT SOLUTIONS; PD BIMETALLIC NANODENDRITES; METHANOL OXIDATION; OXYGEN REDUCTION; ELECTROCHEMICAL APPLICATIONS; CARBON NANOTUBES; FACILE SYNTHESIS; GRAPHENE OXIDE	Dendritic platinum nanoparticles (DPNs) with high surface area have attractive electrocatalytic properties. We report an aqueous solution phase synthesis of DPNs in the presence of various amphiphilic molecules (including surfactants) bypassing the use of organic solvents, seeds, templates or other additives and benefiting from low temperatures and short reaction time (Wang in J Am Chem Soc 132: 13636, 2010; Wang in J Am Chem Soc 133: 9674, 2011; Wang in J Am Chem Soc 135: 16762, 2013). Here we extend this concept to develop an economical and effective solution phase synthesis of DPNs by a simple one-step method with the assistance of polyoxyethylene nonylphenyl ether. The developed strategy remarkably simplifies the synthetic procedures compared to the reported ones. The obtained DPNs exhibit enhanced catalytic activity during methanol oxidation reaction in comparison with the commercially available platinum black. Here we report an aqueous solution phase synthesis for dendritic platinum nanoparticles (DPNs) with a high surface area in the presence of polyoxyethylene nonylphenyl ether.	[Wang, Hongjing; Wang, Liang] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Imura, Masataka; Malgras, Victor; Li, Cuiling; Yamauchi, Yusuke] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, World Premier Int WPI Res Ctr, Tsukuba, Ibaraki 3050044, Japan	Wang, L (reprint author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China.	wangliang@ciac.ac.cn; Yamauchi.Yusuke@nims.go.jp	Malgras, Victor/A-8221-2015; Wang, Hongjing/F-2800-2012; Yamauchi, Yusuke/D-2780-2015	Malgras, Victor/0000-0002-5667-9118; 	National Natural Science Foundation of China [21273218]; Japan Society for the Promotion of Science (JSPS) [26708028]; Japanese-Taiwanese Cooperative Program of the Japan Science and Technology Agency (JST); Canon Foundation	This work was supported by the National Natural Science Foundation of China (No. 21273218). This research was partially supported by the Grant-in-Aid for Young Scientists A (Research Project Number: 26708028) of the Japan Society for the Promotion of Science (JSPS), Japanese-Taiwanese Cooperative Program of the Japan Science and Technology Agency (JST), and The Canon Foundation.	Lim B, 2011, ANGEW CHEM INT EDIT, V50, P76, DOI 10.1002/anie.201002024; Mohanty A, 2010, ANGEW CHEM INT EDIT, V49, P4962, DOI 10.1002/anie.201000902; Yamauchi Y, 2013, J CERAM SOC JPN, V121, P831, DOI 10.2109/jcersj2.121.831; Li CL, 2013, ANGEW CHEM INT EDIT, V52, P8050, DOI 10.1002/anie.201303035; Yu T, 2011, ANGEW CHEM INT EDIT, V50, P2773, DOI 10.1002/anie.201007859; Wang L, 2011, CHEM-EUR J, V17, P8810, DOI 10.1002/chem.201100386; Kim C, 2010, ELECTROCHEM COMMUN, V12, P1596, DOI 10.1016/j.elecom.2010.09.004; Ataee-Esfahani H, 2013, ANGEW CHEM INT EDIT, V52, P13611, DOI 10.1002/anie.201307126; Zhao X, 2012, J MATER CHEM, V22, P19718, DOI 10.1039/c2jm33926a; Teng XW, 2006, SMALL, V2, P249, DOI 10.1002/smll.200500244; Xu Y, 2014, CHEM SOC REV, V43, P2439, DOI 10.1039/c3cs60351b; Wu JB, 2013, ACCOUNTS CHEM RES, V46, P1848, DOI 10.1021/ar300359w; Wang L, 2013, J AM CHEM SOC, V135, P16762, DOI 10.1021/ja407773x; Wang HJ, 2011, J AM CHEM SOC, V133, P14526, DOI 10.1021/ja2058617; Zheng SF, 2007, J PHYS CHEM C, V111, P11174, DOI 10.1021/jp0727042; Surendran G, 2007, CHEM MATER, V19, P5045, DOI 10.1021/cm071672s; Xiao J, 2013, J AM CHEM SOC, V135, P18754, DOI 10.1021/ja410583b; Wang L, 2012, ACS APPL MATER INTER, V4, P2865, DOI 10.1021/am300574e; Guo SJ, 2010, ACS NANO, V4, P547, DOI 10.1021/nn9014483; Chen XM, 2012, J MATER CHEM, V22, P11284, DOI 10.1039/c2jm31133j; Kuang YJ, 2011, ELECTROCHIM ACTA, V56, P8645, DOI 10.1016/j.electacta.2011.07.070; Xia BY, 2012, ANGEW CHEM INT EDIT, V51, P7213, DOI 10.1002/anie.201201553; Guo SJ, 2013, ANGEW CHEM INT EDIT, V52, P8526, DOI 10.1002/anie.201207186; Kang Y, 2013, J AM CHEM SOC, V135, P2741, DOI 10.1021/ja3116839; Wu BH, 2009, ANGEW CHEM INT EDIT, V48, P4751, DOI 10.1002/anie.200900899; Song Y, 2007, NANO LETT, V7, P3650, DOI 10.1021/nl0719123; Porter NS, 2013, ACCOUNTS CHEM RES, V46, P1867, DOI 10.1021/ar3002238; Lin ZH, 2009, CHEM-EUR J, V15, P4656, DOI 10.1002/chem.200802457; Xia BY, 2013, ANGEW CHEM INT EDIT, V52, P12337, DOI 10.1002/anie.201307518; Shen QM, 2008, J PHYS CHEM C, V112, P16385, DOI 10.1021/jp8060043; Ariga K, 2014, CHEM LETT, V43, P36, DOI 10.1246/cl.130987; Cheong S, 2009, J AM CHEM SOC, V131, P14590, DOI 10.1021/ja9065688; Wang HJ, 2012, CHEM MATER, V24, P1591, DOI 10.1021/cm300054b; Ariga K, 2012, B CHEM SOC JPN, V85, P1, DOI 10.1246/bcsj.20110162; Wang L, 2011, J AM CHEM SOC, V133, P9674, DOI 10.1021/ja202655j; Guo SJ, 2008, CHEM-EUR J, V14, P4689, DOI 10.1002/chem.200800077; Sun SH, 2010, CHEM-EUR J, V16, P829, DOI 10.1002/chem.200902320; An K, 2013, J AM CHEM SOC, V135, P16689, DOI 10.1021/ja4088743; Xia BY, 2014, SMALL, V10, P2336, DOI 10.1002/smll.201302648; Wang HL, 2013, NANO LETT, V13, P2976, DOI 10.1021/nl401568x; Wang L, 2010, J AM CHEM SOC, V132, P13636, DOI 10.1021/ja105640p; Yu XQ, 2014, NANOSCALE, V6, P4806, DOI 10.1039/c4nr00180j; Wang HJ, 2012, J AM CHEM SOC, V134, P10819, DOI 10.1021/ja303773z; Han XP, 2014, ADV MATER, V26, P2047, DOI 10.1002/adma.201304867; Huang XQ, 2011, J AM CHEM SOC, V133, P4718, DOI 10.1021/ja1117528; Martinez Rodriguez R.A., 2014, J AM CHEM SOC, V136, P1280	46	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1574-1443	1574-1451		J INORG ORGANOMET P	J. Inorg. Organomet. Polym. Mater.	MAR	2015	25	2					245	250		10.1007/s10904-014-0133-x		6	Polymer Science	Polymer Science	CC4XX	WOS:000350360500007		
J	Rajendran, R; Shrestha, LK; Kumar, RM; Jayavel, R; Hill, JP; Ariga, K				Rajendran, Raja; Shrestha, Lok Kumar; Kumar, Rangasamy Mohan; Jayavel, Ramasamy; Hill, Jonathan P.; Ariga, Katsuhiko			Composite Nanoarchitectonics for Ternary Systems of Reduced Graphene Oxide/Carbon Nanotubes/Nickel Oxide with Enhanced Electrochemical Capacitor Performance	JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS			English	Article						Carbon nanostructures; NiO; Ternary nanocomposite; Electrochemical properties	WALLED CARBON NANOTUBES; ENERGY-STORAGE; SUPERCAPACITOR APPLICATIONS; PHOTOCATALYTIC ACTIVITY; ELECTRODE MATERIALS; NANOPOROUS CARBONS; HYBRID; NANOSTRUCTURES; DENSITY; NANOMATERIALS	Ternary nanocomposite composed of nickel oxide (NiO), multi-walled carbon nanotubes (CNTs), and reduced graphene oxide (RGO) was synthesized based on concept of nanoarchitectonics. During the solvothermal process, graphite oxide was reduced to RGO with concurrent uniform deposition of NiO nanoparticles on the surface of the RGO nanosheets and CNTs. Scanning and transmission electron microscopy observations revealed the uniform distribution of spherical NiO nanocrystals (average size 35 nm) on the CNTs and RGO. The electrochemical performances of NiO and the RGO/CNT/NiO ternary nanocomposite were evaluated by using cyclic voltammetry and chronopotentiometry techniques. A maximum specific capacitance of 367 F g(-1) was achieved for the ternary nanocomposite at a current density of 1 A g(-1) in 6 M KOH electrolyte, which is about 2.2 times greater than that of pristine NiO demonstrating a strong synergistic effect in this RGO/CNT/NiO ternary nanocomposite. Additionally, the ternary nanocomposite electrode showed excellent cycling stability retaining 94 % of the initial capacity after 1,000 cycles.	[Rajendran, Raja; Shrestha, Lok Kumar; Hill, Jonathan P.; Ariga, Katsuhiko] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan; [Rajendran, Raja; Jayavel, Ramasamy] Anna Univ, Ctr Nanosci & Technol, Madras 600025, Tamil Nadu, India; [Kumar, Rangasamy Mohan] Presidency Coll, Dept Phys, Madras 600005, Tamil Nadu, India; [Hill, Jonathan P.; Ariga, Katsuhiko] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020076, Japan	Shrestha, LK (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	SHRESTHA.Lokkumar@nims.go.jp; ARIGA.Katsuhiko@nims.go.jp	ARIGA, Katsuhiko/H-2695-2011		World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan; Core Research for Evolutionary Science and Technology (CREST) program of Japan Science and Technology Agency (JST), Japan; National Institute for Materials Science (NIMS), Japan; Anna University, India; Japan Society for the Promotion of Science (JSPS) [25790021]	This work was partly supported by World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan and the Core Research for Evolutionary Science and Technology (CREST) program of Japan Science and Technology Agency (JST), Japan. RR thanks National Institute for Materials Science (NIMS), Japan and Anna University, India for the internship award. LKS thanks the Japan Society for the Promotion of Science (JSPS) for the Grants-in-Aid for Young Scientists B (25790021).	Tan YB, 2013, J MATER CHEM A, V1, P14814, DOI 10.1039/c3ta12193c; Zhang BA, 2011, CARBON, V49, P4524, DOI 10.1016/j.carbon.2011.06.059; Rakhi RB, 2011, J POWER SOURCES, V196, P8858, DOI 10.1016/j.jpowsour.2011.06.038; Zhai YP, 2011, ADV MATER, V23, P4828, DOI 10.1002/adma.201100984; Shah MSAS, 2013, NANOSCALE, V5, P5093, DOI 10.1039/c3nr00579h; Zhao X, 2012, ACS NANO, V6, P5404, DOI 10.1021/nn3012916; Cao JY, 2013, CARBON, V56, P389, DOI 10.1016/j.carbon.2012.12.075; Yan JA, 2010, ACS NANO, V4, P4247, DOI 10.1021/nn100592d; Zhou GM, 2012, ACS NANO, V6, P3214, DOI 10.1021/nn300098m; Xia XH, 2014, NANOSCALE, V6, P5008, DOI 10.1039/c4nr00024b; Gao Z, 2013, ENERG FUEL, V27, P568, DOI 10.1021/ef301795g; Chen S, 2010, ACS NANO, V4, P2822, DOI 10.1021/nn901311t; Ramanathan M, 2013, PHYS CHEM CHEM PHYS, V15, P10580, DOI 10.1039/c3cp50620g; Bose S, 2012, J MATER CHEM, V22, P767, DOI 10.1039/c1jm14468e; Wang L, 2013, J MATER CHEM A, V1, P8385, DOI 10.1039/c3ta10237h; Torad NL, 2014, CHEM-EUR J, V20, P7895, DOI 10.1002/chem.201400089; Perera SD, 2012, J POWER SOURCES, V215, P1, DOI 10.1016/j.jpowsour.2012.04.059; Ariga K, 2011, J NANOSCI NANOTECHNO, V11, P1, DOI 10.1166/jnn.2011.3839; Tan SM, 2014, PHYS CHEM CHEM PHYS, V16, P7058, DOI 10.1039/c4cp00371c; Wang Y, 2011, DALTON T, V40, P6388, DOI 10.1039/c1dt10397k; Ariga K, 2013, CHEM SOC REV, V42, P6322, DOI 10.1039/c2cs35475f; Yin ZG, 2012, ADV ENERGY MATER, V2, P179, DOI 10.1002/aenm.201100560; Jiang H, 2013, ENERG ENVIRON SCI, V6, P41, DOI 10.1039/c2ee23284g; Ariga K, 2014, NEW J CHEM, V38, P5149, DOI 10.1039/c4nj00864b; Cheng Q, 2011, PHYS CHEM CHEM PHYS, V13, P17615, DOI 10.1039/c1cp21910c; Kim YT, 2005, J MATER CHEM, V15, P4914, DOI 10.1039/b511869g; Izadi-Najafabadi A, 2010, ADV MATER, V22, pE235, DOI 10.1002/adma.200904349; Shrestha LK, 2013, CHEM-ASIAN J, V8, P1662, DOI 10.1002/asia.201300247; Xiao Y, 2012, J ELECTROANAL CHEM, V684, P32, DOI 10.1016/j.jelechem.2012.08.024; Ariga K, 2012, J MATER CHEM, V22, P2369, DOI 10.1039/c1jm14101e; Salunkhe RR, 2014, CHEM-EUR J, V20, P3084, DOI 10.1002/chem.201303652; Yu GH, 2013, NANO ENERGY, V2, P213, DOI 10.1016/j.nanoen.2012.10.006; Hu H, 2005, J PHYS CHEM B, V109, P11520, DOI 10.1021/jp050781w; Vivekchand SRC, 2008, J CHEM SCI, V120, P9, DOI 10.1007/s12039-008-0002-7; Nakanishi W, 2014, NANO TODAY, V9, P378, DOI 10.1016/j.nantod.2014.05.002; Ariga K, 2014, CHEM LETT, V43, P36, DOI 10.1246/cl.130987; Xiao YH, 2012, ADV FUNCT MATER, V22, P4052, DOI 10.1002/adfm.201200519; Jeong MG, 2013, J POWER SOURCES, V244, P806, DOI 10.1016/j.jpowsour.2012.12.037; Sun L, 2012, NANOSCALE, V4, P613, DOI 10.1039/c1nr11411e; Peng LL, 2013, NANO LETT, V13, P2151, DOI 10.1021/nl400600x; Bai Y, 2014, J MATER CHEM A, V2, P3834, DOI 10.1039/c3ta15004f; Bastakoti BP, 2014, PHYS CHEM CHEM PHYS, V16, P10425, DOI 10.1039/c4cp01118j; Ariga K, 2012, B CHEM SOC JPN, V85, P1, DOI 10.1246/bcsj.20110162; Zhang LL, 2009, CHEM SOC REV, V38, P2520, DOI 10.1039/b813846j; Peng LW, 2012, J PHYS CHEM C, V116, P4970, DOI 10.1021/jp209180j; Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y; Kaempgen M, 2009, NANO LETT, V9, P1872, DOI 10.1021/nl8038579; Salunkhe RR, 2014, CHEMSUSCHEM, V7, P1551, DOI 10.1002/cssc.201400147; Chaikittisilp W, 2013, J MATER CHEM A, V1, P14, DOI 10.1039/c2ta00278g; Liang RL, 2011, J MATER CHEM, V21, P17654, DOI 10.1039/c1jm13934g; Pech D, 2010, NAT NANOTECHNOL, V5, P651, DOI [10.1038/nnano.2010.162, 10.1038/NNANO.2010.162]; Lota G, 2011, ENERG ENVIRON SCI, V4, P1592, DOI 10.1039/c0ee00470g; Zheng C, 2012, CARBON, V50, P5167, DOI 10.1016/j.carbon.2012.06.058; Ariga K, 2012, NPG ASIA MATER, V4, DOI 10.1038/am.2012.30; Chua K., 2014, CHEM SOC REV, V43, P291; Liu C, 2010, ADV MATER, V22, pE28, DOI 10.1002/adma.200903328; Liu Y.L.L., 2010, J PHYS CHEM C, V114, P251; Meryl S.D., 2008, NANO LETT, V8, P3498; Reit R, 2013, ELECTROCHIM ACTA, V91, P96, DOI 10.1016/j.electacta.2012.12.058; Shrestha LK, 2013, J AM CHEM SOC, V135, P586, DOI 10.1021/ja3108752; Sofer Z., 2014, ACS NANO, V7, P7106; Zhong-Shuai W.R. Wu, 2010, ACS NANO, V4, P5835	62	4	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1574-1443	1574-1451		J INORG ORGANOMET P	J. Inorg. Organomet. Polym. Mater.	MAR	2015	25	2					267	274		10.1007/s10904-014-0102-4		8	Polymer Science	Polymer Science	CC4XX	WOS:000350360500010		
J	Horiuchi, K; Matsumoto, T; Ota, Y; Kasuga, E; Negishi, T; Yaguchi, T; Sugano, M; Honda, T				Horiuchi, Kazuld; Matsumoto, Takehisa; Ota, Yusuke; Kasuga, Eriko; Negishi, Tatsuya; Yaguchi, Tomomi; Sugano, Mitsutoshi; Honda, Takayuki			Addition of thymidine to culture media for accurate examination of thymidine-dependent small-colony variants of methicillin-resistant Staphylococcus aureus: A pilot study	JOURNAL OF MICROBIOLOGICAL METHODS			English	Article						MRSA screening media; Thymidine; TD-SCVs of MRSA	CYSTIC-FIBROSIS; RECURRENT INFECTIONS; PERSISTENT; TRIMETHOPRIM; SULFAMETHOXAZOLE; IDENTIFICATION; CEFOXITIN; PHENOTYPE; OXACILLIN; STRAINS	Small-colony variants (SCVs) are slow-growing subpopulations of various auxotrophic bacterial strains. Thymidine-dependent SCVs (TD-SCVs) are unable to synthesize thymidine; hence, these variants fail to grow in a medium without thymidine. In this study, we used 10 TD-SCVs of Staphylococcus aureus, of which four strains possessed mecA. We compared the efficacy of a newly modified medium containing thymidine for the detection of TD-SCVs of methicillin-resistant S. aureus (MRSA) to the efficacy of routinely used laboratory media. We observed that none of the 10 TD-SCVs of S. aureus grew in Mueller-Hinton agar, and four TD-SCVs of MRSA failed to grow on all MRSA screening media, except for the ChromID (TM) MRSA medium. Laboratory tests conducted using medium with thymidine incorporated showed that thymidine did not affect the minimum inhibitory concentrations of oxacillin and cefoxitin for clinical isolates of S. aureus, and was able to detect MRSA, including TD-SCVs. These findings showed that thymidine-incorporated media are able to detect TD-SCVs of MRSA without altering the properties of other clinically isolated MRSA strains. (C) 2015 Elsevier B.V. All rights reserved.	[Horiuchi, Kazuld; Matsumoto, Takehisa; Kasuga, Eriko; Negishi, Tatsuya; Yaguchi, Tomomi; Sugano, Mitsutoshi; Honda, Takayuki] Shinshu Univ Hosp, Dept Lab Med, Matsumoto, Nagano 3908621, Japan; [Ota, Yusuke] Shinshu Univ, Sch Med, Sch Hlth Sci, Dept Biomed Lab Sci, Matsumoto, Nagano 390, Japan	Matsumoto, T (reprint author), Shinshu Univ Hosp, Dept Lab Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	ggatcc@shinshu-u.ac.jp			JSPS KAKENHI [26931039]	This work was supported by JSPS KAKENHI Grant Number 26931039.	Seifert H, 1999, EMERG INFECT DIS, V5, P450; Besier S, 2007, INT J MED MICROBIOL, V297, P217, DOI 10.1016/j.ijmm.2007.02.003; Melter O, 2010, FOLIA MICROBIOL, V55, P548, DOI 10.1007/s12223-010-0089-3; vonEiff C, 1997, CLIN INFECT DIS, V25, P1250, DOI 10.1086/516962; Seifert H, 2003, EMERG INFECT DIS, V9, P1316; Neilan BA, 1997, INT J SYST BACTERIOL, V47, P693; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Kipp F, 2003, J NEUROL NEUROSUR PS, V74, P1000, DOI 10.1136/jnnp.74.7.1000; Kipp F, 2004, J CLIN MICROBIOL, V42, P1277, DOI 10.1128/JCM.42.3.1277-1279.2004; Kahl BC, 2003, J CLIN MICROBIOL, V41, P410, DOI 10.1128/JCM.41.1.410-413.2003; Kahl BC, 2003, J CLIN MICROBIOL, V41, P4424, DOI 10.1128/JCM.41.9.4424-4427.2003; Kahl B, 1998, J INFECT DIS, V177, P1023; Proctor RA, 1998, CLIN INFECT DIS, V27, pS68; Chatterjee I, 2008, J BACTERIOL, V190, P834, DOI 10.1128/JB.00912-07; Apfalter P, 2002, DIAGN MICR INFEC DIS, V44, P209, DOI 10.1016/S0732-8893(02)00435-2; Clinical and Laboratory Standards Institute, 2009, METH DIL ANT SUSC TE, P12; Coman Gabriela, 2008, Rev Med Chir Soc Med Nat Iasi, V112, P104; GILLIGAN PH, 1987, J CLIN MICROBIOL, V25, P1258; KOCH AE, 1971, APPL MICROBIOL, V22, P812; Kriegeskorte A., 2014, MBIO, V5; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240; Perry JD, 2004, J CLIN MICROBIOL, V42, P4519, DOI 10.1128/JCM.42.10.4519-4523.2004; PROCTOR RA, 1994, INFECT AGENT DIS, V3, P302; Smyth RW, 2005, J CLIN MICROBIOL, V43, P3797, DOI 10.1128/JCM.43.8.3797-3799.2005; Spanu T, 2005, CLIN INFECT DIS, V41, pE48, DOI 10.1086/432577; Stoakes L, 2006, J CLIN MICROBIOL, V44, P637, DOI 10.1128/JCM.44.2.637-639.2006; STOKES A, 1978, J CLIN PATHOL, V31, P165, DOI 10.1136/jcp.31.2.165; von Eiff C, 2004, DIAGN MICR INFEC DIS, V48, P191, DOI 10.1016/j.diagmicrobio.2003.10.010; Zadik PM, 2001, J MED MICROBIOL, V50, P476	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7012	1872-8359		J MICROBIOL METH	J. Microbiol. Methods	MAR	2015	110						40	44		10.1016/j.mimet.2015.01.007		5	Biochemical Research Methods; Microbiology	Biochemistry & Molecular Biology; Microbiology	CC2RE	WOS:000350191500007		
J	Matsumiya, M; Hata, K; Tsunashima, K				Matsumiya, Masahiko; Hata, Katsunori; Tsunashima, Katsuhiko			Self-diffusion behaviors of ionic liquids by MD simulation based on united-atom force field introduced charge scaling by ab initio MO simulation	JOURNAL OF MOLECULAR LIQUIDS			English	Article						Charge scaling; Ionic liquids; MD simulation; Self-diffusion coefficients; United-atom force field	MOLECULAR-DYNAMICS SIMULATIONS; GAUSSIAN-BASIS SETS; X-RAY-SCATTERING; TRANSPORT-PROPERTIES; PHYSICOCHEMICAL PROPERTIES; PHOSPHONIUM CATIONS; LOW-VISCOSITY; IMIDAZOLIUM; DENSITY; ANIONS	We performed ab initio molecule orbital (MO) calculations to obtain the stable states of the ions in ionic liquids (ILs), partial atomic charges, and scaling factors for a charge scaling. Then, MD simulations based on united-atom (UA) force field introduced a charge scaling were carried out in ILs. The partial atomic charges of ions in ILs were determined by using charges from electrostatic potentials using a grid based method (CHelpG) from the B3LYP/ 6-311G(d,p) level wave function for cations B3LYP/6-311+G(d) one for anions. The scaling factors for [C(2)C(1)lm], RBA] and [FSA] were considered from the dipole interactions. The calculated densities by MD simulation were reproduced the experimental values at 298 K very well and there were errors within 5.0% deviations, because the partial atomic charges of the ions in ILs were scaling down and the coulomb interactions became weaker. Moreover, the self-diffusion coefficients of [C(2)C(1)Im][TFSA] by MD simulation based on UA force field introduced a charge scaling showed the same order for the experimental values at 423 K. Furthermore, the self-diffusion coefficients and the center-of-mass radial distribution functions in [P-2225][TESA] at 298, 323, 348, 373, 398, and 423 K were simulated. The calculated self-diffusion coefficients had a similar tendency with experimental ones. The position of first solvation shell withdrew about 0.25 angstrom and its height became lower due to increase the temperatures. Both the first minimum position around 9-10 angstrom and the second maximum position around 13-14 angstrom also went away. This simulation result indicated that the intermolecular interaction strength between cations and anions became weaker with increasing temperature. (C) 2015 Elsevier B.V. All rights reserved.	[Matsumiya, Masahiko; Hata, Katsunori] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Tsunashima, Katsuhiko] Wakayama Natl Coll Technol, Dept Mat Sci, Wakayama 6440023, Japan	Matsumiya, M (reprint author), Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, 79-2 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	mmatsumi@ynu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [24686101]	This work was partially supported by the Grant-in-Aid for Scientific Research (no. 24686101) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Lopes JNC, 2008, J PHYS CHEM B, V112, P5039, DOI 10.1021/jp800281e; Tsunashima K, 2007, ELECTROCHEM COMMUN, V9, P2353, DOI 10.1016/j.elecom.2007.07.003; Rey-Castro C, 2007, FLUID PHASE EQUILIBR, V256, P62, DOI 10.1016/j.fluid.2006.09.027; Takeuchi M, 2009, J MOL LIQ, V148, P99, DOI 10.1016/j.molliq.2009.07.003; Yan TY, 2004, J PHYS CHEM B, V108, P11877, DOI 10.1021/jp047619y; Kondo H, 2012, ELECTROCHIM ACTA, V66, P313, DOI 10.1016/j.electacta.2012.01.101; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Cadena C, 2006, J PHYS CHEM B, V110, P2821, DOI 10.1021/jp056235k; Youngs TGA, 2008, CHEMPHYSCHEM, V9, P1548, DOI 10.1002/cphc.200800200; Kanzaki R, 2009, J MOL LIQ, V147, P77, DOI 10.1016/j.molliq.2008.10.003; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; Kurachi A, 2012, J APPL ELECTROCHEM, V42, P961, DOI 10.1007/s10800-012-0463-8; FRISCH MJ, 1984, J CHEM PHYS, V80, P3265, DOI 10.1063/1.447079; MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3; Hayamizu K, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3625923; Borodin O, 2009, J PHYS CHEM B, V113, P11463, DOI 10.1021/jp905220k; Tsunashima K, 2011, ELECTROCHEM COMMUN, V13, P178, DOI 10.1016/j.elecom.2010.12.007; MCLEAN AD, 1980, J CHEM PHYS, V72, P5639, DOI 10.1063/1.438980; Lopes JNC, 2008, J PHYS CHEM B, V112, P9449, DOI 10.1021/jp803309c; Tsuzuki S, 2010, J PHYS CHEM B, V114, P16329, DOI 10.1021/jp106870v; Bagno A, 2007, J MOL LIQ, V131, P17, DOI 10.1016/j.molliq.2006.08.023; Wang XJ, 2014, J MOL LIQ, V193, P262, DOI 10.1016/j.molliq.2014.03.011; Sakaebe H, 2003, ELECTROCHEM COMMUN, V5, P594, DOI 10.1016/S1388-2481(03)00137-1; Borodin O, 2006, J PHYS CHEM B, V110, P11481, DOI 10.1021/jp061593o; Lopes JNC, 2004, J PHYS CHEM B, V108, P16893, DOI 10.1021/jp0476545; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Tsuzuki S, 2011, PHYS CHEM CHEM PHYS, V13, P5987, DOI 10.1039/c0cp02087g; Lopes JNC, 2006, J PHYS CHEM B, V110, P19586, DOI 10.1021/jp063901o; Tokuda H, 2006, J PHYS CHEM B, V110, P19593, DOI 10.1021/jp064159v; Liu ZP, 2010, J PHYS CHEM B, V114, P4572, DOI 10.1021/jp911337f; Noda A, 2001, J PHYS CHEM B, V105, P4603, DOI 10.1021/jp004132q; Liu ZP, 2004, J PHYS CHEM B, V108, P12978, DOI 10.1021/jp048369o; Tsuzuki S, 2009, J PHYS CHEM B, V113, P10641, DOI 10.1021/jp811128b; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Lopes JNC, 2004, J PHYS CHEM B, V108, P2038, DOI 10.1021/jp0362133; Wasserscheid P, 2000, ANGEW CHEM INT EDIT, V39, P3772, DOI 10.1002/1521-3773(20001103)39:21<3772::AID-ANIE3772>3.0.CO;2-5; Bedrov D, 2010, J PHYS CHEM B, V114, P4984, DOI 10.1021/jp911670f; Seki S, 2005, ELECTROCHEM SOLID ST, V8, pA577, DOI 10.1149/1.2041330; Legeai S, 2008, ELECTROCHEM COMMUN, V10, P1661, DOI 10.1016/j.elecom.2008.08.005; Borodin O, 2010, J PHYS CHEM B, V114, P6786, DOI 10.1021/jp911950q; Seki S, 2012, J CHEM ENG DATA, V57, P2211, DOI 10.1021/je201289w; Fukuda S, 2008, J MOL LIQ, V143, P2, DOI 10.1016/j.molliq.2008.02.012; Tokuda H, 2005, J PHYS CHEM B, V109, P6103, DOI 10.1021/jp044626d; Shimizu K, 2010, J PHYS CHEM B, V114, P3592, DOI 10.1021/jp9120468; Zhong XJ, 2011, J PHYS CHEM B, V115, P10027, DOI 10.1021/jp204148q; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; Ishikawa M, 2006, J POWER SOURCES, V162, P658, DOI 10.1016/j.jpowsour.2006.02.077; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Chalaris M, 2008, FLUID PHASE EQUILIBR, V267, P47, DOI 10.1016/j.fluid.2008.02.019; Liu X., 2010, MOL SIMULAT, V1, P79; Liu XM, 2012, J PHYS CHEM B, V116, P4934, DOI 10.1021/jp210696r; Macfarlane DR, 2007, ACCOUNTS CHEM RES, V40, P1165, DOI 10.1021/ar7000952; Maginn EJ, 2007, ACCOUNTS CHEM RES, V40, P1200, DOI 10.1021/ar700163c; Ohno H, 2005, ELECTROCHEMICAL ASPECTS OF IONIC LIQUIDS, P1, DOI 10.1002/0471762512; Raghavachari K., 1980, J CHEM PHYS, V72, P650, DOI DOI 10.1063/1.438955; Seki S, 2009, PHYS CHEM CHEM PHYS, V11, P3509, DOI 10.1039/b820343a	56	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7322	1873-3166		J MOL LIQ	J. Mol. Liq.	MAR	2015	203						125	130		10.1016/j.molliq.2014.12.045		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CC2PT	WOS:000350187800017		
J	Kimura, S; Sakakibara, Y; Sato, K; Ote, M; Ito, H; Koganezawa, M; Yamamoto, D				Kimura, Shingo; Sakakibara, Yasufumi; Sato, Kosei; Ote, Manabu; Ito, Hiroki; Koganezawa, Masayuki; Yamamoto, Daisuke			The Drosophila lingerer protein cooperates with Orb2 in long-term memory formation	JOURNAL OF NEUROGENETICS			English	Article						Courtship; fruit fly; memory mutants; protein-protein interaction; RNA-binding proteins	MENTAL-RETARDATION PROTEIN; MESSENGER-RNAS; NEURONAL ISOFORM; APLYSIA CPEB; FACILITATION; COURTSHIP; MELANOGASTER; SYNAPSES; GENE; FORM	Recently mated Drosophila females were shown to be reluctant to copulate and to exhibit rejecting behavior when courted by a male. Males that experience mate refusal by a mated female subsequently attenuate their courtship effort toward not only mated females but also virgin females. This courtship suppression persists for more than a day, and thus represents long-term memory. The courtship long-term memory has been shown to be impaired in heterozygotes as well as homozygotes of mutants in orb2, a locus encoding a set of CPEB RNA-binding proteins. We show that the impaired courtship long-term memory in orb2-mutant heterozygotes is restored by reducing the activity of lig, another putative RNA-binding protein gene, yet on its own the loss-of-function lig mutation is without effect. We further show that Lig forms a complex with Orb2. We infer that a reduction in the Lig levels compensates the Orb2 deficiency by mitigating the negative feedback for Orb2 expression and thereby alleviating defects in long-term memory.	[Kimura, Shingo; Sakakibara, Yasufumi; Sato, Kosei; Ote, Manabu; Ito, Hiroki; Koganezawa, Masayuki; Yamamoto, Daisuke] Tohoku Univ, Grad Sch Life Sci, Div Neurogenet, Sendai, Miyagi 980, Japan	Yamamoto, D (reprint author), Div Neurogenet, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.				MEXT [1802012, 23220007, 24113502]	This work was supported by Grant-in-Aids for Scientific Research (Nos. 1802012, 23220007, and 24113502) from MEXT to D.Y.	Angenstein F, 2002, J NEUROSCI, V22, P8827; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; Irvine K, 2004, INT J DEV BIOL, V48, P1065, DOI 10.1387/ijdb.041893ki; Ramos A, 2003, RNA, V9, P1198, DOI 10.1261/rna.5960503; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Pai TP, 2013, P NATL ACAD SCI USA, V110, P7898, DOI 10.1073/pnas.1216336110; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Chen L, 2003, NEUROSCIENCE, V120, P1005, DOI 10.1016/S0306-4522(03)00406-8; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; Kruttner S, 2012, NEURON, V76, P383, DOI 10.1016/j.neuron.2012.08.028; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Nakano Y, 2001, MOL CELL BIOL, V21, P3775, DOI 10.1128/MCB.21.11.3775-3788.2001; Kuniyoshi H, 2002, GENETICS, V162, P1775; SNOW PM, 1987, J NEUROSCI, V7, P4137; Zalfa F, 2006, CURR OPIN NEUROBIOL, V16, P265, DOI 10.1016/j.conb.2006.05.010; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Pavlopoulos E, 2011, CELL, V147, P1369, DOI 10.1016/j.cell.2011.09.056; Chang JS, 1999, DEV BIOL, V215, P91, DOI 10.1006/dbio.1999.9444; Costa A, 2005, DEV CELL, V8, P331, DOI 10.1016/j.devcel.2005.01.011; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Kuniyoshi H, 2003, J NEUROGENET, V17, P117, DOI 10.1080/01677060390256459; Majumdar A, 2012, CELL, V148, P515, DOI 10.1016/j.cell.2012.01.004; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Baumgartner R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003598; Hall J. C., 1980, STADLER S, V12, P43; Kraft R, 1998, J NEUROSCI, V18, P8886; Kraft R, 2006, J NEUROSCI, V26, P8734, DOI 10.1523/JNEUROSCI.2106-06.2006; BASTOCK M., 1955, BEHAVIOR, V8, P85, DOI 10.1163/156853955X00184; MANNING A, 1967, ANIM BEHAV, V15, P239, DOI 10.1016/0003-3472(67)90006-1; Matsushita-Sakai T., 2010, P NATL ACAD SCI USA, V107, P11987; Richter JD, 2002, CURR OPIN NEUROBIOL, V12, P300, DOI 10.1016/S0959-4388(02)00318-5; Spieth H. T., 1952, B AM MUS NAT HIST, V99, P399; Xu SW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003079; ZAWISTOWSKI S, 1988, J COMP PSYCHOL, V102, P174	44	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0167-7063	1563-5260		J NEUROGENET	J. Neurogenet.	MAR	2015	29	1					8	17		10.3109/01677063.2014.917644		10	Genetics & Heredity; Neurosciences	Genetics & Heredity; Neurosciences & Neurology	CC7UR	WOS:000350574400003		
J	Kimura, K; Sato, C; Yamamoto, K; Yamamoto, D				Kimura, Ken-ichi; Sato, Chiaki; Yamamoto, Kana; Yamamoto, Daisuke			From the back or front: The courtship position is a matter of smell and sight in Drosophila melanogaster males	JOURNAL OF NEUROGENETICS			English	Article						Fruit fly; innate behavior; mating; olfaction; vision	BEHAVIOR; CIRCUITS; MEMORY	During courtship, Drosophila melanogaster males usually position themselves behind the target female. To decipher the sensory cues that guide the males to the courting position, we quantitatively analyzed male locomotion traces within a circular observation chamber, at the center of which an immobilized virgin female was placed as a courtship target. Wild- type males preferentially stayed behind the female under not only daylight but also dark conditions, indicating that vision is dispensable for orientation by males. By contrast, olfaction- defective Or83b(2) homozygous males often positioned themselves in front of a female to court under dark but not daylight conditions. We conclude that vision and olfaction redundantly guide the male fly to move behind the female to perform courtship actions. The visual and olfactory features that provide a male with cues for differentiating between the front and back end of a female are yet to be determined.	[Kimura, Ken-ichi; Sato, Chiaki; Yamamoto, Kana] Hokkaido Univ, Biol Lab, Sapporo, Hokkaido 0028502, Japan; [Yamamoto, Daisuke] Tohoku Univ, Grad Sch Life Sci, Div Neurogenet, Sendai, Miyagi 980, Japan	Kimura, K (reprint author), Hokkaido Univ, Biol Lab, Sapporo Campus, Sapporo, Hokkaido 0028502, Japan.	kimura.kenichi@s.hokkyodai.ac.jp			MEXT [1802012, 23220007, 24113502]	This work was supported by Grant-in-Aids for Scientific Research (Nos. 1802012, 23220007, and 24113502 to D. Y. and 24570081 to K.-I. K.) from MEXT.	SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Coen P, 2014, NATURE, V507, P233, DOI 10.1038/nature13131; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; HIRSCH HVB, 1994, J EXP BIOL, V195, P1; Yamamoto D, 2013, NAT REV NEUROSCI, V14, P681, DOI 10.1038/nrn3567; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; COOK R, 1979, BIOL CYBERN, V34, P91, DOI 10.1007/BF00365473; Immonen E, 2009, BEHAV ECOL, V20, P289, DOI 10.1093/beheco/arp008; Isono Kunio, 1993, P242; Kim WJ, 2012, NAT NEUROSCI, V15, P876, DOI 10.1038/nn.3104; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; MARKOW TA, 1987, P NATL ACAD SCI USA, V84, P6200, DOI 10.1073/pnas.84.17.6200; Spieth H. T., 1952, B AM MUS NAT HIST, V99, P399	16	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0167-7063	1563-5260		J NEUROGENET	J. Neurogenet.	MAR	2015	29	1					18	22		10.3109/01677063.2014.968278		5	Genetics & Heredity; Neurosciences	Genetics & Heredity; Neurosciences & Neurology	CC7UR	WOS:000350574400004		
J	Takayanagi, S; Toba, G; Lukacsovich, T; Ote, M; Sato, K; Yamamoto, D				Takayanagi, Sakino; Toba, Gakuta; Lukacsovich, Tamas; Ote, Manabu; Sato, Kosei; Yamamoto, Daisuke			A fruitless upstream region that defines the species specificity in the male-specific muscle patterning in Drosophila	JOURNAL OF NEUROGENETICS			English	Article						Evolution; neuromuscular system; sex determination gene; enhancers; D. subobscura	SEXUAL ORIENTATION; COURTSHIP BEHAVIOR; MELANOGASTER; LAWRENCE; GENE; EXPRESSION; EVOLUTION	The muscle of Lawrence (MOL) is a male-specific muscle present in the abdomen of some adult Drosophila species. Formation of the MOL depends on innervation by motoneurons that express fruitless, a neural male determinant. Drosophila melanogaster males carry a pair of MOLs in the 5th abdominal segment, whereas D. subobscura males carry a pair in both the 5th and 4th segments. We hypothesized that the fru gene of D. subobscura but not that of D. melanogaster contains a cis element that directs the formation of the additional pair of MOLs. Successively extended 5 ' DNA fragments to the P1 promoter of D. subobscura or the corresponding fragments that are chimeric (i.e., containing both melanogaster and subobscura elements) were introduced into D. melanogaster and tested for their ability to induce the MOL to locate the hypothetical cis element. We found that a 1.5-2-kb genomic fragment located 4 -6-kb upstream of the P1 promoter in D. subobscura but not that of D. melanogaster permits MOL formation in females, provided this fragment is grafted to the distal similar to 4-kb segment from D. melanogaster, demonstrating that this genomic fragment of D. subobscura contains a cis element for the MOL induction.	[Takayanagi, Sakino; Toba, Gakuta; Ote, Manabu; Sato, Kosei; Yamamoto, Daisuke] Tohoku Univ, Grad Sch Life Sci, Div Neurogenet, Sendai, Miyagi 980, Japan; [Lukacsovich, Tamas] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92717 USA	Yamamoto, D (reprint author), Tohoku Univ, Grad Sch Life Sci, Div Neurogenet, Sendai, Miyagi 980, Japan.	daichan@m.tohoku.ac.jp			Japanese Government Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23220007, 26113702, 26114502, 23500380, 26430001]; Takeda Science Foundation;  [21-6797]	This work was supported in part by Grants-in-Aid for Scientific Research (23220007, 26113702 and 26114502 to D.Y. and 23500380 and 26430001 to G.T.) from the Japanese Government Ministry of Education, Culture, Sports, Science and Technology (MEXT), a Life Science Grant from the Takeda Science Foundation to D.Y., and a Grant-in-Aid for JSPS fellows (# 21-6797) to S.T.	Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; Billeter JC, 2004, J COMP NEUROL, V475, P270, DOI 10.1002/cne.20177; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Yamamoto D, 2013, NAT REV NEUROSCI, V14, P681, DOI 10.1038/nrn3567; Fan P, 2013, CELL, V154, P89, DOI 10.1016/j.cell.2013.06.008; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Cande J, 2014, CELL REP, V8, P362, DOI 10.1016/j.celrep.2014.06.023; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Chung H, 2014, SCIENCE, V343, P1148, DOI 10.1126/science.1249998; Pavlou HJ, 2013, CURR OPIN NEUROBIOL, V23, P76, DOI 10.1016/j.conb.2012.09.002; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Darwin C., 1871, DESCENT MAN SELECTIO; Darwin Charles, 1859, ORIGIN SPECIES MEANS; GAILEY DA, 1991, DEVELOPMENT, V113, P879; Gailey DA, 1997, P NATL ACAD SCI USA, V94, P4543, DOI 10.1073/pnas.94.9.4543; LAWRENCE PA, 1984, CELL, V36, P775, DOI 10.1016/0092-8674(84)90357-X; Nojima T, 2010, CURR BIOL, V20, P836, DOI 10.1016/j.cub.2010.02.064; Orgogozo V, 2007, EVOL DEV, V9, P368; Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168; Shirangi TR, 2013, CELL REP, V5, P678, DOI 10.1016/j.celrep.2013.09.039; Takayanagi S., 2012, INT J BIOL, V4, P20; TAYLOR BJ, 1995, DEVELOPMENT, V121, P3079; Usui-Aoki K, 2000, NAT CELL BIOL, V2, P500; Yamamoto D, 2013, J NEUROGENET, V27, P130, DOI 10.3109/01677063.2013.800060	26	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0167-7063	1563-5260		J NEUROGENET	J. Neurogenet.	MAR	2015	29	1					23	29		10.3109/01677063.2014.983101		7	Genetics & Heredity; Neurosciences	Genetics & Heredity; Neurosciences & Neurology	CC7UR	WOS:000350574400005		
J	Ito, H; Morishima, H; Onodera, H; Wakui, D; Uchida, M; Sase, T; Oshio, K; Tanaka, Y				Ito, Hidemichi; Morishima, Hiroyuki; Onodera, Hidetaka; Wakui, Daisuke; Uchida, Masashi; Sase, Taigen; Oshio, Kotaro; Tanaka, Yuichiro			Acute phase endovascular intervention on a pseudoaneurysm formed due to rupture of an anterior communicating artery aneurysm	JOURNAL OF NEUROINTERVENTIONAL SURGERY			English	Article							DETACHABLE COILS; SITE	A 79-year-old woman presented with a subarachnoid hemorrhage. Angiography revealed pseudoaneurysm formation due to rupture of a true saccular anterior communicating artery aneurysm. Coil embolization, limited to the true aneurysm, was performed successfully with a favorable clinical outcome. This procedure can be considered as an alternative treatment option for similar aneurysms in cases where surgical clipping is contraindicated.	[Ito, Hidemichi; Onodera, Hidetaka; Uchida, Masashi; Sase, Taigen; Oshio, Kotaro; Tanaka, Yuichiro] St Marianna Univ, Sch Med, Dept Neurosurg, Kawasaki, Kanagawa 2168511, Japan; [Morishima, Hiroyuki] Kawasaki City Tama Hosp, Dept Neurosurg, Kawasaki, Kanagawa, Japan; [Wakui, Daisuke] Yokohama City Seibu Hosp, Dept Neurosurg, Yokohama, Kanagawa, Japan	Ito, H (reprint author), St Marianna Univ, Sch Med, Dept Neurosurg, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	hdmcito@marianna-u.ac.jp					Nomura M, 2000, J NEUROSURG, V93, P998, DOI 10.3171/jns.2000.93.6.0998; Sorteberg A, 2002, AM J NEURORADIOL, V23, P288; Ishikawa T, 2006, SURG NEUROL, V66, P269, DOI 10.1016/j.surneu.2006.03.030; Lempert TE, 1998, AM J NEURORADIOL, V19, P907; Ide M, 2003, NEUROL MED-CHIR, V43, P443, DOI 10.2176/nmc.43.443; Mori K, 2004, NEUROSURG REV, V27, P289, DOI 10.1007/s10143-004-0336-7	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1759-8478	1759-8486		J NEUROINTERV SURG	J. NeuroInterventional Surg.	MAR	2015	7	3							e9	10.1136/neurintsurg-2013-011006.rep		3	Neuroimaging; Surgery	Neurosciences & Neurology; Surgery	CC6RB	WOS:000350493600001		
J	Togo, F; Lange, G; Natelson, BH; Quigley, KS				Togo, Fumiharu; Lange, Gudrun; Natelson, Benjamin H.; Quigley, Karen S.			Attention network test: Assessment of cognitive function in chronic fatigue syndrome	JOURNAL OF NEUROPSYCHOLOGY			English	Article						chronic fatigue syndrome; information processing; cognition; Attention Network Task; depression	WORKING-MEMORY; DEPRESSION; EFFICIENCY; COMPLAINTS; SPEED; BRAIN	Information processing difficulties are common in patients with chronic fatigue syndrome (CFS). It has been shown that the time it takes to process a complex cognitive task, rather than error rate, may be the critical variable underlying CFS patients' cognitive complaints. The Attention Network Task (ANT) developed by Fan and colleagues may be of clinical utility to assess cognitive function in CFS, because it allows for simultaneous assessment of mental response speed, also called information processing speed, and error rate under three conditions challenging the attention system. Comparison of data from two groups of CFS patients (those with and without comorbid major depressive disorder; n=19 and 22, respectively) to controls (n=29) consistently showed that error rates did not differ among groups across conditions, but speed of information processing did. Processing time was prolonged in both CFS groups and most significantly affected in response to the most complex task conditions. For simpler tasks, processing time was only prolonged in CFS participants with depression. The data suggest that the ANT may be a task that could be used clinically to assess information processing deficits in individuals with CFS.	[Togo, Fumiharu] Univ Tokyo, Grad Sch Educ, Educ Physiol Lab, Tokyo 1130033, Japan; [Lange, Gudrun] UMD New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Lange, Gudrun; Quigley, Karen S.] New Jersey Hlth Care Syst, Dept Vet Affairs, E Orange, NJ USA; [Natelson, Benjamin H.] Beth Israel Deaconess Med Ctr, Pain & Fatigue Study Ctr, New York, NY 10003 USA; [Natelson, Benjamin H.] Albert Einstein Med Ctr, New York, NY USA; [Quigley, Karen S.] Northeastern Univ, Interdisciplinary Affect Sci Lab, Boston, MA 02115 USA	Togo, F (reprint author), Univ Tokyo, Grad Sch Educ, Educ Physiol Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	tougou@p.u-tokyo.ac.jp			NIH [AI-54478]; Japan Society for the Promotion of Science [22500690]	This study was supported in part by NIH AI-54478 and a grant from the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research (C) 22500690). Fumiharu Togo and Benjamin H. Natelson had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.	MacLeod JW, 2010, NEUROPSYCHOLOGY, V24, P637, DOI 10.1037/a0019803; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Short K, 2002, J PSYCHOSOM RES, V52, P475, DOI 10.1016/S0022-3999(02)00290-8; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.neuro.13.1.25; Lange G, 1999, J NEUROL SCI, V171, P3, DOI 10.1016/S0022-510X(99)00243-9; Tiersky LA, 1997, J CLIN EXP NEUROPSYC, V19, P560, DOI 10.1080/01688639708403744; Wearden A, 1997, PSYCHOL MED, V27, P81, DOI 10.1017/S0033291796004035; DeLuca J, 2004, J INT NEUROPSYCH SOC, V10, P101; Lange G, 2005, NEUROIMAGE, V26, P513, DOI 10.1016/j.neuroimage.2005.02.011; DeLuca J, 1997, J NEUROL NEUROSUR PS, V62, P151, DOI 10.1136/jnnp.62.2.151; DELUCA J, 1993, ARCH NEUROL-CHICAGO, V50, P301; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; FUKUDA K, 1994, ANN INTERN MED, V121, P953; Jaskowski P, 1996, PERCEPT MOTOR SKILL, V82, P707; Kalb R, 2006, PROG NEURO-PSYCHOPH, V30, P244, DOI 10.1016/j.pnpbp.2005.10.009; Norman D., 1986, CONSCIOUSNESS SELF R, V4, P1; WILHELM O, 2006, J COGN PSYCHOL, V18, P18, DOI DOI 10.1080/09541440500215921	19	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	MAR	2015	9	1					1	9		10.1111/jnp.12030		9	Psychology; Psychology, Experimental	Psychology	CC6MC	WOS:000350478100001		
J	Tomio, R; Toda, M; Sutiono, AB; Horiguchi, T; Aiso, S; Yoshida, K				Tomio, Ryosuke; Toda, Masahiro; Sutiono, Agung Budi; Horiguchi, Takashi; Aiso, Sadakazu; Yoshida, Kazunari			Gruber's ligament as a useful landmark for the abducens nerve in the transnasal approach	JOURNAL OF NEUROSURGERY			English	Article						anatomy; Gruber's ligament; abducens nerve; transnasal; transsphenoidal; endoscopic	SKULL BASE; PETROSPHENOIDAL LIGAMENT; ENDONASAL APPROACH; SINUS	OBJECT Extended endoscopic transnasal surgeries for skull base lesions have recently been performed. Some expert surgeons have attempted to remove tumors such as chordomas, meningiomas, and pituitary adenomas in the clival region using the transnasal approach and have reported abducens nerve injury as a common complication. There have been many microsurgical anatomical studies of the abducens nerve, but none of these studies has described an anatomical landmark of the abducens nerve in the transnasal approach. In this study the authors used cadaver dissections to describe Gruber's ligament as the most reliable landmark of the abducens nerve in the transnasal transclival view. METHODS The petroclival segment of the abducens nerve was dissected in the interdural space which is also called Dorello's canal, the petroclival venous gulf, or the sphenopetroclival venous confluence using the transnasal approach in 20 specimens obtained from 10 adult cadaveric heads. RESULTS The petroclival Segment of the abducens nerve clearly crossed and attached to Gruber's ligament in the interdural space, as noted in the transnasal view. The average length of the dural porus to the intersection on the abducens nerve was 5.2 +/- 1.0 mm. The length of the posterior clinoid process (PCP) to the intersection on Gruber's ligament was 6.4 +/- 2.6 mm. The average width Of Gruber's ligament at the midsection was 1.6 +/- 0.5 mm. CONCLUSIONS Gruber's ligament is considered a useful landmark, and it is visible in most adults. Thus, surgeons can find the abducens nerve safely by visualizing inferolaterally along Gruber's ligament from the PCP.	[Tomio, Ryosuke; Toda, Masahiro; Horiguchi, Takashi; Yoshida, Kazunari] Keio Univ, Sch Med, Dept Neurosurg, Tokyo 1608582, Japan; [Aiso, Sadakazu] Keio Univ, Sch Med, Dept Anat, Tokyo 1608582, Japan; [Sutiono, Agung Budi] Padjadjaran State Univ, Fac Med, Dept Neurosurg, Dr Hasan Sadikin Hosp, Bandung, Indonesia	Tomio, R (reprint author), Keio Univ, Sch Med, Dept Neurosurg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	tomy0807@hotmail.com		Tomio, Ryosuke/0000-0002-7852-6374			Destrieux C, 1997, J NEUROSURG, V87, P67, DOI 10.3171/jns.1997.87.1.0067; Iaconetta G, 2003, J NEUROSURG, V99, P366, DOI 10.3171/jns.2003.99.2.0366; Snyderman Carl H., 2009, Keio Journal of Medicine, V58, P152; Koutourousiou M, 2012, NEUROSURGERY, V71, P614, DOI 10.1227/NEU.0b013e31825ea3e0; Ozveren MF, 2007, NEUROSURGERY, V60, P1, DOI 10.1227/01.NEU.0000249229.89988.4D; UMANSKY F, 1991, J NEUROSURG, V75, P294, DOI 10.3171/jns.1991.75.2.0294; Icke C, 2010, TURK NEUROSURG, V20, P323, DOI 10.5137/1019-5149.JTN.2921-10.0; Kassam Amin, 2005, Neurosurg Focus, V19, pE4; Kassam Amin B, 2005, Neurosurg Focus, V19, pE6; Katsuno M, 2007, NEUROL MED-CHIR, V47, P307, DOI 10.2176/nmc.47.307; Lang J, 1995, SKULL BASE RELATED S, P85; Tubbs RS, 2014, SURG RADIOL ANAT, V36, P303, DOI 10.1007/s00276-013-1171-8; VIDIC B, 1968, AMER J ROENTGENOL RA, V104, P177	13	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2015	122	3					499	503		10.3171/2014.10.JNS132437		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CC3RJ	WOS:000350266600002		
J	Mori, E; Ueta, T; Maeda, T; Yugue, I; Kawano, O; Shiba, K				Mori, Eiji; Ueta, Takayoshi; Maeda, Takeshi; Yugue, Itaru; Kawano, Osamu; Shiba, Keiichiro			Effect of preservation of the C-6 spinous process and its paraspinal muscular attachment on the prevention of postoperative axial neck pain in C3-6 laminoplasty	JOURNAL OF NEUROSURGERY-SPINE			English	Article						laminoplasty; axial neck pain; paraspinal muscle; cervical spine; spinous process; trapezius muscle	POSTERIOR LONGITUDINAL LIGAMENT; BLOC CERVICAL LAMINOPLASTY; OPEN-DOOR LAMINOPLASTY; COMPRESSIVE MYELOPATHY; SKIP LAMINECTOMY; FOLLOW-UP; OUTCOMES; OSSIFICATION; ANATOMY; MUSCLES	OBJECT Axial neck pain after C3-6 laminoplasty has been reported to be significantly lesser than that after C3-7 laminoplasty because of the preservation of the C-7 spinous process and the attachment of nuchal muscles such as the trapezius and rhomboideus minor, which are connected to the scapula. The C-6 spinous process is the second longest spinous process after that of C-7, and it serves as an attachment point for these muscles. The effect of preserving the C-6 spinous process and its muscular attachment, in addition to preservation of the C-7 spinous process, on the prevention of axial neck pain is not well understood. The purpose of the current study was to clarify whether preservation of the paraspinal muscles of the C-6 spinous process reduces postoperative axial neck pain compared to that after using nonpreservation techniques. METHODS The authors studied 60 patients who underwent C3-6 double-door laminoplasty for the treatment of cervical spondylotic myelopathy or cervical ossification of the posterior longitudinal ligament; the minimum follow-up period was 1 year. Twenty-five patients underwent a C-6 paraspinal muscle preservation technique, and 35 underwent a C-6 nonpreservation technique. A visual analog scale (VAS) and VAS grading (Grades I-IV) were used to assess axial neck pain 1-3 months after surgery and at the final follow-up examination. Axial neck pain was classified as being 1 of 5 types, and its location was divided into 5 areas. The potential correlation between the C-6/C-7 spinous process length ratio and axial neck pain was examined. RESULTS The mean VAS scores (+/- SD) for axial neck pain were comparable between the C6-preservation group and the C6-nonpreservation group in both the early and late postoperative stages (4.1 +/- 3.1 vs 4.0 +/- 3.2 and 3.8 +/- 2.9 vs 3.6 +/- 3.0, respectively). The distribution of VAS grades was comparable in the 2 groups in both postoperative stages. Stiffness was the most prevalent complaint in both groups (64.0% and 54.5%, respectively), and the suprascapular region was the most common site in both groups (60.0% and 57.1%, respectively). The types and locations of axial neck pain were also similar between the groups. The C-6/C-7 spinous process length ratios were similar in the groups, and they did not correlate with axial neck pain. The reductions of range of motion and changes in sagittal alignment after surgery were also similar. CONCLUSIONS The C-6 paraspinal muscle preservation technique was not superior to the C6-nonpreservation technique for preventing postoperative axial neck pain.	[Mori, Eiji; Ueta, Takayoshi; Maeda, Takeshi; Yugue, Itaru; Kawano, Osamu; Shiba, Keiichiro] Spinal Injuries Ctr, Dept Orthopaed Surg, Iizuka, Fukuoka 8208508, Japan	Mori, E (reprint author), Spinal Injuries Ctr, Dept Orthopaed Surg, 550-4 Igisu, Iizuka, Fukuoka 8208508, Japan.	eijimori@orange.ocn.ne.jp					Kawaguchi Y, 1999, J SPINAL DISORD, V12, P392; Vernon H, 2008, J MANIP PHYSIOL THER, V31, P491, DOI 10.1016/j.jmpt.2008.08.006; Hosono N, 2006, EUR SPINE J, V15, P1375, DOI 10.1007/s00586-006-0089-9; Hosono N, 2007, SPINE, V32, P2985; JOHNSON G, 1994, CLIN BIOMECH, V9, P44, DOI 10.1016/0268-0033(94)90057-4; ITOH T, 1985, SPINE, V10, P729, DOI 10.1097/00007632-198510000-00007; Hosono N, 1996, SPINE, V21, P1969, DOI 10.1097/00007632-199609010-00005; HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005; Ratliff JK, 2003, J NEUROSURG, V98, P230, DOI 10.3171/spi.2003.98.3.0230; Ono A, 2008, SPINE, V33, pE349, DOI 10.1097/BRS.0b013e31817152cc; Chiba K, 2006, SPINE, V31, P2998, DOI 10.1097/01.brs.0000250307.78987.6b; Kawaguchi Y, 2003, CLIN ORTHOP RELAT R, P129, DOI 10.1097/01.blo.0000069889.31220.62; ESTLANDER AM, 1995, CLIN J PAIN, V11, P194, DOI 10.1097/00002508-199509000-00006; Fujimori T, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.4.FOCUS1394; Highsmith JM, 2011, J NEUROSURG-SPINE, V14, P619, DOI 10.3171/2011.1.SPINE10206; Johnson GM, 2000, SPINE, V25, P5, DOI 10.1097/00007632-200001010-00003; Kotani Y, 2009, EUR SPINE J, V18, P663, DOI 10.1007/s00586-009-0892-1; Mori E, 2012, EUR SPINE J, V21, P745, DOI 10.1007/s00586-011-2146-2; Otani K, 2009, SPINE, V34, P268, DOI 10.1097/BRS.0b013e318195b27a; Sakaura H, 2007, J SPINAL DISORD TECH, V20, P226; Seichi A, 2001, SPINE, V26, P479, DOI 10.1097/00007632-200103010-00010; Shiraishi T, 2002, J NEUROSURG, V96, P122, DOI 10.3171/spi.2002.96.1.0122; Sivaraman A, 2010, J SPINAL DISORD TECH, V23, P96, DOI 10.1097/BSD.0b013e318198c92a; Yukawa Y, 2007, SPINE, V32, P1980, DOI 10.1097/BRS.0b013e318133fbce	24	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	MAR	2015	22	3					221	229		10.3171/2014.11.SPINE131153		9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CC3RG	WOS:000350266300001		
J	Kotani, K; Yamamoto, Y; Hara, S				Kotani, Kousuke; Yamamoto, Yukihiro; Hara, Setsuko			Enzymatic Preparation of Human Milk Fat Substitutes and Their Oxidation Stability	JOURNAL OF OLEO SCIENCE			English	Article						human milk fat substitute; enzymatic preparation; PUFA; lard	TRIACYLGLYCEROL; ACID; INFANTS	Human milk fat substitutes (HMFSs), rich in palmitic acid (P) at the sn-2 position of triacylglycerol (TAG), were prepared from lard via Novozym435 (R) - and Lipozyme RM-IM (R)-mediated two-step reactions. First, 2-palmitoyl monoacylglycerol (2-P-MAG, 90% purity) was prepared via Novozym435 (R)-mediated ethanolysis of lard. Then, 2-P-MAG, oleic acid (0), linoleic acid (L), and lard were dissolved in hexane and subjected to a Lipozyme RM-IM (R)-mediated reaction for HMFS preparation. The effect of the amount of 2-P-MAG and fatty acids (0 and L) in HMFS preparation were investigated. Under the optimum reaction conditions: 7 mmol of lard, 3.0 mmol of 2-P-MAG, 5.2 mmol of 0, 3.5 mmol of L, 10 mL of hexane, 10 wt% of Lipozyme RM-IMR (R) (against the total weight of substrates), 550 rpm, 37 degrees C and 6 h, a HMFS with total fatty acid composition and P content at the sn-2 position of TAG similar to that of human milk fat was prepared. In the same way, a HMFS having polyunsaturated fatty acids (PUFA) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (PUFA-HMFS) was prepared. The HMFS and PUFA-HMFS prepared in this study, as well as fats extracted from commercially available powdered milk for infants (FPM) were evaluated for their oxidation stability by an auto-oxidation test. The test showed HMFS and PUFA-HMFS to possess greater oxidation stability than that the FPMs. These results indicated that the HMFS and PUFA-HMFS prepared in this study have value as potential ingredients for powdered milk.	[Kotani, Kousuke; Yamamoto, Yukihiro; Hara, Setsuko] Seikei Univ, Fac Sci & Technol, Musashino, Tokyo 1808633, Japan	Yamamoto, Y (reprint author), Seikei Univ, Fac Sci & Technol, 3-3-1 Kichijoji Kitamachi, Musashino, Tokyo 1808633, Japan.	yyamamoto@st.seikei.ac.jp					Alfonso R., 2011, LWT-FOOD SCI TECHNOL, V44, P1986; Srivastava A, 2006, J AGR FOOD CHEM, V54, P5175, DOI 10.1021/jf060623h; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brenna JT, 2007, AM J CLIN NUTR, V85, P1457; Pande G, 2013, J AM OIL CHEM SOC, V90, P1311, DOI 10.1007/s11746-013-2281-5; Lopez-Lopez A, 2002, EUR J CLIN NUTR, V56, P1242, DOI 10.1038/sj.ejcn.1601470; QUINLAN PT, 1995, J PEDIATR GASTR NUTR, V20, P81, DOI 10.1097/00005176-199501000-00014; Ihsan K., 2007, FOOD TECHNOL BIOTECH, V45, P434; JHAM GN, 1982, J AM OIL CHEM SOC, V59, P132, DOI 10.1007/BF02662261; Kennedy K, 1999, AM J CLIN NUTR, V70, P920; Luis E., 2011, BIOCH ENG J, V54, P62; Mottram HR, 1997, RAPID COMMUN MASS SP, V11, P1240, DOI 10.1002/(SICI)1097-0231(199708)11:12<1240::AID-RCM990>3.0.CO;2-5; Nina S. N., 2006, FOOD CHEM, V94, P53; [Standard Method for the Analysis of Fats Oils and Related Materials Japan Oil Chem. Soc.], 2013, PEROXIDE VALUE, p2 5 2 2; Xiaoqiang Zou, 2014, Journal of the American Oil Chemists' Society, V91, DOI 10.1007/s11746-013-2383-0; Yamamoto Y, 2014, J OLEO SCI, V63, P31, DOI 10.5650/jos.ess13129; Yong Hua Wang, 2010, European Food Research and Technology, V230, P769; Zou XQ, 2012, J AGR FOOD CHEM, V60, P9415, DOI 10.1021/jf3017354	18	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	MAR	2015	64	3					275	281		10.5650/jos.ess14254		7	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CC3QV	WOS:000350265000004		
J	Yamamoto, Y; Kawamura, Y; Yamazaki, Y; Kijima, T; Morikawa, T; Nonomura, Y				Yamamoto, Yoshiaki; Kawamura, Yuki; Yamazaki, Yuki; Kijima, Tatsuro; Morikawa, Toshiya; Nonomura, Yoshimune			Palmitoleic Acid Calcium Salt: A Lubricant and Bactericidal Powder from Natural Lipids	JOURNAL OF OLEO SCIENCE			English	Article						palmitoleic acid; fatty acid calcium salt; crystal structure; friction property; bactericidal ability	STAPHYLOCOCCUS-AUREUS; FATTY-ACIDS; ANTIBACTERIAL ACTIVITY; SKIN; SOAPS; MONOGLYCERIDES; TRIBOLOGY; MECHANISM; FLORA; AGE	Palmitoleic acid is a promising bactericidal agent for cleansing products with alternative bactericidal abilities. In this study, we focus on the physical and biological activity of palmitoleic acid calcium salt (C16:1 fatty acid Ca salt) because it forms via an ion-exchange reaction between palmitoleic acid and Ca ions in tap water, and remains on the skin surface during the cleansing process. Here, we prepared C16:1 fatty acid Ca salt to investigate its crystal structure and physical and bactericidal properties. The Ca salt was a plate-shaped lamellar crystalline powder with a particle diameter of several micrometers to several tens of micrometers; it exhibited significant lubricity and alternative bactericidal activity against Staphylococcus aureus (S. aureus) and Propionibacterium acnes (P. acnes). We also examined other fatty acid Ca salts prepared from lauric acid (C12:0 fatty acid), palmitic acid (C16:0 fatty acid), and oleic acid (C18:1 fatty acid). The bactericidal activities and lubricity of the fatty acid Ca salts changed with the alkyl chain length and the degree of unsaturation. The C16:1 fatty acid Ca salt exhibited the strongest selective bactericidal ability among the four investigated fatty acid Ca salts. These findings suggest that C16:1 fatty acid and its Ca salt have potential applications in cleansing and cosmetic products.	[Yamamoto, Yoshiaki; Kawamura, Yuki; Yamazaki, Yuki; Kijima, Tatsuro; Nonomura, Yoshimune] Yamagata Univ, Grad Sch Sci & Engn, Dept Biochem Engn, Yonezawa, Yamagata 9928510, Japan; [Morikawa, Toshiya] Kao Corp, Skin Beauty Labs, Sumida Ku, Tokyo 1318501, Japan	Nonomura, Y (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Dept Biochem Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	nonoy@yz.yamagata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [22540417]	This work was partially supported by a Grant-in-Aid for Scientific Research (C) (No. 22540417) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT).	Nonomura Y, 2002, CHEM LETT, P216, DOI 10.1246/cl.2002.216; Bergsson G, 1999, ANTIMICROB AGENTS CH, V43, P2790; Bergsson G, 2002, INT J ANTIMICROB AG, V20, P258, DOI 10.1016/S0924-8579(02)00205-4; Yang BR, 2001, J AGR FOOD CHEM, V49, P1939, DOI 10.1021/jf001059s; PARCERISA J, 1995, J AGR FOOD CHEM, V43, P13, DOI 10.1021/jf00049a004; Kuramitsu K, 2013, CHEM LETT, V42, P284, DOI 10.1246/cl.2013.284; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Kaijser A, 2000, FOOD CHEM, V71, P67, DOI 10.1016/S0308-8146(00)00132-1; Ralston AW, 1942, J ORG CHEM, V7, P546, DOI 10.1021/jo01200a013; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; CHAMBERLAIN NR, 1991, INFECT IMMUN, V59, P4332; Togashi N, 2007, MOLECULES, V12, P139, DOI 10.3390/12020139; Wille JJ, 2003, SKIN PHARMACOL APPL, V16, P176, DOI 10.1159/000069757; Nonomura Y, 2002, B CHEM SOC JPN, V75, P2305, DOI 10.1246/bcsj.75.2305; Ouattara B, 1997, INT J FOOD MICROBIOL, V37, P155, DOI 10.1016/S0168-1605(97)00070-6; GREENWAY DLA, 1979, J GEN MICROBIOL, V115, P233; Seidel V, 2004, INT J ANTIMICROB AG, V23, P613, DOI 10.1016/j.ijantimicag.2003.11.008; VOLD RD, 1951, J AM CHEM SOC, V73, P2006, DOI 10.1021/ja01149a032; BAGG J, 1964, J AM CHEM SOC, V86, P2759, DOI 10.1021/ja01068a001; Bojar R. A., 2004, CLIN DERMATOL, V22; Gaenier P., 1988, J MATER SCI, V23, P3225; HANSCH C, 1972, J PHARM SCI, V61, P1, DOI 10.1002/jps.2600610102; MATIJEVI.E, 1966, J COLLOID INTERF SCI, V22, P419, DOI 10.1016/0021-9797(66)90087-7; MATSUBAR.A, 1965, B CHEM SOC JPN, V38, P369, DOI 10.1246/bcsj.38.369; Peter M., 1983, J INVEST DERMATOL, V80, P44; Poulenat G, 2004, IND ENG CHEM RES, V43, P1574, DOI 10.1021/ie030508l; SOMERVIL.DA, 1969, BRIT J DERMATOL, VS 81, P14, DOI 10.1111/j.1365-2133.1969.tb12828.x; SOMERVIL.DA, 1969, BRIT J DERMATOL, V81, P248, DOI 10.1111/j.1365-2133.1969.tb13976.x; TAKEHARA M, 1989, COLLOID SURFACE, V38, P149, DOI 10.1016/0166-6622(89)80151-9; YOKE JT, 1958, J PHYS CHEM-US, V62, P753, DOI 10.1021/j150564a030	30	1	1	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	MAR	2015	64	3					283	288		10.5650/jos.ess14176		6	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CC3QV	WOS:000350265000005		
J	Nagai, N; Yamamoto, T; Tanabe, W; Ito, Y; Kurabuchi, S; Mitamura, K; Taga, A				Nagai, Noriaki; Yamamoto, Tetsushi; Tanabe, Wataru; Ito, Yoshimasa; Kurabuchi, Satoshi; Mitamura, Kuniko; Taga, Atsushi			Changes in Plasma Glucose in Otsuka Long-Evans Tokushima Fatty Rats After Oral Administration of Maple Syrup	JOURNAL OF OLEO SCIENCE			English	Article						maple syrup; plasma glucose; grade; type 2 diabetes mellitus; OUT test	PHYTOCHEMICALS; INHIBITION; COMPOUND; LIGNANS; SAP	We investigate whether maple syrup is a suitable sweetener in the management of type 2 diabetes using the Otsuka Long-Evans Tokushima Fatty (OLETF) rat. The enhancement in plasma glucose (PG) and glucose absorption in the small intestine were lower after the oral administration of maple syrup than after sucrose administration in OLETF rats, and no significant differences were observed in insulin levels. These data suggested that maple syrup might inhibit the absorption of glucose from the small intestine and preventing the enhancement of PG in OLETF rats. Therefore, maple syrup might help in the prevention of type 2 diabetes.	[Nagai, Noriaki; Yamamoto, Tetsushi; Tanabe, Wataru; Ito, Yoshimasa; Kurabuchi, Satoshi; Mitamura, Kuniko; Taga, Atsushi] Kinki Univ, Fac Pharm, Osaka 5778502, Japan	Taga, A (reprint author), Kinki Univ, Fac Pharm, 3-4-1 Kowakae, Osaka 5778502, Japan.	punk@phar.kindai.ac.jp					Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Li LY, 2010, J AGR FOOD CHEM, V58, P11673, DOI 10.1021/jf1033398; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Apostolidis E, 2011, J FUNCT FOODS, V3, P100, DOI 10.1016/j.jff.2011.03.003; Gonzalez-Sarrias A, 2012, PHYTOTHER RES, V26, P995, DOI 10.1002/ptr.3677; Ball DW, 2007, J CHEM EDUC, V84, P1647; Li LY, 2011, J FUNCT FOODS, V3, P125, DOI 10.1016/j.jff.2011.02.004; Li LY, 2011, J AGR FOOD CHEM, V59, P7708, DOI 10.1021/jf2011613; Gonzalez-Sarrias A, 2013, FOOD CHEM, V136, P636, DOI 10.1016/j.foodchem.2012.08.023; Perkins TD, 2009, ADV FOOD NUTR RES, V56, P101, DOI 10.1016/S1043-4526(08)00604-9; HAFFNER SM, 1992, DIABETES, V41, P715, DOI 10.2337/diabetes.41.6.715; DAVISON RM, 1973, PLANTA, V109, P95, DOI 10.1007/BF00385455; Legault J, 2010, J MED FOOD, V13, P460, DOI 10.1089/jmf.2009.0029; Nagai N, 2013, J OLEO SCI, V62, P737, DOI 10.5650/jos.62.737; Taga A, 2012, J OLEO SCI, V61, P45, DOI 10.5650/jos.61.45; Taga A, 2012, CHROMATOGRAPHIA, V75, P1009, DOI 10.1007/s10337-012-2199-3	16	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	MAR	2015	64	3					331	335		10.5650/jos.ess14075		5	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CC3QV	WOS:000350265000011		
J	Nagai, N; Yoshioka, C; Ito, Y				Nagai, Noriaki; Yoshioka, Chiaki; Ito, Yoshimasa			Topical Therapies for Rheumatoid Arthritis by Gel Ointments containing Indomethacin Nanoparticles in Adjuvant-Induced Arthritis Rat	JOURNAL OF OLEO SCIENCE			English	Article						nanoparticle; indomethacin; gel ointment; topical drug delivery; adjuvant-induced arthritis	ENHANCED TRANSDERMAL DELIVERY; DRUG-DELIVERY; IN-VIVO; PERCUTANEOUS-ABSORPTION; PLGA NANOPARTICLES; CORNEAL TOXICITY; EYE DROPS; IONTOPHORESIS; NANOMEDICINE; PERMEABILITY	Indomethacin (IMC), a nonsteroidal anti-inflammatory drug, has been used in the treatment of rheumatoid arthritis (RA), although its clinical use has been limited by its systemic side effects that include gastrointestinal lesions. Therefore, the development of IMC formulations that do not cause gastrointestinal lesions is highly anticipated. In this study, we designed new topical formulations containing IMC solid nanoparticles (IMCnano gel ointment), and investigated their pharmacokinetics. In addition, we demonstrate the preventive effects of this topical application of IMC nanoparticles on inflammation in adjuvant-induced arthritis rat (AA rat). The IMCnano gel ointment was prepared using Bead Smash 12 (a bead mill) and additives including 2-hydroxypropyl-beta-cyclodextrin, methylcellulose and Carbopol 934; the mean particle size of the IMC nanoparticles was 173 +/- 91 nm (means +/- S.D.). The application of the IMCnano gel ointment attenuated the increase in paw edema of the hind feet of AA rats in comparison with AA rats treated with gel ointment containing IMC microparticles (IMCmicro gel ointment, particle diameter 17.1 +/- 11.6 mu m, means S.D). In addition, the accumulation of IMC from the IMCnano gel ointment in skin tissue was significantly large than for the IMCmicro gel ointment; however, the plasma IMC concentrations were similar for the IMCmicro and IMCnano gel ointments. Our findings suggest that the dermal application of nanoparticles may enable a medication to be applied without high-systemic drug levels, which could provide efficient and effective therapy that spares patients from unwanted side effects. A formulation of a topical drug delivery system using IMC nanoparticles may provide a delivery option for the clinical treatment of RA.	[Nagai, Noriaki; Yoshioka, Chiaki; Ito, Yoshimasa] Kinki Univ, Fac Pharm, Osaka 5778502, Japan	Ito, Y (reprint author), Kinki Univ, Fac Pharm, 3-4-1 Kowakae, Osaka 5778502, Japan.	itoyoshi@phar.kindai.ac.jp					Al-Jamal Wafa T, 2009, Mol Pharm, V6, P520, DOI 10.1021/mp800187d; Kalia YN, 2004, ADV DRUG DELIVER REV, V56, P619, DOI 10.1016/j.addr.2003.10.026; Huang HC, 2011, J CONTROL RELEASE, V155, P344, DOI 10.1016/j.jconrel.2011.06.004; Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008; Kato S, 2009, J PHYSIOL PHARMACOL, V60, P147; Heyneman CA, 2000, DRUGS, V60, P555, DOI 10.2165/00003495-200060030-00004; Ahmed TA, 2011, PHARM DEV TECHNOL, V16, P497, DOI 10.3109/10837450.2010.495394; FRIES JF, 1989, GASTROENTEROLOGY, V96, P647; Kato S, 2001, YAKUGAKU ZASSHI, V121, P743, DOI 10.1248/yakushi.121.743; Ilbasmis-Tamer S, 2010, J BIOMED NANOTECHNOL, V6, P20, DOI 10.1166/jbn.2010.1099; Huang XH, 2010, ACS NANO, V4, P5887, DOI 10.1021/nn102055s; Debbage P, 2009, CURR PHARM DESIGN, V15, P153; Ricci M, 2005, J PHARM SCI-US, V94, P1149, DOI 10.1002/jps.20335; Nagai N, 2014, J OLEO SCI, V63, P177, DOI 10.5650/jos.ess13082; Williams AC, 2004, ADV DRUG DELIVER REV, V56, P603, DOI 10.1016/j.addr.2003.10.025; Escandell JM, 2007, J PHARMACOL EXP THER, V320, P581, DOI 10.1124/jpet.106.107003; Tomoda K, 2011, COLLOID SURFACE B, V88, P706, DOI 10.1016/j.colsurfb.2011.08.004; Denet AR, 2004, ADV DRUG DELIVER REV, V56, P659, DOI 10.1016/j.addr.2003.10.027; Sakuma S, 2001, INFLAMM RES, V50, P509, DOI 10.1007/PL00000227; Nagai N, 2014, BIOL PHARM BULL, V37, P1109; Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev; Nagai N, 2009, TOXICOLOGY, V255, P124, DOI 10.1016/j.tox.2008.10.005; Tomoda K, 2012, COLLOID SURFACE B, V92, P50, DOI 10.1016/j.colsurfb.2011.11.016; Cevc G, 2004, ADV DRUG DELIVER REV, V56, P675, DOI 10.1016/j.addr.2003.10.028; Mitragotri S, 2004, ADV DRUG DELIVER REV, V56, P589, DOI 10.1016/j.addr.2003.10.024; DeLouise LA, 2012, J INVEST DERMATOL, V132, P964, DOI 10.1038/jid.2011.425; Boisselier E, 2009, CHEM SOC REV, V38, P1759, DOI 10.1039/b806051g; Tomoda K, 2012, COLLOID SURFACE B, V97, P84, DOI 10.1016/j.colsurfb.2012.04.002; HELLEBERG L, 1981, CLIN PHARMACOKINET, V6, P245, DOI 10.2165/00003088-198106040-00001; Kato N, 2009, DIGEST DIS SCI, V54, P2346, DOI 10.1007/s10620-008-0646-7; Kato S, 2002, JPN J PHARMACOL, V89, P1, DOI 10.1254/jjp.89.1; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; FRANZ TJ, 1975, J INVEST DERMATOL, V64, P190, DOI 10.1111/1523-1747.ep12533356; Dobrovolskaia MA, 2008, MOL PHARMACEUT, V5, P487, DOI 10.1021/mp800032f; Maiden L, 2005, GASTROENTEROLOGY, V128, P1172, DOI 10.1053/j.gastro.2005.03.020; Toy R, 2014, NANOMEDICINE-UK, V9, P121, DOI 10.2217/nnm.13.191; Nagai N, 2014, BIOL PHARM BULL, V37, P96; Bjarnason I, 2013, INT J CLIN PRACT, V67, P37, DOI 10.1111/ijcp.12048; Begley DJ, 2004, PHARMACOL THERAPEUT, V104, P29, DOI 10.1016/j.pharmthera.2004.08.001; BILLINGHAM MEJ, 1983, PHARMACOL THERAPEUT, V21, P389, DOI 10.1016/0163-7258(83)90062-1; Chouly C, 1996, J MICROENCAPSUL, V13, P245, DOI 10.3109/02652049609026013; COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384; Consola S, 2007, CHEM-EUR J, V13, P3039, DOI 10.1002/chem.200601449; Doukas AG, 2004, ADV DRUG DELIVER REV, V56, P559, DOI 10.1016/j.addr.2003.10.031; Hultqvist M, 2006, PLOS MED, V3, P1625, DOI 10.1371/journal.pmed.0030348; Kristinsson JK, 1996, INVEST OPHTH VIS SCI, V37, P1199; Misra R., 2014, PHARM ANAL ACTA, V5, P279; MULLER BW, 1985, INT J PHARM, V26, P77, DOI 10.1016/0378-5173(85)90201-7; Nagai N, 2014, TOXICOLOGY, V319, P53, DOI 10.1016/j.tox.2014.02.012; NISHIHATA T, 1988, INT J PHARM, V46, P1; SLOAN KB, 1986, J PHARM SCI, V75, P744, DOI 10.1002/jps.2600750804; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879	52	1	1	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	MAR	2015	64	3					337	346		10.5650/jos.ess14170		10	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CC3QV	WOS:000350265000012		
J	Risbud, MV; Schoepflin, ZR; Mwale, F; Kandel, RA; Grad, S; Iatridis, JC; Sakai, D; Hoyland, JA				Risbud, Makarand V.; Schoepflin, Zachary R.; Mwale, Fackson; Kandel, Rita A.; Grad, Sibylle; Iatridis, James C.; Sakai, Daisuke; Hoyland, Judith A.			Defining the Phenotype of Young Healthy Nucleus Pulposus Cells: Recommendations of the Spine Research Interest Group at the 2014 Annual ORS Meeting	JOURNAL OF ORTHOPAEDIC RESEARCH			English	Article						nucleus pulposus; intervertebral disc; cell phenotype	HUMAN INTERVERTEBRAL DISC; MESENCHYMAL STEM-CELLS; NOTOCHORDAL CELLS; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; BACK-PAIN; ARTICULAR-CARTILAGE; MOUSE IMPLICATIONS; INTEGRIN SUBUNITS; PROGENITOR CELLS	Low back pain is a major physical and socioeconomic problem. Degeneration of the intervertebral disc and especially that of nucleus pulposus (NP) has been linked to low back pain. In spite of much research focusing on the NP, consensus among the research community is lacking in defining the NP cell phenotype. A consensus agreement will allow easier distinguishing of NP cells from annulus fibrosus (AF) cells and endplate chondrocytes, a better gauge of therapeutic success, and a better guidance of tissue-engineering-based regenerative strategies that attempt to replace lost NP tissue. Most importantly, a clear definition will further the understanding of physiology and function of NP cells, ultimately driving development of novel cell-based therapeutic modalities. The Spine Research Interest Group at the 2014 Annual ORS Meeting in New Orleans convened with the task of compiling a working definition of the NP cell phenotype with hope that a consensus statement will propel disc research forward into the future. Based on evaluation of recent studies describing characteristic NP markers and their physiologic relevance, we make the recommendation of the following healthy NP phenotypic markers: stabilized expression of HIF-1, GLUT-1, aggrecan/collagen II ratio >20, Shh, Brachyury, KRT18/19, CA12, and CD24. (c) 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 33:???-???, 2015.	[Risbud, Makarand V.; Schoepflin, Zachary R.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Risbud, Makarand V.; Schoepflin, Zachary R.] Thomas Jefferson Univ, Grad Program Cell & Dev Biol, Philadelphia, PA 19107 USA; [Mwale, Fackson] McGill Univ, Lady Davis Inst Med Res, Div Orthopaed Surg, Montreal, PQ H3T 1E2, Canada; [Kandel, Rita A.] Univ Toronto, Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Grad, Sibylle] AO Res Inst Davos, Davos, Switzerland; [Iatridis, James C.] Icahn Sch Med Mt Sinai, Dept Orthopaed, New York, NY 10029 USA; [Iatridis, James C.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Sakai, Daisuke] Tokai Univ, Sch Med, Dept Orthopaed Surg, Surg Sci, Isehara, Kanagawa 25911, Japan; [Hoyland, Judith A.] Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Ctr Tissue Injury & Repair, Manchester, Lancs, England	Risbud, MV (reprint author), Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA.	Makarand.risbud@jefferson.edu; facksonmwale@yahoo.ca			National Institutes of Arthritis and Musculoskeletal and Skin Diseases [R01AR055655, R01AR064733, R01AR050087, T32AR052273, R01AR064157, R01AR057397]; CIHR	Grant sponsor: National Institutes of Arthritis and Musculoskeletal and Skin Diseases; Grant numbers: R01AR055655 (MVR), R01AR064733 (MVR), R01AR050087 (MVR), T32AR052273 (ZRS), R01AR064157 (JCI), R01AR057397 (JCI); Grant sponsor: CIHR (RAK).	Agrawal A, 2007, AM J PHYSIOL-CELL PH, V293, pC621, DOI 10.1152/ajpcell.00538.2006; Agrawal A, 2008, ARTHRITIS RHEUM, V58, P3798, DOI 10.1002/art.24073; Allon AA, 2012, CELLS TISSUES ORGANS, V196, P99, DOI 10.1159/000332985; Risbud MV, 2007, SPINE, V32, P2537; Choi KS, 2012, MECH DEVELOP, V129, P255, DOI 10.1016/j.mod.2012.07.003; Minogue BM, 2010, ARTHRITIS RHEUM-US, V62, P3695, DOI 10.1002/art.27710; Choi KS, 2011, P NATL ACAD SCI USA, V108, P9484, DOI 10.1073/pnas.1007566108; Xia MS, 2008, CONNECT TISSUE RES, V49, P464, DOI 10.1080/03008200802325425; Weiler C, 2010, EUR SPINE J, V19, P1761, DOI 10.1007/s00586-010-1392-z; Nettles DL, 2004, J ANAT, V204, P515, DOI 10.1111/j.0021-8782.2004.00306.x; Le Maitre CL, 2007, BIOCHEM SOC T, V35, P652; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Yang F, 2009, J PATHOL, V218, P113, DOI 10.1002/path.2519; TROUT JJ, 1982, TISSUE CELL, V14, P359, DOI 10.1016/0040-8166(82)90033-7; Lee CR, 2007, EUR SPINE J, V16, P2174, DOI 10.1007/s00586-007-0475-y; Rutges J, 2010, OSTEOARTHR CARTILAGE, V18, P416, DOI 10.1016/j.joca.2009.09.009; Smolders LA, 2012, J ORTHOP RES, V30, P950, DOI 10.1002/jor.22000; Risbud MV, 2014, NAT REV RHEUMATOL, V10, P44, DOI 10.1038/nrrheum.2013.160; Williams CM, 2014, LANCET, V384, P1586, DOI 10.1016/S0140-6736(14)60805-9; Risbud MV, 2010, AM J PATHOL, V176, P1577, DOI 10.2353/ajpath.2010.090734; Fujita N, 2012, J BONE MINER RES, V27, P401, DOI 10.1002/jbmr.538; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Gogate SS, 2012, J BONE MINER RES, V27, P1106, DOI 10.1002/jbmr.1571; Kim JH, 2009, SPINE, V34, P2486, DOI 10.1097/BRS.0b013e3181b26ed1; Fujita N, 2005, BIOCHEM BIOPH RES CO, V338, P1890, DOI 10.1016/j.bbrc.2005.10.166; Shine KM, 2009, J BONE JOINT SURG AM, V91A, P2205, DOI 10.2106/JBJS.H.01344; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Uchii M, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2474; Iatridis JC, 2007, SPINE, V32, P1493, DOI 10.1097/BRS.0b013e318067dd3f; Fujita N, 2012, J BIOL CHEM, V287, P16975, DOI 10.1074/jbc.M111.334466; Chen J, 2009, CONNECT TISSUE RES, V50, P294, DOI 10.3109/03008200802714925; Tran CM, 2014, J BIOL CHEM, V289, P7374, DOI 10.1074/jbc.M113.526111; Tang YC, 2014, EXP THER MED, V7, P343, DOI 10.3892/etm.2013.1421; Onnerfjord P, 2012, J BIOL CHEM, V287, P18913, DOI 10.1074/jbc.M111.298968; Hirose Y, 2014, J BIOL CHEM, V289, P20594, DOI 10.1074/jbc.M114.565101; Gogate SS, 2011, ARTHRITIS RHEUM-US, V63, P1950, DOI 10.1002/art.30342; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Nelson AC, 2012, J PATHOL, V228, P274, DOI 10.1002/path.4082; Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1; McCann MR, 2012, DIS MODEL MECH, V5, P73, DOI 10.1242/dmm.008128; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Sakai D, 2009, SPINE, V34, P1448, DOI 10.1097/BRS.0b013e3181a55705; Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1; Chen Y, 2013, GENET MOL RES, V12, P1431, DOI 10.4238/2013.April.26.5; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Zeng Y, 2007, J BONE MINER RES, V22, P1851, DOI 10.1359/JBMR.070620; Zhao CQ, 2007, AGEING RES REV, V6, P247, DOI 10.1016/j.arr.2007.08.001; Gilchrist CL, 2011, EUR CELLS MATER, V21, P523; Bedore J, 2013, ARTHRITIS RHEUM-US, V65, P2634, DOI 10.1002/art.38075; Skubutyte R, 2010, ARTHRITIS RHEUM-US, V62, P2707, DOI 10.1002/art.27558; Gilchrist CL, 2007, J ORTHOP RES, V25, P829, DOI 10.1002/jor.20343; Chen J, 2006, EUR SPINE J, V15, pS303, DOI 10.1007/s00586-006-0088-x; Kim KW, 2003, SPINE, V28, P982, DOI 10.1097/00007632-200305150-00005; Risbud MV, 2011, CRIT REV EUKAR GENE, V21, P29; Bartels EM, 1998, SPINE, V23, P1, DOI 10.1097/00007632-199801010-00001; Bridgen DT, 2013, J ORTHOP RES, V31, P1661, DOI 10.1002/jor.22395; BUCKWALTER JA, 1995, SPINE, V20, P1307; Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075548; Chen K, 2013, GENET MOL BIOL, V36, P448, DOI 10.1590/S1415-47572013000300021; Clarke LE, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4505; Dahia CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035944; Dahia CL, 2009, SPINE, V34, P456, DOI 10.1097/BRS.0b013e3181913e98; Evans AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033346; Gilson A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2931; GUNER A, 1995, BIOCHEM SOC T, V23, pS212; Jay GD, 2014, MATRIX BIOL, V39, P17, DOI 10.1016/j.matbio.2014.08.008; Johnson ZI, 2014, MATRIX BIOL, V40, P10, DOI 10.1016/j.matbio.2014.08.014; Liu YX, 2015, J BIOMED MATER RES A, V103, P1053, DOI 10.1002/jbm.a.35243; LYONS GE, 1991, DEVELOPMENT, V111, P233; Maier JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055528; Merceron C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110768; Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929; Murakami H, 2010, MED BIOL ENG COMPUT, V48, P469, DOI 10.1007/s11517-010-0586-1; Mwale F, 2004, Eur Cell Mater, V8, P58; Ni L, 2014, SPINE J, V14, P2451, DOI 10.1016/j.spinee.2014.03.028; Power KA, 2011, ARTHRITIS RHEUM-US, V63, P3876, DOI 10.1002/art.30607; Purmessur D, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4302; Purmessur D, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3344; Rajpurohit R, 2002, CELL TISSUE RES, V308, P401, DOI 10.1007/s00441-002-0563-6; Richardson SM, 2008, HISTOCHEM CELL BIOL, V129, P503, DOI 10.1007/s00418-007-0372-9; Sakai D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2226; Shapiro IM, 2012, BONE, V50, P771, DOI 10.1016/j.bone.2011.12.004; SHVARTZMAN L, 1992, SPINE, V17, P176, DOI 10.1097/00007632-199202000-00010; Smolders LA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4157; Spillekom S, 2014, TISSUE ENG PART C-ME, V20, P652, DOI [10.1089/ten.TEC.2013.0479, 10.1089/ten.tec.2013.0479]; Sun Z, 2013, J ORTHOP RES, V31, P1804, DOI 10.1002/jor.22439; Tang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052020; van den Akker GGH, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4597; Wan R, 2012, MOL MED REP, V6, P16, DOI 10.3892/mmr.2012.859; Winkler T, 2014, PLOS ONE, V9, P98444	92	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-0266	1554-527X		J ORTHOP RES	J. Orthop. Res.	MAR	2015	33	3					283	293		10.1002/jor.22789		11	Orthopedics	Orthopedics	CC6JZ	WOS:000350472500002		
J	Sakata, S; Hayashi, S; Fujishiro, T; Kawakita, K; Kanzaki, N; Hashimoto, S; Iwasa, K; Chinzei, N; Kihara, S; Haneda, M; Ueha, T; Nishiyama, T; Kuroda, R; Kurosaka, M				Sakata, Shuhei; Hayashi, Shinya; Fujishiro, Takaaki; Kawakita, Kohei; Kanzaki, Noriyuki; Hashimoto, Shingo; Iwasa, Kenjiro; Chinzei, Nobuaki; Kihara, Shinsuke; Haneda, Masahiko; Ueha, Takeshi; Nishiyama, Takayuki; Kuroda, Ryosuke; Kurosaka, Masahiro			Oxidative Stress-induced Apoptosis and Matrix Loss of Chondrocytes Is Inhibited by Eicosapentaenoic Acid	JOURNAL OF ORTHOPAEDIC RESEARCH			English	Article						osteoarthritis; eicosapentaenoic acid; chondrocyte; matrix metalloproteinase	ARTICULAR-CARTILAGE; NITRIC-OXIDE; FATTY-ACIDS; OSTEOARTHRITIS; ARTHRITIS; PHOSPHORYLATION; DEGRADATION; DISEASE; MODEL; P53	Eicosapentaenoic acid (EPA) is an antioxidant and n-3 polyunsaturated fatty acid that reduces the production of inflammatory cytokines. We evaluated the role of EPA in chondrocyte apoptosis and degeneration. Normal human chondrocytes were treated with EPA and sodium nitroprusside (SNP). Expression of metalloproteinases (MMPs) was detected by real-time polymerase chain reaction (PCR) and that of apoptosis-related proteins was detected by western blotting. Chondrocyte apoptosis was detected by flow cytometry. C57BL/6J mice were used for the detection of MMP expression by immunohistochemistry and for investigation of chondrocyte apoptosis. EPA inhibited SNP-induced chondrocyte apoptosis, caspase 3 and poly(ADP-ribose) polymerase cleavage, phosphorylation of p38 MAPK and p53, and expression of MMP3 and MMP13. Intra-articular injection of EPA prevented the progression of osteoarthritis (OA) by inhibiting MMP13 expression and chondrocyte apoptosis. EPA treatment can control oxidative stress-induced OA progression, and thus may be a new approach for OA therapy. (c) 2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 33:???-???, 2015.	[Sakata, Shuhei; Hayashi, Shinya; Fujishiro, Takaaki; Kawakita, Kohei; Kanzaki, Noriyuki; Hashimoto, Shingo; Iwasa, Kenjiro; Chinzei, Nobuaki; Kihara, Shinsuke; Haneda, Masahiko; Ueha, Takeshi; Nishiyama, Takayuki; Kuroda, Ryosuke; Kurosaka, Masahiro] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Kobe, Hyogo 657, Japan	Hayashi, S (reprint author), Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Kobe, Hyogo 657, Japan.	shayashi@med.kobe-u.ac.jp					Abramson SB, 2008, OSTEOARTHR CARTILAGE, V16, pS15, DOI 10.1016/S1063-4584(08)60008-4; Kim HH, 2005, J LIPID RES, V46, P1712, DOI 10.1194/jlr.M500105-JLR200; Nakagawa S, 2010, J ORTHOP RES, V28, P156, DOI 10.1002/jor.20976; Takayama K, 2009, ARTHRITIS RHEUM, V60, P2731, DOI 10.1002/art.24864; Knott L, 2011, OSTEOARTHR CARTILAGE, V19, P1150, DOI 10.1016/j.joca.2011.06.005; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Grossi L, 2005, J MED CHEM, V48, P2622, DOI 10.1021/jm049857n; Hansen RA, 2008, J NUTR BIOCHEM, V19, P101, DOI 10.1016/j.jnutbio.2007.01.008; Curtis CL, 2002, ARTHRITIS RHEUM, V46, P1544, DOI 10.1002/art.10305; Mort JS, 2001, ARTHRITIS RES, V3, P337, DOI 10.1186/ar325; Zainal Z, 2009, OSTEOARTHR CARTILAGE, V17, P896, DOI 10.1016/j.joca.2008.12.009; Hashimoto S, 2012, OSTEOARTHR CARTILAGE, V20, P562, DOI 10.1016/j.joca.2012.01.022; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Kim SJ, 2002, J BIOL CHEM, V277, P33501, DOI 10.1074/jbc.M202862200; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523; Hashimoto S, 2009, ARTHRITIS RHEUM, V60, P2340, DOI 10.1002/art.24706; Iwasa K, 2014, J ORTHOP RES, V32, P231, DOI 10.1002/jor.22506; Rowan AD, 2001, EXPERT REV MOL MED, V3, P1; Scott DL, 1998, BRIT J RHEUMATOL, V37, P546; Takebe K, 2011, INT J MOL MED, V27, P329, DOI 10.3892/ijmm.2010.588	20	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-0266	1554-527X		J ORTHOP RES	J. Orthop. Res.	MAR	2015	33	3					359	365		10.1002/jor.22767		7	Orthopedics	Orthopedics	CC6JZ	WOS:000350472500011		
J	Zhang, M; Sonoda, T; Shiota, Y; Mishima, M; Yanai, H; Fujita, M; Taguchi, T				Zhang, Min; Sonoda, Takaaki; Shiota, Yoshihito; Mishima, Masaaki; Yanai, Hikaru; Fujita, Masaya; Taguchi, Takeo			Gas-phase acidity of 1,1-bis(trifluoromethanesulfonyl)propane derivatives and related compounds: experimental and theoretical studies	JOURNAL OF PHYSICAL ORGANIC CHEMISTRY			English	Article						1; 1-bis(trifluoromethanesulfonyl)propane; gas-phase acidity; intramolecular interaction	MUKAIYAMA-MICHAEL REACTION; ORGANIC-SYNTHESIS; CATALYST; SUPERACIDS	The gas-phase acidity (GA) of a series of 1,1-bis(trifluoromethanesulfonyl)propane derivatives, Tf2CHCH2CH(R-1)R-2, and Tf2CHCH2Ar (Ar=phenol derivatives) was determined by measuring proton-transfer equilibria using a Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometer and by computing the free energy of the deprotonated carbanions and the corresponding neutrals. The effects of R-1 and R-2 or Ar groups on the acidity were examined. In Tf2CHCH2CH(R-1)R-2, the GA values calculated using the conformers of neutral molecules that are free from the intramolecular hydrogen-bonding interaction between the acidic hydrogen atom of the Tf2CH moiety and R-1 or R-2 group and between the hydrogen atom of the (CHRR2)-R-1 moiety and the SO2CF3 group were correlated in terms of an equation, GA=-17.0 sigma sigma(I)+3.4 sigma sigma+299.5. On the basis of this correlation, it was elucidated that the intramolecular hydrogen bonding or dipole-dipole interaction in the neutral molecule weakens significantly the acidity. In Tf2CHCH2Ar (5, 6 and 7), the GA was strengthened by the strong hydrogen-bonding interaction between the phenolic hydrogen in the aromatic moiety and the SO2CF3 group in the conjugate anion compared with that in the neutral molecule. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Zhang, Min; Sonoda, Takaaki; Shiota, Yoshihito; Mishima, Masaaki] Kyushu Univ, Inst Mat Chem & Engn, Higashi Ku, Fukuoka 8128581, Japan; [Yanai, Hikaru; Fujita, Masaya; Taguchi, Takeo] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan	Mishima, M (reprint author), Kyushu Univ, Inst Mat Chem & Engn, Higashi Ku, Fukuoka 8128581, Japan.	mishima@ms.ifoc.kyushu-u.ac.jp			Joint Project of Chemical Synthesis Core Research Institutions, the Ministry of Education, Culture, Sport, Science and Technology, Japan	We are indebted to the Joint Project of Chemical Synthesis Core Research Institutions, the Ministry of Education, Culture, Sport, Science and Technology, Japan, for financial support.	Ishihara K, 2001, ANGEW CHEM INT EDIT, V40, P4077, DOI 10.1002/1521-3773(20011105)40:21<4077::AID-ANIE4077>3.0.CO;2-1; Vij A, 1997, COORDIN CHEM REV, V158, P413; KOPPEL IA, 1994, J AM CHEM SOC, V116, P3047, DOI 10.1021/ja00086a038; Kobayashi S, 2002, CHEM REV, V102, P2227, DOI 10.1021/cr010289i; Yanai H, 2010, CHEM COMMUN, V46, P8728, DOI 10.1039/c0cc02438d; Hickner MA, 2004, CHEM REV, V104, P4587, DOI 10.1021/cr020711a; Mauritz KA, 2004, CHEM REV, V104, P4535, DOI 10.1021/cr0207123; Antoniotti S, 2010, ANGEW CHEM INT EDIT, V49, P7860, DOI 10.1002/anie.200906407; DesMarteau DD, 2000, SCIENCE, V289, P72, DOI 10.1126/science.289.5476.72; Frisch M J, 2010, GAUSSIAN 09 REVISION; Ishihara K, 2002, SYNLETT, P1299; Koppel IA, 2000, J AM CHEM SOC, V122, P5114, DOI 10.1021/ja0000753; Leito I, 2009, J PHYS CHEM A, V113, P8421, DOI 10.1021/jp903780k; Taft RW, 1987, PROG PHYS ORG CHEM, V16, P1, DOI 10.1002/9780470171950.ch1; Takahashi A, 2008, CHEM COMMUN, P2385, DOI 10.1039/b800815a; Takahashi A, 2010, J ORG CHEM, V75, P1259, DOI 10.1021/jo902641g; Takasu K, 2009, SYNLETT, P1905, DOI 10.1055/s-0029-1217522; Yamamoto H., 2008, ACID CATALYSIS MODER, V1, P35; Yamamoto H., 2008, ACID CATALYSIS MODER; Yanai H, 2011, CHEM COMMUN, V47, P7245, DOI 10.1039/c1cc12093j; Yanai H, 2007, TETRAHEDRON LETT, V48, P2993, DOI 10.1016/j.tetlet.2007.02.131; Yanai H, 2010, J ORG CHEM, V75, P5375, DOI 10.1021/jo100915e; Yanai H, 2013, MOLECULES, V18, P15531, DOI 10.3390/molecules181215531; Yanai H, 2011, CHEM-EUR J, V17, P11747, DOI 10.1002/chem.201102023; Zhang M, 2013, B CHEM SOC JPN, V86, P813, DOI 10.1246/bcsj.20130052	25	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-3230	1099-1395		J PHYS ORG CHEM	J. Phys. Org. Chem.	MAR	2015	28	3			SI		181	186		10.1002/poc.3304		6	Chemistry, Organic; Chemistry, Physical	Chemistry	CC6JD	WOS:000350470300003		
J	Park, MS; Kim, SH; Sohn, S; Kim, GJ; Kim, YK; Sohn, JH				Park, Mi-Sook; Kim, Sook-Hee; Sohn, Sunju; Kim, Gap-Jung; Kim, Yeon-Kyu; Sohn, Jin-Hun			Brain activation during processing of angry facial expressions in patients with alcohol dependency	JOURNAL OF PHYSIOLOGICAL ANTHROPOLOGY			English	Article						Alcoholism; Anger; BOLD; Anterior cingulate cortex; Medial prefrontal cortex	ANTERIOR CINGULATE CORTEX; NEURAL RESPONSES; ANGER; PERSONALITY; HOSTILITY; DEFICITS; MEN	Background: Alcoholism is associated with abnormal anger processing. The purpose of this study was to investigate brain regions involved in the evaluation of angry facial expressions in patients with alcohol dependency. Methods: Brain blood-oxygenation-level-dependent (BOLD) responses to angry faces were measured and compared between patients with alcohol dependency and controls. Results: During intensity ratings of angry faces, significant differences in BOLD were observed between patients with alcohol dependency and controls. That is, patients who were alcohol-dependent showed significantly greater activation in several brain regions, including the dorsal anterior cingulate cortex (dACC) and medial prefrontal cortex (MPFC). Conclusions: Following exposure to angry faces, abnormalities in dACC and MPFC activation in patients with alcohol dependency indicated possible inefficiencies or hypersensitivities in social cognitive processing.	[Park, Mi-Sook; Sohn, Jin-Hun] Chungnam Natl Univ, Dept Psychol, Taejon 305764, South Korea; [Kim, Sook-Hee] Wonkwang Univ, Grad Sch Hlth & Complementary Med, Iksan 570749, Jeonbuk, South Korea; [Sohn, Sunju] Cheongju Univ, Dept Social Welf, Cheongju 363764, Chungcheongbuk, South Korea; [Kim, Gap-Jung] Hanmaum Alcohol Treatment Ctr, Dept Psychiat, Taejon, South Korea; [Kim, Yeon-Kyu] Kyushu Univ, Fac Design, Grad Sch Integrated Frontier Sci, Dept Ind Design,Minami Ku, Fukuoka 8158540, Japan	Kim, YK (reprint author), Kyushu Univ, Fac Design, Grad Sch Integrated Frontier Sci, Dept Ind Design,Minami Ku, 4-9-1 Shiobaru, Fukuoka 8158540, Japan.	yk-kim@design.kyushu-u.ac.jp; jhsohn@cnu.ac.kr			National Research Foundation of Korea - Korean Government [NRF-2006-2005087]	This research paper is made possible through the help and support from Ms. Jihye Noh and Ms. Ji-Eun Park. I would like to thank Ms. Jihye Noh for her most support in order to conduct the fMRI experiment with alcoholic patients. Ms. Ji-Eun Park kindly read my paper and offered invaluable detailed advices on grammar, organization, and the theme of the paper. I would like to also thank to my participants who made this study possible. This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (No. NRF-2006-2005087).	Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Kelly JF, 2009, ADDICT RES THEORY, V17, P236, DOI 10.1080/16066350902770458; van der Helm E, 2010, SLEEP, V33, P335; Ochsner KN, 2008, BIOL PSYCHIAT, V64, P48, DOI 10.1016/j.biopsych.2008.04.024; Denson TF, 2009, J COGNITIVE NEUROSCI, V21, P734, DOI 10.1162/jocn.2009.21051; Brower KJ, 2003, SLEEP MED REV, V7, P523, DOI 10.1053/smrv.2002.0248; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Handelsman L, 2000, ADDICT BEHAV, V25, P423, DOI 10.1016/S0306-4603(99)00010-6; Philippot P, 1999, ALCOHOL CLIN EXP RES, V23, P1031, DOI 10.1097/00000374-199906000-00010; Gasquoine PG, 2013, NEUROSCI BIOBEHAV R, V37, P340, DOI 10.1016/j.neubiorev.2013.01.002; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Eisenberger NI, 2004, TRENDS COGN SCI, V8, P294, DOI 10.1016/j.tics.2004.05.010; Dougherty DD, 1999, BIOL PSYCHIAT, V46, P466, DOI 10.1016/S0006-3223(99)00063-3; Salloum JB, 2007, ALCOHOL CLIN EXP RES, V31, P1490, DOI 10.1111/j.1530-0277.2007.00447.x; Denson TF, 2014, J COGNITIVE NEUROSCI, V26, P1418, DOI 10.1162/jocn_a_00592; Kim JS, 1998, J KOREAN ACAD FAMILY, V19, P304; Lee D.K., 2000, J KOREAN ACAD ADDICT, V4, P30; Lyons MJ, 1998, 3 IEEE P INT C AUT F; McNair D. M., 1971, MANUAL PROFILE MOOD; Park BK, 2000, J KOREAN ACAD FAMILY, V21, P1427; Parrott DJ, 2003, ALCOHOL CLIN EXP RES, V27, P937, DOI 10.1097/01.ALC.0000071923.78618.5B; SCHONWETTER DJ, 1991, PERS INDIV DIFFER, V12, P1049, DOI 10.1016/0191-8869(91)90034-9; Talairach J., 1988, COPLANAR STEREOTAXIC; Tivis LJ, 1998, ALCOHOL CLIN EXP RES, V22, P902, DOI 10.1097/00000374-199806000-00021	25	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1880-6791	1880-6805		J PHYSIOL ANTHROPOL	J. Physiol. Anthropol.	MAR 1	2015	34								6	10.1186/s40101-015-0046-6		8	Physiology	Physiology	CC6TS	WOS:000350502200001		
J	Ohyama, K; Takasago, S; Kishikawa, N; Kuroda, N				Ohyama, Kaname; Takasago, Shizuka; Kishikawa, Naoya; Kuroda, Naotaka			Poly(L-lactic acid)-modified silica stationary phase for reversed-phase and hydrophilic interaction liquid chromatography	JOURNAL OF SEPARATION SCIENCE			English	Article						Hydrophilic interaction chromatography; Mixed-mode chromatography; Poly(L-lactic acid); Reversed-phase chromatography	PERFORMANCE; MODE; POLAR	Poly(L-lactic acid) is a linear aliphatic thermoplastic polyester that can be produced from renewable resources. A poly(L-lactic acid)-modified silica stationary phase was newly prepared by amide bond reaction between amino groups on aminopropyl silica and carboxylic acid groups at the end of the poly(L-lactic acid) chain. The poly(L-lactic acid)-silica column was characterized in reversed-phase liquid chromatography and hydrophilic interaction liquid chromatography with the use of different mobile phase compositions. The poly(L-lactic acid)-silica column was found to work in both modes, and the retention of test compounds depending on acetonitrile content exhibited "U-shaped" curves, which was an indicator of reversed-phase liquid chromatography/hydrophilic interaction liquid chromatography mixed-mode retention behavior. In addition, carbonyl groups included into the poly(L-lactic acid) backbone work as an electron-accepting group toward a polycyclic aromatic hydrocarbon and provide pi-pi interactions.	[Ohyama, Kaname; Takasago, Shizuka; Kishikawa, Naoya; Kuroda, Naotaka] Nagasaki Univ, Grad Sch Biomed Sci, Course Pharmaceut Sci, Nagasaki 852, Japan	Kuroda, N (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Course Pharmaceut Sci, Nagasaki 852, Japan.	n-kuro@nagasaki-u.ac.jp					Greco G, 2013, J SEP SCI, V36, P1379, DOI 10.1002/jssc.201200920; Ma Q, 2008, J CHROMATOGR A, V1212, P61, DOI 10.1016/j.chroma.2008.10.007; Nam YS, 1999, BIOMATERIALS, V20, P1783, DOI 10.1016/S0142-9612(99)00073-3; Shundo A, 2005, J CHROMATOGR A, V1073, P169, DOI 10.1016/j.chroma.2004.08.062; Li YY, 2011, CHROMATOGRAPHIA, V74, P523, DOI 10.1007/s10337-011-2120-5; Rasal RM, 2010, PROG POLYM SCI, V35, P338, DOI 10.1016/j.progpolymsci.2009.12.003; Ohyama K, 2014, J CHROMATOGR A, V1371, P257, DOI 10.1016/j.chroma.2014.10.073; Liu XD, 2008, J CHROMATOGR A, V1191, P83, DOI 10.1016/j.chroma.2007.12.012; Guo ZM, 2009, J CHROMATOGR A, V1216, P257, DOI 10.1016/j.chroma.2008.11.071; de Aragdo NM, 2005, TALANTA, V67, P1007, DOI 10.1016/j.talanta.2005.04.066; GuanSajonz H, 1996, J CHROMATOGR A, V743, P247, DOI 10.1016/0021-9673(96)00300-7; Liang XJ, 2014, J SEP SCI, V37, P1371, DOI 10.1002/jssc.201400005; Wu JY, 2008, J SEP SCI, V31, P1492, DOI 10.1002/jssc.200800017	13	4	4	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1615-9306	1615-9314		J SEP SCI	J. Sep. Sci.	MAR	2015	38	5					720	723		10.1002/jssc.201401243		4	Chemistry, Analytical	Chemistry	CC2VD	WOS:000350201900003		
J	Daryakenari, AA; Apostoluk, A; Aradilla, D; Sadki, S; Delaunay, JJ				Daryakenari, Ahmad Ahmadi; Apostoluk, Alexandra; Aradilla, David; Sadki, Said; Delaunay, Jean-Jacques			Pulse electropolymerization synthesis of PPy(DBS) nanoparticle layers	JOURNAL OF SOLID STATE ELECTROCHEMISTRY			English	Article						PPy(DBS); Nanoparticle; Pulse electropolymerization; Progressive mechanism	SENSITIZED SOLAR-CELLS; ORIENTED PYROLYTIC-GRAPHITE; POLYPYRROLE NANOPARTICLES; CONDUCTING POLYMERS; POLY(THIOPHENE-3-ACETIC ACID); ELECTROCHEMICAL DEPOSITION; DODECYLBENZENE SULFONATE; ACTIVATION-ENERGY; COUNTER ELECTRODE; GROWTH-MECHANISM	A one-step process using a pulse electropolymerization technique is used to fabricate nanoparticles of polypyrrole (PPy) with dodecyl benzene sulfonate (DBS) anions from an aqueous solution without template and without using any chemical additives. The morphology of particles is controlled by changing the pulse duration (from 120 to 0.5 s), while keeping the relaxation time constant at 15 s. Short pulses resulted in the formation of PPy(DBS) nanoparticles with an average particle size of about 50 nm. The control of the size of the PPy(DBS) nanoparticles is ascribed to a pulse electropolymerization growth mechanism, whereby progressive nucleation associated with two-dimensional growth is initiated at each new pulse cycle from the equilibrium electrolyte solution. Short pulses are needed to avoid nonuniform growth of nanoparticles and control the particle size. Sufficiently long relaxation time is required to restore the equilibrium concentrations in the vicinity of the working electrode by suppressing the double layer. Combining short pulses with sufficiently long relaxation times enables the formation of PPy(DBS) nanoparticles. The proposed short-pulse technique is meant to be applied to the fabrication of a wide range of nanostructured conductive polymers.	[Daryakenari, Ahmad Ahmadi; Delaunay, Jean-Jacques] Univ Tokyo, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Apostoluk, Alexandra] Lyon Univ, INSA Lyon, CNRS, INL,UMR 5270, Lyon, France; [Aradilla, David; Sadki, Said] Grenoble Univ, CEA Grenoble, CEA, CNRS,UJF,SPrAM,UMR5819, Grenoble, France	Delaunay, JJ (reprint author), Univ Tokyo, Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	jean@mech.t.u-tokyo.ac.jp	Delaunay, Jean-Jacques/A-2841-2010		Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25630019]; JSPS Core-to-Core Program, Advanced Research Networks (A)	This work was supported by Grants-in-Aid for Scientific Research (25630019) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) and by JSPS Core-to-Core Program, Advanced Research Networks (A).	Jeon SS, 2011, J PHYS CHEM C, V115, P22035, DOI 10.1021/jp206535c; Sadki S, 2000, CHEM SOC REV, V29, P283; Arkhipov VI, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.045214; Crowley K, 2003, J ELECTROANAL CHEM, V547, P75, DOI 10.1016/S0022-0728(03)00191-8; Hwang BJ, 2000, J ELECTROCHEM SOC, V147, P2252, DOI 10.1149/1.1393516; JOHN R, 1991, J ELECTROANAL CHEM, V306, P157, DOI 10.1016/0022-0728(91)85228-H; Smela E, 1999, ADV MATER, V11, P953; Au KM, 2011, ADV MATER, V23, P5792, DOI 10.1002/adma.201103190; Yang K, 2012, ADV MATER, V24, P5586, DOI 10.1002/adma.201202625; Zha ZB, 2013, ADV MATER, V25, P777, DOI 10.1002/adma.201202211; Zheng W, 2012, LANGMUIR, V28, P10891, DOI 10.1021/la301701g; Pecher J, 2010, CHEM REV, V110, P6260, DOI 10.1021/cr100132y; Xiao YM, 2012, ELECTROCHIM ACTA, V83, P221, DOI 10.1016/j.electacta.2012.07.113; Frutos FJG, 2007, ELECTROCHIM ACTA, V52, P3621, DOI 10.1016/j.electacta.2006.10.021; Jeon SS, 2011, J MATER CHEM, V21, P8146, DOI 10.1039/c1jm10112a; Dubal DP, 2012, J MATER CHEM, V22, P3044, DOI 10.1039/c2jm14470k; Bay L, 2001, J PHYS CHEM B, V105, P8492, DOI 10.1021/jp003872w; Zhang LL, 2009, CHEM SOC REV, V38, P2520, DOI 10.1039/b813846j; Liu Z, 2011, CHEM COMMUN, V47, P4421, DOI 10.1039/c1cc10208g; Wu JH, 2008, J POWER SOURCES, V181, P172, DOI 10.1016/j.jpowsour.2008.03.029; Kwon OS, 2010, J PHYS CHEM C, V114, P18874, DOI 10.1021/jp1083086; Sharma RK, 2008, ELECTROCHEM COMMUN, V10, P268, DOI 10.1016/j.elecom.2007.12.004; BADE K, 1992, ELECTROCHIM ACTA, V37, P2255, DOI 10.1016/0013-4686(92)85120-A; BJORKLUND RB, 1986, J CHEM SOC CHEM COMM, P1293, DOI 10.1039/c39860001293; Bruckenstein S, 2009, ELECTROCHIM ACTA, V54, P3516, DOI 10.1016/j.electacta.2008.11.061; Castagno KRL, 2011, MATER CHEM PHYS, V130, P721, DOI 10.1016/j.matchemphys.2011.07.052; Hwang BJ, 2001, ELECTROCHIM ACTA, V46, P2843, DOI 10.1016/S0013-4686(01)00495-9; Karami H, 2012, ELECTROCHIM ACTA, V61, P154, DOI 10.1016/j.electacta.2011.11.097; Karimi H, 2013, INT J ELECTROCHEM SC, V8, P8905; KUWABATA S, 1988, J CHEM SOC CHEM COMM, P779, DOI 10.1039/c39880000779; Lee KKC, 2012, ADV MATER, V24, P1243, DOI 10.1002/adma.201104170; Li F, 1992, ADV MATER, V10, P673; LI FB, 1992, ELECTROCHIM ACTA, V37, P393, DOI 10.1016/0013-4686(92)87027-W; LI FB, 1992, LANGMUIR, V8, P1645, DOI 10.1021/la00042a025; Nam DH, 2013, J MATER CHEM A, V1, P8061, DOI 10.1039/c3ta11227f; Otero TF, 2011, J SOLID STATE ELECTR, V15, P1169, DOI 10.1007/s10008-010-1170-1; Otero TF, 2008, ELECTROCHIM ACTA, V53, P3166, DOI 10.1016/j.electacta.2007.10.072; Paisal R, 2011, ELECTROCHIM ACTA, V56, P6345, DOI 10.1016/j.electacta.2011.05.024; Quant CA, 2008, COLLOID SURFACE A, V317, P129, DOI 10.1016/j.colsurfa.2007.10.004; West R, 2008, LANGMUIR, V24, P11076, DOI 10.1021/la800774z	40	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1432-8488	1433-0768		J SOLID STATE ELECTR	J. Solid State Electrochem.	MAR	2015	19	3					655	661		10.1007/s10008-014-2647-0		7	Electrochemistry	Electrochemistry	CC6NJ	WOS:000350481600004		
J	Oine, T; Maeda, H; Tsuzuki, T; Nakayama, M; Kasuga, T				Oine, Takahiro; Maeda, Hirotaka; Tsuzuki, Tatsuya; Nakayama, Masanobu; Kasuga, Toshihiro			Relationship between electrical conductivities and structure of hybrid materials derived from mixtures of zinc phosphate glasses with different phosphate-chain lengths and benzimidazole	JOURNAL OF SOLID STATE ELECTROCHEMISTRY			English	Article						Electrical conductivity; Hybrid; Zinc phosphate glass; Benzimidazole; Phosphate-chain length	MOLECULAR-DYNAMICS; FUEL-CELLS; PROTON; MEMBRANE; IMIDAZOLE	Here, we report unique anhydrous proton-conducting hybrid materials derived from mixtures of benzimidazole and zinc metaphosphate glass. Benzimidazole, which melts at 170 A degrees C, caused breaking of the phosphate chains in the glasses, resulting in the formation of hybrid materials. In the present work, various hybrid materials were prepared to clarify the effects of parent glass composition on their electrical conductivities. In the case of 53P(2)O(5) A center dot 47ZnO glass, which contains Qp (1) and Qp (2) and Qp (3) groups, the phosphate chains were broken easily to form benzimidazole and Qp (0) groups. Qp (n) , where n is the number of bridging oxygens to neighboring tetrahedral, describes the bonding of PO4 tetrahedron. Hybrids prepared using benzimidazole and 42P(2)O(5) A center dot 58ZnO glass (which contains many Qp (1) groups) formed the smallest amounts of the Qp (0) group-containing products. The hybrid material prepared with 53P(2)O(5) A center dot 47ZnO glass showed the highest conductivity (e.g., similar to 1 mS/cm at 190 A degrees C). The electrical conductivities of the hybrid materials may be related to the amounts of Qp (0) group-containing products and benzimidazole.	[Oine, Takahiro; Kasuga, Toshihiro] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Maeda, Hirotaka] Nagoya Inst Technol, Ctr Innovat Young Researchers, Showa Ku, Nagoya, Aichi 4668555, Japan; [Tsuzuki, Tatsuya] Cent Glass Co Ltd, Matsusaka, Mie 5450001, Japan; [Nakayama, Masanobu] Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan	Maeda, H (reprint author), Nagoya Inst Technol, Ctr Innovat Young Researchers, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	maeda.hirotaka@nitech.ac.jp					ABE Y, 1988, PHYS REV B, V38, P10166, DOI 10.1103/PhysRevB.38.10166; Roziere J, 2003, ANNU REV MATER RES, V33, P503, DOI 10.1146/annurev.matsci.33.022702.154657; Shao ZG, 2006, SOLID STATE IONICS, V177, P779, DOI 10.1016/j.ssi.2005.12.035; Sahin E, 2002, J MOL STRUCT, V616, P259, DOI 10.1016/S0022-2860(02)00345-9; Pu HT, 2006, ELECTROCHIM ACTA, V51, P5612, DOI 10.1016/j.electacta.2006.02.035; Divisek J, 1998, ELECTROCHIM ACTA, V43, P3811, DOI 10.1016/S0013-4686(98)00140-6; Karadedeli B, 2005, PHYSICA B, V364, P279, DOI 10.1016/j.physb.2005.04.024; Tischendorf B, 2001, J NON-CRYST SOLIDS, V282, P147, DOI 10.1016/S0022-3093(01)00350-7; Chen C, 2009, POLYM DEGRAD STABIL, V94, P1436, DOI 10.1016/j.polymdegradstab.2009.05.016; Jalani NH, 2005, ELECTROCHIM ACTA, V51, P553, DOI 10.1016/j.electacta.2005.05.016; Tischendorf BC, 2003, J NON-CRYST SOLIDS, V316, P261, DOI 10.1016/S0022-3093(02)01795-7; Munch W, 2001, SOLID STATE IONICS, V145, P437, DOI 10.1016/S0167-2738(01)00941-9; Yamada M, 2004, J PHYS CHEM B, V108, P5522, DOI 10.1021/jp030767o; Wiench JW, 2000, J NON-CRYST SOLIDS, V263, P101, DOI 10.1016/S0022-3093(99)00671-7; Dupuis AC, 2011, PROG MATER SCI, V56, P289, DOI 10.1016/j.pmatsci.2010.11.001; Li QF, 2009, PROG POLYM SCI, V34, P449, DOI 10.1016/j.progpolymsci.2008.12.003; BROW RK, 1995, J NON-CRYST SOLIDS, V191, P45, DOI 10.1016/0022-3093(95)00289-8; ANVARI SF, 1991, J MATER SCI, V26, P3639, DOI 10.1007/BF00557156; Kasuga T, 2009, ELECTROCHEM SOLID ST, V12, pB5, DOI 10.1149/1.3028638; Kato H, 2012, MATER LETT, V79, P109, DOI 10.1016/j.matlet.2012.04.025; Lakshminarayana G, 2010, J ELECTROCHEM SOC, V157, pB892, DOI 10.1149/1.3383025; Nakayama M, 2011, PHYS CHEM CHEM PHYS, V13, P9439, DOI 10.1039/c0cp02789h; Oh SY, 2012, ELECTROCHIM ACTA, V75, P11, DOI 10.1016/j.electacta.2012.04.141; Palavit G, 1998, J AM CERAM SOC, V81, P1521	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1432-8488	1433-0768		J SOLID STATE ELECTR	J. Solid State Electrochem.	MAR	2015	19	3					907	912		10.1007/s10008-014-2677-7		6	Electrochemistry	Electrochemistry	CC6NJ	WOS:000350481600029		
J	Toyama, S; Takesue, M; Aida, TM; Watanabe, M; Smith, RL				Toyama, Suguru; Takesue, Masafumi; Aida, Taku M.; Watanabe, Masaru; Smith, Richard L., Jr.			Easy emission-color-control of Mn-doped zinc silicate phosphor by use of pH and supercritical water conditions	JOURNAL OF SUPERCRITICAL FLUIDS			English	Article						Emission color control; Zinc silicate; Hydrothermal reaction; pH control; Supercritical water	LUMINESCENCE PROPERTIES; NANOPARTICLES; PRESSURES; MECHANISM; PHASE; TEMPERATURES; SOLUBILITY; PARTICLES; ZN2SIO4	Emission of Zn2SiO4:Mn2+ can be readily controlled to have continuously variable colors between green and yellow by adjusting the pH of the starting solutions in supercritical water syntheses. Mostly single phase beta-Zn2SiO4:Mn2+ exhibiting yellow emission was formed at a pH of 10.5. By changing pH of the starting solution from low values (ca. 2.8) to high values (ca. 12.5), emission color could be proportionally varied from green emission to yellow emission because the amount of each phase was found to change. The selectivity of alpha- and beta-Zn2SiO4 crystallization in supercritical water is strongly related to the solubility of dissolved species of the zinc ion source, Zn(OH)(2) in water. Photoluminescence results showed that the reaction atmosphere determines emission color over a wide range of dominant wavelengths, 534-571 nm, according to the crystalline phases formed. The use of pH with supercritical water allows a simple control strategy for emission color control of Zn2SiO4:Mn2+ phosphors. (C) 2015 Elsevier B.V. All rights reserved.	[Toyama, Suguru; Takesue, Masafumi; Watanabe, Masaru; Smith, Richard L., Jr.] Tohoku Univ, Res Ctr Supercrit Fluid Technol, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Aida, Taku M.; Smith, Richard L., Jr.] Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Sendai, Miyagi 9808579, Japan	Smith, RL (reprint author), Tohoku Univ, Res Ctr Supercrit Fluid Technol, Aoba Ku, 6-6-11 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	mapirossi65@yahoo.co.jp; smith@scf.che.tohoku.ac.jp	Smith Jr, Richard/E-3495-2012	Smith Jr, Richard/0000-0002-9174-7681			Adschiri T, 2011, GREEN CHEM, V13, P1380, DOI 10.1039/c1gc15158d; TAYLOR HFW, 1962, AM MINERAL, V47, P932; Takesue M, 2009, J SUPERCRIT FLUID, V49, P351, DOI 10.1016/j.supflu.2009.03.007; Kusaba K, 2008, SOLID STATE COMMUN, V148, P382, DOI 10.1016/j.ssc.2008.09.039; Byrappa K, 2007, PROG CRYST GROWTH CH, V53, P117, DOI 10.1016/j.pcrysgrow.2007.04.001; Gerya TV, 2005, EUR J MINERAL, V17, P269, DOI 10.1127/0935-1221/2005/0017-0269; Takesue M, 2009, PROG CRYST GROWTH CH, V55, P98, DOI 10.1016/j.pcrysgrow.2009.09.001; Kaseda K, 2011, J SUPERCRIT FLUID, V58, P279, DOI 10.1016/j.supflu.2011.06.009; Hayashi H, 2010, MATERIALS, V3, P3794, DOI 10.3390/ma3073794; An JS, 2010, J PHYS CHEM C, V114, P10330, DOI 10.1021/jp911731s; Hoppe HA, 2009, ANGEW CHEM INT EDIT, V48, P3572, DOI 10.1002/anie.200804005; Feldmann C, 2003, ADV FUNCT MATER, V13, P511, DOI 10.1002/adfm.200301005; Jiang YQ, 2010, MATER CHEM PHYS, V120, P313, DOI 10.1016/j.matchemphys.2009.11.002; El Mir L, 2014, SUPERLATTICE MICROST, V65, P248, DOI 10.1016/j.spmi.2013.11.006; Mai M, 2009, SOLID STATE SCI, V11, P528, DOI 10.1016/j.solidstatesciences.2008.09.017; Hayashi H, 2010, J CRYST GROWTH, V312, P1968, DOI 10.1016/j.jcrysgro.2010.03.034; Wan JX, 2006, J LUMIN, V121, P32, DOI 10.1016/j.jlumin.2005.09.015; Sui RH, 2012, CHEM REV, V112, P3057, DOI 10.1021/cr2000465; Wagner W, 2002, J PHYS CHEM REF DATA, V31, P387, DOI 10.1063/1.1461829; Wang LL, 2008, J PHYS CHEM C, V112, P18882, DOI 10.1021/jp806392a; Bertail C, 2011, CHEM MATER, V23, P2961, DOI 10.1021/cm2005902; Baes Jr C.F., 1986, HYDROLYSIS CATIONS, P287; FOURNIER RO, 1982, GEOCHIM COSMOCHIM AC, V46, P1969, DOI 10.1016/0016-7037(82)90135-1; Kim YI, 2010, NUCL INSTRUM METH B, V268, P346, DOI 10.1016/j.nimb.2009.09.056; Kubal M, 2001, SEPAR SCI TECHNOL, V36, P3223, DOI 10.1081/SS-100107769; Mathieu R, 1998, REMOTE SENS ENVIRON, V66, P17, DOI 10.1016/S0034-4257(98)00030-3; MIYATA T, 1994, J LUMIN, V60-1, P926, DOI 10.1016/0022-2313(94)90314-X; Ramakrishna PV, 2014, SPECTROCHIM ACTA A, V129, P274, DOI 10.1016/j.saa.2014.03.081; Shibuki K, 2010, J SUPERCRIT FLUID, V54, P266, DOI 10.1016/j.supflu.2010.05.007; Suino A, 2013, MATER CHEM PHYS, V137, P1025, DOI 10.1016/j.matchemphys.2012.11.020; Takesue M, 2007, J SUPERCRIT FLUID, V43, P214, DOI 10.1016/j.supflu.2007.04.014; Takesue M, 2008, J SOLID STATE CHEM, V181, P1307, DOI 10.1016/j.jssc.2008.02.036; Takesue M, 2008, J CRYST GROWTH, V310, P4185, DOI 10.1016/j.jcrysgro.2008.06.068; Takesue M, 2010, MATER CHEM PHYS, V121, P330, DOI 10.1016/j.matchemphys.2010.01.051; Ye RG, 2011, J PHYS CHEM C, V115, P10851, DOI 10.1021/jp2023633	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0896-8446	1872-8162		J SUPERCRIT FLUID	J. Supercrit. Fluids	MAR	2015	98						65	69		10.1016/j.supflu.2015.01.007		5	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CC7AB	WOS:000350519000008		
J	Mohamed, A; Ardyani, T; Sagisaka, M; Ono, SJ; Narumi, T; Kubota, M; Brown, P; James, C; Eastoe, J; Kamari, A; Hashim, N; Isa, IM; Abu Bakar, S				Mohamed, Azmi; Ardyani, Tretya; Sagisaka, Masanobu; Ono, Shinji; Narumi, Tsuyoshi; Kubota, Makoto; Brown, Paul; James, Craig; Eastoe, Julian; Kamari, Azlan; Hashim, Norhayati; Isa, Illyas Md; Abu Bakar, Suriani			Economical and Efficient Hybrid Surfactant with Low Fluorine Content for the Stabilisation of Water-in-CO2 Microemulsions	JOURNAL OF SUPERCRITICAL FLUIDS			English	Article						CO2-philic surfactant; Supercritical carbon dioxide (sc-CO2); W/c microemulsions; Branching factor	SUPERCRITICAL CARBON-DIOXIDE; WATER/SUPERCRITICAL CO2 MICROEMULSION; HYDROCARBON CO2-PHILIC SURFACTANTS; INTERFACIAL PROPERTIES; SILVER NANOPARTICLES; GREEN SOLVENTS; FLUOROCARBON SURFACTANTS; IONIC SURFACTANTS; CHAIN STRUCTURE; PHASE-BEHAVIOR	The relationship between the tail architecture and performance of hybrid AOT analogue surfactants has been investigated. Three hybrid surfactants were synthesised using hydrocarbon CO2-philic tails with different levels of chain branching. The performance of each surfactant was investigated via high-pressure phase behaviour, UV-visible spectroscopy, and air water (a/w) surface tension measurements. Notably, the incorporation of hydrocarbon CO2-philic tails with a high degree of branching has been found to significantly boost CO2-philicity, allowing the surfactant to stabilise water-in-CO2 (w/c) microemulsions at low cloud pressures, P-trans. The newly synthesised hybrid CF2/SIS1 (sodium (4H, 4H, 5H, 5H, 5H-pentafluoropenyl-5,7,7-trimethyl-2-(1,3,3-trimethyl-buthyl)-octyl)-2-sulfosuccinate) is a CO2-philic surfactant that contains the lowest amount of fluorine (15.01 wt%) and exhibits the highest efficiency of any di-chain surfactant to date. High-pressure phase behaviour studies provided a maximum water-to-surfactant molar ratio (w(max)) of % w(max) = 39, which is usually only observed from surfactants with long fluorocarbon chains. The present results are beneficial for expanding the pool of economical, effective, and efficient surfactants available for CO2-based technology. (C) 2015 Elsevier B.V. All rights reserved.	[Mohamed, Azmi; Ardyani, Tretya; Kamari, Azlan; Hashim, Norhayati; Isa, Illyas Md] Univ Pendidikan Sultan Idris, Fac Sci & Math, Dept Chem, Tanjong Malim 35900, Perak, Malaysia; [Mohamed, Azmi; Kamari, Azlan; Hashim, Norhayati; Isa, Illyas Md; Abu Bakar, Suriani] Univ Pendidikan Sultan Idris, Fac Sci & Math, Nanotechnol Res Ctr, Tanjong Malim 35900, Perak, Malaysia; [Sagisaka, Masanobu; Ono, Shinji; Narumi, Tsuyoshi; Kubota, Makoto; James, Craig] Hirosaki Univ, Grad Sch Sci & Technol, Dept Frontier Mat Chem, Hirosaki, Aomori 0368561, Japan; [Brown, Paul] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Eastoe, Julian] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	Mohamed, A (reprint author), Univ Pendidikan Sultan Idris, Fac Sci & Math, Dept Chem, Tanjong Malim 35900, Perak, Malaysia.	azmi.mohamed@fsmt.upsi.edu.my	Mohamed, Azmi/A-2345-2013; Sagisaka, Masanobu/F-1706-2013; Abu Bakar, Suriani/A-4169-2013	Mohamed, Azmi/0000-0001-7310-6680; Sagisaka, Masanobu/0000-0001-9685-7524; 	University Research Grant (GPU-UPSI) [2012-0113-102-01]; Research Acculturation Grant Scheme (RAGS) [2013-0001-101-72]; Malaysia Toray Science Foundation (MTSF) [2012-0138-102-11]; National Nanotechnology Directorate Division Research Grant; NND Grant [2014-0015-102-03]; Universiti Pendidikan Sultan Idris; JSPS; Leading Research Organizations under the G8 Research Councils Initiative for Multilateral Research	The authors thank the University Research Grant (GPU-UPSI; Grant code: 2012-0113-102-01), the Research Acculturation Grant Scheme (RAGS; Grant code: 2013-0001-101-72), the Malaysia Toray Science Foundation (MTSF; Grant code: 2012-0138-102-11), National Nanotechnology Directorate Division Research Grant; (NND Grant code: 2014-0015-102-03) and the Universiti Pendidikan Sultan Idris for financial and facilities support. MS thanks JSPS and Leading Research Organizations under the G8 Research Councils Initiative for Multilateral Research Funding-G8-2012.	Anand M, 2006, J PHYS CHEM B, V110, P14693, DOI 10.1021/jp0614401; Du L, 2009, J SUPERCRIT FLUID, V47, P447, DOI 10.1016/j.supflu.2008.11.011; Fan X, 2005, J AM CHEM SOC, V127, P11754, DOI 10.1021/ja0520387v; Iverson BD, 2013, APPL ENERG, V111, P957, DOI 10.1016/j.apenergy.2013.06.020; Mohamed A, 2011, LANGMUIR, V27, P10562, DOI 10.1021/la2021885; Ji M, 1999, J AM CHEM SOC, V121, P2631, DOI 10.1021/ja9840403; Dhanuka VV, 2006, J COLLOID INTERF SCI, V298, P406, DOI 10.1016/j.jcis.2005.11.057; Eastoe J, 2002, LANGMUIR, V18, P3014, DOI 10.1021/la015576w; Eastoe J, 2000, PHYS CHEM CHEM PHYS, V2, P5235, DOI 10.1039/b005858k; Liu JC, 2002, LANGMUIR, V18, P3086, DOI 10.1021/la011721u; Nave S, 2000, LANGMUIR, V16, P8733, DOI 10.1021/la000341q; Stone MT, 2003, J PHYS CHEM B, V107, P10185, DOI 10.1021/jp035422k; Cummings S, 2012, BIOCHIMIE, V94, P94, DOI 10.1016/j.biochi.2011.06.021; Beckman EJ, 2004, J SUPERCRIT FLUID, V28, P121, DOI 10.1016/S0896-8446(03)00029-9; Honari A, 2013, INT J GREENH GAS CON, V19, P234, DOI 10.1016/j.ijggc.2013.08.016; Orellana JL, 2013, J SUPERCRIT FLUID, V79, P55, DOI 10.1016/j.supflu.2013.01.022; Liu JC, 2003, FLUID PHASE EQUILIBR, V211, P265, DOI 10.1016/S0378-3812(03)00221-8; Mohamed A, 2012, LANGMUIR, V28, P6299, DOI 10.1021/la3005322; Ito A, 1996, LANGMUIR, V12, P5768, DOI 10.1021/la960240l; Eastoe J, 2003, CURR OPIN COLLOID IN, V8, P267, DOI 10.1016/S1359-0294(03)00053-0; Nagarajan R, 2002, LANGMUIR, V18, P31, DOI 10.1021/la010831y; Jessop PG, 2011, GREEN CHEM, V13, P1391, DOI 10.1039/c0gc00797h; Eastoe J, 2003, J COLLOID INTERF SCI, V258, P367, DOI 10.1016/S0021-9797(02)00104-2; Mohamed A, 2010, LANGMUIR, V26, P13861, DOI 10.1021/la102303q; Cooper AI, 2001, ADV MATER, V13, P1111, DOI 10.1002/1521-4095(200107)13:14<1111::AID-ADMA1111>3.0.CO;2-L; Estevez C, 2009, RSC GREEN CHEM SER, P407, DOI 10.1039/9781847552686-00407; Krafft MP, 2003, CURR OPIN COLLOID IN, V8, P213, DOI 10.1016/S1359-0294(03)00057-8; Alexander S, 2014, LANGMUIR, V30, P3413, DOI 10.1021/la500332s; Cummings S, 2012, SOFT MATTER, V8, P7044, DOI 10.1039/c2sm25735a; Hussain YA, 2012, IND ENG CHEM RES, V51, P11401, DOI 10.1021/ie3014007; Chen X, 2010, J SUPERCRIT FLUID, V55, P712, DOI 10.1016/j.supflu.2010.08.019; Adkins SS, 2010, J COLLOID INTERF SCI, V346, P455, DOI 10.1016/j.jcis.2009.12.059; Dupont A, 2004, LANGMUIR, V20, P9960, DOI 10.1021/la0483820; DeSimone JM, 2002, SCIENCE, V297, P799, DOI 10.1126/science.1069622; Hollamby MJ, 2009, ANGEW CHEM INT EDIT, V48, P4993, DOI 10.1002/anie.200901543; Capello C, 2007, GREEN CHEM, V9, P927, DOI 10.1039/b617536h; Anastas P, 2010, CHEM SOC REV, V39, P301, DOI 10.1039/b918763b; Johnston KP, 1996, SCIENCE, V271, P624, DOI 10.1126/science.271.5249.624; Sagisaka M, 2008, LANGMUIR, V24, P10116, DOI 10.1021/la8014145; Wai CM, 2003, ACS SYM SER, V860, P2; Eastoe J, 2012, CURR OPIN COLLOID IN, V17, P266, DOI 10.1016/j.cocis.2012.06.006; Ryoo W, 2003, IND ENG CHEM RES, V42, P6348, DOI 10.1021/ie0300427; [Anonymous], 2000, RE PHAS OUT PLANPOSF; Weibel GL, 2003, MICROELECTRON ENG, V65, P145, DOI 10.1016/S0167-9317(02)00747-5; Sagisaka M, 2003, LANGMUIR, V19, P8161, DOI 10.1021/la027040w; Eastoe J, 2006, LANGMUIR, V22, P9832, DOI 10.1021/la060764d; Eastoe J, 2001, J AM CHEM SOC, V123, P988, DOI 10.1021/ja005795o; Sagisaka M, 2011, LANGMUIR, V27, P5772, DOI 10.1021/la104990c; Krafft MP, 2001, ADV DRUG DELIVER REV, V47, P209, DOI 10.1016/S0169-409X(01)00107-7; Eastoe J, 2000, LANGMUIR, V16, P4511, DOI 10.1021/la991564n; Blanchard LA, 1999, NATURE, V399, P28, DOI 10.1038/19887; McClain JB, 1996, SCIENCE, V274, P2049, DOI 10.1126/science.274.5295.2049; Aratono M, 2005, SURF SCI CRC, V124, P1; Bell PW, 2005, LANGMUIR, V21, P11608, DOI 10.1021/la052392z; Consani K.A., 1990, J SUPERCRIT FLUID, V3, P51, DOI 10.1016/0896-8446(90)90008-A; Dalvi VH, 2010, J PHYS CHEM C, V114, P15553, DOI 10.1021/jp102047e; Dean Jr, 2000, METH BIOTEC, V13, P17; Dickson JL, 2005, IND ENG CHEM RES, V44, P1370, DOI 10.1021/ie048999c; Downer A, 1999, LANGMUIR, V15, P7591, DOI 10.1021/la990549f; Dupont A, 2004, LANGMUIR, V20, P9953, DOI 10.1021/la048447z; Eastoe J, 2007, AUST J CHEM, V60, P630, DOI 10.1071/CH07117; Eastoe J, 2005, PHYS CHEM CHEM PHYS, V7, P1352, DOI 10.1039/b418985j; Gold S, 2006, COLLOID POLYM SCI, V284, P1333, DOI 10.1007/s00396-006-1519-2; HARRISON K, 1994, LANGMUIR, V10, P3536, DOI 10.1021/la00022a028; Hutton BH, 1999, COLLOID SURFACE A, V146, P227, DOI 10.1016/S0927-7757(98)00792-4; Mallakapour S., 2012, GREEN SOLVENTS, P1; Mohamed A., 2011, SCH SCI REV, V93, P73; Pitt AR, 1996, COLLOID SURFACE A, V114, P321, DOI 10.1016/0927-7757(96)03593-5; Sagisaka M, 2003, LANGMUIR, V19, P220, DOI 10.1021/la020340t; Sagisaka M, 2013, J OLEO SCI, V62, P481, DOI 10.5650/jos.62.481; Sagisaka M, 2004, LANGMUIR, V20, P2560, DOI 10.1021/la036074g; Sagisaka M, 2012, LANGMUIR, V28, P10988, DOI 10.1021/la301305q; Sagisaka M, 2007, LANGMUIR, V23, P2369, DOI 10.1021/la062789i; Sagisaka M, 2013, LANGMUIR, V29, P7618, DOI 10.1021/la400376g; Sagisaka M., 2008, J JPN SOC COLOUR MAT, V81, P331; Sagisaka M, 2014, LANGMUIR, V30, P6057, DOI 10.1021/la501328s; Sagisaka M, 2009, J OLEO SCI, V58, P75, DOI 10.5650/jos.58.75; Sagisaka M, 2010, J SUPERCRIT FLUID, V53, P131, DOI 10.1016/j.supflu.2009.12.016; Scamehorn J.F., 1986, PHENOMENA MIXED SURF, P1; Stone MT, 2004, J PHYS CHEM B, V108, P1962, DOI 10.1021/jp036224w; Stubenrauch C., 2009, MICROEMULSIONS BACKG, P2; Tabor RF, 2006, LANGMUIR, V22, P963, DOI 10.1021/la052418m; USEPA, VOLT ORG COMP VOCS T; YOSHINO N, 1995, LANGMUIR, V11, P466, DOI 10.1021/la00002a016; Young JL, 2011, RSC GREEN CHEM SER, P44, DOI 10.1039/9781849732963-00044	85	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0896-8446	1872-8162		J SUPERCRIT FLUID	J. Supercrit. Fluids	MAR	2015	98						127	136		10.1016/j.supflu.2015.01.012		10	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CC7AB	WOS:000350519000015		
J	Ohtani, M; Okimoto, Y; Oishi, Y; Wang, PY; Kobiro, K				Ohtani, Masataka; Okimoto, Yuki; Oishi, Yuya; Wang, Pengyu; Kobiro, Kazuya			Insight into alcohol reduction by saccharides and their homologues in supercritical water via aldehyde-mediated radical formation	JOURNAL OF SUPERCRITICAL FLUIDS			English	Article						Direct alcohol reduction; Saccharide-derived compounds; Supercritical water; alpha-Hydroxyaldehyde	SECONDARY ALCOHOLS; SUBCRITICAL WATER; ORGANIC-SYNTHESIS; VERLEY REDUCTION; 2-PROPANOL; HYDROGENATION; TEMPERATURES; PRESSURES; MECHANISM; BECKMANN	Benzhydrol was directly reduced to diphenylmethane by alpha-hydroxyaldehydes and dialdehyde, being saccharide degradates, without using a hydride reagent, in supercritical water at 400 degrees C for 10 min. A lower-temperature reaction in subcritical water at 300 degrees C primarily generated 1,1,2,2-tetraphenylethane. A plausible reaction pathway was proposed, involving radical formation via the degradation of hemiacetal intermediates derived from benzhydrol and aldehydes. (C) 2014 Elsevier B.V. All rights reserved.	[Ohtani, Masataka; Okimoto, Yuki; Oishi, Yuya; Wang, Pengyu; Kobiro, Kazuya] Kochi Univ Technol, Sch Environm Sci & Engn, Kami, Kochi 7828502, Japan	Kobiro, K (reprint author), Kochi Univ Technol, Sch Environm Sci & Engn, 185 Miyanokuchi, Kami, Kochi 7828502, Japan.	kobiro.kazuya@kochi-tech.ac.jp	OHTANI, Masataka/B-5616-2013	OHTANI, Masataka/0000-0003-1016-1812			Anikeev V., 2014, SUPERCRITICAL FLUID, P1; Savage PE, 2010, RSC ENERGY ENVIRON S, P192; Wakui H, 2004, J AM CHEM SOC, V126, P8658, DOI 10.1021/ja0477874; Honma T, 2014, J SUPERCRIT FLUID, V90, P1, DOI 10.1016/j.supflu.2014.03.007; Wang PY, 2011, J CHEM ENG JPN, V44, P577, DOI 10.1252/jcej.10we308; Wang PY, 2010, J SUPERCRIT FLUID, V52, P222, DOI 10.1016/j.supflu.2009.12.013; Aida TM, 2007, J SUPERCRIT FLUID, V42, P110, DOI 10.1016/j.supflu.2006.12.017; Wang PY, 2011, J SUPERCRIT FLUID, V58, P360, DOI 10.1016/j.supflu.2011.07.009; Chen X, 2012, J SUPERCRIT FLUID, V62, P178, DOI 10.1016/j.supflu.2011.10.022; Chheda JN, 2007, GREEN CHEM, V9, P342, DOI 10.1039/b611568c; Aida TM, 2010, J SUPERCRIT FLUID, V55, P208, DOI 10.1016/j.supflu.2010.08.013; Promdej C, 2011, IND ENG CHEM RES, V50, P8492, DOI 10.1021/ie200298c; Kobiro K, 2013, J SUPERCRIT FLUID, V77, P63, DOI 10.1016/j.supflu.2013.02.012; Sasaki M, 2002, GREEN CHEM, V4, P285, DOI 10.1039/b203968k; Kabyemela BM, 1997, IND ENG CHEM RES, V36, P5063, DOI 10.1021/ie9704354; Kabyemela BM, 1998, IND ENG CHEM RES, V37, P357, DOI 10.1021/ie9704408; Nolen SA, 2003, GREEN CHEM, V5, P663, DOI 10.1039/b308499j; Arita T, 2003, TETRAHEDRON LETT, V44, P1083, DOI 10.1016/S0040-4039(02)02704-1; Boero M, 2004, J AM CHEM SOC, V126, P6280, DOI 10.1021/ja049363f; Daimon A, 2006, J SUPERCRIT FLUID, V37, P215, DOI 10.1016/j.supflu.2005.09.001; Ikushima Y, 2000, J AM CHEM SOC, V122, P1908, DOI 10.1021/ja9925251; Ikushima Y, 1999, ANGEW CHEM INT EDIT, V38, P2910, DOI 10.1002/(SICI)1521-3773(19991004)38:19<2910::AID-ANIE2910>3.0.CO;2-C; Ikushima Y, 2001, ANGEW CHEM INT EDIT, V40, P210, DOI 10.1002/1521-3773(20010105)40:1<210::AID-ANIE210>3.3.CO;2-Z; Itami K, 2003, J AM CHEM SOC, V125, P6058, DOI 10.1021/ja034227g; Kamitanaka T, 2003, TETRAHEDRON LETT, V44, P4551, DOI 10.1016/S0040-4039(03)00975-4; Kamitanaka T, 2009, J SUPERCRIT FLUID, V49, P221, DOI 10.1016/j.supflu.2009.01.006; Kamitanaka T, 2007, TETRAHEDRON, V63, P1429, DOI 10.1016/j.tet.2006.11.071; Kobiro K, 2009, TETRAHEDRON, V65, P807, DOI 10.1016/j.tet.2008.11.074; Lermontov SA, 2003, J FLUORINE CHEM, V121, P223, DOI 10.1016/S0022-1139(03)00036-8; Li C. I., 1997, ORGANIC REACTIONS AQ; Lindstrom U.M., 2007, ORGANIC REACTIONS WA, P1; Marcus Y., 2012, SUPERCRITICAL WATER, P1; Sominsky L, 2004, J ORG CHEM, V69, P1492, DOI 10.1021/jo035251f; Takahashi H, 2002, CHEM PHYS LETT, V363, P80, DOI 10.1016/S0009-2614(02)01142-9; Wang PY, 2007, B CHEM SOC JPN, V80, P1828, DOI 10.1246/bcsj.80.1828; Waterlot C, 2000, CAN J CHEM, V78, P1242; Zhang R, 2003, CHEM COMMUN, P1548, DOI 10.1039/b302683c	37	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0896-8446	1872-8162		J SUPERCRIT FLUID	J. Supercrit. Fluids	MAR	2015	98						147	152		10.1016/j.supflu.2014.11.017		6	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CC7AB	WOS:000350519000017		
J	Ishizuka, M; Kubota, K; Kita, J; Shimoda, M; Kato, M; Mori, S; Iso, Y; Yamagishi, H; Kojima, M				Ishizuka, Mitsuru; Kubota, Keiichi; Kita, Junji; Shimoda, Mitsugi; Kato, Masato; Mori, Shozo; Iso, Yukihiro; Yamagishi, Hidetsugu; Kojima, Masaru			Aspartate aminotransferase-to-platelet ratio index is associated with liver cirrhosis in patients undergoing surgery for hepatocellular carcinoma	JOURNAL OF SURGICAL RESEARCH			English	Article						Aspartate aminotransferase-to-platelet ratio index; Fibrosis marker; Hepatocellular carcinoma; Liver cirrhosis	OXALIPLATIN-BASED CHEMOTHERAPY; CHRONIC HEPATITIS-C; TRANSIENT ELASTOGRAPHY; FIBROSIS; DISEASE; BIOPSY; RESECTION; PEPTIDE; MARKER; FIBROGENESIS	Background: Among various preoperative evaluations of liver function, accurate assessment of liver cirrhosis (LC) is especially important in patients undergoing surgery for hepatocellular carcinoma (HCC). Objective: To explore the most significant laboratory parameter associated with LC in patients undergoing surgery for HCC. Methods: From among 588 HCC patients in our collected database who underwent liver surgery, 371 for whom sufficient laboratory data were evaluable, including direct serum fibrosis markers such as hyaluronic acid and type 3 procollagen peptide (P-3-P), were enrolled. Receiver operating characteristic (ROC) curve analysis was used to define the ideal cutoff values of laboratory parameters, and the area under the ROC curve for LC was measured. Univariate and multivariate analyses were performed to clarify the laboratory parameter most significantly associated with LC. Results: Multivariate analysis of 13 laboratory parameters that had been selected by univariate analysis showed that the aspartate aminotransferase-to-platelet ratio index (APRI) (<= 0.8/>0.8) (odds ratio, 2.687; 95% confidence interval 1.215-5.940; P = 0.015) was associated with LC, along with the aspartate aminotransferase to alanine aminotransferase ratio, the indocyanine green retention ratio at 15 min (ICG R15), and the level of hyaluronic acid. Among these four parameters associated with LC, ROC curve analysis revealed that APRI (0.757) had the largest area under the ROC (aspartate aminotransferase to alanine aminotransferase 0.505, ICG R15 0.714, and hyaluronic acid 0.743). Conclusions: APRI is closely associated with LC in patients undergoing surgery for HCC. (C) 2015 Elsevier Inc. All rights reserved.	[Ishizuka, Mitsuru; Kubota, Keiichi; Kita, Junji; Shimoda, Mitsugi; Kato, Masato; Mori, Shozo; Iso, Yukihiro] Dokkyo Med Univ, Dept Surg Gastroenterol, Mibu, Tochigi 3210293, Japan; [Yamagishi, Hidetsugu; Kojima, Masaru] Dokkyo Med Univ, Anat & Diagnost Pathol, Mibu, Tochigi 3210293, Japan	Ishizuka, M (reprint author), Dokkyo Med Univ, Dept Surg Gastroenterol, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	mm-ishizuka@umin.ac.jp					Cadranel JF, 2000, HEPATOLOGY, V32, P477, DOI 10.1053/jhep.2000.16602; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Ratziu V, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-6; Schmeltzer PA, 2011, GASTROENTEROL CLIN N, V40, P507, DOI 10.1016/j.gtc.2011.06.010; Rubbia-Brandt L, 2004, ANN ONCOL, V15, P460, DOI 10.1093/annonc/mdh095; ENGSTROMLAURENT A, 1985, HEPATOLOGY, V5, P638, DOI 10.1002/hep.1840050420; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Cucchetti A, 2012, WORLD J GASTROENTERO, V18, P6398, DOI 10.3748/wjg.v18.i44.6398; HOPEROSS M, 1994, OPHTHALMOLOGY, V101, P529; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Talwalkar JA, 2007, CLIN GASTROENTEROL H, V5, P1214, DOI 10.1016/j.cgh.2007.07.020; Rockey DC, 2006, HEPATOLOGY, V43, pS113, DOI 10.1002/hep.21046; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Soubrane O, 2010, ANN SURG, V251, P454, DOI 10.1097/SLA.0b013e3181c79403; Imamura H, 2003, ARCH SURG-CHICAGO, V138, P1198, DOI 10.1001/archsurg.138.11.1198; MENGHINI G, 1958, GASTROENTEROLOGY, V35, P190; BABBS C, 1988, LANCET, V1, P1021; Talwalkar JA, 2008, HEPATOLOGY, V47, P332, DOI 10.1002/hep.21972; Xia F, 2012, ANN SURG ONCOL, V19, P1284, DOI 10.1245/s10434-011-2042-3; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Overman MJ, 2010, J CLIN ONCOL, V28, P2549, DOI 10.1200/JCO.2009.27.5701; Pares A, 1996, HEPATOLOGY, V24, P1399, DOI 10.1002/hep.510240615; Halfon P, 2002, COMP HEPATOL, V1, P3, DOI 10.1186/1476-5926-1-3; Laharie D, 2006, ALIMENT PHARM THERAP, V23, P1621, DOI 10.1111/j.1365-2036.2006.02929.x; Makuuchi M, 1998, HEPATO-GASTROENTEROL, V45, P1267; MIYAGAWA S, 1995, AM J SURG, V169, P589, DOI 10.1016/S0002-9610(99)80227-X; Sebastiani G, 2007, WORLD J GASTROENTERO, V13, P525; Tanwar S, 2013, HEPATOLOGY, V57, P103, DOI 10.1002/hep.26030; TORRESSALINAS M, 1986, GASTROENTEROLOGY, V90, P1241	30	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAR	2015	194	1					63	68		10.1016/j.jss.2014.09.009		6	Surgery	Surgery	CC5FH	WOS:000350384000009		
J	Hashiba, M; Huq, A; Tomino, A; Hirakawa, A; Hattori, T; Miyabe, H; Tsuda, M; Takeyama, N				Hashiba, Masamitsu; Huq, Aminul; Tomino, Atsutoshi; Hirakawa, Akihiko; Hattori, Tomonori; Miyabe, Hiromichi; Tsuda, Masanobu; Takeyama, Naoshi			Neutrophil extracellular traps in patients with sepsis	JOURNAL OF SURGICAL RESEARCH			English	Article						Neutrophil extracellular traps; Sepsis; Cell-free DNA; Myeloperoxidase; Neutrophil elastase; Immunofluorescence staining; E coli	SEPTIC SHOCK; ORGAN FAILURE; EXPRESSION; DNA; STREPTOCOCCUS; GUIDELINES; SEVERITY; CAPTURE; ESCAPE; ALLOWS	Background: Release of neutrophil extracellular traps (NETs) has been identified as an important aspect of innate immunity. We examined whether sepsis had any influence on ex vivo generation of NETs by neutrophils. Materials and methods: We isolated neutrophils from consecutive patients with sepsis (n = 17) and without sepsis (n = 18) admitted to the intensive care unit. Neutrophils were activated by incubation with phorbol-12-myristate-13-acetate (PMA) to induce release of NETs, and NET formation was assessed by measuring the extracellular DNA level. Immunolabeling and fluorescence imaging were also performed. Extracellular killing of bacteria by NETs was studied by co-culture of Escherichia coli and neutrophils in the presence of a phagocytosis inhibitor. To assess in vivo NET formation, plasma levels of cell-free DNA and histones were measured. Results: After stimulation with PMA, neutrophils isolated from septic patients released 4.08 +/- 1.02% of their total DNA, whereas neutrophils from nonseptic patients released 29.06 +/- 2.94% (P = <0.0001). Immunofluorescent staining of released DNA, elastase, and myeloperoxidase also revealed similar results. Neutrophils from nonseptic patients showed effective extracellular killing of E coli through NETs, whereas neutrophils from septic patients did not (P < 0.001). Plasma levels of cell-free DNA and histones were higher in septic patients than nonseptic patients (P < 0.001). Conclusions: The ex vivo generation of NETs is downregulated in neutrophils isolated from patients with sepsis. However, it is unclear whether in vivo NET formation is also impaired during sepsis, so further investigation is necessary. (C) 2015 Elsevier Inc. All rights reserved.	[Hashiba, Masamitsu; Huq, Aminul; Tomino, Atsutoshi; Hirakawa, Akihiko; Hattori, Tomonori; Miyabe, Hiromichi; Tsuda, Masanobu; Takeyama, Naoshi] Fujita Hlth Univ, Dept Emergency & Acute Intens Care Med, Toyoake, Aichi 4701192, Japan	Takeyama, N (reprint author), Fujita Hlth Univ, Dept Emergency & Acute Intens Care Med, Toyoake, Aichi 4701192, Japan.	takeyama@fujita-hu.ac.jp					KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Saukkonen K, 2008, CLIN CHEM, V54, P1000, DOI 10.1373/clinchem.2007.101030; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Taylor NJ, 2013, HEPATOLOGY, V57, P1142, DOI 10.1002/hep.26102; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Margraf S, 2008, SHOCK, V30, P352, DOI 10.1097/SHK.0b013e31816a6bb1; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Pillay J, 2010, J LEUKOCYTE BIOL, V88, P211, DOI 10.1189/jlb.1209793; Keshari RS, 2012, CYTOM PART A, V81A, P238, DOI 10.1002/cyto.a.21178; Martins PS, 2003, SHOCK, V20, P208, DOI 10.1097/01.shk.0000079425.52617.db; Drifte G, 2013, CRIT CARE MED, V41, P820, DOI 10.1097/CCM.0b013e318274647d; Reddy RC, 2010, CURR OPIN HEMATOL, V17, P18, DOI 10.1097/MOH.0b013e32833338f3; Warren HS, 2010, J INFECT DIS, V201, P223, DOI 10.1086/649557; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Barrientos L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00166; Brinkmann V., 2010, JOVE-J VIS EXP, V36, P1724, DOI DOI 10.3791/1724/J0VE.C0M/VIDE0/1724; Guimaraes-Costa AB, 2006, P NATL ACAD SCI USA, V106, P6748; Hirose T, 2012, AM J RESP CRIT CARE, V185, P1130; Kaufmann I, 2006, SHOCK, V26, P254, DOI 10.1097/01.shk.0000223131.64512.7a; Makkar Manisha, 2013, J Clin Neonatol, V2, P25, DOI 10.4103/2249-4847.109243; Meng W, 2012, CRIT CARE, V16, DOI 10.1186/cc11442; MOORE FD, 1991, ARCH SURG-CHICAGO, V126, P70; Narayana MA, 2013, FRONT IMMUNOL, V4, P1; Nicholson JKA, 1996, CYTOMETRY, V26, P16; Tomino A, 2013, J CLIN INVEST UPDATE, V1, P3; TSCHAIKOWSKY K, 1993, CLIN INVESTIGATOR, V72, P18; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; WENISCH C, 1995, CLIN DIAGN LAB IMMUN, V2, P241; ZHANG P, 1994, SHOCK, V2, P133, DOI 10.1097/00024382-199408000-00009	37	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAR	2015	194	1					248	254		10.1016/j.jss.2014.09.033		7	Surgery	Surgery	CC5FH	WOS:000350384000032		
J	Vyssotski, M; Lagutin, K; MacKenzie, A; Itabashi, Y				Vyssotski, Mikhail; Lagutin, Kirill; MacKenzie, Andrew; Itabashi, Yutaka			Chemical Synthesis and Gas Chromatographic Behaviour of gamma-Stearidonic (18:4n-6) Acid	JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY			English	Article						Stearidonic; Delta 3 PUFA; Octadecatetraenoic; Octadecapentaenoic; GC; GC-MS; NMR	POLYUNSATURATED FATTY-ACIDS; GC-MS; IDENTIFICATION; DERIVATIVES; CONVERSION; TISSUES; SAMPLES; LIPIDS	gamma-Stearidonic acid, 18:4n-6, a potential product of beta-oxidation of arachidonic acid (20:4n-6), was only recently positively identified in a living organism-a thermophilic cyanobacterium Tolypothrix sp., albeit at low levels, whilst some indirect evidence suggests its wider presence, e.g. in a unicellular marine alga. We have prepared 18:4n-6 using an iodolactonisation chain-shortening approach from 22:5n-6 and obtained its H-1-, C-13-, COSY- and HSQC NMR spectra, with 18:5n-3 spectra also recorded for a comparison. The GC and GC-MS behaviour of its methyl ester was also studied. Like another Delta 3 polyunsaturated acid, octadecapentaenoic (18:5n-3), 18:4n-6 rapidly yields 2-trans isomer upon formation of dimethyloxazoline derivative. On a polar ionic liquid phase (SLB-IL100, 200 A degrees C) the methyl ester could be mistaken for 18:3n-3, while on methylsilicone phase (BP1, 210 A degrees C) it eluted ahead of 18:3n-6 and 18:4n-3, suggesting that when present it may be easily misidentified during GC analysis of fatty acids.	[Vyssotski, Mikhail; Lagutin, Kirill; MacKenzie, Andrew] Callaghan Innovat, Lower Hutt 5040, New Zealand; [Itabashi, Yutaka] Hokkaido Univ, Fac Fisheries Sci, Lab Bioanalyt Chem, Hakodate, Hokkaido 0418611, Japan	Vyssotski, M (reprint author), Callaghan Innovat, 69 Gracefield Rd,POB 31310, Lower Hutt 5040, New Zealand.	mikhail.vyssotski@callaghaninnovation.govt.nz			New Zealand Foundation for Research, Science and Technology grant [C08X0709]; Callaghan Innovation SIF project "Novel bioactives"	Authors are grateful to Dr Kevin Mitchell for help with HPLC, Dr Yinrong Lu for QToF MS support, Dr. Herbert Wong for NMR-spectra recording, Alison Speakman for invaluable help with information retrieval and Dr Michael Steward for editing the manuscript (all-Callaghan Innovation, New Zealand) and to anonymous reviewers for their help in improving the manuscript. Dr. Roderick Weston (Industrial Research Limited, New Zealand) participated in the project during the initial stage of the work. Pig testes were a gift from Taranaki Abattoir Co., North Island, New Zealand. DME extract of pig testes was prepared by Dr Peter Dyer (Callaghan Innovation, New Zealand). This work was supported by the New Zealand Foundation for Research, Science and Technology grant C08X0709 "High value lipids" and by the Callaghan Innovation SIF project "Novel bioactives".	ACKMAN R G, 1974, Chromatographia, V7, P107, DOI 10.1007/BF02269820; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Andrianasolo EH, 2008, J NAT PROD, V71, P1197, DOI 10.1021/np800124k; CARREAU JP, 1978, J CHROMATOGR, V151, P384, DOI 10.1016/S0021-9673(00)88356-9; Rezanka T, 2012, PHYTOCHEMISTRY, V78, P147, DOI 10.1016/j.phytochem.2012.02.028; Hiraga Y, 2002, J NAT PROD, V65, P1494, DOI 10.1021/np0201265; Sola F, 1999, J APPL TOXICOL, V19, P279, DOI 10.1002/(SICI)1099-1263(199907/08)19:4<279::AID-JAT579>3.0.CO;2-X; BIERI JG, 1965, COMP BIOCHEM PHYSIOL, V15, P275, DOI 10.1016/0010-406X(65)90131-3; Catchpole OJ, 2006, Extraction of highly unsaturated lipids with liquid dimethyl ether, Patent No. [WO2007136281 (A1), 2007136281]; CHRISTIE WW, 1986, LIPIDS, V21, P657, DOI 10.1007/BF02537217; DJERASSI C, 1956, J ORG CHEM, V21, P1547, DOI 10.1021/jo01118a627; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ghioni C, 2001, LIPIDS, V36, P145, DOI 10.1007/s11745-001-0701-0; HOLMAN RT, 1965, J AM OIL CHEM SOC, V42, P540, DOI 10.1007/BF02540098; KUKLEV DV, 1991, BIOORG KHIM+, V17, P1433; PABON HJJ, 1965, RECL TRAV CHIM PAY-B, V84, P1319; POULOS A, 1986, BIOCHEM J, V240, P891; Santercole V, 2012, LIPIDS, V47, P329, DOI 10.1007/s11745-011-3645-y; STRUIJK CB, 1966, RECL TRAV CHIM PAY-B, V85, P1233; Svetashev VI, 2011, LIPIDS, V46, P463, DOI 10.1007/s11745-011-3550-4; Svetashev VI, 2014, J PHYCOL, V50, P322, DOI 10.1111/jpy.12162; VYSOTSKII MV, 1990, TETRAHEDRON LETT, V31, P4367, DOI 10.1016/S0040-4039(00)97624-X	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0003-021X	1558-9331		J AM OIL CHEM SOC	J. Am. Oil Chem. Soc.	MAR	2015	92	3					383	391		10.1007/s11746-014-2588-x		9	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CC7QO	WOS:000350563400009		
J	Hayakawa, S; Ohashi, K; Shibata, R; Kataoka, Y; Miyabe, M; Enomoto, T; Joki, Y; Shimizu, Y; Kambara, T; Uemura, Y; Yuasa, D; Ogawa, H; Matsuo, K; Hiramatsu-Ito, M; van den Hoff, MJB; Walsh, K; Murohara, T; Ouchi, N				Hayakawa, Satoko; Ohashi, Koji; Shibata, Rei; Kataoka, Yoshiyuki; Miyabe, Megumi; Enomoto, Takashi; Joki, Yusuke; Shimizu, Yuuki; Kambara, Takahiro; Uemura, Yusuke; Yuasa, Daisuke; Ogawa, Hayato; Matsuo, Kazuhiro; Hiramatsu-Ito, Mizuho; van den Hoff, Maurice J. B.; Walsh, Kenneth; Murohara, Toyoaki; Ouchi, Noriyuki			Cardiac Myocyte-Derived Follistatin-Like 1 Prevents Renal Injury in a Subtotal Nephrectomy Model	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							CHRONIC KIDNEY-DISEASE; ACTIVATED PROTEIN-KINASE; BRAIN NATRIURETIC PEPTIDE; CONGESTIVE-HEART-FAILURE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; DIABETIC-NEPHROPATHY; PRESSURE-OVERLOAD; OXIDATIVE STRESS; ANGIOTENSIN-II	Heart disease contributes to the progression of CKD. Heart tissue produces a number of secreted proteins, also known as cardiokines, which participate in intercellular and intertissue communication. We recently reported that follistatin-like 1 (Fstl1) functions as a cardiokine with cardioprotective properties. Here, we investigated the role of cardiac Fstl1 in renal injury after subtotal nephrectomy. Cardiac-specific Fstl1-deficient (cFstl1-KO) mice and wild-type mice were subjected to subtotal (5/6) nephrectonny. cFstl1-KO mice showed exacerbation of urinary albumin excretion, glonnerular hypertrophy, and tubulointerstitial fibrosis after subtotal renal ablation compared with wild-type mice. cFstl1-KO mice also exhibited increased mRNA levels of proinflammatory cytokines, including TNF-alpha and IL-6, NADPH oxidase components, and fibrotic mediators, in the remnant kidney. Conversely, systemic administration of adenoviral vectors expressing Fstl1 (Ad-Fstl1) to wild-type mice with subtotal nephrectonny led to amelioration of albuminuria, glomerular hypertrophy, and tubulointerstitial fibrosis, accompanied by reduced expression of proinflammatory mediators, NADPH oxidase components, and fibrotic markers in the remnant kidney. In cultured human mesangial cells, treatment with recombinant FSTL1 attenuated TNF-alpha-stimulated expression of proinflammatory cytokines. Treatment of mesangial cells with FSTL1 augmented the phosphorylation of AMP-activated protein kinase (AMPK), and inhibition of AMPK activation abrogated the anti-inflammatory effects of FSTL1. These data suggest that Fstl1 functions in cardiorenal communication and that the lack of Fstl1 production by myocytes promotes glonnerular and tubulointerstitial damage in the kidney.	[Hayakawa, Satoko; Shibata, Rei; Kataoka, Yoshiyuki; Miyabe, Megumi; Enomoto, Takashi; Joki, Yusuke; Shimizu, Yuuki; Kambara, Takahiro; Uemura, Yusuke; Yuasa, Daisuke; Ogawa, Hayato; Matsuo, Kazuhiro; Hiramatsu-Ito, Mizuho; Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Ohashi, Koji; Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Nagoya, Aichi 4668550, Japan; [van den Hoff, Maurice J. B.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Anat Embryol & Physiol, NL-1105 AZ Amsterdam, Netherlands; [Walsh, Kenneth] Boston Univ, Sch Med, Dept Mol Cardiol, Boston, MA 02118 USA	Ouchi, N (reprint author), Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	ohashik@med.nagoya-u.ac.jp; nouchi@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014		Takeda Science Foundation; Uehara Memorial Foundation; Daiichi-Sankyo Foundation of Life Science; SENSHIN Medical Research Foundation; Cardiovascular Research Fund, Tokyo, Japan	This work was supported by Grant-in-Aid for Scientific Research, Grant-in-Aid for Challenging Exploratory Research, and grants from Takeda Science Foundation, the Uehara Memorial Foundation, Daiichi-Sankyo Foundation of Life Science, and SENSHIN Medical Research Foundation to N.O. R.S. was supported with the Grant-in-Aid for Young Scientists B and the Uehara Memorial Foundation. K.O. was supported with the Grant-in-Aid for Scientific Research C and The Cardiovascular Research Fund, Tokyo, Japan.	Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Fan NG, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/752519; Niu P, 2004, CIRCULATION, V109, P1789, DOI 10.1161/01.CIR.0000118466.47982.CC; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI13914; Adams DC, 2010, AM J PHYSIOL-RENAL, V299, pF1320, DOI 10.1152/ajprenal.00325.2010; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Shibata R, 2007, CARDIOVASC RES, V74, P471, DOI 10.1016/j.cardiores.2007.02.010; SHIBANUMA M, 1993, EUR J BIOCHEM, V217, P13, DOI 10.1111/j.1432-1033.1993.tb18212.x; Shimano M, 2012, CIRCULATION, V126, pE327, DOI 10.1161/CIRCULATIONAHA.112.150656; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Hambrock HO, 2004, J BIOL CHEM, V279, P11727, DOI 10.1074/jbc.M309318200; Le Luduec JB, 2008, AM J TRANSPLANT, V8, P2297, DOI 10.1111/j.1600-6143.2008.02398.x; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Ohashi K, 2007, ARTERIOSCL THROM VAS, V27, P1910, DOI 10.1161/ATVBAHA.107.147645; BERTANI T, 1989, AM J PATHOL, V134, P419; Vanderheyden M, 2004, J AM COLL CARDIOL, V44, P2349, DOI 10.1016/j.jacc.2004.09.038; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; Ghosh SS, 2012, AM J PHYSIOL-RENAL, V302, pF439, DOI 10.1152/ajprenal.00356.2010; Miyamae T, 2006, J IMMUNOL, V177, P4758; Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Upadhyay A, 2011, NEPHROL DIAL TRANSPL, V26, P920, DOI 10.1093/ndt/gfq471; Kawabata D, 2004, ARTHRITIS RHEUM, V50, P660, DOI 10.1002/art.20023; Dao Q, 2001, J AM COLL CARDIOL, V37, P379, DOI 10.1016/S0735-1097(00)01156-6; Nagaya N, 2000, AM J PHYSIOL-REG I, V278, pR1019; Kasahara M, 2000, J AM SOC NEPHROL, V11, P1691; Manna P, 2013, J CELL BIOCHEM, V114, P2334, DOI 10.1002/jcb.24578; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Ogura Y, 2012, CIRCULATION, V126, P1728, DOI 10.1161/CIRCULATIONAHA.112.115089; Decleves AE, 2011, J AM SOC NEPHROL, V22, P1846, DOI 10.1681/ASN.2011010026; Chaly Y, 2012, ARTHRITIS RHEUM-US, V64, P1082, DOI 10.1002/art.33422; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386; McClellan WM, 2002, J AM SOC NEPHROL, V13, P1928, DOI 10.1097/01.ASN.0000018409.45834.FA; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; de Vinuesa SG, 2006, J AM SOC NEPHROL, V17, pS206, DOI 10.1681/ASN.2006080916; Doroudgar S, 2011, TRENDS MOL MED, V17, P207, DOI 10.1016/j.molmed.2010.12.003; El-Armouche A, 2011, CIRC-HEART FAIL, V4, P621, DOI 10.1161/CIRCHEARTFAILURE.110.960625; Goicoechea Marian, 2005, Kidney Int Suppl, pS35; Gong RJ, 2006, J AM SOC NEPHROL, V17, P2464, DOI 10.1681/ASN.2006020185; Hulo S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-64; Johansen K S, 1979, Ugeskr Laeger, V141, P2598; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Lara-Pezzi E, 2008, ENDOCRINOLOGY, V149, P5822, DOI 10.1210/en.2008-0151; Morimoto A, 1999, HYPERTENSION, V33, P1146; Niu P, 2003, HYPERTENS RES, V26, P731, DOI 10.1291/hypres.26.731; Palm F, 2011, CLIN EXP PHARMACOL P, V38, P424, DOI 10.1111/j.1440-1681.2011.05532.x; Quiroz Y, 2008, AM J PHYSIOL-RENAL, V294, pF336; Satriano J, 2013, AM J PHYSIOL-RENAL, V305, pF727, DOI 10.1152/ajprenal.00293.2013; Shimano M, 2011, P NATL ACAD SCI USA, V108, pE899, DOI 10.1073/pnas.1108559108; Suganami T, 2001, J AM SOC NEPHROL, V12, P2652; Sylva M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022616; Tanaka K, 2007, CIRC J, V71, P1927, DOI 10.1253/circj.71.1927; Tanaka T, 2010, CURR OPIN NEPHROL HY, V19, P43, DOI 10.1097/MNH.0b013e3283328eed; Widera C, 2009, CLIN CHEM, V55, P1794, DOI 10.1373/clinchem.2009.129411; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1; Yoshida H, 1998, KIDNEY INT, V53, P880, DOI 10.1111/j.1523-1755.1998.00830.x	60	1	1	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	MAR	2015	26	3					636	646		10.1681/ASN.2014020210		11	Urology & Nephrology	Urology & Nephrology	CC3RF	WOS:000350266100017		
J	Yasuda, Y; Sato, K; Sugimoto, N				Yasuda, Yuki; Sato, Kaoru; Sugimoto, Norihiko			A Theoretical Study on the Spontaneous Radiation of Inertia-Gravity Waves Using the Renormalization Group Method. Part I: Derivation of the Renormalization Group Equations	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							POTENTIAL VORTICITY ANOMALIES; UNSTEADY ROTATIONAL FLOW; QUASI-GEOSTROPHIC THEORY; LOCAL MASS CONSERVATION; SHALLOW-WATER SYSTEM; SPECTRAL PARAMETERIZATION; BAROCLINIC INSTABILITY; ASYMPTOTIC ANALYSIS; GEOPHYSICAL FLOWS; BALANCED MODELS	By using the renormalization group (RG) method, the interaction between balanced flows and Doppler-shifted inertia-gravity waves (GWs) is formulated for the hydrostatic Boussinesq equations on the f plane. The derived time-evolution equations [RG equations (RGEs)] describe the spontaneous GW radiation from the components slaved to the vortical flow through the quasi resonance, together with the GW radiation reaction on the large-scale flow. The quasi resonance occurs when the space-time scales of GWs are partially comparable to those of slaved components. This theory treats a coexistence system with slow time scales composed of GWs significantly Doppler-shifted by the vortical flow and the balanced flow that interact with each other. The theory includes five dependent variables having slow time scales: one slow variable (linear potential vorticity), two Doppler-shifted fast ones (GW components), and two diagnostic fast ones. Each fast component consists of horizontal divergence and ageostrophic vorticity. The spontaneously radiated GWs are regarded as superpositions of the GW components obtained as low-frequency eigenmodes of the fast variables in a given vortical flow. Slowly varying nonlinear terms of the fast variables are included as the diagnostic components, which are the sum of the slaved components and the GW radiation reactions. A comparison of the balanced adjustment equation (BAE) by Plougonven and Zhang with the linearized RGE shows that the RGE is formally reduced to the BAE by ignoring the GW radiation reaction, although the interpretation on the GW radiation mechanism is significantly different; GWs are radiated through the quasi resonance with a balanced flow because of the time-scale matching.	[Yasuda, Yuki; Sato, Kaoru] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan; [Sugimoto, Norihiko] Keio Univ, Dept Phys, Yokohama, Kanagawa, Japan	Yasuda, Y (reprint author), Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan.	yyuuki@eps.s.u-tokyo.ac.jp	Satoh, Kaoru/P-2047-2015		Ministry of Education, Culture, Sports and Technology (MEXT), Japan [25 8466, 25247075, 25800265]; Leading Graduate Course for Frontiers of Mathematical Sciences and Physics (FMSP) program at the University of Tokyo	This study was supported partly by Grant-in-Aid for Research Fellow (25 8466), by Grant-in-Aid for Scientific Research (A) (25247075), and by Grant-in-Aid for the Young Scientists (B) (25800265) of the Ministry of Education, Culture, Sports and Technology (MEXT), Japan, and by the Leading Graduate Course for Frontiers of Mathematical Sciences and Physics (FMSP) program at the University of Tokyo.	Alexander MJ, 1999, J ATMOS SCI, V56, P4167, DOI 10.1175/1520-0469(1999)056<4167:ASPOMF>2.0.CO;2; Snyder C, 2007, J ATMOS SCI, V64, P4417, DOI 10.1175/2007JAS2351.1; Sugimoto N, 2007, FLUID DYN RES, V39, P731, DOI 10.1016/j.fluiddyn.2007.07.001; Warner CD, 2001, J ATMOS SCI, V58, P1837, DOI 10.1175/1520-0469(2001)058<1837:AUSPFN>2.0.CO;2; Vanneste J, 2013, ANNU REV FLUID MECH, V45, P147, DOI 10.1146/annurev-fluid-011212-140730; Lott F, 2012, J ATMOS SCI, V69, P2134, DOI 10.1175/JAS-D-11-0296.1; Zhang FQ, 2004, J ATMOS SCI, V61, P440, DOI 10.1175/1520-0469(2004)061<0440:GOMGWI>2.0.CO;2; Viudez A, 2007, J FLUID MECH, V593, P359, DOI 10.1017/S0022112007008816; Alexander MJ, 2010, Q J ROY METEOR SOC, V136, P1103, DOI 10.1002/qj.637; Vanneste J, 2004, J ATMOS SCI, V61, P211, DOI 10.1175/1520-0469(2004)061<0211:ESIWAT>2.0.CO;2; Saujani S, 2006, J FLUID MECH, V569, P447, DOI 10.1017/S0022112006002783; Plougonven R, 2014, REV GEOPHYS, V52, P33, DOI 10.1002/2012RG000419; OSULLIVAN D, 1995, J ATMOS SCI, V52, P3695, DOI 10.1175/1520-0469(1995)052<3695:GOIWIA>2.0.CO;2; Plougonven R, 2007, J ATMOS SCI, V64, P2502, DOI 10.1175/JAS3953.1; Hines CO, 1997, J ATMOS SOL-TERR PHY, V59, P387, DOI 10.1016/S1364-6826(96)00080-6; Plougonven R, 2005, J ATMOS SCI, V62, P1545, DOI 10.1175/JAS3426.1; Miyazaki K, 2010, J ATMOS SCI, V67, P1315, DOI 10.1175/2009JAS3334.1; Plougonven R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023730; Plougonven R, 2013, Q J ROY METEOR SOC, V139, P101, DOI 10.1002/qj.1965; Dritschel DG, 2003, J FLUID MECH, V488, P123, DOI 10.1017/S0022112003004920; Ford R, 2000, J ATMOS SCI, V57, P1236, DOI 10.1175/1520-0469(2000)057<1236:BATSQS>2.0.CO;2; Kunihiro T, 1997, PROG THEOR PHYS, V97, P179, DOI 10.1143/PTP.97.179; Yasuda Y, 2015, J ATMOS SCI, V72, P984, DOI 10.1175/JAS-D-13-0371.1; McIntyre ME, 2000, J ATMOS SCI, V57, P1214, DOI 10.1175/1520-0469(2000)057<1214:PVIOAH>2.0.CO;2; CHEN LY, 1994, PHYS REV LETT, V73, P1311, DOI 10.1103/PhysRevLett.73.1311; Chen LY, 1996, PHYS REV E, V54, P376, DOI 10.1103/PhysRevE.54.376; KUNIHIRO T, 1995, PROG THEOR PHYS, V94, P503, DOI 10.1143/PTP.94.503; McIntyre ME, 2009, J ATMOS SCI, V66, P1315, DOI 10.1175/2008JAS2538.1; Bender C. M., 1999, ADV MATH METHODS SCI; Buhler O, 2005, J FLUID MECH, V534, P67, DOI 10.1017/S0022112005004374; Holton J., 2004, INT GEOPHYS SERIES, V88; LEITH CE, 1980, J ATMOS SCI, V37, P958, DOI 10.1175/1520-0469(1980)037<0958:NNMIAQ>2.0.CO;2; LORENZ EN, 1980, J ATMOS SCI, V37, P1685, DOI 10.1175/1520-0469(1980)037<1685:ASAQGE>2.0.CO;2; Lott F, 2010, J ATMOS SCI, V67, P157, DOI 10.1175/2009JAS3134.1; Mohebalhojeh AR, 2007, J ATMOS SCI, V64, P1794, DOI 10.1175/JAS3934.1; Mohebalhojeh AR, 2007, J ATMOS SCI, V64, P1782, DOI 10.1175/JAS3933.1; Mohebalhojeh AR, 2001, J ATMOS SCI, V58, P2411, DOI 10.1175/1520-0469(2001)058<2411:HOBCFT>2.0.CO;2; Muraki DJ, 1999, J ATMOS SCI, V56, P1547, DOI 10.1175/1520-0469(1999)056<1547:TNOCTQ>2.0.CO;2; Olafsdottir EI, 2008, J FLUID MECH, V596, P169, DOI 10.1017/S0022112007009408; Plougonven R, 2007, J ATMOS SCI, V64, P1737, DOI 10.1175/JAS3901.1; Snyder C, 2009, J ATMOS SCI, V66, P3464, DOI 10.1175/2009JAS3147.1; Sugimoto N, 2008, J ATMOS SCI, V65, P235, DOI 10.1175/2007JAS2404.1; Vallis G. K., 2006, ATMOSPHERIC OCEANIC; Wang SG, 2010, J ATMOS SCI, V67, P1438, DOI 10.1175/2010JAS3327.1; Wang SG, 2010, Q J ROY METEOR SOC, V136, P1773, DOI 10.1002/qj.676; WARN T, 1995, Q J ROY METEOR SOC, V121, P723, DOI 10.1002/qj.49712152313; Wirosoetisno D, 2002, J ATMOS SCI, V59, P3382, DOI 10.1175/1520-0469(2002)059<3382:FGWABD>2.0.CO;2	47	2	2	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	MAR	2015	72	3					957	983		10.1175/JAS-D-13-0370.1		27	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CC4OQ	WOS:000350333100001		
J	Yasuda, Y; Sato, K; Sugimoto, N				Yasuda, Yuki; Sato, Kaoru; Sugimoto, Norihiko			A Theoretical Study on the Spontaneous Radiation of Inertia-Gravity Waves Using the Renormalization Group Method. Part II: Verification of the Theoretical Equations by Numerical Simulation	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							JET-FRONT SYSTEMS; MU-RADAR; VORTEX DIPOLES; LINEAR-MODEL; GENERATION; SCALE; DYNAMICS; REGION	The renormalization group equations (RGEs) describing spontaneous inertia-gravity wave (GW) radiation from part of a balanced flow through a quasi resonance that were derived in a companion paper by Yasuda et al. are validated through numerical simulations of the vortex dipole using the Japan Meteorological Agency nonhydrostatic model (JMA-NHM). The RGEs are integrated for two vortical flow fields: the first is the initial condition that does not contain GWs used for the JMA-NHM simulations, and the second is the simulated thirtieth-day field by the JMA-NHM. The theoretically obtained GW distributions in both RGE integrations are consistent with the numerical simulations using the JMA-NHM. This result supports the validity of the RGE theory. GW radiation in the dipole is physically interpreted either as the mountain-wave-like mechanism proposed by McIntyre or as the velocity-variation mechanism proposed by Viudez. The shear of the large-scale flow likely determines which mechanism is dominant. In addition, the distribution of GW momentum fluxes is examined based on the JMA-NHM simulation data. The GWs propagating upward from the jet have negative momentum fluxes, while those propagating downward have positive ones. The magnitude of momentum fluxes is approximately proportional to the sixth power of the Rossby number between 0.15 and 0.4.	[Yasuda, Yuki; Sato, Kaoru] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan; [Sugimoto, Norihiko] Keio Univ, Dept Phys, Yokohama, Kanagawa, Japan	Yasuda, Y (reprint author), Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan.	yyuuki@eps.s.u-tokyo.ac.jp	Satoh, Kaoru/P-2047-2015		Ministry of Education, Culture, Sports and Technology (MEXT), Japan [25.8466, 25247075, 25800265]; Leading Graduate Course for Frontiers of Mathematical Sciences and Physics (FMSP) program at the University of Tokyo	The authors thank Syugo Hayashi for his kind instruction in using JMA-NHM. The authors are deeply grateful to Dr. Garcia and reviewers for critically reading our manuscript and giving constructive comments. This study was supported partly by Grant-in-Aid for Research Fellow (25.8466), by Grant-in-Aid for Scientific Research (A) (25247075), and by Grant-in-Aid for the Young Scientists (B) (25800265) of the Ministry of Education, Culture, Sports and Technology (MEXT), Japan, and by the Leading Graduate Course for Frontiers of Mathematical Sciences and Physics (FMSP) program at the University of Tokyo. All simulations were completed with the supercomputer at the National Institute of Polar Research (NIPR). All figures in this paper were drawn using the DCL library.	Snyder C, 2007, J ATMOS SCI, V64, P4417, DOI 10.1175/2007JAS2351.1; Yasuda Y, 2015, J ATMOS SCI, V72, P957, DOI 10.1175/JAS-D-13-0370.1; SATO K, 1994, J ATMOS TERR PHYS, V56, P755, DOI 10.1016/0021-9169(94)90131-7; Zhang FQ, 2004, J ATMOS SCI, V61, P440, DOI 10.1175/1520-0469(2004)061<0440:GOMGWI>2.0.CO;2; Viudez A, 2007, J FLUID MECH, V593, P359, DOI 10.1017/S0022112007008816; UCCELLINI LW, 1987, MON WEATHER REV, V115, P721, DOI 10.1175/1520-0493(1987)115<0721:TSSAPE>2.0.CO;2; [Anonymous], 2008, WPA WRITING PROGRAM, V31.3, P3, DOI DOI 10.1175/2008JAS2539.1; OSULLIVAN D, 1995, J ATMOS SCI, V52, P3695, DOI 10.1175/1520-0469(1995)052<3695:GOIWIA>2.0.CO;2; SNYDER C, 1993, J ATMOS SCI, V50, P3194, DOI 10.1175/1520-0469(1993)050<3194:FDNAFF>2.0.CO;2; Plougonven R, 2007, J ATMOS SCI, V64, P2502, DOI 10.1175/JAS3953.1; Miyazaki K, 2010, J ATMOS SCI, V67, P1315, DOI 10.1175/2009JAS3334.1; Plougonven R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023730; Plougonven R, 2013, Q J ROY METEOR SOC, V139, P101, DOI 10.1002/qj.1965; Tateno S, 2008, J METEOROL SOC JPN, V86, P719, DOI 10.2151/jmsj.86.719; Saito K, 2006, MON WEATHER REV, V134, P1266, DOI 10.1175/MWR3120.1; CHEN LY, 1994, PHYS REV LETT, V73, P1311, DOI 10.1103/PhysRevLett.73.1311; Chen LY, 1996, PHYS REV E, V54, P376, DOI 10.1103/PhysRevE.54.376; McIntyre ME, 2009, J ATMOS SCI, V66, P1315, DOI 10.1175/2008JAS2538.1; Berestov AL, 1979, IZV AS USSR ATMOS OC, V15, P443; Buhler O, 2005, J FLUID MECH, V534, P67, DOI 10.1017/S0022112005004374; FLIERL GR, 1987, ANNU REV FLUID MECH, V19, P493, DOI 10.1146/annurev.fluid.19.1.493; HIROTA I, 1986, J METEOROL SOC JPN, V64, P995; Plougonven R, 2007, J ATMOS SCI, V64, P1737, DOI 10.1175/JAS3901.1; SATO K, 1989, J METEOROL SOC JPN, V67, P325; Snyder C, 2009, J ATMOS SCI, V66, P3464, DOI 10.1175/2009JAS3147.1; Viudez A., 2008, J PHYS OCEANOGR, V38, P243, DOI [10.1175/ 2006JPO3692.1., DOI 10.1175/2006JP03692.1]; Wang SG, 2010, J ATMOS SCI, V67, P1438, DOI 10.1175/2010JAS3327.1; Wang SG, 2009, J ATMOS SCI, V66, P1294, DOI 10.1175/2008JAS2830.1; Wang SG, 2010, Q J ROY METEOR SOC, V136, P1773, DOI 10.1002/qj.676; Wei JH, 2014, J ATMOS SCI, V71, P929, DOI 10.1175/JAS-D-13-0171.1	30	2	2	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	MAR	2015	72	3					984	1009		10.1175/JAS-D-13-0371.1		26	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CC4OQ	WOS:000350333100002		
J	Jiang, JH; Su, H; Zhai, CX; Shen, TJ; Wu, TW; Zhang, J; Cole, JNS; von Salzen, K; Donner, LJ; Seman, C; Del Genio, A; Nazarenko, LS; Dufresne, JL; Watanabe, M; Morcrette, C; Koshiro, T; Kawai, H; Gettelman, A; Millan, L; Read, WG; Livesey, NJ; Kasai, Y; Shiotani, M				Jiang, Jonathan H.; Su, Hui; Zhai, Chengxing; Shen, T. Janice; Wu, Tongwen; Zhang, Jie; Cole, Jason N. S.; von Salzen, Knut; Donner, Leo J.; Seman, Charles; Del Genio, Anthony; Nazarenko, Larissa S.; Dufresne, Jean-Louis; Watanabe, Masahiro; Morcrette, Cyril; Koshiro, Tsuyoshi; Kawai, Hideaki; Gettelman, Andrew; Millan, Luis; Read, William G.; Livesey, Nathaniel J.; Kasai, Yasko; Shiotani, Masato			Evaluating the Diurnal Cycle of Upper-Tropospheric Ice Clouds in Climate Models Using SMILES Observations	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							GENERAL-CIRCULATION MODEL; TROPICAL OCEANIC CONVECTION; SYSTEM MODEL; CUMULUS CONVECTION; ATMOSPHERE MODEL; UNITED-STATES; WATER-VAPOR; PRECIPITATION; SCHEME; CMIP5	Upper-tropospheric ice cloud measurements from the Superconducting Submillimeter Limb Emission Sounder (SMILES) on the International Space Station (ISS) are used to study the diurnal cycle of upper-tropospheric ice cloud in the tropics and midlatitudes (40 degrees S-40 degrees N) and to quantitatively evaluate ice cloud diurnal variability simulated by 10 climatemodels. Over land, the SMILES-observed diurnal cycle has a maximum around 1800 local solar time (LST), while the model-simulated diurnal cycles have phases differing from the observed cycle by -4 to 12 h. Over ocean, the observations show much smaller diurnal cycle amplitudes than over land with a peak at 1200 LST, while the modeled diurnal cycle phases are widely distributed throughout the 24-h period. Most models show smaller diurnal cycle amplitudes over ocean than over land, which is in agreement with the observations. However, there is a large spread of modeled diurnal cycle amplitudes ranging from 20% to more than 300% of the observed over both land and ocean. Empirical orthogonal function (EOF) analysis on the observed and model-simulated variations of ice clouds finds that the first EOF modes over land from both observation and model simulations explain more than 70% of the ice cloud diurnal variations and they have similar spatial and temporal patterns. Over ocean, the first EOF from observation explains 26.4% of the variance, while the first EOF from most models explains more than 70%. The modeled spatial and temporal patterns of the leading EOFs over ocean show large differences from observations, indicating that the physical mechanisms governing the diurnal cycle of oceanic ice clouds are more complicated and not well simulated by the current climate models.	[Jiang, Jonathan H.; Su, Hui; Zhai, Chengxing; Shen, T. Janice; Millan, Luis; Read, William G.; Livesey, Nathaniel J.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Wu, Tongwen; Zhang, Jie] China Meteorol Adm, Beijing Climate Ctr, Beijing, Peoples R China; [Cole, Jason N. S.; von Salzen, Knut] Environm Canada, Canadian Ctr Climate Modeling & Anal, Victoria, BC, Canada; [Donner, Leo J.; Seman, Charles] Geophys Fluid Dynam Lab, Princeton, NJ USA; [Del Genio, Anthony; Nazarenko, Larissa S.] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Dufresne, Jean-Louis] Inst Pierre Simon Laplace, Lab Meteorol Dynam, Paris, France; [Watanabe, Masahiro] Univ Tokyo, Atmosphere & Ocean Res Inst, Model Interdisciplinary Res Climate, Kashiwa, Chiba, Japan; [Morcrette, Cyril] Met Off Hadley Ctr, Exeter, Devon, England; [Koshiro, Tsuyoshi; Kawai, Hideaki] Japan Meteorol Agcy, Meteorol Res Inst, Tsukuba, Ibaraki, Japan; [Gettelman, Andrew] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Kasai, Yasko] Natl Inst Informat & Commun Technol, Tokyo, Japan; [Shiotani, Masato] Kyoto Univ, Res Inst Sustainable Humanosphere, Kyoto, Japan	Jiang, JH (reprint author), Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91011 USA.	jonathan.h.jiang@jpl.nasa.gov	Morcrette, Cyril/H-7282-2012; Dufresne, Jean-Louis/I-5616-2015; Millan, Luis/J-2759-2015	Morcrette, Cyril/0000-0002-4240-8472; Dufresne, Jean-Louis/0000-0003-4764-9600; 	NASA [ROSES08-USPI, ROSES12-MAP, ROSES13-NDOA]; NASA; BCC; CCCma; GFDL; GISS; IPSL; MIROC; MOHC; MRI; NCAR; MERRA	The authors appreciate the funding support by the NASA ROSES08-USPI, ROSES12-MAP, and ROSES13-NDOA programs. This work was performed at the NASA-sponsored Jet Propulsion Laboratory, California Institute of Technology. We are also very thankful for the support from climate modeling centers across the globe, including BCC, CCCma, GFDL, GISS, IPSL, MIROC, MOHC, MRI, NCAR, and MERRA.	Sui CH, 1998, J ATMOS SCI, V55, P2345, DOI 10.1175/1520-0469(1998)055<2345:RCPISD>2.0.CO;2; Yoshimura H, 2015, MON WEATHER REV, V143, P597, DOI 10.1175/MWR-D-14-00068.1; Russell GL, 1995, ATMOS OCEAN, V33, P683; [Anonymous], 2009, J ADV MODEL EARTH SY, DOI DOI 10.3894/JAMES.2009.1.12; ZHANG GJ, 1995, ATMOS OCEAN, V33, P407; Feng Z, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016451; Jiang JH, 2004, ATMOS SCI LETT, V5, P146, DOI 10.1002/asl.77; WALLACE JM, 1975, MON WEATHER REV, V103, P406, DOI 10.1175/1520-0493(1975)103<0406:DVIPAT>2.0.CO;2; Stuart-Menteth AC, 2003, J GEOPHYS RES-OCEANS, V108, DOI [10.1029/2002JC001534, 10.1029/2002jc001534]; [Anonymous], 2012, ARCH REV, V10, P3, DOI DOI 10.1029/2012JD017640; Chen SS, 1997, Q J ROY METEOR SOC, V123, P357, DOI 10.1002/qj.49712353806; Kim D, 2012, J CLIMATE, V25, P4641, DOI 10.1175/JCLI-D-11-00447.1; Wu TW, 2010, CLIM DYNAM, V34, P123, DOI 10.1007/s00382-008-0487-2; Nitis T, 2005, Q J ROY METEOR SOC, V131, P305, DOI 10.1256/qj.04.42; Dufresne JL, 2013, CLIM DYNAM, V40, P2123, DOI 10.1007/s00382-012-1636-1; Li JL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023788; Su H, 2013, J GEOPHYS RES-ATMOS, V118, P2762, DOI 10.1029/2012JD018575; Lee MI, 2007, J HYDROMETEOROL, V8, P344, DOI 10.1175/JHM581.1; Kikuchi K, 2008, J CLIMATE, V21, P2680, DOI 10.1175/2007JCLI2051.1; [Anonymous], 2012, ARCH REV, V10, P3, DOI DOI 10.2151/JMSJ.2012-A02; Rio C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036779; Su H, 2013, J CLIMATE, V26, P399, DOI 10.1175/JCLI-D-12-00152.1; Mapes BE, 2000, J ATMOS SCI, V57, P1515, DOI 10.1175/1520-0469(2000)057<1515:CISSTE>2.0.CO;2; Takemura T, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005029; Dai A, 1999, J CLIMATE, V12, P2451, DOI 10.1175/1520-0442(1999)012<2451:EOCSMP>2.0.CO;2; von Salzen K, 2013, ATMOS OCEAN, V51, P104, DOI 10.1080/07055900.2012.755610; Scinocca JF, 2004, J ATMOS SCI, V61, P1993, DOI 10.1175/1520-0469(2004)061<1993:TVOMTP>2.0.CO;2; ALBRIGHT MD, 1985, MON WEATHER REV, V113, P1663, DOI 10.1175/1520-0493(1985)113<1663:TDVODC>2.0.CO;2; Wu TW, 2013, J GEOPHYS RES-ATMOS, V118, P4326, DOI 10.1002/jgrd.50320; Del Genio AD, 2010, J CLIMATE, V23, P2722, DOI 10.1175/2009JCLI3340.1; Hourdin F, 2013, CLIM DYNAM, V40, P2193, DOI 10.1007/s00382-012-1343-y; Morcrette CJ, 2012, Q J ROY METEOR SOC, V138, P964, DOI 10.1002/qj.969; Donner LJ, 2011, J CLIMATE, V24, P3484, DOI 10.1175/2011JCLI3955.1; Klein SA, 2013, J GEOPHYS RES-ATMOS, V118, P1329, DOI 10.1002/jgrd.50141; Waliser DE, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010015; Su H, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025505; Delanoe J, 2011, Q J ROY METEOR SOC, V137, P2064, DOI 10.1002/qj.882; Bechtold P, 2004, Q J ROY METEOR SOC, V130, P3119, DOI 10.1256/qj.03.103; Wu TW, 2012, CLIM DYNAM, V38, P725, DOI 10.1007/s00382-011-0995-3; Nesbitt SW, 2003, J CLIMATE, V16, P1456, DOI 10.1175/1520-0442-16.10.1456; Gettelman A, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013797; [Anonymous], 2009, ENERGY ENV PROTECTIO, V23, P24, DOI DOI 10.1029/2008JD009946; Jiang JH, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017237; Wu DL, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008931; Chikira M, 2010, J ATMOS SCI, V67, P2171, DOI 10.1175/2010JAS3316.1; Liu XH, 2005, METEOROL Z, V14, P499, DOI 10.1127/0941-2948/2005/0059; GREGORY D, 1990, MON WEATHER REV, V118, P1483, DOI 10.1175/1520-0493(1990)118<1483:AMFCSW>2.0.CO;2; Sato T, 2009, J CLIMATE, V22, P4809, DOI 10.1175/2009JCLI2890.1; Johnson RH, 1999, J CLIMATE, V12, P2397, DOI 10.1175/1520-0442(1999)012<2397:TCOTC>2.0.CO;2; Tian BJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027752; Benedict JJ, 2013, J CLIMATE, V26, P426, DOI 10.1175/JCLI-D-12-00103.1; Park S, 2009, J CLIMATE, V22, P3449, DOI 10.1175/2008JCLI2557.1; Yang GY, 2001, MON WEATHER REV, V129, P784, DOI 10.1175/1520-0493(2001)129<0784:TDCITT>2.0.CO;2; Watanabe M, 2009, CLIM DYNAM, V33, P795, DOI 10.1007/s00382-008-0489-0; Derbyshire SH, 2011, Q J ROY METEOR SOC, V137, P1856, DOI 10.1002/qj.875; May PT, 2012, J CLIMATE, V25, P5309, DOI 10.1175/JCLI-D-11-00538.1; Del Genio AD, 2012, J CLIMATE, V25, P3755, DOI 10.1175/JCLI-D-11-00384.1; Kuang ZM, 2006, J ATMOS SCI, V63, P1895, DOI 10.1175/JAS3723.1; RANDALL DA, 1991, J ATMOS SCI, V48, P40, DOI 10.1175/1520-0469(1991)048<0040:DVOTHC>2.0.CO;2; Wilson DR, 1999, Q J ROY METEOR SOC, V125, P1607, DOI 10.1256/smsqj.55706; ALBRIGHT MD, 1981, J ATMOS SCI, V38, P1429, DOI 10.1175/1520-0469(1981)038<1429:ADSOTD>2.0.CO;2; Wu DL, 2006, IEEE T GEOSCI REMOTE, V44, P1156, DOI 10.1109/TGRS.2006.869994; [Anonymous], 2010, SHARING, V19, P5, DOI DOI 10.1175/2010JCLI3679.1; Tian BJ, 2013, J GEOPHYS RES-ATMOS, V118, P114, DOI 10.1029/2012JD018607; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Dai A, 2004, J CLIMATE, V17, P930, DOI 10.1175/1520-0442(2004)017<0930:TDCAID>2.0.CO;2; Bowman KP, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005763; Collins W, 2008, METEOROL OFF HADLEY, V74, P47; Davis CP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022681; Dolinar EK, 2015, CLIM DYNAM, V44, P2229, DOI 10.1007/s00382-014-2158-9; Gary W. M., 1977, MON WEATHER REV, V105, P1171, DOI [10.1175/1520-0493(1977)105&LT;1171:DVODCC&GT;2.0.CO;2, DOI 10.1175/1520-0493(1977)105<1171:DVODCC>2.0.CO;2]; Gregory J, 1999, 7 HADL CTR; HENDON HH, 1993, J GEOPHYS RES-ATMOS, V98, P16623, DOI 10.1029/93JD00525; Hesthaven J., 2007, C MO AP C M, V21, DOI DOI 10.2277/ 0521792118; HOUZE RA, 1981, REV GEOPHYS, V19, P541, DOI 10.1029/RG019i004p00541; Jiang J. H., 2010, J GEOPHYS RES, V115, DOI [10.1029/ 2010JD014379., DOI 10.1029/2010JD014379]; KRAUS EB, 1963, J ATMOS SCI, V20, P551, DOI 10.1175/1520-0469(1963)020<0551:TDPCOT>2.0.CO;2; Liu CH, 1998, J ATMOS SCI, V55, P2329, DOI 10.1175/1520-0469(1998)055<2329:ANSOTD>2.0.CO;2; Livesey N. J, 2013, JPLD33509; Lorenz E. N., 1956, 1 STAT FOR PROJ; Manabe T, 2008, IEICE T COMMUN, VE91B, P1760, DOI 10.1093/ietcom/e91-b.6.1760; MCGARRY MM, 1978, MON WEATHER REV, V106, P101, DOI 10.1175/1520-0493(1978)106<0101:DVICAA>2.0.CO;2; Millan L, 2013, J GEOPHYS RES-ATMOS, V118, P6468, DOI 10.1002/jgrd.50322; Ray C. L., 1928, P R MON WEA REV, V56, P140, DOI [10.1175/1520-0493(1928)56&LT;140:DVORAS&GT;2.0.CO;2, DOI 10.1175/1520-0493(1928)56<140:DVORAS>2.0.CO;2]; REED RJ, 1981, MON WEATHER REV, V109, P2527, DOI 10.1175/1520-0493(1981)109<2527:DVOSCO>2.0.CO;2; SALBY ML, 1991, B AM METEOROL SOC, V72, P467, DOI 10.1175/1520-0477(1991)072<0467:AOGCIF>2.0.CO;2; Slingo J, 2003, ANN GEOPHYS-ITALY, V46, P139; SMITH RNB, 1990, Q J ROY METEOR SOC, V116, P435, DOI 10.1256/smsqj.49209; Soden BJ, 2000, GEOPHYS RES LETT, V27, P2173, DOI 10.1029/2000GL011436; Stanfield RE, 2014, J CLIMATE, V27, P4189, DOI 10.1175/JCLI-D-13-00558.1; Stratton RA, 2012, Q J ROY METEOR SOC, V138, P1121, DOI 10.1002/qj.991; Su H, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014971; Taylor PC, 2014, J ATMOS SCI, V71, P754, DOI 10.1175/JAS-D-13-0112.1; Taylor PC, 2012, J ATMOS SCI, V69, P3652, DOI 10.1175/JAS-D-12-088.1; Tian BJ, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004117; Wu D. L., 2004, JPLD19299; Yukimoto S., 2011, 64 MET RES I; Zhang GJ, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001005	98	1	1	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	MAR	2015	72	3					1022	1044		10.1175/JAS-D-14-0124.1		23	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CC4OQ	WOS:000350333100004		
J	Nishimura, Y; Tsutsui, Y; Hirayama, K				Nishimura, Yusaku; Tsutsui, Yoshiro; Hirayama, Kenjiro			Intraday return and volatility spillover mechanism from Chinese to Japanese stock market	JOURNAL OF THE JAPANESE AND INTERNATIONAL ECONOMIES			English	Article						Return/volatility spillover; China related stock index; High-frequency data; Intraday periodicity	AUTOREGRESSIVE CONDITIONAL HETEROSKEDASTICITY; US; INFORMATION; PRICES	We analyze the mechanism of return and volatility spillover effects from the Chinese to the Japanese stock market. We construct a stock price index comprised of those companies that have substantial operations in China. This China-related index responds to changes in the Shanghai Composite Index more strongly than does the TOPIX (the market index of the Tokyo Stock Exchange). This result suggests that China has a large impact on Japanese stocks via China-related firms in Japan. Furthermore, we find evidence that this response has become stronger as the Chinese economy has gained importance in recent years. J. Japanese Int. Economies 35 (2015) 23-42. Institute of International Economy, University of International Business and Economics, 10 East Huixin Street, Chaoyang District, Beijing 100029, China; Faculty of Economics, Konan University, 8-9-1 Okamoto, Higashinadaku, Kobe 6588501, Japan; School of Economics, Kwansei Gakuin University, Uegahara, Nishinomiya-shi 662-8501, Japan. (C) 2014 Elsevier Inc. All rights reserved.	[Nishimura, Yusaku] Univ Int Business & Econ, Inst Int Econ, Beijing 100029, Peoples R China; [Tsutsui, Yoshiro] Konan Univ, Fac Econ, Higashinada Ku, Kobe, Hyogo 6588501, Japan; [Hirayama, Kenjiro] Kwansei Gakuin Univ, Sch Econ, Nishinomiya, Hyogo 6628501, Japan	Nishimura, Y (reprint author), Univ Int Business & Econ, UIBE, Keyanlou 1103,10 East Huixin St, Beijing, Peoples R China.	yusaku.nishimura@gmail.com; tsutsui@center.konan-u.ac.jp; hiraken@kwansei.ac.jp					Andersen T. G., 1997, J EMPIR FINANC, V4, P115, DOI DOI 10.1016/S0927-5398(97)00004-2; Andersen Torben G., 2000, J INT FINANC MARK I, V10, P107, DOI 10.1016/S1042-4431(99)00029-3; ENGLE RF, 1995, ECONOMET THEOR, V11, P122; Andersen TG, 1998, J FINANC, V53, P219, DOI 10.1111/0022-1082.85732; HAMAO Y, 1990, REV FINANC STUD, V3, P281, DOI 10.1093/rfs/3.2.281; ROZEFF MS, 1976, J FINANC ECON, V3, P379, DOI 10.1016/0304-405X(76)90028-3; LONGIN F, 1995, J INT MONEY FINANC, V14, P3, DOI 10.1016/0261-5606(94)00001-H; Baillie RT, 1996, J ECONOMETRICS, V74, P3, DOI 10.1016/S0304-4076(95)01749-6; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.1093/biomet/65.2.297; KAROLYI GA, 1995, J BUS ECON STAT, V13, P11; Ng A, 2000, J INT MONEY FINANC, V19, P207, DOI 10.1016/S0261-5606(00)00006-1; Andersen TG, 2001, J AM STAT ASSOC, V96, P42, DOI 10.1198/016214501750332965; Baur D, 2006, J INT MONEY FINANC, V25, P598, DOI 10.1016/j.jimonfin.2005.11.010; ARIEL RA, 1987, J FINANC ECON, V18, P161, DOI 10.1016/0304-405X(87)90066-3; Asher H. B., 1983, CAUSAL MODELING; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; Box G. E., 1976, TIME SERIES ANAL FOR; Caporale G. M., 2006, J EC FINANCE, V30, P376, DOI 10.1007/BF02752742; Chen S., 2008, WORLD ECON, V5, P30; Christofi A., 1999, J MULTINATIONAL FINA, V9, P79, DOI 10.1016/S1042-444X(98)00047-4; Chung C.F., 1999, WORKING PAPER; Enders W., 2003, APPL ECONOMETRIC TIM; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; GALLANT AR, 1981, J ECONOMETRICS, V15, P211, DOI 10.1016/0304-4076(81)90115-9; Hirayama K., 2013, JPN J MONET FINANC E, V1, P37; Hussain S. M., 2008, INT RES J FINANCE EC, V22, P205; JEON BN, 1990, Q REV ECON BUS, V30, P15; Jeong J., 1999, GLOBAL FINANCE J, V10, P53, DOI 10.1016/S1044-0283(99)00005-8; Karolyi G.A., 1994, PACIFIC BASIN FINANC, V2, P405, DOI 10.1016/0927-538X(94)90003-5; Kim SJ, 2005, J JPN INT ECON, V19, P338, DOI 10.1016/j.jjie.2004.03.002; Kocenda E., 2007, EC SYSTEMS, V31, P184, DOI 10.1016/j.ecosys.2006.12.004; Koopman SJ, 2005, J EMPIR FINANC, V12, P445, DOI DOI 10.1016/J.JEMPFIN.2004.04.009; LIN WL, 1994, REV FINANC STUD, V7, P507, DOI 10.1093/rfs/7.3.507; Liu C., 2008, WORLD EC PAP, V5, P30; Men M., 2010, J CHIN EC FOREIGN TR, V3, P235; Nishimura Y., 2012, DISCUSSION PAPERS EC, V12-01; Perets J. P., 2002, CONTRIBUTIONS FINANC, P211; ROSS SA, 1989, J FINANC, V44, P1, DOI 10.2307/2328272; THEODOSSIOU P, 1993, J FINANC RES, V16, P337; Tsutsui Y, 2005, J JPN INT ECON, V19, P322, DOI 10.1016/j.jjie.2004.05.001; Tsutsui Y, 2007, ASIAN ECON J, V21, P369, DOI 10.1111/j.1467-8381.2007.00262.x; Wang S. S., 2004, J INT FINANC MARK I, V14, P235, DOI 10.1016/j.intfin.2003.07.002; Xekalaki E., 2010, ARCH MODELS FINANCIA; Yamamoto T., 1988, TIME SERIES ANAL EC; Zellner A., 1974, J ECONOMETRICS, V2, P17, DOI DOI 10.1016/0304-4076(74)90028-1	45	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1583	1095-8681		J JPN INT ECON	J. Jpn. Inst. Econ.	MAR	2015	35						23	42		10.1016/j.jjie.2014.11.005		20	Economics; International Relations	Business & Economics; International Relations	CC7FQ	WOS:000350533500002		
J	Rogoff, KS; Tashiro, T				Rogoff, Kenneth S.; Tashiro, Takeshi			Japan's exorbitant privilege	JOURNAL OF THE JAPANESE AND INTERNATIONAL ECONOMIES			English	Article						Exorbitant privilege; Return differentials; Safe haven; Rare disasters; Maturity transformation; Carry trade	DISASTERS; RETURNS	The concept of "exorbitant privilege" has received great attention from policy makers as well as academics worldwide. The idea originally referred to the willingness of foreigners to hold large quantities of US government debt at extremely low interest rates, due to the dollar's world reserve currency status. In recent years, the term exorbitant privilege has been expanded to explain why the US appears to be enjoying excess return from its external assets over liabilities across all asset classes, including foreign direct investment, equities and other forms of portfolio investment. In this paper, we give a brief review of the recent literature on exorbitant privilege, and then proceed to discuss exorbitant privilege in the context of another country, Japan, which has been the world's largest creditor nation for more than two decades. In contrast to the common perception that japan has been a particularly poor international investor, we find that Japan enjoys exorbitant privilege in both the broad and narrow sense. Japan also earns higher expected returns from maturity transformation. Thus although the dollar is the reserve currency, the yen also has enjoyed a safe haven effect in the recent period. J. Japanese Int. Economies 35 (2015) 43-61. Economics Department, Harvard University, Cambridge, MA, United States; Industrial Structure Policy Division, Ministry of Economy, Trade and Industry, Tokyo, Japan; RIETI, Tokyo, Japan. (C) 2015 Published by Elsevier Inc.	[Rogoff, Kenneth S.] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Tashiro, Takeshi] Minist Econ Trade & Ind, Ind Struct Policy Div, Tokyo, Japan; [Tashiro, Takeshi] RIETI, Tokyo, Japan	Rogoff, KS (reprint author), Harvard Univ, Dept Econ, Cambridge, MA 02138 USA.	krogoff@harvard.edu; Takeshi_Tashiro@hks14.harvard.edu					Hassan TA, 2013, J FINANC, V68, P2269, DOI 10.1111/jofi.12081; Lewis KK, 2011, ANNU REV FINANC ECON, V3, P435, DOI 10.1146/annurev-financial-102710-144841; Clarida R, 2009, J INT MONEY FINANC, V28, P1375, DOI 10.1016/j.jimonfin.2009.08.010; Obstfeld M, 2012, AM ECON REV, V102, P1, DOI 10.1257/aer.102.3.1; Jorda O, 2012, J INT ECON, V88, P74, DOI 10.1016/j.jinteco.2012.03.001; Lane PR, 2007, J INT ECON, V73, P223, DOI 10.1016/j.jinteco.2007.02.003; Baba N, 2009, J BANK FINANC, V33, P1953, DOI 10.1016/j.jbankfin.2009.05.007; Ranaldo A, 2010, REV FINANC, V14, P385, DOI 10.1093/rof/rfq007; Barro RJ, 2009, AM ECON REV, V99, P243, DOI 10.1257/aer.99.1.243; Barro RJ, 2012, ANNU REV ECON, V4, P83, DOI 10.1146/annurev-economics-080511-110932; Botman Dennis P. J., 2013, 13228 IMF; Charles Engel, 2014, HDB INT EC, V4, P453; Curcuru SE, 2013, J INT MONEY FINANC, V36, P1, DOI 10.1016/j.jimonfin.2013.02.002; Curcuru SE, 2008, Q J ECON, V123, P1495, DOI 10.1162/qjec.2008.123.4.1495; De Bock R., 2013, 1308 IMF; Eichengreen B., 2011, EXORBITANT PRIVILEGE; Emmanuel Farhi, 2013, RARE DISASTER UNPUB; Fukuda S, 2012, J BANK FINANC, V36, P3185, DOI 10.1016/j.jbankfin.2012.01.003; Gohrband Christopher A., 2015, MEASURING WEALTH FIN; International Crisis Group, 2002, CHALL PEAC PAST PRES, P2; International Monetary Fund, 1993, BAL PAYM MAN, VFifth; Lane P. R., 2005, 11589 NBER; Lane Philip R., 2013, 497 EUR EC EC; Lane Philip R., 2009, JAPANS BUBBLE DEFLAT; Lane PR, 2009, J JPN INT ECON, V23, P177, DOI 10.1016/j.jjie.2008.11.002; McKinnon R., 2013, UNLOVED DOLLAR STAND; MEESE RA, 1983, J INT ECON, V14, P3, DOI 10.1016/0022-1996(83)90017-X; Michael Habib Maurizio, 2010, EUROPEAN CENTRAL BAN, V1158; Pierre-Olivier Gourinchas, 2014, HDB INT EC, V4, P585; Pierre-Olivier Gourinchas, 2010, 2010E20 IMES; Prasad E., 2014, DOLLAR TRAP US DOLLA; Rey H., 2007, G7 CURRENT ACCOUNT I, P11; Rogoff Kenneth S, 2014, JAPANS EXORBITANT PR; Taylor A. M., 2006, 12580 NBER; Triffin R., 1960, GOLD DOLLAR CRISIS F	35	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1583	1095-8681		J JPN INT ECON	J. Jpn. Inst. Econ.	MAR	2015	35						43	61		10.1016/j.jjie.2014.11.003		19	Economics; International Relations	Business & Economics; International Relations	CC7FQ	WOS:000350533500003		
J	Yukutake, N; Iwata, S; Idee, T				Yukutake, Norifumi; Iwata, Shinichiro; Idee, Takako			Strategic interaction between inter vivos gifts and housing acquisition	JOURNAL OF THE JAPANESE AND INTERNATIONAL ECONOMIES			English	Article						Intergenerational transfer; Home purchase; Exchange motive; Informal care	INTERGENERATIONAL TRANSFERS; BORROWING CONSTRAINTS; PARENTAL WEALTH; HOME-OWNERSHIP; HOMEOWNERSHIP; BEQUESTS; MOTIVES; ADULTS; SWEDEN; CARE	This paper models the interdependence of parental inter vivos gifts and children's home purchases when informal care affects decision making. We use data from Japanese households who purchased a detached house in an urban area to test this strategic interaction. Considering both censoring and endogeneity of inter vivos gifts, which are identified by information on formal care, our preferred results demonstrate that inter vivos gifts do not significantly increase the purchase price of housing. Theory suggests that this occurs when informal care tends to be a heavy burden for children. However, subsample analysis of young home buyers indicates that the empirical results are consistent with the literature: children who receive parental gifts tend to purchase a higher-priced dwelling. One potential explanation is that relatively young adult children are less likely to take charge of care obligations, and accordingly, parental gifts are only expected to relax their liquidity constraints. Subsample analysis appears to indicate that the underlying motivation of parental gifts is influenced by the timing of children's home purchase decisions. J. Japanese Int. Economies 35 (2015) 62-77. Housing Research 82 Advancement Foundation of Japan, 6-3 Nibancho, Chiyoda, Tokyo 102-0084, Japan; Faculty of Economics, University of Toyama, 3190 Gofuku, Toyama, Toyama 930-8555, Japan; Faculty of Economics, Seikei University, 3-3-1 Kichijojikitamachi, Musashino, Tokyo 180-8633, Japan. (C) 2014 Elsevier Inc. All rights reserved.	[Yukutake, Norifumi] Housing Res & Adv Fdn Japan, Chiyoda Ku, Tokyo 1020084, Japan; [Iwata, Shinichiro] Toyama Univ, Fac Econ, Toyama 9308555, Japan; [Idee, Takako] Seikei Univ, Fac Econ, Musashino, Tokyo 1808633, Japan	Iwata, S (reprint author), Toyama Univ, Fac Econ, 3190 Gofuku, Toyama 9308555, Japan.	iwata@eco.u-toyama.ac.jp			Japan Economic Research Foundation	We would like to thank two anonymous reviewers, Lawrence Brown, Toshiyuki Hirai, Daiji Kawaguchi, Wataru Kureishi, Yung Lung Lee, Oleksandr Movshuk, and Michio Naoi, as well as participants in seminars at Hitotsubashi University, Keio University, Konan University, Ritsumeikan University, Tohoku University, and University of Tokyo and conferences at ARSC, AsRES, ENHR, JEA, NAAN, and NARSC for their valuable comments. We are also grateful to the Japan Federation of Housing Organizations for access to microdata. Part of this paper was written while Shinichiro Iwata was visiting Department of Urban Studies, University of Glasgow. He gratefully acknowledges its hospitality. The views expressed here are solely those of the authors and do not reflect any of the institutions they belong to. This research was part of a project of Housing Research 82 Advancement Foundation of japan and supported by the Japan Economic Research Foundation.	Abe A.K., 2009, POLITICAL SOCIAL EC; Van Houtven CH, 2004, J HEALTH ECON, V23, P1159, DOI 10.1016/j.jhealeco.2004.04.008; Ost CE, 2012, URBAN STUD, V49, P2137, DOI 10.1177/0042098011427185; Mulder CH, 1999, EUR SOCIOL REV, V15, P323; Auten G, 1996, J PUBLIC ECON, V59, P55, DOI 10.1016/0047-2727(94)01475-2; Engelhardt GV, 1998, J URBAN ECON, V44, P135, DOI 10.1006/juec.1997.2064; Guiso L, 2002, J MONEY CREDIT BANK, V34, P315, DOI 10.1353/mcb.2002.0039; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Artie R., 1978, J ECON THEORY, V18, P38; BECKER GS, 1974, J POLIT ECON, V82, P1063, DOI 10.1086/260265; BERNHEIM BD, 1985, J POLIT ECON, V93, P1045, DOI 10.1086/261351; Cirman A., 2008, EUROPEAN J HOUSING P, V8, P303, DOI 10.1080/14616710802256710; COX D, 1987, J POLIT ECON, V95, P508, DOI 10.1086/261470; Izuhara M, 2004, J SOC POLICY, V33, P649, DOI 10.1017/S0047279404008049; Izuhara M., 2006, CHANGING JAPANESE FA, P161; Laitner J, 2001, J PUBLIC ECON, V79, P205, DOI 10.1016/S0047-2727(00)00101-8; Luea HM, 2008, CONTEMP ECON POLICY, V26, P420, DOI 10.1111/j.1465-7287.2008.00106.x; McGarry K, 1999, J PUBLIC ECON, V73, P321, DOI 10.1016/S0047-2727(99)00017-1; Norton E. C., 2013, BE J EC ANAL POLI, V14, P377; Norton EC, 2006, SOUTH ECON J, V73, P157; Spilerman S, 2012, SOC SCI RES, V41, P207, DOI 10.1016/j.ssresearch.2011.08.002; VICTORIO AG, 1993, ECON LETT, V42, P149, DOI 10.1016/0165-1765(93)90053-F; Zhou Y., 2007, Q J HOUS LAND EC, V66, P29	23	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1583	1095-8681		J JPN INT ECON	J. Jpn. Inst. Econ.	MAR	2015	35						62	77		10.1016/j.jjie.2014.11.002		16	Economics; International Relations	Business & Economics; International Relations	CC7FQ	WOS:000350533500004		
J	Viaene, JM; Zhao, LX				Viaene, Jean-Marie; Zhao, Laixun			Inspection, testing errors and trade in tainted products	JOURNAL OF THE JAPANESE AND INTERNATIONAL ECONOMIES			English	Article						Tainting; Errors of testing; Experience good; Asymmetric information; Sabotage; Self correction	INTERNATIONAL-TRADE; QUALITY; INFORMATION; INVESTMENT; SUBSIDIES; MODEL	This paper examines international trade and inspection involving tainted products in a model of quality choice, facing fears that globalization is the cause of numerous food incidents. Particularly, we ask the following questions: (i) What are the conditions under which foreign firms choose to produce tainted goods? (ii) Does globalization via freer trade lower product safety? (iii) Why are goods imported even though they are known to be harmful? We show the existence of a free trade Nash equilibrium characterized by production and trade of high-quality non-tainted products. However, free trade cannot prevent the export of tainted goods, because the foreign firm may deviate under different combinations of parameters. We identify self-correcting mechanisms such as nationalism and a political-economy re-allocation of public resources in favor of customs authorities. Nevertheless, we also uncover activities that exacerbate tainted production like errors of testing and sabotage by rival firms. J. Japanese Int. Economies 35 (2015) 99-116. Erasmus University Rotterdam, Tinbergen Institute, The Netherlands; CESifo, Germany; Research Institute of Economics & Business, Kobe University, Kobe 657-8501, Japan. Crown Copyright (C) 2014 Published by Elsevier Inc. All rights reserved.	[Viaene, Jean-Marie] Erasmus Univ, Tinbergen Inst, Rotterdam, Netherlands; [Viaene, Jean-Marie] CESifo, Munich, Germany; [Zhao, Laixun] Kobe Univ, Res Inst Econ & Business, Kobe, Hyogo 6578501, Japan	Viaene, JM (reprint author), Erasmus Univ, Erasmus Sch Econ, Dept Econ, H9-34,POB 1738, NL-3000 DR Rotterdam, Netherlands.	viaene@ese.eur.nl; zhao@rieb.kobe-u.ac.jp			Japan Society for the Promotion of Science [24330079]	We are most grateful to Hideshi Itoh, our Editor in Charge, and two anonymous referees for their helpful comments on earlier versions of the paper. In addition we thank Vladimir Karamychev and seminar participants at Beijing, Erasmus, ETSG, GRIPS, Kobe, Midwest Meetings, Southern Methodist, the Tinbergen Institute and the Vanderbilt conference in honor of W.J. Ethier for helpful comments and suggestions. We are especially thankful to Joel Habets and Harro van Heuvelen for excellent research assistance. Zhao gratefully acknowledges partial funding from a Grant-in-Aid for Basic Research (24330079) from the Japan Society for the Promotion of Science. Needless to say, we are responsible for any remaining errors.	Daughety AF, 2008, RAND J ECON, V39, P973, DOI 10.1111/j.1756-2171.2008.00046.x; MUSSA M, 1978, J ECON THEORY, V18, P301, DOI 10.1016/0022-0531(78)90085-6; Yeaple SR, 2005, J INT ECON, V65, P1, DOI 10.1016/j.jinteco.2004.01.001; NELSON P, 1970, J POLIT ECON, V78, P311, DOI 10.1086/259630; Bureau JC, 1998, EUR REV AGRIC ECON, V25, P437; BAGWELL K, 1989, J INT ECON, V27, P69, DOI 10.1016/0022-1996(89)90078-0; Baumol W. J., 1992, JPN WORLD ECON, V4, P275, DOI 10.1016/0922-1425(92)90031-K; Berges-Sennou F., 2005, J AGR FOOD IND ORG, V3, P1; Blanes-Cristobal JV, 2008, ECON LETT, V101, P110, DOI 10.1016/j.econlet.2008.06.012; Castro Luis, 2014, 4697 CESIFO; CHEN ML, 1991, J INT ECON, V31, P251, DOI 10.1016/0022-1996(91)90038-8; Costinot A, 2012, REV ECON STUD, V79, P581, DOI 10.1093/restud/rdr033; DAS SP, 1989, J INT ECON, V27, P299, DOI 10.1016/0022-1996(89)90057-3; Dinopoulos E, 2007, J LABOR ECON, V25, P553, DOI 10.1086/513297; DIXIT A, 1992, J ECON PERSPECT, V6, P107; Helpman H, 2004, AM ECON REV, V94, P300; Janssen MCW, 2010, GAME ECON BEHAV, V68, P192, DOI 10.1016/j.geb.2009.06.001; Kimball A. M., 2006, RISKY TRADE INFECT D; Konrad KA, 2000, J LAW ECON ORGAN, V16, P155, DOI 10.1093/jleo/16.1.155; Krautheim S, 2012, J INT ECON, V87, P27, DOI 10.1016/j.jinteco.2011.11.004; LAZEAR EP, 1989, J POLIT ECON, V97, P561, DOI 10.1086/261616; Maskus K.E., 2005, POLICY RES WORKING P, V3590; Moraga-Gonzalez J. L., 2015, INT EC REV IN PRESS; Oktaviani R., 2010, MANAGING CHALLENGES; Persson T., 2000, POLITICAL EC; QIU LD, 1994, J INT ECON, V36, P333; Roy S, 1998, J INT ECON, V46, P253, DOI 10.1016/S0022-1996(97)00053-6; SALOP SC, 1987, J IND ECON, V36, P19, DOI 10.2307/2098594; Shaked A., 1984, MONOPOLISTIC COMPETI; Shy O, 2000, ECONOMICA, V67, P79, DOI 10.1111/1468-0335.00196; Veblen T., 1923, ABSENTEE OWNERSHIP B	31	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1583	1095-8681		J JPN INT ECON	J. Jpn. Inst. Econ.	MAR	2015	35						99	116		10.1016/j.jjie.2014.11.001		18	Economics; International Relations	Business & Economics; International Relations	CC7FQ	WOS:000350533500006		
J	Ishii, H; Azuma, K; Kawahara, A; Yamada, K; Imamura, Y; Tokito, T; Kinoshita, T; Kage, M; Hoshino, T				Ishii, Hidenobu; Azuma, Koichi; Kawahara, Akihiko; Yamada, Kazuhiko; Imamura, Yohei; Tokito, Takaaki; Kinoshita, Takashi; Kage, Masayoshi; Hoshino, Tomoaki			Significance of Programmed Cell Death-Ligand 1 Expression and its Association with Survival in Patients with Small Cell Lung Cancer	JOURNAL OF THORACIC ONCOLOGY			English	Article						Small cell lung cancer; PD-L1; Immunohistochemistry; Prognostic factor	CLINICAL-SIGNIFICANCE; TUMOR AGGRESSIVENESS; PD-L1 EXPRESSION; B7-H1 EXPRESSION; CARCINOMA; SAFETY; IMMUNORESISTANCE; OVEREXPRESSION; ACTIVATION; MECHANISM	Background: Programmed cell death 1 receptor-ligand interaction is a major pathway often hijacked by tumors to suppress immune control. The aim of this retrospective study was to investigate the prevalence and prognostic roles of programmed cell death -ligand 1 (PD-L1) expression in small cell lung cancer (SCLC). Methods: The expression of PD-L1 was evaluated by immunohistochemical analysis in 102 specimens of SCLC. Tumors with staining in over 5% of tumor cells were scored as positive for PD-L1 expression. Survival analysis was performed using the Kaplan-Meier method. Results: Expression of PD-L1 in tumor cells was observed in 71.6% (73 of 102) of SCLCs, and was significantly correlated with a limited disease (LD) stage. SCLC patients with PD-L1-positive tumors showed significantly longer overall survival (OS) than those with PD-L1-negative (median OS, 16.3 versus 7.3 months; p < 0.001, respectively). Multivariate analyses demonstrated that a good performance status, LD stage, and expression of PD-L1 were significantly predictive of better OS, independently of other factors. We found no relevance between PD-L1 expression and progression-free survival for first-line treatment in LD- and extensive disease-SCLC patients. Conclusions: In patients with SCLC, expression of PD-L1 is positively correlated with a LD stage, and is independently predictive of a favorable outcome.	[Ishii, Hidenobu; Azuma, Koichi; Yamada, Kazuhiko; Imamura, Yohei; Tokito, Takaaki; Kinoshita, Takashi; Hoshino, Tomoaki] Kurume Univ, Sch Med, Dept Internal Med, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka 8300011, Japan; [Kawahara, Akihiko; Kage, Masayoshi] Kurume Univ Hosp, Dept Diagnost Pathol, Kurume, Fukuoka, Japan	Azuma, K (reprint author), Kurume Univ, Sch Med, Dept Internal Med, Div Respirol Neurol & Rheumatol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	azuma@med.kurume-u.ac.jp					Lipson EJ, 2013, CANCER IMMUNOL RES, V1, P54, DOI 10.1158/2326-6066.CIR-13-0034; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Thompson RH, 2006, CLIN GENITOURIN CANC, V5, P206, DOI 10.3816/CGC.2006.n.038; Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; Mu CY, 2011, MED ONCOL, V28, P682, DOI 10.1007/s12032-010-9515-2; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Crane CA, 2009, ONCOGENE, V28, P306, DOI 10.1038/onc.2008.384; Jiang XF, 2013, CLIN CANCER RES, V19, P598, DOI 10.1158/1078-0432.CCR-12-2731; Chen YB, 2012, TUMORI, V98, P751, DOI 10.1700/1217.13499; Gao Q, 2009, CLIN CANCER RES, V15, P971, DOI 10.1158/1078-0432.CCR-08-1608; Droeser RA, 2013, EUR J CANCER, V49, P2233, DOI 10.1016/j.ejca.2013.02.015; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Velcheti V, 2014, LAB INVEST, V94, P107, DOI 10.1038/labinvest.2013.130; Wu CP, 2006, ACTA HISTOCHEM, V108, P19, DOI 10.1016/j.acthis.2006.01.003; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hino R, 2010, CANCER-AM CANCER SOC, V116, P1757, DOI 10.1002/cncr.24899; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Schalper KA, 2014, CLIN CANCER RES, V20, P2773, DOI 10.1158/1078-0432.CCR-13-2702; Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469; Yang CY, 2014, EUR J CANCER, V50, P1361, DOI 10.1016/j.ejca.2014.01.018; Ettinger David S, 2004, Oncology (Williston Park), V18, P3; Taube JM, 2012, SCI TRANSL MED, V4, P127, DOI DOI 10.1126/SCITRANSLMED.3003689; Thompson RH, 2007, CLIN CANCER RES, V13, p709S, DOI 10.1158/1078-0432.CCR-06-1868; Thompson RH, 2005, CANCER, V104, P2084, DOI 10.1002/cncr.21470	29	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	MAR	2015	10	3					426	430		10.1097/JTO.0000000000000414		5	Oncology; Respiratory System	Oncology; Respiratory System	CC1QX	WOS:000350118000009		
J	Yatabe, Y; Kerr, KM; Utomo, A; Rajadurai, P; Tran, VK; Du, X; Chou, TY; Enriquez, MLD; Lee, GK; Iqbal, J; Shuangshoti, S; Chung, JH; Hagiwara, K; Liang, ZY; Normanno, N; Park, K; Toyooka, S; Tsai, CM; Waring, P; Zhang, L; McCormack, R; Ratcliffe, M; Itoh, Y; Sugeno, M; Mok, T				Yatabe, Yasushi; Kerr, Keith M.; Utomo, Ahmad; Rajadurai, Pathmanathan; Van Khanh Tran; Du, Xiang; Chou, Teh-Ying; Enriquez, Ma. Luisa D.; Lee, Geon Kook; Iqbal, Jabed; Shuangshoti, Shanop; Chung, Jin-Haeng; Hagiwara, Koichi; Liang, Zhiyong; Normanno, Nicola; Park, Keunchil; Toyooka, Shinichi; Tsai, Chun-Ming; Waring, Paul; Zhang, Li; McCormack, Rose; Ratcliffe, Marianne; Itoh, Yohji; Sugeno, Masatoshi; Mok, Tony			EGFR Mutation Testing Practices within the Asia Pacific Region Results of a Multicenter Diagnostic Survey	JOURNAL OF THORACIC ONCOLOGY			English	Article						EGFR mutation; Non-small-cell lung cancer; Testing; Survey; Multicenter	CELL LUNG-CANCER; TYROSINE KINASE INHIBITORS; FACTOR RECEPTOR GENE; 1ST-LINE TREATMENT; STANDARD CHEMOTHERAPY; OPEN-LABEL; GEFITINIB; ADENOCARCINOMA; SENSITIVITY; ERLOTINIB	Introduction: The efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer (NSCLC) patients necessitates accurate, timely testing. Although EGFR mutation testing has been adopted by many laboratories in Asia, data are lacking on the proportion of NSCLC patients tested in each country, and the most commonly used testing methods. Methods: A retrospective survey of records from NSCLC patients tested for EGFR mutations during 2011 was conducted in 11 Asian Pacific countries at 40 sites that routinely performed EGFR mutation testing during that period. Patient records were used to complete an online questionnaire at each site. Results: Of the 22,193 NSCLC patient records surveyed, 31.8% (95% confidence interval: 31.2%-32.5%) were tested for EGFR mutations. The rate of EGFR mutation positivity was 39.6% among the 10,687 cases tested. The majority of samples were biopsy and/or cytology samples (71.4%). DNA sequencing was the most commonly used testing method accounting for 40% and 32.5% of tissue and cytology samples, respectively. A pathology report was available only to 60.0% of the sites, and 47.5% were not members of a Quality Assurance Scheme. Conclusions: In 2011, EGFR mutation testing practices varied widely across Asia. These data provide a reference platform from which to improve the molecular diagnosis of NSCLC, and EGFR mutation testing in particular, in Asia.	[Yatabe, Yasushi] Aichi Canc Ctr, Dept Pathol & Mol Diagnost, Nagoya, Aichi 4648681, Japan; [Kerr, Keith M.] Univ Aberdeen, Sch Med, Dept Pathol, Aberdeen AB9 2ZD, Scotland; [Utomo, Ahmad] Stem Cell & Canc Inst SCI, KalGen Lab, Jakarta, Indonesia; [Rajadurai, Pathmanathan] Monash Univ Malaysia, Sch Med, Kuala Lumpur, Malaysia; [Rajadurai, Pathmanathan] Sime Darby Med Ctr, Kuala Lumpur, Malaysia; [Van Khanh Tran] Hanoi Med Univ, Ctr Gene & Prot Res, Hanoi 100803, Vietnam; [Du, Xiang] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Du, Xiang] Fudan Univ, Inst Pathol, Shanghai 200433, Peoples R China; [Chou, Teh-Ying] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Enriquez, Ma. Luisa D.] St Lukes Med Ctr, Res & Biotechnol Div, Quezon City, Philippines; [Enriquez, Ma. Luisa D.] De La Salle Univ, COS CENSER, Manila, Philippines; [Lee, Geon Kook] Natl Canc Ctr, Dept Pathol, Goyang Si, Gyeonggi Do, South Korea; [Iqbal, Jabed] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Shuangshoti, Shanop] Chulalongkorn Hosp, Chulalongkorn GenePRO Ctr, Bangkok, Thailand; [Chung, Jin-Haeng] Seoul Natl Univ, Bundang Hosp, Seoul, South Korea; [Hagiwara, Koichi] Saitama Med Univ, Dept Resp Med, Saitama, Japan; [Liang, Zhiyong] Beijing Union Med Coll Hosp, Beijing, Peoples R China; [Normanno, Nicola] Fdn Giovanni Pascale IRCCS, Ist Nazl Studio & Cura Tumori, Naples, Italy; [Park, Keunchil] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Innovat Canc Med Inst,Div Hematol Oncol, Seoul, South Korea; [Toyooka, Shinichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Clin Genom Med Thorac Surg, Okayama, Japan; [Tsai, Chun-Ming] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Waring, Paul] Univ Melbourne, Melbourne, Vic, Australia; [Zhang, Li] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [McCormack, Rose; Ratcliffe, Marianne] AstraZeneca, Personalised Healthcare, Macclesfield, Cheshire, England; [Itoh, Yohji; Sugeno, Masatoshi] AstraZeneca, Div Clin Sci, Osaka, Japan; [Mok, Tony] Chinese Univ Hong Kong, Dept Clin Oncol, State Key Lab South China, Hong Kong Canc Inst, Sha Tin, Hong Kong, Peoples R China	Yatabe, Y (reprint author), Aichi Canc Ctr, Dept Pathol & Mol Diagnost, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	yyatabe@aichi-cc.jp			AstraZeneca	This investigator-initiated retrospective study was funded by AstraZeneca. The authors thank the staff who completed the online survey at the participating testing sites; the CRO, WorldWide Clinical Trials; and AstraZeneca's Observational Research Centre.	Ellison G, 2013, J CLIN PATHOL, V66, P79, DOI 10.1136/jclinpath-2012-201194; Lee JS, 2009, J THORAC ONCOL, V4, pS283; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Dearden S, 2013, ANN ONCOL, V24, P2371, DOI 10.1093/annonc/mdt205; Xue C, 2012, LUNG CANCER, V77, P371, DOI 10.1016/j.lungcan.2012.04.014; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Lindeman NI, 2013, ARCH PATHOL LAB MED, V137, P828, DOI 10.5858/arpa.2012-0720-OA; Goto K, 2012, ANN ONCOL, V23, P2914, DOI 10.1093/annonc/mds121; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Tokumo M, 2005, CLIN CANCER RES, V11, P1167; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Yoshida K, 2007, J THORAC ONCOL, V2, P22, DOI 10.1097/01243894-200701000-00006; GLOBOCAN (IARC), 2012, LUNG CANC FACT SHEET; Marchetti A, 2010, Pathologica, V102, P119; Pirker Robert, 2010, J Thorac Oncol, V5, P1706, DOI 10.1097/JTO.0b013e3181f1c8de	19	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	MAR	2015	10	3					438	445		10.1097/JTO.0000000000000422		8	Oncology; Respiratory System	Oncology; Respiratory System	CC1QX	WOS:000350118000011		
J	Ichihara, E; Hotta, K; Nogami, N; Kuyama, S; Kishino, D; Fujii, M; Kozuki, T; Tabata, M; Harada, D; Chikamori, K; Aoe, K; Ueoka, H; Hosokawa, S; Bessho, A; Hisamoto-Sato, A; Kubo, T; Oze, I; Takigawa, N; Tanimoto, M; Kiura, K				Ichihara, Eiki; Hotta, Katsuyuki; Nogami, Naoyuki; Kuyama, Shoichi; Kishino, Daizo; Fujii, Masanori; Kozuki, Toshiyuki; Tabata, Masahiro; Harada, Daijiro; Chikamori, Kenichi; Aoe, Keisuke; Ueoka, Hiroshi; Hosokawa, Shinobu; Bessho, Akihiro; Hisamoto-Sato, Akiko; Kubo, Toshio; Oze, Isao; Takigawa, Nagio; Tanimoto, Mitsune; Kiura, Katsuyuki			A Phase II Trial of Gefitinib in Combination with Bevacizumab as First-Line Therapy for Advanced Non-Small Cell Lung Cancer with Activating EGFR Gene Mutations: The Okayama Lung Cancer Study Group Trial 1001	JOURNAL OF THORACIC ONCOLOGY			English	Article						Epidermal growth factor mutation; Non-small cell lung cancer; Gefitinib; Bevacizumab	GROWTH-FACTOR-RECEPTOR; TYROSINE KINASE; OPEN-LABEL; IN-VIVO; ERLOTINIB; CHEMOTHERAPY; INHIBITOR; MULTICENTER; CARBOPLATIN; PACLITAXEL	Purpose: Whether bevacizumab enhances the effect of the epidermal growth factor receptor (EGFR) inhibitor gefitinib on EGFR mutant non-small cell lung cancers (NSCLCs) remains unknown. We conducted a phase II trial to investigate the efficacy and safety of gefitinib when combined with bevacizumab as first-line therapy in patients with advanced NSCLC harboring EGFR gene mutations. Methods: In this trial, 42 patients with a performance status of 0 to 2 received gefitinib (250 mg/d) and bevacizumab (15 mg/kg, every 3 weeks). The primary end point of this study was the 1-year progression-free survival (PFS) rate. We assumed that a 1-year PFS rate of 55% would indicate potential usefulness and that a 1-year PFS rate of 40% would constitute the lower limit of interest. Results: Forty-two patients were enrolled in the study with a median age of 73 (range 42-86) years. Activating EGFR gene mutations included exon 19 deletion (57%) and L858R point mutations in exon 21 (38%). The objective response rate was 73.8% and included two complete responses. The 1-year PFS rate and median PFS time were 56.7% (95% confidence interval [CI] 39.9-70.5) and 14.4 months (95% CI 10.1-19.2), respectively. The median PFS differed significantly between EGFR exon 19 deletion and the L858R point mutation (18.0 versus 9.4 months, respectively; p = 0.006). The median overall survival had not yet been reached. Severe adverse events included grade 3 skin rash (15%), hypertension (17%), aspartate transaminase/alanine aminotransferase elevation (17%), proteinuria (7%), intracranial hemorrhage (2%), and grade 4 perforation of the digestive tract (2%). There were no treatment-related deaths. Conclusion: Gefitinib in combination with bevacizumab as first-line therapy seems to be a favorable and well-tolerated treatment for patients with advanced NSCLC with activating EGFR gene mutations, especially those with EGFR exon 19 deletion mutations, although the primary end point was not met because the lower limit of the CI was less than 40%.	[Ichihara, Eiki; Hotta, Katsuyuki; Tabata, Masahiro; Hisamoto-Sato, Akiko; Kubo, Toshio; Tanimoto, Mitsune; Kiura, Katsuyuki] Okayama Univ Hosp, Dept Resp Med, Okayama 7008558, Japan; [Ichihara, Eiki] Vanderbilt Univ, Med Ctr, Dept Hematol Oncol, Nashville, TN USA; [Nogami, Naoyuki; Kozuki, Toshiyuki; Harada, Daijiro] NHO Shikoku Canc Ctr, Dept Resp Med, Matsuyama, Ehime, Japan; [Kuyama, Shoichi] NHO Iwakuni Clin Ctr, Dept Resp Med, Iwakuni, Japan; [Kishino, Daizo; Chikamori, Kenichi; Aoe, Keisuke; Ueoka, Hiroshi] NHO Yamaguchi Ube Med Ctr, Dept Med Oncol, Ube, Yamaguchi, Japan; [Fujii, Masanori] Japanese Red Cross Kobe Hosp, Dept Resp Internal Med, Kobe, Hyogo, Japan; [Harada, Daijiro] Sumitomo Besshi Hosp, Div Clin Oncol, Niihama, Japan; [Aoe, Keisuke] NHO Yamaguchi Ube Med Ctr, Dept Clin Res, Ube, Yamaguchi, Japan; [Hosokawa, Shinobu; Bessho, Akihiro] Japanese Red Cross Okayama Hosp, Dept Resp Med, Okayama, Japan; [Oze, Isao] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Takigawa, Nagio] Kawasaki Med Univ, Dept Gen Internal Med 4, Okayama, Japan	Ichihara, E (reprint author), Okayama Univ Hosp, Dept Resp Med, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	ichiha-e@md.okayama-u.ac.jp			Uehara Memorial Foundation; AstraZeneca; Merck Serono; Taiho Pharmaceutical; Dainippon Sumitomo Pharma; Kyowa-Hakko Kirin; Chugai Pharma; Eisai; Pfizer; Takeda; Lilly; Quintiles; Ono Pharmaceutical; Daiichi Sankyo; Yakult; PAREXEL International; MSD; Boehringer Ingelheim; Sanofi; Nihon Shinyaku; Taisho Toyama; Nihon Kayaku; Novartis	Ichihara received research grant from Uehara Memorial Foundation and the department that he currently belongs to received funding from AstraZeneca. Hotta received honoraria from Lilly, AstraZeneca, Taiho Pharmaceutical, Pfizer, Chugai Pharma, and Sanofi. Nogami received honoraria from Pfizer, Taiho Pharmaceutical, Daiichi Sankyo, Lilly, AstraZeneca, and Chugai Pharma and grant from Merck Serono, Taiho Pharmaceutical, Dainippon Sumitomo Pharma, Kyowa-Hakko Kirin, Chugai Pharma, Eisai, Pfizer, Takeda, Lilly, Quintiles, Ono Pharmaceutical, Daiichi Sankyo, AstraZeneca, Yakult, PAREXEL International, MSD, and Boehringer Ingelheim. Kuyama received honoraria from AstraZeneca and Chugai Pharma. Kozuki received honoraria from AstraZeneca and Chugai Pharma. Harada received honoraria from Taiho Pharmaceutical and Boehringer Ingelheim. Chikamori received grant from Chugai Pharma. Aoe received grant from Lilly. Ueoka received honoraria from Novartis, Chugai Pharma, Pfizer, AstraZeneca, Boehringer Ingelheim, Shionogi, Ono Pharmaceutical, and Kyorin Pharma. Takigawa received honoraria from Lilly, Nihon Kayaku, AstraZeneca, Daiichi Sankyo, Chugai Pharma, Taiho Pharmaceutical, Pfizer, Boehringer Ingelheim, and Sanofi and grant from chugai Pharma, Sanofi, Boehringer Ingelheim, AstraZeneca, Taiho Pharmaceutical, Kyowa-Hakko Kirin, Nihon Shinyaku, Taisho Toyama, Lilly, and Nihon Kayaku. Kiura received honoraria from Lilly, Chugai Pharma, Taiho Pharmaceutical, and Pfizer and grant from Chugai Pharma, Sanofi, Pfizer, Novartis, and Daiichi Sankyo.	Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Ramalingam SS, 2008, J CLIN ONCOL, V26, P60, DOI 10.1200/JCO.2007.13.1144; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Hirata A, 2002, CANCER RES, V62, P2554; Ciardiello F, 2003, CLIN CANCER RES, V9, P1546; Jung YD, 2002, EUR J CANCER, V38, P1133, DOI 10.1016/S0959-8049(02)00013-8; Naumov GN, 2009, CLIN CANCER RES, V15, P3484, DOI 10.1158/1078-0432.CCR-08-2904; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; De Luca A, 2008, J CELL PHYSIOL, V214, P559, DOI 10.1002/jcp.21260; Herbst RS, 2011, LANCET, V377, P1846, DOI 10.1016/S0140-6736(11)60545-X; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Petit AMV, 1997, AM J PATHOL, V151, P1523; Ciardiello F, 2000, CLIN CANCER RES, V6, P3739; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Hayakawa H, 2013, CANCER SCI, V104, P1440, DOI 10.1111/cas.12284; Ichihara E, 2009, CANCER RES, V69, P5091, DOI 10.1158/0008-5472.CAN-08-4204; Ichihara E, 2013, LUNG CANCER, V81, P435, DOI 10.1016/j.lungcan.2013.05.021; Kimura H, 2006, CANCER SCI, V97, P642, DOI 10.1111/j.1349-7006.2006.00216.x; Seto T, 2014, LANCET ONCOL, V15, P1236, DOI 10.1016/S1470-2045(14)70381-X; Tonra JR, 2006, CLIN CANCER RES, V12, P2197, DOI 10.1158/1078-0432.CCR-05-1682	26	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	MAR	2015	10	3					486	491		10.1097/JTO.0000000000000434		6	Oncology; Respiratory System	Oncology; Respiratory System	CC1QX	WOS:000350118000017		
J	Hoshimoto, S; Takeuchi, H; Ono, S; Sim, MS; Huynh, JL; Huang, SK; Marzese, DM; Kitagawa, Y; Hoon, DSB				Hoshimoto, Sojun; Takeuchi, Hiroya; Ono, Shigeshi; Sim, Myung Shin; Huynh, Jamie L.; Huang, Sharon K.; Marzese, Diego M.; Kitagawa, Yuko; Hoon, Dave S. B.			Genome-Wide Hypomethylation and Specific Tumor-Related Gene Hypermethylation are Associated with Esophageal Squamous Cell Carcinoma Outcome	JOURNAL OF THORACIC ONCOLOGY			English	Article						Esophageal squamous cell carcinoma; LINE-1; DNA methylation; Prognosis; Tumor-related genes	CPG ISLAND HYPERMETHYLATION; PROMOTER HYPERMETHYLATION; POOR-PROGNOSIS; QUANTITATIVE-ANALYSIS; DNA METHYLATION; DOWN-REGULATION; CANCER; PROGRESSION; EXPRESSION; LINE-1	Introduction: Esophageal squamous cell carcinoma (ESCC) is a cancer of variable outcomes with limited effective treatments resulting in poor overall survival (OS). Epigenetic alterations contributing to this deadly cancer type that can be used as novel therapeutic or diagnostic targets are still poorly understood. Methods: We explored genome-wide DNA methylation data from The Cancer Genome Atlas project and identified a panel of tumor-related genes hypermethylated in ESCC. The methylation statuses of RASSF1, RARB, CDKN2A (p16INK4a, p14ARF), APC, and RUNX3 genes and long interspersed nucleotide element-1 (LINE-1) were validated in a large cohort (n = 140) of clinically well-annotated ESCC specimens and esophageal normal mucosa (n = 28) using a quantitative methylation-specific polymerase chain reaction. Results: Hypermethylation of RARB, p16INK4a, RASSF1, APC, RUNX3, and p14ARF were observed in 55%, 24%, 20%, 19%, 14%, and 8% of specimens, respectively. Hypermethylation of APC was significantly associated with tumor depth (p = 0.02) and American Joint Committee on Cancer stage (p = 0.03). Global DNA methylation level, assessed by LINE-1, was significantly lower in ESCC than in normal mucosa (p < 0.0001), and lower in greater than or equal to T2 (n = 69) than T1 tumors (n = 45; p = 0.03). There was a significant inverse correlation between LINE-1 and RARB methylation (p = 0.008). Importantly, hypermethylation of RASSF1 and APC genes was significantly associated with overall survival (OS; p = 0.006 and p = 0.007, respectively). In addition, patients with tumors containing a higher number of methylated genes (greater than two genes) presented worse OS (p = 0.003). Conclusions: This study demonstrates that epigenetic alterations of a panel of tumor-related genes and the noncoding region LINE-1 can be used as prognostic indicators and help in clinical management of ESCC patients.	[Hoshimoto, Sojun; Ono, Shigeshi; Huynh, Jamie L.; Huang, Sharon K.; Marzese, Diego M.; Hoon, Dave S. B.] St Johns Hlth Ctr, John Wayne Canc Inst, Dept Mol Oncol, Santa Monica, CA 90404 USA; [Hoshimoto, Sojun; Takeuchi, Hiroya; Ono, Shigeshi; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Sim, Myung Shin] St Johns Hlth Ctr, John Wayne Canc Inst, Biostat Div, Santa Monica, CA 90404 USA	Hoon, DSB (reprint author), St Johns Hlth Ctr, John Wayne Canc Inst, Dept Mol Oncol, 2200 Santa Monica Blvd, Santa Monica, CA 90404 USA.	hoond@jwci.org			Ruth and Martin H. Weil Fund (Los Angeles, CA)	This study was supported by the Ruth and Martin H. Weil Fund (Los Angeles, CA). The authors have no other conflict of interest to declare.	Ando N, 2000, ANN SURG, V232, P225, DOI 10.1097/00000658-200008000-00013; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Kamangar F, 2009, GASTROENTEROL CLIN N, V38, P27, DOI 10.1016/j.gtc.2009.01.004; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Tepper J, 2008, J CLIN ONCOL, V26, P1086, DOI 10.1200/JCO.2007.12.9593; Tanemura A, 2009, CLIN CANCER RES, V15, P1801, DOI 10.1158/1078-0432.CCR-08-1361; Guo MZ, 2006, CLIN CANCER RES, V12, P4515, DOI 10.1158/1078-0432.CCR-05-2858; Law S, 2003, ANN SURG, V238, P339, DOI 10.1097/01.sla.0000086545.45918.ee; Sato F, 2006, CANCER, V106, P483, DOI 10.1002/cncr.21657; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Shigaki H, 2013, GASTRIC CANCER, V16, P480, DOI 10.1007/s10120-012-0209-7; de Maat MFG, 2008, J CLIN ONCOL, V26, P2327, DOI 10.1200/JCO.2007.14.0723; Iwagami S, 2013, ANN SURG, V257, P449, DOI 10.1097/SLA.0b013e31826d8602; Umetani N, 2005, BIOCHEM BIOPH RES CO, V329, P219, DOI 10.1016/j.bbrc.2005.01.088; Lee HS, 2009, CLIN CANCER RES, V15, P812, DOI 10.1158/1078-0432.CCR-08-0266; Urschel JD, 2003, AM J SURG, V185, P538, DOI 10.1016/S0002-9610(03)00066-7; de Maat MFG, 2010, CLIN CANCER RES, V16, P2811, DOI 10.1158/1078-0432.CCR-09-2717; McShane LM, 2005, J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Kawakami K, 2000, J NATL CANCER I, V92, P1805, DOI 10.1093/jnci/92.22.1805; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Bravi F, 2012, ANN ONCOL, V23, P765, DOI 10.1093/annonc/mdr295; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chao YK, 2009, ANN SURG, V249, P392, DOI 10.1097/SLA.0b013e3181949e9f; de Maat MFG, 2010, AM J PATHOL, V177, P2347, DOI 10.2353/ajpath.2010.091103; de Maat MFG, 2007, MOL CANCER RES, V5, P461, DOI 10.1158/1541-7786.MCR-06-0358; Eslick GD, 2009, GASTROENTEROL CLIN N, V38, P17, DOI 10.1016/j.gtc.2009.01.008; Fujiwara S, 2008, DIS ESOPHAGUS, V21, P125, DOI 10.1111/j.1442-2050.2007.00735.x; Guo W, 2013, CLIN EXP METASTAS, V30, P977, DOI 10.1007/s10585-013-9597-2; Hoshimoto S, 2012, J INVEST DERMATOL, V132, P1689, DOI 10.1038/jid.2012.36; Kim YT, 2009, DIS ESOPHAGUS, V22, P143, DOI 10.1111/j.1442-2050.2008.00862.x; Kuroki T, 2003, CLIN CANCER RES, V9, P1441; Lo PHY, 2007, CANCER LETT, V257, P199, DOI 10.1016/j.canlet.2007.07.018; Long CZ, 2007, CANCER INVEST, V25, P685, DOI 10.1080/07357900701561131; Miyata Hiroshi, 2011, Gen Thorac Cardiovasc Surg, V59, P461, DOI 10.1007/s11748-011-0780-6; Murata A, 2013, BRIT J CANCER, V109, P408, DOI 10.1038/bjc.2013.289; Oka D, 2009, CANCER, V115, P3412, DOI 10.1002/cncr.24394; Sunami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018884; Tonomoto Y, 2007, ONCOLOGY-BASEL, V73, P346, DOI 10.1159/000135350; Wang YM, 2003, CLIN CANCER RES, V9, P5257; Yuequan Jiang, 2010, Ann Thorac Surg, V90, P908, DOI 10.1016/j.athoracsur.2010.05.060; Zare M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-24; Zhu YH, 2013, CANCER RES, V73, P2298, DOI 10.1158/0008-5472.CAN-12-2663	43	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	MAR	2015	10	3					509	517		10.1097/JTO.0000000000000441		9	Oncology; Respiratory System	Oncology; Respiratory System	CC1QX	WOS:000350118000020		
J	Kimura, M; Endo, H; Inoue, T; Nishino, K; Uchida, J; Kumagai, T; Kukita, Y; Kato, K; Imamura, F; Inoue, M				Kimura, Madoka; Endo, Hiroko; Inoue, Takako; Nishino, Kazumi; Uchida, Junji; Kumagai, Toru; Kukita, Yoji; Kato, Kikuya; Imamura, Fumio; Inoue, Masahiro			Analysis of ERBB Ligand-Induced Resistance Mechanism to Crizotinib by Primary Culture of Lung Adenocarcinoma with EML4-ALK Fusion Gene	JOURNAL OF THORACIC ONCOLOGY			English	Article						Lung cancer; Anaplastic lymphoma kinase; Crizotinib resistance; Primary culture; ERBB	ALK INHIBITORS; CANCER CELLS; ACTIVATION	Introduction: Using cell line-based assays, the secretion of erythroblastic leukemia viral oncogene homologue (ERBB) ligands has been reported to contribute to resistance against crizotinib in lung cancer with the echinoderm microtubule-associated protein-like 4 and anaplastic lymphoma kinase fusion gene. However, it is difficult to predict the role of the ligands in each patient. Here, we report an analysis of the mechanism of resistance behind crizotinib resistance using a primary culture of cancer cells from pleural effusion of an anaplastic lymphoma kinase-positive lung cancer patient who was clinically resistant to crizotinib. Methods: Primary cancer cells were prepared as cancer tissue-originated spheroids (CTOSs) according to previously described methods. CTOSs were maintained in StemPro medium, and a sensitivity assay was performed under growth factor-free conditions, or under stimulation with epidermal growth factor (EGF) or neuregulin-1/heregulin. The effect of treatment with crizotinib alone or a combination of crizotinib and erlotinib was examined. Results: Cancer cells (LB53) were established to be CTOSs from a patient who was clinically resistant to crizotinib. The CTOSs were sensitive to crizotinib under growth factor-free conditions in vitro, whereas resistant under stimulation with EGF or neuregulin-1. These ligands rescued the inhibition of intracellular signaling by crizotinib. Pleural effusion from the patient also activated EGF receptor signaling to the similar extent of EGF stimulation. The resistance to crizotinib by EGF was reversed by blocking EGF receptor signaling by erlotinib in vitro. Conclusion: Stimulation by ERBB ligands is suggested to be responsible for resistance to crizotinib in this patient. The CTOS method may enable analysis of resistance mechanism for targeted therapy in individual patients.	[Kimura, Madoka; Inoue, Takako; Nishino, Kazumi; Uchida, Junji; Kumagai, Toru; Imamura, Fumio] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Oncol, Osaka 5378511, Japan; [Endo, Hiroko; Inoue, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Osaka 5378511, Japan; [Kukita, Yoji; Kato, Kikuya] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Mol & Med Genet, Osaka 5378511, Japan	Inoue, M (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	imamura-fu@mc.pref.osaka.jp; inoue-ma2@mc.pref.osaka.jp			Osaka foundation for the prevention of cancer and cardiovascular diseases; Takeda Science Foundation; Naito Foundation	This work was partly supported by Osaka foundation for the prevention of cancer and cardiovascular diseases (HE), Takeda Science Foundation (MI), and The Naito Foundation (MI).	Sasaki T, 2011, CANCER RES, V71, P6051, DOI 10.1158/0008-5472.CAN-11-1340; Kondo J, 2011, P NATL ACAD SCI USA, V108, P6235, DOI 10.1073/pnas.1015938108; Okuyama H, 2013, J UROLOGY, V190, P302, DOI 10.1016/j.juro.2012.12.106; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Katayama R, 2011, P NATL ACAD SCI USA, V108, P7535, DOI 10.1073/pnas.1019559108; Tanizaki J, 2012, CLIN CANCER RES, V18, P6219, DOI 10.1158/1078-0432.CCR-12-0392; Endo H, 2013, J THORAC ONCOL, V8, P131, DOI 10.1097/JTO.0b013e3182779ccf; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316	8	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	MAR	2015	10	3					527	530		10.1097/JTO.0000000000000381		4	Oncology; Respiratory System	Oncology; Respiratory System	CC1QX	WOS:000350118000022		
J	Jimenez-Yuste, V; Lejniece, S; Klamroth, R; Suzuki, T; Santagostino, E; Karim, FA; Saugstrup, T; Moss, J				Jimenez-Yuste, V.; Lejniece, S.; Klamroth, R.; Suzuki, T.; Santagostino, E.; Karim, F. A.; Saugstrup, T.; Moss, J.			The pharmacokinetics of a B-domain truncated recombinant factor VIII, turoctocog alfa (NovoEight (R)), in patients with hemophilia A	JOURNAL OF THROMBOSIS AND HAEMOSTASIS			English	Article						blood coagulation disorders; hemophiliaA; N8 recombinant factorVIII; pharmacokinetics; turoctocog alfa	PROPHYLACTIC TREATMENT; PEDIATRIC-PATIENTS; EFFICACY; SAFETY; N8; POPULATION	BackgroundTuroctocog alfa (NovoEight((R))) is a human recombinant coagulation factorVIII (rFVIII) for the treatment of patients with hemophiliaA. ObjectivesTo evaluate the pharmacokinetics of turoctocog alfa in all age groups across clinical trials. Patients/methodsData from previously treated patients with severe hemophiliaA (FVIII activity level of 1%) with no history of FVIII inhibitors, in a non-bleeding state, were included. The pharmacokinetics were assessed following a wash-out period and a subsequent single intravenous 50IUkg(-1) dose of turoctocog alfa. Blood was sampled during a 48-h period postdose. Standard pharmacokinetic (PK) parameters were estimated on the basis of plasma FVIII activity vs. time (PK profiles) with non-compartmental methods. Furthermore, a population PK analysis was conducted. ResultsData from 76 patients (aged 1-60years) enrolled globally across six clinical trials were included, totaling 105 turoctocog alfa PK profiles. Single-dose PK results 3-6months after the first dose of turoctocog alfa were comparable with the results obtained after the first dose. Similar PK characteristics were shown for different lots and strengths of the drug product. Overall, area under the plasma concentration (activity) curve from administration to infinity (AUC) and t(1/2) tended to increase with increasing age, with lower AUC and shorter t(1/2) being seen in children than in adolescents and adults. The PK profiles of turoctocog alfa and other commercially available plasma-derived FVIII and rFVIII products were similar in all age groups. ConclusionsThe PK characteristics of turoctocog alfa have been thoroughly studied, and shown to be consistent over time, reproducible between different lots and strengths of drug product, and similar to those observed for other FVIII products.	[Jimenez-Yuste, V.] Univ Autonoma Madrid, La Paz Univ Hosp, Hemophilia Ctr, Madrid 28046, Spain; [Lejniece, S.] Chemotherapy & Hematol Clin, Riga, Latvia; [Klamroth, R.] Vivantes Hosp Friedrichshain, Hemophilia Treatment Ctr, Berlin, Germany; [Suzuki, T.] Tokyo Med Univ Hosp, Tokyo, Japan; [Santagostino, E.] IRCCS Ca Granda Fdn Maggiore Hosp, Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy; [Karim, F. A.] Natl Blood Ctr, Kuala Lumpur, Malaysia; [Saugstrup, T.; Moss, J.] Novo Nordisk AS, Soborg, Denmark	Jimenez-Yuste, V (reprint author), Univ Autonoma Madrid, Hosp Univ La Paz, Unidad Coagulopatias, Serv Hematol, P Castellana 261, Madrid 28046, Spain.	vjyuste@gmail.com			Novo Nordisk A/S (Bagsvaerd, Denmark)	This program was sponsored by Novo Nordisk A/S (Bagsvaerd, Denmark). The investigators, trial staff and patients are thanked for their participation. C. Wenzel Tornoe (Novo Nordisk A/S) performed population-based PK modeling, and A.-M. Paarup (Novo Nordisk A/S) provided editorial support for manuscript preparation.	Martinowitz U, 2011, HAEMOPHILIA, V17, P854, DOI 10.1111/j.1365-2516.2011.02495.x; Lentz SR, 2013, HAEMOPHILIA, V19, P691, DOI 10.1111/hae.12159; Giles AR, 1998, THROMB HAEMOSTASIS, V79, P872; Christiansen MLS, 2010, HAEMOPHILIA, V16, P878, DOI 10.1111/j.1365-2516.2010.02333.x; [Anonymous], 2012, SUMM PROD CHAR ADV; Bjorkman S, 2012, BLOOD, V119, P612, DOI 10.1182/blood-2011-07-360594; Blanchette VS, 2008, J THROMB HAEMOST, V6, P1319, DOI 10.1111/j.1538-7836.2008.03032.x; Barrowcliffe TW, 2002, SEMIN THROMB HEMOST, V28, P247, DOI 10.1055/s-2002-32658; Thim L, 2010, HAEMOPHILIA, V16, P349, DOI 10.1111/j.1365-2516.2009.02135.x; Kulkarni R, 2013, HAEMOPHILIA, V19, P698, DOI 10.1111/hae.12165; EMA, 144533 EMACHMPBPMP; Ezban M, 2014, EUR J HAEMATOL, V93, P369, DOI 10.1111/ejh.12366; ICH, 2010, TRIP HARM GUID GOOD; Jimenez-Yuste V, 2013, BLOOD, V122; Lee M, 2001, DESIGN PHARM STUDIES; Morfini M, 2014, EUR J HAEMATOL, V93, P361, DOI 10.1111/ejh.12359	16	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1538-7933	1538-7836		J THROMB HAEMOST	J. Thromb. Haemost.	MAR	2015	13	3					370	379		10.1111/jth.12816		10	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CC7LH	WOS:000350548500006		
J	Oze, T; Hiramatsu, N; Yakushijin, T; Yamada, R; Harada, N; Morishita, N; Oshita, M; Mita, E; Ito, T; Inui, Y; Inada, M; Tamura, S; Yoshihara, H; Imai, Y; Kato, M; Miyagi, T; Yoshida, Y; Tatsumi, T; Kasahara, A; Hayashi, N; Takehara, T				Oze, T.; Hiramatsu, N.; Yakushijin, T.; Yamada, R.; Harada, N.; Morishita, N.; Oshita, M.; Mita, E.; Ito, T.; Inui, Y.; Inada, M.; Tamura, S.; Yoshihara, H.; Imai, Y.; Kato, M.; Miyagi, T.; Yoshida, Y.; Tatsumi, T.; Kasahara, A.; Hayashi, N.; Takehara, T.			The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1	JOURNAL OF VIRAL HEPATITIS			English	Article						chronic hepatitis C; discontinuation rate; drug adherence; older patients; telaprevir with pegylated interferon and ribavirin	VIRUS-INFECTION; PEGINTERFERON	Triple therapy with telaprevir, pegylated interferon and ribavirin has been reported to improve antiviral efficacy but have potentially severe adverse effects in patients with chronic hepatitis C. To avoid the severe effects of telaprevir, lowering the dose has been suggested. However, impact of dosage changes on antiviral and adverse effects remains unclear. One hundred and sixty-six Japanese patients with HCV genotype 1 were treated with triple therapy. The drug exposure of each medication was calculated by averaging the dose actually taken. The overall SVR rate was 82%. The telaprevir discontinuation rate was 26%. The factors associated with discontinuation were an older age (65y.o.) and a higher average dose during treatment. The telaprevir discontinuation rates were 42%, 25% and 14% in patients at 35, 25-35 and <25mg/kg/day of telaprevir and 58% in older patients at 35mg/kg/day of TVR. The factors associated with SVR were treatment-naive, relapse to previous treatment, higher average telaprevir dose during treatment and completion of treatment. The SVR rate was higher, at 91%, in patients at 25-35mg/kg/day of telaprevir than the 71% and 78% observed in those at <25 and 35mg/kg/day of drug. In Japanese patients, a mean telaprevir dose of 25-35mg/kg/day during treatment can augment its efficacy in triple therapy for patients with HCV genotype 1.	[Oze, T.; Hiramatsu, N.; Yakushijin, T.; Yamada, R.; Harada, N.; Morishita, N.; Miyagi, T.; Yoshida, Y.; Tatsumi, T.; Takehara, T.] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka 5650871, Japan; [Oshita, M.] Osaka Police Hosp, Osaka, Osaka, Japan; [Mita, E.] Natl Hosp Org Osaka Natl Hosp, Osaka, Osaka, Japan; [Ito, T.] Osaka Koseinenkin Hosp, Osaka, Osaka, Japan; [Inui, Y.] Hyogo Prefectural Nishinomiya Hosp, Nishinomiya, Hyogo, Japan; [Inada, M.] Toyonaka City Hosp, Toyonaka, Osaka, Japan; [Tamura, S.] Minoh City Hosp, Osaka, Japan; [Yoshihara, H.] Osaka Rosai Hosp, Sakai, Osaka, Japan; [Imai, Y.] Ikeda Municipal Hosp, Ikeda, Osaka, Japan; [Kato, M.] Natl Hosp Org Minami Wakayama Med Ctr, Tanabe, Wakayama, Japan; [Kasahara, A.] Osaka Univ Hosp, Dept Gen Med, Suita, Osaka, Japan; [Hayashi, N.] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan	Hiramatsu, N (reprint author), Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	hiramatsu@gh.med.osaka-u.ac.jp			Ministry of Health Labour and Welfare of Japan; Ministry of Education, Science and Culture of Japan	This study was funded by a Grant-in-Aid for Research on Hepatitis and BSE from Ministry of Health Labour and Welfare of Japan, and Scientific Research from the Ministry of Education, Science and Culture of Japan.	Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Furusyo N, 2013, J HEPATOL, V59, P205, DOI 10.1016/j.jhep.2013.03.020; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Akuta N, 2010, HEPATOLOGY, V52, P421, DOI 10.1002/hep.23690; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Fukuda K, 2014, HEPATOL RES, V44, P1165, DOI 10.1111/hepr.12229; Hayashi N, 2012, J VIRAL HEPATITUS, V19, P134; Kawakami Y, 2014, ANTIVIR THER, V19, P277, DOI 10.3851/IMP2706; Mauss S, 2014, HEPATOLOGY, V59, P46, DOI 10.1002/hep.26602; Oze T, 2014, J GASTROENT IN PRESS, DOI [10.1007/s00535-014-0965-8, DOI 10.1007/S00535-014-0965-8]; Suzuki F, 2009, HEPATOL RES, V39, P1056, DOI 10.1111/j.1872-034X.2009.00548.x; Zeuzem S, 2014, GASTROENTEROLOGY, V146, P430, DOI 10.1053/j.gastro.2013.10.058	18	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1352-0504	1365-2893		J VIRAL HEPATITIS	J. Viral Hepatitis	MAR	2015	22	3					254	262		10.1111/jvh.12289		9	Gastroenterology & Hepatology; Infectious Diseases; Virology	Gastroenterology & Hepatology; Infectious Diseases; Virology	CC7KN	WOS:000350546300005		
J	Nukui, M; Mori, Y; Murphy, EA				Nukui, Masatoshi; Mori, Yasuko; Murphy, Eain A.			A Human Herpesvirus 6A-Encoded MicroRNA: Role in Viral Lytic Replication	JOURNAL OF VIROLOGY			English	Article							CHRONIC-FATIGUE-SYNDROME; VIRUS-ENCODED MICRORNAS; READING FRAME U14; MULTIPLE-SCLEROSIS; CELLULAR RECEPTOR; CYTOMEGALOVIRUS; IDENTIFICATION; EXPRESSION; LATENCY; PROTEIN	Human herpesvirus 6A (HHV-6A), a member of the betaherpesvirus family, is associated with several human diseases. Like all herpesviruses, HHV-6A establishes a lifelong, latent infection in its host. Reactivation of HHV-6A is frequent within the immunosuppressed and immunocompromised populations and results in lytic viral replication within multiple organs, often leading to severe disease. MicroRNAs (miRNAs) are key regulators of multiple cellular processes that regulate the translation of specific transcripts. miRNAs carried by herpesviruses play important roles in modulating the host cell, thereby facilitating a suitable environment for productive viral infection and/or latency. Currently, there are approximately 150 known human herpesvirus-encoded miRNAs, although an miRNA(s) encoded by HHV-6A has yet to be reported. We hypothesized that HHV-6A, like other members of the human herpesvirus family, encodes miRNAs, which function to promote viral infection. We utilized deep sequencing of small RNA species isolated from cells harboring HHV-6A to identify five novel small noncoding RNA species that originate from the viral genome, one of which has the characteristics of a viral miRNA. These RNAs are expressed during productive infection by either bacterial artificial chromosome (BAC)-derived virus in Jjhan cells or wild-type HHV-6A strain U1102 virus in HSB2 cells and are associated with the RNA induced silencing complex (RISC) machinery. Growth analyses of mutant viruses that lack each individual miRNA revealed that a viral miRNA candidate (miR-U86) targets the HHV-6A IE gene U86, thereby regulating lytic replication. The identification and biological characterization of this HHV-6A-specific miRNA is the first step to defining how the virus regulates its life cycle. IMPORTANCE A majority of the human population is infected with human herpesvirus 6A (HHV-6A), a betaherpesvirus family member. Infections usually occur in young children, and upon resolution, the virus remains in a latent state within the host. Importantly, during times of weakened immune responses, the virus can reactivate and is correlated with significant disease states. Viruses encode many different types of factors that both undermine the host antiviral response and regulate viral replication, including small RNA species called microRNAs (miRNAs). Here we report that HHV-6A encodes at least one miRNA, which we named miR-U86. We have characterized the requirement of this viral miRNA and its impact on the viral life cycle and found that it functions to regulate a viral protein important for efficient viral replication. Our data suggest that viral miRNAs are important for HHV-6A and that they may serve as an important therapeutic target to inhibit the virus.	[Nukui, Masatoshi; Murphy, Eain A.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44106 USA; [Mori, Yasuko] Kobe Univ, Grad Sch Med, Div Clin Virol, Kobe, Hyogo 657, Japan	Murphy, EA (reprint author), Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44106 USA.	murphye@ccf.org			National Institute of Allergy and Infectious Diseases [RAI101080A]; Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Disease Research [U54AI057160]	This study was supported by grants from the National Institute of Allergy and Infectious Diseases (grant no. RAI101080A) and the Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Disease Research (grant no. U54AI057160) awarded to E.A.M.	Ablashi D, 2014, ARCH VIROL, V159, P863, DOI 10.1007/s00705-013-1902-5; Akhyani N, 2000, J INFECT DIS, V182, P1321, DOI 10.1086/315893; Tuddenham L, 2012, J VIROL, V86, P1638, DOI 10.1128/JVI.05911-11; Lee SH, 2012, P NATL ACAD SCI USA, V109, P9575, DOI 10.1073/pnas.1207496109; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Ablashi DV, 2000, J CLIN VIROL, V16, P179, DOI 10.1016/S1386-6532(99)00079-7; Flores O, 2013, J VIROL, V87, P6589, DOI 10.1128/JVI.00504-13; DOWNING RG, 1987, LANCET, V2, P390; Lu F, 2010, J VIROL, V84, P2697, DOI 10.1128/JVI.01997-09; Baldick CJ, 1996, J VIROL, V70, P6097; Trifari S, 2013, P NATL ACAD SCI USA, V110, P18608, DOI 10.1073/pnas.1317191110; O'Connor CM, 2014, J VIROL, V88, P5524, DOI 10.1128/JVI.00481-14; Jung YJ, 2014, J VIROL, V88, P9027, DOI 10.1128/JVI.00721-14; Adams MJ, 2012, ARCH VIROL, V157, P1411, DOI 10.1007/s00705-012-1299-6; Tang S, 2009, J VIROL, V83, P1433, DOI 10.1128/JVI.01723-08; YAMANISHI K, 1988, LANCET, V1, P1065; Kalejta RF, 2003, MOL CELL BIOL, V23, P1885, DOI 10.1128/MCB.23.6.1885-1895.2003; Zeng ZY, 2014, SCI CHINA LIFE SCI, V57, P315, DOI 10.1007/s11427-013-4577-y; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Michael MZ, 2003, MOL CANCER RES, V1, P882; Dunn W, 2005, CELL MICROBIOL, V7, P1684, DOI 10.1111/j.1462-5822.2005.00598.x; Reeves WC, 2000, CLIN INFECT DIS, V31, P48, DOI 10.1086/313908; Grey F, 2008, J CLIN VIROL, V41, P186, DOI 10.1016/j.jcv.2007.11.024; Murphy EJ, 2008, LIPIDS, V43, P105, DOI 10.1007/s11745-008-3156-7; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cullen BR, 2011, CURR OPIN VIROL, V1, P211, DOI 10.1016/j.coviro.2011.04.003; Gottwein E, 2013, CURR TOP MICROBIOL, V371, P201, DOI 10.1007/978-3-642-37765-5_8; Gravel A, 2003, VIROLOGY, V308, P340, DOI 10.1016/S0042-6822(03)00007-2; Grey F, 2007, PLOS PATHOG, V3, P1593, DOI 10.1371/journal.ppat.0030163; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lilja AE, 2008, J VIROL, V82, P2170, DOI 10.1128/JVI.02316-07; Moody R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003857; O'Connor CM, 2011, J VIROL, V85, P3700, DOI 10.1128/JVI.02442-10; Ronmark E, 1999, ALLERGY, V54, P926, DOI 10.1034/j.1398-9995.1999.00044.x; SALAHUDDIN SZ, 1986, SCIENCE, V234, P596, DOI 10.1126/science.2876520; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; Stefan A, 1997, J VIROL, V71, P5758; Takemoto M, 2005, J VIROL, V79, P13037, DOI 10.1128/JVI.79.20.13037-13046.2005; Tang HM, 2010, VIROLOGY, V407, P360, DOI 10.1016/j.virol.2010.08.018; Tang HM, 2013, P NATL ACAD SCI USA, V110, P9096, DOI 10.1073/pnas.1305187110; Tsao EH, 2009, J GEN VIROL, V90, P2581, DOI 10.1099/vir.0.012815-0; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wu WJ, 2013, SCI CHINA LIFE SCI, V56, P373, DOI 10.1007/s11427-013-4458-4	43	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	MAR	2015	89	5					2615	2627		10.1128/JVI.02007-14		13	Virology	Virology	CC2XD	WOS:000350207400016		
J	Taura, M; Kudo, E; Kariya, R; Goto, H; Matsuda, K; Hattori, S; Vaeteewoottacharn, K; McDonald, F; Suico, MA; Shuto, T; Kai, H; Okada, S				Taura, Manabu; Kudo, Eriko; Kariya, Ryusho; Goto, Hiroki; Matsuda, Kouki; Hattori, Shinichiro; Vaeteewoottacharn, Kulthida; McDonald, Fiona; Suico, Mary Ann; Shuto, Tsuyoshi; Kai, Hirofumi; Okada, Seiji			COMMD1/Murr1 Reinforces HIV-1 Latent Infection through I kappa B-alpha Stabilization	JOURNAL OF VIROLOGY			English	Article							EPITHELIAL SODIUM-CHANNEL; CD4(+) T-CELLS; UBIQUITIN LIGASE; COMMD1-DEPENDENT UBIQUITINATION; POSTINTEGRATION LATENCY; ALVEOLAR MACROPHAGES; RESTRICTION FACTORS; COMMD PROTEINS; ACTIVATION; REPLICATION	The transcription factor NF-kappa B is important for HIV-1 transcription initiation in primary HIV-1 infection and reactivation in latently HIV-1-infected cells. However, comparative analysis of the regulation and function of NF-kappa B in latently HIV-1-infected cells has not been done. Here we show that the expression of I kappa B-alpha, an endogenous inhibitor of NF-kappa B, is enhanced by latent HIV-1 infection via induction of the host-derived factor COMMD1/Murr1 in myeloid cells but not in lymphoid cells by using four sets of latently HIV-1-infected cells and the respective parental cells. I kappa B-alpha protein was stabilized by COMMD1, which attenuated NF-kappa B signaling during Toll-like receptor ligand and tumor necrosis factor alpha treatment and enhanced HIV-1 latency in latently HIV-1-infected cells. Activation of the phosphoinositol 3-kinase (PI3K)-JAK pathway is involved in COMMD1 induction in latently HIV-1-infected cells. Our findings indicate that COMMD1 induction is the NF-kappa B inhibition mechanism in latently HIV-1-infected cells that contributes to innate immune deficiency and reinforces HIV-1 latency. Thus, COMMD1 might be a double-edged sword that is beneficial in primary infection but not beneficial in latent infection when HIV-1 eradication is considered. IMPORTANCE HIV-1 latency is a major barrier to viral eradication in the era of combination antiretroviral therapy. In this study, we found that COMMD1/Murr1, previously identified as an HIV-1 restriction factor, inhibits the proteasomal degradation of I kappa B-alpha by increasing the interaction with I kappa B-alpha in latently HIV-1-infected myeloid cells. I kappa B-alpha protein was stabilized by COMMD1, which attenuated NF-kappa B signaling during the innate immune response and enhanced HIV-1 latency in latently HIV-1-infected cells. Activation of the PI3K-JAK pathway is involved in COMMD1 induction in latently HIV-1-infected cells. Thus, the host-derived factor COMMD1 is beneficial in suppressing primary infection but enhances latent infection, indicating that it may be a double-edged sword in HIV-1 eradication.	[Taura, Manabu; Kudo, Eriko; Kariya, Ryusho; Goto, Hiroki; Matsuda, Kouki; Hattori, Shinichiro; Vaeteewoottacharn, Kulthida; Okada, Seiji] Kumamoto Univ, Ctr AIDS Res, Div Hematopoiesis, Kumamoto, Japan; [McDonald, Fiona] Univ Otago, Dept Physiol, Dunedin, New Zealand; [Suico, Mary Ann; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto, Japan	Okada, S (reprint author), Kumamoto Univ, Ctr AIDS Res, Div Hematopoiesis, Kumamoto, Japan.	okadas@kumamoto-u.ac.jp			Ministry of Education, Science, Sports, and Culture (MEXT) of Japan [23107725, 248328]; Global COE Programs (Research Center Aiming at the Control of AIDS) from MEXT; Health and Labor Sciences Research Grant from the Ministry of Health, Labor, and Welfare of Japan [H25-AIDS-I-002]; Japan Foundation for AIDS Prevention fellowship; Japan Society for Promotion of Science fellowship; Research Foundation for Pharmaceutical Sciences; KANAE Foundation for the Promotion of Medical Science; SENSHIN Medical Research Foundation	This work was supported by Grants-in-Aid for Science Research from the Ministry of Education, Science, Sports, and Culture (MEXT) of Japan (23107725 to S.O. and 248328 to M.T.); by the Global COE Programs (Research Center Aiming at the Control of AIDS) from MEXT; by a Health and Labor Sciences Research Grant from the Ministry of Health, Labor, and Welfare of Japan (H25-AIDS-I-002 to S.O.); by a Japan Foundation for AIDS Prevention fellowship (to M.T.); by a Japan Society for Promotion of Science fellowship (to M.T. and E.K.); and by a research grant from The Research Foundation for Pharmaceutical Sciences, The KANAE Foundation for the Promotion of Medical Science, and The SENSHIN Medical Research Foundation (to M.T.).	Abdel-Mohsen M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-106; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Mufti AR, 2007, ARCH BIOCHEM BIOPHYS, V463, P168, DOI 10.1016/j.abb.2007.01.033; Duverger A, 2009, J VIROL, V83, P3078, DOI 10.1128/JVI.02058-08; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Dahabieh MS, 2013, J VIROL, V87, P4716, DOI 10.1128/JVI.03478-12; Doyon G, 2013, AIDS, V27, pF7, DOI 10.1097/QAD.0b013e3283570620; Calvanese V, 2013, VIROLOGY, V446, P283, DOI 10.1016/j.virol.2013.07.037; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Chang TN, 2011, BIOCHEM BIOPH RES CO, V411, P506, DOI 10.1016/j.bbrc.2011.06.149; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-500; Allouch A, 2013, P NATL ACAD SCI USA, V110, pE3997, DOI 10.1073/pnas.1306719110; Pillai SK, 2012, P NATL ACAD SCI USA, V109, P3035, DOI 10.1073/pnas.1111573109; Bartuzi P, 2013, BBA-MOL BASIS DIS, V1832, P2315, DOI 10.1016/j.bbadis.2013.09.014; BAGASRA O, 1992, P NATL ACAD SCI USA, V89, P6285, DOI 10.1073/pnas.89.14.6285; Finzi D, 1999, NAT MED, V5, P512; Lambotte O, 2000, J ACQ IMMUN DEF SYND, V23, P114; Burnett JC, 2010, J VIROL, V84, P5958, DOI 10.1128/JVI.00161-10; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Emiliani S, 1998, J VIROL, V72, P1666; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; De Bie P, 2005, J HERED, V96, P803, DOI 10.1093/jhered/esi110; BEACH RS, 1992, AIDS, V6, P701, DOI 10.1097/00002030-199207000-00013; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; Kudo E, 2013, BIOORG MED CHEM LETT, V23, P606, DOI 10.1016/j.bmcl.2012.12.034; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; Ruelas DS, 2013, CELL, V155, P519, DOI 10.1016/j.cell.2013.09.044; Emiliani S, 1996, P NATL ACAD SCI USA, V93, P6377, DOI 10.1073/pnas.93.13.6377; Maine GN, 2007, CELL CYCLE, V6, P672, DOI 10.4161/cc.6.6.3989; Yaron A, 1998, NATURE, V396, P590; Vonk WIM, 2010, J BIOL CHEM, V285, P28991, DOI 10.1074/jbc.M110.101477; Schlaepfer E, 2006, J IMMUNOL, V176, P2888; Nowak P, 2006, CYTOKINE, V34, P17, DOI 10.1016/j.cyto.2006.03.010; Ke Y, 2010, AM J PHYSIOL-RENAL, V298, pF1445, DOI 10.1152/ajprenal.00257.2009; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; O'Hara A, 2014, J CELL SCI, V127, P3659, DOI 10.1242/jcs.149328; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Taura M, 2012, MOL CELL BIOL, V32, P1581, DOI 10.1128/MCB.06454-11; Arts EJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007161; Berro R, 2007, J BIOL CHEM, V282, P8207, DOI 10.1074/jbc.M606324200; Chen Z, 2008, MOL CANCER THER, V7, P1949, DOI 10.1158/1535-7163.MCT-07-2046; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; Dahabieh MS, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-17; Drevillon L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018334; Fernandez G, 2013, J VIROL, V87, P3966, DOI 10.1128/JVI.03251-12; Furusawa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029012; Greene WC, 2004, NAT IMMUNOL, V5, P18, DOI 10.1038/ni0104-18; Liu LJ, 2012, CELL RES, V22, P603, DOI 10.1038/cr.2011.199; MCELRATH MJ, 1991, J CLIN INVEST, V87, P27, DOI 10.1172/JCI114981; MIKOVITS JA, 1992, J CLIN INVEST, V90, P1486, DOI 10.1172/JCI116016; Novis CL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-119; Tachado SD, 2008, J BIOL CHEM, V283, P33191, DOI 10.1074/jbc.M805067200; Tachado SD, 2010, BLOOD, V115, P3606, DOI 10.1182/blood-2009-10-250787; Taura M, 2013, FREE RADICAL BIO MED, V65, P778, DOI 10.1016/j.freeradbiomed.2013.08.161; Thibault S, 2009, VIROLOGY, V389, P20, DOI 10.1016/j.virol.2009.04.019; Thoms HC, 2010, CANCER RES, V70, P139, DOI 10.1158/0008-5472.CAN-09-1397; Yukl S, 2009, VIROLOGY, V387, P98, DOI 10.1016/j.virol.2009.01.013; Zack JA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-37; Zhang JL, 2007, J CLIN INVEST, V117, P473, DOI 10.1172/JCI28971	63	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	MAR	2015	89	5					2643	2658		10.1128/JVI.03105-14		16	Virology	Virology	CC2XD	WOS:000350207400018		
J	Kanda, T; Miyata, M; Kano, M; Kondo, S; Yoshizaki, T; Iizasa, H				Kanda, Teru; Miyata, Mamiko; Kano, Makoto; Kondo, Satoru; Yoshizaki, Tomokazu; Iizasa, Hisashi			Clustered MicroRNAs of the Epstein-Barr Virus Cooperatively Downregulate an Epithelial Cell-Specific Metastasis Suppressor	JOURNAL OF VIROLOGY			English	Article							HUMAN GAMMA-HERPESVIRUSES; NASOPHARYNGEAL CARCINOMA; DNA-SEQUENCE; ENCODED MICRORNAS; GASTRIC-CARCINOMA; GENE-EXPRESSION; VIRAL-DNA; EBV; MIRNAS; IDENTIFICATION	The Epstein-Barr virus (EBV) encodes its own microRNAs (miRNAs); however, their biological roles remain elusive. The commonly used EBV B95-8 strain lacks a 12-kb genomic region, known as BamHI A rightward transcripts (BART) locus, where a number of BART miRNAs are encoded. Here, bacterial artificial chromosome (BAC) technology was used to generate an EBV B95-8 strain in which the 12-kb region was fully restored at its native locus [BART(+) virus]. Epithelial cells were stably infected with either the parental B95-8 virus or the BART(+) virus, and BART miRNA expression was successfully reconstituted in the BART(+) virus-infected cells. Microarray analyses of cellular gene expression identified N-myc downstream regulated gene 1 (NDRG1) as a putative target of BART miRNAs. The NDRG1 protein was barely expressed in B cells, highly expressed in epithelial cells, including primary epithelial cells, and strongly downregulated in the BART(+) virus-infected epithelial cells of various origins. Although in vitro reporter assays identified BART22 as being responsible for the NDRG1 downregulation, EBV genetic analyses revealed that BART22 was not solely responsible; rather, the entire BART miRNA cluster 2 was responsible for the downregulation. Immunohistochemical analyses revealed that the expression level of the NDRG1 protein was downregulated significantly in EBV-positive nasopharyngeal carcinoma specimens. Considering that NDRG1 encodes an epithelial differentiation marker and a suppressor of metastasis, these data implicate a causative relationship between BART miRNA expression and epithelial carcinogenesis in vivo. IMPORTANCE EBV-related epithelial cancers, such as nasopharyngeal carcinomas and EBV-positive gastric cancers, encompass more than 80% of EBV-related malignancies. Although it is known that they express high levels of virally encoded BART miRNAs, how these miRNAs contribute to EBV-mediated epithelial carcinogenesis remains unknown. Although a number of screenings have been performed to identify targets of viral miRNAs, many targets likely have not been identified, especially in case of epithelial cell infection. This is the first study to use EBV genetics to perform unbiased screens of cellular genes that are differentially expressed in viral miRNA-positive and -negative epithelial cells. The result indicates that multiple EBV-encoded miRNAs cooperatively downregulate NDRG1, an epithelial differentiation marker and suppressor of metastasis. The experimental system described in this study should be useful for further clarifying the mechanism of EBV-mediated epithelial carcinogenesis.	[Kanda, Teru; Miyata, Mamiko] Aichi Canc Ctr, Res Inst, Div Microbiol & Oncol, Chikusa Ku, Nagoya, Aichi 464, Japan; [Kano, Makoto; Kondo, Satoru; Yoshizaki, Tomokazu] Kanazawa Univ, Grad Sch Med Sci, Div Otolaryngol Head & Neck Surg, Kanazawa, Ishikawa, Japan; [Iizasa, Hisashi] Shimane Univ, Fac Med, Dept Microbiol, Izumo, Shimane, Japan	Kanda, T (reprint author), Aichi Canc Ctr, Res Inst, Div Microbiol & Oncol, Chikusa Ku, Nagoya, Aichi 464, Japan.	tkanda@aichi-cc.jp			JSPS Kakenhi grant [24590567]; Ministry of Health, Labor, and Welfare, Japan; Uehara Memorial Foundation; Takeda Science Foundation	This study was supported by JSPS Kakenhi grant 24590567, by a Grant-in- Aid for Scientific Research from the Ministry of Health, Labor, and Welfare, Japan, by the Uehara Memorial Foundation, and by the Takeda Science Foundation.	Edwards RH, 2008, J VIROL, V82, P9094, DOI 10.1128/JVI.00785-08; Iizasa H, 2010, J BIOL CHEM, V285, P33358, DOI 10.1074/jbc.M110.138362; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Cosmopoulos K, 2009, J VIROL, V83, P2357, DOI 10.1128/JVI.02104-08; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bg1146; Zhu JY, 2009, J VIROL, V83, P3333, DOI 10.1128/JVI.01689-08; Raab-Traub N, 2012, CURR OPIN VIROL, V2, P453, DOI 10.1016/j.coviro.2012.07.001; Gottwein E, 2011, CELL HOST MICROBE, V10, P515, DOI 10.1016/j.chom.2011.09.012; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Lung RWM, 2009, NEOPLASIA, V11, P1174, DOI 10.1593/neo.09888; RAABTRAUB N, 1980, CELL, V22, P257, DOI 10.1016/0092-8674(80)90173-7; Strong MJ, 2014, J VIROL, V88, P10696, DOI 10.1128/JVI.01457-14; SADLER RH, 1995, J VIROL, V69, P1132; Marquitz AR, 2014, J VIROL, V88, P1389, DOI 10.1128/JVI.02662-13; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/2326106; Riley KJ, 2012, EMBO J, V31, P2207, DOI 10.1038/emboj.2012.63; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Vereide DT, 2014, ONCOGENE, V33, P1258, DOI 10.1038/onc.2013.71; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Dolken L, 2010, CELL HOST MICROBE, V7, P324, DOI 10.1016/j.chom.2010.03.008; Marquitz AR, 2012, SEMIN CANCER BIOL, V22, P166, DOI 10.1016/j.semcancer.2011.12.001; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Walz N, 2010, J VIROL, V84, P716, DOI 10.1128/JVI.01302-09; Kitagawa N, 2013, CANCER LETT, V331, P52, DOI 10.1016/j.canlet.2012.12.002; NAKANO Y, 1995, GENE, V162, P157, DOI 10.1016/0378-1119(95)00320-6; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Kanda T, 2004, J VIROL, V78, P7004, DOI 10.1128/JVI.78.12.7004-7015.2004; Shimada A, 2009, GENE DEV, V23, P18, DOI 10.1101/gad.1708009; Marquitz AR, 2011, VIROLOGY, V412, P392, DOI 10.1016/j.virol.2011.01.028; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Kuzembayeva M, 2014, CURR OPIN VIROL, V7, P61, DOI 10.1016/j.coviro.2014.04.003; SKARE J, 1982, J VIROL, V44, P1088; Kim DN, 2007, J VIROL, V81, P1033, DOI 10.1128/JVI.02271-06; Klinke O, 2014, SEMIN CANCER BIOL, V26, P52, DOI 10.1016/j.semcancer.2014.02.002; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; BLOSS TA, 1994, J VIROL, V68, P8217; Cai XZ, 2006, PLOS PATHOG, V2, P236, DOI 10.1371/journal.ppat.0020023; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen HL, 2005, J VIROL, V79, P1724, DOI 10.1128/JVI.79.3.1724-1733.2005; Dawson CW, 2000, VIROLOGY, V272, P204, DOI 10.1006/viro.2000.0344; de Jesus O, 2003, J GEN VIROL, V84, P1443, DOI 10.1099/vir.0.19054-0; Feederle Regina, 2010, Herpesviridae, V1, P6, DOI 10.1186/2042-4280-1-6; Fruscalzo A, 2001, GENE, V265, P165, DOI 10.1016/S0378-1119(01)00345-6; GILLIGAN KJ, 1991, J VIROL, V65, P6252; HITT MM, 1989, EMBO J, V8, P2639; Hsu CY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003974; Kanda T, 2013, J BIOL CHEM, V288, P24189, DOI 10.1074/jbc.M113.491167; Kanda T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027758; Lachat P, 2002, HISTOCHEM CELL BIOL, V118, P399, DOI 10.1007/s00418-002-0460-9; Lo AKF, 2012, J PATHOL, V227, P392, DOI 10.1002/path.4025; Qiu J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002193; Ramakrishnan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027271; Rickinson AB, 2007, FIELDS VIROLOGY, P2603; Seto E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001063; Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484; Smith PR, 2000, J VIROL, V74, P3082, DOI 10.1128/JVI.74.7.3082-3092.2000; TAKADA K, 1991, VIRUS GENES, V5, P147, DOI 10.1007/BF00571929; TAKIMOTO T, 1986, CANCER RES, V46, P2541	65	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	MAR	2015	89	5					2684	2697		10.1128/JVI.03189-14		14	Virology	Virology	CC2XD	WOS:000350207400021		
J	Watanabe, S; Ohno, S; Shirogane, Y; Suzuki, SO; Koga, R; Yanagi, Y				Watanabe, Shumpei; Ohno, Shinji; Shirogane, Yuta; Suzuki, Satoshi O.; Koga, Ritsuko; Yanagi, Yusuke			Measles Virus Mutants Possessing the Fusion Protein with Enhanced Fusion Activity Spread Effectively in Neuronal Cells, but Not in Other Cells, without Causing Strong Cytopathology	JOURNAL OF VIROLOGY			English	Article							SUBACUTE SCLEROSING-PANENCEPHALITIS; KNOCK-IN MICE; CELLULAR RECEPTOR; MEMBRANE-FUSION; UNTRANSLATED REGIONS; CYTOPLASMIC TAIL; MATRIX PROTEIN; BRAIN-TISSUES; IMMUNE CELLS; F-PROTEIN	Subacute sclerosing panencephalitis (SSPE) is caused by persistent measles virus (MV) infection in the central nervous system (CNS). Since human neurons, its main target cells, do not express known MV receptors (signaling lymphocyte activation molecule [SLAM] and nectin 4), it remains to be understood how MV infects and spreads in them. We have recently reported that fusion- enhancing substitutions in the extracellular domain of the MV fusion (F) protein (T461I and S103I/ N462S/ N465S), which are found in multiple SSPE virus isolates, promote MV spread in human neuroblastoma cell lines and brains of suckling hamsters. In this study, we show that hyperfusogenic viruses with these substitutions also spread efficiently in human primary neuron cultures without inducing syncytia. These substitutions were found to destabilize the prefusion conformation of the F protein trimer, thereby enhancing fusion activity. However, these hyperfusogenic viruses exhibited stronger cytopathology and produced lower titers at later time points in SLAM- or nectin 4-expressing cells compared to the wild-type MV. Although these viruses spread efficiently in the brains of SLAM knock-in mice, they did not in the spleens. Taken together, the results suggest that enhanced fusion activity is beneficial for MV to spread in neuronal cells where no cytopathology occurs, but detrimental to other types of cells due to strong cytopathology. Acquisition of enhanced fusion activity through substitutions in the extracellular domain of the F protein may be crucial for MV's extensive spread in the CNS and development of SSPE. IMPORTANCE Subacute sclerosing panencephalitis (SSPE) is a fatal disease caused by persistent measles virus (MV) infection in the central nervous system (CNS). Its cause is not well understood, and no effective therapy is currently available. Recently, we have reported that enhanced fusion activity of MV through the mutations in its fusion protein is a major determinant of efficient virus spread in human neuronal cells and brains of suckling hamsters. In this study, we show that those mutations render the conformation of the fusion protein less stable, thereby making it hyperfusogenic. Our results also show that enhanced fusion activity is beneficial for MV to spread in the CNS but detrimental to other types of cells in peripheral tissues, which are strongly damaged by the virus. Our findings provide important insight into the mechanism for the development of SSPE after MV infection.	[Watanabe, Shumpei; Ohno, Shinji; Shirogane, Yuta; Koga, Ritsuko; Yanagi, Yusuke] Kyushu Univ, Fac Med, Dept Virol, Fukuoka 812, Japan; [Suzuki, Satoshi O.] Kyushu Univ, Fac Med, Dept Neuropathol, Fukuoka 812, Japan	Watanabe, S (reprint author), Kyushu Univ, Fac Med, Dept Virol, Fukuoka 812, Japan.	wshunpei@virology.med.kyushu-u.ac.jp; yyanagi@virology.med.kyushu-u.ac.jp			Ministry of Health, Labor, and Welfare (the Research Committee of Prion Disease and Slow Virus Infection) of Japan; JSPS Kakenhi grants [21249032, 24115005, 24790444]	This study was supported by grants from the Ministry of Health, Labor, and Welfare (the Research Committee of Prion Disease and Slow Virus Infection) of Japan, and by JSPS Kakenhi grants 21249032, 24115005, and 24790444.	Allen IV, 1996, J NEUROPATH EXP NEUR, V55, P471, DOI 10.1097/00005072-199604000-00010; Masse N, 2002, J VIROL, V76, P13034, DOI 10.1128/JVI.76.24.13034-13038.2002; Brancati F, 2010, AM J HUM GENET, V87, P265, DOI 10.1016/j.ajhg.2010.07.003; NIWA H, 1991, GENE, V108, P193; Erlenhoefer C, 2001, J VIROL, V75, P4499, DOI 10.1128/JVI.75.10.4499-4505.2001; Ayata M, 2002, J VIROL, V76, P13062, DOI 10.1128/JVI.76.24.13062-13068.2002; BILLETER MA, 1994, ANN NY ACAD SCI, V724, P367, DOI 10.1111/j.1749-6632.1994.tb38934.x; Heidmeier S, 2014, VIRUS RES, V180, P43, DOI 10.1016/j.virusres.2013.12.016; Cathomen T, 1998, J VIROL, V72, P1224; Ning X, 2002, VIRUS RES, V86, P123, DOI 10.1016/S0168-1702(02)00042-4; Plemper RK, 2003, J VIROL, V77, P4181, DOI 10.1128/JVI.77.7.4181-4190.2003; Rima BK, 2005, VIRUS RES, V111, P132, DOI 10.1016/j.virusres.2005.04.005; Takeda M, 2008, J VIROL, V82, P11979, DOI 10.1128/JVI.00867-08; Cathomen T, 1998, EMBO J, V17, P3899, DOI 10.1093/emboj/17.14.3899; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Seki F, 2011, J VIROL, V85, P11871, DOI 10.1128/JVI.05067-11; Gutierrez J, 2010, DEV MED CHILD NEUROL, V52, P901, DOI 10.1111/j.1469-8749.2010.03717.x; NANICHE D, 1993, J VIROL, V67, P6025; Altomonte J, 2010, MOL THER, V18, P275, DOI 10.1038/mt.2009.231; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; SCHMID A, 1992, VIROLOGY, V188, P910, DOI 10.1016/0042-6822(92)90552-Z; Higuchi H, 2000, CANCER RES, V60, P6396; Baricevic M, 2007, VIRUS GENES, V35, P17, DOI 10.1007/s11262-006-0035-2; ROTA JS, 1994, VIRUS RES, V31, P317, DOI 10.1016/0168-1702(94)90025-6; Leonard VHJ, 2008, J CLIN INVEST, V118, P2448, DOI 10.1172/JCI35454; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Reymond N, 2001, J BIOL CHEM, V276, P43205, DOI 10.1074/jbc.M103810200; Ferreira CSA, 2010, J VIROL, V84, P3033, DOI 10.1128/JVI.01559-09; Tatsuo H, 2000, NATURE, V406, P893; Tahara M, 2007, J VIROL, V81, P6827, DOI 10.1128/JVI.00248-07; Bellini WJ, 2005, J INFECT DIS, V192, P1686, DOI 10.1086/497169; Takeda M, 2005, J VIROL, V79, P14346, DOI 10.1128/JVI.79.22.14346-14354.2005; McQuaid S, 2002, LAB INVEST, V82, P403; Hsu EC, 2001, VIROLOGY, V279, P9, DOI 10.1006/viro.2000.0711; Avila M, 2014, J VIROL, V88, P2951, DOI 10.1128/JVI.03123-13; CATTANEO R, 1988, CELL, V55, P255, DOI 10.1016/0092-8674(88)90048-7; CATTANEO R, 1986, VIROLOGY, V154, P97, DOI 10.1016/0042-6822(86)90433-2; Frenzke M, 2013, J VIROL, V87, P2526, DOI 10.1128/JVI.03037-12; Gainey MD, 2008, J VIROL, V82, P9369, DOI 10.1128/JVI.01054-08; Griffin DE, 2007, FIELDS VIROLOGY, V1, P1551; Hashimoto K, 2002, J VIROL, V76, P6743, DOI 10.1128/JVI.76.13.6743-6749.2002; HOMMA M, 1982, MICROBIOL IMMUNOL, V26, P1195; Hotta H, 2006, MICROBIOL IMMUNOL, V50, P525; KIRK J, 1991, NEUROPATH APPL NEURO, V17, P289, DOI 10.1111/j.1365-2990.1991.tb00726.x; Koga R, 2010, J VIROL, V84, P5360, DOI 10.1128/JVI.02525-09; Lemon K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001263; Ludlow M, 2013, J VIROL, V87, P4033, DOI 10.1128/JVI.03258-12; MAKINO S, 1977, MICROBIOL IMMUNOL, V21, P193; MANCHESTER M, 1994, P NATL ACAD SCI USA, V91, P2161, DOI 10.1073/pnas.91.6.2161; Moulin E, 2011, J MED VIROL, V83, P1614, DOI 10.1002/jmv.22152; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Ohno S, 2007, J VIROL, V81, P1650, DOI 10.1128/JVI.02134-06; Plemper RK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002058; Prussia AJ, 2008, BIOCHEMISTRY-US, V47, P13573, DOI 10.1021/bi801513p; Rima BK, 2006, J PATHOL, V208, P199, DOI 10.1002/path.1873; ROTA JS, 1992, VIROLOGY, V188, P135, DOI 10.1016/0042-6822(92)90742-8; Schneider-Schaulies J, 2003, J NEUROVIROL, V9, P247, DOI 10.1080/13550280390193993; Tahara M, 2007, J VIROL, V81, P2564, DOI 10.1128/JVI.02449-06; Watanabe S, 2013, J VIROL, V87, P2648, DOI 10.1128/JVI.02632-12	61	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	MAR	2015	89	5					2710	2717		10.1128/JVI.03346-14		8	Virology	Virology	CC2XD	WOS:000350207400023		
J	Earley, LF; Kawano, Y; Adachi, K; Sun, XX; Dai, MS; Nakai, H				Earley, Lauriel F.; Kawano, Yasuhiro; Adachi, Kei; Sun, Xiao-Xin; Dai, Mu-Shui; Nakai, Hiroyuki			Identification and Characterization of Nuclear and Nucleolar Localization Signals in the Adeno-Associated Virus Serotype 2 Assembly-Activating Protein	JOURNAL OF VIROLOGY			English	Article							SPECIFICALLY BINDS; IMPORTIN-ALPHA; EXPORT SIGNALS; LARGE-T; PREDICTION; SEQUENCES; SHUTTLE; DOMAINS; B23; B23/NUCLEOPHOSMIN	Assembly-activating protein (AAP) of adeno-associated virus serotype 2 (AAV2) is a nucleolar-localizing protein that plays a critical role in transporting the viral capsid VP3 protein to the nucleolus for assembly. Here, we identify and characterize AAV2 AAP (AAP2) nuclear (NLS) and nucleolar (NoLS) localization signals near the carboxy-terminal region of AAP2 (amino acid positions 144 to 184) (AAP2(144-184)). This region contains five basic-amino-acid-rich (BR) clusters, KSKRSRR (AAP2BR1), RRR (AAP2BR2), RFR (AAP2BR3), RSTSSR (AAP2BR4), and RRIK (AAP2BR5), from the amino terminus to the carboxy terminus. We created 30 AAP2BR mutants by arginine/ lysine-to-alanine mutagenesis or deletion of AAP2BRs and 8 and 1 green fluorescent protein (GFP)-AAP2BR and beta-galactosidase-AAP2BR fusion proteins, respectively, and analyzed their intracellular localization in HeLa cells by immunofluorescence microscopy. The results showed that AAP2(144-184) has redundant multipartite NLSs and that any combinations of 4 AAP2BRs, but not 3 or less, can constitute a functional NLS-NoLS; AAP2BR1 and AAP2BR2 play the most influential role for nuclear localization, but either one of the two AAP2BRs is dispensable if all 4 of the other AAP2BRs are present, resulting in 3 different, overlapping NLS motifs; and the NoLS is shared redundantly among the five AAP2BRs and functions in a context-dependent manner. AAP2BR mutations not only resulted in aberrant intracellular localization, but also attenuated AAP2 protein expression to various degrees, and both of these abnormalities have a significant negative impact on capsid production. Thus, this study reveals the organization of the intermingling NLSs and NoLSs in AAP2 and provides insights into their functional roles in capsid assembly. IMPORTANCE Adeno-associated virus (AAV) has become a popular and successful vector for in vivo gene therapy; however, its biology has yet to be fully understood. In this regard, the recent discovery of the assembly-activating protein (AAP), a nonstructural, nucleolarlocalizing AAV protein essential for viral capsid assembly, has provided us a new opportunity to better understand the fundamental processes required for virion formation. Here, we identify clusters of basic amino acids in the carboxy terminus of AAP from AAV serotype 2 (AAV2) that act as nuclear and nucleolar localization signals. We also demonstrate their importance in maintaining AAP expression levels and efficient production of viral capsids. Insights into the functions of AAP can elucidate the requirements and process for AAV capsid assembly, which may lead to improved vector production for use in gene therapy. This study also contributes to the growing body of work on nuclear and nucleolar localization signals.	[Earley, Lauriel F.] Oregon Hlth & Sci Univ, Sch Med, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Earley, Lauriel F.; Kawano, Yasuhiro; Adachi, Kei; Sun, Xiao-Xin; Dai, Mu-Shui; Nakai, Hiroyuki] Oregon Hlth & Sci Univ, Sch Med, Dept Mol & Med Genet, Portland, OR 97201 USA; [Kawano, Yasuhiro] Takara Bio Inc, Otsu, Shiga, Japan	Nakai, H (reprint author), Oregon Hlth & Sci Univ, Sch Med, Dept Mol & Med Genet, Portland, OR 97201 USA.	nakaih@ohsu.edu			Public Health Service [R01 DK078388, R01 NS088399, T32 GM071338, T32 AI007472]; Takara Bio Inc.	This work was supported by Public Health Service grants (R01 DK078388, R01 NS088399, T32 GM071338, and T32 AI007472) and a Sponsored Research Fund from Takara Bio Inc.	Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; SZEBENI A, 1995, BIOCHEMISTRY-US, V34, P8037, DOI 10.1021/bi00025a009; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Bevington JM, 2007, VIROLOGY, V357, P102, DOI 10.1016/j.virol.2006.07.050; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; ADACHI Y, 1993, J BIOL CHEM, V268, P13930; Melen K, 2007, J VIROL, V81, P5995, DOI 10.1128/JVI.01714-06; Sonntag F, 2011, J VIROL, V85, P12686, DOI 10.1128/JVI.05359-11; SCHMIDTZACHMANN MS, 1993, J CELL SCI, V105, P799; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; VALDEZ BC, 1994, J BIOL CHEM, V269, P23776; Svistunova DM, 2012, J HISTOCHEM CYTOCHEM, V60, P152, DOI 10.1369/0022155411429704; Hu W, 2005, MOL CELL BIOL, V25, P3087, DOI 10.1128/MCB.25.8.3087-3108.2005; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Hiscox JA, 2002, ARCH VIROL, V147, P1077, DOI 10.1007/s00705-001-0792-0; Cros JF, 2005, TRAFFIC, V6, P205, DOI 10.1111/j.1600-0854.2004.00263.x; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; FANKHAUSER C, 1991, MOL CELL BIOL, V11, P2567; Olson MOJ, 2005, HISTOCHEM CELL BIOL, V123, P203, DOI 10.1007/s00418-005-0754-9; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Johnson JS, 2009, J VIROL, V83, P2632, DOI 10.1128/JVI.02309-08; Lange A, 2010, TRAFFIC, V11, P311, DOI 10.1111/j.1600-0854.2009.01028.x; Hiscox JA, 2007, NAT REV MICROBIOL, V5, P119, DOI 10.1038/nrmicro1597; Naumer M, 2012, J VIROL, V86, P13038, DOI 10.1128/JVI.01675-12; Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107; Nakai H, 2005, J VIROL, V79, P214, DOI 10.1128/JVI.79.1.214-224.2005; Prieto G, 2014, BIOINFORMATICS, V30, P1220, DOI 10.1093/bioinformatics/btu016; ARIS JP, 1991, P NATL ACAD SCI USA, V88, P931, DOI 10.1073/pnas.88.3.931; Arnold M, 2006, J BIOL CHEM, V281, P20883, DOI 10.1074/jbc.M602189200; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Fu SC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr493; Howes SH, 1996, J VIROL, V70, P3581; Kawano Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066211; Kosugi S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003841; Kulshreshtha V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101216; LACASSE EC, 1995, NUCLEIC ACIDS RES, V23, P1647, DOI 10.1093/nar/23.10.1647; Liu JY, 2006, FEBS LETT, V580, P1405, DOI 10.1016/j.febslet.2006.01.064; Matthews D, 2011, PROTEIN REV, V15, P321, DOI 10.1007/978-1-4614-0514-6_14; Musinova YR, 2011, BBA-MOL CELL RES, V1813, P27, DOI 10.1016/j.bbamcr.2010.11.003; Pederson T, 2011, COLD SPRING HARB PER, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A000638; Qiu JM, 1999, VIROLOGY, V257, P373, DOI 10.1006/viro.1999.9664; RICHARDSON WD, 1986, CELL, V44, P77, DOI 10.1016/0092-8674(86)90486-1; Viranaicken W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022296; Wang YZ, 2011, BBA-MOL CELL RES, V1813, P109, DOI 10.1016/j.bbamcr.2010.09.017; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Wistuba A, 1997, J VIROL, V71, P1341	49	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	MAR	2015	89	6					3038	3048		10.1128/JVI.03125-14		11	Virology	Virology	CC2XQ	WOS:000350208900005		
J	Katoh, H; Kubota, T; Kita, S; Nakatsu, Y; Aoki, N; Mori, Y; Maenaka, K; Takeda, M; Kidokoro, M				Katoh, Hiroshi; Kubota, Toru; Kita, Shunsuke; Nakatsu, Yuichiro; Aoki, Natsuko; Mori, Yoshio; Maenaka, Katsumi; Takeda, Makoto; Kidokoro, Minoru			Heat Shock Protein 70 Regulates Degradation of the Mumps Virus Phosphoprotein via the Ubiquitin-Proteasome Pathway	JOURNAL OF VIROLOGY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; INCLUSION-BODIES; IN-VIVO; FUNCTIONAL-CHARACTERIZATION; NUCLEOCAPSID PROTEIN; POLYMERASE COMPLEX; CELLULAR CHAPERONE; V PROTEIN; INFECTION; TRANSCRIPTION	Mumps virus (MuV) infection induces formation of cytoplasmic inclusion bodies (IBs). Growing evidence indicates that IBs are the sites where RNA viruses synthesize their viral RNA. However, in the case of MuV infection, little is known about the viral and cellular compositions and biological functions of the IBs. In this study, pulldown purification and N-terminal amino acid sequencing revealed that stress-inducible heat shock protein 70 (Hsp72) was a binding partner of MuV phosphoprotein (P protein), which was an essential component of the IB formation. Immunofluorescence and immunoblotting analyses revealed that Hsp72 was colocalized with the P protein in the IBs, and its expression was increased during MuV infection. Knockdown of Hsp72 using small interfering RNAs (siRNAs) had little, if any, effect on viral propagation in cultured cells. Knockdown of Hsp72 caused accumulation of ubiquitinated P protein and delayed P protein degradation. These results show that Hsp72 is recruited to IBs and regulates the degradation of MuV P protein through the ubiquitin-proteasome pathway. IMPORTANCE Formation of cytoplasmic inclusion bodies (IBs) is a common characteristic feature in mononegavirus infections. IBs are considered to be the sites of viral RNA replication and transcription. However, there have been few studies focused on host factors recruited to the IBs and their biological functions. Here, we identified stress-inducible heat shock protein 70 (Hsp72) as the first cellular partner of mumps virus (MuV) phosphoprotein (P protein), which is an essential component of the IBs and is involved in viral RNA replication/transcription. We found that the Hsp72 mobilized to the IBs promoted degradation of the MuV P protein through the ubiquitin-proteasome pathway. Our data provide new insight into the role played by IBs in mononegavirus infection.	[Katoh, Hiroshi; Kubota, Toru; Nakatsu, Yuichiro; Aoki, Natsuko; Mori, Yoshio; Takeda, Makoto; Kidokoro, Minoru] Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan; [Kita, Shunsuke; Maenaka, Katsumi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biomol Sci, Sapporo, Hokkaido 060, Japan	Katoh, H (reprint author), Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan.	kato0704@nih.go.jp			Ministry of Education, Culture, Sports, Science and Technology [25893295]; Ministry of Health, Labor and Welfare of Japan	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (Grant-in-Aid for Research Activity Start-up 25893295) and the Ministry of Health, Labor and Welfare of Japan.	BASKERVILLE A, 1985, J PATHOL, V147, P199, DOI 10.1002/path.1711470308; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Hviid A, 2008, LANCET, V371, P932, DOI 10.1016/S0140-6736(08)60419-5; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Cox R, 2013, J VIROL, V87, P7558, DOI 10.1128/JVI.00653-13; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Motz C, 2013, SCIENCE, V339, P690, DOI 10.1126/science.1230949; Lahaye X, 2012, J VIROL, V86, P4743, DOI 10.1128/JVI.06501-11; Lifland AW, 2012, J VIROL, V86, P8245, DOI 10.1128/JVI.00215-12; Kettern N, 2010, BIOL CHEM, V391, P481, DOI 10.1515/BC.2010.058; Saito H, 1996, MICROBIOL IMMUNOL, V40, P271; Lahaye X, 2009, J VIROL, V83, P7948, DOI 10.1128/JVI.00554-09; TANABAYASHI K, 1990, VIROLOGY, V177, P124, DOI 10.1016/0042-6822(90)90466-5; Geisbert TW, 1995, VIRUS RES, V39, P129, DOI 10.1016/0168-1702(95)00080-1; Cox R, 2014, P NATL ACAD SCI USA, V111, P15208, DOI 10.1073/pnas.1413268111; Carsillo T, 2006, J VIROL, V80, P2904, DOI 10.1128/JVI.80.6.2904-2912.2006; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hoenen T, 2012, J VIROL, V86, P11779, DOI 10.1128/JVI.01525-12; Katoh H, 2013, J VIROL, V87, P489, DOI 10.1128/JVI.02186-12; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; TSURUDOME M, 1986, J GEN VIROL, V67, P2259, DOI 10.1099/0022-1317-67-10-2259; Whelan SPJ, 2004, CURR TOP MICROBIOL, V283, P61; Mayer MP, 2005, REV PHYSIOL BIOCH P, V153, P1, DOI 10.1007/s10254-004-0025-5; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Brown G, 2005, VIROLOGY, V338, P69, DOI 10.1016/j.virol.2005.05.004; Burch AD, 2004, J VIROL, V78, P7175, DOI 10.1128/JVI.78.13.7175-7178.2004; Carlos TS, 2005, J VIROL, V79, P14112, DOI 10.1128/JVI.79.22.14112-14121.2005; DUC-NGUYEN HUU, 1967, J VIROL, V1, P415; Gray PM, 2004, CELL IMMUNOL, V231, P14, DOI 10.1016/j.cellimm.2004.12.002; Gray PM, 2001, J VIROL, V75, P10065, DOI 10.1128/JVI.75.21.10065-10072.2001; Heinrich BS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000958; Hirayama E, 2004, J VIROL, V78, P1263, DOI 10.1128/JVI.78.3.1263-1270.2004; Kaufer S, 2012, J VIROL, V86, P1079, DOI 10.1128/JVI.02662-10; Lamb RA, 2006, FIELDS VIROLOGY, V5th, P1449; Li G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016546; Li X, 2008, BRAIN RES REV, V59, P245, DOI 10.1016/j.brainresrev.2008.08.003; Menager P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000315; Munday DC, 2015, J VIROL, V89, P917, DOI 10.1128/JVI.01783-14; NORRBY E, 1970, J VIROL, V6, P237; Rosenzweig R, 2008, BIOCHEM SOC T, V36, P807, DOI 10.1042/BST0360807; TAKEUCHI K, 1990, VIROLOGY, V178, P247, DOI 10.1016/0042-6822(90)90400-L	44	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	MAR	2015	89	6					3188	3199		10.1128/JVI.03343-14		12	Virology	Virology	CC2XQ	WOS:000350208900016		
J	Zawierucha, K; Kolicka, M; Takeuchi, N; Kaczmarek, L				Zawierucha, K.; Kolicka, M.; Takeuchi, N.; Kaczmarek, L.			What animals can live in cryoconite holes? A faunal review	JOURNAL OF ZOOLOGY			English	Review						Annelida; Arthropoda; biodiversity; climate change; cryoconite; extreme habitats; extremophiles; glaciers melting; invertebrates; Nematoda; Rotifera; Tardigrada	FRESH-WATER TARDIGRADES; GLOBAL DIVERSITY; ARCTIC GLACIER; MESENCHYTRAEUS-SOLIFUGUS; HIMALAYAN GLACIER; TERRESTRIAL; ROTIFERA; COMMUNITIES; ANTARCTICA; BACTERIAL	Despite the large number of studies on glaciers, knowledge regarding biota in cryoconite holes is limited. Cryophilic animals are often neglected in ecological studies on glacial habitats, but are important for the functioning of these environments. Owing to climate change and the melting of polar ice, cryophilic fauna could be threatened in the near future. We provide the first comprehensive survey of invertebrates inhabiting the cryoconite holes of Alpine, Antarctic, Arctic, Himalayan and Patagonian glaciers. At present, the list of taxa is rather short and includes five phyla (Rotifera, Annelida, Tardigrada, Nematoda and Arthropoda). Owing to generally poor knowledge of the fauna of cryoconite holes, there could be more than the 25 currently known species. In addition, we present the geographical distributions of the taxa and discuss the diversity of invertebrates living in cryoconite holes and make predictions regarding the faunal diversity of these habitats.	[Zawierucha, K.; Kolicka, M.; Kaczmarek, L.] Adam Mickiewicz Univ, Fac Biol, Dept Anim Taxon & Ecol, PL-61614 Poznan, Poland; [Takeuchi, N.] Chiba Univ, Grad Sch Sci, Dept Earth Sci, Chiba, Japan; [Kaczmarek, L.] Univ Estatal Amazon, Lab Ecol Nat & Aplicada Invertebrados, Puyo, Ecuador	Zawierucha, K (reprint author), Adam Mickiewicz Univ, Fac Biol, Dept Anim Taxon & Ecol, Umultowska 89, PL-61614 Poznan, Poland.	k.p.zawierucha@gmail.com			National Science Center [NCN 2013/11/N/NZ8/00597, N N304 014939]	The authors thank Diego Fontaneto and another (anonymous) reviewer for their valuable comments that improved the manuscript. Studies were supported by National Science Center grant no. NCN 2013/11/N/NZ8/00597 to K.Z. and National Science Center grant no. N N304 014939 for L.K.	Aitchison C.W., 2001, P229; Coulson SJ, 2014, SOIL BIOL BIOCHEM, V68, P440, DOI 10.1016/j.soilbio.2013.10.006; Irvine-Fynn TDL, 2012, ENVIRON MICROBIOL, V14, P2998, DOI 10.1111/j.1462-2920.2012.02876.x; Mieczan T, 2013, POLAR BIOL, V36, P249, DOI 10.1007/s00300-012-1256-6; Balsamo M, 2008, HYDROBIOLOGIA, V595, P85, DOI 10.1007/s10750-007-9006-4; Segers H, 2007, ZOOTAXA, P1; Meehl GA, 2005, SCIENCE, V307, P1769, DOI 10.1126/science.1106663; Edwards A, 2014, FEMS MICROBIOL ECOL, V89, P222, DOI 10.1111/1574-6941.12283; Porazinska DL, 2004, ARCT ANTARCT ALP RES, V36, P84, DOI 10.1657/1523-0430(2004)036[0084:TBABOC]2.0.CO;2; Hodson A, 2008, ECOL MONOGR, V78, P41, DOI 10.1890/07-0187.1; Segers H, 2008, HYDROBIOLOGIA, V595, P49, DOI 10.1007/s10750-007-9003-7; Cameron KA, 2012, FEMS MICROBIOL ECOL, V82, P254, DOI 10.1111/j.1574-6941.2011.01277.x; Miller WR, 2005, ZOOTAXA, P57; Coulson SJ, 2012, POLAR BIOL, V35, P1651, DOI 10.1007/s00300-012-1205-4; Pugh PJA, 1998, POLAR BIOL, V19, P177, DOI 10.1007/s003000050232; WHARTON RA, 1985, BIOSCIENCE, V35, P499, DOI 10.2307/1309818; Martin P, 2008, HYDROBIOLOGIA, V595, P117, DOI 10.1007/s10750-007-9009-1; Fjellberg A, 2010, ZOOTAXA, P27; Takeuchi N, 2001, ARCT ANTARCT ALP RES, V33, P115, DOI 10.2307/1552211; Altiero T, 2001, ZOOL ANZ, V240, P217, DOI 10.1078/0044-5231-00028; OERLEMANS J, 1986, THEOR APPL CLIMATOL, V37, P126, DOI 10.1007/BF00867846; Somme L, 1996, EUR J ENTOMOL, V93, P349; Anesio AM, 2009, GLOBAL CHANGE BIOL, V15, P955, DOI 10.1111/j.1365-2486.2008.01758.x; Anesio AM, 2012, TRENDS ECOL EVOL, V27, P219, DOI 10.1016/j.tree.2011.09.012; Van Damme K, 2011, HYDROBIOLOGIA, V676, P57, DOI 10.1007/s10750-011-0892-0; Pugh PJA, 2008, J BIOGEOGR, V35, P2176, DOI 10.1111/j.1365-2699.2008.01953.x; Shain DH, 2001, CAN J ZOOL, V79, P1813, DOI 10.1139/cjz-79-10-1813; KOHSHIMA S, 1984, NATURE, V310, P225, DOI 10.1038/310225a0; Bellas CM, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/045021; BROADY PA, 1989, ANTARCT SCI, V1, P215; DARTNALL HJG, 1983, HYDROBIOLOGIA, V104, P57, DOI 10.1007/BF00045952; DASTYNCH H, 1985, Acta Zoologica Cracoviensia, V28, P169; DASTYCH H, 1991, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V88, P141; Dastych Hieronymus, 2003, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V100, P73; Dastych Hieronymus, 2004, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V101, P169; Dastych Hieronymus, 1993, Veroeffentlichungen des Tiroler Landesmuseum Ferdinandeum, V73, P5; DESMET WH, 1994, BELG J ZOOL, V124, P27; Drygalski E. V., 1897, GRONLAND EXPEDITION, P93; Edwards A., 2013, ENVIRON RES LETT, V8, P1; Fountain AG, 2004, J GLACIOL, V50, P35, DOI 10.3189/172756504781830312; GERDEL R. W., 1960, TRANS AMER MICROSC SOC, V79, P256, DOI 10.2307/3223732; Goodman D., 1971, ECOLOGICAL INVESTIGA; Greven Hartmut, 2005, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V102, P11; Grongaard A, 1999, ZOOL ANZ, V238, P211; GrOngaard A., 1992, FELTKURSUS ARKTISK B, P155; Guil N, 2013, SYST BIODIVERS, V11, P181, DOI 10.1080/14772000.2013.798370; Hall M. H. P., 2003, BIOSCIENCE, V53, P132; Jensen A. S., 1928, FESTKRIFT UDGIVET KO; Kaczmarek, 2009, ZOOTAXA, V2275, P60; KIKUCHI Y, 1994, HYDROBIOLOGIA, V293, P59; Kisielewski J., 1997, FAUNA SODKOWODNA POL, V31, P1; Kohshima S., 1987, B GLACIER RES, V5, P63; Kohshima S, 1985, GLACIOLOGICAL STUDIE, P94; Kraus H., 1977, THESIS U INNSBRUCK, P1; MCINNES SJ, 1994, J NAT HIST, V28, P257, DOI 10.1080/00222939400770131; MCINTYRE NF, 1984, CAN J EARTH SCI, V21, P152, DOI 10.1139/e84-016; Mihelcic F., 1963, Mikrokosmos, V52, P44; Mihelcic F., 1959, Zoologischer Anzeiger, V163, P254; Mueller D. R., 2001, NOVA HEDWIGIA S, V123, P173; Pilato G, 1998, ZOOL ANZ, V236, P181; Porter PR, 2008, ANN GLACIOL, V48, P25, DOI 10.3189/172756408784700734; Potapow M., 2001, SYNOPSES PALAEARCTIC, V3, P1; Ramazzotti G., 1968, TARDIGRADI POZZETTI, V3, P1; Reid J. W., 2002, DEV HYDROBIOL, V156, P201; RICCI C, 1983, HYDROBIOLOGIA, V104, P175, DOI 10.1007/BF00045965; Roberts TJ, 2010, ANN GLACIOL, V51, P163, DOI 10.3189/172756411795931949; Sawstrom C, 2002, POLAR BIOL, V25, P591, DOI 10.1007/s00300-002-0388-5; Schutte UME, 2010, MOL ECOL, V19, P54, DOI 10.1111/j.1365-294X.2009.04479.x; Semeria Y., 2003, B MENS SOC LINN LYON, V73, P191; Serra M, 2008, J PLANKTON RES, V30, P1207, DOI 10.1093/plankt/fbn077; Shain DH, 2000, J MORPHOL, V246, P192, DOI 10.1002/1097-4687(200012)246:3<192::AID-JMOR3>3.0.CO;2-B; Singh P, 2014, FEMS MICROBIOL LETT, V351, P14, DOI 10.1111/1574-6968.12345; Singh P, 2014, EXTREMOPHILES, V18, P229, DOI 10.1007/s00792-013-0609-6; Steinbock O., 1936, Z GLETSCHERK GLAZIAL, V24, P1; Takeuchi N., 2011, ENCY EARTH SCI SER, P330; Takeuchi N, 2004, ARCT ANTARCT ALP RES, V36, P92, DOI 10.1657/1523-0430(2004)036[0092:ASACOT]2.0.CO;2; Takeuchi N, 2000, B GLACIOLOGICAL RES, V17, P51; Vincent WF, 2000, NATURWISSENSCHAFTEN, V87, P137, DOI 10.1007/s001140050692; Wharton R. A., 1983, MADRONO, V30, P201; Wittrock V. B., 1885, STUDIEN FORSCHUNGEN, P67	80	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-8369	1469-7998		J ZOOL	J. Zool.	MAR	2015	295	3					159	169		10.1111/jzo.12195		11	Zoology	Zoology	CC6LI	WOS:000350476000001		
J	Nakamura, M; Yamazaki, O; Shirai, A; Horita, S; Satoh, N; Suzuki, M; Hamasaki, Y; Noiri, E; Kume, H; Enomoto, Y; Homma, Y; Seki, G				Nakamura, Motonobu; Yamazaki, Osamu; Shirai, Ayumi; Horita, Shoko; Satoh, Nobuhiko; Suzuki, Masashi; Hamasaki, Yoshifumi; Noiri, Eisei; Kume, Haruki; Enomoto, Yutaka; Homma, Yukio; Seki, George			Preserved Na/HCO3 cotransporter sensitivity to insulin may promote hypertension in metabolic syndrome	KIDNEY INTERNATIONAL			English	Article						insulin resistance; IRS1; IRS2; NBCe1; proximal tubule; siRNA	RENAL PROXIMAL TUBULE; IMPROVED INCUBATION CONDITIONS; PANCREATIC BETA-CELLS; IN-VIVO FUNCTION; BICARBONATE ABSORPTION; RECEPTOR SUBSTRATE-1; PHOSPHATIDYLINOSITOL 3-KINASE; ENDOTHELIAL DYSFUNCTION; BIPHASIC REGULATION; GLUCOSE-METABOLISM	Hyperinsulinemia can contribute to hypertension through effects on sodium transport. To test whether the stimulatory effect of insulin on renal proximal tubule sodium transport is preserved in insulin resistance, we compared the effects of insulin on abdominal adipocytes and proximal tubules in rats and humans. Insulin markedly stimulated the sodium-bicarbonate cotransporter (NBCe1) activity in isolated proximal tubules through the phosphoinositide 3-kinase (PI3-K) pathway. Gene silencing in rats showed that while insulin receptor substrate (IRS)1 mediates the insulin effect on glucose uptake into adipocytes, IRS2 mediates the insulin effect on proximal tubule transport. The stimulatory effect of insulin on glucose uptake into adipocytes was severely reduced, but its stimulatory effect on NBCe1 activity was completely preserved in insulin-resistant Otsuka Long-Evans Tokushima Fatty (OLETF) rats and patients with insulin resistance. Despite widespread reduction of IRS1 and IRS2 expression in insulin-sensitive tissues, IRS2 expression in the kidney cortex was exceptionally preserved in both OLETF rats and patients with insulin resistance. Unlike liver, acute insulin injection failed to change the expression levels of IRS2 and sterol regulatory element-binding protein 1 in rat kidney cortex, indicating that regulatory mechanisms of IRS2 expression are distinct in liver and kidney. Thus, preserved stimulation of proximal tubule transport through the insulin/IRS2/PI3-K pathway may play an important role in the pathogenesis of hypertension associated with metabolic syndrome.	[Nakamura, Motonobu; Yamazaki, Osamu; Shirai, Ayumi; Horita, Shoko; Satoh, Nobuhiko; Suzuki, Masashi; Hamasaki, Yoshifumi; Noiri, Eisei; Seki, George] Univ Tokyo, Fac Med, Dept Internal Med, Tokyo 1130033, Japan; [Kume, Haruki; Enomoto, Yutaka; Homma, Yukio] Univ Tokyo, Fac Med, Dept Urol, Tokyo 1130033, Japan	Seki, G (reprint author), Univ Tokyo, Fac Med, Dept Internal Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	georgeseki-tky@umin.ac.jp			Tokyo Society of Medical Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan	This study was supported in part by grants from the Tokyo Society of Medical Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Catena C, 2003, KIDNEY INT, V64, P2163, DOI 10.1046/j.1523-1755.2003.00313.x; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Endo Y, 2011, CELL METAB, V13, P550, DOI 10.1016/j.cmet.2011.02.015; Wang YX, 2006, EMBO J, V25, P5049, DOI 10.1038/sj.emboj.7601387; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Tsunekawa S, 2011, DIABETES, V60, P2883, DOI 10.2337/db11-0340; Laye MJ, 2009, J PHYSIOL-LONDON, V587, P3729, DOI 10.1113/jphysiol.2009.172601; Strazzullo P, 2001, J HYPERTENS, V19, P2157, DOI 10.1097/00004872-200112000-00007; Strazzullo P, 2006, J HYPERTENS, V24, P1633, DOI 10.1097/01.hjh.0000239300.48130.07; Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; Rondinone CM, 1997, P NATL ACAD SCI USA, V94, P4171, DOI 10.1073/pnas.94.8.4171; Zheng YN, 2003, J AM SOC NEPHROL, V14, P1116, DOI 10.1097/01.ASN.0000064700.58048.C1; Yang DK, 2011, J CLIN INVEST, V121, P956, DOI 10.1172/JCI43475; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; BAUM M, 1987, J CLIN INVEST, V79, P1104, DOI 10.1172/JCI112925; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Steinberg HO, 1996, J CLIN INVEST, V97, P2601, DOI 10.1172/JCI118709; Zheng YN, 2005, J AM SOC NEPHROL, V16, P2288, DOI 10.1681/ASN.2005020193; Alonso-Castro AJ, 2008, J ETHNOPHARMACOL, V118, P252, DOI 10.1016/j.jep.2008.04.007; Jiang ZY, 1999, J CLIN INVEST, V104, P447, DOI 10.1172/JCI5971; Mima A, 2011, KIDNEY INT, V79, P883, DOI 10.1038/ki.2010.526; Nishiyama A, 2010, J PHARMACOL EXP THER, V332, P1072, DOI 10.1124/jpet.109.158113; NATALI A, 1993, CLIN SCI, V85, P327; RODBELL M, 1964, J BIOL CHEM, V239, P375; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Kubota T, 2003, CIRCULATION, V107, P3073, DOI 10.1161/01.CIR.0000070937.52035.25; Benito Manuel, 2011, Archives of Physiology and Biochemistry, V117, P96, DOI 10.3109/13813455.2011.563748; Carvalho E, 1999, FASEB J, V13, P2173; FERAILLE E, 1994, AM J PHYSIOL, V267, pF55; GESEK FA, 1991, AM J PHYSIOL, V260, pF695; Horita S, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/391762; Levesque J, 2008, J NUTRIGENET NUTRIGE, V1, P100, DOI 10.1159/000112457; Li Y, 2008, J AM SOC NEPHROL, V19, P252, DOI 10.1681/ASN.2007030289; Matsumoto M, 2002, DIABETES, V51, P1672, DOI 10.2337/diabetes.51.6.1672; MullerBerger S, 1997, PFLUG ARCH EUR J PHY, V434, P383, DOI 10.1007/s004240050411; MullerBerger S, 1997, PFLUG ARCH EUR J PHY, V434, P373, DOI 10.1007/s004240050410; Panchapakesan U, 2005, NAT CLIN PRACT NEPHR, V1, P33, DOI 10.1038/ncpneph0029; QuinonesGalvan A, 1997, J NEPHROL, V10, P188; Ruiz OS, 1998, REGUL PEPTIDES, V77, P155, DOI 10.1016/S0167-0115(98)00115-3; Shirai A, 2014, J AM SOC NEPHROL, V25, P1523, DOI 10.1681/ASN.2013060596; SKOTT P, 1991, DIABETOLOGIA, V34, P275, DOI 10.1007/BF00405088; Thirone Ana C P, 2006, Trends Endocrinol Metab, V17, P72, DOI 10.1016/j.tem.2006.01.005; Vallon V, 2009, J AM SOC NEPHROL, V20, P721, DOI 10.1681/ASN.2008040415; Yamada K, 2000, J BIOL CHEM, V275, P22278, DOI 10.1074/jbc.M908048199; Zhang JD, 2001, P NATL ACAD SCI USA, V98, P3756, DOI 10.1073/pnas.071054598	49	6	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	MAR	2015	87	3					535	542		10.1038/ki.2014.351		8	Urology & Nephrology	Urology & Nephrology	CC7FO	WOS:000350533300010		
J	Higashijima, Y; Tanaka, T; Nangaku, M				Higashijima, Yoshiki; Tanaka, Tetsuhiro; Nangaku, Masaomi			Incretin-based drugs and renoprotection-is hyperfiltration key? Reply	KIDNEY INTERNATIONAL			English	Letter							GLUCAGON-LIKE PEPTIDE-1; INJURY		[Higashijima, Yoshiki; Tanaka, Tetsuhiro; Nangaku, Masaomi] Univ Tokyo, Grad Sch Med, Div Nephrol & Endocrinol, Tokyo 1138655, Japan	Nangaku, M (reprint author), Univ Tokyo, Grad Sch Med, Div Nephrol & Endocrinol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	mnangaku-tky@umin.ac.jp					Glorie LLF, 2012, AM J PHYSIOL-RENAL, V303, pF681, DOI 10.1152/ajprenal.00075.2012; Gutzwiller JP, 2004, J CLIN ENDOCR METAB, V89, P3055, DOI 10.1210/jc.2003-031403; Fujita H, 2014, KIDNEY INT, V85, P579, DOI 10.1038/ki.2013.427; Katagiri D, 2013, J AM SOC NEPHROL, V24, P2034, DOI 10.1681/ASN.2013020134; Tanaka T, 2014, KIDNEY INT, V86, P701, DOI 10.1038/ki.2014.236; Tonneijck L, 2015, KIDNEY INT, V87, P660, DOI 10.1038/ki.2014.398	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	MAR	2015	87	3					661	661		10.1038/ki.2014.410		1	Urology & Nephrology	Urology & Nephrology	CC7FO	WOS:000350533300026		
J	Osaki, K; Okazaki, K; Tashiro, Y; Matsubara, H; Iwamoto, Y				Osaki, Kanji; Okazaki, Ken; Tashiro, Yasutaka; Matsubara, Hirokazu; Iwamoto, Yukihide			Influences of knee flexion angle and portal position on the location of femoral tunnel outlet in anterior cruciate ligament reconstruction with anteromedial portal technique	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Double-bundle anterior cruciate ligament reconstruction; Femoral tunnel outlet; Lateral structure; 3D MRI	ACL RECONSTRUCTION; LENGTH; PLACEMENT	To evaluate the influences of knee flexion angle and portal position on the location of femoral tunnel outlet in anterior cruciate ligament (ACL) reconstruction with the anteromedial (AM) portal technique. We recruited 6 volunteers with 12 normal knees. Each knee was flexed 120A degrees or 135A degrees and scanned with an open MRI. A 3D knee model was created. Virtual femoral tunnels were created on the footprint of the AM bundle and the posterolateral (PL) bundle of the ACL from three arthroscopic portals: the standard AM portal, the far medial and low portal, and the far medial and high (FMH) portal. The location of the femoral tunnel outlet was evaluated by comparing to the dissected cadaveric knee. Both increased flexion angle and lowering the drilling portal have a similar influence on the femoral tunnel outlet by moving them anterior and distally. Medialization of the portal moves them posteriorly and distally. PL tunnels created on the 120A degrees knee model are more likely to be located under the lateral head of the gastrocnemius especially when they are drilled through the AM or FMH portals. If the femoral tunnel outlet is located under the soft tissue such as gastrocnemius attachment, suspension fixation devices may lapse into fixation failure by sitting on the soft tissue rather than the cortex bone surface. It is more desirable to drill in 135A degrees knee flexion rather than 120A degrees, and through a lower portal, to avoid creating the femoral tunnel outlet under soft tissues. Experimental research.	[Osaki, Kanji; Okazaki, Ken; Tashiro, Yasutaka; Matsubara, Hirokazu; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, Fukuoka 8128582, Japan	Okazaki, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	okazaki@ortho.med.kyushu-u.ac.jp		Okazaki, Ken/0000-0003-1274-8406			ANDERSSON C, 1991, CLIN ORTHOP RELAT R, P255; Neven E, 2008, ARTHROSCOPY, V24, P436, DOI 10.1016/j.arthro.2007.09.013; Gadikota HR, 2012, AM J SPORT MED, V40, P882, DOI 10.1177/0363546511434276; Logan JS, 2012, KNEE SURG SPORT TR A, V20, P1289, DOI 10.1007/s00167-011-1745-0; Lubowitz JH, 2009, ARTHROSCOPY, V25, P95, DOI 10.1016/j.arthro.2008.10.012; Taketomi S, 2011, KNEE SURG SPORT TR A, V19, P424, DOI 10.1007/s00167-010-1246-6; Farrow LD, 2010, KNEE SURG SPORT TR A, V18, P747, DOI 10.1007/s00167-009-0902-1; Giron F, 2007, ARTHROSCOPY, V23, P7, DOI 10.1016/j.arthro.2006.08.008; Nakamura M, 2009, ARTHROSCOPY, V25, P481, DOI 10.1016/j.arthro.2008.11.010; Kaseta MK, 2008, CLIN ORTHOP RELAT R, V466, P1467, DOI 10.1007/s11999-008-0238-z; Williams RJ, 2004, J BONE JOINT SURG AM, V86A, P225; Basdekis G, 2009, ARTHROSCOPY, V25, P1108, DOI 10.1016/j.arthro.2009.05.018; Fu FH, 2008, AM J SPORT MED, V36, P1263, DOI 10.1177/0363546508314428; Bedi A, 2010, ARTHROSCOPY, V26, P342, DOI 10.1016/j.arthro.2009.12.006; Ilahi OA, 2012, ARTHROSCOPY, V28, P486, DOI 10.1016/j.arthro.2011.09.018; Churchill DL, 1998, CLIN ORTHOP RELAT R, P111; Basdekis G, 2008, ARTHROSCOPY, V24, P459, DOI 10.1016/j.arthro.2007.10.012; Dye SF, 1998, J BONE JOINT SURG AM, V80A, P1380; Golish SR, 2007, ARTHROSCOPY, V23, P1187, DOI 10.1016/j.arthro.2007.06013; Nakamae A, 2014, KNEE SURG SPORT TR A, V22, P181, DOI 10.1007/s00167-012-2346-2; Steiner ME, 2009, AM J SPORT MED, V37, P1912, DOI 10.1177/0363546509340407; Wang JH, 2012, ARTHROSCOPY, V28, P1094, DOI 10.1016/j.arthro.2011.12.017; Zantop T, 2007, ARTHROSCOPY, V23, P938, DOI 10.1016/j.arthro.2007.04.009; Zantop T, 2008, ARCH ORTHOP TRAUM SU, V128, P509, DOI 10.1007/s00402-007-0480-y; Zysk SP, 2000, ARCH ORTHOP TRAUM SU, V120, P59	25	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	MAR	2015	23	3					777	784		10.1007/s00167-013-2705-7		8	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CC2XU	WOS:000350209300015		
J	Jang, CL; Shimizu, Y; Lee, GH				Jang, Chang-Lae; Shimizu, Yasuyuki; Lee, Gi Ha			Numerical simulation of the fluvial processes in the channels by sediment mining	KSCE JOURNAL OF CIVIL ENGINEERING			English	Article						sediment mining; mining pit; fluvial processes; numerical simulation; experiment	MIGRATION; RIVER; DAMS	This study aims to experimentally and numerically investigate the fluvial processes of channels disturbed through sand or gravel mining. A two-dimensional numerical model is applied to simulate flume experiments. A moving boundary-fitted coordinate system is used to describe the channel changes. As a numerical scheme, the cubic interpolated pseudoparticle method is used to calculate the flow field and bed changes, which introduces little numerical diffusion. The numerical model is verified with experimental data. The inflow sediment from the upstream is trapped into a pit and the sediment deposit wedge migrated to the downstream with a steep submerged angle of repose. The numerical and experimental results show that the sediment deposit wedge in the pit migrates to the downstream under the condition of steady state. The adjustment time within the disturbed channels increases as the dimension of the pit is increased. The sediment mining pit migrates with speed in the steep channel. Moreover, the numerical experiments show that the migration speed is proportional to the sediment inflow. And the disturbed channels by the sediment mining are affected by the sediment inflow conditions of the upstream and adjusted to the new state of equilibrium.	[Shimizu, Yasuyuki] Hokkaido Univ, Div Environm & Resource Engn, Hokkaido 0608628, Japan; [Lee, Gi Ha] Kyungpook Natl Univ, Gyeongbuk 742711, South Korea		cljang@ut.ac.kr; yasu@eng.hokudai.ac.jp; leegiha@knu.ac.kr			Technical Innovation of Construction Program - Ministry of Land, Transport and Maritime Affairs of Korea [11-TI-C06, 12 Technical Innovation C02]	This research was supported by a grant (11-TI-C06) and a grant (12 Technical Innovation C02) from Technical Innovation of Construction Program funded by Ministry of Land, Transport and Maritime Affairs of Korea.	Gob F, 2005, RIVER RES APPL, V21, P791, DOI 10.1002/rra.883; Jang CL, 2005, J HYDRAUL ENG-ASCE, V131, P565, DOI 10.1061/(ASCE)0733-9429(2005)131:7(565); Rinaldi M, 2005, RIVER RES APPL, V21, P805, DOI 10.1002/rra.884; Kondolf GM, 1997, ENVIRON MANAGE, V21, P533, DOI 10.1007/s002679900048; Kondolf GM, 2002, GEOMORPHOLOGY, V45, P35, DOI 10.1016/S0169-555X(01)00188-X; Brandt SA, 2000, CATENA, V40, P375, DOI 10.1016/S0341-8162(00)00093-X; Cao ZX, 2004, ADV WATER RESOUR, V27, P533, DOI DOI 10.1016/J.ADVWATRES.2004.02.017; Chaw K. W., 2005, J HYDRAUL ENG-ASCE, V10, P485; GILL MA, 1994, J HYDRAUL ENG-ASCE, V120, P1337, DOI 10.1061/(ASCE)0733-9429(1994)120:11(1337); Kishi T., 1976, BED FORM FLOW RESIST, V67, P1; KONDOLF GM, 1994, LANDSCAPE URBAN PLAN, V28, P225; Kuroki M., 1984, P JSCE, V342, P87; LEE HY, 1994, J HYDRAUL ENG-ASCE, V120, P693, DOI 10.1061/(ASCE)0733-9429(1994)120:6(693); LEE HY, 1993, J HYDRAUL ENG-ASCE, V119, P64, DOI 10.1061/(ASCE)0733-9429(1993)119:1(64); Meyer-Peter E., 1948, P 2 IAHR C, V2, P39; Van Rijn L. C., 1996, HDB COASTAL OCEAN EN, P611; Williams G.P., 1984, DOWNSTREAM EFFECTS D; Wu WM, 2008, WORLD ENV WAT RES C, P1; YABE T, 1990, J PHYS SOC JPN, V59, P2301, DOI 10.1143/JPSJ.59.2301	19	0	0	KOREAN SOCIETY OF CIVIL ENGINEERS-KSCE	SEOUL	50-7 OGUM-DONG, SONGPA-KU, SEOUL, 138-857, SOUTH KOREA	1226-7988	1976-3808		KSCE J CIV ENG	KSCE J. Civ. Eng.	MAR	2015	19	3					771	778		10.1007/s12205-012-0608-7		8	Engineering, Civil	Engineering	CC0WL	WOS:000350059500037		
J	Fujikawa, T; Ikeda, S				Fujikawa, Tatsuya; Ikeda, Shigehiro			Primary iliopsoas abscess in a diabetic patient	LANCET INFECTIOUS DISEASES			English	Editorial Material									[Fujikawa, Tatsuya] Seikeikai Hosp, Dept Internal Med, Sakai, Osaka, Japan; [Ikeda, Shigehiro] Seikeikai Hosp, Dept Orthopaed Surg, Sakai, Osaka, Japan; [Fujikawa, Tatsuya] Mitoyo Gen Hosp, Dept Internal Med, Kanonji, Kagawa 7691695, Japan	Fujikawa, T (reprint author), Mitoyo Gen Hosp, Dept Internal Med, Kanonji, Kagawa 7691695, Japan.	tfujikawa-gi@umin.ac.jp						0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1473-3099	1474-4457		LANCET INFECT DIS	Lancet Infect. Dis.	MAR	2015	15	3					360	360				1	Infectious Diseases	Infectious Diseases	CC3SA	WOS:000350268500035		
J	Pileri, S; Kwong, YL; Tan, LHC; Ohshima, K				Pileri, Stefano; Kwong, Yok Lam; Tan, Leonard Hwan-Cheong; Ohshima, Koicui			CD30 detection in haematological malignancies: diagnosis and therapeutics	LEUKEMIA RESEARCH			English	Editorial Material									[Pileri, Stefano] Univ Bologna, Sch Med, Dept Expt Diagnos & Specialty Med, S Orsola Malpighi Hosp,Dept Expt, Bologna, Italy; [Kwong, Yok Lam] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Tan, Leonard Hwan-Cheong] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Ohshima, Koicui] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan	Pileri, S (reprint author), Univ Bologna, Sch Med, Dept Expt Diagnos & Specialty Med, S Orsola Malpighi Hosp,Dept Expt, Bologna, Italy.							0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2126			LEUKEMIA RES	Leuk. Res.	MAR	2015	39	3					388	388		10.1016/j.leukres.2014.12.004		1	Oncology; Hematology	Oncology; Hematology	CB9NG	WOS:000349957800020		
J	Liu, LJ; Long, Q; Aoki, T; Namikoshi, T; Abe, Y; Miyata, M; Teraguchi, M; Kaneko, T; Wang, YD; Zhang, CH				Liu, Lijia; Long, Qing; Aoki, Toshiki; Namikoshi, Takeshi; Abe, Yunosuke; Miyata, Mari; Teraguchi, Masahiro; Kaneko, Takashi; Wang, Yudan; Zhang, Chunhong			A Chiral Supramolecular Polymer Membrane with no Chiral Substituents by Highly Selective Photocyclic Aromatization of a One-Handed Helical Cis-cisoidal Polyphenylacetylene	MACROMOLECULAR CHEMISTRY AND PHYSICS			English	Article						one-handed helicity; photocyclic aromatization; polyacetylenes; supramolecular polymer membranes	POLY(PHENYLACETYLENE)S; PHENYLACETYLENES; ACETYLENES; POLYACETYLENES; CONFORMATION; ORGANIZATION; RECOGNITION; DERIVATIVES; MONOMERS; CHAINS	A one-handed helical cis-cisoidal polyphenylacetylene (P) is successfully synthesized by an asymmetric-induced polymerization of a chiral-substituted phenylacetylene having two hydroxymethyl groups. Quantitative photocyclic aromatization of P in a membrane-state followed by in situ removal of the chiral substituents affords a one-handed helical supramolecular polymer membrane of the corresponding cyclic trimer (T) with no chiral substituents. The original one-handed helicity of the precursor P is successfully transmitted to the resulting supramolecular helicity of de-T. Both the hydrogen bonds and the pi-pi stacking are thought to contribute to the retention of the chirality during the two-step reaction in the membrane state.	[Liu, Lijia; Long, Qing; Wang, Yudan; Zhang, Chunhong] Harbin Engn Univ, Coll Mat Sci & Chem Engn, Key Lab Superlight Mat & Surface Technol, Polymer Mat Res Ctr,Minist Educ, Harbin 150001, Peoples R China; [Aoki, Toshiki; Abe, Yunosuke; Miyata, Mari; Teraguchi, Masahiro; Kaneko, Takashi] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan; [Namikoshi, Takeshi] Kitami Inst Technol, Mat Sci & Engn, Kitami, Hokkaido 0908507, Japan	Liu, LJ (reprint author), Harbin Engn Univ, Coll Mat Sci & Chem Engn, Key Lab Superlight Mat & Surface Technol, Polymer Mat Res Ctr,Minist Educ, Harbin 150001, Peoples R China.	liulijia@hrbeu.edu.cn; toshaoki@eng.niigata-u.ac.jp			National Science Foundation of China [21204014, 51373044, LC201404]; Fundamental Research Funds for the Central Universities, China [HEUCFT1009, HEUCFQ1417, HEUCF20130910004, HEUCF201403008]; Daicel Corporation (Tokyo, Japan);  [19350054]	Financial support from the Grant-in-Aid for Scientific Research (B) (No.19350054), Japan, the National Science Foundation of China (21204014, 51373044 and LC201404), and the Fundamental Research Funds for the Central Universities, China (Nos. HEUCFT1009, HEUCFQ1417, HEUCF20130910004, HEUCF201403008), and the Daicel Corporation (Tokyo, Japan) is gratefully acknowledged.	SIMIONESCU CI, 1977, J POLYM SCI POL CHEM, V15, P2497, DOI 10.1002/pol.1977.170151018; Brunsveld L, 2001, CHEM REV, V101, P4071, DOI 10.1021/cr990125q; Rudick JG, 2008, ACCOUNTS CHEM RES, V41, P1641, DOI 10.1021/ar800086w; Liu LJ, 2013, J AM CHEM SOC, V135, P602, DOI 10.1021/ja3113214; Aoki T, 2006, POLYMER, V47, P4867, DOI 10.1016/j.polymer.2006.04.047; Aoki T, 2003, J AM CHEM SOC, V125, P6346, DOI 10.1021/ja021233o; Murphy AR, 2007, CHEM REV, V107, P1066, DOI 10.1021/cr0501386; Nakano T, 2001, CHEM REV, V101, P4013, DOI 10.1021/cr0000978; Yashima E, 2009, CHEM REV, V109, P6102, DOI 10.1021/cr900162q; Liu LJ, 2010, MACROMOLECULES, V43, P9268, DOI 10.1021/ma101999k; Iamsaard S, 2014, NAT CHEM, V6, P229, DOI [10.1038/nchem.1859, 10.1038/NCHEM.1859]; de Greef TFA, 2008, NATURE, V453, P171, DOI 10.1038/453171a; Suzuki N, 2013, J AM CHEM SOC, V135, P13073, DOI 10.1021/ja405570q; Aoki T, 2005, POLYM J, V37, P717, DOI 10.1295/polymj.37.717; Li LS, 2007, ANGEW CHEM INT EDIT, V46, P5873, DOI 10.1002/anie.200701328; Miyata M, 2014, CHEM LETT, V43, P1476, DOI 10.1246/cl.140469; LEHN JM, 1990, ANGEW CHEM INT EDIT, V29, P1304, DOI 10.1002/anie.199013041; Percec V, 2006, J AM CHEM SOC, V128, P16365, DOI 10.1021/ja0665848; De Greef TFA, 2009, CHEM REV, V109, P5687, DOI 10.1021/cr900181u; Otsuka I, 2007, MACROMOLECULES, V40, P8930, DOI 10.1021/ma7020776; George SJ, 2012, J AM CHEM SOC, V134, P17789, DOI 10.1021/ja3086005; Folmer BJB, 2000, ADV MATER, V12, P874, DOI 10.1002/1521-4095(200006)12:12<874::AID-ADMA874>3.3.CO;2-3; Teraguchi M, 2012, ACS MACRO LETT, V1, P1258, DOI 10.1021/mz300309c; Zang Y, 2012, CHEM COMMUN, V48, P4761, DOI 10.1039/c2cc00030j; Yang WY, 2006, J AM CHEM SOC, V128, P3484, DOI 10.1021/ja057823e; Akagi K, 2009, CHEM REV, V109, P5354, DOI 10.1021/cr900198k; AOKI T, 1993, CHEM LETT, P2009, DOI 10.1246/cl.1993.2009; Bao CY, 2007, TETRAHEDRON, V63, P7443, DOI 10.1016/j.tet.2007.03.125; Cheuk KKL, 2007, MACROMOLECULES, V40, P2633, DOI 10.1021/ma062629d; Eiji Y., 1999, NATURE, V399, P449; Hadano S, 2009, MACROMOL CHEM PHYSIC, V210, P718, DOI 10.1002/macp.200800594; KISHIMOTO Y, 1994, J AM CHEM SOC, V116, P12131, DOI 10.1021/ja00105a095; Liu LJ, 2013, MACROMOL RAPID COMM, V34, P1140, DOI 10.1002/marc.201300318; Matsushita S., 2013, ANGEW CHEM INT EDIT, V53, P1659; Miyata M, 2013, POLYMER, V54, P4431, DOI 10.1016/j.polymer.2013.05.063; Miyata M, 2014, KOBUNSHI RONBUNSHU, V71, P372; Roosma J., 2008, J AM CHEM SOC, V130, P602; Sanda F, 2005, MACROMOLECULES, V38, P8149, DOI 10.1021/ma051529p; Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601; Yoshikawa I, 2008, ANGEW CHEM INT EDIT, V47, P1038, DOI 10.1002/anie.200704535	40	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1022-1352	1521-3935		MACROMOL CHEM PHYS	Macromol. Chem. Phys.	MAR	2015	216	5					530	537		10.1002/macp.201400526		8	Polymer Science	Polymer Science	CC6VQ	WOS:000350507500007		
J	Mineart, KP; Jiang, X; Jinnai, H; Takahara, A; Spontak, RJ				Mineart, Kenneth P.; Jiang, Xi; Jinnai, Hiroshi; Takahara, Atsushi; Spontak, Richard J.			Morphological Investigation of Midblock-Sulfonated Block Ionomers Prepared from Solvents Differing in Polarity	MACROMOLECULAR RAPID COMMUNICATIONS			English	Article						block copolymers; electron tomography; ionomers; morphology; self-organization; polymer nanostructures	THERMOPLASTIC ELASTOMER GELS; TRIBLOCK COPOLYMER GELS; DIELECTRIC ELASTOMERS; DIBLOCK COPOLYMERS; THIN-FILMS; LONG-CHAIN; PHASE; ACTUATORS; POLYMERS; BEHAVIOR	Recent developments regarding charged multiblock copolymers that can form physical networks and exhibit robust mechanical properties herald new and exciting opportunities for contemporary technologies requiring amphiphilic attributes. Due to the presence of strong interactions, however, control over the phase behavior of such materials remains challenging, especially since their morphologies can be solvent-templated. In this study, transmission electron microscopy and microtomography are employed to examine the morphological characteristics of midblock-sulfonated pentablock ionomers prepared from solvents differing in polarity. Resultant images confirm that discrete, spherical ion-rich microdomains form in films cast from a relatively nonpolar solvent, whereas an apparently mixed morphology with a continuous ion-rich pathway is generated when the casting solvent is more highly polar. Detailed 3D analysis of the morphological characteristics confirms the coexistence of hexagonally-packed nonpolar cylinders and lamellae, which facilitates the diffusion of ions and/or other polar species through the nanostructured medium.	[Mineart, Kenneth P.; Spontak, Richard J.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [Jiang, Xi; Jinnai, Hiroshi; Takahara, Atsushi] Kyushu Univ, Inst Mat Chem & Engn, Nishi Ku, Fukuoka 8190395, Japan; [Spontak, Richard J.] N Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA	Spontak, RJ (reprint author), N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.	Rich_Spontak@ncsu.edu	Jinnai, Hiroshi/F-8456-2014		Nonwovens Institute at North Carolina State University; IMI Program of the National Science Foundation [DMR 08-43934]	This work was supported by the Nonwovens Institute at North Carolina State University and the IMI Program of the National Science Foundation under Award No. DMR 08-43934.	Abetz V., 2003, ENCY POLYM SCI TECHN, V1, P482; Alexandridis P, 2000, AMPHIPHILIC BLOCK CO; Bendejacq D, 2002, MACROMOLECULES, V35, P6645, DOI 10.1021/ma020158z; Bates FS, 1999, PHYS TODAY, V52, P32, DOI 10.1063/1.882522; Vargantwar PH, 2011, SOFT MATTER, V7, P1651, DOI 10.1039/c0sm01210f; Matsen MW, 1999, J CHEM PHYS, V111, P7139, DOI 10.1063/1.480006; Gozen AO, 2011, SOFT MATTER, V7, P3268, DOI 10.1039/c0sm01169j; Takenaka M, 2007, MACROMOLECULES, V40, P4399, DOI 10.1021/ma070739u; Park MJ, 2008, MACROMOLECULES, V41, P3678, DOI 10.1021/ma702733f; Choi JH, 2010, IND ENG CHEM RES, V49, P12093, DOI 10.1021/ie1002476; Ott H, 2001, MACROMOLECULES, V34, P2121, DOI 10.1021/ma0017079; Guo ZJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.028301; CROWTHER RA, 1970, PROC R SOC LON SER-A, V317, P319, DOI 10.1098/rspa.1970.0119; Chantawansri TL, 2014, CHEM PHYS LETT, V612, P157, DOI 10.1016/j.cplett.2014.08.013; Bohbot-Raviv Y, 2000, PHYS REV LETT, V85, P3428, DOI 10.1103/PhysRevLett.85.3428; Lee S, 2010, SCIENCE, V330, P349, DOI 10.1126/science.1195552; Ruzette AV, 2005, NAT MATER, V4, P19, DOI 10.1038/nmat1295; Jinnai H, 2009, POLYMER, V50, P1067, DOI 10.1016/j.polymer.2008.12.023; Shankar R, 2007, ADV MATER, V19, P2218, DOI 10.1002/adma.200602644; Kim B, 2011, ADV FUNCT MATER, V21, P3242, DOI 10.1002/adfm.201100298; Cochran EW, 2006, MACROMOLECULES, V39, P2449, DOI 10.1021/ma0527707; Seitz ME, 2007, MACROMOLECULES, V40, P1218, DOI 10.1021/ma061993+; Jinnai H, 2009, SOFT MATTER, V5, P2042, DOI 10.1039/b901008d; Elabd YA, 2011, MACROMOLECULES, V44, P1, DOI 10.1021/ma101247c; Xu T, 2005, MACROMOLECULES, V38, P10788, DOI 10.1021/ma050221c; Choi JH, 2012, J MEMBRANE SCI, V394, P169, DOI 10.1016/j.memsci.2011.12.036; Higuchi T, 2013, MACROMOLECULES, V46, P6991, DOI 10.1021/ma401193u; Jinnai H, 2010, MACROMOLECULES, V43, P1675, DOI 10.1021/ma902035p; Shankar R, 2007, SOFT MATTER, V3, P1116, DOI 10.1039/b705737g; Khandpur AK, 1995, MACROMOLECULES, V28, P8796, DOI 10.1021/ma00130a012; Bates FS, 2012, SCIENCE, V336, P434, DOI 10.1126/science.1215368; Disabb-Miller ML, 2013, MACROMOLECULES, V46, P949, DOI 10.1021/ma301947t; Young NP, 2014, SOLID STATE IONICS, V263, P87, DOI 10.1016/j.ssi.2014.05.012; Geise GM, 2013, J MEMBRANE SCI, V427, P186, DOI 10.1016/j.memsci.2012.09.029; He YY, 2007, J PHYS CHEM B, V111, P4645, DOI 10.1021/jp064574n; Zhu S, 2013, ADV FUNCT MATER, V23, P2308, DOI 10.1002/adfm.201202405; Morkved TL, 1996, SCIENCE, V273, P931, DOI 10.1126/science.273.5277.931; Chantawansri TL, 2011, J POLYM SCI POL PHYS, V49, P1479, DOI 10.1002/polb.22335; Geise G. M., 2012, J MEMBRANE SCI, V423-424, P195; Hamley IW, 1998, PHYS BLOCK COPOLYMER; Haynes W.M., 2013, HDB CHEM PHYS; Holden G., 2004, THERMOPLASTIC ELASTO; Jueun J., 2011, SOFT MATTER, V7, P10424; Laurer JH, 1998, J POLYM SCI POL PHYS, V36, P2513; Laurer JH, 1998, J POLYM SCI POL PHYS, V36, P2379; Mineart K. P., UNPUB; Mineart KP, 2013, SOFT MATTER, V9, P7695, DOI 10.1039/c3sm51136g; Moore HD, 2010, J MATER CHEM, V20, P6316, DOI 10.1039/c0jm00068j; Mortensen K, 1998, CURR OPIN COLLOID IN, V3, P12; Patel NP, 2004, MACROMOLECULES, V37, P2829, DOI 10.1021/ma049975k; Saito T, 2010, MACROMOLECULES, V43, P599, DOI 10.1021/ma9023125; Spontak RJ, 1996, MACROMOLECULES, V29, P2850, DOI 10.1021/ma9515691; Sudarsan AP, 2005, ANAL CHEM, V77, P5167, DOI 10.1021/ac050448o; Tallury S. S., 2014, J CHEM PHYS, V141; Tallury SS, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4896612; Vargantwar PH, 2013, J MATER CHEM A, V1, P3430, DOI 10.1039/c2ta00022a; Vargantwar PH, 2012, ADV FUNCT MATER, V22, P2100, DOI 10.1002/adfm.201101985; Vargantwar PH, 2012, MACROMOL RAPID COMM, V33, P61, DOI 10.1002/marc.201100535; Vargantwar PH, 2012, J MATER CHEM, V22, P25262, DOI 10.1039/c2jm35504c; Zhang LH, 2013, ACS MACRO LETT, V2, P217, DOI 10.1021/mz3006632	60	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1022-1336	1521-3927		MACROMOL RAPID COMM	Macromol. Rapid Commun.	MAR	2015	36	5					432	438		10.1002/marc.201400627		7	Polymer Science	Polymer Science	CC6WI	WOS:000350509300002		
J	Yamamura, H; Watanabe, M; Kawahara, S; Miyagawa, A; Kawai, M				Yamamura, Hatsuo; Watanabe, Mutsumi; Kawahara, Sho; Miyagawa, Atsushi; Kawai, Masao			Polysulfonylated cyclodextrins. Part 14. Structural validation of tris-and pentakis(6-O-mesitylsulfony)cyclomaltooctaose isomers by H-1-NMR spectrometry	MAGNETIC RESONANCE IN CHEMISTRY			English	Article						MR; 1H NMR; TOCSY; COSY; ROESY; cyclodextrin; polysulfonate; regioisomer	BETA-CYCLODEXTRIN; MONO(TRIMETHYLAMMONIO)-BETA-CYCLODEXTRINS; BIS(TRIMETHYLAMMONIO)-BETA-CYCLODEXTRINS; SPECTROSCOPY		[Yamamura, Hatsuo; Watanabe, Mutsumi; Kawahara, Sho; Miyagawa, Atsushi; Kawai, Masao] Nagoya Inst Technol, Dept Life & Mat Engn, Fac Engn, Showa Ku, Nagoya, Aichi 4668555, Japan	Yamamura, H (reprint author), Nagoya Inst Technol, Dept Life & Mat Engn, Fac Engn, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	yamamura.hatsuo@nitech.ac.jp					Yamamura H, 2004, J AM CHEM SOC, V126, P14224, DOI 10.1021/ja045612r; Atwood J. L., 1996, COMPREHENSIVE SUPRAM; FUJITA K, 1988, J ORG CHEM, V53, P1943, DOI 10.1021/jo00244a018; FUJITA K, 1984, TETRAHEDRON LETT, V25, P5533, DOI 10.1016/S0040-4039(01)81618-X; FUJITA K, 1989, CHEM LETT, P821, DOI 10.1246/cl.1989.821; FUJITA K, 1986, J AM CHEM SOC, V108, P4509, DOI 10.1021/ja00275a042; Rekharsky M, 2001, J AM CHEM SOC, V123, P5360, DOI 10.1021/ja003810j; Yamamura H, 2003, B CHEM SOC JPN, V76, P171, DOI 10.1246/bcsj.76.171; YAMAMURA H, 1991, CHEM PHARM BULL, V39, P2505; Yamamura H, 2007, TETRAHEDRON, V63, P2064, DOI 10.1016/j.tet.2006.12.033; Yamamura H, 2001, J PHYS ORG CHEM, V14, P416, DOI 10.1002/poc.381; Yamamura H., 1999, J CHEM SOC PERK T, V1, P3111; YAMAMURA H, 1993, J ORG CHEM, V58, P2936, DOI 10.1021/jo00063a005; YAMAMURA H, 1993, B CHEM SOC JPN, V66, P585, DOI 10.1246/bcsj.66.585	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-1581	1097-458X		MAGN RESON CHEM	Magn. Reson. Chem.	MAR	2015	53	3					237	243		10.1002/mrc.4165		7	Chemistry, Multidisciplinary; Chemistry, Physical; Spectroscopy	Chemistry; Spectroscopy	CC4EV	WOS:000350304600011		
J	Furuichi, M; Otsuka, N				Furuichi, Masahiko; Otsuka, Natsuhiko			Proposing a common platform of shipping cost analysis of the Northern Sea Route and the Suez Canal Route	MARITIME ECONOMICS & LOGISTICS			English	Article						shipping cost analysis; maritime transport; Northern Sea Route (NSR); Suez Canal Route (SCR)		Maritime trade between East Asia and Northwest Europe using the Northern Sea Route (NSR) has been recently increasing, because ship operators may take advantage of the shorter sailing distance of NSR whose navigable season has become longer because of retreating Arctic sea ice. As Arctic sea ice continues to retreat because of global warming, the NSR is now approximately 40 per cent shorter than the Suez Canal Route (SCR) for such trade. In 2013, shipping on the NSR marked a record 10 year-high volume of 1.36 million tons with 71 voyages. Accordingly, comparative analyses of estimated shipping cost via the NSR and the alternative conventional routes, especially the SCR, have been carried out. Furthermore, NSR/SCR-combined shipping, that is, when a vessel transits the NSR during the warmer months and the SCR in the colder months, has already been proposed as a realistic scenario for Arctic shipping in the previous studies. Since assumptions used in the cost estimations vary among the studies, as discussed by Lasserre, there remain some difficulties when comparing estimated shipping costs. This study aims at establishing a common platform of a wide range of cost estimation assumptions, through clarifying and analysing the cost components contained in the current literature. In addition, interviews with NSR shipping professionals were conducted concerning the NSR fee on an unofficial basis, since typically such fees are determined based on negotiations between ice breaker escort service provider and shipping company. An empirical analysis revealed that NSR/SCR-combined shipping of container cargo between East Asia and Northwest Europe can be commercially feasible.	[Furuichi, Masahiko] Kyoto Univ, Grad Sch Management, Dept Architecture Bldg, Sakyo Ku, Kyoto 6068501, Japan; [Otsuka, Natsuhiko] North Japan Port Consultants Ltd NJPC, Chuo Ku, Sapporo, Hokkaido 0600052, Japan	Furuichi, M (reprint author), Kyoto Univ, Grad Sch Management, Dept Architecture Bldg, Sakyo Ku, Room 205,Yoshida Honmachi, Kyoto 6068501, Japan.				International Association of Ports and Harbors (IAPH)	This study is largely based on 'Effects of the Arctic Sea Routes (NSR and NWP) Navigability on Port Industry' (Project period: 2011-2013), funded by International Association of Ports and Harbors (IAPH). Our special thanks first go to IAPH and all the members of the Port Planning and Development Committee (PPDC) of IAPH. Furthermore, the authors present special thanks to Mr Mitsuhiko Okada, the president of Overseas Coastal Development Institute (OCDI) of Japan for his insight comments.	Schoyen H, 2011, J TRANSP GEOGR, V19, P977, DOI 10.1016/j.jtrangeo.2011.03.003; Lasserre F, 2014, TRANSPORT RES A-POL, V66, P144, DOI 10.1016/j.tra.2014.05.005; Verny J, 2009, INT J PROD ECON, V122, P107, DOI 10.1016/j.ijpe.2009.03.018; Liu MJ, 2010, J TRANSP GEOGR, V18, P434, DOI 10.1016/j.jtrangeo.2009.08.004; Arpiainen M., 2006, K63 AK ARCT TECHN; Falck H., 2012, SHIPPING ARCTIC WATE; Furuichi M., 2012, PORT PLANN DEV COMM; Hino M., 2011, PROGR MARITIME SHIPP; IMO, 2009, 2 IMO GHG STUD 2009; Isakov N.A., 1999, 139 INSROP; Japan Ship-owners Association, 2012, SHIPP FACT 2012; Maritime Press Japan, 2012, T NEWL BUILT MERCH F; MOL, 2012, LIST EXP CHARG EUR L; Omre A., 2012, THESIS NORWEGIAN U S; Panama Canal Authority, 2012, PAN CAN FEES; Russian Ministry of Justice, 2014, N45T1 RUSS MIN JUST; Ship & Ocean Foundation, 2000, NO SEA ROUT SHORT SE; Suez Canal Authority, 2012, SUEZ CAN FEES; UNCTAD, 2011, REV MAR TRANSP 2011	19	0	0	PALGRAVE MACMILLAN LTD	BASINGSTOKE	BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND	1479-2931	1479-294X		MARIT ECON LOGIST	Marit. Econ. Logist.	MAR	2015	17	1			SI		9	31		10.1057/mel.2014.29		23	Transportation	Transportation	CC5HU	WOS:000350390500002		
J	Tani, J; Kido, H				Tani, Jun-ichi; Kido, Hiroyasu			First-principles calculations of phonon and thermodynamic properties of OsSi2	MATERIALS SCIENCE IN SEMICONDUCTOR PROCESSING			English	Article						Silicides; Phonons; Thermodynamic properties; First-principles calculation	OSMIUM DISILICIDE	The structure, lattice dynamics, and some thermodynamic properties of orthorhombic OsSi2 were investigated using a first-principles density functional theory (DFT). Linear response theory was used to calculate the phonon dispersion relation and phonon density of states for OsSi2 as well as its infrared and Raman active mode frequencies. In this study, the thermodynamic properties, including vibrational entropy (S-vib), constant-volume specific heat (C-v), and Debye temperature (Theta(D)), were predicted theoretically and discussed. (C) 2014 Elsevier Ltd. All rights reserved.	[Tani, Jun-ichi; Kido, Hiroyasu] Osaka Municipal Tech Res Inst, Elect Mat Res Div, Joto Ku, Osaka 5368553, Japan	Tani, J (reprint author), Osaka Municipal Tech Res Inst, Elect Mat Res Div, Joto Ku, 1-6-50 Morinomiya, Osaka 5368553, Japan.	tani@omtri.or.jp					BOST MC, 1985, J APPL PHYS, V58, P2696, DOI 10.1063/1.335906; LIN JS, 1993, PHYS REV B, V47, P4174, DOI 10.1103/PhysRevB.47.4174; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; LEFKI K, 1991, SOLID STATE COMMUN, V80, P791, DOI 10.1016/0038-1098(91)90509-T; [Anonymous], 2010, MAT STUD CASTEP MAN; Gonze X, 1997, PHYS REV B, V55, P10337, DOI 10.1103/PhysRevB.55.10337; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; Refson K, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.155114; Leong D, 1997, NATURE, V387, P686; Gonze X, 1997, PHYS REV B, V55, P10355, DOI 10.1103/PhysRevB.55.10355; Clark SJ, 2005, Z KRISTALLOGR, V220, P567, DOI 10.1524/zkri.220.5.567.65075; ROUSSEAU DL, 1981, J RAMAN SPECTROSC, V10, P253, DOI 10.1002/jrs.1250100152; SCHELLENBERG L, 1988, J LESS-COMMON MET, V144, P341, DOI 10.1016/0022-5088(88)90148-8; Birkholz U., 1995, HDB THERMOELECTRICS; Borisenko V. E, 2000, SEMICONDUCTING SILIC; Born M., 1954, DYNAMICAL THEORY CRY; ENGSTROM I, 1970, ACTA CHEM SCAND, V24, P2117, DOI 10.3891/acta.chem.scand.24-2117; Filonov AB, 1997, APPL PHYS LETT, V70, P976, DOI 10.1063/1.118453; Maeda Y, 2007, THIN SOLID FILMS, V515, P8118, DOI 10.1016/j.tsf.2007.02.023; MASON K, 1983, J CRYST GROWTH, V63, P34, DOI 10.1016/0022-0248(83)90424-4; Migas DB, 2001, PHYS REV B, V64; Minisini B, 2008, COMP MATER SCI, V43, P812, DOI 10.1016/j.commatsci.2008.01.058; Tani J, 2010, PHYSICA B, V405, P2200, DOI 10.1016/j.physb.2010.02.008; Tani J, 2011, COMP MATER SCI, V50, P2009, DOI 10.1016/j.commatsci.2011.01.053	24	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1369-8001	1873-4081		MAT SCI SEMICON PROC	Mater. Sci. Semicond. Process	MAR	2015	31						251	255		10.1016/j.mssp.2014.11.049		5	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Engineering; Materials Science; Physics	CC6XY	WOS:000350513500036		
J	Rose, A; Raghavan, N; Thangavel, S; Maheswari, BU; Nair, DP; Venugopal, G				Rose, Aleena; Raghavan, Nivea; Thangavel, Sakthivel; Maheswari, B. Uma; Nair, Devika P.; Venugopal, Gunasekaran			Investigation of cyclic voltammetry of graphene oxide/polyaniline/polyvinylidene fluoride nanofibers prepared via electrospinning	MATERIALS SCIENCE IN SEMICONDUCTOR PROCESSING			English	Article						Nanofibers; Graphene-oxide; Polyaniline; Electrospinning; Supercapacitor	SUPERCAPACITOR ELECTRODES; CARBON NANOFIBERS; OXIDE; NANOSTRUCTURES; MEMBRANE	Nanofibers of graphene-oxide/polyaniline/polyvinylidene fluoride (GO/PANI/PVDF) and pure PANI have been produced by electrospinning process. The morphology of obtained nanofibers was characterized by scanning electron microscope. GO/PANI/PVDF nanofibers exhibited better fiber morphology than PANI/PVDF and pure PANI. Electrochemical study of nanofibers was done by using cyclic voltammetry. From the charge-discharge analysis, the specific capacitance of 170.63 F/g was obtained for GO/PANI/PVDF nanofibers, which evidently shows a new pathway for the development of these nanofibers for futuristic supercapacitor applications. (C) 2014 Elsevier Ltd. All rights reserved.	[Rose, Aleena; Raghavan, Nivea; Thangavel, Sakthivel; Maheswari, B. Uma; Nair, Devika P.; Venugopal, Gunasekaran] Karunya Univ, Dept Nanosci & Technol, Nanomat Res Lab NmRL, Coimbatore 641114, Tamil Nadu, India; [Venugopal, Gunasekaran] Tohoku Univ, Elect Commun Res Inst, Solid State Elect Lab, Aoba Ku, Sendai, Miyagi 9808577, Japan	Venugopal, G (reprint author), Karunya Univ, Dept Nanosci & Technol, Nanomat Res Lab NmRL, Coimbatore 641114, Tamil Nadu, India.	gunasekaran@karunya.edu			DST Nanomission, New Delhi, India	The authors thank DST Nanomission, New Delhi, India for providing financial support to carry out the research work and Center for Research in Nanotechnology (CRN) at Karunya University, Coimbatore, for their assistance in doing sample characterization. The author (AR) also wish to thank Mrs. B. Uma Maheswari, Ph.D Scholar in the Dept. of Nanoscience and Technology for her help in doing electrospinning experiment in the beginning of this project work.	Tantis I, 2012, EXPRESS POLYM LETT, V6, P283, DOI 10.3144/expresspolymlett.2012.31; Fan P, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/36/365702; Zhang F, 2013, ELECTROCHIM ACTA, V114, P125, DOI 10.1016/j.electacta.2013.09.153; Wang HL, 2009, ELECTROCHEM COMMUN, V11, P1158, DOI 10.1016/j.elecom.2009.03.036; Martin CR, 1996, CHEM MATER, V8, P1739, DOI 10.1021/cm960166s; Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7; Chowdhury P, 2005, INDIAN J CHEM TECHN, V12, P671; Zhao L, 2013, NANOSCALE, V5, P4902, DOI 10.1039/c3nr33927k; Li ZJ, 2012, APPL SURF SCI, V258, P3726, DOI 10.1016/j.apsusc.2011.12.015; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Gomez H, 2011, J POWER SOURCES, V196, P4102, DOI 10.1016/j.jpowsour.2010.11.002; Krishnamoorthy K, 2014, MATER RES BULL, V50, P499, DOI 10.1016/j.materresbull.2013.11.019; Jiang H, 2013, ENERG ENVIRON SCI, V6, P41, DOI 10.1039/c2ee23284g; Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481; Zhou ZP, 2013, J POWER SOURCES, V222, P410, DOI 10.1016/j.jpowsour.2012.09.004; Wang C, 2013, J APPL POLYM SCI, V127, P3026, DOI 10.1002/app.37656; Krishnamoorthy K, 2014, CHEM ENG J, V251, P116, DOI 10.1016/j.cej.2014.04.006; Krishnamoorthy K, 2014, SCI ADV MATER, V6, P349, DOI 10.1166/sam.2014.1722; Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037; Xu B, 2011, ENERG ENVIRON SCI, V4, P2826, DOI 10.1039/c1ee01198g; Kim CH, 2012, CARBON, V50, P2472, DOI 10.1016/j.carbon.2012.01.069; Venugopal G, 2012, MATER CHEM PHYS, V132, P29, DOI 10.1016/j.matchemphys.2011.10.040; Ondarcuhu T, 1998, EUROPHYS LETT, V42, P215, DOI 10.1209/epl/i1998-00233-9; Bao QL, 2010, ADV FUNCT MATER, V20, P782, DOI 10.1002/adfm.200901658; Deng LJ, 2013, ELECTROCHIM ACTA, V112, P448, DOI 10.1016/j.electacta.2013.08.158; Huang Y., 2011, NANOTECHNOLOGY, V22; Seredych E.M., 2012, J MATER CHEM, V22, P23525	27	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1369-8001	1873-4081		MAT SCI SEMICON PROC	Mater. Sci. Semicond. Process	MAR	2015	31						281	286		10.1016/j.mssp.2014.10.051		6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Engineering; Materials Science; Physics	CC6XY	WOS:000350513500040		
J	Sun, DF; Wang, TY; Xu, YH; Li, RX; Sato, T				Sun, Dongfeng; Wang, Tingyu; Xu, Yaohui; Li, Ruixing; Sato, Tsugio			Hierarchical bismuth oxychlorides constructed by porous nanosheets: Preparation, growth mechanism, and application in photocatalysis	MATERIALS SCIENCE IN SEMICONDUCTOR PROCESSING			English	Article						Bismuth oxychloride; Citric acid; Hierarchical; Solvothermal; Nanosheets	REACTABLE IONIC LIQUIDS; VISIBLE-LIGHT; CITRIC-ACID; 001 FACETS; SOLVOTHERMAL SYNTHESIS; HYDROTHERMAL SYNTHESIS; SOLID-SOLUTIONS; BAND-GAP; BIOCL; NANOSTRUCTURES	Hierarchical structures bismuth oxychlorides (BiOCl) were synthesized via a solvothermal process assisted with citric acid using methanol as a solvent. The as-synthesized hierarchical structures were constructed by porous nanosheets. The crystal growth and morphology structures of BiOCl were significantly influenced by the amount of citric acid, the solvothermal time and the solvent used in reaction. Based on the electron microscope observations, the growth of such hierarchitectures has been proposed as an Ostwald ripening process followed by self-assembly. Pore-size distribution analysis revealed that both mesopores and macropores existed in the product. UV-vis spectroscopy was employed to estimate the band gap energies and light utilization efficiency of the BiOCl hierarchical structures. Moreover, the adsorption capability and photocatalytic activities of BiOCl hierarchical structures were evaluated on the degradation of rhodamine B and methyl orange under either UV light or simulated sunlight illumination, respectively. The results assumed that BiOCl hierarchical structures sample showed much higher photocatalytic activity than the conventionally prepared sample and commercial TiO2 (Degussa, P25). (C) 2014 Elsevier Ltd. All rights reserved.	[Sun, Dongfeng; Wang, Tingyu; Xu, Yaohui; Li, Ruixing] Beihang Univ, Sch Mat Sci & Engn, Key Lab Aerosp Mat & Performance, Minist Educ, Beijing 100191, Peoples R China; [Sato, Tsugio] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Li, RX (reprint author), Beihang Univ, Sch Mat Sci & Engn, Key Lab Aerosp Mat & Performance, Minist Educ, Beijing 100191, Peoples R China.	ruixingli@yahoo.com			National Natural Science Foundation of China [NSFC513-72006]; High-End Returned Overseas Talents, Ministry of Human Resources and Social Security, China [411]; Innovation Foundation of BUAA for Ph.D. Graduates [YWF-14-YJSY-005]	The authors appreciate the financial support from the National Natural Science Foundation of China (NSFC513-72006) and the Start-Up Fund for High-End Returned Overseas Talents, Ministry of Human Resources and Social Security, China (Renshetinghan 2010, No. 411) and the Innovation Foundation of BUAA for Ph.D. Graduates (YWF-14-YJSY-005).	Zhang J, 2013, COLLOID SURFACE A, V420, P89, DOI 10.1016/j.colsurfa.2012.11.054; Cao BC, 2013, J AM CERAM SOC, V96, P544, DOI 10.1111/jace.12073; Liu HP, 2014, INFORM SCIENCES, V266, P75, DOI 10.1016/j.ins.2014.01.010; Jiang J, 2012, J AM CHEM SOC, V134, P4473, DOI 10.1021/ja210484t; Deng H, 2005, CHEM-EUR J, V11, P6519, DOI 10.1002/chem.200500540; Chen XM, 2007, ACCOUNTS CHEM RES, V40, P162, DOI 10.1021/ar068084p; Lu ZG, 2011, CHEM MATER, V23, P2848, DOI 10.1021/cm200205n; Qin XY, 2013, MATER LETT, V100, P285, DOI 10.1016/j.matlet.2013.03.045; Liu YY, 2011, CHEM-EUR J, V17, P9342, DOI 10.1002/chem.201100952; Xu Y, 2014, DALTON T, V43, P479, DOI 10.1039/c3dt52004h; Liu L, 2008, ENVIRON SCI TECHNOL, V42, P2342, DOI 10.1021/es070980o; Yu JG, 2010, J PHYS CHEM C, V114, P13642, DOI 10.1021/jp101816c; Xia JX, 2013, J PHYS CHEM SOLIDS, V74, P298, DOI 10.1016/j.jpcs.2012.10.002; Weng SX, 2013, J MATER CHEM A, V1, P3068, DOI 10.1039/c2ta01004f; Peng SJ, 2013, CHEM-ASIAN J, V8, P258, DOI 10.1002/asia.201200856; Huo YN, 2012, APPL CATAL B-ENVIRON, V111, P334, DOI 10.1016/j.apcatb.2011.10.016; Sun DF, 2014, CATAL COMMUN, V51, P1, DOI 10.1016/j.catcom.2014.03.004; Barreca D, 2001, PHYS CHEM CHEM PHYS, V3, P1743, DOI 10.1039/b009482j; Chen JJ, 2014, MATER RES BULL, V49, P560, DOI 10.1016/j.materresbull.2013.09.040; Kilin DS, 2008, CHEM PHYS LETT, V458, P113, DOI 10.1016/j.cplett.2008.04.046; Chen L, 2012, CATAL COMMUN, V23, P54, DOI 10.1016/j.catcom.2012.03.001; Tratnyek PG, 2006, NANO TODAY, V1, P44, DOI 10.1016/S1748-0132(06)70048-2; Zhang J, 2002, CHEM MATER, V14, P4172, DOI 10.1021/cm020077h; Guan ML, 2013, J AM CHEM SOC, V135, P10411, DOI 10.1021/ja402956f; Xiong JY, 2013, CHEM ENG J, V220, P228, DOI 10.1016/j.cej.2013.01.033; Zhang J, 2012, MATER LETT, V79, P259, DOI 10.1016/j.matlet.2012.04.045; Zhao W, 2004, J AM CHEM SOC, V126, P4782, DOI 10.1021/ja0396753; Xiong JY, 2011, RSC ADV, V1, P1542, DOI 10.1039/c1ra00335f; Cheng HF, 2014, NANOSCALE, V6, P2009, DOI 10.1039/c3nr05529a; Zhang K, 2012, CRYST GROWTH DES, V12, P793, DOI 10.1021/cg201112j; Wang DH, 2012, NANOSCALE, V4, P7780, DOI 10.1039/c2nr32533k; Ye P, 2013, MATER LETT, V108, P168, DOI 10.1016/j.matlet.2013.06.059; Cui ZK, 2013, J ALLOY COMPD, V549, P70, DOI 10.1016/j.jallcom.2012.09.075; Luo WB, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2771089; Feng Y.L, 2008, CRYST GROWTH DES, V8, P1427; Ren KX, 2013, DALTON T, V42, P9706, DOI 10.1039/c3dt50498k; Wu JJ, 2009, EUR J INORG CHEM, P2789, DOI 10.1002/ejic.200900199; Zhang PL, 2009, J MOL CATAL A-CHEM, V309, P50, DOI 10.1016/j.molcata.2009.04.014; Zhang XY, 2014, J MATER CHEM A, V2, P2275, DOI 10.1039/c3ta14587e; Zhu L.P., 2012, CRYSTENGCOMM, V12, P3791	40	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1369-8001	1873-4081		MAT SCI SEMICON PROC	Mater. Sci. Semicond. Process	MAR	2015	31						666	677		10.1016/j.mssp.2014.12.046		12	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Engineering; Materials Science; Physics	CC6XY	WOS:000350513500091		
J	Kuwae, K; Shiozawa, Y				Kuwae, Kazuhiro; Shiozawa, Yuichi			A remark on the uniqueness of Silverstein extensions of symmetric Dirichlet forms	MATHEMATISCHE NACHRICHTEN			English	Article						Dirichlet form; Silverstein extension; symmetric Markov process; intrinsic metric	STOCHASTIC COMPLETENESS; MARKOV-PROCESSES; WEIGHTED GRAPHS; VOLUME GROWTH; SPACES	We prove the uniqueness of the Silverstein extension of symmetric Dirichlet forms under some condition on intrinsic metrics. As its application, we present some non-local Dirichlet forms which possess the uniqueness of the Silverstein extension and generate non-conservative Hunt processes. (C) 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Kuwae, Kazuhiro] Kumamoto Univ, Grad Sch Sci & Technol, Dept Math & Engn, Kumamoto 8608555, Japan; [Shiozawa, Yuichi] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Environm & Math Sci, Okayama 7008530, Japan	Shiozawa, Y (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, Dept Environm & Math Sci, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	kuwae@gpo.kumamoto-u.ac.jp; shiozawa@ems.okayama-u.ac.jp			Japan Society for the Promotion of Science [22340036, 23740078]	The authors would like to thank the referee for valuable comments. The first author was partially supported by a Grant-in-Aid for Scientific Research (B) No. 22340036 from the Japan Society for the Promotion of Science. The second author was partially supported by the Grant-in-Aid for Young Scientists (B) No. 23740078 from the Japan Society for the Promotion of Science.	Kuwae K, 2010, ANN PROBAB, V38, P1532, DOI 10.1214/09-AOP516; Haeseler S, 2012, J SPECTR THEOR, V2, P397, DOI 10.4171/JST/35; Keller M, 2012, J REINE ANGEW MATH, V666, P189, DOI 10.1515/CRELLE.2011.122; Wojciechowski RK, 2011, PROG PROBAB, V64, P163; Huang XP, 2013, J FUNCT ANAL, V265, P1556, DOI 10.1016/j.jfa.2013.06.004; BENVENIS.A, 1973, INVENT MATH, V21, P183, DOI 10.1007/BF01390195; BIROLI M, 1991, CR ACAD SCI I-MATH, V313, P593; CHEN ZQ, 1992, PROBAB THEORY REL, V94, P135, DOI 10.1007/BF01192442; Chen ZQ, 2003, J FUNCT ANAL, V201, P262, DOI 10.1016/S0022-1236(03)00087-9; Chen Z.-Q., 2012, SYMMETRIC MARKOV PRO; Eberle A., 1999, LECT NOTES MATH, V1718; Fitzsimmons PJ, 2001, POTENTIAL ANAL, V15, P151, DOI 10.1023/A:1011249920221; Folz M, 2014, T AM MATH SOC, V366, P2089; Frank RL, 2014, J FUNCT ANAL, V266, P4765, DOI 10.1016/j.jfa.2014.02.008; Fukushima M., 2011, DIRICHLET FORMS SYMM; Grigor'yan A, 2012, MATH Z, V271, P1211, DOI 10.1007/s00209-011-0911-x; Huang XP, 2014, POTENTIAL ANAL, V40, P117, DOI 10.1007/s11118-013-9342-0; Huang X., 2011, THESIS U BIELEFELD B; Huang XP, 2014, J THEOR PROBAB, V27, P634, DOI 10.1007/s10959-012-0456-x; Kawabata T, 1996, OSAKA J MATH, V33, P881; Kuwae K., 2011, NAGOYA MATH IN PRESS; Kuwae K, 2002, POTENTIAL ANAL, V16, P221, DOI 10.1023/A:1014081124510; Ma Z. M., 1992, INTRO THEORY NONSYMM; Masamune J, 2011, MATH NACHR, V284, P2249, DOI 10.1002/mana.200910211; Schilling RL, 2012, PUBL RES I MATH SCI, V48, P1, DOI 10.2977/PRIMS/58; Shiozawa Y., FORUM MATH IN PRESS; Shiozawa Y, 2014, J THEOR PROBAB, V27, P404, DOI 10.1007/s10959-012-0424-5; Silverstein M. L., 1974, LECT NOTES MATH, V426; SILVERST.ML, 1974, ILLINOIS J MATH, V18, P310; STURM KT, 1994, J REINE ANGEW MATH, V456, P173; Sturm K.-Th., 1995, PROGR PROBAB, V36, P231	31	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0025-584X	1522-2616		MATH NACHR	Math. Nachr.	MAR	2015	288	4					389	401		10.1002/mana.201300322		13	Mathematics	Mathematics	CC7LR	WOS:000350549600002		
J	van Leeuwen, TH; Manalo, E; van der Meij, J				van Leeuwen, Theo H.; Manalo, Emmanuel; van der Meij, Jan			Electroencephalogram Recordings Indicate That More Abstract Diagrams Need More Mental Resources to Process	MIND BRAIN AND EDUCATION			English	Article							STUDENTS USE; SCIENCE; REPRESENTATIONS; COMPONENTS; ATTENTION; AMPLITUDE; IMAGERY; WORDS; BRAIN; P300	There is considerable interest in the cultivation of student graphic literacy among educators and researchers, especially in the sciences. Previous research, however, has shown that many students manifest difficulties in using diagrammatic representations. One explanation that has been proposed to account for these difficulties is that certain forms of diagrams may be more demanding of mental effort to use. Although there had been behavioral evidence to support this explanation, neurophysiological evidence had not confirmed it. Here, we provide evidence, from electroencephalogram recordings of brain activity focusing on the P3b component, that more abstract diagrams (such as graphs) demand greater mental resources to process compared to pictures and texteven when amount of detail has been accounted for. Our results provide initial neurophysiological evidence for the impact of cognitive cost on student learning behaviors and outcomes. Consideration of this finding is important in pedagogical design and, more broadly, in media communication.	[van Leeuwen, Theo H.; van der Meij, Jan] Univ Twente, Fac Behav Sci, NL-7500 AE Enschede, Netherlands; [Manalo, Emmanuel] Kyoto Univ, Grad Sch Educ, Kyoto, Japan	van Leeuwen, TH (reprint author), Univ Twente, Fac Behav Sci, POB 217, NL-7500 AE Enschede, Netherlands.	theovleeuwen@gmail.com					Ainsworth S, 2003, COGNITIVE SCI, V27, P669, DOI 10.1016/S0364-0213(03)00033-8; Cheng PCH, 2004, LECT NOTES ARTIF INT, V2980, P242; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Scharrer L, 2012, LEARN INSTR, V22, P231, DOI 10.1016/j.learninstruc.2011.11.004; ANDERSON JR, 1978, PSYCHOL REV, V85, P249, DOI 10.1037/0033-295X.85.4.249; Hegarty M, 1999, J EDUC PSYCHOL, V91, P684, DOI 10.1037//0022-0663.91.4.684; Brandeis D, 1998, BEHAV BRAIN RES, V94, P111, DOI 10.1016/S0166-4328(97)00174-5; Ainsworth S, 2011, SCIENCE, V333, P1096, DOI 10.1126/science.1204153; Bowen GM, 1999, J RES SCI TEACH, V36, P1020, DOI 10.1002/(SICI)1098-2736(199911)36:9<1020::AID-TEA4>3.0.CO;2-#; Fink GR, 1997, BRAIN, V120, P1779, DOI 10.1093/brain/120.10.1779; Cromley JG, 2010, CONTEMP EDUC PSYCHOL, V35, P59, DOI 10.1016/j.cedpsych.2009.10.002; Kawashima R, 2005, J GERONTOL A-BIOL, V60, P380; Mayer RE, 2003, LEARN INSTR, V13, P125, DOI 10.1016/S0959-4752(02)00016-6; PYLYSHYN ZW, 1973, PSYCHOL BULL, V80, P1, DOI 10.1037/h0034650; Cox R, 1999, LEARN INSTR, V9, P343, DOI 10.1016/S0959-4752(98)00051-6; NAVON D, 1979, PSYCHOL REV, V86, P214, DOI 10.1037/0033-295X.86.3.214; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Chen AT, 2007, BIOL PSYCHOL, V76, P230, DOI 10.1016/j.biopsycho.2007.08.007; Cox R., 2003, EUR COGN SCI C EUROC; desJong R., 1988, J EXPT PSYCHOL HUMAN, V14, P682; Dufour-Janvier B., 1987, PROBLEMS REPRESENTAT, P110; HEMBREE R, 1992, J RES MATH EDUC, V23, P242, DOI 10.2307/749120; Kramer A., 1991, HDB COGNITIVE PSYCHO, P179; LARKIN JH, 1987, COGNITIVE SCI, V11, P65, DOI 10.1016/S0364-0213(87)80026-5; Manalo E, 2014, LECT NOTES COMPUT SC, V8578, P78, DOI 10.1007/978-3-662-44043-8_13; Manalo E, 2011, SCIENCE, V334, P761, DOI 10.1126/science.334.6057.761-a; Manalo E., 2012, LNCS LNAI, V7352, P35; Manalo E, 2013, EDUC STUD-UK, V39, P118, DOI 10.1080/03055698.2012.680577; Mandl H., 1989, KNOWLEDGE ACQUISITIO; Martinez A, 1997, NEUROREPORT, V8, P1685, DOI 10.1097/00001756-199705060-00025; Mayer R.E., 2001, MULTIMEDIA LEARNING; Pedone R, 2001, MEM COGNITION, V29, P214, DOI 10.3758/BF03194915; Schnotz W., 1994, COMPREHENSION GRAPHI; Tversky B, 2011, TOP COGN SCI, V3, P499, DOI 10.1111/j.1756-8765.2010.01113.x; Uesaka Y, 2012, APPL COGNITIVE PSYCH, V26, P251, DOI 10.1002/acp.1816; Uesaka Y, 2007, LEARN INSTR, V17, P322, DOI 10.1016/j.leaminstrue.2007.02.006; Uesaka Y, 2010, LECT NOTES ARTIF INT, V6170, P197, DOI 10.1007/978-3-642-14600-8_19; vansLeeuwen T. H., 1998, BEHAV BRAIN RES, V94, P97; Zhang J., 1977, COGNITIVE SCI, V21, P179	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1751-2271	1751-228X		MIND BRAIN EDUC	Mind Brain Educ.	MAR	2015	9	1					19	28		10.1111/mbe.12064		10	Education & Educational Research; Psychology, Developmental	Education & Educational Research; Psychology	CC3YN	WOS:000350287400005		
J	Avila, LA; Aps, LRMM; Sukthankar, P; Poscariu, N; Gudlur, S; Simo, L; Szoszkiewicz, R; Park, Y; Lee, SY; Iwamoto, T; Ferreira, LCS; Tomich, JM				Avila, L. Adriana; Aps, Luana R. M. M.; Sukthankar, Pinakin; Poscariu, Nicoleta; Gudlur, Sushanth; Simo, Ladislav; Szoszkiewicz, Robert; Park, Yoonseong; Lee, Stella Y.; Iwamoto, Takeo; Ferreira, Luis C. S.; Tomich, John M.			Branched Amphiphilic Cationic Oligopeptides Form Peptiplexes with DNA: A Study of Their Biophysical Properties and Transfection Efficiency	MOLECULAR PHARMACEUTICS			English	Article						cationic branched peptides; BAPCs; nanofibers; condensed DNA; peptiplex; plasmid DNA; nonviral; gene deliver; nontoxic	CELL-PENETRATING PEPTIDES; NUCLEIC-ACID DELIVERY; GENE DELIVERY; PLASMID DNA; COMPLEXES; THERAPY; PROTEIN; CYTOTOXICITY; CONDENSATION; CHALLENGES	Over the past decade, peptides have emerged as a new family of potential carriers in gene therapy. Peptides are easy to synthesize and quite stable. Additionally, sequences shared by the host proteome are not expected to be immunogenic or trigger inflammatory responses, which are commonly observed with viral approaches. We recently reported on a new class of branched amphiphilic peptide capsules (BAPCs) that self-assemble into extremely stable nanospheres. These capsules are capable of retaining and delivering alpha-emitting radionuclides to cells. Here we report that, in the presence of double stranded plasmid DNA, BAPCs are unable to form. Instead, depending of the peptide/DNA ratios, the peptides either coat the plasmid surface forming nanofibers (high peptide to DNA ratio) or condense the plasmid into nanometer-sized compacted structures (at low peptide to DNA ratios). Different gene delivery efficiencies are observed for the two types of assemblies. The compacted nanometer-sized structures display much higher transfection efficiencies in HeLa cells. This level of transfection is greater than that observed for a lipid-based reagent when the total number of viable transfected cells is taken into account.	[Avila, L. Adriana; Sukthankar, Pinakin; Gudlur, Sushanth; Tomich, John M.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Aps, Luana R. M. M.; Ferreira, Luis C. S.] Univ Sao Paulo, Inst Biomed Sci, BR-05508900 Sao Paulo, SP, Brazil; [Poscariu, Nicoleta; Szoszkiewicz, Robert] Kansas State Univ, Dept Phys, Manhattan, KS 66506 USA; [Simo, Ladislav; Park, Yoonseong] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Lee, Stella Y.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Iwamoto, Takeo] Jikei Univ, Sch Med, Core Res Facil, Div Biochem, Tokyo 1058461, Japan	Tomich, JM (reprint author), Kansas State Univ, Dept Biochem, 141 Chalmers Hall, Manhattan, KS 66506 USA.	jtomich@ksu.edu	Szoszkiewicz, Robert/I-3910-2013; 	Szoszkiewicz, Robert/0000-0002-2770-8848; Sukthankar, Pinakin/0000-0002-9043-5846	PHS-NIH Grant [R01 GM074096]; Terry Johnson Cancer Center at Kansas State University; JSPS KAKENHI [23590649]	We acknowledge Dr. Maria Teresa Lamy and Dr. Julio H. K. Rozenfeld from the Institute of Physics, University of Sao Paulo, Brazil, for assisting in the zeta potential measurements. We thank Dr. Prem Thapa, from the Microscopy & Analytical Imaging Lab of University of Kansas, for help with the TEM images. Also, we thank Dr. Catherine Ewen from the flow cytometry lab of Kansas State University for her advice in analyzing flow cytometer data. This is publication 14-165-J from the Kansas Agricultural Experiment Station. Partial support for this project was provided by PHS-NIH Grant GM # R01 GM074096 (to J.M.T) and the Terry Johnson Cancer Center at Kansas State University for summer support (for P.S. and S.G.). and JSPS KAKENHI Grant # 23590649 (to T.I.).	Branco MC, 2009, ACTA BIOMATER, V5, P817, DOI 10.1016/j.actbio.2008.09.018; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007; Ignatovich IA, 2003, J BIOL CHEM, V278, P42625, DOI 10.1074/jbc.M301431200; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/nmeth.2649, 10.1038/NMETH.2649]; Wasungu L, 2006, J CONTROL RELEASE, V116, P255, DOI 10.1016/j.jconrel.2006.06.024; Miele E, 2012, INT J NANOMED, V7, P3637, DOI 10.2147/IJN.S23696; Ray A, 2000, FASEB J, V14, P1041; Xue LY, 2010, AUTOPHAGY, V6, P248; WU GY, 1988, J BIOL CHEM, V263, P14621; Fant K, 2010, MOL PHARMACEUT, V7, P1734, DOI 10.1021/mp1001312; Honary S, 2013, TROP J PHARM RES, V12, P265, DOI 10.4314/tjpr.v12i2.20; Zhi DF, 2010, BIOCONJUGATE CHEM, V21, P563, DOI 10.1021/bc900393r; Li C, 2012, BIOCONJUGATE CHEM, V23, P1832, DOI 10.1021/bc300162g; Koynova R, 2009, SOFT MATTER, V5, P3187, DOI 10.1039/b902027f; Zhdanov RI, 2002, BIOELECTROCHEMISTRY, V58, P53, DOI 10.1016/S1567-5394(02)00132-9; Elsabahy M, 2011, CURR DRUG DELIV, V8, P235; Baoum A, 2012, INT J PHARMACEUT, V427, P134, DOI 10.1016/j.ijpharm.2011.08.012; Sarker SR, 2013, INT J NANOMED, V8, P1361, DOI 10.2147/IJN.S38903; Newland B, 2012, J AM CHEM SOC, V134, P4782, DOI 10.1021/ja2105575; Amand HL, 2012, BIOCHEM BIOPH RES CO, V418, P469, DOI 10.1016/j.bbrc.2012.01.041; BOTTEGA R, 1992, BIOCHEMISTRY-US, V31, P9025, DOI 10.1021/bi00152a045; Safinya CR, 2001, CURR OPIN STRUC BIOL, V11, P440, DOI 10.1016/S0959-440X(00)00230-X; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Jafari M, 2012, CURR MED CHEM, V19, P197; Hong SP, 2004, BIOCONJUGATE CHEM, V15, P774, DOI 10.1021/bc049962b; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Zhou T, 2013, NANOSCALE, V5, P8288, DOI 10.1039/c3nr01630g; Avila L. A., 2014, J NANOPHARMACEUTICS, V2, P1; Feigner P. L., 1987, P NATL ACAD SCI USA, V84, P7413; GROVE A, 1991, P NATL ACAD SCI USA, V88, P6418, DOI 10.1073/pnas.88.15.6418; GRUEN LC, 1970, ANAL CHIM ACTA, V50, P299, DOI 10.1016/0003-2670(70)80069-1; Gudlur S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045374; Kingston R. E., 2003, CURR PROTOC MOL BIOL, DOI [DOI 10.1002/0471142727.MB0901S63, 10.1002/0471142727.mb0901s63]; Mann A, 2011, MOL PHARMACEUT, V8, P1729, DOI 10.1021/mp2000814; Moore S., 1981, ENZYMES A, V14, P281, DOI 10.1016/S1874-6047(08)60341-8; Nicolau C, 1998, MEDICAL APPLICATIONS OF LIPOSOMES, P347, DOI 10.1016/B978-044482917-7/50020-X; Per Thoren E. G., 2000, FEBS LETT, V482, P265; Pires P, 1999, BBA-BIOMEMBRANES, V1418, P71, DOI 10.1016/S0005-2736(99)00023-1; Prochiantz A, 2011, METHODS MOL BIOL, V683, P249, DOI 10.1007/978-1-60761-919-2_18; Rosenzweig HS, 2000, BIOCONJUGATE CHEM, V11, P306, DOI 10.1021/bc9901144; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; Simoes S, 1999, GENE THER, V6, P1798, DOI 10.1038/sj.gt.3301015; Sukthankar P, 2013, LANGMUIR, V29, P14648, DOI 10.1021/la403492n; Sukthankar P, 2014, BBA-BIOMEMBRANES, V1838, P2296, DOI 10.1016/j.bbamem.2014.02.005; Yamano S, 2011, J CONTROL RELEASE, V152, P278, DOI 10.1016/j.jconrel.2011.02.004	47	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	MAR	2015	12	3					706	715		10.1021/mp500524s		10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CC5HY	WOS:000350390900005		
J	Deo, VK; Kato, T; Park, EY				Deo, Vipin K.; Kato, Tatsuya; Park, Enoch Y.			Chimeric Virus-Like Particles Made Using GAG and M1 Capsid Proteins Providing Dual Drug Delivery and Vaccination Platform	MOLECULAR PHARMACEUTICS			English	Article						virus-like particles; drug delivery system; vaccination; chimeric; silkworm expression system	UNIVERSAL INFLUENZA VACCINES; LIPOSOMAL DOXORUBICIN; SILKWORM LARVAE; CANCER-THERAPY; IN-VITRO; TUMOR; NANOCARRIERS; EXPRESSION; PACLITAXEL; DISPLAY	Nanobiomaterials such as enveloped virus-like particles with specificity can serve a dual function of vaccination and drug delivery system. Here, we expressed colon carcinoma cell-targeting chimeric virus-like particles (VLPs) made using two capsid proteins, gag and M1 from influenza virus A/swine flu/Iowa/15/30/H1N1 in silkworms. These chimeric VLPs displayed a glycosylphosphatidylinositol-anchored single-chain variable fragment region targeting colon carcinoma cells, and their shape was smooth, with an average particle size of 21 nm in diameter. Large unilamellar vesicles made from DOPC:DOPA (2:1) containing calcein-AM (10 mu M) or doxorubicin (13.7 nM) were used to package chimeric VLPs. VLPs showed high specificity in targeting cancer cells and delivered the dye and drug to cells successfully. Chimeric VLPs were injected into BALB/c mice, and the serum showed specificity for M1 protein as a model.	[Deo, Vipin K.; Park, Enoch Y.] Shizuoka Univ, Grad Sch Sci & Technol, Integrated Biosci Sect, Lab Biotechnol,Suruga Ku, Shizuoka 4228529, Japan; [Kato, Tatsuya; Park, Enoch Y.] Shizuoka Univ, Res Inst Green Sci & Technol, Biotechnol Lab, Suruga Ku, Shizuoka 4228529, Japan	Park, EY (reprint author), Shizuoka Univ, Grad Sch Sci & Technol, Integrated Biosci Sect, Lab Biotechnol,Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	park.enoch@shizuoka.ac.jp	Kato, Tatsuya/E-3095-2010; 	Park, Enoch Y./0000-0002-7840-1424	Ministry of Education, Culture, Sports, Science and Technology, Japan	We thank Prof. Hiroshi Ueda and Prof. Masahito Yamazaki of Tokyo University and Research Institute of Electronics of Shizuoka University for providing the scFv plasmid and calcein-AM. We are grateful to Mr. Takeshi Yamamoto for providing technical assistance in ELISA experiments. This work was supported in part by Promotion of Nanobio-Technology Research to support Aging and Welfare Society from the Ministry of Education, Culture, Sports, Science and Technology, Japan. No additional external funding was received for this study.	WILLS JW, 1994, J VIROL, V68, P6605; Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Deo VK, 2013, J BIOTECHNOL, V165, P69, DOI 10.1016/j.jbiotec.2013.02.013; Yu F, 2001, J VIROL, V75, P2753, DOI 10.1128/JVI.75.6.2753-2764.2001; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Nishikawa M, 2005, BIOL PHARM BULL, V28, P195, DOI 10.1248/bpb.28.195; Fischlechner M, 2006, ANGEW CHEM INT EDIT, V45, P784, DOI 10.1002/anie.200502620; Jiang XY, 2013, BIOMATERIALS, V34, P2969, DOI 10.1016/j.biomaterials.2012.12.049; Quan FS, 2012, VIROLOGY, V430, P127, DOI 10.1016/j.virol.2012.05.006; Deo VK, 2014, PHARM RES-DORDR, V31, P2166, DOI 10.1007/s11095-014-1316-4; Tsuji Y, 2011, J BIOTECHNOL, V155, P185, DOI 10.1016/j.jbiotec.2011.07.008; Laginha KM, 2005, CLIN CANCER RES, V11, P6944, DOI 10.1158/1078-0432.CCR-05-0343; Kang SM, 2012, EXPERT REV VACCINES, V11, P995, DOI 10.1586/ERV.12.70; Peer D, 2004, NEOPLASIA, V6, P343, DOI 10.1593/neo.03460; Russell SD, 2010, J CLIN ONCOL, V28, P3416, DOI 10.1200/JCO.2009.23.6950; Zheng M, 2014, INFECTION, V42, P251, DOI 10.1007/s15010-013-0546-4; Agudelo D, 2014, INT J BIOL MACROMOL, V66, P144, DOI 10.1016/j.ijbiomac.2014.02.028; Deo VK, 2011, J VIROL METHODS, V177, P147, DOI 10.1016/j.jviromet.2011.07.012; Wang D, 2010, J VIROL, V84, P4673, DOI 10.1128/JVI.02306-09; Raja KS, 2003, BIOMACROMOLECULES, V4, P472, DOI 10.1021/bm025740+; Latham T, 2001, J VIROL, V75, P6154, DOI 10.1128/JVI.75.13.6154-6165.2001; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Main C, 2006, HEALTH TECHNOL ASSES, V10, P1; Brown SD, 2009, BIOCHEMISTRY-US, V48, P11155, DOI 10.1021/bi901306p; Grgacic EVL, 2006, METHODS, V40, P60, DOI 10.1016/j.ymeth.2006.07.018; Cho K, 2013, FREE RADICAL BIO MED, V60, P201, DOI 10.1016/j.freeradbiomed.2013.02.022; Goerner M, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-8; Harris A, 1999, J GEN VIROL, V80, P863; Juarez Victoria, 2012, Open Virol J, V6, P270, DOI 10.2174/1874357901206010270; Kamiya K, 2010, BBA-BIOMEMBRANES, V1798, P1625, DOI 10.1016/j.bbamem.2010.05.011; Parent L., 2014, NUCLEUS, V2, P92; Roy P, 2009, ADV EXP MED BIOL, V655, P145, DOI 10.1007/978-1-4419-1132-2_11; Senavirathna LK, 2013, THERANOSTICS, V3, P687, DOI 10.7150/thno.6381; Udit AK, 2010, BIOCONJUGATE CHEM, V21, P399, DOI 10.1021/bc900399e; Vogt VM, 1999, J VIROL, V73, P7050	37	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	MAR	2015	12	3					839	845		10.1021/mp500860x		7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CC5HY	WOS:000350390900017		
J	Kikuchi, S; Kishimoto, H; Tazawa, H; Hashimoto, Y; Kuroda, S; Nishizaki, M; Nagasaka, T; Shirakawa, Y; Kagawa, S; Urata, Y; Hoffman, RM; Fujiwara, T				Kikuchi, Satoru; Kishimoto, Hiroyuki; Tazawa, Hiroshi; Hashimoto, Yuuri; Kuroda, Shinji; Nishizaki, Masahiko; Nagasaka, Takeshi; Shirakawa, Yasuhiro; Kagawa, Shunsuke; Urata, Yasuo; Hoffman, Robert M.; Fujiwara, Toshiyoshi			Biological Ablation of Sentinel Lymph Node Metastasis in Submucosally Invaded Early Gastrointestinal Cancer	MOLECULAR THERAPY			English	Article							EARLY GASTRIC-CANCER; ENDOSCOPIC MUCOSAL RESECTION; EARLY COLORECTAL-CANCER; REPLICATION-SELECTIVE ADENOVIRUS; GREEN FLUORESCENT PROTEIN; ONCOLYTIC VIROTHERAPY; GENE-EXPRESSION; PHASE-I; CARCINOMA; TUMOR	Currently, early gastrointestinal cancers are treated endoscopically, as long as there are no lymph node metastases. However, once a gastrointestinal cancer invades the submucosal layer, the lymph node metastatic rate rises to higher than 10%. Therefore, surgery is still the gold standard to remove regional lymph nodes containing possible metastases. Here, to avoid prophylactic surgery, we propose a less-invasive biological ablation of lymph node metastasis in subnnucosally invaded gastrointestinal cancer patients. We have established an orthotopic early rectal cancer xenograft model with spontaneous lymph node metastasis by implantation of green fluorescent protein (GFP)-labeled human colon cancer cells into the submucosal layer of the murine rectum. A solution containing telomerase-specific oncolytic adenovirus was injected into the peritumoral submucosal space, followed by excision of the primary rectal tumors mimicking the endoscopic submucosal dissection (ESD) technique. Seven days after treatment, GFP signals had completely disappeared indicating that sentinel lymph node metastasis was selectively eradicated. Moreover, biologically treated mice were confirmed to be relapse-free even 4 weeks after treatment. These results indicate that virus-mediated biological ablation selectively targets lymph node metastasis and provides a potential alternative to surgery for subnnucosal invasive gastrointestinal cancer patients.	[Kikuchi, Satoru; Kishimoto, Hiroyuki; Tazawa, Hiroshi; Hashimoto, Yuuri; Kuroda, Shinji; Nishizaki, Masahiko; Nagasaka, Takeshi; Shirakawa, Yasuhiro; Kagawa, Shunsuke; Fujiwara, Toshiyoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama 7008558, Japan; [Tazawa, Hiroshi] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan; [Urata, Yasuo] Oncolys BioPharma Inc, Tokyo, Japan; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA	Fujiwara, T (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	toshi_f@md.okayama-u.ac.jp	TAZAWA, Hiroshi/B-2247-2011	TAZAWA, Hiroshi/0000-0003-4658-1050	Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanae Foundation for the Promotion of Medical Science; 106th Annual Congress of the JSS Memorial Surgical Research Fund, Tokyo, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labour and Welfare of Japan	We thank Tomoko Sueishi and Tae Yamanishi for their excellent technical support. We also thank Yoshiko Mod and Ryo Inada for helpful discussions. This work was supported in part by grants from The Mochida Memorial Foundation for Medical and Pharmaceutical Research (H.K.); The Kanae Foundation for the Promotion of Medical Science (H.K.); The 106th Annual Congress of the JSS Memorial Surgical Research Fund, Tokyo, Japan (H.K.) Young Scientists (B), The Ministry of Education, Culture, Sports, Science and Technology, Japan (H.K.), the Ministry of Education, Culture, Sports, Science, and Technology of Japan (T.F.) and the Ministry of Health, Labour and Welfare of Japan (T.F.). Y.U. is the president and CEO of Oncolys BioPharma, Inc., the manufacturer of viruses. H.T. and T.F. are consultants for Oncolys BioPharma, Inc. The other authors declare no conflict of interest.	Ando N, 2000, ANN SURG, V232, P225, DOI 10.1097/00000658-200008000-00013; Gotoda T, 2007, GASTRIC CANCER, V10, P1, DOI 10.1007/s10120-006-0408-1; Hagendoorn J, 2006, CANCER RES, V66, P3360, DOI 10.1158/0008-5472.CAN-05-2655; Wang HS, 2005, DIS COLON RECTUM, V48, P1182, DOI 10.1007/s10350-004-0935-y; Bouvet M, 2006, CANCER RES, V66, P11293, DOI 10.1158/0008-5472.CAN-06-2662; Kishimoto H, 2011, CELL CYCLE, V10, P2737, DOI 10.4161/cc.10.16.16756; Nascimbeni R, 2002, DIS COLON RECTUM, V45, P200, DOI 10.1007/s10350-004-6147-7; Park BH, 2008, LANCET ONCOL, V9, P533, DOI 10.1016/S1470-2045(08)70107-4; Liu TC, 2007, NAT CLIN PRACT ONCOL, V4, P101, DOI 10.1038/ncponc0736; Yang M, 2004, CANCER RES, V64, P8651, DOI 10.1158/0008-5472.CAN-04-3118; Yamasaki Y, 2012, EUR J CANCER, V48, P2282, DOI 10.1016/j.ejca.2011.12.020; Repici A, 2012, ENDOSCOPY, V44, P137, DOI 10.1055/s-0031-1291448; Burton JB, 2008, NAT MED, V14, P882, DOI 10.1038/nm.1727; Kudo S, 1997, WORLD J SURG, V21, P694; Kawashima T, 2004, CLIN CANCER RES, V10, P285, DOI 10.1158/1078-0432.CCR-1075-3; Kojima T, 1998, GASTROINTEST ENDOSC, V48, P550, DOI 10.1016/S0016-5107(98)70108-7; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; VOLK EE, 1995, GASTROENTEROLOGY, V109, P1801, DOI 10.1016/0016-5085(95)90746-7; Uchida H, 2013, MOL THER, V21, P561, DOI 10.1038/mt.2012.211; Nemunaitis J, 2010, MOL THER, V18, P429, DOI 10.1038/mt.2009.262; Borie F, 2004, ANN SURG ONCOL, V11, P512, DOI 10.1245/ASO.2004.06.025; Christiansen Ailsa, 2011, Genes Cancer, V2, P1146, DOI 10.1177/1947601911423028; Fujiwara T, 2006, J CLIN ONCOL, V24, P1689, DOI 10.1200/JCO.2005.03.4116; Fujiwara T, 2009, EXPERT OPIN BIOL TH, V9, P321, DOI 10.1517/14712590802715731 ; Gu J, 2002, GENE THER, V9, P30, DOI 10.1038/sj.gt.3301619; Hashimoto Y, 2008, CANCER SCI, V99, P385, DOI 10.1111/j.1349-7006.2007.00665.x; Inoue H, 2002, J GASTROEN HEPATOL, V17, P382, DOI 10.1046/j.1440-1746.2002.02732.x; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kishimoto H, 2006, NAT MED, V12, P1213, DOI 10.1038/nm1404; Kishimoto H, 2009, MOL CANCER THER, V8, P3001, DOI 10.1158/1535-7163.MCT-09-0556; Kojima T, 2010, ANN SURG, V251, P1079, DOI 10.1097/SLA.0b013e3181deb69d; Kojima T, 2009, J CLIN INVEST, V119, P3172, DOI 10.1172/JCI38609; Kume K, 2014, WORLD J GASTROENTERO, V20, P6425, DOI 10.3748/wjg.v20.i21.6425; Mainprize KS, 1998, BRIT J SURG, V85, P469; Montgomery Marissa, 2013, Gastroenterol Rep (Oxf), V1, P105, DOI 10.1093/gastro/got016; Nivatvongs S, 2000, WORLD J SURG, V24, P1052; Sasaki T, 2011, CLIN CANCER RES, V17, P1828, DOI 10.1158/1078-0432.CCR-10-2066; Takeshita K, 1997, GUT, V40, P123; Takeuchi H, 2013, DIGEST SURG, V30, P104, DOI 10.1159/000350875; Uraoka Toshio, 2009, Drug Des Devel Ther, V2, P131; Yamamoto H, 1999, GASTROINTEST ENDOSC, V50, P701, DOI 10.1016/S0016-5107(99)80026-1	42	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	MAR	2015	23	3					501	509		10.1038/mt.2014.244		9	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CC3RM	WOS:000350267000010		
J	Ono, M; Ohkouchi, S; Kanehira, M; Tode, N; Kobayashi, M; Ebina, M; Nukiwa, T; Irokawa, T; Ogawa, H; Akaike, T; Okada, Y; Kurosawa, H; Kikuchi, T; Ichinose, M				Ono, Manabu; Ohkouchi, Shinya; Kanehira, Masahiko; Tode, Naoki; Kobayashi, Makoto; Ebina, Masahito; Nukiwa, Toshihiro; Irokawa, Toshiya; Ogawa, Hiromasa; Akaike, Takaaki; Okada, Yoshinori; Kurosawa, Hajime; Kikuchi, Toshiaki; Ichinose, Masakazu			Mesenchymal Stem Cells Correct Inappropriate Epithelial-mesenchyme Relation in Pulmonary Fibrosis Using Stanniocalcin-1	MOLECULAR THERAPY			English	Article							ENDOPLASMIC-RETICULUM STRESS; MULTIPOTENT STROMAL CELLS; ACUTE LUNG INJURY; LIFE-SPAN; GROWTH; CANCER; APOPTOSIS; TRIAL; MSCS; DIFFERENTIATION	Current hypotheses suggest that aberrant wound healing has a critical role in the pathogenesis of idiopathic pulmonary fibrosis (IPF). In these hypotheses, continuous TGF-beta 1 secretion by alveolar epithelial cells (AECs) in abnormal wound healing has a critical role in promoting fibroblast differentiation into myofibroblasts. Mesenchymal stem cells (MSCs) home to the injury site and reduce fibrosis by secreting multifunctional antifibrotic humoral factors in IPF. In this study, we show that MSCs can correct the inadequate-communication between epithelial and mesenchymal cells through STC1 (Stanniocalcin-1) secretion in a bleomycin-induced IPF model. Inhalation of recombinant STC1 shows the same effects as the injection of MSCs. Using STC1 plasmid, it was possible to enhance the ability of MSCs to ameliorate the fibrosis. MSCs secrete large amounts of STC1 in response to TGF-beta 1 in comparison to AECs and fibroblasts. The antifibrotic effects of STC1 include reducing oxidative stress, endoplasmic reticulum (ER) stress, and TGF-beta 1 production in AECs. The STC1 effects can be controlled by blocking uncoupling protein 2 (UCP2) and the secretion is affected by the PI3/AKT/mTORC1 inhibitors. Our findings suggest that STC1 tends to correct the inappropriate epithelial mesenchymal relationships and that STC1 plasnnid transfected to MSCs or STC1 inhalation could become promising treatments for IPF.	[Ono, Manabu; Ohkouchi, Shinya; Kanehira, Masahiko; Tode, Naoki; Kobayashi, Makoto; Kikuchi, Toshiaki; Ichinose, Masakazu] Tohoku Univ, Grad Sch Med, Dept Resp Med, Sendai, Miyagi 9808574, Japan; [Ohkouchi, Shinya; Irokawa, Toshiya; Ogawa, Hiromasa; Kurosawa, Hajime] Tohoku Univ, Grad Sch Med, Dept Occupat Hlth, Sendai, Miyagi 9808574, Japan; [Kanehira, Masahiko] Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Sendai, Miyagi 9808574, Japan; [Ebina, Masahito] Tohoku Pharmaceut Univ Hosp, Ctr Pulm, Sendai, Miyagi, Japan; [Nukiwa, Toshihiro] Japan AntiTB Assoc, Tokyo, Japan; [Akaike, Takaaki] Tohoku Univ, Grad Sch Med, Dept Environm Hlth Sci & Mol Toxicol, Sendai, Miyagi 9808574, Japan; [Okada, Yoshinori] Tohoku Univ, Inst Dev Aging & Canc, Dept Thorac Surg, Sendai, Miyagi 9808574, Japan	Ohkouchi, S (reprint author), Tohoku Univ, Grad Sch Med, Dept Resp Med, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	ohkouchi@idac.tohoku.ac.jp			Japan society for the Promotion of Science [JSPS-24591149, 24592080]; Japan Science and Technology Agency [JST-AS242Z01715P]	This work was supported by grants from the Japan society for the Promotion of Science (JSPS-24591149, 24592080) and Japan Science and Technology Agency (JST-AS242Z01715P). Thanks to RIKEN BioResource Center (Tsukuba, Japan) and Prockop at TEXAS A&M University for kindly providing the MSCs cell lines and human naive MSCs and for supporting our facilities damaged by the East-Japan Earthquake in 2011. We also thank Brent Bell for reading the manuscript. All authors have no conflict of interest to commercial companies concerning this work. Conception and design: M.O., S.O.; analysis and interpretation: M.O., S.O., M.K., N.T., M.K., M.E., T.K., T.I., H.O., Y.O.; drafting the manuscript for important intellectual content: S.O., H.K., T.A., M.I.	Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Liu GZ, 2010, J NATL CANCER I, V102, P812, DOI 10.1093/jnci/djq127; Samudio I, 2008, CANCER RES, V68, P5198, DOI 10.1158/0008-5472.CAN-08-0555; Maitra M, 2012, P NATL ACAD SCI USA, V109, P21064, DOI 10.1073/pnas.1217069110; Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Matthay MA, 2010, CHEST, V138, P965, DOI 10.1378/chest.10-0518; Venkateshiah SB, 2006, CHEST, V130, P227, DOI 10.1378/chest.130.1.227; Homer RJ, 2011, ARCH PATHOL LAB MED, V135, P780, DOI 10.1043/2010-0296-RA.1; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Wong AP, 2007, AM J PHYSIOL-LUNG C, V293, pL740, DOI 10.1152/ajplung.00050.2007; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857; Varghese R, 2002, ENDOCRINOLOGY, V143, P868, DOI 10.1210/en.143.3.868; Cordeiro JV, 2013, NAT REV MOL CELL BIO, V14, P249, DOI 10.1038/nrm3541; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Ohkouchi S, 2012, MOL THER, V20, P417, DOI 10.1038/mt.2011.259; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Ito D, 2004, MOL CELL BIOL, V24, P9456, DOI 10.1128/MCB.24.21.9456-9469.2004; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Oh JY, 2014, STEM CELLS, V32, P1553, DOI 10.1002/stem.1608; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Katsha AM, 2011, MOL THER, V19, P196, DOI 10.1038/mt.2010.192; Tamura S, 2011, ANTICANCER RES, V31, P325; Gupta N, 2012, THORAX, V67, P533, DOI 10.1136/thoraxjnl-2011-201176; Jenkins G, 2012, THORAX, V67, P179, DOI 10.1136/thoraxjnl-2011-200195; Yeung BHY, 2012, MOL CELL ENDOCRINOL, V349, P272, DOI 10.1016/j.mce.2011.11.007; Wu JY, 2012, J ENDODONT, V38, P614, DOI 10.1016/j.joen.2012.01.014; Mori T, 2005, MOL CELL BIOL, V25, P5183, DOI 10.1128/MCB.25.12.5183-5195.2005; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Datta A, 2011, BRIT J PHARMACOL, V163, P141, DOI 10.1111/j.1476-5381.2011.01247.x; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; Toonkel RL, 2013, AM J RESP CRIT CARE, V188, P133, DOI 10.1164/rccm.201207-1204PP; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Block GJ, 2009, STEM CELLS, V27, P670, DOI [10.1002/stem.20080742, 10.1634/stemcells.stemcells.2008-0742]; Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Krasnodembskaya A, 2012, AM J PHYSIOL-LUNG C, V302, pL1003, DOI 10.1152/ajplung.00180.2011; McNulty Katrina, 2012, Proc Am Thorac Soc, V9, P164, DOI 10.1513/pats.201201-010AW; Nishioka Yasuhiko, 2013, J Med Invest, V60, P175; Semon JA, 2010, CELL TISSUE RES, V341, P147, DOI 10.1007/s00441-010-0994-4; Sharma A, 2014, MOL CANCER RES, V12, P1205, DOI 10.1158/1541-7786.MCR-14-0124; Sheikh-Hamad D, 2010, AM J PHYSIOL-RENAL, V298, pF248, DOI 10.1152/ajprenal.00260.2009; Takeda Y, 2004, J GENE MED, V6, P833, DOI 10.1002/jgm.583; Tzouvelekis A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-171	50	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	MAR	2015	23	3					549	560		10.1038/mt.2014.217		12	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CC3RM	WOS:000350267000014		
J	Merker, M; Blin, C; Mona, S; Duforet-Frebourg, N; Lecher, S; Willery, E; Blum, MGB; Ruch-Gerdes, S; Mokrousov, I; Aleksic, E; Allix-Beguec, C; Antierens, A; Augustynowicz-Kopec, E; Banff', M; Barletta, F; Beckr, HP; Barry, CE; Bonnet, M; Borroni, E; Campos-Herrero, I; Cirillo, D; Cox, H; Crowe, S; Crudu, V; Die, R; Drobniewski, F; Fauville-Dufaux, M; Gagneuxr, S; Ghebremichael, S; Hanekom, M; Hoffner, S; Jiao, WW; Kalon, S; Kohl, TA; Kontsevaya, I; Lillebaek, T; Maeda, S; Nikolayevskyy, V; Rasmussen, M; Rastogi, N; Samper, S; Sanchez-Padilla, E; Savic, B; Shamputa, IC; Shen, A; Sng, LH; Stakenas, P; Toit, K; Varaine, F; Vukovic, D; Wahl, C; Warren, R; Supply, P; Niemann, S; Wirth, T				Merker, Matthias; Blin, Camille; Mona, Stefano; Duforet-Frebourg, Nicolas; Lecher, Sophie; Willery, Eve; Blum, Michael G. B.; Ruech-Gerdes, Sabine; Mokrousov, Igor; Aleksic, Eman; Allix-Beguec, Caroline; Antierens, Annick; Augustynowicz-Kopec, Ewa; Banff', Marie; Barletta, Francesca; Beckr, Hans Peter; Barry, Clifton E., III; Bonnet, Maryline; Borroni, Emanuele; Campos-Herrero, Isolina; Cirillo, Daniela; Cox, Helen; Crowe, Suzanne; Crudu, Valeriu; Die, Roland; Drobniewski, Francis; Fauville-Dufaux, Maryse; Gagneuxr, Sebastien; Ghebremichael, Solomon; Hanekom, Madeleine; Hoffner, Sven; Jiao, Wei-wei; Kalon, Stobdan; Kohl, Thomas A.; Kontsevaya, Irina; Lillebaek, Troels; Maeda, Shinji; Nikolayevskyy, Vladyslav; Rasmussen, Michael; Rastogi, Nalin; Samper, Sofia; Sanchez-Padilla, Elisabeth; Savic, Branislava; Shamputa, Isdore Chola; Shen, Adong; Sng, Li-Hwei; Stakenas, Petras; Toit, Kadri; Varaine, Francis; Vukovic, Dragana; Wahl, Celine; Warren, Robin; Supply, Philip; Niemann, Stefan; Wirth, Thierrv			Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage	NATURE GENETICS			English	Article							DRUG-RESISTANT TUBERCULOSIS; NEW-YORK-CITY; MUTATION-RATE; MAXIMUM-LIKELIHOOD; SOUTH-AFRICA; MCE OPERONS; STRAINS; POPULATION; EMERGENCE; TRANSMISSION	Mycobacterium tuberculosis strains of the Beijing lineage are globally distributed and are associated with the massive spread of multidrug-resistant (MDR) tuberculosis in Eurasia. Here we reconstructed the biogeographical structure and evolutionary history of this lineage by genetic analysis of 4,987 isolates from 99 countries and whole-genome sequencing of 110 representative isolates. We show that this lineage initially originated in the Far East, from where it radiated worldwide in several waves. We detected successive increases in population size for this pathogen over the last 200 years, practically coinciding with the Industrial Revolution, the First World War and HIV epidemics. Two MDR clones of this lineage started to spread throughout central Asia and Russia concomitantly with the collapse of the public health system in the former Soviet Union. Mutations identified in genes putatively under positive selection and associated with virulence might have favored the expansion of the most successful branches of the lineage.	[Merker, Matthias; Kohl, Thomas A.] Mol Mycobacteriol Res Ctr Borstel, Borstel, Germany; [Blin, Camille; Mona, Stefano] Ecole Prat Flautes Etud, Lab Biol Integrat Populat Evolut Mol, Paris, France; [Blin, Camille; Mona, Stefano; Wirth, Thierrv] Univ Paris 06, Univ Paris 04, Ecole Prat Hautes Etud,UMR CNRS 7205, Inst Systemat Evolut Biodivers,Museum Natl Hist N, Paris, France; [Duforet-Frebourg, Nicolas; Blum, Michael G. B.] Univ Grenoble 1, CNRS, Lab Techn Ingn Med Complexite Informat Math & App, Grenoble, France; [Lecher, Sophie; Willery, Eve; Supply, Philip] Ctr Infect & Immun Lille, INSERM, U1019, Lille, France; [Lecher, Sophie; Willery, Eve; Supply, Philip] CNRS, UMR 8204, Lille, France; [Lecher, Sophie; Willery, Eve; Supply, Philip] Univ Lille Nord, Ctr Infect & Immun Lille, Lille, France; [Lecher, Sophie; Willery, Eve; Supply, Philip] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; Res Ctr Borstel, Natl Reference Ctr Mycobacteria, Borstel, Germany; [Mokrousov, Igor] St Petersburg Pasteur Inst, Lab Mol Microbiol, St Petersburg, Russia; [Aleksic, Eman] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Allix-Beguec, Caroline; Wahl, Celine; Supply, Philip] Genoscreen, Lille, France; [Antierens, Annick] Med Sans Frontieres Switzerland, Dept Med, Geneva, Switzerland; [Augustynowicz-Kopec, Ewa] Natl TB & Lung Dis Res Inst, Dept Microbiol, Warsaw, Poland; [Banff', Marie] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Barletta, Francesca] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Mol Epidemiol Unit TB, Lima, Peru; [Beckr, Hans Peter; Gagneuxr, Sebastien] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Barry, Clifton E., III; Shamputa, Isdore Chola] NIAID, TB Res Sect, US NIH, Bethesda, MD 20892 USA; [Bonnet, Maryline; Sanchez-Padilla, Elisabeth] Epictr, Clin Res Dept, Paris, France; [Borroni, Emanuele; Cirillo, Daniela] Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy; [Campos-Herrero, Isolina] Hosp Univ Gran Canaria Dr Negrin, Dept Microbiol, Las Palmas Gran Canaria, Spain; [Cox, Helen] Univ Cape Town, Div Med Microbiol, ZA-7925 Cape Town, South Africa; [Crowe, Suzanne] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Crowe, Suzanne] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Crudu, Valeriu] Phthysiopneumol Inst, Natl TB Reference Lab, Kishinev, Moldova; [Die, Roland] Schleswig Holstein Univ Hosp, Inst Epidemiol, Kiel, Germany; [Drobniewski, Francis; Nikolayevskyy, Vladyslav] Barts & London Queen Marys Sch Med & Dent, Publ Hlth England Natl Mycobacterial Reference, London, England; Barts & London Queen Marys Sch Med & Dent, Publ Hlth England Natl Mycobacterial Reference &, London, England; [Drobniewski, Francis; Nikolayevskyy, Vladyslav] Barts & London Queen Marys Sch Med & Dent, Human Immunodeficiency Virus Grp, London, England; [Drobniewski, Francis; Nikolayevskyy, Vladyslav] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, London, England; [Fauville-Dufaux, Maryse] TB & Mycobacteria Sci Inst Publ Hlth, Brussels, Belgium; [Ghebremichael, Solomon] Publ Hlth Agcy Sweden, Dept Microbiol, Solna, Sweden; [Hanekom, Madeleine; Warren, Robin] Univ Stellenbosch, Fac Med & Hlth Sci, Ctr TB Res,Div Mol Biol & Human Genet, Ctr Excellence Biomed TB Res,MRC,Natl Res Fdn,Dep, Cape Town, South Africa; [Hoffner, Sven] Swedish Inst Communicable Dis Control, Dept Diagnost & Vaccinol, Solna, Sweden; [Jiao, Wei-wei; Shen, Adong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Children, Beijing, Peoples R China; [Jiao, Wei-wei; Shen, Adong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Natl Key Discipline Pediat,Minist Educ, Beijing, Peoples R China; [Kalon, Stobdan] US Agcy Int Dev Qual Hlth Care Project, Bishkek, Kyrgyzstan; [Kontsevaya, Irina] Sarnara Oblast TB Serv, Samara, Russia; [Lillebaek, Troels; Rasmussen, Michael] Statens Serum Inst, Int Reference Lab Mycobacteriol, DK-2300 Copenhagen, Denmark; [Maeda, Shinji] Japan Anti TB Assoc, Res Inst TB, Tokyo, Japan; [Rastogi, Nalin] WHO, Inst Paslieur Guadeloupe, Supranat TB Reference Lab, Abymes, France; [Samper, Sofia] Hosp Univ Miguel Servet, Inst Invest Sanit Aragon, Zaragoza, Spain; [Savic, Branislava; Vukovic, Dragana] Univ Belgrade, Fac Med, Inst Microbiol & Immunol, Belgrade, Serbia; [Sng, Li-Hwei] Singapore Gen Hosp, Dept Pathol, Cent TB Lab, Singapore, Singapore; [Stakenas, Petras] Vilnius Univ, Inst Biotechnol, Dept Immunol & Cell Biol, Vilnius, Lithuania; [Toit, Kadri] Tartu Univ Hosp, United Labs, Tartu, Estonia; [Varaine, Francis] Med Sans Frontieres, Dept Med, Paris, France; [Niemann, Stefan] German Ctr Infect Res, Borstel Site, Borstel, Germany	Wirth, T (reprint author), Ecole Prat Flautes Etud, Lab Biol Integrat Populat Evolut Mol, Paris, France.	philip.supply@ibl.cnrs.fr; sniemann@fz-borstel.de; wirth@rnram.fr	Wirth, Thierry/B-4915-2008; Niemann, Stefan/C-9327-2011; BLUM, Michael/F-9978-2010; Barry, III, Clifton/H-3839-2012; Merker, Matthias/P-7399-2015	BLUM, Michael/0000-0003-4174-7373; Merker, Matthias/0000-0003-1386-2331	European Community [278864]; European Union [223681]; Action Transversale du Museum National d'Histoire Naturelle 'Les Microorganismes; Acteurs Cles dans les Ecosystemes	We gratefully acknowledge L. Cowan and J. Posey (US Centers for Disease Control and Prevention) for pros ding us with significant amounts of genot)iping data for M. tuberculosis Beijing isolates. We thank T. Ubben, I. Radzio, F Struwe-Sonnenschein and). Zallet (Research Center Borstel) for excellent technical assistance. We acknowledge J. Peh for her assistance and support in the study and I. Comas for statistical advice. Parts of this work have been supported by grants from the European Community's Seventh ilramework Programme (FP7120072013) under grant agreement 278864 in the framework ot. the European Union PathoNGenTrace project and grant agreement 223681 in the framework of the TB-PAN-NET project. We also thank Action Transversale du Museum National d'Histoire Naturelle 'Les Microorganismes, Acteurs Cles dans les Ecosystemes' for financial support. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahidjo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021738; Ahmad S, 2004, SCAND J IMMUNOL, V60, P382, DOI 10.1111/j.0300-9475.2004.01490.x; Niemann S, 2010, J CLIN MICROBIOL, V48, P3544, DOI 10.1128/JCM.00715-10; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Kato-Maeda M, 2012, CLIN VACCINE IMMUNOL, V19, P1227, DOI 10.1128/CVI.00250-12; Wilson IJ, 1998, GENETICS, V150, P499; Nieselt-Struwe K, 2001, MOL BIOL EVOL, V18, P1204; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; de Vos M, 2013, ANTIMICROB AGENTS CH, V57, P827, DOI 10.1128/AAC.01541-12; Ribeiro SCM, 2014, J CLIN MICROBIOL, V52, P2615, DOI 10.1128/JCM.00498-14; Munsiff SS, 2003, J INFECT DIS, V188, P356, DOI 10.1086/376837; OHTA T, 1973, GENET RES, V22, P201; Klopper M, 2013, EMERG INFECT DIS, V19, P449, DOI [10.3201/EID1903.120246, 10.3201/eid1903.120246, 10.3201//EID1903.120246]; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Comas I, 2011, TRENDS MICROBIOL, V19, P492, DOI 10.1016/j.tim.2011.07.002; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Beaumont MA, 1999, GENETICS, V153, P2013; Mokrousov I, 2013, CLIN MICROBIOL REV, V26, P342, DOI 10.1128/CMR.00087-12; Li XZ, 2004, ANTIMICROB AGENTS CH, V48, P2415, DOI 10.1128/AAC.48.7.2415-2423.2004; Blom J, 2011, BIOINFORMATICS, V27, P1351, DOI 10.1093/bioinformatics/btr151; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103; Duforet-Frebourg N, 2014, MOL BIOL EVOL, V31, P2483, DOI 10.1093/molbev/msu182; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Aguilar D, 2010, TUBERCULOSIS, V90, P319, DOI 10.1016/j.tube.2010.08.004; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Casali N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-60; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; DROLET GJ, 1945, AM J PUBLIC HEALTH, V35, P689; Ebrahimi-Rad Mina, 2003, Emerg Infect Dis, V9, P838; Etienne G, 2009, J BACTERIOL, V191, P2613, DOI 10.1128/JB.01235-08; Fang J., 2013, ATLAS SUSTAINABILITY; Gioffre A, 2005, MICROBES INFECT, V7, P325, DOI 10.1016/j.micinf.2004.11.007; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Holden C, 1999, SCIENCE, V286, P1670, DOI 10.1126/science.286.5445.1670; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Laruelle Marlene, 2009, CHINA EURASIA FORUM, V7, P93; Maloney E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000534; Meikle V, 2009, CLIN VACCINE IMMUNOL, V16, P1352, DOI 10.1128/CVI.00211-09; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Namouchi A, 2012, GENOME RES, V22, P721, DOI 10.1101/gr.129544.111; Osorio NS, 2013, MOL BIOL EVOL, V30, P1326, DOI 10.1093/molbev/mst038; PLIKAYTIS BB, 1994, J CLIN MICROBIOL, V32, P1542; Ragheb MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-145; Reyes JF, 2010, INFECT GENET EVOL, V10, P1046, DOI 10.1016/j.meegid.2010.06.016; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Sirakova TD, 2002, J BACTERIOL, V184, P6796, DOI 10.1128/JB.184.24.6796-6802.2002; Stavrum R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026295; Stoffels K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063128; Supply P, 2011, INFECT GENET EVOL, V11, P251, DOI 10.1016/j.meegid.2010.12.009; WHO, 2013, GLOB TUB REP; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160	78	20	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					242	+				10	Genetics & Heredity	Genetics & Heredity	CC4MQ	WOS:000350327900014		
J	Plummer, J; Shikama, T				Plummer, John; Shikama, Tatsuo			Nuclear materials in Japan	NATURE MATERIALS			English	Editorial Material									[Shikama, Tatsuo] Tohoku Univ, Int Res Ctr Nucl Mat, Inst Mat Res, Sendai, Miyagi 980, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	MAR	2015	14	3					258	259				2	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CC1WP	WOS:000350136400004		
J	Withers, F; Del Pozo-Zamudio, O; Mishchenko, A; Rooney, AP; Gholinia, A; Watanabe, K; Taniguchi, T; Haigh, SJ; Geim, AK; Tartakovskii, AI; Novoselov, KS				Withers, F.; Del Pozo-Zamudio, O.; Mishchenko, A.; Rooney, A. P.; Gholinia, A.; Watanabe, K.; Taniguchi, T.; Haigh, S. J.; Geim, A. K.; Tartakovskii, A. I.; Novoselov, K. S.			Light-emitting diodes by band-structure engineering in van der Waals heterostructures	NATURE MATERIALS			English	Article							P-N-JUNCTIONS; FILMS; MOS2; PHOTOLUMINESCENCE; EXCITONS	The advent of graphene and related 2D materials1,2 has recently led to a new technology: heterostructures based on these atomically thin crystals(3). The paradigm proved itself extremely versatile and led to rapid demonstration of tunnelling diodes with negative differential resistance(4), tunnelling transistors(5), photovoltaic devices(6,7) and so on. Here, we take the complexity and functionality of such van der Waals heterostructures to the next level by introducing quantum wells (QWs) engineered with one atomic plane precision. We describe light-emitting diodes (LEDs) made by stacking metallic graphene, insulating hexagonal boron nitride and various semiconducting monolayers into complex but carefully designed sequences. Our first devices already exhibit an extrinsic quantum efficiency of nearly 10% and the emission can be tuned over a wide range of frequencies by appropriately choosing and combining 2D semiconductors (monolayers of transition metal dichalcogenides). By preparing the heterostructures on elastic and transparent substrates, we show that they can also provide the basis for flexible and semi-transparent electronics. The range of functionalities for the demonstrated heterostructures is expected to grow further on increasing the number of available 2D crystals and improving their electronic quality.	[Withers, F.; Mishchenko, A.; Novoselov, K. S.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Del Pozo-Zamudio, O.; Tartakovskii, A. I.] Univ Sheffield, Dept Phys & Astron, Sheffield S3 7RH, S Yorkshire, England; [Rooney, A. P.; Gholinia, A.; Haigh, S. J.] Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England; [Watanabe, K.; Taniguchi, T.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Geim, A. K.] Univ Manchester, Manchester Ctr Mesosci & Nanotechnol, Manchester M13 9PL, Lancs, England	Novoselov, KS (reprint author), Univ Manchester, Sch Phys & Astron, Oxford Rd, Manchester M13 9PL, Lancs, England.	kostya@manchester.ac.uk	Del Pozo-Zamudio, Osvaldo/G-7768-2014; Novoselov, Kostya/G-9581-2014; Geim, Andre/J-7888-2012; WATANABE, Kenji/H-2825-2011; Mishchenko, Artem/C-7561-2011; Haigh, Sarah/D-1309-2014	Novoselov, Kostya/0000-0003-4972-5371; Geim, Andre/0000-0003-2861-8331; WATANABE, Kenji/0000-0003-3701-8119; Mishchenko, Artem/0000-0002-0427-5664; Haigh, Sarah/0000-0001-5509-6706	Royal Society; Royal Academy of Engineering; US Army; European Science Foundation (ESF) under the EUROCORES Programme EuroGRAPHENE (GOSPEL); European Research Council; EC-FET European Graphene Flagship; Engineering and Physical Sciences Research Council (UK); Leverhulme Trust (UK); US Office of Naval Research; US Defence Threat Reduction Agency; US Air Force Office of Scientific Research, FP7 ITN S<SUP>3</SUP>NANO; SEP-Mexico; CONACYT	This work was supported by The Royal Society, Royal Academy of Engineering, US Army, European Science Foundation (ESF) under the EUROCORES Programme EuroGRAPHENE (GOSPEL), European Research Council, EC-FET European Graphene Flagship, Engineering and Physical Sciences Research Council (UK), the Leverhulme Trust (UK), US Office of Naval Research, US Defence Threat Reduction Agency, US Air Force Office of Scientific Research, FP7 ITN S<SUP>3</SUP>NANO, SEP-Mexico and CONACYT.	Lee CH, 2014, NAT NANOTECHNOL, V9, P676, DOI [10.1038/nnano.2014.150, 10.1038/NNANO.2014.150]; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Britnell L, 2012, SCIENCE, V335, P947, DOI 10.1126/science.1218461; Pospischil A, 2014, NAT NANOTECHNOL, V9, P257, DOI [10.1038/nnano.2014.14, 10.1038/NNANO.2014.14]; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Haigh SJ, 2012, NAT MATER, V11, P764, DOI [10.1038/nmat3386, 10.1038/NMAT3386]; Britnell L, 2013, SCIENCE, V340, P1311, DOI 10.1126/science.1235547; Reineke S, 2009, NATURE, V459, P234, DOI 10.1038/nature08003; Kang J, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4774090; Yu WJ, 2013, NAT NANOTECHNOL, V8, P952, DOI [10.1038/nnano.2013.219, 10.1038/NNANO.2013.219]; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Novoselov KS, 2011, REV MOD PHYS, V83, P837, DOI 10.1103/RevModPhys.83.837; Ross JS, 2014, NAT NANOTECHNOL, V9, P268, DOI [10.1038/nnano.2014.26, 10.1038/NNANO.2014.26]; Britnell L, 2012, NANO LETT, V12, P1707, DOI 10.1021/nl3002205; Baugher BWH, 2014, NAT NANOTECHNOL, V9, P262, DOI [10.1038/nnano.2014.25, 10.1038/NNANO.2014.25]; Yao Y, 2012, NAT PHOTONICS, V6, P432, DOI 10.1038/NPHOTON.2012.143; Sundaram RS, 2013, NANO LETT, V13, P1416, DOI 10.1021/nl400516a; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Mak KF, 2013, NAT MATER, V12, P207, DOI [10.1038/nmat3505, 10.1038/NMAT3505]; Britnell L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2817; Gutierrez HR, 2013, NANO LETT, V13, P3447, DOI 10.1021/nl3026357; Lee GH, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3662043; Rivera P., PREPRINT; Ross JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2498; Sachs B., 2013, APPL PHYS LETT, V103; Sercombe D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03489; Tongay S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02657; Xiao D., 2012, PHYS REV LETT, V08	30	32	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	MAR	2015	14	3					301	306				6	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CC1WP	WOS:000350136400017		
J	Inaba, S; Hosono, H; Ito, S				Inaba, Seiji; Hosono, Hideo; Ito, Setsuro			Entropic shrinkage of an oxide glass	NATURE MATERIALS			English	Article							INORGANIC GLASSES; PHOSPHATE-GLASSES; SPECTROSCOPY; FIBERS; RELAXATION; TRANSITION; BEHAVIOR; RANGE; RAMAN; NMR	Entropic elasticity, a property typical of rubbers andwell known in organic polymers with appropriate network structures, is not known to occur in oxide glasses(1,2). Here, we report the occurrence of entropic elasticity in phosphate-glass fibres with highly anisotropic structures, drawn by mechanical elongation from supercooled liquids. We observed a large lengthwise shrinkage of similar to 35% for phosphate glasses with an enhanced one-dimensional structure, as well as a distinct endotherm on reheating them up to temperatures between that of the glass transition temperature and the softening temperature. Our results strongly suggest the possibility of designing oxide glasses with a rubbery nature at high temperatures.	[Inaba, Seiji; Hosono, Hideo; Ito, Setsuro] Tokyo Inst Technol, Mat & Struct Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Hosono, Hideo] Tokyo Inst Technol, Frontier Res Ctr, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Inaba, S (reprint author), Asahi Glass Co Ltd, Res Ctr, Kanagawa Ku, 1150 Hazawa Cho, Yokohama, Kanagawa 2218755, Japan.	seiji.inaba@agc.com	Hosono, Hideo/J-3489-2013	Hosono, Hideo/0000-0001-9260-6728	MEXT Element Strategy Initiative to form core research centres	A part of the present research was supported by the fund from the MEXT Element Strategy Initiative to form core research centres. We would like to thank S. Kohara and H. Tajiri (Japan Synchrotron Radiation Research Institute, JASRI), Y. Benino (Okayama University), and N. Shimizu and H. Takagi (High Energy Accelerator Research Organization, KEK) for insightful discussions. High-energy X-ray diffraction experiments were performed at the BL04B2 beamline of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (Proposal No. 2014A1096).	WONG J, 1971, APPL SPECTROSC REV, V4, P155, DOI 10.1080/05704927108082604; GIBBS JH, 1958, J CHEM PHYS, V28, P373, DOI 10.1063/1.1744141; NELSON BN, 1979, J CHEM PHYS, V71, P2739, DOI 10.1063/1.438679; STOCKHORST H, 1986, J NON-CRYST SOLIDS, V85, P105, DOI 10.1016/0022-3093(86)90083-9; Kohara S, 2001, NUCL INSTRUM METH A, V467, P1030, DOI 10.1016/S0168-9002(01)00630-1; Brow RK, 2000, J NON-CRYST SOLIDS, V263, P1, DOI 10.1016/S0022-3093(99)00620-1; Greaves GN, 2007, ADV PHYS, V56, P1, DOI 10.1080/00018730601147426; Novita DI, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.195501; Rouxel T, 2007, J AM CERAM SOC, V90, P3019, DOI 10.1111/j.1551-2916.2007.01945.x; Nesbitt HW, 2011, J NON-CRYST SOLIDS, V357, P170, DOI 10.1016/j.jnoncrysol.2010.09.031; Bruckner R, 1996, GLASTECH BER-GLASS, V69, P396; Duffrene L, 1997, J NON-CRYST SOLIDS, V215, P208, DOI 10.1016/S0022-3093(97)00077-X; Eisenberg A., 1970, J NONCRYST SOLIDS, V3, P279, DOI 10.1016/0022-3093(70)90183-3; EISENBER.A, 1969, J POLYM SCI POL LETT, V7, P471, DOI 10.1002/pol.1969.110070612; Eisenberg A., 1967, J MACROMOL SCI CHEM, V1, P121, DOI 10.1080/10601326708053920; EISENBER.A, 1966, J CHEM PHYS, V45, P1673, DOI 10.1063/1.1727813; Harper C. A., 1975, HDB PLASTICS ELASTOM; Hornboll L, 2006, J AM CERAM SOC, V89, P70, DOI 10.1111/j.1551-2916.2005.00736.x; Martin B, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1895483; Meyer K, 1997, J NON-CRYST SOLIDS, V209, P227, DOI 10.1016/S0022-3093(96)00563-7; Micoulaut M, 2007, J NON-CRYST SOLIDS, V353, P1732, DOI 10.1016/j.jnoncrysol.2007.01.078; Pelletier JM, 1999, J NON-CRYST SOLIDS, V258, P119, DOI 10.1016/S0022-3093(99)00518-9; Roundy D, 2013, AM J PHYS, V81, P20, DOI 10.1119/1.4757908; Shang HX, 2005, J AM CERAM SOC, V88, P2625, DOI 10.1111/j.1551-2916.2005.00464.x; SUZUKI S, 1981, J NON-CRYST SOLIDS, V46, P163, DOI 10.1016/0022-3093(81)90157-5; Treloar L. R. G., 2005, PHYS RUBBER ELASTICI; Ya M, 2008, J AM CERAM SOC, V91, P745, DOI 10.1111/j.1551-2916.2007.02100.x; Zarzycki J., 1991, GLASSES VITREOUS STA	28	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	MAR	2015	14	3					312	317				6	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CC1WP	WOS:000350136400019		
J	Zeljkovic, I; Okada, Y; Serbyn, M; Sankar, R; Walkup, D; Zhou, WW; Liu, JW; Chang, GQ; Wang, YJ; Hasan, MZ; Chou, FC; Lin, H; Bansil, A; Fu, L; Madhavan, V				Zeljkovic, Ilija; Okada, Yoshinori; Serbyn, Maksym; Sankar, R.; Walkup, Daniel; Zhou, Wenwen; Liu, Junwei; Chang, Guoqing; Wang, Yung Jui; Hasan, M. Zahid; Chou, Fangcheng; Lin, Hsin; Bansil, Arun; Fu, Liang; Madhavan, Vidya			Dirac mass generation from crystal symmetry breaking on the surfaces of topological crystalline insulators	NATURE MATERIALS			English	Article							EXPERIMENTAL REALIZATION; STATES; SUPERCONDUCTORS; PB1-XSNXSE; MICROSCOPY; TEXTURE; PHASE; SNTE	The tunability of topological surface states and controllable opening of the Dirac gap are of fundamental and practical interest in the field of topological materials. In the newly discovered topological crystalline insulators (TCIs), theory predicts that the Dirac node is protected by a crystalline symmetry and that the surface state electrons can acquire a mass if this symmetry is broken. Recent studies have detected signatures of a spontaneously generated Dirac gap in TCIs; however, the mechanism of mass formation remains elusive. In this work, we present scanning tunnelling microscopy (STM) measurements of the TCI Pb1-xSnxSe for a wide range of alloy compositions spanning the topological and non-topological regimes. The STM topographies reveal a symmetry-breaking distortion on the surface, which imparts mass to the otherwise massless Dirac electrons-a mechanism analogous to the long sought-after Higgs mechanism in particle physics. Interestingly, the measured Dirac gap decreases on approaching the trivial phase, whereas the magnitude of the distortion remains nearly constant. Our data and calculations reveal that the penetration depth of Dirac surface states controls the magnitude of the Dirac mass. At the limit of the critical composition, the penetration depth is predicted to go to infinity, resulting in zero mass, consistent with our measurements. Finally, we discover the existence of surface states in the non-topological regime, which have the characteristics of gapped, double-branched Dirac fermions and could be exploited in realizing superconductivity in these materials.	[Zeljkovic, Ilija; Okada, Yoshinori; Walkup, Daniel; Zhou, Wenwen; Madhavan, Vidya] Boston Coll, Dept Phys, Chestnut Hill, MA 02467 USA; [Okada, Yoshinori] Tohoku Univ, WPI AIMR, Sendai, Miyagi 9808577, Japan; [Serbyn, Maksym; Liu, Junwei; Fu, Liang] MIT, Cambridge, MA 02139 USA; [Serbyn, Maksym] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Sankar, R.; Chou, Fangcheng] Natl Taiwan Univ, Ctr Condensed Matter Sci, Taipei 10617, Taiwan; [Sankar, R.] Acad Sinica, Inst Phys, Taipei 11529, Taiwan; [Chang, Guoqing; Lin, Hsin] Natl Univ Singapore, Graphene Res Ctr, Singapore 117542, Singapore; [Chang, Guoqing; Lin, Hsin] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore; [Wang, Yung Jui; Bansil, Arun] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Hasan, M. Zahid] Princeton Univ, Dept Phys, Joseph Henry Lab, Princeton, NJ 08544 USA; [Madhavan, Vidya] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Madhavan, Vidya] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA	Madhavan, V (reprint author), Boston Coll, Dept Phys, Chestnut Hill, MA 02467 USA.	vm1@illinois.edu	Lin, Hsin/F-9568-2012; Okada, Yoshinori/A-1731-2014; liu, junwei/B-1468-2010; Zeljkovic, Ilija/N-9439-2013; 	Lin, Hsin/0000-0002-4688-2315; liu, junwei/0000-0001-8051-7349; chang, guoqing/0000-0003-1180-3127	US Department of Energy, Scanned Probe Division [DE-FG02-12ER46880]; US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-SC0010526, NSF-DMR-1104498]; Singapore National Research Foundation under NRF Award [NRF-NRFF2013-03]; JSPS KAKENHI [26707016, 00707656]; US Department of Energy [DE-FG02-07ER46352]; Advanced Light Source, Berkeley; DOE [DE-AC02-05CH11231]; US National Science Foundation Grant [NSF-DMR-1006492]; MOST-Taiwan [NSC-102-2119-M-002-004]	We thank R. Buczko, C. Chamon, J. C. Seamus Davis, M. El-Batanouny, A. Mesaros, Y. Ran and A. Soumyanarayanan for useful conversations and G. McMahon for help with EDS measurements. V.M. gratefully acknowledges funding from the US Department of Energy, Scanned Probe Division under Award Number DE-FG02-12ER46880 for the support of I.Z., Y.O., W.Z. and D.W. for this project. Work at Massachusetts Institute of Technology is supported by US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under Award DE-SC0010526 (L.F.), and NSF-DMR-1104498 (M.S.). H.L. acknowledges the Singapore National Research Foundation for support under NRF Award No. NRF-NRFF2013-03. Y.O. was partly supported by JSPS KAKENHI Grant Numbers 26707016 and 00707656. The work at Northeastern University is supported by the US Department of Energy grant number DE-FG02-07ER46352, and benefited from Northeastern University's Advanced Scientific Computation Center (ASCC), theory support at the Advanced Light Source, Berkeley and the allocation of supercomputer time at the NERSC through DOE grant number DE-AC02-05CH11231. Work at Princeton University is supported by the US National Science Foundation Grant, NSF-DMR-1006492. F.C. acknowledges the support provided by MOST-Taiwan under project number NSC-102-2119-M-002-004.	AGNIHOTRI OP, 1979, MATER SCI ENG, V38, P33, DOI 10.1016/0025-5416(79)90028-4; Serbyn M, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.035402; LaShell S, 1996, PHYS REV LETT, V77, P3419, DOI 10.1103/PhysRevLett.77.3419; Okada Y, 2013, SCIENCE, V341, P1496, DOI 10.1126/science.1239451; Tanaka Y, 2012, NAT PHYS, V8, P800, DOI [10.1038/nphys2442, 10.1038/NPHYS2442]; Roushan P, 2009, NATURE, V460, P1106, DOI 10.1038/nature08308; Lawler MJ, 2010, NATURE, V466, P347, DOI 10.1038/nature09169; Hanaguri T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.081305; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Li G, 2007, NAT PHYS, V3, P623, DOI 10.1038/nphys653; Hoesch M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.241401; Zeljkovic I, 2014, NAT PHYS, V10, P572, DOI 10.1038/NPHYS3012; Tanaka Y, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.155105; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Linder J, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.014513; Fu LA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.106802; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Zeljkovic I, 2012, NAT MATER, V11, P585, DOI [10.1038/nmat3315, 10.1038/NMAT3315]; Chen YL, 2009, SCIENCE, V325, P178, DOI 10.1126/science.1173034; Wojek BM, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115106; Hsieh D, 2009, NATURE, V460, P1101, DOI 10.1038/nature08234; Xia Y, 2009, NAT PHYS, V5, P398, DOI 10.1038/NPHYS1274; Dziawa P, 2012, NAT MATER, V11, P1023, DOI [10.1038/nmat3449, 10.1038/NMAT3449]; Goldstein G., 2014, PREPRINT; Gyenis A, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.125414; Hashimoto K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.256802; Hsieh TH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1969; Klijn J, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.205327; Liu JW, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.241303; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; SNYKERS M, 1972, MATER RES BULL, V7, P831, DOI 10.1016/0025-5408(72)90133-X; Soumyanarayanan A., 2013, PREPRINT; Xu SY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2191; Yan CH, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.186801	34	14	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	MAR	2015	14	3					318	324		10.1038/NMAT4215		7	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CC1WP	WOS:000350136400020		
J	Hirata, S; Sakai, Y; Masui, K; Tanaka, H; Lee, SY; Nomura, H; Nakamura, N; Yasumatsu, M; Nakanotani, H; Zhang, QS; Shizu, K; Miyazaki, H; Adachi, C				Hirata, Shuzo; Sakai, Yumi; Masui, Kensuke; Tanaka, Hiroyuki; Lee, Sae Youn; Nomura, Hiroko; Nakamura, Nozomi; Yasumatsu, Mao; Nakanotani, Hajime; Zhang, Qisheng; Shizu, Katsuyuki; Miyazaki, Hiroshi; Adachi, Chihaya			Highly efficient blue electroluminescence based on thermally activated delayed fluorescence	NATURE MATERIALS			English	Article							LIGHT-EMITTING-DIODES; MOLECULAR-ORBITAL METHODS; DEVICES; ABSORPTION; COMPLEXES; SINGLET	Organic compounds that exhibit highly efficient, stable blue emission are required to realize inexpensive organic light-emitting diodes for future displays and lighting applications. Here, we define the design rules for increasing the electroluminescence efficiency of blue-emitting organic molecules that exhibit thermally activated delayed fluorescence. We show that a large delocalization of the highest occupied molecular orbital and lowest unoccupied molecular orbital in these charge-transfer compounds enhances the rate of radiative decay considerably by inducing a large oscillator strength even when there is a small overlap between the two wavefunctions. A compound based on our design principles exhibited a high rate of fluorescence decay and efficient up-conversion of triplet excitons into singlet excited states, leading to both photoluminescence and internal electroluminescence quantum yields of nearly 100%.	[Hirata, Shuzo; Sakai, Yumi; Masui, Kensuke; Tanaka, Hiroyuki; Lee, Sae Youn; Nomura, Hiroko; Nakamura, Nozomi; Yasumatsu, Mao; Nakanotani, Hajime; Zhang, Qisheng; Shizu, Katsuyuki; Miyazaki, Hiroshi; Adachi, Chihaya] Kyushu Univ, Ctr Organ Photon & Elect Res OPERA, Nishi Ku, Fukuoka 8190395, Japan; [Sakai, Yumi] Dyden Corp, Dept Res & Dev, Kurume, Fukuoka 8390864, Japan; [Masui, Kensuke] Fujifilm Corp, Adv Core Technol Labs, Ashigarakami, Kanagawa 2588577, Japan; [Lee, Sae Youn; Nakanotani, Hajime; Zhang, Qisheng; Shizu, Katsuyuki; Adachi, Chihaya] JST, ERATO, Adachi Mol Exciton Engn Project, Nishi Ku, Fukuoka 8190395, Japan; [Nakanotani, Hajime] Inst Syst Informat Technol & Nanotechnol ISIT, Innovat Organ Device Lab, Nishi Ku, Fukuoka 8190395, Japan; [Miyazaki, Hiroshi] Nippon Steel & Sumikin Chem Co Ltd, Kitakyushu, Fukuoka 8048503, Japan; [Adachi, Chihaya] Kyushu Univ, Int Inst Carbon Neutral Energy Res, Nishi Ku, Fukuoka 8190395, Japan	Adachi, C (reprint author), Kyushu Univ, Ctr Organ Photon & Elect Res OPERA, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	adachi@opera.kyushu-u.ac.jp	Nakanotani, Hajime/A-4513-2015		World-Leading Innovative R&D on Science and Technology (FIRST); nternational Institute for Carbon Neutral Energy Research [WPI-I2CNER]; MEXT	This work was supported in part by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) and the International Institute for Carbon Neutral Energy Research (WPI-I2CNER) sponsored by MEXT. The authors thank K. Tokumaru for stimulating discussions regarding this work. The authors also thank W. J. Potscavage Jr for assistance with preparation of this manuscript.	Kondakov DY, 2007, J APPL PHYS, V102, DOI 10.1063/1.2818362; Tanaka H, 2012, CHEM COMMUN, V48, P11392, DOI 10.1039/c2cc36237f; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Uoyama H, 2012, NATURE, V492, P234, DOI 10.1038/nature11687; Deaton JC, 2010, J AM CHEM SOC, V132, P9499, DOI 10.1021/ja1004575; FRISCH MJ, 1984, J CHEM PHYS, V80, P3265, DOI 10.1063/1.447079; Dias FB, 2013, ADV MATER, V25, P3707, DOI 10.1002/adma.201300753; Adachi C, 2001, J APPL PHYS, V90, P5048, DOI 10.1063/1.1409582; Kim S, 2011, ADV MATER, V23, P3511, DOI 10.1002/adma.201101066; Kondakov DY, 2009, J APPL PHYS, V106, DOI 10.1063/1.3273407; Endo A, 2009, ADV MATER, V21, P4802, DOI 10.1002/adma.200900983; Okumoto K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2266452; Li J, 2013, ADV MATER, V25, P3319, DOI 10.1002/adma.201300575; Reineke S, 2009, NATURE, V459, P234, DOI 10.1038/nature08003; Nakagawa T, 2012, CHEM COMMUN, V48, P9580, DOI 10.1039/c2cc31468a; Mehes G, 2012, ANGEW CHEM INT EDIT, V51, P11311, DOI 10.1002/anie.201206289; STRICKLER SJ, 1962, J CHEM PHYS, V37, P814, DOI 10.1063/1.1733166; Jeon SO, 2012, J MATER CHEM, V22, P4233, DOI 10.1039/c1jm14832j; Zhang QS, 2014, NAT PHOTONICS, V8, P326, DOI 10.1038/NPHOTON.2014.12; Lee SY, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4749285; Hashimoto M, 2011, J AM CHEM SOC, V133, P10348, DOI 10.1021/ja202965y; Baldo MA, 1998, NATURE, V395, P151; Fukagawa H, 2012, ORG ELECTRON, V13, P1197, DOI 10.1016/j.orgel.2012.03.019; Goushi K, 2012, NAT PHOTONICS, V6, P253, DOI 10.1038/nphoton.2012.31; Endo A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3558906; Zhang QS, 2012, J AM CHEM SOC, V134, P14706, DOI 10.1021/ja306538w; Yu ZB, 2011, ADV MATER, V23, P3989, DOI 10.1002/adma.201101986; Lee J, 2013, J MATER CHEM C, V1, P4599, DOI 10.1039/c3tc30699b; Serevicius T, 2013, PHYS CHEM CHEM PHYS, V15, P15850, DOI 10.1039/c3cp52255e; Peng QM, 2013, ADV OPT MATER, V1, P362, DOI 10.1002/adom.201300028; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; DITCHFIE.R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; Frisch M. J., 2004, GAUSSIAN 09 REVISION; Mulliken RS, 1939, J CHEM PHYS, V7, P14, DOI 10.1063/1.1750317; Nakanotani H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02127; Sato K, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.247401; TANG CW, 1987, APPL PHYS LETT, V51, P913, DOI 10.1063/1.98799	37	25	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	MAR	2015	14	3					330	336		10.1038/NMAT4154		7	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CC1WP	WOS:000350136400022		
J	Kurosaki, T; Kometani, K; Ise, W				Kurosaki, Tomohiro; Kometani, Kohei; Ise, Wataru			Memory B cells	NATURE REVIEWS IMMUNOLOGY			English	Review							GERMINAL CENTER SELECTION; FOLLICULAR HELPER-CELLS; CD4(+) T-CELLS; PLASMA-CELLS; IMMUNOLOGICAL MEMORY; ANTIBODY-RESPONSES; IMMUNE-RESPONSE; NEUTRALIZING ANTIBODIES; AFFINITY MATURATION; PROTECTIVE IMMUNITY	The immune system can remember a previously experienced pathogen and can evoke an enhanced response to reinfection that depends on memory lymphocyte populations. Recent advances in tracking antigen-experienced memory B cells have revealed the existence of distinct classes of cells that have considerable functional differences. Some of these differences seem to be determined by the stimulation history during memory cell formation. To induce rapid recall antibody responses, the contributions of other types of cells, such as memory T follicular helper cells, have also now begun to be appreciated. In this Review, we discuss these and other recent advances in our understanding of memory B cells, focusing on the underlying mechanisms that are required for rapid and effective recall antibody responses. of	[Kurosaki, Tomohiro; Ise, Wataru] Osaka Univ, Lab Lymphocyte Differentiat, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Kurosaki, Tomohiro; Ise, Wataru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Kurosaki, Tomohiro; Kometani, Kohei] RIKEN, Ctr Integrat Med Sci, Lab Lymphocyte Differentiat, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Kurosaki, T (reprint author), Osaka Univ, Lab Lymphocyte Differentiat, World Premier Int Immunol Frontier Res Ctr, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	kurosaki@ifrec.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology in Japan; Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST); Secom Science and Technology Foundation; RIKEN Special Postdoctoral Researchers Program	The authors thank Y. Takahashi and P. D. Burrows for critical reading of the manuscript, and T. Inoue for sharing unpublished data. This work was supported in part by grants provided by the Ministry of Education, Culture, Sports, Science, and Technology in Japan (to W.I. and T.K.); Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST; to T.K.); Secom Science and Technology Foundation (to T.K.); and RIKEN Special Postdoctoral Researchers Program (to K.K.).	Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barrington RA, 2002, J EXP MED, V196, P1189, DOI 10.1084/jem.20021110; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Engels N, 2009, NAT IMMUNOL, V10, P1018, DOI 10.1038/ni.1764; Yang ZY, 2012, IMMUNITY, V36, P857, DOI 10.1016/j.immuni.2012.02.009; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Xiong HZ, 2012, J EXP MED, V209, P353, DOI 10.1084/jem.20111941; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Benson MJ, 2008, J IMMUNOL, V180, P3655; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; He JS, 2013, J EXP MED, V210, P2755, DOI 10.1084/jem.20131539; MacLeod MKL, 2011, J IMMUNOL, V186, P2889, DOI 10.4049/jimmunol.1002955; Takemori T, 2014, EUR J IMMUNOL, V44, P1258, DOI 10.1002/eji.201343716; Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Kardava L, 2011, J CLIN INVEST, V121, P2614, DOI 10.1172/JCI45685; Klein U, 1997, BLOOD, V89, P1288; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Talay O, 2012, NAT IMMUNOL, V13, P396, DOI 10.1038/ni.2256; Schwickert TA, 2009, J EXP MED, V206, P2907, DOI 10.1084/jem.20091225; Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Maruyama M, 2000, NATURE, V407, P636; Brightbill HD, 2010, J CLIN INVEST, V120, P2218, DOI 10.1172/JCI40141; Hikida M, 2009, J EXP MED, V206, P681, DOI 10.1084/jem.20082100; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Clybouw C, 2011, BLOOD, V118, P4120, DOI 10.1182/blood-2011-04-347096; Yang Y, 2012, P NATL ACAD SCI USA, V109, P5388, DOI 10.1073/pnas.1121627109; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Obukhanych TV, 2006, J EXP MED, V203, P305, DOI 10.1084/jem.20052036; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; Keating R, 2013, NAT IMMUNOL, V14, P1266, DOI 10.1038/ni.2741; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Ise W, 2014, P NATL ACAD SCI USA, V111, P11792, DOI 10.1073/pnas.1404671111; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Hebeis BJ, 2004, J EXP MED, V199, P593, DOI 10.1084/jem.20030091; Charles ED, 2011, BLOOD, V117, P5425, DOI 10.1182/blood-2010-10-312942; Wang NS, 2012, NAT IMMUNOL, V13, P604, DOI 10.1038/ni.2294; Tsai LM, 2014, IMMUNOL CELL BIOL, V92, P57, DOI 10.1038/icb.2013.68; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Weber JP, 2012, EUR J IMMUNOL, V42, P1981, DOI 10.1002/eji.201242540; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Bossaller L, 2006, J IMMUNOL, V177, P4927; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Fischer SF, 2007, BLOOD, V110, P3978, DOI 10.1182/blood-2007-05-091306; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Heesters BA, 2013, IMMUNITY, V38, P1164, DOI 10.1016/j.immuni.2013.02.023; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; BEREK C, 1992, IMMUNOL REV, V126, P5, DOI 10.1111/j.1600-065X.1992.tb00628.x; Boswell KL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003853; Carrington EM, 2010, P NATL ACAD SCI USA, V107, P10967, DOI 10.1073/pnas.1005256107; Chen M, 2014, NAT MED, V20, P507, DOI 10.1038/nm.3521; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; FORSTER R, 1994, BLOOD, V84, P830; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Liu WL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002820; Montecino-Rodriguez E, 2012, IMMUNITY, V36, P13, DOI 10.1016/j.immuni.2011.11.017; Shimoda M, 2006, J IMMUNOL, V176, P2122; Weill JC, 2013, CURR OPIN IMMUNOL, V25, P334, DOI 10.1016/j.coi.2013.05.004; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	94	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	MAR	2015	15	3					149	159		10.1038/nri3802		11	Immunology	Immunology	CC4MR	WOS:000350328000009		
J	Tawa, M; Shimosato, T; Iwasaki, H; Imamura, T; Okamura, T				Tawa, Masashi; Shimosato, Takashi; Iwasaki, Hirotaka; Imamura, Takeshi; Okamura, Tomio			Vasorelaxing effects of the soluble guanylyl cyclase activator BAY 60-2770 in nitrate-tolerant monkey and canine coronary arteries	NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY			English	Article						sGC activator; Nitrate tolerance; Coronary artery; Relaxation	BLOOD-VESSELS; NITRIC-OXIDE; NITROVASODILATORS	Nitrate tolerance is an important problem in the treatment of ischemic heart diseases. The present study investigated whether or not a soluble guanylyl cyclase (sGC) activator can be used as a coronary vasodilator under nitrate-tolerant conditions. Helically cut strips of endothelium-denuded monkey and canine coronary arteries were suspended in organ chambers for isometric tension recording. Nitrate tolerance was induced by a 1-h treatment with nitroglycerin (0.1 mM) followed by 1-h washout of the agent. Control strips were not exposed previously to nitroglycerin, but otherwise were treated identically. The relaxant response to nitroglycerin was dramatically impaired by previous exposure to the drug for 1 h in either monkey or canine coronary arteries, indicating the development of nitrate tolerance. In contrast, development of nitrate tolerance did not affect the relaxant potency and efficacy of the sGC activator BAY 60-2770 in either the monkey or canine coronary arteries. These findings suggest that it may be possible to use sGC activators as substitute drugs for nitroglycerin if tolerance is developed during the treatment of ischemic heart diseases.	[Tawa, Masashi; Shimosato, Takashi; Iwasaki, Hirotaka; Imamura, Takeshi; Okamura, Tomio] Shiga Univ Med Sci, Dept Pharmacol, Otsu, Shiga 5202192, Japan; [Shimosato, Takashi] NISSEI BILIS Co Ltd, Res Dept, Koka, Shiga 5280052, Japan	Tawa, M (reprint author), Shiga Univ Med Sci, Dept Pharmacol, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	tawa@belle.shiga-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23390055]	The authors wish to thank Dr. J. P. Stasch (Institute of Cardiovascular Research, Pharma Research Centre, Bayer AG) for the gift of BAY compounds. This study was supported in part by the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Grant No. 23390055).	Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Follmann M, 2013, ANGEW CHEM INT EDIT, V52, P9442, DOI 10.1002/anie.201302588; Schindler U, 2006, MOL PHARMACOL, V69, P1260, DOI 10.1124/mol.105.018747; Hink U, 2007, J AM COLL CARDIOL, V50, P2226, DOI 10.1016/j.jacc.2007.08.031; Munzel T, 2013, EUR HEART J, V34, P2666, DOI 10.1093/eurheartj/eht249; Stasch JP, 2002, BRIT J PHARMACOL, V136, P773, DOI 10.1038/sj.bjp.0704778; Mulsch A, 2001, CIRCULATION, V103, P2188; Boerrigter G, 2007, HYPERTENSION, V49, P1128, DOI 10.1161/HYPERTENSIONAHA.106.083832; Bice JS, 2014, CARDIOVASC RES, V101, P220, DOI 10.1093/cvr/cvt257; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Fraccarollo D, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0421-1; MERKEL LA, 1992, EUR J PHARMACOL, V216, P29, DOI 10.1016/0014-2999(92)90205-I; Murohara T, 1996, J VASC RES, V33, P78, DOI 10.1159/000159135; Omura T, 2001, CLIN EXP PHARMACOL P, V28, P259, DOI 10.1046/j.1440-1681.2001.03436.x; O'Rourke ST, 2003, BRIT J PHARMACOL, V139, P1326, DOI 10.1038/sj.bjp.0705383; Tawa M, 2014, J PHARMACOL SCI, V125, P169, DOI 10.1254/jphs.14046FP; Zhou ZM, 2008, AM J PHYSIOL-HEART C, V295, pH1763, DOI 10.1152/ajpheart.51.2008	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-1298	1432-1912		N-S ARCH PHARMACOL	Naunyn-Schmiedebergs Arch. Pharmacol.	MAR	2015	388	3					381	385		10.1007/s00210-014-1083-0		5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC4GZ	WOS:000350311800010		
J	Okuyama, Y; Uchida, HA; Tenta, M; Nunoue, T; Umebayashi, R; Morinaga, H; Kitamura, S; Maeshima, Y; Sugiyama, H; Wada, J				Okuyama, Yuka; Uchida, Haruhito Adam; Tenta, Masafumi; Nunoue, Tomokazu; Umebayashi, Ryoko; Morinaga, Hiroshi; Kitamura, Shinji; Maeshima, Yohei; Sugiyama, Hitoshi; Wada, Jun			AUTOIMMUNE PANCREATITIS AND MINIMAL CHANGE NEPHROTIC SYNDROME: AN UNUSUAL ASSOCIATION?	NEPHROLOGY			English	Letter							INVOLVEMENT		[Okuyama, Yuka; Uchida, Haruhito Adam; Tenta, Masafumi; Nunoue, Tomokazu; Umebayashi, Ryoko; Morinaga, Hiroshi; Kitamura, Shinji; Wada, Jun] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008530, Japan; [Maeshima, Yohei] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Chron Kidney Dis & Cardiovasc Dis, Okayama 7008530, Japan; [Sugiyama, Hitoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Chron Kidney Dis & Peritoneal Dialysis, Okayama 7008530, Japan	Okuyama, Y (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008530, Japan.		Wada, Jun/B-2023-2011	Wada, Jun/0000-0003-1468-5170			Francois H, 2007, AM J KIDNEY DIS, V49, P158, DOI 10.1053/j.ajkd.2006.10.015; Alexander MP, 2013, KIDNEY INT, V83, P455, DOI 10.1038/ki.2012.382; Watanabe T, 2012, ARTHRITIS RHEUM-US, V64, P914, DOI 10.1002/art.33386; SHALHOUB RJ, 1974, LANCET, V2, P556; Kusuda T, 2011, PANCREAS, V40, P1120, DOI 10.1097/MPA.0b013e31821fc796; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5358	1440-1797		NEPHROLOGY	Nephrology	MAR	2015	20	3					225	226		10.1111/nep.12370		2	Urology & Nephrology	Urology & Nephrology	CC3TY	WOS:000350274200017		
J	Fung, CCA; Amari, SI				Fung, C. C. Alan; Amari, S. -i.			Spontaneous Motion on Two-Dimensional Continuous Attractors	NEURAL COMPUTATION			English	Article							EXCITATORY NEURONAL NETWORK; FREELY MOVING RATS; SYNAPTIC DEPRESSION; HEAD-DIRECTION; NEURAL-NETWORKS; DYNAMICAL SYNAPSES; ANTERIOR THALAMUS; ADAPTATION; POSTSUBICULUM; ORIENTATION	Attractor models are simplified models used to describe the dynamics of firing rate profiles of a pool of neurons. The firing rate profile, or the neuronal activity, is thought to carry information. Continuous attractor neural networks (CANNs) describe the neural processing of continuous information such as object position, object orientation, and direction of object motion. Recently it was found that in one-dimensional CANNs, short-term synaptic depression can destabilize bump-shaped neuronal attractor activity profiles. In this article, we study two-dimensional CANNs with short-term synaptic depression and spike frequency adaptation. We found that the dynamics of CANNs with short-term synaptic depression and CANNs with spike frequency adaptation are qualitatively similar. We also found that in both kinds of CANNs, the perturbative approach can be used to predict phase diagrams, dynamical variables, and speed of spontaneous motion.	[Fung, C. C. Alan] Hong Kong Univ Sci & Technol, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Amari, S. -i.] RIKEN, Brain Sci Inst, Lab Math Neurosci, Wako, Saitama 3510198, Japan	Fung, CCA (reprint author), Hong Kong Univ Sci & Technol, Dept Phys, Hong Kong, Hong Kong, Peoples R China.	phccfung@ust.hk; amari@brain.riken.jp			Research Grants Council of Hong Kong [604512, 605813, N_HKUST 606/12]	This study is partially supported by the Research Grants Council of Hong Kong (grants 604512, 605813 and N_HKUST 606/12).	OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; TAUBE JS, 1990, J NEUROSCI, V10, P436; Zhang K, 1996, J NEUROSCI, V16, P2112; Kilpatrick ZP, 2010, J COMPUT NEUROSCI, V28, P193, DOI 10.1007/s10827-009-0199-6; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319; Fleidervish IA, 1996, J PHYSIOL-LONDON, V493, P83; Benda J, 2003, NEURAL COMPUT, V15, P2523, DOI 10.1162/089976603322385063; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985; FUNAHASHI S, 1993, J NEUROSCI, V13, P1479; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Loebel A, 2002, J COMPUT NEUROSCI, V13, P111, DOI 10.1023/A:1020110223441; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Pouget A, 1998, NEURAL COMPUT, V10, P373, DOI 10.1162/089976698300017809; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; Wu S, 2008, NEURAL COMPUT, V20, P994, DOI 10.1162/neco.2008.10-06-378; Ben-Yishai B., 1995, P NATL ACAD SCI USA, V92, P3844, DOI [DOI 10.1073/PNAS.92.9.3844, 10.1073/pnas.92.9.3844]; BLAIR HT, 1995, J NEUROSCI, V15, P6260; Fung C. C. A., 2012, ADV NEURAL INFORM PR, V25, P1097; Fung CCA, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00073; Fung CCA, 2012, NEURAL COMPUT, V24, P1147, DOI 10.1162/NECO_a_00269; Fung CCA, 2010, NEURAL COMPUT, V22, P752, DOI 10.1162/neco.2009.07-08-824; Kilpatrick ZP, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00085; Kilpatrick ZP, 2010, PHYSICA D, V239, P547, DOI 10.1016/j.physd.2009.06.003; Lu Y, 2011, NEURAL COMPUT, V23, P1248, DOI 10.1162/NECO_a_00111; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127; Taube JS, 1998, HIPPOCAMPUS, V8, P87, DOI 10.1002/(SICI)1098-1063(1998)8:2<87::AID-HIPO1>3.0.CO;2-4; Wang H., 2014, RICH SPECTRUM UNPUB; Wimmer K, 2014, NAT NEUROSCI, V17, P431, DOI 10.1038/nn.3645; York LC, 2009, J COMPUT NEUROSCI, V27, P607, DOI 10.1007/s10827-009-0172-4	33	1	1	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0899-7667	1530-888X		NEURAL COMPUT	Neural Comput.	MAR	2015	27	3					507	547		10.1162/NECO_a_00711		41	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	CC3AX	WOS:000350217600001		
J	Petcov, ST				Petcov, S. T.			Predicting the values of the leptonic CP violation phases in theories with discrete flavour symmetries	NUCLEAR PHYSICS B			English	Article							DOUBLE-BETA-DECAY; NEUTRINO OSCILLATIONS; MAJORANA NEUTRINOS; PARTICLE PHYSICS; MIXING ANGLES; MASS; PARAMETRIZATION; AMPLIFICATION; LEPTOGENESIS; DIRAC	Using the fact that the neutrino mixing matrix U = (UeU nu)-U-dagger, where U-e and U-nu result from the diagonalisation of the charged lepton and neutrino mass matrices, we consider a number of forms of U-nu associated with a variety of discrete symmetries: i) bimaximal (BM) and ii) tri-bimaximal (TBM) forms, the forms corresponding iii) to the conservation of the lepton charge L' = L-e - L-mu - L-tau (LC), iv) to golden ratio type A (GRA) mixing, v) to golden ratio type B (GRB) mixing, and vi) to hexagonal (HG) mixing. Employing the minimal form of U-e, in terms of angles and phases it contains, that can provide the requisite corrections to U-nu so that reactor, atmospheric and solar neutrino mixing angles theta(13), theta(23) and theta(12) have values compatible with the current data, including a possible sizable deviation of theta(23) from pi/4, we discuss the possibility to obtain predictions for the CP violation phases in the neutrino mixing matrix. Considering the "standard ordering" of the 12 and the 23 rotations in U-e and following the approach developed in [1] we derive predictions for the Dirac phase delta and the rephasing invariant J(CP) in the cases of GRA, ORB and HG forms of U-nu (results for the TBM and BM (LC) forms were obtained in [1]). We show also that under rather general conditions within the scheme considered the values of the Majorana phases in the PMNS matrix can be predicted for each of the forms of U-nu discussed. We give examples of these predictions and of their implications for neutrinoless double beta decay. In the GRA, ORB and HG cases, as in the TBM one, relatively large CP violation effects in neutrino oscillations are predicted (vertical bar J(CP)vertical bar similar to (0.031-0.034)). Distinguishing between the TBM, BM (LC), GRA, GRB and HG forms of U-nu requires a measurement of cos (3 or a relatively high precision measurement of J(CP).	[Petcov, S. T.] Ist Nazl Fis Nucl, SISSA, I-34136 Trieste, Italy; [Petcov, S. T.] Univ Tokyo, Kavli IPMU WPI, Kashiwa, Chiba 2778583, Japan; [Petcov, S. T.] Bulgarian Acad Sci, Inst Nucl Res & Nucl Energy, BU-1784 Sofia, Bulgaria	Petcov, ST (reprint author), Ist Nazl Fis Nucl, SISSA, Via Bonomea 265, I-34136 Trieste, Italy.				European Union FP7 ITN INVISIBLES (Marie Curie Actions) [PITN-GA-2011-289442-INVISIBLES]; INFN program on Theoretical Astroparticle Physics (TASP); Italian Ministry of Education, University and Research (MIUR) [2012CPPYP7]; World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan	The author would like to thank I. Girardi, A. Titov, W. Rodejohann and He Zhang for useful discussions. This work was supported in part also by the European Union FP7 ITN INVISIBLES (Marie Curie Actions, PITN-GA-2011-289442-INVISIBLES), by the INFN program on Theoretical Astroparticle Physics (TASP), by the research grant 2012CPPYP7 (Theoretical Astroparticle Physics) under the program PRIN 2012 funded by the Italian Ministry of Education, University and Research (MIUR), and by the World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan.	Abe K., ARXIV14031432; Adams C., ARXIV13075700; Adulpravitchai A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/6/063026; Agarwalla S.K., ARXIV13126520; Altarelli G., 2012, J HIGH ENERGY PHYS, V1208; Altarelli G., ARXIV12055133; Chen MC, 2009, PHYS LETT B, V681, P444, DOI 10.1016/j.physletb.2009.10.059; Yoshimura M, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.113007; Baltz AJ, 1998, PHYS REV LETT, V81, P5730, DOI 10.1103/PhysRevLett.81.5730; LANGACKER P, 1987, NUCL PHYS B, V282, P589, DOI 10.1016/0550-3213(87)90699-7; Kajiyama Y, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.117301; Antusch S, 2005, PHYS LETT B, V631, P42, DOI 10.1016/j/physletb.2005.09.075; Masina I, 2006, PHYS LETT B, V633, P134, DOI 10.1016/j.physletb.2005.10.097; Xing ZZ, 2002, PHYS LETT B, V533, P85, DOI 10.1016/S0370-2693(02)01649-0; MINKOWSKI P, 1977, PHYS LETT B, V67, P421, DOI 10.1016/0370-2693(77)90435-X; An FP, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.061801; Adamson P, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.191801; Luhn C, 2013, NUCL PHYS B, V875, P80, DOI 10.1016/j.nuclphysb.2013.07.003; Altarelli G, 2004, NUCL PHYS B, V689, P157, DOI [10.1016/j.nuclphysb.2004.04.012, 10.1016/j.nuclphysb.2004.02.012]; Barger V, 1998, PHYS LETT B, V437, P107, DOI 10.1016/S0370-2693(98)00880-6; King SF, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/4/045018; Petcov ST, 2006, NUCL PHYS B, V738, P219, DOI 10.1016/j.nuciphysb.2005.12.028; WOLFENSTEIN L, 1978, PHYS REV D, V18, P958, DOI 10.1103/PhysRevD.18.958; Altarelli G, 2010, REV MOD PHYS, V82, P2701, DOI 10.1103/RevModPhys.82.2701; Harrison PF, 2002, PHYS LETT B, V530, P167, DOI 10.1016/S0370-2693(02)01336-9; KAYSER B, 1984, PHYS REV D, V30, P1023, DOI 10.1103/PhysRevD.30.1023; [Anonymous], 2001, PHYS REV D; Harrison PF, 2002, PHYS LETT B, V535, P163, DOI 10.1016/S0370-2693(02)01753-7; Albright CH, 2010, EUR PHYS J C, V70, P1099, DOI 10.1140/epjc/s10052-010-1492-2; BILENKY SM, 1980, PHYS LETT B, V94, P495, DOI 10.1016/0370-2693(80)90927-2; BILENKY SM, 1987, REV MOD PHYS, V59, P671, DOI 10.1103/RevModPhys.59.671; Albright CH, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.113006; Giunti C, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.053013; MOHAPATRA RN, 1980, PHYS REV LETT, V44, P912, DOI 10.1103/PhysRevLett.44.912; Abe K, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.061802; King SF, 2013, PHYS LETT B, V726, P312, DOI 10.1016/j.physletb.2013.08.052; KRASTEV PI, 1988, PHYS LETT B, V205, P84, DOI 10.1016/0370-2693(88)90404-2; He XG, 2003, PHYS LETT B, V560, P87, DOI 10.1016/S0370-2693(03)00390-3; Hanlon AD, 2014, PHYS LETT B, V729, P185, DOI 10.1016/j.physletb.2013.12.063; Antusch S, 2013, NUCL PHYS B, V866, P255, DOI 10.1016/j.nuclphysb.2012.09.002; Giunti C, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.113006; King SF, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/5/056201; Meroni A, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.113003; Romanino A, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.013003; Antusch S., 2007, JHEP, V0704, P060; Antusch S, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.117301; Bazzocchi F., ARXIV12055135; BILENKY SM, 1984, NUCL PHYS B, V247, P61, DOI 10.1016/0550-3213(84)90372-9; Capozzi F., 2014, ARXIV13122878V2; Capozzi F, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.093018; Chao W, 2013, J HIGH ENERGY PHYS, V1302; Chen M.-C., 2013, J HIGH ENERGY PHYS, V1310, P112; Dasgupta B., ARXIV14040272; de Gouvea A., ARXIV13104340; Ding G.-J., ARXIV14040592; Dinh DN, 2013, PHYS LETT B, V719, P154, DOI 10.1016/j.physletb.2013.01.015; Duarah C., ARXIV12108265; Everett LL, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.085005; Frampton PH, 2004, NUCL PHYS B, V687, P31, DOI 10.1016/j.nuclphysb.2004.03.014; Garg S.K., 2013, J HIGH ENERGY PHYS, V1310, P128; Gell-Mann M., 1979, TALK SAN C FEB; Girardi I., ARXIV14108056; Girardi I., 2014, J HIGH ENERGY PHYS, V1402, P050; Glashow S.L., 1979, CARGESE LECT; Gollu S, 2013, MOD PHYS LETT A, V28; Gollu S., ARXIV13033393; Gonzalez-Garcia MC, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP12(2012)123; Hall L.J., 2013, J HIGH ENERGY PHYS, V1311; Hochmuth KA, 2007, PHYS LETT B, V654, P177, DOI 10.1016/j.physletb.2007.08.072; Ibarra A, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.013005; Ishimori H, 2010, PROG THEOR PHYS SUPP, P1; Kile J, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.013004; King S. F., 2005, JHEP, V0508, P105; Liu Z, 2014, PHYS LETT B, V733, P226, DOI 10.1016/j.physletb.2014.04.049; Marzocca D, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2011)009; Marzocca D., 2013, J HIGH ENERGY PHYS, V1305, P073; Molinaro E, 2009, EUR PHYS J C, V61, P93, DOI 10.1140/epjc/s10052-009-0985-3; Nakamura K., 2014, CHINESE PHYS C, V38; Pascoli S, 2003, PHYS LETT B, V564, P241, DOI 10.1016/S0370-2693(03)00698-1; Petcov ST, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.073002; PETCOV ST, 1982, PHYS LETT B, V110, P245, DOI 10.1016/0370-2693(82)91246-1; Petcov ST, 2005, PHYS SCRIPTA, VT121, P94, DOI 10.1088/0031-8949/2005/T121/013; Rodejohann W, 2011, INT J MOD PHYS E, V20, P1833, DOI 10.1142/S0218301311020186; Rodejohann W, 2009, PHYS LETT B, V671, P267, DOI 10.1016/j.physletb.2008.12.010; Shimizu Y., ARXIV14051521; Vissani F., ARXIVHEPPH9708483; WOLFENSTEIN L, 1981, PHYS LETT B, V107, P77, DOI 10.1016/0370-2693(81)91151-5; Yanagida T., 1979, P WORKSH UN THEOR BA	88	15	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	MAR	2015	892						400	428		10.1016/j.nuclphysb.2015.01.011		29	Physics, Particles & Fields	Physics	CC1HT	WOS:000350092500020		
J	Hanada, M; Shimada, H				Hanada, Masanori; Shimada, Hidehiko			On the continuity of the commutative limit of the 4d N=4 non-commutative super Yang-Mills theory	NUCLEAR PHYSICS B			English	Article							LATTICE GAUGE-THEORY; LIGHT-CONE; ULTRAVIOLET FINITENESS; FIELD-THEORIES; REDUCED MODEL; MATRIX MODEL; ONE-LOOP	We study the commutative limit of the non-commutative maximally supersymmetric Yang-Mills theory in four dimensions (N = 4 SYM), where non-commutativity is introduced in the two spacelike directions. The commutative limits of non-commutative spaces are important in particular in the applications of non-commutative spaces for regularisation of supersymmetric theories (such as the use of non-commutative spaces as alternatives to lattices for supersymmetric gauge theories and interpretations of some matrix models as regularised supermembrane or superstring theories), which in turn can play a prominent role in the study of quantum gravity via the gauge/gravity duality. In general, the commutative limits are known to be singular and non-smooth due to UV/IR mixing effects. We give a direct proof that UV effects do not break the continuity of the commutative limit of the non-commutative N = 4 SYM to all order in perturbation theory, including non-planar contributions. This is achieved by establishing the uniform convergence (with respect to the non-commutative parameter) of momentum integrals associated with all Feynman diagrams appearing in the theory, using the same tools involved in the proof of finiteness of the commutative N = 4 SYM. (C) 2015 The Authors. Published by Elsevier B.V.	[Hanada, Masanori] Stanford Univ, Stanford Inst Theoret Phys, Stanford, CA 94305 USA; [Hanada, Masanori] Kyoto Univ, Yukawa Inst Theoret Phys, Sakyo Ku, Kyoto 6068502, Japan; [Hanada, Masanori] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068501, Japan; [Shimada, Hidehiko] Okayama Inst Quantum Phys, Okayama, Japan	Hanada, M (reprint author), Stanford Univ, Stanford Inst Theoret Phys, Stanford, CA 94305 USA.	hanada@yukawa.kyoto-u.ac.jp			Japanese Ministry of Education, Sciences and Technology, Sports and Culture (MEXT) [25287046]; National Science Foundation [PHYS-1066293]	The authors would like to thank S. Kovacs, S. Matsuura, F. Sugino for their careful reading of our manuscript and very useful discussions and comments. We would like to thank S. Ananth, L. Brink, L. Dixon, T. McLoughlin, and J. Nishimura for very useful discussions and comments. The work of M. H. is supported in part by the Grant-in-Aid of the Japanese Ministry of Education, Sciences and Technology, Sports and Culture (MEXT) for Scientific Research (No. 25287046), and the National Science Foundation under Grant No. PHYS-1066293 and the hospitality of the Aspen Center for Physics.	Alvarez-Gaume L, 2001, INT J MOD PHYS A, V16, P1123, DOI 10.1142/S0217751X01002759; Ananth S, 2007, NUCL PHYS B, V783, P227, DOI 10.1016/j.nuclphysb.2007.04.005; Ananth S., 2012, JHEP, V1205; Ananth S., 2007, JHEP, V0701; GONZALEZARROYO A, 1983, PHYS REV D, V27, P2397, DOI 10.1103/PhysRevD.27.2397; WEINBERG S, 1960, PHYS REV, V118, P838, DOI 10.1103/PhysRev.118.838; DEWIT B, 1988, NUCL PHYS B, V305, P545, DOI 10.1016/0550-3213(88)90116-2; GRISARU MT, 1979, NUCL PHYS B, V159, P429, DOI 10.1016/0550-3213(79)90344-4; GONZALEZARROYO A, 1983, PHYS LETT B, V120, P174, DOI 10.1016/0370-2693(83)90647-0; Aschieri P, 2006, CLASSICAL QUANT GRAV, V23, P1883, DOI 10.1088/0264-9381/23/6/005; Catterall S, 2009, PHYS REP, V484, P71, DOI 10.1016/j.physrep.2009.09.001; Maldacena J, 1999, INT J THEOR PHYS, V38, P1113, DOI 10.1023/A:1026654312961; Steinacker H, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/13/133001; Hayakawa M, 2000, PHYS LETT B, V478, P394, DOI 10.1016/S0370-2693(00)00242-2; Ishiki G, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.111601; Ishibashi N, 1997, NUCL PHYS B, V498, P467, DOI 10.1016/S0550-3213(97)00290-3; Catterall S, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.065013; Hanada M, 2014, SCIENCE, V344, P882, DOI 10.1126/science.1250122; Douglas MR, 2001, REV MOD PHYS, V73, P977, DOI 10.1103/RevModPhys.73.977; Banks T, 1997, PHYS REV D, V55, P5112, DOI 10.1103/PhysRevD.55.5112; Ishii T, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.106001; Hanada M, 2011, PROG THEOR PHYS, V126, P597, DOI 10.1143/PTP.126.597; Aoki H, 2000, NUCL PHYS B, V565, P176, DOI 10.1016/S0550-3213(99)00633-1; Gomis J, 2000, NUCL PHYS B, V591, P265, DOI 10.1016/S0550-3213(00)00525-3; BRINK L, 1983, NUCL PHYS B, V212, P401, DOI 10.1016/0550-3213(83)90678-8; Hashimoto A, 1999, PHYS LETT B, V465, P142, DOI 10.1016/S0370-2693(99)01037-0; MANDELSTAM S, 1983, NUCL PHYS B, V213, P149, DOI 10.1016/0550-3213(83)90179-7; Armoni A, 2001, PHYS LETT B, V513, P406, DOI 10.1016/S0370-2693(01)00763-8; Bichl AA, 2004, INT J MOD PHYS A, V19, P4231, DOI 10.1142/S0217751X04018221; BRINK L, 1983, PHYS LETT B, V123, P323, DOI 10.1016/0370-2693(83)91210-8; CAPPER DM, 1984, NUCL PHYS B, V241, P463, DOI 10.1016/0550-3213(84)90056-7; Catterall S., 2004, JHEP, V0411; Catterall S., 2010, J HIGH ENERGY PHYS, V1012; Catterall S., 2012, J HIGH ENERGY PHYS, V1211, P072; Catterall S., ARXIV10090529HEPTH; Chu C.S., 2001, JHEP, V0108; Ferrari AF, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.085012; Fischler W., 2014, JHEP, V1401, P137; Gates S., ARXIVHEPTH0108200; Goldstone J., 1982, UNPUB; Hanada M., 2010, JHEP, V1011, P112; Hanada M., 2011, JHEP, V1101, P058; Hayakawa M., ARXIVHEPTH9912167; Honda M., 2013, J HIGH ENERGY PHYS, V1311, P200; Hoppe J., 1982, THESIS MIT; Ishiki G., 2009, JHEP, V0909, P029; Itzhaki N, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.046004; Jack I, 2001, PHYS LETT B, V514, P401, DOI 10.1016/S0370-2693(01)00824-3; Kanamori I, 2009, NUCL PHYS B, V811, P420, DOI 10.1016/j.nuclphysb.2008.11.021; Kaplan DB, 2005, J HIGH ENERGY PHYS; Kawamoto S., 2012, J HIGH ENERGY PHYS, V1208, P168; Khoze VV, 2001, J HIGH ENERGY PHYS; Maldacena JM, 1999, J HIGH ENERGY PHYS; Maldacena J.M., 2003, JHEP, V0301; Matsumoto T., 2014, JHEP, V1406, P163; Matusis A, 2000, J HIGH ENERGY PHYS; Minwalla S, 2000, J HIGH ENERGY PHYS; Myers RC, 1999, J HIGH ENERGY PHYS; Pernici M, 2001, PHYS LETT B, V504, P131, DOI 10.1016/S0370-2693(01)00279-9; SANTAMBROGIO A, 2001, JHEP, V101, P24; Seiberg N, 2000, J HIGH ENERGY PHYS; SMITH A, 1985, NUCL PHYS B, V261, P285, DOI 10.1016/0550-3213(85)90576-0; Sugino F, 2005, J HIGH ENERGY PHYS; Unsal M., 2006, JHEP, V0604; Vaidya S, 2001, PHYS LETT B, V512, P403, DOI 10.1016/S0370-2693(01)00641-4; Whittaker E.T., 1927, COURSE MODERN ANAL; Ydri B., 2007, MOD PHYS LETT A, V22, P2565, DOI 10.1142/S0217732307025649; Zanon D, 2001, PHYS LETT B, V504, P101, DOI 10.1016/S0370-2693(01)00271-4; Zanon D, 2001, PHYS LETT B, V502, P265, DOI 10.1016/S0370-2693(01)00194-0	69	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	MAR	2015	892						449	474		10.1016/j.nuclphysb.2015.01.016		26	Physics, Particles & Fields	Physics	CC1HT	WOS:000350092500022		
J	Ono, T; Yuki, K; Awano-Tanabe, S; Fukagawa, K; Shimoyama, M; Ozawa, Y; Ozeki, N; Shiba, D; Tsubota, K				Ono, Takeshi; Yuki, Kenya; Awano-Tanabe, Sachiko; Fukagawa, Kazumi; Shimoyama, Masaru; Ozawa, Yoko; Ozeki, Naoki; Shiba, Daisuke; Tsubota, Kazuo			Driving Self-restriction and Motor Vehicle Collision Occurrence in Glaucoma	OPTOMETRY AND VISION SCIENCE			English	Article						primary open-angle glaucoma; driving self-restriction; motor vehicle collision; quality of life; visual field	OPEN-ANGLE GLAUCOMA; INCREASED DEPRESSIVE SYMPTOMS; VISUAL-FIELD LOSS; OLDER-ADULTS; GENDER-DIFFERENCES; CRASH INVOLVEMENT; DRIVERS; RISK; CESSATION; PATTERNS	Purpose. To confirm that subjects with primary open-angle glaucoma (POAG) who avoid driving in high-risk situations are less likely to be involved in motor vehicle collisions (MVCs) than those who do not. Methods. This study evaluated 252 consecutive Japanese aged between 40 and 85 years with POAG. All participants were requested to answer a questionnaire on their driving habits, including self-restriction in driving at night, in rain, in fog, on freeways, and lane changing, and history of MVCs. Those who reported restricting their driving in one or more ways constituted the self-restriction group, and those who reported no self-restriction made up the no-restriction group. The prevalence of MVCs and the crash rate (number of MVCs/10,000 km driven) were compared between the two groups. The association between prevalence of MVCs and the number of driving self-restrictions was also evaluated. Results. The association between driving self-restriction and MVCs was observed among the male subjects, not among the female subjects. Among the male subjects, the prevalence of MVCs was significantly higher in the no-restriction group than in the self-restriction group (no-restriction group, 33/107 = 30.8%; self-restriction group, 9/66 = 13.6%, p = 0.01). The crash rate was also significantly higher in the no-restriction group (no-restriction group, 1.4 +/- 0.8; self-restriction group, 0.4 +/- 0.3, average +/- SE, p = 0.01). No restriction was significantly associated with MVCs (multivariable-adjusted odds ratios, 2.43 [95% confidence interval, 1.03 to 5.73]). The number of driving self-restrictions was also associated with MVCs (multivariable-adjusted odds ratios, 0.41 [95% confidence interval, 0.18 to 0.99], per one increment of self-restriction). Conclusions. Driving self-restriction may be associated with a reduced prevalence of MVCs in men with POAG.	[Ono, Takeshi; Yuki, Kenya; Awano-Tanabe, Sachiko; Fukagawa, Kazumi; Shimoyama, Masaru; Ozawa, Yoko; Ozeki, Naoki; Shiba, Daisuke; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo 1608582, Japan; [Awano-Tanabe, Sachiko] Tanabe Eye Clin, Yamanashi, Japan; [Fukagawa, Kazumi] Iidabashi Eye Clin, Tokyo, Japan	Yuki, K (reprint author), Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Shinanomachi 35, Tokyo 1608582, Japan.	yukikenya114@gmail.com					Adler G, 2005, SOC WORK HEALTH CARE, V40, P75, DOI 10.1300/J010v40n03_05; Anderson D. R., 1999, AUTOMATED STATIC PER; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; Crabb DP, 1998, BRIT J OPHTHALMOL, V82, P1236, DOI 10.1136/bjo.82.11.1236; Marottoli RA, 1997, J AM GERIATR SOC, V45, P202; Horswill MS, 2010, J INT NEUROPSYCH SOC, V16, P939, DOI 10.1017/S135561771000055X; Bengtsson B, 2000, INVEST OPHTH VIS SCI, V41, P2201; Ball K, 1998, ACCIDENT ANAL PREV, V30, P313, DOI 10.1016/S0001-4575(97)00102-4; Owsley C, 1999, J GERONTOL A-BIOL, V54, pM203, DOI 10.1093/gerona/54.4.M203; D'Ambrosio LA, 2008, J WOMEN AGING, V20, P265, DOI 10.1080/08952840801984758; Edwards JD, 2009, J GERONTOL A-BIOL, V64, P300, DOI 10.1093/gerona/gln019; Ramulu PY, 2009, OPHTHALMOLOGY, V116, P1846, DOI 10.1016/j.ophtha.2009.03.033; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Alsop J, 2001, ACCIDENT ANAL PREV, V33, P353, DOI 10.1016/S0001-4575(00)00049-X; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; MAROTTOLI RA, 1993, J GERONTOL, V48, pS255; Man-Son-Hing M, 2007, J AM GERIATR SOC, V55, P878, DOI 10.1111/j.1532-5415.2007.01177.x; Tanabe S, 2011, INVEST OPHTH VIS SCI, V52, P4177, DOI 10.1167/iovs.10-6264; Varma R, 2004, OPHTHALMOLOGY, V111, P1439, DOI 10.1016/j.ophtha.2004.01.025; McGwin G, 2005, INVEST OPHTH VIS SCI, V46, P4437, DOI 10.1167/iovs.05-0750; Coleman AL, 2008, SURV OPHTHALMOL, V53, pS3, DOI 10.1016/j.survophthal.2008.08.006; Ragland DR, 2005, J GERONTOL A-BIOL, V60, P399; Ramulu PY, 2014, OPTOMETRY VISION SCI, V91, P187, DOI 10.1097/OPX.0000000000000139; Nelson-Quigg JM, 2000, INVEST OPHTH VIS SCI, V41, P2212; Owsley C, 2002, JAMA-J AM MED ASSOC, V288, P841, DOI 10.1001/jama.288.7.841; Owsley C, 2010, VISION RES, V50, P2348, DOI 10.1016/j.visres.2010.05.021; McGwin G, 2004, INVEST OPHTH VIS SCI, V45, P3934, DOI 10.1167/iovs.04-0524; Freeman EE, 2006, AM J PUBLIC HEALTH, V96, P1254, DOI 10.2105/AJPH.2005.069146; Betz ME, 2010, J AM GERIATR SOC, V58, P1931, DOI 10.1111/j.1532-5415.2010.03010.x; Brabyn JA, 2005, OPTOMETRY VISION SCI, V82, P755, DOI 10.1097/01.opx.0000174723.64798.2b; Crizzle AM, 2013, ACCIDENT ANAL PREV, V50, P724, DOI 10.1016/j.aap.2012.06.025; Devlin A, 2014, AUSTRALAS J AGEING, V33, P74, DOI 10.1111/ajag.12061; Donorfio LKM, 2009, J SAFETY RES, V40, P221, DOI 10.1016/j.jsr.2009.04.002; Edwards J, 2009, AM SCHOLAR, V78, P5; El Chliaoutakis Joannes, 2002, J Safety Res, V33, P431; Freeman EE, 2005, OPTOMETRY VISION SCI, V82, P765, DOI 10.1097/01.opx.0000175008.88427.05; Gilhotra JS, 2001, CLIN EXP OPHTHALMOL, V29, P104, DOI 10.1046/j.1442-9071.2001.00411.x; Gruber N, 2013, TRAFFIC INJ PREV, V14, P477, DOI 10.1080/15389588.2012.727510; Hu PS, 1998, ACCIDENT ANAL PREV, V30, P569, DOI 10.1016/S0001-4575(98)00019-0; Jimenez-Mejias E, 2013, INJURY PREV, V19, P280, DOI 10.1136/injuryprev-2012-040467; JOHNSON CA, 1983, ARCH OPHTHALMOL-CHIC, V101, P371; Klein R., 2013, INVEST OPHTH VIS SCI, V54, P5; Marottoli RA, 1997, J GERONTOL A-BIOL, V52, pM184; Molnar LJ, 2013, J SAFETY RES, V46, P107, DOI 10.1016/j.jsr.2013.05.001; Parc C, 2012, J FR OPHTALMOL, V35, P235, DOI 10.1016/j.jfo.2011.06.007; Roberts SE, 2008, ACCIDENT ANAL PREV, V40, P559, DOI 10.1016/j.aap.2007.08.017; Ross LA, 2009, J GERONTOL B-PSYCHOL, V64, P163, DOI 10.1093/geronb/gbn034; Sengupta S, 2014, OPHTHALMOLOGY, V121, P727, DOI 10.1016/j.ophtha.2013.09.042; Sharma BR, 2008, PUBLIC HEALTH, V122, P1399, DOI 10.1016/j.puhe.2008.06.009; van Landingham SW, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-4; Wickens CM, 2013, J AFFECT DISORDERS, V145, P253, DOI 10.1016/j.jad.2012.04.046	51	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	MAR	2015	92	3					357	364				8	Ophthalmology	Ophthalmology	CC4HO	WOS:000350314000020		
J	Ohyama, K; Moriyama, M; Hayashida, JN; Tanaka, A; Maehara, T; Ieda, S; Furukawa, S; Ohta, M; Imabayashi, Y; Nakamura, S				Ohyama, K.; Moriyama, M.; Hayashida, J-N; Tanaka, A.; Maehara, T.; Ieda, S.; Furukawa, S.; Ohta, M.; Imabayashi, Y.; Nakamura, S.			Saliva as a potential tool for diagnosis of dry mouth including Sjogren's syndrome	ORAL DISEASES			English	Article						xerostomia; Sjogren's syndrome; saliva; cytokine; secretory IgA; chromogranin A	CHROMOGRANIN-A; IMMUNOGLOBULIN-A; HUMAN TEARS; XEROSTOMIA; GLANDS; STRESS; ASSOCIATION; CYTOKINES; PROFILES; DISEASE	OBJECTIVES: Recently, the use of saliva as a diagnostic tool has gained considerable attention because it is non-invasive and easy to perform repeatedly. In this study, we focused on soluble molecules in saliva to establish a new diagnostic method for xerostomia. MATERIALS AND METHODS: Saliva was obtained from 90 patients with Sjogren's syndrome (SS), 22 patients with xerostomia associated with neurogenic/neuropsychiatric disorders and drugs (XND), 30 patients with radiation-induced xerostomia (RX), and 36 healthy controls. Concentrations of helper T (Th) cytokines in saliva were measured by flow cytometric analysis. Concentrations of secretory IgA (SIgA) and chromogranin A (CgA) were measured by ELISA. RESULTS: Unstimulated and stimulated whole saliva from patients with SS, XND, and RX was significantly reduced compared with controls. Th1 and Th2 cytokines from SS patients were significantly higher than controls. Furthermore, Th2 cytokines were closely associated with strong lymphocytic accumulation in salivary glands from SS patients, while Th1 and Th17 cytokines were negatively associated. SIgA levels were not significantly different between all patient groups and controls. CgA levels from XND patients were significantly higher than controls. CONCLUSIONS: The measurement of cytokines, CgA, and SIgA in saliva is suggested to be useful for the diagnosis of xerostomia and also to reveal disease status.	[Ohyama, K.; Moriyama, M.; Hayashida, J-N; Tanaka, A.; Maehara, T.; Ieda, S.; Furukawa, S.; Ohta, M.; Imabayashi, Y.; Nakamura, S.] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Sect Oral & Maxillofacial Oncol, Fukuoka 8128582, Japan	Moriyama, M (reprint author), Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Sect Oral & Maxillofacial Oncol,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	moriyama@dent.kyushu-u.ac.jp			Ministry of Health Labour and Welfare, Japan	This work was supported by 'Research on Measures for Intractable Diseases' Project: matching fund subsidy from the Ministry of Health Labour and Welfare, Japan.	Zhang L, 2012, CELL MOL LIFE SCI, V69, P3341, DOI 10.1007/s00018-012-1027-0; Scully C, 2005, BRIT DENT J, V199, P423, DOI 10.1038/sj.bdj.4812740; Guggenheimer J, 2003, J AM DENT ASSOC, V134, P61; KOHLER PF, 1985, ARTHRITIS RHEUM, V28, P1128, DOI 10.1002/art.1780281008; Szodoray P, 2005, CLIN IMMUNOL, V117, P168, DOI 10.1016/j.clim.2005.06.016; Bosch JA, 2002, INT REV NEUROBIOL, V52, P213; Dhabhar FS, 2009, J PSYCHIATR RES, V43, P962, DOI 10.1016/j.jpsychires.2009.05.010; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Billings RJ, 1996, COMMUNITY DENT ORAL, V24, P312, DOI 10.1111/j.1600-0528.1996.tb00868.x; [Anonymous], 2000, INT J PSYCHOPHYSIOL, V37, P219; LaFrance MW, 2008, CURR EYE RES, V33, P525, DOI 10.1080/02713680802190085; Lau C, 2013, J BIOL CHEM, V288, P26888, DOI 10.1074/jbc.M113.452458; NAVAZESH M, 1983, AM J OTOLARYNG, V4, P283, DOI 10.1016/S0196-0709(83)80072-6; [Anonymous], PSYCHONEUROENDOCRINO, V22, P423; DANIELS TE, 1994, ARTHRITIS RHEUM, V37, P869, DOI 10.1002/art.1780370615; Maehara T, 2012, CLIN EXP IMMUNOL, V169, P89, DOI 10.1111/j.1365-2249.2012.04606.x; Maehara T, 2012, ANN RHEUM DIS, V71, P2011, DOI 10.1136/annrheumdis-2012-201477; BAHN SL, 1972, ORAL SURG ORAL MED O, V33, P49, DOI 10.1016/0030-4220(72)90207-1; Bosch JA, 1998, J PSYCHOPHYSIOL, V12, P384; Cook EB, 2001, J IMMUNOL METHODS, V254, P109, DOI 10.1016/S0022-1759(01)00407-0; ETTINGER RL, 1981, AUST DENT J, V26, P365; Fujibayashi TSS, 1993, MOD RHEUMATOL, V14, P425; Greenspan D, 1996, Oncology (Williston Park), V10, P7; GREENSPA.JS, 1974, ORAL SURG ORAL MED O, V37, P217, DOI 10.1016/0030-4220(74)90417-4; Ivanovski K, 2012, Prilozi, V33, P219; Kanno T, 1998, BIOMED RES-TOKYO, V19, P411; Matear DW, 2005, J R SOC PROMO HEALTH, V125, P35, DOI 10.1177/146642400512500113; Moriyama M, 2012, CLIN EXP IMMUNOL, V169, P17, DOI 10.1111/j.1365-2249.2012.04587.x; Moriyama M, 2013, J AUTOIMMUN, DOI S0896-8411(13)00103-0; Nakamura S, 1997, J ORAL PATHOL MED, V26, P426, DOI 10.1111/j.1600-0714.1997.tb00243.x; Nakane H, 2002, INT J PSYCHOPHYSIOL, V46, P85, DOI 10.1016/S0167-8760(02)00067-3; Nakane H, 1998, BIOMED RES-TOKYO, V19, P401; Nonzee Vimonpun, 2012, Journal of the Medical Association of Thailand, V95, P96; Ohyama Y, 1996, ARTHRITIS RHEUM, V39, P1376, DOI 10.1002/art.1780390816; Ohyama Y, 1998, ARTHRITIS RHEUM, V41, P1972, DOI 10.1002/1529-0131(199811)41:11<1972::AID-ART12>3.0.CO;2-M; Rahman S, 2013, Eur J Prosthodont Restor Dent, V21, P80; Ring C, 2000, PSYCHOPHYSIOLOGY, V37, P634, DOI 10.1017/S0048577200991030; SPIELMAN A, 1981, ORAL SURG ORAL MED O, V51, P144, DOI 10.1016/0030-4220(81)90031-1; Tsunawaki S, 2002, J RHEUMATOL, V29, P1884; Wang Q., 2013, CLIN CHIM ACTA, V427, P79	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-523X	1601-0825		ORAL DIS	Oral Dis.	MAR	2015	21	2					224	231		10.1111/odi.12252		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CB9XC	WOS:000349986500012		
J	Ide, Y; Nakahara, T; Nasu, M; Ishikawa, H				Ide, Y.; Nakahara, T.; Nasu, M.; Ishikawa, H.			Cell dynamics in Hertwig's epithelial root sheath and surrounding mesenchyme in mice irradiated to the head	ORAL DISEASES			English	Article						irradiation; dental root; Hertwig's epithelial root sheath; pediatric stem cell transplantation; childhood leukemia; micro-CT	TOOTH DEVELOPMENT; PERMANENT TEETH; RADIATION; DENTINOGENESIS; RAT; TRANSPLANTATION; EXPRESSION; CHILDREN; NESTIN	OBJECTIVE: To investigate the mechanisms that cause damage to root formation as a result of irradiation to the mouse head, morphological changes in molar dental roots and cell dynamics in Hertwig's epithelial root sheath (HERS), and surrounding mesenchymal tissue were examined. MATERIALS AND METHODS: To perform the experiments, 5-day-old C57BL/6 mice were randomly divided into three groups: the control group (0 Gy) and irradiated groups (10 and 20 Gy). Micro-CT analysis, HE staining, immunohistochemistry analysis, and TUNEL assay were then performed. RESULTS: Roots in irradiated mice were dose-dependently shorter than those of control mice. Cells located outside the root dentin, with abnormal morphology in irradiated mice, were positive for an odontoblast marker. HERS fragmentation occurred earlier in irradiated mice than in control mice, and HERS was trapped by the calcified apical tissue. A dose-dependent reduction in the number of proliferating cells within the apical dental pulp and periapical periodontal ligament surrounding HERS was observed in irradiated mice. Apoptotic cells in the dental pulp and periodontal ligament surrounding HERS were hardly seen. CONCLUSIONS: These results indicate that the early disappearance of HERS and the proliferative suppression of the surrounding mesenchymal cells, which was induced by irradiation, caused dental root malformation.	[Ide, Y.; Nakahara, T.] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Dev & Regenerat Dent, Tokyo 1028159, Japan; [Nasu, M.] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Res Ctr Odontol, Tokyo 1028159, Japan; [Ishikawa, H.] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept NDU Life Sci, Tokyo 1028159, Japan	Ide, Y (reprint author), Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Dev & Regenerat Dent, Chiyoda Ku, 1-9-20 Fujimi, Tokyo 1028159, Japan.	ideaki@tky.ndu.ac.jp			Japan Society for the Promotion of Science (JSPS) [24689073]; JSPS [20390501, 24592848]; Ministry of Education, Culture, Sports, Science and Technology of Japan [22791818, 22791943]	We thank all the staff from the Department of Developmental and Regenerative Dentistry, and the Department of NDU Life Sciences, School of Life Dentistry at Tokyo, The Nippon Dental University. This work was supported in part by a Grant-in-Aid for Young Scientists (A) (No. 24689073 to T.N.) from the Japan Society for the Promotion of Science (JSPS); a Grant-in-Aid for Scientific Research (B) (No. 20390501 to H.I., T.N., M.N., and Y.I.) from JSPS; a Grant-in-Aid for Scientific Research (C) (No. 24592848 to Y.I., T.N., H.I., and M.N.) from JSPS; and a Grant-in-Aid for Young Scientists (B) (Nos. 22791818 and 22791943 to Y.I.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abe S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt43; ADKINS KF, 1967, ARCH ORAL BIOL, V12, P1569, DOI 10.1016/0003-9969(67)90191-4; THOMAS HF, 1995, INT J DEV BIOL, V39, P231; Terling C, 1995, INT J DEV BIOL, V39, P947; Nakatomi M, 2006, J DENT RES, V85, P427; Lungova V, 2011, J ANAT, V218, P699, DOI 10.1111/j.1469-7580.2011.01367.x; Saito K, 2013, J ENDODONT, V39, P1250, DOI 10.1016/j.joen.2013.06.017; Holtta P, 2005, CANCER, V103, P181, DOI 10.1002/cncr.20762; Holtta P, 2005, CANCER-AM CANCER SOC, V103, P1484, DOI 10.1002/cncr.20967; COLLETT WK, 1965, J DENT RES, V44, P84, DOI 10.1177/00220345650440013501; DAHLLOF G, 1988, ORAL SURG ORAL MED O, V65, P41, DOI 10.1016/0030-4220(88)90189-2; ENGLISH J. A., 1956, ORAL SURG ORAL MED AND ORAL PATHOL, V9, P1132, DOI 10.1016/0030-4220(56)90076-7; Ide Y, 2013, ANAT REC, V296, P1247, DOI 10.1002/ar.22725; Imhof SM, 1996, OPHTHALMOLOGY, V103, P263; Inomata H, 1971, TOHOKU MED J, V82, P331; ITOIZ ME, 1983, J BIOL BUCCALE, V11, P109; KASTE SC, 1994, ORAL SURG ORAL MED O, V77, P95; Koppang H S, 1967, Odontol Tidskr, V75, P413; KOPPANG HS, 1973, SCAND J DENT RES, V81, P303; Leist M, 1925, Z STOMATOL, V23, P797; MCGINNIS JP, 1985, J AM DENT ASSOC, V111, P584; MEDAK H, 1952, J DENT RES, V31, P559, DOI 10.1177/00220345520310040601; Nakahara T, 2011, ODONTOLOGY, V99, P105, DOI 10.1007/s10266-011-0037-y; Nakahara T, 2007, HUM CELL, V20, P63, DOI 10.1111/j.1749-0774.2007.00031.x; Nakahara Taka, 2006, Dent Clin North Am, V50, P265, DOI 10.1016/j.cden.2005.11.004; Nanci A, 2003, TENCATES ORAL HISTOL, P240; Quispe-Salcedo A, 2012, BIOMED RES-TOKYO, V33, P119; Ten Cate A R, 1996, Oral Dis, V2, P55; Tominaga N, 2013, DIFFERENTIATION, V85, P91, DOI 10.1016/j.diff.2013.01.003	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-523X	1601-0825		ORAL DIS	Oral Dis.	MAR	2015	21	2					232	239		10.1111/odi.12253		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CB9XC	WOS:000349986500013		
J	Furukawa, S; Moriyama, M; Kawano, S; Tanaka, A; Maehara, T; Hayashida, JN; Goto, Y; Kiyoshima, T; Shiratsuchi, H; Ohyama, Y; Ohta, M; Imabayashi, Y; Nakamura, S				Furukawa, S.; Moriyama, M.; Kawano, S.; Tanaka, A.; Maehara, T.; Hayashida, J-N; Goto, Y.; Kiyoshima, T.; Shiratsuchi, H.; Ohyama, Y.; Ohta, M.; Imabayashi, Y.; Nakamura, S.			Clinical relevance of Kuttner tumour and IgG4-related dacryoadenitis and sialoadenitis	ORAL DISEASES			English	Article						Kuttner tumour; IgG4-related dacryoadenitis and sialoadenitis; Mikulicz's disease; chronic sialoadenitis	CHRONIC SCLEROSING SIALADENITIS; SUBMANDIBULAR-GLAND; MIKULICZS-DISEASE; PANCREATITIS; LESIONS	OBJECTIVES: Kuttner tumour (KT), so-called chronic sclerosing sialoadenitis, is characterised by concomitant swelling of the submandibular glands secondary to strong lymphocytic infiltration and fibrosis independent of sialolith formation. However, recent studies have indicated that some patients with KT develop high serum levels of IgG4 and infiltration of IgG4-positive plasma cells, namely IgG4-related dacryoadenitis and sialoadenitis (IgG4-DS), so-called Mikulicz's disease. The aim of this study was to clarify the clinical and pathological associations between KT and IgG4-DS. MATERIALS AND METHODS: Fifty-four patients pathologically diagnosed with KT or chronic sialoadenitis were divided into two groups according to the presence or absence of sialolith (KT-S (+) or KT-S (-), respectively). RESULTS: There were no significant differences in the clinical findings, including the mean age, sex and disease duration, between the two groups. All patients in the KT-S (+) group showed unilateral swelling without infiltration of IgG4-positive plasma cells or a history of other IgG4-related diseases (IgG4-RD), while those in the KT-S (-) group showed bilateral swelling (37.5%), strong infiltration of IgG4-positive plasma cells (87.5%) and a history of other IgG4-RD (12.5%). CONCLUSIONS: These results suggest an association between the pathogeneses of KT-S (-) and IgG4-DS, but not KT-S (+).	[Furukawa, S.; Moriyama, M.; Kawano, S.; Tanaka, A.; Maehara, T.; Hayashida, J-N; Goto, Y.; Ohta, M.; Imabayashi, Y.; Nakamura, S.] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Sect Oral & Maxillofacial Oncol, Fukuoka 8128582, Japan; [Kiyoshima, T.] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Lab Oral Pathol, Fukuoka 8128582, Japan; [Shiratsuchi, H.] Kyushu Univ, Fac Med, Grad Sch Med Sci, Dept Otolaryngol, Fukuoka 8128582, Japan; [Ohyama, Y.] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Sect Oral & Maxillofacial Surg, Fukuoka 8128582, Japan	Moriyama, M (reprint author), Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Sect Oral & Maxillofacial Oncol,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	moriyama@dent.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [26293430]; Takeda Science Foundation	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (26293430) and Takeda Science Foundation.	Ahuja AT, 2003, ULTRASOUND MED BIOL, V29, P913, DOI 10.1016/S0301-5629(03)00889-5; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; SEIFERT G, 1992, PATHOL RES PRACT, V188, P836; Stone JH, 2012, ARTHRITIS RHEUM-US, V64, P3061, DOI 10.1002/art.34593; Umehara H, 2012, MOD RHEUMATOL, V22, P1, DOI 10.1007/s10165-011-0508-6; Yamamoto M, 2005, AUTOIMMUN REV, V4, P195, DOI 10.1016/j.autrev.2004.10.005; Tanaka A, 2012, ARTHRITIS RHEUM-US, V64, P254, DOI 10.1002/art.33320; Zen Y, 2004, AM J SURG PATHOL, V28, P1193, DOI 10.1097/01.pas.0000136449.37936.6c; Yoshita K, 2012, NEPHROL DIAL TRANSPL, V27, P2755, DOI 10.1093/ndt/gfr761; Moriyama M, 2013, CLIN ORAL INVEST, V17, P1995, DOI 10.1007/s00784-012-0905-z; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Hamano H, 2002, LANCET, V359, P1403, DOI 10.1016/S0140-6736(02)08359-9; Maehara T, 2012, ANN RHEUM DIS, V71, P2011, DOI 10.1136/annrheumdis-2012-201477; Hamed G, 2007, RESPIROLOGY, V12, P455, DOI 10.1111/j.1400-1843.2007.01053.x; Ikeda Minoru, 1994, Auris Nasus Larynx, V21, P103; ISACSSON G, 1982, CLIN OTOLARYNGOL, V7, P231, DOI 10.1111/j.1365-2273.1982.tb01389.x; Kitagawa S, 2005, AM J SURG PATHOL, V29, P783, DOI 10.1097/01.pas.0000164031.59940.fc; Kuttner H, 1996, BEITR KLIN CHIR, V15, P815; RASANEN O, 1972, ACTA OTO-LARYNGOL, V74, P297, DOI 10.3109/00016487209128454; SEIFERT G, 1977, HNO, V25, P81; Shimizu M, 2009, ORAL SURG ORAL MED O, V108, P105, DOI 10.1016/j.tripleo.2009.02.032; Takano K, 2010, AM J OTOLARYNG, V31, P429, DOI 10.1016/j.amjoto.2009.08.002; Yamamoto Motohisa, 2006, Mod Rheumatol, V16, P335, DOI 10.1007/s10165-006-0518-Y	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-523X	1601-0825		ORAL DIS	Oral Dis.	MAR	2015	21	2					257	262		10.1111/odi.12259		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CB9XC	WOS:000349986500016		
J	Ohta, H; Solanki, J				Ohta, H.; Solanki, J.			Incorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan	OSTEOPOROSIS INTERNATIONAL			English	Review						Bazedoxifene; Fracture; Japan; Osteoporosis; Selective estrogen receptor modulator (SERM)	ESTROGEN-RECEPTOR MODULATOR; VITAMIN-D SUPPLEMENTATION; VERTEBRAL FRACTURE RISK; BONE-MINERAL DENSITY; RANDOMIZED CONTROLLED-TRIAL; RESEARCH TOWER TRIAL; NUTRITION EXAMINATION SURVEY; HORMONE REPLACEMENT THERAPY; AMERICAN MENOPAUSE SOCIETY; CONTROLLED CLINICAL-TRIAL	The incidence of osteoporosis-related fractures in Asian countries is steadily increasing. Optimizing osteoporosis treatment is especially important in Japan, where the rate of aging is increasing rapidlyelderly population is increasing rapidly and life expectancy is among the longest in the world. There are several therapies currently available in Japan for the treatment of postmenopausal osteoporosis, each with a unique risk/benefit profile. A novel selective estrogen receptor modulator, bazedoxifene (BZA), was recently approved for the treatment of postmenopausal osteoporosis in Japan. Results from a 2-year, phase 2 trial in postmenopausal Japanese women showed that BZA significantly improved lumbar spine and total hip bone mineral density compared with placebo, while maintaining endometrial and breast safety, consistent with results from 2 global, phase 3 trials including a 2-year osteoporosis prevention study and a 3-year osteoporosis treatment study. In the pivotal 3-year treatment study, BZA significantly reduced the incidence of new vertebral fractures compared with placebo; in a post hoc analysis of a subgroup of women at higher risk of fractures, BZA significantly reduced the risk of nonvertebral fractures compared with placebo and raloxifene. A 2-year extension of the 3-year treatment study demonstrated the sustained efficacy of BZA over 5 years of treatment. BZA was generally safe and well tolerated in these studies. In a "super-aging" society such as Japan, long-term treatment for postmenopausal osteoporosis is a considerable need. BZA may be considered as a first choice for younger women anticipating long-term treatment, and also an appropriate option for older women who are unable or unwilling to take bisphosphonates.	[Ohta, H.] Int Univ Hlth & Welf, Womens Med Ctr, Sanno Med Ctr, Clin Med Res Ctr,Minato Ku, Tokyo 1070052, Japan; [Solanki, J.] Orchard End, Amersham HP6 5LE, Bucks, England	Ohta, H (reprint author), Int Univ Hlth & Welf, Womens Med Ctr, Sanno Med Ctr, Clin Med Res Ctr,Minato Ku, 8-5-35 Akasaka, Tokyo 1070052, Japan.	ohtah@iuhw.ac.jp; jit.solanki1@btinternet.com			Pfizer	Medical writing support for this manuscript was provided by Melissa Brunckhorst, PhD, at MedErgy and Linda Romagnano, PhD, of Peloton Advantage and was funded by Pfizer. The authors retained full editorial control over the content of the article.	Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Hagino H, 2010, J ORTHOP SCI, V15, P737, DOI 10.1007/s00776-010-1543-4; de Villiers TJ, 2011, OSTEOPOROSIS INT, V22, P567, DOI 10.1007/s00198-010-1302-6; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Sugimoto T, 2014, OSTEOPOROSIS INT, V25, P1173, DOI 10.1007/s00198-013-2516-1; Orimo H, 2011, CURR MED RES OPIN, V27, P1273, DOI 10.1185/03007995.2011.580341; Pasion EG, 2007, J BONE MINER METAB, V25, P105, DOI 10.1007/s00774-006-0735-7; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Hammar ML, 2007, BJOG-INT J OBSTET GY, V114, P1522, DOI 10.1111/j.1471-0528.2007.01537.x; Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148; Itabashi A, 2011, J BONE MINER RES, V26, P519, DOI 10.1002/jbmr.252; Tosteson ANA, 2003, AM J MED, V115, P209, DOI 10.1016/S0002-9343(03)00362-0; Martino S, 2005, CURR MED RES OPIN, V21, P1441, DOI 10.1185/030079905X61839; DAWSONHUGHES B, 1990, NEW ENGL J MED, V323, P878, DOI 10.1056/NEJM199009273231305; Naylor GM, 2006, GUT, V55, P1545, DOI 10.1136/gut.2005.080358; Hagino H, 2009, BONE, V44, P1078, DOI 10.1016/j.bone.2009.02.016; Goldstein SR, 2011, MENOPAUSE, V18, P17, DOI 10.1097/gme.0b013e3181e84bb4; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Komm BS, 2001, ANN NY ACAD SCI, V949, P317; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Cummings SR, 2010, NEW ENGL J MED, V362, P686, DOI 10.1056/NEJMoa0808692; Matsumoto T, 2005, J CLIN ENDOCR METAB, V90, P5031, DOI 10.1210/jc.2004-2552; Silverman SL, 2008, J BONE MINER RES, V23, P1923, DOI [10.1359/jbmr.080710, 10.1359/JBMR.080710]; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Matsumoto T, 2011, BONE, V49, P605, DOI 10.1016/j.bone.2011.07.011; Li Y, 2013, CHINESE MED J-PEKING, V126, P457, DOI 10.3760/cma.j.issn.0366-6999.20121626; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; Jackson RD, 2006, J BONE MINER RES, V21, P817, DOI 10.1359/JBMR.060312; White RH, 2009, THROMB RES, V123, pS11, DOI 10.1016/S0049-3848(09)70136-7; Nakamura T, 2012, J CLIN ENDOCR METAB, V97, P3097, DOI 10.1210/jc.2011-3479; Carmel AS, 2012, OSTEOPOROSIS INT, V23, P2479, DOI 10.1007/s00198-011-1868-7; Urade M, 2011, J ORAL MAXIL SURG, V69, pE364, DOI 10.1016/j.joms.2011.03.051; Peano BJ, 2009, ENDOCRINOLOGY, V150, P1897, DOI 10.1210/en.2008-1210; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701; Iikuni N, 2012, J BONE MINER METAB, V30, P674, DOI 10.1007/s00774-012-0365-1; Silverman S, 2012, OSTEOPOROSIS INT, V23, P797, DOI 10.1007/s00198-011-1775-y; Silverman SL, 2012, OSTEOPOROSIS INT, V23, P351, DOI 10.1007/s00198-011-1691-1; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Okazaki R, 2012, OSTEOPOROSIS INT, V23, P1737, DOI 10.1007/s00198-011-1782-z; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Hong H, 2013, NUTR RES PRACT, V7, P409, DOI 10.4162/nrp.2013.7.5.409; Harvey JA, 2009, MENOPAUSE, V16, P1193, DOI [10.1097/gme.0b013e3181a7fb1e, 10.1097/gme.0b013e3181a7fb1c]; Chang KCN, 2010, J STEROID BIOCHEM, V118, P117, DOI 10.1016/j.jsbmb.2009.11.003; Matsumoto T, 2009, OSTEOPOROSIS INT, V20, P1429, DOI 10.1007/s00198-008-0816-7; Tatsuno I, 2013, ENDOCR J, V60, P643; Schneider JP, 2009, GERIATRICS, V64, P18; Komm BS, 2005, ENDOCRINOLOGY, V146, P3999, DOI 10.1210/en.2005-0030; Shea B, 2002, ENDOCR REV, V23, P552, DOI 10.1210/er.2001.7002; Bonnick SL, 2010, MENOPAUSE, V17, P25, DOI 10.1097/gme.0b013e3181e617e6; Miller PD, 2008, J BONE MINER RES, V23, P525, DOI 10.1359/JBMR.071206; [Anonymous], 2013, PROL PACK INS; Peris P, 2012, BONE, V51, P54, DOI 10.1016/j.bone.2012.03.026; Kanis JA, 2009, BONE, V44, P1049, DOI 10.1016/j.bone.2009.02.014; Siris ES, 2006, MAYO CLIN PROC, V81, P1013; Nakamura T, 2013, CALCIFIED TISSUE INT, V93, P137, DOI 10.1007/s00223-013-9734-6; Palacios S, 2013, MATURITAS, V76, P81, DOI 10.1016/j.maturitas.2013.06.008; Nakano T, 2014, J BONE MINER METAB, V32, P441, DOI 10.1007/s00774-013-0505-2; ARCHER DF, 1994, OBSTET GYNECOL, V83, P686; Archer DF, 2009, MENOPAUSE, V16, P1109, DOI 10.1097/gme.0b013e3181a818db; Atik O Sahap, 2006, Clin Orthop Relat Res, V443, P19, DOI 10.1097/01.blo.0000200248.34876.fe; Boonen S, 2008, J INTERN MED, V264, P315, DOI 10.1111/j.1365-2796.2008.02010.x; Bow CH, 2012, OSTEOPOROSIS INT, V23, P879, DOI 10.1007/s00198-011-1627-9; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Christiansen C, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-130; Crabtree JS, 2008, MOL CELL ENDOCRINOL, V287, P40, DOI 10.1016/j.mce.2008.01.027; Fujita T, 1996, CALCIFIED TISSUE INT, V59, pS34, DOI 10.1007/s002239900174; Gallagher JC, 2014, J BONE MINER RES, V29, P1081, DOI 10.1002/jbmr.2121; Geusens Piet, 2009, Curr Osteoporos Rep, V7, P12; Ikeda S, 2013, ANN C EUR CALC TISS; Iki Masayuki, 2012, Clin Calcium, V22, P797, DOI CliCa1206797803; International Osteoporosis Foundation, 2014, FACTS STAT OST ITS I; Iwamoto Jun, 2002, J Orthop Sci, V7, P637, DOI 10.1007/s007760200114; Joo NS, 2013, J BONE MINER RES, V28, P764, DOI 10.1002/jbmr.1790; Kharode Y, 2008, ENDOCRINOLOGY, V149, P6084, DOI 10.1210/en.2008-0817; Komm BS, 2011, BONE, V49, P376, DOI 10.1016/j.bone.2011.05.024; Matsumoto T, 2012, CURR OSTEOPOROS REP, V10, P248, DOI 10.1007/s11914-012-0116-1; McCloskey E, 2009, J BONE MINER RES, V24, pS140; McDonnell DP, 2002, RECENT PROG HORM RES, V57, P295, DOI 10.1210/rp.57.1.295; Mosca L, 2009, STROKE, V40, P147, DOI 10.1161/STROKEAHA.108.518621; Nagata C, 1996, MATURITAS, V25, P201, DOI 10.1016/S0378-5122(96)01067-5; Nakamura T, 2014, J CLIN ENDOCR METAB, V99, P2599, DOI 10.1210/jc.2013-4175; Nakamura T, 2006, J BONE MINER METAB, V24, P414, DOI 10.1007/s00774-006-0702-3; National Osteoporosis Foundation, 2010, FAST FACTS OST; NishizawaY Hagiwara S, 1995, J BONE MINER METAB, V13, P23; Utian WH, 2010, MENOPAUSE, V17, P242, DOI 10.1097/gme.0b013e3181d0f6b9; Orimo Hajime, 2012, Arch Osteoporos, V7, P3; Orimo H, 2009, ARCH OSTEOPOROS, V4, P71; Orimo H, 1996, J BONE MINER METAB, V14, P73, DOI 10.1007/BF01768835; Palacios S, 2011, INT MEN SOC WORLD C; Palacios S, 2012, GYNECOL ENDOCRINOL, V28, P770, DOI 10.3109/09513590.2012.679062; Pinkerton JV, 2009, MENOPAUSE, V16, P1102, DOI 10.1097/gme.0b013e3181a816be; Prakash C, 2008, DRUG METAB DISPOS, V36, P1753, DOI 10.1124/dmd.108.021808; Reid IR, 2013, NUTRIENTS, V5, P2522, DOI 10.3390/nu5072522; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321; Soong YK, 2013, OSTEOPOROSIS INT, V24, P511, DOI 10.1007/s00198-012-1984-z; Sugimoto T, 2013, CURR MED RES OPIN, V29, P195, DOI 10.1185/03007995.2012.761956; Sugimoto T, 2011, CLIN PRACTICE GUIDE; Wells G, 2002, ENDOCR REV, V23, P529, DOI 10.1210/er.2001.5002; Wells G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004523.pub3; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2; Yamamoto T, 2013, J BONE MINER METAB, V31, P199, DOI 10.1007/s00774-012-0403-z; Yamauchi H, 2003, J BONE MINER METAB, V21, P198, DOI 10.1007/s00774-003-0409-7; Yoh K, 2012, Jpn Clin Med, V3, P9, DOI 10.4137/JCM.S8291; Yoh K, 2012, CURR MED RES OPIN, V28, P1757, DOI 10.1185/03007995.2012.736860	108	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	MAR	2015	26	3					849	863		10.1007/s00198-014-2940-x		15	Endocrinology & Metabolism	Endocrinology & Metabolism	CC2ZP	WOS:000350214100002		
J	Ochi, K; Inoue, E; Furuya, T; Ikari, K; Toyama, Y; Taniguchi, A; Yamanaka, H; Momohara, S				Ochi, K.; Inoue, E.; Furuya, T.; Ikari, K.; Toyama, Y.; Taniguchi, A.; Yamanaka, H.; Momohara, S.			Ten-year incidences of self-reported non-vertebral fractures in Japanese patients with rheumatoid arthritis: discrepancy between disease activity control and the incidence of non-vertebral fracture	OSTEOPOROSIS INTERNATIONAL			English	Article						Disease activity; Functional impairment; Incidence; Non-vertebral fracture; Osteoporosis; Rheumatoid arthritis	PROSPECTIVE OBSERVATIONAL COHORT; MODIFYING ANTIRHEUMATIC DRUGS; POPULATION-BASED COHORT; BONE-MINERAL DENSITY; DISTAL RADIUS; HIP FRACTURE; OSTEOPOROTIC FRACTURE; TOTTORI PREFECTURE; RISK; WOMEN	A Summary Despite improvements in rheumatoid arthritis disease activity of in the past 10 years, the incidence of self-reported non-vertebral fractures did not decrease in our cohort of 9,987 patients. This study may indicate that osteoporosis treatment and non-vertebral fracture prevention remain important regardless of the rheumatoid arthritis disease activity. Introduction Although rheumatoid arthritis (RA) is a risk factor for osteoporosis and fractures, few studies have described the association between disease activity and the fracture incidence in patients with RA. This study aimed to investigate changes in the non-vertebral fracture incidence between 2001 and 2010 in our Institute of Rheumatology Rheumatoid Arthritis (IORRA) cohort. Methods The IORRA is a prospective observational cohort study of Japanese RA patients. A total of 9,987 patients with RA were enrolled in this cohort from 2000 to 2010. The clinical parameter and non-vertebral fracture occurrence data were collected biannually through self-reported questionnaires. Incidences of self-reported non-vertebral fractures were also analyzed via standardization according to gender, age, and disease activity during each 2-year period. Results From 2001 to 2010, the percentage of patients with 28-joint disease activity score remission increased from 7.8 to 39.7 %, prednisolone intake decreased from 51.4 to 41.3 %, and bisphosphonate intake increased from 5.0 to 23.4 %. The non-vertebral fracture incidence rates were 24.6/1,000 person-years in 2001 and 35.5/1,000 person-years in 2010, with no apparent change even after standardization. The overall non-vertebral fracture incidence was significantly higher in the autumn/winter than in the spring/summer (p = 0.02). Conclusion Despite improvements in disease activity and functional disability, the non-vertebral fracture incidence exhibited no apparent change between 2001 and 2010 in our patients with RA. Osteoporosis treatment and non-vertebral fracture prevention remain important regardless of the disease control in patients with RA.	[Ochi, K.; Ikari, K.; Momohara, S.] Tokyo Womens Med Univ, Inst Rheumatol, Dept Orthoped Surg, Shinjuku Ku, Tokyo, Japan; [Inoue, E.; Furuya, T.; Taniguchi, A.; Yamanaka, H.] Tokyo Womens Med Univ, Inst Rheumatol, Shinjuku Ku, Tokyo, Japan; [Ochi, K.; Toyama, Y.] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1608582, Japan	Ochi, K (reprint author), Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	ochi@1998.jukuin.keio.ac.jp			Japan Society for the Promotion of Science; Nakatomi Foundation; Japan Orthopedics and Traumatology Foundation, Inc. [277]; Japan Osteoporosis Foundation; Japan Osteoporosis Society	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science, the Nakatomi Foundation, the Japan Orthopedics and Traumatology Foundation, Inc. No. 277, and the Japan Osteoporosis Foundation to KO as well as from the Japan Osteoporosis Society to TF.	Hagino H, 2010, J ORTHOP SCI, V15, P737, DOI 10.1007/s00776-010-1543-4; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Lane NE, 2003, ARTHRITIS RES THER, V5, P214, DOI 10.1186/ar797; NEVITT MC, 1992, AM J EPIDEMIOL, V135, P490; Matsuda Y, 2003, ARTHRIT RHEUM-ARTHR, V49, P784, DOI 10.1002/art.11465; Orstavik RE, 2004, ANN RHEUM DIS, V63, P177, DOI 10.1136/ard.2003.005850; Furuya T, 2009, CLIN RHEUMATOL, V28, P1325, DOI 10.1007/s10067-009-1229-5; Angeli A, 2006, BONE, V39, P253, DOI 10.1016/j.bone.2006.02.005; Wright NC, 2011, J RHEUMATOL, V38, P1680, DOI 10.3899/jrheum.101196; Furuya T, 2011, CLIN RHEUMATOL, V30, P1105, DOI 10.1007/s10067-011-1748-8; Kawai VK, 2013, ARTHRIT CARE RES, V65, P1085, DOI 10.1002/acr.21937; Aletaha D, 2007, BEST PRACT RES CL RH, V21, P663, DOI 10.1016/j.berh.2007.02.004; Hagino H, 1999, BONE, V24, P265, DOI 10.1016/S8756-3282(98)00175-6; VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916; Adachi JD, 2010, MAYO CLIN PROC, V85, P806, DOI 10.4065/mcp.2010.0082; Weiss RJ, 2010, J RHEUMATOL, V37, P2247, DOI 10.3899/jrheum.100363; van Staa TP, 2006, ARTHRITIS RHEUM, V54, P3104, DOI 10.1002/art.22117; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Cheng CK, 2010, J RHEUMATOL, V37, P2221, DOI 10.3899/jrheum.091368; COOPER C, 1995, ANN RHEUM DIS, V54, P49, DOI 10.1136/ard.54.1.49; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; Furuya T, 2007, J RHEUMATOL, V34, P303; Furuya T, 2013, OSTEOPOROSIS INT, V24, P1257, DOI 10.1007/s00198-012-2080-0; Furuya T, 2008, J BONE MINER METAB, V26, P499, DOI 10.1007/s00774-007-0836-y; Genovese MC, 2013, J RHEUMATOL, V40, P768, DOI 10.3899/jrheum.120687; Hagino H, 2005, OSTEOPOROSIS INT, V16, P1963, DOI 10.1007/s00198-005-1974-5; Honkanen K, 1999, AM J EPIDEMIOL, V150, P511; HOOYMAN JR, 1984, ARTHRITIS RHEUM, V27, P1353, DOI 10.1002/art.1780271205; Ismail AA, 2000, OSTEOPOROSIS INT, V11, P248, DOI 10.1007/s001980050288; Khandewal S, 2012, BONE, V51, P1025, DOI 10.1016/j.bone.2012.08.118; Kim SY, 2012, J BONE MINER RES, V27, P789, DOI 10.1002/jbmr.1489; Kim SY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3107; Lau EMC, 2001, OSTEOPOROSIS INT, V12, P239, DOI 10.1007/s001980170135; Momohara S, 2012, MOD RHEUMATOL, V22, P209, DOI 10.1007/s10165-011-0495-7; Ochi K, 2012, MOD RHEUMATOL, V22, P290, DOI 10.1007/s10165-011-0494-8; Ochi Kensuke, 2013, Arch Osteoporos, V8, P159, DOI 10.1007/s11657-013-0159-7; Ochi K, 2014, CLIN RHEUMATOL, V33, P477, DOI 10.1007/s10067-013-2415-z; Ochi Kensuke, 2013, Arch Osteoporos, V8, P130, DOI 10.1007/s11657-013-0130-7; Rothman K, 2008, MODERN EPIDEMIOLOGY; Roussy JP, 2013, OSTEOPOROSIS INT, V24, P2483, DOI 10.1007/s00198-013-2321-x; Tanaka E, 2008, ANN RHEUM DIS, V67, P1153, DOI 10.1136/ard.2007.072751; Urano W, 2009, J BONE MINER METAB, V27, P574, DOI 10.1007/s00774-009-0073-7; Yamanaka H, 2007, MOD RHEUMATOL, V17, P283; Yamanaka H, 2012, MOD RHEUMATOL, V23, P1	44	1	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	MAR	2015	26	3					961	968		10.1007/s00198-014-2911-2		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CC2ZP	WOS:000350214100012		
J	Asamiya, Y; Yajima, A; Shimizu, S; Otsubo, S; Tsuchiya, K; Nitta, K				Asamiya, Y.; Yajima, A.; Shimizu, S.; Otsubo, S.; Tsuchiya, K.; Nitta, K.			Associations between the levels of sclerostin, phosphate, and fibroblast growth factor-23 and treatment with vitamin D in hemodialysis patients with low intact PTH level	OSTEOPOROSIS INTERNATIONAL			English	Article						Fibroblast growth factor-23; Parathyroid hormone; Phosphate; Sclerostin	CLINICAL-PRACTICE GUIDELINE; CHRONIC KIDNEY-DISEASE; BONE-MINERAL DENSITY; PARATHYROID-HORMONE; SERUM SCLEROSTIN; SECONDARY HYPERPARATHYROIDISM; POSTMENOPAUSAL WOMEN; ENERGY-METABOLISM; OSTEOCYTES; MANAGEMENT	A Summary Serum sclerostin levels could be closely associated with serum phosphate and fibroblast growth factor-23 levels in hemodialysis patients with low intact parathyroid hormone (PTH) levels. Further study is required to indicate whether these close associations are present in patients with spontaneously low PTH levels without any vitamin D treatment. Introduction Intact parathyroid hormone (iPTH) is involved in the interaction between sclerostin and phosphate/fibroblast growth factor-23 (FGF23) in animal models. However, their relationship in patients on hemodialysis (HD) is unclear. Methods Data of 102 HD patients were collected regarding clinical and laboratory parameters and mineral bone disorder medications. The patients were divided into subgroups according to the iPTH level (A, <70 pg/mL; B, 70-150 pg/mL; C, 150-300 pg/mL; and D, >= 300 pg/mL). Results The sclerostin level was significantly and positively correlated with phosphate and log of FGF23 levels in subgroups A, B, and combined A and B. Multiple linear regression analysis in the combined A and B subgroup revealed that male sex (t = 3.24, P = 0.01; 95 % confidence interval [CI] 11.78 to 50.43) and phosphate level (t = 2.13, P = 0.04; 95 % CI, 1.08 to 36.91) were independent factors for serum sclerostin level. The log of serum FGF23 level (t = 1.90, P = 0.06, 95 % CI -1.85 to 63.50) appeared to be an important factor for serum sclerostin level. The frequency of patients using vitamin D treatment was not significantly different among subgroups A (93.1 %), B (88.0 %), C (85.2 %), and D (90.5 %). Conclusion Serum sclerostin levels were associated with serum phosphate and FGF23 levels in patients with low iPTH levels. Further study is required to indicate whether these close associations are present in patients with spontaneously low iPTH levels without vitamin D treatment.	[Asamiya, Y.; Yajima, A.; Tsuchiya, K.; Nitta, K.] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjuku Ku, Tokyo 1628666, Japan; [Yajima, A.] Otsuki Municipal Cent Hosp, Div Nephrol, Dept Med, Yamanashi 4010015, Japan; [Yajima, A.] Hokkaido Univ, Grad Sch Dent Med, Dept Dev Biol Hard Tissue, Kita Ku, Sapporo, Hokkaido 0608586, Japan; [Shimizu, S.] Tokyo Womens Med Univ, Med Res Inst, Shinjuku Ku, Tokyo 1628666, Japan; [Otsubo, S.] Sangenjaya Hosp, Dept Blood Purificat, Setagaya Ku, Tokyo 1540024, Japan; [Tsuchiya, K.] Tokyo Womens Med Univ, Dept Blood Purificat, Kidney Ctr, Shinjuku Ku, Tokyo 1628666, Japan	Asamiya, Y (reprint author), Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjuku Ku, 8-1 Kawada Chou, Tokyo 1628666, Japan.	asamiyaasamiya@gmail.com					Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Devarajan-Ketha H, 2012, BIOCHEM BIOPH RES CO, V417, P830, DOI 10.1016/j.bbrc.2011.12.048; Mirza FS, 2010, J CLIN ENDOCR METAB, V95, P1991, DOI 10.1210/jc.2009-2283; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Ryan ZC, 2013, P NATL ACAD SCI USA, V110, P6199, DOI 10.1073/pnas.1221255110; Pereira RC, 2009, BONE, V45, P1161, DOI 10.1016/j.bone.2009.08.008; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Dawson-Hughes B, 2014, EUR J ENDOCRINOL, V170, P645, DOI 10.1530/EJE-13-0862; Modder UI, 2011, J BONE MINER RES, V26, P373, DOI 10.1002/jbmr.217; Rowe PSN, 2012, CELL BIOCHEM FUNCT, V30, P355, DOI 10.1002/cbf.2841; Cejka D, 2012, NEPHROL DIAL TRANSPL, V27, P226, DOI 10.1093/ndt/gfr270; Atkins GJ, 2012, OSTEOPOROSIS INT, V23, P2067, DOI 10.1007/s00198-012-1915-z; [Anonymous], 2009, KIDNEY INT S, V113, pS1; Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P877, DOI 10.2215/CJN.06550810; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Gaudio A, 2010, J CLIN ENDOCR METAB, V95, P2248, DOI 10.1210/jc.2010-0067; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Atkins GJ, 2011, J BONE MINER RES, V26, P1425, DOI 10.1002/jbmr.345; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; Moester MJC, 2010, CALCIFIED TISSUE INT, V87, P99, DOI 10.1007/s00223-010-9372-1; Polyzos SA, 2012, OSTEOPOROSIS INT, V23, P1171, DOI 10.1007/s00198-010-1525-6; McClung MR, 2014, NEW ENGL J MED, V370, P412, DOI 10.1056/NEJMoa1305224; Sabbagh Y, 2012, J BONE MINER RES, V27, P1757, DOI 10.1002/jbmr.1630; Pelletier S, 2013, CLIN J AM SOC NEPHRO, V8, P819, DOI 10.2215/CJN.07670712; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Baron Roland, 2007, Curr Osteoporos Rep, V5, P73; de Oliveira RB, 2013, NEPHROL DIAL TRANSPL, V28, P2510, DOI 10.1093/ndt/gft234; Ferreira JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079721; Fukagawa M, 2011, AM J NEPHROL, V33, P427, DOI 10.1159/000327654; Fukagawa M, 2008, THER APHER DIAL, V12, P514, DOI 10.1111/j.1744-9987.2008.00648.x; Inaba M, 1999, METABOLISM, V48, P904, DOI 10.1016/S0026-0495(99)90227-5; Jean G, 2013, NEPHROL DIAL TRANSPL, V28, P2932, DOI 10.1093/ndt/gft222; Kogawa M, 2013, J BONE MINER RES, V28, P2436, DOI 10.1002/jbmr.2003; National Kidney Foundation, 2003, AM J KIDNEY DIS S, V42, pS1, DOI DOI 10.1016/S0272-6386(03)00905-3; Rowe PSN, 2012, CRIT REV EUKAR GENE, V22, P61; Shidara K, 2008, CALCIFIED TISSUE INT, V82, P278, DOI 10.1007/s00223-008-9127-4; Wijenayaka AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025900; Yamashita H, 2005, J CLIN ENDOCR METAB, V90, P4211, DOI 10.1210/jc.2004-2498	40	1	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	MAR	2015	26	3					1017	1028		10.1007/s00198-014-2934-8		12	Endocrinology & Metabolism	Endocrinology & Metabolism	CC2ZP	WOS:000350214100018		
J	Nagata, Y; Inaba, M; Imanishi, Y; Okazaki, H; Yamada, S; Mori, K; Shoji, S; Koyama, H; Okuno, S				Nagata, Y.; Inaba, M.; Imanishi, Y.; Okazaki, H.; Yamada, S.; Mori, K.; Shoji, S.; Koyama, H.; Okuno, S.			Increased undercarboxylated osteocalcin/intact osteocalcin ratio in patients undergoing hemodialysis	OSTEOPOROSIS INTERNATIONAL			English	Article						Chronic kidney disease; Hemodialysis; Osteocalcin; Undercarboxylated osteocalcin	BONE-MINERAL DENSITY; CHRONIC KIDNEY-DISEASE; VITAMIN-K DEFICIENCY; ELDERLY-WOMEN; IMMUNORADIOMETRIC ASSAY; BIOCHEMICAL MARKERS; RENAL DYSFUNCTION; RESORPTION MARKER; JAPANESE SUBJECTS; SERUM-LEVELS	A Summary Serum undercarboxylated osteocalcin (ucOC)/intact osteocalcin (iOC) ratio increased >1.0 in the patients undergoing hemodialysis, particularly in those with high bone turnover state. Consequently, serum ucOC/iOC ratio might lose its significance as a bone metabolic marker to indicate vitamin K deficiency in hemodialysis patients. Introduction Serum intact osteocalcin (iOC), undercarboxylated OC (ucOC), and the ucOC/iOC ratio are considered clinically relevant indices in pre-dialysis chronic kidney disease (CKD) and hemodialysis (HD) patients, despite their accumulation in uremic serum. Methods Serum iOC and ucOC were measured along with serum intact parathyroid hormone (iPTH), bone alkaline phosphatase (BAP), and tartrate-resistant acid phosphatase (TRACP)-5b in 89 pre-dialysis CKD and 189 HD patients. Results Serum iOC and ucOC showed significantly negative correlations with estimated glomerular filtration rate in pre-dialysis CKD patients, although serum ucOC/iOC ratio did not correlate. Serum ucOC was significantly greater in HD patients than in pre-dialysis CKD patients, while serum iOC did not differ significantly, resulting in serum ucOC/iOC ratio >1.0 in 135 (71.4 %) out of 189 HD patients. HD patients with high serum ucOC/iOC ratio (>1.0) had a significantly younger age and significantly higher values of body mass index, serum creatinine, albumin, phosphate, iPTH, and TRACP-5b than those with low ucOC/iOC ratio (<= 1.0). The baseline iPTH and P1NP correlated with the changes of the ucOC/iOC ratio during the 2 days of the inter-dialytic period. Multivariate analysis showed that log [ucOC/iOC] in HD patients was significantly associated with log [iPTH], log [BAP], or log [TRACP-5b]. Conclusion Serum ucOC/iOC ratio >1.0 was observed in as high as 71.4 % of HD patients, preferentially with high bone turnover state, in comparison with pre-dialysis CKD patients. These data suggested that serum ucOC/iOC ratio might lose its significance as a bone metabolic marker to indicate vitamin K deficiency in HD patients.	[Nagata, Y.; Inaba, M.; Imanishi, Y.; Yamada, S.; Mori, K.] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Abeno Ku, Osaka 5458585, Japan; [Okazaki, H.; Shoji, S.; Okuno, S.] Shirasagi Hosp, Kidney Ctr, Osaka, Japan; [Koyama, H.] Hyogo Coll Med, Dept Internal Med, Div Diabet Endocrinol & Metab, Nishinomiya, Hyogo 6638501, Japan	Inaba, M (reprint author), Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	inaba-m@med.osaka-cu.ac.jp					GARNERO P, 1994, J BONE MINER RES, V9, P255; Miyauchi A, 2010, BONE, V47, P493, DOI 10.1016/j.bone.2010.05.022; Holden RM, 2010, CLIN J AM SOC NEPHRO, V5, P590, DOI 10.2215/CJN.06420909; Pilkey RM, 2007, AM J KIDNEY DIS, V49, P432, DOI 10.1053/j.ajkd.2006.11.041; SZULC P, 1994, J BONE MINER RES, V9, P1591; [Anonymous], 2009, KIDNEY INT S, V113, pS1; Klawansky S, 2003, OSTEOPOROSIS INT, V14, P570, DOI 10.1007/s00198-003-1435-y; SZULC P, 1993, J CLIN INVEST, V91, P1769, DOI 10.1172/JCI116387; Gal-Moscovici A, 2007, SEMIN DIALYSIS, V20, P423, DOI 10.1111/j.1525-139X.2007.00319.x; Nagasue K, 2003, BIOMED PHARMACOTHER, V57, P98, DOI 10.1016/S0753-3322(02)00344-X; Westenfeld R, 2012, AM J KIDNEY DIS, V59, P186, DOI 10.1053/j.ajkd.2011.10.041; Kanazawa I, 2011, OSTEOPOROSIS INT, V22, P187, DOI 10.1007/s00198-010-1184-7; Okuno S, 2005, OSTEOPOROSIS INT, V16, P501, DOI 10.1007/s00198-004-1712-4; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Takahashi M, 2000, CLIN CHIM ACTA, V294, P67, DOI 10.1016/S0009-8981(99)00251-X; Inaba M, 1999, OSTEOPOROSIS INT, V9, P525, DOI 10.1007/s001980050180; Kumeda Y, 2000, J CLIN ENDOCR METAB, V85, P4157, DOI 10.1210/jc.85.11.4157; Delmas PD, 2000, OSTEOPOROSIS INT, V11, P2; Prats-Puig A, 2010, DIABETES CARE, V33, P661, DOI 10.2337/dc09-1837; Kanazawa I, 2009, J CLIN ENDOCR METAB, V94, P45, DOI 10.1210/jc.2008-1455; DELMAS PD, 1990, ENDOCRIN METAB CLIN, V19, P1; Kasukawa Y, 2013, J BONE MINER METAB, V32, P290; Maeno Y, 2009, CALCIFIED TISSUE INT, V85, P310, DOI 10.1007/s00223-009-9278-y; Maeno Y, 2005, CLIN CHEM, V51, P2312, DOI 10.1373/clinchem.2005.051524; Miki T, 2003, J BONE MINER METAB, V21, P161, DOI 10.1007/s007740300025; Nimptsch K, 2007, ANN NUTR METAB, V51, P563, DOI 10.1159/000114211; Nishimura Jun, 2007, Clin Calcium, V17, P1702; Nishizawa Y, 2008, J BONE MINER METAB, V26, P265, DOI 10.1007/s00774-007-0826-0; Ohashi T, 2007, CLIN CHIM ACTA, V376, P205, DOI 10.1016/j.cca.2006.08.021; PRICE PA, 1981, J BIOL CHEM, V256, P2760; PRICE PA, 1981, J BIOL CHEM, V256, P2754; Rosenquist C, 1994, J BONE MINER RES, V9, pS37; Shidara K, 2008, CALCIFIED TISSUE INT, V82, P278, DOI 10.1007/s00223-008-9127-4; Shiraki M, 2007, IYAKU YAKUGAKU, V57, P537; Shiraki M, 2010, J BONE MINER METAB, V28, P578, DOI 10.1007/s00774-010-0167-2; Yamada S, 2008, CLIN ENDOCRINOL, V69, P189, DOI 10.1111/j.1365-2265.2008.03187.x	36	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	MAR	2015	26	3					1053	1061		10.1007/s00198-014-2954-4		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CC2ZP	WOS:000350214100022		
J	Honda, A; Matsumoto, M; Kato, T; Umemura, Y				Honda, A.; Matsumoto, M.; Kato, T.; Umemura, Y.			Exercise characteristics influence femoral cross-sectional geometry: a magnetic resonance imaging study in elite female athletes	OSTEOPOROSIS INTERNATIONAL			English	Article						Bone geometry; Exercise; Female athlete; MRI	QUANTITATIVE COMPUTED-TOMOGRAPHY; BONE-MINERAL DENSITY; FOLLOW-UP; OLD STARTERS; YOUNG; STRENGTH; WOMEN; SIZE; MASS; BENEFITS	A Summary The associations between mid-femoral cross-sectional geometry and exercise characteristics were investigated in female athletes. The effects on bone geometry for weight-bearing sports with low-to-high-impact were greater than those for non-impact weight-bearing sports, whereas low-impact or high-strain-magnitude/low-strain-rate sports had less of an effect on bone geometry compared with higher-impact sports. Introduction Many previous studies have investigated tibial geometry in athletes; however, few studies have examined the associations between femoral cross-sectional geometry and exercise characteristics. The aim of this study was to investigate these relationships using magnetic resonance imaging (MRI) at the femoral mid-shaft. Methods One hundred and fifty-three female elite athletes, aged 18-34 years, were classified into five groups based on the characteristics of their sports. Sports were considered non-impact (n = 27), low- or moderate-impact (n = 39), odd-impact (n = 38), high-strain-magnitude/low-strain-rate (n = 10), or high-impact (n = 39). Bone geometrical parameters, including cortical area, periosteal perimeter, and moment of inertia (bone strength index), were determined using MRI images. Resuls Higher-impact groups displayed bone expansion, with significantly greater periosteal perimeters, cortical areas (similar to 37.3 %), and minimum moments of inertia (I-min, similar to 92.3 %) at the mid-femur than non- and low-impact groups. After adjusting for age, height, and weight, the cortical area and I-min of the low-impact and high-strain-magnitude/low-strain-rate groups were also significantly greater than those of the non-impact group. Conclusion Higher-impact sports with high strain rates stimulated periosteal bone formation and improved bone geometry and strength indices at the femoral mid-shaft. Although our results indicate that weight-bearing sports are beneficial even if they are low impact, the effects of lower-impact or high-strain-magnitude/low-strain-rate sports on bone geometry were less pronounced than the effects of higher-impact sports at the femoral mid-shaft.	[Honda, A.; Matsumoto, M.; Umemura, Y.] Chukyo Univ, Sch Hlth & Sport Sci, Lab Exercise Physiol & Biomech, Toyota, Aichi 4700393, Japan; [Kato, T.] Suzuka Univ Med Sci, Fac Hlth Sci, Dept Clin Nutr, Sports Sci & Exercise Physiol Lab, Suzuka, Japan	Honda, A (reprint author), Chukyo Univ, Sch Hlth & Sport Sci, Lab Exercise Physiol & Biomech, 101 Tokodachi, Toyota, Aichi 4700393, Japan.	a.hond0920@gmail.com			Japan Institute of Sports Sciences (JISS); Japan Society for the Promotion of Science, Japan [21700714]	This work was supported by The Japan Institute of Sports Sciences (JISS). We thank all of the athletes who participated in this study, as well as the staff of JISS. We especially thank Hideyuki Takahashi and Hiroyuki Tohdo for their advice on MRI analysis.; This study was supported by Grants in Aid for Young Scientists (B) of the Japan Society for the Promotion of Science (21700714), Japan, 2009.	Anderson DD, 1996, J APPL BIOMECH, V12, P292; Kontulainen S, 2001, J BONE MINER RES, V16, P195, DOI 10.1359/jbmr.2001.16.2.195; Seeman E, 2003, NEW ENGL J MED, V349, P320, DOI 10.1056/NEJMp038101; Frost HM, 1997, J BONE MINER RES, V12, P1539, DOI 10.1359/jbmr.1997.12.10.1539; Kontulainen S, 2003, J BONE MINER RES, V18, P352, DOI 10.1359/jbmr.2003.18.2.352; Kato T, 2006, J APPL PHYSIOL, V100, P839, DOI 10.1152/japplphysiol.00666.2005; Valdimarsson O, 2005, J BONE MINER RES, V20, P906, DOI 10.1359/JBMR.050107; Nikander R, 2005, J BONE MINER RES, V20, P520, DOI 10.1359/JBMR.041119; Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5; Honda A, 2008, J APPL PHYSIOL, V105, P849, DOI 10.1152/japplphysiol.00902.2007; Duncan CS, 2002, MED SCI SPORT EXER, V34, P673, DOI 10.1097/00005768-200204000-00018; Heinonen A, 2001, BONE, V29, P279, DOI 10.1016/S8756-3282(01)00574-9; Nikander R, 2010, OSTEOPOROSIS INT, V21, P1687, DOI 10.1007/s00198-009-1101-0; Mosley JR, 1998, BONE, V23, P313, DOI 10.1016/S8756-3282(98)00113-6; Turner CH, 2003, EXERC SPORT SCI REV, V31, P45, DOI 10.1097/00003677-200301000-00009; Saxon LK, 2005, BONE, V36, P185, DOI 10.1016/j.bone.2004.08.003; Nilsson M, 2009, J BONE MINER RES, V24, P125, DOI [10.1359/jbmr.080909, 10.1359/JBMR.080909]; Chang G, 2009, OSTEOPOROSIS INT, V20, P779, DOI 10.1007/s00198-008-0730-z; Ducher G, 2009, BONE, V45, P760, DOI 10.1016/j.bone.2009.06.021; Erlandson MC, 2012, J BONE MINER RES, V27, P104, DOI 10.1002/jbmr.514; Kato T, 2009, BRIT J SPORT MED, V43, P932, DOI 10.1136/bjsm.2008.052308; Nichols DL, 2007, SPORTS MED, V37, P1001, DOI 10.2165/00007256-200737110-00006; Nordstrom A, 2005, J BONE MINER RES, V20, P202, DOI 10.1359/JBMR.041012; Pikkarainen E, 2009, SCAND J MED SCI SPOR, V19, P166, DOI 10.1111/j.1600-0838.2008.00773.x; Torstveit MK, 2005, BRIT J SPORT MED, V39, P282, DOI 10.1136/bjsm.2004.012781; Warden SJ, 2007, J BONE MINER RES, V22, P251, DOI 10.1359/JBMR.061107	26	1	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	MAR	2015	26	3					1093	1098		10.1007/s00198-014-2935-7		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CC2ZP	WOS:000350214100026		
J	Sakai, A; Ito, M; Tomomitsu, T; Tsurukami, H; Ikeda, S; Fukuda, F; Mizunuma, H; Inoue, T; Saito, H; Nakamura, T				Sakai, A.; Ito, M.; Tomomitsu, T.; Tsurukami, H.; Ikeda, S.; Fukuda, F.; Mizunuma, H.; Inoue, T.; Saito, H.; Nakamura, T.		e-ADVANCED Study Grp	Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis	OSTEOPOROSIS INTERNATIONAL			English	Article						Bisphosphonate; Bone mineral density; Bone turnover markers; Eldecalcitol; Vitamin D	BONE-MINERAL DENSITY; RANDOMIZED-OPEN-LABEL; POSTMENOPAUSAL WOMEN; BIOCHEMICAL MARKERS; DOUBLE-BLIND; TRABECULAR BONE; CLINICAL-TRIAL; DENOSUMAB; TURNOVER; THERAPY	A Summary Combined treatment with alendronate and eldecalcitol was found to be more effective in reducing the bone turnover markers and increasing bone mineral density than alendronate treatment with vitamin D3 and calcium supplementation in the osteoporotic patients. Introduction We compared the clinical efficacy and safety of combined treatment with alendronate plus eldecalcitol (ALN + ELD) with those of treatment with ALN plus vitamin D and calcium (ALN + VitD). Methods Osteoporotic 219 patients were randomly assigned to the ALN + ELD, or the ALN + VitD group. Primary endpoint was the inter-group differences in lumbar spine BMD (L-BMD) at patient's last visit. Secondary endpoints included the differences in BMD at other sites and the bone turnover marker (BTM) levels. Results L-BMD, total hip BMD and femoral neck (FN-BMD) increased from baseline by 7.30, 2.41, and 2.70 % in the ALN + ELD group, and by 6.52, 2.27, and 1.18 % in the ALN + VitD group, respectively. Inter-group differences of the L-BMD and total hip BMD values were not significant. The increase of the FN-BMD was larger in the ALN + ELD group than the ALN + VitD group. Reductions of the BTMs were greater in the ALN + ELD group than the ALN + VitD group. Interaction of the percent increase of the L-BMD with the baseline values of the BTMs was observed in the ALN + VitD group only. The increases of the FN-BMD in patients with lower baseline values of type-I-collagen C-telopeptide (sCTX) and serum 25(OH) D levels < 20 ng/mL were significantly larger in the ALN + ELD group than the other group. Conclusion Combination treatment of ALN plus ELD was more effective in reducing the BTMs and increasing the FN-BMD than ALN treatment with vitamin D3 and calcium.	[Sakai, A.] Univ Occupat & Environm Hlth, Dept Orthopaed Surg, Kitakyushu, Fukuoka 807, Japan; [Ito, M.] Nagasaki Univ Hosp, Med Work Life Balance Ctr, Nagasaki, Japan; [Tomomitsu, T.] Kawasaki Coll Allied Hlth Profess, Dept Radiol Technol, Kurashiki, Okayama, Japan; [Tsurukami, H.] Tsurukami Clin Orthopaed & Rheumatol Hosp, Kumamoto, Japan; [Ikeda, S.] Ken Ai Mem Hosp, Onga, Japan; [Fukuda, F.] Kitakyushu Gen Hosp, Kitakyushu, Fukuoka, Japan; [Mizunuma, H.] Hirosaki Univ Sch Med, Dept Obstet & Gynecol, Hirosaki, Aomori, Japan; [Inoue, T.] Taisho Pharmaceut Co Ltd, Tokyo, Japan; [Saito, H.] Chugai Pharmaceut Co Ltd, Tokyo, Japan; [Nakamura, T.] Natl Ctr Global Hlth & Med, Shinjyuku Ku, Tokyo 1628655, Japan	Nakamura, T (reprint author), Natl Ctr Global Hlth & Med, Shinjyuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	t-nak@utopia.ocn.ne.jp			Taisho Pharmaceutical; Chugai Pharmaceutical	The study was jointly designed by primary investigator and the sponsor, Chugai Pharmaceutical and Taisho pharmaceutical. The sponsor had responsibility for data collection and quality control. Analyses for publication were the responsibilities of the sponsor. All authors contributed to the manuscript and approved the final version for submission. The authors would like to acknowledge the other members of the e-ADVANCED study group: Hiroo Yamane, Masahiro Shiraishi, Kunitaka Menuki, Sanshiro Hashimoto, Toshihiro Sadamatsu, Tomohiro Fukuda, Kazuki Miyazono, Hirofumi Kataoka, Masataka Gotoh, and Ohsei tsuji. The study was funded by Taisho Pharmaceutical.	Recknor C, 2013, OBSTET GYNECOL, V121, P1291, DOI 10.1097/AOG.0b013e318291718c; Lisse TS, 2013, CRIT REV EUKAR GENE, V23, P195; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; de Freitas PHL, 2011, BONE, V49, P335, DOI 10.1016/j.bone.2011.05.022; OKANO T, 1989, BIOCHEM BIOPH RES CO, V163, P1444, DOI 10.1016/0006-291X(89)91140-6; MIYAMOTO K, 1993, CHEM PHARM BULL, V41, P1111; Matsumoto T, 2005, J CLIN ENDOCR METAB, V90, P5031, DOI 10.1210/jc.2004-2552; Matsumoto T, 2011, BONE, V49, P605, DOI 10.1016/j.bone.2011.07.011; Kendler DL, 2010, J BONE MINER RES, V25, P72, DOI 10.1359/jbmr.090716; Shiraki M, 1999, OSTEOPOROSIS INT, V10, P183, DOI 10.1007/s001980050214; Genant HK, 1996, J BONE MINER RES, V11, P984; Ravn P, 1999, BONE, V24, P237, DOI 10.1016/S8756-3282(98)00183-5; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Roux C, 2014, BONE, V58, P48, DOI 10.1016/j.bone.2013.10.006; Harada S, 2012, J BONE MINER RES, V27, P461, DOI 10.1002/jbmr.555; Orimo H, 2001, J BONE MINER METAB, V19, P331, DOI 10.1007/s007740170001; Krzeszinski JY, 2014, NATURE, V512, P431, DOI 10.1038/nature13375; Brown JP, 2009, J BONE MINER RES, V24, P153, DOI [10.1359/jbmr.080901, 10.1359/JBMR.0809010]; Russell RGG, 2007, ANN NY ACAD SCI, V1117, P209, DOI 10.1196/annals.1402.089; Kikuta J, 2013, P NATL ACAD SCI USA, V110, P7009, DOI [10.1073/pnas.1218799110, 10.1073/1218799110]; Bauer DC, 2006, J BONE MINER RES, V21, P292, DOI 10.1359/JBMR.051018; Chugai Pharmaceutical Co. Ltd., COMM TECHN DOC ELD 2; Greenspan SL, 1998, J BONE MINER RES, V13, P1431, DOI 10.1359/jbmr.1998.13.9.1431; Iwamoto J, 2005, J BONE MINER METAB, V23, P238, DOI 10.1007/s00774-004-0590-3; Matsumoto T, 2010, J STEROID BIOCHEM, V121, P261, DOI 10.1016/j.jsbmb.2010.03.035; Mori S, 2013, J BONE MINER METAB, V31, P258, DOI 10.1007/s00774-013-0441-1; Nakamura T, 2014, J CLIN ENDOCR METAB, V99, P2599, DOI 10.1210/jc.2013-4175; Nakamura T, 2014, OSTEOPOROSIS INT, V25, P367, DOI 10.1007/s00198-013-2398-2; Nenonen A, 2005, J BONE MINER RES, V20, P1804, DOI 10.1359/JBMR.050403; Ochi H, 1998, J OKAYAMA MED ASSOC, V110, P31; Saito H, 2014, J STEROID BIOCHEM, V144, P189, DOI 10.1016/j.jsbmb.2013.11.013; Scott LJ, 2014, DRUG AGING, V31, P555, DOI 10.1007/s40266-014-0191-3	32	2	2	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	MAR	2015	26	3					1193	1202		10.1007/s00198-014-2991-z		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CC2ZP	WOS:000350214100037		
J	Sugiyama, T; Kugimiya, F; Kono, S; Kim, YT; Oda, H				Sugiyama, T.; Kugimiya, F.; Kono, S.; Kim, Y. T.; Oda, H.			Warfarin use and fracture risk: an evidence-based mechanistic insight	OSTEOPOROSIS INTERNATIONAL			English	Letter							ORAL ANTICOAGULANTS; OSTEOPOROTIC FRACTURES; ATRIAL-FIBRILLATION; ELDERLY-PATIENTS; HIP FRACTURE; BONE MASS; QUALITY; THERAPY; OSTEOCALCIN; ADAPTATION		[Sugiyama, T.; Kugimiya, F.; Kono, S.; Kim, Y. T.; Oda, H.] Saitama Med Univ, Dept Orthopaed Surg, Moroyama, Saitama 3500495, Japan	Sugiyama, T (reprint author), Saitama Med Univ, Dept Orthopaed Surg, 38 Morohongo, Moroyama, Saitama 3500495, Japan.	tsugiym@saitama-med.ac.jp					Kavukcuoglu NB, 2009, J MECH BEHAV BIOMED, V2, P348, DOI 10.1016/j.jmbbm.2008.10.010; Gage BF, 2006, ARCH INTERN MED, V166, P241, DOI 10.1001/archinte.166.2.241; Sugiyama T, 2002, J BONE MINER METAB, V20, P196, DOI 10.1007/s007740200028; Shanbhogue VV, 2015, J BONE MINER RES, V30, P176, DOI 10.1002/jbmr.2310; Caraballo PJ, 1999, ARCH INTERN MED, V159, P1750, DOI 10.1001/archinte.159.15.1750; Fusaro M, 2014, CURR VASC PHARMACOL, DOI [10.2174/15701611113119990146, DOI 10.2174/15701611113119990146]; Jamal SA, 1998, ANN INTERN MED, V128, P829; Mamdani M, 2003, PHARMACOTHERAPY, V23, P1, DOI 10.1592/phco.23.1.1.31922; Misra D, 2014, OSTEOPOROSIS INT, V25, P1677, DOI 10.1007/s00198-014-2662-0; Pilon D, 2004, PHARMACOEPIDEM DR S, V13, P289, DOI 10.1002/pds.888; Rejnmark L, 2007, INT J CARDIOL, V118, P338, DOI 10.1016/j.ijcard.2006.07.022; Rey-Sanchez P, 2011, J BONE MINER METAB, V29, P546, DOI 10.1007/s00774-010-0250-8; Sato Y, 2010, CEREBROVASC DIS, V29, P73, DOI 10.1159/000256650; Sugiyama T, 2013, ANN INTERN MED, V159, P856, DOI 10.7326/0003-4819-159-12-201312170-00014; Sugiyama T, 2004, LANCET, V363, P1076, DOI 10.1016/S0140-6736(04)15855-8; Sugiyama T, 2007, J ENDOCRINOL, V194, P213, DOI 10.1677/JOS-07-0119; Sugiyama T, 2001, J BONE MINER METAB, V19, P146, DOI 10.1007/s007740170034; Sugiyama T, 2002, LANCET, V359, P1160, DOI 10.1016/S0140-6736(02)08147-3; Walsh JS, 2012, TRENDS ENDOCRIN MET, V23, P163, DOI 10.1016/j.tem.2011.10.002; Woo C, 2008, J AM GERIATR SOC, V56, P1171, DOI 10.1111/j.1532-5415.2008.01786.x	20	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	MAR	2015	26	3					1231	1232		10.1007/s00198-014-2912-1		2	Endocrinology & Metabolism	Endocrinology & Metabolism	CC2ZP	WOS:000350214100042		
J	Hotta, M				Hotta, M.			High prevalence of vitamin D insufficiency and deficiency among patients with anorexia nervosa in Japan	OSTEOPOROSIS INTERNATIONAL			English	Letter									Natl Grad Inst Policy Studies, Hlth Serv Ctr, Minato Ku, Tokyo 1068677, Japan	Hotta, M (reprint author), Natl Grad Inst Policy Studies, Hlth Serv Ctr, Minato Ku, 7-22-1 Roppongi, Tokyo 1068677, Japan.	marihs@grips.ac.jp					Yoshimura N, 2013, OSTEOPOROSIS INT, V24, P2775, DOI 10.1007/s00198-013-2372-z; Haagensen AL, 2008, OSTEOPOROSIS INT, V19, P289, DOI 10.1007/s00198-007-0476-z; Matsuo K, 2009, PEDIATR INT, V51, P559, DOI 10.1111/j.1442-200X.2009.02834.x	3	1	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	MAR	2015	26	3					1233	1233		10.1007/s00198-014-2957-1		1	Endocrinology & Metabolism	Endocrinology & Metabolism	CC2ZP	WOS:000350214100043		
J	Itoh, N; Kanai, K; Kimura, Y; Chikazawa, S; Hori, Y; Hoshi, F				Itoh, Naoyuki; Kanai, Kazutaka; Kimura, Yuya; Chikazawa, Seishiro; Hori, Yasutomo; Hoshi, Fumio			Prevalence of intestinal parasites in breeding kennel dogs in Japan	PARASITOLOGY RESEARCH			English	Article						Dog; Intestinal parasite; Breeding kennel; Giardia spp.; Cystoisospora spp.	GIARDIA-INTESTINALIS; CATS; INFECTIONS; EPIDEMIOLOGY; HOOKWORMS; LAMBLIA; BIOLOGY; UPDATE	The present study is the first to show overall prevalences of intestinal parasites among breeding kennel dogs in Japan. A total of 573 fresh fecal samples were collected from dogs at 12 breeding kennels. Giardia-specific coproantigen was examined by ELISA kit (SNAP(A (R)) Giardia, IDEXX Laboratories, Inc., Maine, USA). Other intestinal parasites were determined microscopically using the formalin-ethyl acetate sedimentation technique. Overall prevalences of two genera of protists, Giardia spp. and Cystoisospora spp., were 25.7 and 1.2 %, respectively. The prevalence of helminthes was recorded as: Toxocara canis 0.2 %, Toxascaris leonina 0.9 %, Ancylostoma caninum 0.2 %, Trichuris vulpis 2.1 %, and Spirometra erinacei 0.4 %. According to age categories, Giardia spp., Cystoisospora spp., and T. leonina in < 1-year-old dogs were significantly more prevalent than in a parts per thousand yen1-year-old dogs (61.0 vs. 19.8 %, P < 0.0001; 7.3 vs. 0.2 %, P < 0.0001; and 4.9 vs. 0.2 %, P < 0.001; respectively). With respect to fecal condition, the prevalences of T. leonina and T. vulpis were significantly higher in unformed stool dogs than in formed ones (2.4 vs. 0 %, P < 0.01, and 4.3 vs. 0.8 %, P < 0.05, respectively). In all of the breeding kennels except for one kennel, intestinal parasite infections were found at the high prevalent, ranging from 16.0 to 70.0 %.	[Itoh, Naoyuki; Kanai, Kazutaka; Kimura, Yuya; Chikazawa, Seishiro; Hori, Yasutomo; Hoshi, Fumio] Kitasato Univ, Sch Vet Med, Dept Small Anim Internal Med, Towada, Aomori 0348628, Japan	Itoh, N (reprint author), Kitasato Univ, Sch Vet Med, Dept Small Anim Internal Med, Higashi 23-35-1, Towada, Aomori 0348628, Japan.	naoitoh@vmas.kitasato-u.ac.jp					Itoh N, 2011, PARASITOL RES, V109, P253, DOI 10.1007/s00436-011-2258-y; YOUNG KH, 1979, J CLIN MICROBIOL, V10, P852; Ballweber LR, 2010, TRENDS PARASITOL, V26, P180, DOI 10.1016/j.pt.2010.02.005; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Robertson ID, 2002, MICROBES INFECT, V4, P867, DOI 10.1016/S1286-4579(02)01607-6; Claerebout E, 2009, VET PARASITOL, V161, P41, DOI 10.1016/j.vetpar.2008.11.024; Bowman DD, 2010, TRENDS PARASITOL, V26, P162, DOI 10.1016/j.pt.2010.01.005; Bugg RJ, 1999, VET J, V157, P295, DOI 10.1053/tvjl.1998.0327; Carranza PG, 2010, MICROBES INFECT, V12, P71, DOI 10.1016/j.micinf.2009.09.008; CROESE J, 1994, ANN INTERN MED, V120, P369; Dupont S, 2013, J SMALL ANIM PRACT, V54, P475, DOI 10.1111/jsap.12119; Good B, 2004, CLIN INFECT DIS, V39, P173, DOI 10.1086/421492; HENDRIX CM, 1987, VET CLIN N AM-SMALL, V17, P1355; HOREJS R, 1994, VET MED-CZECH, V39, P93; Itoh N, 2009, J VET SCI, V10, P305, DOI 10.4142/jvs.2009.10.4.305; Itoh N, 2011, VET PARASITOL, V176, P74, DOI 10.1016/j.vetpar.2010.10.048; Itoh N, 2005, J VET MED SCI, V67, P717, DOI 10.1292/jvms.67.717; KIRKPATRICK CE, 1987, VET CLIN N AM-SMALL, V17, P1405; KIRKPATRICK CE, 1987, VET CLIN N AM-SMALL, V17, P1377; LINDSAY DS, 1994, PARASITOL TODAY, V10, P214, DOI 10.1016/0169-4758(94)90116-3; Mundim MJS, 2007, VET PARASITOL, V144, P356, DOI 10.1016/j.vetpar.2006.09.039; Overgaauw PAM, 1997, CRIT REV MICROBIOL, V23, P233, DOI 10.3109/10408419709115138; PARSONS JC, 1987, VET CLIN N AM-SMALL, V17, P1307; Prucca CG, 2009, CELL MICROBIOL, V11, P1706, DOI 10.1111/j.1462-5822.2009.01367.x; Tangtrongsup S, 2010, TOP COMPANION ANIM M, V25, P155, DOI 10.1053/j.tcam.2010.07.003; Taylor MA, 2007, VET PARASITOL, P356	26	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0932-0113	1432-1955		PARASITOL RES	Parasitol. Res.	MAR	2015	114	3					1221	1224		10.1007/s00436-015-4322-5		4	Parasitology	Parasitology	CC0QC	WOS:000350039600048		
J	Moendeg, KJ; Angeles, JMM; Goto, Y; Leonardo, LR; Kirinoki, M; Villacorte, EA; Rivera, PT; Inoue, N; Chigusa, Y; Kawazu, S				Moendeg, Kharleezelle J.; Angeles, Jose Ma M.; Goto, Yasuyuki; Leonardo, Lydia R.; Kirinoki, Masashi; Villacorte, Elena A.; Rivera, Pilarita T.; Inoue, Noboru; Chigusa, Yuichi; Kawazu, Shin-ichiro			Development and optimization of cocktail-ELISA for a unified surveillance of zoonotic schistosomiasis in multiple host species	PARASITOLOGY RESEARCH			English	Article						Schistosoma japonicum; Schistosomiasis; Zoonoses; Diagnosis	TANDEM REPEAT PROTEINS; JAPONICUM INFECTION; THIOREDOXIN PEROXIDASE-1; WATER-BUFFALOS; DIAGNOSIS; SERODIAGNOSIS; PHILIPPINES; TRANSMISSION; ANTIBODIES; CANDIDATE	The zoonotic characteristic of the human parasite Schistosoma japonicum infecting a significant number of wild and domestic animals highlights the need to develop a unified surveillance in multiple host species for a strengthened schistosomiasis control. It has been shown in several studies that water buffaloes and dogs are considered important reservoirs in the transmission of the schistosome parasite to humans. Recombinant antigens like thioredoxin peroxidase-1 (SjTPx-1) and tandem repeat proteins (Sj1TR, Sj7TR) have been shown to be good diagnostic antigens individually in humans, water buffaloes, and dogs in previous studies. Mixing these antigens together in a cocktail-ELISA might not only improve their diagnostic potentials but rather produce a multi-host species detection means for zoonotic schistosomiasis. In this study, we aimed to develop and optimize cocktail-ELISA by testing different combinations of these recombinant antigens in humans, water buffaloes, and dogs. As compared with the diagnostic potential calculated for each of the three recombinant antigens used, their combination has presented improved specificities, positive predictive values, and kappa values. Using samples collected from various endemic areas in the Philippines, results showed that the combination of SjTPx-1/Sj7TR/Sj1TR has the highest sensitivity in humans (84.1 %), water buffaloes, and dogs (80 %) and specificity (100 %) in all host species. This study therefore suggests the use of cocktail-ELISA in improving the zoonotic surveillance in schistosomiasis endemic areas.	[Moendeg, Kharleezelle J.; Angeles, Jose Ma M.; Inoue, Noboru; Kawazu, Shin-ichiro] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan; [Goto, Yasuyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Resource Sci, Lab Mol Immunol, Tokyo, Japan; [Leonardo, Lydia R.; Villacorte, Elena A.; Rivera, Pilarita T.] Univ Philippines, Coll Publ Hlth, Dept Parasitol, Manila, Philippines; [Kirinoki, Masashi; Chigusa, Yuichi] Dokkyo Med Univ, Lab Trop Med & Parasitol, Mibu, Tochigi, Japan	Kawazu, S (reprint author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan.	skawazu@obihiro.ac.jp	Goto, Yasuyuki/E-9028-2011	Goto, Yasuyuki/0000-0002-8654-7888	Japan Society for the Promotion of Science [24405044, 23689024]; Japan Science and Technology Agency [AS232Z00111F]; Japan Society for the Promotion of Science Foreign Postdoctoral Grant [P14088]	We would like to thank the staff of the Department of Parasitology, College of Public Health, University of the Philippines Manila and to Peebles Grayle Tamayo for helping in the experiments done in the Philippines. This study was supported in part by a Grant-in-Aid for Scientific Research (24405044 to SK and 23689024 to YG) from the Japan Society for the Promotion of Science; and A-STEP Grant (AS232Z00111F to YG) from the Japan Science and Technology Agency; and Japan Society for the Promotion of Science Foreign Postdoctoral Grant (P14088).	Angeles JMM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001800; Angeles JM, 2014, SCHISTOSOMIASIS EPID, P87; He YX, 2001, TRENDS PARASITOL, V17, P320, DOI 10.1016/S1471-4922(01)01904-3; Gray DJ, 2007, AM J TROP MED HYG, V77, P866; Doenhoff MJ, 2004, TRENDS PARASITOL, V20, P35, DOI 10.1016/j.pt.2003.10.019; Lyashchenko KP, 2000, J IMMUNOL METHODS, V242, P91, DOI 10.1016/S0022-1759(00)00241-6; Zhou YP, 2009, PARASITOL RES, V105, P1435, DOI 10.1007/s00436-009-1575-x; Angeles JM, 2011, AM J TROP MED HYG, V85, P674, DOI 10.4269/ajtmh.2011.11-0245; McGarvey ST, 2006, B WORLD HEALTH ORGAN, V84, P446, DOI 10.2471/BLT.05.026427; Zhou XH, 2010, DIAGN MICR INFEC DIS, V67, P337, DOI 10.1016/j.diagmicrobio.2010.03.003; Houghton RL, 2002, CLIN DIAGN LAB IMMUN, V9, P883, DOI 10.1128/CDLI.9.4.883-891.2002; Cheng PC, 2007, VET PARASITOL, V150, P314, DOI 10.1016/j.vetpar.2007.09.022; Gray DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004058; Hara Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-165; Houghton RL, 2000, J INFECT DIS, V181, P325, DOI 10.1086/315165; Jin YM, 2010, CLIN VACCINE IMMUNOL, V17, P476, DOI 10.1128/CVI.00418-09; Kim Sera, 2003, Korean Journal of Parasitology, V41, P203; Li S, 2011, PARASITOL RES, V108, P1295, DOI 10.1007/s00436-010-2179-1; Nara T, 2007, AM J TROP MED HYG, V76, P384; Peng SY, 2008, RES VET SCI, V85, P527, DOI 10.1016/j.rvsc.2008.02.005; Qian CY, 2011, PARASITOL RES, V108, P493, DOI 10.1007/s00436-010-2112-7; Rudge JW, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000340; WHO Fact Sheet on Schistosomiasis, 2014, WHO FACT SHEET SCHIS	23	1	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0932-0113	1432-1955		PARASITOL RES	Parasitol. Res.	MAR	2015	114	3					1225	1228		10.1007/s00436-015-4312-7		4	Parasitology	Parasitology	CC0QC	WOS:000350039600049		
J	Fujimura, N				Fujimura, Naofumi			The influence of electoral institutions on legislative representation: Evidence from Japan's single non-transferable vote and single-member district systems	PARTY POLITICS			English	Article						Electoral incentive; electoral institution; Japan; policy specialization; political representation	PROPORTIONAL REPRESENTATION; CENTRIFUGAL INCENTIVES; FAVORED MINORITIES; PERSONAL VOTE; PARTY; CENTRIPETAL; PLURALITY; CULTIVATE; ELECTIONS; REFORM	This study aims to offer empirical evidence of how electoral systems influence the way legislators represent their constituencies. In particular, it analyses the influence of electoral systems on legislators' representations in terms of a pattern of policy areas represented by them. By comparing legislators' behaviour under Japan's multi-member district, single non-transferable vote and single-member district systems, I demonstrate that electoral systems with higher district magnitude (i.e. higher number of seats per district) are more likely to offer electoral incentives for legislators to represent specific benefits, including particularistic interests in targeted policy areas. On the other hand, electoral systems with lower district magnitude are more likely to provide electoral incentives for representing diverse benefits, including general interests in various policy areas.	[Fujimura, Naofumi] Kobe Univ, Grad Sch Law, Kobe, Hyogo 6578501, Japan	Fujimura, N (reprint author), Kobe Univ, Grad Sch Law, Nada Ku, 2-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	fujimura@emerald.kobe-u.ac.jp			Japan Society for the promotion of Science [23730136]	This work was partly supported by a Grant-in-Aid for Scientific Research from the Japan Society for the promotion of Science [research project number: 23730136].	Crisp BF, 2004, J POLIT, V66, P823; Shugart MS, 2005, AM J POLIT SCI, V49, P437, DOI 10.1111/j.0092-5853.2005.00133.x; Carey JM, 1995, ELECT STUD, V14, P417, DOI 10.1016/0261-3794(94)00035-2; Bawn K, 2003, J THEOR POLIT, V15, P5; Pekkanen R, 2006, AM POLIT SCI REV, V100, P183; Stratmann T, 2002, AM J POLIT SCI, V46, P506, DOI 10.2307/3088395; Edwards MS, 2007, ELECT STUD, V26, P338, DOI 10.1016/j.electstud.2006.06.008; Calvo E, 2011, AM J POLIT SCI, V55, P27, DOI 10.1111/j.1540-5907.2010.00482.x; COX GW, 1990, AM J POLIT SCI, V34, P903, DOI 10.2307/2111465; Cox GW, 1999, BRIT J POLIT SCI, V29, P33, DOI 10.1017/S0007123499000022; Crisp Brian F, 2009, J LEGISLATIVE STUDIE, V15, P35; Dow JK, 2011, BRIT J POLIT SCI, V41, P341, DOI 10.1017/S0007123410000360; Dow JK, 2001, ELECT STUD, V20, P109, DOI 10.1016/S0261-3794(99)00041-4; EstevezAbe M, 2008, CAMB STUD COMPAR, P1, DOI 10.1017/CBO9780511510069; Ezrow L, 2011, BRIT J POLIT SCI, V41, P448, DOI 10.1017/S000712341000044X; Ezrow L, 2008, BRIT J POLIT SCI, V38, P479, DOI 10.1017/S0007123408000240; Ezrow L, 2005, EUR J POLIT RES, V44, P881, DOI 10.1111/j.1475-6765.2005.00251.x; Hirano S, 2006, WORLD POLIT, V59, P51, DOI 10.1353/wp.2007.0017; Hug S, 2012, ELECT STUD, V31, P192, DOI 10.1016/j.electstud.2011.10.008; Inoguchi Takashi, 1987, ZOKU GIIN NO KENKYU; Krauss Ellis S., 2010, RISE FALL JAPANS LDP; Krauss ES, 2004, J JPN STUD, V30, P1, DOI 10.1353/jjs.2004.0021; Machidori S, 2005, JAPAN ECHO, V32, P38; Mizusaki T, 2007, SOUSENKYO NO TOKUHYO; MYERSON RB, 1993, AM POLIT SCI REV, V87, P856, DOI 10.2307/2938819; Nonaka N, 2008, JIMINTO SEIJI NO OWA; Sato S, 1986, JIMINTO SEIKEN; Tatebayashi M, 2004, GIIN KODO NO SEIJI K	28	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1354-0688	1460-3683		PARTY POLIT	Party Polit.	MAR	2015	21	2					209	221		10.1177/1354068812472578		13	Political Science	Government & Law	CC6RH	WOS:000350494400004		
J	Imai, R; Miyazaki, O; Horiuchi, T; Kurosawa, H; Nosaka, S				Imai, Rumi; Miyazaki, Osamu; Horiuchi, Tetsuya; Kurosawa, Hideo; Nosaka, Shunsuke			Local diagnostic reference level based on size-specific dose estimates: Assessment of pediatric abdominal/pelvic computed tomography at a Japanese national children's hospital	PEDIATRIC RADIOLOGY			English	Article						Size-specific dose estimates; Diagnostic reference level; CT; Child; Radiation dose	CT; CHILDHOOD; EXPOSURE; SCANS; RISK	A child's body size is not accurately reflected by volume CT dose index (CTDIvol) and dose-length product (DLP). Size-specific dose estimation (SSDE) was introduced recently as a new index of radiation dose. However, it has not yet been established as a diagnostic reference level (DRL). To calculate the SSDE of abdominal/pelvic CT and compare the SSDE with CTDIvol. To calculate the DRLs of CTDIvol and SSDE. Our hypotheses are: SSDE values will be greater than CTDIvol, and our DRL will be smaller than the known DRLs of other countries. The CTDIvol and DLP of 117 children who underwent abdominal/pelvic CT were collected retrospectively. The SSDE was calculated from the sum of the lateral and anteroposterior diameters. The relationships between body weight and effective diameter and between effective diameter and CTDIvol/SSDE were compared. Further, the local DRL was compared with the DRLs of other countries. Body weight and effective diameter and effective diameter and SSDE were positively correlated. In children ages 1, 5 and 10 years, the SSDE is closer to the exposure dose of CTDIvol for the 16-cm phantom, while in children ages 15 years, the SSDE falls between CTDIvol for the 16-cm phantom and that for the 32-cm phantom. The local DRL was lower than those of other countries. With SSDE, the radiation dose increased with increasing body weight. Since SSDE takes body size into account, it proved to be a useful indicator for estimating the exposure dose.	[Imai, Rumi; Miyazaki, Osamu; Kurosawa, Hideo; Nosaka, Shunsuke] Natl Ctr Child Hlth & Dev, Dept Radiol, Setagaya Ku, Tokyo 1578535, Japan; [Horiuchi, Tetsuya] Osaka Univ, Grad Sch Med, Dept Med Phys & Engn, Div Med Technol & Sci,Course Hlth Sci, Suita, Osaka 5650871, Japan	Imai, R (reprint author), Natl Ctr Child Hlth & Dev, Dept Radiol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	imai-rm@ncchd.go.jp			National Center for Child Health and Development, Japan [23 A - 4, 26-20]	This article was supported by the Grant of National Center for Child Health and Development, Japan, 23 A - 4, 26-20	Shrimpton PC, 2006, BRIT J RADIOL, V79, P968, DOI 10.1259/bjr/93277434; [Anonymous], 2002, IEC PUBL; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Brisse HJ, 2009, J RADIOL, V90, P207; Verdun FR, 2008, EUR RADIOL, V18, P1980, DOI 10.1007/s00330-008-0963-4; Boone J. M., 2011, 204 AAPM; Buls N, 2010, CT PAEDIAT DOSES BEL; Galanski M, 2007, PAEDIAT CT EXPOSURE; ICRP, 1996, ANN ICRP, V26; ICRP, 1991, ANN ICRP, V21; ICRP, 2013, ANN ICRP, V42; International Commission on Radiological Protection (ICRP), 2007, ICRP PUBL, V102; Kritsaneepaiboon S, 2012, ACTA RADIOL, V52, P820; Lindskoug BA, 1992, BRIT J RADIOL, V65, pS431; Lindskoug BA, 1992, RADIAT PROT DOSIM, V43, pS289; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; McNitt-Gray M, 2011, ASSESSING RAD DOES D; Miyazaki O, 2008, RADIAT MED, V26, P98, DOI 10.1007/s11604-007-0199-2; Sivit JC, 2008, PEDIATR RADIOL, V38, pS675; Slovis TL, 2002, PEDIATR RADIOL, V32, P221, DOI 10.1007/s00247-002-0666-y; Strauss KJ, 2011, PEDIAT RADIOL S2, V41, pS472; Thomas KE, 2011, PEDIAT RADIOL S2, V41, pS562; Tsushima Yoshito, 2010, BMC Med Imaging, V10, P24, DOI 10.1186/1471-2342-10-24	23	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	MAR	2015	45	3					345	353		10.1007/s00247-014-3189-4		9	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	CC7NQ	WOS:000350555300005		
J	Seo, S; Ochi, T; Yazaki, Y; Okawada, M; Doi, T; Miyano, G; Koga, H; Lane, GJ; Yamataka, A				Seo, Shogo; Ochi, Takanori; Yazaki, Yuta; Okawada, Manabu; Doi, Takashi; Miyano, Go; Koga, Hiroyuki; Lane, Geoffrey J.; Yamataka, Atsuyuki			Soft tissue interposition is effective for protecting the neourethra during hypospadias surgery and preventing postoperative urethrocutaneous fistula: a single surgeon's experience of 243 cases	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Hypospadias; Urethroplasty; Soft tissue interposition; External spermatic fascia; Fistula	URETHROPLASTY; REPAIR; FLAP; LONG	Soft tissue interposition (STI) during hypospadias repair (HR) purportedly prevents postoperative urethrocutaneous fistula (PUF) by supporting the neourethra. We report our experience. Data from 243 hypospadias patients treated by a single surgeon from 1997 to 2014 by urethroplasty (UP) with STI (n = 229; UP + STI) and UP without STI (n = 14; UP-STI) were collated prospectively and compared for incidence of PUF. Re-operative UP were excluded. Hypospadias was distal (n = 55), mid-shaft (n = 59), proximal/penoscrotal (n = 109), scrotal (n = 15), and perineal (n = 5). UP was single-staged in 86, multi-staged in 157; mean age at UP was 3.1 +/- A 2.4 years. Soft tissue used for STI was prepucial inner dartos fascia (inner dartos: n = 88), ventral dartos fascia (ventral dartos: n = 15), pedicled external spermatic fascia (ESF: n = 84), adipose tissue surrounding the spermatic cord (pericordal: n = 9), scrotal adipose tissue (n = 8), or a combination of tissues (combined: n = 25). Mean follow-up was 6.4 +/- A 4.6 (range 0.6-16.8) years. Overall incidence of PUF was 10/243 (4.1 %); 7/229 (3.1 %) for UP + STI and 3/14 (21.4 %) in UP-STI (p < 0.05); incidence versus type of hypospadias was 1/55 for distal (1.8 %), 3/59 for mid-shaft (5.1 %), 5/109 for proximal/penoscrotal (4.6 %), 0/15 for scrotal (0 %), and 1/5 for perineal (20 %); incidence versus type of STI was 7/88 for inner dartos, 0/15 for ventral dartos, 0/84 for ESF, 0/9 for pericordal adipose tissue, 0/8 for scrotal adipose tissue, and 0/25 for combined. All PUF were repaired successfully. Satisfaction with penile cosmesis was acceptable (10.3 %) or good (89.7 %) without any testicular complications or scrotal deformity. STI, especially ESF, would appear to effectively prevent PUF in HR.	[Seo, Shogo; Ochi, Takanori; Yazaki, Yuta; Okawada, Manabu; Doi, Takashi; Miyano, Go; Koga, Hiroyuki; Lane, Geoffrey J.; Yamataka, Atsuyuki] Juntendo Univ, Sch Med, Dept Pediat Gen & Urogenital Surg, Bunkyo Ku, Tokyo 1138421, Japan	Seo, S (reprint author), Juntendo Univ, Sch Med, Dept Pediat Gen & Urogenital Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	sseo@juntendo.ac.jp; yama@juntendo.ac.jp					Spinoit AF, 2013, J UROLOGY, V189, P2276, DOI 10.1016/j.juro.2012.12.100; SNOW BW, 1986, J UROLOGY, V136, P861; Snodgrass W, 2011, J PEDIATR UROL, V7, P2, DOI 10.1016/j.jpurol.2010.05.011; Cimador M, 2013, INT J UROL, V20, P1000, DOI 10.1111/iju.12092; Sarhan OM, 2009, J PEDIATR UROL, V5, P378, DOI 10.1016/j.jpurol.2009.02.204; Snodgrass WT, 2002, UROLOGY, V60, P157, DOI 10.1016/S0090-4295(02)01620-5; Kraft KH, 2010, UROL CLIN N AM, V37, P167, DOI 10.1016/j.ucl.2010.03.003; Baskin L, 2001, BJU INT, V87, P534, DOI 10.1046/j.1464-410X.2001.00092.x; Bush NC, 2012, J PEDIAT UROL, V9, P252; Buskin L, 1994, J UROLOGY, V151, P1668; Churchill BM, 1996, J UROLOGY, V156, P2047, DOI 10.1016/S0022-5347(01)65432-6; Dhua Anjan Kumar, 2012, J Indian Assoc Pediatr Surg, V17, P16, DOI 10.4103/0971-9261.91080; Duckett JW, 1998, CAMPBELLS UROLOGY, P2094; Elder JS, 1987, UROL CLIN N AM, V29, P285; Hanna M, 2004, HYPOSPADIAS SURG, P127; KASS EJ, 1990, J UROLOGY, V144, P520; Khan M, 2014, HYPOSPADIAS REPAIR S, DOI [10.1155/2014/453039, DOI 10.1155/2014/453039]; LAU JTK, 1982, PLAST RECONSTR SURG, V70, P206, DOI 10.1097/00006534-198208000-00015; Liu GC, 2006, J PEDIATR SURG, V41, P554, DOI 10.1016/j.jpedsurg.2005.11.051; Mouriquand PDE, 2011, CURR OPIN UROL, V21, P465, DOI 10.1097/MOU.0b013e32834a6da3; Retwik AB, 1994, J UROLOGY, V152, P1229; Shimotakahara A, 2011, J PEDIATR SURG, V46, P2370, DOI 10.1016/j.jpedsurg.2011.09.033; Snodgrass Warren, 2008, J Pediatr Urol, V4, P250, DOI 10.1016/j.jpurol.2007.12.007; Snow BW, 1995, J UROLOGY, V153, P427; Subramaniam Ramnath, 2011, Semin Plast Surg, V25, P206, DOI 10.1055/s-0031-1281490; Yamataka A, 2008, J PEDIATR SURG, V43, P2260, DOI 10.1016/j.jpedsurg.2008.08.055; Yamataka A, 1998, J PEDIATR SURG, V33, P1788, DOI 10.1016/S0022-3468(98)90285-8	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	MAR	2015	31	3					297	303		10.1007/s00383-015-3655-6		7	Pediatrics; Surgery	Pediatrics; Surgery	CC0OF	WOS:000350034600013		
J	Suehiro, K; Morikage, N; Murakami, M; Yamashita, O; Ueda, K; Samura, M; Hamano, K				Suehiro, K.; Morikage, N.; Murakami, M.; Yamashita, O.; Ueda, K.; Samura, M.; Hamano, K.			Study on different bandages and application techniques for achieving stiffer compression	PHLEBOLOGY			English	Article						Chronic venous insufficiency; bandage; application; stiffness	LEG COMPRESSION; IN-VIVO; STIFFNESS	Objectives The objective of this study was to investigate the relationship between interface pressure and stiffness of compression achieved by various combinations of bandages and application techniques. Method There were eight healthy volunteers. One roll (4.5m) of four types of bandages with different extensibilities (0, 90, 108 and 218%) was applied to the leg in single-layer bandage fashion with eight random tensions. Then, the leg was wrapped with one to eight rolls in multi-layer bandage fashion. Results Each combination of bandage and application technique displayed an indigenous linear interface pressure-static stiffness index relationship. With single-layer bandage, lower extensibility was associated with higher static stiffness index at a given interface pressure. With multi-layer bandage, the static stiffness index at a given interface pressure was independent of the bandage type. Conclusion The stiffness at a given interface pressure was affected by the extensibility with single-layer bandage but not with multi-layer bandage.	[Suehiro, K.; Morikage, N.; Murakami, M.; Yamashita, O.; Ueda, K.; Samura, M.; Hamano, K.] Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Div Vasc Surg, Ube, Yamaguchi 7558505, Japan	Suehiro, K (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	ksuehiro-circ@umin.ac.jp					Milic DJ, 2010, J VASC SURG, V51, P655, DOI 10.1016/j.jvs.2009.10.042; Partsch H, 2008, DERMATOL SURG, V34, P600, DOI 10.1111/j.1524-4725.2007.34116.x; Partsch H, 2006, DERMATOL SURG, V32, P224, DOI 10.1111/j.1524-4725.2006.32039.x; Partsch H, 2005, DERMATOL SURG, V31, P625; Coleridge-Smith P, 2006, EUR J VASC ENDOVASC, V31, P83, DOI 10.1016/j.ejvs.2005.07.019; Eberhardt RT, 2005, CIRCULATION, V111, P2398, DOI 10.1161/01.CIR.0000164199.72440.08; Mosti G, 2009, ACTA VULNOLOGICA, V7, P1; Partsch H, 1999, DERMATOL SURG, V25, P695, DOI 10.1046/j.1524-4725.1999.98040.x; Suehiro Kotaro, 2012, Ann Vasc Dis, V5, P347, DOI 10.3400/avd.oa.12.00020	9	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0268-3555	1758-1125		PHLEBOLOGY	Phlebology	MAR	2015	30	2					92	97		10.1177/0268355513515651		6	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CC6PP	WOS:000350488400003		
J	Liu, ZD; Irifune, T; Greaux, S; Arimoto, T; Shinmei, T; Higo, Y				Liu, Zhaodong; Irifune, Tetsuo; Greaux, Steeve; Arimoto, Takeshi; Shinmei, Toru; Higo, Yuji			Elastic wave velocity of polycrystalline Mj(80)Py(20) garnet to 21 GPa and 2,000 K	PHYSICS AND CHEMISTRY OF MINERALS			English	Article						Garnet; Elastic wave velocity; Elastic moduli; Velocity gradients	EQUATION-OF-STATE; MANTLE TRANSITION REGION; MGSIO3 TETRAGONAL GARNET; SUBDUCTED BASALTIC CRUST; MAJORITE SOLID-SOLUTION; MULTI-ANVIL APPARATUS; EARTHS LOWER MANTLE; HIGH-PRESSURE; SYSTEM MG4SI4O12-MG3AL2SI3O12; ULTRASONIC INTERFEROMETRY	The elastic wave velocities of polycrystalline Mj(80)Py(20) garnet along the majorite-pyrope system have been measured at pressures up to 21 GPa and temperatures up to 2,000 K using ultrasonic interferometry in conjunction with in situ X-ray diffraction techniques in a Kawai-type multi-anvil apparatus. The elastic moduli of Mj(80)Py(20) garnet and their pressure and temperature derivatives are determined by a two-dimensional linear fitting of the present experimental data, yielding: K (S) = 161.5 (7) GPa, a,K (S)/a,P = 4.42 (4), a,K (S)/a,T = -0.0154 (2) GPa/K, G = 86.2 (2) GPa, a,G/a,P = 1.28 (1), a,G/a,T = -0.0096 (5) GPa/K. The present results together with those of the studies on the majorite-pyrope solid solutions suggest the pressure and temperature derivatives of elastic moduli are insensitive to the majorite content in the majorite-pyrope system. The velocity gradients of the majoritic garnets in the majorite-pyrope system are 3 6 times lower than those required to account for the high seismic velocity gradients observed in the mantle transition zone.	[Liu, Zhaodong; Irifune, Tetsuo; Greaux, Steeve; Arimoto, Takeshi; Shinmei, Toru] Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan; [Irifune, Tetsuo; Greaux, Steeve] Tokyo Inst Technol, Earth Life Sci Inst, Tokyo 1528550, Japan; Japan Synchrotron Radiat Inst, Kobe, Hyogo 6785198, Japan	Liu, ZD (reprint author), Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan.	zhaodong@sci.ehime-u.ac.jp			JSPS [25220712]	The authors are grateful to H. Ohfuji and M. Nishi for their helps in FE-SEM observations. We thank C. Zhou, T. Kunimoto, Y. Tange, N. Cai, W. Du, and X. Wang for their experimental technical assistances and valuable discussions. We appreciate Y. Nishihara for his help in FTIR measurements. We are also grateful for constructive reviews by Dr. C. McCammon and two anonymous reviewers. The present study is supported by the Grant-in-Aid for Scientific Research (S) by JSPS to T. Irifune (Grant No. 25220712).	AKAOGI M, 1977, PHYS EARTH PLANET IN, V15, P90, DOI 10.1016/0031-9201(77)90013-9; Sinogeikin SV, 2002, EARTH PLANET SC LETT, V203, P549, DOI 10.1016/S0012-821X(02)00851-8; Li B, 2007, P NATL ACAD SCI USA, V104, P9145, DOI 10.1073/pnas.0608609104; Kono Y, 2010, J EARTH SCI-CHINA, V21, P782, DOI 10.1007/s12583-010-0112-2; DAVIES GF, 1975, PHYS EARTH PLANET IN, V10, P336, DOI 10.1016/0031-9201(75)90060-6; KENNETT BLN, 1991, GEOPHYS J INT, V105, P429, DOI 10.1111/j.1365-246X.1991.tb06724.x; Kono Y, 2010, PHYS EARTH PLANET IN, V183, P196, DOI 10.1016/j.pepi.2010.03.010; Hirose K, 1999, NATURE, V397, P53; Irifune T, 1998, NATURE, V392, P702, DOI 10.1038/33663; Wang YB, 1998, PHYS EARTH PLANET IN, V105, P59, DOI 10.1016/S0031-9201(97)00072-1; IRIFUNE T, 1993, EARTH PLANET SC LETT, V117, P101, DOI 10.1016/0012-821X(93)90120-X; Gwanmesia GD, 2006, PHYS EARTH PLANET IN, V155, P179, DOI 10.1016/j.pepi.2005.10.008; BROWN JM, 1981, GEOPHYS J ROY ASTR S, V66, P579, DOI 10.1111/j.1365-246X.1981.tb04891.x; LEBAIL A, 1988, MATER RES BULL, V23, P447, DOI 10.1016/0025-5408(88)90019-0; Heinemann S, 1997, PHYS CHEM MINER, V24, P206, DOI 10.1007/s002690050034; Akaogi M, 2002, PHYS EARTH PLANET IN, V132, P303, DOI 10.1016/S0031-9201(02)00075-4; Morishima H, 1999, PHYS CHEM MINER, V27, P3, DOI 10.1007/s002690050234; Irifune T, 2008, NATURE, V451, P814, DOI 10.1038/nature06551; GASPARIK T, 1990, J GEOPHYS RES-SOLID, V95, P15751, DOI 10.1029/JB095iB10p15751; Toby BH, 2001, J APPL CRYSTALLOGR, V34, P210, DOI 10.1107/S0021889801002242; Higo Y, 2009, J SYNCHROTRON RADIAT, V16, P762, DOI 10.1107/S0909049509034980; RINGWOOD AE, 1971, EARTH PLANET SC LETT, V12, P411, DOI 10.1016/0012-821X(71)90026-4; Pacalo REG, 1997, PHYS EARTH PLANET IN, V99, P145; Li BS, 2004, PHYS EARTH PLANET IN, V143, P559, DOI 10.1016/j.pepi.2003.09.020; Bass DJ, 1990, GEOPHYS RES LETT, V17, P1989; BASS JD, 1984, GEOPHYS RES LETT, V11, P237; Coleman LC, 1977, CAN MINERAL, V15, P97; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; GASPARIK T, 1992, J GEOPHYS RES-SOL EA, V97, P15181, DOI 10.1029/92JB01465; Gwanmesia GD, 2000, PHYS CHEM MINER, V27, P445, DOI 10.1007/s002699900054; Gwanmesia GD, 2009, PHYS EARTH PLANET IN, V174, P105, DOI 10.1016/j.pepi.2008.07.029; Gwanmesia GD, 1998, GEOPHYS RES LETT, V25, P4553, DOI 10.1029/1998GL900189; Gwanmesia GD, 2013, PHYS EARTH PLANET IN, V228, P80; Higo Y, 2008, PHYS EARTH PLANET IN, V166, P67; Irifune T., 1987, HIGH PRESSURE RES MI, P231; Irifune T, 1996, PHYS EARTH PLANET IN, V96, P147, DOI 10.1016/0031-9201(96)03147-0; IRIFUNE T, 1986, EARTH PLANET SC LETT, V77, P245, DOI 10.1016/0012-821X(86)90165-2; Kavner A, 2000, J GEOPHYS RES-SOL EA, V105, P5963, DOI 10.1029/1999JB900374; Kono Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL054009; Kubo A, 2000, PHYS EARTH PLANET IN, V121, P85, DOI 10.1016/S0031-9201(00)00162-X; Larson AC, 2000, 86748 LAUR LOS AL NA, V86-748, P1; Li BS, 1998, SCIENCE, V281, P675, DOI 10.1126/science.281.5377.675; Li BS, 1996, PHYS EARTH PLANET IN, V98, P79, DOI 10.1016/S0031-9201(96)03173-1; Li BS, 2002, J PHYS-CONDENS MAT, V14, P11337, DOI 10.1088/0953-8984/14/44/478; Liu J, 2000, PHYS EARTH PLANET IN, V120, P153, DOI 10.1016/S0031-9201(00)00152-7; Mao H-K, 1982, CARNEGIE I WASHINGTO, V81, P279; Meyer H.O.A., 1987, MANTLE XENOLITHS, V1, P501; MOORE RO, 1985, NATURE, V318, P553, DOI 10.1038/318553a0; Murakami M, 2008, EARTH PLANET SC LETT, V274, P339, DOI 10.1016/j.epsl.2008.07.045; Ono S, 2001, EARTH PLANET SC LETT, V190, P57, DOI 10.1016/S0012-821X(01)00375-2; Parise JB, 1996, GEOPHYS RES LETT, V23, P3799, DOI 10.1029/96GL03613; RIGDEN SM, 1994, PHYS EARTH PLANET IN, V86, P35, DOI 10.1016/0031-9201(94)05060-0; Sinogeikin SV, 1997, PHYS CHEM MINER, V24, P115, DOI 10.1007/s002690050024; Sinogeikin SV, 2002, GEOPHYS RES LETT, V29, P2453; Tsuchiya T, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002446; YAGI T, 1992, PHYS EARTH PLANET IN, V74, P1, DOI 10.1016/0031-9201(92)90063-2; YEGANEHHAERI A, 1990, GEOPHYS RES LETT, V17, P2453, DOI 10.1029/GL017i013p02453; Zhou C, 2013, PHYS EARTH PLANET IN, V228, P97; Zou YT, 2012, J APPL PHYS, V112, DOI 10.1063/1.4736407	59	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-1791	1432-2021		PHYS CHEM MINER	Phys. Chem. Miner.	MAR	2015	42	3					213	222		10.1007/s00269-014-0712-y		10	Materials Science, Multidisciplinary; Mineralogy	Materials Science; Mineralogy	CC4GS	WOS:000350310900005		
J	Fujimoto, Y; Maeda, I; Ohyama, K; Hikiba, J; Kataoka, H				Fujimoto, Yoshinori; Maeda, Izumi; Ohyama, Kiyoshi; Hikiba, Juri; Kataoka, Hiroshi			Biosynthesis of 20-hydroxyecdysone in plants: 3 beta-Hydroxy-5 beta-cholestan-6-one as an intermediate immediately after cholesterol in Ajuga hairy roots	PHYTOCHEMISTRY			English	Article						Hairy root; Ajuga reptans var. atropurpurea; Labiatae; 20-Hydroxyecdysone; Phytoecdysteroid; LC-MS/MS; NIH shift	REPTANS VAR ATROPURPUREA; CIS RING JUNCTION; LIQUID-CHROMATOGRAPHY; ECDYSONE BIOSYNTHESIS; MECHANISM; HYDROXYLATION; ECDYSTEROIDS; MIGRATION; OXIDATION; ACID	3 beta-Hydroxy-5 beta-cholestan-6-one was identified in the EtOAc extract of Ajuga hairy roots by microanalysis using LC-MS/MS in the multiple reaction mode (MRM). Furthermore, administration of (2,2,4,4,7,7-H-2(6))- and (2,2,4,4,6,7,7-H-2(7))-cholesterols to the hairy roots followed by LC-MS/MS analysis of the EtOAc extract of the hairy roots indicated that cholesterol was converted to the 5 beta-ketone with hydrogen migration from the C-6 to the C-5 position. These findings, in conjunction with the previous observation that the ketone was efficiently converted to 20-hydroxyecdysone, strongly suggest that the 5 beta-ketone is an intermediate immediately formed after cholesterol during 20-hydroxyecdysone biosynthesis in Ajuga sp. In addition, the mechanism of the 5 beta-ketone formation from cholesterol is discussed. (C) 2014 Elsevier Ltd. All rights reserved.	[Fujimoto, Yoshinori; Maeda, Izumi; Ohyama, Kiyoshi] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan; [Hikiba, Juri; Kataoka, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan	Fujimoto, Y (reprint author), Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan.	fujimoto.y.aa@m.titech.ac.jp					Huang X, 2008, J GENET GENOMICS, V35, P1, DOI 10.1016/S1673-8527(08)60001-6; Hikiba J, 2013, J CHROMATOGR B, V915, P52, DOI 10.1016/j.jchromb.2012.12.014; de Visser SP, 2003, J AM CHEM SOC, V125, P7413, DOI 10.1021/ja034142f; Fitzpatrick PF, 2003, BIOCHEMISTRY-US, V42, P14083, DOI 10.1021/bi035656u; Dinan L, 2001, PHYTOCHEMISTRY, V57, P325, DOI 10.1016/S0031-9422(01)00078-4; BAWEJA R, 1987, ANAL CHIM ACTA, V192, P345, DOI 10.1016/S0003-2670(00)85722-0; Benchekroun Y, 1997, J CHROMATOGR B, V688, P245, DOI 10.1016/S0378-4347(96)00323-4; Clouse S.D., 2011, BIOONE, pe0151; DAVIES TG, 1980, BIOCHEM J, V190, P537; DAVIES TG, 1981, BIOCHEM J, V194, P53; de Miranda MG, 2013, QUIM NOVA, V36, P1160, DOI 10.1590/S0100-40422013000800014; Festucci-Buselli RA, 2008, BOTANY, V86, P978, DOI 10.1139/B08-049; Fujimoto Y, 1997, TETRAHEDRON LETT, V38, P2697, DOI 10.1016/S0040-4039(97)00432-2; Hyodo R, 2000, PHYTOCHEMISTRY, V53, P733, DOI 10.1016/S0031-9422(00)00018-2; LIEBLER DC, 1983, BIOCHEMISTRY-US, V22, P5482, DOI 10.1021/bi00293a005; LOCKLEY WJS, 1975, J CHEM SOC CHEM COMM, P346, DOI 10.1039/c39750000346; NAGAKARI M, 1994, PHYTOCHEMISTRY, V36, P907, DOI 10.1016/S0031-9422(00)90461-8; NAGAKARI M, 1994, J CHEM SOC CHEM COMM, P1761, DOI 10.1039/c39940001761; Narumi Y., 1999, J JPN OIL CHEM SOC, V48, P241; REES HH, 1995, EUR J ENTOMOL, V92, P9; Sakurai A, 1999, PLANT PHYSIOL BIOCH, V37, P351, DOI 10.1016/S0981-9428(99)80041-2; Shinkyo R, 2011, J BIOL CHEM, V286, P33021, DOI 10.1074/jbc.M111.282434; STARCK JP, 1994, B SOC CHIM FR, V131, P210; WAHIDULLA S, 1987, PHYTOCHEMISTRY, V26, P2864, DOI 10.1016/S0031-9422(00)83611-0; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9422			PHYTOCHEMISTRY	Phytochemistry	MAR	2015	111						59	64		10.1016/j.phytochem.2014.12.019		6	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CC7DH	WOS:000350527400007		
J	Tokunaga, T; Hayashi, H; Akiyama, K				Tokunaga, Tamami; Hayashi, Hideo; Akiyama, Kohki			Medicaol, a strigolactone identified as a putative didehydro-orobanchol isomer, from Medicago truncatula	PHYTOCHEMISTRY			English	Article						Barrel medic; Medicago truncatula; Fabaceae; Strigolactone; Gigaspora margarita; Glomeromycota	ARBUSCULAR MYCORRHIZAL FUNGI; ROOT PARASITIC WEEDS; GERMINATION STIMULANTS; CARLACTONE; STRIGA; BIOSYNTHESIS; ARABIDOPSIS; INHIBITION; HORMONES; TOBACCO	A major strigolactone produced by the model legume Medicago truncatula (barrel medic) has been tentatively identified as a didehydro-orobanchol isomer. In this study, a putative didehydro-orobanchol isomer was isolated from root exudates collected from barrel medic grown hydroponically under phosphate-starved conditions. The structure and absolute configurations of this strigolactone, named medicaol, were determined by a combination of spectroscopic analysis and spectral comparison with 4-deoxymedicaol which was synthesized using solvolysis and rearrangement of hydroxymethylhexahy-droindenone to tetrahydroazulenone as a key step. Medicaol has a seven-membered cycloheptadiene in the A ring instead of a typical six-membered cyclohexene. Medicaol and 4-deoxymedicaol showed activity comparable to their corresponding six-membered A ring relatives, orobanchol and 4-deoxyorobanchol (ent-2'-epi-5-deoxystrigol), in inducing hyphal branching of germinating spores of an arbuscular mycorrhizal fungus Gigaspora margarita. Plausible biosynthetic pathways from 4-deoxyorobanchol to medicaol are also proposed. (C) 2014 Elsevier Ltd. All rights reserved.	[Tokunaga, Tamami; Hayashi, Hideo; Akiyama, Kohki] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Naka Ku, Sakai, Osaka 5998531, Japan	Akiyama, K (reprint author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	akiyama@biochem.osakafu-u.ac.jp	Akiyama, Kohki /B-4668-2012		Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry	We thank Prof. Koichi Yoneyama for helpful discussions, Prof. Kazuhiro Toyoda for providing M. truncatula seeds, and Dr. Tomoko Kojima for providing G. margarita spores. This work was supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry.	Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Scaffidi A, 2014, PLANT PHYSIOL, V165, P1221, DOI 10.1104/pp.114.240036; Yoneyama K, 2008, NEW PHYTOL, V179, P484, DOI 10.1111/j.1469-8137.2008.02462.x; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Matusova R, 2005, PLANT PHYSIOL, V139, P920, DOI 10.1104/pp.105.061382; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; Akiyama K, 2010, PLANT CELL PHYSIOL, V51, P1104, DOI 10.1093/pcp/pcq058; Ruyter-Spira C, 2013, TRENDS PLANT SCI, V18, P72, DOI 10.1016/j.tplants.2012.10.003; Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Xie X, 2007, J AGR FOOD CHEM, V55, P8067, DOI 10.1021/jf0715121; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453; Waldie T, 2014, PLANT J, V79, P607, DOI 10.1111/tpj.12488; Welzel P, 1999, CHEM COMMUN, P2017, DOI 10.1039/a901530b; Liu W, 2011, PLANT CELL, V23, P3853, DOI 10.1105/tpc.111.089771; Seto Y, 2014, P NATL ACAD SCI USA, V111, P1640, DOI 10.1073/pnas.1314805111; Booker J, 2005, DEV CELL, V8, P443, DOI 10.1016/j.devcel.2005.01.009; Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; Seto Y, 2014, CURR OPIN PLANT BIOL, V21, P1, DOI 10.1016/j.pbi.2014.06.001; Lopez-Raez JA, 2008, J AGR FOOD CHEM, V56, P6326, DOI 10.1021/jf800760x; Yoneyama K, 2011, PLANT GROWTH REGUL, V65, P495, DOI 10.1007/s10725-011-9620-z; Xie XN, 2013, MOL PLANT, V6, P153, DOI 10.1093/mp/sss139; Cavar S., 2014, PHYTOCHEM REV; de Saint Germain A., 2013, CURR OPIN PLANT BIOL, V16, P583, DOI DOI 10.1016/J.PBI.2013.06.007; Kitahara S, 2011, TETRAHEDRON LETT, V52, P724, DOI 10.1016/j.tetlet.2010.12.010; LANGE GL, 1989, J ORG CHEM, V54, P1805, DOI 10.1021/jo00269a012; Sato D, 2003, J AGR FOOD CHEM, V51, P1162, DOI 10.1021/jf025997z; Scaffidi A, 2013, PLANT J, V76, P1, DOI 10.1111/tpj.12265	28	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9422			PHYTOCHEMISTRY	Phytochemistry	MAR	2015	111						91	97		10.1016/j.phytochem.2014.12.024		7	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CC7DH	WOS:000350527400011		
J	Nakamura, H; Sawada, K; Araie, H; Suzuki, I; Shiraiwa, Y				Nakamura, Hideto; Sawada, Ken; Araie, Hiroya; Suzuki, Iwane; Shiraiwa, Yoshihiro			n-Nonacosadienes from the marine haptophytes Emiliania huxleyi and Gephyrocapsa oceanica	PHYTOCHEMISTRY			English	Article						Emiliania huxleyi; Gephyrocapsa oceanica; Haptophyte; Nonacosadiene; Noelaerhabdaceae; Long chain alkene; Biomarker	LONG-CHAIN ALKENES; BOTRYOCOCCUS-BRAUNII; MICROSCOPIC ALGAE; MICROBIAL MATS; ANTARCTIC LAKE; ALKENONES; SEDIMENTS; PRYMNESIOPHYCEAE; LIPIDS; HYDROCARBONS	The hydrocarbons in cultures of marine haptophytes Emiliania huxleyi NIES837 and Gephyrocapsa oceanica NIES1315 were analyzed, and nonacosadienes and hentriacontadienes were detected as the major compounds in both strains. C-29 and C-31 monoenes and di-, tri- and tetra-unsaturated C-33 alkenes were also detected as minor compounds but not C-37 and C-38 alkenes. The positions of the double bonds in the C-29 and C-31 alkenes were determined by mass spectrometry of their dimethyl disulfide (DMDS) adducts. Among the four C-29 alkenes identified, the most abundant isomer was 2,20-nonacosadiene, and the other three compounds were 1,20-nonacosadiene, 3,20-nonacosadiene and 9-nonacosene, respectively. Hitherto, 2,20-nonacosadiene and 3,20-nonacosadiene were unknown to be natural products. The double bond at the n-9 (omega 9) position in these C-29 alkenes is hypothesized to be derived from precursors of unsaturated fatty acids possessing an n-9 double bond, such as (9Z)-9-octadecenoic acid. Nonacosadienes have the potential for being used as distinct haptophyte biomarkers. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakamura, Hideto; Sawada, Ken] Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Nakamura, Hideto; Sawada, Ken] Japan Sci & Technol Agcy JST, CREST, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Araie, Hiroya; Suzuki, Iwane; Shiraiwa, Yoshihiro] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Araie, Hiroya; Suzuki, Iwane; Shiraiwa, Yoshihiro] Japan Sci & Technol Agcy JST, CREST, Tsukuba, Ibaraki 3058572, Japan	Nakamura, H (reprint author), Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, Kita Ku, N10W8, Sapporo, Hokkaido 0600810, Japan.	hideton@mail.sci.hokudai.ac.jp			Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST) Japan	The study was supported by a fund of Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST) Japan. We thank Ms. C. Kanou of Hokkaido University for helping with the lipid extraction and separation. We are grateful to two anonymous reviewers for constructive comments.	Nakamura H, 2014, ORG GEOCHEM, V66, P90, DOI 10.1016/j.orggeochem.2013.11.007; Jaraula CMB, 2010, ORG GEOCHEM, V41, P386, DOI 10.1016/j.orggeochem.2009.12.004; Gelin F, 1997, ORG GEOCHEM, V26, P659, DOI 10.1016/S0146-6380(97)00035-1; SHIEA J, 1991, ORG GEOCHEM, V17, P309, DOI 10.1016/0146-6380(91)90094-Z; VOLKMAN JK, 1980, PHYTOCHEMISTRY, V19, P2619, DOI 10.1016/S0031-9422(00)83930-8; Rontani JF, 2004, PHYTOCHEMISTRY, V65, P117, DOI 10.1016/j.phytochem.2003.09.021; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; CARLSON DA, 1989, ANAL CHEM, V61, P1564, DOI 10.1021/ac00189a019; BRASSELL SC, 1986, NATURE, V320, P129, DOI 10.1038/320129a0; VOLKMAN JK, 1986, ORG GEOCHEM, V10, P671, DOI 10.1016/S0146-6380(86)80003-1; GELPI E, 1970, PHYTOCHEMISTRY, V9, P603, DOI 10.1016/S0031-9422(00)85700-3; Danbara A, 1999, PLANT CELL PHYSIOL, V40, P762; CONTE MH, 1995, J PHYCOL, V31, P272, DOI 10.1111/j.0022-3646.1995.00272.x; DUNSTAN GA, 1994, PHYTOCHEMISTRY, V35, P155, DOI 10.1016/S0031-9422(00)90525-9; GELPI E, 1968, SCIENCE, V161, P700, DOI 10.1126/science.161.3842.700; Grossi V, 2000, PHYTOCHEMISTRY, V54, P393, DOI 10.1016/S0031-9422(00)00120-5; LEE RF, 1971, PHYTOCHEMISTRY, V10, P593, DOI 10.1016/S0031-9422(00)94703-4; MARLOWE IT, 1984, BRIT PHYCOL J, V19, P203; Matsumoto G., 1979, MEMOIRS NATIONAL I P, V13, P103; MATSUMOTO GI, 1989, HYDROBIOLOGIA, V172, P291, DOI 10.1007/BF00031628; METZGER P, 1993, PHYTOCHEMISTRY, V33, P1125, DOI 10.1016/0031-9422(93)85035-P; Mouzdahir A, 2001, PHYTOCHEMISTRY, V56, P677, DOI 10.1016/S0031-9422(00)00468-4; PRAHL FG, 1987, NATURE, V330, P367, DOI 10.1038/330367a0; RECHKA JA, 1988, ORG GEOCHEM, V13, P727, DOI 10.1016/0146-6380(88)90094-0; Rieley G, 1998, LIPIDS, V33, P617, DOI 10.1007/s11745-998-0248-0; Rontani JF, 2006, J PHYCOL, V42, P800, DOI 10.1111/j.1529-8817.2006.00251.x; Sawada K, 1996, ORG GEOCHEM, V24, P751, DOI 10.1016/S0146-6380(96)00087-3; Sawada K, 2004, PHYTOCHEMISTRY, V65, P1299, DOI 10.1016/j.phytochem.2004.03.015; SEKINO K, 1994, PLANT CELL PHYSIOL, V35, P353; TEMPLIER J, 1991, PHYTOCHEMISTRY, V30, P2209, DOI 10.1016/0031-9422(91)83616-S; van der Meer MTJ, 1999, ORG GEOCHEM, V30, P1585, DOI 10.1016/S0146-6380(99)00141-2	31	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9422			PHYTOCHEMISTRY	Phytochemistry	MAR	2015	111						107	113		10.1016/j.phytochem.2014.12.023		7	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CC7DH	WOS:000350527400013		
J	Kato, A; Hirokami, Y; Kinami, K; Tsuji, Y; Miyawaki, S; Adachi, I; Hollinshead, J; Nash, RJ; Kiappes, JL; Zitzmann, N; Cha, JK; Molyneux, RJ; Fleet, GWJ; Asano, N				Kato, Atsushi; Hirokami, Yuki; Kinami, Kyoko; Tsuji, Yutaro; Miyawaki, Shota; Adachi, Isao; Hollinshead, Jackie; Nash, Robert J.; Kiappes, J. L.; Zitzmann, Nicole; Cha, Jin K.; Molyneux, Russell J.; Fleet, George W. J.; Asano, Naoki			Isolation and SAR studies of bicyclic iminosugars from Castanospermum australe as glycosidase inhibitors	PHYTOCHEMISTRY			English	Article						Castanospermum australe; Castanospermine; Australine; Iminosugar; Glycosidase inhibitor; Structure-activity relationship	ALPHA-GLUCOSIDASE; PYRROLIZIDINE ALKALOIDS; POLYHYDROXYLATED PYRROLIDINE; ENANTIOSELECTIVE SYNTHESIS; BIOLOGICAL-ACTIVITIES; CHAPERONE ACTIVITY; NATURAL OCCURRENCE; GAUCHER-DISEASE; GLUCURONOLACTONE; CELGOSIVIR	We report the isolation and structural determination of fourteen iminosugars, containing five pyrrolizidines and five indolizidines, from Castanospermum australe. The structure of a new alkaloid was elucidated by spectroscopic methods as 6,8-diepi-castanospermine (13). Our side-by-side comparison between bicyclic and corresponding monocyclic iminosugars revealed that inhibition potency and spectrum against each enzyme are clearly changed by their core structures. Castanospermine (10) and 1-deoxynojirimycin (DNJ) have a common D-gluco configuration, and they showed the expected similar inhibition potency and spectrum. In sharp contrast, 6-epi-castanospermine (12) and 1-deoxymannojirimycin (manno-DNJ) both have the D-manno configuration but the alpha-mannosidase inhibition of 6-epi-castanospermine (12) was much better than that of manno-DNJ. 6,8-Diepi-castanospermine (13) could be regarded as a bicyclic derivative of talo-DNJ, but it showed a complete loss of alpha-galactosidase A inhibition. This behavior against alpha-galactosidase A is similar to that observed for 1-epi-australine (6) and altro-DMDP. (C) 2014 Elsevier Ltd. All rights reserved.	[Kato, Atsushi; Hirokami, Yuki; Kinami, Kyoko; Tsuji, Yutaro; Miyawaki, Shota; Adachi, Isao] Toyama Univ, Dept Hosp Pharm, Toyama 9300194, Japan; [Hollinshead, Jackie; Nash, Robert J.] Phytoquest Ltd, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3EB, Dyfed, Wales; [Kiappes, J. L.; Zitzmann, Nicole; Fleet, George W. J.] Univ Oxford, Oxford Glycobiol Inst, Oxford OX1 3QU, England; [Cha, Jin K.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [Molyneux, Russell J.] Univ Hawaii, Daniel K Inouye Coll Pharm, Hilo, HI 96720 USA; [Fleet, George W. J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Asano, Naoki] BioApply Co Ltd, Kanazawa, Ishikawa 9200955, Japan	Kato, A (reprint author), Toyama Univ, Dept Hosp Pharm, Toyama 9300194, Japan.	kato@med.u-toyama.ac.jp; george.fleet@chem.ox.ac.uk			Japanese Society for the Promotion of Science (JSPS) [26460143]; Leverhulme Research Fellowship (GWJF); National Science Foundation; Skaggs-Oxford Scholarship program	This work was supported in part by a Grant-in-Aid for Scientific Research (C) (No. 26460143) (AK) from the Japanese Society for the Promotion of Science (JSPS), Leverhulme Research Fellowship (GWJF) and predoctoral fellowships from the National Science Foundation and Skaggs-Oxford Scholarship program (both to JLK). Dextra, and in particular Dr. Alexander Weymouth-Wilson, are gratefully acknowledged for use of their facilities to prepare L-glucuronolactone that was used in the synthesis of talo-DNJ.	Allan G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076411; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Ayers BJ, 2014, J ORG CHEM, V79, P3398, DOI 10.1021/jo500157p; SAUL R, 1985, P NATL ACAD SCI USA, V82, P93, DOI 10.1073/pnas.82.1.93; Asano N, 2009, CELL MOL LIFE SCI, V66, P1479, DOI 10.1007/s00018-008-8522-3; Matsumura T, 2000, PHARM BIOL, V38, P302, DOI [10.1076/1388-0209(200009)3841-AFT302, 10.1076/1388-0209(200009)38:4;1-A;FT302]; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008; ELBEIN AD, 1991, FASEB J, V5, P3055; Home G, 2011, DRUG DISCOV TODAY, V16, P107, DOI 10.1016/j.drudis.2010.08.017; LIU KKC, 1991, J ORG CHEM, V56, P6280, DOI 10.1021/jo00022a013; MOLYNEUX RJ, 1986, ARCH BIOCHEM BIOPHYS, V251, P450, DOI 10.1016/0003-9861(86)90351-6; Bowen EG, 2010, ORG LETT, V12, P5330, DOI 10.1021/ol102371x; MOLYNEUX RJ, 1988, J NAT PROD, V51, P1198, DOI 10.1021/np50060a024; Kato A, 2008, PHYTOCHEMISTRY, V69, P1261, DOI 10.1016/j.phytochem.2007.11.018; Nash RJ, 2011, FUTURE MED CHEM, V3, P1513, DOI [10.4155/fmc.11.117, 10.4155/FMC.11.117]; Asano N, 2000, TETRAHEDRON-ASYMMETR, V11, P1645, DOI 10.1016/S0957-4166(00)00113-0; Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3; MOLYNEUX RJ, 1990, J NAT PROD, V53, P609, DOI 10.1021/np50069a011; Haraguchi M, 2003, J AGR FOOD CHEM, V51, P4995, DOI 10.1021/jf0341722; Davis BG, 2009, TETRAHEDRON-ASYMMETR, V20, P652, DOI 10.1016/j.tetasy.2009.03.013; Asano N, 2000, TETRAHEDRON-ASYMMETR, V11, P1, DOI 10.1016/S0957-4166(99)00508-X; HOHENSCHUTZ LD, 1981, PHYTOCHEMISTRY, V20, P811, DOI 10.1016/0031-9422(81)85181-3; Martinez RF, 2014, ANGEW CHEM INT EDIT, V53, P1160, DOI 10.1002/anie.201309073; Kato A, 2007, J NAT PROD, V70, P993, DOI 10.1021/np0700826; Durantel D, 2009, CURR OPIN INVEST DR, V10, P860; Luan Z, 2009, CHEMBIOCHEM, V10, P2780, DOI 10.1002/cbic.200900442; Jenkinson SF, 2013, J ORG CHEM, V78, P7380, DOI 10.1021/jo4005487; Ishii S, 2012, P JPN ACAD B-PHYS, V88, P18, DOI 10.2183/pjab.88.18; Kato A, 2003, TETRAHEDRON-ASYMMETR, V14, P325, DOI 10.1016/S0957-4166(02)00799-1; Watson AA, 2001, PHYTOCHEMISTRY, V56, P265, DOI 10.1016/S0031-9422(00)00451-9; Kato A, 1999, CARBOHYD RES, V316, P95, DOI 10.1016/S0008-6215(99)00043-9; Kato A, 2005, J MED CHEM, V48, P2036, DOI 10.1021/jm0495881; Liu G, 2010, CHEM-EUR J, V16, P5755, DOI 10.1002/chem.200903490; SZUMILO T, 1986, ARCH BIOCHEM BIOPHYS, V247, P261, DOI 10.1016/0003-9861(86)90583-7; Arh H.J., 1997, ARZNEIMITTELFORSCH, V47, P734; Ayers BJ, 2012, J ORG CHEM, V77, P7777, DOI 10.1021/jo301243s; Best D, 2010, TETRAHEDRON LETT, V51, P2222, DOI 10.1016/j.tetlet.2010.02.063; Butters TD, 2007, CURR OPIN CHEM BIOL, V11, P412, DOI 10.1016/j.cbpa.2007.05.035; Jensen T, 2009, J ORG CHEM, V74, P8886, DOI 10.1021/jo9019495; Kato A, 1997, J NAT PROD, V60, P312, DOI 10.1021/np960646y; KESSLER M, 1978, BIOCHIM BIOPHYS ACTA, V506, P136, DOI 10.1016/0005-2736(78)90440-6; KIM NS, 1993, J ORG CHEM, V58, P7096, DOI 10.1021/jo00077a034; KIM NS, 1994, TETRAHEDRON LETT, V35, P3489, DOI 10.1016/S0040-4039(00)73217-5; Li ZH, 2013, CHEMBIOCHEM, V14, P1239, DOI 10.1002/cbic.201300197; MOLYNEUX RJ, 1991, BIOCHEMISTRY-US, V30, P9981, DOI 10.1021/bi00105a024; NASH RJ, 1988, TETRAHEDRON LETT, V29, P2487, DOI 10.1016/S0040-4039(00)87914-9; NASH RJ, 1985, J CHEM SOC CHEM COMM, P738, DOI 10.1039/c39850000738; Nash R.J., 1996, ALKALOIDS CHEM BIOL, V11, P375; PAN YT, 1983, BIOCHEMISTRY-US, V22, P3975, DOI 10.1021/bi00285a038; Ritthiwigrom T, 2012, CURR ORG SYNTH, V9, P583; KOYAMA M, 1974, AGR BIOL CHEM TOKYO, V38, P1111; Sanchez-Fernandez EM, 2010, CHEM COMMUN, V46, P5328, DOI 10.1039/c0cc00446d; SASAK VW, 1985, BIOCHEM J, V232, P759; SKUDLAREK MD, 1992, BIOCHEM J, V286, P907; Weymouth-Wilson AC, 2009, TETRAHEDRON LETT, V50, P6307, DOI 10.1016/j.tetlet.2009.08.124; Whitby Kevin, 2004, Antiviral Chemistry & Chemotherapy, V15, P141; Yamashita T, 2002, J NAT PROD, V65, P1875, DOI 10.1021/np020296h	58	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9422			PHYTOCHEMISTRY	Phytochemistry	MAR	2015	111						124	131		10.1016/j.phytochem.2014.12.011		8	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CC7DH	WOS:000350527400015		
J	Masaki, T; Hata, S; Ide, Y				Masaki, T.; Hata, S.; Ide, Y.			Heterogeneity in soil water and light environments and dispersal limitation: what facilitates tree species coexistence in a temperate forest?	PLANT BIOLOGY			English	Article						Habitat association; neutral process; niche assembly; niche overlap index; Ogawa Forest Reserve	HABITAT ASSOCIATIONS; RAIN-FOREST; SPATIAL DISTRIBUTIONS; COMMUNITY STRUCTURE; DECIDUOUS FOREST; SEEDLING DEMOGRAPHY; TROPICAL FORESTS; SOUTHWEST CHINA; DIVERSITY; PATTERNS	In the present study, we analysed the habitat association of tree species in an old-growth temperate forest across all life stages to test theories on the coexistence of tree species in forest communities. An inventory for trees was implemented at a 6-ha plot in Ogawa Forest Reserve for adults, juveniles, saplings and seedlings. Volumetric soil water content (SMC) and light levels were measured in 10-m grids. Relationships between the actual number of stems and environmental variables were determined for 35 major tree species, and the spatial correlations within and among species were analysed. The light level had no statistically significant effect on distribution of saplings and seedlings of any species. In contrast, most species had specific optimal values along the SMC gradient. The optimal values were almost identical in earlier life stages, but were more variable in later life stages among species. However, no effective niche partitioning among the species was apparent even at the adult stage. Furthermore, results of spatial analyses suggest that dispersal limitation was not sufficient to mitigate competition between species. This might result from well-scattered seed distribution via wind and bird dispersal, as well as conspecific density-dependent mortality of seeds and seedlings. Thus, both niche partitioning and dispersal limitation appeared less important for facilitating coexistence of species within this forest than expected in tropical forests. The tree species assembly in this temperate forest might be controlled through a neutral process at the spatial scale tested in this study.	[Masaki, T.] Forestry & Forest Prod Res Inst, Ibaraki 3058687, Japan; [Hata, S.; Ide, Y.] Univ Tokyo, Tokyo, Japan; [Hata, S.] Tokyo Forestry Off, Tokyo, Japan	Masaki, T (reprint author), Forestry & Forest Prod Res Inst, Ibaraki 3058687, Japan.	masaki@ffpri.affrc.go.jp			Technology Development Fund of the Ministry of the Environment, Japan [S-9]	We thank Dr. T. Nakashizuka, Dr. T. Nagaike, and Dr. T. Tanaka for helpful support throughout this study. We also thank Dr. N. Miyashita for critical suggestions on statistical modelling, and Dr. A. Itoh for useful comments on an earlier version of the manuscript. We would like to thank Enago (www.enago.jp) for the English language review. This study was partly funded by the Technology Development Fund (S-9) of the Ministry of the Environment, Japan. Part of the data used in the present study was derived from the Forest Dynamics Database provided by the Forestry and Forest Products Research Institute and from the Monitoring Sites 1000 Project launched by the Ministry of the Environment, Japan. The meteorological data of the Japan Meteorological Agency was obtained from the Agriculture, Forestry and Fisheries Research Council, Japan.	ABE S, 1995, VEGETATIO, V120, P21; Palmiotto PA, 2004, J ECOL, V92, P609, DOI 10.1111/j.0022-0477.2004.00894.x; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Vieilledent G, 2010, OECOLOGIA, V163, P759, DOI 10.1007/s00442-010-1581-9; Lan GY, 2009, ECOL RES, V24, P1117, DOI 10.1007/s11284-009-0590-9; Rosindell J, 2011, TRENDS ECOL EVOL, V26, P340, DOI 10.1016/j.tree.2011.03.024; Hu YH, 2012, OIKOS, V121, P952, DOI 10.1111/j.1600-0706.2011.19831.x; Li L, 2009, OIKOS, V118, P495, DOI 10.1111/j.1600-0706.2009.16753.x; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1046/j.0022-0477.2001.00615.x; Brown C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0502; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Latimer AM, 2006, ECOL APPL, V16, P33, DOI 10.1890/04-0609; Metz MR, 2012, J ECOL, V100, P969, DOI 10.1111/j.1365-2745.2012.01972.x; Baltzer JL, 2008, FUNCT ECOL, V22, P221, DOI 10.1111/j.1365-2435.2007.01374.x; Wang SP, 2012, ECOGRAPHY, V35, P1168, DOI 10.1111/j.1600-0587.2012.00045.x; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Myers JA, 2013, ECOL LETT, V16, P151, DOI 10.1111/ele.12021; Shibata M, 2002, ECOLOGY, V83, P1727, DOI 10.2307/3071991; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Webb CO, 2000, J ECOL, V88, P464, DOI 10.1046/j.1365-2745.2000.00462.x; Gunatilleke CVS, 2006, J TROP ECOL, V22, P371, DOI 10.1017/S0266467406003282; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Chuyong GB, 2011, PLANT ECOL, V212, P1363, DOI 10.1007/s11258-011-9912-4; Lin YC, 2011, OECOLOGIA, V165, P175, DOI 10.1007/s00442-010-1718-x; Ota T, 2012, CAN J FOREST RES, V42, P1976, DOI 10.1139/x2012-141; Baldeck CA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2532; desToledo J. J., 2011, FOREST ECOL MANAG, V262, P331; Gelman A., 2004, BAYESIAN DATA ANAL; Hubbell S. P., 2001, UNIFIED NEUTRAL THEO; Iida S., 1996, PLANT ECOL, V124, P39; Ishida A, 2005, TREE PHYSIOL, V25, P513; Itoh A, 2010, FOREST ECOL MANAG, V259, P323, DOI 10.1016/j.foreco.2009.10.022; Kozlowski T.T., 1991, PHYSL ECOLOGY WOODY; Laurance SGW, 2010, J VEG SCI, V21, P96, DOI 10.1111/j.1654-1103.2009.01122.x; Masaki T, 2002, ECOLOGY, V83, P3497; MASAKI T, 1992, VEGETATIO, V98, P97, DOI 10.1007/BF00045549; MASAKI T, 1994, ECOLOGY, V75, P1903, DOI 10.2307/1941595; Masaki T, 2002, ECOL STU AN, V158, P53; Mizoguchi Y, 2002, ECOL STU AN, V158, P11; NAKASHIZUKA T, 1995, ECOSCIENCE, V2, P245; Nakashizuka T, 2001, TRENDS ECOL EVOL, V16, P205, DOI 10.1016/S0169-5347(01)02117-6; Oki S, 2013, ECOSCIENCE, V20, P194, DOI 10.2980/20-2-3609; Pearse WD, 2013, ECOLOGY, V94, P2861, DOI 10.1890/12-1676.1; Ruger N, 2009, J ECOL, V97, P1360, DOI 10.1111/j.1365-2745.2009.01552.x; Satake Y., 1999, WILD FLOWERS JAPAN W; Schupp E. W., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, São Pedro, Brazil, 6-11 August 2000, P19, DOI 10.1079/9780851995250.0019; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Shen GC, 2013, ECOLOGY, V94, P2436, DOI 10.1890/12-1983.1; Shibata M, 2002, ECOL STU AN, V158, P95; Shibata M, 2010, ECOSCIENCE, V17, P137, DOI 10.2980/17-2-3163; SHIBATA M, 1995, ECOLOGY, V76, P1099, DOI 10.2307/1940918; Tanaka H., 1998, Journal of Sustainable Forestry, V6, P155; WHITTAKER RH, 1958, ECOLOGY, V39, P46, DOI 10.2307/1929966; Yoshinaga S, 2002, ECOL STU AN, V158, P19	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1435-8603	1438-8677		PLANT BIOLOGY	Plant Biol.	MAR	2015	17	2					449	458		10.1111/plb.12253		10	Plant Sciences	Plant Sciences	CC6NC	WOS:000350480800017		
J	Yap, A; Kindgren, P; des Francs-Small, CC; Kazama, T; Tanz, SK; Toriyama, K; Small, I				Yap, Aaron; Kindgren, Peter; des Francs-Small, Catherine Colas; Kazama, Tomohiko; Tanz, Sandra K.; Toriyama, Kinya; Small, Ian			AEF1/MPR25 is implicated in RNA editing of plastid atpF and mitochondrial nad5, and also promotes atpF splicing in Arabidopsis and rice	PLANT JOURNAL			English	Article						RNA editing; splicing; dual targeting; chloroplast; mitochondria; Arabidopsis thaliana; ATP synthase	PENTATRICOPEPTIDE REPEAT PROTEINS; GROUP-II INTRON; MAIZE CHLOROPLASTS; PPR PROTEINS; DYW PROTEIN; GENE; TRANSCRIPTS; THALIANA; PLANTS; DOMAIN	RNA editing is an essential mechanism that modifies target cytidines to uridine in both mitochondrial and plastid mRNA. Target sites are recognized by pentatricopeptide repeat (PPR) proteins. Using bioinformatics predictions based on the code describing sequence recognition by PPR proteins, we have identified an Arabidopsis editing factor required for editing of atpF in plastids. A loss-of-function mutation in ATPF EDITING FACTOR1 (AEF1, AT3G22150) results in severe variegation, presumably due to decreased plastid ATP synthase levels. Loss of editing at the atpF site is coupled with a large decrease in splicing of the atpF transcript, even though the editing site is within an exon and 53 nucleotides distant from the splice site. The rice orthologue of AEF1, MPR25, has been reported to be required for editing of a site in mitochondrial nad5 transcripts, and we confirm that editing of the same site is affected in the Arabidopsis aef1 mutant. We also show that splicing of chloroplast atpF transcripts is affected in the rice mpr25 mutant. AEF1 is thus highly unusual for an RNA editing specificity factor in that it has functions in both organelles. Significance Statement The RNA editing factor AEF1/MPR25 is a sequence-specific RNA binding protein with an unusual multi-functional role in editing and splicing of the chloroplast atpF transcript. It is unique (so far) amongst editing specificity factors in also acting in mitochondria, where it recognizes a similar sequence to induce editing of the nad5 transcript.	[Yap, Aaron; Kindgren, Peter; des Francs-Small, Catherine Colas; Tanz, Sandra K.; Small, Ian] Univ Western Australia, Ctr Excellence Plant Energy Biol, Australian Res Council, Crawley, WA 6009, Australia; [Kazama, Tomohiko; Toriyama, Kinya] Tohoku Univ, Grad Sch Agr Sci, Lab Environm Biotechnol, Sendai, Miyagi 9818555, Japan; [Small, Ian] Univ Western Australia, Ctr Excellence Computat Syst Biol, Crawley, WA 6009, Australia	Small, I (reprint author), Univ Western Australia, Ctr Excellence Plant Energy Biol, Australian Res Council, 35 Stirling Highway, Crawley, WA 6009, Australia.	ian.small@cyllene.uwa.edu.au	Small, Ian/C-1168-2008; Tanz, Sandra/C-2686-2011; Kindgren, Peter/H-4649-2015	Small, Ian/0000-0001-5300-1216; Kindgren, Peter/0000-0003-0947-2648	Australian Research Council [DP120102870, CE140100008, DE120100307]; Wenner-Gren foundation	We are grateful for financial support for this work from the Australian Research Council (grants DP120102870 and CE140100008 to I.S. and DE120100307 to S.K.T.). P.K. was supported by a post-doctoral fellowship from the Wenner-Gren foundation.	de Longevialle AF, 2008, PLANT J, V56, P157, DOI 10.1111/j.1365-313X.2008.03581.x; Prikryl J, 2008, NUCLEIC ACIDS RES, V36, P5152, DOI 10.1093/nar/gkn492; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Peeters NM, 2002, RNA, V8, P497, DOI 10.1017/S1355838202029424; Duchene AM, 2005, P NATL ACAD SCI USA, V102, P16484, DOI 10.1073/pnas.0504682102; Ichinose M, 2012, PLANT J, V70, P271, DOI 10.1111/j.1365-313X.2011.04869.x; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; Ruwe H, 2013, FEBS LETT, V587, P1429, DOI 10.1016/j.febslet.2013.03.022; Zhou WB, 2009, PLANT J, V58, P82, DOI 10.1111/j.1365-313X.2008.03766.x; Carrie C, 2009, PLANT J, V57, P1128, DOI 10.1111/j.1365-313X.2008.03745.x; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; Fujii S, 2011, P NATL ACAD SCI USA, V108, P1723, DOI 10.1073/pnas.1007667108; Kroeger TS, 2009, P NATL ACAD SCI USA, V106, P4537, DOI 10.1073/pnas.0812503106; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Robbins JC, 2009, RNA, V15, P1142, DOI 10.1261/rna.1533909; Zoschke R, 2010, P NATL ACAD SCI USA, V107, P3245, DOI 10.1073/pnas.0909400107; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Toda T, 2012, PLANT J, V72, P450, DOI 10.1111/j.1365-313X.2012.05091.x; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Yagi Y, 2013, RNA BIOL, V10, P1419, DOI 10.4161/rna.24908; Takenaka M, 2012, NAT PROTOC, V7, P1931, DOI 10.1038/nprot.2012.117; Cai WH, 2009, PLANT PHYSIOL, V150, P1260, DOI 10.1104/pp.109.136812; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; de Longevialle AF, 2010, MOL PLANT, V3, P691, DOI 10.1093/mp/ssq025; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Okuda K, 2010, PLANT J, V61, P339, DOI 10.1111/j.1365-313X.2009.04059.x; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Yagi Y, 2014, PLANT J, V78, P772, DOI 10.1111/tpj.12377; Daniell H, 2008, THEOR APPL GENET, V116, P723, DOI 10.1007/s00122-007-0706-y; Asakura Y, 2006, PLANT PHYSIOL, V142, P1656, DOI 10.1104/pp.106.088096; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bentolila S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003584; BORNER GV, 1995, MOL GEN GENET, V246, P739, DOI 10.1007/BF00290721; Castandet B, 2010, NUCLEIC ACIDS RES, V38, P7112, DOI 10.1093/nar/gkq591; Chateigner-Boutin AL, 2011, PLANT J, V65, P532, DOI 10.1111/j.1365-313X.2010.04441.x; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chateigner-Boutin AL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm640; Farre JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052644; Harrison SJ, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-19; Hayes ML, 2013, J BIOL CHEM, V288, P36519, DOI 10.1074/jbc.M113.485755; Jenkins BD, 1997, PLANT CELL, V9, P283, DOI 10.1105/tpc.9.3.283; Jiang Y, 2012, GENET MOL RES, V11, P987, DOI 10.4238/2012.April.19.4; Kong MM, 2013, CHINESE SCI BULL, V58, P3224, DOI 10.1007/s11434-013-5916-x; McCormac DJ, 1999, PLANT CELL, V11, P1709, DOI 10.1105/tpc.11.9.1709; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Till B, 2001, RNA, V7, P1227, DOI 10.1017/S1355838201010445; Watkins KP, 2007, PLANT CELL, V19, P2606, DOI 10.1105/tpc.107.053736; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286	54	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	MAR	2015	81	5					661	669		10.1111/tpj.12756		9	Plant Sciences	Plant Sciences	CC3KW	WOS:000350248500002		
J	Keerthisinghe, S; Nadeau, JA; Lucas, JR; Nakagawa, T; Sack, FD				Keerthisinghe, Sandra; Nadeau, Jeannette A.; Lucas, Jessica R.; Nakagawa, Tsuyoshi; Sack, Fred D.			The Arabidopsis leucine-rich repeat receptor-like kinase MUSTACHES enforces stomatal bilateral symmetry in Arabidopsis	PLANT JOURNAL			English	Article						stomatal morphogenesis; bilateral symmetry; microtubules; microtubule dynamics; Arabidopsis thaliana; At1g75640	CORTICAL MICROTUBULE ARRAY; GATEWAY BINARY VECTORS; DEVELOPING GUARD-CELLS; GAMMA-TUBULIN; THALIANA; GENE; PLANTS; PROLIFERATION; ORGANIZATION; CLAVATA1	Stomata display a mirror-like symmetry that is adaptive for shoot/atmosphere gas exchange. This symmetry includes the facing guard cells around a lens-shaped and bilaterally symmetric pore, as well as radially arranged microtubule arrays that primarily originate at the pore and then grow outwards. Mutations in MUSTACHES (MUS), which encodes a leucine-rich repeat receptor-like kinase, disrupt this symmetry, resulting in defects ranging from skewed pores and abnormally focused and depolarized radial microtubule arrays, to paired guard cells that face away from each other, or a severe loss of stomatal shape. Translational MUSproMUS:tripleGFP fusions are expressed in cell plates in most cells types in roots and shoots, and cytokinesis and cell plates are mostly normal in mus mutants. However, in guard mother cells, which divide and then form stomata, MUS expression is notably absent from new cell plates, and instead is peripherally located. These results are consistent with a role for MUS in enforcing wall building and cytoskeletal polarity at the centre of the developing stoma via signalling from the vicinity of the guard cell membrane. Significance StatementWe show that the Leucine-Rich Repeat Receptor-Like Kinase MUSTACHES (MUS) is essential for stomatal development by enforcing bilateral symmetry after a symmetric division. The loss of function of this gene leads to skewed stomata and twisted pores, as well as associated defects in the position and symmetry of microtubule arrays. The identification of MUS might eventually lead to defining other genes and proteins required for stomatal development.	[Keerthisinghe, Sandra; Sack, Fred D.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Nadeau, Jeannette A.; Lucas, Jessica R.; Sack, Fred D.] Ohio State Univ, Dept Plant Cellular & Mol Biol, Columbus, OH 43210 USA; [Nakagawa, Tsuyoshi] Shimane Univ, Ctr Integrated Res Sci, Dept Mol & Funct Genom, Matsue, Shimane 6908504, Japan	Sack, FD (reprint author), Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada.	fsack@mail.ubc.ca			Natural Sciences and Engineering Research Council of Canada [341685-2012]	This work was supported by Natural Sciences and Engineering Research Council of Canada Discovery Grant #341685-2012 to F.D.S. Takashi Hashimoto (Nara Institute of Science and Technology, Japan) provided seeds harbouring 35Spro:EB1:GFP. Jie Le (Institute of Botany, Chinese Academy of Sciences, Beijing, China) provided seeds harbouring 35Spro:EB1:GFP in a mus-1 background. Seeds of the tmm mus double mutant were a gift from Dominique Bergmann (Department of Biology, Stanford University, Stanford, CA, USA). Eun-Kyoung Lee provided valuable discussions, and Abel Rosado contributed helpful comments on this paper.	Boudolf V, 2004, PLANT CELL, V16, P945, DOI 10.1105/tpc.021774; Bond D, 2012, J BIOL CHEM, V287, P27359, DOI 10.1074/jbc.M112.378018; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dixit R, 2006, MOL BIOL CELL, V17, P1298, DOI 10.1091/mbc.E05-09-0864; Xie ZD, 2010, PLANT CELL, V22, P2306, DOI 10.1105/tpc.110.074609; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Hunt L, 2009, CURR BIOL, V19, P864, DOI 10.1016/j.cub.2009.03.069; Kong ZS, 2010, PLANT CELL, V22, P191, DOI 10.1105/tpc.109.071191; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Zeng CJT, 2009, PLANT CELL, V21, P1129, DOI 10.1105/tpc.109.065953; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Lau OS, 2012, DEVELOPMENT, V139, P3683, DOI 10.1242/dev.080523; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Fishel EA, 2013, PLANT J, V75, P270, DOI 10.1111/tpj.12166; De Smet I, 2009, NAT CELL BIOL, V11, P1166, DOI 10.1038/ncb1009-1166; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Nadeau JA, 2009, CURR OPIN PLANT BIOL, V12, P29, DOI 10.1016/j.pbi.2008.10.006; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Negi J, 2013, CURR BIOL, V23, P479, DOI 10.1016/j.cub.2013.02.001; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Sugano SS, 2010, NATURE, V463, P241, DOI 10.1038/nature08682; Vanneste S, 2011, EMBO J, V30, P3430, DOI 10.1038/emboj.2011.240; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; NAKAMURA RL, 1995, PLANT PHYSIOL, V109, P371, DOI 10.1104/pp.109.2.371; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Falbel TG, 2003, DEVELOPMENT, V130, P4011, DOI 10.1242/dev.00619; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Castells E, 2007, J EXP BOT, V58, P3503, DOI 10.1093/jxb/erm226; Clark E., 1993, DEVELOPMENT, V119, P397; De Young B. J., 2005, PLANT J, V45, P1; Dievart A, 2003, PLANT CELL, V15, P1198, DOI 10.1105/tpc.010504; Hammer O, 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025; Kawakami S., 1997, PLANT BIOTECHNOL, V14, P127; Kuehl R. O, 2000, VARIANCE STABILIZATI; Lucas JR, 2006, J EXP BOT, V57, P71, DOI 10.1093/jxb/erj017; Marc J, 1997, TRENDS PLANT SCI, V2, P223, DOI 10.1016/S1360-1385(97)01042-X; MCDONALD AR, 1993, PLANTA, V191, P357; PALEVITZ BA, 1976, PLANTA, V132, P71, DOI 10.1007/BF00390333; Pillitteri Lynn Jo, 2013, Arabidopsis Book, V11, pe0162, DOI 10.1199/tab.0162; Shiu S., 2001, SCI SIG, V2001, P1; Ueda K, 1999, PROTOPLASMA, V206, P201, DOI 10.1007/BF01279267; Willmer CM, 1996, STOMATA	53	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	MAR	2015	81	5					684	694		10.1111/tpj.12757		11	Plant Sciences	Plant Sciences	CC3KW	WOS:000350248500004		
J	Ogawa-Ohnishi, M; Matsubayashi, Y				Ogawa-Ohnishi, Mari; Matsubayashi, Yoshikatsu			Identification of three potent hydroxyproline O-galactosyltransferases in Arabidopsis	PLANT JOURNAL			English	Article						arabinogalactan protein; O-glycosylation; posttranslational modification; Golgi; Arabidopsis	ARABINOGALACTAN PROTEIN GENE; II ARABINOGALACTAN; CELL-SURFACE; THALIANA; BIOSYNTHESIS; CLASSIFICATION; GLYCOSYLATION; GLYCOPROTEINS; EXPRESSION; EXPANSION	Arabinogalactan proteins (AGPs) are plant-specific extracellular glycoproteins implicated in a variety of processes during growth and development. AGP biosynthesis involves O-galactosylation of hydroxyproline (Hyp) residues followed by a stepwise elongation of the complex sugar chains. However, functionally dominant Hyp O-galactosyltransferases, such that their disruption produces phenocopies of AGP-deficient mutants, remain to be identified. Here, we purified and identified three potent Hyp O-galactosyltransferases, HPGT1, HPGT2 and HPGT3, from Arabidopsis microsomal fractions. Loss-of-function analysis indicated that approximately 90% of the endogenous Hyp O-galactosylation activity is attributable to these three enzymes. AGP14 expressed in the triple mutant migrated much faster on SDS-PAGE than when expressed in wild-type, confirming a considerable decrease in levels of glycosylation of AGPs in the mutant. Loss-of-function mutant plants exhibited a pleiotropic phenotype of longer lateral roots, longer root hairs, radial expansion of the cells in the root tip, small leaves, shorter inflorescence stems, reduced fertility and shorter siliques. Our findings provide genetic evidence that Hyp-linked arabinogalactan polysaccharide chains are critical for AGP function and clues to how arabinogalactan moieties of AGPs contribute to cell-to-cell communication during plant growth and development. Significance StatementArabinogalactan proteins (AGPs) are extracellular glycoproteins critical for plant growth and development, but an understanding of the biosynthesis of AGPs is still incomplete. Our identification of three potent hydroxyproline (Hyp) O-galactosyltransferases (HPGTs) that mediate initial galactosylation of Hyp residues of AGP core proteins provide genetic evidence that Hyp-linked arabinogalactan polysaccharide chains are critical for AGP function as well as clues to how arabinogalactan moieties of AGPs contribute to cell-to-cell communication during plant growth and development.	[Ogawa-Ohnishi, Mari; Matsubayashi, Yoshikatsu] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Matsubayashi, Y (reprint author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	matsu@bio.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [25221105]	This research was supported by a Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science, and Technology (No. 25221105).	Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49; Levitin B, 2008, PLANT J, V56, P351, DOI 10.1111/j.1365-313X.2008.03607.x; Schultz CJ, 2000, PLANT CELL, V12, P1751, DOI 10.1105/tpc.12.9.1751; Qu YM, 2008, PLANT MOL BIOL, V68, P43, DOI 10.1007/s11103-008-9351-3; Ogawa-Ohnishi M, 2013, NAT CHEM BIOL, V9, P726, DOI [10.1038/nchembio.1351, 10.1038/NCHEMBIO.1351]; Yang J, 2007, PLANT J, V49, P629, DOI 10.1111/j.1365-313X.2006.02985.x; Basu D, 2013, J BIOL CHEM, V288, P10132, DOI 10.1074/jbc.M112.432609; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; TSUMURAYA Y, 1984, CARBOHYD RES, V134, P215, DOI 10.1016/0008-6215(84)85039-9; Lin WD, 2011, PLANT PHYSIOL, V155, P1383, DOI 10.1104/pp.110.166520; Coimbra S, 2009, J EXP BOT, V60, P3133, DOI 10.1093/jxb/erp148; Oka T, 2010, PLANT PHYSIOL, V152, P332, DOI 10.1104/pp.109.146266; Knoch E, 2013, PLANT J, V76, P1016, DOI 10.1111/tpj.12353; Li J, 2010, PLANT J, V64, P482, DOI 10.1111/j.1365-313X.2010.04344.x; Geshi N, 2013, PLANT J, V76, P128, DOI 10.1111/tpj.12281; Ma HL, 2010, J EXP BOT, V61, P2647, DOI 10.1093/jxb/erq104; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Gao MG, 1999, PLANT J, V18, P43, DOI 10.1046/j.1365-313X.1999.00428.x; Liang Y, 2010, PLANT PHYSIOL, V154, P632, DOI 10.1104/pp.110.160051; Shi HZ, 2003, PLANT CELL, V15, P19, DOI 10.1105/tpc.007872; ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Acosta-Garcia G, 2004, PLANT CELL, V16, P2614, DOI 10.1105/tpc.104.024588; Dilokpimol A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-90; Kitazawa K, 2013, PLANT PHYSIOL, V161, P1117, DOI 10.1104/pp.112.211722; Knoch E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00198; Oxley D, 1999, P NATL ACAD SCI USA, V96, P14246, DOI 10.1073/pnas.96.25.14246; QI W, 1991, PLANT PHYSIOL, V96, P848, DOI 10.1104/pp.96.3.848; Shpak E, 1999, P NATL ACAD SCI USA, V96, P14736, DOI 10.1073/pnas.96.26.14736; VansHolst G. J., 1981, PLANT PHYSIOL, V68, P979	31	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	MAR	2015	81	5					736	746		10.1111/tpj.12764		11	Plant Sciences	Plant Sciences	CC3KW	WOS:000350248500008		
J	Andika, IB; Maruyama, K; Sun, L; Kondo, H; Tamada, T; Suzuki, N				Andika, Ida Bagus; Maruyama, Kazuyuki; Sun, Liying; Kondo, Hideki; Tamada, Tetsuo; Suzuki, Nobuhiro			Differential contributions of plant Dicer-like proteins to antiviral defences against potato virus X in leaves and roots	PLANT JOURNAL			English	Article						RNA silencing; antiviral defence; Dicer-like protein; potato virus X; Nicotiana benthamiana; Arabidopsis thaliana; root	DEPENDENT RNA-POLYMERASE; YELLOW-VEIN-VIRUS; SMALL INTERFERING RNAS; WHEAT-MOSAIC-VIRUS; CELL-TO-CELL; NICOTIANA-BENTHAMIANA; ARABIDOPSIS-THALIANA; MOVEMENT PROTEIN; SYSTEMIC SPREAD; SALICYLIC-ACID	Members of the plant Dicer-like (DCL) protein family are the critical components of the RNA-silencing pathway that mediates innate antiviral defence. The distinct antiviral role of each individual DCL protein has been established with mostly based on observations of aerial parts of plants. Thus, although the roots are closely associated with the life cycle of many plant viruses, little is known about the antiviral activities of DCL proteins in roots. We observed that antiviral silencing strongly inhibits potato virus X (PVX) replication in roots of some susceptible Solanaceae species. Silencing of the DCL4 homolog in Nicotiana benthamiana partially elevated PVX replication levels in roots. In Arabidopsis thaliana, which was originally considered a non-host plant of PVX, high levels of PVX accumulation in inoculated leaves were achieved by inactivation of DCL4, while in the upper leaves and roots, it required the additional inactivation of DCL2. In transgenic A.thaliana carrying the PVX amplicon with a green fluorescent protein (GFP) gene insertion in the chromosome (AMP243 line), absence of DCL4 enabled high levels of PVX-GFP accumulation in various aerial organs but not in the roots, suggesting that DCL4 is critical for intracellular antiviral silencing in shoots but not in roots, where it can be functionally compensated by other DCL proteins. Together, the high level of functional redundancies among DCL proteins may contribute to the potent antiviral activities against PVX replication in roots. Significance StatementThis study demonstrates the differential contributions of DCL proteins between leaves and roots.	[Andika, Ida Bagus; Maruyama, Kazuyuki; Sun, Liying; Kondo, Hideki; Tamada, Tetsuo; Suzuki, Nobuhiro] Okayama Univ, Inst Plant Sci & Resources IPSR, Kurashiki, Okayama 7100046, Japan; [Sun, Liying] Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China	Andika, IB (reprint author), Okayama Univ, Inst Plant Sci & Resources IPSR, 2-20-1 Chuo, Kurashiki, Okayama 7100046, Japan.	idabagusyf@yahoo.com; hkondo@rib.okayama-u.ac.jp; nsuzuki@rib.okayama-u.ac.jp	Suzuki, Nobuhiro/B-2517-2011		KAKEN-HI [18580042]; JSPS Postdoctoral Fellowship for Foreign Researchers [07F07157]; Wesco Scientific Promotion Foundation; Ohara Foundation for Agricultural Research; Yomogi Inc.	We thank Drs. L.A.J. Mur and D.C. Baulcombe for providing transgenic lines and plasmids; Drs. Y. Watanabe, P. Dunoyer and O. Voinnet for providing mutant lines of A. thaliana; Dr. T. Maeda for providing virus strains; Drs. S. Chiba and M. Nishiguchi for fruitful discussion. This work was supported, in part, by the KAKEN-HI Grant-in-Aid for Scientific Research (to T. T. and H.K., no. 18580042), the JSPS Postdoctoral Fellowship for Foreign Researchers (to I. B. A., no. 07F07157), the Wesco Scientific Promotion Foundation (to H. K.), the Ohara Foundation for Agricultural Research and Yomogi Inc. (to N.S.).	Andika IB, 2012, J GEN VIROL, V93, P1841, DOI 10.1099/vir.0.043513-0; Andika IB, 2006, PLANT MOL BIOL, V60, P423, DOI 10.1007/s11103-005-4429-7; Andika IB, 2013, MOL PLANT MICROBE IN, V26, P1165, DOI 10.1094/MPMI-05-13-0137-R; Andika IB, 2005, MOL PLANT MICROBE IN, V18, P194, DOI 10.1094/MPMI-18-0194; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Pruss G, 1997, PLANT CELL, V9, P859, DOI 10.1105/tpc.9.6.859; Aliyari R, 2009, IMMUNOL REV, V227, P176, DOI 10.1111/j.1600-065X.2008.00722.x; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Barajas D, 2006, MOL PLANT MICROBE IN, V19, P904, DOI 10.1094/MPMI-19-0904; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Cogoni C, 1999, NATURE, V399, P166; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; Moissiard G, 2006, P NATL ACAD SCI USA, V103, P19593, DOI 10.1073/pnas.0604627103; Betti C, 2012, MOL PLANT PATHOL, V13, P198, DOI 10.1111/j.1364-3703.2011.00739.x; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Dalmay T, 2000, PLANT CELL, V12, P369, DOI 10.1105/tpc.12.3.369; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; VANCE VB, 1991, VIROLOGY, V182, P486; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Bayne EH, 2005, PLANT J, V44, P471, DOI 10.1111/j.1365-313X.2005.02539.x; Cruz SS, 1998, PLANT CELL, V10, P495, DOI 10.1105/tpc.10.4.495; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Jaubert M, 2011, PLANT PHYSIOL, V156, P1556, DOI 10.1104/pp.111.178012; Wang XB, 2011, PLANT CELL, V23, P1625, DOI 10.1105/tpc.110.082305; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Scholthof HB, 2011, PLANT PHYSIOL, V156, P1548, DOI 10.1104/pp.111.178764; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Qu F, 2005, J VIROL, V79, P15209, DOI 10.1128/JVI.79.24.15209-15217.2005; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Andika IB, 2013, VIROLOGY, V435, P493, DOI [10.1016/j.virol.2012.10.024, 10.1016/j.viro1.2012.10.024]; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Harries P, 2011, VIROLOGY, V411, P237, DOI 10.1016/j.virol.2010.12.021; Bologna NG, 2014, ANNU REV PLANT BIOL, V65, P473, DOI 10.1146/annurev-arplant-050213-035728; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; Alamillo JM, 2006, PLANT J, V48, P217, DOI 10.1111/j.1365-313X.2006.02861.x; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Baulcombe D, 2005, TRENDS BIOCHEM SCI, V30, P290, DOI 10.1016/j.tibs.2005.04.012; Buck KW, 1996, ADV VIRUS RES, V47, P159, DOI 10.1016/S0065-3527(08)60736-8; DesWilde C., 2001, MOL GENET GENOMICS, V265, P647; Hull R., 2002, MATTHEWS PLANT VIROL; Kapoor M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-451; Ma XF, 2015, J EXP BOT, V66, P919, DOI 10.1093/jxb/eru447; Manabayeva SA, 2013, VIROLOGY, V439, P89, DOI 10.1016/j.virol.2013.01.011; Marjanac G, 2009, NEW PHYTOL, V184, P851, DOI 10.1111/j.1469-8137.2009.03011.x; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Rahim MD, 2007, J GEN VIROL, V88, P1611, DOI 10.1099/vir.0.82720-0; Segers GC, 2007, P NATL ACAD SCI USA, V104, P12902, DOI 10.1073/pnas.0702500104; Sun LY, 2008, RNA, V14, P2557, DOI 10.1261/rna.1125408; Tamada T., 2013, J GEN PLANT PATHOL, V79, P1; Valentine TA, 2002, PROTOPLASMA, V219, P184, DOI 10.1007/s007090200020; Verchot-Lubicz J, 2003, PHYSIOL MOL PLANT P, V62, P55, DOI 10.1016/S0885-5765(03)00040-7; Verchot-Lubicz J, 2007, J GEN VIROL, V88, P1643, DOI 10.1099/vir.0.82667-0; Whitham SA, 2004, CURR OPIN PLANT BIOL, V7, P365, DOI 10.1016/j.pbi.2004.04.006; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	63	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	MAR	2015	81	5					781	793		10.1111/tpj.12770		13	Plant Sciences	Plant Sciences	CC3KW	WOS:000350248500012		
J	Giroud, C; Jachmich, S; Jacquet, P; Jarvinen, A; Lerche, E; Rimini, F; Aho-Mantila, L; Aiba, N; Balboa, I; Belo, P; Angioni, C; Beurskens, M; Brezinsek, S; Casson, FJ; Coffey, I; Cunningham, G; Delabie, E; Devaux, S; Drewelow, P; Frassinetti, L; Figueiredo, A; Huber, A; Hillesheim, J; Garzotti, L; Goniche, M; Groth, M; Kim, HT; Leyland, M; Lomas, P; Maddison, G; Marsen, S; Matthews, G; Meigs, A; Menmuir, S; Puetterich, T; van Rooij, G; Saarelma, S; Stamp, M; Urano, H; Webster, A				Giroud, C.; Jachmich, S.; Jacquet, P.; Jarvinen, A.; Lerche, E.; Rimini, F.; Aho-Mantila, L.; Aiba, N.; Balboa, I.; Belo, P.; Angioni, C.; Beurskens, M.; Brezinsek, S.; Casson, F. J.; Coffey, I.; Cunningham, G.; Delabie, E.; Devaux, S.; Drewelow, P.; Frassinetti, L.; Figueiredo, A.; Huber, A.; Hillesheim, J.; Garzotti, L.; Goniche, M.; Groth, M.; Kim, Hyun-Tae; Leyland, M.; Lomas, P.; Maddison, G.; Marsen, S.; Matthews, G.; Meigs, A.; Menmuir, S.; Puetterich, T.; van Rooij, G.; Saarelma, S.; Stamp, M.; Urano, H.; Webster, A.		JET EFDA Contributors	Progress at JET in integrating ITER-relevant core and edge plasmas within the constraints of an ITER-like wall	PLASMA PHYSICS AND CONTROLLED FUSION			English	Article						tokamak; high triangularity; seeding; power load; pedestal; confinement	ELMY H-MODE; ASDEX UPGRADE; CONFINEMENT; DENSITY; TRIANGULARITY; OPTIMIZATION; OPERATION; TRANSPORT; PEDESTAL; TOKAMAKS	This paper reports the progress made at JET-ILW on integrating the requirements of the reference ITER baseline scenario with normalized confinement factor of 1, at a normalized pressure of 1.8 together with partially detached divertor whilst maintaining these conditions over many energy confinement times. The 2.5 MA high triangularity ELMy H-modes are studied with two different divertor configurations with D-gas injection and nitrogen seeding. The power load reduction with N seeding is reported. The relationship between an increase in energy confinement and pedestal pressure with triangularity is investigated. The operational space of both plasma configurations is studied together with the ELM energy losses and stability of the pedestal of unseeded and seeded plasmas. The achievement of stationary plasma conditions over many energy confinement times is also reported.	[Giroud, C.; Jacquet, P.; Rimini, F.; Balboa, I.; Belo, P.; Beurskens, M.; Casson, F. J.; Cunningham, G.; Devaux, S.; Hillesheim, J.; Garzotti, L.; Kim, Hyun-Tae; Lomas, P.; Maddison, G.; Matthews, G.; Meigs, A.; Saarelma, S.; Stamp, M.; Webster, A.] CCFE, Culham Sci Ctr, Abingdon OX14 3DB, Oxon, England; [Jachmich, S.; Lerche, E.] ERM KMS, Brussels, Belgium; [Jarvinen, A.; Groth, M.] Aalto Univ, Assoc EURATOM Tekes, Espoo 02150, Finland; [Aho-Mantila, L.] VTT Tech Res Ctr Finland, FI-02044 Espoo, Finland; [Aiba, N.; Urano, H.] Japan Atom Energy Agcy, Naka Fus Inst, Naka, Ibaraki 3110193, Japan; [Angioni, C.; Puetterich, T.] Max Planck Inst Plasma Phys, EURATOM Assoc, D-85748 Garching, Germany; [Brezinsek, S.; Huber, A.] Forschungszentrum Julich, Assoc EURATOM FZJ, EK Plasmaphys, D-52425 Julich, Germany; [Coffey, I.] Queens Univ, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland; [Delabie, E.; van Rooij, G.] FOM DIFFER, NL-3430 BE Nieuwegein, Netherlands; [Drewelow, P.; Marsen, S.] Max Planck Inst Plasma Phys, Teilinst Greifswald, D-17491 Greifswald, Germany; [Frassinetti, L.] KTH, SCI, Dept Phys, VR, SE-10691 Stockholm, Sweden; [Figueiredo, A.] Univ Lisbon, Inst Super Tecn, Inst Plasmas & Fusao Nucl, P-1049001 Lisbon, Portugal; [Goniche, M.] CEA, IRFM, F-13108 St Paul Les Durance, France; [Leyland, M.] Univ York, Dept Phys, York Plasma Inst, York YO10 5DD, N Yorkshire, England; [JET EFDA Contributors] JET EFDA, Culham Sci Ctr, Abingdon OX14 3DB, Oxon, England	Giroud, C (reprint author), CCFE, Culham Sci Ctr, Abingdon OX14 3DB, Oxon, England.	carine.giroud@ccfe.ac.uk	Putterich, Thomas/A-6962-2012; Groth, Mathias/G-2227-2013		RCUK Energy Programme [EP/I501045]	This work was carried out within the framework of the European Fusion Development Agreement. For further information on the contents of this paper please contact publications-officer@jet.efda.org. The views and opinions expressed herein do not necessarily reflect those of the European Commission. This work was also part-funded by the RCUK Energy Programme under grant EP/I501045.	Brezinsek S, 2013, J NUCL MATER, V438, pS303, DOI 10.1016/j.jnucmat.2013.01.122; Saarelma S, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/3/035001; Mikhailovskii AB, 1997, PLASMA PHYS REP, V23, P844; Angioni C, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/8/083028; Sauter O, 1999, PHYS PLASMAS, V6, P2834, DOI 10.1063/1.873240; Maget P, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093011; Nave MFF, 2003, NUCL FUSION, V43, P1204, DOI 10.1088/0029-5515/43/10/023; Osborne TH, 2000, PLASMA PHYS CONTR F, V42, pA175, DOI 10.1088/0741-3335/42/5A/319; Doyle EJ, 2007, NUCL FUSION, V47, pS18, DOI 10.1088/0029-5515/47/6/S02; Saibene G, 2002, PLASMA PHYS CONTR F, V44, P1769, DOI 10.1088/0741-3335/44/9/301; Leyland MJ, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/8/083028; Wilson HR, 2002, PHYS PLASMAS, V9, P1277, DOI 10.1063/1.1459058; Rice JE, 2002, NUCL FUSION, V42, P510, DOI 10.1088/0029-5515/42/5/303; Kukushkin AS, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075008; Neu R, 2013, J NUCL MATER, V438, pS34, DOI 10.1016/j.jnucmat.2013.01.006; Snyder PB, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/10/103016; Snyder PB, 2002, PHYS PLASMAS, V9, P2037, DOI 10.1063/1.1449463; Giroud C, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113025; Hawryluk RJ, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/6/065012; de Vries PC, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/12/124032; Sieglin B, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/12/124039; Giroud C, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/6/063022; Maddison GP, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/7/073016; Loarte A, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/3/033007; Angioni C, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/12/124017; Beurskens MNA, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/12/124043; Belli EA, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/4/045006; Campbell DJ, 2001, PHYS PLASMAS, V8, P2041, DOI 10.1063/1.1348334; Casson F, 2014, PLASMA PHYS CONTROL, V57; Frassinetti L, 2015, NUCL FUSION; Goniche M, 2014, 41 EPS C BERL 2014; Jacquet P, 2014, P 25 IAEA FUS EN C S; Jarvinen A, 2014, P 25 IAEA FUS EN C S; Jarvinen A E, 2014, J NUCL MAT IN PRESS; Joffrin E., 2014, P 25 IAEA FUS EN C S; Joffrin E, 2014, 41 EPS C BERL 2014; Lerche E., 2014, J NUCL MAT IN PRESS; Leyland M, 2014, NUCL FUSION, V55; Loarte A, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3567547; Maddison G, 2010, J NUCL MATER, V415, pS313; Maddison GP, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/4/042001; Matthews GF, 2013, J NUCL MATER, V438, pS2, DOI 10.1016/j.jnucmat.2013.01.282; Moulton D, 2011, J NUCL MATER, V415, pS509, DOI 10.1016/j.jnucmat.2011.02.025; Pitts RA, 2013, J NUCL MATER, V438, pS48, DOI 10.1016/j.jnucmat.2013.01.008; Puetterich T., 2013, PLASMA PHYS CONTROL, V55; Rapp J, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/9/095012; Saarelma S, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/10/103020; Saarelma S, 2013, 14 H MOD WORKSH KYUS; Sartori R, 2004, PLASMA PHYS CONTR F, V46, P723, DOI 10.1088/0741-3335/46/5/002; Scarabosio A, 2014, J NUCL MAT UNPUB; Stober J, 2001, PLASMA PHYS CONTR F, V43, pA39, DOI 10.1088/0741-3335/43/12A/304; Stober J, 2000, PLASMA PHYS CONTR F, V42, pA211, DOI 10.1088/0741-3335/42/5A/324; Urano H, 2002, PLASMA PHYS CONTR F, V44, P11, DOI 10.1088/0741-3335/44/1/302; Valovic M, 2002, PLASMA PHYS CONTR F, V44, P1911, DOI 10.1088/0741-3335/44/9/309; Zohm H, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073019	55	5	5	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0741-3335	1361-6587		PLASMA PHYS CONTR F	Plasma Phys. Control. Fusion	MAR	2015	57	3							035004	10.1088/0741-3335/57/3/035004		20	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CC1WD	WOS:000350135000004		
J	Spring, AM; Maeda, D; Ozawa, M; Odoi, K; Qiu, F; Yamamoto, K; Yokoyama, S				Spring, Andrew M.; Maeda, Daisuke; Ozawa, Masaaki; Odoi, Keisuke; Qiu, Feng; Yamamoto, Kazuhiro; Yokoyama, Shiyoshi			Glass transition temperature control by poly(norbornene-dicarboximide) copolymers	POLYMER BULLETIN			English	Article							OPENING METATHESIS POLYMERIZATION; GAS-TRANSPORT; POLYMERS; POLYNORBORNENES; DICARBOXIMIDE; NORBORNENE; ROMP	By the precise combination of both cyclohexyl- and octyl-substituted norbornene-dicarboximide monomers, a series of copolymers were prepared by ring-opening metathesis polymerization utilizing the Grubbs first-generation initiator. This allowed an excellent control over the glass transition temperature between 215 and 126 A degrees C depending upon the percentage of the octyl moiety in the copolymer. Initially two homopolymers, poly(N-cyclohexyl-exo-norbornene-5,6-dicarboximide) and poly(N-octyl-exo-norbornene-5,6-dicarboximide), were prepared to determine the desirable conditions for copolymer preparation. The kinetics of the two homopolymers were monitored using proton nuclear magnetic resonance spectroscopy and size-exclusion chromatography, with monomer conversion being achieved after 120 min in both cases.	[Spring, Andrew M.; Qiu, Feng; Yamamoto, Kazuhiro; Yokoyama, Shiyoshi] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8158580, Japan; [Maeda, Daisuke; Ozawa, Masaaki; Odoi, Keisuke] Nissan Chem Ind Co Ltd, Funabashi, Chiba 2748507, Japan	Yokoyama, S (reprint author), Kyushu Univ, Inst Mat Chem & Engn, 6-1 Kasuga Koen, Kasuga, Fukuoka 8158580, Japan.	s_yokoyama@cm.kyushu-u.ac.jp			Cooperative Research Program of "Network Joint Research Center for Materials and Devices" of the Ministry of Education, Culture, Sports, and Science and Technology, Japan; JSPS KAKENHI [26289108]	The authors acknowledge financial support from the following funding sources. This work was supported by the Cooperative Research Program of "Network Joint Research Center for Materials and Devices" of the Ministry of Education, Culture, Sports, and Science and Technology, Japan and JSPS KAKENHI Grant Number 26289108.	Vargas J, 2004, EUR POLYM J, V40, P1325, DOI 10.1016/j.europolymj.2004.02.019; Yoon KH, 2012, J POLYM SCI POL CHEM, V50, P3914, DOI 10.1002/pola.26171; Yoon KH, 2012, POLYMER, V53, P2290, DOI 10.1016/j.polymer.2012.02.047; Vargas J, 2010, J MEMBRANE SCI, V361, P78, DOI 10.1016/j.memsci.2010.06.007; Yu CY, 2010, MACROMOLECULES, V43, P222, DOI 10.1021/ma901966g; Grove NR, 1999, J POLYM SCI POL PHYS, V37, P3003; ASRAR J, 1994, MACROMOLECULES, V27, P4036, DOI 10.1021/ma00093a002; ASRAR J, 1992, MACROMOLECULES, V25, P5150, DOI 10.1021/ma00046a006; CASTNER KF, 1982, J MOL CATAL, V15, P47, DOI 10.1016/0304-5102(82)80004-7; Choi MC, 2010, J POLYM SCI POL CHEM, V48, P5189, DOI 10.1002/pola.24318; Contreras AP, 2002, MACROMOLECULES, V35, P4677, DOI 10.1021/ma011959p; Contreras AP, 2002, MACROMOL CHEM PHYSIC, V203, P1811, DOI 10.1002/1521-3935(200208)203:12<1811::AID-MACP1811>3.0.CO;2-J; Grubbs RH, 2003, HDB MATATHESIS; Jia Y, 2014, THIN SOLID FILMS, V554, P175, DOI 10.1016/j.tsf.2013.06.071; Jia Y, 2014, JPN J APPL PHYS, V53; Lanier M., 2011, J MED CHEM, V55, P697; Santiago AA, 2011, POLYMER, V52, P4208, DOI 10.1016/j.polymer.2011.07.030; Spring AM, 2014, POLYM J, V46, P576, DOI 10.1038/pj.2014.26; Spring AM, 2009, CHEM COMMUN, V19, P2676; Tlenkopatchev MA, 2003, MACROMOLECULES, V36, P8483, DOI 10.1021/ma030285a; Yu F, 2013, J POLYM SCI POL CHEM, V51, P1278, DOI 10.1002/pola.26505	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0170-0839	1436-2449		POLYM BULL	Polym. Bull.	MAR	2015	72	3					503	521		10.1007/s00289-014-1283-2		19	Polymer Science	Polymer Science	CC3KN	WOS:000350247300008		
J	Motokuni, K; Takeuchi, D; Osakada, K				Motokuni, Kenya; Takeuchi, Daisuke; Osakada, Kohtaro			Cyclopolymerization of 1,6-heptadienes and 1,6,11-dodecatrienes having acyclic substituents catalyzed by Pd-diimine complexes	POLYMER BULLETIN			English	Article						Cyclopolymerization; Pd catalyst; Diene; Triene	ALPHA-OLEFINS; ENANTIOSELECTIVE CYCLOPOLYMERIZATION; CYCLO-COPOLYMERIZATION; NONCONJUGATED DIENES; BLOCK-COPOLYMERS; COBALT COMPLEXES; 1,5-HEXADIENE; ETHYLENE; POLYMERIZATION; POLYMERS	Chloro(methyl)palladium complexes with 1,2-diimine ligand catalyze the cyclopolymerization of 1,6-heptadienes having two alkoxymethyl substituents at 4-position. The obtained polymers contain a trans-fused five-membered ring in every repeating unit. Molecular weights of the polymers are in the range of M (n) = 3,370-13,000 (M (w)/M (n) = 1.28-2.01, by GPC using polystyrene standard), depending on the monomer and the catalyst. The reaction using the Pd complex with a C (2) symmetrical structure forms the polymer with racemo linkage between the monomer units more than meso linkage. The polymerization under ethylene atmosphere produces the copolymer having the diene monomer unit composed of the five-membered ring and the branched oligoethylene block. 1,6,11-Dodecatrienes having four alkoxymethyl groups at the 4- and 9-positions undergo the cyclopolymerization to yield the polymer containing two five-membered rings in every monomer unit. Pd-diimine complexes polymerize 1,6-dienes having acyclic substituents and 1,6,11-dodecatrienes having four substituents at 4- and 9-positions to produce the new polymers having trans-five-membered rings along the polymer chain.	[Motokuni, Kenya; Takeuchi, Daisuke; Osakada, Kohtaro] Tokyo Inst Technol, Chem Resources Lab R1 04, Yokohama, Kanagawa 2268503, Japan	Takeuchi, D (reprint author), Tokyo Inst Technol, Chem Resources Lab R1 04, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	dtakeuch@res.titech.ac.jp	Takeuchi, Daisuke/E-5149-2014; Osakada, Kohtaro/B-9267-2015	Takeuchi, Daisuke/0000-0001-6150-4083; 			COATES GW, 1991, J AM CHEM SOC, V113, P6270, DOI 10.1021/ja00016a053; Yeori A, 2007, MACROMOLECULES, V40, P8521, DOI 10.1021/ma702076w; Wang SL, 2014, J ORGANOMET CHEM, V751, P717, DOI 10.1016/j.jorganchem.2013.08.021; JOHNSON LK, 1995, J AM CHEM SOC, V117, P6414, DOI 10.1021/ja00128a054; Yeori A, 2006, J AM CHEM SOC, V128, P13062, DOI 10.1021/ja0647654; BROOKHART M, 1992, ORGANOMETALLICS, V11, P3920, DOI 10.1021/om00059a071; Guo F, 2011, MACROMOLECULES, V44, P2400, DOI 10.1021/ma200441w; Coates GW, 2000, CHEM REV, V100, P1223, DOI 10.1021/cr990286u; Okada T, 2010, MACROMOLECULES, V43, P7998, DOI 10.1021/ma101146j; NISHIDA H, 1984, B CHEM SOC JPN, V57, P2600, DOI 10.1246/bcsj.57.2600; Tempel DJ, 2000, J AM CHEM SOC, V122, P6686, DOI 10.1021/ja000893v; Killian CM, 1996, J AM CHEM SOC, V118, P11664, DOI 10.1021/ja962516h; Motokuni K, 2011, MACROMOLECULES, V44, P751, DOI 10.1021/ma1022204; Park S, 2006, J AM CHEM SOC, V128, P3510, DOI 10.1021/ja058408p; Park S, 2010, CHEM-EUR J, V16, P8662, DOI 10.1002/chem.201000604; Buschmann WE, 1998, CHEM-EUR J, V4, P1731, DOI 10.1002/(SICI)1521-3765(19980904)4:9<1731::AID-CHEM1731>3.0.CO;2-U; COATES GW, 1993, J AM CHEM SOC, V115, P91, DOI 10.1021/ja00054a014; Guo F, 2011, MACROMOLECULES, V44, P6335, DOI 10.1021/ma201271r; Mecking S, 1998, J AM CHEM SOC, V120, P888, DOI 10.1021/ja964144i; VANASSELT R, 1994, RECL TRAV CHIM PAY B, V113, P88; CAVALLO L, 1993, MACROMOLECULES, V26, P260, DOI 10.1021/ma00054a003; Choo TN, 2002, J AM CHEM SOC, V124, P4188, DOI 10.1021/ja0177071; DEBALLESTEROS OR, 1995, MACROMOLECULES, V28, P2383; Edson JB, 2009, MACROMOL RAPID COMM, V30, P1900, DOI 10.1002/marc.200900422; Han SL, 2012, MACROMOLECULES, V45, P4054, DOI 10.1021/ma300384w; Hustad PD, 2002, J AM CHEM SOC, V124, P11578, DOI 10.1021/ja0273748; Jayaratne KC, 2000, J AM CHEM SOC, V122, P10490, DOI 10.1021/ja002558c; Kim IL, 2000, J POLYM SCI POL CHEM, V38, P1520, DOI 10.1002/(SICI)1099-0518(20000501)38:9<1520::AID-POLA15>3.0.CO;2-5; Necas D, 2006, NEW J CHEM, V30, P671, DOI 10.1039/b601631f; MITANI M, 1995, CHEM LETT, P905, DOI 10.1246/cl.1995.905; Motokuni K, 2014, MACROMOLECULES, V47, P6522, DOI 10.1021/ma500871f; Naga N, 1999, MACROMOLECULES, V32, P1348, DOI 10.1021/ma9814144; Nomura K, 2007, J AM CHEM SOC, V129, P14170, DOI 10.1021/ja076633w; Nomura K, 2006, MACROMOLECULES, V39, P4009, DOI 10.1021/ma0604892; Osakada K, 2004, ADV POLYM SCI, V171, P137, DOI 10.1007/b13016; Perch NS, 2000, J ORG CHEM, V65, P3836, DOI 10.1021/jo0003192; RESCONI L, 1990, J AM CHEM SOC, V112, P4953, DOI 10.1021/ja00168a048; Shi XC, 2011, MACROMOLECULES, V44, P1062, DOI 10.1021/ma1023268; Takeuchi D, 2007, J AM CHEM SOC, V129, P7002, DOI 10.1021/ja0718568; Takeuchi D, 2008, MACROMOL RAPID COMM, V29, P1932, DOI 10.1002/marc.200800424; Takeuchi D, 2009, MACROMOLECULES, V42, P5909, DOI 10.1021/ma901069q; Zhang W, 2008, MACROMOLECULES, V41, P7829, DOI 10.1021/ma801962v	42	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0170-0839	1436-2449		POLYM BULL	Polym. Bull.	MAR	2015	72	3					583	597		10.1007/s00289-014-1293-0		15	Polymer Science	Polymer Science	CC3KN	WOS:000350247300013		
J	Tezuka, K; Koda, K; Katagiri, H; Haba, O				Tezuka, Kunio; Koda, Kuniomi; Katagiri, Hiroshi; Haba, Osamu			Anionic ring-opening polymerization of five-membered cyclic carbonates derived from aldohexopyranosides	POLYMER BULLETIN			English	Article						Aliphatic polycarbonate; Ring-opening polymerization; Anionic polymerization; X-ray structural analysis	GLUCOPYRANOSIDE STRUCTURE; RENEWABLE RESOURCES; CYCLOHEXANE RING; CO2	To investigate the relationship between the steric structures and polymerizability of five-membered cyclic carbonates, the anionic ring-opening polymerizations of methyl 4,6-O-benzylidene-2,3-O-carbonyl-alpha-d-galacto- and mannopyranosides (MBCGa and MBGM, respectively), were examined and compared to the results of the already reported glucopyranoside analog (MBCG). The polymerization of MBCGa proceeded without the elimination of CO2 as in the case of MBCG, while MBCM was not polymerized. To estimate the thermodynamic stability of the carbonate rings of these cyclic carbonates, the model reactions using the corresponding hydroxycarbonates were carried out. The ring-closing reactions of the mannopyranoside-based hydroxycarbonate proceeded to produce cyclic carbonate, while the others did not give cyclic carbonates. This should indicate that the carbonate rings of MBCG and MBCGa were less stable than that of MBCM. The single-crystal X-ray structural analysis indicated that the carbonate rings of MBCG and MBCGa have higher angle strains than that of MBCM. This should suggest that the ring strain of the five-membered cyclic carbonate increases by trans-fusing to the pyranose ring.	[Tezuka, Kunio; Koda, Kuniomi; Katagiri, Hiroshi; Haba, Osamu] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata 9928510, Japan	Haba, O (reprint author), Yamagata Univ, Grad Sch Sci & Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	haba@yz.yamagata-u.ac.jp	Katagiri, Hiroshi/E-2912-2014	Katagiri, Hiroshi/0000-0003-4100-9995			ZHU KJ, 1991, MACROMOLECULES, V24, P1736, DOI 10.1021/ma00008a008; Rokicki G, 2000, PROG POLYM SCI, V25, P259, DOI 10.1016/S0079-6700(00)00006-X; Clements JH, 2003, IND ENG CHEM RES, V42, P663, DOI 10.1021/ie020678i; Yokoe M, 2003, J POLYM SCI POL CHEM, V41, P2312, DOI 10.1002/pola.10772; Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004; Lu XB, 2012, ACCOUNTS CHEM RES, V45, P1721, DOI 10.1021/ar300035z; BROWN CJ, 1954, ACTA CRYSTALLOGR, V7, P92, DOI 10.1107/S0365110X54000175; Tezuka K, 2013, POLYM J, V45, P1183, DOI 10.1038/pj.2013.50; Haba O, 2005, MACROMOLECULES, V38, P3562, DOI 10.1021/ma0476745; Klaus S, 2011, COORDIN CHEM REV, V255, P1460, DOI 10.1016/j.ccr.2010.12.002; Tempelaar S, 2013, CHEM SOC REV, V42, P1312, DOI 10.1039/c2cs35268k; Mikami K, 2013, J AM CHEM SOC, V135, P6826, DOI 10.1021/ja402319m; Azechi M, 2013, J POLYM SCI POL CHEM, V51, P1651, DOI 10.1002/pola.26538; BEBAULT GM, 1974, CARBOHYD RES, V37, P309, DOI 10.1016/S0008-6215(00)82920-1; Betz R, 2007, ACTA CRYSTALLOGR E, V63, pO3890, DOI 10.1107/S1600536807041244; DAINTON FS, 1958, Q REV CHEM SOC, V12, P61, DOI 10.1039/qr9581200061; Doane WM, 1967, CARBOHYD RES, V4, P445, DOI 10.1016/S0008-6215(00)81835-2; Duda A., 2009, HDB RING OPENING POL, DOI DOI 10.1002/9783527628407.CH1; Haba O, 2009, POLYM J, V41, P702, DOI 10.1295/polymj.PJ2008327; Haba O, 2014, POLYM J, V46, P89, DOI 10.1038/pj.2013.70; Kabuto C, 2009, J CRYST SOC JPN, V51, P201; Kalikanda J, 2011, CARBOHYD RES, V346, P2380, DOI 10.1016/j.carres.2011.08.015; Lagisetti C, 2007, J ORG CHEM, V72, P9886, DOI 10.1021/jo0711900; Omae I, 2012, COORDIN CHEM REV, V256, P1384, DOI 10.1016/j.ccr.2012.03.017; PIHLAJA K, 1977, ACTA CHEM SCAND B, V31, P899, DOI 10.3891/acta.chem.scand.31b-0899; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; TEWSON TJ, 1985, J CARBOHYD CHEM, V4, P529, DOI 10.1080/07328308508082675; Wang H, 1998, J POLYM SCI POL CHEM, V36, P1301, DOI 10.1002/(SICI)1099-0518(199806)36:8<1301::AID-POLA13>3.3.CO;2-P; Yokoe M, 2005, J POLYM SCI POL CHEM, V43, P3909, DOI 10.1002/pola.20830	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0170-0839	1436-2449		POLYM BULL	Polym. Bull.	MAR	2015	72	3					615	626		10.1007/s00289-014-1295-y		12	Polymer Science	Polymer Science	CC3KN	WOS:000350247300016		
J	Takasaki, M; Hiroki, K; Iwamura, T				Takasaki, Masato; Hiroki, Kento; Iwamura, Takeru			Synthesis of organic-inorganic polymer hybrids from acrylate polymer having a triphenylimidazole moiety via pi-pi interactions	POLYMER BULLETIN			English	Article						Triphenylimidazole; Acrylate; Methyl methacrylate; Sol-gel reaction; Phenyltrimethoxysilane; Cyclohexyltrimethoxysilane; Polymer hybrid; pi-pi Interaction	HEXAARYLBIIMIDAZOLE; IMIDAZOLE; LIGHT; ACID	Organic-inorganic polymer hybrids were prepared utilizing pi-pi interactions. The sol-gel reaction of phenyltrimethoxysilane (PhTMOS) was carried out in the presence of an acrylate polymer having a triphenylimidazole moiety such as poly(4-(4,5-diphenyl-1H-imidazol-yl)-phenyl acrylate-co-methyl methacrylate) (PDM). Transparent and homogeneous polymer hybrids were obtained from PDM and alkoxysilanes having aromatic groups such as PhTMOS. These polymer hybrids could be obtained in a wide range of mass ratios of PDM/PhSiO1.5 = 9/1-4/6. In these polymer hybrids, the pi-pi interaction played an important role in the dispersion of PDM in the PhSiO1.5 matrix.	[Takasaki, Masato; Iwamura, Takeru] Tokyo City Univ, Dept Chem & Energy Engn, Grad Sch Engn, Setagaya Ku, Tokyo 1588857, Japan; [Hiroki, Kento; Iwamura, Takeru] Tokyo City Univ, Dept Chem & Energy Engn, Fac Engn, Setagaya Ku, Tokyo 1588857, Japan	Iwamura, T (reprint author), Tokyo City Univ, Dept Chem & Energy Engn, Grad Sch Engn, Setagaya Ku, 1-28-1 Tamazutumi, Tokyo 1588857, Japan.	iwamurat@tcu.ac.jp			Japan Society for the Promotion of Science [23510112]	This work was supported by a Grant-in-Aid for Scientific Research (C) (No. 23510112) from the Japan Society for the Promotion of Science.	Bonhote P, 1996, INORG CHEM, V35, P1168, DOI 10.1021/ic951325x; Fujita K, 2008, ORG LETT, V10, P3105, DOI 10.1021/ol801135g; Ogoshi T, 2005, COMPOS INTERFACE, V11, P539, DOI 10.1163/1568554053148735; Schechter A, 2002, SOLID STATE IONICS, V147, P181, DOI 10.1016/S0167-2738(02)00040-1; Kishimoto Y, 2009, J AM CHEM SOC, V131, P4227, DOI 10.1021/ja810032t; Larsen AS, 2000, J AM CHEM SOC, V122, P7264, DOI 10.1021/ja0007511; Siddiqui SA, 2005, TETRAHEDRON, V61, P3539, DOI 10.1016/j.tet.2005.01.116; Sevil F, 2004, J PHYS CHEM SOLIDS, V65, P1659, DOI 10.1016/j.jpcs.2004.04.001; Cavender PL, 1986, US Patent, Patent No. [4,565,875, 4565875]; CHUJO Y, 1992, ADV POLYM SCI, V100, P11; Dowbenko R, 1972, US Patent, Patent No. [3 677,978, 3677978]; Finelli AF, 1969, US Patent, Patent No. [3,446,779, 3446779]; Hofmann K, 1953, IMIDAZOLE ITS DERI 1; Iwamura T, 2008, MACROMOLECULES, V41, P8995, DOI 10.1021/ma801298e; Iwamura T, 2013, POLYMER, V54, P4161, DOI 10.1016/j.polymer.2013.05.066; Iwamura T, 2004, POLYM J, V36, P871, DOI 10.1295/polymj.36.871; Kotone A, 1975, US Patent, Patent No. [3,891,470, 3891470]; Mamalis P, 1976, US Patent, Patent No. [3,968,220, 3968220]; Tamaki R, 1998, CHEM COMMUN, P1131, DOI 10.1039/a708948a; Uchida Katsuhisa, 2004, Journal of Infection and Chemotherapy, V10, P216; Wikes JS, 1992, J CHEM SOC CHEM COMM, V13, P965	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0170-0839	1436-2449		POLYM BULL	Polym. Bull.	MAR	2015	72	3					645	651		10.1007/s00289-014-1297-9		7	Polymer Science	Polymer Science	CC3KN	WOS:000350247300018		
J	Miyazaki, T; Takeda, Y; Hoshiko, A; Shimokita, K; Ogomi, D				Miyazaki, Tsukasa; Takeda, Yuuki; Hoshiko, Akie; Shimokita, Keisuke; Ogomi, Daisuke			Evaluation of Oriented Amorphous Regions in Polymer Films During Uniaxial Deformation; Structural Characterization of a Poly(vinyl alcohol) Film During Stretching in Boric Acid Aqueous Solutions	POLYMER ENGINEERING AND SCIENCE			English	Article							X-RAY-SCATTERING; SIMULTANEOUS SMALL-ANGLE; IN-SITU; SYNCHROTRON SAXS/WAXD; POLY(ETHER ESTER); FIBERS; POLY(ETHYLENE-TEREPHTHALATE); ORIENTATION; CRYSTALLIZATION; DRAWN	We have improved the conventional analytical method of the scattering data obtained with in-situ synchrotron X-ray scattering experiments, which is applicable to the structural characterization of the film during stretching. Four components of molecular chains in the film are divided from two-dimensional wide-angle X-ray diffraction patterns. These components are the oriented crystals, the unoriented ones, the oriented amorphous chains, and the unoriented ones, respectively. This method allows to evaluate directly the degree of orientation of the amorphous chains and the amount of the oriented amorphous fraction in addition to each evaluation for the crystalline regions. This method is applied to the structural characterization of the poly(vinyl alcohol) (PVA) film during stretching in boric acid aqueous solutions, suggesting that boric acid accelerates orientation of molecular chains in the amorphous regions, and increases the oriented amorphous fraction by producing the cross-links between the PVA chains and hindering strain-induced crystallization. At a film break on stretching in the 3 wt% boric acid solution, the oriented amorphous fraction increases up to 70%, which is much higher compared to that in the film stretched in water, 45%. POLYM. ENG. SCI., 55:513-522, 2015. (c) 2014 Society of Plastics Engineers	[Miyazaki, Tsukasa; Takeda, Yuuki; Hoshiko, Akie; Shimokita, Keisuke] Nitto Denko Corp, Funct Design Technol Ctr, Osaka 5678680, Japan; [Ogomi, Daisuke] Nitto Denko Corp, Div Res & Dev, Informat Fine Mat Sect, Hiroshima 7220212, Japan	Miyazaki, T (reprint author), Nitto Denko Corp, Funct Design Technol Ctr, Osaka 5678680, Japan.	tsukasa_miyazaki@gg.nitto.co.jp			Japan Synchrotron Radiation Research Institute (JASRI)	The authors wish to thank Dr. H. Masunaga and Dr. H. Ogawa of the Japan Synchrotron Radiation Research Institute (JASRI) for their support on our experiments at SPring-8. The synchrotron radiation experiments were performed at the BL03XU in the SPring-8 with the approval of JASRI (Proposal No. 2010A7224 and 2010B7270).	AJJI A, 1995, POLYMER, V36, P4023, DOI 10.1016/0032-3861(95)90981-7; Masunaga H, 2011, POLYM J, V43, P471, DOI 10.1038/pj.2011.18; BUTLER MF, 1995, MACROMOLECULES, V28, P6383, DOI 10.1021/ma00123a001; SHIBAYAMA M, 1988, POLYMER, V29, P336, DOI 10.1016/0032-3861(88)90343-6; Miyazaki T, 2010, POLYMER, V51, P5539, DOI 10.1016/j.polymer.2010.09.048; MURTHY NS, 1995, POLYMER, V36, P3863, DOI 10.1016/0032-3861(95)99780-X; Trabelsi S, 2003, MACROMOLECULES, V36, P7624, DOI 10.1021/ma030224c; ZWICK MM, 1965, J APPL POLYM SCI, V9, P2393, DOI 10.1002/app.1965.070090706; Ran SF, 2001, MACROMOLECULES, V34, P2569, DOI 10.1021/ma0016477; Wu J, 2000, MACROMOLECULES, V33, P1765, DOI 10.1021/ma990896w; Ran S, 2001, POLYMER, V42, P1601, DOI 10.1016/S0032-3861(00)00460-2; Ogawa H, 2013, POLYM J, V45, P109, DOI 10.1038/pj.2012.194; Wu J, 2001, POLYMER, V42, P7141, DOI 10.1016/S0032-3861(01)00042-8; EVSTATIEV M, 1992, POLYM ENG SCI, V32, P964, DOI 10.1002/pen.760321408; Finch CA, 1973, POLYVINYL ALCOHOL PR; Fu YG, 1996, J MACROMOL SCI PHYS, VB35, P37, DOI 10.1080/00222349608220375; Hakme C, 2007, J NON-CRYST SOLIDS, V353, P4252, DOI 10.1016/j.jnoncrysol.2007.03.030; Hakme C, 2005, J NON-CRYST SOLIDS, V351, P2742, DOI 10.1016/j.jnoncrysol.2005.05.039; Hakme C, 2006, J NON-CRYST SOLIDS, V352, P4746, DOI 10.1016/j.jnoncrysol.2006.01.126; HARGET PJ, 1979, J POLYM SCI POL PHYS, V17, P531, DOI 10.1002/pol.1979.180170318; Kattan M, 2002, POLYMER, V43, P1399, DOI 10.1016/S0032-3861(01)00719-4; Koerner H, 2003, MACROMOLECULES, V36, P1975, DOI 10.1021/ma020856j; KUROKAWA H, 1992, POLYMER, V33, P2182, DOI 10.1016/0032-3861(92)90886-2; Lu XF, 2001, POLYMER, V42, P8055, DOI 10.1016/S0032-3861(01)00295-6; MIYASAKA K, 1993, ADV POLYM SCI, V108, P91; Miyazaki T, 2007, MACROMOLECULES, V40, P8277, DOI 10.1021/ma070731k; Miyazaki T, 2006, MACROMOLECULES, V39, P2921, DOI 10.1021/ma052595u; Murthy N. S., 1991, J APPL POLYM SCI APP, V47, P185, DOI 10.1002/app.1991.070470013; Murthy NS, 1997, J APPL POLYM SCI, V64, P1363, DOI 10.1002/(SICI)1097-4628(19970516)64:7<1363::AID-APP16>3.0.CO;2-Y; MURTHY NS, 1991, MACROMOLECULES, V24, P1185, DOI 10.1021/ma00005a033; Nogales A, 2003, MACROMOLECULES, V36, P4827, DOI 10.1021/ma0210877; OCHIAI H, 1981, POLYMER, V22, P1456, DOI 10.1016/0032-3861(81)90310-4; PARRAVICINI L, 1994, J APPL POLYM SCI, V52, P875, DOI 10.1002/app.1994.070520706; Sakurada I, 1985, POLYVINYL ALCOHOL FI; Stribeck N, 1997, MACROMOLECULES, V30, P1329, DOI 10.1021/ma9612079; TODOKI M, 1977, J POLYM SCI POL PHYS, V15, P1067, DOI 10.1002/pol.1977.180150613; vans Aerle N. A. J. M., 1991, MACROMOLECULES, V27, P6520; vans Aerle N. A. J. M., 1988, MAKROMOL CHEM, V189, P1569; Vansco G., 1991, J APPL POLYM SCI, V42, P1351; Wu G, 1996, J POLYM SCI POL PHYS, V34, P2035, DOI 10.1002/(SICI)1099-0488(19960915)34:12<2035::AID-POLB9>3.0.CO;2-Y; ZHOU Q, 1995, J POLYM SCI POL PHYS, V33, P909, DOI 10.1002/polb.1995.090330606	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0032-3888	1548-2634		POLYM ENG SCI	Polym. Eng. Sci.	MAR	2015	55	3					513	522		10.1002/pen.23913		10	Engineering, Chemical; Polymer Science	Engineering; Polymer Science	CC3XG	WOS:000350284000004		
J	Minami, Y; Takebe, T; Kanamaru, M; Okamoto, T				Minami, Yutaka; Takebe, Tomoaki; Kanamaru, Masami; Okamoto, Takuji			Development of low isotactic polyolefin	POLYMER JOURNAL			English	Review							ANSA-METALLOCENE DERIVATIVES; ZIRCONOCENE CATALYSTS; MOLECULAR-WEIGHT; POLYPROPYLENE; POLYMERIZATION; PROPYLENE; DICHLORIDES; ELASTOMERS; COMPLEXES; BRIDGES	Polymeric material development has made great progress owing to the innovations in catalyst technology for polymerization. In recent years, the use of polyolefins has been expected to expand to various applications as substitutions for materials such as metal, paper and wood. Therefore, metallocene catalysts are a key technology for producing high-performance polyolefins specifically designed for a given application. In this report, we present a novel polypropylene (low modulus polypropylene: LMPP) with low isotacticity and high molecular weight, and which is synthesized using specific C-2-symmetric doubly bridged metallocene complexes. LMPP possesses some isotactic sequences in stereorandom order, and its tacticity can be precisely controlled through the design of the metallocene catalysts. LMPP can be provided as pellets and be applicable to hot melt adhesives, elastic fibers, nonwoven fabrics and so on, because of its unique elastomeric properties and excellent compatibility with isotactic polypropylene.	[Minami, Yutaka; Takebe, Tomoaki; Okamoto, Takuji] Idemitsu Kosan Co Ltd, Performance Mat Labs, Ichihara, Chiba 2990193, Japan; [Kanamaru, Masami] Idemitsu Kosan Co Ltd, Adv Technol Res Labs, Ichihara, Chiba 2990193, Japan	Minami, Y (reprint author), Idemitsu Kosan Co Ltd, Performance Mat Labs, 1-1 Anesaki Kaigan, Ichihara, Chiba 2990193, Japan.	yutaka.minami@idemitsu.com					EWEN JA, 1984, J AM CHEM SOC, V106, P6355, DOI 10.1021/ja00333a041; MALLIN DT, 1990, J AM CHEM SOC, V112, P2030, DOI 10.1021/ja00161a075; SPALECK W, 1994, ORGANOMETALLICS, V13, P954, DOI 10.1021/om00015a032; SPALECK W, 1992, ANGEW CHEM INT EDIT, V31, P1347, DOI 10.1002/anie.199213471; COATES GW, 1995, SCIENCE, V267, P217, DOI 10.1126/science.267.5195.217; ANDRESEN A, 1976, ANGEW CHEM INT EDIT, V15, P630, DOI 10.1002/anie.197606301; Bravakis AM, 1998, MACROMOLECULES, V31, P1000, DOI 10.1021/ma971325b; DORER B, 1994, ORGANOMETALLICS, V13, P3868, DOI 10.1021/om00022a023; HAFNER K, 1994, ANGEW CHEM INT EDIT, V33, P1479, DOI 10.1002/anie.199414791; Halterman RL, 1997, ORGANOMETALLICS, V16, P3333, DOI 10.1021/om9703548; Herzog TA, 1996, J AM CHEM SOC, V118, P11988, DOI 10.1021/ja962413z; JONES AT, 1963, J POLYM SCI POL LETT, V1, P455, DOI 10.1002/pol.1963.110010815; KRIGBAUM WR, 1965, J POLYM SCI PART A, V3, P767, DOI 10.1002/pol.1965.100030231; Kukral J, 2000, ORGANOMETALLICS, V19, P3767, DOI 10.1021/om000224q; Mandelkern L., 1964, CRYSTALLIZATION POLY; MENGELE W, 1993, ORGANOMETALLICS, V12, P1931, DOI 10.1021/om00029a057; Minami Y., 1999, International Patent, Patent No. [WO99/67303, 9967303]; Okamoto T., 2001, International Patent, Patent No. [WO01/25300, 0125300]; Wunderlich B., 1976, MACROMOLECULAR PHYSI, V2, P115	19	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	MAR	2015	47	3					227	234		10.1038/pj.2014.110		8	Polymer Science	Polymer Science	CD1BH	WOS:000350808200001		
J	Nishimura, T				Nishimura, Tatsuya			Macromolecular templates for the development of organic/inorganic hybrid materials	POLYMER JOURNAL			English	Review							AMORPHOUS CALCIUM-CARBONATE; NACREOUS LAYER FORMATION; CACO3 THIN-FILMS; MATRIX PROTEIN; PINCTADA-FUCATA; MAGNESIUM-IONS; SELF-ORGANIZATION; RELIEF STRUCTURES; ORGANIC POLYMER; BRUSH MATRICES	Biominerals and the formation mechanisms of these materials have been studied intensively for decades. Biominerals have attracted much attention from material scientists because these compounds have significant mechanical and optical properties because of their elaborate structures. We believe that novel functional hybrid materials with hierarchical structures are best prepared using abundant elements and mild conditions, similar to the formation of natural biominerals. This review focuses on using an organic (bio) polymer for the formation of these hybrid materials based on CaCO3 and on understanding the formation of new hybrid materials via bio-inspired approaches. The structure-function relationships of biomineralization-related proteins are discussed. Molecular designs to control the properties of the hybrid materials are also described. The combination of experimentation and molecular simulation is also introduced. These studies provide useful ideas for the development of hybrid materials through biomimetic approaches.	[Nishimura, Tatsuya] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan	Nishimura, T (reprint author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan.	tatsuya@chembio.t.u-tokyo.ac.jp	Nishimura, Tatsuya/A-3013-2013	Nishimura, Tatsuya/0000-0002-8416-4007	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22107003]; SEKISUI Foundation, Tokyo, Japan	I thank all the coworkers for their contributions and specially thank Professor Takashi Kato (The University of Tokyo, Toyko, Japan) and Professor Eiji Yashima (Nagoya University, Nagoya, Japan) for their encouragement. I would also like to thank the Nanotechnology Platform of The University of Tokyo for the tunneling electron microscopy observation. A part of this work was supported by a Grant-in-Aid for Scientific Research (no. 22107003) on the Innovative Areas, 'Fusion Materials: Creative Development of Materials and Exploration of Their Function through Molecular Control' (area no. 2206) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the SEKISUI Chemical Grant Program for research on manufacturing based on innovations inspired by nature from the SEKISUI Foundation, Tokyo, Japan.	Advincula R. C., 2004, POLYM BRUSHES SYNTHE; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Fabritius HO, 2009, ADV MATER, V21, P391, DOI 10.1002/adma.200801219; Kato T, 2006, ANGEW CHEM INT EDIT, V45, P38, DOI 10.1002/anie.200501384; Arakaki A, 2008, J R SOC INTERFACE, V5, P977, DOI 10.1098/rsif.2008.0170; Kajiyama S, 2014, SMALL, V10, P1634, DOI 10.1002/smll.201302745; Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856; Hosoda N, 2003, MACROMOLECULES, V36, P6449, DOI 10.1021/ma025869b; Yamamoto Y, 2008, CRYST GROWTH DES, V8, P4062, DOI 10.1021/cg800447w; Inoue H, 2007, PEPTIDES, V28, P566, DOI 10.1016/j.peptides.2006.12.005; Tagaya A, 2012, POLYM J, V44, P306, DOI 10.1038/pj.2011.141; Sugawara A, 2003, ANGEW CHEM INT EDIT, V42, P5299, DOI 10.1002/anie.200351541; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Raabe D, 2005, ACTA MATER, V53, P4281, DOI 10.1016/j.actamat.2005.05.027; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6; Sugawara A, 2006, ANGEW CHEM INT EDIT, V45, P2876, DOI 10.1002/anie.200503800; Colfen H, 2005, ANGEW CHEM INT EDIT, V44, P5576, DOI 10.1002/anie.200500496; Davis KJ, 2000, SCIENCE, V290, P1134, DOI 10.1126/science.290.5494.1134; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Zhu FJ, 2013, CHEM-ASIAN J, V8, P3002, DOI 10.1002/asia.201300745; Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; Zhu FJ, 2014, CRYSTENGCOMM, V16, P1496, DOI 10.1039/c3ce41649f; Koyama Y, 2012, POLYM J, V44, P30, DOI 10.1038/pj.2011.64; Meldrum FC, 2003, INT MATER REV, V48, P187, DOI 10.1179/095066003225005836; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Matsunaga T, 2007, TRENDS BIOTECHNOL, V25, P182, DOI 10.1016/j.tibtech.2007.02.002; Oaki Y, 2008, ADV MATER, V20, P3633, DOI 10.1002/adma.200800773; Ma YR, 2009, P NATL ACAD SCI USA, V106, P6048, DOI 10.1073/pnas.0810300106; REVOL JF, 1993, INT J BIOL MACROMOL, V15, P329, DOI 10.1016/0141-8130(93)90049-R; Tanaka Y, 2012, POLYM J, V44, P586, DOI 10.1038/pj.2012.28; Tao JH, 2009, P NATL ACAD SCI USA, V106, P22096, DOI 10.1073/pnas.0909040106; Raz S, 2003, ADV FUNCT MATER, V13, P480, DOI 10.1002/adfm.200304285; WATABE N, 1960, NATURE, V188, P334, DOI 10.1038/188334a0; Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Han YL, 2014, POLYM J, V46, P499, DOI 10.1038/pj.2014.36; Han YL, 2014, CRYSTENGCOMM, V16, P3540, DOI 10.1039/c3ce42646g; Ito K, 2012, POLYM J, V44, P38, DOI 10.1038/pj.2011.85; MARCHESSAULT RH, 1959, NATURE, V184, P632, DOI 10.1038/184632a0; Inoue H, 2001, BIOSCI BIOTECH BIOCH, V65, P1840, DOI 10.1271/bbb.65.1840; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Kuse Y, 2009, BIOMACROMOLECULES, V10, P166, DOI 10.1021/bm801073e; Grunenfelder LK, 2014, SMALL, V10, P3207, DOI 10.1002/smll.201400559; REVOL JF, 1992, INT J BIOL MACROMOL, V14, P170, DOI 10.1016/S0141-8130(05)80008-X; Matsuura K, 2013, POLYM J, V45, P529, DOI 10.1038/pj.2012.235; Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; Aizenberg J, 2004, P NATL ACAD SCI USA, V101, P3358, DOI 10.1073/pnas.0307843101; Yamamoto Y, 2010, POLYM J, V42, P583, DOI 10.1038/pj.2010.32; Nishimura T, 2008, ANGEW CHEM INT EDIT, V47, P2800, DOI 10.1002/anie.200705062; Addadi L, 1997, NATURE, V389, P912, DOI 10.1038/40010; Hosoda N, 2001, CHEM MATER, V13, P688, DOI 10.1021/cm000817r; Kato T, 2000, ADV MATER, V12, P1543, DOI 10.1002/1521-4095(200010)12:20<1543::AID-ADMA1543>3.0.CO;2-P; Sommerdijk NAJM, 2008, CHEM REV, V108, P4499, DOI 10.1021/cr078259o; HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311; ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; Miyashita T, 2000, MAR BIOTECHNOL, V2, P409; Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434; Okumura K, 2001, EUR PHYS J E, V4, P121, DOI 10.1007/s101890170150; Kato T, 1998, SUPRAMOL SCI, V5, P411, DOI 10.1016/S0968-5677(98)00041-8; Yamamoto C, 2003, J CHROMATOGR A, V1021, P83, DOI 10.1016/j.chroma.2003.09.017; HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0; Kumagai H, 2012, FARADAY DISCUSS, V159, P483, DOI 10.1039/c2fd20057k; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; CALVERT P, 1988, J MATER SCI, V23, P3801, DOI 10.1007/BF01106796; Mann K, 2000, EUR J BIOCHEM, V267, P5257, DOI 10.1046/j.1432-1327.2000.01602.x; Sofos M, 2009, NAT MATER, V8, P68, DOI [10.1038/nmat2336, 10.1038/NMAT2336]; Sakamoto T, 2011, ANGEW CHEM INT EDIT, V50, P5856, DOI 10.1002/anie.201008191; Meyers MA, 2013, SCIENCE, V339, P773, DOI 10.1126/science.1220854; Tomono H, 2013, J PHYS CHEM B, V117, P14849, DOI 10.1021/jp407721x; Aizenberg J, 2002, J AM CHEM SOC, V124, P32, DOI 10.1021/ja016990l; Kato T, 2010, MRS BULL, V35, P127, DOI 10.1557/mrs2010.632; Sakamoto T, 2009, CRYST GROWTH DES, V9, P622, DOI 10.1021/cg8009628; Bauerlein E., 2007, HDB BIOMINERALIZATIO; Bauerlein E., 2000, BIOMINERALIZATION; Goodby J. W., 2014, HDB LIQUID CRYSTALS; Kato T, 2002, ADV MATER, V14, P869, DOI 10.1002/1521-4095(20020618)14:12<869::AID-ADMA869>3.0.CO;2-E; Kato T, 2000, CHEM LETT, P186; Kono M, 2000, BIOCHEM BIOPH RES CO, V269, P213, DOI 10.1006/bbrc.2000.2274; Kumar S, 2010, CRYSTENGCOMM, V12, P2021, DOI 10.1039/b923049a; Lee K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1720; Lippmann F., 1973, SEDIMENTARY CARBONAT; Mann S., 2001, BIOMINERALIZATION PR; Nishimura T, 2011, CHEM LETT, V40, P458, DOI 10.1246/cl.2011.458; Ooya T, 2002, INT J PHARM, V242, P47, DOI 10.1016/S0378-5173(02)00139-4; Saito T, 2014, MATER HORIZONS, V1, P321, DOI 10.1039/c3mh00134b; Sakamoto T, 2009, POLYM J, V41, P522, DOI 10.1295/polymj.PJ2009024; Sugawara-Narutaki A, 2013, POLYM J, V45, P269, DOI 10.1038/pj.2012.171; TRAVIS DF, 1963, ANN NY ACAD SCI, V109, P177, DOI 10.1111/j.1749-6632.1963.tb13467.x	89	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	MAR	2015	47	3					235	243		10.1038/pj.2014.107		9	Polymer Science	Polymer Science	CD1BH	WOS:000350808200002		
J	Sakai, T; Horinaka, J; Takigawa, T				Sakai, Takashi; Horinaka, Jun-ichi; Takigawa, Toshikazu			A new method to estimate the sol-gel transition entropy in physically gelling systems	POLYMER JOURNAL			English	Article							POLYMER GELS	A Clapeyron-type equation is presented to estimate the transition entropy for the sol-gel transition of physical gels, based on simple thermodynamics for the gels under load. The transition entropy and the transition enthalpy were estimated for kappa-carrageenan/water and gellan/water systems using this Clapeyron-type equation. For the carrageen systems, the transition entropy per unit gel volume (Delta S-V) remained constant, regardless of the polymer concentration and the species and concentration of the added salts. A similar behavior was also observed for the gellan systems. These results suggest that the structure of the crosslink domains of the gels is almost identical, regardless of the polymer concentration and the species and concentration of the added salts, if the comparison was made with a fixed polysaccharide. The values of Delta S-V obtained in this study were higher than those obtained using calorimetry as reported in the literature; however, the difference was not large.	[Sakai, Takashi; Horinaka, Jun-ichi; Takigawa, Toshikazu] Kyoto Univ, Dept Chem Mat, Kyoto 6158510, Japan	Takigawa, T (reprint author), Kyoto Univ, Dept Chem Mat, Nishikyo Ku, Kyoto 6158510, Japan.	takigawa@rheogate.polym.kyoto-u.ac.jp					Miyoshi E, 1999, PROG COLL POL SCI S, V114, P68, DOI 10.1007/3-540-48349-7_11; Takigawa T, 2000, J CHEM PHYS, V113, P7640, DOI 10.1063/1.1312273; CLARK AH, 1987, ADV POLYM SCI, V83, P57; STAUFFER D, 1982, ADV POLYM SCI, V44, P103; GUNNING AP, 1990, INT J BIOL MACROMOL, V12, P338, DOI 10.1016/0141-8130(90)90039-D; Nunez-Santiago MD, 2007, CARBOHYD POLYM, V69, P763, DOI 10.1016/j.carbpol.2007.02.017; REES DA, 1981, PURE APPL CHEM, V53, P1, DOI 10.1351/pac198153010001; Gennes de, 1979, SCALING CONCEPTS POL, P222; Oakenfull D., 2000, HYDROCOLLOIDS 2, P153; ROSSMURPHY SB, 1991, POLYMER GELS, P21; Smidsrod O., 1982, CARBOHYD POLYM, V2, P270, DOI 10.1016/0144-8617(82)90029-7; Takigawa T, 2001, POLYM J, V33, P297, DOI 10.1295/polymj.33.297; Tanaka F., 2011, POLYM PHYS, P129; Te Nijenhuis K, 1997, ADV POLYM SCI, V130, P1	14	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	MAR	2015	47	3					244	248		10.1038/pj.2014.98		5	Polymer Science	Polymer Science	CD1BH	WOS:000350808200003		
J	Takahashi, Y; Tomoda, N; Furukawa, T				Takahashi, Yoshiyuki; Tomoda, Naoko; Furukawa, Takeo			Quantitative analysis of the nucleation and growth of ferroelectric domains during the polarization reversal in thin films of vinylidene fluoride and trifluoroethylene copolymer	POLYMER JOURNAL			English	Article							ATOMIC-FORCE MICROSCOPY; SWITCHING CHARACTERISTICS; CAPACITORS; BEHAVIOR	To study microscopically the kinetics of polarization reversal in vinylidene fluoride and trifluoroethylene copolymers, the piezoresponse force microscope was modified to apply voltage pulses for the purpose of time- slicing and to obtain time-resolved measurements. Reversed domains were clearly distinguished and found to change with pulse duration. It was discovered that there were predetermined nucleation sites, each with respective nucleation times. This situation allowed for the determination of the nucleation rate and growth speed separately. Thus, for the first time, the microscopic model for the kinetics of polarization reversal was established from an experimental basis. The dependence of the nucleation rate and the growth speed on the electric field strength were also investigated, and both nucleation and growth processes were shown to have almost the same activation field strengths as the switching time. This phenomenon explains the time-field equivalence in the switching characteristics holding for a wide range of electric fields.	[Takahashi, Yoshiyuki; Tomoda, Naoko; Furukawa, Takeo] Tokyo Univ Sci, Fac Sci, Dept Chem, Tokyo 1628601, Japan; [Furukawa, Takeo] Kobayasi Inst Phys Res, Tokyo, Japan	Takahashi, Y (reprint author), Tokyo Univ Sci, Fac Sci, Dept Chem, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	ytakahas@rs.tus.ac.jp			Japan Society for the Promotion of Science	We are grateful to Mr N. Moriyama of Kureha Corporation for providing us with copolymer samples. This work is partly supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Gysel R, 2008, J APPL PHYS, V103, DOI 10.1063/1.2907990; Noda K, 2001, JPN J APPL PHYS 1, V40, P4361, DOI 10.1143/JJAP.40.4361; Furukawa T, 2006, IEEE T DIELECT EL IN, V13, P1120, DOI 10.1109/TDEI.2006.1714938; FURUKAWA T, 1984, J APPL PHYS, V56, P1481, DOI 10.1063/1.334102; Gruverman A, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2010605; Ishii H, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.031501; Setter N, 2006, J APPL PHYS, V100, DOI 10.1063/1.2336999; Rodriguez BJ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2942390; Nakajima T, 2005, JPN J APPL PHYS 2, V44, pL1385, DOI 10.1143/JJAP.44.L1385; Wu YJ, 2014, POLYMER, V55, P970, DOI 10.1016/j.polymer.2014.01.004; Dehoff C, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1850652; DVEYAHARON H, 1980, PHYS REV B, V21, P3700, DOI 10.1103/PhysRevB.21.3700; FURUKAWA T, 1989, PHASE TRANSIT, V18, P143, DOI 10.1080/01411598908206863; Gruverman A, 2003, APPL PHYS LETT, V82, P3071, DOI 10.1063/1.1570942; ISHIBASH.Y, 1971, J PHYS SOC JPN, V31, P506; Ishii H, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.041603; Kalinin SV, 2006, NANOTECHNOLOGY, V17, P3400, DOI 10.1088/0957-4484/17/14/010; Kano K., 1999, MATER RES SOC S P, V600, P89; Keller A., 1984, POLYM LIQUID CRYSTAL; Kholkin A. L., 2007, SCANNING PROBE MICRO, VI; Lines M. E., 1977, PRINCIPLES APPL FERR; Morozovska AN, 2007, J APPL PHYS, V102, DOI 10.1063/1.2785824; Strukov B. A., 1998, FERROELECTRIC PHENOM	23	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	MAR	2015	47	3					249	254		10.1038/pj.2014.109		6	Polymer Science	Polymer Science	CD1BH	WOS:000350808200004		
J	Yamashita, N; Okubo, M				Yamashita, Nobuko; Okubo, Masayoshi			Preparation of hemispherical particles by cleavage of micrometer-sized, spherical polystyrene/poly(methyl methacrylate) composite particles with Janus structures: effect of polystyrene-b-poly(methyl methacrylate)	POLYMER JOURNAL			English	Article							SOLVENT EVAPORATION METHOD; BLOCK-COPOLYMERS; MOLECULAR-WEIGHT; MORPHOLOGY; MECHANISMS	We recently reported that two micrometer- sized, hemispherical polymer particles were prepared as a result of the cleavage of spherical Janus polystyrene (PS)/ poly(methyl methacrylate) (PMMA) composite particles after treatment with acetone. The original composite particles were prepared by slow evaporation of toluene from homogeneous PS/ PMMA/ toluene droplets dispersed in an aqueous solution of sodium dodecyl sulfate. This article aims to validate a proposed cleavage mechanism which is based on the induction of internal stress at the interface because of a great difference in the swelling ratio between the PS and PMMA phases. The effect of PS- b- PMMA, which should exist at the interface between both phases and decrease the internal stress, on the cleavage phenomenon was examined. PS/ PS- b- PMMA/ PMMA composite particles were prepared in the same way as the previous study. At 0.31 wt% or greater of PS- b- PMMA (number- average molecular weight: 10.6 x 104- b9.9 x 104), the composite particles did not have a Janus structure but an ex- centered core- shell structure, resulting in no cleavage. At 0.18 wt% or less, they had a Janus structure, and the cleavage phenomenon was observed. The required time to cleave increased with increasing PS- b- PMMA content to below 0.18 wt%. Specifically, the existence of PS- b- PMMA delayed the cleavage of the composite particles into PS and PMMA hemispherical particles. This result supports the proposed cleavage mechanism and provides a tool to easily address the cleavage process for the production of hemispherical particles.	[Yamashita, Nobuko; Okubo, Masayoshi] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo 6578501, Japan; [Okubo, Masayoshi] Rajamangala Univ Technol, Fac Sci & Technol, Dept Chem, Thanyaburi, Thailand; [Okubo, Masayoshi] Smart Spheres Workshop Co Ltd, Kobe, Hyogo, Japan	Okubo, M (reprint author), Kobe Univ, Grad Sch Engn, Kobe, Hyogo 6578501, Japan.	okubo@kobe-u.ac.jp					Okubo M, 2005, POLYMER, V46, P1151, DOI 10.1016/j.polymer.2004.11.057; Sundberg DC, 2003, POLYM REACT ENG, V11, P379, DOI 10.1081/PRE-120024420; Yamashita N, 2012, LANGMUIR, V28, P12886, DOI 10.1021/la302442t; Saito N, 2006, LANGMUIR, V22, P9397, DOI 10.1021/la061298v; CRETON C, 1992, MACROMOLECULES, V25, P3075, DOI 10.1021/ma00038a010; OKUBO M, 1990, MAKROMOL CHEM-M SYMP, V35-6, P307, DOI 10.1002/masy.19900350119; Okubo M, 2005, COLLOID POLYM SCI, V283, P691, DOI 10.1007/s00396-004-1209-x; Tanaka T, 2008, LANGMUIR, V24, P12267, DOI 10.1021/la802287s; WASHIYAMA J, 1993, MACROMOLECULES, V26, P2928, DOI 10.1021/ma00063a043; Yamashita N, 2014, COLLOID POLYM SCI, V292, P733, DOI 10.1007/s00396-013-3120-9	10	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	MAR	2015	47	3					255	258		10.1038/pj.2014.95		4	Polymer Science	Polymer Science	CD1BH	WOS:000350808200005		
J	Ogi, K; Miyauchi, S; Naka, K				Ogi, Koichi; Miyauchi, Sakina; Naka, Kensuke			Amphiphilic POSS-core dendrons for optically transparent thermoplastic films with tunable wettability	POLYMER JOURNAL			English	Article							POLYHEDRAL OLIGOMERIC SILSESQUIOXANE; GOLD NANOPARTICLES; HYBRID POLYMERS; POLYMERIZATION; WATER; NANOCOMPOSITES; COPOLYMERS; MONOMERS; BLOCKS		[Ogi, Koichi; Miyauchi, Sakina; Naka, Kensuke] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Chem & Mat Technol, Kyoto 6068585, Japan	Naka, K (reprint author), Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Chem & Mat Technol, Sakyo Ku, Goshokaido Cho, Kyoto 6068585, Japan.	kenaka@kit.ac.jp					Rosen BM, 2009, CHEM REV, V109, P6275, DOI 10.1021/cr900157q; Mitsuishi M, 2008, CHEM MATER, V20, P4310, DOI 10.1021/cm800067j; Zheng L, 2004, MACROMOLECULES, V37, P8606, DOI 10.1021/ma048557c; Ahn B, 2010, MACROMOLECULES, V43, P10568, DOI 10.1021/ma101276d; Escude NC, 2009, CHEM MATER, V21, P5743, DOI 10.1021/cm902599w; Zhang WA, 2011, MACROMOLECULES, V44, P6891, DOI 10.1021/ma201152t; Waddon AJ, 2003, CHEM MATER, V15, P4555, DOI 10.1021/cm034308b; Zhang WA, 2009, MACROMOLECULES, V42, P2563, DOI 10.1021/ma802803d; Naka K, 2007, LANGMUIR, V23, P9057, DOI 10.1021/la7013286; Tanaka K, 2012, J MATER CHEM, V22, P1733, DOI 10.1039/c1jm14231c; Jiang BB, 2012, MACROMOL RAPID COMM, V33, P767, DOI 10.1002/marc.201100877; Kim KM, 2003, MACROMOLECULES, V36, P867, DOI 10.1021/ma.021303b; Lin H, 2013, CHEM COMMUN, V49, P231, DOI 10.1039/c2cc36881a; Wahab MA, 2008, J POLYM SCI POL CHEM, V46, P5887, DOI 10.1002/pola.22906; Lee J, 2004, MACROMOLECULES, V37, P8523, DOI 10.1021/ma0497759; Wu JA, 2010, MACROMOLECULES, V43, P7637, DOI 10.1021/ma101336c; Cordes DB, 2010, CHEM REV, V110, P2081, DOI 10.1021/cr900201r; Hussain H, 2010, LANGMUIR, V26, P11763, DOI 10.1021/la101686q; Tanaka K, 2009, J POLYM SCI POL CHEM, V47, P5690, DOI 10.1002/pola.23612; Zhang CX, 1998, J AM CHEM SOC, V120, P8380, DOI 10.1021/ja9808853; Choi J, 2004, MACROMOLECULES, V37, P3267, DOI 10.1021/ma0303723; Laine RM, 2005, J MATER CHEM, V15, P3725, DOI 10.1039/b506815k; Pyun J, 2000, MACROMOLECULES, V33, P217, DOI 10.1021/ma9910787; LICHTENHAN JD, 1995, MACROMOLECULES, V28, P8435, DOI 10.1021/ma00128a067; Chang GP, 2009, J NANOSCI NANOTECHNO, V9, P4623, DOI 10.1166/jnn.2009.1280; Kim KM, 2001, J POLYM SCI POL CHEM, V39, P4035, DOI 10.1002/pola.10048; Kim MK, 2001, CHEM COMMUN, P667, DOI 10.1039/b100575h; Park C, 2011, CHEM COMMUN, V47, P12042, DOI 10.1039/c1cc11531f; Tan BH, 2011, MACROMOLECULES, V44, P622, DOI 10.1021/ma102510u; Wang RY, 2001, ANGEW CHEM INT EDIT, V40, P549; Yu X., 2010, J AM CHEM SOC, V132, P1674; Zheng L, 2002, MACROMOLECULES, V35, P2375, DOI 10.1021/ma011855e	32	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	MAR	2015	47	3					259	266				8	Polymer Science	Polymer Science	CD1BH	WOS:000350808200006		
J	Aoki, H; Miyoshi, H; Yamagata, Y				Aoki, Hiroyoshi; Miyoshi, Hiromi; Yamagata, Yutaka			Electrospinning of gelatin nanofiber scaffolds with mild neutral cosolvents for use in tissue engineering	POLYMER JOURNAL			English	Article							FIBROBLAST GROWTH-FACTOR; STEM-CELLS; REGENERATIVE MEDICINE; POLY(ETHYLENE OXIDE); DRUG-DELIVERY; DEPOSITION; SOLVENT; CANCER; N-METHYL-2-PYRROLIDONE; MORPHOLOGY		[Aoki, Hiroyoshi; Miyoshi, Hiromi; Yamagata, Yutaka] RIKEN, Ctr Adv Photon, Wako, Saitama 3510198, Japan	Aoki, H (reprint author), RIKEN, Ctr Adv Photon, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	haoki@riken.jp					Ju J, 2009, ADV MATER, V21, P4343, DOI 10.1002/adma.200900444; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Sanghvi R, 2008, AAPS PHARMSCITECH, V9, P366, DOI 10.1208/s12249-008-9050-z; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Miyawaki O, 2003, BIOPOLYMERS, V70, P482, DOI 10.1002/bip.10473; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Jouyban A, 2010, J PHARM PHARM SCI, V13, P524; Song JH, 2008, J MATER SCI-MATER M, V19, P95, DOI 10.1007/s10856-007-3169-4; Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009; Sanwlani S, 2011, J PHYS CHEM B, V115, P7332, DOI 10.1021/jp201877d; Williams DL, 2009, PROPELL EXPLOS PYROT, V34, P452, DOI 10.1002/prep.200800045; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Choktaweesap N, 2007, POLYM J, V39, P622, DOI 10.1295/polymj.PJ2006190; Chen HC, 2009, POLYM ADVAN TECHNOL, V20, P98, DOI 10.1002/pat.1244; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Zhang S, 2009, J BIOMED MATER RES A, V90A, P671, DOI 10.1002/jbm.a.32136; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Bukoreshtliev NV, 2013, CELL TISSUE RES, V352, P77, DOI 10.1007/s00441-012-1531-4; Schwartz MA, 2013, SCIENCE, V339, P402, DOI 10.1126/science.1233814; Choi EY, 2010, J MATER CHEM, V20, P1907, DOI 10.1039/b919074k; Kai D, 2013, BIOTECHNOL J, V8, P59, DOI 10.1002/biot.201200249; [Anonymous], 2014, CHEMIDPLUS ADV; Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013; Wu J, 2001, J POLYM SCI POL CHEM, V39, P224, DOI 10.1002/1099-0518(20010101)39:1<224::AID-POLA250>3.0.CO;2-X; Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9; Angarano M, 2013, ADV FUNCT MATER, V23, P3277, DOI 10.1002/adfm.201202816; Ji W, 2011, PHARM RES-DORDR, V28, P1259, DOI 10.1007/s11095-010-0320-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011; Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004; Franchi M, 2007, THESCIENTIFICWORLDJO, V7, P404, DOI 10.1100/TSW.2007.92; WESTALL FC, 1983, LIFE SCI, V33, P2425, DOI 10.1016/0024-3205(83)90636-7; Aoki H, 2012, J CHEM ENG JPN, V45, P528; Barton A. F. M., 1991, HDB SOLUBILITY PARAM; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Doughty MJ, 2012, MICROSC RES TECHNIQ, V75, P474, DOI 10.1002/jemt.21080; EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L; Ewell RH, 1944, IND ENG CHEM, V36, P871, DOI 10.1021/ie50418a002; Fernley H. N., 1971, ENZYMES, VIV, P417; LURIA EA, 1987, CELL TISSUE RES, V248, P449; Gkioni K, 2010, TISSUE ENG PART B-RE, V16, P577, DOI 10.1089/ten.TEB.2010.0462; Hansen C. M, 1999, HANSEN SOLUBILITY PA; Hayakawa T, 2010, J HARD TISSUE BIOL, V19, P5; Kim J. W., 2009, J MICROMECH MICROENG, V19; Lide D. R., 1996, PROPERTIES ORGANIC S; Ligocka D, 2003, ARCH TOXICOL, V77, P261, DOI 10.1007/s00204-003-0440-4; LO CC, 1990, J CHEM ECOL, V16, P3245, DOI 10.1007/BF00982095; Marcus Y., 1998, PROPERTIES SOLVENTS; Miller RG, 1998, J BIOMED MATER RES, V41, P237, DOI 10.1002/(SICI)1097-4636(199808)41:2<237::AID-JBM8>3.0.CO;2-J; Morota K, 2004, J COLLOID INTERF SCI, V279, P484, DOI 10.1016/j.jcis.2004.06.075; PARKER AJ, 1962, Q REV CHEM SOC, V16, P163, DOI 10.1039/qr9621600163; Passey S., 2007, CURR PROTOC CELL BIO; Santana H, 2013, INT J PHARMACEUT, V452, P52, DOI 10.1016/j.ijpharm.2013.04.054; Seo H, 2005, POLYM J, V37, P391, DOI 10.1295/polymj.37.391; Tsai SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031200; UMBERGER JQ, 1967, PHOTOGR SCI ENG, V11, P385; Zhuravlev VI, 2008, RUSS J GEN CHEM+, V78, P1189, DOI 10.1134/S1070363208060157	60	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	MAR	2015	47	3					267	277				11	Polymer Science	Polymer Science	CD1BH	WOS:000350808200007		
J	Morisaki, Y; Inoshita, K; Shibata, S; Chujo, Y				Morisaki, Yasuhiro; Inoshita, Kenichi; Shibata, Shotaro; Chujo, Yoshiki			Synthesis of optically active through-space conjugated polymers consisting of planar chiral [2.2] paracyclophane and quaterthiophene	POLYMER JOURNAL			English	Article							ELECTROCHEMICAL POLYMERIZATION; CIRCULAR-DICHROISM; RESOLUTION; CONFIGURATION; OLIGOMERS		[Morisaki, Yasuhiro; Inoshita, Kenichi; Shibata, Shotaro; Chujo, Yoshiki] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Kyoto 6158510, Japan	Morisaki, Y (reprint author), Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Katsura Campus, Kyoto 6158510, Japan.	ymo@chujo.synchem.kyoto-u.ac.jp; chujo@chujo.synchem.kyoto-u.ac.jp					Rowlands GJ, 2008, ORG BIOMOL CHEM, V6, P1527, DOI 10.1039/b800698a; Pye PJ, 1997, J AM CHEM SOC, V119, P6207, DOI 10.1021/ja970654g; Morisaki Y, 2012, CHEM LETT, V41, P990, DOI 10.1246/cl.2012.990; Meyer-Eppler G, 2013, EUR J ORG CHEM, V2013, P4523, DOI 10.1002/ejoc.201300412; Morisaki Y, 2014, CHEM-EUR J, V20, P8386, DOI 10.1002/chem.201402930; Watanabe K, 2011, CHEM COMMUN, V47, P10996, DOI 10.1039/c1cc13711e; Morisaki Y, 2012, POLYM CHEM-UK, V3, P2727, DOI 10.1039/c2py20530k; CRAM DJ, 1955, J AM CHEM SOC, V77, P6289, DOI 10.1021/ja01628a067; Morisaki Y, 2014, J AM CHEM SOC, V136, P3350, DOI 10.1021/ja412197j; Bazan GC, 2007, J ORG CHEM, V72, P8615, DOI 10.1021/jo071176n; Nakano Y, 2010, POLYM CHEM-UK, V1, P460, DOI 10.1039/b9py00288j; MIYAURA N, 1979, TETRAHEDRON LETT, V20, P3437, DOI 10.1016/S0040-4039(01)95429-2; Berova N., 2000, CIRCULAR DICHROISM P; Chakraborty D, 2001, J CHEM PHYS, V115, P184, DOI 10.1063/1.1377876; Gleiter R., 2004, MODERN CYCLOPHANE CH; Guyard L, 2001, ADV MATER, V13, P133, DOI 10.1002/1521-4095(200101)13:2<133::AID-ADMA133>3.0.CO;2-9; Guyard L, 2001, ELECTROCHEM COMMUN, V3, P164, DOI 10.1016/S1388-2481(01)00124-2; LangeveldVoss BMW, 1996, J AM CHEM SOC, V118, P4908, DOI 10.1021/ja9600643; Salhi F, 2002, ORG LETT, V4, P3195, DOI 10.1021/ol026211; Vogtle F., 1993, CYCLOPHANE CHEM SYNT	20	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	MAR	2015	47	3					278	281				4	Polymer Science	Polymer Science	CD1BH	WOS:000350808200008		
J	Matsuda, Y; Sugiura, F; Mays, JW; Tasaka, S				Matsuda, Yasuhiro; Sugiura, Fumitada; Mays, Jimmy Wayne; Tasaka, Shigeru			Atomic force microscopy of thermally renatured xanthan with low molar mass	POLYMER JOURNAL			English	Article							AQUEOUS SODIUM-CHLORIDE; DOUBLE-STRANDED HELIX; CONFORMATION CHANGE; DILUTE-SOLUTION; BEHAVIOR; GUM		[Matsuda, Yasuhiro; Sugiura, Fumitada; Tasaka, Shigeru] Shizuoka Univ, Dept Appl Chem & Biochem Engn, Hamamatsu, Shizuoka 4328561, Japan; [Mays, Jimmy Wayne] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA	Matsuda, Y (reprint author), Shizuoka Univ, Dept Appl Chem & Biochem Engn, Naka Ku, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328561, Japan.	matsuda.yasuhiro@shizuoka.ac.jp					STOKKE BT, 1987, CARBOHYD RES, V160, P13, DOI 10.1016/0008-6215(87)80300-2; Matsuda Y, 2009, POLYM J, V41, P526, DOI 10.1295/polymj.PJ2008300; Matsuda Y, 2014, POLYMER, V55, P4369, DOI 10.1016/j.polymer.2014.06.086; SATO T, 1984, MACROMOLECULES, V17, P2696, DOI 10.1021/ma00142a043; SATO T, 1984, POLYM J, V16, P423, DOI 10.1295/polymj.16.423; Ikeda S, 2012, FOOD SCI TECHNOL RES, V18, P741; Camesano TA, 2001, BIOMACROMOLECULES, V2, P1184, DOI 10.1021/bm015555g; KIRBY AR, 1995, CARBOHYD RES, V267, P161, DOI 10.1016/0008-6215(94)00294-P; Capron G., 1997, POLYMER, V38, P5289; Capron I, 1998, POLYMER, V39, P5725, DOI 10.1016/S0032-3861(97)10344-5; Gunning AP, 1996, ULTRAMICROSCOPY, V63, P1; KAWAKAMI K, 1991, Carbohydrate Polymers, V14, P189; LIU W, 1988, BIOPOLYMERS, V27, P1641, DOI 10.1002/bip.360271009; LIU W, 1988, INT J BIOL MACROMOL, V10, P44, DOI 10.1016/0141-8130(88)90066-9; LIU W, 1987, CARBOHYD RES, V160, P267, DOI 10.1016/0008-6215(87)80317-8; Norisuye T., 1996, POLYM MAT ENCY, P8801; OVIATT HW, 1994, MACROMOLECULES, V27, P2402, DOI 10.1021/ma00087a007; SATO T, 1984, POLYM J, V16, P341, DOI 10.1295/polymj.16.341	18	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	MAR	2015	47	3					282	285				4	Polymer Science	Polymer Science	CD1BH	WOS:000350808200009		
J	Tokudome, S; Kuriki, K; Yokoyama, Y; Sasaki, M; Joh, T; Kamiya, T; Cheng, JL; Ogawa, K; Shirai, T; Imaeda, N; Goto, C; Tokudome, Y; Ichikawa, H; Okuyama, H				Tokudome, Shinkan; Kuriki, Kiyonori; Yokoyama, Yoshifumi; Sasaki, Makoto; Joh, Takashi; Kamiya, Takeshi; Cheng, Jinglei; Ogawa, Kumiko; Shirai, Tomoyuki; Imaeda, Nahomi; Goto, Chiho; Tokudome, Yuko; Ichikawa, Hiromitsu; Okuyama, Harumi			Dietary n-3/long-chain n-3 polyunsaturated fatty acids for prevention of sporadic colorectal tumors: A randomized controlled trial in polypectomized participants	PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS			English	Article						Colorectal tumors; Dietary intervention; n-3 polyunsaturated fatty acids; Polypectomized participants; Randomized controlled trial	CANCER-RISK; FISH CONSUMPTION; COLON-CANCER; CARDIOVASCULAR-DISEASE; METAANALYSIS; ASPIRIN; OMEGA-3-FATTY-ACIDS; CHEMOPREVENTION; POLYMORPHISMS; APOPTOSIS	To address preventive effects of n-3 PUFAs/LC n-3 PUFAs on CRTs, a randomized controlled trial was conducted. One-hundred four experimental group participants were advised to increase intake of n-3 PUFAs, including fish/shell fish, fish oil supplements and perilla oils, and to decrease consumption of n-6 PUFAs and fats/oils as a whole for 24 months. One-hundred one control group participants were only cautioned to reduce consumption of fats/oils as a whole. Random allocation was satisfactorily attained, and participants sufficiently complied with our regimen. Intakes, plasma concentrations, and compositions of the RBC and sigmoid colon membranes of n-3 PUFAs, LC n-3 PUFAs, EPA and DHA increased, and the ratios of n-6 PUFAs/n-3 PUFAs and AA/LC n-3 PUFAs decreased without any adverse response. Twenty-four months after the intervention, the multivariate-adjusted hazard ratio (95% confidence intervals) was estimated to be 0.805 (0.536-1.209) with a signal towards the reduced CRT incidence. (C) 2014 Elsevier Ltd. All rights reserved.	[Tokudome, Shinkan; Kuriki, Kiyonori; Cheng, Jinglei; Imaeda, Nahomi; Goto, Chiho; Tokudome, Yuko; Ichikawa, Hiromitsu] Nagoya City Univ, Grad Sch Med Sci, Dept Publ Hlth, Mizuho Ku, Nagoya, Aichi, Japan; [Tokudome, Shinkan] Natl Inst Hlth & Nutr, Shinjuku Ku, Tokyo 1628636, Japan; [Tokudome, Shinkan] Social Welf Inst Seizanri Kai, Biwajima Care Ctr, Nishi Ku, Nagoya, Aichi, Japan; [Kuriki, Kiyonori] Univ Shizuoka, Dept Nutr & Hlth Sci, Suruga Ku, Shizuoka 4228526, Japan; [Yokoyama, Yoshifumi; Sasaki, Makoto; Joh, Takashi; Kamiya, Takeshi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Mizuho Ku, Nagoya, Aichi, Japan; [Yokoyama, Yoshifumi] Nagoya Med Assoc Hlth Care Ctr, Higashi Ku, Nagoya, Aichi, Japan; [Sasaki, Makoto] Aichi Med Univ, Dept Gastroenterol, Nagakute, Aichi 48011, Japan; [Ogawa, Kumiko; Shirai, Tomoyuki] Nagoya City Univ, Grad Sch Med Sci, Dept Expt Pathol & Tumor Biol, Mizuho Ku, Nagoya, Aichi, Japan; [Ogawa, Kumiko] Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, Tokyo, Japan; [Shirai, Tomoyuki] Nagoya City Rehabil Ctr, Mizuho Ku, Nagoya, Aichi, Japan; [Imaeda, Nahomi] Nagoya Womens Univ, Dept Food Sci & Nutr, Mizuho Ku, Nagoya, Aichi, Japan; [Goto, Chiho] Nagoya Bunri Univ, Dept Hlth & Nutr, Inazawa, Japan; [Tokudome, Yuko] Nagoya Univ Arts & Sci, Sch Nutr Sci, Nisshin, Japan; [Okuyama, Harumi] Kinjo Gakuin Univ, Inst Consumer Sci & Human Life, Moriyama Ku, Nagoya, Aichi, Japan	Tokudome, S (reprint author), Natl Inst Hlth & Nutr, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628636, Japan.	tokudome2013@gmail.com			Ministry of Education, Culture, Sports, Science and Technology, Japan [08457137]; Ministry of Health, Labour and Welfare, Japan; Health, Labour and Welfare, Japan; T. Nanba Memorial Health Care Foundation; Aichi Cancer Research Foundation; Sagawa Foundation for Promotion of Cancer Research; Mitsubishi Foundation	This study was partly supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (08457137 [during 1996-1998]) and for Cancer Research from the Ministry of Health, Labour and Welfare, Japan (9-4 [during 1997-000]) and by Grants from T. Nanba Memorial Health Care Foundation, Aichi Cancer Research Foundation, the Sagawa Foundation for Promotion of Cancer Research, and the Mitsubishi Foundation.	Alpha-Tocopherol T, 1994, NEW ENGL J MED, V330, P1029; Geelen A, 2007, AM J EPIDEMIOL, V166, P1116, DOI 10.1093/aje/kwm197; Chan AT, 2012, CANCER PREV RES, V5, P164, DOI 10.1158/1940-6207.CAPR-11-0391; Glaser C, 2010, METABOLISM, V59, P993, DOI 10.1016/j.metabol.2009.10.022; Sala-Vila A, 2011, CRIT REV FOOD SCI, V51, P855, DOI 10.1080/10408398.2010.483527; Ishikawa H, 2014, GUT, V63, P1755, DOI 10.1136/gutjnl-2013-305827; Moyer VA, 2014, ANN INTERN MED, V160, P558, DOI 10.7326/M14-0198; Pot GK, 2009, AM J CLIN NUTR, V90, P354, DOI 10.3945/ajcn.2009.27630; Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Kearney KE, 2009, INT J CANCER, V125, P249, DOI 10.1002/ijc.24356; Srivastava S, 2001, CLIN CANCER RES, V7, P1118; Nkondjock A, 2003, CANCER DETECT PREV, V27, P55, DOI 10.1016/S0361-090X(02)00179-4; MacLean CH, 2006, JAMA-J AM MED ASSOC, V295, P403, DOI 10.1001/jama.295.4.403; Tiemersma EW, 2002, CANCER CAUSE CONTROL, V13, P383, DOI 10.1023/A:1015236701054; Bartsch H, 1999, CARCINOGENESIS, V20, P2209, DOI 10.1093/carcin/20.12.2209; Thun MJ, 2002, J NATL CANCER I, V94, P252; Touvier M, 2011, CANCER EPIDEM BIOMAR, V20, P1003, DOI 10.1158/1055-9965.EPI-10-1141; Chen ZY, 2000, PROSTAG LEUKOTR ESS, V63, P301, DOI 10.1054/plef.2000.0218; Wu SJ, 2012, AM J MED, V125, P551, DOI 10.1016/j.amjmed.2012.01.022; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; Zock PL, 1998, AM J CLIN NUTR, V68, P142; Pauwels EKJ, 2008, DRUG NEWS PERSPECT, V21, P504, DOI 10.1358/dnp.2008.21.9.1290819; Biesalski HK, 2010, NUTRIENTS, V2, P929, DOI 10.3390/nu2090929; MARNETT LJ, 1992, CANCER RES, V52, P5575; Pot GK, 2008, INT J CANCER, V123, P1974, DOI 10.1002/ijc.23729; Potter JD, 1999, J NATL CANCER I, V91, P916, DOI 10.1093/jnci/91.11.916; Rose DP, 1999, PHARMACOL THERAPEUT, V83, P217, DOI 10.1016/S0163-7258(99)00026-1; Okuyama H, 2001, EUR J LIPID SCI TECH, V103, P418, DOI 10.1002/1438-9312(200106)103:6<418::AID-EJLT418>3.0.CO;2-#; Bai YH, 2012, WORLD J GASTROENTERO, V18, P1672, DOI 10.3748/wjg.v18.i14.1672; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Hooper L, 2006, BRIT MED J, V332, P752, DOI 10.1136/bmj.38755.366331.2F; Wong RSY, 2012, NUTR REV, V70, P483, DOI 10.1111/j.1753-4887.2012.00512.x; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Cheng JL, 2003, CANCER LETT, V193, P17, DOI 10.1016/S0304-3835(02)00717-6; Cathcart MC, 2011, CANCER METAST REV, V30, P363, DOI 10.1007/s10555-011-9324-x; Buckholm I.K., 2000, VIRCHOWS ARCH, V436, P224; Caderni G, 1999, CANCER EPIDEM BIOMAR, V8, P219; Calviello G, 2007, CURR MED CHEM, V14, P3059, DOI 10.2174/092986707782793934; Cotton S, 1996, CRIT REV ONCOGENESIS, V7, P293; Das UN, 1999, PROSTAG LEUKOTR ESS, V61, P157, DOI 10.1054/plef.1999.0085; de Deckere EAM, 1999, EUR J CANCER PREV, V8, P213, DOI 10.1097/00008469-199906000-00009; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Gerber M, 2012, BRIT J NUTR, V107, pS228, DOI 10.1017/S0007114512001614; Higurashi T, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-413; Houlston RS, 2001, GASTROENTEROLOGY, V121, P282, DOI 10.1053/gast.2001.26265; Hull Mark A, 2013, Recent Results Cancer Res, V191, P143, DOI 10.1007/978-3-642-30331-9_8; Imaeda N, 1999, J NUTR SCI VITAMINOL, V45, P519; Japanese Society for Cancer of the Colon and Rectum, 1998, GEN RUL CLIN PATH ST; Kimura Y., 2006, JPN J PUBLIC HLTH, V53, P735; Tokudome Y, 1999, J Epidemiol, V9, P78; Krishnan K, 2000, CRIT REV ONCOL HEMAT, V33, P199, DOI 10.1016/S1040-8428(99)00075-X; LANDS WEM, 1995, AM J CLIN NUTR, V61, p721S; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; Ministry of Health Labour and Welfare, 2009, DIET REF INT JAP; Pham NM, 2013, JPN J CLIN ONCOL, V43, P935, DOI 10.1093/jjco/hyt094; Reddy BS, 2004, INT J CANCER, V112, P1, DOI 10.1002/ijc.20320; Roynette CE, 2004, CLIN NUTR, V23, P139, DOI 10.1016/j.clnu.2003.07.005; Takayama T, 2011, CLIN CANCER RES, V17, P3803, DOI 10.1158/1078-0432.CCR-10-2395; Tokudome S, 2000, ASIAN PACIFIC J CANC, V1, P61; Tokudome S, 2002, JPN J CLIN ONCOL, V32, P550, DOI 10.1093/jjco/hyf108; Tokudome S, 2001, EUR J CLIN NUTR, V55, P735, DOI 10.1038/sj.ejcn.1601215; Tokudome S, 1999, EUR J CANCER PREV, V8, P365, DOI 10.1097/00008469-199908000-00049; Wakabayashi K., 2000, ASIAN PAC J CANCER P, V1, P97; World Cancer Research Fund/ American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; ZELEN M, 1979, NEW ENGL J MED, V300, P1242, DOI 10.1056/NEJM197905313002203	66	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0952-3278	1532-2823		PROSTAG LEUKOTR ESS	Prostaglandins Leukot. Essent. Fatty Acids	MAR	2015	94						1	11		10.1016/j.plefa.2014.09.001		11	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	CC7ED	WOS:000350529600001		
J	Otsuka, R; Kato, Y; Imai, T; Ando, F; Shimokata, H				Otsuka, Rei; Kato, Yuki; Imai, Tomoko; Ando, Fujiko; Shimokata, Hiroshi			Secular trend of serum docosahexaenoic acid, eicosapentaenoic acid, and arachidonic acid concentrations among Japanese-A 4-and 13-year descriptive epidemiologic study	PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS			English	Article						Eicosapentaenoic acid; Docosahexaenoic acid; Arachidonic acid; Japanese; Descriptive epidemiologic study	POLYUNSATURATED FATTY-ACIDS; AGE-RELATED-CHANGES; WHOLE-BLOOD; DIETARY-FAT; PLASMA; N-3; MEN; SUPPLEMENTATION; POPULATION; BRAIN	Cross-sectional studies have shown age-related increases in blood docosahexaenoic and eicosapentaenoic acid and decreases in arachidonic acid. We describe serum docosahexaenoic, eicosapentaenoic, and arachidonic acid concentrations over 13 years (1997-2012) across four study waves and serum fatty acid composition over 4 years (2006-2012) between two study waves according to age groups by sex in the same subjects. We included 443 men and 435 women aged 40-79 years at baseline. Serum arachidonic acid concentrations increased in all sex and age groups over 13 years, and eicosapentaenoic or docosahexaenoic acid concentrations increased in males and females who were younger and middle-aged at baseline. Only serum arachidonic acid composition increased over 4 years in men and women who were 40-69 years at baseline, even after adjustment for arachidonic acid intake. These findings suggest a secular increase trend in serum arachidonic acid levels over 13 years among randomly selected community-dwelling middle-aged and elderly Japanese. (C) 2014 Elsevier Ltd. All rights reserved.	[Otsuka, Rei; Kato, Yuki; Imai, Tomoko; Ando, Fujiko; Shimokata, Hiroshi] Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci NILS LSA, Sect Longitudinal Study Aging, Obu, Aichi 4748511, Japan; [Imai, Tomoko] Doshisha Womens Coll Liberal Arts, Fac Human Life & Sci, Kamigyo Ku, Kyoto, Japan; [Ando, Fujiko] Aichi Shukutoku Univ, Fac Hlth & Med Sci, Nagakute, Aichi, Japan; [Shimokata, Hiroshi] Nagoya Univ Art & Sci, Grad Sch Nutr Sci, Nisshin, Aichi, Japan	Otsuka, R (reprint author), Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci NILS LSA, Sect Longitudinal Study Aging, 430 7 Choume,Morioka Cho, Obu, Aichi 4748511, Japan.	otsuka@ncgg.go.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [22790584]; Research Funding for Longevity Sciences from the National Center for Geriatrics and Gerontology, Japan [25-22]	We wish to express our sincere appreciation to study participants and colleagues in the NILS-LSA for completing the survey for this study. This work was supported in part by Grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology (22790584 to R.O.) and Research Funding for Longevity Sciences from the National Center for Geriatrics and Gerontology, Japan (25-22 to R.O.).	Burdge GC, 2003, BRIT J NUTR, V90, P311, DOI 10.1079/BJN2003901; Crowe FL, 2008, BRIT J NUTR, V99, P168, DOI 10.1017/S000711450779387X; MA J, 1995, AM J CLIN NUTR, V62, P564; Vessby B, 2013, BRIT J NUTR, V110, P871, DOI 10.1017/S0007114512005934; Harris WS, 2013, PROSTAG LEUKOTR ESS, V88, P257, DOI 10.1016/j.plefa.2012.12.004; Hong SH, 2013, CLIN INTERV AGING, V8, P585, DOI 10.2147/CIA.S42096; Serhan CN, 1999, ADV EXP MED BIOL, V469, P287; Kotani S, 2006, NEUROSCI RES, V56, P159, DOI 10.1016/j.neures.2006.06.010; Harris WS, 2012, J NUTR, V142, P1297, DOI 10.3945/jn.112.158295; Wijendran V, 2002, PEDIATR RES, V51, P265, DOI 10.1203/00006450-200203000-00002; Ratnayake WMN, 2009, ANN NUTR METAB, V55, P8, DOI 10.1159/000228994; Nielsen MS, 2013, ATHEROSCLEROSIS, V227, P386, DOI 10.1016/j.atherosclerosis.2012.12.035; Youdim KA, 2000, INT J DEV NEUROSCI, V18, P383, DOI 10.1016/S0736-5748(00)00013-7; Rise P, 2007, PROSTAG LEUKOTR ESS, V76, P363, DOI 10.1016/j.plefa.2007.05.003; Harris JI, 2004, PROSTAG LEUKOTR ESS, V71, P263, DOI 10.1016/j.plefa.2004.06.001; Imai T, 2000, J Epidemiol, V10, pS70; Kakutani S, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-241; Katanoda K, 2002, J NUTR SCI VITAMINOL, V48, P423; Kawabata T, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-138; Kawabata T, 2011, PROSTAG LEUKOTR ESS, V84, P131, DOI 10.1016/j.plefa.2011.01.001; Kobayashi M, 2001, EUR J CLIN NUTR, V55, P643, DOI 10.1038/sj.ejcn.1601194; Kuriki K, 2002, EUR J CLIN NUTR, V56, P524, DOI 10.1038/sj.ejcn.1601344; Merino DM, 2011, MOL GENET METAB, V103, P171, DOI 10.1016/j.ymgme.2011.02.012; Ministry of Health Labour and Welfare of Japan, 2012, ANN REP NAT NUTR SUR; Otsuka R, 2013, LIPIDS, V48, P719, DOI 10.1007/s11745-013-3763-9; Rizzo AM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-7; Saga LC, 2012, INT J FOOD SCI NUTR, V63, P790, DOI 10.3109/09637486.2012.681631; Selvin S., 2004, STAT ANAL EPIDEMIOLO; Shimokata H, 2000, J Epidemiol, V10, pS1; Steffen BT, 2012, EUR J CLIN NUTR, V66, P600, DOI 10.1038/ejcn.2011.215; Whelan J, 2008, J NUTR, V138, P2521, DOI 10.3945/jn.108.095943	31	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0952-3278	1532-2823		PROSTAG LEUKOTR ESS	Prostaglandins Leukot. Essent. Fatty Acids	MAR	2015	94						35	42		10.1016/j.plefa.2014.11.002		8	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	CC7ED	WOS:000350529600005		
J	Iida, Y; Doi, T; Tokuda, H; Matsushima-Nishiwaki, R; Tsujimoto, M; Kuroyanagi, G; Yamamoto, N; Enomoto, Y; Tanabe, K; Otsuka, T; Iwama, T; Ogura, S; Kozawa, O; Iida, H				Iida, Yuko; Doi, Tomoaki; Tokuda, Haruhiko; Matsushima-Nishiwaki, Rie; Tsujimoto, Masanori; Kuroyanagi, Gen; Yamamoto, Naohiro; Enomoto, Yukiko; Tanabe, Kumiko; Otsuka, Takanobu; Iwama, Toru; Ogura, Shinji; Kozawa, Osamu; Iida, Hiroki			Rho-kinase regulates human platelet activation induced by thromboxane A(2) independently of p38 MAP kinase	PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS			English	Article						Platelet; Y27632; Fasudil; U46619; p38 MAP kinase; Cofilin	LIM-KINASE; SOLUBLE CD40L; PHOSPHORYLATION; COFILIN; REORGANIZATION; PROTEINS; DYNAMICS; DISEASE; CELLS; RISK	We have previously demonstrated that ristocetin, an activator of GPIb/IX/V, induces the release of soluble CD40 ligand (sCD40L) via thromboxane Ay production in human platelets. It has been shown that thromboxane Ay induces the activation of Rho-kinase, a downstream effector of Rho, in human platelets. In the present study, we investigated the exact roles of Rho-kinase in thromboxane A(2)-induced platelet activation. We found that U46619, a thromboxane receptor (TP) agonist, induced the phosphorylation of cofilin, a target of Rho-kinase signaling, and that the cofilin phosphorylation by U46619 was suppressed by Y27632 or fasudil, specific inhibitors of Rho-kinase. Y27632 and fasudil markedly decreased large platelet aggregate formation by U46619. The release of sCD40L and secretion of platelet-derived growth factor (PDGF)-AB stimulated by U46619 were inhibited by Y27632 and fasudil. SB203580, a specific inhibitor of p38 mitogen-activated protein (MAP) kinase, reduced the scD40L release and PDGF-AB secretion. Y27632 and fasudil failed to affect the phosphoiylation of p38 MAP kinase whereas SB203580 had little effect on the phosphorylation of cofilin induced by 1346619. In conclusion, our results strongly suggest that Rho-kinase regulates thromboxane A(2)-induced human platelet activation independently of p38 MAP kinase. (C) 2014 Elsevier Ltd. All rights reserved.	[Iida, Yuko; Tanabe, Kumiko; Iida, Hiroki] Gifu Univ, Grad Sch Med, Dept Anesthesiol & Pain Med, Gifu 5011194, Japan; [Doi, Tomoaki; Ogura, Shinji] Gifu Univ, Grad Sch Med, Dept Emergency & Disaster Med, Gifu 5011194, Japan; [Iida, Yuko; Matsushima-Nishiwaki, Rie; Kuroyanagi, Gen; Yamamoto, Naohiro; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu 5011194, Japan; [Tokuda, Haruhiko] Natl Ctr Geriatr & Gerontol, Dept Clin Lab, Obu 4748511, Japan; [Tsujimoto, Masanori; Enomoto, Yukiko; Iwama, Toru] Gifu Univ, Grad Sch Med, Dept Neurosurg, Gifu 5011194, Japan; [Kuroyanagi, Gen; Yamamoto, Naohiro; Otsuka, Takanobu] Nagoya City Univ, Grad Sch Med Sci, Dept Orthoped Surg, Nagoya, Aichi 4678603, Japan	Kozawa, O (reprint author), Gifu Univ, Grad Sch Med, Dept Pharmacol, 1-1 Yanagido, Gifu 5011194, Japan.	okozawa@gifu-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [20590565, 20591825]; Research Grant for Longevity Sciences from National Center for Geriatrics and Gerontology, Japan [25-4]	We thank Dr. Yoshiko Banno for her invaluable suggestion. We are very grateful to Yumiko Kurokawa for her skillful technical assistance. This work was supported in part by a Grant-in-Aid for Scientific Research (20590565 and 20591825) from the Ministry of Education, Science, Sports and Culture of Japan and the Research Grant for Longevity Sciences (25-4) from National Center for Geriatrics and Gerontology, Japan.	Edwards DC, 1999, NAT CELL BIOL, V1, P253; Vanhoutte PM, 2009, CLIN PHARMACOL THER, V86, P212, DOI 10.1038/clpt.2009.108; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Suzuki Y, 1999, BLOOD, V93, P3408; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Arber S, 1998, NATURE, V393, P805; Shimokawa H, 2007, TRENDS PHARMACOL SCI, V28, P296, DOI 10.1016/j.tips.2007.04.006; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Takai Y, 2001, PHYSIOL REV, V81, P153; Schonbeck U, 2001, CIRCULATION, V104, P2266, DOI 10.1161/hc4401.099447; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609; Lievens D, 2009, THROMB HAEMOSTASIS, V102, P206, DOI 10.1160/TH09-01-0029; Varo N, 2003, CIRCULATION, V108, P1049, DOI 10.1161/01.CIR.0000088521.04017.13; Nakahata N, 2008, PHARMACOL THERAPEUT, V118, P18, DOI 10.1016/j.pharmthera.2008.01.001; Kato K, 1996, J NEUROCHEM, V66, P946; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Kahner BN, 2006, J THROMB HAEMOST, V4, P2317, DOI 10.1111/j.1538-7836.2006.02192.x; BERTELE V, 1980, THROMB RES, V18, P543, DOI 10.1016/0049-3848(80)90350-3; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Enomoto Y, 2010, ATHEROSCLEROSIS, V209, P415, DOI 10.1016/j.atherosclerosis.2009.10.024; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; Minuz P, 2006, BIOCHEM J, V400, P127, DOI 10.1042/BJ20061015; Pandey D, 2006, BLOOD, V107, P575, DOI 10.1182/blood-2004-11-4377; Stegner D, 2011, J MOL MED, V89, P109, DOI 10.1007/s00109-010-0691-5; Tohgi H, 1996, THROMB HAEMOSTASIS, V75, P838	28	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0952-3278	1532-2823		PROSTAG LEUKOTR ESS	Prostaglandins Leukot. Essent. Fatty Acids	MAR	2015	94						73	81		10.1016/j.plefa.2014.11.006		9	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	CC7ED	WOS:000350529600010		
J	Yamaguchi, T; Devassy, JG; Gabbs, M; Ravandi, A; Nagao, S; Aukema, HM				Yamaguchi, Tamio; Devassy, Jessay G.; Gabbs, Melissa; Ravandi, Amir; Nagao, Shizuko; Aukema, Harold M.			Dietary flax oil rich in alpha-linolenic acid reduces renal disease and oxylipin abnormalities, including formation of docosahexaenoic acid derived oxylipins in the CD1-pcy/pcy mouse model of nephronophthisis	PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS			English	Article						Oxylipins; Flax oil; alpha-Linolenic acid; Docosahexaenoic acid; Cystic kidney disease; Nephronophthisis; 11-hydroxyeicosatetraenoic acid	POLYCYSTIC KIDNEY-DISEASE; POLYUNSATURATED FATTY-ACIDS; SPRD-CY RAT; ADOLESCENT NEPHRONOPHTHISIS; LIPOXYGENASE PRODUCTS; PROSTANOID PRODUCTION; COX-2 INHIBITION; EPITHELIAL-CELLS; PCY MICE; IN-VITRO	The CD1-pcy/pcy mouse model of nephronophthisis displays reduced renal docosahexaenoic acid (DNA) levels and alterations in renal cyclooxygenase and lipoxygenase oxylipins derived from n-6 fatty acids. Since dietary flax oil ameliorates disease progression, its effect on renal fatty acids and oxylipins was examined. Sixteen weeks of feeding resulted in reduced disease progression and enrichment of renal phospholipid cc-linolenic acid (ALA) and eicosapentaenoic acid, reduction in arachidonic acid (AA), but no change in linoleic acid (LA) or DNA. In diseased kidneys, flax oil feeding mitigated the elevated levels of renal cyclooxygenase derived oxylipins formed from AA and the lowered lipoxygenase and cytochrome P450 derived oxylipins formed from ALA and DHA. Increased DHA oxylipins occurred with flax feeding despite not altering DHA levels. Dietary flax oil may therefore reduce disease progression via mitigation of oxylipin abnormalities. This study also provides evidence of in vivo ALA conversion to DNA in amounts necessary to restore DNA oxylipin levels. (C) 2014 Elsevier Ltd. All rights reserved.	[Yamaguchi, Tamio; Devassy, Jessay G.; Gabbs, Melissa; Aukema, Harold M.] Univ Manitoba, Dept Human Nutr Sci, Winnipeg, MB, Canada; [Yamaguchi, Tamio; Devassy, Jessay G.; Aukema, Harold M.] St Boniface Hosp Res Ctr, Canadian Ctr Agri Food Res Hlth & Med, Winnipeg, MB, Canada; [Ravandi, Amir] St Boniface Hosp Res Ctr, Inst Cardiovasc Sci, Winnipeg, MB, Canada; [Nagao, Shizuko] Fujita Hlth Univ, Educ & Res Ctr Anim Models Human Dis, Toyoake, Aichi, Japan; [Aukema, Harold M.] Manitoba Inst Child Hlth, Winnipeg, MB, Canada	Aukema, HM (reprint author), Univ Manitoba, Dept Human Nutr Sci, Winnipeg, MB, Canada.	aukema@umanitoba.ca		Aukema, Harold/0000-0002-6982-7239; Devassy, Jessay Gopuran/0000-0003-4004-7359	Manitoba Institute of Child Health [35938]; Natural Sciences and Engineering Council of Canada [217412]	This work was supported by the Manitoba Institute of Child Health (35938) and the Natural Sciences and Engineering Council of Canada (217412). The authors thank Joy Gauthier and Tanja Winter for their technical assistance.	Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; REEVES PG, 1993, J NUTR, V123, P1939; Hao CM, 2008, ANNU REV PHYSIOL, V70, P357, DOI 10.1146/annurev.physiol.70.113006.100614; Caligiuri SPB, 2013, J NUTR, V143, P1421, DOI 10.3945/jn.113.177360; Yoshida Y, 2009, NEUROBIOL AGING, V30, P174, DOI 10.1016/j.neurobiolaging.2007.06.012; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Adler DH, 2008, J CLIN INVEST, V118, P2121, DOI 10.1172/JCI30473; Sankaran D, 2004, LIPIDS, V39, P207, DOI 10.1007/s11745-004-1221-7; Xu T, 2012, MOL BIOL REP, V39, P7743, DOI 10.1007/s11033-012-1611-2; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Chakrabarti SK, 2009, OBESITY, V17, P1657, DOI 10.1038/oby.2009.192; Salomon R, 2009, PEDIATR NEPHROL, V24, P2333, DOI 10.1007/s00467-008-0840-z; Yamaguchi T, 2000, KIDNEY INT, V57, P1460, DOI 10.1046/j.1523-1755.2000.00991.x; Levy BD, 2010, PROSTAG LEUKOTR ESS, V82, P327, DOI 10.1016/j.plefa.2010.02.003; Deems R, 2007, METHOD ENZYMOL, V432, P59, DOI 10.1016/S0076-6879(07)32003-X; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Burdge G, 2004, CURR OPIN CLIN NUTR, V7, P137, DOI 10.1097/00075197-200403000-00006; Lundstrom SL, 2013, MOL NUTR FOOD RES, V57, P1378, DOI 10.1002/mnfr.201200827; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Ogborn MR, 2002, LIPIDS, V37, P1059, DOI 10.1007/s11745-002-1001-4; Omran H, 2001, J AM SOC NEPHROL, V12, P107; Aukema Harold M., 2003, FASEB Journal, V17, P298; AUKEMA HM, 1992, LIPIDS, V27, P429, DOI 10.1007/BF02536384; GOLDSTEIN DJ, 1995, J AM SOC NEPHROL, V6, P1468; HALL AV, 1993, AM J KIDNEY DIS, V22, P326; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; HEINEGAR.D, 1973, CLIN CHIM ACTA, V43, P305, DOI 10.1016/0009-8981(73)90466-X; Ibrahim NHM, 2014, MOL NUTR FOOD RES, V58, P768, DOI 10.1002/mnfr.201300332; INGRAM AJ, 1995, AM J KIDNEY DIS, V25, P320, DOI 10.1016/0272-6386(95)90015-2; Sankaran D, 2007, AM J PHYSIOL-RENAL, V293, pF821, DOI 10.1152/ajprenal.00257.2006; Sapieha P, 2011, SCI TRANSL MED, V3, P69; Schuchardt JP, 2014, PROSTAG LEUKOTR ESS, V90, P27, DOI 10.1016/j.plefa.2013.12.008; Schulze-Tanzil G, 2002, HISTOL HISTOPATHOL, V17, P477; SETTY BNY, 1985, BIOCHIM BIOPHYS ACTA, V833, P484, DOI 10.1016/0005-2760(85)90106-7; Wakefield AP, 2012, J NUTR BIOCHEM, V23, P908, DOI 10.1016/j.jnutbio.2011.04.016; Warford-Woolgar L, 2006, AM J PHYSIOL-RENAL, V290, pF897, DOI 10.1152/ajprenal.00332.2005; Wohlfeil ER, 1997, BBA-LIPID LIPID MET, V1345, P109, DOI 10.1016/S0005-2760(96)00170-1; Yamaguchi T, 1997, AM J KIDNEY DIS, V30, P703, DOI 10.1016/S0272-6386(97)90496-0; Yamaguchi T, 2014, LIPIDS, V49, P39, DOI 10.1007/s11745-013-3859-2; Yang LJ, 2013, ONCOL LETT, V6, P197, DOI 10.3892/ol.2013.1336	42	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0952-3278	1532-2823		PROSTAG LEUKOTR ESS	Prostaglandins Leukot. Essent. Fatty Acids	MAR	2015	94						83	89		10.1016/j.plefa.2014.11.009		7	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	CC7ED	WOS:000350529600011		
J	Mostofa, MG; Hossain, MA; Fujita, M				Mostofa, Mohammad Golam; Hossain, Mohammad Anwar; Fujita, Masayuki			Trehalose pretreatment induces salt tolerance in rice (Oryza sativa L.) seedlings: oxidative damage and co-induction of antioxidant defense and glyoxalase systems	PROTOPLASMA			English	Article						Salt toxicity; Osmoprotectants; Oxidative stress; Trehalose; Antioxidant defense; Glyoxalase system; Oryza sativa L.	TRANSGENIC TOBACCO SEEDLINGS; ABIOTIC STRESS; SALINITY STRESS; GLUTATHIONE-REDUCTASE; SPINACH-CHLOROPLASTS; MOLECULAR-MECHANISMS; LIPID-PEROXIDATION; OSMOTIC ADJUSTMENT; HYDROGEN-PEROXIDE; NACL SALINITY	Salinity in the form of abiotic stress adversely effects plant growth, development, and productivity. Various osmoprotectants are involved in regulating plant responses to salinity; however, the precise role of trehalose (Tre) in this process remains to be further elucidated. The present study investigated the regulatory role of Tre in alleviating salt-induced oxidative stress in hydroponically grown rice seedlings. Salt stress (150 and 250 mM NaCl) for 72 h resulted in toxicity symptoms such as stunted growth, severe yellowing, and leaf rolling, particularly at 250 mM NaCl. Histochemical observation of reactive oxygen species (ROS; O-2 (a (TM) a') and H2O2) indicated evident oxidative stress in salt-stressed seedlings. In these seedlings, the levels of lipoxygenase (LOX) activity, malondialdehyde (MDA), H2O2, and proline (Pro) increased significantly whereas total chlorophyll (Chl) and relative water content (RWC) decreased. Salt stress caused an imbalance in non-enzymatic antioxidants, i.e., ascorbic acid (AsA) content, AsA/DHA ratio, and GSH/GSSG ratio decreased but glutathione (GSH) content increased significantly. In contrast, Tre pretreatment (10 mM, 48 h) significantly addressed salt-induced toxicity symptoms and dramatically depressed LOX activity, ROS, MDA, and Pro accumulation whereas AsA, GSH, RWC, Chl contents, and redox status improved considerably. Salt stress stimulated the activities of SOD, GPX, APX, MDHAR, DHAR, and GR but decreased the activities of CAT and GST. However, Tre-pretreated salt-stressed seedlings counteracted SOD and MDHAR activities, elevated CAT and GST activities, further enhanced APX and DHAR activities, and maintained GPX and GR activities similar to the seedlings stressed with salt alone. In addition, Tre pretreatment enhanced the activities of methylglyoxal detoxifying enzymes (Gly I and Gly II) more efficiently in salt-stressed seedlings. Our results suggest a role for Tre in protecting against salt-induced oxidative damage attributed to reduced ROS accumulation, elevation of non-enzymatic antioxidants, and co-activation of the antioxidative and glyoxalase systems.	[Mostofa, Mohammad Golam; Fujita, Masayuki] Kagawa Univ, Lab Plant Stress Responses, Dept Appl Biol Sci, Fac Agr, Miki, Kagawa 7610795, Japan; [Mostofa, Mohammad Golam] Bangabandhu Sheikh Mujibur Rahman Agr Univ, Dept Biochem & Mol Biol, Gazipur 1706, Bangladesh; [Hossain, Mohammad Anwar] Bangladesh Agr Univ, Dept Genet & Plant Breeding, Mymensingh 2202, Bangladesh	Fujita, M (reprint author), Kagawa Univ, Lab Plant Stress Responses, Dept Appl Biol Sci, Fac Agr, Miki, Kagawa 7610795, Japan.	mostofabmb@gmail.com; fujita@ag.kagawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	M.G. Mostofa gratefully acknowledges the funding from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Abraham G, 2010, PROTOPLASMA, V245, P105, DOI 10.1007/s00709-010-0147-3; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Di Martino C, 2003, NEW PHYTOL, V158, P455, DOI 10.1046/j.1469-8137.2003.00770.x; Viveros MFA, 2013, MOL BIOL REP, V40, P3281, DOI 10.1007/s11033-012-2403-4; Cummins I, 1999, PLANT J, V18, P285, DOI 10.1046/j.1365-313X.1999.00452.x; James RA, 2002, FUNCT PLANT BIOL, V29, P1393, DOI 10.1071/FP02069; Munns R, 2011, ADV BOT RES, V57, P1, DOI 10.1016/B978-0-12-387692-8.00001-1; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Chen H, 2010, ENVIRON REV, V18, P309, DOI 10.1139/A10-014; Hossain MA, 2009, AUST J CROP SCI, V3, P53; Chang BW, 2014, PLANT PHYSIOL BIOCH, V77, P140, DOI 10.1016/j.plaphy.2014.02.001; Hossain Mohammad Anwar, 2010, Physiology and Molecular Biology of Plants, V16, P259, DOI 10.1007/s12298-010-0028-4; Poor P, 2011, PLANT BIOLOGY, V13, P105, DOI 10.1111/j.1438-8677.2010.00344.x; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Lutts S, 1995, J EXP BOT, V46, P1843, DOI 10.1093/jxb/46.12.1843; Bae HH, 2005, PHYSIOL PLANTARUM, V125, P114, DOI 10.1111/j.1399-3054.2005.00537.x; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; El-Shabrawi H, 2010, PROTOPLASMA, V245, P85, DOI 10.1007/s00709-010-0144-6; Singla-Pareek SL, 2008, TRANSGENIC RES, V17, P171, DOI 10.1007/s11248-007-9082-2; Yadav SK, 2005, FEBS LETT, V579, P6265, DOI 10.1016/j.febslet.2005.10.006; Ali Q, 2011, J AGRON CROP SCI, V197, P258, DOI 10.1111/j.1439-037X.2010.00463.x; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Zhang JL, 2013, PHOTOSYNTH RES, V115, P1, DOI 10.1007/s11120-013-9813-6; Saha P, 2010, INDIAN J EXP BIOL, V48, P593; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Metwally A, 2003, PLANT PHYSIOL, V132, P272, DOI 10.1104/pp.102.018457; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Roxas VP, 1997, NAT BIOTECHNOL, V15, P988, DOI 10.1038/nbt1097-988; Dutilleul C, 2003, PLANT PHYSIOL, V131, P264, DOI 10.1104/pp.011155; Yadav SK, 2005, BIOCHEM BIOPH RES CO, V337, P61, DOI 10.1016/j.bbrc.2005.08.263; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; Mustafiz A, 2011, FUNCT INTEGR GENOMIC, V11, P293, DOI 10.1007/s10142-010-0203-2; Elia AC, 2003, ECOTOX ENVIRON SAFE, V55, P162, DOI 10.1016/S0147-6513(02)00123-9; Fernandez O, 2010, TRENDS PLANT SCI, V15, P409, DOI 10.1016/j.tplants.2010.04.004; Sudhakar C, 2001, PLANT SCI, V161, P613, DOI 10.1016/S0168-9452(01)00450-2; Mostofa MG, 2013, ECOTOXICOLOGY, V22, P959, DOI 10.1007/s10646-013-1073-x; Turan S, 2013, PROTOPLASMA, V250, P209, DOI 10.1007/s00709-012-0395-5; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mishra P, 2013, PROTOPLASMA, V250, P3, DOI 10.1007/s00709-011-0365-3; Upadhyaya CP, 2011, BIOTECHNOL LETT, V33, P2297, DOI 10.1007/s10529-011-0684-7; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P385; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Saito R, 2011, PLANT CELL ENVIRON, V34, P1454, DOI 10.1111/j.1365-3040.2011.02344.x; Sevengor S, 2011, AFR J AGR RES, V6, P4920; Roxas VP, 2000, PLANT CELL PHYSIOL, V41, P1229, DOI 10.1093/pcp/pcd051; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Mostofa MG, 2014, PLANT GROWTH REGUL, V73, P31, DOI 10.1007/s10725-013-9865-9; DODERER A, 1992, BIOCHIM BIOPHYS ACTA, V1120, P97, DOI 10.1016/0167-4838(92)90429-H; Duman F., 2010, WATER AIR SOIL POLL, V217, P545; Gao JP, 2008, RICE, V1, P36, DOI 10.1007/s12284-008-9006-7; Hossain M.A., 2013, J PLANT SCI MOL BREE, V2, P1, DOI DOI 10.7243/2050-2389-2-2; Hossain MA, 2012, J BOT, DOI [10.1155/2012/872875, DOI 10.1155/2012/872875]; Hossain M.A., 2013, MOL PLANT BREED, V4, P50, DOI DOI 10.5376/MPB.2013.04.0007; Lawlor DW, 2002, ANN BOT-LONDON, V89, P871, DOI 10.1093/aob/mcf110; Li ZG, 2014, BOT STUD, V55, DOI 10.1186/1999-3110-55-20; Luo Y, 2010, BIOL PLANTARUM, V54, P495, DOI 10.1007/s10535-010-0087-y; Ma C, 2013, PLANT GROWTH REGUL, V70, P275, DOI 10.1007/s10725-013-9799-2; Mostofa MG, 2014, PROTOPLASMA, V251, P1373, DOI 10.1007/s00709-014-0639-7; Nedjimi B, 2014, BIOCHEM SYST ECOL, V52, P4, DOI 10.1016/j.bse.2013.10.007; Nounjan N, 2012, J PLANT PHYSIOL, V169, P596, DOI 10.1016/j.jplph.2012.01.004; Qin J, 2010, PLANT SOIL ENVIRON, V56, P325; Reina-Bueno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033587; Tammam AA, 2011, AFR J BIOTECHNOL, V10, P3795; Theerakulpisut P, 2012, ASIAN J CROP SCI, V4, P405; Yadav Sudesh Kumar, 2005, Physiology and Molecular Biology of Plants, V11, P1; Yasar S, 2008, RUSS J PLANT PHYSL, V55, P782; Zeid I. M., 2009, Research Journal of Agriculture and Biological Sciences, V5, P613	70	2	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0033-183X	1615-6102		PROTOPLASMA	Protoplasma	MAR	2015	252	2					461	475		10.1007/s00709-014-0691-3		15	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	CC3IW	WOS:000350241600008		
J	Zhumadilov, K; Ivannikov, A; Stepanenko, V; Abralina, S; Sadvokasova, L; Akilbekov, A; Morzabayev, A; Rakhypbekov, T; Hoshi, M				Zhumadilov, Kassym; Ivannikov, Alexander; Stepanenko, Valeriy; Abralina, Sholpan; Sadvokasova, Lyazzat; Akilbekov, Abdirash; Morzabayev, Aidar; Rakhypbekov, Tolebay; Hoshi, Masaharu			EPR pilot study on the population of Stepnogorsk city living in the vicinity of a uranium processing plant	RADIATION AND ENVIRONMENTAL BIOPHYSICS			English	Article						Stepnogorsk; EPR dosimetry; Tooth enamel	TOOTH ENAMEL DOSIMETRY; SEMIPALATINSK REGION; NUCLEAR TEST; TEST-SITE; PART 1; OPTIMIZATION; SPECTRUM	The aim of this pilot study was to evaluate possible doses in teeth received by workers of a uranium processing plant, in excess to the natural background dose. For this, the electron paramagnetic resonance dosimetry method was applied. Absorbed doses in teeth from the workers were compared with those measured in teeth from the Stepnogorsk city population and a control pool population from Astana city. The measured tooth samples were extracted according to medical indications. In total, 32 tooth enamel samples were analyzed, 5 from Astana city, Kazakhstan (control population), 21 from the residents of Stepnogorsk city (180 km from Astana city), and 6 from the workers of a uranium processing plant. The estimated doses in tooth enamel from the uranium processing plant workers were not significantly different to those measured in enamel from the control population. In teeth from the workers, the maximum dose in excess to background dose was 33 mGy. In two teeth from residents of Stepnogorsk city, however, somewhat larger doses were measured. The results of this pilot study encourage further investigations in an effort to receiving a final conclusion on the exposure situation of the uranium processing plant workers and the residents of Stepnogorsk city.	[Zhumadilov, Kassym; Akilbekov, Abdirash; Morzabayev, Aidar] LN Gumilyov Eurasian Natl Univ, Astana 010008, Kazakhstan; [Ivannikov, Alexander; Stepanenko, Valeriy] Med Radiol Res Ctr, Obninsk 249036, Russia; [Abralina, Sholpan; Sadvokasova, Lyazzat; Rakhypbekov, Tolebay] Semey State Med Univ, Semey 071400, Kazakhstan; [Hoshi, Masaharu] Hiroshima Univ, Res Inst Radiat Biol & Med, Minami Ku, Hiroshima 7348553, Japan	Zhumadilov, K (reprint author), LN Gumilyov Eurasian Natl Univ, Munaitpasova Str 13, Astana 010008, Kazakhstan.	kassymzh@yahoo.com	Zhumadilov, Kassym/O-7356-2014	Zhumadilov, Kassym/0000-0002-0205-4585	Japan Society for the Promotion of Science [21710060]	The present study was supported by Grant-in-Aid for Young Scientists (B) from Japan Society for the Promotion of Science #21710060. The authors would like to express their sincere thanks to Dr. P. Kazymbet and Dr. M. Bakhtin (Astana Medical University, Astana, Kazakhstan) for their assistance in tooth samples collection.	Wieser A, 2006, RADIAT ENVIRON BIOPH, V44, P279, DOI 10.1007/s00411-005-0024-1; Fattibene P, 2011, RADIAT MEAS, V46, P765, DOI 10.1016/j.radmeas.2011.05.001; Hoshi M, 2007, RADIAT MEAS, V42, P1005, DOI 10.1016/j.radmeas.2007.05.045; IAEA Report, 2002, IAEATECDOC1331; Ivannikov A, 2007, RADIAT MEAS, V42, P1015, DOI 10.1016/j.radmeas.2007.05.046; Ivannikov A, 2006, J RADIAT RES, V47, pA39, DOI 10.1269/jrr.47.A39; Ivannikov AI, 2002, RADIAT PROT DOSIM, V101, P531; Ivannikov AI, 2014, RADIAT PROT DOSIM, V159, P125, DOI 10.1093/rpd/ncu132; Ivannikov AI, 1997, RADIAT PROT DOSIM, V71, P175; Ivannikov AI, 2010, HEALTH PHYS, V98, P345, DOI 10.1097/HP.0000348462.29306.59; Sholom S, 2010, HEALTH PHYS, V98, P360, DOI 10.1097/01.HP.0000348002.69740.bd; Tanaka K, 2006, J RADIAT RES, V46, P435; Tieliewuhan E, 2006, RADIAT MEAS, V41, P410, DOI 10.1016/j.radmeas.2005.08.002; Zhumadilov K, 2006, J RADIAT RES, V47, pA47, DOI 10.1269/jrr.47.A47; Zhumadilov K, 2009, RADIAT ENVIRON BIOPH, V48, P419, DOI 10.1007/s00411-009-0235-y; Zhumadilov K, 2007, RADIAT MEAS, V42, P049; Zhumadilov K, 2005, J RADIAT RES, V46, P435, DOI 10.1269/jrr.46.435; Zhumadilov K, 2013, J RADIAT RES, V54, P775, DOI 10.1093/jrr/rrt008	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-634X	1432-2099		RADIAT ENVIRON BIOPH	Radiat. Environ. Biophys.	MAR	2015	54	1					145	149		10.1007/s00411-014-0573-2		5	Biology; Biophysics; Environmental Sciences; Radiology, Nuclear Medicine & Medical Imaging	Life Sciences & Biomedicine - Other Topics; Biophysics; Environmental Sciences & Ecology; Radiology, Nuclear Medicine & Medical Imaging	CC2ZY	WOS:000350215000014		
J	Urbisch, D; Mehling, A; Guth, K; Ramirez, T; Honarvar, N; Kolle, S; Landsiedel, R; Jaworska, J; Kern, PS; Gerberick, F; Natsch, A; Emter, R; Ashikaga, T; Miyazawa, M; Sakaguchi, H				Urbisch, Daniel; Mehling, Annette; Guth, Katharina; Ramirez, Tzutzuy; Honarvar, Naveed; Kolle, Susanne; Landsiedel, Robert; Jaworska, Joanna; Kern, Petra S.; Gerberick, Frank; Natsch, Andreas; Emter, Roger; Ashikaga, Takao; Miyazawa, Masaaki; Sakaguchi, Hitoshi			Assessing skin sensitization hazard in mice and men using non-animal test methods	REGULATORY TOXICOLOGY AND PHARMACOLOGY			English	Article						Skin sensitization; Allergic contact dermatitis (ACD); Adverse outcome pathway (AOP); DPRA; KeratinoSens (TM); LuSens; h-CLAT; (modified) MUSST; Database; Integrated testing strategy (ITS)	LYMPH-NODE ASSAY; APPLICABILITY DOMAIN CLASSIFICATION; IN-VITRO METHODS; TEST H-CLAT; CONTACT ALLERGENS; MAXIMIZATION TEST; GUINEA-PIG; CHEMICALS; IDENTIFICATION; POTENCY	Sensitization, the prerequisite event in the development of allergic contact dermatitis, is a key parameter in both hazard and risk assessments. The pathways involved have recently been formally described in the OECD adverse outcome pathway (AOP) for skin sensitization. One single non-animal test method will not be sufficient to fully address this AOP and in many cases the use of a battery of tests will be necessary. A number of methods are now fully developed and validated. In order to facilitate acceptance of these methods by both the regulatory and scientific communities, results of the single test methods (DPRA, KeratinoSens (TM), LuSens, h-CLAT, (m)MUSST) as well for a the simple '2 out of 3' ITS for 213 substances have been compiled and qualitatively compared to both animal and human data. The dataset was also used to define different mechanistic domains by probable protein-binding mechanisms. In general, the non-animal test methods exhibited good predictivities when compared to local lymph node assay (LLNA) data and even better predictivities when compared to human data. The '2 out of 3' prediction model achieved accuracies of 90% or 79% when compared to human or LLNA data, respectively and thereby even slightly exceeded that of the LLNA. (C) 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license	[Urbisch, Daniel; Guth, Katharina; Ramirez, Tzutzuy; Honarvar, Naveed; Kolle, Susanne; Landsiedel, Robert] BASF SE, Expt Toxicol & Ecol, Ludwigshafen, Germany; [Mehling, Annette] BASF Personal Care & Nutr GmbH, Dusseldorf, Germany; [Jaworska, Joanna] Procter & Gamble NV, B-1853 Strombeek Bever, Belgium; [Kern, Petra S.] Procter & Gamble Technol Beijing Co Ltd, Beijing, Peoples R China; [Gerberick, Frank] Procter & Gamble Co, Cincinnati, OH USA; [Natsch, Andreas; Emter, Roger] Givaudan Schweiz AG, CH-8600 Dubendorf, Switzerland; [Ashikaga, Takao] Shiseido Co Ltd, Shiseido Res Ctr, Tsuzuki Ku, Yokohama, Kanagawa 2248558, Japan; [Miyazawa, Masaaki; Sakaguchi, Hitoshi] Kao Corp, Safety Sci Res Labs, Haga, Tochigi 321349, Japan	Landsiedel, R (reprint author), BASF SE, Expt Toxicol & Ecol, Ludwigshafen, Germany.	robert.landsiedel@basf.com					Ade Nadege, 2006, J Immunotoxicol, V3, P189, DOI 10.1080/15476910600978038; Fabian E, 2013, ARCH TOXICOL, V87, P1683, DOI 10.1007/s00204-013-1090-9; Bruckner AL, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.1.e3; Natsch A, 2011, TOXICOL IN VITRO, V25, P733, DOI 10.1016/j.tiv.2010.12.014; Aptula AO, 2005, CHEM RES TOXICOL, V18, P1420, DOI 10.1021/tx050075m; KLIGMAN AM, 1966, J INVEST DERMATOL, V47, P393, DOI 10.1038/jid.1966.160; LoPachin RM, 2014, CHEM RES TOXICOL, V27, P1081, DOI 10.1021/tx5001046; COOPER JA, 1979, BRIT J CANCER, V39, P87, DOI 10.1038/bjc.1979.10; Bauch C, 2011, TOXICOL IN VITRO, V25, P1162, DOI 10.1016/j.tiv.2011.05.030; Natsch A, 2008, TOXICOL SCI, V102, P110, DOI 10.1093/toxsci/kfm259; Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013; Patlewicz G, 2001, CONTACT DERMATITIS, V44, P331, DOI 10.1034/j.1600-0536.2001.044006331.x; Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006; Thyssen JP, 2007, CONTACT DERMATITIS, V57, P287, DOI 10.1111/j.1600-0536.2007.01220.x; Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869; Ball N, 2011, REGUL TOXICOL PHARM, V60, P389, DOI 10.1016/j.yrtph.2011.05.007; Patlewicz G, 2008, CHEM RES TOXICOL, V21, P521, DOI 10.1021/tx700338q; Schnuch A, 2011, CONTACT DERMATITIS, V65, P167, DOI 10.1111/j.1600-0536.2011.01939.x; Nukada Y, 2012, TOXICOL IN VITRO, V26, P1150, DOI 10.1016/j.tiv.2012.07.001; Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040; Karlberg AT, 2013, CONTACT DERMATITIS, V69, P323, DOI 10.1111/cod.12127; Goebel C, 2012, REGUL TOXICOL PHARM, V63, P40, DOI 10.1016/j.yrtph.2012.02.007; Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868; van der Veen JW, 2014, REGUL TOXICOL PHARM, V69, P371, DOI 10.1016/j.yrtph.2014.04.018; Gerberick F, 2008, ATLA-ALTERN LAB ANIM, V36, P215; Basketter D, 2013, REGUL TOXICOL PHARM, V67, P531, DOI 10.1016/j.yrtph.2013.10.002; Teubner W, 2013, REGUL TOXICOL PHARM, V67, P468, DOI 10.1016/j.yrtph.2013.09.007; Basketter DA, 2014, DERMATITIS, V25, P11, DOI 10.1097/DER.0000000000000003; Roberts DW, 2014, CHEM RES TOXICOL, V27, P240, DOI 10.1021/tx400355n; Roberts DW, 2007, CHEM RES TOXICOL, V20, P44, DOI 10.1021/tx060121y; KLIGMAN AM, 1966, J INVEST DERMATOL, V47, P375, DOI 10.1038/jid.1966.159; Aptula AO, 2009, CHEM RES TOXICOL, V22, P1541, DOI [10.1021/tx9000336, 10.1021/tx9000330]; Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012; Emter R, 2013, TOXICOL IN VITRO, V27, P2225, DOI 10.1016/j.tiv.2013.09.009; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Angers-Loustau A, 2011, REGUL TOXICOL PHARM, V60, P300, DOI 10.1016/j.yrtph.2011.04.006; Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009; Tsujita-Inoue K, 2014, TOXICOL IN VITRO, V28, P626, DOI 10.1016/j.tiv.2014.01.003; Mehling A, 2012, ARCH TOXICOL, V86, P1273, DOI 10.1007/s00204-012-0867-6; Roberts DW, 2007, CHEM RES TOXICOL, V20, P1019, DOI 10.1021/tx700024w; Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213; Aptula AO, 2007, CONTACT DERMATITIS, V56, P54, DOI 10.1111/j.1600-0536.2007.00944.x; Basketter DA, 2006, CONTACT DERMATITIS, V55, P268, DOI 10.1111/j.1600-0536.2006.00930.x; Dearman RJ, 2013, J APPL TOXICOL, V33, P558, DOI 10.1002/jat.1758; FOUSSEREAU J, 1983, CONTACT DERMATITIS, V9, P233, DOI 10.1111/j.1600-0536.1983.tb04373.x; Griem P, 2003, REGUL TOXICOL PHARM, V38, P269, DOI 10.1016/j.yrtph.2003.07.001; Hoffmann S., 2014, ALTEX P, V3; Jackh C, 2012, J IMMUNOTOXICOL, V9, P426, DOI 10.3109/1547691X.2012.664578; Kinsner-Ovaskainen A, 2012, ATLA-ALTERN LAB ANIM, V40, P175; Kolle SN, 2013, REGUL TOXICOL PHARM, V65, P278, DOI 10.1016/j.yrtph.2012.12.006; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Natsch A., TOXICOL SCI; Oesch F, 2014, ARCH TOXICOL, V88, P2135, DOI 10.1007/s00204-014-1382-8; Ramirez T, 2014, TOXICOL IN VITRO, V28, P1482, DOI 10.1016/j.tiv.2014.08.002; Raunio H, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00033; Rovida C., 2014, INTEGRATED TESTING S; Rudback J, 2014, CONTACT DERMATITIS, V70, P329, DOI 10.1111/cod.12234; Schneider K, 2004, REGUL TOXICOL PHARM, V39, P245, DOI 10.1016/j.yrtph.2004.02.002	58	12	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0273-2300	1096-0295		REGUL TOXICOL PHARM	Regul. Toxicol. Pharmacol.	MAR	2015	71	2					337	351		10.1016/j.yrtph.2014.12.008		15	Medicine, Legal; Pharmacology & Pharmacy; Toxicology	Legal Medicine; Pharmacology & Pharmacy; Toxicology	CC7FH	WOS:000350532600026		
J	Ni, L; Cao, JT; Wang, RB				Ni Li; Cao JianTing; Wang RuBin			Dynamic multivariate multiscale entropy based analysis on brain death diagnosis	SCIENCE CHINA-TECHNOLOGICAL SCIENCES			English	Article						EEG signals; approximate entropy; sample entropy; brain death diagnosis		The recently introduced multivariate multiscale sample entropy (MMSE) well evaluates the long correlations in multiple channels, so that it can reveal the complexity of multivariate biological signals. The existing MMSE algorithm deals with short time series statically whereas long time series are common for real-time computation in practical use. As a solution, we novelly proposed our dynamic MMSE (DMMSE) as an extension of MMSE. This helps us gain greater insight into the complexity of each section of time series, producing multifaceted and more robust estimates than the standard MMSE. The simulation results illustrated the feasibility and well performance in the brain death diagnosis.	[Ni Li; Wang RuBin] E China Univ Sci & Technol, Inst Cognit Neurodynam, Shanghai 200237, Peoples R China; [Cao JianTing] Saitama Inst Technol, Dept Elect Engn, Saitama 3690293, Japan; [Cao JianTing] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan	Wang, RB (reprint author), E China Univ Sci & Technol, Inst Cognit Neurodynam, Shanghai 200237, Peoples R China.	rbwang@163.com			KAKENHI (JAPAN) [21360179, 22560425]; Key Project of National Science Foundation of China [11232005]; Ministry of Education Doctoral Foundation [20120074110020]	This work was supported by KAKENHI (Grant Nos. 21360179, 22560425) (JAPAN), also supported by the Key Project of National Science Foundation of China (Grant Nos. 11232005) and The Ministry of Education Doctoral Foundation (Grant Nos. 20120074110020).	Ahmed MU, 2011, IEEE ENG MED BIO, P810; Cao LY, 1998, PHYSICA D, V121, P75, DOI 10.1016/S0167-2789(98)00151-1; Fehr T, 2013, COGN NEURODYNAMICS, V7, P89, DOI 10.1007/s11571-012-9220-2; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Cao J T, 2008, SIGNAL PROCESSING TE, P275, DOI 10.1007/978-0-387-74367-7_15; CAO JT, 2006, KNOWLEDGE BASED INTE, V4253, P1240, DOI 10.1007/11893011_157; Cao JT, 2008, ADVANCES IN COGNITIVE NEURODYNAMICS, PROCEEDINGS, P699, DOI 10.1007/978-1-4020-8387-7_121; Chen Z, 2008, COGN NEURODYNAMICS, V2, P257, DOI 10.1007/s11571-008-9047-z; Costa M, 2002, PHYS REV LETT, V89, P68; Eelco F, 2002, NEUROLOGY, V58, P20; Goshvarpour A, 2013, COGN NEURODYNAMICS, V7, P39, DOI 10.1007/s11571-012-9215-z; Guatama T, 2004, PHYSICA D, V190, P167; Hu M., 2011, IEEE T BIOMEDICAL EN, V59, P12; Hu M, 2011, COGN NEURODYNAMICS, V5, P277, DOI 10.1007/s11571-011-9159-8; Li L, 2010, EVOVING INTELLIGENT, P279; Ni L, 2013, COMPUT MATH METHOD M, V2013; Richmann JS, 2000, AM J PHYSIOL-HEART C, V278, P2039, DOI DOI 10.1177/0269881111408966; SHI QW, 2010, ADV SWARM INTELLIGEN, V6146, P204, DOI 10.1007/978-3-642-13498-2_27; Taylor RM, 1997, SEMIN NEUROL, V17, P265, DOI 10.1055/s-2008-1040938; [杨琨 Yang Kun], 2011, [中国生物医学工程学报, Chinese Journal of Biomedical Engineering], V30, P27	20	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7321	1869-1900		SCI CHINA TECHNOL SC	Sci. China-Technol. Sci.	MAR	2015	58	3					425	433		10.1007/s11431-014-5757-0		9	Engineering, Multidisciplinary; Materials Science, Multidisciplinary	Engineering; Materials Science	CC4QB	WOS:000350336800004		
J	Makihara, K; Yamamoto, Y; Yoshimizu, K; Horiguchi, C; Sakaguchi, H; Fujimoto, K				Makihara, Kanjuro; Yamamoto, Yuta; Yoshimizu, Kenji; Horiguchi, Chikahiro; Sakaguchi, Hitoshi; Fujimoto, Katsumi			A novel controller to increase harvested energy from negating vibration-suppression effect	SMART MATERIALS AND STRUCTURES			English	Article						energy harvesting; piezoelectric; SSHI	POWER; SYSTEMS; DESIGN; OUTPUT	This paper proposes an innovative energy-harvesting controller to increase energy harvested from vibrations. Energy harvesting is a process that removes mechanical energy from a vibrating structure, which necessarily results in damping. The damping associated with piezoelectric energy harvesting suppresses the amplitude of mechanical vibration and reduces the harvested energy. To address this critical problem, we devise an energy-harvesting controller that maintains the vibration amplitude as high as possible to increase the harvested energy. Our proposed switching controller is designed to intentionally stop the switching action intermittently. We experimentally demonstrate that the proposed control scheme successfully increases the harvested energy. The piezoelectric voltage with the proposed controller is larger than that with the original synchronized switching harvesting on inductor (SSHI) technique, which increases the harvested energy. The stored energy with our controller is up to 5.7 times greater than that with the conventional SSHI control scheme.	[Makihara, Kanjuro; Yamamoto, Yuta; Yoshimizu, Kenji] Tohoku Univ, Dept Aerosp Engn, Aoba Ward, Sendai, Miyagi 9808579, Japan; [Horiguchi, Chikahiro; Sakaguchi, Hitoshi; Fujimoto, Katsumi] Murata Mfg Co Ltd, Kyoto 6178555, Japan	Makihara, K (reprint author), Tohoku Univ, Dept Aerosp Engn, Aoba Ward, 6-6-01 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	makihara@ssl.mech.tohoku.ac.jp			Japan Society for the Promotion of Science [23686125, 25630436]	This research was supported by Grant-in-Aid for Young Scientists (A) (No. 23686125) and Challenging Exploratory Research (No. 25630436) from the Japan Society for the Promotion of Science.	Badel A, 2006, J INTEL MAT SYST STR, V17, P831, DOI 10.1177/1045389X06057533; Glynne-Jones P, 2004, SENSOR ACTUAT A-PHYS, V110, P344, DOI 10.1016/j.sna.2003.09.045; Lesieutre GA, 2004, J SOUND VIB, V269, P991, DOI 10.1016/S0022-460X(03)00210-4; Stephen NG, 2006, J SOUND VIB, V293, P409, DOI 10.1016/j.jsv.2005.10.003; Calio R, 2014, SENSORS-BASEL, V14, P4755, DOI 10.3390/s140304755; Shu YC, 2006, SMART MATER STRUCT, V15, P1499, DOI 10.1088/0964-1726/15/6/001; Kan JW, 2009, INT J APPL ELECTROM, V30, P95, DOI 10.3233/JAE-2009-1039; Guyomar D, 2005, IEEE T ULTRASON FERR, V52, P584, DOI 10.1109/TUFFC.2005.1428041; Beeby S., 2010, ENERGY HARVESTING AU; Dicken J, 2012, IEEE T POWER ELECTR, V27, P4514, DOI 10.1109/TPEL.2012.2192291; Guyomar D, 2011, J INTEL MAT SYST STR, V22, P415, DOI 10.1177/1045389X10389205; Karthikeyan L, 2012, IEEE T POWER ELECTR, V27, P4192, DOI 10.1109/TPEL.2012.2190828; Kauffman JL, 2009, J INTEL MAT SYST STR, V20, P495, DOI 10.1177/1045389X08101559; Kazmierski TJ, 2011, ENERGY HARVESTING SYSTEMS: PRINCIPLES, MODELING AND APPLICATIONS, P79, DOI 10.1007/978-1-4419-7566-9_2; Lallart M, 2012, IEEE T IND ELECTRON, V59, P464, DOI 10.1109/TIE.2011.2148675; Makihara K, 2006, SMART MATER STRUCT, V15, P1493, DOI 10.1088/0964-1726/15/5/039; Makihara K, 2013, Japanese patent application, Patent No. [2013-168141, 2013168141]; Makihara K, 2014, International patent application, Patent No. [PCT/JP2014/063319, 2014063319]; Qiu J, 2009, FRONT MECH ENG CHINA, V4, P153; Shen H, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/11/115017; Staley ME, 2005, P SOC PHOTO-OPT INS, V5764, P630, DOI 10.1117/12.604871; Takezawa A, 2014, STRUCT MULTIDISCIP O, V49, P281, DOI 10.1007/s00158-013-0974-x; Zhu LY, 2012, J INTEL MAT SYST STR, V23, P441, DOI 10.1177/1045389X11435433	23	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0964-1726	1361-665X		SMART MATER STRUCT	Smart Mater. Struct.	MAR	2015	24	3							037005	10.1088/0964-1726/24/3/037005		6	Instruments & Instrumentation; Materials Science, Multidisciplinary	Instruments & Instrumentation; Materials Science	CB9NP	WOS:000349958800036		
J	Ning, NY; Yan, BY; Liu, ST; Yao, Y; Zhang, LQ; Chan, TW; Nishi, T; Tian, M				Ning, Nanying; Yan, Bingyue; Liu, Suting; Yao, Yang; Zhang, Liqun; Chan, Tung W.; Nishi, Toshio; Tian, Ming			Improved actuated strain of dielectric elastomer through disruption of hydrogen bonds of thermoplastic polyurethane by adding diaminonaphthalene	SMART MATERIALS AND STRUCTURES			English	Article						dielectric elastomer; hydrogen bond; actuated strain; thermoplastic polyurethane	CONSTANT; COMPOSITES; BLENDS; NANOCOMPOSITES; TEMPERATURE; PRESTRAIN; SILICONE	We used a novel and simple approach to increase the actuated strain at low electric field of thermoplastic polyurethane (TPU) through the disruption of the hydrogen bonds of TPU by adding diaminonaphthalene (DAN) into the matrix. DAN as proton donors disrupted the original N-H/C=O hydrogen bonds between the TPU chains, improving the polarizability of the chains, thus increasing the dielectric constant of TPU. Meanwhile, DAN greatly decreased the elastic modulus of TPU by disrupting the hydrogen bonds of TPU. The simultaneous increase in dielectric constant and decrease in elastic modulus resulted in a 330% increase in electromechanical sensitivity at 103 Hz and a 500% increase in actuated strain at the low electric field of 20 V mu m(-1), facilitating the application of dielectric elastomers (DEs) in the biological and medical fields, where a low electric field is required. In addition, our DAN/TPU DE exhibited good mechanical strength.	[Ning, Nanying; Yan, Bingyue; Liu, Suting; Yao, Yang; Zhang, Liqun; Tian, Ming] Beijing Univ Chem Technol, State Key Lab Organ Inorgan Composites, Beijing 100029, Peoples R China; [Chan, Tung W.] Virginia Polytech Inst & State Univ, Dept Mat Sci & Engn, Blacksburg, VA 24061 USA; [Nishi, Toshio] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 113, Japan	Ning, NY (reprint author), Beijing Univ Chem Technol, State Key Lab Organ Inorgan Composites, Beijing 100029, Peoples R China.	tianm@mail.buct.edu.cn			National Natural Science Foundation of China [51173007, 51221002]	This work was supported by the National Natural Science Foundation of China (Grant Nos. 51173007 and 51221002).	Akbay M C, 2004, THESIS NC STATE U; COLEMAN MM, 1988, MACROMOLECULES, V21, P59, DOI 10.1021/ma00179a014; Mattia J, 2007, MACROMOLECULES, V40, P1546, DOI 10.1021/ma0626362; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; McCarthy DN, 2012, COMPOS SCI TECHNOL, V72, P731, DOI 10.1016/j.compscitech.2012.01.026; Carpi F, 2008, ADV FUNCT MATER, V18, P235, DOI 10.1002/adfm.200700757; O'Halloran A, 2008, J APPL PHYS, V104, DOI 10.1063/1.2981642; Liu ZS, 2002, J APPL POLYM SCI, V85, P2100, DOI 10.1002/app.10763; Ha SM, 2006, ADV MATER, V18, P887, DOI 10.1002/adma.200502437; Jang YJ, 2011, SOFT MATTER, V7, P10818, DOI 10.1039/c1sm06184d; SUNG CSP, 1977, MACROMOLECULES, V10, P452, DOI 10.1021/ma60056a041; Yang C, 2009, CARBON, V47, P1096, DOI 10.1016/j.carbon.2008.12.037; Coleman MM, 1997, MACROMOL CHEM PHYSIC, V198, P117, DOI 10.1002/macp.1997.021980110; Huang C, 2004, ADV FUNCT MATER, V14, P501, DOI 10.1002/adfm.200305021; Yang D, 2012, J APPL POLYM SCI, V125, P2196, DOI 10.1002/app.36428; Liu ZS, 2005, POLYMER, V46, P10119, DOI 10.1016/j.polymer.2005.08.065; Ouyang G, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/7/074002; Palakodeti R, 2006, MATER LETT, V60, P3437, DOI 10.1016/j.matlet.2006.03.053; Stoyanov H, 2011, SOFT MATTER, V7, P194, DOI 10.1039/c0sm00715c; Pei AH, 2011, MACROMOLECULES, V44, P4422, DOI 10.1021/ma200318k; Zhang XQ, 2004, PROC SPIE, V5385, P78, DOI 10.1117/12.540888; Pelrine R, 2000, ADV MATER, V12, P1223, DOI 10.1002/1521-4095(200008)12:16<1223::AID-ADMA1223>3.0.CO;2-2; Yang D, 2012, MATER LETT, V76, P229, DOI 10.1016/j.matlet.2012.02.084; Shankar R, 2007, SOFT MATTER, V3, P1116, DOI 10.1039/b705737g; Yang D, 2013, RSC ADV, V3, P21896, DOI 10.1039/c3ra42688b; Chen L Z, 2008, APPL PHYS LETT, V92; Kofod G, 2001, THESIS TU DENMARK; Kofod G, 2005, IEEE 12 INT S EL ISE, P208; Liu H, 2012, J PHYS D, V45; Mallikarjuna NN, 2005, J APPL POLYM SCI, V97, P1868, DOI 10.1002/app.21405; Saha R, 2010, J APPL POLYM SCI, V117, P122, DOI 10.1002/app.31749; SRICHATRAPIMUK VW, 1978, J MACROMOL SCI PHYS, VB15, P267, DOI 10.1080/00222347808212599; Tiwari A, 2007, MATER LETT, V61, P4587, DOI 10.1016/j.matlet.2007.02.076; Wissler M, 2007, SENSOR ACTUAT A-PHYS, V138, P384, DOI 10.1016/j.sna.2007.05.029; Yang D, 2012, SMART MATER STRUCT, V21; Yang T I, 2011, NANOTECHNOLOGY, V22; Yuse K, 2011, SENSOR ACTUAT A-PHYS, V165, P147, DOI 10.1016/j.sna.2010.08.008; Zhang X, 2004, SMART STRUCT MAT, P78	38	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0964-1726	1361-665X		SMART MATER STRUCT	Smart Mater. Struct.	MAR	2015	24	3							032002	10.1088/0964-1726/24/3/032002		8	Instruments & Instrumentation; Materials Science, Multidisciplinary	Instruments & Instrumentation; Materials Science	CB9NP	WOS:000349958800002		
J	Kurakawa, T; Kakutani, K; Morita, Y; Kato, Y; Yurube, T; Hirata, H; Miyazaki, S; Terashima, Y; Maeno, K; Takada, T; Doita, M; Kurosaka, M; Inoue, N; Masuda, K; Nishida, K				Kurakawa, Takuto; Kakutani, Kenichiro; Morita, Yusuke; Kato, Yuki; Yurube, Takashi; Hirata, Hiroaki; Miyazaki, Shingo; Terashima, Yoshiki; Maeno, Koichiro; Takada, Toru; Doita, Minoru; Kurosaka, Masahiro; Inoue, Nozomu; Masuda, Koichi; Nishida, Kotaro			Functional impact of integrin alpha 5 beta 1 on the homeostasis of intervertebral discs: a study of mechanotransduction pathways using a novel dynamic loading organ culture system	SPINE JOURNAL			English	Article						Intervertebral disc degeneration; Organ culture; Mechanical load; Compression; Mechanoreceptor; Integrin	NUCLEUS PULPOSUS CELLS; CATABOLIC GENE-EXPRESSION; LOW-BACK-PAIN; IN-VITRO; EXTRACELLULAR-MATRIX; LUMBAR DISC; DEGENERATION; VIVO; MODEL; COMPRESSION	BACKGROUND CONTEXT: Intervertebral disc (IVD) degeneration, a major cause of low back pain, is considered to be induced by daily mechanical loading. Mechanical stress is widely known to affect cell survival and extracellular matrix metabolism in many cell types. Although the involvement of integrin alpha 5 beta 1 transmembrane mechanoreceptor in IVD degeneration has been reported, the precise function of integrin alpha 5 beta 1 remains obscure. PURPOSE: To reflect IVD tissue response to mechanical stress using a dynamic loading organ culture system and elucidate the functional impact of integrin alpha 5 beta 1 on the pathomechanism of IVD degeneration. STUDY DESIGN: An ex vivo study using a dynamic loading organ culture system. METHODS: Ninety-six rat IVD explants were examined. Intervertebral discs were subjected to 1.3 MPa, 1.0 Hz dynamic compressive load in the presence or absence of an Arg-Gly-Asp (RGD) peptide with affinity to the fibronectin binding-site of integrin alpha 5 beta 1. Cell viability and histomorphology were assessed. The localization of integrin alpha 5 beta 1 in the IVD was assessed by immunohistochemistry. Gene expression levels of IVD cells were evaluated using real-time reverse transcription-polymerase chain reaction. RESULTS: In the nucleus pulposus (NP), cell density and viability were reduced by dynamic compressive load. Histologic degenerative alterations, mainly seen in the NP, were the morphologic changes of NP cells. In both NP and annulus fibrosus (AF), immunohistochemistry revealed localization of integrin alpha 5 beta 1 and that the messenger-RNA expression of integrin alpha 5 beta 1 was increased by dynamic load. Dynamic load induced a catabolic effect, the stimulation of matrix metalloproteinase-3 and -13 gene expressions by NP and AF cells. The RGD peptide partially blocked the histologic alterations and the catabolic effect. CONCLUSIONS: The dynamic loading organ culture system simulated cellular responses to mechanical loading of the IVD. Our results suggest that IVD cells recognize the mechanical stress through RGD integrins, particularly the alpha 5 beta 1 subtype that is highly expressed in NP and AF cells. Further experiments using this system will provide information about pathomechanisms of IVD degeneration through the mechanotransduction pathways. (C) 2015 Elsevier Inc. All rights reserved.	[Kurakawa, Takuto; Kakutani, Kenichiro; Yurube, Takashi; Hirata, Hiroaki; Miyazaki, Shingo; Terashima, Yoshiki; Maeno, Koichiro; Takada, Toru; Doita, Minoru; Kurosaka, Masahiro; Nishida, Kotaro] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Nada Ku, Kobe, Hyogo 6578501, Japan; [Morita, Yusuke; Kato, Yuki; Inoue, Nozomu] Doshisha Univ, Dept Biomed Engn, Kyoto 6028580, Japan; [Inoue, Nozomu] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; [Masuda, Koichi] Univ Calif San Diego, Sch Med, Dept Orthopaed Surg, La Jolla, CA 92093 USA	Kakutani, K (reprint author), Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kenkakutani@gmail.com			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24592197]	TK: Nothing to disclose. KK: Nothing to disclose. YM: Nothing to disclose. YK: Nothing to disclose. TY: Nothing to disclose. HH: Nothing to disclose. SM: Nothing to disclose. YT: Nothing to disclose. KM: Nothing to disclose. TT: Nothing to disclose. MD: Grant: Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant number: 24592197) (D, no share, 100%). MK: Nothing to disclose. NI: Nothing to disclose. KM: Nothing to disclose. KN: Nothing to disclose.	Lotz JC, 2000, SPINE, V25, P1477, DOI 10.1097/00007632-200006150-00005; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Lim TH, 2006, SPINE, V31, P1291, DOI 10.1097/01.brs.0000218455.28463.f0; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Urban JPG, 2002, BIOCHEM SOC T, V30, P858; Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001; Masuda K, 2005, SPINE, V30, P5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Hayes AJ, 2001, MATRIX BIOL, V20, P107, DOI 10.1016/S0945-053X(01)00125-1; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Yurube T, 2011, J ORTHOP RES, V29, P1284, DOI 10.1002/jor.21406; MacLean JL, 2004, J ORTHOP RES, V22, P1193, DOI 10.1016/j.orthres.2004.04.004; MacLean JJ, 2005, J ORTHOP RES, V23, P1120, DOI 10.1016/j.orthres.2005.01.020; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Nerlich AG, 1997, SPINE, V22, P2781, DOI 10.1097/00007632-199712150-00001; Iatridis JC, 2006, J BONE JOINT SURG AM, V88A, P41, DOI 10.2106/JBJS.E.01407; Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1; Matsumoto T, 1999, SPINE, V24, P315, DOI 10.1097/00007632-199902150-00002; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Aguiar DJ, 1999, EXP CELL RES, V246, P129, DOI 10.1006/excr.1998.4287; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Zhao CQ, 2007, AGEING RES REV, V6, P247, DOI 10.1016/j.arr.2007.08.001; Gilchrist CL, 2007, J ORTHOP RES, V25, P829, DOI 10.1002/jor.20343; Guehring T, 2005, SPINE, V30, P2510, DOI 10.1097/01.brs.0000186591.17114.e9; BUCKWALTER JA, 1995, SPINE, V20, P1307; Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472; Elliott DM, 2004, SPINE, V29, P713, DOI 10.1097/01.BRS.0000116982.19331.EA; Gilchrist CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027170; Guehring T, 2010, EUR SPINE J, V19, P113, DOI 10.1007/s00586-009-1217-0; Hartman RA, 2012, J BIOMECH, V45, P382, DOI 10.1016/j.jbiomech.2011.10.036; Hee HT, 2010, SPINE J, V10, P795, DOI 10.1016/j.spinee.2010.06.009; Hirata H, 2014, J ORTHOP RES, V32, P455, DOI 10.1002/jor.22533; Junger S, 2009, SPINE, V34, P1264, DOI 10.1097/BRS.0b013e3181a0193d; Labat-Robert J, 2004, AGEING RES REV, V3, P233, DOI 10.1016/j.arr.2003.10.002; Lee CR, 2006, SPINE, V31, P515, DOI 10.1097/01.brs.0000201302.59050.72; Le Maitre CL, 2008, BIORHEOLOGY, V45, P563, DOI 10.3233/BIR-2008-0498; Le Maitre CL, 2009, ARTHRITIS RHEUM, V60, P460, DOI 10.1002/art.24248; Le Maitre CL, 2009, J TISSUE ENG REGEN M, V3, P461, DOI 10.1002/term.180; Millward-Sadler SJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2693; RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7; Wang P, 2011, ANN BIOMED ENG, V39, P1101, DOI 10.1007/s10439-010-0221-1; Wiseman MA, 2005, SPINE, V30, P505, DOI 10.1097/01.brs.0000154615.22311.66; Yurube T, 2010, J ORTHOP RES, V28, P1026, DOI 10.1002/jor.21116	45	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	MAR 1	2015	15	3					417	426		10.1016/j.spinee.2014.12.143		10	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CB9XG	WOS:000349987000008		
J	Ito, K; Yukawa, Y; Ito, K; Machino, M; Kanbara, S; Nakashima, H; Hida, T; Ishiguro, N; Imagama, S; Kato, F				Ito, Kenyu; Yukawa, Yasutsugu; Ito, Keigo; Machino, Masaaki; Kanbara, Shunske; Nakashima, Hiroaki; Hida, Tetsuro; Ishiguro, Naoki; Imagama, Shiro; Kato, Fumihiko			Dynamic changes in the spinal cord cross-sectional area in patients with myelopathy due to cervical ossification of posterior longitudinal ligament	SPINE JOURNAL			English	Article						Spinal cord cross-sectional area; Multidetector-row computed tomography; Ossification of posterior longitudinal ligament; Cervical spine; Dynamic; K-line	MOTION; RANGE; PATHOGENESIS; LAMINOPLASTY; ETIOLOGY	BACKGROUND CONTEXT: Dynamic changes in the spinal cord cross-sectional area due to cervical ossification of the posterior longitudinal ligament (C-OPLL) are unknown, but dynamic multidetector-row computed tomography (MDCT) may be a useful tool. PURPOSE: The purpose of this study was to evaluate the influence of dynamic factors on the spinal cord in patients with C-OPLL using MDCT during flexion and extension after myelography. STUDY DESIGN/SETTING: This was a prospective cohort study. PATIENT SAMPLE: Participants included 107 prospectively enrolled consecutive patients with C-OPLL and myelopathy. OUTCOME MEASURE: The outcome measure was the extension/flexion ratio at the spinal cord cross-sectional area at the most stenotic cervical level (SCASL). METHODS: Dynamic MDCT was performed, and the SCASL was measured. Patients were divided into the kyphosis group or lordosis group according to C2-C7 alignment. They were divided further into the K-line (-) group or K-line (+) group. The Japanese Orthopedic Association (JOA) score was used to determine myelopathy severity. RESULTS: All patients with C-OPLL had myelopathy, with a mean JOA score of 10.7 and mean disease duration of 16.7 months. The average extension/flexion ratio at all disc levels was less than 100%, suggesting that the spinal cord was compressed more during extension. In the kyphosis group, the spinal cord was compressed slightly more during flexion than during extension. In the K-line (-) group, the spinal cord was compressed more during flexion, although C2-C7 alignment was slightly lordotic on average. Large changes in the spinal cord cross-sectional area during extension-flexion and disease duration significantly influenced the severity of myelopathy. CONCLUSIONS: Dynamic MDCT was useful for evaluating dynamic changes in the spinal cord. At the most stenotic level, the spinal cord became narrower during extension at all disc levels. In the kyphosis group and K-line (-) group, it became narrower during flexion. Cervical flexion may induce greater spinal cord compression in patients with kyphosis and K-line (-). (C) 2015 Elsevier Inc. All rights reserved.	[Ito, Kenyu; Yukawa, Yasutsugu; Ito, Keigo; Machino, Masaaki; Kanbara, Shunske; Kato, Fumihiko] Chubu Rosai Hosp, Dept Orthopaed Surg, Nagoya, Aichi 4448530, Japan; [Ito, Kenyu; Nakashima, Hiroaki; Hida, Tetsuro; Ishiguro, Naoki; Imagama, Shiro] Nagoya Univ Hosp, Dept Orthopaed Surg, Grad Sch Med, Nagoya, Aichi 4668550, Japan	Ito, K (reprint author), Nagoya Univ Hosp, Dept Orthopaed Surg, Grad Sch Med, 65 Tsurumai Showa Ward, Nagoya, Aichi 4668550, Japan.	kenyubankara@yahoo.co.jp					Iwasaki M, 2007, SPINE, V32, P647, DOI 10.1097/01.brs.0000257560.91147.86; Matsunaga S, 2002, J NEUROSURG, V96, P168, DOI 10.3171/spi.2002.96.2.0168; HOLMES A, 1994, SPINE, V19, P2505, DOI 10.1097/00007632-199411001-00003; Matsunaga S, 2012, SPINE, V37, pE309, DOI 10.1097/BRS.0b013e318241ad33; Morio Y, 1999, SPINAL CORD, V37, P853, DOI 10.1038/sj.sc.3100940; Matsunaga S, 2008, SPINE, V33, P2648, DOI 10.1097/BRS.0b013e31817f988c; Fujiyoshi T, 2010, J CLIN NEUROSCI, V17, P320, DOI 10.1016/j.jocn.2009.06.023; Machino M, 2011, SPINE, V36, P399, DOI 10.1097/BRS.0b013e3181d2510b; Azuma Y, 2010, J SPINAL DISORD TECH, V23, P166, DOI 10.1097/BSD.0b013e31819e9066; Fujimori T, 2012, J NEUROSURG-SPINE, V17, P74, DOI 10.3171/2012.3.SPINE111083; Fujiyoshi T, 2008, SPINE, V33, pE990, DOI 10.1097/BRS.0b013e318188b300; Tian Wei, 2012, Zhonghua Wai Ke Za Zhi, V50, P590; TSUYAMA N, 1984, CLIN ORTHOP RELAT R, P71; Yukawa Y, 2007, SPINE, V32, P1980, DOI 10.1097/BRS.0b013e318133fbce	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	MAR 1	2015	15	3					461	466		10.1016/j.spinee.2014.10.001		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CB9XG	WOS:000349987000015		
J	Elkordy, A; Endo, T; Sato, K; Sonoda, Y; Takahashi, A; Tominaga, T				Elkordy, Alaa; Endo, Toshiki; Sato, Kenichi; Sonoda, Yukihiko; Takahashi, Akira; Tominaga, Teiji			Exclusively epidural spinal metameric arteriovenous shunts: case report and literature review	SPINE JOURNAL			English	Article						Arteriovenous malformation; Cobb syndrome; Epidural arteriovenous shunt; Endovascular treatment; Metameric; Myelopathy; Spinal cord	MALFORMATION COBB-SYNDROME; ENDOVASCULAR EMBOLIZATION; CONSECUTIVE PATIENTS; CORD; CLASSIFICATION; FISTULAS; SKIN; HEMANGIOMA; THERAPY	BACKGROUND CONTEXT: Spinal arteriovenous metameric syndrome (SAMS) is a subgroup of spinal arteriovenous malformations (AVMs). Most SAMS cases have intra- and extradural AVMs and suffer from hematomyelia, subarachnoid hemorrhage, or venous congestive myelopathy. PURPOSE: To present a rare case of SAMS in which spinal AVMs were exclusively epidural. We reviewed previous literature and evaluated the feasibility of a treatment strategy using endovascular interventions, followed by surgical obliteration. STUDY DESIGN: A case report and literature review of SAMS. METHODS: We report a case of a 15-year-old boy suffering from SAMS in which epidural venous ectasia because of extradural AVMs caused spinal cord compression. RESULTS: The patient was successfully treated with multiple sessions of transarterial embolization followed by open surgery. After the treatment, his neurologic deficits resolved. Postoperative angiography confirmed complete obliteration of extradural AVMs. CONCLUSIONS: Although exclusively epidural spinal AVM is an uncommon type of SAMS, combined endovascular and surgical interventions can be an effective treatment for AVMs to achieve better radiologic outcomes and complete resolution of patient symptoms. (C) 2015 Elsevier Inc. All rights reserved.	[Elkordy, Alaa; Endo, Toshiki; Sato, Kenichi; Sonoda, Yukihiko; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 9808574, Japan; [Elkordy, Alaa; Sato, Kenichi; Takahashi, Akira] Tohoku Univ, Grad Sch Med, Dept Neuroendovasc Therapy, Sendai, Miyagi 9808574, Japan; [Elkordy, Alaa] Tanta Univ, Dept Neurol, Neuroendovasc Sect, Tanta 31111, Egypt	Endo, T (reprint author), Tohoku Univ, Grad Sch Med, Dept Neurosurg, 1-1 Seiryo Aoba, Sendai, Miyagi 9808574, Japan.	endo@nsg.med.tohoku.ac.jp		Sonoda, Yukihiko/0000-0001-7651-1374			Cobb S, 1915, ANN SURG, V62, P641, DOI 10.1097/00000658-191512000-00001; Linfante I, 2012, J NEUROSURG-SPINE, V16, P408, DOI 10.3171/2011.12.SPINE11636; Bhattacharya JJ, 2001, INTERV NEURORADIOL, V7, P5; Maramattom BV, 2005, J NEUROSURG-SPINE, V3, P249, DOI 10.3171/spi.2005.3.3.0249; Rodesch G, 2002, NEUROSURGERY, V51, P374, DOI 10.1097/00006123-200208000-00013; [Anonymous], 1996, J ASS PHYS INDIA, V44, P846; Johnson WD, 2009, J NEUROSURG-SPINE, V10, P430, DOI 10.3171/2009.1.SPINE08334; Soeda A, 2003, NEUROSURGERY, V52, P711, DOI 10.1227/01.NEU.0000048483.21777.B7; Spiotta AM, 2011, J NEUROINTERV SURG, V3, P293, DOI 10.1136/jnis.2010.002972; Bao YH, 1997, NEUROSURGERY, V40, P75, DOI 10.1097/00006123-199701000-00017; Matsumaru Y, 1999, INTERV NEURORADIOL, V5, P27; Spetzler RF, 2002, J NEUROSURG, V96, P145, DOI 10.3171/spi.2002.96.2.0145; Schirmer CM, 2012, J NEUROSURG-PEDIATR, V10, P44, DOI 10.3171/2012.3.PEDS11530; Shim JH, 1996, DERMATOLOGY, V193, P45; MIYATAKE S, 1990, J NEUROSURG, V72, P497, DOI 10.3171/jns.1990.72.3.0497; Berenstein A, 2004, SURG NEUROANGIOGRAPH, P737, DOI DOI 10.1007/978-3-642-18888-6_11; Clark MT, 2008, PEDIATR NEUROL, V39, P423, DOI 10.1016/j.pediatrneurol.2008.08.001; Clinton TS, 2003, CUTIS, V71, P283; Dilme-Carreras E, 2010, DERMATOLOGY, V221, P110, DOI 10.1159/000313510; Fairhall JM, 2010, J NEUROSURG-SPINE, V13, P784, DOI [10.3171/2010.5.SPINE09755, 10.3171/2010.5.SP1NE09755]; Gatzonis S, 2010, J NEUROL NEUROSUR PS, V81, P500, DOI 10.1136/jnnp.2009.195610; Gomez JE, 2011, EUR J RADIOL, V79, pe15; HALBACH VV, 1993, NEUROSURGERY, V33, P972; Matsui Y, 2014, J NEUROSURG-SPINE, V20, P142, DOI 10.3171/2013.11.SPINE13419; Niimi Y, 2013, AM J NEURORADIOL, V34, P457, DOI 10.3174/ajnr.A3212; Pascual-Castroviejo I, 2002, J CHILD NEUROL, V17, P847, DOI 10.1177/08830738020170111701; Rodesch G, 2005, NEUROSURGERY, V57, P973, DOI 10.1227/01.NEU.0000181314.94000.CD; Rodesch G, 1997, Interv Neuroradiol, V3, P131; Romeo F, 2009, J NEUROSURG SCI, V53, P59; ROSENWASSER RH, 1993, J NEUROSURG, V79, P153; Sayuthi S, 2006, Med J Malaysia, V61, P239; Song JK, 2001, AM J NEURORADIOL, V22, P40	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	MAR 1	2015	15	3					E15	E22		10.1016/j.spinee.2014.11.022		8	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CB9XG	WOS:000349987000001		
J	French, A; Bravery, C; Smith, J; Chandra, A; Archibald, P; Gold, JD; Artzi, N; Kim, HW; Barker, RW; Meissner, A; Wu, JC; Knowles, JC; Williams, D; Garcia-Cardena, G; Sipp, D; Oh, S; Loring, JF; Rao, MS; Reeve, B; Wall, I; Carr, AJ; Bure, K; Stacey, G; Karp, JM; Snyder, EY; Brindley, DA				French, Anna; Bravery, Christopher; Smith, James; Chandra, Amit; Archibald, Peter; Gold, Joseph D.; Artzi, Natalie; Kim, Hae-Won; Barker, Richard W.; Meissner, Alexander; Wu, Joseph C.; Knowles, Jonathan C.; Williams, David; Garcia-Cardena, Guillermo; Sipp, Doug; Oh, Steve; Loring, Jeanne F.; Rao, Mahendra S.; Reeve, Brock; Wall, Ivan; Carr, Andrew J.; Bure, Kim; Stacey, Glyn; Karp, Jeffrey M.; Snyder, Evan Y.; Brindley, David A.			Enabling Consistency in Pluripotent Stern Cell-Derived Products for Research and Development and Clinical Applications Through Material Standards	STEM CELLS TRANSLATIONAL MEDICINE			English	Article							MINIMUM INFORMATION; LINES; GUIDELINES; DISEASE; ES	There is a need for physical standards (reference materials) to ensure both reproducibility and consistency in the production of somatic cell types from human pluripotent stem cell (hPSC) sources. We have outlined the need for reference materials (RMs) in relation to the unique properties and concerns surrounding hPSC-derived products and suggest in-house approaches to RM generation relevant to basic research, drug screening, and therapeutic applications. hPSCs have an unparalleled potential as a source of somatic cells for drug screening, disease modeling, and therapeutic application. Undefined variation and product variability after differentiation to the lineage or cell type of interest impede efficient translation and can obscure the evaluation of clinical safety and efficacy. Moreover, in the absence of a consistent population, data generated from in vitro studies could be unreliable and irreproducible. Efforts to devise approaches and tools that facilitate improved consistency of hPSC-derived products, both as development tools and therapeutic products, will aid translation. Standards exist in both written and physical form; however, because many unknown factors persist in the field, premature written standards could inhibit rather than promote innovation and translation. We focused on the derivation of physical standard RMs. We outline the need for RMs and assess the approaches to in-house RM generation for hPSC-derived products, a critical tool for the analysis and control of product variation that can be applied by researchers and developers. We then explore potential routes for the generation of RMs, including both cellular and noncellular materials and novel methods that might provide valuable tools to measure and account for variation. Multiparametric techniques to identify "signatures" for therapeutically relevant cell types, such as neurons and cardiomyocytes that can be derived from hPSCs, would be of significant utility, although physical RMs will be required for clinical purposes.	[French, Anna; Smith, James; Barker, Richard W.; Wall, Ivan; Carr, Andrew J.; Brindley, David A.] Univ Oxford, Ctr Adv Sustainable Med Innovat, Oxford UCL, Oxford OX3 7LG, England; [Carr, Andrew J.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Nuffield Orthopaed Ctr, Oxford OX3 7LG, England; [Brindley, David A.] Univ Oxford, Said Business Sch, Oxford OX3 7LG, England; [Bravery, Christopher] Consulting Adv Biol Ltd, London, England; [Chandra, Amit; Archibald, Peter] Univ Loughborough, Wolfson Sch Mech & Mfg Engn, Ctr Biol Engn, Loughborough, Leics, England; [Gold, Joseph D.; Wu, Joseph C.] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA USA; [Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Stanford, CA USA; [Meissner, Alexander; Garcia-Cardena, Guillermo] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Anesthesiol, Boston, MA USA; [Artzi, Natalie] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Kim, Hae-Won] Dankook Univ, Dept Dent Biomat, Sch Dent, Cheonan, South Korea; [Knowles, Jonathan C.; Wall, Ivan] Dankook Univ, Dept Nanobiomed Sci, Plus NBM Global Res Ctr Regenerat Med BK21, Cheonan, South Korea; [Wall, Ivan] Dankook Univ, Biomat & Tissue Engn Lab, Dept Nanobiomed Sci, Cheonan, South Korea; [Wall, Ivan] Dankook Univ, WCU Res Ctr, Cheonan, South Korea; [Meissner, Alexander; Reeve, Brock; Karp, Jeffrey M.; Brindley, David A.] Harvard Univ, Stem Cell Inst, Cambridge, MA USA; [Meissner, Alexander; Garcia-Cardena, Guillermo] Broad Inst MIT & Harvard, Cambridge, MA USA; [Meissner, Alexander; Brindley, David A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Knowles, Jonathan C.] UCL, Div Biomat & Tissue Engn, UCL Eastman Dent Inst, London, England; [Wall, Ivan] UCL, Dept Biochem Engn, London, England; [Brindley, David A.] UCL, Ctr Behav Med, UCL Sch Pharm, London, England; [Garcia-Cardena, Guillermo] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Excellence Vasc Biol,Dept Pathol, Boston, MA 02115 USA; [Karp, Jeffrey M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Regenerat Therapeut, Boston, MA 02115 USA; [Karp, Jeffrey M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Biomed Engn, Boston, MA 02115 USA; [Garcia-Cardena, Guillermo] Harvard Univ, Sch Med, Program Dev & Regenerat Biol, Boston, MA USA; [Sipp, Doug] RIKEN, Ctr Dev Biol, Kobe, Hyogo, Japan; [Oh, Steve] ASTAR, Bioproc Technol Inst, Singapore, Singapore; [Loring, Jeanne F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Loring, Jeanne F.] Scripps Res Inst, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Rao, Mahendra S.] NIH, Ctr Regenerat Med, Bethesda, MD 20892 USA; [Bure, Kim] TAP Biosyst, Royston, England; [Stacey, Glyn] Natl Inst Biol Stand & Controls, Ctr MHRA, S Mimms, Herts, England; [Karp, Jeffrey M.] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Snyder, Evan Y.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Snyder, Evan Y.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Snyder, Evan Y.] Sanford Consortium Regenerat Med, La Jolla, CA USA; [Brindley, David A.] Stanford UCSF FDA, CERSI, San Francisco, CA USA	French, A (reprint author), Univ Oxford, Ctr Adv Sustainable Med Innovat, Oxford UCL, Old Rd Campus, Oxford OX3 7LG, England.	anna.french@casmi.org.uk; esnyder@sanfordburnham.org; david.brindley@ndorms.ox.ac.uk			GE Healthcare; Centre for Commercialization of Regenerative Medicine; TAP Biosystems (now Sartorius Stedim), Lonza; California Institute for Regenerative Medicine; SENS Research Foundation; UK Cell Therapy Catapult; NIH Center for Regenerative Medicine; New York Stem Cell Foundation; ThermoFisher Scientific; Eisai; Medipost (U.S.); Medipost (Korea); Celgene; Roche; Oxford Biomedica; Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation; Technology Strategy Board	We express our sincere thanks to the following organizations that have contributed to the consortium as funding and events partners-without whom the consortium and the benefits it will bring to stem cell translation would be constrained: GE Healthcare, Centre for Commercialization of Regenerative Medicine, TAP Biosystems (now Sartorius Stedim), Lonza, California Institute for Regenerative Medicine, SENS Research Foundation, UK Cell Therapy Catapult, NIH Center for Regenerative Medicine, New York Stem Cell Foundation, ThermoFisher Scientific, Eisai, Medipost (U.S.), Medipost (Korea), Celgene, Roche, and Oxford Biomedica. Additionally, the Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation is a past recipient of funding from the Technology Strategy Board to support an investigation into cell therapy regulation. We also extend our sincere thanks to Dr. Peter Andrews (Sheffield University) and Dr. Sue Dopson (University of Oxford) for contributing to this research.	Akopian V, 2010, IN VITRO CELL DEV, V46, P247; Engle SJ, 2013, CELL STEM CELL, V12, P669, DOI 10.1016/j.stem.2013.05.011; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Bravery CA, 2014, CYTOTHERAPY, V16, P1187, DOI 10.1016/j.jcyt.2014.05.024; Josephson R, 2007, STEM CELLS, V25, P437, DOI 10.1634/stemcells.2006-0236; Allen RH, 2000, TECHNOL FORECAST SOC, V64, P171, DOI 10.1016/S0040-1625(99)00104-3; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Muller FJ, 2011, NAT METHODS, V8, P315, DOI [10.1038/nmeth.1580, 10.1038/NMETH.1580]; Loring JF, 2006, STEM CELLS, V24, P145, DOI 10.1634/stemcells.2005-0432; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Merkle FT, 2013, CELL STEM CELL, V12, P656, DOI 10.1016/j.stem.2013.05.016; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Alper J, 2009, NAT BIOTECHNOL, V27, P213, DOI 10.1038/nbt0309-213a; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Stacey GN, 2013, CELL STEM CELL, V13, P385, DOI 10.1016/j.stem.2013.09.007; Turner M, 2013, CELL STEM CELL, V13, P382, DOI 10.1016/j.stem.2013.08.003; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Armbruster David, 2007, Clin Biochem Rev, V28, P105; Chen A, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt401; Food and Drug Administration, 2011, GUID IND POT TESTS C; Geron, 2010, GER PROC 1 HUM CLIN; Global Biological Standards Institute, 2013, CAS STAND LIF SCI RE; International Stem Cell Banking Initiative, 2009, STEM CELL REV, V5, P301; Murphy CL, 2002, TISSUE ENG, V8, P551, DOI 10.1089/107632702760240472; National Institute for Biological Standards and Control, WORK STAND FITC UNT; Sheridan B, 2012, BIOPROCESS INT, V10, P18; WHO, 2010, WHO TECH REP SER, V957, P1; Zhai ZC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064786	33	3	3	ALPHAMED PRESS	DURHAM	318 BLACKWELL ST, STE 260, DURHAM, NC 27701-2884 USA	2157-6564	2157-6580		STEM CELL TRANSL MED	Stem Cells Transl. Med.	MAR	2015	4	3					217	223		10.5966/sctm.2014-0233		7	Cell & Tissue Engineering	Cell Biology	CC6YL	WOS:000350514800014		
J	Yan, JX; Hitomi, T; Takenaka, K; Kato, M; Kobayashi, H; Okuda, H; Harada, KH; Koizumi, A				Yan, Junxia; Hitomi, Toshiaki; Takenaka, Katsunobu; Kato, Masayasu; Kobayashi, Hatasu; Okuda, Hiroko; Harada, Kouji H.; Koizumi, Akio			Genetic Study of Intracranial Aneurysms	STROKE			English	Article						genetics; intracranial aneurysms	GENOME-WIDE ASSOCIATION; SUBARACHNOID HEMORRHAGE; RISK-FACTORS; IDENTIFIES 3; VARIANT; LOCI; METAANALYSIS; EXPRESSION; EDNRA	Background and Purpose-Rupture of intracranial aneurysms (IAs) causes subarachnoid hemorrhage, leading to immediate death or severe disability. Identification of the genetic factors involved is critical for disease prevention and treatment. We aimed to identify the susceptibility genes for IAs. Methods-Exome sequencing was performed in 12 families with histories of multiple cases of IA (number of cases per family >= 3), with a total of 42 cases. Various filtering strategies were used to select the candidate variants. Replicate association studies of several candidate variants were performed in probands of 24 additional IA families and 426 sporadic IA cases. Functional analysis for the mutations was conducted. Results-After sequencing and filtering, 78 variants were selected for the following reasons: allele frequencies of variants in 42 patients was significantly (P<0.05) larger than expected; variants were completely shared by all patients with IA within >= 1 family; variants predicted damage to the structure or function of the protein by PolyPhen-2 (Polymorphism Phenotyping V2) and SIFT (Sorting Intolerance From Tolerant). We selected 10 variants from 9 genes (GPR63, ADAMST15, MLL2, IL10RA, PAFAH2, THBD, IL11RA, FILIP1L, and ZNF222) to form 78 candidate variants by considering commonness in families, known disease genes, or ontology association with angiogenesis. Replicate association studies revealed that only p.E133Q in ADAMTS15 was aggregated in the familial IA cases (odds ratio, 5.96; 95% confidence interval, 2.40-14.82; P=0.0001; significant after the Bonferroni correction [P=0.05/78=0.0006]). Silencing ADAMTS15 and overexpression of ADAMTS15 p.E133Q accelerated endothelial cell migration, suggesting that ADAMTS15 may have antiangiogenic activity. Conclusions-ADAMTS15 is a candidate gene for IAs.	[Yan, Junxia] Cent S Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha, Hunan, Peoples R China; [Yan, Junxia; Hitomi, Toshiaki; Kobayashi, Hatasu; Okuda, Hiroko; Harada, Kouji H.; Koizumi, Akio] Kyoto Univ, Grad Sch Med, Dept Hlth & Environm Sci, Kyoto 6068501, Japan; [Takenaka, Katsunobu; Kato, Masayasu] Takayama Red Cross Hosp, Dept Neurosurg, Takayama, Japan	Koizumi, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Hlth & Environm Sci, Sakyo Ku, Konoe Cho, Kyoto 6068501, Japan.	koizumi.akio.5v@kyoto-u.ac.jp					Ruigrok YM, 2005, LANCET NEUROL, V4, P179, DOI 10.1016/S1474-4422(05)01015-X; Alg VS, 2013, NEUROLOGY, V80, P2154, DOI 10.1212/WNL.0b013e318295d751; Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563; Stehbens WE, 1998, NEUROSURGERY, V43, P1258, DOI 10.1097/00006123-199811000-00156; de Wit MCY, 2009, J NEUROL NEUROSUR PS, V80, P426, DOI 10.1136/jnnp.2008.149419; Hussain I, 2013, STROKE, V44, P2670, DOI 10.1161/STROKEAHA.113.001753; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Akiyama K, 2010, J HUM GENET, V55, P656, DOI 10.1038/jhg.2010.82; Ruigrok YM, 2004, NEUROLOGY, V62, P891; Low SK, 2012, HUM MOL GENET, V21, P2102, DOI 10.1093/hmg/dds020; Yamada S, 2004, CIRCULATION, V110, P3727, DOI 10.1161/01.CIR.0000143077.23367.18; Yasuno K, 2011, P NATL ACAD SCI USA, V108, P19707, DOI 10.1073/pnas.1117137108; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Teunissen LL, 1996, STROKE, V27, P544; Bilguvar K, 2008, NAT GENET, V40, P1472, DOI 10.1038/ng.240; Hitomi T, 2013, BIOCHEM BIOPH RES CO, V438, P13, DOI 10.1016/j.bbrc.2013.07.004; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Yamada S, 2003, STROKE, V34, P2781, DOI 10.1161/01.STR.0000103857.13812.9A; Foroud T, 2012, STROKE, V43, P2846, DOI 10.1161/STROKEAHA.112.656397; Guo SZ, 2014, METHODS MOL BIOL, V1135, P393, DOI 10.1007/978-1-4939-0320-7_32; Kwon M, 2014, INT J CANCER, V135, P48, DOI 10.1002/ijc.28662; Zhang J, 2008, INT J STROKE, V3, P272, DOI 10.1111/j.1747-4949.2008.00224.x	23	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	MAR	2015	46	3					620	+		10.1161/STROKEAHA.114.007286		13	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CC3XP	WOS:000350284900016		
J	Tokuyama, H; Okano, K; Sugimoto, K; Momoi, Y; Okuyama, K; Toya, H				Tokuyama, Hidetoshi; Okano, Kentaro; Sugimoto, Kenji; Momoi, Yuichi; Okuyama, Keiichiro; Toya, Hiroki			Total Synthesis of (-)-Haouamine B Pentaacetate and Structural Revision of Haouamine B	SYNTHESIS-STUTTGART			English	Editorial Material									[Tokuyama, Hidetoshi] Univ Penn, Philadelphia, PA 19104 USA; [Tokuyama, Hidetoshi] Univ Tokyo, Grp Prof Tohru Fukuyama, Tokyo 1138654, Japan; [Tokuyama, Hidetoshi] Tohoku Univ, Sendai, Miyagi 980, Japan; [Okano, Kentaro] Univ Tokyo, Labs Prof Tohru Fukuyama, Tokyo 1138654, Japan; [Okano, Kentaro] Tohoku Univ, Prof Hidetoshi Tokuyamas Grp, Sendai, Miyagi 980, Japan; [Sugimoto, Kenji] Tohoku Univ, Res Grp Prof Hidetoshi Tokuyama, Sendai, Miyagi 980, Japan; [Sugimoto, Kenji] Toyama Univ, Res Grp Prof Yuji Matsuya, Toyama, Japan	Tokuyama, H (reprint author), Tohoku Univ, Sendai, Miyagi 980, Japan.		Okano, Kentaro/J-8165-2014	Okano, Kentaro/0000-0003-2029-8505			Tang TP, 2002, J ORG CHEM, V67, P7819, DOI 10.1021/jo025957u; Matveenko M, 2012, J AM CHEM SOC, V134, P9291, DOI 10.1021/ja301326k; Garrido L, 2003, J ORG CHEM, V68, P293, DOI 10.1021/jo020487p; Baran PS, 2006, J AM CHEM SOC, V128, P3908, DOI 10.1021/ja0602997; Okuyama K, 2011, SYNLETT, P73, DOI 10.1055/s-0030-1259096	5	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	MAR	2015	47	5					A42	A45				4	Chemistry, Organic	Chemistry	CC3BS	WOS:000350219900005		
J	Uyama, Y; Yamazaki, E; Clark, K; Wang, CY; Woro, E; Tong, FY; Sachidanandan, S; Rodriguez, A; Oh, H; Saleh, K; Cirunay, J; Wapeewuttikorn, A; Rogov, E; Alshahwan, KW; Herrera, I; Mthetwa, J; Fakudze, F; Osawa, T				Uyama, Yoshiaki; Yamazaki, Eriko; Clark, Katherine; Wang, Chao-Yi; Woro, Endang; Tong, Foo Yang; Sachidanandan, Sumitra; Rodriguez, Ana; Oh, Hojin; Saleh, Kamaruzaman; Cirunay, Joyce; Wapeewuttikorn, Akanid; Rogov, Evgeny; Alshahwan, Khaled W.; Herrera, Ileana; Mthetwa, Joseph; Fakudze, Fortunate; Osawa, Tomoko		E6 Discussion Grp Int Pharmaceut	General Principles for the Education and Training of GCP Inspectors: The Outcome of Discussions by International Regulatory Experts in the Discussion Group on the ICH E6 Guideline	THERAPEUTIC INNOVATION & REGULATORY SCIENCE			English	Article						good clinical practice; clinical trials; regulatory inspection; implementation; harmonization	CLINICAL-TRIALS	In response to the globalization of drug development, regulatory inspection of Good Clinical Practice (GCP) has recently been conducted not only by International Conference on Harmonisation (ICH) regions but also non-ICH regions. To promote the international implementation of GCP, consistent understanding and interpretation of its concept among regions are important. This article summarizes the background and past activities of the E6 Discussion Group, established under the Regulators Forum.	[Uyama, Yoshiaki; Yamazaki, Eriko; Osawa, Tomoko] Pharmaceut & Med Devices Agcy, Tokyo 1000013, Japan; [Clark, Katherine] Therapeut Goods Adm, Dept Hlth, Woden, ACT, Australia; [Wang, Chao-Yi] Food & Drug Adm, Chinese Taipei, Taiwan; [Woro, Endang] Natl Agcy Drug & Food Control, Jakarta, Indonesia; [Tong, Foo Yang; Sachidanandan, Sumitra] Hlth Sci Author, Singapore, Singapore; [Rodriguez, Ana] European Med Agcy, London, England; [Oh, Hojin] Minist Food & Drug Safety, Cheongju, South Korea; [Saleh, Kamaruzaman] Minist Hlth Selangor Darul Ehsan, Natl Pharmaceut Control Bur, Shah Alam, Malaysia; [Cirunay, Joyce] Food & Drug Adm, Muntinlupa, Philippines; [Wapeewuttikorn, Akanid] Food & Drug Adm, Nonthaburi, Thailand; [Rogov, Evgeny] Fed Serv Surveillance Healthcare & Social Dev Ros, Moscow, Russia; [Alshahwan, Khaled W.] Saudi Food & Drug Author, Riyadh, Saudi Arabia; [Herrera, Ileana] Minist Hlth, San Jose, Costa Rica; [Mthetwa, Joseph] Southern African Dev Community Secretariat, Gaborone, Botswana; [Fakudze, Fortunate] Minist Hlth, Matsapha, Swaziland	Uyama, Y (reprint author), Pharmaceut & Med Devices Agcy, Off Safety 1, Div Epidemiol, Chiyoda Ku, Shin Kasumigaseki Bldg,3-3-2 Kasumigaseki, Tokyo 1000013, Japan.	uyama-yoshiaki@pmda.go.jp					Asano K, 2013, CLIN PHARMACOL THER, V94, P195, DOI 10.1038/clpt.2013.106; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441; FDA Thailand, NOT COND IMP INV GAT; Health Sciences Authority, GUID GCP COMPL INSP; ICH, 2010, ICH 20 ANN VAL BEN I; ICH, 1998, ICH E6 GUID GUID GOO; Lido JJ, 2009, THERAPEUTIC INNOVATI, V43, P63	7	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2168-4790	2168-4804		THER INNOV REGUL SCI	Ther. Innov. Regul. Sci.	MAR	2015	49	2					249	253		10.1177/2168479014551646		5	Medical Informatics; Pharmacology & Pharmacy	Medical Informatics; Pharmacology & Pharmacy	CC6RF	WOS:000350494000006		
J	Nakai, K; Tanaka, T				Nakai, Kiyohito; Tanaka, Taihei			Introducing Internet Retailing of OTC Drugs in Japan: Revision of the Pharmaceutical Affairs Law	THERAPEUTIC INNOVATION & REGULATORY SCIENCE			English	Article						OTC drugs; retailing via Internet; Pharmaceutical Affairs Law		Only the low-risk category of over-the-counter (OTC) drugs was permitted to be sold via the Internet, which was stipulated by the ordinance of the Minister of Health, Labour and Welfare under the Pharmaceutical Affairs Law in Japan. Two Japanese retailers of OTC drugs, who want to retail OTC drugs via the Internet, launched proceedings against the rule, and the Supreme Court gave a decision that the ministerial ordinance is illegal and invalid. The Ministry of Health, Labour and Welfare immediately started discussion to make rules for Internet retailing of OTC drugs. Finally, a bill designed to enable Internet retailing of OTC drugs was passed by the Diet on December 5, 2013, and the act was promulgated on December 13. The act was enforced on June 12, 2014. This article briefly touches on the decision process and also illustrates the key points of the new rules for Internet retailing.	[Nakai, Kiyohito; Tanaka, Taihei] Minist Hlth Labour & Welf, Pharmaceut & Food Safety Bur, Tokyo 1140002, Japan	Nakai, K (reprint author), Minist Hlth Labour & Welf, Pharmaceut & Food Safety Bur, Kita Ku, Oji 6-6-1-1404, Tokyo 1140002, Japan.	nakaikiyohito@hotmail.com						0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2168-4790	2168-4804		THER INNOV REGUL SCI	Ther. Innov. Regul. Sci.	MAR	2015	49	2					284	288		10.1177/2168479014555911		5	Medical Informatics; Pharmacology & Pharmacy	Medical Informatics; Pharmacology & Pharmacy	CC6RF	WOS:000350494000012		
J	Kawano, D; Okamoto, T; Fujishita, T; Suzuki, Y; Kitahara, H; Shimamatsu, S; Maehara, Y				Kawano, Daigo; Okamoto, Tatsuro; Fujishita, Takatoshi; Suzuki, Yuzo; Kitahara, Hirokazu; Shimamatsu, Shinichiro; Maehara, Yoshihiko			Surgical results of resectable small cell lung cancer	THORACIC CANCER			English	Article						Limited-stage disease; pneumonectomy; small cell lung cancer	RESECTION; CHEMOTHERAPY; CARCINOMA; SURVIVAL; SURGERY; MANAGEMENT; TRIAL	BackgroundThe standard of care for patients with small cell lung cancer (SCLC) is chemotherapy and radiotherapy, even for patients with limited disease. To define the role of surgical resection in patients with limited SCLC, we investigated the outcomes of patients diagnosed with limited-stage disease (LD) SCLC. MethodsThe records of 57 LD SCLC patients who underwent surgical resection from April 1974 to March 2012 were retrospectively analyzed. ResultsThere were six women and 51 men, with a median age of 63.5 years. The overall five-year survival rate was 28.6% (median, 18.2 months). The p-stage II and III patients had a significantly worse survival than the p-stage I patients (13.4% vs. 43.4%, P = 0.0036). However, the c-stage was not found to correlate with survival. Patients who underwent pneumonectomy had a significantly worse outcome than those who underwent other surgical procedures (0.0% vs. 32.0%, P = 0.0002). In a multivariate Cox proportional hazards analysis, p-stage II or III (hazard ratio [HR] 3.040 P = 0.0017) and pneumonectomy (HR 6.177, P = 0.00159) were significant independent predictors of an adverse survival outcome. ConclusionsSurgical treatment can be considered in SCLC patients with pathologically proven N0 status, although pneumonectomy should be avoided.	[Kawano, Daigo; Okamoto, Tatsuro; Fujishita, Takatoshi; Suzuki, Yuzo; Kitahara, Hirokazu; Shimamatsu, Shinichiro; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan	Kawano, D (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	daigo-k9@surg2.med.kyushu-u.ac.jp					Lim E, 2008, J THORAC ONCOL, V3, P1267, DOI 10.1097/JTO.0b013e318189a860; Vallieres E, 2009, J THORAC ONCOL, V4, P1049, DOI 10.1097/JTO.0b013e3181b27799; HARA N, 1991, J SURG ONCOL, V47, P53, DOI 10.1002/jso.2930470112; OSTERLIND K, 1986, EUR J CANCER CLIN ON, V22, P589, DOI 10.1016/0277-5379(86)90048-9; Badzio A, 2004, EUR J CARDIO-THORAC, V26, P183, DOI 10.1016/j.ejcts.2004.04.012; LASSEN U, 1995, J CLIN ONCOL, V13, P1215; Edge SB, 2010, AJCC CANC STAGING MA; FOX W, 1973, LANCET, V2, P63; Ginsberg Robert J., 1995, Annals of Thoracic Surgery, V60, P615, DOI 10.1016/0003-4975(95)00537-U; Inoue M, 2000, ANN THORAC SURG, V70, P1615, DOI 10.1016/S0003-4975(00)01401-6; Johnson Bruce E, 2006, J Natl Compr Canc Netw, V4, P602; Kalemkerian GP, 2011, J NATL COMPR CANC NE, V9, P1086; Kohman L J, 1997, Chest Surg Clin N Am, V7, P105; MEYER JA, 1982, J THORAC CARDIOV SUR, V83, P12; SHIELDS TW, 1982, J THORAC CARDIOV SUR, V84, P481; Sobin LH, 2009, TNM CLASSIFICATION M; Varlotto JM, 2011, J THORAC CARDIOV SUR, V142, P538, DOI 10.1016/j.jtcvs.2010.11.062	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1759-7706	1759-7714		THORAC CANCER	Thorac. Cancer	MAR	2015	6	2					141	145		10.1111/1759-7714.12154		5	Oncology; Respiratory System	Oncology; Respiratory System	CC6RA	WOS:000350493500003		
J	Hayashi, S; Tanaka, H; Hoshi, H				Hayashi, Shinya; Tanaka, Hidekazu; Hoshi, Hiroaki			Imaging characteristics of local recurrences after stereotactic body radiation therapy for stage I non-small cell lung cancer: Evaluation of mass-like fibrosis	THORACIC CANCER			English	Article						Local neoplasm recurrence; lung cancer; positron-emission tomography; radiation fibrosis; stereotactic body radiotherapy	ABLATIVE RADIOTHERAPY; F-18-FDG PET/CT; TUMOR RECURRENCE; CT; INJURY; SBRT; PATTERNS; TRIAL	BackgroundThis study aimed to evaluate stereotactic body radiation therapy (SBRT) in patients with stage I non-small cell lung cancer (NSCLC) in terms of radiation-induced changes and computed tomography (CT) features of local recurrence by 18F-fluorodeoxyglucose positron emission tomography (F-18-FDG-PET). MethodsFrom January 2006 to December 2012, 81 patients with NSCLC received SBRT. Follow-up consisted of non-contrast enhanced CT scans performed before and every four months after SBRT. In addition, 18F-FDG-PET/CT was conducted before SBRT for each patient, and one year later for each case suspected of recurrence. The CT findings were classified into two categories: mass-like fibrosis and others. The mass-like fibrosis category was subdivided into two patterns: mass-like consolidation (with air bronchogram) and mass-like opacity. ResultsSix patients had histologically confirmed local recurrence, including 83% (5/6) with mass-like opacity pattern and one case of modified conventional pattern (P = 0.02). In contrast, the non-recurrent group exhibited only 7% (5/75) with mass-like opacity and 13% (10/75) with mass-like consolidation pattern. Five patients with local recurrence presented with the mass-like opacity pattern, compared with 33% of patients (5/15) from the non-recurrent group (P = 0.01) and showed an increase in maximum diameter at 12 months after SBRT. The recurrent group also had a significantly higher standardized uptake value (SUVmax) than the non-recurrent group (P < 0.001), with all values >5 (range: 5.7-25.4). ConclusionThe following characteristics of mass-like fibrosis should be considered indicators of local recurrence after SBRT: opacity pattern, increasing maximum diameter, and SUVmax > 5.	[Hayashi, Shinya; Tanaka, Hidekazu; Hoshi, Hiroaki] Gifu Univ, Grad Sch Med, Dept Radiol, Gifu 5011194, Japan	Hayashi, S (reprint author), Gifu Univ, Grad Sch Med, Dept Radiol, 1-1 Yanagido, Gifu 5011194, Japan.	shayashi@gifu-u.ac.jp					Senthi S, 2012, LANCET ONCOL, V13, P802, DOI 10.1016/S1470-2045(12)70242-5; Baumann P, 2009, J CLIN ONCOL, V27, P3290, DOI 10.1200/JCO.2008.21.5681; Huang K, 2012, RADIOTHER ONCOL, V102, P335, DOI 10.1016/j.radonc.2011.12.018; Dahele M, 2011, J THORAC ONCOL, V6, P1221, DOI 10.1097/JTO.0b013e318219aac5; Takeda A, 2008, INT J RADIAT ONCOL, V70, P1057, DOI 10.1016/j.ijrobp.2007.07.2383; Linda A, 2011, EUR J RADIOL, V79, P147, DOI 10.1016/j.ejrad.2009.10.029; Takeda A, 2013, LUNG CANCER, V79, P248, DOI 10.1016/j.lungcan.2012.11.008; Kimura T, 2006, INT J RADIAT ONCOL, V66, P483, DOI 10.1016/j.ijrobp.2006.05.008; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Nagata Y, 2005, INT J RADIAT ONCOL, V63, P1427, DOI 10.1016/j.ijrobp.2005.05.034; Matsuo Y, 2007, INT J CLIN ONCOL, V12, P356, DOI 10.1007/s10147-007-0691-9; Nakajima N, 2013, ANN NUCL MED, V27, P261, DOI 10.1007/s12149-012-0682-4; Nagata Y, 2011, INT J RADIAT ONCOL, V79, P660, DOI 10.1016/j.ijrobp.2010.10.004; Kato S, 2010, JPN J RADIOL, V28, P259, DOI 10.1007/s11604-009-0415-3; Nagata Y, 2010, INT J RADIAT ONCOL, V78, pS27; Onishi H, 2011, INT J RADIAT ONCOL, V81, P1352, DOI 10.1016/j.ijrobp.2009.07.1751; Trovo M, 2010, LUNG CANCER, V69, P77, DOI 10.1016/j.lungcan.2009.09.006; Israel O, 2007, J NUCL MED, V48, p28S; Takeda T, 2004, AM J ROENTGENOL, V182, P1123; Tarohda TI, 2011, MED PHYS, V38, P4141, DOI 10.1118/1.3604151	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1759-7706	1759-7714		THORAC CANCER	Thorac. Cancer	MAR	2015	6	2					186	193		10.1111/1759-7714.12162		8	Oncology; Respiratory System	Oncology; Respiratory System	CC6RA	WOS:000350493500010		
J	Ikezoe, K; Handa, T; Tanizawa, K; Kubo, T; Ito, I; Sokai, A; Nakatsuka, Y; Nagai, S; Izumi, T; Mishima, M				Ikezoe, K.; Handa, T.; Tanizawa, K.; Kubo, T.; Ito, I.; Sokai, A.; Nakatsuka, Y.; Nagai, S.; Izumi, T.; Mishima, M.			A toll-like receptor 3 single nucleotide polymorphism in Japanese patients with sarcoidosis	TISSUE ANTIGENS			English	Article						cardiac sarcoidosis; single nucleotide polymorphism; toll-like receptor 3	CARDIAC SARCOIDOSIS; TLR3 GENE; INTERFERON; MANAGEMENT; DISEASE; CARDIOMYOPATHY; SUSCEPTIBILITY; INVOLVEMENT; MYOCARDITIS; DIAGNOSIS	Toll-like receptor 3 (TLR3) may be associated with T helper 1 immune response. This study aimed to investigate the role of a functional TLR3 single nucleotide polymorphism (SNP) in sarcoidosis. We genotyped 220 Japanese patients with sarcoidosis and 140 controls for TLR3SNP rs3775291 to analyze its association with susceptibility to sarcoidosis and assessed its relationship to clinical features in 172 patients over 2years. The TLR3 rs3775291 genotype was not significantly associated with disease susceptibility. However, patients with cardiac sarcoidosis (CS) significantly more frequently had the TT genotype (p<0.01) or the T allele (p<0.05) than those patients without CS. We conclude that TLR3SNP rs3775291 may affect cardiac involvement in Japanese patients with sarcoidosis.	[Ikezoe, K.; Handa, T.; Ito, I.; Sokai, A.; Nakatsuka, Y.; Mishima, M.] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto 6068507, Japan; [Tanizawa, K.] Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto 6068507, Japan; [Kubo, T.] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto 6068507, Japan; [Nagai, S.; Izumi, T.] Clin Res Ctr, Kyoto Cent Clin, Kyoto, Japan	Handa, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto 6068507, Japan.	hanta@kuhp.kyoto-u.ac.jp			Ministry of Health, Labor and Welfare of Japan; Japan Society for the Promotion of Science	We appreciate the help provided by Dr S. Kadowaki (Ono Municipal Hospital) in collecting control samples. We are grateful to Professor K. Chin and Dr T. Oga (Department of Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University) for their academic advice. We would also like to thank Ms M. Yokota and Ms S. Nakajima for their help in the outpatient clinical practice, and Ms I. Morioka and Ms S. Shima for their secretarial help. We are grateful to Mr S. Ueda, Ms N. Matsuzaki, and Ms M. Hiramatsu for their technical assistance; Ms Y. Maeda for her laboratory work; and Ms T. Toki for her help with the manuscript preparation. This work was supported by a research fund from the Ministry of Health, Labor and Welfare of Japan and a Grant-in-Aid from the Japan Society for the Promotion of Science. Complete responsibility for the integrity and accuracy of the data analysis: TH. Conception and design: TH. Analysis and interpretation of the data: KI, TH, and KT. Writing of the paper: KI. Critical revision of the article for important intellectual content: TH, SN, TK, AS, YN, TI, and MM. Final approval of the article: SN, TI, and MM. Collection and assembly of the data and samples: KI, TH, KT, II, TK, and SN.	Abston ED, 2013, AM J PHYSIOL-REG I, V304, pR267, DOI 10.1152/ajpregu.00516.2011; Pabst S, 2006, CLIN EXP IMMUNOL, V143, P420, DOI 10.1111/j.1365-2249.2006.03008.x; Nagai S, 2008, CLIN CHEST MED, V29, P565, DOI 10.1016/j.ccm.2008.03.006; Perales-Linares R, 2013, IMMUNOLOGY, V140, P153, DOI 10.1111/imm.12143; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; O'Dwyer DN, 2013, AM J RESP CRIT CARE, V188, P1442, DOI 10.1164/rccm.201304-0760OC; Hamzeh NY, 2012, CHEST, V141, P154, DOI 10.1378/chest.11-0263; Joshi AD, 2008, EUR J IMMUNOL, V38, P3436, DOI 10.1002/eji.200838629; Kutikhin AG, 2011, HUM IMMUNOL, V72, P1095, DOI 10.1016/j.humimm.2011.07.307; Birnie DH, 2014, HEART RHYTHM, V11, P1304, DOI 10.1016/j.hrthm.2014.03.043; Okura Y, 2003, J AM COLL CARDIOL, V41, P322, DOI 10.1016/S0735-1097(02)02715-8; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Alazemi S, 2006, INT J CLIN PRACT, V60, P201, DOI 10.1111/j.1368-5031.2005.00651.x; Judson MA, 1999, SARCOIDOSIS VASC DIF, V16, P75; Assmann TS, 2014, EUR J ENDOCRINOL, V170, P519, DOI 10.1530/EJE-13-0963; Pabst S, 2013, ADV EXP MED BIOL, V756, P239, DOI 10.1007/978-94-007-4549-0_30; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Dubrey SW, 2010, PROG CARDIOVASC DIS, V52, P336, DOI 10.1016/j.pcad.2009.11.010; Askar E, 2009, J MED VIROL, V81, P1204, DOI 10.1002/jmv.21491; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Soejima K, 2009, J CARDIOVASC ELECTR, V20, P578, DOI 10.1111/j.1540-8167.2008.01417.x; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Valeyre D, 2014, LANCET, V383, P1155, DOI 10.1016/S0140-6736(13)60680-7; Chakravarty SD, 2012, SEMIN ARTHRITIS RHEU, V42, P206, DOI 10.1016/j.semarthrit.2012.03.008; Gao B, 2010, GASTROENTEROLOGY RES, V2010; Gorbea C, 2010, J BIOL CHEM, V285, P23206, DOI 10.1074/jbc.M109.047464; Handa T, 2010, SARCOIDOSIS VASC DIF, V27, P27; Handa T, 2003, SARCOIDOSIS VASC DIF, V20, P190; IWAI K, 1994, SARCOIDOSIS, V11, P26; Naruse TK, 2000, TISSUE ANTIGENS, V56, P52, DOI 10.1034/j.1399-0039.2000.560107.x	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-2815	1399-0039		TISSUE ANTIGENS	Tissue Antigens	MAR	2015	85	3					204	208		10.1111/tan.12535		5	Cell Biology; Immunology; Pathology	Cell Biology; Immunology; Pathology	CC6DW	WOS:000350456100008		
J	Inoue, N; Watanabe, M; Katsumata, Y; Ishido, N; Hidaka, Y; Iwatani, Y				Inoue, N.; Watanabe, M.; Katsumata, Y.; Ishido, N.; Hidaka, Y.; Iwatani, Y.			Association between functional polymorphisms in the toll-like receptor 4 (TLR4) gene and HD severity	TISSUE ANTIGENS			English	Letter							PATTERN-RECOGNITION RECEPTORS; TUMOR-NECROSIS-FACTOR; HASHIMOTOS-DISEASE; PROTEIN; CELLS		[Inoue, N.; Watanabe, M.; Katsumata, Y.; Ishido, N.; Iwatani, Y.] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Biomed Informat, Suita, Osaka 5650871, Japan; [Hidaka, Y.] Osaka Univ, Grad Sch Med, Dept Lab Med, Suita, Osaka 5650871, Japan	Iwatani, Y (reprint author), Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Biomed Informat, Yamadaoka 1-7 Suita, Suita, Osaka 5650871, Japan.	iwatani@sahs.med.osaka-u.ac.jp					Marta M, 2009, AUTOIMMUN REV, V8, P506, DOI 10.1016/j.autrev.2009.01.006; Nanba T, 2009, THYROID, V19, P495, DOI 10.1089/thy.2008.0423; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Morohoshi K, 2011, DISCOV MED, V67, P505; Duan ZX, 2007, SHOCK, V28, P160, DOI 10.1097/SHK.0b013e31803df782; Liu Y, 2014, INT J BIOCHEM CELL B, V47, P47, DOI [10.1016/j.biocel.2013.11.018, 10.1016/j.bioce1.2013.11.018]; Aust G, 1996, CLIN EXP IMMUNOL, V105, P148, DOI 10.1046/j.1365-2249.1996.d01-726.x; Chu WM, 2013, CANCER LETT, V328, P222, DOI 10.1016/j.canlet.2012.10.014; Watanabe M, 2002, THYROID, V12, P801, DOI 10.1089/105072502760339370	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-2815	1399-0039		TISSUE ANTIGENS	Tissue Antigens	MAR	2015	85	3					209	211		10.1111/tan.12518		3	Cell Biology; Immunology; Pathology	Cell Biology; Immunology; Pathology	CC6DW	WOS:000350456100009		
J	Stickley, A; Koyanagi, A; Roberts, B; Leinsalu, M; Goryakin, Y; McKee, M				Stickley, Andrew; Koyanagi, Ai; Roberts, Bayard; Leinsalu, Mall; Goryakin, Yevgeniy; McKee, Martin			Smoking status, nicotine dependence and happiness in nine countries of the former Soviet Union	TOBACCO CONTROL			English	Article							HAZARDOUS ALCOHOL-CONSUMPTION; CROSS-SECTIONAL SURVEY; SELF-REPORTED SMOKING; EX-SMOKERS; PSYCHIATRIC-DISORDERS; MULTILEVEL DATA; CESSATION; HEALTH; TOBACCO; HAPPIER	Background The US Food and Drug Administration has established a policy of substantially discounting the health benefits of reduced smoking in its evaluation of proposed regulations because of the cost to smokers of the supposed lost pleasure they suffer by no longer smoking. This study used data from nine countries of the former Soviet Union (fSU) to explore this association in a setting characterised by high rates of (male) smoking and smoking-related mortality. Methods Data came from a cross-sectional population-based study undertaken in 2010/2011 in Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia and Ukraine. Information was collected from 18 000 respondents aged >= 18 on smoking status (never, ex-smoking and current smoking), cessation attempts and nicotine dependence. The association between these variables and self-reported happiness was examined using ordered probit regression analysis. Results In a pooled country analysis, never smokers and ex-smokers were both significantly happier than current smokers. Smokers with higher levels of nicotine dependence were significantly less happy than those with a low level of dependence. Conclusions This study contradicts the idea that smoking is associated with greater happiness. Moreover, of relevance for policy in the fSU countries, given the lack of public knowledge about the detrimental effects of smoking on health but widespread desire to quit reported in recent research, the finding that smoking is associated with lower levels of happiness should be incorporated in future public health efforts to help encourage smokers to quit by highlighting that smoking cessation may result in better physical and emotional health.	[Stickley, Andrew; Roberts, Bayard; McKee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England; [Stickley, Andrew; Leinsalu, Mall] Sodertorn Univ, Stockholm Ctr Hlth Soc Transit SCOHOST, S-14189 Huddinge, Sweden; [Stickley, Andrew] Univ Tokyo, Grad Sch Med, Dept Human Ecol, Tokyo, Japan; [Koyanagi, Ai] Fundacio St Joan de Deu, Res & Dev Unit, Barcelona, Spain; [Koyanagi, Ai] Cibersam, Inst Salud Carlos 3, Ctr Invest Biomed Red Salud Mental, Madrid, Spain; [Leinsalu, Mall] Natl Inst Hlth Dev, Dept Epidemiol & Biostat, Tallinn, Estonia; [Goryakin, Yevgeniy] Univ E Anglia, Norwich Med Sch, Hlth Econ Grp, Norwich NR4 7TJ, Norfolk, England	Stickley, A (reprint author), Sodertorn Univ, Stockholm Ctr Hlth Soc Transit SCOHOST, S-14189 Huddinge, Sweden.	andrew.stickley@sh.se	Goryakin, Yevgeniy/E-4658-2015	Goryakin, Yevgeniy/0000-0002-3063-6099	European Union [HEALTH-F2-2009-223344]; CIBERSAM	This work was supported by the European Union's 7th Framework Programme, project HEALTH-F2-2009-223344. The European Commission cannot accept any responsibility for any information provided or views expressed. AK's work was supported by a Miguel Servet contract by CIBERSAM.	Adan A, 2000, HUM PSYCHOPHARM CLIN, V15, P287, DOI 10.1002/1099-1077(200006)15:4<287::AID-HUP175>3.3.CO;2-C; Fidler JA, 2009, NICOTINE TOB RES, V11, P1182, DOI 10.1093/ntr/ntp120; Parrott AC, 2012, HUM PSYCHOPHARM CLIN, V27, P150, DOI 10.1002/hup.1247; Kahler CW, 2009, NICOTINE TOB RES, V11, P833, DOI 10.1093/ntr/ntp073; Wierzbicka A, 2004, DAEDALUS-US, V133, P34, DOI 10.1162/001152604323049370; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Murphy A, 2014, EUR J PUBLIC HEALTH, V24, P572, DOI 10.1093/eurpub/ckt213; Mentzakis E, 2013, SOC SCI MED, V89, P1, DOI 10.1016/j.socscimed.2013.04.019; Shahab L, 2012, DRUG ALCOHOL DEPEN, V121, P38, DOI 10.1016/j.drugalcdep.2011.08.011; McClave AK, 2009, ADDICT BEHAV, V34, P491, DOI 10.1016/j.addbeh.2009.01.005; Weinstein ND, 2005, TOB CONTROL, V14, P55, DOI 10.1136/tc.2004.008375; Cockerham WC, 2012, SOCIOL HEALTH ILL, V34, P943, DOI 10.1111/j.1467-9566.2011.01454.x; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; Dube SR, 2009, INT J PUBLIC HEALTH, V54, P68, DOI 10.1007/s00038-009-0009-y; Fong GT, 2004, NICOTINE TOB RES, V6, P341, DOI 10.1080/14622200412331320743; Abdel-Khalek AM, 2006, SOC BEHAV PERSONAL, V34, P139, DOI 10.2224/sbp.2006.34.2.139; Murphy A, 2014, HEALTH PLACE, V27, P205, DOI 10.1016/j.healthplace.2014.02.015; Schiffrin HH, 2010, J HAPPINESS STUD, V11, P33, DOI 10.1007/s10902-008-9104-7; Breslau N, 2004, BIOL PSYCHIAT, V55, P69, DOI 10.1016/S0006-3223(03)00317-2; Wang MP, 2014, ADDICTION, V109, P1165, DOI 10.1111/add.12531; Mojtabai R, 2013, AM J PUBLIC HEALTH, V103, P1656, DOI 10.2105/AJPH.2012.300911; Piper ME, 2012, ANN BEHAV MED, V43, P262, DOI 10.1007/s12160-011-9329-2; McCartney G, 2011, TOB CONTROL, V20, P166, DOI 10.1136/tc.2010.037929; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Blanchflower DG, 2011, ACAD MANAGE PERSPECT, V25, P6; Lee WB, 2009, HEALTH PSYCHOL, V28, P457, DOI 10.1037/a0014669; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Shahab L, 2009, NICOTINE TOB RES, V11, P553, DOI 10.1093/ntr/ntp031; Vartiainen E, 2002, J EPIDEMIOL COMMUN H, V56, P167, DOI 10.1136/jech.56.3.167; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; Piqueras JA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-443; Roberts B, 2013, NICOTINE TOB RES, V15, P271, DOI 10.1093/ntr/nts100; Aubin HJ, 2012, NEUROSCI BIOBEHAV R, V36, P271, DOI 10.1016/j.neubiorev.2011.06.007; Beard E., 2014, J SMOKING CESSATION, V9, P1; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Braillon A, 2013, PUBLIC HEALTH, V127, P395, DOI 10.1016/j.puhe.2013.01.018; Brawley OW, 2014, CA-CANCER J CLIN, V64, P5, DOI 10.3322/caac.21210; Carmody TP, 2007, J PSYCHOACTIVE DRUGS, V39, P499; Centers for Disease Control and Prevention, TOB REL MORT; Chaiton MO, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-356; Chassin L, 2002, HEALTH PSYCHOL, V21, P438, DOI 10.1037//0278-6133.21.5.438; Chu A, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.038349; Cook BL, 2003, ADDICTION, V98, P1547, DOI 10.1046/j.1360-0443.2003.00563.x; FAGERSTROM K O, 1990, Ear Nose and Throat Journal, V69, P763; Footman K, 2013, NICOTINE TOB RES, V15, P1628, DOI 10.1093/ntr/ntt034; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Moore SC, 2009, APPL ECON LETT, V16, P395, DOI 10.1080/13504850601018502; OECD, 2013, OECD GUID MEAS SUBJ; Parrott AC, 2003, WORLD J BIOL PSYCHIA, V4, P49; Roberts B, 2012, AM J PUBLIC HEALTH, V102, P1320, DOI 10.2105/AJPH.2011.300547; Roberts B, 2013, SIGHT SOUND, V23, P22; Schoenbaum M, 1997, AM J PUBLIC HEALTH, V87, P755, DOI 10.2105/AJPH.87.5.755; Song AV, 2014, AM J PUBLIC HEALTH, V104, pE42, DOI 10.2105/AJPH.2013.301737; Stickley A, 2009, SCAND J PUBLIC HEALT, V37, P632, DOI 10.1177/1403494809105434; VEENHOVEN R, 1997, REV QUEBECOISE PSYCH, V0018	55	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0964-4563	1468-3318		TOB CONTROL	Tob. Control	MAR	2015	24	2					190	197		10.1136/tobaccocontrol-2014-052092		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CC4QH	WOS:000350337500022		
J	Yamamoto-Wilson, JR				Yamamoto-Wilson, John R.			The Spanish Bawd.	TRANSLATION AND LITERATURE			English	Book Review									[Yamamoto-Wilson, John R.] Sophia Univ, Tokyo, Japan	Yamamoto-Wilson, JR (reprint author), Sophia Univ, Tokyo, Japan.						MABBE J, 2013, SPANISH BAWD	1	0	0	EDINBURGH UNIV PRESS	EDINBURGH	THE TUN-HOLYROOD RD, 12 2F JACKSONS ENTRY, EDINBURGH EH8 8PJ, ENGLAND	0968-1361	1750-0214		TRANSL LIT	Transl. Lit.	MAR	2015	24	1					99	103		10.3366/tal.2015.0188		5	Literature	Literature	CC6NN	WOS:000350482000051		
J	Nakamura, S; Hayashidani, H; Okabe, N; Une, Y				Nakamura, S.; Hayashidani, H.; Okabe, N.; Une, Y.			Aberrant Forms of Yersinia pseudotuberculosis as Spheroplasts and Filaments in Yersiniosis in Squirrel Monkeys	VETERINARY PATHOLOGY			English	Article						amoxicillin; atypical bacterial forms; cephazolin; filament; spheroplast; squirrel monkey; Yersinia pseudotuberculosis	GRAM-NEGATIVE BACTERIA; ANTIBIOTICS; MORPHOLOGY; PROTEINS	This report describes atypical cases of yersiniosis in squirrel monkeys in which aberrant forms of Yersinia pseudotuberculosis were seen. There were 2 outbreaks due to yersiniosis in squirrel monkeys in Japan. The monkeys had systemic necrotizing and hemorrhagic lesions with Gram-negative rod-shaped bacilli and microthromboembolism in the kidneys. Some lesions contained filaments, globular bodies, and other pleomorphic forms of bacteria. All forms were usually seen in the same lesions, and those with pleomorphic morphology appeared to be an intermediate form between the rod-shaped bacteria and the filaments or globular bodies. In addition, they had strong immunolabeling for Y. pseudotuberculosis, as did the rod-shaped bacteria. Therefore, the globular bodies, filaments, and others are strongly suspected to be shape-changed bacilli of Y. pseudotuberculosis. These morphologically altered bacteria could cause errors in diagnosis since they resemble fungi or protozoa, and special staining techniques, including immunohistochemistry, can be helpful in establishing the correct diagnosis.	[Nakamura, S.; Une, Y.] Azabu Univ, Lab Vet Pathol, Sagamihara, Kanagawa 2525201, Japan; [Hayashidani, H.] Tokyo Univ Agr & Technol, Inst Symbiot Sci & Technol, Fuchu, Tokyo, Japan; [Okabe, N.] Aso Cuddly Dominion, Kumamoto, Japan	Une, Y (reprint author), Azabu Univ, Sch Vet Med, Lab Vet Pathol, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	une@azabu-u.ac.jp	HAYASHIDANI, HIDEKI/G-1126-2013; 	Une, Yumi/0000-0002-2112-1894	Ministry of Health, Labor and Welfare of Japan [H24-Shinko-Ippan-006];  [23310169]	The author(s) received the following financial support for the research, authorship, and/or publication of this article: This work was supported by a Grant-in-Aid for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labor and Welfare of Japan (H24-Shinko-Ippan-006), and Grant-in-Aid for Scientific Research (B) (#23310169).	Dalhoff A, 2003, CHEMOTHERAPY, V49, P172, DOI 10.1159/000071141; LORIAN V, 1982, J CLIN MICROBIOL, V16, P382; Iwata T, 2008, VET MICROBIOL, V129, P404, DOI 10.1016/j.vetmic.2007.11.029; BRONSON RT, 1972, AM J PATHOL, V69, P289; MAGNUSSEN CR, 1980, J CLIN MICROBIOL, V12, P690; BASKIN GB, 1977, J AM VET MED ASSOC, V171, P908; COULSON AFW, 1984, NATURE, V309, P668, DOI 10.1038/309668a0; SPRATT BG, 1988, REV INFECT DIS, V10, P699	8	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0300-9858	1544-2217		VET PATHOL	Vet. Pathol.	MAR	2015	52	2					393	396		10.1177/0300985814532820		4	Pathology; Veterinary Sciences	Pathology; Veterinary Sciences	CC7NX	WOS:000350556100022		
J	Tung, T; Matsuyama, T				Tung, Tony; Matsuyama, Takashi			Invariant shape descriptor for 3D video encoding	VISUAL COMPUTER			English	Article						Invariant shape descriptor; Dynamic surface; Geometry image; 3D video; Reeb graph	RECOGNITION; COMPRESSION; SURFACE; DEFORMATION; ANIMATION; GEOMETRY; CAPTURE; MESHES	This paper presents a novel approach to represent spatio-temporal visual information. We introduce a surface-based shape model whose structure is invariant to surface variations over time to describe 3D dynamic surfaces (e.g., 3D video obtained from multiview video capture). The descriptor is defined as a graph lying on object surfaces and anchored to invariant local features (e.g., surface point extrema). Geodesic consistency-based priors are used as cues within a probabilistic framework to maintain the graph invariant, even though the surfaces undergo non-rigid deformations. Our contribution brings to 3D geometric data a temporally invariant structure that relies only on intrinsic surface properties, and is independent of surface parameterization (i.e., surface mesh connectivity). The proposed descriptor can therefore be used for efficient dynamic surface encoding, through transformation into 2D (geometry) images, as its structure can provide an invariant representation for dynamic 3D mesh models. Various experiments on challenging publicly available datasets are performed to assess invariant property and performance of the descriptor.	[Tung, Tony; Matsuyama, Takashi] Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto, Japan	Tung, T (reprint author), Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto, Japan.	tony2ng@gmail.com; tm@i.kyoto-u.ac.jp			JST-CREST	This work was supported in part by the JST-CREST project "Creation of Human-Harmonized Information Technology for Convivial Society". The authors thank Dr. Lyndon Hill for his preliminary work on this project.	Alexa M., 2000, COMPUT GRAPH FORUM, V19, P411, DOI 10.1111/1467-8659.00433; Allard J., 2007, MARKERLESS 3D INTERA; Floater MS, 1997, COMPUT AIDED GEOM D, V14, P231, DOI 10.1016/S0167-8396(96)00031-3; Alliez P, 2005, MATH VIS, P3, DOI 10.1007/3-540-26808-1_1; Rothganger F, 2006, INT J COMPUT VISION, V66, P231, DOI 10.1007/s11263-005-3674-1; Memoli F, 2005, FOUND COMPUT MATH, V5, P313, DOI 10.1007/s10208-004-0145-y; Starck J, 2007, IEEE COMPUT GRAPH, V27, P21, DOI 10.1109/MCG.2007.68; Cornea ND, 2005, VISUAL COMPUT, V21, P945, DOI 10.1007/s00371-005-0308-0; Matsuyama T, 2004, COMPUT VIS IMAGE UND, V96, P393, DOI 10.1016/j.cviu.2004.03.012; Cignoni P, 1998, COMPUT GRAPH FORUM, V17, P167, DOI 10.1111/1467-8659.00236; Gu XF, 2002, ACM T GRAPHIC, V21, P355; Erickson J, 2004, DISCRETE COMPUT GEOM, V31, P37, DOI 10.1007/s00454-003-2948-z; Kavan L, 2007, I3D 2007: ACM SIGGRAPH SYMPOSIUM ON INTERACTIVE 3D GRAPHICS AND GAMES, PROCEEDINGS, P39; Sumner RW, 2004, ACM T GRAPHIC, V23, P399, DOI 10.1145/1015706.1015736; Hilaga M, 2001, COMP GRAPH, P203; FORSYTH D, 1991, IEEE T PATTERN ANAL, V13, P971, DOI 10.1109/34.99233; Carranza J, 2003, ACM T GRAPHIC, V22, P569, DOI 10.1145/882262.882309; Taubin G, 1998, ACM T GRAPHIC, V17, P84, DOI 10.1145/274363.274365; Baran I., 2007, ACM T GRAPHIC, V26, P27; Blum H., 1967, MODELS PERCEPTION SP, P362; Briceno H., 2003, EUR SIGGRAPH S COMP, P136; Bronstein AM, 2007, IEEE T VIS COMPUT GR, V13, P902, DOI 10.1109/TVCG.2007.1041; Cagniart C., 2010, P EUR C COMP VIS; Carr N. A., 2006, P 4 EUR S GEOM PROC, P181; de Aguiar E, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360697; Edelsbrunner H., 2004, P S COMP GEOM; Franco J., 2004, P IEEE C COMP VIS PA; Guo Y.W., 2005, SPRINGER LNCS; Habe H., 2004, P PICT COD S; Huang P., 2010, P 3DPVT; Jiang H., 2012, P EUR C COMP VIS; Kanade T., 1996, P IEEE C COMP VIS PA; Karni Z, 2004, COMPUT GRAPH-UK, V28, P25, DOI 10.1016/j.cag.2003.10.002; Klein T., 2005, P TOP BAS METH VIS; Mamou K., 2008, P IEEE INT C MULT EX; Matsuyama T., 2012, 3D VIDEO ITS APPL; Morse M., 1934, CALCULUS VARIATIONS, P18; Mortara M., 2002, P SHAP MOD INT; Mundy J. L., 1992, GEOMETRIC INVARIANCE; Palagyi K, 1999, GRAPH MODEL IM PROC, V61, P199, DOI 10.1006/gmip.1999.0498; Pascucci V., 2007, ACM T GRAPHIC, V26, P58; REEB G, 1946, CR HEBD ACAD SCI, V222, P847; Saboret L., 2012, CGAL REFERENCE MANUA; SANDER P. V., 2003, P S GEOM PROC, P146; Seitz S., 2006, P IEEE C COMP VIS PA; Starck J., 2005, P IEEE INT C COMP VI; Tung T., 2010, P IEEE C COMP VIS PA; Tung T, 2012, IEEE T PATTERN ANAL, V34, P1645, DOI 10.1109/TPAMI.2011.258; Tung T., 2012, P AS C COMP VIS; Tung T., 2007, P IEEE C COMP VIS PA; Tung T., 2005, International Journal of Shape Modeling, V11, DOI 10.1142/S0218654305000748; Vlasic D., 2008, ACM T GRAPHIC, V27, P97	52	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0178-2789	1432-2315		VISUAL COMPUT	Visual Comput.	MAR	2015	31	3					311	324		10.1007/s00371-014-0925-6		14	Computer Science, Software Engineering	Computer Science	CC3DB	WOS:000350223900006		
J	Otsubo, S; Yokomizo, A; Mochida, O; Shiota, M; Tatsugami, K; Inokuchi, J; Naito, S				Otsubo, Satoshi; Yokomizo, Akira; Mochida, Osamu; Shiota, Masaki; Tatsugami, Katsunori; Inokuchi, Junich; Naito, Seiji			Significance of prostate-specific antigen-related factors in incidental prostate cancer treated by holmium laser enucleation of the prostate	WORLD JOURNAL OF UROLOGY			English	Article						Incidental prostate cancer; Benign prostatic hyperplasia; Holmium laser enucleation of the prostate; Prostate-specific antigen	TRANSURETHRAL RESECTION; RADICAL PROSTATECTOMY; HYPERPLASIA; ERA	Recently, more vaporization techniques are available for the treatment of benign prostate hyperplasia (BPH). However, the detection of incidental prostate cancer (Pca) is impossible in vaporization techniques because of unavailability prostate tissue for histopathological analysis. To evaluate the clinical backgrounds and the usefulness of prostate-specific antigen (PSA)-related factors in incidental Pca, we employed our BPH patients cohort treated by holmium laser enucleation of the prostate (HoLEP). A total of 365 HoLEPs were performed by a single surgeon. The pathological results and pre- and post-HoLEP PSA, PSA density and PSA velocity were analyzed retrospectively. Incidental Pca was identified in 25 (6.8 %) of the 365 patients treated with HoLEP. There were significant differences between BPH and Pca in terms of prostate volume (55.5 vs. 47 ml, p = 0.0365), preoperative PSA (4.50 vs. 7.14 ng/ml, p = 0.0107), PSA density (0.079 vs. 0.155 ng/ml/cm(3), p = 0.0005), and postoperative PSA velocity (0.04 vs. 0.22 ng/ml/year, p = 0.0033), respectively. Comparisons of Gleason score subgroups in the 25 patients with incidental Pca identified significant differences in preoperative PSA (6.06 vs. 21.6 ng/ml, p = 0.0191) and postoperative PSA velocity (0.185 vs. 1.32 ng/ml/year, p = 0.0382) between the Gleason score 3 + 3 and Gleason score > 3 + 3 groups, respectively. Risk factors associated with incidental Pca were smaller prostate volume, higher preoperative PSA, and higher PSA density. Postoperative PSA velocity was also significantly increased in patients with incidental Pca, especially those with higher Gleason score. These finding may be useful in incident Pca patients treated by the vaporization technique.	[Otsubo, Satoshi; Yokomizo, Akira; Shiota, Masaki; Tatsugami, Katsunori; Inokuchi, Junich; Naito, Seiji] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Higashi Ku, Fukuoka 8128582, Japan; [Mochida, Osamu] Southwest Urol Clin, Fukuoka, Japan	Yokomizo, A (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Urol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yokoa@uro.med.kyushu-u.ac.jp			Kakenhi from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), Japan [25462484, 24890160]; Medical Research Promotion Grant from Takeda Science Foundation, Japan	This work was supported by Kakenhi (Grant Nos. 25462484 and 24890160) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), Japan, and a Medical Research Promotion Grant from Takeda Science Foundation, Japan.	Elmansy HM, 2009, UROLOGY, V74, P1105, DOI [10.1016/j.urology.2009.06.039, 10.1016/j.urologry.2009.06.039]; Tinmouth WW, 2005, J ENDOUROL, V19, P550, DOI 10.1089/end.2005.19.550; Naspro R, 2004, J UROLOGY, V171, P1203, DOI 10.1097/01.ju.0000099162.12144.8f; Nunez R, 2011, INT J UROL, V18, P543, DOI 10.1111/j.1442-2042.2011.02776.x; Melchior S, 2009, BJU INT, V103, P1478, DOI 10.1111/j.1464-410X.2008.08279.x; Jones JS, 2009, PROSTATE CANCER P D, V12, P57, DOI 10.1038/pcan.2008.14; Eggener SE, 2011, J UROLOGY, V185, P869, DOI 10.1016/j.juro.2010.10.057; Arlen PM, 2008, J UROLOGY, V179, P2181, DOI 10.1016/j.juro.2008.01.099; Capitanio U, 2008, EUR UROL, V54, P118, DOI 10.1016/j.eururo.2008.02.018; Elzayat EA, 2009, J UROLOGY, V182, P133, DOI 10.1016/j.juro.2009.02.117; Hirasawa Y, 2012, BJU INT, V110, pE864, DOI 10.1111/j.1464-410X.2012.11381.x; Nomura H, 2009, INT J UROL, V16, P657, DOI 10.1111/j.1442-2042.2009.02333.x; ZHANG G, 1991, J UROLOGY, V146, P99; Zigeuner RE, 2003, UROLOGY, V62, P451, DOI 10.1016/S0090-4295(03)00459-X	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-4983	1433-8726		WORLD J UROL	World J. Urol.	MAR	2015	33	3					329	333		10.1007/s00345-014-1310-9		5	Urology & Nephrology	Urology & Nephrology	CC5AO	WOS:000350369100006		
J	Yamane, M; Kawashima, K; Yamaguchi, K; Nagao, S; Sato, M; Suzuki, M; Honda, K; Hagita, H; Kuhlmann, O; Poirier, A; Fowler, S; Funk, C; Simon, S; Aso, Y; Ikeda, S; Ishigai, M				Yamane, Mizuki; Kawashima, Kosuke; Yamaguchi, Koji; Nagao, Shunsuke; Sato, Mika; Suzuki, Masayuki; Honda, Kiyofumi; Hagita, Hitoshi; Kuhlmann, Olaf; Poirier, Agnes; Fowler, Stephen; Funk, Christoph; Simon, Sandrine; Aso, Yoshinori; Ikeda, Sachiya; Ishigai, Masaki			In vitro profiling of the metabolism and drug-drug interaction of tofogliflozin, a potent and highly specific sodium-glucose co-transporter 2 inhibitor, using human liver microsomes, human hepatocytes, and recombinant human CYP	XENOBIOTICA			English	Article						CYP; diabetes mellitus; induction; inhibition; metabolism; SGLT2	SGLT2 INHIBITORS; RENAL GLUCOSURIA; AGENTS; RATS; MICE	1. The metabolism and drug-drug interaction (DDI) risk of tofogliflozin, a potent and highly specific sodium-glucose co-transporter 2 inhibitor, were evaluated by in vitro studies using human liver microsomes, human hepatocytes, and recombinant human CYPs. 2. The main metabolite of tofogliflozin was the carboxylated derivative (M1) in human hepatocytes, which was the same as in vivo. The metabolic pathway of tofogliflozin to M1 was considered to be as follows: first, tofogliflozin was catalyzed to the primary hydroxylated derivative (M4) by CYP2C18, CYP4A11 and CYP4F3B, then M4 was oxidized to M1. 3. Tofogliflozin had no induction potential on CYP1A2 and CYP3A4. Neither tofogliflozin nor M1 had inhibition potential on CYPs, with the exception of a weak CYP2C19 inhibition by M1. 4. Not only are multiple metabolic enzymes involved in the tofogliflozin metabolism, but the drug is also excreted into urine after oral administration, indicating that tofogliflozin is eliminated through multiple pathways. Thus, the exposure of tofogliflozin would not be significantly altered by DDI caused by any co-administered drugs. Also, tofogliflozin seems not to cause significant DDI of co-administered drugs because tofogliflozin has no CYP induction or inhibition potency, and the main metabolite M1 has no clinically relevant CYP inhibition potency.	[Yamane, Mizuki; Kawashima, Kosuke; Yamaguchi, Koji; Nagao, Shunsuke; Sato, Mika; Suzuki, Masayuki; Honda, Kiyofumi; Aso, Yoshinori; Ishigai, Masaki] Chugai Pharmaceut Co Ltd, Div Res, Shizuoka, Japan; [Hagita, Hitoshi] Chugai Res Inst Med Sci Inc, Shizuoka, Japan; [Kuhlmann, Olaf; Poirier, Agnes; Fowler, Stephen; Funk, Christoph; Simon, Sandrine] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Basel, Switzerland; [Ikeda, Sachiya] Chugai Pharmaceut Co Ltd, Project & Lifecycle Management Unit, Tokyo, Japan	Yamane, M (reprint author), Chugai Pharmaceut Co Ltd, Div Res, 1-135 Komakado, Gotemba, Shizuoka 4128513, Japan.	yamanemzk@chugai-pharm.co.jp					Vallon V, 2011, J AM SOC NEPHROL, V22, P104, DOI 10.1681/ASN.2010030246; Bjornsson TD, 2003, DRUG METAB DISPOS, V31, P815, DOI 10.1124/dmd.31.7.815; Magen D, 2005, KIDNEY INT, V67, P34, DOI 10.1111/j.1523-1755.2005.00053.x; Nagata T, 2013, BRIT J PHARMACOL, V170, P519, DOI 10.1111/bph.12269; Vallon V, 2013, AM J PHYSIOL-RENAL, V304, pF156, DOI 10.1152/ajprenal.00409.2012; Scheen AJ, 2005, DRUG SAFETY, V28, P601, DOI 10.2165/00002018-200528070-00004; Suzuki M, 2012, J PHARMACOL EXP THER, V341, P692, DOI 10.1124/jpet.112.191593; Santer R, 2003, J AM SOC NEPHROL, V14, P2873, DOI 10.1097/01.ASN.0000092790.89332.D2; Ohtake Y, 2012, J MED CHEM, V55, P7828, DOI 10.1021/jm300884k; Nagata T, 2013, AM J PHYSIOL-ENDOC M, V304, pE414, DOI 10.1152/ajpendo.00545.2012; Idris I, 2009, DIABETES OBES METAB, V11, P79, DOI 10.1111/j.1463-1326.2008.00982.x; Isaji M, 2007, CURR OPIN INVEST DR, V8, P285; Schwab D, 2012, DIABETOLOGIA, V55, pS316; Schwab D, 2013, CLIN PHARMACOKINET, V52, P463, DOI 10.1007/s40262-013-0051-z; Suzuki M, 2014, DIABETES OBES METAB, V16, P622, DOI 10.1111/dom.12259; Washburn WN, 2012, EXPERT OPIN THER PAT, V22, P483, DOI 10.1517/13543776.2012.680437; Yamaguchi K, 2013, J PHARMACOL EXP THER, V345, P52, DOI 10.1124/jpet.113.203125; Zell M, 2014, XENOBIOTICA, V44, P369, DOI 10.3109/00498254.2013.839847	18	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0049-8254	1366-5928		XENOBIOTICA	Xenobiotica	MAR	2015	45	3					230	238		10.3109/00498254.2014.976296		9	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CC6CH	WOS:000350451700006		
J	Nakamura, A; Hasegawa, Y; Kamei, M				Nakamura, Akihiro; Hasegawa, Yoichi; Kamei, Miwako			Learning Outcomes of Six-year Pharmaceutical Education Program	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Editorial Material									[Nakamura, Akihiro] Showa Univ, Sch Pharm, Tokyo 1428555, Japan; [Hasegawa, Yoichi] Meijo Univ, Fac Pharm, Tenpaku Ku, Nagoya, Aichi 4688503, Japan; [Kamei, Miwako] Nihon Univ, Sch Pharm, Funabashi, Chiba 2748555, Japan	Hasegawa, Y (reprint author), Meijo Univ, Fac Pharm, Tenpaku Ku, 150 Yagotoyama, Nagoya, Aichi 4688503, Japan.	yhasegaw@meijo-u.ac.jp						0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					331	332				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000001		
J	Kamei, M; Imoto, Y; Otowa, R; Shida, M; Hirai, Y; Nakamura, A				Kamei, Miwako; Imoto, Yumi; Otowa, Ryo; Shida, Miharu; Hirai, Yumi; Nakamura, Akihiro			Outcome of the 6-Year Curriculum for Pharmacy Education: "Contribution to Medical Care and Society: How Will I Act as a Pharmacist in the Future?"-A Report on the 3rd National Student Workshop-	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						six-year curriculum; pharmacy education; students' workshop		In August 2013, the Pharmaceutical Society of Japan held the Third National Student Workshop in Tokyo. A total of 88 people-70 sixth-year undergraduate students from 70 universities, and 18 alumni who had participated in the First and the Second Workshops attended this Workshop. The theme of this Workshop was "Contribution to medical care and society: How will I act as a pharmacist in the future?" The first day took the form of a World Cafe, with participants exchanging information on such topics as, "The purpose for choosing a pharmacy major, and my achievement status", "My favorite aspects of my college", and "My dreams and paths: Painting my future image". Later that day, participants discussed and gave presentations on the ways they would be contributing as pharmacists to society and medical care. On the second day, participants discussed and gave presentations on the efforts they would like to make as pharmacists to contribute to society and medical care. The final session was a general assembly for discussion on the ways they would be contributing as pharmacists to society and medical care. Throughout the two days, attendees participated in discussions with an awareness of their common ground, in that they all had national qualification in spite of different intended paths. In this article, 4 sixth-year students (their status at the time of the symposium) from the Workshop introduce outlines of the discussions and products from each group.	[Kamei, Miwako] Nihon Univ, Sch Pharm, Funabashi, Chiba 2748555, Japan; [Imoto, Yumi] Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Kyoto 6100395, Japan; [Otowa, Ryo] Tohoku Pharmaceut Univ, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Shida, Miharu] Kobe Pharmaceut Univ, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Hirai, Yumi] Kumamoto Univ, Sch Pharm, Chuo Ku, Kumamoto 8620973, Japan; [Nakamura, Akihiro] Showa Univ, Sch Pharm, Shinagawa Ku, Tokyo 1428555, Japan	Kamei, M (reprint author), Nihon Univ, Sch Pharm, 7-7-1 Narashinodai, Funabashi, Chiba 2748555, Japan.	kamei.miwako@nihon-u.ac.jp					Brown J., 2008, WORLD CAFE SHAPING O; Katori K., 2009, WORLD CAFE WO YAROU; Kawakita J., 1967, HASSOHO SOUZOUSEIKAI; Kawakita J., 1970, ZOKU HASSOHO KJ HO N	4	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					333	337				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000002		
J	Takahashia, H; Kosano, H				Takahashia, Hiroshi; Kosano, Hiroshi			Introduction of Outcome-based Education in Pharmaceutical Education in Japan	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						outcome-based education; pharmaceutical education; model core curriculum; rubric		Although Japanese medical and pharmaceutical educators have been interested in outcome-based education (OBE) in recent years, there are still many difficulties and problematic concepts involved in curriculum building, especially in determining objectives and assessment methods. From 2015, OBE will be incorporated in a model core curriculum of pharmaceutical education in Japan. In this paper, we will introduce the outline of an operative sample of OBE derived from the National Competency Standards Framework for Pharmacists in Australia. The products shown in this paper are examples of standards, elements, and some rubric scales and descriptors in the domain of "Practical ability in pharmaceutical therapy", as presented by the Ministry of Education, Culture, Sports, Science and Technology of Japan, and as proposed by many participants attending The Pharmaceutical Society of Japan's 3rd advanced workshop for pharmaceutical educators in 2013. We expect a helpful outline will enable each educational institution to design an appropriate OBE curriculum.	[Takahashia, Hiroshi] Miyoshi Pharm, Akita 0140014, Japan; [Kosano, Hiroshi] Teikyo Univ, Itabashi Ku, Tokyo 1738605, Japan	Kosano, H (reprint author), Teikyo Univ, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	h-kosano@pharm.teikyo-u.ac.jp					Harden RM, 1999, MED TEACH, V21, P7; Hart D., 1992, AUTHENTIC ASSESSMENT; Matsushita K., 2012, KYOTO U RES HIGHER E, V18, P75; Ministry of Education Culture Sports Science and Technology, 2014, MOD COR CURR PHARM E; Ministry of Education Culture Sports Science and Technology Central Council for Education, 2012, AR MIR WO KIZ TAM DA; Pharmaceutical Society of Australia, 2010, NAT COMP STAND FRAM; The Pharmaceutical Society of Japan, 2014, 3 ADV WORKSH PHARM T	7	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					339	343				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000003		
J	Sato, E				Sato, Eiji			Design of Spiral Curriculum for Pharmacy Students to Reach the Outcome	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						spiral curriculum; pharmacy education; outcome-based education; practical ability in medical therapy		The third advanced workshop of the Pharmaceutical Society of Japan for pharmaceutical teachers was held from October 12th to 14th, 2013, and participants discussed an outcome-based approach to curriculum development in pharmacy education. In this article, I report the outcome-based spiral curriculum model of group 2A, which was designed to enable pharmacy students to understand a patient's condition, and to provide a basic practical ability in medical therapy. In the curriculum, pharmacy students will learn biochemistry and functional morphology in the first and second years, skills to interview patients in the third year, pathophysiology and pharmacotherapeutics in the third and fourth years, skills to estimate patient disease from physical examination in the fourth year, and practice in understanding real patient conditions in a clinical clerkship in the fifth year. The curriculum also included learning and evaluation methods.	Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Fukuyama, Hiroshima 7290292, Japan	Sato, E (reprint author), Fukuyama Univ, Fac Pharm & Pharmaceut Sci, 1 Sanzo,Gakuen Cho, Fukuyama, Hiroshima 7290292, Japan.	sato@fupharm.fukuyama-u.ac.jp					Harden RM, 1999, MED TEACH, V21, P141, DOI 10.1080/01421599979752; Miller GE, 1990, ACAD MED S, V65, P63	2	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					345	347				3	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000004		
J	Okada, H				Okada, Hiroshi			Program to Learn about the Empowerment: Diabetic Theater, a Workshop Including Drama and Discussion	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Editorial Material									[Okada, Hiroshi] Natl Hosp Org Kyoto Med Ctr, Clin Res Inst, Div Prevent Med, Fushimi Ku, Kyoto 6128555, Japan	Okada, H (reprint author), Natl Hosp Org Kyoto Med Ctr, Clin Res Inst, Div Prevent Med, Fushimi Ku, 1-1 Mukaihata Cho, Kyoto 6128555, Japan.	bufobufo.ok@gmail.com						0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					349	350				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000005		
J	Okazaki, K				Okazaki, Kentaro			"Throw Your Hammer!" The Essence of Patient Empowerment in Diabetes	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						patient empowerment; patient-health care provider relationship; communication; diabetes; drama		The empowerment approach to patients with diabetes is a philosophy that was introduced by Robert M. Anderson and Martha M. Funnell of Michigan Diabetes Research and Training Center in the 1990s. This approach is based on the observation that more than 98% of diabetes care is performed by patients themselves. Dr. Anderson, Ms. Funnell, and their colleagues found that every patient has a right and an ability to solve his/her own problem in his/her own diabetes. Therefore healthcare providers should provide support for patients own endeavors. Empowerment has three essential elements: 1) the patient is centered, they make a final decision of their daily self-management, and are responsible for those decisions and the results; 2) patient support is the main role of healthcare providers; and 3) patient and healthcare providers should collaborate. In this author's opinion, it is important for healthcare providers to improve their communication skills to use the empowerment approach to help patients change their behaviors in the real world. To encourage empowerment, we created a unique learning program for healthcare providers, named "Diabetes Theater". This program is an interactive workshop comprising two parts: drama and discussion.	Nagoya Univ, Grad Sch Med, Dept Dev Community Oriented Healthcare Syst, Showa Ku, Nagoya, Aichi 4668550, Japan	Okazaki, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Dev Community Oriented Healthcare Syst, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	okazaki@med.nagoya-u.ac.jp					Anderson B., 2003, PRACTICAL PSYCHOL DI; Anderson R. M., 2005, ART EMPOWERMENT STOR; Arakaki Y., 2008, JPN J DIABET MAST CL, V6, P564; Asahina T., 2010, ENDOCRINOLOGY DIABET, V31, P268; Funnell MM, 2004, CLIN DIABETES, V22, P123, DOI DOI 10.2337/DIACLIN.22.3.115; Funnell M M, 1991, Diabetes Educ, V17, P37, DOI 10.1177/014572179101700108; Nishikawa T, 2013, HYPERTENS RES, V36, P924, DOI 10.1038/hr.2013.107; Okada H., 2012, CLIN PHARM, V4, P504	8	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					351	355				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000006		
J	Nishimura, H; Okadab, H				Nishimura, Hiroyuki; Okadab, Hiroshi			Diabetes Theater in Kumamoto: Scenario of the Diabetes Theater and Contents of Discussion	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						Diabetes Theater; patient support; psychology; pharmacist		Diabetes Theater (DT) is reenactment of pharmacists treating their patients during medical interviews. DT shows different pharmacists treating their patients using different methods. After the performance, the participants can learn from reflecting on the plays and their own work. At the 134th Annual Meeting of the Pharmaceutical Society of Japan, Kumamoto we performed 3 plays. The plays were about a diabetic patient with hypoglycemia who consults 3 pharmacists who have 3 different approaches. Clinical pharmacists in Kumamoto performed and created DT. After DT, we received responses for each play from participants. Some participants stated that it is necessary for pharmacists to respect patients' feelings and that pharmacists should speak to patients in layman's terms. Participants generally understood the purpose of DT. Some participants said that they do not have enough time to console patients. Pharmacists who performed as patients said that they were better able to see from the patients' point of view during medical interviews.	[Nishimura, Hiroyuki] Jinnouchi Hosp, Dept Pharm, Chuo Ku, Kumamoto 8620976, Japan; [Okadab, Hiroshi] Natl Hosp Org Kyoto Med Ctr, Clin Res Inst, Div Prevent Med, Fushimi Ku, Kyoto 6128555, Japan	Nishimura, H (reprint author), Jinnouchi Hosp, Dept Pharm, Chuo Ku, 6-2-3 Kuhonji, Kumamoto 8620976, Japan.	pharm@jinnouchi.or.jp						0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					357	361				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000007		
J	Okada, H				Okada, Hiroshi			Evaluation of Diabetes Theater: Results of Questionnaire Survey and Discussion	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						Diabetes Theater; patient centered care; psychology; pharmacist; empowerment		We started Diabetes Theater (DT), a program for medical staff, with a short drama and discussion with attendees in 2009. The program has two parts. One is a short drama enacting realistic scenes between medical staff and patients. After that, facilitators prompt responses from the audience. The basic concept of the program is empowerment for patients: a process of empowerment in terms of discovery and development of one's own life. People are empowered when they have sufficient knowledge to make rational decisions, sufficient control and resources to implement their decisions, and sufficient experience to evaluate the effectiveness of their decisions. We performed DT at the Annual Meeting of the Pharmaceutical Society of Japan, Kumamoto. Thereafter, we researched the positive educational effects of the program by issuing a questionnaire; the results are presented herein, along with some of our views on the benefits of a drama program on pharmacist training and undergraduate education. The total number of respondents was 78 (M/F, 40/38). Hospital pharmacists comprised 38%; students 26%; academia 19%; community pharmacists 9%; and others 8%. In conclusion, DT was well accepted by attendances as a unique program to learn effective patient communication skills and thereby achieve better patient-pharmacist relations. Our findings suggest that DT might be an interesting approach to improve attitudes of pharmacists in diabetes care with the aim of empowerment.	Natl Hosp Org Kyoto Med Ctr, Clin Res Inst, Div Prevent Med, Fushimi Ku, Kyoto 6128555, Japan	Okada, H (reprint author), Natl Hosp Org Kyoto Med Ctr, Clin Res Inst, Div Prevent Med, Fushimi Ku, 1-1 Mukaihata Cho, Kyoto 6128555, Japan.	bufobufo.ok@gmail.com					Anderson R, 2000, NAT HIST, V109, P23; Funnell MM, 2004, CLIN DIABETES, V22, P123, DOI DOI 10.2337/DIACLIN.22.3.115; Funnell M M, 1991, Diabetes Educ, V17, P37, DOI 10.1177/014572179101700108; Okada H., 2012, CLIN PHARM, V4, P504; Okada H., 2011, HIMAN TO TOUNYOUBYOU, V10, P733; Okada H., 2013, THE PHARM MONTHLY, V55, P228	6	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					363	366				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000008		
J	Okada, H				Okada, Hiroshi			In What Ways Can We Expand on Empowerment to Pharmacists?	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						Diabetes Theater; patient support; pharmacist; diabetes		The number of Japanese patients with chronic diseases is increasing year by year largely because of the acceleration of demographic aging and lifestyle changes in Japan. Although many patients with chronic diseases receive their medications from pharmacists, many community pharmacists have not changed their communication style with their patients. Empowerment is the basic idea that patient support is not widely known by pharmacists but the certified diabetes educator (CDE). We started Diabetes Theater, a program for healthcare providers that includes short drama and discussion with attendees, in 2009. The concept of the program is empowerment for patients: a process to help patients make better healthcare decisions. In addition, we launched another educational program to help community pharmacists learn about communication skills with diabetes patients named "The Three star Pharmacist Training Program" in 2012. In this article, we discuss our forthcoming plans to spread these ideas of empowerment among pharmacists.	Natl Hosp Org Kyoto Med Ctr, Clin Res Inst, Div Prevent Med, Fushimi Ku, Kyoto 6128555, Japan	Okada, H (reprint author), Natl Hosp Org Kyoto Med Ctr, Clin Res Inst, Div Prevent Med, Fushimi Ku, 1-1 Mukaihata Cho, Kyoto 6128555, Japan.	bufobufo.ok@gmail.com					Anderson R, 2000, NAT HIST, V109, P23; Krass I, 2007, DIABETIC MED, V24, P677, DOI 10.1111/j.1464-5491.2007.02143.x; Machado M, 2007, ANN PHARMACOTHER, V41, P1569, DOI 10.1345/aph.1K151; COMPASS Project, 2014, COMM PHARM DIAB PAT; Funnell MM, 2004, CLIN DIABETES, V22, P123, DOI DOI 10.2337/DIACLIN.22.3.115; Funnell M M, 1991, Diabetes Educ, V17, P37, DOI 10.1177/014572179101700108; Okada H., 2012, CLIN PHARM, V4, P504; Okada H., 2013, 3 STAR PHARM WO MEZA; Okada H., 2013, THE PHARM MONTHLY, V55, P228; Okada H., 2011, J JPN PHARM ASS, V63, P703; Shoji M., 2014, JPN J SOC PHARM, V33, P2; Wiedenmayer K., 2006, DEV PHARM PRACTICE F; Wiedenmayer K., 2011, DEV PHARM PRACTICE F	13	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					367	371				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000009		
J	Nakase, I; Nomura, W				Nakase, Ikuhiko; Nomura, Wataru			Chemical Biology for Pharmaceutical Science-Integrative Approaches for Elucidation of Biological Phenomena-Foreword-	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Editorial Material									[Nakase, Ikuhiko] Osaka Prefecture Univ, Res Org 21st Century, Nanosci & Nanotechnol Res Ctr, Naka Ku, Sakai, Osaka 5998570, Japan; [Nomura, Wataru] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan	Nakase, I (reprint author), Osaka Prefecture Univ, Res Org 21st Century, Nanosci & Nanotechnol Res Ctr, Naka Ku, 1-2 Gakuen Cho, Sakai, Osaka 5998570, Japan.	i-nakase@21c.osakafu-u.ac.jp						0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					373	374				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000010		
J	Nakase, I				Nakase, Ikuhiko			Creation of Artificial Receptors Activated by Coiled-coil Peptides and Cellular Regulation	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						artificial receptor; leucine-zipper peptide; protein-protein interaction; receptor dimerization	SIGNAL-TRANSDUCTION; DIMERIZATION; LIGAND; CELLS; EGF; PHOSPHORYLATION; PATHWAYS; SYSTEM; CANCER; ERK	Exploiting the ability of coiled-coil peptides to induce dimer formation, we designed an artificial epidermal growth factor receptor (EGFR) in which dimerization is essential for increasing the tyrosine kinase activity of its intracellular domain. Using leucine-zipper coiled-coil peptides, the surface-exposed E3 ((EIAALEK)(3)) tag sequence was fused with EGFR (E3-EGFR) lacking domains I-III and a part of IV, which participate in dimerization of EGFR after binding to natural ligand (that is, epidermal growth factor). To dimerize E3-EGFR we synthesized conjugates of two K4 ((KIAALKE)(4)) peptides, called K4-conjugates, with linker lengths approximately 10 angstrom that mimic the distance of EGFR dimerization. Receptor phosphorylation of E3-EGFR was found to increase within 5 min in CHO cells expressing E3-EGFR after treatment with K4 conjugates. Increased lamellipodia formation and migration of the cells was also observed when treated with the artificial ligands. This receptor model can be applied to a wide variety of membrane-associated proteins to control cellular processes and to elucidate the functional mechanisms of these proteins using chemical biology.	Osaka Prefecture Univ, Res Org 21st Century, Nanosci & Nanotechnol Res Ctr, Naka Ku, Sakai, Osaka 5998570, Japan	Nakase, I (reprint author), Osaka Prefecture Univ, Res Org 21st Century, Nanosci & Nanotechnol Res Ctr, Naka Ku, 1-2 Gakuen Cho, Sakai, Osaka 5998570, Japan.	i-nakase@21c.osakafu-u.ac.jp					Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Lindhout DA, 2004, BIOPOLYMERS, V75, P367, DOI 10.1002/bip.20150; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; Kiessling LL, 2006, ANGEW CHEM INT EDIT, V45, P2348, DOI 10.1002/anie.200502794; Putyrski M, 2011, CHEM BIOL, V18, P1126, DOI 10.1016/j.chembiol.2011.07.013; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; Ahmed AU, 2013, JNCI-J NATL CANCER I, V105, P968, DOI 10.1093/jnci/djt141; Hwang Y, 2011, MOL CANCER RES, V9, P1199, DOI 10.1158/1541-7786.MCR-11-0229; Yano Y, 2008, ACS CHEM BIOL, V3, P341, DOI 10.1021/cb8000556; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Ghosh R, 2011, CANCER RES, V71, P1871, DOI 10.1158/0008-5472.CAN-10-1872; Yano Y, 2009, BBA-BIOMEMBRANES, V1788, P2124, DOI 10.1016/j.bbamem.2009.07.017; Dise RS, 2008, AM J PHYSIOL-GASTR L, V294, pG276, DOI 10.1152/ajpgi.00340.2007; Litowski JR, 2002, J BIOL CHEM, V277, P37272, DOI 10.1074/jbc.M204257200; Griffith BR, 2004, J AM CHEM SOC, V126, P1608, DOI 10.1021/ja037646m; Liu W, 2008, BIOTECHNOL BIOENG, V101, P975, DOI 10.1002/bit.21961; Liu WH, 2009, J BIOCHEM, V145, P575, DOI 10.1093/jb/mvp013; Mammen MS, 1998, ANGEW CHEM INT EDIT, V37, P2754, DOI DOI 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3; Nakase I, 2012, ANGEW CHEM INT EDIT, V51, P7464, DOI 10.1002/anie.201201805; Narayanan P, 2011, J CLIN INVEST, V121, P1524, DOI 10.1172/JCI44327; Nogami M, 2003, FEBS LETT, V536, P71, DOI 10.1016/S0014-5793(03)00013-9; Saito T, 2004, ENDOCRINOLOGY, V145, P4232, DOI 10.1210/en.2004-0401; Song GJ, 2007, P NATL ACAD SCI USA, V104, P18303, DOI 10.1073/pnas.0702857104; Tanaka K, 2009, BIOTECHNOL PROGR, V25, P1138, DOI 10.1002/btpr.185; Yarden Y, 2001, EUR J CANCER, V37, pS3	25	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					375	381				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000011		
J	Ishikawa, H				Ishikawa, Hayato			Total Synthesis of Biologically Active Alkaloids Using Bio-inspired Indole Oxidation	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						bio-inspired reaction; diketopiperazine; one-pot reaction; WIN 64821; ditryptophenaline; naseseazine B	CONCISE TOTAL-SYNTHESIS; DIKETOPIPERAZINE ALKALOIDS; ASPERGILLUS SP; 4-(4,6-DIMETHOXY-1,3,5-TRIAZIN-2-YL)-4-METHYL-MORPHOLINIUM CHLORIDE; TRYPTOPHAN DERIVATIVES; CONDENSING AGENT; CARBOXYLIC-ACIDS; NATURAL-PRODUCTS; GENERAL-APPROACH; SUBSTANCE-P	Many tryptophan-based dimeric diketopiperazine (DKP) alkaloids including WIN 64821 and ditryptophenaline, which exhibit fascinating biological activities, have been isolated from fungi These alkaloids possess a unique architecture; therefore several total syntheses of these compounds have been accomplished via bio-inspired reactions. Despite these elegant strategies, we were convinced that a more direct bio-inspired solution for the preparation of tryptophan-based DKP alkaloids was possible because in a true biosynthesis, direct dimerization of tryptophan occurs in aqueous media without incorporation of a protecting group on the substrates. Thus we developed direct bio-inspired dimerization reactions in aqueous, acidic media, along with a novel biomimetic pathway, to provide C-2-symmetric and non-symmetric dimeric compounds from commercially available amine-free tryptophan derivatives using Mn(OAc)(3), VOF3, and V2O5 as one-electron oxidants. In addition, concise two-pot or three-step syntheses of the naturally occurring dimeric DKP alkaloids (+)-WIN 64821, (-)-ditryptophenaline, and (+)-naseseazine B were accomplished with total yields of 20%, 13%, and 20%, respectively. The present synthesis has several noteworthy features: 1) the tryptophan-based C-2-symmetric and non-symmetric dimeric key intermediates can be prepared on a multigram scale in one step; 2) the developed oxidation reaction was carried out in aqueous, acidic solution without deactivation of the metal oxidants; 3) protection of the primary amine can be avoided by salt formation in aqueous acid; 4) for the total two-pot operation, the reaction media are environmentally friendly water and ethanol; 5) satisfactory total yields are obtained compared with previously reported syntheses.	Kumamoto Univ, Grad Sch Sci & Technol, Dept Chem, Chuo Ku, Kumamoto 8608555, Japan	Ishikawa, H (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Dept Chem, Chuo Ku, 2-39-1 Kurokami, Kumamoto 8608555, Japan.	ishikawa@sci.kumamoto-u.ac.jp					Anthoni U, 1999, ALKAL CHEM, V13, P163, DOI 10.1016/S0735-8210(99)80025-9; Saruwatari T, 2014, CHEMBIOCHEM, V15, P656, DOI 10.1002/cbic.201300751; Ishikawa H, 2008, J AM CHEM SOC, V130, P420, DOI 10.1021/ja078192m; DeLorbe JE, 2011, J AM CHEM SOC, V133, P6549, DOI 10.1021/ja201789v; Ishikawa H, 2009, J AM CHEM SOC, V131, P4904, DOI 10.1021/ja809842b; Overman LE, 2001, J AM CHEM SOC, V123, P9465, DOI 10.1021/ja0166141; NAKAGAWA M, 1981, TETRAHEDRON LETT, V22, P5323, DOI 10.1016/S0040-4039(01)92492-X; Verotta L, 2002, BIOORGAN MED CHEM, V10, P2133, DOI 10.1016/S0968-0896(02)00078-0; Kieffer ME, 2013, J AM CHEM SOC, V135, P5557, DOI 10.1021/ja4023557; BARROW CJ, 1993, J ORG CHEM, V58, P6016, DOI 10.1021/jo00074a031; Movassaghi M, 2011, J AM CHEM SOC, V133, P13002, DOI 10.1021/ja2057852; Raju R, 2009, ORG LETT, V11, P3862, DOI 10.1021/ol901466r; Kim J, 2009, SCIENCE, V324, P238, DOI 10.1126/science.1170777; Kunishima M, 1999, TETRAHEDRON, V55, P13159, DOI 10.1016/S0040-4020(99)00809-1; Ding G, 2008, J NAT PROD, V71, P1861, DOI 10.1021/np800357g; Perez-Balado C, 2010, ORG BIOMOL CHEM, V8, P5179, DOI 10.1039/c0ob00531b; Kim J, 2010, J AM CHEM SOC, V132, P14376, DOI 10.1021/ja106869s; Kunishima M, 1999, TETRAHEDRON LETT, V40, P5327, DOI 10.1016/S0040-4039(99)00968-5; Sodeoka M, 2012, PURE APPL CHEM, V84, P1369, DOI 10.1351/PAC-CON-11-10-31; Perez-Balado C, 2009, CHEM-EUR J, V15, P9928, DOI 10.1002/chem.200901056; Kim J, 2011, J AM CHEM SOC, V133, P14940, DOI 10.1021/ja206743v; Boyer N, 2012, CHEM SCI, V3, P1798, DOI 10.1039/c2sc20270k; Iwasa E, 2010, J AM CHEM SOC, V132, P4078, DOI 10.1021/ja101280p; Iwasa E, 2011, TETRAHEDRON, V67, P6587, DOI 10.1016/j.tet.2011.05.081; Kim J, 2009, CHEM SOC REV, V38, P3035, DOI 10.1039/b819925f; Cai SX, 2012, TETRAHEDRON LETT, V53, P2615, DOI 10.1016/j.tetlet.2012.03.043; Perez-Balado C, 2008, ORG LETT, V10, P3701, DOI 10.1021/ol8013073; Gotoh H, 2012, J AM CHEM SOC, V134, P13240, DOI 10.1021/ja306229x; Kunishima M, 2001, TETRAHEDRON, V57, P1551, DOI 10.1016/S0040-4020(00)01137-6; Movassaghi M, 2008, ANGEW CHEM INT EDIT, V47, P1485, DOI 10.1002/anie.200704960; Ishikawa H, 2002, TETRAHEDRON LETT, V43, P5637, DOI 10.1016/S0040-4039(02)01137-1; Tadano S, 2013, ANGEW CHEM INT EDIT, V52, P7990, DOI 10.1002/anie.201303143; Kunishima M, 2002, CHEM PHARM BULL, V50, P549, DOI 10.1248/cpb.50.549; BARROW CJ, 1995, BIOORG MED CHEM LETT, V5, P377; Cordell G. A., 1981, ALKALOIDS CHEM PHYSL, V20, P3; Goveky SP, 2007, TETRAHEDRON, V63, P8499, DOI 10.1016/j.tet.2007.05.127; Hino T., 1989, ALKALOIDS, V34, P1, DOI 10.1016/S0099-9598(08)60226-6; Hiramoto M., 1994, S CHEM NATURAL PRODU, V36, P557; Kunishima M, 2012, CHEM-EUR J, V18, P15856, DOI 10.1002/chem.201202236; Kunishima M, 1999, SYNLETT, P1255; OLEYNEK JJ, 1994, J ANTIBIOT, V47, P399; POPP JL, 1994, J ANTIBIOT, V47, P411; SEDLOCK DM, 1994, J ANTIBIOT, V47, P391; Tadano S, 2014, SYNLETT, V25, P157, DOI 10.1055/s-0033-1340160	44	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					383	390				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000012		
J	Tochio, H; Murayama, S; Inomata, K; Morimoto, D; Ohno, A; Shirakawa, M				Tochio, Hidehito; Murayama, Shuhei; Inomata, Kohsuke; Morimoto, Daichi; Ohno, Ayako; Shirakawa, Masahiro			Non-invasive Analysis of Proteins in Living Cells Using NMR Spectroscopy	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						nuclear magnetic resonance; macromolecular crowding effect; electroporation; fluorine-19	NUCLEAR-MAGNETIC-RESONANCE; MAMMALIAN-CELLS; STINT-NMR; COMPARTMENTS; FOLD	NMR spectroscopy enables structural analyses of proteins and has been widely used in the structural biology field in recent decades. NMR spectroscopy can be applied to proteins inside living cells, allowing characterization of their structures and dynamics in intracellular environments. The simplest "in-cell NMR" approach employs bacterial cells; in this approach, live Escherichia coli cells overexpressing a specific protein are subjected to NMR. The cells are grown in an NMR active isotope-enriched medium to ensure that the overexpressed proteins are labeled with the stable isotopes. Thus the obtained NMR spectra, which are derived from labeled proteins, contain atomic-level information about the structure and dynamics of the proteins. Recent progress enables us to work with higher eukaryotic cells such as HeLa and HEK293 cells, for which a number of techniques have been developed to achieve isotope labeling of the specific target protein. In this review, we describe successful use of electroporation for in-cell NMR. In addition, F-19-NMR to characterize protein-ligand interactions in cells is presented. Because F-19 nuclei rarely exist in natural cells, when F-19-labeled proteins are delivered into cells and F-19-NMR signals are observed, one can safely ascertain that these signals originate from the delivered proteins and not other molecules.	[Tochio, Hidehito; Murayama, Shuhei; Morimoto, Daichi; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Inomata, Kohsuke] Osaka Univ, OLABB, QBiC, RIKEN, Suita, Osaka 5650874, Japan; [Ohno, Ayako] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Nutr Physiol, Tokushima 7708503, Japan	Tochio, H (reprint author), Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, A4-132 Kyoto Daigaku Katsura, Kyoto 6158510, Japan.	tochio@mb.biophys.kyoto-u.ac.jp					Staudacher T, 2013, SCIENCE, V339, P561, DOI 10.1126/science.1231675; Takaoka Y, 2013, CHEM COMMUN, V49, P2801, DOI 10.1039/c3cc39205h; Ogino S, 2009, J AM CHEM SOC, V131, P10834, DOI 10.1021/ja904407w; Xie JJ, 2009, J MED CHEM, V52, P3516, DOI 10.1021/jm9000743; Mamin HJ, 2013, SCIENCE, V339, P557, DOI 10.1126/science.1231540; Inomata K, 2009, NATURE, V458, P106, DOI 10.1038/nature07839; Banci L, 2013, NAT CHEM BIOL, V9, P297, DOI [10.1038/nchembio.1202, 10.1038/NCHEMBIO.1202]; Schlesinger AP, 2011, J AM CHEM SOC, V133, P8082, DOI 10.1021/ja201206t; Sakakibara D, 2009, NATURE, V458, P102, DOI 10.1038/nature07814; Tsukiji S, 2009, NAT CHEM BIOL, V5, P341, DOI 10.1038/nchembio.157; Sarkar M, 2013, P NATL ACAD SCI USA, V110, P19342, DOI 10.1073/pnas.1312678110; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Banci L, 2013, CHEM BIOL, V20, P747, DOI 10.1016/j.chembiol.2013.05.007; Luh LM, 2013, J AM CHEM SOC, V135, P13796, DOI 10.1021/ja405244v; Serber Z, 2006, NAT PROTOC, V1, P2701, DOI 10.1038/nprot.2006.181; Park SH, 2012, NATURE, V491, P779, DOI 10.1038/nature11580; Sakai T, 2006, J BIOMOL NMR, V36, P179, DOI 10.1007/s10858-006-9079-9; Danielsson J, 2013, J AM CHEM SOC, V135, P10266, DOI 10.1021/ja404425r; Selenko P, 2008, NAT STRUCT MOL BIOL, V15, P321, DOI 10.1038/nsmb.1395; Barbieri L, 2014, BBA-MOL CELL RES, V1843, P2492, DOI 10.1016/j.bbamcr.2014.06.009; Bertrand K, 2012, J AM CHEM SOC, V134, P12798, DOI 10.1021/ja304809s; Burz DS, 2006, NAT PROTOC, V1, P146, DOI 10.1038/nprot.2006.23; Burz DS, 2006, NAT METHODS, V3, P91, DOI 10.1038/NMETH851; Kubo S, 2013, ANGEW CHEM INT EDIT, V52, P1208, DOI 10.1002/anie.201207243; Mentre P., 2006, EAU CELLULE; Waudby CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072286	26	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					391	398				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000013		
J	Saito, H				Saito, Hirohide			Synthetic RNA Technologies to Control Functions of Mammalian Cells	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						RNA; translation; RNA switch; synthetic biology; bionanotechnology	PROTEIN; SWITCHES; MODULE	We recently succeeded in producing nanostructures made of RNA-protein (RNP) complexes. We show that RNA and the ribosomal protein L7Ae can form a triangular-like nanostructure that consists of three L7Ae proteins, which form the apices of the triangle, bound to one RNA scaffold. This shape is created through a 60 kink introduced into the RNA structure on L7Ae binding. By varying the size of the RNA scaffold we could in turn alter the overall size of the triangular nanostructure. Several functions can be added to this nanostructure by the introduction of effector proteins fused to L7Ae. The design and construction of functional RNP nanostructures that detect specific cancer cells are discussed herein. In parallel, we developed synthetic RNP translational switches to control production levels of particular proteins depending on certain input (s) within the intracellular environment. The RNP-binding module was successfully incorporated into mRNA to generate functional RNP switches. The designed ON/OFF translational switches detect expression of the trigger factor and repress or activate expression of a desired protein (e.g., apoptosis regulator) in target mammalian cells. Taken together, RNP-binding module could be employed for constructing designer genetic switches and functional nanostructures to regulate cellular processes.	[Saito, Hirohide] Kyoto Univ, Ctr iPS Cell Res & Applicat, Sakyo Ku, Kyoto 6068507, Japan; [Saito, Hirohide] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068501, Japan	Saito, H (reprint author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	hirohide.saito@cira.kyoto-u.ac.jp					Saito H, 2010, NAT CHEM BIOL, V6, P71, DOI [10.1038/nchembio.273, 10.1038/NCHEMBIO.273]; Saito H, 2001, EMBO J, V20, P1797, DOI 10.1093/emboj/20.7.1797; Hagiya M, 2014, ACCOUNTS CHEM RES, V47, P1681, DOI 10.1021/ar400318d; Jaeger L, 2000, ANGEW CHEM INT EDIT, V39, P2521, DOI 10.1002/1521-3773(20000717)39:14<2521::AID-ANIE2521>3.0.CO;2-P; Nasalean L, 2006, NUCLEIC ACIDS RES, V34, P1381, DOI 10.1093/nar/gkl008; Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686; Osada E, 2014, ACS NANO, V8, P8130, DOI 10.1021/nn502253c; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Endo K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt347; Endo K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3393; Hara T, 2013, CHEM COMMUN, V49, P3833, DOI 10.1039/c3cc38688k; Kashida S, 2012, NUCLEIC ACIDS RES, V40, P9369, DOI 10.1093/nar/gks668; Ohno H, 2011, NAT NANOTECHNOL, V6, P115, DOI 10.1038/nnano.2010.268; Saito H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1157; Shu D, 2011, NAT NANOTECHNOL, V6, P658, DOI [10.1038/nnano.2011.105, 10.1038/NNANO.2011.105]	16	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					399	404				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000014		
J	Nomura, W				Nomura, Wataru			Application and Potential of Genome Engineering by Artificial Enzymes	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						genome editing; transcription activator-like effector; zinc finger	ZINC-FINGER NUCLEASES; CONTROLLING GENE-EXPRESSION; TRANSCRIPTION FACTOR-IIIA; DNA-BINDING SPECIFICITY; SEA-URCHIN EMBRYOS; TARGETED MUTAGENESIS; DIRECTED EVOLUTION; CRYSTAL-STRUCTURE; PROTEIN-DNA; HUMAN-CELLS	Artificial zinc finger proteins (ZFPs) consist of Cys(2)-His(2)-type modules composed of approximately 30 amino acids that adopt a beta beta alpha structure and coordinate a zinc ion. ZFPs recognizing specific DNA target sequences can substitute for the binding domains of various DNA-modifying enzymes to create designer nucleases, recombinases, and methylases with programmable sequence specificity. Enzymatic genome editing and modification can be applied to many fields of basic research and medicine. The recent development of new platforms using transcription activator-like effector (TALE) proteins or the clustered regularly interspaced short palindromic repeats/CRISPR-associated protein (CRISPR/Cas) system has expanded the range of possibilities for genome-editing technologies. These technologies empower investigators with the ability to efficiently knockout or regulate the functions of genes of interest. In this review, we discuss historical advancements in artificial ZFP applications and important issues that may influence the future of genome editing and engineering technologies. The development of artificial ZFPs has greatly increased the feasibility of manipulating endogenous gene functions through transcriptional control and gene modification. Advances in the ZFP, TALE, and CRISPR/Cas platforms have paved the way for the next generation of genome engineering approaches. Perspectives for the future of genome engineering are also discussed, including applications of targeting specific genomic alleles and studies in synthetic biology.	Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan	Nomura, W (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kandasurugadai, Tokyo 1010062, Japan.	nomura.mr@tmd.ac.jp	Nomura, Wataru/F-5812-2015				Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; MILLER J, 1985, EMBO J, V4, P1609; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; Akopian A, 2003, P NATL ACAD SCI USA, V100, P8688, DOI 10.1073/pnas.1533177100; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Gordley RM, 2009, P NATL ACAD SCI USA, V106, P5053, DOI 10.1073/pnas.0812502106; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Ansai S, 2013, GENETICS, V193, P739, DOI 10.1534/genetics.112.147645; Carvin CD, 2003, NUCLEIC ACIDS RES, V31, P6493, DOI 10.1093/nar/gkg853; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; McNamara AR, 2002, NUCLEIC ACIDS RES, V30, P3818, DOI 10.1093/nar/gkf501; Segal DJ, 2001, CURR OPIN BIOTECH, V12, P632, DOI 10.1016/S0958-1669(01)00272-5; Gordley RM, 2007, J MOL BIOL, V367, P802, DOI 10.1016/j.jmb.2007.01.017; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Tsuji S, 2013, BIOCHEM BIOPH RES CO, V441, P262, DOI 10.1016/j.bbrc.2013.10.060; Lamb BM, 2013, NUCLEIC ACIDS RES, V41, P9779, DOI 10.1093/nar/gkt754; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Dreier B, 2001, J BIOL CHEM, V276, P29466, DOI 10.1074/jbc.M102604200; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Gersbach CA, 2010, NUCLEIC ACIDS RES, V38, P4198, DOI [10.1093/nar/gkq125, 10.1093/nar/gka125]; Sirk SJ, 2014, NUCLEIC ACIDS RES, V42, P4755, DOI 10.1093/nar/gkt1389; Turan S, 2011, J MOL BIOL, V407, P193, DOI 10.1016/j.jmb.2011.01.004; Dreier B, 2005, J BIOL CHEM, V280, P35588, DOI 10.1074/jbc.M506654200; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Gaj T, 2013, NUCLEIC ACIDS RES, V41, P3937, DOI 10.1093/nar/gkt071; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Ochiai H, 2012, P NATL ACAD SCI USA, V109, P10915, DOI 10.1073/pnas.1202768109; Joung JK, 2000, P NATL ACAD SCI USA, V97, P7382, DOI 10.1073/pnas.110149297; Wah DA, 1997, NATURE, V388, P97; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; REBAR EJ, 1994, SCIENCE, V263, P671, DOI 10.1126/science.8303274; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98; Nagaoka M, 2001, BIOCHEM BIOPH RES CO, V282, P1001, DOI 10.1006/bbrc.2001.4672; ISHINO Y, 1987, J BACTERIOL, V169, P5429; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Segal DJ, 2003, BIOCHEMISTRY-US, V42, P2137, DOI 10.1021/bi026806o; Nomura W, 2007, J AM CHEM SOC, V129, P8676, DOI 10.1021/ja0705588; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Nomura W, 2012, BIOCHEMISTRY-US, V51, P1510, DOI 10.1021/bi201878x; Xu GL, 1997, NAT GENET, V17, P376, DOI 10.1038/ng1297-376; Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Gaj T, 2014, J AM CHEM SOC, V136, P5047, DOI 10.1021/ja4130059; Maeder ML, 2013, NAT METHODS, V10, P243, DOI [10.1038/nmeth.2366, 10.1038/NMETH.2366]; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Choo Y, 1997, CURR OPIN STRUC BIOL, V7, P117, DOI 10.1016/S0959-440X(97)80015-2; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; DIAKUN GP, 1986, NATURE, V324, P698, DOI 10.1038/324698a0; Dreier B, 2000, J MOL BIOL, V303, P489, DOI 10.1006/jmbi.2000.4133; Gaj T., 2010, P NATL ACAD SCI USA, V108, P498; Hirata T, 2005, BIOORG MED CHEM LETT, V15, P2197, DOI 10.1016/j.bmcl.2005.03.040; Hosoi S, 2014, DEV GROWTH DIFFER, V56, P92, DOI 10.1111/dgd.12099; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Kamiuchi T, 1998, BIOCHEMISTRY-US, V37, P13827, DOI 10.1021/bi9811112; KLUG A, 1987, COLD SPRING HARB SYM, V52, P473; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; NAGAOKA M, 1994, J AM CHEM SOC, V116, P4085, DOI 10.1021/ja00088a057; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nomura W, 2003, BIOCHEM BIOPH RES CO, V300, P87, DOI 10.1016/S0006-291X(02)02792-4; Romer P, 2009, P NATL ACAD SCI USA, V106, P20526, DOI 10.1073/pnas.0908812106	79	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					405	414				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000015		
J	Kusu, F				Kusu, Fumiyo			Development and Application of Electroanalytical Methods in Biomedical Fields	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						electro-analytical method; acid sensor; HPLC; specular reflection measurement; voltammetry	PERFORMANCE LIQUID-CHROMATOGRAPHY; FLOW-INJECTION ANALYSIS; SPECULAR REFLECTIVITY MEASUREMENT; ELECTRICAL POTENTIAL OSCILLATION; COMPOUND-IODINE-GLYCERIN; ELECTRODE-SOLUTION INTERFACE; BIOACTIVE REDOX COMPONENTS; PRECIOUS DENTAL ALLOYS; FATTY-ACID CONTENT; CANNED GREEN TEA	To summarize our electroanalytical research in the biomedical field over the past 43 years, this review describes studies on specular reflection measurement, redox potential determination, amperometric acid sensing, HPLC with electrochemical detection, and potential oscillation across a liquid membrane. The specular reflection method was used for clarifying the adsorption of neurotransmitters and their related drugs onto a gold electrode and the interaction between dental alloys and compound iodine glycerin. A voltammetric screening test using a redox potential for the antioxidative effect of flavonoids was proposed. Amperometric acid sensing based on the measurement of the reduction prepeak current of 2-methyl-1,4-naphthoquinone (VK3) or 3,5-di-tert-butyl-1,2-benzoquinone (DBBQ) was applied to determine acid values of fats and oils, titrable acidity of coffee, and enzyme activity of lipase, free fatty acids (FFAs) in serum, short-chain fatty acids in feces, etc. The electrode reactions of phenothiazines, catechins, and cholesterol were applied to biomedical analysis using HPLC with electrochemical detection. A three-channel electrochemical detection system was utilized for the sensitive determination of redox compounds in Chinese herbal medicines. The behavior of barbituric acid derivatives was examined based on potential oscillation measurements.	Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan	Kusu, F (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	kusu@toyaku.ac.jp					Kotani A, 2009, ANAL SCI, V25, P1007; Matsumoto D, 2010, J CHROMATOGR A, V1217, P2986, DOI 10.1016/j.chroma.2010.02.050; HAYASHI Y, 1994, ANAL CHEM, V66, P2874, DOI 10.1021/ac00090a013; Jin D, 2004, BIOMED CHROMATOGR, V18, P662, DOI 10.1002/bmc.370; Kotani A, 2008, J PHARMACEUT BIOMED, V48, P780, DOI 10.1016/j.jpba.2008.08.002; Kotani A, 2009, ANAL SCI, V25, P925; KUSU F, 1994, J AOAC INT, V77, P1686; Jin DR, 2004, B CHEM SOC JPN, V77, P1147, DOI 10.1246/bcsj.77.1147; Danila AM, 2007, J AGR FOOD CHEM, V55, P1139, DOI 10.1021/jf062815i; ARAI K, 1994, BIOELECTROCH BIOENER, V33, P159, DOI 10.1016/0302-4598(94)85007-0; Kotani A, 2014, J PHARMACEUT BIOMED, V97, P47, DOI 10.1016/j.jpba.2014.04.009; Kotani A, 2003, J CHROMATOGR B, V788, P269, DOI 10.1016/S1570-0232(02)01036-X; Taguchi J, 2003, J ELECTROANAL CHEM, V557, P91, DOI 10.1016/S0022-0728(03)00351-6; Kotani A, 2007, ANAL SCI, V23, P157, DOI 10.2116/analsci.23.157; Yang B, 2001, ANAL SCI, V17, P599, DOI 10.2116/analsci.17.599; Hojo K, 2007, J CHROMATOGR A, V1166, P135, DOI 10.1016/j.chroma.2007.08.020; Yang B, 2000, ANAL BIOCHEM, V283, P77, DOI 10.1006/abio.2000.4624; Kotani A, 2006, ANAL BIOCHEM, V350, P99, DOI 10.1016/j.ab.2005.11.007; Kotani A, 2011, J ELECTROANAL CHEM, V656, P85, DOI 10.1016/j.jelechem.2011.01.005; Yang B, 2001, CHEM PHARM BULL, V49, P747, DOI 10.1248/cpb.49.747; Chen XC, 2012, J CHROMATOGR A, V1256, P105, DOI 10.1016/j.chroma.2012.07.061; ARAI K, 1995, ELECTROCHIM ACTA, V40, P2913, DOI 10.1016/0013-4686(95)00222-Z; Arai K., 2001, LIQUID INTERFACES CH, P699; Arai K, 1997, ELECTROCHIM ACTA, V42, P2493, DOI 10.1016/S0013-4686(96)00438-0; ARAI K, 1991, BUNSEKI KAGAKU, V40, P775; Chen LM, 2014, J PHARMACEUT BIOMED, V95, P93, DOI 10.1016/j.jpba.2014.02.015; Fuse T, 2000, ELECTROCHIM ACTA, V45, P2933, DOI 10.1016/S0013-4686(00)00371-6; FUSE T, 1995, BUNSEKI KAGAKU, V44, P29; FUSE T, 1995, BUNSEKI KAGAKU, V44, P771; Fuse T, 1997, J PHARMACEUT BIOMED, V15, P1515, DOI 10.1016/S0731-7085(97)00039-3; Fuse T, 1997, J AGR FOOD CHEM, V45, P2124, DOI 10.1021/jf960690j; Hojo K, 2011, J CHROMATOGR B, V879, P751, DOI 10.1016/j.jchromb.2011.02.017; Hojo K, 2010, BIOMED CHROMATOGR, V24, P600, DOI 10.1002/bmc.1332; Hosokawa YY, 2009, ELECTROCHIM ACTA, V54, P6412, DOI 10.1016/j.electacta.2009.06.005; Ito N, 2010, ANAL METHODS-UK, V2, P174, DOI 10.1039/b9ay00195f; Koitabashi M, 2003, BUNSEKI KAGAKU, V52, P1137, DOI 10.2116/bunsekikagaku.52.1137; Kotani A, 2011, ELECTROANAL, V23, P2709, DOI 10.1002/elan.201100223; Kotani A, 2008, BUNSEKI KAGAKU, V57, P199, DOI 10.2116/bunsekikagaku.57.199; Kotani A, 2000, ANAL BIOCHEM, V284, P65, DOI 10.1006/abio.2000.4682; Kotani A, 2005, CHEM PHARM BULL, V53, P319, DOI 10.1248/cpb.53.319; Kotani A, 2003, J CHROMATOGR A, V986, P239, DOI 10.1016/S0021-9673(02)02009-5; Kotani A., 2006, TRENDS IN CHROMATOGR, V2, P69; Kotani A, 2014, BUNSEKI KAGAKU, V63, P41, DOI 10.2116/bunsekikagaku.63.41; Kotani A., 2004, REV POLAROGR, V50, P109; Kotani A, 2012, ELECTROCHEMISTRY, V80, P340, DOI 10.5796/electrochemistry.80.340; Kotani A, 2003, ANAL SCI, V19, P865, DOI 10.2116/analsci.19.865; Kusu F, 1996, ANAL BIOCHEM, V235, P191, DOI 10.1006/abio.1996.0111; KUSU F, 1985, SURF SCI, V158, P633, DOI 10.1016/0039-6028(85)90337-1; KUSU F, 1985, DENKI KAGAKU, V53, P361; KUSU F, 1992, CHEM PHARM BULL, V40, P3284; Kusu F, 1997, DENKI KAGAKU, V65, P51; Kusu F, 2005, SENSOR ACTUAT B-CHEM, V108, P858, DOI 10.1016/j.snb.2004.11.030; KUSU F, 1993, DENKI KAGAKU, V61, P860; KUSU F, 1984, J ELECTROANAL CHEM, V161, P169, DOI 10.1016/S0022-0728(84)80258-2; KUSU F, 1994, DENKI KAGAKU, V62, P542; KUSU F, 1995, CHEM PHARM BULL, V43, P1158; Kusu F, 1998, ELECTROCHIM ACTA, V43, P1873, DOI 10.1016/S0013-4686(97)00308-3; Matsunaga I, 2009, ANAL BIOCHEM, V393, P222, DOI 10.1016/j.ab.2009.06.032; McIntyre J. D. E., 1973, ADV ELECTROCHEMISTRY, V9, P658; Ohe K, 2000, BUNSEKI KAGAKU, V49, P503, DOI 10.2116/bunsekikagaku.49.503; Ohe K, 2000, ELECTROCHEMISTRY, V68, P582; Ohtsuki S, 2001, ELECTROANAL, V13, P404, DOI 10.1002/1521-4109(200104)13:5<404::AID-ELAN404>3.3.CO;2-9; TAKAMURA K, 1983, CHEM PHARM BULL, V31, P1821; TAKAMURA K, 1981, CHEM PHARM BULL, V29, P3083; TAKAMURA K, 1986, CHEM PHARM BULL, V34, P2315; TAKAMURA K, 1979, J ELECTROANAL CHEM, V102, P109, DOI 10.1016/S0022-0728(79)80034-0; TAKAMURA K, 1982, BIOELECTROCH BIOENER, V9, P499, DOI 10.1016/0302-4598(82)85008-3; TAKAMURA K, 1987, BUNSEKI KAGAKU, V36, P38; TAKAMURA K, 1981, DENKI KAGAKU, V49, P562; TAKAMURA K, 1971, J ELECTROANAL CHEM, V31, P225, DOI 10.1016/S0022-0728(71)80061-X; TAKAMURA K, 1981, BIOELECTROCH BIOENER, V8, P229, DOI 10.1016/0302-4598(81)80044-X; TAKAMURA K, 1987, METHOD BIOCHEM ANAL, V32, P155, DOI 10.1002/9780470110539.ch3; TAKAMURA K, 1981, ELECTROCHIM ACTA, V26, P979, DOI 10.1016/0013-4686(81)85066-9; TAKAMURA K, 1988, DENKI KAGAKU, V56, P1072; TAKAMURA K, 1990, J ELECTROCHEM SOC, V137, P2132, DOI 10.1149/1.2086897; TAKAMURA K, 1987, NIPPON KAGAKU KAISHI, P366; TAKAMURA K, 1976, ANAL BIOCHEM, V74, P512, DOI 10.1016/0003-2697(76)90233-5; Takamura K, 1996, ANAL SCI, V12, P343, DOI 10.2116/analsci.12.343; TAKAMURA K, 1983, DENKI KAGAKU, V51, P141; TAKAMURA K, 1981, CHEM PHARM BULL, V29, P1810; TAKAMURA K, 1995, ANAL SCI, V11, P979, DOI 10.2116/analsci.11.979; TAKAMURA K, 1987, CHEM PHARM BULL, V35, P1327; TAKAMURA K, 1995, J ELECTROANAL CHEM, V396, P507, DOI 10.1016/0022-0728(95)03962-G; TAKAMURA K, 1981, BIOELECTROCH BIOENER, V8, P125, DOI 10.1016/0302-4598(81)85013-1; TAKAMURA K, 1985, NIPPON KAGAKU KAISHI, P1035; TAKAMURA T, 1974, ELECTROCHIM ACTA, V19, P933, DOI 10.1016/0013-4686(74)85046-2; Watanabe F., 1975, DENKI KAGAKU, V43, P469; WATANABE F, 1977, DENKI KAGAKU, V45, P689; Xia J, 2006, J PHARMACEUT BIOMED, V41, P1401, DOI 10.1016/j.jpba.2006.02.030; Yang B, 2001, ELECTROCHEMISTRY, V69, P519	90	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					415	430				16	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000016		
J	Kasahara, T				Kasahara, Tadashi			Study of Cytokine Signaling: The Quest for Immunomodulatory Drugs Interacting with Cytokine Production and Activity	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						cytokine signaling; eosinophilia; focal adhesion kinase; JAK2V617F; melanoma metastasis; immunoregulatory compound	FOCAL ADHESION KINASE; NF-KAPPA-B; JAK2 V617F MUTANT; LEUKEMIC-CELL LINE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; LARGE GRANULAR LYMPHOCYTES; PEROXIDE-INDUCED APOPTOSIS; COLONY-STIMULATING FACTOR; MIGRATION IN-VITRO; INTERLEUKIN-8 PRODUCTION	I have been engaged in research and education in the fields of immunology and biochemistry at a medical college and college of pharmacy for 40 years. The original reasons why I began studying cytokines and some of the interests that have motivated me to continue working in the field of cytokine research are described: 1) the roles of cytokines in various immunological and inflammatory diseases (e.g., chemokines in bacterial infections and inflammatory diseases, particularly the role of interleukin-5 and eotaxins in eosinophilia); 2) the role of focal adhesion kinase in antiapoptosis and metastasis of melanoma; 3) recent findings on the role of JAK2/STAT pathways, particularly how JAK2V617F mutation induces dysregulated proliferation and tumorigenesis; and 4) the interactions of various chemical compounds and natural products in cytokine gene activation and signaling. Previous discoveries and published findings by my research group are described, along with comments and discussion pertaining to recent developments in the field.	[Kasahara, Tadashi] Int Univ Hlth & Welfare, Grad Sch, Minato Ku, Tokyo 1070062, Japan; [Kasahara, Tadashi] Keio Univ, Fac Pharm, Minato Ku, Tokyo 1058512, Japan; [Kasahara, Tadashi] Jichi Med Univ, Div Inflammat Res, Shimotsuke, Tochigi 3290498, Japan	Kasahara, T (reprint author), Int Univ Hlth & Welfare, Grad Sch, Minato Ku, 1-3-3 Minamiaoyama, Tokyo 1070062, Japan.	kasahara-td@oregano.ocn.ne.jp					Abe M, 2009, INT IMMUNOPHARMACOL, V9, P870, DOI 10.1016/j.intimp.2009.03.011; Sonoda Y, 1998, IMMUNOPHARMACOLOGY, V38, P287, DOI 10.1016/S0162-3109(97)00091-X; Sonoda Y, 2000, J BIOL CHEM, V275, P16309, DOI 10.1074/jbc.275.21.16309; Matsui S, 2004, INT IMMUNOPHARMACOL, V4, P1633, DOI 10.1016/j.intimp.2004.07.023; KASAHARA T, 1991, IMMUNOLOGY, V74, P60; Ozawa H, 2012, ONCOL LETT, V3, P19, DOI 10.3892/ol.2011.422; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Kamishimoto J, 2011, CELL SIGNAL, V23, P849, DOI 10.1016/j.cellsig.2011.01.009; Funakoshi-Tago M, 2008, CELL SIGNAL, V20, P1679, DOI 10.1016/j.cellsig.2008.05.013; Sonoda Y, 2010, ONCOL REP, V23, P371, DOI 10.3892/or_00000645; Sumi K, 2011, FEBS LETT, V585, P1884, DOI 10.1016/j.febslet.2011.04.068; SAITO S, 1993, CYTOKINE, V5, P81, DOI 10.1016/1043-4666(93)90027-3; Harada Y, 2012, CANCER LETT, V319, P83, DOI 10.1016/j.canlet.2011.12.034; Funakoshi-Tago M, 2008, BIOCHEM PHARMACOL, V76, P1681, DOI 10.1016/j.bcp.2008.09.012; Funakoshi-Tago M, 2008, BIOCHEM PHARMACOL, V76, P662, DOI 10.1016/j.bcp.2008.06.015; Kasahara T, 2002, ANTIOXID REDOX SIGN, V4, P491, DOI 10.1089/15230860260196290; Oshio T, 2009, INT IMMUNOPHARMACOL, V9, P403, DOI 10.1016/j.intimp.2008.12.013; Furusawa JI, 2009, INT IMMUNOPHARMACOL, V9, P499, DOI 10.1016/j.intimp.2009.01.031; Provost V, 2013, J LEUKOCYTE BIOL, V94, P213, DOI 10.1189/jlb.0212074; Sakurai S, 2002, BIOCHEM BIOPH RES CO, V293, P174, DOI 10.1016/S0006-291X(02)00192-4; Tanifuji S, 2010, INT IMMUNOPHARMACOL, V10, P769, DOI 10.1016/j.intimp.2010.04.007; Sonoda Y, 1997, BIOCHEM BIOPH RES CO, V241, P769, DOI 10.1006/bbrc.1997.7895; Sonoda Y, 1999, J BIOL CHEM, V274, P10566, DOI 10.1074/jbc.274.15.10566; Kaneda T, 2008, CANCER LETT, V270, P354, DOI 10.1016/j.canlet.2008.05.042; Ichikawa D, 2004, BIOL PHARM BULL, V27, P1353, DOI 10.1248/bpb.27.1353; Matsuoka H, 2003, ALLERGY, V58, P139, DOI 10.1034/j.1398-9995.2003.23790.x; Funakoshi-Tago M, 2011, INT IMMUNOPHARMACOL, V11, P1150, DOI 10.1016/j.intimp.2011.03.012; Kamata S, 2014, MOL NUTR FOOD RES, V58, P1309, DOI 10.1002/mnfr.201300758; KASAHARA T, 1983, J IMMUNOL, V131, P2379; Funakoshi M, 2001, INT IMMUNOPHARMACOL, V1, P595, DOI 10.1016/S1567-5769(00)00035-7; TAKAHASHI M, 1995, CIRC RES, V76, P750; Cance WG, 2013, SCI SIGNAL, V6, ppe10; Dong H, 2002, BIOCHEM BIOPH RES CO, V298, P675, DOI 10.1016/S0006-291X(02)02528-7; Fufusawa J., 2009, CELL SIGNAL, V21, P778; Funakoshi M, 2001, BIOCHEM BIOPH RES CO, V283, P248, DOI 10.1006/bbrc.2001.4759; Funakoshi-Tago M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052844; Funakoshi-Tago M, 2009, J BIOL CHEM, V284, P12680, DOI 10.1074/jbc.M808879200; Funakoshi-Tago M, 2012, YAKUGAKU ZASSHI, V132, P1267; Funakoshi-Tago M, 2003, J BIOL CHEM, V278, P29359, DOI 10.1074/jbc.M213115200; Funakoshi-Tago M, 2012, CELL SIGNAL, V24, P2024, DOI 10.1016/j.cellsig.2012.06.014; Funakoshi-Tago M, 2010, J BIOL CHEM, V285, P5296, DOI 10.1074/jbc.M109.040733; Funakoshi-Tago M, 2014, INT IMMUNOPHARMACOL, V20, P258, DOI 10.1016/j.intimp.2014.02.035; Funakoshi-Tago M, 2010, INT IMMUNOPHARMACOL, V10, P562, DOI 10.1016/j.intimp.2010.02.003; FURUTANI Y, 1986, NUCLEIC ACIDS RES, V14, P3167, DOI 10.1093/nar/14.8.3167; HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914; Ichikawa D, 2006, BIOCHEM BIOPH RES CO, V351, P93, DOI 10.1016/j.bbrc.2006.10.010; Ishii Isao, 2012, Front Oncol, V2, P137, DOI 10.3389/fonc.2012.00137; KASAHARA T, 1980, CELL IMMUNOL, V49, P142, DOI 10.1016/0008-8749(80)90064-7; KASAHARA T, 1987, J IMMUNOL, V138, P1804; KASAHARA T, 1981, IMMUNOLOGY, V42, P175; KASAHARA T, 1983, J IMMUNOL, V130, P1784; KASAHARA T, 1979, INT ARCH ALLER A IMM, V58, P260; KASAHARA T, 1985, J IMMUNOL, V134, P1682; KASAHARA T, 1982, IMMUNOLOGY, V45, P687; KO YC, 1992, J IMMUNOL METHODS, V149, P227, DOI 10.1016/0022-1759(92)90254-Q; KO YC, 1993, INFECT IMMUN, V61, P1307; Kostourou V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3020; Matsui S, 2006, INT IMMUNOPHARMACOL, V6, P369, DOI 10.1016/j.intimp.2005.08.025; Matsushima K., 2014, WATASHINO KENKYUU RI; Minagami T., 2014, GAN BUNSHI HYOUTEKIY; Miyamasu M, 1997, ALLERGY, V52, P317, DOI 10.1111/j.1398-9995.1997.tb00997.x; Miyamasu M, 1999, CYTOKINE, V11, P751, DOI 10.1006/cyto.1999.0487; MORITA M, 1993, EUR CYTOKINE NETW, V4, P351; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; MUKAIDA N, 1987, J IMMUNOL, V139, P3321; MURAGUCHI A, 1982, J IMMUNOL, V129, P2486; NAKANO Y, 1994, INFECT IMMUN, V62, P377; NIETO MA, 1989, J IMMUNOL, V143, P4166; Nishizawa C, 2009, FREE RADICAL RES, V43, P1240, DOI [10.3109/13814780903260764, 10.3109/10715760903273849]; Oda T, 2002, J IMMUNOL, V169, P3329; Oda T, 1998, J INTERF CYTOK RES, V18, P905, DOI 10.1089/jir.1998.18.905; Quintas-Cardama A, 2011, EXPERT OPIN INV DRUG, V20, P961, DOI 10.1517/13543784.2011.579560; Rothenberg ME, 2008, NEW ENGL J MED, V358, P1215, DOI 10.1056/NEJMoa070812; SAITO S, 1994, BIOCHEM BIOPH RES CO, V200, P378, DOI 10.1006/bbrc.1994.1459; SCALA G, 1984, NATURE, V309, P56, DOI 10.1038/309056a0; Sonbol Mohamad Bassam, 2013, Ther Adv Hematol, V4, P15, DOI 10.1177/2040620712461047; Sonoda Y, 1997, J BIOL CHEM, V272, P15366, DOI 10.1074/jbc.272.24.15366; Sonoda Y, 2004, BBA-MOL CELL BIOL L, V1683, P22, DOI 10.1016/j.bbalip.2004.04.002; Sonoda Y, 2001, BIOCHEM BIOPH RES CO, V281, P282, DOI 10.1006/bbrc.2001.4352; Takahashi M, 1997, J CLIN IMMUNOL, V17, P53, DOI 10.1023/A:1027388412806; Takahashi R, 2007, BBA-GEN SUBJECTS, V1770, P518, DOI 10.1016/j.bbagen.2006.11.011; Takamoto M, 1997, IMMUNOLOGY, V90, P511, DOI 10.1046/j.1365-2567.1997.00208.x; TSUCHIYA I, 1993, CYTOKINE, V5, P595, DOI 10.1016/S1043-4666(05)80010-9; TSUNODA H, 1990, MICROBIOL IMMUNOL, V34, P377; Ueda F, 2013, CELL SIGNAL, V25, P2115, DOI 10.1016/j.cellsig.2013.07.003; Utsubo R, 2004, BIOL PHARM BULL, V27, P1735, DOI 10.1248/bpb.27.1735; Verstovsek S., 2009, HEMATOL-AM SOC HEMAT, V2009, P636; WAKASUGI H, 1982, INT ARCH ALLER A IMM, V67, P322; YAGISAWA H, 1990, IMMUNOLOGY, V71, P242; Yamada H, 1997, BIOCHEM BIOPH RES CO, V231, P365, DOI 10.1006/bbrc.1997.6100; YAMAGUCHI Y, 1990, EXP HEMATOL, V18, P1152; YAMAGUCHI Y, 1990, J IMMUNOL, V145, P873; YAMAGUCHI Y, 1988, J EXP MED, V167, P1737, DOI 10.1084/jem.167.5.1737; Yoshida N, 2007, BIOL PHARM BULL, V30, P1826, DOI 10.1248/bpb.30.1826	94	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					431	447				17	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000017		
J	Ohizumi, Y				Ohizumi, Yasushi			A New Strategy for Preventive and Functional Therapeutic Methods for Dementia-Approach Using Natural Products-	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						nobiletin; natural product; dementia; Alzheimer's disease; dementia model animal; functional food	NERVE GROWTH-FACTOR; NGF-POTENTIATING ACTIVITY; ACTIVATED PROTEIN-KINASE; SENESCENCE-ACCELERATED MOUSE; HUMAN ASTROCYTOMA-CELLS; RAT PHEOCHROMOCYTOMA CELLS; IMPROVES MEMORY IMPAIRMENT; MEDIATED NEURITE OUTGROWTH; MILD COGNITIVE IMPAIRMENT; NF-KAPPA-B	Alzheimer's disease (AD) has become a serious social problem in Japan. However, effective preventive and fundamental therapeutic methods for AD have not yet been developed. Using a new strategy in the course of our survey of numerous natural resouces having neurotrophic activity, we isolated a variety of active constituents and proved their pharmacological properties. As a result, we successfully found nobiletin, a compound with anti-dementia activity that comes from citrus peels. Also, we have demonstrated that nobiletin ameliorates cognitive impairment in several dementia model animals such as chronically amyloid beta (A beta) infused rats, amyloid precursor protein transgenic (APPTg) mice, olfactory-bulbectomized (OBX) mice, N-methyl-D-aspartate (NMDA) receptor antagonist (MK-801) -treated mice, senescence-accelated mice and bilaterial common carotid arteries occlusion mice. In a APPTg mouse of AD, nobiletin greatly improved memory impairment, and this was accompanied by a marked decrease in A beta deposition. Also, in OBX mice memory impairment was markedly recoverd by nobiletin, accompanied by improvement of a decrease indensity of cholinergic neurons. Interestingly, nobiletin improves age-related congnitive impairment and decreased hyper-phosphorylation of tau as well as oxidative stress in senescence-accelerated mice. In cultured cells, nobiletin reversed the A beta-induced inhibition of glutamate-induced increases in cAMP response element binding protein (CREB) phosphorylation and modulated gen expression of thioredoxin-interacting protein and NMDA resceptor subunits. These results suggest that nobiletin prevents memory impairment and exhibits a protecting action against neurodgeneration in AD model animals. Nobiletin and citrus peels thus have potential as functional foods for prevention of dementia.	[Ohizumi, Yasushi] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Ohizumi, Yasushi] Tohoku Univ, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Ohizumi, Yasushi] Univ Shizuoka, Fac Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan; [Ohizumi, Yasushi] Tohoku Fukushi Univ, Kansei Res Inst, Aoba Ku, Sendai, Miyagi 9893201, Japan; [Ohizumi, Yasushi] Yokohama Coll Pharm, Totsuka Ku, Yokohama, Kanagawa 2450066, Japan	Ohizumi, Y (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	ohizumi@tfu-mail.tfu.ac.jp					Alonso M, 2002, NEUROBIOL LEARN MEM, V77, P119, DOI 10.1006/nlme.2000.4000; Bobkova NV, 2014, J ALZHEIMERS DIS, V38, P425, DOI 10.3233/JAD-130779; Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058; Lee YC, 2011, MOL CELL BIOCHEM, V347, P103, DOI 10.1007/s11010-010-0618-z; Van Dam D, 2011, BRIT J PHARMACOL, V164, P1285, DOI 10.1111/j.1476-5381.2011.01299.x; Shin RW, 2007, ACTA NEUROPATHOL, V113, P627, DOI 10.1007/s00401-007-0211-z; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Wang XJ, 2010, J ALZHEIMERS DIS, V21, P813, DOI 10.3233/JAD-2010-100216; Seki T, 2013, GERIATR GERONTOL INT, V13, P236, DOI 10.1111/j.1447-0594.2012.00892.x; Peters JM, 2003, AM J PSYCHIAT, V160, P1995, DOI 10.1176/appi.ajp.160.11.1995; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; NITTA A, 1994, NEUROSCI LETT, V170, P63, DOI 10.1016/0304-3940(94)90239-9; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Giannakopoulos Panteleimon, 2009, V24, P20, DOI 10.1159/000197881; Lu YH, 2010, NEUROSCI LETT, V484, P6, DOI 10.1016/j.neulet.2010.07.078; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Auld DS, 2002, PROG NEUROBIOL, V68, P209, DOI 10.1016/S0301-0082(02)00079-5; Lin N, 2003, BIOCHEM PHARMACOL, V65, P2065, DOI 10.1016/S0006-2952(03)00203-X; Fujiwara H, 2006, J NEUROSCI RES, V84, P427, DOI 10.1002/jnr.20891; Hozumi S, 2003, BEHAV BRAIN RES, V138, P9, DOI 10.1016/S0166-4328(02)00183-3; Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Nakajima A, 2007, J PHARMACOL SCI, V105, P122, DOI 10.1254/jphs.SC0070155; Choi Y, 2011, J AGR FOOD CHEM, V59, P12843, DOI 10.1021/jf2033208; Yabuki Y, 2014, NEUROSCIENCE, V259, P126, DOI 10.1016/j.neuroscience.2013.11.051; Saito T, 2007, BIOCHEM BIOPH RES CO, V357, P371, DOI 10.1016/j.bbrc.2007.03.169; Li SM, 2006, MOL NUTR FOOD RES, V50, P291, DOI 10.1002/mnfr.200500214; Choi SY, 2007, BIOL PHARM BULL, V30, P772, DOI 10.1248/bpb.30.772; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Tang MX, 2011, NUTR CANCER, V63, P227, DOI 10.1080/01635581.2011.523506; Su JD, 2012, FREE RADICAL BIO MED, V52, P126, DOI 10.1016/j.freeradbiomed.2011.10.002; Huang YJ, 2012, CURR NEUROPHARMACOL, V10, P272, DOI 10.2174/157015912803217288; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Yamamoto Y, 2009, BRAIN RES, V1295, P218, DOI 10.1016/j.brainres.2009.07.081; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Benke TA, 1998, NATURE, V393, P793; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Li P, 2002, LIFE SCI, V71, P1821, DOI 10.1016/S0024-3205(02)01949-5; Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007; Mishizen-Eberz AJ, 2004, NEUROBIOL DIS, V15, P80, DOI 10.1016/j.nbd.2003.09.016; Miyata Y, 2011, LIFE SCI, V88, P613, DOI 10.1016/j.lfs.2011.01.024; Nakajima A, 2013, BEHAV BRAIN RES, V250, P351, DOI 10.1016/j.bbr.2013.05.025; Obara Y, 1999, EUR J PHARMACOL, V370, P79, DOI 10.1016/S0014-2999(99)00077-1; Li YS, 2004, YAKUGAKU ZASSHI, V124, P417, DOI 10.1248/yakushi.124.417; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Li P, 2000, EUR J PHARMACOL, V406, P203, DOI 10.1016/S0014-2999(00)00662-2; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Rudrabhatla P, 2011, FASEB J, V25, P3896, DOI 10.1096/fj.11-181297; Onozuka H, 2008, J PHARMACOL EXP THER, V326, P739, DOI 10.1124/jpet.108.140293; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631; Dawbarn D, 2003, NEUROPATH APPL NEURO, V29, P211, DOI 10.1046/j.1365-2990.2003.00487.x; Li YS, 2004, J NAT PROD, V67, P725, DOI 10.1021/np0302908; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Li YS, 2001, J NAT PROD, V64, P806, DOI 10.1021/np000602w; Djordjevic J, 2008, NEUROBIOL AGING, V29, P693, DOI 10.1016/j.neurobiolaging.2006.11.014; Sze CI, 2001, J NEUROL SCI, V182, P151, DOI 10.1016/S0022-510X(00)00467-6; Matsuzaki K, 2006, NEUROSCI LETT, V400, P230, DOI 10.1016/j.neulet.2006.02.077; Yasuda N, 2014, BRAIN RES, V1559, P46, DOI 10.1016/j.brainres.2014.02.007; Tomobe K, 2009, NEUROCHEM RES, V34, P660, DOI 10.1007/s11064-009-9923-x; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Berg L, 1998, ARCH NEUROL-CHICAGO, V55, P326, DOI 10.1001/archneur.55.3.326; Chanmahasathien W, 2003, PHYTOCHEMISTRY, V64, P981, DOI 10.1016/50031-9422(03)00431-X; Miyamoto S, 2008, CARCINOGENESIS, V29, P1057, DOI 10.1093/carcin/bgn080; Nagase H, 2005, BIOCHEM BIOPH RES CO, V337, P1330, DOI 10.1016/j.bbrc.2005.10.001; Brim BL, 2013, BEHAV BRAIN RES, V238, P211, DOI 10.1016/j.bbr.2012.10.026; Takeda T, 2009, NEUROCHEM RES, V34, P639, DOI 10.1007/s11064-009-9922-y; Choi SY, 2007, J ETHNOPHARMACOL, V113, P149, DOI 10.1016/j.jep.2007.05.021; Okatani Y, 2002, NEUROBIOL AGING, V23, P639, DOI 10.1016/S0197-4580(02)00005-2; Das SR, 2011, BEHAV BRAIN RES, V222, P122, DOI 10.1016/j.bbr.2011.03.045; Asakawa T, 2011, CHEM COMMUN, V47, P2868, DOI 10.1039/c0cc04936k; Butterfield DA, 1997, P NATL ACAD SCI USA, V94, P674, DOI 10.1073/pnas.94.2.674; Cammarota M, 2000, MOL BRAIN RES, V76, P36, DOI 10.1016/S0169-328X(99)00329-0; Chanmahasathien W, 2003, CHEM PHARM BULL, V51, P1332, DOI 10.1248/cpb.51.1332; Chanmahasathien Wisinee, 2004, Natural Medicines, V58, P76; Cummings JL, 2004, NEW ENGL J MED, V351, P56; Fujiwara H, 2011, J PHARMACOL SCI, V116, P384, DOI 10.1254/jphs.11001SC; Fujiwara H, 2014, CAN J PHYSIOL PHARM, V92, P351, DOI 10.1139/cjpp-2013-0440; Guo Y, 2007, CHEM PHARM BULL, V55, P1532, DOI 10.1248/cpb.55.1532; Guo YQ, 2006, PLANTA MED, V72, P373, DOI 10.1055/s-2005-916210; Guo YQ, 2006, CHEM PHARM BULL, V54, P123, DOI 10.1248/cpb.54.123; Guo YQ, 2006, J NAT PROD, V69, P274, DOI 10.1021/np050276q; Han D, 2009, J BIOL CHEM, V284, P13422, DOI 10.1074/jbc.M901095200; HECKERS S, 1994, J NEUROSCI, V14, P1271; Hirata Y, 2008, BIOCHEM PHARMACOL, V75, P1504, DOI 10.1016/j.bcp.2007.12.019; Ihara Y., 2007, ALZHEIMER BYO NI NAR, P18; Ikeda A, 2013, NEUROSCI LETT, V549, P135, DOI 10.1016/j.neulet.2013.06.004; Kanda K, 2012, BBA-GEN SUBJECTS, V1820, P461, DOI 10.1016/j.bbagen.2011.11.015; Kimura J, 2014, BIOL PHARM BULL, V37, P1555; Kimura J, 2013, BIOL PHARM BULL, V36, P1646, DOI 10.1248/bpb.b13-00230; Kimura J., 2011, PHARMACOMETRICS, V81, P23; Kunimasa K, 2010, CANCER SCI, V101, P2462, DOI 10.1111/j.1349-7006.2010.01668.x; Lee YS, 2010, BIOCHEM PHARMACOL, V79, P1674, DOI 10.1016/j.bcp.2010.01.034; Li P, 2003, DEV BRAIN RES, V145, P177, DOI 10.1016/S0165-3806(03)00239-6; Li P, 2003, J PHARMACOL SCI, V93, P122, DOI 10.1254/jphs.93.122; Li P, 1999, NEUROSCI LETT, V273, P53, DOI 10.1016/S0304-3940(99)00629-1; Li P, 1999, BIOL PHARM BULL, V22, P752; Li P, 2000, BIOL PHARM BULL, V23, P890; Li Y., 2003, CHEM PHARM BULL, V59, P1103; Li Yu-Shan, 2001, Natural Medicines, V55, P90; Li YS, 2003, J NAT PROD, V66, P696, DOI 10.1021/np020577p; Li YS, 2003, CHEM PHARM BULL, V51, P872, DOI 10.1248/cpb.51.872; Li YS, 2001, J ORG CHEM, V66, P2165, DOI 10.1021/jo001460d; Li YS, 2003, CHEM LETT, V32, P728; Li YS, 2001, J PHARM PHARMACOL, V53, P915, DOI 10.1211/0022357011776108; Luo Gang, 2008, Cancer Biol Ther, V7, P966; Ma QL, 2007, J NEUROCHEM, V103, P1594, DOI 10.1111/j.1471-4159.2007.04869.x; Matsuzaki K, 2008, EUR J PHARMACOL, V578, P194, DOI 10.1016/j.ejphar.2007.09.028; Miyata Y, 2008, BIOCHEM BIOPH RES CO, V366, P168, DOI 10.1016/j.bbrc.2007.11.100; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823; Nagase H, 2005, BIOCHEMISTRY-US, V44, P13683, DOI 10.1021/bi050643x; Nakajima A, 2014, CLIN PSYCHOPHARM NEU, V12, P75, DOI 10.9758/cpn.2014.12.2.75; Nakajima A, 2007, J PHARMACOL EXP THER, V321, P784, DOI 10.1124/jpet.106.117010; Nemoto K, 2013, BIOCHEM BIOPH RES CO, V431, P530, DOI 10.1016/j.bbrc.2013.01.024; NOMURA Y, 1989, EXP GERONTOL, V24, P49, DOI 10.1016/0531-5565(89)90034-X; Obara Y, 2002, J PHARMACOL EXP THER, V301, P803, DOI 10.1124/jpet.301.3.803; Obara Y, 2000, LIFE SCI, V67, P1659, DOI 10.1016/S0024-3205(00)00742-6; Obara Y, 1998, BRAIN RES, V806, P79, DOI 10.1016/S0006-8993(98)00731-8; Obara Y, 2001, MOL PHARMACOL, V59, P1287; Ohizumi Y, 1997, JPN J PHARMACOL, V73, P263, DOI 10.1254/jjp.73.263; Ohizumi Y., 2004, J APPL PHARM, V12, P195; Ohta T, 1998, TETRAHEDRON LETT, V39, P6229, DOI 10.1016/S0040-4039(98)01282-9; Osborn Gerald G, 2010, J Am Osteopath Assoc, V110, pS16; PROCTER AW, 1989, J NEUROCHEM, V53, P698, DOI 10.1111/j.1471-4159.1989.tb11760.x; Rahim M. A., 2008, PHARMACOMETRICS, V74, P131; Rahim M. A., 2009, BIOCHEM, V48, P7713; Rahim M. A., 2008, EUR J PHARMACOL, V600, P10; Roche K. W., 1996, NEURON, V16, P179; Sagare AP, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011452; Saigusa D, 2011, ANAL BIOANAL CHEM, V400, P3635, DOI 10.1007/s00216-011-5031-2; Saito M, 2006, EUR J PHARM SCI, V28, P263, DOI 10.1016/j.ejps.2006.02.004; Tanaka S, 2004, BIOCHEM PHARMACOL, V68, P433, DOI 10.1016/j.bcp.2004.04.006; TARRICONE BJ, 1993, BRAIN RES, V632, P41, DOI 10.1016/0006-8993(93)91136-G; Yamada K, 1999, BRIT J PHARMACOL, V128, P419, DOI 10.1038/sj.bjp.0702811; Yamaguchi K., 2009, PHARMACOMETRICS, V76, P33; Yamamoto T, 1997, BEHAV BRAIN RES, V83, P57, DOI 10.1016/S0166-4328(97)86046-9; Yasuda T, 2003, CHEM PHARM BULL, V51, P1426, DOI 10.1248/cpb.51.1426	137	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					449	464				16	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000018		
J	Yamada, T				Yamada, Takaaki			Pharmacological Study and Pharmaceutical Intervention to Reduce Intravenous Injection-induced Vascular Injury	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						vascular injury; vinorelbine; epirubicin; pharmaceutical intervention; endothelial cell	ENDOTHELIAL-CELL INJURY; BREAST-CANCER; VENOUS IRRITATION; INDUCED APOPTOSIS; ANTICANCER DRUGS; IN-VITRO; VINORELBINE; EXTRAVASATION; DEXRAZOXANE; PHLEBITIS	Intravenous injection often causes vascular injury such as venous irritation, vascular pain, and phlebitis. Vascular injury deteriorates the patient's QOL and sometimes limits the continuation of injection therapy. Pharmaceutical intervention and pharmacological mechanisms used to reduce vascular injury induced by vinorelbine and epirubicin were reviewed. A multivariate logistic regression analysis revealed that the dose of vinorelbine (>= 40 mg) was a significant predictor for venous irritation. Alteration of the volume of normal saline for vinorelbine dissolution, from 50 to 100 mL, significantly decreased the grade of venous irritation. On the other hand, the phlebitis scores were significantly higher in patients treated with epirubicin ready-to-use solution compared with lyophilized powder. The change of formulation of epirubicin to lyophilized powder decreased the risk of venous irritation. The concentration inducing 50% cell viability inhibition was lower in the order of vesicant, irritant, and nonvesicant drugs on porcine aorta endothelial cells (PAECs), suggesting that the injuring effects of anticancer drugs on PAECs may be relevant as an indicator of the frequency of their vascular injury. The exposure to vinorelbine of PAECs rapidly depleted intracellular glutathione levels and increased intracellular reactive oxygen species production. Moreover, exposure to epirubicin increased intracellular lipid peroxide levels and enhanced the phosphorylation of p38 mitogen-activated protein kinase. These results demonstrate that oxidative stress plays an important role in vinorelbine- and epirubicin-induced endothelial cell injury, and may therefore increase the potential for vascular injury upon intravenous injection.	Kyushu Univ Hosp, Dept Pharm, Higashi Ku, Fukuoka 8128582, Japan	Yamada, T (reprint author), Kyushu Univ Hosp, Dept Pharm, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yamada-t@pharm.med.kyushu-u.ac.jp					Aki T, 2008, J PHARMACOL SCI, V106, P415, DOI 10.1254/jphs.FP0072035; Aki T, 2008, J PHARMACOL SCI, V107, P238, DOI 10.1254/jphs.08053FP; Anami SMN, 2006, JPN J PHARM HLTH CAR, V32, P1105; MAKI DG, 1991, ANN INTERN MED, V114, P845; Lebrecht D, 2007, BRIT J PHARMACOL, V151, P771, DOI 10.1038/sj.bjp.0707294; Yamada T, 2012, FREE RADICAL BIO MED, V52, P1285, DOI 10.1016/j.freeradbiomed.2012.02.003; Mouridsen HT, 2007, ANN ONCOL, V18, P546, DOI 10.1093/annonc/mdl413; LARSON DL, 1982, CANCER, V49, P1796, DOI 10.1002/1097-0142(19820501)49:9<1796::AID-CNCR2820490911>3.0.CO;2-M; Hasinoff BB, 1998, CURR MED CHEM, V5, P1; Verso M, 2003, J CLIN ONCOL, V21, P3665, DOI 10.1200/JCO.2003.08.008; Sauerland C, 2006, ONCOL NURS FORUM, V33, P1134, DOI 10.1188/06.ONF.1134-1141; Swain SM, 1997, J CLIN ONCOL, V15, P1318; Uslusoy E, 2008, J AM ACAD NURSE PRAC, V20, P172, DOI 10.1111/j.1745-7599.2008.00305.x; Tsai KL, 2014, BIOCHEM PHARMACOL, V88, P189, DOI 10.1016/j.bcp.2013.12.005; Yamada T, 2011, J PHARMACOL SCI, V117, P125, DOI 10.1254/jphs.11070SC; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Merli F, 2012, LEUKEMIA LYMPHOMA, V53, P581, DOI 10.3109/10428194.2011.621565; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Tesfamariam B, 2007, VASC PHARMACOL, V46, P229, DOI 10.1016/j.vph.2006.11.005; Piccart MJ, 2001, J CLIN ONCOL, V19, P3103; Langer SW, 2001, ANN ONCOL, V12, P405, DOI 10.1023/A:1011163823321; Kim DS, 2005, BIOCHEM PHARMACOL, V70, P1066, DOI 10.1016/j.bcp.2005.06.026; Zhang L, 2012, APOPTOSIS, V17, P25, DOI 10.1007/s10495-011-0653-6; Nagata K, 2012, SUPPORT CARE CANCER, V20, P951, DOI 10.1007/s00520-011-1166-0; Yamada T, 2010, FREE RADICAL BIO MED, V48, P120, DOI 10.1016/j.freeradbiomed.2009.10.032; Wu S, 2002, J MOL CELL CARDIOL, V34, P1595, DOI 10.1006/jmcc.2002.2110; IGNOFFO RJ, 1980, CANCER TREAT REV, V7, P17, DOI 10.1016/S0305-7372(80)80023-5; Asako E., 2008, JPN J CANC CHEMOTHER, V35, P1163; Beckers MMJ, 2010, THROMB RES, V125, P318, DOI 10.1016/j.thromres.2009.06.008; DONEHOWER RC, 1987, CANCER TREAT REP, V71, P1171; DORR RT, 1990, BLOOD REV, V4, P41, DOI 10.1016/0268-960X(90)90015-K; Jackson A, 1998, Nurs Times, V94, P71; Kohno Emiko, 2008, Int J Med Sci, V5, P218; Kohno E, 2009, INT J MED SCI, V6, P218; Kuwahara Takashi, 1998, Journal of Toxicological Sciences, V23, P77; Nakayama Shoichi, 2002, Gan To Kagaku Ryoho, V29, P633; Nakazawa Y., 2005, JPN J CANC CHEMOTHER, V32, P24; Polovich M., 2005, CHEMOTHERAPY BIOTHER, P70; Recchioni R, 2002, METABOLISM, V51, P1384, DOI 10.1053/meta.2002.35579; Rittenberg C N, 1995, Oncol Nurs Forum, V22, P707; Schulmeister Lisa, 2007, Clin J Oncol Nurs, V11, P387, DOI 10.1188/07.CJON.387-395; Suga Yukio, 2009, Gan To Kagaku Ryoho, V36, P93; Sugimoto M., 2009, JPN J CANC CHEMOTHER, V36, P969; Tsai KL, 2012, CELL BIOCHEM BIOPHYS, V62, P467, DOI 10.1007/s12013-011-9333-y; Vassilomanolakis M, 2001, SUPPORT CARE CANCER, V9, P108, DOI 10.1007/s005200000190; Wang Z, 2014, CANCER CHEMOTH PHARM, V74, P239, DOI 10.1007/s00280-014-2487-8; WATANABE H, 2008, HOSP PHARM, V43, P571; Yamada T, 2012, SUPPORT CARE CANCER, V20, P1549, DOI 10.1007/s00520-011-1244-3; Yoh K, 2004, JPN J CLIN ONCOL, V34, P206, DOI 10.1093/jjco/hyh029; Yoh K, 2007, LUNG CANCER, V55, P337, DOI 10.1016/j.lungcan.2006.10.016; Zhang J, 2013, TOXICOL MECH METHOD, V23, P665, DOI 10.3109/15376516.2013.837130	51	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					465	472				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000019		
J	Akamine, Y				Akamine, Yumiko			Determinants of the Stereoselective Pharmacokinetics of Fexofenadine	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						enantiomer; fexofenadine; drug-transporters; pharmacokinetics; P-glycoprotein; organic anion transporting polypeptide	HEALTHY MALE-VOLUNTEERS; P-GLYCOPROTEIN; DRUG-INTERACTIONS; BILIARY-EXCRETION; HEPATIC-UPTAKE; HUMAN PLASMA; ENANTIOMERS; TRANSPORTERS; DISPOSITION; OATP	Drug transporters play an important role in the clinical pharmacokinetics of many therapeutic agents. Although it is estimated that about half of all therapeutic agents are chiral, there has been little information on the stereoselective pharmacokinetics related to drug transporters. This review focuses on the drug transporters contributing to the stereoselective pharmacokinetics of fexofenadine enantiomers in humans. Fexofenadine is administered clinically as a racemic mixture, and the plasma concentration of (R)-fexofenadine is about 1.5-fold higher than that of the (S)-enantiomer. Because fexofenadine is poorly metabolized by cytochrome P450s, its pharmacokinetics depends on its drug-transporter activities. First, we examined whether drug-transporter polymorphisms influence fexofenadine enantiomer pharmacokinetics. The findings suggested that a combination of multiple transporters involving organic anion transporting polypeptide (OATP) 2B1, P-glycoprotein (P-gp), and multidrug resistance-associated protein 2 (MRP2) react to stereoselective fexofenadine exposure. Subsequently, we evaluated the roles of P-gp and OATPs in fexofenadine enantiomer pharmacokinetics using these inducer/inhibitors. Coadministration of P-gp inducer/inhibitors significantly altered the pharmacokinetics of fexofenadine enantiomers. In addition, the OATP inhibitors rifampicin and apple juice also affected fexofenadine enantiomer pharmacokinetics. Moreover, in in vitro studies, the uptake of both fexofenadine enantiomers into OATP2B1 cRNA-injected oocytes was significantly higher than that into water-injected oocytes, and this effect was greater for (R) -fexofenadine. Taken together, these studies indicated that multiple transporters including P-gp, OATPs, and MRP2 play important roles in fexofenadine enantiomer pharmacokinetics. Furthermore, OATP2B1 is a key determinant of the stereoselective pharmacokinetics of fexofenadine, and drug transporters may have chiral discrimination ability.	[Akamine, Yumiko] Univ Ryukyus, Fac Med, Dept Hosp Pharm, Nishihara, Okinawa 900215, Japan; [Akamine, Yumiko] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacokinet, Higashi Ku, Fukuoka 8128582, Japan	Akamine, Y (reprint author), Univ Ryukyus, Fac Med, Dept Hosp Pharm, 207 Uehara, Nishihara, Okinawa 900215, Japan.	yumiko-ryk@umin.ac.jp					Akamine Y, 2015, J CLIN PHARM THER, V40, P98, DOI 10.1111/jcpt.12213; Akamine Y, 2012, CNS DRUGS, V26, P959, DOI 10.1007/s40263-012-0008-z; Hutt AJ, 1996, DRUGS, V52, P1; Kanazawa H, 2003, J PHARMACEUT BIOMED, V30, P1817, DOI 10.1016/S0731-7085(02)00524-1; Tateishi T, 2008, BRIT J CLIN PHARMACO, V65, P693, DOI 10.1111/j.1365-2125.2008.03116.x; Shirasaka Y, 2013, J PHARM SCI-US, V102, P280, DOI 10.1002/jps.23357; Shimizu M, 2006, BRIT J CLIN PHARMACO, V61, P538, DOI 10.1111/j.1365-2125.2006.02613.x; Kusuhara H, 2013, DRUG METAB DISPOS, V41, P206, DOI 10.1124/dmd.112.048330; [Anonymous], 1992, CHIRALITY, V4, P338; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Hamman MA, 2001, CLIN PHARMACOL THER, V69, P114, DOI 10.1067/mcp.2001.113697; Miura M, 2007, CHIRALITY, V19, P223, DOI 10.1002/chir.20370; Nozawa T, 2002, J PHARMACOL EXP THER, V302, P804, DOI 10.1124/jpet.302.2.804; Akamine Y, 2010, XENOBIOTICA, V40, P782, DOI 10.3109/00498254.2010.515318; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Wang ZQ, 2002, CLIN PHARMACOL THER, V71, P414, DOI 10.1067/mcp.2002.124080; JAMALI F, 1989, J PHARM SCI, V78, P695, DOI 10.1002/jps.2600780902; Andersson T, 2001, CLIN PHARMACOKINET, V40, P411, DOI 10.2165/00003088-200140060-00003; Sakugawa T, 2009, BRIT J CLIN PHARMACO, V67, P535, DOI 10.1111/j.1365-2125.2009.03396.x; Dresser GK, 2002, CLIN PHARMACOL THER, V71, P11, DOI 10.1067/mcp.2002.121152; ACOCELLA G, 1971, CHEMOTHERAPY, V16, P356; Simpson K, 2000, DRUGS, V59, P301, DOI 10.2165/00003495-200059020-00020; [Anonymous], 2009, PROD INF RIF; Cvetkovic M, 1999, DRUG METAB DISPOS, V27, P866; Andersson T, 2008, CLIN DRUG INVEST, V28, P263, DOI 10.2165/00044011-200828050-00001; Miura M, 2007, J PHARMACEUT BIOMED, V43, P741, DOI 10.1016/j.jpba.2006.07.033; Akamine Y, 2012, BRIT J CLIN PHARMACO, V73, P478, DOI 10.1111/j.1365-2125.2011.04106.x; Matsushima S, 2008, DRUG METAB DISPOS, V36, P663, DOI 10.1124/dmd.107.017814; Russell T, 1998, CLIN PHARMACOL THER, V64, P612, DOI 10.1016/S0009-9236(98)90052-2; Yasui-Furukori N, 2005, CLIN PHARMACOL THER, V77, P17, DOI 10.1016/j.clpt.2004.08.026; Akamine Y, 2014, EUR J CLIN PHARMACOL, V70, P1087, DOI 10.1007/s00228-014-1705-y; Shimizu M, 2005, DRUG METAB DISPOS, V33, P1477, DOI 10.1124/dmd.105.004622; Shirasaka Y, 2014, PHARM RES-DORDR, V31, P2035, DOI 10.1007/s11095-014-1305-7; Ayrton A, 2001, XENOBIOTICA, V31, P469, DOI 10.1080/00498250110060969; Robbins DK, 1998, BIOPHARM DRUG DISPOS, V19, P455, DOI 10.1002/(SICI)1099-081X(199810)19:7<455::AID-BDD130>3.3.CO;2-N; BLASCHKE G, 1979, ARZNEIMITTEL-FORSCH, V29-2, P1640; Goto T, 2010, CLIN CHIM ACTA, V411, P1375, DOI 10.1016/j.cca.2010.04.014; HOWE R, 1966, NATURE, V210, P1336, DOI 10.1038/2101336a0; Kaminsky LS, 1997, PHARMACOL THERAPEUT, V73, P67, DOI 10.1016/S0163-7258(96)00140-4; Lin G. Q., 2011, CHIRAL DRUGS CHEM BI, P3; Shiohira H, 2012, PHARM RES-DORDR, V29, P2310, DOI 10.1007/s11095-012-0757-x; Tahara H, 2005, DRUG METAB DISPOS, V33, P963, DOI 10.1124/dmd.105.004192; Tian X, 2008, DRUG METAB DISPOS, V36, P61, DOI 10.1124/dmd.107.017319; Tybring G, 1997, CLIN PHARMACOL THER, V62, P129, DOI 10.1016/S0009-9236(97)90060-6; Uno T, 2008, J CLIN PHARM THER, V33, P67, DOI 10.1111/j.1365-2710.2008.00887.x; Yamada S, 2009, THER DRUG MONIT, V31, P764, DOI 10.1097/FTD.0b013e3181bf7db6	46	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					473	481				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000020		
J	Nagano, M; Toshima, JY; Toshima, J				Nagano, Makoto; Toshima, Junko Y.; Toshima, Jiro			Rab GTPases Networks in Membrane Traffic in Saccharomyces cerevisiae	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						Rab/Ypt GTPase; membrane traffic; Rab5; budding yeast	NUCLEOTIDE EXCHANGE FACTOR; CLATHRIN-MEDIATED ENDOCYTOSIS; GTP-BINDING PROTEIN; ACTIVATING PROTEIN; SECRETORY PATHWAY; GOLGI-APPARATUS; BUDDING YEAST; TRANSPORT; COMPLEX; CASCADE	Intracellular membrane trafficking between membranous compartments is essential for organelle biogenesis, structure, and identity. Rab/Ypt GTPases are well-characterized regulators of intracellular membrane trafficking, functioning as molecular switches that alternate between GTP- and GDP-bound forms. In Saccharomyces cerevisiae, 11 Rab/Ypt GTPases have been identified and their functions are known to be conserved in their mammalian counterparts. In yeast, the secretory pathway is regulated by sequential activation and inactivation (the so-called Rab cascade) of three types of yeast Rab protein Ypt1p, Ypt31p/32p and Sec4p -via specific guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). In addition to these Rabs, we and others have recently demonstrated that Ypt6p is predominantly localized to the early Golgi compartment, and functions as another regulator of anterograde transport for intra-Golgi trafficking in the secretory pathway. On the other hand, the endocytic pathway is known to be regulated by three yeast Rab5s (Vps21p, Ypt52p and Ypt53p) and one Rab7 (Ypt7p). Rab5 and Rab7 are key determinants of endosome identity, and the Rab5-Rab7 cascade is important for the progression from early to late endosome. Our recent study demonstrates that the endocytic pathway branches into two vacuolar targeting pathways, the Rab5-dependent vacuole protein sorting (VPS) pathway and the Rab5-independent pathway. In this review, we focus on recent advances in our understanding of molecular mechanisms that regulate the localization and activity of yeast Rab GTPases in intracellular membrane trafficking.	[Nagano, Makoto; Toshima, Junko Y.; Toshima, Jiro] Tokyo Univ Sci, RIST, Res Ctr RNA Sci, Katsushika Ku, Tokyo 1258585, Japan; [Toshima, Junko Y.] Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan; [Toshima, Jiro] Tokyo Univ Sci, Dept Biol Sci & Technol, Katsushika Ku, Tokyo 1258585, Japan	Toshima, J (reprint author), Tokyo Univ Sci, RIST, Res Ctr RNA Sci, Katsushika Ku, 6-3-1 Niijyuku, Tokyo 1258585, Japan.	jtosiscb@rs.noda.tus.ac.jp					Casey PJ, 1996, J BIOL CHEM, V271, P5289; SCHMITT HD, 1988, CELL, V53, P635, DOI 10.1016/0092-8674(88)90579-X; Paulsel AL, 2013, J BIOL CHEM, V288, P18162, DOI 10.1074/jbc.M113.457069; Rivera-Molina FE, 2009, P NATL ACAD SCI USA, V106, P14408, DOI 10.1073/pnas.0906536106; HORAZDOVSKY BF, 1994, EMBO J, V13, P1297; Lachmann J, 2012, MOL BIOL CELL, V23, P2516, DOI 10.1091/mbc.E11-12-1030; Stepp JD, 1997, J CELL BIOL, V139, P1761, DOI 10.1083/jcb.139.7.1761; WICHMANN H, 1992, CELL, V71, P1131, DOI 10.1016/S0092-8674(05)80062-5; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Benli M, 1996, EMBO J, V15, P6460; Nickerson DP, 2012, TRAFFIC, V13, P1411, DOI 10.1111/j.1600-0854.2012.01390.x; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; JEDD G, 1995, J CELL BIOL, V131, P583, DOI 10.1083/jcb.131.3.583; Wang CW, 2003, J CELL BIOL, V163, P973, DOI 10.1083/jcb.200308071; Sacher M, 2008, TRAFFIC, V9, P2032, DOI 10.1111/j.1600-0854.2008.00833.x; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Weinberg J, 2012, TRENDS CELL BIOL, V22, P1, DOI 10.1016/j.tcb.2011.09.001; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Nottingham RM, 2009, P NATL ACAD SCI USA, V106, P14185, DOI 10.1073/pnas.0907725106; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Boettner DR, 2012, NAT CELL BIOL, V14, P2, DOI 10.1038/ncb2403; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; Bensen ES, 2001, MOL BIOL CELL, V12, P13; Beraud-Dufour S, 2002, J CELL SCI, V115, P1779; CHAPMAN RE, 1994, CURR BIOL, V4, P1019, DOI 10.1016/S0960-9822(00)00231-1; Du LL, 2001, MOL BIOL CELL, V12, P1215; Faini M, 2013, TRENDS CELL BIOL, V23, P279, DOI 10.1016/j.tcb.2013.01.005; Gerrard SR, 2000, MOL BIOL CELL, V11, P613; Itoh T, 2002, MOL CELL BIOL, V22, P7744, DOI 10.1128/MCB.22.22.7744-7757.2002; Kamena F, 2008, J CELL SCI, V121, P1293, DOI 10.1242/jcs.016998; Kawamura S, 2014, BIOCHEM BIOPH RES CO, V450, P519, DOI 10.1016/j.bbrc.2014.06.002; Lipatova Z, 2013, MOL BIOL CELL, V24, P3133, DOI 10.1091/mbc.E13-05-0269; Lipatova Z, 2012, AUTOPHAGY, V8, P1271, DOI 10.4161/auto.20872; Luo ZL, 2003, J BIOL CHEM, V278, P791, DOI 10.1074/jbc.M209120200; Nakatsukasa K, 2014, J BIOL CHEM, V289, P20970, DOI 10.1074/jbc.M114.548297; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Siniossoglou S, 2000, EMBO J, V19, P4885, DOI 10.1093/emboj/19.18.4885; Suda Y, 2012, TRAFFIC, V13, P505, DOI 10.1111/j.1600-0854.2011.01316.x; Suda Y, 2013, P NATL ACAD SCI USA, V110, P18976, DOI 10.1073/pnas.1308627110; Toshima JY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4498; Tsvetanova NG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002862; Will E, 2001, J BIOL CHEM, V276, P12135, DOI 10.1074/jbc.M011451200	55	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					483	492				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000021		
J	Hoshi, Y; Tani, N; Tabata, H; Wakamatsu, S; Munakata, M; Maruyama, K; Kodama, H; Oshitari, T; Natsugari, H; Takahashi, H				Hoshi, Yujiro; Tani, Norihiko; Tabata, Hidetsugu; Wakamatsu, Shintaro; Munakata, Mitsutoshi; Maruyama, Kazuo; Kodama, Hiroko; Oshitari, Tetsuta; Natsugari, Hideaki; Takahashi, Hideyo			Development of a Therapeutic Agent for Menkes Disease: Solubilization of a Copper-Disulfiram Complex	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						Menkes disease; disulfiram; cyclodextrin; X-ray crystallographic analysis	COMBINATION THERAPY; MACULAR MOUSE; MODEL; DIETHYLDITHIOCARBAMATE; SYSTEM	Menkes disease (MD) is a neurodegenerative disorder characterized by copper deficiency. It is caused by defective intestinal absorption of copper resulting from a deficiency of a copper-transporting ATPase, ATP7A. We investigated the effects of combination therapy with copper and disulfiram, a known lipophilic chelator. We synthesized a copper-disulfiram complex (Cu-DSF) and determined its crystal structure by X-ray crystallographic analysis. Unfortunately, Cu-DSF was not orally bioavailable due to its lipophilicity. We therefore planned to use cyclodextrin as a solubilizing agent to increase the water solubility of Cu-DSF. After comparisons of the effects of cyclodextrins (alpha, beta, gamma), it was found that addition of beta-cyclodextrin (beta-CyD) increased the solubility of Cu-DSF. Moreover, the modified beta-CyD, hydroxy-propyl-beta-cyclodextrin, was yet more effective as a solubilizing agent. For the development of a convenient method to determine the concentration of Cu-DSF included by beta-cyclodextrins, a standard curve based on UV-visible (VIS) absorption was derived.	[Hoshi, Yujiro; Tani, Norihiko; Tabata, Hidetsugu; Wakamatsu, Shintaro; Maruyama, Kazuo; Oshitari, Tetsuta; Natsugari, Hideaki; Takahashi, Hideyo] Teikyo Univ, Fac Pharma Sci, Itabashi Ku, Tokyo 1738605, Japan; [Munakata, Mitsutoshi] Tohoku Univ, Sch Med, Dept Pediat, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Kodama, Hiroko] Teikyo Univ, Sch Med, Itabashi Ku, Tokyo 1738605, Japan	Takahashi, H (reprint author), Teikyo Univ, Fac Pharma Sci, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	hide-tak@pharm.teikyo-u.ac.jp					Victoriano LI, 2000, COORDIN CHEM REV, V196, P383, DOI 10.1016/S0010-8545(99)00221-0; Ogawa E, 2012, J TRACE ELEM MED BIO, V26, P102, DOI 10.1016/j.jtemb.2012.04.017; Cen DZ, 2004, J MED CHEM, V47, P6914, DOI 10.1021/jm049568z; KRUCK TPA, 1973, CAN J CHEM, V51, P3563, DOI 10.1139/v73-531; Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p; Nomura S, 2014, J NUCL MED, V55, P845, DOI 10.2967/jnumed.113.131797; Bhadhprasit W, 2012, J TRACE ELEM MED BIO, V26, P105, DOI 10.1016/j.jtemb.2012.05.002; BONAMICO M, 1965, ACTA CRYSTALLOGR, V19, P886, DOI 10.1107/S0365110X65004619; Gu Y. H., 2009, JPN J PEDIAT MED, V41, P437; Harata K., 2000, CYCLODEXTRIN CHOBUNS, P28; Kodama H, 2005, J INHERIT METAB DIS, V28, P971, DOI 10.1007/s10545-005-0150-6; Tang JZ, 2010, J PHARM PHARMACOL, V62, P1354; Wang SL, 2004, CURR EYE RES, V29, P51, DOI 10.1080/02713680490513209	13	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					493	499				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000022		
J	Eguchi, R; Kato, M; Kaneko, E; Kusaba, K; Yoshikawa, M; Yamano, T; Seo, T; Hagihara, A				Eguchi, Rika; Kato, Masahisa; Kaneko, Erina; Kusaba, Kenji; Yoshikawa, Manabu; Yamano, Toru; Seo, Takashi; Hagihara, Akihito			A Systematic Review of Decided Litigated Cases on Adverse Drug Events in Japan: Classification of Decided Cases Appearing in Law Reports	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						adverse drug event; duty of care; duty of information; medical lawsuit; pharmacist law revision		Much of the damage to health caused by drugs could be prevented by appropriate care. A well-defined duty of care and further information are required for healthcare professionals. Although there are many litigation cases to use as references, neither the extent of the duty of care nor the obligation to explain medication according to the type of drug prescribed has yet been fully established. Thus, we systematically collected decided cases of adverse drug events, and assessed the degree of the duties of care and information. Specifically, we collected decided cases in which physicians, dentists, pharmacists, nurses, or hospitals had been sued. Data were derived from Bessatsu Jurist Iryo-kago Hanrei Hyakusen, Hanrei Jihou, and Hanrei Times from 1989 to November 2013, and information on precedents in the records of the Supreme Court of Japan from 2001 to November 2013. We analyzed the cases, and assessed the following according to the type of drug: (1) standards and explanations when dealing with drugs that were critical issues in litigation, and (2) the degree of the physician's or pharmacist's duties of care and information. In total, 126 cases were collected. The number of drug categories classified was 27, and 9 were considered of practical importance. After this systematic review, we found a trend in the degree of the required level of care and information on several drugs. With respect to duties of care and information, the gap between the required level and actual practice suggests that healthcare professionals must improve their care and explanations.	[Eguchi, Rika; Kato, Masahisa; Kaneko, Erina; Kusaba, Kenji; Yoshikawa, Manabu] Fukuoka City Pharmaceut Assoc Pharm Nanakuma Bran, Jyonan Ku, Fukuoka 8140133, Japan; [Yamano, Toru; Seo, Takashi] Fukuoka City Pharmaceut Assoc, Chuo Ku, Fukuoka 8100021, Japan; [Eguchi, Rika; Hagihara, Akihito] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Higashi Ku, Fukuoka 8128582, Japan	Eguchi, R (reprint author), Fukuoka City Pharmaceut Assoc Pharm Nanakuma Bran, Jyonan Ku, 7-42-25 Nanakuma, Fukuoka 8140133, Japan.	Lika.Eguchi@gmail.com					[Anonymous], 2000, HANREI JIHOU, P110; [Anonymous], 1991, HANREI JIHOU, P96; [Anonymous], 1996, HANREI JIHOU, P99; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; [Anonymous], 1997, HANREI JIHOU, P44; [Anonymous], 1995, HANREI TIMES, P206; [Anonymous], 1996, HANREI TIMES, P232; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; [Anonymous], 1995, HANREI TIMES, P214; [Anonymous], 1990, HANREI JIHOU, P80; [Anonymous], 1993, HANREI JIHOU, P114; [Anonymous], 1996, HANREI JIHOU, P107; [Anonymous], 1991, HANREI TIMES, P221; [Anonymous], 2001, HANREI JIHOU, P90; [Anonymous], 2005, HANREI TIMES, P197; Bai K., 1996, BESSATSU JURIST IRYO, P80; International Conference Harmonisation, ICH TOP E2A CLIN SAF; Katahira K., 2009, B SCH MED, V26, P125; Lee A, 1997, BRIT MED J, V315, P519; Ministry of Health Labour and Welfare, 2013, YAK WO MAN	20	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					501	506				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000023		
J	Tsubai, T; Noda, Y; Hibi, Y; Mouri, A; Nishikawa, S; Yamada, K; Nakao, M				Tsubai, Tomomi; Noda, Yukihiro; Hibi, Yoko; Mouri, Akihiro; Nishikawa, Sakiko; Yamada, Kiyofumi; Nakao, Makoto			Practical Program to Gather Patient Information from a Diversified Perspective and Provide Appropriate Therapies in Practical Hospital Training	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						hospital practical training; clinical practice program; medical information; physical assessment; pharmaceutical education		In the 11-week practical hospital training of pharmaceutical students in Nagoya University Hospital, a clinical practice program has been implemented with the objective of compensating for any deficits students may have in skills and attitudes due to insufficiencies in their formal education. The program aims to enable the students to observe patients from various angles, obtain from them information necessary for drug therapy, and propose multiple treatment methods according to the patient's background and situation. Tests are conducted before and after the program to assess the students' knowledge and to confirm whether lectures on basic knowledge of practical skills had been provided and whether practical skill training had been performed. The rate of correct answers on the postprogram test rose significantly after the practice program compared with the preprogram scores, thus confirming that the students' knowledge improved. Because the content of their knowledge and the experience that they had acquired previously was in accordance with older guidelines, however, it will be necessary to update students' knowledge regularly and to instill knowledge, skills, and attitudes that they will be able to apply in actual medical practice. In the questionnaire after the end of the program, more than 80% of the students indicated that they had benefitted. Many responded that this program would be useful for their practical hospital training on the wards and for their future work. This suggests that the program is extremely beneficial to the students.	[Tsubai, Tomomi; Nakao, Makoto] Kinjo Gakuin Univ, Coll Pharm, Moriyama Ku, Nagoya, Aichi 4638521, Japan; [Tsubai, Tomomi; Noda, Yukihiro] Meijo Univ, Grad Sch Pharm, Div Clin Sci & Neuropsychopharmacol, Tempaku Ku, Nagoya, Aichi 4688503, Japan; [Noda, Yukihiro; Mouri, Akihiro] Meijo Univ, Fac Pharm, Div Clin Sci & Neuropsychopharmacol, Tempaku Ku, Nagoya, Aichi 4688503, Japan; [Hibi, Yoko; Yamada, Kiyofumi] Nagoya Univ, Grad Sch, Dept Neuropsychopharmacol, Showa Ku, Nagoya, Aichi 4668560, Japan; [Hibi, Yoko; Yamada, Kiyofumi] Nagoya Univ, Grad Sch, Hosp Pharm, Showa Ku, Nagoya, Aichi 4668560, Japan; [Nishikawa, Sakiko] Aichi Gakuin Univ, Sch Pharm, Chikusa Ku, Nagoya, Aichi 4648650, Japan	Noda, Y (reprint author), Meijo Univ, Grad Sch Pharm, Div Clin Sci & Neuropsychopharmacol, Tempaku Ku, 150 Yagotoyama, Nagoya, Aichi 4688503, Japan.	ynoda@meijo-u.ac.jp	清文, 山田/I-7487-2014	清文, 山田/0000-0002-5280-5180			Hayashi M., 2012, JPN J PHARM HLTH CAR, V38, P339; Kato H., 2009, JPN J PHARM HLTH CAR, V35, P24; Ministry of Education Culture Sports Science and Technology, 2014, REV PHARM ED MOD COR; Ministry of Education Culture Sports Science and Technology, 2014, OUTL PHARM ED MOD CO; Ministry of Health Labour and Welfare, 2014, PROM TEAM MED TREATM; Ministry of Health Labour and Welfare, 2014, PHARM ED 6 YEAR PROG; Ministry of Health Labour and Welfare, 2014, METH OP PHARM ED BUS; Otori T, 2012, YAKUGAKU ZASSHI, V132, P381; Suzuki S, 2009, YAKUGAKU ZASSHI, V129, P1103; Tokunaga J., 2008, JPN J PHARM HLTH CAR, V34, P847; Tokunaga J, 2013, YAKUGAKU ZASSHI, V133, P243; Yokoyama H, 2011, YAKUGAKU ZASSHI, V131, P153, DOI 10.1248/yakushi.131.153	12	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					507	518				12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000024		
J	Onda, M; Imai, H; Nanaumi, Y; Hirano, A; Fujii, S; Arakawa, Y				Onda, Mitsuko; Imai, Hirohisa; Nanaumi, Yoko; Hirano, Akimitsu; Fujii, Shingo; Arakawa, Yukio			Nationwide Study on Relations between Workload and Outcomes of Home Visiting Service by Community Pharmacists	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						home-visiting service; community pharmacy; pharmacist; workload; outcome	ADVERSE DRUG EVENTS; CARE	A nationwide survey was conducted to verify relations between the workload of home-visiting service by community pharmacists and outcomes. Data were collected on 5447 patients from 1890 pharmacies. Most (61.9%) pharmacists visited patients' homes twice monthly, spending there a net average of 20.6 work minutes. At the time of the survey, 29.8% of the patients had improvement of adherence compared with at start of home visits; 65.5% had no change, and 1.4% had gotten worse. Similarly, 41.6% had decreased unused medications, 54.4% had no change, and 2.3% had increased. Home-visiting pharmacists found adverse drug events (ADEs) caused by drug administration in 14.4% of their patients. They dealt with 44.2% of these cases by discontinuing administration of the responsible drug, 24.5% by reducing the dosage, and 18.3% by changing drugs, with a total of 88.1% having been improved. Prescription changes intended to correct problems occurred in 37.1% of the patients. In patients whom the pharmacists visited more often, a higher percent had ADEs, had their prescription changed to correct problems, and had improved adherence and unused medications. The average actual work time was longer in patients whose outcomes improved than in those whose outcomes did not. A higher involvement in homecare by pharmacists was found to improve outcomes of drug treatment.	[Onda, Mitsuko; Hirano, Akimitsu; Fujii, Shingo; Arakawa, Yukio] Osaka Univ Pharmaceut Sci, Takatsuki, Osaka 5691094, Japan; [Imai, Hirohisa] Natl Inst Publ Hlth, Wako, Saitama 3510197, Japan; [Nanaumi, Yoko] Adv Pharma Res Off, Nara 6310805, Japan	Onda, M (reprint author), Osaka Univ Pharmaceut Sci, 4-20-1 Nasahara, Takatsuki, Osaka 5691094, Japan.	onda@gly.oups.ac.jp					Miller GC, 2006, MED J AUSTRALIA, V184, P321; Tache SV, 2011, ANN PHARMACOTHER, V45, P977, DOI 10.1345/aph.1P627; Lund BC, 2010, ANN PHARMACOTHER, V44, P957, DOI 10.1345/aph.1M657; Honma K, 2004, YAKUGAKU ZASSHI, V124, P693, DOI 10.1248/yakushi.124.693; Katsuno J., 2009, JPN J CANC CHEMOT S1, V36, P101; Kazi Y., 2007, MED AND DRUG J, V59, P1117; Miller GC, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003701; Nakamura M., 2007, JPN J CANC CHEMOTHER, V34, P239; Nanaumi Y, 2011, YAKUGAKU ZASSHI, V131, P843; Onda M., 2013, JPN J SOC PHARM, V32, P2; Onda M., 2004, GERIATR GERONTOL INT, V4, P132, DOI 10.1111/j.1447-0594.2004.00240.x; Shibazaki A., 2006, JPN J CANC CHEMOTHER, V33, P305; Shiraishi T., 2008, JPN J CANC CHEMOTHER, V35, P71; Takasaki Y., 2008, JPN J CANC CHEMOT S1, V35, P91; Tsuzuki I., 2006, JPN J CANC CHEMOTHER, V27, P675; Usuda A., 2001, JPN J PHARM HLTH CAR, V27, P480	16	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					519	527				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000025		
J	Ohtani, H; Imaoka, A; Akiyoshi, T				Ohtani, Hisakazu; Imaoka, Ayuko; Akiyoshi, Takeshi			Current Status of Illegal Trade in Pharmaceutical Products on Internet Auction Sites in Japan and Responses of Site Administrators to Such Transactions	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						Internet; online; auction; over the counter drug; illegal trading; dealing		In Japan, it is illegal to sell pharmaceuticals on Internet auction sites, although a considerable number of pharmaceuticals are listed on such sites. We investigated the current situation regarding the illegal trade in pharmaceuticals on Japanese Internet auction sites and the responses of site administrators to such transactions. We searched for pharmaceuticals and "gray" items that were suspected of being pharmaceuticals on Yahoo-oku! (Yahoo! Auctions, Japan) over a 37-day period and then submitted violation reports indicating that selling pharmaceuticals is illegal or that the description of an item was insufficient. The reports were directed to the site administrators and forwarded to the sellers. One hundred and six pharmaceutical products and 34 gray items were identified during the study period. After the submission of the violation reports, only 28 of the pharmaceutical products and one of the gray items were deleted by the administrator, while 18 of the pharmaceutical products and 7 of the gray items were withdrawn by their sellers. However, 41 pharmaceuticals and 20 gray items were sold. Most of the gray items were listed using characteristic terms or abbreviations without photographic images. More than 70% of the identified pharmaceuticals had a contraindication (s) other than hypersensitivity. In conclusion, the illegal trade in pharmaceuticals on Internet auction sites remains a serious problem in Japan, and the responses of site administrators to such transactions are inadequate. The government and pharmaceutical industry may have to take measures such as providing public and administrative guidance to stop the illegal trade in pharmaceuticals on the Internet.	[Ohtani, Hisakazu; Imaoka, Ayuko; Akiyoshi, Takeshi] Keio Univ, Fac Pharm, Minato Ku, Tokyo 1058512, Japan	Ohtani, H (reprint author), Keio Univ, Fac Pharm, Minato Ku, 1-5-30 Shibakouen, Tokyo 1058512, Japan.	ohtani-tky@umin.net					Cantrell FL, 2005, CLIN TOXICOL, V43, P375, DOI 10.1081/CLT-200066073; Kojuma T., 2013, DIAMOND WEEKLY  0525, P104	2	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					529	534				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000026		
J	Uchiyama, N; Kikura-Hanajiri, R; Hakamatsuka, T				Uchiyama, Nahoko; Kikura-Hanajiri, Runi; Hakamatsuka, Takashi			Evaluation of an On-site Drug-testing Device for the Detection of Synthetic Cannabinoids in Illegal Herbal Products	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						synthetic cannabinoid; drug-screening device; illegal drug; naphthoylindole; immune assay; designer drug	PREVALENCE; JAPAN	Recently, illegal herbal or liquid products containing psychoactive compounds have been a serious problem damaging human health and causing numerous traffic accidents. Reports indicate that most of those herbal products contain various types of synthetic cannabinoids. There are many on-site drug-testing devices; however, synthetic cannabinoids are not targeted compounds for suchdevices. In this study, we evaluated the on-site drug-testing device "K2/Spice Test" for the detection of 12 different types of 38 synthetic cannabinoids (including 13 naphthoylindole-type synthetic cannabinoids) and a natural cannabinoid (Delta(9)-tetrahydrocannabinol). Although this device is primarily used for the detection of metabolites of naphthoylindole-type synthetic cannabinoids in urine samples, we applied it to detect synthetic cannabinoids in illegal herbal products for rapid screening analyses. As a result of the on-site examination of synthetic cannabinoids, 10 naphthoylindole-type synthetic cannabinoids [five narcotics (JWH-018, JWH-073, AM-2201, MAM-2201, and JWH-122); five designated substances (JWH-015, JWH-200, AM-1220, JWH-019, and JWH-020)], and two other types of synthetic cannabinoid [designated substances (a benzoylindole AM-694 and a naphthoyl-naphthalene CB-13)] showed positive results (the limit of detection ranged from 50 to 250 mu g/mL). Furthermore, MeOH extracts of illegal herbal products containing naphthoylindole-type synthetic cannabinoids also showed positive results (the limit of detection ranged from 2.5 to 10 mg herbal products/mL). Therefore, we found that this device may be useful for the on-site examination of some naphthoylindole-type synthetic cannabinoids not only in urine samples but also in illegal herbal products.	[Uchiyama, Nahoko; Kikura-Hanajiri, Runi; Hakamatsuka, Takashi] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan	Uchiyama, N (reprint author), Natl Inst Hlth Sci, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	nuchiyama@nihs.go.jp					Uchiyama N, 2010, FORENSIC SCI INT, V198, P31, DOI 10.1016/j.forsciint.2010.01.004; Kikura-Hanajiri R, 2013, FORENSIC TOXICOL, V31, P44, DOI 10.1007/s11419-012-0165-2; Wiley JL, 1998, J PHARMACOL EXP THER, V285, P995; Express Diagnostics Int'l Inc, 2014, DRUGCHECK K2 SPIC TE; Huffman John W., 2009, P49, DOI 10.1007/978-1-59745-503-9_3; Kikura-Hanajiri R, 2013, YAKUGAKU ZASSHI, V133, P31; Sugimura T., 2012, JJAAM, V23, P842; Uchiyama N, 2011, FORENSIC TOXICOL, V29, P25, DOI 10.1007/s11419-010-0100-3	8	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	2015	135	3					535	541				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HY	WOS:000350093000027		
J	Kim, SC				Kim, Seung Chul			SUNYATA AND KOKORO: SCIENCE-RELIGION DIALOGUE IN THE JAPANESE CONTEXT	ZYGON			English	Review						Buddhism; circuminsessional integratation; God; Kokoro; Keiji Nishitani; religion (shukyo); science-religion dialogue; Sunyata; Paul Swanson		When we read books or essays about the dialogue between religion and science, or when we attend conferences on the theme of religion and science, we cannot avoid the impression that they actually are dealing, almost without exception, not with a dialogue between religion and science, but with a dialogue between Christianity and science. This could easily be affirmed by looking at the major publications in this field. But how can the science-religion dialogue take place in a world where conventional Christian concepts of God, religion, and science are foreign and unfamiliar? Is the critique that the scientist plays God still valid when there is no God at all? This article tries to answer the questions mentioned above, and seeks to sketch out some aspects of the science-religion dialogue in Japan which I believe could contribute a new paradigm for understanding and describing ultimate reality.	Nanzan Univ, Nanzan Inst Relig & Culture, Showa Ku, Nagoya, Aichi 4668673, Japan	Kim, SC (reprint author), Nanzan Univ, Nanzan Inst Relig & Culture, Showa Ku, 18 Yamazato Cho, Nagoya, Aichi 4668673, Japan.	sechkim@gmail.com					Balagangadhara S. N., 2012, RECONCEPTUALIZING IN; Boyer P., 2001, RELIG EXPLAINED EVOL; Dennett Daniel, 2006, BREAKING SPELL RELIG; Jan Assmann, 2005, GEWALTPOTENTIAL MONO; Kim Seung Chul, 2009, KAMI IDENSHI IDENSHI; Masuzawa Tomoko, 2005, INVENTION WORLD RELI; Nakayama Shigeru, 1980, NIHONJIN NO KAGAKUKA; Nishitani Keiji, 1982, SHUKYO TOWA NANIKA R; Pence Gregory E., 2002, BRAVE NEW BIOETHICS; Sait Naruya, 2009, SEIBUTUGAKUSHA BUKKY; Sasaki Chikara, 1996, KAGAKURON NY MON; Swanson Paul, 2005, BULLETIN, V29, P20; Swanson Paul, 2011, BRAIN SCI KOKORO ASI, pvii; Whitehead A. N, 1925, SCI MODERN WORLD; Wilmut I., 2000, 2 CREATION DOLLY AGE; Wilson Edward O., 1978, HUMAN NATURE; Yichir Murakami, 1993, NIHONJIN  KINDAI KAG	17	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0591-2385	1467-9744		ZYGON	Zygon	MAR	2015	50	1					155	171		10.1111/zygo.12153		17	Social Issues; Religion	Social Issues; Religion	CB9UO	WOS:000349978900010		
J	Toji, Y; Miyamoto, G; Raabe, D				Toji, Yuki; Miyamoto, Goro; Raabe, Dierk			Carbon partitioning during quenching and partitioning heat treatment accompanied by carbide precipitation	ACTA MATERIALIA			English	Article						Quenching and partitioning; Carbide; Cementite; EPMA; Atom probe tomography	ATOM-PROBE MICROANALYSIS; MARTENSITE; CEMENTITE; AUSTENITE; STEELS; TRANSFORMATION; FERRITE; SCALE; TRANSMISSION; EVOLUTION	Carbon partitioning from martensite into austenite in the quenching and partitioning (Q&P) process has been suggested to be controlled by the constrained carbon equilibrium (CCE) criterion. It defines an approach for predicting the carbon concentration in austenite under the condition that competing reactions such as carbide formation and bainite transformation are suppressed. Carbide precipitation in martensite is, however, often observed during the partitioning step, even in low-carbon steels as well as in high-carbon steels, even when containing a high amount of Si. Therefore, carbon partitioning from martensite into austenite is studied here, considering carbide precipitation in martensite. Carbon partitioning was investigated by means of a field-emission electron probe micro analysis (FE-EPMA) and atom probe tomography (APT), using 1.07 wt.% and 0.59 wt.% carbon steels with various martensite volume fractions. Carbon partitioning from martensite to austenite was clearly observed in all specimens, even though a considerable amount of carbide precipitated inside the martensite. The austenite carbon concentration after the partitioning step was not influenced by either the martensite volume fraction or the bulk carbon content. A modified model for predicting the austenite carbon concentration after the partitioning step was proposed to explain the experimental results by assuming carbon equilibria between austenite, ferrite and cementite under a constrained condition. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Toji, Yuki] JFE Steel Corp, Steel Res Lab, Chuo Ku, Chiba 2600835, Japan; [Miyamoto, Goro] Tohoku Univ, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Raabe, Dierk] Max Planck Inst Eisenforsch GmbH, D-40237 Dusseldorf, Germany	Toji, Y (reprint author), JFE Steel Corp, Steel Res Lab, Chuo Ku, 1 Kawasaki Cho, Chiba 2600835, Japan.	y-toji@jfesteel.co.jp	Miyamoto, Goro/G-2802-2010; Raabe, Dierk/A-6470-2009	Raabe, Dierk/0000-0003-0194-6124			Ande K.C., 2010, ACTA MAT, V58, P6276; Hallstedt B, 2010, CALPHAD, V34, P129, DOI 10.1016/j.calphad.2010.01.004; Kelly TF, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2709758; Hellman OC, 2000, MICROSC MICROANAL, V6, P437, DOI 10.1007/s100050010051; Li YJ, 2011, ACTA MATER, V59, P3965, DOI 10.1016/j.actamat.2011.03.022; Edmonds DV, 2006, MAT SCI ENG A-STRUCT, V438, P25, DOI 10.1016/j.msea.2006.02.133; Choi P, 2005, ACTA MATER, V53, P4473, DOI 10.1016/j.actamat.2005.06.006; Speer J, 2003, ACTA MATER, V51, P2611, DOI 10.1016/S1359-6454(03)00059-4; BHADESHIA HKDH, 1979, METALL TRANS A, V10, P895, DOI 10.1007/BF02658309; De Cooman BC, 2006, STEEL RES INT, V77, P634; Herbig M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.126103; Toji Y, 2014, ACTA MATER, V65, P215, DOI 10.1016/j.actamat.2013.10.064; Liu ZQ, 2013, ACTA MATER, V61, P3120, DOI 10.1016/j.actamat.2013.02.003; Miyamoto G, 2007, ACTA MATER, V55, P5027, DOI 10.1016/j.actamat.2007.05.023; BLAVETTE D, 1993, REV SCI INSTRUM, V64, P2911, DOI 10.1063/1.1144382; CEREZO A, 1988, REV SCI INSTRUM, V59, P862, DOI 10.1063/1.1139794; Li YJ, 2012, ACTA MATER, V60, P4005, DOI 10.1016/j.actamat.2012.03.006; Santofimia MJ, 2009, ACTA MATER, V57, P4548, DOI 10.1016/j.actamat.2009.06.024; Duarte MJ, 2013, SCIENCE, V341, P372, DOI 10.1126/science.1230081; Santofimia MJ, 2010, MAT SCI ENG A-STRUCT, V527, P6429, DOI 10.1016/j.msea.2010.06.083; Battezzati L, 2005, ACTA MATER, V53, P1849, DOI 10.1016/j.actamat.2004.12.035; BHADESHIA HKDH, 1981, ACTA METALL MATER, V29, P1117, DOI 10.1016/0001-6160(81)90063-8; De Moor E, 2012, STEEL RES INT, V83, P322, DOI 10.1002/srin.201100318; Hono K, 1999, ACTA MATER, V47, P3127, DOI 10.1016/S1359-6454(99)00175-5; Marquis E., 2012, MICROSC TODAY, V20, P44; Miller M. K., 2000, ATOM PROBE TOMOGRAPH; Miller M.K., 1996, ATOM PROBE FIELD ION; Nematollahi GA, 2013, ACTA MATER, V61, P1773, DOI 10.1016/j.actamat.2012.12.001; Petch N. J., 1944, J IRON STEEL I, V149, P143; Santofimia MJ, 2009, METALL MATER TRANS A, V40A, P46, DOI 10.1007/s11661-008-9701-4; Speer John G., 2005, Mat. Res., V8, P417, DOI 10.1590/S1516-14392005000400010; Speer JG, 2003, AUSTENITE FORMATION AND DECOMPOSITION, P505; Thompson K, 2007, ULTRAMICROSCOPY, V107, P124, DOI 10.1016/j.ultramic.2006.06.007; WELLS MGH, 1964, ACTA METALL MATER, V12, P389, DOI 10.1016/0001-6160(64)90009-4	34	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	MAR	2015	86						137	147		10.1016/j.actamat.2014.11.049		11	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CB6IO	WOS:000349730900013		
J	Tong, Y; Iwashita, T; Dmowski, W; Bei, H; Yokoyama, Y; Egami, T				Tong, Y.; Iwashita, T.; Dmowski, W.; Bei, H.; Yokoyama, Y.; Egami, T.			Structural rejuvenation in bulk metallic glasses	ACTA MATERIALIA			English	Article						Bulk metallic glasses; Structure; Rejuvenation; Creep; X-ray diffraction	TENSILE PLASTIC ELONGATION; AMORPHOUS-ALLOYS; ROOM-TEMPERATURE; EMBRITTLEMENT; RELAXATION; DEFORMATION; TRANSITION; BEHAVIOR	Using high-energy X-ray diffraction we study structural changes in bulk metallic glasses after uniaxial compressive homogeneous deformation at temperatures slightly below the glass transition. We observe that deformation results in structural disordering corresponding to an increase in the fictive, or effective, temperature. However, the structural disordering saturates after yielding. Examination of the experimental structure and molecular dynamics simulation suggests that local changes in the atomic connectivity network are the main driving force of the structural rejuvenation. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Tong, Y.; Dmowski, W.; Egami, T.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA; [Iwashita, T.; Egami, T.] Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; [Bei, H.; Egami, T.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; [Yokoyama, Y.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Dmowski, W (reprint author), Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.	wdmowski@utk.edu	Iwashita, Takuya/D-2724-2009		Department of Energy, Office of Sciences, Basic Energy Science, Materials Science and Engineering Division	This work was supported by the Department of Energy, Office of Sciences, Basic Energy Science, Materials Science and Engineering Division. The authors are grateful to J.S. Langer for useful discussions.	Yao KF, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2187516; Lu J, 2003, ACTA MATER, V51, P3429, DOI 10.1016/S1359-6454(03)00164-2; Dmowski W, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.205502; EGAMI T, 1982, J PHYS F MET PHYS, V12, P2141, DOI 10.1088/0305-4608/12/10/010; Zhang Y, 2006, NAT MATER, V5, P857, DOI 10.1038/nmat1758; Li WD, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4827299; Levashov VA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.064205; Faupel F, 2003, REV MOD PHYS, V75, P237, DOI 10.1103/RevModPhys.75.237; Park KW, 2008, ACTA MATER, V56, P5440, DOI 10.1016/j.actamat.2008.07.033; Kumar G, 2009, ACTA MATER, V57, P3572, DOI 10.1016/j.actamat.2009.04.016; Murali P, 2005, ACTA MATER, V53, P1467, DOI 10.1016/j.actamat.2004.11.040; Ono IK, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.095703; Schuh CA, 2007, ACTA MATER, V55, P4067, DOI 10.1016/j.actamat.2007.01.052; Yokoyama Y, 2008, ACTA MATER, V56, P6097, DOI 10.1016/j.actamat.2008.08.026; ARGON AS, 1983, ACTA METALL MATER, V31, P499, DOI 10.1016/0001-6160(83)90038-X; Dmowski W., 2008, ADV ENG MATER, V10, P5; Dmowski W., 2007, J MATER RES, V22, P7; Dmowski W., 2010, ACTA MAT, V58, P10; Dmowski W, 2007, MAT SCI ENG A-STRUCT, V471, P125, DOI 10.1016/j.msea.2006.12.137; EGAMI T, 1978, J MATER SCI, V13, P2587, DOI 10.1007/BF00552688; Harmon J.S., 2007, PHYS REV LETT, V99, P4; Langer JS, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056107; Ott R.T., 2008, ACTA MAT, V56, P9; Schroers J., 2004, PHYS REV LETT, V93, P4; Spaepen F., 1977, ACTA METALL, V25, P9; SROLOVITZ D, 1981, PHYS REV B, V24, P6936, DOI 10.1103/PhysRevB.24.6936; Suzuki Y., 1987, PHYS REV B, V35, P7; Tong Y, 2013, ACTA MATER, V61, P1204, DOI 10.1016/j.actamat.2012.10.030; Tong Y, 2013, SCRIPTA MATER, V69, P570, DOI 10.1016/j.scriptamat.2013.06.020; Yokoyama Y, 2002, MATER TRANS, V43, P2316, DOI 10.2320/matertrans.43.2316; Yokoyama Y, 2001, MATER TRANS, V42, P623, DOI 10.2320/matertrans.42.623; Yokoyama Y, 2002, MATER TRANS, V43, P3199, DOI 10.2320/matertrans.43.3199; Yokoyama Y, 2009, PHIL MAG LETT, V89, P322, DOI 10.1080/09500830902873575; Yokoyama Y, 2014, MAT SCI ENG A-STRUCT, V606, P74, DOI 10.1016/j.msea.2014.03.041	34	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	MAR	2015	86						240	246		10.1016/j.actamat.2014.12.020		7	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CB6IO	WOS:000349730900022		
J	Sun, SH; Koizumi, Y; Kurosu, S; Li, YP; Chiba, A				Sun, Shi-Hai; Koizumi, Yuichiro; Kurosu, Shingo; Li, Yun-Ping; Chiba, Akihiko			Phase and grain size inhomogeneity and their influences on creep behavior of Co-Cr-Mo alloy additive manufactured by electron beam melting	ACTA MATERIALIA			English	Article						Cobalt chromium alloys; Powder processing; Phase transformation; Creep; Electron beam melting	STACKING-FAULT ENERGY; TEMPERATURE; DEPENDENCE; CLIMB; STEEL; AL	Co-28Cr-6Mo-0.23C-0.17N alloy cylindrical rods were fabricated by electron beam melting (EBM) with cylindrical axes along the build direction. The inhomogeneity in microstructures of the as-fabricated rods and heat-treated rods were investigated, along with the creep behavior of the heat-treated rods, focusing on the influence of microstructural inhomogeneity. Although the constituent phase varied along the build direction in the as-EBM-built rod, from single epsilon-hexagonal close-packed (hcp) phase in the bottom to single gamma-face-centered cubic (fcc) phase in the top, the gamma-fcc phase can be kept in a wide range of build height, i.e. similar to 40 mm from the top finishing plane. The as-EBM-built rods consisting of both epsilon phase and gamma phase can be transformed into single epsilon-hcp phase by the aging treatment at 800 degrees C for 24 h. However, the epsilon-hcp grain size in the aged rod was heterogeneous along the build height. The grain size increased along the build height at first, then decreased gradually to the position where the phase transitioned from gamma-fcc to epsilon-hcp in the as-EBM-built rod. The grain size was nearly uniform on the top part, which used to be single gamma-fcc phase. The values of stress exponent n and apparent activation energy Q were determined to be 5.0 and 365 kJ mol(-1), respectively. Intergranular fracture occurred, and fracture nearly always occurred in the homogeneous fine-grain region. The decrease in stacking fault energy with increasing temperature keeps the dislocations expanding and increases the apparent activation energy. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Sun, Shi-Hai] Tohoku Univ, Dept Mat Proc, Sendai, Miyagi 9808579, Japan; [Sun, Shi-Hai; Koizumi, Yuichiro; Li, Yun-Ping; Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9800812, Japan; [Kurosu, Shingo] Iwate Ind Res Inst, Morioka, Iwate 0200857, Japan	Koizumi, Y (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9800812, Japan.	koizumi@imr.tohoku.ac.jp	Li, Yunping/A-8109-2011; Koizumi, Yuichiro/C-2697-2011	Li, Yunping/0000-0002-4657-2923; Koizumi, Yuichiro/0000-0001-7061-7135	Japan Society for the Promotion of Science (JSPS); Cooperative Research and Development Center for Advanced Materials, Institute for Materials Research, Tohoku University	This research was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS). This work was partly supported by the inter-university cooperative research program of the Cooperative Research and Development Center for Advanced Materials, Institute for Materials Research, Tohoku University.	Yan M, 2001, J MATER SCI, V36, P285, DOI 10.1023/A:1004843621542; Murr LE, 2010, ACTA MATER, V58, P1887, DOI 10.1016/j.actamat.2009.11.032; Yamanaka K, 2012, METALL MATER TRANS A, V43A, P4875, DOI 10.1007/s11661-012-1303-5; Birol Y, 2010, MAT SCI ENG A-STRUCT, V527, P1938, DOI 10.1016/j.msea.2009.11.021; Tang N, 2013, CORROS SCI, V75, P262, DOI 10.1016/j.corsci.2013.06.009; Murr LE, 2010, MAT SCI ENG A-STRUCT, V527, P1861, DOI 10.1016/j.msea.2009.11.015; Birol Y, 2011, MAT SCI ENG A-STRUCT, V528, P1117, DOI 10.1016/j.msea.2010.10.037; Kurosu S, 2010, METALL MATER TRANS A, V41A, P2613, DOI 10.1007/s11661-010-0273-8; HAN YF, 1987, MATER SCI ENG, V89, P25, DOI 10.1016/0025-5416(87)90246-1; Birol Y, 2010, MAT SCI ENG A-STRUCT, V527, P6091, DOI 10.1016/j.msea.2010.06.015; Qi HB, 2006, P I MECH ENG B-J ENG, V220, P1845, DOI 10.1243/09544054JEM438; Tang N, 2011, CORROS SCI, V53, P4324, DOI 10.1016/j.corsci.2011.08.015; Ramirez DA, 2011, ACTA MATER, V59, P4088, DOI 10.1016/j.actamat.2011.03.033; Sun SH, 2014, ACTA MATER, V64, P154, DOI 10.1016/j.actamat.2013.10.017; Gaytan SM, 2010, METALL MATER TRANS A, V41A, P3216, DOI 10.1007/s11661-010-0388-y; BARRETT CR, 1965, T METALL SOC AIME, V233, P1116; ERICSSON T, 1966, ACTA METALL MATER, V14, P853, DOI 10.1016/0001-6160(66)90006-X; Gaytan SM, 2011, MAT SCI APPL, V2, P355; HIRANO K, 1962, J APPL PHYS, V33, P3049, DOI 10.1063/1.1728564; Hirth J. P., 1982, THEORY DISLOCATIONS; Li YP, 2012, MATER CHEM PHYS, V133, P29, DOI 10.1016/j.matchemphys.2011.12.081; ARGON AS, 1981, ACTA METALL MATER, V29, P293, DOI 10.1016/0001-6160(81)90156-5; MOHAMED FA, 1974, ACTA METALL MATER, V22, P779, DOI 10.1016/0001-6160(74)90088-1; Mukherjee A.K., 1969, T AM SOC MET, V62, P155; Murr LE, 2013, ACTA MATER, V61, P4289, DOI 10.1016/j.actamat.2013.04.002; OLSON GB, 1976, METALL TRANS A, V7, P1897, DOI 10.1007/BF02659822; Ramirez DA, 2011, MAT SCI ENG A-STRUCT, V528, P5379, DOI 10.1016/j.msea.2011.03.053; Strondl A, 2008, MAT SCI ENG A-STRUCT, V480, P138, DOI 10.1016/j.msea.2007.07.012	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	MAR	2015	86						305	318		10.1016/j.actamat.2014.11.012		14	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CB6IO	WOS:000349730900029		
J	Chen, Y; Zhao, X; Bai, M; Chandio, A; Wu, R; Xiao, P				Chen, Y.; Zhao, X.; Bai, M.; Chandio, A.; Wu, R.; Xiao, P.			Effect of platinum addition on oxidation behaviour of gamma/gamma ' nickel aluminide	ACTA MATERIALIA			English	Article						Platinum; Nickel aluminide; Oxidation; Stress; Interface	THERMAL BARRIER COATINGS; BOND COAT; CYCLIC OXIDATION; NI; SYSTEMS; SUPERALLOYS; PERFORMANCE; MECHANISMS; SUBSTRATE; STRESS	Bulk gamma/gamma' nickel aluminide alloys of composition (in at.%) Ni-20Al with the addition of 0, 5, 10 and 15Pt were fabricated using arc melting, and the microstructure of the alloys was characterized. The oxidation behaviours of the alloys at 1150 degrees C were studied and compared in terms of oxide spallation, oxide microstructure and growth, residual stress in the alpha-Al2O3 scale and oxide/alloy interface morphology. Progressively increased platinum addition into the alloys results in (1) improvement in the resistance to oxide spallation, (2) reduction in oxidation of nickel, (3) lower stresses in the alpha-Al2O3 scale and (4) more planar oxide/alloy interfaces. In addition, for short-time oxidation (<= 1 h), the stresses in the alpha-Al2O3 scale on the gamma' phase region of the alloy are lower than those on the gamma/gamma' mixed phase region. Discussion on the platinum effect has been focused on selective oxidation of the alloy and stress development in the oxide scale. It is concluded that the selective oxidation of aluminium promoted by platinum plays a crucial role in the evolution of the oxidation behaviour with the platinum addition. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Chen, Y.; Bai, M.; Chandio, A.; Xiao, P.] Univ Manchester, Sch Mat, Manchester M1 7HS, Lancs, England; [Zhao, X.; Xiao, P.] Shanghai Jiao Tong Univ, Shanghai Key Lab Adv High Temp Mat & Precis Formi, Shanghai 200240, Peoples R China; [Wu, R.] Natl Inst Mat Sci, Global Res Ctr Environm & Energy Based Nanomat Sc, Tsukuba, Ibaraki, Japan	Xiao, P (reprint author), Univ Manchester, Sch Mat, Manchester M1 7HS, Lancs, England.	p.xiao@manchester.ac.uk					Evans HE, 2011, SURF COAT TECH, V206, P1512, DOI 10.1016/j.surfcoat.2011.05.053; Gleeson B, 2009, J MATER SCI, V44, P1704, DOI 10.1007/s10853-009-3251-z; Evans AG, 2001, PROG MATER SCI, V46, P505, DOI 10.1016/S0079-6425(00)00020-7; Zhao X, 2008, SURF COAT TECH, V202, P2905, DOI 10.1016/j.surfcoat.2007.10.030; FARRELL MS, 1987, SURF COAT TECH, V32, P69, DOI 10.1016/0257-8972(87)90098-3; Gleeson B, 2004, MATER SCI FORUM, V461-464, P213; Tolpygo VK, 2000, ACTA MATER, V48, P3283, DOI 10.1016/S1359-6454(00)00156-7; Lipkin DM, 1996, OXID MET, V45, P267, DOI 10.1007/BF01046985; Wu RT, 2010, ACTA MATER, V58, P5578, DOI 10.1016/j.actamat.2010.06.027; Peng X, 2000, J AM CERAM SOC, V83, P1165; WACHTMAN JB, 1959, J AM CERAM SOC, V42, P254, DOI 10.1111/j.1151-2916.1959.tb15462.x; Nicholls J, 2003, MRS BULL, V28, P659, DOI 10.1557/mrs2003.194; Pint BA, 1998, MAT SCI ENG A-STRUCT, V245, P201, DOI 10.1016/S0921-5093(97)00851-4; Tolpygo VK, 1998, ACTA MATER, V46, P927, DOI 10.1016/S1359-6454(97)00306-6; Balint DS, 2003, ACTA MATER, V51, P3965, DOI 10.1016/S1359-6454(03)00221-0; Balint DS, 2005, J MECH PHYS SOLIDS, V53, P949, DOI 10.1016/j.jmps.2004.11.002; Das DK, 2013, PROG MATER SCI, V58, P151, DOI 10.1016/j.pmatsci.2012.08.002; FOUNTAIN JG, 1976, OXID MET, V10, P341, DOI 10.1007/BF00612031; Gong XY, 1998, OXID MET, V50, P355, DOI 10.1023/A:1018848607100; Hayashi S, 2005, ACTA MATER, V53, P3319, DOI 10.1016/j.actamat.2005.03.046; Hayashi S., 2005, HIGH TEMP OXID CORRO, V2006, P229; Hayashi S, 2008, MATER TRANS, V49, P1550, DOI 10.2320/matertrans.MRA2008001; Jiang C, 2007, ACTA MATER, V55, P1641, DOI 10.1016/j.actamat.2006.10.024; HE J, 1995, J AM CERAM SOC, V78, P1347, DOI 10.1111/j.1151-2916.1995.tb08493.x; Krishna GR, 1998, MAT SCI ENG A-STRUCT, V251, P40, DOI 10.1016/S0921-5093(98)00655-8; Nesbitt JA, 2003, MATER SCI FORUM, V426-4, P209; Nychka JA, 2008, MAT SCI ENG A-STRUCT, V490, P359, DOI 10.1016/j.msea.2008.01.043; Purvis AL, 2001, SURF COAT TECH, V146, P1, DOI 10.1016/S0257-8972(01)01362-7; Rickerby D.S., 1999, US Patent, Patent No. [5,981,091, 5981091]; Rickerby D.S., 1997, US Patent, Patent No. [5,942,337, 5942337]; Stacy JP, 2007, SURF COAT TECH, V202, P632, DOI 10.1016/j.surfcoat.2007.06.053; Tolpygo VK, 2004, ACTA MATER, V52, P5115, DOI 10.1016/j.actamat.2004.07.019; Tolpygo VK, 1998, ACTA MATER, V46, P5153, DOI 10.1016/S1359-6454(98)00133-5; Zhang Y, 1999, METALL MATER TRANS A, V30, P2679, DOI 10.1007/s11661-999-0308-1; Zhao X, 2014, SURF COAT TECH, V247, P48, DOI 10.1016/j.surfcoat.2014.02.065; Zhao X, 2011, ACTA MATER, V59, P6401, DOI 10.1016/j.actamat.2011.07.001; Zhao X, 2008, THIN SOLID FILMS, V517, P828, DOI 10.1016/j.tsf.2008.08.006	37	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	MAR	2015	86						319	330		10.1016/j.actamat.2014.12.023		12	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CB6IO	WOS:000349730900030		
J	Sakamoto, S; Kiura, Y; Okazaki, T; Shinagawa, K; Ichinose, N; Shibukawa, M; Orita, Y; Shimonaga, K; Kajihara, Y; Kurisu, K				Sakamoto, Shigeyuki; Kiura, Yoshihiro; Okazaki, Takahito; Shinagawa, Katsuhiro; Ichinose, Nobuhiko; Shibukawa, Masaaki; Orita, Yoji; Shimonaga, Koji; Kajihara, Yosuke; Kurisu, Kaoru			Usefulness of dual protection combined with blood aspiration for distal embolic protection during carotid artery stenting	ACTA NEUROCHIRURGICA			English	Article						Blood aspiration; Carotid artery stenting; Distal filter; Flow reversal; Visible debris	CEREBRAL PROTECTION; FILTER PROTECTION; RANDOMIZED-TRIAL; FLOW REVERSAL; HIGH-RISK; ENDARTERECTOMY; OCCLUSION; DEVICES	We describe dual protection (simultaneous flow reversal and distal filter) combined with blood aspiration as a novel technique to provide distal embolic protection during carotid artery stenting (CAS). Between July 2011 and August 2014, 190 patients with internal carotid artery (ICA) stenosis underwent 190 CAS procedures as follows. After post-dilation of the stent using dual protection, the aspiration catheter was placed between the distal filter and the proximal end of the stent, and the blood was aspirated several times from the ICA. We assessed hyper-intensity spots in diffusion-weighted images (DWI), and major adverse events (MAE) defined as major stroke, myocardial infarction and death after CAS. We then assessed visible debris captured in aspirated blood, the distal filter and a blood filter during flow reversal. The overall technical success rate was 100 %, and all stenoses were dilated. Hyper-intense spots were found in 33 (17.3 %) of 190 DWI. The rate of MAE within 30 days was 1.05 % (2/190). Visible debris in 175 of 190 CAS procedures was captured in 92 (52.5 %) of these 175. In 25 (27.2 %) of these 92, visible debris was captured in all of aspirated blood, the distal filter and the blood filter during flow reversal, only the blood filter during flow reversal (n = 19; 20.7 %), only the distal filter (n = 14; 15.2 %), only aspirated blood (n = 11; 12 %), aspirated blood and the blood filter during flow reversal (n = 10; 10.8 %), aspirated blood and the distal filter (n = 7; 7.6 %) and the distal filter and blood filter during flow reversal (n = 6; 6.5 %). Adding a distal filter and blood aspiration to flow reversal during CAS could provide effective distal embolic protection.	[Sakamoto, Shigeyuki; Kiura, Yoshihiro; Okazaki, Takahito; Shinagawa, Katsuhiro; Ichinose, Nobuhiko; Kurisu, Kaoru] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Neurosurg, Minami Ku, Hiroshima 7348551, Japan; [Shibukawa, Masaaki; Orita, Yoji; Shimonaga, Koji] JA Hiroshima Gen Hosp, Dept Neurosurg, Hiroshima 7388503, Japan; [Kajihara, Yosuke] Itsukaichi Mem Hosp, Dept Neurosurg, Saeki Ku, Hiroshima 7315156, Japan	Sakamoto, S (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Neurosurg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	sakamoto@hiroshima-u.ac.jp					Parodi JC, 2000, J VASC SURG, V32, P1127, DOI 10.1067/mva.2000.109209; Montorsi P, 2011, J AM COLL CARDIOL, V58, P1656, DOI 10.1016/j.jacc.2011.07.015; Sakamoto S, 2013, NEUROSURG REV, V36, P551, DOI 10.1007/s10143-013-0481-y; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Brott TG, 2011, J AM COLL CARDIOL, V57, P1002, DOI 10.1016/j.jacc.2010.11.005; Brewster LP, 2011, J VASC SURG, V54, P1000, DOI 10.1016/j.jvs.2011.03.279; Bijuklic K, 2012, J AM COLL CARDIOL, V59, P1383, DOI 10.1016/j.jacc.2011.11.035; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Harada K, 2014, ANN VASC SURG, V28, P651, DOI 10.1016/j.avsg.2013.04.032; Milosevic ZV, 2007, J ENDOVASC THER, V14, P86, DOI 10.1583/06-1926.1; Parodi JC, 2002, J ENDOVASC THER, V9, P20, DOI 10.1583/1545-1550(2002)009<0020:SBAABT>2.0.CO;2; Sorimachi T, 2011, AM J NEURORADIOL, V32, P288, DOI 10.3174/ajnr.A2276; Sorimachi T, 2010, NEUROSURGERY, V67, P1260, DOI 10.1227/NEU.0b013e3181ef5e85	13	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAR	2015	157	3					371	377		10.1007/s00701-014-2311-6		7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CC0LR	WOS:000350027700004		
J	Endo, Y; Furuta, A; Nishino, I				Endo, Yukari; Furuta, Akiko; Nishino, Ichizo			Danon disease: a phenotypic expression of LAMP-2 deficiency	ACTA NEUROPATHOLOGICA			English	Review						Lysosome; LAMP2; Autophagy; Autophagic vacuolar myopathy; Cardiomyopathy	MEMBRANE-PROTEIN LAMP-2; LYSOSOMAL MEMBRANE; AUTOPHAGIC VACUOLES; MYOPATHIES; GENE; CARDIOMYOPATHY; GLYCOPROTEIN; DEGRADATION; BIOGENESIS; PHAGOSOMES	Danon disease is an X-linked disorder clinically characterized by the triad of hypertrophic cardiomyopathy, myopathy, and intellectual disability. Cardiomyopathy is a severe and life-threatening problem, for which cardiac transplantation is the only therapeutic option. The most striking finding in muscle biopsy samples is small basophilic granules scattered in myofibers, which are in fact small autophagic vacuoles surrounded by membranes with sarcolemmal features characterized by the recruitment of sarcolemmal proteins and acetylcholine esterase and by the presence of basal lamina on its luminal side. The mechanism underlying the formation of these autophagic vacuoles with unique sarcolemmal features (AVSF) still remains a mystery and its origin is unknown. In heart, cardiomyocytes show dramatically increased vacuolation and degenerative features, including myofibrillar disruption and lipofuscin accumulation. In brain, pale granular neurons and neurons with lipofuscin-like granules may be seen. Danon disease is caused by loss-of-function mutations in the LAMP2 gene, which encodes lysosome-associated membrane protein 2 (LAMP-2), a single-spanned transmembrane protein localized in the limiting membranes of lysosomes and late endosomes. Most mutations lead to splicing defects or protein truncation, resulting in a loss of transmembrane and/or cytoplasmic domains, leading to LAMP-2 protein deficiency. LAMP-2 is required for the maturation of autophagosomes by fusion with lysosomes; therefore, LAMP-2 deficiency leads to a failure in macroautophagy. There are three LAMP-2 isoforms, LAMP-2A, -2B, and -2C. Clinical features of Danon disease are thought to be mediated by loss of the LAMP-2B isoform which is the major isoform expressed in muscle. It is also known that LAMP-2 plays a role in chaperone-mediated autophagy and RNA- and DNA-targeting autophagy. However, the precise pathophysiological mechanism through which LAMP-2 deficiency causes Danon disease is still not fully understood and its elucidation would promote the development of new therapies.	[Endo, Yukari; Nishino, Ichizo] NCNP, Translat Med Ctr, Dept Clin Dev, Tokyo 1878551, Japan; [Endo, Yukari; Nishino, Ichizo] NCNP, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo 1878551, Japan; [Furuta, Akiko] Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Neuropathol, Bunkyo Ku, Tokyo 1138421, Japan	Nishino, I (reprint author), NCNP, Translat Med Ctr, Dept Clin Dev, 4-1-1 Ogawahigashi Cho, Tokyo 1878551, Japan.	nishino@ncnp.go.jp			Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP, Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labor, and Welfare [26-8]	This study was supported by Intramural Research Grant (26-8) for Neurological and Psychiatric Disorders of NCNP, Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labor, and Welfare. The authors thank Professor Ikuya Nonaka for his help in electron microscopy analysis, and Ms. Megumu Ogawa and Ms. Kaoru Tatezawa for their technical assistance.	Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x; Saftig P, 2001, TRENDS MOL MED, V7, P37, DOI 10.1016/S1471-4914(00)01868-2; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Nemazanyy I, 2013, EMBO MOL MED, V5, P870, DOI 10.1002/emmm.201202057; HATEM CL, 1995, J CELL SCI, V108, P2093; DANON MJ, 1981, NEUROLOGY, V31, P51; Schneede A, 2011, J CELL MOL MED, V15, P280, DOI 10.1111/j.1582-4934.2009.00973.x; Boucek D, 2011, GENET MED, V13, P563, DOI 10.1097/GIM.0b013e31820ad795; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Tanaka Y, 2000, NATURE, V406, P902; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854; KONECKI DS, 1995, BIOCHEM BIOPH RES CO, V215, P757, DOI 10.1006/bbrc.1995.2528; GOUGH NR, 1995, DNA CELL BIOL, V14, P863, DOI 10.1089/dna.1995.14.863; Sugie K, 2005, J NEUROPATH EXP NEUR, V64, P513; Stypmann J, 2006, BASIC RES CARDIOL, V101, P281, DOI 10.1007/s00395-006-0591-6; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; Fujiwara Y, 2013, AUTOPHAGY, V9, P403, DOI 10.4161/auto.23002; Malicdan MC, 2008, NEUROMUSCULAR DISORD, V18, P521, DOI 10.1016/j.nmd.2008.04.010; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Fujiwara Y, 2013, AUTOPHAGY, V9, P1167, DOI 10.4161/auto.24880; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Furuta A, 2013, ACTA NEUROPATHOL, V125, P459, DOI 10.1007/s00401-012-1075-4; Eskelinen EL, 2005, TRAFFIC, V6, P1058, DOI 10.1111/j.1600-0854.2005.00337.x; Fukuda M, 1994, Subcell Biochem, V22, P199; FURUNO K, 1989, J BIOCHEM-TOKYO, V106, P708; LIPPINCOTTSCHWARTZ J, 1987, CELL, V49, P669, DOI 10.1016/0092-8674(87)90543-5; Malicdan MCV, 2012, BRAIN PATHOL, V22, P82, DOI 10.1111/j.1750-3639.2011.00543.x; Nishino Ichizo, 2003, Curr Neurol Neurosci Rep, V3, P64, DOI 10.1007/s11910-003-0040-y; Nishino Ichizo, 2006, Semin Pediatr Neurol, V13, P90, DOI 10.1016/j.spen.2006.06.004; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Sugie K, 2002, NEUROLOGY, V58, P1773	35	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	MAR	2015	129	3					391	398		10.1007/s00401-015-1385-4		8	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CC2VO	WOS:000350203000005		
J	Koh, S; Ikeda, C; Watanabe, S; Oie, Y; Soma, T; Watanabe, H; Maeda, N; Nishida, K				Koh, Shizuka; Ikeda, Chikako; Watanabe, Shinya; Oie, Yoshinori; Soma, Takeshi; Watanabe, Hitoshi; Maeda, Naoyuki; Nishida, Kohji			Effect of non-invasive tear stability assessment on tear meniscus height	ACTA OPHTHALMOLOGICA			English	Article						dry eye; non-invasive tear stability assessment; tear film; tear meniscus	OPTICAL COHERENCE TOMOGRAPHY; DRY EYE DISEASE; FILM STABILITY; ELDERLY CAUCASIANS; OCULAR SURFACE; SCHIRMER TEST; DIAGNOSIS	PurposeTo investigate the effect of non-invasive tear stability assessment with forced eye opening on the lower tear meniscus. MethodsTwenty-three eyes of 23 patients with aqueous-deficient dry eye and 23 eyes of 23 normal subjects were enrolled. All subjects underwent imaging with a Keratograph 5M equipped with a modified tear film scanning function. Lower tear meniscus images were captured, and tear meniscus height (TMH) was measured with an integrated ruler before and after non-invasive Keratograph break-up time (NIKBUT) measurements in each subject. Subjects were instructed to keep their eyes open as long as possible during NIKBUT measurements, and the recording was discontinued at the next blink. ResultsThe TMH values of the normal and dry eye groups were 0.200.05mm and 0.14 +/- 0.03mm, respectively, at baseline. The TMH values of dry eyes were significantly smaller than those of normal eyes (p<0.001). Significant increases in TMH values were observed in both normal (0.10 +/- 0.12mm) and dry eyes (0.04 +/- 0.09mm) with the NIKBUT measurement (p<0.001, p=0.039). A moderate negative correlation was observed between increased TMH and baseline TMH in dry eyes (r=-0.44, p=0.03), whereas no correlation was observed in normal eyes (r=0.04, p=0.85). ConclusionsForced eye opening required for the non-invasive tear stability assessment influences the TMH measurement possibly due to reflex tear secretion, even in patients with aqueous-deficient dry eye. TMH should be assessed before tests that require forced eye opening.	[Koh, Shizuka; Ikeda, Chikako; Watanabe, Shinya; Oie, Yoshinori; Soma, Takeshi; Watanabe, Hitoshi; Maeda, Naoyuki; Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka 5650871, Japan; [Ikeda, Chikako] Rohto Pharmaceut Co Ltd, Res & Dev Div, Kyoto, Japan	Koh, S (reprint author), Osaka Univ, Grad Sch Med, Dept Ophthalmol, 2-2 Yamadaoka,Room E7, Suita, Osaka 5650871, Japan.	skoh@ophthal.med.osaka-u.ac.jp					Altan-Yaycioglu R, 2013, CURR EYE RES, V38, P736, DOI 10.3109/02713683.2013.774422; Qiu XD, 2011, CORNEA, V30, P543, DOI 10.1097/ICO.0b013e3181fb84ea; Mainstone JC, 1996, CURR EYE RES, V15, P653, DOI 10.3109/02713689609008906; [Anonymous], 2007, OCUL SURF, V52, P93; Stern ME, 1998, CORNEA, V17, P584, DOI 10.1097/00003226-199811000-00002; MENGHER LS, 1985, CURR EYE RES, V4, P1, DOI 10.3109/02713688508999960; Koh S, 2003, AM J OPHTHALMOL, V136, P513, DOI 10.1016/S0002-9394(03)00317-9; [Anonymous], 2007, OCUL SURF, V52, P108; Savini G, 2006, OPHTHAL SURG LAS IM, V37, P112; Nichols KK, 2004, CORNEA, V23, P762, DOI 10.1097/01.ico.0000133997.07144.9e; Wang JH, 2006, INVEST OPHTH VIS SCI, V47, P4349, DOI 10.1167/iovs.05-1654; Ibrahim OMA, 2010, OPHTHALMOLOGY, V117, P1923, DOI 10.1016/j.ophtha.2010.01.057; Hong JX, 2013, CORNEA, V32, P716, DOI 10.1097/ICO.0b013e3182714425; [Anonymous], 2007, OCUL SURF, V52, P75; Doughty MJ, 2001, CURR EYE RES, V22, P420; Goto T, 2003, AM J OPHTHALMOL, V135, P607, DOI 10.1016/S0002-9394(02)02221-3; Shen MX, 2009, INVEST OPHTH VIS SCI, V50, P2722, DOI 10.1167/iovs.08-2704; Bandlitz S, 2014, ACTA OPHTHALMOL, V92, pE112, DOI 10.1111/aos.12275; CHO P, 1993, OPTOMETRY VISION SCI, V70, P152, DOI 10.1097/00006324-199302000-00011; Doughty Michael J, 2002, Cont Lens Anterior Eye, V25, P57, DOI 10.1016/S1367-0484(01)00005-4; Fujibayashi T, 2004, MOD RHEUMATOL, V14, P425; Li JH, 2012, EYE CONTACT LENS, V38, P183, DOI 10.1097/ICL.0b013e318252ce0c; LUCCA J A, 1990, CLAO Journal, V16, P109; Lv HB, 2014, ACTA OPHTHALMOL, V92, pE96, DOI 10.1111/aos.12063; Johnson ME, 2005, OPTOMETRY VISION SCI, V82, P1030, DOI 10.1097/01.opx.0000192352.78935.e0; Qiu XD, 2012, ACTA OPHTHALMOL, V90, pe359, DOI 10.1111/j.1755-3768.2012.02413.x; Schirmer O, 1903, GRAEFES ARCH CLIN EX, V56, P197; Kojima T, 2004, INVEST OPHTH VIS SCI, V45, P1369, DOI 10.1167/iovs.03-0712; vansBijsterveld OP, 1969, ARCH OPHTHALMOL-CHIC, V82, P10; Yokoi N, 1999, BRIT J OPHTHALMOL, V83, P92, DOI 10.1136/bjo.83.1.92; Yuan YM, 2010, AM J OPHTHALMOL, V149, P932, DOI 10.1016/j.ajo.2010.01.004; Zaman ML, 1998, EXP EYE RES, V67, P681, DOI 10.1006/exer.1998.0571; Zheng XD, 2014, ACTA OPHTHALMOL, V92, pE105, DOI 10.1111/aos.12260	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-375X	1755-3768		ACTA OPHTHALMOL	Acta Ophthalmol.	MAR	2015	93	2					E135	E139		10.1111/aos.12516		5	Ophthalmology	Ophthalmology	CB8SC	WOS:000349900200008		
J	Dagvadorj, A; Takehara, K; Bavuusuren, B; Morisaki, N; Gochoo, S; Mori, R				Dagvadorj, Amarjargal; Takehara, Kenji; Bavuusuren, Bayasgalantai; Morisaki, Naho; Gochoo, Soyolgerel; Mori, Rintaro			The quick and easy Mongolian Rapid Baby Scale shows good concurrent validity and sensitivity	ACTA PAEDIATRICA			English	Article						Child development; Developing country; Mongolian Rapid Baby Scale; Screening tool; Validation	RANDOMIZED CONTROLLED-TRIAL; DEVELOPING-COUNTRIES; CHILD-DEVELOPMENT; STAGES QUESTIONNAIRES; RISK; INFANTS; INTERVENTION; INVENTORY; OUTCOMES; AGES	AimIn developing countries, around 200 million children with poor development cannot excel academically. Detecting children with developmental delay is fundamental in targeting early interventions. As the lack of a convenient screening tool in Mongolia remains a significant barrier, we aimed to produce an easy-to-administer developmental screening tool in Mongolia and to validate it against an internationally recognised instrument, the Bayley Scales of Infant and Toddler Development Third Edition (Bayley-III). MethodsWe developed the Mongolian Rapid Baby Scale consisting of 161 items arranged under seven developmental domains for children aged from zero months 16days to 42months 15days. We recruited 150 children in Ulaanbaatar, Mongolia. After conducting face and content validity of the tool, we evaluated concurrent validity. ResultsConcurrent validity ranged from high correlation (r=0.86) to very high (r=0.97) for each of the corresponding domains between the two tests. Summary statistics showed good sensitivity (81.8%) and moderate specificity (52.3%). ConclusionOur newly developed tool takes only 15min to complete and is easy to administer. It demonstrated good concurrent validity and sensitivity for the screening of developmental status in young children. This innovative tool will be useful to identify children who may benefit from early interventions in Mongolia.	[Dagvadorj, Amarjargal; Takehara, Kenji; Morisaki, Naho; Mori, Rintaro] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo 1578535, Japan; [Bavuusuren, Bayasgalantai] Childrens Hosp, Natl Ctr Maternal & Child Hlth, Ulaanbaatar, Mongol Peo Rep; [Morisaki, Naho] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo, Japan; [Gochoo, Soyolgerel] Minist Hlth, Ulaanbaatar, Mongol Peo Rep	Dagvadorj, A (reprint author), Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	dagvadorj-a@ncchd.go.jp			Government of Japan [23406035]	The study was funded by a Grant-in-Aid (No. 23406035) from the Government of Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency of Standardization and Metrology, 2011, EARL LEARN DEV STAND; Gollenberg AL, 2010, CHILD CARE HLTH DEV, V36, P485, DOI 10.1111/j.1365-2214.2009.01041.x; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Barnett WS, 2011, SCIENCE, V333, P975, DOI 10.1126/science.1204534; Azzaya G, 2010, MONG J OBSTET GYNECO, V1, P573; Bayley N, 2006, BAYLEY SCALES INFANT; Bayley N., 1993, BAYLEY SCALES INFANT; Campenelli P., 1997, B METHODOLOGIE SOCIO, V55, P5, DOI DOI 10.1177/075910639705500103; Connolly BH, 2012, PEDIATR PHYS THER, V24, P345, DOI 10.1097/PEP.0b013e318267c5cf; Enjoji M, 2009, ENJOJI SCALE INFANT; Farnik Małgorzata, 2012, Patient Relat Outcome Meas, V3, P1, DOI 10.2147/PROM.S14405; Frankenburg WK, 1990, DENVER II TECHNICAL; Gochoo S, 2010, MONGOLIAN MATERNAL C; Gorman KS, 1996, CHILD DEV, V67, P314; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Hashimoto Keiji, 2012, Jikeikai Medical Journal, V59, P5; Hwang AW, 2013, RES DEV DISABIL, V34, P3112, DOI 10.1016/j.ridd.2013.06.037; Khan NZ, 2013, PEDIATRICS, V131, pE486, DOI 10.1542/peds.2011-2421; KNOBLOCH H, 1966, PEDIATRICS, V38, P1095; Liao HF, 2008, PERCEPT MOTOR SKILL, V107, P29, DOI 10.2466/PMS.107.1.29-44; Manaseki-Holland S, 2010, PEDIATRICS, V126, pE1485, DOI 10.1542/peds.2009-1531; Miyake K, 2012, KINDER INFANT DEV SC; Peacock S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-17; Plichta S., 2012, MUNROS STAT METHODS; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD; Simard MN, 2012, PEDIATRICS, V130, pE108, DOI 10.1542/peds.2011-3532; Weiss LG, 2010, PRACT RESOUR MENT, pIX, DOI 10.1016/B978-0-12-374177-6.10010-8; World Medical A, 2002, J POSTGRAD MED, V48, P206	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0803-5253	1651-2227		ACTA PAEDIATR	Acta Paediatr.	MAR	2015	104	3					E94	E99		10.1111/apa.12884		6	Pediatrics	Pediatrics	CC0XF	WOS:000350062400001		
J	Kato-Noguchi, H; Hamada, N; Clements, DR				Kato-Noguchi, Hisashi; Hamada, Naoko; Clements, David R.			Phytotoxicities of the invasive species Plantago major and non-invasive species Plantago asiatica	ACTA PHYSIOLOGIAE PLANTARUM			English	Article						Allelopathy; Growth inhibitor; Invasive plant; Phytotoxicity; Plantago	ALLELOPATHY; GERMINATION; GROWTH; EXTRACTS; CONSTITUENTS; MECHANISM; GENES	Although Plantago major and Plantago asiatica have similar life-history characteristics, P. major populations expand much more rapidly than P. asiatica in habitats where both species occur. One potential factor contributing to this disparity is the production of phytotoxic compounds. However, the phytotoxic characteristics of P. major and P. asiatica have not yet reported. Therefore, we conducted an investigation of possible phytotoxic compounds with allelopathic activity in both species. Aqueous methanol extracts of both plant species inhibited root and hypocotyl growth of garden cress (Lepidium sativum) in a concentration dependent manner. However, the inhibitory effect of P. major was greater than that of P. asiatica. The extracts were further purified by several chromatographic runs and two main phytotoxic compounds were isolated and identified through spectral analysis as (-)-3-hydroxy-beta-ionone and blumenol A. (-)-3-Hydroxy-beta- ionone and blumenol A inhibited the growth and germination of garden cress at concentrations greater than 1 and 30 mu M, respectively. The level of (-)-3-hydroxy-beta-ionone in P. major was 7.2-fold greater than that in P. asiatica, while the level of blumenol A was equal in both plant species. Although these Plantago species produce two main phytotoxic compounds with allelopathic activity, the higher level of (-)-3-hydroxy-beta-ionone in P. major may result in it contributing the primary inhibitory effects of the extract of P. major. (-)-3-hydroxy-beta-ionone may also serve to distinguish the invasive habit of two species and may be involved in the expansion in habitats of P. major.	[Kato-Noguchi, Hisashi; Hamada, Naoko] Kagawa Univ, Dept Appl Biol Sci, Fac Agr, Miki, Kagawa 7610795, Japan; [Clements, David R.] Trinity Western Univ, Dept Biol, Langley, BC V2Y 1Y1, Canada	Kato-Noguchi, H (reprint author), Kagawa Univ, Dept Appl Biol Sci, Fac Agr, Miki, Kagawa 7610795, Japan.	hisashi@ag.kagawa-u.ac.jp					Chiang LC, 2002, ANTIVIR RES, V55, P53, DOI 10.1016/S0166-3542(02)00007-4; Samuelsen AB, 2000, J ETHNOPHARMACOL, V71, P1, DOI 10.1016/S0378-8741(00)00212-9; Bonanomi G, 2006, NEW PHYTOL, V169, P571, DOI 10.1111/j.1469-8137.2005.01611.x; Mack RN, 1996, BIOL CONSERV, V78, P107, DOI 10.1016/0006-3207(96)00021-3; Drenovsky RE, 2012, ANN BOT-LONDON, V110, P141, DOI 10.1093/aob/mcs100; Meiners SJ, 2012, PLANT ECOL, V213, P1861, DOI 10.1007/s11258-012-0121-6; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Yuan YG, 2013, J PLANT ECOL, V6, P253, DOI 10.1093/jpe/rts033; Oracz K, 2012, PLANT CELL PHYSIOL, V53, P81, DOI 10.1093/pcp/pcr124; Belz RG, 2007, PEST MANAG SCI, V63, P308, DOI 10.1002/ps.1320; HUBBELL SP, 1983, OECOLOGIA, V60, P321, DOI 10.1007/BF00376846; Cappuccino N, 2006, BIOL LETTERS, V2, P189, DOI 10.1098/rsbl.2005.0433; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; GONZALEZ AG, 1994, J NAT PROD, V57, P400, DOI 10.1021/np50105a013; Mathieu S, 2005, J EXP BOT, V56, P2721, DOI 10.1093/jxb/eri265; THOMPSON JD, 1991, NEW PHYTOL, V117, P115, DOI 10.1111/j.1469-8137.1991.tb00951.x; Ritchie S, 1998, NEW PHYTOL, V140, P363, DOI 10.1046/j.1469-8137.1998.00299.x; BARNES JP, 1986, WEED SCI, V34, P384; HAWTHORN WR, 1974, CAN J PLANT SCI, V54, P383; SAGAR GR, 1964, J ECOL, V52, P189, DOI 10.2307/2257792; Watling JI, 2011, OECOLOGIA, V165, P153, DOI 10.1007/s00442-010-1777-z; Chengxu W, 2011, PROCEDIA ENG, V18, P240; Conley TR, 1999, PLANT PHYSIOL, V119, P599, DOI 10.1104/pp.119.2.599; DellaGreca M, 2004, J NAT PROD, V67, P1492, DOI 10.1021/np049857q; Dietz H, 1996, PHYTOCHEMISTRY, V42, P1005, DOI 10.1016/0031-9422(96)00020-9; GULDNER A, 1991, J AGR FOOD CHEM, V39, P2142; IKEDA H, 1992, J VEG SCI, V3, P217, DOI 10.2307/3235682; IKEDA H, 1995, ACTA BOT NEERL, V44, P151; IKEDA H, 1990, Ecological Research, V5, P41, DOI 10.1007/BF02348462; Kato-Noguchi H, 2006, J CHEM ECOL, V32, P1101, DOI 10.1007/s10886-006-9041-z; KATONOGUCHI H, 1993, PHYTOCHEMISTRY, V33, P553, DOI 10.1016/0031-9422(93)85447-Y; Kobayashi T, 1999, PLANT BIOLOGY, V1, P445, DOI 10.1055/s-2007-978538; Lockwood Julie L., 2001, Biological Invasions, V3, P1, DOI 10.1023/A:1011412820174; Matsuo K, 1989, J PHYTOGEOGRAPHY TAX, V37, P129; Mohamed I. K., 2011, International Journal of Biodiversity and Conservation, V3, P83; Sunohara Y, 2000, J WEED SCI TECHNOL, V45, P184; Vartapetian BB, 1997, ANN BOT-LONDON, V79, P3, DOI 10.1006/anbo.1996.0295; Weston LA, 2003, CRIT REV PLANT SCI, V22, P367, DOI 10.1080/713610861	38	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0137-5881	1861-1664		ACTA PHYSIOL PLANT	Acta Physiol. Plant.	MAR	2015	37	3								10.1007/s11738-015-1794-y		8	Plant Sciences	Plant Sciences	CC0TU	WOS:000350050500018		
J	Wada, S; Maki, S; Niedz, RP; Reed, BM				Wada, Sugae; Maki, Shinya; Niedz, Randall P.; Reed, Barbara M.			Screening genetically diverse pear species for in vitro CaCl2, MgSO4 and KH2PO4 requirements	ACTA PHYSIOLOGIAE PLANTARUM			English	Article						Growth medium; Mesos components; Micropropagation; Mineral nutrition; Pyrus	TOBACCO TISSUE CULTURES; GROWTH; MEDIA; L.	Conservation of important plant germplasm is often difficult due to the specific growth requirements of genetically diverse species including in vitro culture collections. Recently the mesos components (CaCl2, MgSO4, KH2PO4) of Murashige and Skoog medium were identified as one of the most influential groups of nutrients for five pear genotypes. To determine if this requirement also applied to a larger germplasm collection, 18 genotypes in six species were screened. Shoot quality, shoot length, leaf spots and leaf color were the most affected responses. Seven of nine Pyrus communis cultivars had improved shoot quality, five had significantly longer shoots, better leaf color and fewer leaf spots while two had more shoots. Two of the four Pyrus pyrifolia cultivars had improved shoot quality while three had better leaf color and fewer leaf spots. Pyrus calleryana 'Capital', Pyrus cordata and Pyrus ussuriensis 'Harbin' had longer shoots while Pyrus koehnei had less callus. P. ussuriensis 'Hang Pa Li' was the only genotype where shoot quality declined at high mesos concentrations. Quantitative ion analysis detected substantially higher concentrations of Ca, Mg and K, but significantly less Fe, in the shoots cultured on increased mesos compared to controls. This study confirms that increased mesos improved growth of P. communis and P. pyrifolia cultivars, but produced fewer significantly improved responses for four other species.	[Wada, Sugae] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [Maki, Shinya] Niihama Natl Coll Technol, Dept Appl Chem & Biotechnol, Niihama, Ehime, Japan; [Niedz, Randall P.] USDA, US Hort Res Lab, Agr Res Serv, Ft Pierce, FL 34945 USA; [Reed, Barbara M.] USDA, Agr Res Serv, Corvallis, OR 97333 USA	Wada, S (reprint author), Oregon State Univ, Dept Hort, 4017 Agr & Life Sci Bldg, Corvallis, OR 97331 USA.	Sugae.Wada@oregonstate.edu; maki@chem.niihama-nct.ac.jp; Randall.Niedz@ars.usda.gov; Barbara.Reed@ars.usda.gov			Oregon Association of Nurseries; Oregon Department of Agriculture; USDA-ARS CRIS [5358-21000-0-38-00D]	We thank NCGR lab personnel for assistance with collection of the data. This project was funded by a grant from the Oregon Association of Nurseries and the Oregon Department of Agriculture and by USDA-ARS CRIS project 5358-21000-0-38-00D.	Reed BM, 2013, IN VITRO CELL DEV-PL, V49, P699, DOI 10.1007/s11627-013-9556-2; Niedz RP, 2007, IN VITRO CELL DEV-PL, V43, P370, DOI 10.1007/s11627-007-9062-5; Niedz RP, 2007, SCI HORTIC-AMSTERDAM, V112, P349, DOI 10.1016/j.scienta.2006.12.044; DRIVER JA, 1984, HORTSCIENCE, V19, P507; Reed BM, 2013, IN VITRO CELL DEV-PL, V49, P343, DOI 10.1007/s11627-013-9504-1; [Anonymous], 2010, DES EXP; Bell RL, 2009, IN VITRO CELL DEV-PL, V45, P708, DOI 10.1007/s11627-009-9196-8; Bell R.L., 2002, ACTA HORTIC, V596, P412; Bondarev N, 2003, PLANT SCI, V165, P845, DOI 10.1016/S0168-9452(03)00283-8; Bosela MJ, 2008, IN VITRO CELL DEV-PL, V44, P316, DOI 10.1007/s11627-008-9114-5; Bucher M, 2007, POTATO BIOL BIOTECHN, P311, DOI 10.1016/B978-044451018-1/50057-9; LINSMAIE.EM, 1965, PHYSIOL PLANTARUM, V18, P100, DOI 10.1111/j.1399-3054.1965.tb06874.x; Lloyd G, 1981, COMB P INT PLANT PRO, V30, P421; MARSCHNER H., 1995, MINERAL NUTR HIGHER; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Preece JE, 1995, PLANT TISSUE CULTURE, V1, P26; QUOIRIN M, 1977, Acta Horticulturae (Wageningen), V78, P437; Reed BM, 1999, MANAGEMENT FIELD IN, P132; Reed BM, 1998, PLANT GEN RES NEWSLE, V115, P1; Reed BM, 2013, PROTOCOLS MICROPROPA, P554; Sallanon H, 1997, PLANT SCI, V124, P107, DOI 10.1016/S0168-9452(97)04591-3; Singha S, 1986, POMONA, V19, P4; Skirvin RM, 1981, CLONING AGR PLANTS V, P51; Troyanos YE, 2000, PLANT SOIL, V225, P73, DOI 10.1023/A:1026596612035; Wada S, 2013, IN VITRO CELL DEV-PL, V49, P356, DOI 10.1007/s11627-013-9508-x; Wada S, 2015, IN VITRO CELL DEV-PL, V51, P19, DOI 10.1007/s11627-015-9662-4; Zhao H, 1990, HDB PLANT CELL CULTU, V6, P264	27	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0137-5881	1861-1664		ACTA PHYSIOL PLANT	Acta Physiol. Plant.	MAR	2015	37	3								10.1007/s11738-014-1754-y		10	Plant Sciences	Plant Sciences	CC0TU	WOS:000350050500021		
J	Yasmin, C; Otoi, T; Setiadi, MA; Karja, NWK				Yasmin, Cut; Otoi, Takeshige; Setiadi, Mohamad Agus; Karja, Ni Wayan Kurniani			MATURATION AND FERTILISATION OF SHEEP OOCYTES CULTURED IN SERUM-FREE MEDIUM CONTAINING SILK PROTEIN SERICIN	ACTA VETERINARIA HUNGARICA			English	Article						Albumin; antioxidants; in vitro maturation; meiotic competence; ovine oocyte; silk protein; sericin	IN-VITRO MATURATION; EMBRYO DEVELOPMENT; BOVINE EMBRYOS; SILKWORMS	Sericin is a water-soluble component of silk and has been used as a biomaterial due to its antibacterial and ultraviolet radiation-resistant properties. This study was designed to evaluate the effect of sericin supplementation in a maturation medium on the meiotic competence and fertilisability of sheep oocytes. Cumulus-oocyte complexes (COCs) were cultured in TCM199 supplemented with sericin at various concentrations of 0 (control), 0.1, 0.25 and 0.5%, either with or without bovine serum albumin (BSA). When the COCs were matured without BSA, the supplementation of 0.1% sericin significantly increased the rates of maturation to metaphase II and the total fertilisation of oocytes compared with the other concentrations of sericin. When the COCs were matured with BSA, the beneficial effects of 0.1% sericin supplementation on the maturation and fertilisation of oocytes were not observed. Our findings indicate that supplementation with 0.1% sericin during maturation culture may improve the nuclear maturation and fertilisability of sheep oocytes. Moreover, it may be possible to replace BSA with sericin in chemically defined media without the risk of disease transmission.	[Yasmin, Cut; Setiadi, Mohamad Agus; Karja, Ni Wayan Kurniani] Bogor Agr Univ, Dept Clin Reprod & Pathol, Div Reprod, Bogor, Jawa Barat, Indonesia; [Otoi, Takeshige] United Grad Sch Vet Sci, Lab Anim Reprod, Yamaguchi 7538515, Japan	Otoi, T (reprint author), United Grad Sch Vet Sci, Lab Anim Reprod, Yamaguchi 7538515, Japan.	otoi@yamaguchi-u.ac.jp			JSPS/DGHE	This work was partly supported by the JSPS/DGHE Joint Research Project 2011-2013.	Kato N, 1998, BIOSCI BIOTECH BIOCH, V62, P145, DOI 10.1271/bbb.62.145; Hosoe M, 2014, J REPROD DEVELOP, V60, P268, DOI 10.1262/jrd.2013-110; Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4; Isobe T, 2012, THERIOGENOLOGY, V78, P747, DOI 10.1016/j.theriogenology.2012.03.021; Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608; Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002; Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057; Dash R, 2008, BMB REP, V41, P236; de Matos DG, 2002, THERIOGENOLOGY, V57, P1443, DOI 10.1016/S0093-691X(02)00643-X; Do LTK, 2014, REPROD DOMEST ANIM, V49, pe17, DOI 10.1111/rda.12274; George F, 2008, THERIOGENOLOGY, V69, P612, DOI 10.1016/j.theriogenology.2007.11.008; Souza-Fabjan JMG, 2013, REPROD BIOL, V13, P325, DOI 10.1016/j.repbio.2013.09.005; Thibier M, 2006, REPROD DOMEST ANIM, V41, P260, DOI 10.1111/j.1439-0531.2006.00721.x	13	1	1	AKADEMIAI KIADO RT	BUDAPEST	PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY	0236-6290	1588-2705		ACTA VET HUNG	Acta Vet. Hung.	MAR	2015	63	1					110	117		10.1556/AVet.2015.009		8	Veterinary Sciences	Veterinary Sciences	CC0NT	WOS:000350033300011		
J	Komatsu, H; Ota, M; Sato, Y; Watanabe, M; Smith, RL				Komatsu, Hiroyuki; Ota, Masaki; Sato, Yoshiyuki; Watanabe, Masaru; Smith, Richard L., Jr.			Hydrogen and Carbon Dioxide Adsorption with Tetra-n-Butyl Ammonium Semi-Clathrate Hydrates for Gas Separations	AICHE JOURNAL			English	Article						separations; gas adsorption; formation kinetics; structure; anion	SIMULATED FUEL GAS; FLUE-GAS; CO2 CAPTURE; TETRABUTYLAMMONIUM FLUORIDE; ENERGY-RESOURCES; BROMIDE; EQUILIBRIA; BIOGAS; SALTS; TBAB	Gas adsorption rates of H-2, CO2, and H-2-CO2 gas mixture (H-2/CO2=3.4) with tetra-n-butyl ammonium salt (bromide, chloride, and fluoride) semi-clathrate hydrate particles were measured at 269 K to assess their properties for gas separation. Equilibrium gas occupancies in the S-cages of the particles were in order of (high to low) for hexagonal structure-I, tetragonal structure-I, and superlattice of cubic structure-I structures with the maximum fractional occupancy by CO2 being about 40%. The CO2 diffusion rate depended on the anion size of the salt, which is attributed to distortion of the S-cage that is close to the molecular size of CO2. Simulations of semi-clathrate hydrate particles with theory showed that H-2/CO2 selectivities could be as high as 36 (3.0 mol% TBAF) and that selectivities for an ideal membrane (3.3 mol% TBAF) could be >100 (269 K, 0.3-4.5 MPa). Semi-clathrate hydrates have wide application as separation media for gas mixtures. (c) 2014 American Institute of Chemical Engineers AIChE J, 61: 992-1003, 2015	[Komatsu, Hiroyuki] Niigata Univ, Dept Chem & Chem Engn, Niigata 9502181, Japan; [Ota, Masaki; Sato, Yoshiyuki; Watanabe, Masaru] Tohoku Univ, Grad Sch Engn, Res Ctr Supercrit Fluid Technol, Sendai, Miyagi 9808579, Japan; [Smith, Richard L., Jr.] Tohoku Univ, Grad Sch Environm Studies, Res Ctr Supercrit Fluid Technol, Sendai, Miyagi 9808579, Japan	Smith, RL (reprint author), Tohoku Univ, Grad Sch Environm Studies, Res Ctr Supercrit Fluid Technol, Sendai, Miyagi 9808579, Japan.	smith@scf.che.tohoku.ac.jp	Smith Jr, Richard/E-3495-2012	Smith Jr, Richard/0000-0002-9174-7681	Japan Society for the Promotion of Science	The authors are grateful for Japan Society for the Promotion of Science for partial financial support of this research through a Grant-in-Aid for Scientific Research and a doctoral course fellowship.	Aaron D, 2005, SEPAR SCI TECHNOL, V40, P321, DOI 10.1081/SS-200042244; Alarcon-Rodriguez A, 2010, RENEW SUST ENERG REV, V14, P1353, DOI 10.1016/j.rser.2010.01.006; Bezanehtak K, 2002, J CHEM ENG DATA, V47, P161, DOI 10.1021/je010122m; Alfonso D, 2009, BIOMASS BIOENERG, V33, P1070, DOI 10.1016/j.biombioe.2009.04.002; Lin HQ, 2006, SCIENCE, V311, P639, DOI 10.1126/science.1118079; Shimada W, 2003, JPN J APPL PHYS 2, V42, pL129, DOI 10.1143/JJAP.42.L129; Ryckebosch E, 2011, BIOMASS BIOENERG, V35, P1633, DOI 10.1016/j.biombioe.2011.02.033; Sakamoto J, 2008, CHEM ENG SCI, V63, P5789, DOI 10.1016/j.ces.2008.08.026; Li SF, 2009, J NAT GAS CHEM, V18, P15, DOI 10.1016/S1003-9953(08)60085-7; Muromachi S, 2014, CHEM COMMUN, V50, P11476, DOI 10.1039/c4cc02111h; Sloan ED, 2003, NATURE, V426, P353, DOI 10.1038/nature02135; Staykova DK, 2003, J PHYS CHEM B, V107, P10299, DOI 10.1021/jp027787v; TSANG CY, 1981, CHEM ENG SCI, V36, P993, DOI 10.1016/0009-2509(81)80085-1; Adeyemo A, 2010, INT J GREENH GAS CON, V4, P478, DOI 10.1016/j.ijggc.2009.11.011; Mohammed YS, 2013, RENEW SUST ENERG REV, V22, P257, DOI 10.1016/j.rser.2013.01.020; Kang SP, 2000, ENVIRON SCI TECHNOL, V34, P4397, DOI 10.1021/es001148l; Kumar R, 2009, J ENVIRON ENG-ASCE, V135, P411, DOI 10.1061/(ASCE)EE.1943-7870.0000002; Simo M, 2009, IND ENG CHEM RES, V48, P9247, DOI 10.1021/ie900446v; Seo YT, 2005, ENVIRON SCI TECHNOL, V39, P2315, DOI 10.1021/es049269z; Duc NH, 2007, ENERG CONVERS MANAGE, V48, P1313, DOI 10.1016/j.enconman.2006.09.024; Park S, 2013, ENVIRON SCI TECHNOL, V47, P7571, DOI 10.1021/es400966x; Fermoso J, 2012, J CHEM TECHNOL BIOT, V87, P1367, DOI 10.1002/jctb.3857; Bauer F, 2013, BIOFUEL BIOPROD BIOR, V7, P499, DOI 10.1002/bbb.1423; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Xu CG, 2013, ENERGY, V59, P719, DOI 10.1016/j.energy.2013.07.056; Oyama H, 2005, FLUID PHASE EQUILIBR, V234, P131, DOI 10.1016/j.fluid.2005.06.005; SPANO JO, 1968, J CHEM ENG DATA, V13, P168, DOI 10.1021/je60037a007; Fan SS, 2009, ENERG FUEL, V23, P4202, DOI 10.1021/ef9003329; Kamata Y, 2005, ENERG FUEL, V19, P1717, DOI 10.1021/ef0497098; Alonso-Vicario A, 2010, MICROPOR MESOPOR MAT, V134, P100, DOI 10.1016/j.micromeso.2010.05.014; Davidson DW, 1973, WATER A COMPREHENSIV, V2; DYADIN YA, 1987, J STRUCT CHEM+, V28, P394, DOI 10.1007/BF00753818; DYADIN YA, 1976, J STRUCT CHEM+, V17, P566; Hashimoto S, 2012, J CHEM ENG JPN, V45, P444; Komarov VY, 2007, J INCL PHENOM MACRO, V59, P11, DOI 10.1007/s10847-006-9151-9; Komatsu H, 2014, CHEM ENG SCI, V108, P270, DOI 10.1016/j.ces.2014.01.001; Komatsu H, 2013, FLUID PHASE EQUILIBR, V357, P80, DOI 10.1016/j.fluid.2013.05.027; Linga P, 2008, ENVIRON SCI TECHNOL, V42, P315, DOI 10.1021/es071824k; MCMULLAN R, 1959, J CHEM PHYS, V31, P1231, DOI 10.1063/1.1730574; Onstot WJ, 2001, IND ENG CHEM RES, V40, P242, DOI 10.1021/ie0003685; Perpina C, 2009, RENEW ENERG, V34, P555, DOI 10.1016/j.renene.2008.05.047; Rodionova T, 2010, J PHYS CHEM B, V114, P11838, DOI 10.1021/jp103939q; Shimada W, 2005, ACTA CRYSTALLOGR C, V61, pO65, DOI 10.1107/S0108270104032743; Sizikov AA, 2012, ENERG FUEL, V26, P3711, DOI 10.1021/ef300350z; Sloan E.D., 2007, CLATHRATE HYDRATES N; Song YC, 2013, ENERG FUEL, V27, P3341, DOI 10.1021/ef400257a; Tang JF, 2013, CHEM ENG RES DES, V91, P1777, DOI 10.1016/j.cherd.2013.03.013; Yorizane M., 1970, KAGAKU KOGAKU, V34, P953; Zhong DL, 2012, IND ENG CHEM RES, V51, P14806, DOI 10.1021/ie300641g	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-1541	1547-5905		AICHE J	AICHE J.	MAR	2015	61	3					992	1003		10.1002/aic.14689		12	Engineering, Chemical	Engineering	CB8XH	WOS:000349915000022		
J	Isogai, T; Yasunaga, H; Matsui, H; Tanaka, H; Horiguchi, H; Fushimi, K				Isogai, Toshiaki; Yasunaga, Hideo; Matsui, Hiroki; Tanaka, Hiroyuki; Horiguchi, Hiromasa; Fushimi, Kiyohide			Effectiveness of Inferior Vena Cava Filters on Mortality as an Adjuvant to Antithrombotic Therapy	AMERICAN JOURNAL OF MEDICINE			English	Article						Deep vein thrombosis; Inferior vena cava filter; In-hospital mortality; Pulmonary embolism; Venous thromboembolism	DEEP-VEIN THROMBOSIS; INSTRUMENTAL VARIABLE METHODS; ACUTE PULMONARY-EMBOLISM; VENOUS THROMBOEMBOLISM; PROPENSITY SCORE; MANAGEMENT; RISK; PREVENTION; PREVALENCE; DIAGNOSIS	BACKGROUND: Despite growing evidence of complications, inferior vena cava filters are being used increasingly in patients with venous thromboembolism based on limited efficacy data. In such a controversial situation, the effectiveness of filter use on mortality as an adjuvant to antithrombotic therapy for pulmonary embolism remains uncertain. METHODS: Using the Diagnosis Procedure Combination database in Japan, we identified patients hospitalized with pulmonary embolism who received anticoagulation or thrombolytic therapy from the day of admission. We compared the in-hospital mortality between patients who received a filter and patients who did not, using propensity score and instrumental variable methods. RESULTS: Of 13,125 eligible patients, 3948 received a filter, and 9177 did not receive a filter. The propensity score-matched analysis showed that filter use was significantly associated with lower in-hospital mortality than nonuse (2.6% vs 4.7%, P < .001; risk ratio 0.55; 95% confidence interval [CI], 0.43-0.71; risk difference -2.1%; 95% CI, -3.0% to -1.2%; number needed to treat, 48; 95% CI, 34-82). We obtained similar results in the inverse probability of treatment-weighting analysis. The instrumental variable analysis confirmed that filter use was associated with a decreased risk of in-hospital mortality with adjustment for all measured variables (risk difference -2.5%, 95% CI, -4.6% to -0.4%). CONCLUSIONS: This study suggested that filter use was potentially effective for reducing in-hospital mortality in patients with pulmonary embolism. Prospective studies are needed to confirm the effectiveness observed in our results and to define which subpopulations of patients would benefit most from filters. (C) 2015 Elsevier Inc. All rights reserved.	[Isogai, Toshiaki; Yasunaga, Hideo; Matsui, Hiroki] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1130033, Japan; [Isogai, Toshiaki; Tanaka, Hiroyuki] Tokyo Metropolitan Tama Med Ctr, Dept Cardiol, Tokyo, Japan; [Horiguchi, Hiromasa] Clin Res Ctr, Dept Clin Data Management & Res, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan	Yasunaga, H (reprint author), Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, 7-3-1 Hongo, Tokyo 1130033, Japan.	yasunagah-tky@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan [H25-Policy-010]; Council for Science and Technology Policy, Japan [0301002001001]	This work was supported by grants from the Ministry of Health, Labour and Welfare, Japan (Research on Policy Planning and Evaluation grant number: H25-Policy-010), and the Council for Science and Technology Policy, Japan (Funding Program for World-Leading Innovative R&D on Science and Technology, FIRST program grant number: 0301002001001). The sponsors had no roles in the study.	Fasullo S, 2011, AM J MED SCI, V341, P33, DOI 10.1097/MAJ.0b013e3181f1fc3e; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Kucher N, 2006, CIRCULATION, V113, P577, DOI 10.1161/CIRCULATIONAHA.105.592592; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Sarosiek S, 2013, JAMA INTERN MED, V173, P513, DOI 10.1001/jamainternmed.2013.343; Brookhart MA, 2010, PHARMACOEPIDEM DR S, V19, P537, DOI 10.1002/pds.1908; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; Girard P, 2002, CHEST, V122, P963, DOI 10.1378/chest.122.3.963; Becattini C, 2010, THROMB RES, V125, pE82, DOI 10.1016/j.thromres.2009.09.017; Xu S, 2010, VALUE HEALTH, V13, P273, DOI 10.1111/j.1524-4733.2009.00671.x; Muriel A, 2014, J AM COLL CARDIOL, V63, P1675, DOI 10.1016/j.jacc.2014.01.058; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Wells PS, 2014, JAMA-J AM MED ASSOC, V311, P717, DOI 10.1001/jama.2014.65; Mismetti P, 2008, REV PNEUMOL CLIN, V64, P328, DOI 10.1016/j.pneumo.2008.09.011; Sumitani M, 2011, ANESTHESIOLOGY, V114, P84, DOI 10.1097/ALN.0b013e318200197d; Chatterjee S, 2014, JAMA-J AM MED ASSOC, V311, P2414, DOI 10.1001/jama.2014.5990; Hammond CJ, 2009, CLIN RADIOL, V64, P502, DOI 10.1016/j.crad.2009.01.009; Wang SL, 2013, ANN MED, V45, P474, DOI 10.3109/07853890.2013.832951; Tanabe Y, 2014, J CARDIOL, V63, P385, DOI 10.1016/j.jjcc.2013.10.003; Sharifi M, 2013, AM J CARDIOL, V111, P273, DOI 10.1016/j.amjcard.2012.09.027; Pollack CV, 2011, J AM COLL CARDIOL, V57, P700, DOI 10.1016/j.jacc.2010.05.071; Nicholson W, 2010, ARCH INTERN MED, V170, P1827, DOI 10.1001/archinternmed.2010.316; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Stein PD, 2012, AM J MED, V125, P478, DOI 10.1016/j.amjmed.2011.05.025; Decousus H, 2005, CIRCULATION, V112, P416, DOI 10.1161/CIRCULATIONHA.104.512834; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; White RH, 2013, JAMA INTERN MED, V173, P506, DOI 10.1001/jamainternmed.2013.2352; Prasad V, 2013, JAMA INTERN MED, V173, P493, DOI 10.1001/jamainternmed.2013.2725; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Stein PD, 2011, AM J MED, V124, P655, DOI 10.1016/j.amjmed.2011.02.021; Casez P, 2010, J CLIN EPIDEMIOL, V63, P790, DOI 10.1016/j.jclinepi.2009.09.002; Dong BR, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004437.pub3, DOI 10.1002/14651858.CD004437.PUB3]; Ando M, 2011, CIRC J, V75, P1258, DOI 10.1253/circj.CJ-88-0010; Kearon C, 2012, CHEST, V141, pe419S, DOI DOI 10.1378/CHEST.11-2301; Meyer G, 2014, NEW ENGL J MED, V370, P1402, DOI 10.1056/NEJMoa1302097; Spencer FA, 2010, ARCH INTERN MED, V170, P1456, DOI 10.1001/archinternmed.2010.272	37	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9343	1555-7162		AM J MED	Am. J. Med.	MAR	2015	128	3								10.1016/j.amjmed.2014.10.034		9	Medicine, General & Internal	General & Internal Medicine	CC0DC	WOS:000350004200033		
J	Hakuba, N; Ikemune, K; Okada, M; Hato, N				Hakuba, Nobuhiro; Ikemune, Keizo; Okada, Masahiro; Hato, Naohito			Use of ambulatory anesthesia with manually assisted ventilation for tympanic membrane regeneration therapy in children	AMERICAN JOURNAL OF OTOLARYNGOLOGY			English	Article							FIBROBLAST-GROWTH-FACTOR; PERFORATIONS; SEVOFLURANE; HALOTHANE; INDUCTION; REPAIR	Purpose: To present the utility of ambulatory anesthesia using manually assisted ventilation via a facemask for tympanic membrane (TM) regeneration therapy in children. Material and methods: The study included 10 children (age 4-11 years) in whom the duration of perforation before treatment exceeded 6 months and who were followed for at least 1 year after treatment between December 2009 and December 2012. Under ambulatory anesthesia using manually assisted ventilation via a facemask, TM regenerative therapy with atelocollagen combined with basic fibroblast growth factor was performed in children who could not tolerate the procedure under local anesthesia alone. Results: All of the children completed the TM regenerative therapy under ambulatory anesthesia in less than 5 min. Complete closure was achieved in nine (81.8%) ears after 1 year of postoperative follow-up. Conclusion: TM regenerative therapy can be performed under local anesthesia in less than 5 min without a skin incision. However, local anesthesia is often insufficient in small children undergoing this procedure. Therefore, ambulatory anesthesia using manually assisted ventilation via a facemask is appropriate to complete this procedure safely in small children. (C) 2015 Elsevier Inc. All rights reserved.	[Hakuba, Nobuhiro; Okada, Masahiro; Hato, Naohito] Ehime Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Toon City, Ehime 7910295, Japan; [Ikemune, Keizo] Ehime Univ, Sch Med, Dept Anesthesiol & Resuscitolog, Toon City, Ehime 7910295, Japan	Hakuba, N (reprint author), Ehime Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Shizugawa Cho, Toon City, Ehime 7910295, Japan.	hakuba@m.ehime-u.ac.jp					Akasaka Y, 2007, WOUND REPAIR REGEN, V15, P378, DOI 10.1111/j.1524-475X.2007.00240.x; Zhang Q, 2012, CLIN OTOLARYNGOL, V37, P446, DOI 10.1111/coa.12017; Hakuba N, 2010, OTOL NEUROTOL, V31, P118, DOI 10.1097/MAO.0b013e3181c34f01; Guenther E, 2003, ANN EMERG MED, V42, P783, DOI 10.1016/mem.2003.383; Kanemaru SI, 2011, OTOL NEUROTOL, V32, P1218, DOI 10.1097/MAO.0b013e31822e0e53; Lou ZC, 2011, INT J PEDIATR OTORHI, V75, P1285, DOI 10.1016/j.ijporl.2011.07.012; Baum VC, 1997, ANESTH ANALG, V85, P313; Hakuba N, 2003, LARYNGOSCOPE, V113, P1352, DOI 10.1097/00005537-200308000-00016; Isago T, 2006, SURG TODAY, V36, P765, DOI 10.1007/s00595-004-3230-6; Kawase T, 2010, J PERIODONTOL, V81, P1653, DOI 10.1902/jop.2010.100194; Ma YX, 2002, ACTA OTO-LARYNGOL, V122, P586, DOI 10.1080/000164802320396259; MCDOWALL RH, 1995, J CLIN ANESTH, V7, P273, DOI 10.1016/0952-8180(95)00017-C; MONDAIN M, 1994, AM J OTOLARYNG, V15, P344, DOI 10.1016/0196-0709(94)90133-3; Ortiz AC, 2014, COCHRANE DB SYST REV, V2; SPANDOW O, 1995, J LARYNGOL OTOL, V109, P1041; Tanaka S, 1996, ANESTH ANALG, V82, P821, DOI 10.1097/00000539-199604000-00025; Truy E, 1994, ARCH OTOLARYNGOL, V120, P1329	17	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0196-0709	1532-818X		AM J OTOLARYNG	Am. J. Otolaryngol.	MAR-APR	2015	36	2					153	157		10.1016/j.amjoto.2014.10.012		5	Otorhinolaryngology	Otorhinolaryngology	CB9FJ	WOS:000349937100007		
J	Abe, T; Ebara, T; Miyaura, K; Kumazaki, Y; Nakahira, M; Sugasawa, M; Shikama, N; Kato, S				Abe, Takanori; Ebara, Takeshi; Miyaura, Kazunori; Kumazaki, Yu; Nakahira, Mitsuhiko; Sugasawa, Masashi; Shikama, Naoto; Kato, Shingo			Malignant melanoma of the nasal cavity treated with stereotactic radiotherapy using CyberKnife: report of 2 cases	AMERICAN JOURNAL OF OTOLARYNGOLOGY			English	Article							MUCOSAL MELANOMA; NECK; HEAD; CANCER	Radiotherapy with high doses per fraction may have the potential to control radioresistant tumors, such as malignant melanoma. Here we report 2 cases with malignant melanoma of the nasal cavity treated with hypofractionated stereotactic radiotherapy using CyberKnife(R). (C) 2015 Elsevier Inc. All rights reserved.	[Abe, Takanori; Miyaura, Kazunori; Kumazaki, Yu; Shikama, Naoto; Kato, Shingo] Saitama Med Univ, Int Med Ctr, Dept Radiat Oncol, Hidaka, Saitama 3501298, Japan; [Ebara, Takeshi] Gunma Prefectural Canc Ctr, Ohta, Gumma, Japan; [Nakahira, Mitsuhiko; Sugasawa, Masashi] Saitama Med Univ, Int Med Ctr, Dept Otolaryngol, Hidaka, Saitama 3501298, Japan	Abe, T (reprint author), Saitama Med Univ, Int Med Ctr, Dept Radiat Oncol, Yamane 1397-1, Hidaka, Saitama 3501298, Japan.	mrtaka100@yahoo.co.jp					Temam S, 2005, CANCER, V103, P313, DOI 10.1002/cncr.20775; Yanagi T, 2009, INT J RADIAT ONCOL, V74, P15, DOI 10.1016/j.ijrobp.2008.07.056; OVERGAARD J, 1986, RADIOTHER ONCOL, V5, P183, DOI 10.1016/S0167-8140(86)80048-2; Krengli M, 2006, INT J RADIAT ONCOL, V65, P751, DOI 10.1016/j.ijropb.2006.01.016; Patel SG, 2002, HEAD NECK-J SCI SPEC, V24, P247, DOI 10.1002/hed.10019; Timmerman RD, 2008, SEMIN RADIAT ONCOL, V18, P215, DOI 10.1016/j.semradonc.2008.04.001; SAUSE WT, 1991, INT J RADIAT ONCOL, V20, P429; Wada H, 2004, INT J RADIAT ONCOL, V59, P495, DOI 10.1016/j.ijrobp.2003.11.013; GILLIGAN D, 1991, BRIT J RADIOL, V64, P1147; Wagner M, 2008, AM J CLIN ONCOL-CANC, V31, P43, DOI 10.1097/COC.0b013e318134ee88; Lee N, 2002, INT J RADIAT ONCOL, V53, P630, DOI 10.1016/S0360-3016(02)02756-6; Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G; FOWLER JF, 1989, BRIT J RADIOL, V62, P679; Levendag PC, 2002, RADIOTHER ONCOL, V63, P67, DOI 10.1016/S0167-8140(02)00008-7; OVERGAARD J, 1986, INT J RADIAT ONCOL, V12, P867; Ozyigit G, 2013, HEAD NECK-J SCI SPEC, V35, P69	16	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0196-0709	1532-818X		AM J OTOLARYNG	Am. J. Otolaryngol.	MAR-APR	2015	36	2					306	309		10.1016/j.amjoto.2014.11.010		4	Otorhinolaryngology	Otorhinolaryngology	CB9FJ	WOS:000349937100039		
J	Mizutani, K; Sonoda, S; Wakita, H; Shimpo, K				Mizutani, Kenmei; Sonoda, Shigeru; Wakita, Hideaki; Shimpo, Kan			Protein Kinase C Activator, Bryostatin-1, Promotes Exercise-Dependent Functional Recovery in Rats with Cerebral Infarction	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Bryostatin-1; Stroke Rehabilitation; Exercise; Neuronal Plasticity; Protein Kinase C	SYNAPTIC PLASTICITY; VOLUNTARY EXERCISE; STROKE; EXPRESSION; INDUCTION; GROWTH	Recently, it has become widely known that neuronal reorganization in the perilesional cortex contributes to some improvement of hemiparesis after stroke. Here, the authors examined in vivo the effects of administration of bryostatin-1, an activator of protein kinase C, combined with voluntary exercise on functional recovery and on cortical phosphorylation of -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor subunit GluR1 after infarction. In behavioral evaluation, the mean latency until falling from a rotating rod in the group with exercise and administered agent at 8 days after infarction was significantly longer than that in the other groups. Although there were no significant changes in GluR1 phosphorylation between bryostatin-1 administration alone and the untreated groups, exercise induced an increase in phosphorylated-Ser845-GluR1. Moreover, combining exercise with administration led to increased phosphorylated-Ser831-GluR1. These results suggest that bryostatin-1 facilitated exercise-induced paralysis recovery, which is possibly mediated by synaptic plasticity related to an increase in synaptic transmission efficiency.	[Mizutani, Kenmei; Sonoda, Shigeru; Shimpo, Kan] Fujita Hlth Univ, Div Biochem, Fujita Mem Nanakuri Inst, Tsu, Mie 5141296, Japan; [Wakita, Hideaki] Fujita Hlth Univ, Dept Internal Med, Nanakuri Sanat, Tsu, Mie 5141296, Japan	Mizutani, K (reprint author), Fujita Hlth Univ, Div Biochem, Fujita Mem Nanakuri Inst, 423 Oodoricho, Tsu, Mie 5141296, Japan.				Japan Society for the Promotion of Science KAKENHI [23700642, 26350596]	Disclosures: Supported by Japan Society for the Promotion of Science KAKENHI grant numbers 23700642 and 26350596. Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.	Kawahira K, 2010, BRAIN INJURY, V24, P1202, DOI 10.3109/02699052.2010.506855; Lykissas MG, 2007, CURR NEUROVASC RES, V4, P143, DOI 10.2174/156720207780637216; Liepert J, 2000, STROKE, V31, P1210; Johansson BB, 2000, STROKE, V31, P223; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; Mizutani K, 2011, BRAIN RES, V1416, P61, DOI 10.1016/j.brainres.2011.08.012; Lee HK, 2000, NATURE, V405, P955; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Etcheberrigaray R, 2004, P NATL ACAD SCI USA, V101, P11141, DOI 10.1073/pnas.0403921101; Sun MK, 2008, P NATL ACAD SCI USA, V105, P13620, DOI 10.1073/pnas.0805952105; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Brown CE, 2008, STROKE, V39, P1286, DOI 10.1161/STROKEAHA.107.498238; Mizutani K, 2013, NEUROL SCI, V34, P861, DOI 10.1007/s10072-012-1137-3; Mizutani K, 2014, NEUROL SCI, V35, P53, DOI 10.1007/s10072-013-1477-7; Paxinos G, 1998, RAT BRAIN STEREOTAXI; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAR	2015	94	3					239	243		10.1097/PHM.0000000000000227		5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CC2VT	WOS:000350203500008		
J	Taniguchi, H				Taniguchi, Haruka			How the Physical Properties of Food Influence Its Selection by Infant Japanese Macaques Inhabiting a Snow-Covered Area	AMERICAN JOURNAL OF PRIMATOLOGY			English	Article						food characteristics; food access and processing; bite force; relative feeding index; age differences	MONKEYS MACACA-FUSCATA; CAPUCHINS CEBUS-APELLA; FEEDING-BEHAVIOR; AGE-DIFFERENCES; RHESUS-MONKEYS; PRIMATES; ONTOGENY; JUVENILE; FOREST; FRUIT	Dietary differences exist between infant and adult female non-human primates. These differences are considered to be related to the low ability of infants to bite, handle, and obtain food items. This study aimed to provide a comprehensive examination of how the physical properties of food items (fracture toughness, size, processing, and height) influence food selection by infant primates. In this study, four mother-infant Japanese macaque (Macaca fuscata) pairs were investigated in a snow-covered area during winter. The feeding behavior of both mothers and infants was recorded. The size, need for processing, and height of food items were recorded by direct observation, while the fracture toughness of food items (evaluating the required bite force by incisors) was measured using a rheometer. On average, infants spent 14% less time feeding than their mothers, and there were dietary differences between mothers and infants. Compared to their mothers, infants fed relatively more frequently on food items that were small, at a low position, or that could be consumed without processing. In addition, infants spent less time feeding on food items that were tougher than 2,000J/m(2). Thus, infants fed relatively more frequently on food items that are easy to obtain. This food selection by infants reduced the costs of feeding and allowed them to avoid falling from high trees. Am. J. Primatol. 77:285-295, 2015. (c) 2014 Wiley Periodicals, Inc.	Kyoto Univ, Grad Sch Sci, Lab Human Evolut, Kyoto, Japan	Taniguchi, H (reprint author), Kyoto Univ, Grad Sch Sci, Lab Human Evolut, Kyoto, Japan.	haruka@jinrui.zool.kyoto-u.ac.jp					Altmann J, 1974, BEHAVIOUR, V49, P3, DOI DOI 10.1163/156853974X00534; Altmann J, 1980, BABOON MOTHERS INFAN; McGraw WS, 2011, AM J PHYS ANTHROPOL, V144, P140, DOI 10.1002/ajpa.21402; Wright B, 2008, INT J PRIMATOL, V29, P1455, DOI 10.1007/s10764-008-9294-1; VANSCHAIK CP, 1986, BEHAVIOUR, V99, P296, DOI 10.1163/156853986X00595; WATANUKI Y, 1993, PRIMATES, V34, P419, DOI 10.1007/BF02382651; Gunst N, 2010, AM J PRIMATOL, V72, P960, DOI 10.1002/ajp.20856; Johnson SE, 2004, HUM NATURE-INT BIOS, V15, P45, DOI 10.1007/s12110-004-1003-y; Stone AI, 2006, ETHOLOGY, V112, P105, DOI 10.1111/j.1439-0310.2005.01121.x; Jaeggi AV, 2010, AM J PRIMATOL, V72, P62, DOI 10.1002/ajp.20752; Norconk MA, 2011, ANAT REC, V294, P2092, DOI 10.1002/ar.21506; DECHOW PC, 1990, AM J PHYS ANTHROPOL, V83, P219, DOI 10.1002/ajpa.1330830211; Vogel ER, 2008, J HUM EVOL, V55, P60, DOI 10.1016/j.jhevol.2007.12.005; Nakamichi M, 1998, FOLIA PRIMATOL, V69, P35; OFTEDAL OT, 1991, PHILOS T ROY SOC B, V334, P161, DOI 10.1098/rstb.1991.0105; Gunst N, 2008, BEHAVIOUR, V145, P195, DOI 10.1163/156853907783244701; Rapaport LG, 2008, EVOL ANTHROPOL, V17, P189, DOI 10.1002/evan.20180; WRANGHAM RW, 1993, INT J PRIMATOL, V14, P243, DOI 10.1007/BF02192634; DEROUSSEAU CJ, 1983, AM J PHYS ANTHROPOL, V61, P483, DOI 10.1002/ajpa.1330610411; Tarnaud L, 2004, INT J PRIMATOL, V25, P803, DOI 10.1023/B:IJOP.0000029123.78167.63; Burnham K. P., 2002, MODEL SELECTION MULT; Chalmers N, 1972, PRIMATE SOCIALIZATIO, P63; Dunbar DC, 1998, NEUROSCI BIOBEHAV R, V22, P541, DOI 10.1016/S0149-7634(97)00042-0; HAMADA Y, 1983, J ANTHROPOL SOC NIP, V91, P347; HAMADA Y, 1982, Primates, V23, P542, DOI 10.1007/BF02373965; Hanya G, 2003, PRIMATES, V44, P333, DOI 10.1007/s10329-003-0047-7; HIKAMI K, 1990, J COMP PSYCHOL, V104, P233, DOI 10.1037//0735-7036.104.3.233; Hill DA, 1996, AM J PRIMATOL, V38, P221; Ichihara K, 1990, STAT BIOSCIENCE PRAC; ISHIDA H, 1972, Journal of the Anthropological Society of Nippon, V80, P125; IWAMOTO M, 1984, J ANTHROPOL SOC NIP, V92, P273; Iwamoto M., 1987, PRIMATE RES, V3, P18; Iwamoto M., 1977, Journal anthrop. Soc. Nippon, V85, P281; IWAMOTO T, 1982, Primates, V23, P153, DOI 10.1007/BF02381158; Janson Charles H., 1993, P57; Kanuma K, 2000, SHIMOKITA PENINSULA, P25; KARSSEMEIJER GJ, 1990, BEHAVIOUR, V113, P273, DOI 10.1163/156853990X00527; KINZEY WG, 1990, AM J PHYS ANTHROPOL, V81, P5, DOI 10.1002/ajpa.1330810103; Montgomery D. C., 2001, INTRO LINEAR REGRESS; Nakagawa N, 1997, AM J PRIMATOL, V41, P267, DOI 10.1002/(SICI)1098-2345(1997)41:4<267::AID-AJP1>3.0.CO;2-V; Nakagawa N, 2010, JAPANESE MACAQUES, P1, DOI 10.1007/978-4-431-53886-8; Nakagawa Naofumi, 2008, Mammal Study, V33, P157, DOI 10.3106/1348-6160-33.4.157; NAKAGAWA N, 1989, PRIMATES, V30, P441, DOI 10.1007/BF02380873; Nakayama Y, 1999, ECOL RES, V14, P291, DOI 10.1046/j.1440-1703.1999.143306.x; Nowell AA, 2008, BEHAVIOUR, V145, P171, DOI 10.1163/156853907783244747; RHINE RJ, 1978, FOLIA PRIMATOL, V30, P64, DOI 10.1159/000155855; SHIPLEY LA, 1994, AM NAT, V143, P1055, DOI 10.1086/285648; Sussman R. W., 1977, P515; Suzuki A., 1965, Primates, V6, P31, DOI 10.1007/BF01794458; TANAKA I, 1992, ANIM BEHAV, V44, P129, DOI 10.1016/S0003-3472(05)80762-6; Tarnaud L, 2008, AM J PRIMATOL, V70, P1103, DOI 10.1002/ajp.20603; Ueno A, 2005, INFANT BEHAV DEV, V28, P481, DOI 10.1016/j.infbeh.2005.04.001; Vogel ER, J HUMAN EVO IN PRESS; Wells JP, 2001, AM J PHYS ANTHROPOL, V115, P80, DOI 10.1002/ajpa.1059	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0275-2565	1098-2345		AM J PRIMATOL	Am. J. Primatol.	MAR	2015	77	3					285	295		10.1002/ajp.22344		11	Zoology	Zoology	CB8OU	WOS:000349891000006		
J	Koops, K; Schoning, C; McGrew, WC; Matsuzawa, T				Koops, Kathelijne; Schoening, Caspar; McGrew, William C.; Matsuzawa, Tetsuro			Chimpanzees Prey on Army Ants at Seringbara, Nimba Mountains, Guinea: Predation Patterns and Tool Use Characteristics	AMERICAN JOURNAL OF PRIMATOLOGY			English	Article						insectivory; tool use; army ants; chimpanzee; ant dip	PAN-TROGLODYTES-TROGLODYTES; WILD CHIMPANZEES; SOUTHEAST CAMEROON; OBTAIN TERMITES; WEST-AFRICA; FOREST; CONGO; EVOLUTION; INSIGHTS; SET	Chimpanzees are renowned for their use of foraging tools in harvesting social insects and some populations use tools to prey on aggressive army ants (Dorylus spp.). Tool use in army ant predation varies across chimpanzee study sites with differences in tool length, harvesting technique, and army ant species targeted. However, surprisingly little is known about the detailed ecology of army ant predation. We studied army ant predation by chimpanzees (Pan troglodytes verus) at the Seringbara study site in the Nimba Mountains, Guinea (West Africa), over 10 years (2003-2013). We investigated chimpanzee selectivity with regards to army ant prey species. We assessed the temporal variation in army ant-feeding and examined whether army ant predation was related to rainfall or ripe fruit availability. Moreover, we examined whether chimpanzees showed selectivity regarding plant species used for tool manufacture, as well as the relationship between tool species preference and tool collection distance. Lastly, we measured tool properties and investigated the use of tool sets and composite tools in army ant predation. Seringbara chimpanzees preyed on one army ant species (D. nigricans) more often than expected based on encounter rates, which may be explained by the overlap in altitudinal distribution between chimpanzees and D. nigricans. Army ant predation was not related to rainfall or fruit availability. Chimpanzees were selective in their choice of tool materials and collected their preferred tool species (Alchornea hirtella) from greater distances than they did other species. Lastly, Seringbara chimpanzees used both tool sets and composite tools (tree perch) in army ant predation. Tool types (dig vs. dip) differed in width and strength, but not length. Tool composites were found at 40% of ant-feeding sites. Our study sheds new light on the ecology of army ant predation and provides novel insights into chimpanzee selection of army ant prey and tool species. Am. J. Primatol. 77:319-329, 2015. (c) 2014 Wiley Periodicals, Inc.	[Koops, Kathelijne; McGrew, William C.] Univ Cambridge, Dept Archaeol & Anthropol, Div Biol Anthropol, Cambridge CB2 1QH, England; [Schoening, Caspar] Free Univ Berlin, Arbeitsgrp Funkt Biodiversitat, Inst Biol, Berlin, Germany; [Matsuzawa, Tetsuro] Kyoto Univ, Primate Res Inst, Kyoto, Aichi 6068501, Japan	Koops, K (reprint author), Univ Cambridge, Dept Archaeol & Anthropol, Div Biol Anthropol, Henry Wellcome Bldg,Fitzwilliam St, Cambridge CB2 1QH, England.	kk370@cam.ac.uk					MCGREW WC, 1974, J HUM EVOL, V3, P501, DOI 10.1016/0047-2484(74)90010-4; Hashimoto C, 2000, PRIMATES, V41, P103, DOI 10.1007/BF02557466; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Humle T, 2002, AM J PRIMATOL, V58, P133, DOI 10.1002/ajp.10055; Sanz CM, 2007, J HUM EVOL, V52, P420, DOI 10.1016/j.jhevol.2006.11.001; Schoning C, 2008, J HUM EVOL, V55, P48, DOI 10.1016/j.jhevol.2007.12.002; MCBEATH NM, 1982, J HUM EVOL, V11, P65, DOI 10.1016/S0047-2484(82)80032-8; Rothman JM, 2014, J HUM EVOL, V71, P59, DOI 10.1016/j.jhevol.2014.02.016; Pascual-Garrido A, 2012, FOLIA PRIMATOL, V83, P24, DOI 10.1159/000338898; Koops K, 2013, ANIM BEHAV, V85, P175, DOI 10.1016/j.anbehav.2012.10.022; McGrew WC, 2009, PRIMATES, V50, P363, DOI 10.1007/s10329-009-0148-z; Takemoto H, 2004, AM J PHYS ANTHROPOL, V124, P81, DOI 10.1002/ajpa.10342; McGrew WC, 2014, J HUM EVOL, V71, P4, DOI [10.1016/j.jhevol.2013.07.016, 10.1016/j.jhevol.2013.67.016]; Schoning C, 2005, OIKOS, V110, P231, DOI 10.1111/j.0030-1299.2005.13672.x; BREWER SM, 1990, FOLIA PRIMATOL, V54, P100, DOI 10.1159/000156429; Sanz CM, 2009, INT J PRIMATOL, V30, P411, DOI 10.1007/s10764-009-9350-5; Hicks TC, 2005, AM J PRIMATOL, V65, P221, DOI 10.1002/ajp.20111; McGrew WC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0422; Boesch C, 2009, J HUM EVOL, V56, P560, DOI 10.1016/j.jhevol.2009.04.001; Mobius Y, 2008, ANIM BEHAV, V76, P37, DOI 10.1016/j.anbehav.2008.01.008; SUGIYAMA Y, 1995, PRIMATES, V36, P193, DOI 10.1007/BF02381345; Sanz C, 2004, AM NAT, V164, P567, DOI 10.1086/424803; BOESCH C, 1990, FOLIA PRIMATOL, V54, P86, DOI 10.1159/000156428; Deblauwe I, 2006, AM J PRIMATOL, V68, P1191, DOI 10.1002/ajp.20318; Deblauwe I, 2008, AM J PHYS ANTHROPOL, V135, P42, DOI 10.1002/ajpa.20703; Field A, 2005, DISCOVERING STAT USI; Humle T, 2001, FOLIA PRIMATOL, V72, P57, DOI 10.1159/000049924; Koops K, 2011, PRIMATOL MONOGR, P277, DOI 10.1007/978-4-431-53921-6_29; Matsuzawa Tetsuro, 1996, P211; Matsuzawa T, 2011, PRIMATOL MONOGR, P1, DOI 10.1007/978-4-431-53921-6; McGrew William C., 2001, P160; McGrew WC, 2007, INT J PRIMATOL, V28, P1237, DOI 10.1007/s10764-007-9215-8; MCGREW WC, 1983, AM J PRIMATOL, V5, P171, DOI 10.1002/ajp.1350050207; McGrew WC, 1992, CHIMPANZEE MAT CULTU; Pascual-Garrido A, 2013, AM J PRIMATOL, V75, P1231, DOI 10.1002/ajp.22187; Peters MK, 2009, BIOL CONSERV, V142, P668, DOI 10.1016/j.biocon.2008.11.021; Sanz CM, 2010, AM J PRIMATOL, V72, P17, DOI 10.1002/ajp.20744; Schoning C, 2008, ZOOTAXA, P39; Schoning C, 2007, J ZOOL, V271, P125, DOI 10.1111/j.1469-7998.2006.00177.x; Shimada MK, 2000, PAN AFRICA NEWS, V7, P7; Shumaker RW, 2011, ANIMAL TOOL BEHAV US; SUZUKI S, 1995, BEHAVIOUR, V132, P219, DOI 10.1163/156853995X00711	42	3	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0275-2565	1098-2345		AM J PRIMATOL	Am. J. Primatol.	MAR	2015	77	3					319	329		10.1002/ajp.22347		11	Zoology	Zoology	CB8OU	WOS:000349891000009		
J	Sakamoto, K; Nasu, H; Nimura, A; Hamada, J; Akita, K				Sakamoto, Kazuaki; Nasu, Hisayo; Nimura, Akimoto; Hamada, Junichiro; Akita, Keiichi			An anatomic study of the structure and innervation of the pronator quadratus muscle	ANATOMICAL SCIENCE INTERNATIONAL			English	Article						Pronator quadratus muscle; Superficial head; Deep head; Anterior interosseous nerve	ANTERIOR INTEROSSEOUS NERVE; WRIST DENERVATION	The pronator quadratus muscle is composed of the superficial and deep heads. However, to date there is no consensus on the variations of each head. To add to this enigma, the innervation patterns of each head have not been thoroughly studied. The present study was conducted to clarify the structure and innervation of the pronator quadratus muscle by minute dissection of 46 forearms from 26 cadavers. The origin, insertion, shape, and direction of the muscle fascicles in each head were observed. The intramuscular distribution and the innervation patterns to each head were investigated. The attachment of the deep head was examined using Masson's trichrome staining technique. Each head consisted of various muscle fascicles which differed in shape and direction. The most distal muscle fascicle extended toward the head of the ulna. On microscopic study, this most distal fascicle was observed to reach the base of the ulnar styloid process. The nerves innervating the superficial head penetrated through the deep head and ran on the anterior surface of the radius from medial to lateral. This tendency was common to all of the forearms studied. We confirmed that each head of the pronator quadratus muscle consisted of various muscle fascicles. The attachment to the base of the ulnar styloid process is considered to be an important structure that prevents the head of the ulna from impacting against the carpal bones. Knowledge of the innervation pattern to each head is critical for preserving the function of the pronator quadratus muscle during surgery for distal radial fracture.	[Sakamoto, Kazuaki; Nasu, Hisayo; Nimura, Akimoto; Akita, Keiichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Clin Anat, Bunkyo Ku, Tokyo 1138510, Japan; [Sakamoto, Kazuaki; Hamada, Junichiro] Kuwano Kyoritsu Hosp, Dept Orthoped Surg, Fukushima, Japan	Akita, K (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Clin Anat, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	akita.fana@tmd.ac.jp					FUKUMOTO K, 1993, J HAND SURG-AM, V18A, P484, DOI 10.1016/0363-5023(93)90096-L; Gordon KD, 2004, J ORTHOPAED RES, V22, P208, DOI 10.1016/S0736-0266(03)00115-3; Stuart PR, 1996, J HAND SURG-BRIT EUR, V21B, P714, DOI 10.1016/S0266-7681(96)80175-6; Sachar K, 2012, J HAND SURG-AM, V37A, P1489, DOI 10.1016/j.jhsa.2012.04.036; Imatani J, 2005, J HAND SURG-BRIT EUR, V30B, P220, DOI 10.1016/j.jhsb.2004.12.009; Bergmann R., 1988, MIOP '88: Microwaves and Optoelectronics. Conference Proceedings; Frohse F, 1908, MUSKELN MENSCHLICHEN, P147; Grafe MW, 2005, J HAND SURG-AM, V30A, P1221, DOI 10.1016/j.jhsa.2005.06.010; Johnson R K, 1976, J Hand Surg Am, V1, P205; Koebke VJ, 1984, ANAT ANZEIGER, V157, P311; Lin DL, 2006, J HAND SURG-AM, V31A, P904, DOI 10.1016/j.jhsa.2006.02.028; Rauber K, 1929, LEHRBUCH ATLAS ANATM, P126; Svizenska I, 2005, J HAND SURG-BRIT EUR, V30B, P635, DOI 10.1016/j.jhsb.2005.06.017; WILHELM A, 1958, Z Anat Entwicklungsgesch, V120, P331, DOI 10.1007/BF00525089	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1447-6959	1447-073X		ANAT SCI INT	Anat. Sci. Int.	MAR	2015	90	2					82	88		10.1007/s12565-014-0234-1		7	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	CB8WK	WOS:000349912500003		
J	Kakegawa, A; Yokouchi, K; Itsubo, T; Kawagishi, K; Karasawa, M; Moriizumi, T; Fukushima, N				Kakegawa, Akira; Yokouchi, Kumiko; Itsubo, Toshiro; Kawagishi, Kyutaro; Karasawa, Mika; Moriizumi, Tetsuji; Fukushima, Nanae			Correlation between motor function and axonal morphology in neonatally sciatic nerve-injured rats	ANATOMICAL SCIENCE INTERNATIONAL			English	Article						Axonal morphology; Crush injury; Motor function; Neonatal rats; Sciatic nerve	CRUSH INJURIES; NEURONS; REGENERATION; LESIONS; RECOVERY; NUMBERS; BRANCH; DEATH	The present study was conducted to investigate the correlation between motor function and axonal morphology in neonatally sciatic nerve-injured rats. The left sciatic nerve of newborn rats was transected or crushed, and functionality of the sciatic nerve was assessed by the static sciatic index after 8 weeks. After functional assessment, the common peroneal nerves in the control, nerve-transected, and nerve-crushed rats were removed and prepared for morphometric examinations. The cross-sectional area of the nerve, total number of myelinated axons, and size of each myelinated axon were analyzed for each group. The control rats showed normal motor function, whereas the nerve-transected rats showed severe motor dysfunction. The cross-sectional area of the nerve and total number of myelinated axons were reduced after nerve transection. Moreover, the percentage per size class of myelinated axons was almost uniform in the control rats, while the distribution was shifted to the left in the nerve-transected rats. Furthermore, no large myelinated axons were observed in the nerve-transected rats. The nerve-crushed rats showed various gait functions with various distribution patterns of axonal size, and the rats were divided into two groups with and without uninjured residual large axons. The results showed that the importance of regenerated medium-sized axons in cases without large axons and of residual large axons in cases with large axons in motor function. It was revealed that motor function was related closely to axonal size in neonatally nerve-injured rats.	[Kakegawa, Akira; Yokouchi, Kumiko; Kawagishi, Kyutaro; Karasawa, Mika; Moriizumi, Tetsuji; Fukushima, Nanae] Shinshu Univ, Sch Med, Dept Anat, Matsumoto, Nagano 3908621, Japan; [Kakegawa, Akira] Teikyo Heisei Univ, Fac Hlth Care, Dept Judo Phys Therapy, Tokyo, Japan; [Itsubo, Toshiro] Shinshu Univ, Sch Med, Dept Orthopaed Surg, Matsumoto, Nagano 3908621, Japan	Fukushima, N (reprint author), Shinshu Univ, Sch Med, Dept Anat, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	nanae@shinshu-u.ac.jp					Mazzer PYCN, 2008, J NEUROSCI METH, V173, P249, DOI 10.1016/j.jneumeth.2008.06.019; Varejao ASP, 2001, MICROSURG, V21, P383, DOI 10.1002/micr.21803; Bervar M, 2000, J NEUROSCI METH, V102, P109, DOI 10.1016/S0165-0270(00)00281-8; Luis AL, 2007, J NEUROSCI METH, V163, P92, DOI 10.1016/j.jneumeth.2007.02.017; BONDOK AA, 1984, EXP NEUROL, V86, P322, DOI 10.1016/0014-4886(84)90190-0; Higashiyama F, 2005, J NEUROSURG, V102, P390; Itsubo T, 2012, NEUROL RES, V34, P908, DOI 10.1179/1743132812Y.0000000089; JENQ CB, 1987, BRAIN RES, V409, P250, DOI 10.1016/0006-8993(87)90709-8; JENQ CB, 1988, BRAIN RES, V457, P63, DOI 10.1016/0006-8993(88)90057-1; JENQ CB, 1985, NEUROSCI LETT, V61, P43, DOI 10.1016/0304-3940(85)90398-2; JENQ CB, 1987, EXP NEUROL, V95, P492, DOI 10.1016/0014-4886(87)90155-5; Kakegawa A, 2006, NEUROREPORT, V17, P1149, DOI 10.1097/01.wnr.0000230502.47973.fe; Koyama J, 2003, NEUROL RES, V25, P701, DOI 10.1179/016164103101202192; Koyama J, 2003, NEUROSCI RES, V46, P85, DOI 10.1016/S0168-0102(03)00033-6; POVLSEN B, 1994, RESTOR NEUROL NEUROS, V7, P21, DOI 10.3233/RNN-1994-7104; POVLSEN B, 1993, J NEUROL SCI, V120, P153, DOI 10.1016/0022-510X(93)90267-3; SCHMALBRUCH H, 1984, J COMP NEUROL, V224, P252, DOI 10.1002/cne.902240206; SNIDER WD, 1992, J NEUROBIOL, V23, P1231, DOI 10.1002/neu.480230913; Varejao AS, 2001, J NEUROSCI METH, V15, P1	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1447-6959	1447-073X		ANAT SCI INT	Anat. Sci. Int.	MAR	2015	90	2					97	103		10.1007/s12565-014-0236-z		7	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	CB8WK	WOS:000349912500005		
J	Tsutsumi, M; Arakawa, T; Terashima, T; Miki, A				Tsutsumi, Masahiro; Arakawa, Takamitsu; Terashima, Toshio; Miki, Akinori			Intramuscular nerve distribution pattern in the human tibialis posterior muscle	ANATOMICAL SCIENCE INTERNATIONAL			English	Article						Intramuscular tendon; Macroscopic anatomy; Morphogenesis; Posterior tibial muscle; Tibial nerve	HUMAN FOOT; RAMIFICATION PATTERN; DEEP BRANCH; TENDON	The human tibialis posterior muscle (TPM) has developed to maintain the foot arches for adopting bipedal locomotion. The insertion tendon of this muscle is U-shaped in a cross section, and the fibular part of the muscle whose muscle fibers originated from the fibula has a unique architecture. To understand the developmental history of the human TPM, distribution pattern of intramuscular nerves was investigated in ten sides of eight cadavers. Muscular branches entering the TPM could be classified into five types according to the distribution pattern in the muscle. The nerves innervating the part deeper to the insertion tendon ran transversely in the medial direction toward the tibia. Muscular branches innervating the fibular part ran medioinferiorly, and in four cases had communicating rami with the nerve innervating the other parts of this muscle. Muscular branches innervating the superficial layer whose muscle bundles originated from the tibia ran laterally toward the fibula. These results suggest that the fibular part might develop from the common primordium of the TPM, and the deeper layer of the muscle might expand laterally during the development to acquire a new attaching space on the interosseous membrane and fibula. The superficial layer might also develop laterally to acquire the additional attaching spaces on the fascia of the flexor digitorum longus muscle and flexor hallucis longus muscle, thus the insertion tendon might become U-shaped. With these measures, the TPM might be able to increase muscle volume to yield stronger power.	[Tsutsumi, Masahiro; Arakawa, Takamitsu; Miki, Akinori] Kobe Univ, Dept Rehabil Sci, Grad Sch Hlth Sci, Suma Ku, Kobe, Hyogo 6540142, Japan; [Terashima, Toshio] Kobe Univ, Div Dev Neurobiol, Dept Physiol & Cell Biol, Grad Sch Med,Chuo Ku, Kobe, Hyogo 6500017, Japan	Arakawa, T (reprint author), Kobe Univ, Dept Rehabil Sci, Grad Sch Hlth Sci, Suma Ku, 7-10-2 Tomogaoka, Kobe, Hyogo 6540142, Japan.	arakawa@people.kobe-u.ac.jp			JSPS KAKENHI [21700530, 22500460]; Mitsui Life Social Welfare Foundation	The authors are grateful for the technical assistance of Dr T. Setsu and Mr Y. Sakihama. We also thank members of Division of Developmental Neurobiology, Department of Physiology and Cell Biology, Kobe University Graduate School of Medicine. Financial support for this study was provided by JSPS KAKENHI Grant Numbers 21700530, 22500460 and by a grant from the Mitsui Life Social Welfare Foundation.	AKITA K, 1994, ACTA ANAT, V149, P225; AKITA K, 1993, J ANAT, V182, P433; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; Arangio GA, 2009, CLIN BIOMECH, V24, P385, DOI 10.1016/j.clinbiomech.2009.01.009; Morton DJ, 1924, J BONE JOINT SURG, V6, P56; Arakawa T, 2006, ANAT SCI INT, V81, P187, DOI 10.1111/j.1447-073x.2006.00143.x; Arakawa T, 2005, ANN ANAT, V187, P287, DOI 10.1016/j.aanat.2005.02.009; Bardeen CR, 1906, AM J ANAT, V6, P256; Brathnach AS, 1965, FRAZERS ANATOMY HUMA; DECLAU F, 1988, ARCH OTO-RHINO-LARYN, V245, P218, DOI 10.1007/BF00463930; Frohse F, 1913, HDB ANATOMIE MENSC 2, V2, P573; Gustavson K. H., 1956, CHEM REACTIVITY COLL; Harrison RJ, 1972, CUNNINGHAMS TXB ANAT, P168; HOMMA T, 1991, ACTA ANAT, V141, P139; Howell AB, 1938, J MORPHOL, V62, P177, DOI 10.1002/jmor.1050620203; Klenerman L, 2006, HUMAN FOOT COMPANION, P27; Kodama K, 1986, Kaibogaku Zasshi, V61, P107; KOIZUMI M, 1995, J ANAT, V186, P395; KUMAKI K, 1970, Acta Anatomica Nipponica, V45, P311; LANGDON JH, 1990, INT J PRIMATOL, V11, P575, DOI 10.1007/BF02197058; Lee JH, 2011, CLIN ANAT, V24, P91, DOI 10.1002/ca.21062; LEWIS OJ, 1964, J ANAT, V98, P209; Moore KL, 2013, CLIN ORIENTED ANATOM, P508; Morimoto I, 1983, ACTA ANAT NIPPON, V58, P74; Morton DJ, 1964, HUMAN FOOT ITS EVOLU; Neumann DA, 2009, KINESIOLOGY MUSCULOS, P573; Warwick R, 1973, GRAYS ANATOMY	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1447-6959	1447-073X		ANAT SCI INT	Anat. Sci. Int.	MAR	2015	90	2					104	112		10.1007/s12565-014-0237-y		9	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	CB8WK	WOS:000349912500006		
J	Hayashi, S; Hirai, S; Naito, M; Kawata, S; Qu, N; Hatayama, N; Terayama, H; Moriyama, H; Itoh, M				Hayashi, Shogo; Hirai, Shuichi; Naito, Munekazu; Kawata, Shinichi; Qu, Ning; Hatayama, Naoyuki; Terayama, Hayato; Moriyama, Hiroshi; Itoh, Masahiro			Scimitar vein descending from the right inferior lobe to the inferior vena cava beneath the diaphragm: a rare case	ANATOMICAL SCIENCE INTERNATIONAL			English	Article						Pulmonary vein; Scimitar vein; Anomaly; Gross anatomy; Human	PULMONARY VENOUS RETURN; VARIANT; ANOMALIES; FORM	Scimitar syndrome is a rare anomaly involving a pulmonary vein flowing into the inferior vena cava (scimitar vein) and is commonly associated with lung hypoplasia wherein a scimitar vein drains the entire lung. We report a rare case of a scimitar vein draining only the right inferior lobe found in a 77-year-old male cadaver. In this case, no hypoplastic lung or abnormal lobulation were observed. The scimitar vein drained the inferior lobe of the right lung after piercing the diaphragm and draining into the inferior vena cava. The remaining two right pulmonary veins, draining the superior and middle lobes, terminated into the left atrium. To the best of our knowledge, this is the first report of a scimitar vein during gross anatomical dissection in an adult cadaver. In adults, scimitar veins are often benign, incidental findings, and little is known about them. The present case of a scimitar vein partially draining the lung without lung hypoplasia offers important insights into the formative processes of the pulmonary venous system.	[Hayashi, Shogo; Hirai, Shuichi; Naito, Munekazu; Kawata, Shinichi; Qu, Ning; Hatayama, Naoyuki; Itoh, Masahiro] Tokyo Med Univ, Dept Anat, Shinjuku Ku, Tokyo 1608402, Japan; [Terayama, Hayato] Tokai Univ, Sch Med, Dept Anat, Div Basic Med Sci, Hiratsuka, Kanagawa 25912, Japan; [Moriyama, Hiroshi] Showa Univ, Sch Med, Dept Anat, Tokyo 142, Japan	Hayashi, S (reprint author), Tokyo Med Univ, Dept Anat, Shinjuku Ku, Tokyo 1608402, Japan.	shogo@tokyo-med.ac.jp	Hayashi, Shogo/K-7268-2015	Hayashi, Shogo/0000-0003-0302-7658			DUPUIS C, 1992, AM J CARDIOL, V70, P502, DOI 10.1016/0002-9149(92)91198-D; MATHEY J, 1968, THORAX, V23, P398, DOI 10.1136/thx.23.4.398; TAKEDA S, 1994, CHEST, V105, P292, DOI 10.1378/chest.105.1.292; Bratincsak A, 2010, CONGENIT HEART DIS, V5, P174, DOI 10.1111/j.1747-0803.2010.00401.x; CUKIER A, 1994, CHEST, V105, P294, DOI 10.1378/chest.105.1.294; Gudjonsson U, 2006, SEMIN THORAC CARDIOV, V9, P56, DOI 10.1053/j.pcsu.2006.02.011; Korkmaz AA, 2011, J CARDIAC SURG, V26, P529, DOI 10.1111/j.1540-8191.2011.01309.x; Legras A, 2012, CHEST, V142, P1039, DOI 10.1378/chest.11-2732; Rodrigues MA, 2013, WORLD J RADIOL, V28, P215; Schoenwolf GC, 2009, LARSENS HUMAN EMBRYO, P385; Tortoriello TA, 2002, TEX HEART I J, V29, P319	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1447-6959	1447-073X		ANAT SCI INT	Anat. Sci. Int.	MAR	2015	90	2					123	125		10.1007/s12565-014-0230-5		3	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	CB8WK	WOS:000349912500008		
J	Kuroda, M; Ohta, J; Mita, N; Miyoshi, S; Kadoi, Y; Saito, S				Kuroda, Masataka; Ohta, Joe; Mita, Norikatsu; Miyoshi, Sohtaro; Kadoi, Yuji; Saito, Shigeru			Notch of the Anterior Leaflet of the Tricuspid Valve with Severe Tricuspid Regurgitation	ANESTHESIA AND ANALGESIA			English	Editorial Material							3-DIMENSIONAL TRANSESOPHAGEAL ECHOCARDIOGRAPHY; MITRAL-VALVE; CLEFT		[Kuroda, Masataka; Ohta, Joe; Kadoi, Yuji; Saito, Shigeru] Gunma Univ, Grad Sch Med, Dept Anesthesiol, Maebashi, Gumma 3718511, Japan; [Mita, Norikatsu; Miyoshi, Sohtaro] Saitama Prefectural Cardiovasc & Resp Ctr, Dept Anesthesiol, Kumagaya, Saitama, Japan	Kuroda, M (reprint author), Gunma Univ, Grad Sch Med, Dept Anesthesiol, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	m.kurohyou@gmail.com					SILVER MD, 1971, CIRCULATION, V43, P333; Lang RM, 2012, J AM SOC ECHOCARDIOG, V25, P3, DOI 10.1016/j.echo.2011.11.010; Cheng HL, 2012, ANESTH ANALG, V114, P731, DOI 10.1213/ANE.0b013e3182468db3; EICHHORN P, 1992, J AM COLL CARDIOL, V20, P1175; Motoyoshi N, 2001, ANN THORAC SURG, V71, P1350, DOI 10.1016/S0003-4975(00)02575-3; Townsley MM, 2010, ANESTH ANALG, V111, P1366, DOI 10.1213/ANE.0b013e3181f91c97	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	MAR	2015	120	3					576	579		10.1213/ANE.0000000000000570		4	Anesthesiology	Anesthesiology	CB8CM	WOS:000349856000015		
J	Okura, D; Horishita, T; Ueno, S; Yanagihara, N; Sudo, Y; Uezono, Y; Minami, T; Kawasaki, T; Sata, T				Okura, Dan; Horishita, Takafumi; Ueno, Susumu; Yanagihara, Nobuyuki; Sudo, Yuka; Uezono, Yasuhito; Minami, Tomoko; Kawasaki, Takashi; Sata, Takeyoshi			Lidocaine Preferentially Inhibits the Function of Purinergic P2X7 Receptors Expressed in Xenopus Oocytes	ANESTHESIA AND ANALGESIA			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; RAT SPINAL-CORD; NEUROPATHIC PAIN; LOCAL-ANESTHETICS; SYSTEMIC LIDOCAINE; P2X(7) RECEPTORS; SODIUM-CHANNELS; CYTOKINE PRODUCTION; ION-CHANNEL; PC12 CELLS	BACKGROUND: Lidocaine has been widely used to relieve acute pain and chronic refractory pain effectively by both systemic and local administration. Numerous studies reported that lidocaine affects several pain signaling pathways as well as voltage-gated sodium channels, suggesting the existence of multiple mechanisms underlying pain relief by lidocaine. Some extracellular adenosine triphosphate (ATP) receptor subunits are thought to play a role in chronic pain mechanisms, but there have been few studies on the effects of lidocaine on ATP receptors. We studied the effects of lidocaine on purinergic P2X3, P2X4, and P2X7 receptors to explore the mechanisms underlying pain-relieving effects of lidocaine. METHODS: We investigated the effects of lidocaine on ATP-induced currents in ATP receptor subunits, P2X3, P2X4, and P2X7 expressed in Xenopus oocytes, by using whole-cell, two-electrode, voltage-clamp techniques. RESULTS: Lidocaine inhibited ATP-induced currents in P2X7, but not in P2X3 or P2X4 subunits, in a concentration-dependent manner. The half maximal inhibitory concentration for lidocaine inhibition was 282 +/- 45 mu mol/L. By contrast, mepivacaine, ropivacaine, and bupivacaine exerted only limited effects on the P2X7 receptor. Lidocaine inhibited the ATP concentration-response curve for the P2X7 receptor via noncompetitive inhibition. Intracellular and extracellular N-(2,6-dimethylphenylcarbamoylmethyl) triethylammonium bromide (QX-314) and benzocaine suppressed ATP-induced currents in the P2X7 receptor in a concentration-dependent manner. In addition, repetitive ATP treatments at 5-minute intervals in the continuous presence of lidocaine revealed that lidocaine inhibition was use-dependent. Finally, the selective P2X7 receptor antagonists Brilliant Blue G and AZ11645373 did not affect the inhibitory actions of lidocaine on the P2X7 receptor. CONCLUSIONS: Lidocaine selectively inhibited the function of the P2X7 receptor expressed in Xenopus oocytes. This effect may be caused by acting on sites in the ion channel pore both extracellularly and intracellularly. These results help to understand the mechanisms underlying the analgesic effects of lidocaine when it is administered locally at least.	[Okura, Dan; Horishita, Takafumi; Minami, Tomoko; Kawasaki, Takashi; Sata, Takeyoshi] Univ Occupat & Environm Hlth, Sch Med, Dept Anesthesiol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Ueno, Susumu] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Occupat Toxicol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Yanagihara, Nobuyuki] Univ Occupat & Environm Hlth, Sch Med, Dept Pharmacol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Sudo, Yuka] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Mol Pathol & Metab Dis, Noda, Chiba 278, Japan; [Uezono, Yasuhito] Natl Canc Ctr, Canc Pathophysiol Div, Chuou Ku, Tokyo, Japan	Horishita, T (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Anesthesiol, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	thori@med.uoeh-u.ac.jp			Japan Society for the Promotion of Science [22591756]	Funding: This study was supported by a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science, 22591756 (to TS).	Abelson KSP, 2002, NEUROSCI LETT, V317, P93, DOI 10.1016/S0304-3940(01)02440-5; Andoh T, 1997, ANESTHESIOLOGY, V87, P1199, DOI 10.1097/00000542-199711000-00025; Lai J, 2003, CURR OPIN NEUROBIOL, V13, P291, DOI 10.1016/S0959-4388(03)00074-6; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Roberts JA, 2008, J BIOL CHEM, V283, P20126, DOI 10.1074/jbc.M800294200; Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; DEVULDER JER, 1993, CLIN J PAIN, V9, P220; Groudine SB, 1998, ANESTH ANALG, V86, P235, DOI 10.1097/00000539-199802000-00003; Browne LE, 2013, J NEUROSCI, V33, P3557, DOI 10.1523/JNEUROSCI.2235-12.2013; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Jiang LH, 2000, MOL PHARMACOL, V58, P82; Mao JR, 2000, PAIN, V87, P7, DOI 10.1016/S0304-3959(00)00229-3; Becker D, 2008, J BIOL CHEM, V283, P25725, DOI 10.1074/jbc.M803855200; Horishita T, 2008, ANESTH ANALG, V107, P1579, DOI 10.1213/ane.0b013e318184b966; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Hollmann MW, 2000, ANESTHESIOLOGY, V93, P858, DOI 10.1097/00000542-200009000-00038; Xiong ZL, 1998, EUR J PHARMACOL, V363, P81, DOI 10.1016/S0014-2999(98)00769-9; Ferrari D, 2006, J IMMUNOL, V176, P3877; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Clark AK, 2010, J NEUROSCI, V30, P573, DOI 10.1523/JNEUROSCI.3295-09.2010; Okura D, 2014, ANESTH ANALG, V118, P554, DOI 10.1213/ANE.0000000000000070; Stokes L, 2006, BRIT J PHARMACOL, V149, P880, DOI 10.1038/sj.bjp.0706933; BIELLA G, 1993, BRAIN RES, V603, P201, DOI 10.1016/0006-8993(93)91238-N; Amir R, 2006, J PAIN, V7, pS1, DOI 10.1016/j.jpain.2006.01.444; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; BRAU ME, 1995, J GEN PHYSIOL, V105, P485, DOI 10.1085/jgp.105.4.485; Buchanan DD, 2010, SUPPORT CARE CANCER, V18, P899, DOI 10.1007/s00520-010-0864-3; Cohen SP, 2003, ACTA ANAESTH SCAND, V47, P910, DOI 10.1034/j.1399-6576.2003.00163.x; COOKE ED, 1977, LANCET, V2, P797; de Klaver MJM, 2003, ANESTH ANALG, V97, P465, DOI 10.1213/01.ANE.0000073162.27208.E9; Eltzschig HK, 2013, ANESTHESIOLOGY, V118, P1001, DOI 10.1097/ALN.0b013e3182874686; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Furuya R, 1999, ANESTH ANALG, V88, P174, DOI 10.1097/00000539-199901000-00033; Gum RJ, 2012, PURINERG SIGNAL, V8, pS41, DOI 10.1007/s11302-011-9272-5; Hahnenkamp K, 2006, BRIT J ANAESTH, V96, P77, DOI 10.1093/bja/aei271; Hollmann MW, 2002, ANESTHESIOLOGY, V97, P1451, DOI 10.1097/00000542-200212000-00017; Honore P, 2002, PAIN, V99, P11, DOI 10.1016/S0304-3959(02)00032-5; Janig W, 2008, PAIN, V137, P5, DOI 10.1016/j.pain.2008.04.001; Lang PM, 2003, ANESTHESIOLOGY, V99, P232, DOI 10.1097/00000542-200307000-00038; Michel AD, 2006, EUR J PHARMACOL, V534, P19, DOI 10.1016/j.ejphar.2006.01.009; Nagata K., 2009, MOL PAIN, V23, P20; Nagy I, 1996, PAIN, V64, P59, DOI 10.1016/0304-3959(95)00072-0; Nakanishi M, 2007, ANESTH ANALG, V104, P1136, DOI 10.1213/01.ane.0000260615.12553.4e; Su DS, 2010, ANESTH ANALG, V111, P768, DOI 10.1213/ANE.0b013e3181e9e897; Xiao WH, 2008, PAIN, V137, P218, DOI 10.1016/j.pain.2008.02.018; Xiong KM, 2005, BRIT J PHARMACOL, V145, P576, DOI 10.1038/sj.bjp.0706192	54	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	MAR	2015	120	3					597	605		10.1213/ANE.0000000000000585		9	Anesthesiology	Anesthesiology	CB8CM	WOS:000349856000018		
J	Nagayama, K; Tomonari, H; Kitashima, F; Miyawaki, S				Nagayama, Kunihiro; Tomonari, Hiroshi; Kitashima, Fumiaki; Miyawaki, Shouichi			Extraction treatment of a Class II division 2 malocclusion with mandibular posterior discrepancy and changes in stomatognathic function	ANGLE ORTHODONTIST			English	Article						Class II division 2; Posterior discrepancy; Stomatognathic function; Lip bumper	ORTHODONTIC TREATMENT; CHEWING PATTERN; JAW MOVEMENTS; OPEN BITE; CROSSBITE; ANTERIOR; CHILDREN; FORCES; MOTION	This case report describes the successful extraction treatment of a Class II division 2 malocclusion with mandibular posterior discrepancy and a congenitally missing maxillary lateral incisor on the left side. The posterior space in the mandibular arch was small, and the mandibular second molars were impacted, with distal tipping. The discrepancies in the maxillary and mandibular arches were resolved by extraction of the maxillary lateral incisor on the right side and the mandibular second premolars on both sides. The mesial movement of the mandibular first molars occurred appropriately, with the second molars moving into an upright position. A lip bumper was used with a preadjusted edgewise appliance in the maxillary dentition to reinforce molar anchorage and labial movement of the retroclined incisors. Despite the extraction treatment, a deep bite could be corrected without aggravation as a result of the lip bumper and utility arch in the mandibular dentition. Thus, an Angle Class I molar relationship and an ideal overbite were achieved. The occlusal contact area and masticatory muscle activities during maximum clenching increased after treatment. The maximum closing velocity and the maximum gape during chewing increased, and the chewing pattern changed from the chopping to grinding type. The findings in the present case suggest that the correction of a deep bite might be effective for improving stomatognathic function.	[Nagayama, Kunihiro; Tomonari, Hiroshi; Kitashima, Fumiaki; Miyawaki, Shouichi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Orthodont, Hlth Res Course,Field Dev Med, Kagoshima 8908544, Japan	Miyawaki, S (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Orthodont, Hlth Res Course,Field Dev Med, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	miyawaki@dent.kagoshima-u.ac.jp					Lee SJ, 2010, AM J ORTHOD DENTOFAC, V137, P194, DOI 10.1016/j.ajodo.2008.03.031; Sohn BW, 1997, AM J ORTHOD DENTOFAC, V112, P403, DOI 10.1016/S0889-5406(97)70048-9; Bock N, 2008, EUR J ORTHODONT, V30, P606, DOI 10.1093/ejo/cjn062; Buschang PH, 2007, AM J ORTHOD DENTOFAC, V131, P627, DOI 10.1016/j.ajodo.2005.06.037; Canut JA, 1999, EUR J ORTHODONT, V21, P377, DOI 10.1093/ejo/21.4.377; Chen LL, 2010, AM J ORTHOD DENTOFAC, V137, P187, DOI 10.1016/j.ajodo.2008.03.021; Dyer F M, 2001, J Orthod, V28, P271, DOI 10.1093/ortho/28.4.271; Hashish DI, 2009, AM J ORTHOD DENTOFAC, V135, P106, DOI 10.1016/j.ajodo.2007.10.038; Hidaka O, 1999, J DENT RES, V78, P1336; Johnsen SE, 2007, EXP BRAIN RES, V178, P126, DOI 10.1007/s00221-006-0719-9; Kubota N, 2010, CRANIO, V28, P19; Maeda A, 2008, ANGLE ORTHOD, V78, P1125, DOI 10.2319/111907-539.1; Merrifield LL, 1978, JCH TWEED FDN, V6, P10; MERRIFIELD LL, 1994, AM J ORTHOD DENTOFAC, V106, P641; Millett DT, 2006, COCHRANE DB SYST REV, V18; Miyawaki S, 2005, J DENT RES, V84, P133; Miyawaki S, 2004, AM J ORTHOD DENTOFAC, V126, P549, DOI 10.1016/j.ajodo.2003.10.033; O'Donnell S, 1998, AM J ORTHOD DENTOFAC, V113, P247, DOI 10.1016/S0889-5406(98)70293-8; Piancino MG, 2013, EUR J PAEDIATR DENT, V14, P156; Piancino MG, 2012, J ELECTROMYOGR KINES, V22, P273, DOI 10.1016/j.jelekin.2011.12.003; Tome W, 2009, ANGLE ORTHOD, V79, P1078, DOI [10.2319/052708-282R.1, 10.2319/052708-282.1]; Wada K, 1977, J OSAKA U DENT SOC, V22, P239; WICKWIRE NA, 1981, ANGLE ORTHOD, V51, P48; Yashiro K, 2012, J ORAL REHABIL, V39, P100, DOI 10.1111/j.1365-2842.2011.02256.x; Yousefian J, 2006, AM J ORTHOD DENTOFAC, V130, P771, DOI 10.1016/j.ajodo.2005.07.016	25	0	0	E H ANGLE EDUCATION RESEARCH FOUNDATION, INC	NEWTON N	1615 BEACON ST, NEWTON N, MA 02468-1507 USA	0003-3219	1945-7103		ANGLE ORTHOD	Angle Orthod.	MAR	2015	85	2					314	321		10.2319/031414-194.1		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CC7ET	WOS:000350531200020		
J	Tomita, N; Hattori, Y; Fujisawa, S; Hashimoto, C; Taguchi, J; Takasaki, H; Sakai, R; Tateishi, U; Ishigatsubo, Y				Tomita, Naoto; Hattori, Yukako; Fujisawa, Shin; Hashimoto, Chizuko; Taguchi, Jun; Takasaki, Hirotaka; Sakai, Rika; Tateishi, Ukihide; Ishigatsubo, Yoshiaki			Post-therapy F-18-fluorodeoxyglucose positron emission tomography for predicting outcome in patients with peripheral T cell lymphoma	ANNALS OF HEMATOLOGY			English	Article						Overall survival; Peripheral T cell lymphomas; Positron emission tomography; Prognosis; Progression-free survival	NON-HODGKINS-LYMPHOMA; SUV-BASED ASSESSMENT; PROGNOSTIC VALUE; F-18-FDG PET; FDG-PET; RESPONSE CRITERIA; CHEMOTHERAPY; INTERIM; CLASSIFICATION; PROJECT	The International Harmonization Project on Lymphoma recommends F-18-fluorodeoxyglucose (FDG)-positron emission tomography (PET) for the routine assessment of treatment efficacy in patients with FDG-avid lymphomas such as Hodgkin's and diffuse large B cell lymphomas. The utility of FDG-PET in predicting outcomes in patients with peripheral T cell lymphomas (PTCL) has not been fully elucidated. We retrospectively determined the predictive value of FDG-PET after first-line treatment (post-PET) for outcome in PTCL. Of the 36 patients enrolled, 16 were histologically diagnosed with PTCL not otherwise specified and 20 were diagnosed with angioimmunoblastic T cell lymphoma. All patients received curative-intent anthracycline-containing chemotherapy regimens. Post-PET images were visually evaluated by local nuclear medicine physicians. The median observation period for the surviving patients was 44 months. Positive and negative post-PET results were obtained in 31 % (11/36) and 69 % (25/36) of patients, respectively. The 3-year progression-free survival rates in the positive and negative post-PET result groups were 18 % and 62 %, respectively (P < 0.001). Nine of the 11 patients in the positive post-PET result group experienced progressive disease (PD) (positive predictive value, 82 %), whereas 16 of the 25 patients in the negative post-PET result group did not experience PD (negative predictive value, 64 %). The 3-year overall survival rates in the positive and negative post-PET result groups were 44 % and 84 %, respectively (P = 0.03). Our findings indicate that post-PET is predictive of outcome in patients with PTCL.	[Tomita, Naoto; Ishigatsubo, Yoshiaki] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 232, Japan; [Hattori, Yukako; Takasaki, Hirotaka; Sakai, Rika] Kanagawa Canc Ctr, Dept Med Oncol, Yokohama, Kanagawa 2410815, Japan; [Fujisawa, Shin] Yokohama City Univ, Med Ctr, Dept Hematol, Yokohama, Kanagawa 232, Japan; [Hashimoto, Chizuko] Yamato Municipal Hosp, Dept Hematol Oncol, Yamato, Japan; [Taguchi, Jun] Shizuoka Red Cross Hosp, Dept Hematol, Shizuoka, Japan; [Tateishi, Ukihide] Yokohama City Univ, Grad Sch Med, Dept Radiol, Yokohama, Kanagawa 232, Japan	Tomita, N (reprint author), Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 232, Japan.	cavalier@ch-yamate.dlenet.com					Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Bishu S, 2007, LEUKEMIA LYMPHOMA, V48, P1531, DOI 10.1080/10428190701344915; Hutchings M, 2006, BLOOD, V107, P52, DOI 10.1182/blood-2005-06-2252; Schmitz N, 2010, BLOOD, V116, P3418, DOI 10.1182/blood-2010-02-270785; Juweid ME, 2007, J CLIN ONCOL, V25, P571, DOI 10.1200/JCO.2006.08.2305; Weisenburger DD, 2011, BLOOD, V117, P3402, DOI 10.1182/blood-2010-09-310342; Gallamini A, 2004, BLOOD, V103, P2474, DOI 10.1182/blood-2003-09-3080; Cheson BD, 1999, J CLIN ONCOL, V17, P1244; Li YJ, 2013, J NUCL MED, V54, P507, DOI 10.2967/jnumed.112.110262; Kako S, 2007, ANN ONCOL, V18, P1685, DOI 10.1093/annonc/mdm265; Gallamini A, 2007, J CLIN ONCOL, V25, P3746, DOI 10.1200/JCO.2007.11.6525; Itti E, 2009, J NUCL MED, V50, P527, DOI 10.2967/jnumed.108.057703; Haioun C, 2005, BLOOD, V106, P1376, DOI 10.1182/blood-2005-01-0272; Lin C, 2007, J NUCL MED, V48, P1626, DOI 10.2967/jnumed.107.042093; Rudiger T, 2002, ANN ONCOL, V13, P140, DOI 10.1093/annonc/mdf033; Cahu X, 2011, ANN ONCOL, V22, P705, DOI 10.1093/annonc/mdq415; Miller TP, 1998, NEW ENGL J MED, V339, P21, DOI 10.1056/NEJM199807023390104; SHIPP MA, 1993, NEW ENGL J MED, V329, P987; Hadithi M, 2006, J NUCL MED, V47, P1622; Karantanis D, 2008, CLIN LYMPHOMA MYELOM, V8, P94, DOI 10.3816/CLM.2008.n.010; Khong PL, 2008, ANN HEMATOL, V87, P613, DOI 10.1007/s00277-008-0494-8; Fujita M, 2000, PATHOL INT, V50, P696; Mori M, 2005, INT J HEMATOL, V81, P246, DOI 10.1532/IJH97.03147; Savage KJ, 2011, HEMATOL-AM SOC HEMAT, P515, DOI 10.1182/asheducation-2011.1.515; Suh C, 2008, J NUCL MED, V49, P1783, DOI 10.2967/jnumed.108.053355; Tomita N, 2014, HEMATOL ONC IN PRESS; Tomita N, 2007, CANCER, V109, P1146, DOI 10.1002/cncr.22507; TSURUO T, 1982, CANCER RES, V42, P1462; Wu HB, 2010, NUCL MED COMMUN, V31, P195, DOI 10.1097/MNM.0b013e32833310fa; Zinzani PL, 2011, CURR HEMATOL MALIG R, V6, P241, DOI 10.1007/s11899-011-0098-6	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	MAR	2015	94	3					431	436		10.1007/s00277-014-2227-5		6	Hematology	Hematology	CA9EY	WOS:000349225200009		
J	Yano, S; Mori, S; Saito, T; Yokoyama, H; Machishima, T; Shimada, T; Yahagi, Y; Sugiyama, K; Ogasawara, Y; Takahara, S; Kasama, K; Katsube, A; Kamiyama, Y; Suzuki, K; Inui, Y; Usui, N; Aiba, K; Yamashita, T				Yano, Shingo; Mori, Shinichiro; Saito, Takeshi; Yokoyama, Hiroki; Machishima, Tomohito; Shimada, Takaki; Yahagi, Yuichi; Sugiyama, Katsuki; Ogasawara, Yoji; Takahara, Shinobu; Kasama, Kinuyo; Katsube, Atsushi; Kamiyama, Yutaro; Suzuki, Kazuhito; Inui, Yumiko; Usui, Noriko; Aiba, Keisuke; Yamashita, Takuya			Pharmacokinetics for once-daily modified release formulation of tacrolimus hydrate in unrelated hematopoietic stem cell transplantation	ANNALS OF HEMATOLOGY			English	Article						Once-daily tacrolimus; Pharmacokinetics; Allogeneic hematopoietic stem cell transplantation; GVHD	BONE-MARROW-TRANSPLANTATION; HOST-DISEASE PROPHYLAXIS; LIVER-TRANSPLANTATION; MYOCARDIAL HYPERTROPHY; PHASE-III; PROGRAF; RECIPIENTS; ADVAGRAF; CYCLOSPORINE; NEED	A once-daily modified release formulation of oral tacrolimus (Tac QD) has been developed in response to the problem of nonadherence. However, there have been no data available about the efficacy of Tac QD conversion from intravenous Tac (Tac i.v.) in allogeneic hematopoietic stem cell transplantation (allo-SCT). We analyzed the pharmacokinetics (PK) of Tac QD in allo-SCT recipients. A total of 10 patients with hematological malignancies who received allo-SCT from unrelated donors were enrolled. Patients received Tac i.v. at 0.03 mg/kg a day before transplantation. Administration of Tac i.v. was converted to Tac QD at a 1:4 ratio when the patients had recovered from regimen-related gastrointestinal toxicity and could tolerate oral medication. After conversion, six out of 10 patients (60 %) showed a sustained decrease in Tac exposure and required dose adjustment. The conversion from Tac i.v. to Tac QD should be performed under close medical supervision. Area under the curve (AUC) and the trough of Tac QD showed a correlation, and the trough should be maintained above 7.5 ng/ml to provide an adequate AUC. Although four patients received bone marrow from an HLA DRB1 1 antigen-mismatched unrelated donor, no patients developed grade III-IV acute graft-versus-host disease (GVHD). The modification of Tac QD to maintain a whole-blood trough concentration above 7.5 ng/ml may be as effective as Tac BID.	[Yano, Shingo; Saito, Takeshi; Yokoyama, Hiroki; Machishima, Tomohito; Shimada, Takaki; Yahagi, Yuichi; Sugiyama, Katsuki; Ogasawara, Yoji; Takahara, Shinobu; Kasama, Kinuyo; Katsube, Atsushi; Kamiyama, Yutaro; Suzuki, Kazuhito; Inui, Yumiko; Usui, Noriko; Aiba, Keisuke] Jikei Univ, Sch Med, Div Clin Oncol & Hematol, Minato Ku, Tokyo 1058461, Japan; [Mori, Shinichiro] St Lukes Int Hosp, Dept Hematol & Oncol, Tokyo, Japan; [Yamashita, Takuya] Natl Canc Ctr, Dept Hematol & Hematopoiet Stem Cell Transplantat, Tokyo, Japan	Yano, S (reprint author), Jikei Univ, Sch Med, Div Clin Oncol & Hematol, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	yano@jikei.ac.jp			Ministry of Health, Labour and Welfare, Japan	This work was supported by Health and Labour Sciences Research Grants for Clinical Cancer Research from the Ministry of Health, Labour and Welfare, Japan. We thank the nursing staff who cared for the patients at Jikei University Hospital and SRL laboratory staff who analyzed the plasma concentration of Tac.	Hougardy JM, 2011, TRANSPLANTATION, V91, P566, DOI 10.1097/TP.0b013e3182098ff0; Wu MJ, 2011, TRANSPLANTATION, V92, P648, DOI 10.1097/TP.0b013e3182292426; Comuzzi C, 2010, TRANSPL P, V42, P1320, DOI 10.1016/j.transproceed.2010.03.106; Perkins J, 2010, BIOL BLOOD MARROW TR, V16, P937, DOI 10.1016/j.bbmt.2010.01.010; Yanada M, 2004, BONE MARROW TRANSPL, V34, P331, DOI 10.1038/sj.bmt.1704596; First MR, 2008, THER DRUG MONIT, V30, P159, DOI 10.1097/FTD.0b013e318167909a; Mano A, 2009, TRANSPL P, V41, P3831, DOI 10.1016/j.transproceed.2009.05.040; Kramer BK, 2010, AM J TRANSPLANT, V10, P2632, DOI 10.1111/j.1600-6143.2010.03256.x; Jelassi ML, 2011, TRANSPL P, V43, P491, DOI 10.1016/j.transproceed.2011.01.043; Crespo M, 2009, TRANSPL P, V41, P2115, DOI 10.1016/j.transproceed.2009.05.014; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Nakata Y, 2000, TRANSPLANTATION, V69, P1960, DOI 10.1097/00007890-200005150-00039; ATKISON P, 1995, LANCET, V345, P894, DOI 10.1016/S0140-6736(95)90011-X; Ichimaru N, 2008, TRANSPL P, V40, P1362, DOI 10.1016/j.transproceed.2008.02.083; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Mehta P, 1999, BONE MARROW TRANSPL, V24, P1323, DOI 10.1038/sj.bmt.1702053; Mita A, 2014, TRANSPL P, V46, P794, DOI 10.1016/j.transproceed.2014.01.006; Osunkwo I, 2004, BIOL BLOOD MARROW TR, V10, P246, DOI 10.1016/j.bbmt.2003.11.005; Ratanatharathorn V, 1998, BLOOD, V92, P2303; BUSUTTIL RW, 1994, NEW ENGL J MED, V331, P1110; Trunecka P, 2010, AM J TRANSPLANT, V10, P2313, DOI 10.1111/j.1600-6143.2010.03255.x; van Hooff JP, 2011, CLIN TRANSPLANT, V25, pE1, DOI 10.1111/j.1399-0012.2010.01377.x	22	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	MAR	2015	94	3					491	496		10.1007/s00277-014-2233-7		6	Hematology	Hematology	CA9EY	WOS:000349225200017		
J	Hasegawa, T; Aisa, Y; Shimazaki, K; Nakazato, T				Hasegawa, Tetsuo; Aisa, Yoshinobu; Shimazaki, Kengo; Nakazato, Tomonori			Cytomegalovirus reactivation with bendamustine in patients with low-grade B-cell lymphoma	ANNALS OF HEMATOLOGY			English	Letter							INFECTION; RITUXIMAB		[Hasegawa, Tetsuo; Aisa, Yoshinobu; Shimazaki, Kengo; Nakazato, Tomonori] Yokohama Municipal Citizens Hosp, Dept Hematol, Hodogaya Ku, Yokohama, Kanagawa 2408555, Japan	Nakazato, T (reprint author), Yokohama Municipal Citizens Hosp, Dept Hematol, Hodogaya Ku, 56 Okazawa Cho, Yokohama, Kanagawa 2408555, Japan.	n-tomo@eurus.dti.ne.jp					Eid AJ, 2010, DRUGS, V70, P965, DOI 10.2165/10898540-000000000-00000; Kahl BS, 2010, CANCER, V116, P106, DOI 10.1002/cncr.24714; Rummel MJ, 2005, J CLIN ONCOL, V23, P3383, DOI 10.1200/JCO.2005.08.100; Lim SH, 2012, ANN HEMATOL, V91, P643, DOI 10.1007/s00277-011-1307-z; Boeckh M, 2003, BIOL BLOOD MARROW TR, V9, P543, DOI 10.1016/S1083-8791(03)00287-8; Hosoda T, 2013, LEUKEMIA LYMPHOMA, V54, P1327, DOI 10.3109/10428194.2012.739285; Matthew Rong Jie T, 2014, LEUKEMIA LYMPHOMA, V55, P182; Mitsumori Toru, 2014, Rinsho Ketsueki, V55, P239; Takeda N, 2001, Kansenshogaku Zasshi, V75, P775; Torres HA, 2006, CLIN LYMPHOMA MYELOM, V6, P393, DOI 10.3816/CLM.2006.n.016	10	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	MAR	2015	94	3					515	517		10.1007/s00277-014-2182-1		3	Hematology	Hematology	CA9EY	WOS:000349225200023		
J	Kamachi, K; Fukushima, N; Ando, T; Sato, K; Ohshima, K; Yokoo, M; Shindo, T; Kubota, Y; Kojima, K; Kimura, S				Kamachi, Kazuharu; Fukushima, Noriyasu; Ando, Toshihiko; Sato, Ken-ichi; Ohshima, Koichi; Yokoo, Masako; Shindo, Takero; Kubota, Yasushi; Kojima, Kensuke; Kimura, Shinya			Coexistence of ALK-anaplastic large cell lymphoma and CD4+T cell large granular lymphocytic leukemia	ANNALS OF HEMATOLOGY			English	Letter							T-CELL; STAT3 MUTATIONS; FREQUENT		[Kamachi, Kazuharu; Fukushima, Noriyasu; Ando, Toshihiko; Yokoo, Masako; Shindo, Takero; Kubota, Yasushi; Kojima, Kensuke; Kimura, Shinya] Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, Saga 840, Japan; [Fukushima, Noriyasu; Sato, Ken-ichi] Int Univ Hlth andWelfare, Dept Med Sci Technol, Sch Hlth Sci Fukuoka, Ohkawa 8318501, Japan; [Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan; [Kubota, Yasushi] Saga Univ Hosp, Dept Blood Transfus Med, Saga, Japan	Fukushima, N (reprint author), Int Univ Hlth andWelfare, Dept Med Sci Technol, Sch Hlth Sci Fukuoka, Enokizu 137-1, Ohkawa 8318501, Japan.	fukushin@iuhw.ac.jp					Ohgami RS, 2013, LEUKEMIA, V27, P2244, DOI 10.1038/leu.2013.104; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Couronne L, 2013, HAEMATOLOGICA, V98, P1748, DOI 10.3324/haematol.2013.085068; Arber DA, 2000, J MOL DIAGN, V2, P178, DOI 10.1016/S1525-1578(10)60636-8; Chen WC, 2008, WHO CLASSIFICATION T, P272; Howard MT, 2010, AM J CLIN PATHOL, V133, P936, DOI 10.1309/AJCPIIL1Y5QXTIBP; Lima M, 2003, AM J PATHOL, V163, P763, DOI 10.1016/S0002-9440(10)63703-0; Matutes E, 2001, BRIT J HAEMATOL, V115, P801, DOI 10.1046/j.1365-2141.2001.03220.x; Qiu ZY, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-82; Watters RJ, 2011, LEUKEMIA LYMPHOMA, V52, P2217, DOI 10.3109/10428194.2011.593276	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	MAR	2015	94	3					539	540		10.1007/s00277-014-2176-z		2	Hematology	Hematology	CA9EY	WOS:000349225200030		
J	Momose, Y; Aimi, Y; Hirayama, T; Kataoka, M; Ono, M; Yoshino, H; Satoh, T; Gamou, S				Momose, Yuichi; Aimi, Yuki; Hirayama, Tomomi; Kataoka, Masaharu; Ono, Masae; Yoshino, Hideaki; Satoh, Toru; Gamou, Shinobu			De Novo Mutations in the BMPR2 Gene in Patients with Heritable Pulmonary Arterial Hypertension	ANNALS OF HUMAN GENETICS			English	Article						BMPR2 gene; de novo mutation; parental identification; pulmonary arterial hypertension	ANTICIPATION	A substantial proportion of patients with pulmonary arterial hypertension (PAH) have mutations in the Bone Morphogenetic Protein Receptor type-2 (BMPR2) gene. PAH due to BMPR2 mutations is inherited as an autosomal dominant trait with several unique features, including a wide variety of mutations, reduced penetrance, a skewed gender ratio, variable expressivity and genetic anticipation. To address the genetic background of these unique features of BMPR2 mutation, we conducted a systematic analysis of 15 PAH families with BMPR2 mutation. The exonic protein coding sequence of BMPR2 was amplified by polymerase chain reaction and the products were sequenced directly to detect point mutations in BMPR2. Parental identification was carried out to confirm the parental relationship using multiplex 15 loci analysis. Combining mutation detection in family members with parental identification, we described three cases of de novo mutation in the BMPR2 gene by different modes in a PAH family. These de novo mutations may account for the wide variety of mutations in BMPR2. Taken together with the juvenile onset of the disease, there is possibly some balance of de novo mutations and untransmittable mutations which keeps the frequency of PAH low in the general population.	[Momose, Yuichi; Aimi, Yuki; Hirayama, Tomomi; Kataoka, Masaharu; Yoshino, Hideaki; Satoh, Toru] Kyorin Univ, Sch Med, Dept Internal Med 2, Div Cardiol, Hachioji, Tokyo 1928508, Japan; [Aimi, Yuki; Hirayama, Tomomi; Gamou, Shinobu] Kyorin Univ, Sch Hlth Sci, Dept Mol Biol, Hachioji, Tokyo 1928508, Japan; [Kataoka, Masaharu] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Ono, Masae] Kyorin Univ, Sch Med, Dept Pediat, Hachioji, Tokyo 1928508, Japan; [Ono, Masae] Tokyo Teishin Hosp, Dept Pediat, Tokyo, Japan	Gamou, S (reprint author), Kyorin Univ, Sch Hlth Sci, Dept Mol Biol, 476 Miyashita Cho, Hachioji, Tokyo 1928508, Japan.	gamou@ks.kyorin-u.ac.jp			Ministry of Health, Labour, and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology; medical department collaborative project of Kyorin University; Kyorin University School of Health Sciences	This work was supported in part by a Health and Labour Sciences Research Grant from the Ministry of Health, Labour, and Welfare of Japan, by the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, by a Grant from the medical department collaborative project of Kyorin University, and by a Fellowship from Kyorin University School of Health Sciences.	Aimi Y, 2013, J HUM GENET, V58, P815, DOI 10.1038/jhg.2013.100; Kabata H, 2013, RESPIROLOGY, V18, P1076, DOI 10.1111/resp.12117; RICH S, 1987, ANN INTERN MED, V107, P216; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Sztrymf B, 2007, RESPIRATION, V74, P123, DOI 10.1159/000098818; LOYD JE, 1995, AM J RESP CRIT CARE, V152, P93; Austin ED, 2009, SEMIN RESP CRIT CARE, V30, P386, DOI 10.1055/s-0029-1233308; Larkin EK, 2012, AM J RESP CRIT CARE, V186, P892, DOI 10.1164/rccm.201205-0886OC; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Cogan JD, 2006, AM J RESP CRIT CARE, V174, P590, DOI 10.1164/rccm.200602-165OC; Soubrier F, 2013, J AM COLL CARDIOL, V62, pD13, DOI 10.1016/j.jacc.2013.10.035; Cogan JD, 2005, GENET MED, V7, P169, DOI 10.1097/01.GIM.000156525.09595.E9; Kataoka M, 2013, GENET MED, V15, P941, DOI 10.1038/gim.2013.41; Morisaki H, 2004, HUM MUTAT, V23, P632, DOI 10.1002/humu.9251	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-4800	1469-1809		ANN HUM GENET	Ann. Hum. Genet.	MAR	2015	79	2					85	91		10.1111/ahg.12096		7	Genetics & Heredity	Genetics & Heredity	CB9MQ	WOS:000349956200001		
J	Baik, SH; Fane, M; Park, JH; Cheng, YL; Fann, DYW; Yun, UJ; Choi, Y; Park, JS; Chai, BH; Park, JS; Back, SH; Jeong, JI; Jang, YJ; Bahn, G; Lee, JY; Li, YI; Sobey, CG; Uchida, T; Park, JH; Kim, HT; Tang, SC; Arumugam, TV; Jo, DG				Baik, Sang-Ha; Fane, Mitchell; Park, Joon Hyung; Cheng, Yi-Lin; Fann, David Yang-Wei; Yun, Ui Jeong; Choi, Yuri; Park, Jong-Sung; Chai, Bing Han; Park, Jin Su; Back, Seung Hyun; Jeong, Jae In; Jang, Ye Jin; Bahn, Gahee; Lee, Joo-Yong; Li, Yu-I; Sobey, Christopher G.; Uchida, Takafumi; Park, Jae Hyung; Kim, Hong Tae; Tang, Sung-Chun; Arumugam, Thiruma V.; Jo, Dong-Gyu			Pin1 Promotes Neuronal Death in Stroke by Stabilizing Notch Intracellular Domain	ANNALS OF NEUROLOGY			English	Article							PROLYL-ISOMERASE PIN1; ISCHEMIC-STROKE; STEM-CELLS; PHOSPHORYLATION; ACTIVATION; APOPTOSIS; PATHWAY; CANCER; FBW7; DEPHOSPHORYLATION	ObjectiveStroke is a leading cause of mortality and disability. The peptidyl-prolyl cis/trans isomerase Pin1 regulates factors involved in cell growth. Recent evidence has shown that Pin1 plays a major role in apoptosis. However, the role of Pin1 in ischemic stroke remains to be investigated. MethodsWe used Pin1 overexpression and knockdown to manipulate Pin1 expression and explore the effects of Pin1 in cell death on ischemic stress in vitro and in a mouse stroke model. We also used Pin 1 inhibitor, -secretase inhibitor, Notch1 intracellular domain (NICD1)-deleted mutant cells, and Pin1 mutant cells to investigate the underlying mechanisms of Pin1-NICD1-mediated cell death. ResultsOur findings indicate that Pin1 facilitates NICD1 stability and its proapoptotic function following ischemic stroke. Thus, overexpression of Pin1 increased NICD1 levels and enhanced its potentiation of neuronal death in simulated ischemia. By contrast, depletion or knockout of Pin1 reduced the NICD1 level, which in turn desensitized neurons to ischemic conditions. Pin1 interacted with NICD1 and increased its stability by inhibiting FBW7-induced polyubiquitination. We also demonstrate that Pin1 and NICD1 levels increase following stroke. Pin1 heterozygous (+/-) and knockout (-/-) mice, and also wild-type mice treated with an inhibitor of Pin1, each showed reduced brain damage and improved functional outcomes in a model of focal ischemic stroke. InterpretationThese results suggest that Pin1 contributes to the pathogenesis of ischemic stroke by promoting Notch signaling, and that inhibition of Pin1 is a novel approach for treating ischemic stroke. Ann Neurol 2015;77:504-516	[Baik, Sang-Ha; Park, Joon Hyung; Yun, Ui Jeong; Choi, Yuri; Park, Jong-Sung; Park, Jin Su; Back, Seung Hyun; Jeong, Jae In; Jang, Ye Jin; Bahn, Gahee; Arumugam, Thiruma V.; Jo, Dong-Gyu] Sungkyunkwan Univ, Sch Pharm, Suwon 440746, South Korea; [Fane, Mitchell; Cheng, Yi-Lin; Fann, David Yang-Wei; Chai, Bing Han; Arumugam, Thiruma V.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Park, Jin Su; Back, Seung Hyun; Bahn, Gahee; Park, Jae Hyung; Jo, Dong-Gyu] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Suwon 440746, South Korea; [Lee, Joo-Yong] Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Li, Yu-I] Natl Taiwan Univ, Coll Med, Dept & Grad Inst Forens Med, Taipei 10764, Taiwan; [Sobey, Christopher G.] Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia; [Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan; [Park, Jae Hyung] Sungkyunkwan Univ, Coll Engn, Suwon 440746, South Korea; [Kim, Hong Tae] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [Tang, Sung-Chun] Natl Taiwan Univ Hosp, Dept Neurol, Stroke Ctr, Taipei, Taiwan; [Arumugam, Thiruma V.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore	Arumugam, TV (reprint author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore.	phstva@nus.edu.sg; jodg@skku.edu	Arumugam, Thiruma/B-4898-2011		Basic Science Research Program of the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2012R1A1A2009093, 2012R1A2A2A01047551, 2012R1A5A2A28671860]; Korean Healthcare Technology R&D Project, Ministry of Health, Welfare, and Family Affairs, Republic of Korea [HI09C13450400]; Australian Research Council Future Fellowship [FT100100427]; National University of Singapore	This research was supported by the Basic Science Research Program of the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2012R1A1A2009093, 2012R1A2A2A01047551, 2012R1A5A2A28671860); the Korean Healthcare Technology R&D Project, Ministry of Health, Welfare, and Family Affairs, Republic of Korea (HI09C13450400); an Australian Research Council Future Fellowship (FT100100427) awarded to T.V.A.; and a start-up fund provided by the National University of Singapore.	O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Arumugam TV, 2006, NAT MED, V12, P621, DOI 10.1038/nm1403; Schroeter EH, 1998, NATURE, V393, P382; Min SH, 2012, MOL CELL, V46, P771, DOI 10.1016/j.molcel.2012.04.012; Kesavapany S, 2007, MOL BIOL CELL, V18, P3645, DOI 10.1091/mbc.E07-03-0237; Cheng YL, 2014, NEUROBIOL DIS, V62, P286, DOI 10.1016/j.nbd.2013.10.009; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(05)00083-3; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Hoeck JD, 2010, NAT NEUROSCI, V13, P1365, DOI 10.1038/nn.2644; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Sandy AR, 2013, J IMMUNOL, V191, P1606, DOI 10.4049/jimmunol.1301116; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Wulf GM, 2002, J BIOL CHEM, V277, P47976, DOI 10.1074/jbc.C200538200; Rustighi A, 2014, EMBO MOL MED, V6, P99, DOI 10.1002/emmm.201302909; Arumugam TV, 2011, MOL PHARMACOL, V80, P23, DOI 10.1124/mol.111.071076; Lathia JD, 2008, J NEUROCHEM, V107, P1471, DOI 10.1111/j.1471-4159.2008.05715.x; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11; Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503; Eckerdt F, 2005, J BIOL CHEM, V280, P36575, DOI 10.1074/jbc.M504548200; Galas MC, 2006, J BIOL CHEM, V281, P19296, DOI 10.1074/jbc.M601849200; Stanya KJ, 2008, J CELL BIOL, V183, P49, DOI 10.1083/jcb.200806172; Becker EBE, 2007, CELL CYCLE, V6, P1332; Desla Pompa JL, 1997, DEVELOPMENT, V124, P1139; DisCarlo A., 2009, AGE AGEING, V38, P4; Fann DYW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.326; Fassbender JM, 2011, EXP NEUROL, V227, P302, DOI 10.1016/j.expneurol.2010.12.002; Okun E, 2007, J NEUROCHEM, V102, P1232, DOI 10.1111/j.1471-4159.2007.04615.x; Park JS, 2015, ANN RHEUM DIS, V74, P267, DOI 10.1136/annrheumdis-2013-203467; Rajbhandari P, 2014, ONCOGENE, V33, P1438, DOI 10.1038/onc.2013.78; Rudrabhatla Parvathi, 2008, J Biol Chem, V283, P26737, DOI 10.1074/jbc.M801633200; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Shen ZJ, 2005, NAT IMMUNOL, V6, P1280, DOI 10.1038/ni1266; Wang SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042828; Wei ZL, 2011, STROKE, V42, P2589, DOI 10.1161/STROKEAHA.111.614834	38	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	MAR	2015	77	3					504	516		10.1002/ana.24347		13	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CC6EC	WOS:000350456800014		
J	Lei, XY; Li, YJ; Xie, QW; Liang, L				Lei, Xiyang; Li, Yongjun; Xie, Qiwei; Liang, Liang			Measuring Olympics achievements based on a parallel DEA approach	ANNALS OF OPERATIONS RESEARCH			English	Article						Data envelopment analysis; Olympics achievements; Parallel structure; Efficiency decomposition	DATA ENVELOPMENT ANALYSIS; DECISION-MAKING UNITS; MULTICOMPONENT EFFICIENCY MEASUREMENT; 2-STAGE NETWORK STRUCTURES; JOINT DETERMINATION; HIGHER-EDUCATION; SHARED INPUTS; GAME MODEL; PERFORMANCE; DECOMPOSITION	Measuring the performance of participating nations in the Olympic Games is an important application of data envelopment analysis (DEA). Prior literature only considers participating nations' performance in the Summer Olympic Games. It may be unfair to some nations who are good at the Winter Olympics, but poor at the Summer Olympics. Therefore, we believe it is better to consider the two Olympics together when measuring performance of participants. This paper treats the two Olympics as a parallel system in which each subsystem corresponds to a Summer Olympics or a Winter Olympics, and extends a parallel DEA approach to evaluate the efficiency of each participant. An efficiency decomposition procedure is proposed to obtain the efficiency rang of each Olympic subsystem. Finally, we apply the proposed approach to the latest real data set of the 2012 Summer Olympics and 2010 Winter Olympics.	[Lei, Xiyang; Li, Yongjun; Liang, Liang] Univ Sci & Technol China, Sch Management, Hefei 230026, Anhui, Peoples R China; [Xie, Qiwei] Toyota Technol Inst, Dept Elect & Informat, Nagoya, Aichi 4500002, Japan; [Xie, Qiwei] Chinese Acad Sci, Inst Automat, Beijing 100190, Peoples R China	Li, YJ (reprint author), Univ Sci & Technol China, Sch Management, Hefei 230026, Anhui, Peoples R China.	lxysun@mail.ustc.edu.cn; lionli@mail.ustc.edu.cn; qwxie2012@gmail.com; lliang@ustc.edu.cn			National Natural Science Foundation of China [61101219, 71271196]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [71121061]; Fund for International Cooperation and Exchange of the National Natural Science Foundation of China [71110107024]; Fundamental Research Funds for the Central Universities	The authors thank the editor-in-chief Professor Endre Boros and the reviewers for their constructive comments and suggestions, which have helped to improve the quality of this paper. The authors also thank Professor Alec Morton for his valuable suggestions and his technical check on this paper. This research is supported by National Natural Science Foundation of China under Grants (No. 61101219, 71271196), the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (No. 71121061), the Fund for International Cooperation and Exchange of the National Natural Science Foundation of China (No. 71110107024) and the Fundamental Research Funds for the Central Universities.	Ali AI, 1994, DATA ENVELOPMENT ANA, P63; Amirteimoori A, 2006, APPL MATH COMPUT, V177, P11, DOI 10.1016/j.amc.2005.10.029; Du JA, 2011, EUR J OPER RES, V210, P390, DOI 10.1016/j.ejor.2010.08.025; Yang CH, 2014, ANN OPER RES, V217, P565, DOI 10.1007/s10479-014-1536-3; Li YJ, 2012, OMEGA-INT J MANAGE S, V40, P611, DOI 10.1016/j.omega.2011.11.007; Yu MM, 2008, APPL ECON LETT, V15, P647, DOI 10.1080/13504850600721858; Lins MPE, 2003, EUR J OPER RES, V148, P312, DOI 10.1016/S0377-2217(02)00687-2; Castelli L, 2010, ANN OPER RES, V173, P207, DOI 10.1007/s10479-008-0414-2; Kao C, 2008, EUR J OPER RES, V185, P418, DOI 10.1016/j.ejor.2006.11.041; Bougnol ML, 2006, ANN OPER RES, V145, P339, DOI 10.1007/s10479-006-0039-2; Chen Y, 2010, EUR J OPER RES, V207, P339, DOI 10.1016/j.ejor.2010.03.031; Tsai PF, 2002, EUR J OPER RES, V141, P21, DOI 10.1016/S0377-2217(01)00223-5; Prior D, 2006, ANN OPER RES, V145, P281, DOI 10.1007/s10479-006-0035-6; Grigoroudis E, 2013, ANN OPER RES, V205, P5, DOI 10.1007/s10479-012-1206-2; BEASLEY JE, 1995, J OPER RES SOC, V46, P441, DOI 10.1057/jors.1995.63; Liang L, 2008, NAV RES LOG, V55, P643, DOI 10.1002/nav.20308; Jahanshahloo GR, 2004, APPL MATH COMPUT, V155, P283, DOI 10.1016/s0096-3003(03)00780-x; Chen Y, 2006, ANN OPER RES, V145, P5, DOI 10.1007/s10479-006-0022-y; de Mello JCCBS, 2009, IMA J MANAG MATH, V20, P201, DOI 10.1093/imaman/dpn025; Chen Y, 2009, EUR J OPER RES, V196, P1170, DOI 10.1016/j.ejor.2008.05.011; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Bogetoft P, 1997, ANN OPER RES, V73, P277, DOI 10.1023/A:1018985313272; Cook WD, 2000, J PROD ANAL, V14, P209, DOI 10.1023/A:1026598803764; Churilov L, 2006, COMPUT OPER RES, V33, P2057, DOI 10.1016/j.cor.2004.09.027; Cook WD, 2004, EUR J OPER RES, V157, P540, DOI 10.1016/S0377-2217(03)00298-4; Azizi H, 2013, MEASUREMENT, V46, P1325, DOI 10.1016/j.measurement.2012.11.050; Chen WC, 2010, ANN OPER RES, V181, P287, DOI 10.1007/s10479-010-0743-9; Chiang CI, 2011, MATH COMPUT MODEL, V54, P2464, DOI 10.1016/j.mcm.2011.06.002; Cook WD, 2010, ANN OPER RES, V173, P163, DOI 10.1007/s10479-008-0421-3; de Franca JMF, 2010, ANN OPER RES, V173, P39, DOI 10.1007/s10479-009-0536-1; Du J, 2014, ANN OPER RES, V221, P161, DOI 10.1007/s10479-011-0838-y; Emrouznejad A, 2014, ANN OPER RES, V214, P1, DOI 10.1007/s10479-014-1535-4; Emrouznejad A, 2008, SOCIOECONOMIC PLANNI, V42, P151, DOI DOI 10.1016/J.SEPS.2007.07.002; Emrouznejad A, 2010, EUR J OPER RES, V200, P297, DOI 10.1016/j.ejor.2009.01.001; Fare R, 1997, ECON LETT, V56, P187, DOI 10.1016/S0165-1765(97)81899-X; Hai H. L., 2007, WSEAS T SYSTEMS, V6, P1196; Kao C, 2012, J OPER RES SOC, V63, P64, DOI 10.1057/jors.2011.16; Kao C, 2012, FUZZY SET SYST, V198, P83, DOI 10.1016/j.fss.2012.01.004; Khodabakhshi M, 2014, ANN OPER RES, V214, P187, DOI 10.1007/s10479-012-1117-2; Li YJ, 2008, OMEGA-INT J MANAGE S, V36, P933, DOI 10.1016/j.omega.2007.05.003; Lozano S, 2002, J OPER RES SOC, V53, P501, DOI 10.1057/palgrave/jors/2601327; Molinero CM, 1996, J OPER RES SOC, V47, P1273, DOI 10.1057/jors.1996.154; Moreno P, 2014, ANN OPER RES, V214, P99, DOI 10.1007/s10479-012-1074-9; Mello Jõao Carlos C.B. Soares de, 2012, Pesqui. Oper., V32, P21; Wu J, 2009, OMEGA-INT J MANAGE S, V37, P909, DOI 10.1016/j.omega.2008.07.001; Wu J, 2009, EUR J OPER RES, V197, P722, DOI 10.1016/j.ejor.2008.06.030; Wu J, 2010, J SPORT ECON, V11, P549, DOI 10.1177/1527002509352619; Yang CC, 2014, ANN OPER RES, V214, P167, DOI 10.1007/s10479-011-0926-z; Yang YS, 2000, J OPER RES SOC JPN, V43, P343; Zha Y, 2010, EUR J OPER RES, V205, P332, DOI 10.1016/j.ejor.2010.01.010; Zhang D, 2009, J OPER RES SOC, V60, P983, DOI 10.1057/palgrave.jors.2602638; Zhou ZB, 2013, ANN OPER RES, V206, P585, DOI 10.1007/s10479-013-1365-9	52	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0254-5330	1572-9338		ANN OPER RES	Ann. Oper. Res.	MAR	2015	226	1					379	396		10.1007/s10479-014-1708-1		18	Operations Research & Management Science	Operations Research & Management Science	CB8BE	WOS:000349852400017		
J	Jardim, ACG; Igloi, Z; Shimizu, JF; Santos, VAFFM; Felippe, LG; Mazzeu, BF; Amako, Y; Furlan, M; Harris, M; Rahal, P				Jardim, A. C. G.; Igloi, Z.; Shimizu, J. F.; Santos, V. A. F. F. M.; Felippe, L. G.; Mazzeu, B. F.; Amako, Y.; Furlan, M.; Harris, M.; Rahal, P.			Natural compounds isolated from Brazilian plants are potent inhibitors of hepatitis C virus replication in vitro	ANTIVIRAL RESEARCH			English	Article						Brazilian plants; Natural compounds; Antiviral; Hepatitis C virus; Replication	MAYTENUS-ILICIFOLIA CELASTRACEAE; PEPEROMIA-BLANDA; PLUS RIBAVIRIN; NS5A INHIBITOR; LIFE-CYCLE; INFECTION; SILYMARIN; EPIDEMIOLOGY; QUERCETIN; REPLICONS	Compounds extracted from plants can provide an alternative approach to new therapies. They present characteristics such as high chemical diversity, lower cost of production and milder or inexistent side effects compared with conventional treatment. The Brazilian flora represents a vast, largely untapped, resource of potential antiviral compounds. In this study, we investigate the antiviral effects of a panel of natural compounds isolated from Brazilian plants species on hepatitis C virus (HCV) genome replication. To do this we used firefly luciferase-based HCV sub-genomic replicons of genotypes 2a (JFH-1), lb and 3a and the compounds were assessed for their effects on both HCV replication and cellular toxicity. Initial screening of compounds was performed using the maximum non-toxic concentration and 4 compounds that exhibited a useful therapeutic index (favourable ratio of cytotoxicity to antiviral potency) were selected for extra analysis. The compounds APS (EC50= 2.3 mu M), a natural alkaloid isolated from Maytrenus ilicifolia, and the lignans 3*43 (EC50= 4.0 mu M), 3*20 (EC50= 8.2 mu M) and 5*362 (EC50= 38.9 mu M) from Peperomia blanda dramatically inhibited HCV replication as judged by reductions in luciferase activity and HCV protein expression in both the subgenomic and infectious systems. We further show that these compounds are active against a daclatasvir resistance mutant subgenomic replicon. Consistent with inhibition of genome replication, production of infectious JFH-1 virus was significantly reduced by all 4 compounds. These data are the first description of Brazilian natural compounds possessing anti-HCV activity and further analyses are being performed in order to investigate the mode of action of those compounds. (C) 2015 The Authors. Published by Elsevier B.V.	[Jardim, A. C. G.] UFU Fed Univ Uberlandia, Inst Biomed Sci ICBIM, Uberlandia, MG, Brazil; [Jardim, A. C. G.; Shimizu, J. F.; Mazzeu, B. F.; Rahal, P.] UNESP Sao Paulo State Univ, Inst Biosci Language & Exact Sci IBILCE, Dept Biol, Sao Jose Do Rio Preto, SP, Brazil; [Igloi, Z.; Harris, M.] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Igloi, Z.; Harris, M.] Univ Leeds, Astbuiy Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Santos, V. A. F. F. M.; Felippe, L. G.; Furlan, M.] UNESP Sao Paulo State Univ, Inst Chem, Dept Organ Chem, Araraquara, SP, Brazil; [Amako, Y.] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo 113, Japan	Jardim, ACG (reprint author), Ave Amazonas,Bloco 4C Sala 216, BR-38405302 Uberlandia, MG, Brazil.	caroljardim@gmail.com; z.Igloi@leeds.ac.uk; jacquelineshimizu@gmail.com; vaniaapf@gmail.com; lidiane_iq@yahoo.com.br; bruna.mazzeu@gmail.com; amako-yt@igakuken.or.jp; mayfurlan@gmail.com; m.harris@leeds.ac.uk; prahal@ibilce.unesp.br	CEPID-FAPESP, CIBFar/J-2382-2015; 	Harris, Mark/0000-0002-9821-1003	Sao Paulo Research Foundation - FAPESP "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo" [2011/00313-3, 2011/11753-4]; Wellcome Trust [096670MA]	This study was supported by Grants from Sao Paulo Research Foundation - FAPESP "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo" (2011/00313-3 and 2011/11753-4). Work in the MH laboratory is funded by a Wellcome Trust Senior Investigator Award (096670MA).	Ahmed-Belkacem A, 2010, GASTROENTEROLOGY, V138, P1112, DOI 10.1053/j.gastro.2009.11.053; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Duarte MCT, 2005, J ETHNOPHARMACOL, V97, P305, DOI 10.1016/j.jep.2004.11.016; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Santos VAFFM, 2012, J NAT PROD, V75, P991, DOI 10.1021/np300077r; Gonzalez O, 2009, HEPATOLOGY, V50, P1756, DOI 10.1002/hep.23232; Chevaliez S, 2007, WORLD J GASTROENTERO, V13, P2461; Targett-Adams P, 2005, J GEN VIROL, V86, P3075, DOI 10.1099/vir.0.81334-0; Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003; Lyn RK, 2009, VIROLOGY, V394, P130, DOI 10.1016/j.virol.2009.08.022; Calland N, 2012, VIRUSES-BASEL, V4, P2197, DOI 10.3390/v4102197; Hussein G, 2000, PHYTOTHER RES, V14, P510, DOI 10.1002/1099-1573(200011)14:7<510::AID-PTR646>3.0.CO;2-B; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Huang SD, 2013, ORG LETT, V15, P590, DOI 10.1021/ol3034065; Bachmetov L, 2012, J VIRAL HEPATITIS, V19, pE81, DOI 10.1111/j.1365-2893.2011.01507.x; dos Santos VAFFM, 2013, MOLECULES, V18, P1053, DOI 10.3390/molecules18011053; Rinck G, 2001, J VIROL, V75, P9470, DOI 10.1128/JVI.75.19.9470-9482.2001; Polyak SJ, 2010, P NATL ACAD SCI USA, V107, P5995, DOI 10.1073/pnas.0914009107; Wagoner J, 2010, HEPATOLOGY, V51, P1912, DOI 10.1002/hep.23587; Felippe LG, 2012, ORG BIOMOL CHEM, V10, P4208, DOI 10.1039/c2ob25109d; Polyak SJ, 2007, GASTROENTEROLOGY, V132, P1925, DOI 10.1053/j.gastro.2007.02.038; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Macdonald A, 2003, J BIOL CHEM, V278, P17775, DOI 10.1074/jbc.M210900200; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436; Mann J, 2002, NAT REV CANCER, V2, P143, DOI 10.1038/nrc723; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Ross-Thriepland D, 2014, J VIROL, V88, P1421, DOI 10.1128/JVI.03017-13; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346; Lan KH, 2012, LIVER INT, V32, P989, DOI 10.1111/j.1478-3231.2011.02621.x; Guedj J, 2013, P NATL ACAD SCI USA, V110, P3991, DOI 10.1073/pnas.1203110110; Chen Y, 2001, Zhonghua Gan Zang Bing Za Zhi, V9 Suppl, P12; Choi M, 2014, VIRUS GENES, V49, P208, DOI 10.1007/s11262-014-1098-0; da Costa PM, 2008, TOXICOL IN VITRO, V22, P854, DOI 10.1016/j.tiv.2008.01.003; Felippe LG, 2008, PHYTOCHEMISTRY, V69, P445, DOI 10.1016/j.phytochem.2007.08.012; Gullo FP, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/340787; Haid S., 2012, GASTROENTEROLOGY, V143, pe215; Kitazato K., 2007, DRUG DISCOVERIES THE, V1; LIU J, 1994, J ETHNOPHARMACOL, V42, P183; Saeed M, 2012, ANTIMICROB AGENTS CH, V56, P5365, DOI 10.1128/AAC.01256-12; Wu SF, 2012, J VIRAL HEPATITIS, V19, P364, DOI 10.1111/j.1365-2893.2011.01558.x; Wyles DL, 2009, ANTIMICROB AGENTS CH, V53, P2660, DOI 10.1128/AAC.01546-08; Wyles DL, 2007, J VIROL, V81, P3005, DOI 10.1128/JVI.02083-06; Yi ZG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001255	46	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-3542	1872-9096		ANTIVIR RES	Antiviral Res.	MAR	2015	115						39	47		10.1016/j.antiviral.2014.12.018		9	Pharmacology & Pharmacy; Virology	Pharmacology & Pharmacy; Virology	CC2NJ	WOS:000350181600005		
J	Matsuoka, Y; Yoshida, R; Nakayama, H; Nagata, M; Hirosue, A; Tanaka, T; Kawahara, K; Nakagawa, Y; Sakata, J; Arita, H; Hiraki, A; Shinohara, M				Matsuoka, Yuichiro; Yoshida, Ryoji; Nakayama, Hideki; Nagata, Masashi; Hirosue, Akiyuki; Tanaka, Takuya; Kawahara, Kenta; Nakagawa, Yoshihiro; Sakata, Jyunki; Arita, Hidetaka; Hiraki, Akimitsu; Shinohara, Masanori			The tumour stromal features are associated with resistance to 5-FU-based chemoradiotherapy and a poor prognosis in patients with oral squamous cell carcinoma	APMIS			English	Article						Oral squamous cell carcinoma (OSCC); cancer-associated fibroblasts (CAFs); tumour-associated macrophages (TAMs); prognosis; resistance	CANCER-ASSOCIATED FIBROBLASTS; NECK-CANCER; MACROPHAGES; PROGRESSION; HEAD; PHENOTYPE; INVASION; GROWTH; POLARIZATION; FLUOROURACIL	It has been increasingly recognized that the tumour microenvironment is a critical factor involved in cancer progression. However, little is known about the clinical value of the stromal features in oral squamous cell carcinoma (OSCC). The purpose of this study was to determine the clinical significance of cancer-associated fibroblasts (CAFs) and tumour-associated macrophages (TAMs) in OSCC. OSCC specimens were obtained from 60 patients who underwent surgery following 5-fluorouracil-based chemoradiotherapy. Paraffin-embedded sections obtained from biopsy specimens were immunohistochemically analysed. The associations among CAFs, TAMs and various clinicopathological features were examined, and the effects of CAFs and TAMs on the prognosis were evaluated. In the group with a high level of CAFs, the incidence of advanced pT- and pN-stage cases was significantly higher than that in the group with the low level. A high TAMs tumour expression was significantly correlated with a poor response to preoperative chemoradiotherapy. A Kaplan-Meier analysis revealed that higher numbers of CAFs and TAMs were significantly correlated with a poor prognosis. These findings suggest that TAMs are a potential biomarker for predicting the clinical response to 5-FU-based chemoradiotherapy, and the expression status of the CAFs and TAMs may be useful for making treatment decisions to improve the survival of OSCC patients.	[Matsuoka, Yuichiro; Yoshida, Ryoji; Nakayama, Hideki; Nagata, Masashi; Hirosue, Akiyuki; Tanaka, Takuya; Kawahara, Kenta; Nakagawa, Yoshihiro; Sakata, Jyunki; Arita, Hidetaka; Hiraki, Akimitsu; Shinohara, Masanori] Kumamoto Univ, Grad Sch Life Sci, Dept Oral Surg, Kumamoto 8608556, Japan; Kumamoto Univ, Grad Sch Life Sci, Dept Maxillofacial Surg, Kumamoto 8608556, Japan	Yoshida, R (reprint author), Kumamoto Univ, Grad Sch Life Sci, Dept Oral & Maxillofacial Surg, Chuo Ku, Honjo 1-1-1, Kumamoto 8608556, Japan.	ryoshida1126@gmail.com			Ministry of Education, Culture, Sports, Science and Technology, a Japan	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology, a Japan Grant-in-Aid for Research Activity Start-up (R.Y.). We thank Professor Brian Quinn for proofreading the manuscript.	Marsh D, 2011, J PATHOL, V223, P470, DOI 10.1002/path.2830; Grugan KD, 2010, P NATL ACAD SCI USA, V107, P11026, DOI 10.1073/pnas.0914295107; Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Polanska UM, 2013, J CELL PHYSIOL, V228, P1651, DOI 10.1002/jcp.24347; Yoshikawa K, 2012, CANCER SCI, V103, P2012, DOI 10.1111/j.1349-7006.2012.02411.x; Weizman N, 2014, ONCOGENE, V33, P3812, DOI 10.1038/onc.2013.357; Comito G, 2014, ONCOGENE, V33, P2423, DOI 10.1038/onc.2013.191; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Hammes LS, 2007, GYNECOL ONCOL, V105, P157, DOI 10.1016/j.ygyno.2006.11.023; Leek RD, 1996, CANCER RES, V56, P4625; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Reinartz S, 2014, INT J CANCER, V134, P32, DOI 10.1002/ijc.28335; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Komohara Y, 2014, CANCER SCI, V105, P1, DOI 10.1111/cas.12314; Ono S, 2013, CHEST, V143, P963, DOI 10.1378/chest.12-0913; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Barcellos-Hoff MH, 2013, NAT REV CANCER, V13, P511, DOI 10.1038/nrc3536; Shah JP, 2009, ORAL ONCOL, V45, P394, DOI 10.1016/j.oraloncology.2008.05.017; Jung DW, 2010, INT J CANCER, V127, P332, DOI 10.1002/ijc.25060; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hoshino A, 2011, CANCER RES, V71, P4769, DOI 10.1158/0008-5472.CAN-10-3228; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; MILAS L, 1987, CANCER RES, V47, P1069; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Fujii N, 2012, J ORAL PATHOL MED, V41, P444, DOI 10.1111/j.1600-0714.2012.01127.x; Ito TK, 2007, ONCOGENE, V26, P7194, DOI 10.1038/sj.onc.1210535; Herrera M, 2013, CANCER SCI, V104, P437, DOI 10.1111/cas.12096; Shigeoka M, 2013, CANCER SCI, V104, P1112, DOI 10.1111/cas.12188; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; YAMAMOTO E, 1983, CANCER, V51, P2175, DOI 10.1002/1097-0142(19830615)51:12<2175::AID-CNCR2820511205>3.0.CO;2-M; DesWever O, 2008, INT J CANCER, V123, P2229; Jinushi M, 2012, AM J CANCER RES, V2, P529; Ohri CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021874; Shimosato Y, 1971, JPN J CLIN ONCOL, V1, P19	42	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0903-4641	1600-0463		APMIS	APMIS	MAR	2015	123	3					205	214		10.1111/apm.12344		10	Immunology; Microbiology; Pathology	Immunology; Microbiology; Pathology	CC4CP	WOS:000350298700005		
J	Gurzu, S; Kadar, Z; Sugimura, H; Bara, T; Bara, T; Halmaciu, I; Jung, I				Gurzu, Simona; Kadar, Zoltan; Sugimura, Haruhiko; Bara, Tivadar; Bara, Tivadar, Jr.; Halmaciu, Ioana; Jung, Ioan			Gastric cancer in young vs old Romanian patients: immunoprofile with emphasis on maspin and mena protein reactivity	APMIS			English	Article						Gastric cancer; maspin; mena protein; angiogenesis; microsatellite status	EXPRESSION; PROGNOSIS; DIFFUSE	Increasing number of early-onset gastric carcinomas (GCs) and controversial results regarding the differences among young and older patients with this type of cancer are the reasons why correlation of clinicopathological factors with molecular markers is necessary. The aim of our study was to compare the demographic, clinical and immunohistochemical (IHC) aspects in Romanian patients with GC diagnosed below and above 45years old. In 191 samples provided from patients with GC, the clinicopathological parameters were correlated with a panel of 15 antibodies: E-cadherin, HER-2, VEGF, CD31, CD105, COX-2, maspin, bax, bcl-2, p53, Ki67, MLH-1, MSH-2, mena protein and vimentin. Compared to the conventional cases, GCs diagnosed below 45years old were more frequently located at the gastroesophageal junction and presented a higher percentage of lymph node metastases. The diffuse type E-cadherin/mena/p53/Ki67/bax-negative cases that displayed nuclear maspin positivity were also more frequently in younger patients. The intestinal type early-onset GCs were the most angiogenic ones, the apoptotic rate being lower than in the intestinal type GCs of the aged. Compared to the conventional cases, in the early-onset GCs the nuclear maspin-mediated antiproliferative activity is more intense in diffuse type while the mena-dependent tumor cell proliferation is more characteristic for intestinal type GCs.	[Gurzu, Simona; Kadar, Zoltan; Jung, Ioan] Univ Med & Pharm, Dept Pathol, Targu Mures 540139, Romania; [Kadar, Zoltan] Univ Med & Pharm, Dept Oncol, Targu Mures 540139, Romania; [Bara, Tivadar; Bara, Tivadar, Jr.] Univ Med & Pharm, Dept Surg, Targu Mures 540139, Romania; [Sugimura, Haruhiko] Hamamatsu Univ Sch Med, Dept Tumor Pathol, Hamamatsu, Shizuoka 4313192, Japan; [Halmaciu, Ioana] Univ Med & Pharm, Dept Anat & Embryol, Targu Mures 540139, Romania	Gurzu, S (reprint author), Univ Med & Pharm, Dept Pathol, 38 Ghe Marinescu St, Targu Mures 540139, Romania.	simonagurzu@yahoo.com			research projects frame - Romanian government [POSDRU/159/1.5/S/136893]; team research project - University of Medicine and Pharmacy of Tirgu-Mures, Romania [POS-UMFTGM-CC-13-01-V01, No 15/16189/2013]; Studium foundation	This study was partially supported by the research projects frame POSDRU/159/1.5/S/136893 funded by the Romanian government and the team research project POS-UMFTGM-CC-13-01-V01, No 15/16189/2013 funded by the University of Medicine and Pharmacy of Tirgu-Mures, Romania, and Studium foundation.	Fitzgerald RC, 2010, J MED GENET, V47, P436, DOI 10.1136/jmg.2009.074237; Kim M, 2012, CARCINOGENESIS, V33, P2344, DOI 10.1093/carcin/bgs280; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Gurzu S, 2013, BIOMED RES INT, DOI 10.1155/2013/365192; Gunther T, 2000, MODERN PATHOL, V13, P621, DOI 10.1038/modpathol.3880107; Kim BS, 2014, SURGERY, V155, P1030, DOI 10.1016/j.surg.2013.08.016; Kim KH, 2014, WORLD J GASTROENTERO, V20, P3369, DOI 10.3748/wjg.v20.i12.3369; Yao T, 2006, WORLD J GASTROENTERO, V12, P2510; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31; Aoyagi Keishiro, 2013, World J Crit Care Med, V2, P48, DOI 10.5492/wjccm.v2.i4.48; Boku N, 2014, GASTRIC CANCER, V17, P1, DOI 10.1007/s10120-013-0252-z; Edge SB, 2010, AJCC CANC STAGING MA, P145; Gurzu S, 2013, NEOPLASMA, V60, P373, DOI 10.4149/neo_2013_049; Gurzu S, 2014, WORLD J CLI IN PRESS; International Agency for Research. Stomach cancer, EST INC MORT PREV WO; Isobe T, 2013, ONCOL REP, V30, P43, DOI 10.3892/or.2013.2467; Kim YJ, 2008, CANCER INVEST, V26, P152, DOI 10.1080/07357900701518909; Koyama Y, 2010, EXP THER MED, V1, P627, DOI 10.3892/etm_00000098; Lauwers GY, 2010, WHO CLASSIFICATION T, V98, P48; Schildberg CW, 2014, ADV MED SCI-POLAND, V59, P142, DOI 10.1016/j.advms.2014.03.002; Suzuki S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-659; Tereanu C, 2013, EUR J CANCER PREV, V22, P199, DOI 10.1097/CEJ.0b013e3283581d90	22	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0903-4641	1600-0463		APMIS	APMIS	MAR	2015	123	3					223	233		10.1111/apm.12347		11	Immunology; Microbiology; Pathology	Immunology; Microbiology; Pathology	CC4CP	WOS:000350298700007		
J	Zhang, Y; Okada, R; Isaka, M; Tatsuno, I; Isobe, KI; Hasegawa, T				Zhang, Yan; Okada, Ryo; Isaka, Masanori; Tatsuno, Ichiro; Isobe, Ken-Ichi; Hasegawa, Tadao			Analysis of the roles of NrdR and DnaB from Streptococcus pyogenes in response to host defense	APMIS			English	Article						Streptococcus pyogenes; NrdR; DnaB; host defense	GROUP-A STREPTOCOCCUS; 2-DIMENSIONAL GEL-ELECTROPHORESIS; SHOCK-LIKE SYNDROME; ESCHERICHIA-COLI; RIBONUCLEOTIDE REDUCTASES; IN-VIVO; REGULATORY SYSTEM; EXPRESSION ANALYSIS; OXIDATIVE STRESS; PROTEIN	Toxic shock syndrome caused by Streptococcus pyogenes (S. pyogenes) is a re-emerging infectious disease. Many virulence-associated proteins play important roles in its pathogenesis and the production of these proteins is controlled by many regulatory factors. CovS is one of the most important two-component sensor proteins in S. pyogenes, and it has been analyzed extensively. Our recent analyses revealed the existence of a transposon between covS and nrdR in several strains, and we speculated that this insertion has some importance. Hence, we examined the significances of the NrdR stand-alone regulator and DnaB, which is encoded by the gene located immediately downstream of nrdR in S. pyogenes infection. We established an nrdR-only knockout strain, and both nrdR and partial dnaB knockout strain. These established knockout strains exhibited a deteriorated response to H2O2 exposure. nrdR and partial dnaB knockout strain was more easily killed by human polynuclear blood cells, but the nrdR-only knockout strain had no significant difference compared to wild type in contrast to the combined knockout strain. In addition, the mouse infection model experiment illustrated that nrdR and partial dnaB knockout strain, but not the nrdR-only knockout strain, was less virulent compared with the parental strain. These results suggest that DnaB is involved in response to host defense.	[Zhang, Yan; Okada, Ryo; Isaka, Masanori; Tatsuno, Ichiro; Hasegawa, Tadao] Nagoya City Univ, Grad Sch Med Sci, Dept Bacteriol, Nagoya, Aichi 4678601, Japan; [Zhang, Yan; Isobe, Ken-Ichi] Nagoya Univ, Grad Sch Med, Dept Immunol, Nagoya, Aichi 4648601, Japan	Hasegawa, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Bacteriol, Mizuho Ku, 1 Kawasumi Mizuho Cho, Nagoya, Aichi 4678601, Japan.	tadaoh@med.nagoya-cu.ac.jp			MEXT/JSPSKAKENHI Grant from the Ministry of Education, Science and Culture of the Japanese government [24590531]	This study was supported by MEXT/JSPSKAKENHI Grant Number 24590531 from the Ministry of Education, Science and Culture of the Japanese government. The authors thank Enago (www.enago.jp) for the English language review.	Maher RL, 2011, J CELL BIOCHEM, V112, P2672, DOI 10.1002/jcb.23211; Nakamura T, 2004, ARCH MICROBIOL, V181, P74, DOI 10.1007/s00203-003-0632-6; LANCEFIELD RC, 1957, J EXP MED, V106, P525, DOI 10.1084/jem.106.4.525; Tatsuno I, 2007, MICROBIOL-SGM, V153, P4253, DOI 10.1099/mic.0.2007/009555-0; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Lukomski S, 2000, INFECT IMMUN, V68, P535, DOI 10.1128/IAI.68.2.535-542.2000; Monje-Casas F, 2001, J BIOL CHEM, V276, P18031, DOI 10.1074/jbc.M011728200; Federle MJ, 1999, J BACTERIOL, V181, P3649; CONE LA, 1987, NEW ENGL J MED, V317, P146, DOI 10.1056/NEJM198707163170305; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Borovok I, 2004, MOL MICROBIOL, V54, P1022, DOI 10.1111/j.1365-2958.2004.04325.x; Bailey S, 2007, NUCLEIC ACIDS RES, V35, P4728, DOI 10.1093/nar/gkm507; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Bird LE, 2000, BIOCHEMISTRY-US, V39, P171, DOI 10.1021/bi9918801; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; HAUSER AR, 1991, J CLIN MICROBIOL, V29, P1562; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Ato M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003455; Case ED, 2011, J BACTERIOL, V193, P4396, DOI 10.1128/JB.00294-11; Cole JN, 2010, MBIO, V1, DOI 10.1128/mBio.00191-10; GIBERT I, 1990, MOL GEN GENET, V220, P400, DOI 10.1007/BF00391745; Grinberg I, 2006, J BACTERIOL, V188, P7635, DOI 10.1128/JB.00903-06; Grinberg I, 2009, J BACTERIOL, V191, P1169, DOI 10.1128/JB.01145-08; Hasegawa T, 2002, CURR MICROBIOL, V45, P13, DOI 10.1007/s00284-001-0042-4; Hasegawa T, 2010, APMIS, V118, P167, DOI 10.1111/j.1600-0463.2009.02574.x; Hasegawa T, 2002, ARCH MICROBIOL, V177, P451, DOI 10.1007/s00203-002-0412-8; Hasegawa T, 2010, MICROBIOL-SGM, V156, P184, DOI 10.1099/mic.0.031955-0; Hoopman TC, 2011, INFECT IMMUN, V79, P745, DOI 10.1128/IAI.01060-10; Ichikawa M, 2011, MICROBIOL-SGM, V157, P3187, DOI 10.1099/mic.0.050534-0; Ikebe T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000832; Indiani C, 2013, FRONT BIOSCI-LANDMRK, V18, P312, DOI 10.2741/4102; Inokuchi H, 2013, J BIOL CHEM, V288, P32952, DOI 10.1074/jbc.M113.507772; Jordan A, 1996, MOL MICROBIOL, V19, P777, DOI 10.1046/j.1365-2958.1996.424950.x; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Masuno K, 2014, J MED MICROBIOL, V63, P504, DOI 10.1099/jmm.0.070300-0; Mesa P, 2006, J MOL BIOL, V357, P1077, DOI 10.1016/j.jmb.2005.12.027; Minami M, 2010, ANTIMICROB AGENTS CH, V54, P98, DOI 10.1128/AAC.00804-09; MIRRETT S, 1979, J CLIN MICROBIOL, V10, P482; Mowa MB, 2009, J BACTERIOL, V191, P985, DOI 10.1128/JB.01409-08; NAKAYAMA N, 1984, J BIOL CHEM, V259, P88; Nordlund Pär, 2006, Annu Rev Biochem, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Okada N, 1998, MICROBIOL-SGM, V144, P3079; Panosa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011328; Prieto-Alamo MJ, 2000, J BIOL CHEM, V275, P13398, DOI 10.1074/jbc.275.18.13398; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; REICHARDT W, 1992, FEMS MICROBIOL LETT, V100, P313, DOI 10.1111/j.1574-6968.1992.tb05721.x; Roca I, 2008, J BACTERIOL, V190, P4849, DOI 10.1128/JB.00185-08; Rodionov DA, 2005, TRENDS GENET, V21, P385, DOI 10.1016/j.tig.2005.05.011; Sawai J, 2007, ANTIMICROB AGENTS CH, V51, P461, DOI 10.1128/AAC.00539-06; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Tanaka M, 2005, ANTIMICROB AGENTS CH, V49, P88, DOI 10.1128/AAC.49.1.88-96.2005; Tatsuno I, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-144; Torrents E, 2007, J BACTERIOL, V189, P5012, DOI 10.1128/JB.00440-07; West SC, 1996, CELL, V86, P177, DOI 10.1016/S0092-8674(00)80088-4	56	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0903-4641	1600-0463		APMIS	APMIS	MAR	2015	123	3					252	259		10.1111/apm.12340		8	Immunology; Microbiology; Pathology	Immunology; Microbiology; Pathology	CC4CP	WOS:000350298700011		
J	Obara, S				Obara, Shin'ya			Dynamic-characteristics analysis of an independent microgrid consisting of a SOFC triple combined cycle power generation system and large-scale photovoltaics	APPLIED ENERGY			English	Article						SOFC triple combined cycle; Independent microgrid; Inertial force; Large-scale solar power plant	ENERGY-STORAGE SYSTEM; FUEL-CELL; LOAD; STABILIZATION; PERFORMANCE; OPERATION; CAPACITY; PLANTS; MODEL	The solid oxide fuel cell triple combined cycle (SOFC-TCC) power generation system considered in this study is of rated power 1.4 MW, and it consists of SOFC (542 kW), a gas turbine (G/T, 550 kW), and a steam turbine (S/T, 308 kW). The relation of the frequency deviation based on the difference between supply and demand of an independent microgrid that interconnects the SOFC-TCC system and large-scale photovoltaics was investigated through numerical analysis. Because the stabilization of the load fluctuations of the SOFC and S/T required 1.8 to 2 h, control of load fluctuations occurring over periods of 2 h or less was mainly determined by the governor-free control of the G/T. Furthermore, the power characteristics (frequency) owing to cyclic fluctuations (changes occurring over a period of several minutes or less) to sustained fluctuations (changes occurring over a period exceeding 20 min) of a microgrid with large-scale photovoltaics was found to be strongly influenced by the magnitude of the inertial force of the G/T and SIT. From the analysis results, long-term supply-and-demand fluctuations, such as changes occurring seasonally and down to a period of 1 day, are mainly controlled by output adjustment of the SOFC and S/T, whereas the operation controlled by the setting of the governor-free control of the G/T and the inertial system of rotary machines is appropriate for short-term power fluctuations. (C) 2014 Elsevier Ltd. All rights reserved.	Kitami Inst Technol, Power Engn Lab, Dep Elect & Elect Engn, Kitami, Hokkaido 0908507, Japan	Obara, S (reprint author), Kitami Inst Technol, Power Engn Lab, Dep Elect & Elect Engn, Koen Cho 165, Kitami, Hokkaido 0908507, Japan.	obara@mail.kitami-it.ac.jp					Nandar CSA, 2013, RENEW ENERG, V56, P16, DOI 10.1016/j.renene.2012.10.032; Amita M, 2012, INT J ELECTR POWER E, V34, P1; [Anonymous], 2012, FUEL CELLS B, V7, P5; Choi JH, 2014, APPL THERM ENG, V71, P301, DOI 10.1016/j.applthermaleng.2014,07.001; Ou TC, 2014, ENERGY, V66, P314, DOI 10.1016/j.energy.2014.01.042; [Anonymous], 1994, IEEE PES 94; [Anonymous], 2014, OUTP FLUCT ALL METH; XU JG, 1989, AICHE J, V35, P88, DOI 10.1002/aic.690350109; [Anonymous], 2014, EL POW SUPPL DAT 201; Saejia M, 2011, PHYSICA C, V471, P1385, DOI 10.1016/j.physc.2011.05.200; Zhang XW, 2010, J POWER SOURCES, V195, P685, DOI 10.1016/j.jpowsour.2009.07.045; Kandepu R, 2007, ENERGY, V32, P406, DOI 10.1016/j.energy.2006.07.034; Ngamroo I, 2012, INT J ELEC POWER, V43, P969, DOI 10.1016/j.ijepes.2012.05.051; [Anonymous], 2003, C40225 TASK FORC CIG; Arsalis A, 2008, J POWER SOURCES, V181, P313, DOI 10.1016/j.jpowsour.2007.11.104; Baba K, 2002, IEEJ T POWER ENERGY, V122, P392; Barelli L, 2013, APPL ENERG, V110, P173, DOI 10.1016/j.apenergy.2013.04.011; Bignell W, 1999, ELECTR POW SYST RES, V51, P153, DOI 10.1016/S0378-7796(98)00163-1; Darcovich K, 2013, APPL ENERG, V111, P853, DOI 10.1016/j.apenergy.2013.03.088; Daud MZ, 2013, ENERG CONVERS MANAGE, V73, P256, DOI 10.1016/j.enconman.2013.04.013; Giovanni De F, 2014, APPL ENERG, V113, P1686; Hafsia A, 2011, ENRGY PROCED, V6, P643, DOI 10.1016/j.egypro.2011.05.074; Jia HJ, 2014, INT J ELEC POWER, V54, P516, DOI 10.1016/j.ijepes.2013.07.025; Koohi-Kamali S, 2014, ENERG CONVERS MANAGE, V84, P562, DOI 10.1016/j.enconman.2014.04.072; Lukas MD, 2001, IEEE T ENERGY CONVER, V16; Manoj D, 2010, CURR APPL PHYS, V10, P265; Manoj D, 2011, RENEW ENERG, V36, P1693; Manuel Jesus V, 2013, APPL ENERG, V105, P170; Marcos J, 2014, SOL ENERGY, V99, P28, DOI 10.1016/j.solener.2013.10.037; Padulles J, 2000, J POWER SOURCES, V86, P495, DOI 10.1016/S0378-7753(99)00430-9; Qi Zhang, 2013, Applied Energy, V112, DOI 10.1016/j.apenergy.2013.03.073; RAGHAVAN MR, 1989, MECH MACH THEORY, V24, P499, DOI 10.1016/0094-114X(89)90006-2; Rodolfo D, 2014, APPL ENERG, V115, P242; Samir S, 2012, APPL ENERG, V96, P222; Stiller C, 2005, P ASME TURB EXP; Taniguchi H, 2009, MODELING SIMULATION; Tao Ma, 2013, Applied Energy, V112, DOI 10.1016/j.apenergy.2012.12.004; Thomas P, 1999, SIMULATION IND PROCE; Thorud B, 2004, P FUEL CELL FOR LUC; Vachirasricirikul S, 2011, APPL ENERG, V88, P3860, DOI 10.1016/j.apenergy.2011.04.055; Wang JL, 2011, ENRGY PROCED, V12, DOI 10.1016/j.egypro.2011.10.132; Xiandong Ma, 2013, Applied Energy, V112, DOI 10.1016/j.apenergy.2012.12.035; Yinjiao Xing, 2014, Applied Energy, V113, DOI 10.1016/j.apenergy.2013.07.008	43	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0306-2619	1872-9118		APPL ENERG	Appl. Energy	MAR 1	2015	141						19	31		10.1016/j.apenergy.2014.12.013		13	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CB8LF	WOS:000349880400003		
J	Saga, K; Hasegawa, F; Miyagi, S; Atobe, S; Okada, S; Imou, K; Osaka, N; Yamagishi, T				Saga, Kiyotaka; Hasegawa, Fumio; Miyagi, Syoko; Atobe, Sueko; Okada, Shigeru; Imou, Kenji; Osaka, Noriko; Yamagishi, Tetsu			Comparative evaluation of wet and dry processes for recovering hydrocarbon from Botryococcus Braunii	APPLIED ENERGY			English	Article						Botiyococcus braunii; Biofuel; Thermal pretreatment; Concentrated slurry; Solvent extraction	THERMOCHEMICAL LIQUEFACTION; HYDROTHERMAL LIQUEFACTION; BIOFUEL PRODUCTION; GREEN MICROALGAE; OIL EXTRACTION; ENERGY; BIODIESEL; BIOMASS; GROWTH; LIPIDS	This study aimed to document the material balance and evaluate the energy profit ratios (EPRs) of two processes for recovering hydrocarbon from the green microalgae Botiyococcus braunii, which produces hydrocarbon intercellularly, releases it extracellularly, and accumulates it in the extracellular matrix in colony-form. The first is a wet process that elutes an extraction inhibitor through heat, eliminates it through solid-liquid separation, and extracts a hydrocarbon using hexane. The second is a dry process that extracts hydrocarbon by hexane after drying. The EPR of the wet process (3.5) was approximately twice that of the dry process (1.8). Therefore, hydrocarbon can be efficiently recovered from B. braunii without drying. (C) 2014 Elsevier Ltd. All rights reserved.	[Saga, Kiyotaka] Biomat Tokyo Co Ltd, Chiba 2730864, Japan; [Hasegawa, Fumio; Miyagi, Syoko; Atobe, Sueko; Okada, Shigeru; Imou, Kenji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Osaka, Noriko; Yamagishi, Tetsu] Tokyo Gas Co Ltd, Tech Res Inst, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Saga, K (reprint author), Biomat Tokyo Co Ltd, 1-17-25-109 Kitahoncho, Chiba 2730864, Japan.	k.saga@biomt.jp; PXL05260@nifty.ne.jp; miyagi@bme.en.a.u-tokyo.ac.jp; atobe@bme.en.a.u-tokyo.ac.jp; aokada@mail.ecc.u-tokyo.ac.jp; aimou@mail.ecc.u-tokyo.ac.jp; nosaka@tokyo-gas.co.jp; tetsu-y@tokyo-gas.co.jp			New Energy and Industrial Technology Development Organization (NEDO)	This study was funded by a project for the Strategic Development of Next-Generation Bioenergy Utilization Technology of the New Energy and Industrial Technology Development Organization (NEDO), entitled "Efficient Production of Hydrocarbon from Microalgae".	Andrich G, 2006, ACTA ALIMENT HUNG, V35, P195, DOI 10.1556/AAlim.35.2006.2.6; Patil PD, 2012, FUEL, V97, P822, DOI 10.1016/j.fuel.2012.02.037; FRENZ J, 1989, BIOTECHNOL BIOENG, V34, P755, DOI 10.1002/bit.260340605; Demirbas A, 2011, APPL ENERG, V88, P3541, DOI 10.1016/j.apenergy.2010.12.050; Yoshimura T, 2013, BIORESOURCE TECHNOL, V133, P232, DOI 10.1016/j.biortech.2013.01.095; Barreiro DL, 2013, BIOMASS BIOENERG, V53, P113, DOI 10.1016/j.biombioe.2012.12.029; Mercer P, 2011, EUR J LIPID SCI TECH, V113, P539, DOI 10.1002/ejlt.201000455; Patil PD, 2011, BIORESOURCE TECHNOL, V102, P118, DOI 10.1016/j.biortech.2010.06.031; Okada S, 1995, J APPL PHYCOL, V7, P555, DOI 10.1007/BF00003942; Sawayama S, 1999, BIOMASS BIOENERG, V17, P33, DOI 10.1016/S0961-9534(99)00019-7; Peralta-Ruiz Y, 2013, APPL ENERG, V101, P226, DOI 10.1016/j.apenergy.2012.06.065; Liu CZ, 2013, APPL ENERG, V102, P971, DOI 10.1016/j.apenergy.2012.08.016; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Eroglu E, 2010, BIORESOURCE TECHNOL, V101, P2359, DOI 10.1016/j.biortech.2009.11.043; Rawat I, 2013, APPL ENERG, V103, P444, DOI 10.1016/j.apenergy.2012.10.004; DOTE Y, 1994, FUEL, V73, P1855, DOI 10.1016/0016-2361(94)90211-9; Fortier MOP, 2014, APPL ENERG, V122, P73, DOI 10.1016/j.apenergy.2014.01.077; Kanda H, 2011, FUEL, V90, P1264, DOI 10.1016/j.fuel.2010.10.057; Xu LX, 2011, BIORESOURCE TECHNOL, V102, P5113, DOI 10.1016/j.biortech.2011.01.066; Razon LF, 2011, APPL ENERG, V88, P3507, DOI 10.1016/j.apenergy.2010.12.052; Kanda H, 2012, FUEL, V95, P88, DOI 10.1016/j.fuel.2011.11.064; Furuhashi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066483; INOUE S, 1994, BIOMASS BIOENERG, V6, P269, DOI 10.1016/0961-9534(94)90066-3; Isa A, 2011, J JPN PETROL INST, V54, P395, DOI 10.1627/jpi.54.395; Kita K, 2010, APPL ENERG, V87, P2420, DOI 10.1016/j.apenergy.2009.11.036; Lee AK, 2012, BIOMASS BIOENERG, V46, P89, DOI 10.1016/j.biombioe.2012.06.034; Magota A, 2012, BIORESOURCE TECHNOL, V123, P195, DOI 10.1016/j.biortech.2012.07.095; Rao AR, 2012, BIORESOURCE TECHNOL, V123, P528, DOI 10.1016/j.biortech.2012.07.009; Saga K, 2013, J JPN I ENERGY, V92, P1212, DOI [10.3775/jie.92.1212, DOI 10.3775/JIE.92.1212]; SAWAYAMA S, 1992, APPL MICROBIOL BIOT, V38, P135	30	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0306-2619	1872-9118		APPL ENERG	Appl. Energy	MAR 1	2015	141						90	95		10.1016/j.apenergy.2014.12.018		6	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CB8LF	WOS:000349880400009		
J	Harase, S				Harase, Shin			Quasi-Monte Carlo point sets with small t-values and WAFOM	APPLIED MATHEMATICS AND COMPUTATION			English	Article						Quasi-Monte Carlo method; Multivariate numerical integration; Digital net; (t, m, s)-net; Walsh figure of merit	HIGH-DIMENSIONAL INTEGRATION; DIGITAL NETS; CONSTRUCTION; SEQUENCES	The t-value of a (t, m, s)-net is an important criterion of point sets for quasi-Monte Carlo integration, and many point sets are constructed in terms of the t-values, as this leads to small integration error bounds. Recently, Matsumoto, Saito, and Matoba proposed the Walsh figure of merit (WAFOM) as a quickly computable criterion of point sets that ensures higher order convergence for function classes of very high smoothness. In this paper, we consider a search algorithm for point sets whose t-value and WAFOM are both small, so as to be effective for a wider range of function classes. For this, we fix digital (t, m, s)-nets with small t-values (e.g., Sobol' or Niederreiter-Xing nets) in advance, apply random linear scrambling, and select scrambled digital (t, m, s)-nets in terms of WAFOM. Experiments show that the resulting point sets improve the rates of convergence for smooth functions and are robust for non-smooth functions. (C) 2015 Elsevier Inc. All rights reserved.	Tokyo Inst Technol, Grad Sch Innovat Management, Meguro Ku, Tokyo 1528550, Japan	Harase, S (reprint author), Tokyo Inst Technol, Grad Sch Innovat Management, Meguro Ku, W9-115,2-12-1 Ookayama, Tokyo 1528550, Japan.	harase@craft.titech.ac.jp			 [24 7985];  [26730015];  [26310211]	The author is thankful to the anonymous referees for their valuable comments and suggestions. The author also wishes to express his gratitude to Professor Makoto Matsumoto at Hiroshima University and Professor Syoiti Ninomiya at Tokyo Institute of Technology for continuous encouragement and many helpful comments. The author was partially supported by Grant-in-Aid for JSPS Fellows 24 7985, Young Scientists (B) 26730015, and Scientific Research (B) 26310211.	Joe S, 2008, SIAM J SCI COMPUT, V30, P2635, DOI 10.1137/070709359; Novak E, 1996, NUMER MATH, V75, P79, DOI 10.1007/s002110050231; Dick J, 2013, ACTA NUMER, V22, P133, DOI 10.1017/S0962492913000044; Matousek J, 1998, J COMPLEXITY, V14, P527, DOI 10.1006/jcom.1998.0489; Dick J, 2013, SIAM J DISCRETE MATH, V27, P1335, DOI 10.1137/120893677; Dick J, 2007, SIAM J NUMER ANAL, V45, P2141, DOI 10.1137/060658916; Matsumoto M, 2014, MATH COMPUT, V83, P1233; Owen AB, 2003, STAT SINICA, V13, P1; Dick J., 2010, DIGITAL NETS SEQUENC; Dick J, 2009, MONTE CARLO AND QUASI-MONTE CARLO METHODS 2008, P73, DOI 10.1007/978-3-642-04107-5_5; Genz A, 1987, NUMERICAL INTEGRATIO, P337; Genz A.C., 1984, TOOLS METHODS LANGUA, P81; Glasserman P., 2004, STOCHASTIC MODELLING, V53; Goda T., 2014, MEAN SQUARE QUASIMON; Harase S., 2013, SEARCH EXTENSIBLE LO; L'Ecuyer P, 2009, FINANC STOCH, V13, P307, DOI 10.1007/s00780-009-0095-y; Matsumoto M., 2014, WALSH FIGURE MERIT D; Matsumoto M., 2013, SPRINGER P MATH STAT, V65, P569; Morohosi H, 2000, MONTE CARLO AND QUASI-MONTE CARLO METHODS 1998, P377; Niederreiter H., 1992, CBMS NSF REGIONAL C, V63; Ohori R., THESIS U TOKYO; Owen A. B., 1995, LECT NOTES STAT, V106, P299; Pirsic G, 2002, MONTE CARLO AND QUASI-MONTE CARLO METHODS 2000, P434; Pirsic G, 2001, J COMPLEXITY, V17, P827, DOI 10.1006/jcom.2001.0597; Sloan I. H., 1994, LATTICE METHODS MULT; Sobol' I. M., 1967, Zhurnal Vychislitel'noi Matematiki i Matematicheskoi Fiziki, V7; Suzuki K., 2014, WAFOM ABELIAN GROUPS; XING CP, 1995, ACTA ARITH, V73, P87; Yoshiki T., 2014, 11 INT C MONT CARL Q; Yoshiki T., HIROSHIMA M IN PRESS	30	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0096-3003	1873-5649		APPL MATH COMPUT	Appl. Math. Comput.	MAR 1	2015	254						318	326		10.1016/j.amc.2014.12.144		9	Mathematics, Applied	Mathematics	CB8BC	WOS:000349852200030		
J	Tabata, M; Eshima, N; Sakai, Y				Tabata, Minoru; Eshima, Nobuoki; Sakai, Yuusuke			Existence and computation of solutions to the initial value problem for the replicator equation of evolutionary game defined by the Dixit-Stiglitz-Krugman model in an urban setting: Concentration of workers motivated by disparity in real wages	APPLIED MATHEMATICS AND COMPUTATION			English	Article						Numerical solution; Evolutionary game; Replicator equation; Spatial economics; The Dixit-Stiglitz-Krugman model	CORE-PERIPHERY MODEL; ECONOMIC-GEOGRAPHY; SHORT-RUN; INCREASING RETURNS; SPATIAL ECONOMICS; COOPERATION; UNIQUENESS; EQUILIBRIA; NETWORKS; SYSTEM	Consider an evolutionary game whose payoffs are defined as the distribution of real wages. The distribution of real wages is determined by the Dixit-Stiglitz-Krugman model in an urban setting, and workers (players) move toward points that offer higher real wages and away from points that offer below-average real wages. This game is described by the replicator equation whose unknown function denotes the distribution of workers. The growth rate of population contains an operator that maps an unknown function to the distribution of real wages. We prove that if the elasticity of substitution and the transport costs are sufficiently small, then the initial value problem for this equation has a unique global solution. We obtain a numerical solution by making use of an iteration scheme. We prove estimates for approximation error in this numerical solution. Moreover we prove that if workers are concentrated at a point at the initial time, then the global solution converges to a long-run equilibrium attained when all workers are concentrated at the point. The highest growth rate is attained at the point and the pure best reply is given at the point. (C) 2015 Elsevier Inc. All rights reserved.	[Tabata, Minoru; Sakai, Yuusuke] Osaka Prefecture Univ, Dept Math Sci, Sakai, Osaka 5998531, Japan; [Eshima, Nobuoki] Oita Univ, Dept Stat, Oita 8795593, Japan	Tabata, M (reprint author), Osaka Prefecture Univ, Dept Math Sci, Sakai, Osaka 5998531, Japan.	mnrtabata@luck.ocn.ne.jp; eshima@med.oita-u.ac.jp; akagi.nango@gmail.com		Tabata, Minoru/0000-0003-3876-7437	Ministry of Education, Culture, Sports, Science and Technology of Japan [24540137]	We would like to express our deepest gratitude to the anonymous reviewers for their valuable suggestions. This work is supported by Grant-in-aid for Scientific Research (24540137), Ministry of Education, Culture, Sports, Science and Technology of Japan.	Deng XY, 2014, J THEOR BIOL, V361, P81, DOI 10.1016/j.jtbi.2014.07.009; KRUGMAN P, 1980, AM ECON REV, V70, P950; Wang Z, 2014, J THEOR BIOL, V349, P50, DOI 10.1016/j.jtbi.2014.01.037; Castro S, 2012, PAPERS REGIONAL SCI, V91, P401; Cressman Ross, 2014, P NAT ACAD SCI, V111; Fujita M, 2010, JPN ECON REV, V61, P1, DOI 10.1111/j.1468-5876.2009.00504.x; Hofbauer J, 1988, THEORY EVOLUTION DYN; Ikeda K, 2012, J ECON DYN CONTROL, V36, P754, DOI 10.1016/j.jedc.2011.08.014; KRUGMAN P, 1991, J POLIT ECON, V99, P483, DOI 10.1086/261763; Krugman P., 1996, SELF ORG EC; Mossay P., 2011, F811 CIRJE U TOK; Mossay P, 2006, J URBAN ECON, V59, P389, DOI 10.1016/j.jue.2005.10.007; Mossay P, 2003, REG SCI URBAN ECON, V33, P419, DOI 10.1016/S0166-0462(02)00041-8; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Pavlidis NG, 2007, APPL MATH COMPUT, V184, P93, DOI 10.1016/j.amc.2005.11.177; Tabata M, 2014, APPL MATH COMPUT, V234, P339, DOI 10.1016/j.amc.2014.02.014; Tabata M, 2013, NONLINEAR ANAL-REAL, V14, P2116, DOI 10.1016/j.nonrwa.2013.04.001; Tabata M., 2014, IMA J APPL MATH; Tabata M, 2015, NONLINEAR ANAL-REAL, V23, P26, DOI 10.1016/j.nonrwa.2014.11.004; Tabata M., ABSTR APPL IN PRESS; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Wang Z, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/3/033041; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep03055; Wang Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00369; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep02470; Wang Zhen, 2014, J THEOR BIOL, V349, P349; Weibull J. W., 1997, EVOLUTIONARY GAME TH	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0096-3003	1873-5649		APPL MATH COMPUT	Appl. Math. Comput.	MAR 1	2015	254						419	451		10.1016/j.amc.2015.01.029		33	Mathematics, Applied	Mathematics	CB8BC	WOS:000349852200038		
J	Yoshihara, N; Ueno, T; Takagi, A; Trejo, JAO; Haruna, K; Suga, Y; Komatsu, M; Tanaka, K; Ikeda, S				Yoshihara, Nagisa; Ueno, Takashi; Takagi, Atsushi; Trejo, Juan Alejandro Oliva; Haruna, Kunitaka; Suga, Yasushi; Komatsu, Masaaki; Tanaka, Keiji; Ikeda, Shigaku			The significant role of autophagy in the granular layer in normal skin differentiation and hair growth	ARCHIVES OF DERMATOLOGICAL RESEARCH			English	Article						Autophagy; Keratinocyte; Keratinization; Hair growth; Keratohyalin granule; Keratinization-related proteins	BETA-CELL MASS; EPIDERMAL-KERATINOCYTES; INFLAMMATORY RESPONSES; DEFICIENT MICE; EXPRESSION; ACTIVATION; MECHANISMS; DISEASE; BARRIER; MARKER	As a major intracellular degradation system, autophagy contributes to the maintenance of skin keratinocyte homeostasis. However, the precise role of autophagy in skin differentiation has not been fully investigated. To clarify whether autophagy plays a role in skin differentiation and maturation, autophagy-related gene 7 (Atg7)-deficient mice were generated. Atg7-deficient mice cannot survive for more than 24 h after birth. Therefore, the skins of Atg7-deficient mice and wild-type mice (as a control) were grafted onto severe combined immunodeficient mice. The resulting morphological and pathological changes were monitored for 28 days. Histopathological examination revealed acanthosis, hyperkeratosis, and abnormal hair growth in the skin grafts from the Atg7-deficient mice. Immune-density analysis of the skin grafts revealed reduced immunostaining of keratinization-related proteins, including loricrin, filaggrin, and involucrin, in the skin grafts from the Atg7-deficient mice. Furthermore, quantitative RT-PCR and Western blot analyses revealed the reduced expression of these three keratinization-related proteins in the skin grafts from the Atg7-deficient mice. Morphometric analysis using electron microscopy further revealed a reduction in the number and diameter of the keratohyalin and trichohyalin granules in these skin grafts. The differences were maintained for at least 1 month after transplantation. These results show that autophagy has a significant role in epidermal keratinization and hair growth until a certain stage of maturation.	[Yoshihara, Nagisa; Takagi, Atsushi; Haruna, Kunitaka; Suga, Yasushi; Ikeda, Shigaku] Juntendo Univ Grad Sch Med, Dept Dermatol & Allergol, Bunkyo Ku, Tokyo 1138421, Japan; [Ueno, Takashi; Trejo, Juan Alejandro Oliva] Juntendo Univ Grad Sch Med, Div Prote & Biomol Sci, Res Support Ctr, Tokyo, Japan; [Komatsu, Masaaki; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Prot Metab Project, Tokyo 113, Japan	Ikeda, S (reprint author), Juntendo Univ Grad Sch Med, Dept Dermatol & Allergol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	ikeda@juntendo.ac.jp			Ministry of Health, Labor, and Welfare, Japan [H23-028]; TU [18076005]; Takeda Science Foundation (TU)	We are grateful to Dr. Norihito Tada, Dr. Takatoshi Kuhara, and the staff of the Atopy Research Center for breeding the Atg7-deficient mice. We thank Mr. Atsushi Furuhata and Ms. Yuko Kojima of the Laboratory of Biomedical Imaging Research, and Dr. Masato Koike and Mr. Mitsutaka Yoshida of the Laboratory of Ultrastructure Research and the Laboratory of Molecular and Biochemical Research, Research Support Center, Juntendo University Graduate School of Medicine, Tokyo, Japan, for technical assistance. This work was supported, in part, by the "Research on Measures for Intractable Diseases" Project matching fund subsidy (H23-028) from the Ministry of Health, Labor, and Welfare, Japan (AT, SI), a Grant-in-aid for Scientific Research on Priority Areas (18076005 to MK, TU), and a Research Grant from the Takeda Science Foundation (TU).	Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Leung DYM, 2013, ALLERGOL INT, V62, P151, DOI 10.2332/allergolint.13-RAI-0564; Fujishima Y, 2011, ARCH BIOCHEM BIOPHYS, V506, P223, DOI 10.1016/j.abb.2010.12.009; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Aymard E, 2011, EXP DERMATOL, V20, P263, DOI 10.1111/j.1600-0625.2010.01157.x; Eckhart L, 2000, J INVEST DERMATOL, V115, P1148, DOI 10.1046/j.1523-1747.2000.00205.x; Elias PM, 2005, J INVEST DERMATOL, V125, P183, DOI 10.1111/j.0022-202X.2005.23668.x; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Lippens S, 2000, CELL DEATH DIFFER, V7, P1218, DOI 10.1038/sj.cdd.4400785; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Rossiter H, 2013, J DERMATOL SCI, V71, P67, DOI 10.1016/j.jdermsci.2013.04.015; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Boehncke WH, 2007, CLIN DERMATOL, V25, P596, DOI 10.1016/j.clindermatol.2007.08.014; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI 10.1056/NEJMra1205406; Haruna K, 2008, J DERMATOL SCI, V52, P213, DOI 10.1016/j.jdermsci.2008.07.005; Juanes S, 2009, J INVEST DERMATOL, V129, P1429; Lee HM, 2011, J IMMUNOL, V186, P1248, DOI 10.4049/jimmunol.1001954; Rendl M, 2002, J INVEST DERMATOL, V119, P1150, DOI 10.1046/j.1523-1747.2002.19532.x; Shi JH, 2012, ARCH DERMATOL RES, V304, P209, DOI 10.1007/s00403-012-1204-x; Sukseree S, 2012, PLOS ONE, V7, pe389; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Wang RC, 2011, J INVEST DERMATOL, V131, P990, DOI 10.1038/jid.2010.423	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-3696	1432-069X		ARCH DERMATOL RES	Arch. Dermatol. Res.	MAR	2015	307	2					159	169		10.1007/s00403-014-1508-0		11	Dermatology	Dermatology	CC2VR	WOS:000350203300007		
J	Wang, L; Guo, LL; Wang, LH; Zhang, GX; Shang, J; Murao, K; Chen, DF; Fan, XH; Fu, WQ				Wang, Lei; Guo, Ling-Ling; Wang, Lin-Hui; Zhang, Guo-Xing; Shang, Jing; Murao, Koji; Chen, Deng-Feng; Fan, Xiang-Hua; Fu, Wen-Qing			Oxidative stress and substance P mediate psychological stress-induced autophagy and delay of hair growth in mice	ARCHIVES OF DERMATOLOGICAL RESEARCH			English	Article						Chronic restraint stress; Hair cycle; Reactive oxygen species; Substance P; Autophagy	LIPID-PEROXIDATION; IMMOBILIZATION STRESS; RESTRAINT STRESS; TELOGEN STAGE; MAST-CELLS; SKIN; SYSTEM; FOLLICLES; APOPTOSIS; BIOLOGY	Neuropeptide substance P (SP) and reactive oxygen species (ROS) have been demonstrated to play an important role in psychological stress-induced alteration of hair cycle, the underlying mechanism remains unknown. The present study aims to investigate possible contribution of SP and ROS in chronic restraint stress (CRS, a chronic psychological stress model) induced abnormal of hair cycle and induction of autophagy. Mouse CRS model was applied for 18 days with or without treatment antioxidant Tempol (a free radical scavenger) or SP receptor (NK1) antagonist (RP67580). After CRS procedure, hair growth cycle, oxidative stress markers and skin tissue autophagy levels were analyzed by ELISA or western blot. Our results revealed that CRS reduced body weight gain, distance of movement and times of standing, affected hair cycle by prolonging the telogen stage and delaying subsequent anagen and catagen stage. In addition, CRS resulted in increase of lipid peroxidation levels and reduction of the activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) and increase of autophagy markers (microtubule-associated proteins, light chain 3-II, LC3-II, and Beclin-1) in mice skin. Treatment with Tempol restored GSH-Px activity, and significantly reduced increases of lipid peroxidation levels and LC3-II and Beclin-1 expressions, as well as normalized hair cycle. In addition; RP67580 also restored SOD and GSH-Px activities, and markedly reduced increases of lipid peroxidation levels and LC3-II and Beclin-1 expressions, and normalized hair cycle. Our study provides the first strong evidence for SP and ROS play a role not only in alteration of hair cycle but also in induction of autophagy in psychological stress model, suggesting autophagy may contribute to psychological stress-induced abnormal of hair cycle.	[Wang, Lei; Fu, Wen-Qing] Soochow Univ, Coll Med, Dept Clin Psychol, Suzhou 215123, Peoples R China; [Guo, Ling-Ling] Soochow Univ, Coll Med, Dept Pathol, Suzhou 215123, Peoples R China; [Wang, Lin-Hui; Zhang, Guo-Xing] Soochow Univ, Coll Med, Dept Physiol, Suzhou 215123, Peoples R China; [Shang, Jing] China Pharmaceut Univ, New Drug Screening Ctr, Nanjing 210009, Peoples R China; [Murao, Koji] Kagawa Univ, Dept Clin Lab, Fac Med, Miki, Kagawa 7610793, Japan; [Chen, Deng-Feng] Harrison Int Peace Hosp, Dept Surg, Hengsui 053000, Peoples R China; [Fan, Xiang-Hua] Nangtong Univ, Dept Dermatol, Affiliated Hosp 2, Nantong 226001, Peoples R China	Fu, WQ (reprint author), Soochow Univ, Coll Med, Dept Clin Psychol, 199 Ren Ai Rd,Dushu Lake Campus,Ind Pk, Suzhou 215123, Peoples R China.	zhangguoxing@suda.edu.cn; fuwenqing@suda.edu.cn			National Nature Science Foundation of China [81270316]; Soochow University [Q413400111]	This work is supported by the National Nature Science Foundation of China (81270316), the Research Program of Soochow University (Q413400111).	Akar A, 2002, J DERMATOL SCI, V29, P85, DOI 10.1016/S0923-1811(02)00015-4; Arck PC, 2001, FASEB J, V15, P2536, DOI 10.1096/fj.00-0699fje; Gu HF, 2012, ATHEROSCLEROSIS, V223, P69, DOI 10.1016/j.atherosclerosis.2012.01.021; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Seo JS, 2012, J NEUROSCI, V32, P9690, DOI 10.1523/JNEUROSCI.0794-12.2012; Chiba S, 2012, PROG NEURO-PSYCHOPH, V39, P112, DOI 10.1016/j.pnpbp.2012.05.018; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Schnackenberg CG, 1999, HYPERTENSION, V33, P424; Anisman H, 2002, BRAIN BEHAV IMMUN, V16, P513, DOI 10.1016/S0889-1591(02)00009-0; Huang J, 2011, ANTIOXID REDOX SIGN, V14, P2215, DOI 10.1089/ars.2010.3554; Hutchinson KM, 2012, NEUROBIOL LEARN MEM, V97, P250, DOI 10.1016/j.nlm.2012.01.003; Scandalios JG, 2005, BRAZ J MED BIOL RES, V38, P995, DOI 10.1590/S0100-879X2005000700003; Krause K, 2006, SEMIN CUTAN MED SURG, V25, P2, DOI 10.1016/j.sder.2006.01.002; Schallreuter KU, 1999, J INVEST DERM SYMP P, V4, P91, DOI 10.1038/sj.jidsp.5640189; ASKENASE PW, 1983, J IMMUNOL, V131, P2687; Dhabhar FS, 2013, CLIN DERMATOL, V31, P18, DOI 10.1016/j.clindermatol.2011.11.003; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Aoki E, 2003, EXP DERMATOL, V12, P371, DOI 10.1034/j.1600-0625.2002.120403.x; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Silva RH, 2004, NEUROPHARMACOLOGY, V46, P895, DOI 10.1016/j.neuropharm.2003.11.032; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Paus R, 1999, NEW ENGL J MED, V341, P491; HAHN SM, 1992, CANCER RES, V52, P1750; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Kennedy PGE, 1997, P NATL ACAD SCI USA, V94, P4167, DOI 10.1073/pnas.94.8.4167; MAGGI CA, 1993, J AUTON PHARMACOL, V13, P23, DOI 10.1111/j.1474-8673.1993.tb00396.x; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; Bauer ME, 2009, ANN NY ACAD SCI, V1153, P139, DOI 10.1111/j.1749-6632.2008.03966.x; Katayama M, 2007, EXP DERMATOL, V16, P553, DOI 10.1111/j.1600-0625.2007.00558.x; Canu N, 2005, J NEUROCHEM, V92, P1228, DOI 10.1111/j.1471-4159.2004.02956.x; Theoharides TC, 2004, TRENDS PHARMACOL SCI, V25, P563, DOI 10.1016/j.tips.2004.09.007; Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; Ansel J C, 1997, J Investig Dermatol Symp Proc, V2, P23; Arck PC, 2003, AM J PATHOL, V162, P803, DOI 10.1016/S0002-9440(10)63877-1; BEAUJOUAN JC, 1993, BRIT J PHARMACOL, V108, P793; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085226; Joachim RA, 2004, PSYCHOSOM MED, V66, P564, DOI 10.1097/01.psy.0000132878.08780.93; Kawana S, 2006, J DERMATOL SCI, V42, P47, DOI 10.1016/j.jdermsci.2005.12.004; Linley JE, 2012, P NATL ACAD SCI USA, V109, pE1578, DOI 10.1073/pnas.1201544109; Liu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061574; Naziroglu Mustafa, 2000, Cell Biochemistry and Function, V18, P169, DOI 10.1002/1099-0844(200009)18:3<169::AID-CBF870>3.3.CO;2-K; Paus R, 1999, ANN NY ACAD SCI, V885, P350; Peters EMJ, 2012, BRIT J DERMATOL, V167, P105, DOI 10.1111/j.1365-2133.2012.11094.x; Sahin E, 2007, COMP BIOCHEM PHYS C, V144, P342, DOI 10.1016/j.cbpc.2006.10.009; Singh LK, 1999, BRAIN BEHAV IMMUN, V13, P225, DOI 10.1006/brbi.1998.0541; SPENCER LV, 1987, DERMATOL CLIN, V5, P565; TAGUCHI Y, 1982, P NATL ACAD SCI-BIOL, V79, P6837, DOI 10.1073/pnas.79.22.6837; Wu HH, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-19; Zafir A, 2009, INDIAN J BIOCHEM BIO, V46, P53; Zhang GX, 2009, CARDIOVASC RES, V81, P389, DOI 10.1093/cvr/cvn304; Zhang GX, 2004, HYPERTENSION, V43, P117, DOI 10.1161/01.HYP.0000105110.12667.F8	52	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-3696	1432-069X		ARCH DERMATOL RES	Arch. Dermatol. Res.	MAR	2015	307	2					171	181		10.1007/s00403-014-1521-3		11	Dermatology	Dermatology	CC2VR	WOS:000350203300008		
J	Nagasaka, M; Morioka, I; Yokota, T; Fujita, K; Kurokawa, D; Koda, T; Shibata, A; Yamada, H; Ito, Y; Uchino, E; Shirai, C; Iijima, K				Nagasaka, Miwako; Morioka, Ichiro; Yokota, Tomoyuki; Fujita, Kaori; Kurokawa, Daisuke; Koda, Tsubasa; Shibata, Akio; Yamada, Hideto; Ito, Yoshiya; Uchino, Eiko; Shirai, Chika; Iijima, Kazumoto			Incidence of short stature at 3 years of age in late preterm infants: a population-based study	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article							FOR-GESTATIONAL-AGE; FETAL-GROWTH; BORN; OUTCOMES; CHILDREN; BIRTH; HEIGHT; RISK; GENE	Objectives This study aimed to investigate the incidence of short stature at 3 years of age in a Japanese cohort of late preterm infants who were born at 34-36 weeks' gestational age (GA). We compared these late preterm infants with term infants (3741 weeks' GA), and evaluated the effect of birth weight on the incidence of short stature. Methods A longitudinal population-based study of 26 970 neonates who were born between 34 weeks' and 41 weeks' GA in 2006-2008 was conducted in Kobe, Japan. Of these neonates, 1414 were late preterm and 25 556 were term infants. The late preterm infants were then divided into three subgroups based on birth weight as determined by Japanese neonatal anthropometric charts for GA at birth: large-for-GA (n=140), appropriate-for-GA (AGA, n=1083), and small-for-GA (SGA, n=191). The incidence of short stature at 3 years of age was calculated in the late preterm group and compared with that in the term group, and between the AGA and SGA groups with late preterm birth. Results The incidence of short stature in the late preterm group was 2.9%, which was significantly higher than that in the term group (1.4%). Late preterm SGA infants developed short stature with a significantly higher (9.4%) incidence than that of late preterm AGA infants (2.1%). Conclusions The incidence of short stature in 3-year-old children who were late preterm infants has a 2-fold higher risk than that in term infants. The risk of developing short stature is increased 4.5-fold if they are SGA.	[Nagasaka, Miwako; Morioka, Ichiro; Yokota, Tomoyuki; Fujita, Kaori; Kurokawa, Daisuke; Koda, Tsubasa; Shibata, Akio; Iijima, Kazumoto] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 6500017, Japan; [Yamada, Hideto] Kobe Univ, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Ito, Yoshiya] Japanese Red Cross Hokkaido Coll Nursing, Kitami, Hokkaido, Japan; [Uchino, Eiko; Shirai, Chika] Kobe City Publ Hlth Ctr, Kobe, Hyogo, Japan	Morioka, I (reprint author), Kobe Univ, Grad Sch Med, Dept Pediat, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ichim@med.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23791224]; Morinaga Hoshi-kai Foundation [H24]; Public Health Research Foundation	This work was supported in part by Scientific Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (23791224), the Morinaga Hoshi-kai Foundation (H24), and the Public Health Research Foundation (2013).	Engle WA, 2007, PEDIATRICS, V120, P1390, DOI 10.1542/peds.2007-2952; Arends N, 2002, J CLIN ENDOCR METAB, V87, P2720, DOI 10.1210/jc.87.6.2720; Petrini JR, 2009, J PEDIATR-US, V154, P169, DOI 10.1016/j.jpeds.2008.08.020; Itabashi K, 2007, EARLY HUM DEV, V83, P327, DOI 10.1016/j.earlhumdev.2006.07.002; Lee PA, 2003, PEDIATRICS, V111, P1253, DOI 10.1542/peds.111.6.1253; Talge NM, 2010, PEDIATRICS, V126, P1124, DOI 10.1542/peds.2010-1536; Leger J, 1996, PEDIATR RES, V40, P101, DOI 10.1203/00006450-199607000-00018; Wang ML, 2004, PEDIATRICS, V114, P372, DOI 10.1542/peds.114.2.372; MILLER HC, 1971, PEDIATRICS, V48, P511; Boyle EM, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e896; Chyi LJ, 2008, J PEDIATR-US, V153, P25, DOI 10.1016/j.jpeds.2008.01.027; Djelmis J, 1998, COLLEGIUM ANTROPOL, V22, P491; Ester WA, 2009, J CLIN ENDOCR METAB, V94, P4717, DOI 10.1210/jc.2008-1502; Itabashi K, 2014, PEDIATR INT, V56, P702, DOI 10.1111/ped.12331; KARLBERG J, 1995, PEDIATR RES, V38, P733, DOI 10.1203/00006450-199511000-00017; Kaur H, 2012, EARLY HUM DEV, V88, P473, DOI 10.1016/j.earlhumdev.2011.11.007; Kawashima Y, 2012, ENDOCR J, V59, P179; Ministry of Health Labour and Welfare in Japan, DEM STAT; Ministry of Health Labour and Welfare in Japan, 2002, CHARTS STAND GROWTH; PAZ I, 1993, AM J DIS CHILD, V147, P337; Pierrat V, 2011, ARCH DIS CHILD-FETAL, V96, pF348, DOI 10.1136/adc.2010.185470; Tanaka Toshiaki, 2012, Clin Pediatr Endocrinol, V21, P57, DOI 10.1297/cpe.21.57; Walenkamp MJE, 2005, J CLIN ENDOCR METAB, V90, P2855, DOI 10.1210/jc.2004-1254	23	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888	1468-2044		ARCH DIS CHILD	Arch. Dis. Child.	MAR	2015	100	3					250	254		10.1136/archdischild-2014-307045		5	Pediatrics	Pediatrics	CB8JB	WOS:000349874400009		
J	Fukui, K; Kaneuji, A; Sugimori, T; Ichiseki, T; Matsumoto, T				Fukui, Kiyokazu; Kaneuji, Ayumi; Sugimori, Tanzo; Ichiseki, Toru; Matsumoto, Tadami			Does rotational acetabular osteotomy affect subsequent total hip arthroplasty?	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article						Rotational acetabular osteotomy; Total hip arthroplasty; Hip dysplasia; Midterm results	CROSS-LINKED POLYETHYLENE; LOW-FRICTION ARTHROPLASTY; FEMORAL-HEAD; LONG-TERM; CONGENITAL DISLOCATION; FOLLOW-UP; PERIACETABULAR OSTEOTOMY; INNOMINATE OSTEOTOMY; CHIARI OSTEOTOMY; DYSPLASTIC HIP	Rotational acetabular osteotomy (RAO) has been used successfully in patients with developmental dysplasia of the hip (DDH). However, some patients are forced to undergo total hip arthroplasty (THA) because of the progression of osteoarthritis. We evaluated the effect of previous RAO on the outcome of THA performed for degenerative arthritis secondary to DDH, comparing outcomes for patients with THA and prior RAO versus outcomes for patients with THA and no prior RAO. At an average follow-up point of 8.2 years (range 7-11 years), we compared outcomes in dysplastic hips for 22 hips (group R) in patients who underwent THA after successful RAO with outcomes for a well-matched control group of 30 hips in patients who underwent primary THA (group C) during the same period. Both groups had similar midterm results. No acetabular or femoral components exhibited loosening or revision in either group. Harris hip scores (HHSs) at the most recent follow-up had not been compromised by RAO, and there were no significant differences in intraoperative blood loss and operative time between the two groups. Although there was a tendency toward superolateral placement of the acetabular component in group R, there were no significant differences in the mean steady-state linear and volumetric wear rates between the two groups. There were no infections, dislocations, intraoperative fractures, damaged nerves, or deep vein thromboses in either group. Our midterm results demonstrated that RAO does not lead to higher revision rates, compromised HHSs, or shortened survivorship in eventual THA for DDH.	[Fukui, Kiyokazu; Kaneuji, Ayumi; Sugimori, Tanzo; Ichiseki, Toru; Matsumoto, Tadami] Kanazawa Med Univ, Dept Orthopaed Surg, Uchinada, Ishikawa 9200293, Japan	Fukui, K (reprint author), Kanazawa Med Univ, Dept Orthopaed Surg, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	66406kf@kanazawa-med.ac.jp					Manning DW, 2005, J ARTHROPLASTY, V20, P880, DOI 10.1016/j.arth.2005.03.033; SALTER RB, 1961, J BONE JOINT SURG BR, V43, P518; Sochart DH, 1997, J BONE JOINT SURG AM, V79A, P1599; ZICAT B, 1995, J BONE JOINT SURG AM, V77A, P432; LEWINNEK GE, 1978, J BONE JOINT SURG AM, V60, P217; CHIARI K, 1974, CLIN ORTHOP RELAT R, P55; Devane PA, 1999, CLIN ORTHOP RELAT R, P59; Hashemi-Nejad A, 2002, J ARTHROPLASTY, V17, P731, DOI 10.1054/arth.2002.31974; Siebenrock KA, 2003, J BONE JOINT SURG AM, V85A, P278; Hartofilakidis G, 1996, J BONE JOINT SURG AM, V78A, P683; HARRIS WH, 1982, J BONE JOINT SURG AM, V64, P1063; Little NJ, 2009, CLIN ORTHOP RELAT R, V467, P2895, DOI 10.1007/s11999-009-0845-3; Hartofilakidis G, 1998, J BONE JOINT SURG AM, V80A, P510; Millis MB, 1996, AAOS INSTR COURS LEC, V45, P209; Okano K, 2008, ACTA ORTHOP, V79, P12, DOI 10.1080/17453670710014699; MULROY RD, 1990, J BONE JOINT SURG AM, V72A, P1536; Kelley S S, 1994, J Arthroplasty, V9, P503, DOI 10.1016/0883-5403(94)90097-3; ENGH CA, 1987, J BONE JOINT SURG BR, V69, P45; Delp SL, 1996, CLIN ORTHOP RELAT R, P137; RUSSOTTI GM, 1991, J BONE JOINT SURG AM, V73A, P587; [Anonymous], 2003, CLIN OTHROP RELAT RE, DOI 10.1097/00003086-200302000-00033; Yasunaga Y, 2004, ACTA ORTHOP SCAND, V75, P10, DOI 10.1080/00016470410001708020; NINOMIYA S, 1984, J BONE JOINT SURG AM, V66A, P430; HARTOFILAKIDIS G, 1988, J BONE JOINT SURG BR, V70, P182; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737; Bohm P, 2002, J BONE JOINT SURG AM, V84A, P178; Peters CL, 2001, J ARTHROPLASTY, V16, P188, DOI 10.1054/arth.2001.20903; Fukui K, 2013, J ARTHROPLASTY, V28, P1654, DOI 10.1016/j.arth.2012.12.020; JOHNSTON RC, 1979, J BONE JOINT SURG AM, V61, P639; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629; HARRIS WH, 1977, J BONE JOINT SURG AM, V59, P752; LINDE F, 1988, ACTA ORTHOP SCAND, V59, P254, DOI 10.3109/17453678809149356; MASSIE WK, 1950, J BONE JOINT SURG AM, V32-A, P519; WOOLSON ST, 1983, J BONE JOINT SURG AM, V65, P1099; DELEE JG, 1976, CLIN ORTHOP RELAT R, P20; DELP SL, 1993, J BIOMECH, V26, P485, DOI 10.1016/0021-9290(93)90011-3; Doehring TC, 1996, J ARTHROPLASTY, V11, P693, DOI 10.1016/S0883-5403(96)80008-8; Fukui K, 2013, HIP INT, V23, P129, DOI 10.5301/hipint.5000010; GANZ R, 1988, CLIN ORTHOP RELAT R, P26; Gill TJ, 1998, J BONE JOINT SURG AM, V80A, P969; GRUEN TA, 1979, CLIN ORTHOP RELAT R, P17; HARTWIG CH, 1995, ARCH ORTHOP TRAUM SU, V114, P269, DOI 10.1007/BF00452085; Johanson P-D, 2010, ANN M AM AC ORTH SUR; Mac Kenzie James R., 1996, Journal of Bone and Joint Surgery American Volume, V78, P55; Macnicol ME, 2004, J BONE JOINT SURG BR, V86B, P648, DOI 10.1302/0301-620X.86B5.14653; MCQUEARY FG, 1988, J BONE JOINT SURG AM, V70A, P1140; Minoda Y, 2006, ARCH ORTHOP TRAUM SU, V126, P394, DOI 10.1007/s00402-006-0141-6; Morsi E, 1996, CLIN ORTHOP RELAT R, P164; Numair J, 1997, J BONE JOINT SURG AM, V79A, P1352; Pagnano W, 1996, J Bone Joint Surg Am, V78, P1004; Parvizi J, 2004, CLIN ORTHOP RELAT R, P118, DOI 10.1097/01.blo.0000128287.98083.63; RODRIGUEZ JA, 1995, J BONE JOINT SURG AM, V77A, P1227; SCHER MA, 1991, J BONE JOINT SURG BR, V73, P626; SCHULLER HM, 1993, J BONE JOINT SURG BR, V75, P468; Schutzer S F, 1994, J Arthroplasty, V9, P359, DOI 10.1016/0883-5403(94)90045-0; Soderman P, 2001, CLIN ORTHOP RELAT R, P189; Tokunaga K, 2011, CLIN ORTHOP RELAT R, V469, P237, DOI 10.1007/s11999-010-1375-8; Tompkins GS, 1997, J BONE JOINT SURG AM, V79A, P169; Wiberg G., 1939, ACTA CHIR SCAND, V83, P29; WOLFGANG GL, 1990, CLIN ORTHOP RELAT R, P173; YODER SA, 1988, CLIN ORTHOP RELAT R, P79	61	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0936-8051	1434-3916		ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	MAR	2015	135	3					407	415		10.1007/s00402-015-2154-5		9	Orthopedics; Surgery	Orthopedics; Surgery	CB8BI	WOS:000349852800015		
J	Chi, LNU; Tabuchi, K; Nakamagoe, M; Nakayama, M; Nishimura, B; Hara, A				Le Nguyen Uyen Chi; Tabuchi, Keiji; Nakamagoe, Mariko; Nakayama, Masahiro; Nishimura, Bungo; Hara, Akira			Ceramide/sphingomyelin cycle involvement in gentamicin-induced cochlear hair cell death	ARCHIVES OF TOXICOLOGY			English	Article						Ceramide/sphingomyelin cycle; De novo ceramide biosynthesis; Gentamicin	NEUTRAL SPHINGOMYELINASE; SPHINGOLIPID METABOLISM; CERAMIDE; ACTIVATION; APOPTOSIS; SYNTHASE; PROTEIN; EXPRESSION; INHIBITOR; CULTURE	Ceramide, a sphingolipid metabolite, regulates diverse cellular processes including apoptosis, cell senescence, the cell cycle, and cellular differentiation. Exogenously administered ceramide reportedly increased cochlear hair cell death due to gentamicin-induced ototoxicity. Ceramide is mainly generated via a ceramide/sphingomyelin cycle by sphingomyelinase and sphingomyelin synthase or via de novo synthesis by serine palmitoyltransferase and ceramide synthase. This study was designed to investigate the possible involvement of neutral sphingomyelinase, sphingomyelin synthase, or serine palmitoyltransferase in hair cell death due to gentamicin. The basal turns of the organ of Corti of Sprague-Dawley rats were dissected on postnatal days 3-5. Cochlear cultures were exposed to media containing 35 mu M gentamicin for 48 h to assess the effects of GW4869 (a neutral sphingomyelinase inhibitor), 2-hydroxyoleic acid (a sphingomyelin synthase activator), and myriocin (a serine palmitoyltransferase inhibitor). Hair cell loss was significantly decreased in the presence of GW4869 or 2-hydroxyoleic acid. Myriocin had no significant effects against gentamicin-induced hair cell loss. In addition, neutral sphingomyelinase was activated by gentamicin exposure. The present findings strongly suggest that the ceramide/sphingomyelin cycle plays an important role in the protection of hair cells against gentamicin-induced ototoxicity.	[Le Nguyen Uyen Chi; Tabuchi, Keiji; Nakamagoe, Mariko; Nakayama, Masahiro; Nishimura, Bungo; Hara, Akira] Univ Tsukuba, Dept Otolaryngol, Fac Med, Tsukuba, Ibaraki 3058576, Japan; [Le Nguyen Uyen Chi] Univ Med & Pharm, Dept Otolaryngol, Fac Med, Ho Chi Minh City, Vietnam	Tabuchi, K (reprint author), Univ Tsukuba, Dept Otolaryngol, Fac Med, Tennodai 1-1-1, Tsukuba, Ibaraki 3058576, Japan.	ktabuchi@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24592541]	This work was supported by a Grant-in-Aid for Scientific Research (C) 24592541 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; Tomiuk S, 1998, P NATL ACAD SCI USA, V95, P3638, DOI 10.1073/pnas.95.7.3638; Wu DY, 2007, J IMMUNOL, V179, P4829; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M2067447200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Zeidan YH, 2007, TRENDS MOL MED, V13, P327, DOI 10.1016/j.molmed.2007.06.002; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Aubin I, 2005, M S-MED SCI, V21, P1034; Babenko NA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P180, DOI 10.1134/S0006297912020095; Cubi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068055; De Luca T, 2005, BIOFACTORS, V25, P43; Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje; Krut O, 2006, J BIOL CHEM, V281, P13784, DOI 10.1074/jbc.M511306200; Liao LZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082379; Martin ML, 2013, J LIPID RES, V54, P1457, DOI 10.1194/jlr.M036749; Mullen TD, 2001, APOPSIS PHYSL PATHOL, P88; Nakamagoe M, 2010, HEARING RES, V261, P67, DOI 10.1016/j.heares.2010.01.004; Nishimura B, 2010, NEUROSCI LETT, V485, P1, DOI 10.1016/j.neulet.2010.08.014; Qin JD, 2012, J BIOL CHEM, V287, P13620, DOI 10.1074/jbc.M111.304857; SOBKOWICZ HM, 1993, ACTA OTO-LARYNGOL, P3; Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102; Tabuchi K, 2010, NEUROSCIENCE, V166, P665, DOI 10.1016/j.neuroscience.2009.12.038; Tabuchi K, 2007, NEUROSCIENCE, V149, P213, DOI 10.1016/j.neuroscience.2007.06.061; VANDEWAT.T, 1974, ANN OTO RHINOL LARYN, V83, P1	26	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5761	1432-0738		ARCH TOXICOL	Arch. Toxicol.	MAR	2015	89	3					415	421		10.1007/s00204-014-1259-x		7	Toxicology	Toxicology	CC0MP	WOS:000350030200010		
J	Watabe, T; Suzuki, K				Watabe, Takashi; Suzuki, Kunifumi			Internet communication of outpatients with Asperger's disorder or schizophrenia in Japan	ASIA-PACIFIC PSYCHIATRY			English	Article						Asperger's disorder; communication; Internet; mobile phone; schizophrenia	AUTISM SPECTRUM DISORDERS; ELECTRONIC SCREEN MEDIA; FUNCTIONING AUTISM; PROGRAM	IntroductionThere is insufficient information about the Internet usage of psychiatric patients. The aim of this study is to investigate the usage of Internet communication among subjects with Asperger's disorder (AD) or schizophrenia. MethodsA questionnaire survey was carried out in Japan among 29 outpatients with AD, 32 outpatients with schizophrenia, and 97 age-matched normal volunteers. This study limited the participants to young male adults (20- to 39-year-olds) using the Internet. ResultsPeople with a diagnosis of AD prefer personal computers to mobile phones as their Internet terminal, have an inclination to use anonymous media, and tend to think that they can communicate more correctly through the Internet than face-to-face communication. People with a diagnosis of schizophrenia employ the Internet to a degree almost similar to controls, and tend to rely on unknown persons, but also sometimes feel hurt when communicating on the Internet. Moreover, their sensitivity to the risks of the Internet tends to decrease with the aggravation of their psychotic symptoms. DiscussionIt may be important to pay attention to the excessive use of some limited media by people with a diagnosis of AD. Providing people with a diagnosis of schizophrenia with sufficient information about the risks of the Internet is also important.	[Watabe, Takashi; Suzuki, Kunifumi] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4618673, Japan; [Watabe, Takashi] Moriyamasou Hosp, Nagoya, Aichi, Japan	Watabe, T (reprint author), Nagoya Univ, Grad Sch Med, Higashi Ku, 1-1-20 Daiko Minami, Nagoya, Aichi 4618673, Japan.	watabe.takashi@h.nagoya-u.jp					Akiyoshi M, 2008, INFORM SOC, V24, P292, DOI 10.1080/01972240802356067; Mineo BA, 2009, J AUTISM DEV DISORD, V39, P172, DOI 10.1007/s10803-008-0616-0; Mazurek MO, 2012, J AUTISM DEV DISORD, V42, P1757, DOI 10.1007/s10803-011-1413-8; Kurita H, 2005, PSYCHIAT CLIN NEUROS, V59, P490, DOI 10.1111/j.1440-1819.2005.01403.x; Ploog BO, 2013, J AUTISM DEV DISORD, V43, P301, DOI 10.1007/s10803-012-1571-3; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Ishii K, 2006, J COMMUN, V56, P346, DOI 10.1111/j.1460-2466.2006.00023.x; OZONOFF S, 1995, NEUROPSYCHOLOGY, V9, P491, DOI 10.1037//0894-4105.9.4.491; Golan O, 2006, DEV PSYCHOPATHOL, V18, P591, DOI 10.1017/S0954579406060305; Spinzy Y, 2012, PSYCHIAT RES, V198, P319, DOI 10.1016/j.psychres.2012.02.022; Sachs G, 2004, SCHIZOPHR RES, V68, P27, DOI 10.1016/S0920-9964(03)00131-2; Mazurek MO, 2013, J AUTISM DEV DISORD, V43, P1258, DOI 10.1007/s10803-012-1659-9; Spaniel F, 2008, SCHIZOPHR RES, V98, P312, DOI 10.1016/j.schres.2007.09.005; Kowalski RM, 2011, RES AUTISM SPECT DIS, V5, P1201, DOI 10.1016/j.rasd.2011.01.007; Green J, 2000, J AUTISM DEV DISORD, V30, P279, DOI 10.1023/A:1005523232106; Frith U, 2004, J CHILD PSYCHOL PSYC, V45, P672, DOI 10.1111/j.1469-7610.2004.00262.x; Shane HC, 2008, J AUTISM DEV DISORD, V38, P1499, DOI 10.1007/s10803-007-0527-5; Bauser DS, 2012, PSYCHIAT RES, V195, P9, DOI 10.1016/j.psychres.2011.07.017; Durkin K, 2010, RES AUTISM SPECT DIS, V4, P314, DOI 10.1016/j.rasd.2009.09.017; Granholm E, 2012, SCHIZOPHRENIA BULL, V38, P414, DOI 10.1093/schbul/sbr155; Kretschmer E., 1921, KORPERBAU CHARAKTER; Ministry of Internal Affairs and Communications (MIC), 2010, WHIT PAP INF COMM JA; Miyata K, 2008, ASIAN J SOC PSYCHOL, V11, P42, DOI 10.1111/j.1467-839X.2007.00242.x; OECD Health Data, 2011, HLTH GLANC 2011 OECD; Schrank B, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1550; Steinwachs DM, 2011, PSYCHIAT SERV, V62, P1296, DOI 10.1176/appi.ps.62.11.1296; Wakabayashi Akio, 2004, Shinrigaku Kenkyu, V75, P78	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1758-5864	1758-5872		ASIA-PAC PSYCHIAT	Asia-Pac. Psychiatry	MAR	2015	7	1					27	35		10.1111/appy.12108		9	Psychiatry	Psychiatry	CB9VH	WOS:000349981000004		
J	Hendrawan, D; Hatta, T; Ohira, H				Hendrawan, Donny; Hatta, Takeshi; Ohira, Hideki			Do the letters F, A and S represent Indonesian letter fluency stimuli?	ASIA-PACIFIC PSYCHIATRY			English	Article						cultural background difference; Kolmogorov-Smirnov test of normality; letter fluency; ranking of letters; ratio comparison	VERBAL FLUENCY; PREFRONTAL ACTIVATION; CATEGORY FLUENCY; PERFORMANCE; SCHIZOPHRENIA; TESTS; TASK; INDIVIDUALS; DEPRESSION; RANKING	IntroductionThe letters F, A and S, originally used in the English letter fluency stimuli test, have been frequently adopted to assess executive function in many languages. However, few studies reported the significance of FAS testing employed in different languages. The current study explored whether FAS could be widely applied to the Indonesian language. MethodsA total of 211 undergraduate students from state and private universities who participated in this study were randomly assigned into four groups. Each group was exposed to six different letter fluency stimuli. The total number of words the participants produced for each letter stimulus were averaged and ranked to determine the degree of difficulty in generating words. Furthermore, the normal distribution and equal ratio comparison were examined to verify the representative letter fluency stimuli. In addition, the effect of sex and university affiliation on letter fluency performance was also analyzed. ResultsThe letters A and S were among the easiest letters used to generate words; however, the letter F was regarded as a difficult stimulus. Furthermore, only the number of words beginning the letter S was distributed according to a normal curve. The number of words starting with the letters F and A were not normally distributed. Although sex difference was not associated with letter fluency performance, difference in university affiliation showed a significant effect on performance. DiscussionOur findings suggest that consideration of several stimuli factors is required to accurately measure performance in the letter fluency task in a specific language.	[Hendrawan, Donny] Univ Indonesia, Fac Psychol, Depok City 16424, Indonesia; [Hendrawan, Donny; Hatta, Takeshi; Ohira, Hideki] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Hatta, Takeshi] Kansai Univ Welf Sci, Kashiwara, Japan	Hendrawan, D (reprint author), Univ Indonesia, Fac Psychol, Depok City 16424, Indonesia.	donny.hendrawan@ui.ac.id					Abrahams S, 2003, HUM BRAIN MAPP, V20, P29, DOI 10.1002/hbm.10126; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Schulz KF, 2002, LANCET, V359, P966, DOI 10.1016/S0140-6736(02)08029-7; Baldo JV, 2006, J INT NEUROPSYCH SOC, V12, P896, DOI 10.1017/S1355617706061078; Kosmidis MH, 2004, J INT NEUROPSYCH SOC, V10, P164, DOI 10.1017/S1355617704102014; Videbech P, 2003, PSYCHIAT RES-NEUROIM, V123, P49, DOI 10.1016/S0925-4927(03)00002-7; Okada G, 2003, NEUROPSYCHOBIOLOGY, V47, P21, DOI 10.1159/000068871; Schwartz S, 2003, BRAIN LANG, V87, P400, DOI 10.1016/S0093-934X(03)00141-X; Brickman AM, 2005, ARCH CLIN NEUROPSYCH, V20, P561, DOI 10.1016/j.acn.2004.12.006; Senhorini MCT, 2006, J CLIN EXP NEUROPSYC, V28, P1191, DOI 10.1080/13803390500350969; Gyurak A, 2009, COGN AFFECT BEHAV NE, V9, P144, DOI 10.3758/CABN.9.2.144; Leggio MG, 2000, J NEUROL NEUROSUR PS, V69, P102, DOI 10.1136/jnnp.69.1.102; Weiss EM, 2006, J INT NEUROPSYCH SOC, V12, P502, DOI 10.1017/S1355617706060656; Kubota Y, 2005, SCHIZOPHR RES, V77, P65, DOI 10.1016/j.svhres.2005.01.007; BOLLA KI, 1990, J CLIN PSYCHOL, V46, P623, DOI 10.1002/1097-4679(199009)46:5<623::AID-JCLP2270460513>3.0.CO;2-C; BORKOWSK.JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; BUTLER M, 1991, PROF PSYCHOL-RES PR, V22, P510, DOI 10.1037//0735-7028.22.6.510; Chan AS, 1999, J INT NEUROPSYCH SOC, V5, P525, DOI 10.1017/S135561779956606X; Curtis VA, 2001, J AFFECT DISORDERS, V66, P111, DOI 10.1016/S0165-0327(00)00240-8; Hendrawan D, 2012, INT J PSYCHOPHYSIOL, V84, P277, DOI 10.1016/j.ijpsycho.2012.03.006; Hendrawan D, 2010, PSYCHOLOGIA, V53, P14; Ito E., 2002, STUDIES INFORM SCI, V15, P81; Ito E., 2006, JPN J NEUROPSYCHOL, V22, P146; Ito E., 2004, JPN J NEUROPSYCHOL, V20, P254; Kosmidis MH, 2005, PSYCHIAT RES, V134, P233, DOI 10.1016/j.psychres.2005.02.003; Moore DJ, 2006, SCHIZOPHR RES, V87, P254, DOI 10.1016/j.schres.2006.06.005; Muhadjir Nazief B. A. A., 1996, FREKUENSI KOSAKATA B; Ostberg P, 2005, BRAIN LANG, V95, P273, DOI 10.1016/j.bandl.2005.01.010; Pusat Bahasa Departemen Pendidikan Nasional Republik Indonesia, 2008, KAM BES BAH IND DAR; Rodriguez-Aranda C, 2006, J NEUROL, V253, P1414, DOI 10.1007/s00415-006-0225-9; Rosselli M, 2002, INT J NEUROSCI, V112, P759, DOI 10.1080/00207450290025752; Sauzeon H, 2004, BRAIN LANG, V89, P192, DOI 10.1016/S0093-934X(03)00367-5; Slosman DO, 2001, BRAIN RES REV, V36, P230, DOI 10.1016/S0165-0173(01)00099-6; STEENHUIS RE, 1995, J CLIN EXP NEUROPSYC, V17, P773, DOI 10.1080/01688639508405166; Sumiyoshi C, 2004, SCHIZOPHR RES, V69, P15, DOI 10.1016/S0920-9964(03)00174-9; Tombaugh T. N., 1999, ARCH CLIN NEUROPSYCH, V14, P162	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1758-5864	1758-5872		ASIA-PAC PSYCHIAT	Asia-Pac. Psychiatry	MAR	2015	7	1					64	71		10.1111/appy.12082		8	Psychiatry	Psychiatry	CB9VH	WOS:000349981000008		
J	Kitazoe, N; Inoue, S; Izumoto, Y; Kumagai, N; Iwasaki, Y				Kitazoe, Noriko; Inoue, Shimpei; Izumoto, Yuji; Kumagai, Naoko; Iwasaki, Yasumasa			The Autism-Spectrum Quotient in university students: Pattern of changes in its scores and associated factors	ASIA-PACIFIC PSYCHIATRY			English	Article						Autism Spectrum Disorder (ASD); Autism-Spectrum Quotient (AQ); mental state; University Personality Inventory (UPI); university student	JAPANESE VERSION; AQ; RELIABILITY; POPULATION; PREVALENCE; DISORDERS; CHILDREN; COLLEGE; TRAITS	IntroductionSupport to university students with autism spectrum disorders (ASD) is becoming increasingly important. To determine the validity of the Autism-Spectrum Quotient (AQ) for ASD screening of university students, we conducted longitudinal measurements of the AQ in a large sample of university students and investigated the possibility of changes in the AQ and associated factors. MethodsThe AQ, University Personality Inventory (UPI), and the willingness of the students to be interviewed were determined at admission in students from four departments of Kochi University; the AQ was determined again in the second year. Changes in the AQ and associated factors were analyzed statistically. ResultsThe number of valid responses in the initial survey was 3427 (87.2%). The AQ was significantly higher in the group with high UPI scores (F=156.08, P<0.001). Of the 486 students interviewed at admission, 22 had suspected ASD. The sensitivity/specificity of the AQ for ASD was 81.8%/92.0%. A total of 319 (11.0%) students responded to the second-year survey, which revealed significant decrease of the AQ in the group with high AQ values at admission. DiscussionThe AQ measured at admission was correlated with the UPI score, regardless of the sex or department; in the second survey, the scores decreased significantly in those with high AQ values at admission, suggesting that an unstable mental state can produce a temporary increase of the AQ scores.	[Kitazoe, Noriko; Iwasaki, Yasumasa] Kochi Univ, Students Hlth Serv Ctr, Kochi 7808520, Japan; [Inoue, Shimpei] Fukushima Med Univ, Dept Neuropsychiat, Aizu Med Ctr, Fukushima, Japan; [Izumoto, Yuji] Kochi Hlth Sci Ctr, Div Child Psychiat, Dept Psychiat, Kochi, Japan; [Kumagai, Naoko] Kochi Univ, Kochi Med Sch, Integrated Ctr Adv Med Technol, Nankoku, Kochi, Japan	Kitazoe, N (reprint author), Kochi Univ, Students Hlth Serv Ctr, 2-5-1 Akebono Cho, Kochi 7808520, Japan.	kitazoe@kochi-u.ac.jp			Japan Society for the Promotion of Science [1853757]	This study was supported by a grant-in-aid for Scientific Research (C) (1853757) from Japan Society for the Promotion of Science.	Kurita H, 2005, PSYCHIAT CLIN NEUROS, V59, P490, DOI 10.1111/j.1440-1819.2005.01403.x; Cath DC, 2008, PSYCHOPATHOLOGY, V41, P101, DOI 10.1159/000111555; Wakabayashi A, 2006, J AUTISM DEV DISORD, V36, P263, DOI 10.1007/s10803-005-0061-2; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Kurita H, 2006, PSYCHIAT CLIN NEUROS, V60, P373, DOI 10.1111/j.1440-1819.2006.01516.x; Hoekstra RA, 2008, J AUTISM DEV DISORD, V38, P1555, DOI 10.1007/s10803-008-0538-x; Hurst RM, 2007, PERS INDIV DIFFER, V43, P1938, DOI 10.1016/j.paid.2007.06.012; Nevill REA, 2011, J AUTISM DEV DISORD, V41, P1619, DOI 10.1007/s10803-011-1189-x; Kunihira Y, 2006, J AUTISM DEV DISORD, V36, P553, DOI 10.1007/s10803-006-0094-1; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; VanBergeijk E, 2008, J AUTISM DEV DISORD, V38, P1359, DOI 10.1007/s10803-007-0524-8; White SW, 2011, AUTISM, V15, P683, DOI 10.1177/1362361310393363; Arvidsson T., 1997, AUTISM, V1, P163, DOI 10.1177/1362361397012004; Austin J. E., 2005, PERS INDIV DIFFER, V38, P451; Honda H, 1996, BRIT J PSYCHIAT, V169, P228, DOI 10.1192/bjp.169.2.228; Iwata A., 2007, JPN J STUD DISABIL D, V35, P52; Jobe E. L., 2007, PERS INDIV DIFFER, V42, P1479; Kajita M, 2002, PSYCHIAT CLIN NEUROS, V56, P123, DOI 10.1046/j.1440-1819.2002.00947.x; Kanai C, 2011, RES AUTISM SPECT DIS, V5, P1451, DOI 10.1016/j.rasd.2011.02.005; Kobayashi T., 2003, PSYCHIATRY, V2, P397; Matsubara T., 1995, SHINRITESUTONYUMON, P145; Nishimura Y., 2006, JPN J LEARN DISABILI, V15, P302; Sakai W., 2009, CAMPUS HLTH, V46, P322; Sasaki T., 2010, JPN J PSYCHIAT TREAT, V25, P1647; Stewart E. M., 2009, PER INDIVID DIF, V47, P224; Wakabayashi A., 2003, JAPANESE J AUTISTIC, V2, P11; Wakabayashi Akio, 2004, Shinrigaku Kenkyu, V75, P78; Woodbury-Smith R, 2005, J AUTISM DEV DISORD, V35, P331; World Health Organization, 1993, ICD 10 CLASS MENT BE	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1758-5864	1758-5872		ASIA-PAC PSYCHIAT	Asia-Pac. Psychiatry	MAR	2015	7	1					105	112		10.1111/appy.12094		8	Psychiatry	Psychiatry	CB9VH	WOS:000349981000013		
J	Oda, E				Oda, Eiji			Cross-sectional and longitudinal associations between serum bilirubin and dyslipidemia in a health screening population	ATHEROSCLEROSIS			English	Article						Bilirubin; Triglycerides; HDL cholesterol; Oxidative stress	CORONARY-HEART-DISEASE; METABOLIC SYNDROME; GILBERTS-SYNDROME; OXIDATIVE STRESS; CARDIOVASCULAR PROTECTION; RISK-FACTOR; MEN; ANTIOXIDANT; RESISTANCE; CHILDREN	Objective: To investigate cross-sectional and longitudinal associations between serum total bilirubin (TB) and dyslipidemia. Methods: Odds ratios (ORs) of prevalent dyslipidemia for TB were calculated in 2113 men and 1265 women. Correlation coefficients between baseline TB as well as the change in TB over 5 years and baseline log triglycerides, baseline HDL cholesterol and the changes in log triglycerides and HDL cholesterol over 5 years were calculated. Hazard ratios (HRs) of incident hypertriglyceridemia and hypo-HDL cholesterolemia for TB over 5 years were calculated in 1324 men and 915 women and 1583 men and 884 women, respectively. Results: The ORs of prevalent hypertriglyceridemia and hypo-HDL cholesterolemia for each one SD increase in TB were 0.83 (p < 0.001) in men and 0.71 (p = 0.074) in women and 0.64 (p < 0.001) in men and 0.78 (p = 0.089) in women, respectively adjusted for age, smoking, and other confounders. The baseline TB was significantly correlated with baseline log triglycerides and HDL cholesterol both in men and women while the change in TB was significantly correlated with the changes in log triglycerides and HDL cholesterol in men and the change in HDL cholesterol in women. The HRs of incident hypertriglyceridemia and hypo-HDL cholesterolemia for each one SD increase in TB were 0.99 (p = 0.848) in men and 0.74 (p = 0.033) in women and 1.08 (p = 0.345) in men and 0.85 (p = 0.220) in women, respectively adjusted for age, smoking, and other confounders. Conclusion: Baseline TB was significantly associated with both prevalent hypertriglyceridemia and hypo-HDL cholesterolemia in men and with incident hypertriglyceridemia in women. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	Tachikawa Med Ctr, Med Check Up Ctr, Nagaoka, Niigata 9400053, Japan	Oda, E (reprint author), Tachikawa Med Ctr, Med Check Up Ctr, Nagachou 2-2-16, Nagaoka, Niigata 9400053, Japan.	ijie@venus.sannet.ne.jp					Bulmer AC, 2013, PROG LIPID RES, V52, P193, DOI 10.1016/j.plipres.2012.11.001; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Oda E, 2012, HEART VESSELS, V27, P29, DOI 10.1007/s00380-011-0123-7; Troughton JA, 2007, EUR J CARDIOV PREV R, V14, P79, DOI 10.1097/01.hjr.0000230097.81202.9f; Novotny L, 2003, EXP BIOL MED, V228, P568; Maruhashi T, 2012, CIRCULATION, V126, P598, DOI 10.1161/CIRCULATIONAHA.112.105775; Boon AC, 2012, FREE RADICAL BIO MED, V52, P2120, DOI 10.1016/j.freeradbiomed.2012.03.002; Oda E, 2012, KIDNEY BLOOD PRESS R, V36, P47, DOI 10.1159/000339027; Kimm H, 2009, STROKE, V40, P3422, DOI 10.1161/STROKEAHA.109.560649; Hopkins PN, 1996, ARTERIOSCL THROM VAS, V16, P250; Perlstein TS, 2008, AM J MED, V121, P781, DOI 10.1016/j.amjmed.2008.03.045; Oda E, 2013, ACTA DIABETOL, V50, P417, DOI 10.1007/s00592-012-0447-5; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Erdogan D, 2006, ATHEROSCLEROSIS, V184, P431, DOI 10.1016/j.atherosclerosis.2005.05.01; Madhavan M, 1997, ATHEROSCLEROSIS, V131, P107, DOI 10.1016/S0021-9150(97)06088-7; Wallner M, 2013, CLIN SCI, V125, P257, DOI 10.1042/CS20120661; Vitek L, 2007, ADV CLIN CHEM, V43, P1, DOI 10.1016/S0065-2423(06)43001-8; Youn JY, 2014, DIABETES, V63, P2344, DOI 10.2337/db13-0719; Wu YH, 2011, J DIABETES, V3, P217, DOI 10.1111/j.1753-0407.2011.00138.x; Lin LY, 2009, ATHEROSCLEROSIS, V203, P563, DOI 10.1016/j.atherosclerosis.2008.07.021; Choi SH, 2013, NUTR METAB CARDIOVAS, V23, P31, DOI 10.1016/j.numecd.2011.03.001; Bulmer AC, 2008, ATHEROSCLEROSIS, V199, P390, DOI 10.1016/j.atherosclerosis.2007.11.022; Schwertner HA, 1998, ATHEROSCLEROSIS, V136, P383, DOI 10.1016/S0021-9150(97)00232-3; Perlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Riphagen IJ, 2014, DIABETES, V63, P2845, DOI 10.2337/db13-1652; Van Hoydonck PGA, 2001, INT J EPIDEMIOL, V30, P1465; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; BREIMER LH, 1995, CLIN CHEM, V41, P1504; Lee MJ, 2014, DIABETES METAB, V40, P305, DOI 10.1016/j.diabet.2014.04.006; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; Oda E, 2011, CIRC J, V75, P190, DOI 10.1253/circj.CJ-10-0645; Oda E, 2014, ATHEROSCLEROSIS, V235, P334, DOI 10.1016/j.atherosclerosis.2014.05.927; Wallner M, 2013, CANCER PREV RES, V6, P1056, DOI 10.1158/1940-6207.CAPR-13-0125; Yesilova Z, 2008, J GASTROEN HEPATOL, V23, P1556, DOI 10.1111/j.1440-1746.2008.05388.x	36	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	MAR	2015	239	1					31	37		10.1016/j.atherosclerosis.2014.12.053		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CB6RH	WOS:000349753800005		
J	Notsu, Y; Yano, S; Shibata, H; Nagai, A; Nabika, T				Notsu, Yoshitomo; Yano, Shozo; Shibata, Hiroshi; Nagai, Atsushi; Nabika, Toru			Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study	ATHEROSCLEROSIS			English	Article						Arginine; Asymmetric dimethylarginine (ADMA); Atherosclerosis; Intima-media thickness (IMT)	INTIMA-MEDIA THICKNESS; ASYMMETRIC DIMETHYLARGININE ADMA; NITRIC-OXIDE SYNTHASE; TYPE-2 DIABETES-MELLITUS; STAGE RENAL-DISEASE; CARDIOVASCULAR-DISEASE; ENDOGENOUS METHYLARGININES; CAROTID ATHEROSCLEROSIS; MORTALITY; PROGRESSION	Background: Asymmetric dimethylarginine (ADMA), which acts an endogenous inhibitor of nitric oxide synthase (NOS), is involved in the pathogenesis of cardiovascular disease. Arginine (Arg) may regulate vascular endothelial function, since Arg is the substrate of NO competing with ADMA. In our previous study, low Arg/ADMA ratio is an independent risk for microangiopathy-related cerebral damage. Purpose: Here, we performed a cross-sectional study to evaluate the association between the Arg/ADMA ratio and the maximal intima-media thickness (IMT) in the carotid artery. Subjects and Methods: Participants were 785 community-dwelling Japanese people without any severe disorders. Plasma concentration of Arg and ADMA in fasting blood sample was determined using HPLC. IMT was measured in the bilateral carotid artery by ultrasonography. Results: Among quartiles stratified by the Arg/ADMA ratio, ANOVA showed a significant difference in IMT and the IMT in Q1 (the lowest quartile) was significantly higher than that in Q4 (the highest quartile). In multiple linear regression analysis, age, the male gender, lower BMI, the presence of hypertension and lower Arg/ADMA ratio were independently correlated with IMT, while IMT was not correlated with Arg or ADMA alone. In addition, the Arg/ADMA ratio was associated with IMT independent of age, sex, BMI and the presence of hypertension with odds ratio 0.21 (95%CI: 0.05-0.88) in multiple logistic regression analysis for IMT 1.5 mm or more. Conclusion: Imbalance of Arg and ADMA is independently involved in the progression of atherosclerosis, and the Arg/ADMA ratio may be a sensitive marker for atherosclerosis. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Notsu, Yoshitomo; Yano, Shozo; Shibata, Hiroshi; Nagai, Atsushi] Shimane Univ, Dept Lab Med, Fac Med, Izumo, Shimane 6938501, Japan; [Nabika, Toru] Shimane Univ, Dept Funct Pathol, Fac Med, Izumo, Shimane 6938501, Japan	Yano, S (reprint author), Shimane Univ, Dept Lab Med, Fac Med, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	syano@med.shimane-u.ac.jp			 [24591230]	This work is partly supported by Grant-In-Aids for Scientific research, Kakenhi (C) (24591230) (to SY).	Abedini S, 2010, KIDNEY INT, V77, P44, DOI 10.1038/ki.2009.382; Staalso JM, 2013, STROKE, V44, P1273, DOI 10.1161/STROKEAHA.111.000605; Zoccali C, 2002, J AM SOC NEPHROL, V13, P490; Bode-Boger SM, 2007, PHARMACOL THERAPEUT, V114, P295, DOI 10.1016/j.pharmthera.2007.03.002; Boger RH, 2009, PHARMACOL RES, V60, P481, DOI 10.1016/j.phrs.2009.07.001; Teerlink T, 2009, PHARMACOL RES, V60, P448, DOI 10.1016/j.phrs.2009.08.002; Kielstein JT, 2006, STROKE, V37, P2024, DOI 10.1161/01.STR.0000231640.32543.11; Hamano T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049122; Boger RH, 2009, CIRCULATION, V119, P1592, DOI 10.1161/CIRCULATIONAHA.108.838268; Maas R, 2009, STROKE, V40, P2715, DOI 10.1161/STROKEAHA.109.552539; Baldassarre D, 2012, J AM COLL CARDIOL, V60, P1489, DOI 10.1016/j.jacc.2012.06.034; Cardounel AJ, 2007, J BIOL CHEM, V282, P879, DOI 10.1074/jbc.M603606200; Nicholls SJ, 2007, CIRCULATION, V116, P2315, DOI 10.1161/CIRCULATIONAHA.107.693986; Notsu Y, 2009, AM J HYPERTENS, V22, P257, DOI 10.1038/ajh.2008.346; Anderssohn M, 2012, J CARD FAIL, V18, P904, DOI 10.1016/j.cardfail.2012.10.011; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Masuda H, 1999, BRIT J PHARMACOL, V126, P211, DOI 10.1038/sj.bjp.0702298; Schlaich MP, 2004, CIRCULATION, V110, P3680, DOI 10.1161/01.CIR.0000149748.79945.52; Cardounel AJ, 2002, J BIOL CHEM, V277, P33995, DOI 10.1074/jbc.M108983200; Anderssohn M, 2010, DIABETES VASC DIS RE, V7, P105, DOI 10.1177/1479164110366053; Pizzarelli F, 2013, AGE, V35, P2465, DOI 10.1007/s11357-013-9523-1; Luiking YC, 2012, AM J PHYSIOL-ENDOC M, V303, pE1177, DOI 10.1152/ajpendo.00284.2012; Furuki K, 2008, HYPERTENS RES, V31, P1185, DOI 10.1291/hypres.31.1185; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Baylis C, 2012, CURR OPIN NEPHROL HY, V21, P1, DOI 10.1097/MNH.0b013e32834d54ca; Bai YY, 2013, AGEING RES REV, V12, P699, DOI 10.1016/j.arr.2012.02.003; Boger RH, 2011, J INTERN MED, V269, P349, DOI 10.1111/j.1365-2796.2010.02322.x; Chirinos JA, 2008, HYPERTENSION, V52, P1051, DOI 10.1161/HYPERTENSIONAHA.108.120352; Cobanoglu AK, 2013, INT UROL NEPHROL, V45, P1463, DOI 10.1007/s11255-012-0345-3; Davids M, 2013, METABOLISM, V62, P1455, DOI 10.1016/j.metabol.2013.05.017; Dobashi Y, 2002, ANALYST, V127, P54, DOI 10.1039/b106828h; Ellger B, 2008, ENDOCRINOLOGY, V149, P3148, DOI 10.1210/en.2007-1558; Furuki K, 2007, ATHEROSCLEROSIS, V191, P206, DOI 10.1016/j.atherosclerosis.2006.03.022; Hamano T, 2011, AM J HYPERTENS, V24, P643, DOI 10.1038/ajh.2011.37; Imai Enyu, 2007, Clin Exp Nephrol, V11, P41, DOI 10.1007/s10157-006-0453-4; Jaenecke I, 2012, J BIOL CHEM, V287, P30853, DOI 10.1074/jbc.M112.350322; Kanazawa I, 2011, CLIN ENDOCRINOL, V74, P467, DOI 10.1111/j.1365-2265.2010.03946.x; Krzyzanowska K, 2007, DIABETES CARE, V30, P1834, DOI 10.2337/dc07-0019; Lind L, 2009, ATHEROSCLEROSIS, V203, P544, DOI 10.1016/j.atherosclerosis.2008.07.016; Nanayakkara PWB, 2005, KIDNEY INT, V68, P2230, DOI 10.1111/j.1523-1755.2005.00680.x; Nijveldt RJ, 2003, CLIN NUTR, V22, P23, DOI 10.1054/clnu.2002.0613; Polak JF, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000087; Serg M, 2011, BLOOD PRESSURE, V20, P111, DOI 10.3109/08037051.2010.533821; Visser M, 2012, BRIT J NUTR, V107, P1458, DOI 10.1017/S0007114511004648; Wijnands KAP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086135; Xia W, 2012, J ENDOCRINOL INVEST, V35, P824; Zsuga J, 2007, CEREBROVASC DIS, V23, P388, DOI 10.1159/000101461	48	5	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	MAR	2015	239	1					61	66		10.1016/j.atherosclerosis.2014.12.030		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CB6RH	WOS:000349753800010		
J	Nagayama, D; Yamaguchi, T; Saiki, A; Imamura, H; Sato, Y; Ban, N; Kawana, H; Nagumo, A; Shirai, K; Tatsuno, I				Nagayama, Daiji; Yamaguchi, Takashi; Saiki, Atsuhito; Imamura, Haruki; Sato, Yuta; Ban, Noriko; Kawana, Hidetoshi; Nagumo, Ayako; Shirai, Kohji; Tatsuno, Ichiro			High serum uric acid is associated with increased cardio-ankle vascular index (CAVI) in healthy Japanese subjects: A cross-sectional study	ATHEROSCLEROSIS			English	Article						Cardio-ankle vascular index (CAVI); Serum uric acid; Gender difference	TYPE-2 DIABETIC-PATIENTS; PULSE-WAVE VELOCITY; CHRONIC HEART-FAILURE; ARTERIAL STIFFNESS; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; RISK-FACTORS; FOLLOW-UP; MORTALITY; ATHEROSCLEROSIS	Objective: To investigate the association of serum uric acid (SUA) with arterial stiffness assessed by cardio-ankle vascular index (CAVI). Methods: We analyzed the cross-sectional data from 27,360 healthy Japanese subjects (12,910 males and 14,450 females) aged between 20 and 74 years without a past history of heart disease, stroke, hypertension, diabetes, nephritis or gout. We investigated whether SUA was independently associated with CAVI in a gender-specific manner. Results: BMI, CAVI, systolic/diastolic BP, GOT, GPT, gamma-GTP, triglyceride (TG), creatinine and SUA were higher and HDL-C was lower in males than in females. Next, they were stratified by SUA into 3 groups: lower tertile (T1), middle tertile (T2) and upper tertile (T3) and by gender. CAVI increased progressive with increasing SUA tertile, after adjusting for age, BMI and systolic BP (sBP) identified in multiple regression analysis for CAVI. Multivariate analysis showed that the odds ratios (95% CI) relative to T1 for high CAVI (> 90th percentile) were 1.233 (0.928-1.638) in T2 and 1.352 (1.031-1.773) in T3 for males, and 1.133 (0.984-1.303) in T2 and 1.361 (1.098-1.687) in T3 for females, after adjusting for confounders. Furthermore, increase in adjusted CAVI was observed in a lower SUA range in females compared to that observed in males. Conclusion: We demonstrated an independent correlation between SUA and CAVI, and observed gender difference in the SUA range for increase in CAVI. These results may suggest the need to set different target SUA levels for men and women in anti-hyperuricemic treatment for atherosclerosis prevention. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Nagayama, Daiji; Yamaguchi, Takashi; Saiki, Atsuhito; Imamura, Haruki; Sato, Yuta; Ban, Noriko; Kawana, Hidetoshi; Nagumo, Ayako; Tatsuno, Ichiro] Toho Univ, Sakura Med Ctr, Ctr Diabet Endocrinol & Metab, Sakura, Chiba 2858741, Japan; [Nagayama, Daiji] Shin Oyama City Hosp, Ctr Endocrinol & Metab, Oyama City, Tochigi 3230028, Japan; [Shirai, Kohji] Toho Univ, Sakura Med Ctr, Dept Vasc Funct, Sakura, Chiba 2858741, Japan	Tatsuno, I (reprint author), Toho Univ, Sakura Med Ctr, Ctr Diabet Endocrinol & Metab, 564-1 Shimoshizu, Sakura, Chiba 2858741, Japan.	ichiro.tatsuno@med.toho-u.ac.jp					Culleton BF, 1999, ANN INTERN MED, V131, P7; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Noike H, 2010, J ATHEROSCLER THROMB, V17, P517; Kuo CF, 2010, RHEUMATOLOGY, V49, P141, DOI 10.1093/rheumatology/kep364; Sugawara J, 2005, J HUM HYPERTENS, V19, P401, DOI 10.1038/sj.jhh.1001838; Nieto FJ, 2000, ATHEROSCLEROSIS, V148, P131, DOI 10.1016/S0021-9150(99)00214-2; LEVINE W, 1989, J CLIN EPIDEMIOL, V42, P257, DOI 10.1016/0895-4356(89)90061-9; FREEDMAN DS, 1995, AM J EPIDEMIOL, V141, P637; ANTON FM, 1986, METABOLISM, V35, P343; Farquharson CA, 2002, CIRCULATION, V106, P221, DOI 10.1161/01.CIR.0000022140.61460.1D; Matsui Y, 2004, HYPERTENS RES, V27, P851, DOI 10.1291/hypres.27.851; Shirai K, 2011, J ATHEROSCLER THROMB, V18, P924; Miyashita Y, 2009, J ATHEROSCLER THROMB, V16, P539; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; Nakamura K, 2008, CIRC J, V72, P598; Nagayama D, 2013, OBES RES CLIN PRACT, V7, pE139, DOI 10.1016/j.orcp.2011.08.154; BENGTSSON C, 1988, ACTA MED SCAND, V224, P549; Shirai K, 2006, J ATHEROSCLER THROMB, V13, P101; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kim HJ, 2009, DIABETES RES CLIN PR, V85, P30, DOI 10.1016/j.diabres.2009.03.013; KLEIN R, 1973, ARCH INTERN MED, V132, P401, DOI 10.1001/archinte.132.3.401; Kubozono T, 2007, CIRC J, V71, P89, DOI 10.1253/circj.71.89; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; BURACK RC, 1985, J CHRON DIS, V38, P865, DOI 10.1016/0021-9681(85)90111-0; FESSEL WJ, 1980, AM J MED, V68, P401, DOI 10.1016/0002-9343(80)90111-4; Kubota Y, 2011, ARTERY RES, V5, P91; Leyva F, 1998, EUR HEART J, V19, P1814, DOI 10.1053/euhj.1998.1188; McKelvey T.G., 1988, AM J PHYSIOL, V254, P753; Miyashita Y, 2010, J ATHEROSCLER THROMB, V17, P1070; Miyashita Y, 2009, J ATHEROSCLER THROMB, V16, P621; Nagayama D, 2010, INT J CLIN PRACT, V64, P1796, DOI 10.1111/j.1742-1241.2010.02399.x; Nagayama D, 2014, INT HEART J, V55, P337; Odden MC, 2014, AM J KIDNEY DIS, V64, P550, DOI 10.1053/j.ajkd.2014.04.024; Ohira M., 2011, METABOLISM, V60, P878; Pietro S., 2014, J FUNCT FOODS, V6, P11; The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus, 2010, J JPN DIABETES SOC, V2010, P450; Wen W, 2015, ATHEROSCLEROSIS, V238, P147, DOI 10.1016/j.atherosclerosis.2014.10.089; Yambe T, 2004, BIOMED PHARMACOTHER, V58, P95	39	3	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	MAR	2015	239	1					163	168		10.1016/j.atherosclerosis.2015.01.011		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CB6RH	WOS:000349753800025		
J	Nishimura, H; Shimadera, H; Kondo, A; Bao, H; Shrestha, KL; Inoue, Y				Nishimura, Hiroshi; Shimadera, Hikari; Kondo, Akira; Bao, Hai; Shrestha, Kundan Lal; Inoue, Yoshio			Evaluation of light dependence of monoterpene emission and its effect on surface ozone concentration	ATMOSPHERIC ENVIRONMENT			English	Article						Monoterpenes; Light intensity; Japanese coniferous tree; Ozone; WRF/CMAQ	VOLATILE ORGANIC-COMPOUNDS; QUERCUS-ILEX L.; BIOGENIC EMISSIONS; NORTHEAST ASIA; VOC EMISSIONS; UNITED-STATES; GLOBAL-MODEL; TEMPERATURE; ISOPRENE; AEROSOLS	This study evaluated the effect of light intensity on monoterpene emission from the three dominant coniferous tree species in Japan (Cryptomeria japonica, Chamaecyparis obtusa and Pinus densiflora). Monoterpene emission experiments were conducted by using a growth chamber where temperature and light intensity can be controlled. In the experiments, air temperature was set at 30 degrees C and light intensity was set at 0, 500, 700, 850, 1200, and 1400 mu mol m(-2) s(-1). Because monoterpene emissions from the three tree species similarly increased with increasing light intensity, a new empirical equation considering light dependence was proposed to estimate monoterpene emission. In addition, monoterpene emission in the Kinki region of Japan was estimated with and without light dependence using meteorological field produced by the Weather Research and Forecasting model (WRF) in summer 2010. The monoterpene emissions estimated with light dependence were larger than those without light dependence in the daytime under clear sky conditions and consistently smaller in the nighttime. In order to evaluate the effect of light dependence of monoterpene emission on ozone concentration in the Kinki region, two cases of air quality simulations by the Community Multiscale Air Quality model (CMAQ) were conducted using the monoterpene emission data estimated with and without light dependence. Comparisons of the two cases showed that the monoterpene emission changes due to light dependence slightly but systematically affected ozone concentrations. Monoterpene generally played a role of reducing ozone concentration in the CMAQ simulations. Consequently, because of the light dependence, the mean daily maximum ozone concentrations decreased by 0.3 ppb on average with a maximum of 2.2 ppb, and the mean daily minimum values increased by 0.4 ppb on average with a maximum of 1.8 ppb in the Kinki region in summer 2010. (C) 2015 Elsevier Ltd. All rights reserved.	[Nishimura, Hiroshi; Kondo, Akira; Inoue, Yoshio] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Shimadera, Hikari] Osaka Univ, Ctr Environm Innovat Design Sustainabil, Suita, Osaka 5650871, Japan; [Bao, Hai] Inner Mongolia Normal Univ, Chem & Environm Sci Coll, Hohhot 010022, Peoples R China; [Shrestha, Kundan Lal] Kathmandu Univ, Sch Sci, Dhulikhel, Nepal	Nishimura, H (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	nishimura@ea.see.eng.osaka-u.ac.jp			JSPS [26740038]	This research was supported by JSPS KAKENHI Grant Number 26740038.	Vallat A, 2005, PHYTOCHEMISTRY, V66, P1540, DOI 10.1016/j.phytochem.2005.04.038; Byun D, 2006, APPL MECH REV, V59, P51, DOI 10.1115/1.2128636; GUENTHER AB, 1993, J GEOPHYS RES-ATMOS, V98, P12609, DOI 10.1029/93JD00527; Itahashi S, 2013, ATMOS ENVIRON, V70, P204, DOI 10.1016/j.atmosenv.2013.01.026; Bertin N, 1997, ATMOS ENVIRON, V31, P135, DOI 10.1016/S1352-2310(97)00080-0; LAMB B, 1985, J GEOPHYS RES-ATMOS, V90, P2380, DOI 10.1029/JD090iD01p02380; Guenther A, 2006, ATMOS CHEM PHYS, V6, P3181; TINGEY DT, 1980, PLANT PHYSIOL, V65, P797, DOI 10.1104/pp.65.5.797; Kannari A, 2007, ATMOS ENVIRON, V41, P3428, DOI 10.1016/j.atmosenv.2006.12.015; Bao H, 2008, ENVIRON RES, V106, P156, DOI 10.1016/j.envres.2007.09.009; Matsunaga SN, 2013, ATMOS ENVIRON, V69, P124, DOI 10.1016/j.atmosenv.2012.12.004; Schurgers G, 2009, ATMOS CHEM PHYS, V9, P3409; Bao H, 2010, ATMOS ENVIRON, V44, P421, DOI 10.1016/j.atmosenv.2009.10.021; Penuelas J, 1999, ENVIRON POLLUT, V105, P17, DOI 10.1016/S0269-7491(98)00214-0; Goldstein AH, 2007, ENVIRON SCI TECHNOL, V41, P1514, DOI 10.1021/es072476p; Guenther AB, 2012, GEOSCI MODEL DEV, V5, P1471, DOI 10.5194/gmd-5-1471-2012; Llusia J, 2002, ATMOS ENVIRON, V36, P3931, DOI 10.1016/S1352-2310(02)00321-7; Wiedinmyer C, 2011, GEOSCI MODEL DEV, V4, P625, DOI 10.5194/gmd-4-625-2011; Solmon F, 2004, ATMOS ENVIRON, V38, P3853, DOI 10.1016/j.atmosenv.2004.03.054; Situ S, 2013, ATMOS CHEM PHYS, V13, P11803, DOI 10.5194/acp-13-11803-2013; Skamarock WC, 2008, J COMPUT PHYS, V227, P3465, DOI 10.1016/j.jcp.2007.01.037; Back J, 2005, BOREAL ENVIRON RES, V10, P409; Carter W.P.L., 2000, DOCUMENTATION SAPRC, P95; Chatani S, 2014, AEROSOL AIR QUAL RES, V14, P396, DOI 10.4209/aaqr.2013.02.0035; Ciccioli P, 1997, J GEOPHYS RES-ATMOS, V102, P23319, DOI 10.1029/97JD01372; Demarcke M, 2010, ATMOS ENVIRON, V44, P3261, DOI 10.1016/j.atmosenv.2010.05.054; Emery C., 2001, ENHANCED METEOROLOGI; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Kajino M, 2013, ATMOS ENVIRON, V79, P67, DOI 10.1016/j.atmosenv.2013.06.024; Larcher W., 2001, OKOPHYSIOLOGIE PFLAN; OPRF, 2012, REP PROJ EST IMP DES; Sakulyanontvittaya T, 2008, ENVIRON SCI TECHNOL, V42, P8784, DOI 10.1021/es800817r; Schuh G, 1997, J ATMOS CHEM, V27, P291, DOI 10.1023/A:1005850710257; Shimadera Hikari, 2014, Asian Journal of Atmospheric Environment, V8, P25, DOI 10.5572/ajae.2014.8.1.025; Shimadera H, 2009, ATMOS ENVIRON, V43, P5894, DOI 10.1016/j.atmosenv.2009.08.022; Shimadera H, 2013, ASIA-PAC J ATMOS SCI, V49, P347, DOI 10.1007/s13143-013-0033-y; Staudt M, 2011, BIOGEOSCIENCES, V8, P2757, DOI 10.5194/bg-8-2757-2011; VOGEL B, 1995, J GEOPHYS RES-ATMOS, V100, P22907, DOI 10.1029/95JD01228; YOKOUCHI Y, 1985, ATMOS ENVIRON, V19, P1271, DOI 10.1016/0004-6981(85)90257-4; Zemankova K, 2010, ENVIRON POLLUT, V158, P462, DOI 10.1016/j.envpol.2009.08.032; Zhihui W., 2003, ATMOS ENVIRON, V37, P3771, DOI 10.1016/S1352-2310(03)00462-X	41	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	MAR	2015	104						143	153		10.1016/j.atmosenv.2015.01.011		11	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CC2QF	WOS:000350189000015		
J	Dear, BF; Zou, JB; Ali, S; Lorian, CN; Johnston, L; Sheehan, J; Staples, LG; Gandy, M; Fogliati, VJ; Klein, B; Titov, N				Dear, Blake F.; Zou, Judy B.; Ali, Shehzad; Lorian, Carolyn N.; Johnston, Luke; Sheehan, Joanne; Staples, Lauren G.; Gandy, Milena; Fogliati, Vincent J.; Klein, Britt; Titov, Nickolai			Clinical and Cost-Effectiveness of Therapist-Guided Internet-Delivered Cognitive Behavior Therapy for Older Adults With Symptoms of Anxiety: A Randomized Controlled Trial	BEHAVIOR THERAPY			English	Article						anxiety; older adults; internet; cognitive behavior therapy (CBT); cost-effectiveness	LATE-LIFE ANXIETY; PSYCHOLOGICAL TREATMENTS; PRIMARY-CARE; DEPRESSION; DISORDERS; PHQ-9; PSYCHOTHERAPY; METAANALYSIS; COMORBIDITY; PREVALENCE	There is preliminary support for internet-delivered cognitive behaviour therapy (iCBT) as a way of improving access to treatment among older adults with anxiety. The aim of this randomized controlled trial (RCT) was to examine the efficacy, long-term outcomes, and cost-effectiveness of an iCBT program for adults over 60 years of age with anxiety. Successful applicants were randomly allocated to either the treatment group (n = 35) or the waitlist control group (n = 37). The online treatment course was delivered over 8 weeks and provided with brief weekly contact with a clinical psychologist via telephone or secure email. Eighty-four percent of participants completed the iCBT course within the 8 weeks and 90% provided data at posttreatment. Significantly lower scores on measures of anxiety (Cohen's d = 1.43; 95% CI: 0.89 - 1.93) and depression (Cohen's d =1.79; 95% CI: 1.21 - 2.32) were found among the treatment group compared to the control group at posttreatment. These lower scores were maintained at 3-month and 12-month follow-up and the treatment group rated the iCBT treatment as acceptable. The treatment group had slightly higher costs ($92.2; 95% CI: $38.7 to $149.2) and Quality-Adjusted Life-Years (QALYs = 0.010; 95% CI: 0.003 to 0.018) than the control group at posttreatment and the intervention was found to have a greater than 95% probability of being cost-effective. The results support iCBT as an efficacious and cost-effective treatment option for older adults with symptoms of anxiety.	[Dear, Blake F.; Zou, Judy B.; Lorian, Carolyn N.; Johnston, Luke; Sheehan, Joanne; Staples, Lauren G.; Gandy, Milena; Fogliati, Vincent J.; Titov, Nickolai] Macquarie Univ, N Ryde, NSW 2109, Australia; [Ali, Shehzad] Univ York, York YO10 5DD, N Yorkshire, England; [Klein, Britt] Federat Univ Australia, Mt Helen, Vic, Australia; [Klein, Britt] Natl Inst Mental Hlth Res, Tokyo, Japan; [Klein, Britt] Australian Natl Univ, Canberra, ACT 0200, Australia; [Klein, Britt] Swinburne Univ Technol, Hawthorn, Vic 3122, Australia	Dear, BF (reprint author), Macquarie Univ, ECentreClin, Dept Psychol, N Ryde, NSW 2109, Australia.	blake.dear@mq.edu.au			National Priority Driven Research Program Grant from beyondblue; National Health and Medical Research Council (NHMRC) Australian Public Health Fellowship	The authors gratefully acknowledge the participants for their involvement and helpful comments. This research was enabled by a National Priority Driven Research Program Grant from beyondblue. The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. BFD is supported by a National Health and Medical Research Council (NHMRC) Australian Public Health Fellowship. LGS, and SA had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.	Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; Dear BF, 2011, BEHAV RES THER, V49, P830, DOI 10.1016/j.brat.2011.09.007; Cuijpers Pim, 2009, Cognitive Behaviour Therapy, V38, P66, DOI 10.1080/16506070802694776; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Hedman E, 2012, EXPERT REV PHARM OUT, V12, P745, DOI [10.1586/erp.12.67, 10.1586/ERP.12.67]; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037//0022-006X.59.1.12; Titov Nickolai, 2011, Cognitive Behaviour Therapy, V40, P126, DOI 10.1080/16506073.2010.550059; Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4; Ayers CR, 2007, PSYCHOL AGING, V22, P8, DOI 10.1037/0882-7974.22.1.8; Byers AL, 2010, ARCH GEN PSYCHIAT, V67, P489, DOI 10.1001/archgenpsychiatry.2010.35; Gyani A, 2013, BEHAV RES THER, V51, P597, DOI 10.1016/j.brat.2013.06.004; Andreescu C, 2007, BRIT J PSYCHIAT, V190, P344, DOI 10.1192/bjp.bp.106.027169; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Trollor JN, 2007, AM J GERIAT PSYCHIAT, V15, P455, DOI 10.1097/JGP.0b013e3180590ba9; Wetherell JL, 2005, PSYCHIAT CLIN N AM, V28, P871, DOI 10.1016/j.psc.2005.09.006; Gould RL, 2012, J AM GERIATR SOC, V60, P218, DOI 10.1111/j.1532-5415.2011.03824.x; Spek V, 2007, PSYCHOL MED, V37, P1797, DOI 10.1017/S0033291707000542; Barlow DH, 2004, BEHAV THER, V35, P205, DOI 10.1016/S0005-7894(04)80036-4; Brenes GA, 2008, AGING MENT HEALTH, V12, P158, DOI 10.1080/13607860601124115; Kroenke K, 2007, ANN INTERN MED, V146, P317; Australian Government Department of Health, 2003, MED BEN SCHED BOOK; Australian Government Department of Health, 2003, PHARM BEN SCHED; Brazier J, 2007, MEASURING VALUING HL; Dear B. F., EXAMINING SELF UNPUB; Dear BF, 2013, AUST NZ J PSYCHIAT, V47, P169, DOI 10.1177/0004867412466154; Fenwick E., 2004, HEALTH ECON, V13, P11; Glick HA, 2007, EC EVALUATION CLIN T; Grek A, 2007, CAN J PSYCHIAT, V52, p47S; Gum Amber M, 2009, Am J Geriatr Psychiatry, V17, P769, DOI 10.1097/JGP.0b013e3181ad4f5a; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; McCabe C., 2008, PHARMACOECONOMICS, V26, P12; Nordhus I, 2003, J CONSULT CLIN PSYCH, V71, P643, DOI 10.1037/0022-006X.71.4.643; Norman Richard, 2013, Appl Health Econ Health Policy, V11, P287, DOI 10.1007/s40258-013-0035-z; Phelan E, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-63; Scogin F, 2005, CLIN PSYCHOL-SCI PR, V12, P222, DOI 10.1093/clipsy/bpi033; Titov N., 2011, BEHAV RES THER; Titov N., 2014, PLOS ONE, Ve89591; Titov N., 2013, PLOS ONE, V262873; Titov N, 2012, SPANISH J CLIN PSYCH, V17, P237; Wild B., AM J GERIATRIC PSYCH; World Health Organization, 1990, COMP INT DIAGN INT V; Zou JB, 2012, J ANXIETY DISORD, V26, P650, DOI 10.1016/j.janxdis.2012.04.002	46	3	3	ASSOC ADV BEHAVIOR THERAPY	NEW YORK	305 7TH AVE #16A, NEW YORK, NY 10001-6008 USA	0005-7894	1878-1888		BEHAV THER	Behav. Therapy	MAR	2015	46	2					206	217				12	Psychology, Clinical	Psychology	CC0FX	WOS:000350012300006		
J	Kim, YM; Lee, HW; Kim, S; Watanabe, C; Park, YK				Kim, Young-Min; Lee, Hyung Won; Kim, Seungdo; Watanabe, Chuichi; Park, Young-Kwon			Non-Isothermal Pyrolysis of Citrus Unshiu Peel	BIOENERGY RESEARCH			English	Article						Citrus unshiu peel; Pectin; TGA; EGA-MS; MS-GC/MS	CATALYTIC PYROLYSIS; BIOMASS; HEMICELLULOSE; DEGRADATION; CELLULOSE; RESIDUES	In this study, the non-isothermal pyrolysis of citrus unshui (C. unshiu) peel was studied by thermogravimetric analysis (TGA) and evolved gas analysis/pyrolyzer-gas chromatography/mass spectrometry (EGA/Py-GC/MS). Two types of analytical pyrolysis-GC/MS experiments, EGA-MS and multi-shot GC/MS, were conducted to determine the thermal profiles of the pyrolysis products, as well as the detailed pyrolysis product distribution of each thermal zone. The pyrolysis of pectin, hemicellulose, cellulose, and lignin was also carried out to interpret the pyrolysis behavior of C. unshiu peel. TGA and EGA-MS of C. unshiu peel revealed five main weight loss stages, such as water and limonene vaporization, pyrolysis of pectin, hemicellulose, cellulose, lignin, and char stabilization. Multi-shot GC/MS revealed the specific pyrolysis products of each component of C. unshiu peel. Limonene was vaporized with water below 140 A degrees C. Large amounts of methanol, acetic acid, 5-hydroxymethylfurfural, 3,5-dihydroxy-6-methyl-2,3-dihydro-4H-pyran-one, and p-vinylguaiacol were produced between 140 and 280 A degrees C, at which temperature range pectin and hemicellulose decomposed. The specific pyrolyzates of cellulose formed between 211 and 360 A degrees C, and a small amount of lignin pyrolyzates were also detected over a wide temperature range (141-360 A degrees C). At temperatures higher than 360 A degrees C, small amounts of aromatics were produced as the by-products of char stabilization.	[Kim, Young-Min; Lee, Hyung Won; Park, Young-Kwon] Univ Seoul, Grad Sch Energy & Environm Syst Engn, Seoul 130743, South Korea; [Kim, Young-Min; Watanabe, Chuichi] Frontier Labs Ltd, Koriyama, Fukushima 9638862, Japan; [Kim, Seungdo] Univ Chuncheon, Dept Environm Sci & Biotechnol, Chunchon 200702, South Korea; [Park, Young-Kwon] Univ Seoul, Sch Environm Engn, Seoul 130743, South Korea	Park, YK (reprint author), Univ Seoul, Sch Environm Engn, Seoul 130743, South Korea.	catalica@uos.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Education [2012R1A1B3003394]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2012R1A1B3003394).	Rivas B, 2008, J AGR FOOD CHEM, V56, P2380, DOI 10.1021/jf073388r; Marin FR, 2007, FOOD CHEM, V100, P736, DOI 10.1016/j.foodchem.2005.04.040; Aguiar L, 2008, J ANAL APPL PYROL, V83, P124, DOI 10.1016/j.jaap.2008.06.009; Park HJ, 2008, CHEM ENG J, V143, P124, DOI 10.1016/j.jec.2007.12.031; Faravelli T, 2010, BIOMASS BIOENERG, V34, P290, DOI 10.1016/j.biombioe.2009.10.018; Chen BL, 2009, CHEMOSPHERE, V76, P127, DOI 10.1016/j.chemosphere.2009.02.004; Shen DK, 2010, BIORESOURCE TECHNOL, V101, P6136, DOI 10.1016/j.biortech.2010.02.078; Carlson TR, 2011, ENERG ENVIRON SCI, V4, P145, DOI 10.1039/c0ee00341g; Wang SR, 2013, BIORESOURCE TECHNOL, V143, P378, DOI 10.1016/j.biortech.2013.06.026; Yang HP, 2007, FUEL, V86, P1781, DOI 10.1016/j.fuel.2006.12.013; Hosoya T, 2009, J ANAL APPL PYROL, V85, P237, DOI 10.1016/j.jaap.2008.11.028; Miranda R, 2009, J ANAL APPL PYROL, V86, P245, DOI 10.1016/j.jaap.2009.06.001; Choi IS, 2013, APPL ENERG, V102, P204, DOI 10.1016/j.apenergy.2012.03.066; Girisuta B, 2012, BIORESOURCE TECHNOL, V126, P92, DOI 10.1016/j.biortech.2012.09.013; Boluda-Aguilar M, 2010, BIORESOURCE TECHNOL, V101, P3506, DOI 10.1016/j.biortech.2009.12.063; Garcia-Maraver A, 2013, WASTE MANAGE, V33, P2245, DOI 10.1016/j.wasman.2013.07.010; Wang KG, 2014, GREEN CHEM, V16, P727, DOI 10.1039/c3gc41288a; Blasi CD, 2008, PROGR ENERGY COMBUST, V34, P47; Gullu D, 2001, ENERG CONVERS MANAGE, V42, P1349, DOI 10.1016/S0196-8904(00)00126-6; Kim YM, 2011, KOREAN J CHEM ENG, V28, P2012, DOI 10.1007/s11814-011-0177-3; Liu Q, 2008, J ANAL APPL PYROL, V82, P17; Lopez-Velazquez DA, 2013, J ANAL APPL PYROL, V99, P170; Materazzi M, 2006, TALANTA, V69, P781; McGrath T, 2001, FUEL, V80, P1787, DOI 10.1016/S0016-2361(01)00062-X; PARK YK, 1996, J KOREAN SOC FOOD SC, V25, P659; Rane Zab Anish Kumar P, 2012, INT J DRUG DEV RES, V4, P155; Shin T, 2011, PYROLYSIS-GC/MS DATA BOOK OF SYNTHETIC POLYMERS: PYROGRAMS, THERMOGRAMS AND MS OF PYROLYZATES, P1; [吴逸民 WU Yi-min], 2009, [燃料化学学报, Journal of Fuel Chemistry and Technology], V37, P427	28	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1939-1234	1939-1242		BIOENERG RES	BioEnergy Res.	MAR	2015	8	1					431	439		10.1007/s12155-014-9534-5		9	Energy & Fuels; Environmental Sciences	Energy & Fuels; Environmental Sciences & Ecology	CC0UA	WOS:000350051300036		
J	Takahara, T; Minamoto, T; Doi, H				Takahara, Teruhiko; Minamoto, Toshifumi; Doi, Hideyuki			Effects of sample processing on the detection rate of environmental DNA from the Common Carp (Cyprinus carpio)	BIOLOGICAL CONSERVATION			English	Article						eDNA; False negative; Freezing; PCR inhibition; Quantitative PCR (qPCR)	WATER SAMPLES; PCR; PERSISTENCE; ABUNDANCE; EDNA	Environmental DNA methods have been used to monitor the presence of aquatic vertebrates in natural systems, although detection of DNA in the environment is sometimes a challenge. In this study, we evaluated the effect of sample processing on the detection of a species' environmental DNA in the water. Specifically, we examined whether freezing and then thawing water samples prior to analysis was an effective method of preserving them. The detection of Common Carp DNA was lower in samples that were frozen and thawed than in samples that were not, even though there was no difference in the DNA concentration, which was included with the DNA undetectable samples. In both types of samples, the DNA detection rate tended to be higher in a 2-mu L volume of template DNA solution than in a 5-mu L volume. DNA was detected in all non-frozen samples that were analyzed using a 2-mu L template, both in three wells (three PCR replicate reactions per sample) with 40 PCR cycles and in eight wells with 55 cycles. The detection of Common Carp DNA in samples that were frozen and thawed was likely to increase through the use of the TaqMan Environmental Master Mix, which is used recently to efficiently release PCR inhibition. Our results suggest that environmental DNA detection is influenced by the processing of water samples after collection and by PCR reaction conditions. Use of non-frozen samples and a smaller DNA solution are recommended for detection of environmental DNA with quantitative PCR assays. (C) 2014 Elsevier Ltd. All rights reserved.	[Takahara, Teruhiko; Doi, Hideyuki] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima, Hiroshima 7398530, Japan; [Minamoto, Toshifumi] Kobe Univ, Grad Sch Human Dev & Environm, Nada Ku, Kobe, Hyogo 6578501, Japan	Takahara, T (reprint author), Hiroshima Univ, Grad Sch Integrated Arts & Sci, 1-7-1 Kagamiyama, Higashihiroshima, Hiroshima 7398521, Japan.	takahara@hiroshima-u.ac.jp; minamoto@people.kobe-u.ac.jp; doih@hiroshima-u.ac.jp	Minamoto, Toshifumi/C-6453-2009; 	Doi, Hideyuki/0000-0002-2701-3982	JSPS KAKENHI [24770022, 24657020]; Ministry of the Environment, Japan [4RF-1302]	We are grateful to C.S. Goldberg, C.R. Turner, R.C. Everhart, K.L. Uy, and P.F. Thomsen for useful comments on the previous version of the manuscript. We also thank Dr. K. Deiner and two anonymous reviewers for their critical comments and revision of the manuscript. This research was supported by JSPS KAKENHI Grant Numbers 24770022 and 24657020 to HD and TM, respectively, as well as by the Environment Research and Technology Development Fund (4RF-1302) of the Ministry of the Environment, Japan.	Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Treguier A, 2014, J APPL ECOL, V51, P871, DOI 10.1111/1365-2664.12262; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Darling JA, 2011, ENVIRON RES, V111, P978, DOI 10.1016/j.envres.2011.02.001; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Hartman LJ, 2005, MOL CELL PROBE, V19, P51, DOI 10.1016/j.mcp.2004.07.006; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Keskin E, 2014, BIOCHEM SYST ECOL, V56, P68, DOI 10.1016/j.bse.2014.05.003; Bronnenhuber JE, 2013, CONSERV GENET RESOUR, V5, P971, DOI 10.1007/s12686-013-9946-0; Bayley PB, 2001, T AM FISH SOC, V130, P620, DOI 10.1577/1548-8659(2001)130<0620:AATEPO>2.0.CO;2; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Jane S.F., 2014, MOL ECOL RE IN PRESS; McKee A.M., BIOL CONSERV; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; R Core Team, 2014, R LANG ENV STAT COMP; Suomalainen LR, 2006, APPL ENVIRON MICROB, V72, P1702, DOI 10.1128/AEM.72.2.1702-1704.2006; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Tamamura S., 2012, J GROUNDW HYDROL, V54, P107; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520	32	9	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0006-3207	1873-2917		BIOL CONSERV	Biol. Conserv.	MAR	2015	183				SI		64	69		10.1016/j.biocon.2014.11.014		6	Biodiversity Conservation; Ecology; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	CB8KO	WOS:000349878700008		
J	Zschokke, S; Nakata, K				Zschokke, Samuel; Nakata, Kensuke			Vertical asymmetries in orb webs	BIOLOGICAL JOURNAL OF THE LINNEAN SOCIETY			English	Article						Araneidae; Cyclosa; gravity; prey tumbling hypothesis; spider web; sticky-spiral spacing; trap; web architecture; web geometry	WEAVING SPIDERS ARANEAE; BUILDING SPIDERS; PREY-CAPTURE; ARANEIDAE; DESIGN; ORIENTATION; DIADEMATUS; PATTERNS; GEOMETRY; TRAP	In almost all vertical orb webs the hub is above the geometric centre and consequently, the extent of the capture area is larger below the hub than above. In addition to this vertical web-extent asymmetry, orb webs show vertical asymmetries in number of spiral loops, mesh widths, and angles between radii. However, it was unknown whether these asymmetries are adaptations to the web-extent asymmetry or whether they are linked to gravity in a different way than through web-extent asymmetry. We reviewed known vertical asymmetries of orb webs, and we analysed the asymmetries of webs built by four different Cyclosa species, which show large intra- and inter-specific variation in web-extent asymmetry. We found all analysed structural asymmetries to be linked both to web-extent asymmetry and to gravity: Larger web extents below the hub and gravity both led to more sticky-spiral loops and to smaller angles between radii below the hub, whereas web-extent asymmetry and gravity had opposing effects on mesh width (mean and peripheral). Independent of web-extent asymmetry, almost all analysed webs had narrower peripheral meshes and smaller angles between radii below the hub than above. We interpret the narrow peripheral meshes along the web's lower edge as an adaptation to prevent tumbling prey from escaping, and the small angles between radii as an adaptation to prevent the sticky-spiral lines in these narrow meshes to come into contact with each other.(c) 2015 The Linnean Society of London, Biological Journal of the Linnean Society, 2015, 114, 659-672.	[Zschokke, Samuel] Univ Basel, Sect Conservat Biol, Dept Environm Sci, CH-4056 Basel, Switzerland; [Nakata, Kensuke] Kyoto Womens Univ, Higashiyama Ku, Kyoto 6058501, Japan; [Nakata, Kensuke] Nagasaki Inst Appl Sci, Fac Human Environm, Nagasaki 8510193, Japan; [Nakata, Kensuke] Tokyo Keizai Univ, Kokubunji, Tokyo 1858502, Japan	Zschokke, S (reprint author), Univ Basel, Sect Conservat Biol, Dept Environm Sci, St Johanns Vorstadt 10, CH-4056 Basel, Switzerland.	samuel.zschokke@unibas.ch	Zschokke, Samuel/B-2583-2009; Nakata, Kensuke/D-9447-2011	Zschokke, Samuel/0000-0002-5307-9010; Nakata, Kensuke/0000-0002-1207-3448			Eberhard WG, 2014, BIOL J LINN SOC, V111, P437, DOI 10.1111/bij.12207; Hesselberg T, 2013, J INSECT BEHAV, V26, P283, DOI 10.1007/s10905-012-9335-7; STOWE MK, 1978, J ARACHNOL, V6, P141; Wu CC, 2013, J EXP BIOL, V216, P3342, DOI 10.1242/jeb.083618; Agnarsson I, 2009, J ZOOL, V278, P134, DOI 10.1111/j.1469-7998.2009.00558.x; Blackledge TA, 2006, ETHOLOGY, V112, P1194, DOI 10.1111/j.1439-0310.2006.01277.x; ZSCHOKKE S, 1995, EUR J ENTOMOL, V92, P523; Kuntner M, 2008, CLADISTICS, V24, P147, DOI 10.1111/j.1096-0031.2007.00176.x; Hesselberg T, 2010, ETHOLOGY, V116, P535, DOI 10.1111/j.1439-0310.2010.01760.x; SANDOVAL CP, 1994, FUNCT ECOL, V8, P701, DOI 10.2307/2390229; Coslovsky M, 2009, J INSECT BEHAV, V22, P29, DOI 10.1007/s10905-008-9151-2; desCrespigny FEC, 2001, AUSTR J ZOOLOGY, V49, P213; EBERHARD WG, 1975, J NAT HIST, V9, P93, DOI 10.1080/00222937500770071; Eberhard W.G., 1989, Bulletin of the British Arachnological Society, V8, P45; EBERHARD W G, 1986, P70; Eberhard W.G., 1981, Bulletin of the British Arachnological Society, V5, P189; EISNER T, 1964, SCIENCE, V146, P1058, DOI 10.1126/science.146.3647.1058; ENDO T, 1988, RES POPUL ECOL, V30, P107, DOI 10.1007/BF02512606; Foelix RF, 2011, BIOL SPIDERS; FORSTER LM, 1985, NEW ZEAL J ZOOL, V12, P455; Fraser CML, 2010, AQUAT BIOL, V11, P91, DOI 10.3354/ab00294; Gregoric M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026847; Hansell M, 2005, ANIMAL ARCHITECTURE; Heiling AM, 1998, J ARACHNOL, V26, P91; HIEBER CS, 1984, Z TIERPSYCHOL, V65, P250; Le Guelte L, 1967, REV COMPORTEMENT ANI, V1, P23; Liao CP, 2009, BEHAV ECOL, V20, P1194, DOI 10.1093/beheco/arp119; LIN LH, 1995, NATURE, V373, P146, DOI 10.1038/373146a0; Maciejewski W, 2010, J THEOR BIOL, V265, P604, DOI 10.1016/j.jtbi.2010.05.025; MASTERS WM, 1983, ANIM BEHAV, V31, P1043, DOI 10.1016/S0003-3472(83)80010-4; MAYER GERTRUD, 1952, ZEITSCHR TIERPSYCHOL, V9, P337; Moya-Larano J, 2009, J EVOLUTIONARY BIOL, V22, P854; Nakata K, 2012, ANIM BEHAV, V83, P821, DOI 10.1016/j.anbehav.2011.12.030; Nakata K, 2010, P ROY SOC B-BIOL SCI, V277, P3019, DOI 10.1098/rspb.2010.0729; Opell BD, 1997, BIOL J LINN SOC, V62, P443, DOI 10.1111/j.1095-8312.1997.tb01635.x; Peters H. M., 1939, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V36, P179, DOI 10.1007/BF00403146; PETERS HM, 1947, Z NATURFORSCH B, V2, P227; PETERS HM, 1951, Z NATURFORSCH B, V6, P90; PETERS HANS, 1937, ZEIT SCHR MORPH U OKOL TIERE, V32, P613, DOI 10.1007/BF00407454; Peters H. M., 1954, Umschau, V54, P368; Prenter J, 2012, ANIM BEHAV, V83, P1195, DOI 10.1016/j.anbehav.2012.02.010; REED CF, 1965, BEHAVIOUR, V25, P98, DOI 10.1163/156853965X00129; RISCH P, 1977, BEHAV GENET, V7, P199, DOI 10.1007/BF01066276; ROBINSON MH, 1972, J NAT HIST, V6, P687, DOI 10.1080/00222937200770631; RYPSTRA AL, 1982, OECOLOGIA, V52, P31, DOI 10.1007/BF00349008; Tilquin A., 1942, TOILE GEOMETRIQUE AR; Vollrath F, 1997, PHYSIOL BEHAV, V62, P735, DOI 10.1016/S0031-9384(97)00186-8; WIEHLE HERMANN, 1931, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V22, P349, DOI 10.1007/BF00408816; WIRTH E, 1992, J COMP PHYSIOL A, V171, P359; Witt P. N., 1968, SPIDERS WEB PROBLEMS; WITT PN, 1965, SCIENCE, V149, P1190, DOI 10.1126/science.149.3689.1190; WITT PN, 1972, AM ZOOL, V12, P445; Zaera R, 2014, J ROYAL SOC INTERFAC, V11, P1; Zschokke S, 2000, EUR ARACHNOL, V2002, P99; Zschokke S, 1999, J ARACHNOL, V27, P542; Zschokke S, 2011, J ARACHNOL, V39, P358; Zschokke S, 2010, NATURWISSENSCHAFTEN, V97, P43, DOI 10.1007/s00114-009-0609-7; Zschokke S., 2004, EUROPEAN ARACHNOLOGY, V1, P367; Zschokke S, 2000, J COMP PHYSIOL A, V186, P999, DOI 10.1007/s003590000155; Zschokke S, 2006, CAN J ZOOL, V84, P964, DOI 10.1139/Z06-074; Zschokke Samuel, 1993, Bulletin of the British Arachnological Society, V9, P169; Zschokke S, 2005, J ARACHNOL, V33, P205, DOI 10.1636/CT04-72.1	62	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0024-4066	1095-8312		BIOL J LINN SOC	Biol. J. Linnean Soc.	MAR	2015	114	3					659	672		10.1111/bij.12456		14	Evolutionary Biology	Evolutionary Biology	CB6PN	WOS:000349749100014		
J	Osakada, F; Takahashi, M				Osakada, Fumitaka; Takahashi, Masayo			Challenges in Retinal Circuit Regeneration: Linking Neuronal Connectivity to Circuit Function	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Review						stem cell; neural circuit; retina; rabies virus; transsynaptic tracing; visual system	EMBRYONIC STEM-CELLS; MARMOSET CALLITHRIX-JACCHUS; VESICULAR STOMATITIS-VIRUS; MOUSE VISUAL-CORTEX; NEW-WORLD MONKEY; IN-VIVO; RABIES VIRUS; GENE-EXPRESSION; PHOTORECEPTOR PRECURSORS; NEURAL REGENERATION	Tremendous progress has been made in retinal regeneration, as exemplified by successful transplantation of retinal pigment epithelia and photoreceptor cells in the adult retina, as well as by generation of retinal tissue from embryonic stem cells and induced pluripotent cells. However, it remains unknown how new photoreceptors integrate within retinal circuits and contribute to vision restoration. There is a large gap in our understanding, at both the cellular and behavioral levels, of the functional roles of new neurons in the adult retina. This gap largely arises from the lack of appropriate methods for analyzing the organization and function of new neurons at the circuit level. To bridge this gap and understand the functional roles of new neurons in living animals, it will be necessary to identify newly formed connections, correlate them with function, manipulate their activity, and assess the behavioral outcome of these manipulations. Recombinant viral vectors are powerful tools not only for controlling gene expression and reprogramming cells, but also for tracing cell fates and neuronal connectivity, monitoring biological functions, and manipulating the physiological state of a specific cell population. These virus-based approaches, combined with electrophysiology and optical imaging, will provide circuit-level insight into neural regeneration and facilitate new strategies for achieving vision restoration in the adult retina. Herein, we discuss challenges and future directions in retinal regeneration research.	[Osakada, Fumitaka] Nagoya Univ, Grad Sch Pharmaceut Sci, Lab Cellular Pharmacol, Nagoya, Aichi 4648601, Japan; [Osakada, Fumitaka] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; [Osakada, Fumitaka] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Takahashi, Masayo] RIKEN Ctr Dev Biol, Lab Retinal Regenerat, Kobe, Hyogo 6500047, Japan	Osakada, F (reprint author), Nagoya Univ, Grad Sch Pharmaceut Sci, Lab Cellular Pharmacol, Nagoya, Aichi 4648601, Japan.	fosakada@ps.nagoya-u.ac.jp			Japan Society for the Promotion of Science; Japan Science and Technology Agency; Naito Foundation; Kanae Foundation for the Promotion of Medical Science; Suzuken Memorial Foundation; Hokuto Foundation for Bioscience; Brain Science Program of National Institutes of Natural Sciences; Pioneer Fund	The authors thank Edward M. Callaway (The Salk Institute for Biological Institute), E. J. Chichilnisky (Stanford University), Yoshiki Sasai (RIKEN), Akinori Akaike (Kyoto University), Hachiro Sugimoto (Kyoto University), and their laboratory members for continued support and challenging discussions; Hitoshi Niwa (RIKEN) for the mouse ES cell lines; Hirofumi Suemori and Norio Nakatsuji (Kyoto University) for the monkey and human ES cell lines; Jun Takahashi (Kyoto University) for the monkey ES cell lines; Sinya Yamanaka (Kyoto University) for the mouse and human iPS cell lines; Yoshiki Sasai for the SDIA and SFEB methods; Emma L. West and Robin R. Ali (University College London) for photoreceptor transplantation and discussions; Edward M. Callaway for the rabies viruses; Karl Deisseroth (Stanford University), Edward S. Boyden (Massachusetts Institute of Technology), Loren L. Looger (Janelia Farm), Constance L. Cepko (Harvard Medical School), Botond Roska (Friedrich Miescher Institute for Biomedical Research), Greg D. Field (University of Southern California), and Nicholas Brecha (University of California at Los Angeles) for sharing unpublished data and reagents; Esther Richler for comments on the manuscript. The authors are grateful for the support from the Japan Society for the Promotion of Science (F.O.), the Japan Science and Technology Agency (F.O.), the Naito Foundation (F.O.), the Kanae Foundation for the Promotion of Medical Science (F.O.), the Suzuken Memorial Foundation (F.O.), the Hokuto Foundation for Bioscience (F.O.), the Brain Science Program of National Institutes of Natural Sciences (F.O.), and the Pioneer Fund (F.O.).	Alisky JM, 2000, NEUROREPORT, V11, P2669, DOI 10.1097/00001756-200008210-00013; Choi J, 2010, P NATL ACAD SCI USA, V107, P16703, DOI 10.1073/pnas.1006233107; Osakada F, 2013, NAT PROTOC, V8, P1583, DOI 10.1038/nprot.2013.094; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Gonzalez-Cordero A, 2013, NAT BIOTECHNOL, V31, P741, DOI 10.1038/nbt.2643; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Etessami R, 2000, J GEN VIROL, V81, P2147; Field GD, 2007, ANNU REV NEUROSCI, V30, P1, DOI 10.1146/annurev.neuro.30.051606.094252; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; White AJR, 1998, J NEUROPHYSIOL, V80, P2063; Dymecki SM, 2010, METHOD ENZYMOL, V477, P183, DOI 10.1016/S0076-6879(10)77011-7; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Solomon SG, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00096; Lafon M, 2005, J NEUROVIROL, V11, P82, DOI 10.1080/13550280590900427; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Kim J, 2012, NAT METHODS, V9, P96, DOI [10.1038/nmeth.1784, 10.1038/NMETH.1784]; Dull T, 1998, J VIROL, V72, P8463; Carr AJF, 2013, TRENDS NEUROSCI, V36, P385, DOI 10.1016/j.tins.2013.03.006; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Mank M, 2008, NAT METHODS, V5, P805, DOI [10.1038/nmeth.1243, 10.1038/NMETH.1243]; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Lakowski J, 2010, HUM MOL GENET, V19, P4545, DOI 10.1093/hmg/ddq378; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Das AV, 2006, DEV BIOL, V299, P283, DOI 10.1016/j.ydbio.2006.07.029; Lisowski L, 2014, NATURE, V506, P382, DOI 10.1038/nature12875; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Ooto S, 2004, P NATL ACAD SCI USA, V101, P13654, DOI 10.1073/pnas.0402129101; Haruta M, 2004, INVEST OPHTH VIS SCI, V45, P1020, DOI 10.1167/iovs.03-1034; West EL, 2012, STEM CELLS, V30, P1424, DOI 10.1002/stem.1123; Osakada F, 2009, J PHARMACOL SCI, V109, P168, DOI 10.1254/jphs.08R19FM; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Yamazaki Y, 2011, EXP BRAIN RES, V213, P63, DOI 10.1007/s00221-011-2778-9; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/nmeth.1782, 10.1038/NMETH.1782]; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/nmeth.2333, 10.1038/NMETH.2333]; Field GD, 2010, NATURE, V467, P673, DOI 10.1038/nature09424; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/nmeth.2996, 10.1038/NMETH.2996]; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Schnell MJ, 2010, NAT REV MICROBIOL, V8, P51, DOI 10.1038/nrmicro2260; Akemann W, 2010, NAT METHODS, V7, P643, DOI [10.1038/nmeth.1479, 10.1038/NMETH.1479]; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Barber AC, 2013, P NATL ACAD SCI USA, V110, P354, DOI 10.1073/pnas.1212677110; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Miyoshi H, 1998, J VIROL, V72, P8150; Asokan A, 2010, NAT BIOTECHNOL, V28, P79, DOI 10.1038/nbt.1599; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Lakowski J, 2011, STEM CELLS, V29, P1391, DOI 10.1002/stem.694; Harris KD, 2013, NATURE, V503, P51, DOI 10.1038/nature12654; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Santos-Ferreira T, 2015, STEM CELLS, V33, P79, DOI 10.1002/stem.1824; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; Wake H, 2013, TRENDS NEUROSCI, V36, P209, DOI 10.1016/j.tins.2012.11.007; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; McCarty DM, 2003, GENE THER, V10, P2112, DOI 10.1038/sj.gt.3302134; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; NAGY A, 1990, DEVELOPMENT, V110, P815; Kato S, 2011, HUM GENE THER, V22, P1511, DOI 10.1089/hum.2011.111; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Huang H, 2010, NAT NANOTECHNOL, V5, P602, DOI [10.1038/nnano.2010.125, 10.1038/NNANO.2010.125]; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Mellough CB, 2012, STEM CELLS, V30, P673, DOI 10.1002/stem.1037; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Kamao H, 2014, STEM CELL REP, V2, P205, DOI 10.1016/j.stemcr.2013.12.007; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Lamba D, 2008, CELL STEM CELL, V2, P538, DOI 10.1016/j.stem.2008.05.002; RYAN MD, 1994, EMBO J, V13, P928; Wang X, 2012, NAT METHODS, V9, P266, DOI [10.1038/nmeth.1892, 10.1038/NMETH.1892]; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Rancz EA, 2011, NAT NEUROSCI, V14, P527, DOI 10.1038/nn.2765; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Assawachananont J, 2014, STEM CELL REP, V2, P662, DOI 10.1016/j.stemcr.2014.03.011; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Bennett J, 1997, INVEST OPHTH VIS SCI, V38, P2857; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Osakada F, 2009, NAT PROTOC, V4, P811, DOI 10.1038/nprot.2009.51; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; Rakic P, 2002, J NEUROSCI, V22, P614; Salzmann MFV, 2012, J NEUROSCI, V32, P7881, DOI 10.1523/JNEUROSCI.4832-11.2012; Glickfeld LL, 2013, NAT NEUROSCI, V16, P219, DOI 10.1038/nn.3300; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Karl MO, 2008, P NATL ACAD SCI USA, V105, P19508, DOI 10.1073/pnas.0807453105; Hellstrom M, 2009, GENE THER, V16, P521, DOI 10.1038/gt.2008.178; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Inoue M, 2015, NAT METHODS, V12, P64, DOI [10.1038/nmeth.3185, 10.1038/NMETH.3185]; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Beier KT, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00011; Beier KT, 2011, P NATL ACAD SCI USA, V108, P15414, DOI 10.1073/pnas.1110854108; Boldogkoi Z, 2009, NAT METHODS, V6, P127, DOI [10.1038/nmeth.1292, 10.1038/NMETH.1292]; Brenin D, 1997, TRANSPLANT P, V29, P1761, DOI 10.1016/S0041-1345(97)00046-8; Carr AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008152; Choi J, 2011, J COMP NEUROL, V519, P3402, DOI 10.1002/cne.22680; Cowan WM, 1998, NEURON, V20, P413, DOI 10.1016/S0896-6273(00)80985-X; Dalkara D, 2013, SCI TRANSL MED, V5, pra176; Del Debbio CB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012425; Demers SP, 2007, CLONING STEM CELLS, V9, P512, DOI 10.1089/clo.2007.0029; Gafni O, 2013, NATURE, V504, P282; Goodchild AK, 1996, J COMP NEUROL, V366, P55, DOI 10.1002/(SICI)1096-9861(19960226)366:1<55::AID-CNE5>3.0.CO;2-J; Harris J. A., 2012, CURR PROTOC NEUROSCI, V20, P1, DOI [10.1002/0471142301.ns0120s59, DOI 10.1002/0471142301.NS0120S59]; Hasegawa K, 2007, STEM CELLS, V25, P1707, DOI 10.1634/stemcells.2006-0813; Homma K, 2013, STEM CELLS, V31, P1149, DOI 10.1002/stem.1372; Jin ZB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017084; Krestel HE, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e39; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Larsen Delaine D, 2007, Front Neural Circuits, V1, P5, DOI 10.3389/neuro.04.005.2007; Mitchell JF, 2014, J NEUROSCI, V34, P1183, DOI 10.1523/JNEUROSCI.3899-13.2014; Nathanson JL, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.019.2009; Nhan HL, 2012, J COMP NEUROL, V520, P52, DOI 10.1002/cne.22685; Okano H, 2014, NEUROSCI RE IN PRESS; Osakada F, 2009, BIOTECHNOL GENET ENG, V26, P297; Osakada F, 2011, INFLAMM REGEN, V31, P33; Pages JC, 2004, J GENE MED, V6, pS67, DOI 10.1002/jgm.498; Rattner A, 2006, NAT REV NEUROSCI, V7, P860, DOI 10.1038/nrn2007; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Ueda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002800; Vassilieva S, 2000, EXP CELL RES, V258, P361, DOI 10.1006/excr.2000.4940; Velez-Fort M, 2014, NEURON, V83, P1431, DOI 10.1016/j.neuron.2014.08.001; Wan J, 2008, VISION RES, V48, P223, DOI 10.1016/j.visres.2007.11.002; Wan J, 2007, BIOCHEM BIOPH RES CO, V363, P347, DOI 10.1016/j.bbre.2007.08.178; Watakabe A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046157; Zhong XF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5047	183	0	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAR	2015	38	3					341	357				17	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HR	WOS:000350092300001		
J	Hata, T; Shibata, Y; Okano, M; Kodera, A; Ueda, M; Iwamoto, H; Tomida, H; Iwamoto, H; Hirose, J				Hata, Toshiyuki; Shibata, Yu; Okano, Miku; Kodera, Asako; Ueda, Misato; Iwamoto, Hiroshi; Tomida, Hisao; Iwamoto, Hiroyuki; Hirose, Junzo			Flexibility of the Coordination Geometry at the N-Site of Cu(II)(2) Human Serum-Transferrin Induced by the Different Orientations of Arg124	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						copper transferrin; conformational change energy; coordination geometry change	ELECTRON-PARAMAGNETIC RESONANCE; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURES; IRON RELEASE; CUPRIC IONS; LACTOFERRIN; BINDING; LOBE	The ESR spectra of dicupric human serum-transferrin (serum-Tf) were measured from -20 to 37 degrees C in the liquid state (56% glycerol at pH 7.6). Two coordination geometries (types B-1 and B-2) with different ESR parameters were present at the N-site. The contents of the coordination geometry of type B-1 at the N-site increased as the temperature increased. The equilibrium constant between the coordination geometries of types B-1 and B-2 was determined by ESR spectra. The enthalpy value from type B-2 to B-1 was +5.3 kcal/mol, as obtained from a van't Hoff plot. The two conformational energies of the cluster models of the copper-binding site at the N-site of dicupric human serum-Tf, where the Arg124 residue was oriented in two different directions (conformations I and II), were calculated by Density Functional Theory, and the enthalpy value from conformation II to I was +2.1 kcal/mol. The enthalpy value was similar to that (+5.3 kcal/mol) obtained by the coordination geometrical change from type B-2 to B-1 in Cu(II)(2) serum-Tf. In conformations I and II, the residue of Arg124 at the N-site is located either far from or near the copper-binding site, respectively, and in both cases the coordination geometry of the cupric ions at the N-site has changed from a flattened tetrahedron to a trigonal bipyramid. This result implies that the ESR spectral change from type B-2 to B-1 is caused by the presence of two different orientations of Arg124 in the change from conformation II to I.	[Hata, Toshiyuki; Okano, Miku; Kodera, Asako; Ueda, Misato; Tomida, Hisao; Hirose, Junzo] Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Fukuyama, Hiroshima 7290292, Japan; [Shibata, Yu; Iwamoto, Hiroshi; Iwamoto, Hiroyuki] Fukuyama Univ, Fac Life Sci & Biotechnol, Fukuyama, Hiroshima 7290292, Japan	Hata, T (reprint author), Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Gakuen Cho, Fukuyama, Hiroshima 7290292, Japan.	hata@fupharm.fukuyama-u.ac.jp			Fukuyama University	This research was partly supported by the research fund of Fukuyama University (FY 2013). We thank Mr. Hiroshige Hirose for help in preparing the figures using computer graphics.	Adams TE, 2003, J BIOL CHEM, V278, P6027, DOI 10.1074/jbc.M210349200; MacGillivray RTA, 1998, BIOCHEMISTRY-US, V37, P7919, DOI 10.1021/bi980355j; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; KUROKAWA H, 1995, J MOL BIOL, V254, P196, DOI 10.1006/jmbi.1995.0611; HARRIS WR, 1994, INORG CHEM, V33, P4991, DOI 10.1021/ic00100a024; McCoy J, 2011, P NATL ACAD SCI USA, V108, P1331, DOI 10.1073/pnas.1017877108; Baker HM, 2003, BIOCHEMISTRY-US, V42, P7084, DOI 10.1021/bi020689f; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Halbrooks PJ, 2004, J MOL BIOL, V339, P217, DOI 10.1016/j.jmb.2004.03.049; HARIDAS M, 1995, ACTA CRYSTALLOGR D, V51, P629, DOI 10.1107/S0907444994013521; Harris W R, 1989, Adv Exp Med Biol, V249, P67; Hirose J, 2012, ARCH BIOCHEM BIOPHYS, V525, P71, DOI 10.1016/j.abb.2012.05.018; Hirose J, 1996, BBA-PROTEIN STRUCT M, V1296, P103, DOI 10.1016/0167-4838(96)00058-1; Noinaj N, 2012, NATURE, V483, P53, DOI 10.1038/nature10823; Sakajiri T, 2012, ISRN BIOPHYSICS, V2012; Shongwe MS, 2004, J INORG BIOCHEM, V98, P199, DOI 10.1016/j.jinorgbio.2003.10.009; SMITH CA, 1994, ACTA CRYSTALLOGR D, V50, P302, DOI 10.1107/S0907444994000491; SMITH CA, 1992, BIOCHEMISTRY-US, V31, P4527, DOI 10.1021/bi00133a020; Yokoi H., 1983, PROTEIN NUCL ACID EN, V26, P83; ZWEIER JL, 1978, J BIOL CHEM, V253, P7616; ZWEIER JL, 1977, J BIOL CHEM, V252, P6090	21	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAR	2015	38	3					358	364				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HR	WOS:000350092300002		
J	Wu, D; Quan, YS; Kamiyama, F; Kusamori, K; Katsumi, H; Sakane, T; Yamamoto, A				Wu, Dan; Quan, Ying-shu; Kamiyama, Fumio; Kusamori, Kosuke; Katsumi, Hidemasa; Sakane, Toshiyasu; Yamamoto, Akira			Improvement of Transdermal Delivery of Sumatriptan Succinate Using a Novel Self-dissolving Microneedle Array Fabricated from Sodium Hyaluronate in Rats	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						microneedle; sumatriptan succinate; sodium hyaluronate; transdermal drug delivery; transdermal absorption; absorption enhancement	OPTICAL COHERENCE TOMOGRAPHY; DRUG-DELIVERY; IN-VITRO; MIGRAINE; EFFICACY; INSULIN; SYSTEM; SAFETY; SKIN; PHARMACOKINETICS	The purpose of the present study was to develop an alternative transdermal formulation containing sumatriptan succinate (SS) for the treatment of migraine. Novel self-dissolving SS-loaded microneedle arrays (MNs) were fabricated from sodium hyaluronate and their efficacy for transdermal delivery of SS was characterized. The resulting MNs maintained their skin piercing abilities for at least 30 mm after being placed at a high relative humidity of 75%. Rapid release of SS from the MNs was also observed in vitro. Optical coherence tomography images demonstrated that MNs were able to successfully pierce into rat skin without any bending or cracking, and needles were completely dissolved within 1 h. MNs significantly increased transepidermal water loss; however, skin barrier function gradually recovered to control levels within 24h, in contrast to the skin damage observed after tape stripping treatment. These findings indicated that the micropores created by MNs quickly resealed, and that the skin damage was reversible. Furthermore, a dose-dependent plasma concentration of SS was obtained after transdermal delivery using SS-loaded MNs in rats. Absorption of SS delivered by MNs was similar to that observed after subcutaneous injection and was associated with high bioavailability (ca. 90%), which was much higher than that produced by oral administration. These findings suggested that application of SS-loaded MNs to the skin provided an effective alternative approach to enhance the transdermal delivery of SS without serious skin damage, and would be likely to improve patient compliance.	[Wu, Dan; Kusamori, Kosuke; Katsumi, Hidemasa; Sakane, Toshiyasu; Yamamoto, Akira] Kyoto Pharmaceut Univ, Dept Biopharmaceut, Yamashina Ku, Kyoto 6078414, Japan; [Quan, Ying-shu; Kamiyama, Fumio] CosMED Pharmaceut Co Ltd, Minami Ku, Kyoto 6078414, Japan	Yamamoto, A (reprint author), Kyoto Pharmaceut Univ, Dept Biopharmaceut, Yamashina Ku, Kyoto 6078414, Japan.	yamamoto@mb.kyoto-phu.ac.jp					Donnelly RF, 2010, J CONTROL RELEASE, V147, P333, DOI 10.1016/j.jconrel.2010.08.008; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Smith TR, 2012, HEADACHE, V52, P612, DOI 10.1111/j.1526-4610.2012.02094.x; Vikelis M, 2012, NEUROPSYCH DIS TREAT, V8, P429, DOI 10.2147/NDT.S27456; Zhou CP, 2010, INT J PHARMACEUT, V392, P127, DOI 10.1016/j.ijpharm.2010.03.041; Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005; Park JH, 2005, J CONTROL RELEASE, V104, P51, DOI 10.1016/j.jconrel.2005.02.002; Migalska K, 2011, PHARM RES-DORDR, V28, P1919, DOI 10.1007/s11095-011-0419-4; Pierce M, 2009, HEADACHE, V49, P817, DOI 10.1111/j.1526-4610.2009.01437.x; Gill HS, 2008, CLIN J PAIN, V24, P585, DOI 10.1097/AJP.0b013e31816778f9; Arulmozhi DK, 2005, VASC PHARMACOL, V43, P176, DOI 10.1016/j.vph.2005.07.001; Liu S, 2014, EUR J PHARM BIOPHARM, V86, P267, DOI 10.1016/j.ejpb.2013.10.001; Agrawal V, 2010, AAPS PHARMSCITECH, V11, P1718, DOI 10.1208/s12249-010-9540-7; Li GH, 2009, INT J PHARM, V368, P109, DOI 10.1016/j.ijpharm.2008.10.008; Hiraishi Y, 2013, INT J PHARMACEUT, V441, P570, DOI 10.1016/j.ijpharm.2012.10.042; Donnelly RF, 2009, DRUG DEV IND PHARM, V35, P1242, DOI 10.1080/03639040902882280; Liu S, 2012, J CONTROL RELEASE, V161, P933, DOI 10.1016/j.jconrel.2012.05.030; Hardebo JE, 1998, CEPHALALGIA, V18, P487, DOI 10.1046/j.1468-2982.1998.1807487.x; Kim YC, 2013, J CONTROL RELEASE, V172, P579, DOI 10.1016/j.jconrel.2013.04.016; Yin DF, 2013, BIOL PHARM BULL, V36, P1283; Alexander A, 2012, J CONTROL RELEASE, V164, P26, DOI 10.1016/j.jconrel.2012.09.017; Qiu YQ, 2008, J CONTROL RELEASE, V129, P144, DOI 10.1016/j.jconrel.2008.04.019; SEVELIUS H, 1980, BRIT J CLIN PHARMACO, V10, P259; Cull RE, 1997, J NEUROL NEUROSUR PS, V62, P490, DOI 10.1136/jnnp.62.5.490; DIXON CM, 1993, DRUG METAB DISPOS, V21, P761; Femenia-Font A, 2005, J PHARM SCI-US, V94, P2183, DOI 10.1002/jps.20447; Garnock-Jones KP, 2013, DRUGS, V73, P1483, DOI 10.1007/s40265-013-0104-5; Ito Y, 2012, INT J PHARMACEUT, V436, P387, DOI 10.1016/j.ijpharm.2012.06.047; Jhee SS, 2001, CLIN PHARMACOKINET, V40, P189, DOI 10.2165/00003088-200140030-00004; Jui-Chen T., 1991, INT J PHARMACEUT, V72, P227, DOI DOI 10.1016/0378-5173(91)90112-2; Katsumi H, 2012, J PHARM SCI-US, V101, P3230, DOI 10.1002/jps.23136; LACEY LF, 1995, EUR J CLIN PHARMACOL, V47, P543; Patel SR, 2007, EUR J PHARM BIOPHARM, V66, P296, DOI 10.1016/j.ejpb.2006.11.001; Zhang Y, 2012, PHARM RES-DORDR, V29, P170, DOI 10.1007/s11095-011-0524-4	34	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAR	2015	38	3					365	373				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HR	WOS:000350092300003		
J	Motoyama, K; Onodera, R; Tanaka, N; Kameyama, K; Higashi, T; Kariya, R; Okada, S; Arima, H				Motoyama, Keiichi; Onodera, Risako; Tanaka, Nao; Kameyama, Kazuhisa; Higashi, Taishi; Kariya, Ryusho; Okada, Seiji; Arima, Hidetoshi			Evaluation of Antitumor Effects of Folate-Conjugated Methyl-beta-cyclodextrin in Melanoma	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						folate receptor; methyl-beta-cyclodextrin; melanoma; autophagy	RED-BLOOD-CELLS; LIPID RAFTS; CANCER DEVELOPMENT; LUNG METASTASIS; AUTOPHAGY; RECEPTOR; INVOLVEMENT; BECLIN-1; THERAPY; ALPHA	Melanoma is a life-threatening disorder and its incidence is increasing gradually. Despite the numerous treatment approaches, conventional systemic chemotherapy has not reduced the mortality rate among melanoma patients, probably due to the induction of toxicity to normal tissues. Recently, we have developed folate-conjugated methyl-beta-cyclodextrin (FA-M-beta-CyD) and clarified its potential as a new antitumor agent involved in autophagic cell death. However, it remains uncertain whether FA-M-beta-CyD exerts anticancer effects against melanomas. Therefore, in this study, we investigated the effects of FA-M-beta-CyD on the folate receptor-alpha (FR-alpha)-expressing melanoma cell-selective cytotoxic effect. FA-M-beta-CyD showed cytotoxic effects in Ihara cells, a human melanoma cell line expressing FR-alpha. In sharp contrast to methyl-beta-cyclodextrin, FA-M-beta-CyD entered Ihara cells [FR-alpha(+)] through FR-alpha-mediated endocytosis. Additionally, FA-M-beta-CyD elicited the formation of autophagosomes in Ihara cells. Notably, FA-M-beta-CyD suppressed melanoma growth in BALB/c nude recombinase-activating gene-2 (Rag-2)/Janus kinase 3 (Jak3) double deficient mice bearing Ihara cells. Therefore, these results suggest that FA-M-beta-CyD could be utilized as a potent anticancer agent for melanoma chemotherapy by regulating autophagy.	[Motoyama, Keiichi; Onodera, Risako; Tanaka, Nao; Kameyama, Kazuhisa; Higashi, Taishi; Arima, Hidetoshi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Phys Pharmaceut, Chuo Ku, Kumamoto 8620973, Japan; [Kariya, Ryusho; Okada, Seiji] Kumamoto Univ, Div Hematopoiesis, Ctr AIDS Res, Chuo Ku, Kumamoto 8600811, Japan; [Arima, Hidetoshi] Kumamoto Univ, Program Leading Grad Sch HIGO Hlth Life Sci Inter, Chuo Ku, Kumamoto 8600811, Japan	Arima, H (reprint author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Phys Pharmaceut, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	arimah@gpo.kumamoto-u.ac.jp			Japan Society for the Promotion of Science [25870537]; Ministry of Health Labour and Welfare [24100701]	This work was funded by the Japan Society for the Promotion of Science (Grant-in-Aid for Young Scientists (B) (25870537)) and the Ministry of Health Labour and Welfare (Grant-in-Aid for Third Term Comprehensive Control Research for Cancer Program (24100701)).	Grosse PY, 1998, BRIT J CANCER, V78, P1165, DOI 10.1038/bjc.1998.648; WEITMAN SD, 1992, CANCER RES, V52, P6708; Ono A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/539748; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Motoyama K, 2009, EUR J PHARM SCI, V38, P249, DOI 10.1016/j.ejps.2009.07.010; Low PS, 2009, CURR OPIN CHEM BIOL, V13, P256, DOI 10.1016/j.cbpa.2009.03.022; Guan YY, 2014, BIOMATERIALS, V35, P3060, DOI 10.1016/j.biomaterials.2013.12.027; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; ANTONY AC, 1992, BLOOD, V79, P2807; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Lu YJ, 2002, ADV DRUG DELIVER REV, V54, P675, DOI 10.1016/S0169-409X(02)00042-X; Houghton AN, 2002, CANCER CELL, V2, P275, DOI 10.1016/S1535-6108(02)00161-7; Kelemen LE, 2006, INT J CANCER, V119, P243, DOI 10.1002/ijc.21712; McNamee CE, 2006, BIOPHYS J, V91, P1960, DOI 10.1529/biophysj.106.082420; Takeuchi H, 2005, CANCER RES, V65, P3336; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Szente L, 1999, ADV DRUG DELIVER REV, V36, P17, DOI 10.1016/S0169-409X(98)00092-1; Nukolova NV, 2011, BIOMATERIALS, V32, P5417, DOI 10.1016/j.biomaterials.2011.04.006; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Gabizon A, 2010, CANCER CHEMOTH PHARM, V66, P43, DOI 10.1007/s00280-009-1132-4; Chen H, 2009, MOL CANCER THER, V8, P1955, DOI 10.1158/1535-7163.MCT-09-0045; Motoyama K, 2009, BIOL PHARM BULL, V32, P700; Gomes AJ, 2013, MOL PHARMACEUT, V10, P3544, DOI 10.1021/mp3005534; Parker N, 2005, ANAL BIOCHEM, V338, P284, DOI 10.1016/j.ab.2004.12.026; Motoyama K, 2006, EUR J PHARM SCI, V29, P111, DOI 10.1016/j.ejps.2006.06.002; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; Onodera R, 2013, INT J PHARMACEUT, V452, P116, DOI 10.1016/j.ijpharm.2013.04.071; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Antony AC, 1996, ANNU REV NUTR, V16, P501; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; UEKAMA K, 1987, CRIT REV THER DRUG, V3, P1; Onodera R, 2011, J INCL PHENOM MACRO, V70, P321, DOI 10.1007/s10847-010-9843-z; Liu EY, 2012, J CELL SCI, V125, P2349, DOI 10.1242/jcs.093708; Hara K, 2006, ONCOL REP, V16, P1215; Mi Y., 2011, BIOMATERIALS, V32; Onodera R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04417; Onodera R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01104; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Sanchez-del-Campo L, 2009, PIGM CELL MELANOMA R, V22, P588, DOI 10.1111/j.1755-148X.2009.00586.x; Toffoli G, 1997, INT J CANCER, V74, P193, DOI 10.1002/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO;2-F	41	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAR	2015	38	3					374	379				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HR	WOS:000350092300004		
J	Nagata, M; Ishiwata, Y; Takahashi, Y; Takahashi, H; Saito, K; Fujii, Y; Kihara, K; Yasuhara, M				Nagata, Masashi; Ishiwata, Yasuyoshi; Takahashi, Yutaka; Takahashi, Hiromitsu; Saito, Kazutaka; Fujii, Yasuhisa; Kihara, Kazunori; Yasuhara, Masato			Pharmacokinetic-Pharmacodynamic Analysis of Sunitinib-Induced Thrombocytopenia in Japanese Patients with Renal Cell Carcinoma	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						sunitinib; pharmacokinetic-pharmacodynamic analysis; thrombocytopenia; renal cell carcinoma	RESISTANCE PROTEIN BCRP/ABCG2; TYROSINE KINASE INHIBITOR; ANTITUMOR-ACTIVITY; CLINICAL-EFFICACY; INTERFERON-ALPHA; PHASE-II; SAFETY; CANCER; SU11248; MYELOSUPPRESSION	The aim of the present study was to clarify the therapeutic range and adequate dose of sunitinib in Japanese renal cell carcinoma patients by means of a pharmacokinetic pharmacodynamic analysis of sunitinib-induced thrombocytopenia. Six patients with renal cell carcinoma were enrolled in this study. After starting the sunitinib treatment, between three and seven blood samples were obtained from each patient just before the administration of sunitinib. Serum concentrations of sunitinib and its active metabolite N-desethyl-sunitinib were fit to the 1-compartment model with first-order absorption. Changes in platelet counts were fit to the pharmacokinetic pharmacodynamic model, in which the proliferation of platelet progenitor cells was assumed to be linearly inhibited by sunitinib and its metabolite. All patients using 50 mg as an initial dose of sunitinib developed grade 2 or 3 thrombocytopenia. The pharmacokinetic pharmacodynamic model created successfully described the time course of sunitinib-induced thrombocytopenia and could predict changes in platelet counts after alterations to the dosage of sunitinib administered. The simulation results indicated that the total trough level of sunitinib to avoid severe thrombocytopenia should be <100 ng/mL, and also that the initial daily dose of sunitinib could be reduced to 37.5 mg or 25mg in most Japanese patients. In addition to the pharmacokinetic-guided dosage adjustment, the careful monitoring of platelet counts is required for the safe use of sunitinib.	[Nagata, Masashi; Ishiwata, Yasuyoshi; Takahashi, Yutaka; Takahashi, Hiromitsu] Tokyo Med & Dent Univ, Dept Pharm, Hosp Med, Bunkyo Ku, Tokyo 1138519, Japan; [Saito, Kazutaka; Fujii, Yasuhisa; Kihara, Kazunori] Tokyo Med & Dent Univ, Dept Urol, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138519, Japan; [Yasuhara, Masato] Tokyo Med & Dent Univ, Dept Pharmacokinet & Pharmacodynam, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138519, Japan	Yasuhara, M (reprint author), Tokyo Med & Dent Univ, Dept Pharmacokinet & Pharmacodynam, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	yasuhara.mpha@tmd.ac.jp			Japan Society for the Promotion of Science [23928021]	This work was supported by a Grant-in-Aid for the Encouragement of Scientists [23928021] from the Japan Society for the Promotion of Science.	Goodman VL, 2007, CLIN CANCER RES, V13, P1367, DOI 10.1158/1078-0432.CCR-06-2328; Ni ZL, 2010, CURR DRUG METAB, V11, P603; Tatokoro M, 2011, CANCER SCI, V102, P137, DOI 10.1111/j.1349-7006.2010.01756.x; Houk BE, 2009, CLIN CANCER RES, V15, P2497, DOI 10.1158/1078-0432.CCR-08-1893; Uemura H, 2010, JPN J CLIN ONCOL, V40, P194, DOI 10.1093/jjco/hyp146; Faivre S, 2006, J CLIN ONCOL, V24, P25, DOI 10.1200/JCO.2005.02.2194; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Gore ME, 2009, LANCET ONCOL, V10, P757, DOI 10.1016/S1470-2045(09)70162-7; Najjar YG, 2014, EUR J CANCER, V50, P1084, DOI 10.1016/j.ejca.2014.01.025; Houk BE, 2010, CANCER CHEMOTH PHARM, V66, P357, DOI 10.1007/s00280-009-1170-y; Kumar R, 2009, BRIT J CANCER, V101, P1717, DOI 10.1038/sj.bjc.6605366; Yamasaki Y, 2008, CLIN PHARMACOL THER, V84, P95, DOI 10.1038/sj.clpt.6100459; Friberg LE, 2002, J CLIN ONCOL, V20, P4713, DOI 10.1200/JCO.2002.02.140; Lyman SD, 1998, BLOOD, V91, P1101; Chow LQM, 2007, J CLIN ONCOL, V25, P884, DOI 10.1200/JCO.2006.06.3602; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Kim KA, 2010, J CLIN PHARM THER, V35, P705, DOI 10.1111/j.1365-2710.2009.01127.x; Yuasa T, 2012, BJU INT, V109, P1349, DOI 10.1111/j.1464-410X.2011.10534.x; Blanchet B, 2009, CLIN CHIM ACTA, V404, P134, DOI 10.1016/j.cca.2009.03.042; Hansson E K, 2013, CPT Pharmacometrics Syst Pharmacol, V2, pe85, DOI 10.1038/psp.2013.62; Kim HR, 2013, CANCER CHEMOTH PHARM, V72, P825, DOI 10.1007/s00280-013-2258-y; Lankheet NAG, 2014, BRIT J CANCER, V110, P2441, DOI 10.1038/bjc.2014.194; Lee SH, 2014, ASIA-PAC J CLIN ONCO, V10, P237, DOI 10.1111/ajco.12163; Miyake H, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0978-4; Mizuno T, 2012, DRUG METAB PHARMACOK, V27, P631, DOI 10.2133/dmpk.DMPK-12-RG-026; Mizuno T, 2014, THER DRUG MONIT, V36, P310, DOI 10.1097/FTD.0000000000000025; YAMAOKA K, 1983, J PHARMACOBIO-DYNAM, V6, P595; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879	28	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAR	2015	38	3					402	410				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HR	WOS:000350092300008		
J	Yokoo, M; Kubota, Y; Tabe, Y; Kimura, S				Yokoo, Masako; Kubota, Yasushi; Tabe, Yoko; Kimura, Shinya			Comparative Study of the Anti-leukemic Effects of Imatinib Mesylate, Glivec (TM) Tablet and Its Generic Formulation, OHK9511	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						OHK9511; generic; imatinib mesylate; chronic myeloid leukemia; adherence	CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE INHIBITOR; CHRONIC-PHASE; 3RD-GENERATION BISPHOSPHONATE; ANTICANCER DRUGS; PLASMA-LEVELS; CELL-LINE; RESPONSES; EFFICACY; OUTCOMES	Long-term treatment with imatinib mesylate (IM) allows patients with chronic myeloid leukemia (CML) to live a near-normal lifespan. However, the fact that tyrosine kinase inhibitors, including IM, are extremely expensive is a major cause of poor adherence, resulting in disease relapse or drug resistance. Therefore, physicians are encouraged to prescribe generic drugs to reduce the financial burden of medical expenses. In Japan, only generic drugs that have a basic chemical structure and pharmacokinetic data that are the same as those of the original drug are approved. However, it is not mandatory to demonstrate that generic drugs have adequate biological effects. This is one of the reasons why Japanese hematologists do not often use generic IM. The aim of the present study was to compare the anti-leukemic effects of Glivec (TM) (a commercial IM) and its generic formulation, OHK9511. The IC50 values of OHK9511 and Glivec (TM) were comparable, and both induced similar levels of apoptosis in several CML cell lines. Furthermore, the overall survival of OHK9511-treated mice transplanted with BCR-ABL-positive cells was similar to that of mice treated with Glivec (TM). Although the experiments performed herein were basic, the results suggest that physicians should consider using generic IM.	[Yokoo, Masako; Kubota, Yasushi; Kimura, Shinya] Saga Univ, Div Hematol Resp Med & Oncol, Dept Internal Med, Fac Med, Saga 8498501, Japan; [Kubota, Yasushi] Saga Univ Hosp, Dept Transfus Med, Saga 8498501, Japan; [Tabe, Yoko] Juntendo Univ, Dept Clin Lab Med, Sch Med, Bunkyo Ku, Tokyo 1138421, Japan	Kubota, Y (reprint author), Saga Univ, Div Hematol Resp Med & Oncol, Dept Internal Med, Fac Med, Saga 8498501, Japan.	kubotay@cc.saga-u.ac.jp			Ohara Pharmaceutical Co., Ltd.; Novartis	This study was funded by a research grant from Ohara Pharmaceutical Co., Ltd. S.K. is a consultant for and has received research funding from Novartis, and has received honoraria from Bristol-Myers Squibb.	Widmer N, 2014, EUR J CANCER, V50, P2020, DOI 10.1016/j.ejca.2014.04.015; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Rohon P, 2012, INT J HEMATOL, V96, P1, DOI 10.1007/s12185-012-1116-8; Marin D, 2010, J CLIN ONCOL, V28, P2381, DOI 10.1200/JCO.2009.26.3087; Noens L, 2009, BLOOD, V113, P5401, DOI 10.1182/blood-2008-12-196543; Naito H, 2006, LEUKEMIA RES, V30, P1443, DOI 10.1016/j.leukres.2006.01.006; Wu EQ, 2010, CURR MED RES OPIN, V26, P61, DOI 10.1185/03007990903396469; Tabe Y, 2004, BLOOD, V103, P1815, DOI 10.1182/blood-2003-03-0802; Larson RA, 2008, BLOOD, V111, P4022, DOI 10.1182/blood-2007-10-116475; Jin L, 2011, BRIT J CANCER, V104, P91, DOI 10.1038/sj.bjc.6606007; Kimura S, 2005, BLOOD, V106, P3948, DOI 10.1182/blood-2005-06-2209; Ito T, 2007, EUR J HAEMATOL, V78, P417, DOI 10.1111/j.1600-0609.2007.00835.x; Ibrahim AR, 2011, BLOOD, V117, P3733, DOI 10.1182/blood-2010-10-309807; Hahn EA, 2003, J CLIN ONCOL, V21, P2138, DOI 10.1200/JCO.2003.12.154; Smith TJ, 2011, NEW ENGL J MED, V364, P2060, DOI 10.1056/NEJMsb1013826; Dusetzina SB, 2014, J CLIN ONCOL, V32, P306, DOI 10.1200/JCO.2013.52.9123; Kuroda J, 2003, BLOOD, V102, P2229, DOI 10.1182/blood-2003-01-0305; Baccarani M, 2014, INT J HEMATOL, V99, P616, DOI 10.1007/s12185-014-1566-2; Picard S, 2007, BLOOD, V109, P3496, DOI 10.1182/blood-2006-07-036012; Ricci C, 2002, CANCER RES, V62, P5995; Singh N, 2009, EUR J CLIN PHARMACOL, V65, P545, DOI 10.1007/s00228-009-0621-z; Asfour Inas A, 2009, Cases J, V2, P9342, DOI 10.1186/1757-1626-2-9342; Chouffai Z., 2010, CASE REP ONCOL, V3, P272; Eskazan AE, 2014, LEUKEMIA LYMPHOMA, V55, P2935, DOI 10.3109/10428194.2014.905774; Eskazan AE, 2014, BRIT J HAEMATOL, V167, P139, DOI 10.1111/bjh.12937; Gambacorti-Passerini C, 2011, JNCI-J NATL CANCER I, V103, P553, DOI 10.1093/jnci/djr060; Gogtay J, 2010, INT J HEMATOL, V92, P772, DOI 10.1007/s12185-010-0718-2; Goubran Hadi Alphonse, 2009, J Med Case Rep, V3, P7112, DOI 10.1186/1752-1947-3-7112; Kimura S, 2004, INT J HEMATOL, V79, P37, DOI 10.1007/BF02983531; Kodama Y, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-152; Mattar M, 2010, INT J HEMATOL, V91, P104, DOI 10.1007/s12185-009-0431-1; Mitra D, 2012, INT J HEMATOL, V95, P263, DOI 10.1007/s12185-012-1010-4	32	2	2	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAR	2015	38	3					411	416				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HR	WOS:000350092300009		
J	Hashimoto, Y; Shimizu, T; Abu Lila, AS; Ishida, T; Kiwada, H				Hashimoto, Yosuke; Shimizu, Taro; Abu Lila, Amr Selim; Ishida, Tatsuhiro; Kiwada, Hiroshi			Relationship between the Concentration of Anti-polyethylene Glycol (PEG) Immunoglobulin M (IgM) and the Intensity of the Accelerated Blood Clearance (ABC) Phenomenon against PEGylated Liposomes in Mice	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						anti-polyethylene glycol (PEG); immunoglobulin M (IgM); PEGylated liposome (SL); accelerated blood clearance (ABC) phenomenon; complement activation	STERICALLY STABILIZED LIPOSOMES; POLY(ETHYLENE GLYCOL); REPEATED INJECTION; COMPLEMENT; ANTIBODIES; SURFACE; ACTIVATION; DENSITY; IMMUNOGENICITY; NANOPARTICLES	PEGylation, which is the surface modification of nanocarriers with polyethylene glycol (PEG), has increased the circulation time and reduced the immunogenic responses to nanocarriers. However, many reports have demonstrated that the intravenous injection of sterically stabilized PEGylated liposome (SL) causes an accelerated blood clearance (ABC) of subsequent doses via anti-PEG immunoglobulin M (IgM)-mediated complement activation. In the present study, the relationships between serum anti-PEG IgM concentration, the intensity of complement activation and the hepatic clearance of SL were quantitatively investigated for their role in the ABC phenomenon. Interestingly, with increasing serum anti-PEG IgM concentrations, the intensity of complement activation increased linearly, while the intensity of the hepatic clearance of SL was increased and then saturated. In addition, only 15-17% of anti-PEG IgM in blood circulation induced by SL at different doses was associated with a second dose SL. The present results indicate that it is the hepatic uptake of SL that is the limiting step in the ABC phenomenon, rather than the association of anti-PEG IgM to the SL and a subsequent complement activation.	[Hashimoto, Yosuke; Shimizu, Taro; Abu Lila, Amr Selim; Ishida, Tatsuhiro; Kiwada, Hiroshi] Univ Tokushima, Dept Pharmacokinet & Biopharmaceut, Subdiv Biopharmaceut Sci, Inst Hlth Biosci, Tokushima 7708505, Japan; [Abu Lila, Amr Selim] Zagazig Univ, Dept Pharmaceut & Ind Pharm, Fac Pharm, Zagazig 44519, Egypt	Ishida, T (reprint author), Univ Tokushima, Dept Pharmacokinet & Biopharmaceut, Subdiv Biopharmaceut Sci, Inst Hlth Biosci, 1-78-1 Sho Machi, Tokushima 7708505, Japan.	ishida@tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24390010]; Takeda Foundation	The authors thank Mr. J. L. McDonald for his kind assistance in writing the manuscript. This study was supported, in part, by the Takeda Foundation and by a Grant-in-Aid for Scientific Research (B) (24390010) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abu Lila AS, 2013, J CONTROL RELEASE, V172, P38, DOI 10.1016/j.jconrel.2013.07.026; ALLEN TM, 1991, BIOCHIM BIOPHYS ACTA, V1068, P133, DOI 10.1016/0005-2736(91)90201-I; Wang CL, 2013, EUR J PHARM BIOPHARM, V85, P744, DOI 10.1016/j.ejpb.2013.10.002; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; KLIBANOV AL, 1990, FEBS LETT, V268, P235, DOI 10.1016/0014-5793(90)81016-H; Kaminskas LM, 2011, J PHARM SCI-US, V100, P5069, DOI 10.1002/jps.22682; Sroda K, 2005, CELL MOL BIOL LETT, V10, P37; Maeda H, 2012, J CONTROL RELEASE, V164, P138, DOI 10.1016/j.jconrel.2012.04.038; TORCHILIN VP, 1994, BBA-BIOMEMBRANES, V1195, P11, DOI 10.1016/0005-2736(94)90003-5; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; LASIC DD, 1991, BIOCHIM BIOPHYS ACTA, V1070, P187, DOI 10.1016/0005-2736(91)90162-2; Ishida T, 2005, J CONTROL RELEASE, V105, P305, DOI 10.1016/j.jconrel.2005.04.003; Ishida T, 2008, INT J PHARM, V354, P56, DOI 10.1016/j.ijpharm.2007.11.005; RICHTER AW, 1983, INT ARCH ALLER A IMM, V70, P124; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/nnm.11.19, 10.2217/NNM.11.19]; Pham CTN, 2011, J BIOL CHEM, V286, P123, DOI 10.1074/jbc.M110.180760; Shimizu T, 2012, BIOL PHARM BULL, V35, P1336; Suzuki T, 2012, INT J PHARMACEUT, V436, P636, DOI 10.1016/j.ijpharm.2012.07.049; Szebeni J, 2011, ADV DRUG DELIVER REV, V63, P1020, DOI 10.1016/j.addr.2011.06.017; Allen C, 2002, BIOSCIENCE REP, V22, P225, DOI 10.1023/A:1020186505848; Wang XY, 2007, J CONTROL RELEASE, V119, P236, DOI 10.1016/j.jconrel.2007.02.010; Dams ETM, 2000, J PHARMACOL EXP THER, V292, P1071; Armstrong JK, 2007, CANCER-AM CANCER SOC, V110, P103, DOI 10.1002/cncr.22739; HARASHIMA H, 1993, J PHARMACOKINET BIOP, V21, P299, DOI 10.1007/BF01059781; BARTLETT GR, 1959, J BIOL CHEM, V234, P469; Rus H, 2005, IMMUNOL RES, V33, P103, DOI 10.1385/IR:33:2:103; ARMSTRONG SJ, 1990, J GEN VIROL, V71, P2313, DOI 10.1099/0022-1317-71-10-2313; BORSOS T, 1981, MOL IMMUNOL, V18, P863, DOI 10.1016/0161-5890(81)90008-0; Hashimoto Y, 2014, TOXICOL APPL PHARM, V277, P30, DOI 10.1016/j.taap.2014.03.002; Ishihara T, 2009, PHARM RES-DORD, V26, P2270, DOI 10.1007/s11095-009-9943-x; Jones HE, 2009, VACCINE, V27, P5806, DOI 10.1016/j.vaccine.2009.07.063; Li CL, 2012, J PHARM SCI-US, V101, P3864, DOI 10.1002/jps.23254; Liu YJ, 2011, J PHARMACOL TOX MET, V64, P238, DOI 10.1016/j.vascn.2011.07.003; LYNCH DM, 1993, EUR J IMMUNOGENET, V20, P1, DOI 10.1111/j.1744-313X.1993.tb00090.x; Park K, 2013, J CONTROL RELEASE, V165, P234, DOI 10.1016/j.jconrel.2013.01.003; Singh AK, 1996, BIOTECHNOL PROGR, V12, P272, DOI 10.1021/bp9500674; Takemoto S, 2006, DRUG METAB PHARMACOK, V21, P458, DOI 10.2133/dmpk.21.458; Zhao YX, 2012, INT J NANOMED, V7, P2891, DOI 10.2147/IJN.S30943	38	2	2	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAR	2015	38	3					417	424				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HR	WOS:000350092300010		
J	Tanaka, S; Hosokawa, M; Yonezawa, T; Hayashi, W; Ueda, K; Iwakawa, S				Tanaka, Shota; Hosokawa, Mika; Yonezawa, Takeshi; Hayashi, Wataru; Ueda, Kumiko; Iwakawa, Seigo			Induction of Epithelial-Mesenchymal Transition and Down-Regulation of miR-200c and miR-141 in Oxaliplatin-Resistant Colorectal Cancer Cells	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						colorectal cancer; drug resistance; oxaliplatin; epithelial-mesenchymal transition; microRNA	E-CADHERIN; REPRESSORS ZEB1; TARGETING ZEB1; TUMOR-GROWTH; EXPRESSION; MIGRATION; INVASION; FAMILY; LINES; TRANSPORTERS	Epithelial-mesenchymal transition (EMT) and changes in the expression of the microRNA-200 (miR-200) family were examined in the human colorectal cancer (CRC) cell line SW620 with acquired oxaliplatin (L-OHP) resistance. Two CRC cell lines, SW480, derived from primary CRC, and SW620, derived from lymph node metastasis, which were obtained from the same patient, were used in the present study. L-OHP-resistant SW620 cells were obtained by exposure to L-OHP for 155d. The concentration of L-OHP was increased to 80 mu M in a stepwise manner. The IC50 value of L-OHP was increased 16-fold in L-OHP-resistant SW620 cells, which also displayed mesenchymal cell-like characteristics, such as the down-regulation of E-cadherin and up-regulation of vimentin. However, L-OHP-resistant SW480 cells were not obtained when the concentration of L-OHP was increased in a similar stepwise manner. The expression levels of members of the miR-200 family (miR-200a, miR-200b, miR-429, miR-200c, and miR-141) were significantly higher in SW480 cells than in SW620 cells. The expression levels of miR-200c and miR-141 were significantly lower in L-OHP-resistant SW620 cells than in control SW620 cells. L-OHP-resistant SW620 cells did not exhibit cross-resistance to other anti-cancer drugs used to treat CRC, such as 5-fluorouracil, irinotecan, and the active metabolite of irinotecan (SN-38). These results suggest that the down-regulated expression of miR-200c and miR-141 plays a role in selective resistance to L-OHP and EMT in CRC cells during repeated treatments with L-OHP.	[Tanaka, Shota; Hosokawa, Mika; Yonezawa, Takeshi; Hayashi, Wataru; Ueda, Kumiko; Iwakawa, Seigo] Kobe Pharmaceut Univ, Dept Pharmaceut, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Hosokawa, M (reprint author), Kobe Pharmaceut Univ, Dept Pharmaceut, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	ikehatam@kobepharma-u.ac.jp					Wang ZW, 2010, DRUG RESIST UPDATE, V13, P109, DOI 10.1016/j.drup.2010.07.001; Liu LY, 2014, CHEM-BIOL INTERACT, V217, P1, DOI 10.1016/j.cbi.2014.04.002; Hsu DSS, 2010, CLIN CANCER RES, V16, P4561, DOI 10.1158/1078-0432.CCR-10-0593; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Samimi G, 2004, CLIN CANCER RES, V10, P4661, DOI 10.1158/1078-0432.CCR-04-0137; Chen ML, 2012, CLIN EXP METASTAS, V29, P457, DOI 10.1007/s10585-012-9463-7; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Zhou YF, 2014, MOL ONCOL, V8, P83, DOI 10.1016/j.molonc.2013.09.004; Larson CA, 2009, MOL PHARMACOL, V75, P324, DOI 10.1124/mol.108.052381; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Rasmussen MH, 2013, MOL ONCOL, V7, P637, DOI 10.1016/j.molonc.2013.02.016; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Puhr M, 2012, AM J PATHOL, V181, P2188, DOI 10.1016/j.ajpath.2012.08.011; Chen JQ, 2012, MED ONCOL, V29, P2527, DOI 10.1007/s12032-011-0117-4; Martinez-Cardus A, 2009, MOL CANCER THER, V8, P194, DOI 10.1158/1535-7163.MCT-08-0659; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Xu K, 2013, MOL CARCINOGEN, V52, P70, DOI 10.1002/mc.21832; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Gourdier I, 2002, FEBS LETT, V529, P232, DOI 10.1016/S0014-5793(02)03347-1; Kakumoto M, 2002, BIOL PHARM BULL, V25, P1604, DOI 10.1248/bpb.25.1604; Kan JY, 2013, BIOMED RES INT, DOI 10.1155/2013/159786; Liu Zhen, 2010, Chin J Cancer, V29, P661; Mashita N, 2014, J SURG ONCOL, V110, P745, DOI 10.1002/jso.23705; Morelli MP, 2009, MOL CANCER THER, V8, P2546, DOI 10.1158/1535-7163.MCT-09-0380; Qian X, 2013, CELL CYCLE, V12, P1385, DOI 10.4161/cc.24477; Saxena M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.61; Seetharam RN, 2010, ANTICANCER RES, V30, P2531; Takahashi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046684; Takano M, 2009, DRUG METAB PHARMACOK, V24, P418	36	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAR	2015	38	3					435	440				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HR	WOS:000350092300012		
J	Yamaori, S; Takami, K; Shiozawa, A; Sakuyama, K; Matsuzawa, N; Ohmori, S				Yamaori, Satoshi; Takami, Ken; Shiozawa, Ayaka; Sakuyama, Kanako; Matsuzawa, Naoki; Ohmori, Shigeru			In Vitro Inhibition of CYP2C9-Mediated Warfarin 7-Hydroxylation by Iguratimod: Possible Mechanism of Iguratimod-Warfarin Interaction	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						iguratimod; warfarin; CYP2C9; inhibition; drug-drug interaction; polymorphism	ACTIVE RHEUMATOID-ARTHRITIS; PLACEBO-CONTROLLED TRIAL; DRUG-DRUG INTERACTIONS; DOUBLE-BLIND; CYP2C9; METHOTREXATE; PREDICTION; P-4502C9; THERAPY	Iguratimod is a novel disease-modifying antirheumatic drug. A blue letter (safety advisory) for drug interaction between iguratimod and warfarin was issued by the Ministry of Health, Labour and Welfare of Japan in May 2013. Iguratimod may affect warfarin metabolism catalyzed by CYP. However, it is not clear whether iguratimod inhibits warfarin oxidation. This study was performed to investigate the effects of iguratimod on warfarin 7-hydroxylation with human liver microsomes (HLMs) and recombinant CYP enzymes. Iguratimod concentration-dependently inhibited R,S-warfarin 7-hydroxylase activity of HLMs with an IC50 value of 15.2 mu M. The inhibitory effect was examined with S-warfarin and R-warfarin to determine which enantiomer was more potently inhibited by iguratimod. Iguratimod potently inhibited the S-warfarin 7-hydroxylase activity of HLMs with an IC50 value of 14.1 mu M, but showed only slight inhibition of R-warfarin 7-hydroxylation. Furthermore, iguratimod inhibited the S-warfarin 7-hydroxylase activity of recombinant CYP2C9.1 (rCYP2C9.1) and rCYP2C9.3 in a concentration-dependent manner with IC50 values of 10.8 and 20.1 mu M, respectively. Kinetic analysis of the inhibition of S-warfarin 7-hydroxylation by iguratimod indicated competitive-type inhibition for HLMs and rCYP2C9.1 but mixed-type inhibition for rCYP2C9.3. The K-i values for HLMs, rCYP2C9.1, and rCYP2C9.3 were 6.74, 4.23, and 14.2 mu M, respectively. Iguratimod did not exert metabolism-dependent inhibition of S-warfarin 7-hydroxylation. These results indicated that iguratimod is a potent direct inhibitor of CYP2C9-mediated warfarin 7-hydroxylation and that its inhibitory effect on CYP2C9.1 was more sensitive than that on CYP2C9.3.	[Yamaori, Satoshi; Shiozawa, Ayaka; Sakuyama, Kanako; Matsuzawa, Naoki; Ohmori, Shigeru] Shinshu Univ Hosp, Dept Pharm, Matsumoto, Nagano 3908621, Japan; [Yamaori, Satoshi; Shiozawa, Ayaka; Ohmori, Shigeru] Shinshu Univ, Dept Biochem Pharmacol & Toxicol, Grad Sch Med, Matsumoto, Nagano 3908621, Japan; [Takami, Ken] Shinshu Univ, Sch Med, Matsumoto, Nagano 3908621, Japan	Ohmori, S (reprint author), Shinshu Univ Hosp, Dept Pharm, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	somori@shinshu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported in part by a Grant-in-Aid for Encouragement of Scientists from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Brown HS, 2006, CLIN PHARMACOKINET, V45, P1035, DOI 10.2165/00003088-200645100-00006; Iwakawa S, 2006, BIOL PHARM BULL, V29, P1983, DOI 10.1248/bpb.29.1983; Camidge R, 2005, J CLIN ONCOL, V23, P4719, DOI 10.1200/JCO.2005.09.129; RETTIE AE, 1992, CHEM RES TOXICOL, V5, P54, DOI 10.1021/tx00025a009; Maekawa K, 2006, PHARMACOGENET GENOM, V16, P497; Kumar V, 2006, DRUG METAB DISPOS, V34, P1966, DOI 10.1124/dmd.106.010926; Lee CR, 2002, PHARMACOGENETICS, V12, P251, DOI 10.1097/00008571-200204000-00010; [Anonymous], 2013, INT FORM KOLBET TABL; Yuan R, 2002, DRUG METAB DISPOS, V30, P1311, DOI 10.1124/dmd.30.12.1311; OREILLY RA, 1974, CLIN PHARMACOL THER, V16, P348; Yamaori S, 2012, DRUG METAB PHARMACOK, V27, P294, DOI 10.2133/dmpk.DMPK-11-RG-107; Obach RS, 2006, J PHARMACOL EXP THER, V316, P336, DOI 10.1124/jpet.105.093229; Baba Takahiko, 2002, Drug Metab Pharmacokinet, V17, P522, DOI 10.2133/dmpk.17.522; Hanatani T, 2003, EUR J CLIN PHARMACOL, V59, P233, DOI 10.1007/s00228-003-0603-5; Hara M, 2014, MOD RHEUMATOL, V24, P410, DOI 10.3109/14397595.2013.843756; Ishiguro N, 2013, MOD RHEUMATOL, V23, P430, DOI 10.1007/s10165-012-0724-8; LANG D, 1995, J CHROMATOGR B, V672, P305, DOI 10.1016/0378-4347(95)00222-5; Yamazaki H, 1997, BIOCHEM PHARMACOL, V54, P1195, DOI 10.1016/S0006-2952(97)00304-3	18	2	2	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAR	2015	38	3					441	447				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HR	WOS:000350092300013		
J	Chiba, T; Kimura, S; Takahashi, K; Morimoto, Y; Maeda, T; Sanbe, A; Ueda, H; Kudo, K				Chiba, Takeshi; Kimura, Soichiro; Takahashi, Katsuo; Morimoto, Yasunori; Maeda, Tomoji; Sanbe, Atsushi; Ueda, Hideo; Kudo, Kenzo			Serotonin Regulates beta-Casein Expression via 5-HT7 Receptors in Human Mammary Epithelial MCF-12A Cells	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						serotonin; beta-casein; 5-hydroxytryptamine (5-HT)(7) receptor; human mammary gland; milk protein	GLAND; ACTIVATION; LACTATION; PROTEIN; PHOSPHORYLATION; TRANSCRIPTION; GROWTH	We previously reported that serotonin (5-hydroxytryptamine; 5-HT) suppresses beta-casein expression, a differentiation marker in mammary epithelial cells, via inhibition of the signal transducer and activator of transcription 5 (STAT5) phosphorylation in the human mammary epithelial cell line, MCF-12A. In this study, we investigated the expression pattern of the different 5-HT receptor subtypes in MCF-12A cells, and identified the receptors involved in 5-HT-mediated suppression of beta-casein protein expression. beta-Casein mRNA expression was inhibited by 30 mu M 5-HT in a time-dependent manner. Treatment with 30 mu M 5-HT for 72h decreased beta-casein protein levels and STAT5 phosphorylation (pSTAT5). The cells expressed four 5-HT receptors subtypes (5-HTR1D, 2B, 3A, and 7) at the mRNA and protein level, and their expression was elevated by prolactin (PRL) treatment. Additionally, the mRNA levels of 5-HTR1D and 5-HTR7 were significantly higher than the other 5-HT receptors in the cells. Tryptophan hydroxylase 1 mRNA was detectable in the cells in the absence of PRL, and PRL treatment significantly increased its expression. beta-Casein and pSTAT5/STAT5 levels in the cells co-treated with 5-HT and a selective 5-HTR1D inhibitor, BRL15572, were equal to those observed in cells treated with 5-HT alone. However, in the cells co-treated with 5-HT and a selective 5-HTR7 inhibitor, SB269970, beta-casein and pSTAT5/STAT5 levels increased in a SB269970 concentration-dependent manner. In conclusion, we showed that 5-HT regulates beta-casein expression via 5-HTR7 in MCF-12A human mammary epithelial cells.	[Chiba, Takeshi; Takahashi, Katsuo; Kudo, Kenzo] Iwate Med Univ, Dept Clin Pharmaceut & Pharm Practice, Sch Pharm, Yahaba, Iwate 0283603, Japan; [Kimura, Soichiro; Morimoto, Yasunori; Ueda, Hideo] Josai Univ, Dept Hosp Pharm, Fac Pharmaceut Sci, Sakadoshi, Saitama 3500295, Japan; [Maeda, Tomoji] Iwate Med Univ, Dept Neurosci, Sch Pharm, Yahaba, Iwate 0283603, Japan; [Sanbe, Atsushi] Iwate Med Univ, Dept Pharmacotherapeut, Sch Pharm, Yahaba, Iwate 0283603, Japan	Chiba, T (reprint author), Iwate Med Univ, Dept Clin Pharmaceut & Pharm Practice, Sch Pharm, 2-1-1 Nishitokuta, Yahaba, Iwate 0283603, Japan.	chibat@iwate-med.ac.jp			JSPS KAKENHI [23792666]	This work was supported by JSPS KAKENHI (Grant-in-Aid for Young Scientists) Grant number 23792666.	Zhang YQ, 2006, CANCER RES, V66, P5592, DOI 10.1158/0008-5472.CAN-05-4004; Hernandez LL, 2011, J ENDOCRINOL, V209, P45, DOI 10.1530/JOE-10-0452; Lauder JM, 2004, DEV CELL, V6, P165, DOI 10.1016/S1534-5807(04)00033-4; Hernandez LL, 2009, J ENDOCRINOL, V203, P123, DOI 10.1677/JOE-09-0187; WILDE CJ, 1995, BIOCHEM J, V305, P51; Clevenger CV, 2001, LUPUS, V10, P706, DOI 10.1191/096120301717164949; Pai VP, 2008, J BIOL CHEM, V283, P30901, DOI 10.1074/jbc.M802476200; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; Stull MA, 2007, P NATL ACAD SCI USA, V104, P16708, DOI 10.1073/pnas.0708136104; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; Liu XW, 1996, MOL ENDOCRINOL, V10, P1496, DOI 10.1210/me.10.12.1496; Hernandez LL, 2012, AM J PHYSIOL-ENDOC M, V302, pE1009, DOI 10.1152/ajpendo.00666.2011; RUI H, 1994, ENDOCRINOLOGY, V135, P1299, DOI 10.1210/en.135.4.1299; Marshall AM, 2014, J MAMMARY GLAND BIOL, V19, P139, DOI 10.1007/s10911-013-9304-6; Wagner KU, 2004, MOL CELL BIOL, V24, P5510, DOI 10.1128/MCB.24.12.5510-5520.2004; Chiba T, 2014, BIOL PHARM BULL, V37, P1336, DOI 10.1248/bpb.b14-00273; Guseva D, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00306; Pai VP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017028; Laporta J, 2013, J DAIRY SCI, V96, P5146, DOI 10.3168/jds.2013-6718; Ling L, 2004, J BIOL CHEM, V279, P32737, DOI 10.1074/jbc.M400601200; Pai VP, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2448; Pai Vaibhav P, 2011, Commun Integr Biol, V4, P532, DOI 10.4161/cib.4.5.16492	22	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAR	2015	38	3					448	453				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HR	WOS:000350092300014		
J	Hoshino, M; Ikarashi, N; Hirobe, R; Hayashi, M; Hiraoka, H; Yokobori, K; Ochiai, T; Kusunoki, Y; Kon, R; Tajima, M; Ochiai, W; Sugiyama, K				Hoshino, Motohiro; Ikarashi, Nobutomo; Hirobe, Ryuta; Hayashi, Mami; Hiraoka, Hironori; Yokobori, Kohsuke; Ochiai, Takumi; Kusunoki, Yoshiki; Kon, Risako; Tajima, Masataka; Ochiai, Wataru; Sugiyama, Kiyoshi			Effects of Menthol on the Pharmacokinetics of Triazolam and Phenytoin	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						CYP; menthol; warfarin; triazolam; phenytoin	CYTOCHROME-P450; EXPRESSION; KETOCONAZOLE; DRUGS; INHIBITION; MICROSOMES; MIDAZOLAM; WARFARIN; MOUSE; LIVER	We have previously shown that menthol attenuates the anticoagulant effect of warfarin by increasing the expression levels of CYP3A and CYP2C in the liver. This study evaluated the effects of menthol on the pharmacokinetics of the CYP3A substrate triazolam and the CYP2C substrate phenytoin. Menthol was orally administered to mice for 7d. Twenty-four hours after the administration of menthol, triazolam was orally administered, and the plasma concentration was measured. In addition, the CYP3A metabolic activity for triazolam and the CYP3A expression level in the liver were determined. The effects of menthol on the pharmacokinetics of phenytoin were assessed in the same manner. In the menthol-treated group, the area under the blood concentration time curve (AUC) of triazolam was lower and its clearance was higher compared with the control group. The CYP3A metabolic activity and CYP3A expression level in the liver were significantly increased in the menthol-treated group compared with the control group. Similarly, the AUC of phenytoin was lower and the hepatic CYP2C expression level was higher in the menthol-treated group. Thus, menthol lowered the plasma concentrations of triazolam and phenytoin when concurrently administered. These effects may be attributed to an increased metabolic activity for these drugs due to the increased expression of CYP3A and CYP2C in the liver.	[Hoshino, Motohiro; Ikarashi, Nobutomo; Hirobe, Ryuta; Hayashi, Mami; Hiraoka, Hironori; Yokobori, Kohsuke; Ochiai, Takumi; Kusunoki, Yoshiki; Kon, Risako; Tajima, Masataka; Ochiai, Wataru; Sugiyama, Kiyoshi] Hoshi Univ, Dept Clin Pharmacokinet, Shinagawa Ku, Tokyo 1428501, Japan	Sugiyama, K (reprint author), Hoshi Univ, Dept Clin Pharmacokinet, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	sugiyama@hoshi.ac.jp			Japan Food Chemical Research Foundation	This work was supported by the Japan Food Chemical Research Foundation. We thank Ms. Mao Seki, Ms. Shiori Nakano, Ms. Haruka Naito, and Ms. Yuri Sugiyama for their technical assistance.	SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Kusunoki Y, 2014, EUR J PHARM SCI, V54, P17, DOI 10.1016/j.ejps.2013.12.019; Bajpai M, 1996, DRUG METAB DISPOS, V24, P1401; Perloff MD, 2000, J PHARMACOL EXP THER, V292, P618; Di YM, 2008, CURR PHARM DESIGN, V14, P1723, DOI 10.2174/138161208784746798; VARHE A, 1994, CLIN PHARMACOL THER, V56, P601; Emoto C, 2000, XENOBIOTICA, V30, P943; Thummel KE, 1998, ANNU REV PHARMACOL, V38, P389, DOI 10.1146/annurev.pharmtox.38.1.389; Villikka K, 1997, CLIN PHARMACOL THER, V61, P8, DOI 10.1016/S0009-9236(97)90176-4; Neels HM, 2004, CLIN CHEM LAB MED, V42, P1228, DOI 10.1515/CCLM.2004.245; Backman JT, 2008, EUR J CLIN PHARMACOL, V64, P17, DOI 10.1007/s00228-007-0389-y; Boxenbaum H, 1999, J PHARM PHARM SCI, V2, P47; BUTLER TC, 1957, J PHARMACOL EXP THER, V119, P1; Coderre Karen, 2010, Pharmacotherapy, V30, P110, DOI 10.1592/phco.30.1.110; Foster AC, 2004, J PHARMACOL EXP THER, V311, P547, DOI 10.1124/jpet.103.063487; Fukumori S, 2007, DRUG METAB PHARMACOK, V22, P377, DOI 10.2133/dmpk.22.377; Hoshino M, 2014, EUR J PHARM SCI, V56, P92, DOI 10.1016/j.ejps.2014.02.011; Ikarashi N, 2011, XENOBIOTICA, V41, P486, DOI 10.3109/00498254.2011.551848; Ishii M, 2014, EUR J PHARM SCI, V51, P180, DOI 10.1016/j.ejps.2013.09.017; Kassebaum PJ, 2005, ANN PHARMACOTHER, V39, P365, DOI 10.1345/aph.1E537; Kupfer DJ, 1997, NEW ENGL J MED, V336, P341, DOI 10.1056/NEJM199701303360506; KUPFERSCHMIDT HHT, 1995, CLIN PHARMACOL THER, V58, P20, DOI 10.1016/0009-9236(95)90068-3; MASUDA Y, 1981, J PHARMACOL EXP THER, V217, P805; Neerati P, 2011, EUR J PHARM SCI, V44, P27, DOI 10.1016/j.ejps.2011.05.005; Schrag ML, 2001, DRUG METAB DISPOS, V29, P70; SHAND DG, 1975, J PHARMACOL EXP THER, V195, P424; Tajima M, 2012, EUR J PHARM SCI, V47, P108, DOI 10.1016/j.ejps.2012.05.008; TOUCHETTE MA, 1992, BRIT J CLIN PHARMACO, V34, P75; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879	29	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAR	2015	38	3					454	460				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HR	WOS:000350092300015		
J	Eldin, NE; Elnahas, HM; Mandy, MA; Ishida, T				Eldin, Noha Essam; Elnahas, Hanan Mohamed; Mandy, Mahmoud Abd-Elghany; Ishida, Tatsuhiro			Liposomal Pemetrexed: Formulation, Characterization and in Vitro Cytotoxicity Studies for Effective Management of Malignant Pleural Mesothelioma	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						liposome; malignant pleural mesothelioma; polyethylene glycol; pemetrexed	DRUG-DELIVERY; LUNG-CANCER; MULTITARGETED ANTIFOLATE; BREAST-CANCER; PHASE-III; DOXORUBICIN; CHOLESTEROL; PHARMACOKINETICS; OXALIPLATIN; MODEL	Pemetrexed (PMX) is a newly developed multi-targeted anti-folate with promising clinical activity in many solid tumors including malignant pleural mesothelioma (MPM). However, PMX does not show sufficient anti-tumor activity in vivo when used alone either due to inefficient delivery of adequate concentrations to tumor tissue or dose-limiting side effects. In order to overcome these problems and to achieve potent anti-tumor activity, PMX was encapsulated into a liposomal delivery system. In the present study, various formulations of liposomal PMX were prepared. The effect of formulation parameters on the encapsulation efficiency of PMX within liposomes was evaluated. In addition, the influence of drug release rate on the in vitro cytotoxicity was investigated. Encapsulation of PMX within liposomes was remarkably increased by the incorporation of cholesterol within liposomal membranes and by increasing the total lipid concentration. Encapsulation efficiency was found to be unaffected by the type of phospholipid used or the inclusion of a cation lipid, DC-6-14. Interestingly, encapsulation of PMX within "fluid" liposomes was found to allow efficient release of PMX from liposomes resulting in a potent in vitro cytotoxicity against MPM MSTO-211H cell line. On the other hand, entrapment of PMX within "solid" liposomes substantially hindered PMX release from liposomes, and thus PMX failed to exert any in vitro cytotoxicity. These results suggest that encapsulation of PMX within "fluid" liposomes might represent a novel strategy to enhance the therapeutic efficacy of PMX while minimizing the side effect encountered by the non selective delivery of free PMX to various body tissues.	[Eldin, Noha Essam; Elnahas, Hanan Mohamed; Mandy, Mahmoud Abd-Elghany] Zagazig Univ, Dept Pharmaceut & Ind Pharm, Fac Pharm, Zagazig 44519, Egypt; [Eldin, Noha Essam; Ishida, Tatsuhiro] Univ Tokushima, Inst Hlth Biosci, Dept Pharmacokinet & Biopharmaceut, Tokushima 7708505, Japan	Ishida, T (reprint author), Univ Tokushima, Inst Hlth Biosci, Dept Pharmacokinet & Biopharmaceut, Tokushima 7708505, Japan.	ishida@tokushima-u.ac.jp			Tokushima University	The authors thank Mr. James L. McDonald for his helpful advice in developing the English manuscript. This work was partially supported by a research program for development of intelligent Tokushima artificial exosome (iTEX) from Tokushima University.	Adjei Alex A, 2004, Clin Lung Cancer, V5 Suppl 2, pS51, DOI 10.3816/CLC.2004.s.003; ALINO SF, 1989, BIOCHEM SOC T, V17, P1000; Allen Theresa M., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P513, DOI 10.2174/187152006778699121; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Garg A, 2009, INT J PHARM, V366, P201, DOI 10.1016/j.ijpharm.2008.09.016; Tseng YL, 2002, MOL PHARMACOL, V62, P864, DOI 10.1124/mol.62.4.864; Anderson M, 2004, DRUG DELIV, V11, P33, DOI 10.1080/10717540490265243; Srisuk P, 2012, INT J PHARMACEUT, V427, P426, DOI 10.1016/j.ijpharm.2012.01.045; Lee TY, 2007, CANCER RES, V67, P10958, DOI 10.1158/0008-5471CAN-07-2233; Medina OP, 2004, CURR PHARM DESIGN, V10, P2981, DOI 10.2174/1381612043383467; Liang XM, 2004, J COLLOID INTERF SCI, V278, P53, DOI 10.1016/j.jcis.2004.05.042; Hofheinz RD, 2005, ANTI-CANCER DRUG, V16, P691, DOI 10.1097/01.cad.0000167902.53039.5a; Dos Santos N, 2004, BBA-BIOMEMBRANES, V1661, P47, DOI 10.1016/j.bbamem.2003.11.016; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Charrois GJR, 2004, BBA-BIOMEMBRANES, V1663, P167, DOI 10.1016/j.bbamem.2004.03.006; Lammers T, 2008, BRIT J CANCER, V99, P392, DOI 10.1038/sj.bjc.6604483; Chorachoo J, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/157635; LASIC DD, 1995, SCIENCE, V267, P1275, DOI 10.1126/science.7871422; Richards DA, 2011, INVEST NEW DRUG, V29, P963, DOI 10.1007/s10637-010-9414-6; Abu Lila AS, 2009, J CONTROL RELEASE, V137, P8, DOI 10.1016/j.jconrel.2009.02.023; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Gill PS, 1996, J CLIN ONCOL, V14, P2353; TAYLOR KMP, 1995, BIOCHEMISTRY-US, V34, P3841, DOI 10.1021/bi00011a042; Jain RK, 1998, NAT MED, V4, P655, DOI 10.1038/nm0698-655; Abu-Lila A, 2009, J CONTROL RELEASE, V134, P18, DOI 10.1016/j.jconrel.2008.10.018; Allen TM, 2005, CLIN CANCER RES, V11, P3567, DOI 10.1158/1078-0432.CCR-04-2517; Moro M, 1997, CANCER RES, V57, P1922; Pluen A, 2001, P NATL ACAD SCI USA, V98, P4628, DOI 10.1073/pnas.081626898; MCINTOSH TJ, 1980, BIOPHYS J, V29, P237; Uemura T, 2010, CANCER SCI, V101, P2404, DOI 10.1111/j.1349-7006.2010.01690.x; Abraham SA, 2005, METHOD ENZYMOL, V391, P71; BALLY MB, 1990, BIOCHIM BIOPHYS ACTA, V1023, P133, DOI 10.1016/0005-2736(90)90018-J; Cagdas FM, 2011, PHARM DEV TECHNOL, V16, P408, DOI 10.3109/10837451003774401; Chao TC, 2003, CANCER INVEST, V21, P837, DOI 10.1081/CNV-120025086; Chen J, 2006, DRUG DEV IND PHARM, V32, P719, DOI 10.1080/03639040500529077; Chen SE, 2012, AM J HEALTH-SYST PH, V69, P377, DOI 10.2146/ajhp110281; Goudar Ranjit K, 2008, Ther Clin Risk Manag, V4, P205; JULIANO RL, 1978, BIOCHEM PHARMACOL, V27, P21, DOI 10.1016/0006-2952(78)90252-6; Jung MH, 2009, J KOREAN MED SCI, V24, P1004, DOI 10.3346/jkms.2009.24.6.1004; Katayama K, 2002, INT J PHARM, V248, P93, DOI 10.1016/S0378-5173(02)00427-1; LITZINGER DC, 1992, BIOCHIM BIOPHYS ACTA, V1113, P201, DOI 10.1016/0304-4157(92)90039-D; Manegold C, 2009, EXPERT REV ANTICANC, V9, P1195, DOI [10.1586/era.09.97, 10.1586/ERA.09.97]; Maruyama K, 1999, ADV DRUG DELIVER REV, V40, P89, DOI 10.1016/S0169-409X(99)00042-3; Misset JL, 2004, ANN ONCOL, V15, P1123, DOI 10.1093/annonc/mdh279; Schultz RM, 2005, PROG DRUG RES, V63, P275	45	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAR	2015	38	3					461	469				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HR	WOS:000350092300016		
J	Kaneko, YK; Takii, M; Kojima, Y; Yokosawa, H; Ishikawa, T				Kaneko, Yukiko K.; Takii, Miki; Kojima, Yumiko; Yokosawa, Hiroko; Ishikawa, Tomohisa			Structure-Dependent Inhibitory Effects of Green Tea Catechins on Insulin Secretion from Pancreatic beta-Cells	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						catechin; insulin secretion; beta-cell	EPIGALLOCATECHIN GALLATE; LIPID-BILAYERS; HUMAN PLASMA; POLYPHENOLS; ATP; (-)-EPIGALLOCATECHIN-3-GALLATE; CHANNELS	The effects of green tea catechins on glucose-stimulated insulin secretion (GSIS) were investigated in the beta-cell line INS-1D. Epigallocatechin gallate (EGCG) at 10 mu M or gallocatechin gallate (GCG) at 30 mu M caused significant inhibitory effects on GSIS, and each of these at 100 mu M almost abolished it. In contrast, epicatechin (EC) or catechin (CA) had no effect on GSIS at concentrations up to 100 mu M. We thus investigated the structure activity relationship by using epigallocatechin (EGC) and gallocatechin (GC) containing a trihydroxyl group in the B-ring, and epicatechin gallate (ECG) and catechin gallate (CG) containing the gallate moiety. EGC, GC, and ECG caused an inhibition of GSIS, although significant effects were obtained only at 100 mu M. At this concentration, EGC almost abolished GSIS, whereas GC and ECG partially inhibited it. In contrast, CG did not affect GSIS at concentrations up to 100 mu M. EGCG also abolished the insulin secretion induced by tolbutamide, an ATP-sensitive K+ channel blocker, and partially inhibited that induced by 30 mM K+. Moreover, EGCG, but not EC, inhibited the oscillation of intracellular Ca2+ concentration induced by 11.1 mm glucose. These results suggest that some catechins at supraphysiological concentrations have inhibitory effects on GSIS, the potency of which depends on their structure; the order of potency was EGCG>GCG>EGC>GC approximate to ECG. The inhibitory effects seem to be mediated by the inhibition of voltage-dependent Ca2+ channels, which is caused, at least in part, by membrane hyperpolarization resulting from the activation of K+ channels.	[Kaneko, Yukiko K.; Takii, Miki; Kojima, Yumiko; Yokosawa, Hiroko; Ishikawa, Tomohisa] Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Pharmacol, Suruga Ku, Shizuoka 4228526, Japan	Ishikawa, T (reprint author), Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Pharmacol, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	ishikat@u-shizuoka-ken.ac.jp			Japan Society for the Promotion of Science JSPS KAKENHI Grant [26750336, 20590085]	This study was supported in part by Grants-in-Aid for Young Scientists (YKK, 26750336) and Scientific Research (TI, 20590085) from Japan Society for the Promotion of Science JSPS KAKENHI Grant.	Li CH, 2006, J BIOL CHEM, V281, P10214, DOI 10.1074/jbc.M512792200; Uekusa Y, 2008, BIOSCI BIOTECH BIOCH, V72, P3289, DOI 10.1271/bbb.80435; Waltner-Law ME, 2002, J BIOL CHEM, V277, P34933, DOI 10.1074/jbc.M204672200; Chemler JA, 2007, APPL MICROBIOL BIOT, V77, P797, DOI 10.1007/s00253-007-1227-y; Nakagawa K, 1997, BIOSCI BIOTECH BIOCH, V61, P1981; Chow HHS, 2001, CANCER EPIDEM BIOMAR, V10, P53; Ueda M, 2008, BIOCHEM BIOPH RES CO, V377, P286, DOI 10.1016/j.bbrc.2008.09.128; Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006; Shimizu M, 2000, BIOFACTORS, V13, P61; SALAH N, 1995, ARCH BIOCHEM BIOPHYS, V322, P339, DOI 10.1006/abbi.1995.1473; Tsuchiya H, 1999, PHARMACOLOGY, V59, P34, DOI 10.1159/000028303; Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011; Antcliff JF, 2005, EMBO J, V24, P229, DOI 10.1038/sj.emboj.7600487; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Jin JY, 2007, PHARMACOL RES, V56, P237, DOI 10.1016/j.phrs.2007.06.004; John SA, 2001, J GEN PHYSIOL, V118, P391, DOI 10.1085/jgp.118.4.391; Kajiya K, 2001, BIOSCI BIOTECH BIOCH, V65, P2638, DOI 10.1271/bbb.65.2638; Kamihira M, 2008, BIOSCI BIOTECH BIOCH, V72, P1372, DOI 10.1271/bbb.70786; Kitano K, 1997, BIOPHYS CHEM, V65, P157, DOI 10.1016/S0301-4622(96)02254-5; Lotito SB, 2000, P SOC EXP BIOL MED, V225, P32, DOI 10.1046/j.1525-1373.2000.22504.x; Wolfram S, 2007, J AM COLL NUTR, V26, p373S; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914	22	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAR	2015	38	3					476	481				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HR	WOS:000350092300018		
J	Takeuchi, T; Shimakawa, G; Tamura, M; Yokosawa, H; Arata, Y				Takeuchi, Tomoharu; Shimakawa, Genki; Tamura, Mayumi; Yokosawa, Hideyoshi; Arata, Yoichiro			ISG15 Regulates RANKL-Induced Osteoclastogenic Differentiation of RAW264 Cells	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						interferon-stimulated gene 15kDa (ISG15); osteoclast; interferon; receptor activator of nuclear factor-kappa B ligand (RANKL); RAW264; ATP6v0d2	INTERFERON-BETA; PRECURSOR FUSION; PROTEIN-KINASE; IN-VITRO; ACTIVATION; PATHWAY	Interferon-stimulated gene 15 kDa (ISG15) is a protein upregulated by interferon-beta that negatively regulates osteoclastogenesis. We investigated the role of ISG15 in receptor activator of nuclear factor-kappa B ligand (RANKL)-induced osteoclastogenic differentiation of murine RAW264 cells. RANKL stimulation induced ISG15 expression in RAW264 cells at both the mRNA and protein levels. Overexpression of ISG15 in RAW264 cells resulted in suppression of cell fusion in RANKL-stimulated cells as well as the reduced expression of ATP6v0d2, a gene essential for cell fusion in osteoclastogenic differentiation. These results suggest that ISG15 suppresses RANKL-induced osteoclastogenesis, at least in part, through inhibition of ATP6v0d2 expression.	[Takeuchi, Tomoharu; Shimakawa, Genki; Tamura, Mayumi; Arata, Yoichiro] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 3500295, Japan; [Yokosawa, Hideyoshi] Aichi Gakuin Univ, Sch Pharm, Chikusa Ku, Nagoya, Aichi 4648650, Japan	Takeuchi, T (reprint author), Josai Univ, Fac Pharmaceut Sci, 1-1 Keyakidai, Sakado, Saitama 3500295, Japan.	t-take@josai.ac.jp					Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Skaug B, 2010, CELL, V143, P187, DOI 10.1016/j.cell.2010.09.033; Oursler MJ, 2010, J CELL BIOCHEM, V110, P1058, DOI 10.1002/jcb.22640; Ishizuka H, 2011, J BONE MINER RES, V26, P169, DOI 10.1002/jbmr.199; Desai SD, 2012, EXP BIOL MED, V237, P38, DOI 10.1258/ebm.2011.011236; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Albers J, 2011, J CELL BIOL, V192, P1057, DOI 10.1083/jcb.201008012; O'Brien CA, 2013, BONE, V54, P258, DOI 10.1016/j.bone.2012.08.121; Boyce BF, 2013, J BONE MINER RES, V28, P711, DOI 10.1002/jbmr.1885; Zheng H, 2006, J BIOL CHEM, V281, P15809, DOI 10.1074/jbc.M513225200; Zhao QX, 2010, INT J BIOCHEM CELL B, V42, P576, DOI 10.1016/j.biocel.2009.12.018; Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Quinn MT, 2009, J INNATE IMMUN, V1, P509, DOI 10.1159/000228158; Choi J, 2013, CELL SIGNAL, V25, P1222, DOI 10.1016/j.cellsig.2013.02.015; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Bogunovic D, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.36; Hayashida C, 2014, J BIOL CHEM, V289, P11545, DOI 10.1074/jbc.M113.523811; Minakawa M, 2008, BIOL PHARM BULL, V31, P2223, DOI 10.1248/bpb.31.2223; Okumura F, 2013, J BIOL CHEM, V288, P2839, DOI 10.1074/jbc.M112.401851; Takeuchi T, 2005, BIOCHEM BIOPH RES CO, V336, P9, DOI 10.1016/j.bbrc.2005.08.034; Takito J, 2012, J CELL SCI, V125, P662, DOI 10.1242/jcs.090886; Teramachi J, 2010, EXP CELL RES, V316, P3254, DOI 10.1016/j.yexcr.2010.08.006; Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801	26	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAR	2015	38	3					482	486				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HR	WOS:000350092300019		
J	Kadowaki, D; Sakaguchi, S; Miyamoto, Y; Taguchi, K; Muraya, N; Narita, Y; Sato, K; Chuang, VTG; Maruyama, T; Otagiri, M; Hirata, S				Kadowaki, Daisuke; Sakaguchi, Shoichi; Miyamoto, Yohei; Taguchi, Kazuaki; Muraya, Nanako; Narita, Yuki; Sato, Keizo; Chuang, Victor Tuan Giam; Maruyama, Tom; Otagiri, Masaki; Hirata, Sumio			Direct Radical Scavenging Activity of Benzbromarone Provides Beneficial Antioxidant Properties for Hyperuricemia Treatment	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						benzbromarone; uric acid; reactive oxygen species; endothelial dysfunction	MUSCLE-CELL PROLIFERATION; CHRONIC KIDNEY-DISEASE; CHRONIC HEART-FAILURE; URIC-ACID; OXIDATIVE STRESS; BLOOD-PRESSURE; INDEPENDENT MECHANISM; HYPERTENSION; TRANSPORTER; SUPEROXIDE	Uric acid exerts an important antioxidant effect against external oxidative stress under physiological conditions. However, uric acid itself can increase oxidative stress via reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation in adipocytes and vascular cells. Uric acid transporter 1 is involved in the generation of this oxidative stress. Furthermore, uric acid locally activates the renin angiotensin system, thus producing angiotensin II and subsequently increasing intracellular oxidative stress. Benzbromarone has been reported to suppress uric acid reabsorption via uric acid transporter 1 inhibition in renal tubular cells. In this study we evaluated the in vitro antioxidant effect of benzbromarone from several perspectives. First, the direct radical-trapping capacity of benzbromarone was measured by chemiluminescence assay and electron paramagnetic resonance spectroscopy. Second, the intracellular antioxidant activity of benzbromarone in hyperuricemia was evaluated using endothelial cells. In light of these results, benzbromarone is hypothesized directly to scavenge the superoxide anion radical. In addition, benzbromarone inhibited reactive oxygen species production that was induced by angiotensin II or uric acid in endothelial cells. These findings suggest that benzbromarone possesses the ability directly to scavenge radicals and may act as an antioxidant against uric acid and angiotensin II-induced oxidative stresses in endothelial cells at therapeutically achievable levels in blood.	[Kadowaki, Daisuke; Sakaguchi, Shoichi; Muraya, Nanako; Narita, Yuki; Hirata, Sumio] Kumamoto Univ, Dept Clin Pharmacol, Fac Pharmaceut Sci, Chuo Ku, Kumamoto 8620973, Japan; [Kadowaki, Daisuke; Narita, Yuki; Maruyama, Tom; Hirata, Sumio] Kumamoto Univ, Ctr Clin Pharmaceut Sci, Fac Pharmaceut Sci, Chuo Ku, Kumamoto 8620973, Japan; [Miyamoto, Yohei; Taguchi, Kazuaki; Maruyama, Tom; Otagiri, Masaki] Kumamoto Univ, Dept Biopharmaceut, Grad Sch Pharmaceut Sci, Chuo Ku, Kumamoto 8620973, Japan; [Taguchi, Kazuaki; Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, Kumamoto 8600082, Japan; [Sato, Keizo] Kyushu Univ Hlth & Welf, Sch Pharm, Miyazaki 8828508, Japan; [Chuang, Victor Tuan Giam] Curtin Univ, Sch Pharm, Curtin Hlth Innovat Res Inst, Perth, WA 6845, Australia	Kadowaki, D (reprint author), Kumamoto Univ, Dept Clin Pharmacol, Fac Pharmaceut Sci, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	d-kado@kumamoto-u.ac.jp			JSPS [KAKENHI 24790160]; Kidney Foundation, Japan [JFK 10-4]; KUMAYAKU Alumni Research Fund	This work was supported in part by Grants from JSPS (KAKENHI 24790160). The Kidney Foundation, Japan (JFK 10-4), and the KUMAYAKU Alumni Research Fund.	Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d; Enomoto A, 2002, NATURE, V417, P447; Kang DH, 2005, AM J NEPHROL, V25, P425, DOI 10.1159/000087713; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Iwanaga T, 2005, DRUG METAB DISPOS, V33, P1791, DOI 10.1124/dmd.105.006056; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Farquharson CA, 2002, CIRCULATION, V106, P221, DOI 10.1161/01.CIR.0000022140.61460.1D; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Nakagawa T, 2003, AM J NEPHROL, V23, P2, DOI 10.1159/000066303; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d; Anzai N, 2011, SEMIN NEPHROL, V31, P400, DOI 10.1016/j.semnephrol.2011.08.003; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; Kuzkaya N, 2005, BIOCHEM PHARMACOL, V70, P343, DOI 10.1016/j.bcp.2005.05.009; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; TAKAHASHI MA, 1983, ARCH BIOCHEM BIOPHYS, V226, P558, DOI 10.1016/0003-9861(83)90325-9; Wilcox CS, 2005, AM J PHYSIOL-HEART C, V288, pH3, DOI 10.1152/ajpheart.00854.2004; Wilcox CS, 2002, CURR HYPERTENS REP, V4, P160, DOI 10.1007/s11906-002-0041-2; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Lassegue B, 2004, AM J HYPERTENS, V17, P852, DOI 10.1016/j.amjhyper.2004.02.004; Doehner W, 2002, CIRCULATION, V105, P2619, DOI 10.1161/01.CIR.0000017502.58592.ED; Fujimori S, 2011, NUCLEOS NUCLEOT NUCL, V30, P1035, DOI 10.1080/15257770.2011.622732; Harrison D, 2003, AM J CARDIOL, V91, p7A, DOI DOI 10.1016/S0002-9149(02)03144-2]; LYNCH RE, 1978, J BIOL CHEM, V253, P1838; Miyamoto Y, 2010, FEBS LETT, V584, P2816, DOI 10.1016/j.febslet.2010.04.046; Ohno Iwao, 2008, Nihon Jinzo Gakkai Shi, V50, P506; Shah SV, 2004, KIDNEY INT, V66, pS50, DOI 10.1111/j.1523-1755.2004.09108.x; Wilcox CS, 2005, AM J PHYSIOL-REG I, V289, pR913, DOI 10.1152/ajpregu.00250.2005	29	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAR	2015	38	3					487	492				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HR	WOS:000350092300020		
J	Miyata, M; Hayashi, K; Yamakawa, H; Yamazoe, Y; Yoshinari, K				Miyata, Masaaki; Hayashi, Kenjiro; Yamakawa, Hiroki; Yamazoe, Yasushi; Yoshinari, Kouichi			Antibacterial Drug Treatment Increases Intestinal Bile Acid Absorption via Elevated Levels of Ileal Apical Sodium-Dependent Bile Acid Transporter but Not Organic Solute Transporter alpha Protein	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						bile acid; apical sodium-dependent bile acid transporter; ampicillin; organic solute transporter	FARNESOID-X RECEPTOR; OST-BETA; MICE; FXR; IDENTIFICATION; HOMEOSTASIS	Antibacterial drug treatment increases the bile acid pool size and hepatic bile acid concentration through the elevation of hepatic bile acid synthesis. However, the involvement of intestinal bile acid absorption in the increased bile acid pool size remains unclear. To determine whether intestinal bile acid absorption contributes to the increased bile acid pool in mice treated with antibacterial drugs, we evaluated the levels of bile acid transporter proteins and the capacity of intestinal bile acid absorption. Ileal apical sodium-dependent bile acid transporter (ASBT) mRNA and protein levels were significantly increased in ampicillin (ABPC)-treated mice, whereas organic solute transporter alpha (OST alpha) mRNA levels, but not protein levels, significantly decreased in mice. Similar alterations in the expression levels of bile acid transporters were observed in mice treated with bacitracin/neomycin/streptomycin. The capacity for intestinal bile acid absorption was evaluated by an in situ loop method. Increased ileal absorption of taurochenodeoxycholic acid was observed in mice treated with ABPC. These results suggest that intestinal bile acid absorption is elevated in an ASBT-dependent manner in mice treated with antibacterial drugs.	[Miyata, Masaaki; Hayashi, Kenjiro; Yamakawa, Hiroki; Yamazoe, Yasushi; Yoshinari, Kouichi] Tohoku Univ, Div Drug Metab & Mol Toxicol, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Miyata, Masaaki] Natl Fisheries Univ, Dept Food Sci & Technol, Yamaguchi 7596595, Japan	Miyata, M (reprint author), Tohoku Univ, Div Drug Metab & Mol Toxicol, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	mmiyata@fish-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21390039, 20590137]; Yakult Bio-Science Foundation	This study was supported by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grants 21390039 and 20590137] and the Yakult Bio-Science Foundation.	Miyata M, 2011, J PHARMACOL EXP THER, V336, P188, DOI 10.1124/jpet.110.171736; LIN MC, 1990, J BIOL CHEM, V265, P14986; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Ballatori N, 2005, HEPATOLOGY, V42, P1270, DOI 10.1002/hep.20961; Alrefai WA, 2007, PHARM RES, V24, P1803, DOI 10.1007/s11095-007-9289-1; Miyata M, 2009, J PHARMACOL EXP THER, V331, P1079, DOI 10.1124/jpet.109.160093; Rao A, 2008, P NATL ACAD SCI USA, V105, P3891, DOI 10.1073/pnas.0712328105; Dawson PA, 2003, J BIOL CHEM, V278, P33920, DOI 10.1074/jbc.M306370200; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Dawson PA, 2010, BBA-MOL CELL BIOL L, V1801, P994, DOI 10.1016/j.bbalip.2010.06.002; WONG MH, 1995, J BIOL CHEM, V270, P27228; Zollner G, 2006, AM J PHYSIOL-GASTR L, V290, pG923, DOI 10.1152/ajpgi.00490.2005; Landrier JF, 2006, AM J PHYSIOL-GASTR L, V290, pG476, DOI 10.1152/ajpgi.00430.2005; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; Berr F, 1996, GASTROENTEROLOGY, V111, P1611, DOI 10.1016/S0016-5085(96)70024-0; CARULLI N, 1981, GASTROENTEROLOGY, V81, P539; Chen F, 2003, J BIOL CHEM, V278, P19909, DOI 10.1074/jbc.M207903200; KINOUCHI T, 1993, CARCINOGENESIS, V14, P869, DOI 10.1093/carcin/14.5.869; Miyata M, 2009, DRUG METAB DISPOS, V37, P338, DOI 10.1124/dmd.108.022590; Miyata M, 2006, XENOBIOTICA, V36, P631, DOI 10.1080/00498250600776827; Miyata M, 2013, EUR J PHARMACOL, V714, P507, DOI 10.1016/j.ejphar.2013.06.036; Nakahara M, 2005, J BIOL CHEM, V280, P42283, DOI 10.1074/jbc.M507454200	23	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	MAR	2015	38	3					493	496				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1HR	WOS:000350092300021		
J	Jagasia, MH; Greinix, HT; Arora, M; Williams, KM; Wolff, D; Cowen, EW; Palmer, J; Weisdorf, D; Treister, NS; Cheng, GS; Kerr, H; Stratton, P; Duarte, RF; McDonald, GB; Inamoto, Y; Vigorito, A; Arai, S; Datiles, MB; Jacobsohn, D; Heller, T; Kitko, CL; Mitchell, SA; Martin, PJ; Shulman, H; Wu, RS; Cutler, CS; Vogelsang, GB; Lee, SJ; Pavletic, SZ; Flowers, MED				Jagasia, Madan H.; Greinix, Hildegard T.; Arora, Mukta; Williams, Kirsten M.; Wolff, Daniel; Cowen, Edward W.; Palmer, Jeanne; Weisdorf, Daniel; Treister, Nathaniel S.; Cheng, Guang-Shing; Kerr, Holly; Stratton, Pamela; Duarte, Rafael F.; McDonald, George B.; Inamoto, Yoshihiro; Vigorito, Afonso; Arai, Sally; Datiles, Manuel B.; Jacobsohn, David; Heller, Theo; Kitko, Carrie L.; Mitchell, Sandra A.; Martin, Paul J.; Shulman, Howard; Wu, Roy S.; Cutler, Corey S.; Vogelsang, Georgia B.; Lee, Stephanie J.; Pavletic, Steven Z.; Flowers, Mary E. D.			National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Chronic graft-versus-host disease; National Institutes of Health; Diagnosis; Staging	STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; CHRONIC GVHD CONSORTIUM; RISK-FACTORS; NONRELAPSE MORTALITY; SURVIVAL; SEVERITY; OUTCOMES; SCORE; ORGAN	The 2005 National Institutes of Health (NIH) Consensus Conference proposed new criteria for diagnosing and scoring the severity of chronic graft-versus-host disease (GVHD). The 2014 NIH consensus maintains the framework of the prior consensus with further refinement based on new evidence. Revisions have been made to address areas of controversy or confusion, such as the overlap chronic GVHD subcategory and the distinction between active disease and past tissue damage. Diagnostic criteria for involvement of mouth, eyes, genitalia, and lungs have been revised. Categories of chronic GVHD should be defined in ways that indicate prognosis, guide treatment, and define eligibility for clinical trials. Revisions have been made to focus attention on the causes of organ-specific abnormalities. Attribution of organ-specific abnormalities to chronic GVHD has been addressed. This paradigm shift provides greater specificity and more accurately measures the global burden of disease attributed to GVHD, and it will facilitate biomarker association studies. (C) 2015 American Society for Blood and Marrow Transplantation.	[Jagasia, Madan H.] Vanderbilt Univ, Med Ctr, Dept Hematol & Oncol, Nashville, TN 37235 USA; [Greinix, Hildegard T.] Med Univ Vienna, Dept Internal Med, Vienna, Austria; [Arora, Mukta; Weisdorf, Daniel] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Williams, Kirsten M.; Cowen, Edward W.; Pavletic, Steven Z.] Ctr Canc Res, Natl Canc Inst, NIH, Bethesda, MD USA; [Williams, Kirsten M.; Jacobsohn, David] Childrens Natl Hlth Syst, Dept Blood & Marrow Transplantat, Washington, DC USA; [Weisdorf, Daniel] Univ Regensburg, Dept Internal Med, D-93053 Regensburg, Germany; [Palmer, Jeanne] Mayo Clin Arizona, Dept Hematol Oncol Blood & Marrow Transplant, Phoenix, AZ USA; [Treister, Nathaniel S.] Brigham & Womens Hosp, Dept Surg, Div Oral Med & Dent, Boston, MA 02115 USA; [Cheng, Guang-Shing; McDonald, George B.; Martin, Paul J.; Shulman, Howard; Lee, Stephanie J.; Flowers, Mary E. D.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Kerr, Holly] BC Canc Agcy, Dept Hematol, Vancouver, BC, Canada; [Stratton, Pamela] NIH, Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pediat & Reprod Endocrinol Branch, Bethesda, MD 20892 USA; [Duarte, Rafael F.] Inst Catala Oncol, Dept Hematol, Barcelona, Spain; [Inamoto, Yoshihiro] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo, Japan; [Vigorito, Afonso] Hemoctr Unicamp, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil; [Arai, Sally] Stanford Univ, Med Ctr, Dept Blood & Marrow Transplantat, Stanford, CA 94305 USA; [Datiles, Manuel B.] NIH, Natl Eye Inst, Eye Clin, Bethesda, MD 20892 USA; [Heller, Theo] NIH, Natl Inst Diabet & Digest & Kidney Dis, Liver Dis Branch, Bethesda, MD 20892 USA; [Kitko, Carrie L.] Univ Michigan, Ctr Comprehens Canc, Blood & Marrow Transplant Program, Ann Arbor, MI 48109 USA; [Mitchell, Sandra A.] NIH, Dept Appl Res Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Wu, Roy S.] NIH, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA; [Cutler, Corey S.] Dana Farber Canc Inst, Div Hematol Oncol, Boston, MA USA; [Vogelsang, Georgia B.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Flowers, MED (reprint author), Fred Hutchinson Canc Res Ctr, D5-290 POB 19024, Seattle, WA 98109 USA.	mflowers@fredhutch.org		Datiles, Manuel III B./0000-0003-4660-1664	NIH's National Cancer Institute, Center for Cancer Research, Intramural Research Program and Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program; Office of Rare Disease Research, National Center for Advancing Translational Sciences; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute, Division of Blood Diseases and Resources; National Cancer Institute [CA18029, CA118953]; National Institutes of Health	This project was supported by the NIH's National Cancer Institute, Center for Cancer Research, Intramural Research Program and Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program; Office of Rare Disease Research, National Center for Advancing Translational Sciences; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute, Division of Blood Diseases and Resources. This work was also supported in part by grants CA18029 and CA118953 from the National Cancer Institute and the National Institutes of Health. The authors want to acknowledge the following individuals and organizations that, by their participation, made this project possible: American Society for Blood and Marrow Transplantation, Center for International Bone and Marrow Transplant Research, US Chronic GVHD Consortium (supported by ORDR/NCATS and NCI), German-Austrian-Swiss chronic GVHD Consortium, National Marrow Donor Program, the Health Resources and Services Administration, Division of Transplantation, US Department of Human Health and Services, Canadian Blood and Marrow Transplant Group, European Group for Blood and Marrow Transplantation, Pediatric Blood and Marrow Transplant Consortium, and the representatives of the Brazilian Chronic GVHD consortium (Drs. Maria Claudia Moreira, Marcia de Matos Silva and Vaneuza Funke) and Deutsche Jose Carreras Leukamie-Stiftung. The authors would like to thank Dr. Joseph Antin (Dana Farber Cancer Center, Boston, MA) and Dr. Gerard Socie (University Paris VII & AP-HP, Hospital Saint Louis, Paris, France) for their critical review of the manuscript. The authors also thank Marcie Hall for careful review of the manuscript. The organizers are in debt to patients and patient and research advocacy groups, who made this process much more meaningful by their engagement. Acknowledgement goes to the Meredith Cowden GVHD foundation for facilitating the initial planning meeting in Cleveland in November of 2013 in conjunction with the National GVHD Symposium. The project group also recognizes the contributions of numerous colleagues in the field of blood and marrow transplantation in the US and internationally, medical specialists and consultants, the pharmaceutical industry, and the NIH and US Food and Drug Administration professional staff for their intellectual input, dedication, and enthusiasm on the road to completion of these documents. For their expert contributions to this 2014 NIH Consensus Diagnosis and Staging Working Group document special acknowledgements go to Drs. Mark Schubert, Fred Hutchinson Cancer Research Center in Seattle, WA, Tina Dietrich-Ntoukas, University of Regensburg, Germany, Janine Clayton, National Eye Institute, NIH, Bethesda, MD, Melissa A. Merideth, National Human Genome Research Institute, NIH, Bethesda, MD, Tajana Klepac Pulanic, Community Health Center East, Zagreb, Croatia, and Robert Knobler, University of Vienna, Austria.	Aki SZ, 2014, BIOL BLOOD MARROW TR, V20, pS265; Inamoto Y, 2012, OPHTHALMOLOGY, V119, P487, DOI 10.1016/j.ophtha.2011.08.040; Inamoto Y, 2013, BLOOD, V121, P2340, DOI 10.1182/blood-2012-11-465583; Arora M, 2009, BONE MARROW TRANSPL, V43, P149, DOI 10.1038/bmt.2008.305; Akpek G, 2003, BLOOD, V102, P802, DOI 10.1182/blood-2002-10-3141; Williams KM, 2009, JAMA-J AM MED ASSOC, V302, P306, DOI 10.1001/jama.2009.1018; Jagasia M, 2007, BIOL BLOOD MARROW TR, V13, P1207, DOI 10.1016/j.bbmt.2007.07.001; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Hirsch P, 2012, TRANSPLANTATION, V93, P1265, DOI 10.1097/TP.0b013e31824f3dcd; SULLIVAN KM, 1988, BLOOD, V72, P546; Arai S, 2011, BLOOD, V118, P4242, DOI 10.1182/blood-2011-03-344390; Pidala J, 2011, BLOOD, V117, P4651, DOI 10.1182/blood-2010-11-319509; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; WINGARD JR, 1989, BLOOD, V74, P1428; Kuzmina Z, 2012, LEUKEMIA, V26, P746, DOI 10.1038/leu.2011.257; Stewart BL, 2004, BLOOD, V104, P3501, DOI 10.1182/blood-2004-01-0200; Vigorito AC, 2009, BLOOD, V114, P702, DOI 10.1182/blood-2009-03-208983; Cho BS, 2009, LEUKEMIA, V23, P78, DOI 10.1038/leu.2008.276; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179; Lee SJ, 2003, BIOL BLOOD MARROW TR, V9, P215, DOI 10.1053/bbmt.2003.50026; Pidala J, 2012, HAEMATOL-HEMATOL J, V97, P451, DOI 10.3324/haematol.2011.055186; Lee SJ, 2002, BLOOD, V100, P406, DOI 10.1182/blood.V100.2.406; Baird K, 2013, BIOL BLOOD MARROW TR, V19, P632, DOI 10.1016/j.bbmt.2013.01.013; Mueller SM, 2013, BIOL BLOOD MARROW TR, V19, P1574, DOI 10.1016/j.bbmt.2013.07.010; Jacobsohn DA, 2011, BLOOD, V118, P4472, DOI 10.1182/blood-2011-04-349068; Zantomio D, 2006, BONE MARROW TRANSPL, V38, P567, DOI 10.1038/sj.bmt.1705487; Flowers MED, 2011, BLOOD, V117, P3214, DOI 10.1182/blood-2010-08-302109; Shanis D, 2012, SEMIN HEMATOL, V49, P83, DOI 10.1053/j.seminhematol.2011.10.002; Arora M, 2011, BLOOD, V117, P6714, DOI 10.1182/blood-2010-12-323824; Hildebrandt GC, 2011, BONE MARROW TRANSPL, V46, P1283, DOI 10.1038/bmt.2011.35; Jacobs R, 2012, BONE MARROW TRANSPL, V47, P1470, DOI 10.1038/bmt.2012.56; Arora M, 2013, LEUKEMIA, V27, P1196, DOI 10.1038/leu.2012.292; Brook OR, 2014, ABDOM IMAGING, V39, P342, DOI 10.1007/s00261-013-0072-y; Flowers MED, 2009, CHRONIC GRAFT VERSUS HOST DISEASE: INTERDISCIPLINARY MANAGEMENT, P56, DOI 10.1017/CBO9780511576751.007; Herzberg PY, 2010, BIOL BLOOD MARROW TR, V16, P1707, DOI 10.1016/j.bbmt.2010.05.018; Inamoto Y, 2014, BONE MARROW TRANSPL, V49, P532, DOI 10.1038/bmt.2013.225; Inamoto Y, 2014, ARTHRITIS RHEUMATOL, V66, P1044, DOI 10.1002/art.38293; Jacobsohn DA, 2012, BLOOD, V120, P2545, DOI 10.1182/blood-2012-04-424135; Jagasia MH, 2012, BONE MARROW TRANSPL, V47, P1350, DOI 10.1038/bmt.2011.261; Knutsson ES, 2014, BIOL BLOOD MARROW TR, V20, P806, DOI 10.1016/j.bbmt.2014.02.016; Lee Stephanie J, 2008, Hematology Am Soc Hematol Educ Program, P134, DOI 10.1182/asheducation-2008.1.134; Marks C, 2011, BRIT J DERMATOL, V165, P18, DOI 10.1111/j.1365-2133.2011.10360.x; Marks CL, 2011, BONE MARROW TRANSPL, V46, pS66; Ogawa Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03419; Palmer J, 2014, BIOL BLOOD MARROW TR, V20, P337, DOI 10.1016/j.bbmt.2013.11.025; Pavletic SZ, 2005, BLOOD, V106, P3308, DOI 10.1182/blood-2005-04-1614; Perez-Simon JA, 2008, BIOL BLOOD MARROW TR, V14, P1163, DOI 10.1016/j.bbmt.2008.07.015; Pidala J, 2013, BIOL BLOOD MARROW TR, V19, P784, DOI 10.1016/j.bbmt.2013.02.001; Pidala J, 2013, BIOL BLOOD MARROW TR, V19, P967, DOI 10.1016/j.bbmt.2013.03.014; Pidala J, 2011, HAEMATOL-HEMATOL J, V96, P1528, DOI 10.3324/haematol.2011.046367; Spinelli S, 2003, HAEMATOLOGICA, V88, P1163	51	12	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	MAR	2015	21	3					389	401		10.1016/j.bbmt.2014.12.001		13	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CC0EV	WOS:000350009500004		
J	Tanaka, M; Miyamura, K; Terakura, S; Imai, K; Uchida, N; Ago, H; Sakura, T; Eto, T; Ohashi, K; Fukuda, T; Taniguchi, S; Mori, S; Nagamura-Inoue, T; Atsuta, Y; Okamoto, S				Tanaka, Masatsugu; Miyamura, Koichi; Terakura, Seitaro; Imai, Kiyotoshi; Uchida, Naoyuki; Ago, Hiroatsu; Sakura, Toru; Eto, Tetsuya; Ohashi, Kazuteru; Fukuda, Takahiro; Taniguchi, Shuichi; Mori, Shinichiro; Nagamura-Inoue, Tokiko; Atsuta, Yoshiko; Okamoto, Shin-ichiro			Comparison of Cord Blood Transplantation with Unrelated Bone Marrow Transplantation in Patients Older than Fifty Years	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Unrelated bone marrow transplantation; Umbilical cord blood transplantation; Elderly patients	STEM-CELL TRANSPLANTATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; HEMATOLOGIC MALIGNANCIES; PEDIATRIC-PATIENTS; COMPETING RISK; ADULTS; GRAFT; METAANALYSIS; OUTCOMES; THERAPY	We retrospectively compared the transplantation outcomes for patients 50 years or older who received umbilical cord blood transplantation (UCBT) with those who received unrelated bone marrow transplantation (UBMT) for hematologic malignancies. A total of 1377 patients who underwent transplantation between 2000 and 2009 were included: 516 received 8/8 HLA allele-matched UBMT, 295 received 7/8 HLA allele-matched UBMT, and 566 received 4/6 to 6/6 HLA-matched UCBT. Adjusted overall survival (OS) was significantly lower in those who underwent UCBT than those who underwent 8/8 HLA matched UBMT but was similar to that of 7/8 HLA matched UBMT (the 2-year OS after 8/8 HLA matched UBMT, 7/8 HLA matched UBMT, and UCBT were 49% [95% confidence interval (CI), 45% to 55%], 38% [95% CI, 32% to 45%], and 39% [95% CI, 34% to 43%], respectively). However, adjusted OS was similar between 8/8 HLA matched UBMT and UCBT receiving >=.84 x 10(5) CD34(+) cells/kg among those with acute myeloid leukemia and those with acute lymphoblastic leukemia (the 2-year OS was 49% [95% CI, 43% to 55%], and 49% [95% CI, 41% to 58%], respectively). These data suggest that UCB is a reasonable alternative donor/stem cell source for elderly patients with similar outcomes compared with UBM from 8/8 HLA matched unrelated donors when the graft containing >=.84 x 10(5) CD34(+) cells/kg is available. (C) 2015 American Society for Blood and Marrow Transplantation.	[Tanaka, Masatsugu] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Kanagawa 2418515, Japan; [Miyamura, Koichi] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Terakura, Seitaro] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan; [Imai, Kiyotoshi] Sapporo Hokuyu Hosp, Dept Hematol, Sapporo, Hokkaido, Japan; [Uchida, Naoyuki; Taniguchi, Shuichi] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Ago, Hiroatsu] Shimane Prefectural Cent Hosp, Dept Hematol & Oncol, Izumo, Shimane, Japan; [Sakura, Toru] Saiseikai Maebashi Hosp, Leukemia Res Ctr, Maebashi, Gumma, Japan; [Eto, Tetsuya] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan; [Ohashi, Kazuteru] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Fukuda, Takahiro] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo, Japan; [Mori, Shinichiro] St Lukes Int Hosp, Div Hematol & Oncol, Tokyo, Japan; [Nagamura-Inoue, Tokiko] Univ Tokyo, Inst Med Sci, Dept Cell Proc & Transfus, Tokyo, Japan; [Atsuta, Yoshiko] Nagoya Univ, Sch Med, Dept Hematopoiet Stem Cell Transplantat Data Mana, Nagoya, Aichi 466, Japan; [Okamoto, Shin-ichiro] Keio Univ, Sch Med, Dept Med, Div Hematol, Tokyo 160, Japan	Tanaka, M (reprint author), Kanagawa Canc Ctr, Dept Hematol, Asahi Ku, 2-3-2 Nakao, Yokohama, Kanagawa 2418515, Japan.	tanakam@kcch.jp	Terakura, Seitaro/A-6188-2011	Terakura, Seitaro/0000-0002-1194-8046			McSweeney PA, 2001, BLOOD, V97, P3390, DOI 10.1182/blood.V97.11.3390; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Atsuta Y, 2007, INT J HEMATOL, V86, P269, DOI 10.1532/IJH97.06239; Eapen M, 2010, LANCET ONCOL, V11, P653, DOI 10.1016/S1470-2045(10)70127-3; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Rowe JM, 2005, BLOOD, V106, P3760, DOI 10.1182/blood-2005-04-1623; Brunstein CG, 2012, BLOOD, V119, P5591, DOI 10.1182/blood-2011-12-400630; Atsuta Y, 2009, BLOOD, V113, P1631, DOI 10.1182/blood-2008-03-147041; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Wagner JE, 2002, BLOOD, V100, P1611, DOI 10.1182/blood-2002-01-0294; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Slavin S, 1998, BLOOD, V91, P756; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Zhang HR, 2012, BIOL BLOOD MARROW TR, V18, P1164, DOI 10.1016/j.bbmt.2012.01.015; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Hwang WYK, 2007, BIOL BLOOD MARROW TR, V13, P444, DOI 10.1016/j.bbmt.2006.11.005; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Pullarkat V, 2008, BLOOD, V111, P2563, DOI 10.1182/blood-2007-10-116186; Appelbaum FR, 2006, BLOOD, V107, P3481, DOI 10.1182/blood-2005-09-3724; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Takahashi S, 2004, BLOOD, V104, P3813, DOI 10.1182/blood-2004-03-1001; Anasetti C, 2012, NEW ENGL J MED, V367, P1487, DOI 10.1056/NEJMoa1203517; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Lee HS, 2013, ANN HEMATOL, V92, P1685, DOI 10.1007/s00277-013-1847-5; Narimatsu H, 2007, BONE MARROW TRANSPL, V39, P31, DOI 10.1038/sj.bmt.1705539; Pasquini M.C., 2011, CURRENT USE OUTCOME; Tomblyn MB, 2009, J CLIN ONCOL, V27, P3634, DOI 10.1200/JCO.2008.20.2960; Wang J, 2010, LEUKEMIA RES, V34, P1018, DOI 10.1016/j.leukres.2009.11.020	30	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	MAR	2015	21	3					517	525		10.1016/j.bbmt.2014.11.685		9	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CC0EV	WOS:000350009500020		
J	Ohtawa, M; Matsunaga, M; Fukunaga, K; Shimizu, R; Shimizu, E; Arima, S; Ohmori, J; Kita, K; Shiomi, K; Omura, S; Nagamitsu, T				Ohtawa, Masaki; Matsunaga, Mari; Fukunaga, Keiko; Shimizu, Risa; Shimizu, Eri; Arima, Shiho; Ohmori, Junko; Kita, Kiyoshi; Shiomi, Kazuro; Omura, Satoshi; Nagamitsu, Tohru			Design, synthesis, and biological evaluation of air-stable nafuredin-gamma analogs as complex I inhibitors	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Nafuredin-gamma; Air-stable analogs; Complex I inhibitor	NADH-FUMARATE REDUCTASE; CROSS-COUPLING REACTION	Nafuredin-gamma (2), converted from nafuredin (1) under mild basic conditions, demonstrates potent and selective inhibitory activity against helminth complex I. However, 2 is unstable in air because the conjugated dienes are oxygen-labile. To address this, we designed and synthesized air-stable nafuredin-gamma analogs. Although the complex I inhibitory activities of all the new nafuredin-gamma analogs were lower than that of 2, all were in the high nM range (IC50: 300-820 nM). (C) 2015 Elsevier Ltd. All rights reserved.	[Ohtawa, Masaki; Matsunaga, Mari; Fukunaga, Keiko; Shimizu, Risa; Shimizu, Eri; Arima, Shiho; Nagamitsu, Tohru] Kitasato Univ, Grad Sch Pharmaceut Sci, Minato Ku, Tokyo 1088641, Japan; [Shiomi, Kazuro; Omura, Satoshi] Kitasato Univ, Grad Sch Infect Control Sci, Minato Ku, Tokyo 1088641, Japan; [Ohmori, Junko; Kita, Kiyoshi] Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Bunkyo Ku, Tokyo 1130033, Japan	Nagamitsu, T (reprint author), Kitasato Univ, Grad Sch Pharmaceut Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	nagamitsut@pharm.kitasato-u.ac.jp			JSPS KAKENHI [2350132]	This research was partially supported by JSPS KAKENHI Grant Number 2350132. We thank Ms. N. Sato and Dr. K. Nagai (Kitasato University) for kindly measuring NMR and MS spectra.	Amino H, 2000, MOL BIOCHEM PARASIT, V106, P63, DOI 10.1016/S0166-6851(99)00200-5; Raheem IT, 2004, J AM CHEM SOC, V126, P706, DOI 10.1021/ja039550y; DENMARK SE, 1987, J ORG CHEM, V52, P165, DOI 10.1021/jo00377a033; Ishiyama T, 1996, TETRAHEDRON LETT, V37, P6889, DOI 10.1016/0040-4039(96)01505-5; Igarashi Y, 2011, J NAT PROD, V74, P862, DOI 10.1021/np100779t; Takano D, 2001, ORG LETT, V3, P2289, DOI 10.1021/ol010089t; Trost BM, 2010, CHEM-EUR J, V16, P6265, DOI 10.1002/chem.200903356; Chemler SR, 2001, ANGEW CHEM INT EDIT, V40, P4544, DOI 10.1002/1521-3773(20011217)40:24<4544::AID-ANIE4544>3.0.CO;2-N; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Asssandri A., [No title captured], Patent No. [WO2012052918A1, 2012052918]; Brioche JCR, 2007, ORG LETT, V9, P3941, DOI 10.1021/ol701553j; Chackal-Catoen S, 2006, BIOORGAN MED CHEM, V14, P7434, DOI 10.1016/j.bmc.2006.07.024; Crews JR D. A., [No title captured], Patent No. [WO2011087837A2, 2011087837]; Kaiser F, 2002, J ORG CHEM, V67, P9248, DOI 10.1021/jo026232t; Kujat C, 2006, SYNLETT, P419, DOI 10.1055/s-2006-926263; Lay S. V., 1989, TETRAHEDRON LETT, V45, P7161; Nagamitsu T, 2003, TETRAHEDRON LETT, V44, P6441, DOI 10.1016/S0040-4039(03)01583-1; Nagamitsu T, 2008, TETRAHEDRON, V64, P8117, DOI 10.1016/j.tet.2008.06.066; Omura S, 2001, P NATL ACAD SCI USA, V98, P60, DOI 10.1073/pnas.011524698; Shiomi K, 2005, J ANTIBIOT, V58, P50; Takano D, 2001, TETRAHEDRON LETT, V42, P3017, DOI 10.1016/S0040-4039(01)00355-0; Ui H, 2001, J ANTIBIOT, V54, P234; Uyanik M, 2006, ORG LETT, V8, P5649, DOI 10.1021/ol062378t; Yadav JS, 2013, EUR J ORG CHEM, P3076, DOI 10.1002/ejoc.201300083	24	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	MAR 1	2015	23	5					932	943		10.1016/j.bmc.2015.01.030		12	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CB9QL	WOS:000349966700003		
J	Noguchi-Yachide, T; Sakai, T; Hashimoto, Y; Yamaguchi, T				Noguchi-Yachide, Tomomi; Sakai, Taki; Hashimoto, Yuichi; Yamaguchi, Takao			Discovery and structure-activity relationship studies of N6-benzoyladenine derivatives as novel BRD4 inhibitors	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						BRD4; Bromodomain; Benzoyladenine; Structure-activity relationship	X RECEPTOR ANTAGONISTS; BROMODOMAIN INHIBITORS; GENE-EXPRESSION; THALIDOMIDE; SELECTIVITY; PROGRESSION; CHROMATIN; STRATEGY; LEUKEMIA; LIGANDS	Bromodomain and extra-terminal domain (BET) proteins are epigenetic readers that bind to acetylated lysines in histones. Among them, BRD4 is a candidate target molecule of therapeutic agents for diverse diseases, including cancer and inflammatory disease. As a part of our continuing structural development studies of thalidomide to obtain a broad spectrum of biological modifiers based on the 'multi-template' approach, in this work we focused on BRD4-inhibitory activity, and discovered that N6-benzoyladenine derivatives exhibit this activity. Structure-activity relationship studies led to N6-(2,4,5-trimethoxybenzoyl) adenine (29), which exhibits potent BRD4 bromodomain1 inhibitory activity with an IC50 value of 0.427 mu M. N6-Benzoyladenine appears to be a new chemical scaffold for development of BRD4 inhibitors. (C) 2015 Elsevier Ltd. All rights reserved.	[Noguchi-Yachide, Tomomi; Sakai, Taki; Hashimoto, Yuichi; Yamaguchi, Takao] Univ Tokyo, Inst Mol & Cellular, Bunkyo Ku, Tokyo 1130032, Japan	Noguchi-Yachide, T (reprint author), Univ Tokyo, Inst Mol & Cellular, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	noguchi@iam.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science	The work described in this paper was partially supported by Grants-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology, Japan, and a grant from The Japan Society for the Promotion of Science.	McNeill E, 2010, CURR OPIN INVEST DR, V11, P357; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Hideshima T, 2000, BLOOD, V96, P2943; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Sano H, 2005, BIOORGAN MED CHEM, V13, P3079, DOI 10.1016/j.bmc.2005.03.002; Mochizuki K, 2008, J BIOL CHEM, V283, P9040, DOI 10.1074/jbc.M707603200; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334; Denis GV, 2010, FEBS LETT, V584, P3260, DOI 10.1016/j.febslet.2010.05.030; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Picaud S, 2013, P NATL ACAD SCI USA, V110, P19754, DOI 10.1073/pnas.1310658110; Chaidos A, 2014, BLOOD, V123, P697, DOI 10.1182/blood-2013-01-478420; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; SAMPAIO EP, 1993, J INFECT DIS, V168, P408; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Denis Gerald V, 2010, Discov Med, V10, P489; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Garnier JM, 2014, EXPERT OPIN THER PAT, V24, P185, DOI 10.1517/13543776.2014.859244; Hashimoto Y, 2002, BIOORGAN MED CHEM, V10, P461, DOI 10.1016/S0968-0896(01)00308-X; Huong B., 2009, MOL CELL BIOL, V29, P1375; Jung M, 2014, J BIOL CHEM, V289, P9304, DOI 10.1074/jbc.M113.523019; Lambertucci C, 2009, BIOORGAN MED CHEM, V17, P2812, DOI 10.1016/j.bmc.2009.02.030; Motoshima K, 2011, BIOORGAN MED CHEM, V19, P3156, DOI 10.1016/j.bmc.2011.03.065; Nicholls SJ, 2012, CARDIOVASC DRUG THER, V26, P181, DOI 10.1007/s10557-012-6373-5; Noguchi-Yachide T, 2011, HETEROCYCLES, V83, P2137, DOI 10.3987/COM-11-12287; Noguchi-Yachide T, 2007, BIOORG MED CHEM LETT, V17, P3957, DOI 10.1016/j.bmcl.2007.04.090; Nosenko Y, 2011, J PHYS CHEM A, V115, P11403, DOI 10.1021/jp205575w; Sano H, 2006, BIOORG MED CHEM LETT, V16, P3068, DOI 10.1016/j.bmcl.2006.02.021; Smith DJ, 2011, J ORG CHEM, V76, P1513, DOI 10.1021/jo101940k; Wang F., 2011, BIOCHEM J, V425, P71; Woodman EK, 2009, ORG PROCESS RES DEV, V13, P106, DOI 10.1021/op800226b; Zhang BJ, 2014, J MED CHEM, V57, P9184, DOI 10.1021/jm501391g	34	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	MAR 1	2015	23	5					953	959		10.1016/j.bmc.2015.01.022		7	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CB9QL	WOS:000349966700005		
J	Sumii, Y; Kotoku, N; Fukuda, A; Kawachi, T; Sumii, Y; Arai, M; Kobayashi, M				Sumii, Yuji; Kotoku, Naoyuki; Fukuda, Akinori; Kawachi, Takashi; Sumii, Yuta; Arai, Masayoshi; Kobayashi, Motomasa			Enantioselective synthesis of dictyoceratin-A (smenospondiol) and -C, hypoxia-selective growth inhibitors from marine sponge	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						(+)-Dictyoceratin-C; (+)-Dictyoceratin-A (smenospondiol); Hypoxia-selective growth inhibitor; Total synthesis; Absolute stereochemistry	CLERODANE DITERPENOIDS; HYDROQUINONE	Total syntheses of (+)-dictyoceratin-C (1) and (+)-dictyoceratin-A (smenospondiol) (2), hypoxia-selective growth inhibitors isolated from marine sponge, were executed. The absolute stereochemistry of the each compound was determined through the enantioselective total syntheses of them. It revealed that the unnatural enantiomers of them also exhibited the hypoxia-selective growth inhibitory activity against human prostate cancer DU-145 cells. (C) 2015 Elsevier Ltd. All rights reserved.	[Sumii, Yuji; Kotoku, Naoyuki; Fukuda, Akinori; Kawachi, Takashi; Sumii, Yuta; Arai, Masayoshi; Kobayashi, Motomasa] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	Kotoku, N (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamada Oka, Suita, Osaka 5650871, Japan.	kotoku@phs.osaka-u.ac.jp; kobayasi@phs.osaka-u.ac.jp			Hoansha Foundation; Uehara Memorial Foundation; Naito Foundation; Osaka University Project MEET; Ministry of Education, Culture, Sports, Science, and Technology of Japan [26242074, 22241053, 26860065]; Platform for Drug Discovery, Informatics, and Structural Life Science, from the Ministry of Education, Culture, Sports, Science, and Technology of Japan	The authors thank Dr. Kazutake Tsujikawa (Osaka University) for providing the DU145 cells. The authors are grateful to the Hoansha Foundation, the Uehara Memorial Foundation, the Naito Foundation, and Osaka University Project MEET for financial support. This study was also financially supported by Grant-in-Aid for Scientific Research (Nos. 26242074, 22241053 and 26860065), and Platform for Drug Discovery, Informatics, and Structural Life Science, from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Sladic D, 2006, MOLECULES, V11, P1, DOI 10.3390/11010001; Arai M, 2014, BIOORG MED CHEM LETT, V24, P3155, DOI 10.1016/j.bmcl.2014.04.116; KUSHLAN DM, 1989, TETRAHEDRON, V45, P3307, DOI 10.1016/S0040-4020(01)81009-7; Gordaliza M, 2010, MAR DRUGS, V8, P2849, DOI 10.3390/md8122849; HAGIWARA H, 1988, J ORG CHEM, V53, P2308, DOI 10.1021/jo00245a033; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Kluger R, 2000, J ORG CHEM, V65, P214, DOI 10.1021/jo991514n; Gordaliza M, 2012, MAR DRUGS, V10, P358, DOI 10.3390/md10020358; NAKAMURA H, 1986, TETRAHEDRON, V42, P4197, DOI 10.1016/S0040-4020(01)87643-2; Borjesson L., 2007, PCT Int. Appl., Patent No. [WO2007030061A1, 2007030061]; Bruner D. S., 1995, J ORG CHEM, V60, P1114; CAPON RJ, 1987, J ORG CHEM, V52, P5059, DOI 10.1021/jo00231a051; Kato K., 1988, Eur. Pat. Appl., Patent No. [EP269087A2, 269087]; KONDRACKI ML, 1989, J CHEM RES-S, P74; Kwak JH, 2000, J NAT PROD, V63, P1153, DOI 10.1021/np0000791; Payne RJ, 2005, ORG BIOMOL CHEM, V3, P2271, DOI 10.1039/b503802b; Poigny S, 1998, J ORG CHEM, V63, P5890, DOI 10.1021/jo9805192; SARMA AS, 1982, J ORG CHEM, V47, P1727, DOI 10.1021/jo00348a025; Tokoroyama T, 2000, SYNTHESIS-STUTTGART, P611; UIJTTEWAAL AP, 1979, J ORG CHEM, V44, P3157, DOI 10.1021/jo01332a014; Yamada H., 2001, SYNLETT, P1935	21	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	MAR 1	2015	23	5					966	975		10.1016/j.bmc.2015.01.021		10	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CB9QL	WOS:000349966700007		
J	Misawa, T; Demizu, Y; Kawamura, M; Yamagata, N; Kurihara, M				Misawa, Takashi; Demizu, Yosuke; Kawamura, Megumi; Yamagata, Nanako; Kurihara, Masaaki			Structural development of stapled short helical peptides as vitamin D receptor (VDR)-coactivator interaction inhibitors	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Vitamin D receptor; Protein-protein interaction; Stapled peptide; Helical structure	PROTEIN-PROTEIN INTERACTIONS; ENANTIOSELECTIVE EPOXIDATION; D-3-DEPENDENT TRANSCRIPTION; NUCLEAR RECEPTOR; AMINO-ACIDS; DESIGN; COACTIVATORS; FOLDAMERS; LIGANDS; IDENTIFICATION	We developed several stabilized helical heptapeptides (DPI-01-10) composed of L-leucine residues, an alpha,alpha-disubstituted alpha-amino acid (alpha-aminoisobutyric acid [Aib] or hydroxymethylserine [Hms]), and a stapled side chain as inhibitors of vitamin D receptor (VDR)-coactivator interactions. The inhibitory activity of these peptides against VDR-coactivator interactions was evaluated using a receptor cofactor assay system, and DPI-08 demonstrated strong activity (IC50: 3.2 mu M). (C) 2015 Elsevier Ltd. All rights reserved.	[Misawa, Takashi; Demizu, Yosuke; Kawamura, Megumi; Yamagata, Nanako; Kurihara, Masaaki] Natl Inst Hlth Sci, Div Organ Chem, Setagaya Ku, Tokyo 1588501, Japan; [Kawamura, Megumi; Kurihara, Masaaki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan	Demizu, Y (reprint author), Natl Inst Hlth Sci, Div Organ Chem, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	demizu@nihs.go.jp; masaaki@nihs.go.jp			JSPS KAKENHI [26460169, 25893038]; Tokyo Biochemical Research Foundation	This study was supported, in part, by JSPS KAKENHI Grant Numbers 26460169 (YD) and 25893038 (TM), and by a Grant-in-Aid from the Tokyo Biochemical Research Foundation (YD).	Abe J, 2012, ORG BIOMOL CHEM, V10, P7826, DOI 10.1039/c2ob26017d; Mita Y, 2013, BIOORGAN MED CHEM, V21, P993, DOI 10.1016/j.bmc.2012.11.042; Yamagata N, 2011, TETRAHEDRON LETT, V52, P798, DOI 10.1016/j.tetlet.2010.12.030; Stasiak M, 2008, J PEPT SCI, V14, P1163, DOI 10.1002/psc.1054; Nomura W, 2013, ACS CHEM BIOL, V8, P2235, DOI 10.1021/cb400495h; Seebach D, 2008, ACCOUNTS CHEM RES, V41, P1366, DOI 10.1021/ar700263g; Kim YW, 2011, NAT PROTOC, V6, P761, DOI 10.1038/nprot.2011.324; Brown RA, 2013, NAT CHEM, V5, P853, DOI [10.1038/nchem.1747, 10.1038/NCHEM.1747]; Heery DM, 1997, NATURE, V387, P733; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Milroy LG, 2014, CHEM REV, V114, P4695, DOI 10.1021/cr400698c; Tanaka M, 2007, CHEM PHARM BULL, V55, P349, DOI 10.1248/cpb.55.349; Inaba Y, 2009, J MED CHEM, V52, P1438, DOI 10.1021/jm8014348; Fujii S, 2011, J AM CHEM SOC, V133, P20933, DOI 10.1021/ja208797n; Goodman CM, 2007, NAT CHEM BIOL, V3, P252, DOI 10.1038/nchembio876; Horne WS, 2008, ACCOUNTS CHEM RES, V41, P1399, DOI 10.1021/ar800009n; Islam MN, 2014, BIOORGAN MED CHEM, V22, P3862, DOI 10.1016/j.bmc.2014.06.031; Kashiwagi H, 2013, BIOORGAN MED CHEM, V21, P1823, DOI 10.1016/j.bmc.2013.01.042; HOLICK MF, 1971, BIOCHEMISTRY-US, V10, P2799; Demizu Y, 2011, ORG BIOMOL CHEM, V9, P3303, DOI 10.1039/c0ob01146k; Wang SY, 2014, J ORG CHEM, V79, P5287, DOI 10.1021/jo500916j; Ciesielski F, 2012, J MED CHEM, V55, P8440, DOI 10.1021/jm300858s; Azzarito V, 2013, NAT CHEM, V5, P161, DOI [10.1038/nchem.1568, 10.1038/NCHEM.1568]; Demizu Y, 2011, TETRAHEDRON, V67, P6155, DOI 10.1016/j.tet.2011.06.075; Royo S, 2005, J AM CHEM SOC, V127, P2036, DOI 10.1021/ja043116u; Carlberg C, 2012, EXPERT OPIN THER PAT, V22, P417, DOI 10.1517/13543776.2012.673590; Blackwell HE, 2001, J ORG CHEM, V66, P5291, DOI 10.1021/jo015533k; Nandhikonda P, 2012, J MED CHEM, V55, P4640, DOI 10.1021/jm300460c; Asano L, 2013, FEBS LETT, V587, P957, DOI 10.1016/j.febslet.2013.02.028; BRUMBAUG.PF, 1974, J BIOL CHEM, V249, P1251; Bury Y, 2000, MOL PHARMACOL, V58, P1067; Demizu Y, 2013, BIOORG MED CHEM LETT, V23, P4292, DOI 10.1016/j.bmcl.2013.06.002; Demizu Y., 2011, MED CHEM LETT, V21, P6104; Demizu Y, 2013, J ORG CHEM, V78, P12106, DOI 10.1021/jo402133e; Hosoda S., 2006, BIOORGAN MED CHEM, V14, P4327; Igarashi M, 2007, ARCH BIOCHEM BIOPHYS, V460, P240, DOI 10.1016/j.abb.2006.11.026; Imamura Y, 2013, J MED CHEM, V56, P1443, DOI 10.1021/jm301306c; Miura D, 1999, J BIOL CHEM, V274, P16392, DOI 10.1074/jbc.274.23.16392; Pathrose P, 2002, J BONE MINER RES, V17, P2196, DOI 10.1359/jbmr.2002.17.12.2196; Pike JW, 2003, J CELL BIOCHEM, V88, P252, DOI 10.1002/jcb.10326; Sawada D, 2011, J AM CHEM SOC, V133, P7215, DOI 10.1021/ja201481j; Zella LA, 2007, ARCH BIOCHEM BIOPHYS, V460, P206, DOI 10.1016/j.abb.2006.12.016	42	2	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	MAR 1	2015	23	5					1055	1061		10.1016/j.bmc.2015.01.007		7	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CB9QL	WOS:000349966700014		
J	Sakudo, A; Chou, H; Nagatsu, M				Sakudo, Akikazu; Chou, Han; Nagatsu, Masaaki			Antibody-integrated and functionalized graphite-encapsulated magnetic beads, produced using ammonia gas plasma technology, for capturing Salmonella	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Salmonella; Capture; Gas plasma; Amino group; Magnetic beads	MALEIC ANHYDRIDE)-COATED BEADS; ANIONIC POLYMER; RAPID DETECTION; IMMUNOCHROMATOGRAPHIC ASSAY; STRIP ASSAY; VIRUS; NANOPARTICLES; TYPHIMURIUM; SAMPLES; MEAT	Salmonella spp. is the single and most important causative agent of foodborne infections, especially involving foods such as eggs, milk and meat. To prevent infection, a reliable surveillance system is required that can quickly and sensitively detect Salmonella. Here, we describe the development of antibody-integrated magnetic beads that are functionalized by a novel strategy using ammonia gas plasma. Ammonia plasma, produced by a radio frequency (RF) power supply, was allowed to react with the surface of graphite-encapsulated magnetic beads, resulting in the introduction of amino groups. An anti-Salmonella antibody was then anchored by sulfide groups present on the protein surface to the amino groups of the magnetic beads via N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP). The potential usefulness of these magnetic beads for capturing Salmonella was examined as follows. The beads were incubated with Salmonella in liquid medium and then separated from the supernatant by applying a magnetic field. After thorough washing, adsorption of Salmonella to the beads was confirmed by immunochromatography, polymerase chain reaction and a direct culture assay. Our findings indicate that the capture and concentration of Salmonella using the antibody-integrated magnetic beads was more efficient than commercial Dynabeads (R) anti-Salmonella, which are conventionally used for concentrating Salmonella from liquid cultures. We believe this novel bead technology will contribute to the enhanced detection of Salmonella. (C) 2015 Elsevier Ltd. All rights reserved.	[Sakudo, Akikazu] Univ Ryukyus, Fac Med, Sch Hlth Sci, Lab Biometab Chem, Nishihara, Okinawa 9030215, Japan; [Chou, Han; Nagatsu, Masaaki] Shizuoka Univ, Grad Sch Engn, Naka Ku, Hamamatsu, Shizuoka 4328011, Japan; [Nagatsu, Masaaki] Shizuoka Univ, Grad Sch Sci & Technol, Naka Ku, Hamamatsu, Shizuoka 4328011, Japan	Sakudo, A (reprint author), Univ Ryukyus, Fac Med, Sch Hlth Sci, Lab Biometab Chem, 207 Uehara, Nishihara, Okinawa 9030215, Japan.	sakudo@med.u-ryukyu.ac.jp			Bio-oriented Technology Research Advancement Institution (BRAIN); Takahashi Industrial and Economic Research Foundation; Kieikai Research Foundation; Japan Society for the Promotion of Science [21110010, 22110514, 24110717]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry	This work was supported by a Grant-in-Aid for the Promotion of Basic Research Activities for Innovative Biosciences from Bio-oriented Technology Research Advancement Institution (BRAIN) and a Grant-in-Aid from Takahashi Industrial and Economic Research Foundation and Kieikai Research Foundation as well as a Grant-in-Aid for Scientific Research on Innovative Areas (No. 21110010, 22110514, and 24110717) from the Japan Society for the Promotion of Science and a Grant-in-Aid from Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry.	de Freitas CG, 2010, INT J FOOD MICROBIOL, V139, P15, DOI 10.1016/j.ijfoodmicro.2010.02.007; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Pathmanathan SG, 2003, J MED MICROBIOL, V52, P773, DOI 10.1099/jmm.0.05188-0; Shukla S, 2014, CAN J MICROBIOL, V60, P399, DOI 10.1139/cjm-2014-0223; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Kawasaki S, 2009, FOODBORNE PATHOG DIS, V6, P81, DOI 10.1089/fpd.2008.0153; Preechakasedkit P, 2012, BIOSENS BIOELECTRON, V31, P562, DOI 10.1016/j.bios.2011.10.031; Perfezou M, 2012, CHEM SOC REV, V41, P2606, DOI 10.1039/c1cs15134g; Nyachuba DG, 2010, NUTR REV, V68, P257, DOI 10.1111/j.1753-4887.2010.00286.x; [Anonymous], 2002, MICR FOOD AN FEED ST; Merkoci A, 2005, TRAC-TREND ANAL CHEM, V24, P341, DOI 10.1016/j.trac.2004.11.007; Fukuda S, 2005, LETT APPL MICROBIOL, V41, P379, DOI 10.1111/j.1472-765X.2005.01783.x; Gould LH, 2013, MMWR SURVEILL SUMM, V62, P1; Ellingson JLE, 2004, MOL CELL PROBE, V18, P51, DOI 10.1016/j.mcp.2003.09.007; Nagatsu M, 2006, CARBON, V44, P3336, DOI 10.1016/j.carbon.2006.06.005; Paek SH, 2000, METHODS, V22, P53, DOI 10.1006/meth.2000.1036; Bautista DA, 2002, J VET DIAGN INVEST, V14, P427; Ekperigin HE, 1998, VET CLIN N AM-FOOD A, V14, P17; Huang HS, 1999, INT J FOOD MICROBIOL, V51, P85, DOI 10.1016/S0168-1605(99)00102-6; ICMSF, 2002, MICR FOODS 7 MICR TE; Moongkarndi P, 2011, J VET DIAGN INVEST, V23, P797, DOI 10.1177/1040638711408063; de la Escosura-Muniz Alfredo, 2010, Materials Today, V13, DOI 10.1016/S1369-7021(10)70125-5; Porter R.S., OVERVIEW GASTROENTER; SAITO Y, 1993, CHEM PHYS LETT, V212, P379, DOI 10.1016/0009-2614(93)89341-E; Sakudo A, 2009, BIOORG MED CHEM LETT, V19, P4488, DOI 10.1016/j.bmcl.2009.05.127; Sakudo A, 2011, INT J MOL MED, V28, P625, DOI 10.3892/ijmm.2011.733; Sakudo A, 2008, BIOCHEM BIOPH RES CO, V377, P85, DOI 10.1016/j.bbrc.2008.09.083; Sakudo A, 2009, BIOORGAN MED CHEM, V17, P752, DOI 10.1016/j.bmc.2008.11.046; Sakudo A, 2012, INT J MOL MED, V30, P3, DOI 10.3892/ijmm.2012.962; Saraswati TE, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.010205; Saraswati TE, 2012, CARBON, V50, P1253, DOI 10.1016/j.carbon.2011.10.044; Shaw SJ, 1998, J FOOD PROTECT, V61, P1507	32	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	MAR 1	2015	25	5					1012	1016		10.1016/j.bmcl.2015.01.031		5	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CB7UK	WOS:000349833400004		
J	Fukunaga, K; Sakai, D; Watanabe, K; Nakayama, K; Kohara, T; Tanaka, H; Sunada, S; Nabeno, M; Okamoto, M; Saito, K; Eguchi, J; Mori, A; Tanaka, S; Inazawa, K; Horikawa, T				Fukunaga, Kenji; Sakai, Daiki; Watanabe, Kazutoshi; Nakayama, Kazuki; Kohara, Toshiyuki; Tanaka, Hiroshi; Sunada, Shinji; Nabeno, Mika; Okamoto, Masako; Saito, Ken-Ichi; Eguchi, Jun-ichi; Mori, Akiko; Tanaka, Shinji; Inazawa, Keiko; Horikawa, Takashi			Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)pyrimidin-4(3H)-ones as orally-active GSK-3 beta inhibitors for Alzheimer's disease	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Glycogen synthase kinase 3 beta; Alzheimer's disease; Alkylmorpholine	DRUG DISCOVERY; LIGAND EFFICIENCY	We herein describe the results of further evolution of GSK-3 beta inhibitors for Alzheimer's disease from our promising compounds with in vivo tau phosphorylation inhibitory activity by oral administration. Introduction of a low alkyl group instead of the phenyl group at the 3-position of the morpholine moiety aiming to improve pharmacokinetic profiles resulted in potent low molecular weight GSK-3 beta inhibitors with good in vitro pharmacokinetic profiles, which also showed in vivo tau phosphorylation inhibitory activity by oral administration. Effect of the stereochemistry of the alkyl moiety is also discussed using docking models. (C) 2015 Elsevier Ltd. All rights reserved.	[Fukunaga, Kenji; Sakai, Daiki; Watanabe, Kazutoshi; Nakayama, Kazuki; Kohara, Toshiyuki; Tanaka, Hiroshi; Sunada, Shinji; Nabeno, Mika; Okamoto, Masako; Saito, Ken-Ichi; Eguchi, Jun-ichi; Mori, Akiko; Tanaka, Shinji; Inazawa, Keiko; Horikawa, Takashi] Mitsubishi Tanabe Pharma Corp, Div Res, Aoba Ku, Yokohama, Kanagawa 2270033, Japan	Watanabe, K (reprint author), Mitsubishi Tanabe Pharma Corp, Div Res, 2-2-50 Kawagishi, Toda, Saitama 3358505, Japan.						Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; MANSOUR TS, 1990, SYNTHETIC COMMUN, V20, P773, DOI 10.1080/00397919008052321; Leung CS, 2012, J MED CHEM, V55, P4489, DOI 10.1021/jm3003697; Hopkins AL, 2014, NAT REV DRUG DISCOV, V13, P105, DOI 10.1038/nrd4163; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; Ritchie TJ, 2009, DRUG DISCOV TODAY, V14, P1011, DOI 10.1016/j.drudis.2009.07.014; GIANNIS A, 1989, ANGEW CHEM INT EDIT, V28, P218, DOI 10.1002/anie.198902181; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Fukunaga K, 2013, BIOORG MED CHEM LETT, V23, P6933, DOI 10.1016/j.bmcl.2013.09.020; Schonherr H, 2013, ANGEW CHEM INT EDIT, V52, P12256, DOI 10.1002/anie.201303207; OLOFSON RA, 1984, J ORG CHEM, V49, P2081, DOI 10.1021/jo00185a072; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Cappell J, 2010, CNS DRUGS, V24, P909, DOI 10.2165/11539530-000000000-00000; Link J., COMMUNICATION; Liu H.-C., 2012, J EXP CLIN MED, V4, P135; OVERMAN LE, 1985, J ORG CHEM, V50, P4154, DOI 10.1021/jo00221a036	16	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	MAR 1	2015	25	5					1086	1091		10.1016/j.bmcl.2015.01.005		6	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CB7UK	WOS:000349833400020		
J	Kurono, S; Kaneko, Y; Matsuura, S; Niwayama, S				Kurono, Sadamu; Kaneko, Yuka; Matsuura, Shuji; Niwayama, Satomi			Quantification of proteins using C-13(7)-labeled and unlabeled iodoacetanilide by nano liquid chromatography/nanoelectrospray ionization and by selected reaction monitoring mass spectrometry	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Quantitative analysis; Proteomics; Selected reaction monitoring (SRM); Stable isotope labeling; Cysteine modifiers	LASER-DESORPTION/IONIZATION-TIME; QUANTITATIVE PROTEOME ANALYSIS; BIOMARKER DISCOVERY; N-ETHYLMALEIMIDE; C-13-LABELED IODOACETANILIDE; PEPTIDE ANALYSIS; ION-TRAP; IDENTIFICATION; VERIFICATION; STRATEGY	The combination of cysteine-specific modifiers, iodoacetanilide (IAA) and C-13(7)-labeled iodoacetanilide (C-13(7)-IAA), has been applied to absolute quantification of proteins. The selected reaction monitoring (SRM) with the use of nano liquid chromatography/nanoelectrospray ionization ion trap mass spectrometry (nano LC/nano-ESI-IT-MS) analysis was applied to precise quantification of three commercial proteins. Good correlation was observed between the theoretical ratios and observed ratios for all these proteins both in a simple buffer solution and in a complex protein environment. Due to efficient tagging, this method does not require separate synthesis of isotope-labeled peptides for the SRM studies. Therefore, this method is expected to be a useful tool for proteomics research. (C) 2015 Elsevier Ltd. All rights reserved.	[Kurono, Sadamu; Kaneko, Yuka; Matsuura, Shuji] Osaka Univ, Grad Sch Med, Div Hlth Sci, Lab Mol Signature Anal, Suita, Osaka 5650871, Japan; [Kurono, Sadamu; Kaneko, Yuka] Wako Pure Chem Ind Ltd, Lab Chem Div, Osaka 5408605, Japan; [Niwayama, Satomi] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Niwayama, Satomi] Texas Tech Univ, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Lubbock, TX 79430 USA	Niwayama, S (reprint author), Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA.	satomi.niwayama@ttu.edu	Niwayama, Satomi/O-1598-2015	Niwayama, Satomi/0000-0001-6385-5274	JSPS KAKENHI [22501030]; Texas Tech University-Texas Tech University Health Sciences Center Joint Initiative Grant	We are grateful to Dr. Nariaki Matsuura (Osaka University) for giving us technical advice and valuable discussion. We thank Dr. Yasuhiro Tamaki (Osaka University) for giving us the ND sample. We also thank Dr. Hanjoung Cho (Texas Tech University) for synthesizing IAA (1) and <SUP>13</SUP>C<INF>7</INF>-IAA (2). This work was supported by JSPS KAKENHI (22501030) and the Texas Tech University-Texas Tech University Health Sciences Center Joint Initiative Grant.	de Graaf EL, 2011, J PROTEOME RES, V10, P4334, DOI 10.1021/pr200156b; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/nmeth.2015, 10.1038/NMETH.2015]; Kurono S, 2006, BIOORGAN MED CHEM, V14, P8197, DOI 10.1016/j.bmc.2006.09.023; Bouchal P, 2009, J PROTEOME RES, V8, P362, DOI 10.1021/pr800622b; Zabet-Moghaddam M, 2012, J MASS SPECTROM, V47, P1546, DOI 10.1002/jms.3093; Muraoka S, 2012, J PROTEOME RES, V11, P4201, DOI 10.1021/pr300322q; Kaur P, 2012, J PROTEOME RES, V11, P5527, DOI [10.1021/pr300798z, 10.1021/pr300798z1]; Smith L, 2009, NEOPLASIA, V11, P1194, DOI 10.1593/neo.09902; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Matsuo E, 2006, PROTEOMICS, V6, P2042, DOI 10.1002/pmic.200500575; Niwayama S, 2001, BIOORG MED CHEM LETT, V11, P2257, DOI 10.1016/S0960-894X(01)00452-8; Kuyama H, 2003, RAPID COMMUN MASS SP, V17, P1642, DOI 10.1002/rcm.1100; Ou K, 2006, J PROTEOME RES, V5, P2194, DOI 10.1021/pr060115n; Boja ES, 2012, PROTEOMICS, V12, P1093, DOI 10.1002/pmic.201100387; Murphy JP, 2010, PROTEOMICS, V10, P1847, DOI 10.1002/pmic.200900711; Sutton CW, 2010, J PROTEOME RES, V9, P3891, DOI 10.1021/pr100113a; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Kang UB, 2010, J PROTEOME RES, V9, P3750, DOI 10.1021/pr9011014; Kurono S, 2013, BIOORG MED CHEM LETT, V23, P3111, DOI 10.1016/j.bmcl.2013.02.112; Matsuo E, 2009, J CHROMATOGR B, V877, P2607, DOI 10.1016/j.jchromb.2009.05.049; Niwayama S., 2006, BIOORG MED CHEM LETT, V16, P5054; Niwayama S, 2003, BIOORG MED CHEM LETT, V13, P2913, DOI 10.1016/S0960-894X(03)00503-1; Niwayama S, 2009, BIOORG MED CHEM LETT, V19, P5698, DOI 10.1016/j.bmcl.2009.08.011; Watanabe M, 2008, PROTEOM CLIN APPL, V2, P925, DOI 10.1002/prca.200780111; Zabet-Moghaddam M, 2008, BIOORG MED CHEM LETT, V18, P4891, DOI 10.1016/j.bmcl.2008.07.069	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	MAR 1	2015	25	5					1110	1116		10.1016/j.bmcl.2014.12.090		7	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CB7UK	WOS:000349833400024		
J	Yong, DL; Liu, Y; Low, BW; Espanola, CP; Choi, CY; Kawakami, K				Yong, Ding Li; Liu, Yang; Low, Bing Wen; Espanola, Carmela P.; Choi, Chang-Yong; Kawakami, Kazuto			Migratory songbirds in the East Asian-Australasian Flyway: a review from a conservation perspective	BIRD CONSERVATION INTERNATIONAL			English	Article							BIRD MIGRATION; MIGRANT BIRDS; HABITAT USE; LONG-TERM; POPULATION LIMITATION; AFFECT BIODIVERSITY; STOPOVER HABITAT; YUNNAN PROVINCE; SOUTHEAST-ASIA; UNITED-STATES	The East Asian-Australasian Flyway supports the greatest diversity and populations of migratory birds globally, as well as the highest number of threatened migratory species of any flyway, including passerines (15 species). However it is also one of the most poorly understood migration systems, and little is known about the populations and ecology of the passerine migrants that breed, stop over and winter in the habitats along this flyway. We provide the first flyway-wide review of diversity, ecology, and conservation issues relating to 170 species of long-distance and over 80 short-distance migrants from 32 families. Recent studies of songbird migration movements and ecology is limited, and is skewed towards East Asia, particularly Mainland China, Taiwan, Russia, Japan and South Korea. Strong evidence of declines exists for some species, e. g. Yellow-breasted Bunting Emberiza aureola, but tends to be fragmentary, localised or anecdotal for many others. More species have small breeding ranges (< 250,000 km(2)) and/or are dependent on tropical forests as wintering habitat than those in any other Eurasian migratory system, and are thus more vulnerable to habitat loss and degradation throughout their ranges. Poorly regulated hunting for food and the pet trade, invasive species and collisions with man-made structures further threaten migratory songbirds at a number of stop-over or wintering sites, while climate change and habitat loss may be of increasing concern in the breeding ranges. A key conservation priority is to carry out intensive field surveys across the region while simultaneously tapping into citizen science datasets, to identify important stop-over and wintering sites, particularly for poorly-known or globally threatened species across South-East Asia and southern China for targeted conservation actions. Additionally, the advent of miniaturised tracking technology, molecular and isotopic techniques can provide novel insights into migration connectivity, paths and ecology for species in this migration system, complementing data from banding exercises and observation-based surveys, and could prove useful in informing conservation priorities. However, until most states along the East Asian-Australasian flyway ratify the Convention on the Conservation of Migratory Species of Wild Animals (CMS) and other cross-boundary treaties, the relative lack of cross-boundary cooperation, coordination and information sharing in the region will continue to present a stumbling block for effective conservation of migratory passerines.	[Yong, Ding Li] Australian Natl Univ, Fenner Sch Environm & Soc, Acton, ACT 2601, Australia; [Liu, Yang] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yang] Sun Yat Sen Univ, Coll Ecol & Evolut, Guangzhou 510275, Guangdong, Peoples R China; [Yong, Ding Li; Low, Bing Wen] Southeast Asian Biodivers Soc, Singapore 680504, Singapore; [Espanola, Carmela P.] Univ Philippines, Coll Sci, Inst Biol, Quezon City 1101, Metro Manila, Philippines; [Choi, Chang-Yong] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Kawakami, Kazuto] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan	Yong, DL (reprint author), Australian Natl Univ, Fenner Sch Environm & Soc, Linnaeus Way, Acton, ACT 2601, Australia.	ding.li@anu.edu.au		Yong, Ding Li/0000-0003-3115-6916			ABE N, 1982, Journal of the Yamashina Institute for Ornithology, V14, P59; Alonzo-Pasicolan S., 1992, ORIENTAL BIRD CLUB B, V15, P33; Alstrom P, 2011, IBIS, V153, P395, DOI 10.1111/j.1474-919X.2011.01116.x; Anderson P. K., 2011, BIODIVERSITY, V4, P10; Bauer S, 2014, SCIENCE, V344, P54, DOI 10.1126/science.1242552; Sheehy J, 2011, J ORNITHOL, V152, P161, DOI 10.1007/s10336-011-0682-5; Amano T, 2010, BIOL CONSERV, V143, P2238, DOI 10.1016/j.biocon.2010.06.010; Sutherland WJ, 1996, P ROY SOC B-BIOL SCI, V263, P1325, DOI 10.1098/rspb.1996.0194; Zhou DQ, 2012, LANDSCAPE URBAN PLAN, V108, P91, DOI 10.1016/j.landurbplan.2012.08.004; Laaksonen T, 2013, BIOL CONSERV, V168, P99, DOI 10.1016/j.biocon.2013.09.007; Newton I, 2004, IBIS, V146, P197, DOI 10.1111/j.1474-919X.2004.00293.x; Loss SR, 2014, CONDOR, V116, P8, DOI 10.1650/CONDOR-13-090.1; BAIRLEIN F, 1985, OECOLOGIA, V66, P141, DOI 10.1007/BF00378566; McKinnon EA, 2013, AUK, V130, P211, DOI 10.1525/auk.2013.12226; Amano T, 2007, BIOL CONSERV, V137, P271, DOI 10.1016/j.biocon.2007.02.010; Vickery JA, 2014, IBIS, V156, P1, DOI 10.1111/ibi.12118; Sodhi NS, 2010, BIODIVERS CONSERV, V19, P317, DOI 10.1007/s10531-009-9607-5; Alerstam T, 2008, AUK, V125, P831, DOI 10.1525/auk.2008.07142; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Dudgeon D, 2000, BIOSCIENCE, V50, P793, DOI 10.1641/0006-3568(2000)050[0793:LSHCIT]2.0.CO;2; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; PEARSON DJ, 1992, IBIS, V134, P89; [Anonymous], 2007, PRELIMINARY STUDY BI; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Ruth JM, 2012, CONDOR, V114, P698, DOI 10.1525/cond.2012.120020; Johnson MD, 2006, CONSERV BIOL, V20, P1433, DOI 10.1111/j.1523-1739.2006.00490.x; Fujioka M, 2010, WATERBIRDS, V33, P8, DOI 10.1675/063.033.s102; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Sherry TW, 1996, ECOLOGY, V77, P36, DOI 10.2307/2265652; Li HM, 2007, BIODIVERS CONSERV, V16, P1731, DOI 10.1007/s10531-006-9052-7; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Yamaura Y, 2009, ANIM CONSERV, V12, P110, DOI 10.1111/j.1469-1795.2008.00227.x; [Anonymous], 2012, CHINA DAILY; Bradshaw CJA, 2009, TRENDS ECOL EVOL, V24, P541, DOI 10.1016/j.tree.2009.03.019; Stafford JD, 2010, WATERBIRDS, V33, P133, DOI 10.1675/063.033.s110; Hahn S, 2009, OIKOS, V118, P624, DOI 10.1111/j.1600-0706.2009.17309.x; Corlett RT, 2007, BIOTROPICA, V39, P292, DOI 10.1111/j.1744-7429.2007.00271.x; Kwok HK, 2000, FOREST ECOL MANAG, V130, P227, DOI 10.1016/S0378-1127(99)00178-4; Ma ZJ, 2013, BIRD CONSERV INT, V23, P259, DOI 10.1017/S0959270912000378; Chen XW, 2003, FOREST ECOL MANAG, V177, P503, DOI 10.1016/S0378-1127(02)00455-3; ORNAT AL, 1990, AUK, V107, P539; Li XY, 2013, CHINESE SCI BULL, V58, P649, DOI 10.1007/s11434-012-5458-7; Askins R.A., 2000, RESTORING N AM BIRDS; Azman Nur Munira, 2011, Tropical Life Sciences Research, V22, P45; Bairlein Franz, 2009, Ringing & Migration, V24, P162; Bakewell D., 2007, APRIL 2 BUKIT MERTAJ; Bakewell D., 2013, CHUPING PERLIS  1119; Berthold P, 1993, BIRD MIGRATION GEN S; Bing G-C., 2012, KOREAN J ORNITHOL, V19, P23; Bird Conservation Society of Thailand, 2013, 12 THAIL BIRD FAIR 2; Bird JP, 2010, FORKTAIL, P1; Birdfair Asia, 2011, AS BIRD FAIR; BirdLife International, 2012, BIRDLIFE TAX CHECKL; BirdLife International, 2013, BIRDLIFE DAT ZON; Boere G.C., 2006, WATERBIRDS WORLD, P40; Bolshakov C. V., 2001, ACHIEVEMENTS PROBLEM, P372; Brazil M., 2009, BIRDS OF E ASIA; Bruderer B, 1997, NATURWISSENSCHAFTEN, V84, P45, DOI 10.1007/s001140050348; Butler R., 2009, YALE ENV, V360; Cao L, 2008, BIOL CONSERV, V141, P2301, DOI 10.1016/j.biocon.2008.06.022; Cao L, 2008, WATERBIRDS, V31, P645; Carey G. J., 2001, AVIFAUNA HONG KONG; Chabot AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043627; Chan Simba, 2004, BirdingASIA, V1, P16; Chasen F. N., 1932, Bulletin of the Raffles Museum Singapore, V7, P3; Chen S., 2009, CHINA DAILY; Cheng MC, 2010, AVIAN DIS, V54, P109, DOI 10.1637/8960-061709-Reg.1; Chernetsov N., 2012, PASSERINE MIGRATION; China Ornithologists' Society, 2008, CHIN BIRD REP; Choi C-Y, 2004, KOREAN J ORNITHOL, V11, P95; Choi Y-S., 2013, KOREAN J ORNITHOL, V20, P49; Coates B. J., 2001, BIRDS NEW GUINEA BIS; Coates BJ, 1997, GUIDE BIRDS WALLACEA; Convention on Migratory Species, 2014, PART CONV CONS MIGR; Corlett R. T., 2009, ECOLOGY TROPICAL E A; Crosby Michael J., 2006, P332; Dale S, 2013, ORNIS FENNICA, V90, P193; Danhardt J, 2010, OIKOS, V119, P1114, DOI 10.1111/j.1600-0706.2009.18106.x; De Klemm C., 1994, GREEN GLOBE YB INT C, P67; Decandido Robert, 2004, Forktail, V20, P49; Dinata Y, 2008, BIRD CONSERV INT, V18, P30, DOI 10.1017/S0959270908000051; Dingle H, 2004, EMU, V104, P95, DOI 10.1071/MU03026; Dolnik V. R., 1987, STUDY BIRD MIGRATION; Du Min, 2006, Chinese Journal of Zoology, V41, P74; East Asian-Australasian Flyway Partnership, 2012, PARTN CONS MIGR WAT; ELLIS D H, 1990, Journal of Raptor Research, V24, P12; Emmanuel B., 2013, KUKILA INDONESIAN J, V17, P30; FAO (Food and Agriculture Organisation of the United Nations), 2005, FOR RES ASS 2005; Feng Y, 2012, CHINADIALOGUE   1010; Fransson T., 2007, FAGELARET 2006, P19; Gan XJ, 2010, AUK, V127, P317, DOI 10.1525/auk.2009.09147; Germi F., 2009, FORKTAIL, V25, P105; GIBSON-HILL C. A., 1950, BULL RAFFLES MUS, V23, P263; Gilbert M, 2012, BIOL CONSERV, V153, P10, DOI 10.1016/j.biocon.2012.04.024; Gill F., 2013, IOC WORLD BIRD LIST; Gluschenko Y. N., 2011, FAR E J ORNITHOL, V2, P8; Gluschenko Y. N., 2010, FAR E J ORNITHOL, V1, P3; Gombobaatar S., 2011, NATL U MONGOLIA REGI, V8; Greenberg R., 2005, BIRDS 2 WORLDS ECOLO; Greenwood Jeremy J. D., 2007, J ORNITHOL, V148, P77, DOI 10.1007/s10336-007-0239-9; Han Lian-xian, 2007, Zoological Research, V28, P35; Harris JBC, 2013, CLIM RES, V57, P133, DOI 10.3354/cr01172; Heim Wieland, 2012, Avian Ecology and Behaviour, V21, P27; Higuchi H, 2012, J ORNITHOL, V153, pS3, DOI 10.1007/s10336-011-0768-0; Higuchi Hiroyoshi, 2005, Ornithological Science, V4, P109, DOI 10.2326/osj.4.109; Higuchi H., 2013, JOURNEY BIRDS SATELL; Higuchi H., 1999, ACTINIA, V12, P51; Hirano Toshiaki, 1996, Strix, V14, P25; Holmes RT, 2007, IBIS, V149, P2, DOI 10.1111/j.1474-919X.2007.00685.x; Hong Gil-Pyo, 2010, Journal of the Yamashina Institute for Ornithology, V41, P200; Huppop O, 2006, IBIS, V148, P90, DOI 10.1111/j.1474-919X.2006.00536.x; Imanishi Sadao, 2009, Journal of the Yamashina Institute for Ornithology, V40, P96; Iqbal M., 2014, KUKILA J INDONESIAN, V17, P68; Irwin D. E., 2005, BIRDS 2 WORLDS ECOLO, P28; IUCN-WCPA, 2011, PROT AR E AS EV STRE; Jeyarajasingham A., 2012, FIELD GUIDE BIRDS PE; KARR JR, 1976, WILSON BULL, V88, P433; Kennedy R.S, 2000, GUIDE BIRDS PHILIPPI; Kim D-W., 2010, KOREAN J ORNITHOL, V17, P179; Kim D-W, 2009, KOREAN J ORNITHOL, V16, P93; Kim EM, 2013, FORKTAIL, P145; Kirby J. S., 2010, REVIEW; Kirby JS, 2008, BIRD CONSERV INT, V18, P49; Knystautas A., 1993, COLLINS GUIDE BIRDS; Koike S, 2002, IBIS, V144, P150, DOI 10.1046/j.0019-1019.2001.00008.x; Komeda Shigemoto, 2002, Journal of the Yamashina Institute for Ornithology, V34, P96; Kondrashov LG, 2004, FOREST ECOL MANAG, V201, P65, DOI 10.1016/j.foreco.2004.06.012; Kuo YL, 2013, NATURWISSENSCHAFTEN, V100, P729, DOI 10.1007/s00114-013-1069-7; Kuroda N., 1971, J YAMASHINA I ORNITH, V6, P260; Kurosawa R, 2003, CONSERV BIOL, V17, P695, DOI 10.1046/j.1523-1739.2003.01118.x; Kwon Y-S., 2007, KOREAN J ORNITHOL, V14, P51; Leader PJ, 2012, FORKTAIL, P121; Li J., 2012, S CHINA MORNING 1028; Li J., 2013, S CHINA MORNING 1123; Liang W, 2013, BIRD CONSERV INT, V23, P45, DOI 10.1017/S0959270911000499; Lim K. C., 2009, STATE SINGAPORES WIL; Linkie M, 2004, BIODIVERS CONSERV, V13, P1809, DOI 10.1023/B:BIOC.0000035867.90891.ea; Liu Y, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.46; Lobkov E. G., 2011, FAR E J ORN, V2, P27; Low B. W., BIRD BUILDING UNPUB; Luo ST, 2014, ECOL EVOL, V4, P977, DOI 10.1002/ece3.967; Ma Zhi-Jun, 2005, Acta Ecologica Sinica, V25, P1404; Ma ZJ, 2007, ECOL RES, V22, P115, DOI 10.1007/s11284-006-0193-7; MacKinnon J., 1993, FIELD GUIDE BIRDS BO; MacKinnon J., 2005, GIS ASSESSMENT STATU; MacKinnon J R, 2000, FIELD GUIDE BIRDS CH; Mahood S. P., 2013, FORKTAIL, V29, P20; Mahood Simon P., 2013, BirdingASIA, V19, P43; Malhi Y, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0312; McClure H. E., 1973, SOME ECTOPARASITES B; McClure H. E., 1971, NATURAL HIST B SIAM, V24, P41; McClure H. E, 1974, MIGRATION SURVIVAL B; MCCLURE HE, 1967, WILSON BULL, V79, P131; MCCULLOCH MN, 1992, IBIS, V134, P55; MEDWAY L, 1970, IBIS, V112, P184, DOI 10.1111/j.1474-919X.1970.tb00092.x; Miettinen J., 2010, GLOBAL CHANGE BIOL, V17, P2261; Mizuta Taku, 2009, Journal of the Yamashina Institute for Ornithology, V41, P65; Moores N., 2013, FOR BIRD WORKSH MARC; Moores N., 2012, THESIS U NEWCASTLE; Moreau R. E, 1972, PALEARCTIC AFRICAN B; MOREL GJ, 1992, IBIS, V134, P83; Nakamura T., 1965, J YAMASHINA I ORNITH, V4, P217; Nam HY, 2011, IBIS, V153, P494; Nash SV, 1993, SOLD SONG TRADE SE A; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; NISBET I C T, 1972, Ibis, V114, P451, DOI 10.1111/j.1474-919X.1972.tb00850.x; Ogden LJE, 1996, COLLISION COURSE HAZ; Ozaki K., 2008, P 2 INT S MIGR BIRDS, P53; Park J-G., 2008, KOREA TELECOMMUNICAT, V15, P1; Pronkevich V.V., 2011, Amurskii Zoologicheskii Zhurnal, V3, P64; Pronkevich V. V., 2007, 3 INT C MIGR BIRDS P, P66; Rappole J. H., 1983, NEARCTIC AVIAN MIGRA; Rappole JH, 2003, ECOL APPL, V13, P735, DOI 10.1890/1051-0761(2003)013[0735:WVBLFA]2.0.CO;2; Rasmussen PC, 2005, BIRDS S ASIA RIPLEY, V2; Rich C., 2005, ECOLOGICAL CONSEQUEN; Robson C, 2000, GUIDE BIRDS SE ASIA; Round Philip D., 2003, Ringing & Migration, V21, P215; Round PD, 2009, FORKTAIL, P159; Round PD, 2007, J AVIAN BIOL, V38, P133, DOI 10.1111/j.2007.0908-8857.04064.x; Round Philip D., 2011, Natural History Bulletin of the Siam Society, V57, P57; Round PD, 2010, FORKTAIL, P24; Sabah Wildlife Department, 2004, PROT SPEC; Salovarov V. O., 2006, BIOL BULL, V33, P248; Sam V., 1999, SURVEY SARUS C UNPUB; Severinghaus LL, 1999, BIOL CONSERV, V89, P301, DOI 10.1016/S0006-3207(98)00155-4; Severinghaus LL, 1996, IBIS, V138, P460, DOI 10.1111/j.1474-919X.1996.tb08065.x; Shepherd CR, 2004, OPEN SEASON ANAL PET; Shepherd Chris R., 2006, BirdingASIA, V5, P16; Sherry Thomas W., 1995, P85; Shiu Hau-Jie, 2006, Ornithological Science, V5, P151, DOI 10.2326/osj.5.151; Shiu Hau-Jie, 2003, Acta Zoologica Taiwanica, V14, P1; Simpson D.M., 1983, Sea Swallow, V32, P48; Simpson D.M., 1983, Sea Swallow, V32, P82; Sivay MV, 2012, AVIAN DIS, V56, P456, DOI 10.1637/9868-080111-Reg.1; Sodhi N. S., 2006, WINGED INVADERS PEST; Song G., 2013, J ORNITHOL, V155, P347; Tang W., 2003, J HUNAN POLYTECHN EN, V9, P29; Tordoff A. W., 2007, Natural History Bulletin of the Siam Society, V55, P235; Townsend T., 2012, ILLEGAL MIST NETS CH; Townsend T., 2013, BEIJINGS WILD BIRD M; U.S. Fish and Wildlife Service, 2014, US JAP MIGR BIRDS CO; Valchuk Olga, 2005, Alauda, V73, P323; Valchuk O., 2006, MORPHOMETRIC DATA AV; Valencia Mark J., 2007, ASIAN PERSPECT, V31, P127; Wang Ning, 2006, Journal of Beijing Normal University (Natural Science), V42, P295; Wang Y., 1998, AUK, V115, P829; Wang Yong, 2006, Acta Ecologica Sinica, V26, P638, DOI 10.1016/S1872-2032(06)60011-5; Wells D. R., 2006, BIRDS THAI MALAY PEN, V2; Won I-J., 2010, J NAT PARK RES, V1, P29; WON P.O., 1966, J YAMASHINA I ORNITH, V8, P405; Wong T.S., 2014, SNAP SHOT CAGED BIRD; Wood C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001220; Xiao F. Z., 2005, JIANGXI FORESTRY SCI, V3, P8; Xie WJ, 2013, ACTA OCEANOL SIN, V32, P81, DOI 10.1007/s13131-013-0280-x; Yamamoto Yutaka, 1997, Strix, V15, P15; Yanagawa Hisashi, 1998, Research Bulletin of Obihiro University Natural Science, V20, P253; Yang Ting, 2009, Zoological Research, V30, P411, DOI 10.3724/SP.J.1141.2009.04411; YAP F, 2014, BIRDINGASIA      JUN, P76; Yong D. L., 2013, NATURE WATCH, V21, P3; Yong D. L., FORKTAIL IN PRESS; Yong D. L., 2013, NATURALISTS GUIDE BI; YOSHII M, 1989, Journal of the Yamashina Institute for Ornithology, V21, P309; Yu Y. T., 2013, INT BLACK FACED SPOO; Zhao X. M., 2006, BIRD MIGRATION BIRD	224	2	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0959-2709	1474-0001		BIRD CONSERV INT	Bird Conserv. Int.	MAR	2015	25	1					1	37		10.1017/S0959270914000276		37	Ornithology	Zoology	CB6UQ	WOS:000349762600001		
J	Yamashiro, K; Sato, D; Onishi, H; Sugawara, K; Nakazawa, S; Kameyama, S; Maruyama, A				Yamashiro, Koya; Sato, Daisuke; Onishi, Hideaki; Sugawara, Kazuhiro; Nakazawa, Sho; Kameyama, Shigeki; Maruyama, Atsuo			Effect of Changes in Stimulus Site on Activation of the Posterior Parietal Cortex	BRAIN TOPOGRAPHY			English	Article						PPC; BESA; M80	SOMATOSENSORY MISMATCH-NEGATIVITY; MEDIAN NERVE-STIMULATION; CORTICAL NETWORK; RESPONSES; HUMANS; ATTENTION; DISCRIMINATION; RECORDINGS; RESOLUTION; LOCATION	A previous functional magnetic resonance imaging study elucidated the specific activity of the inferior parietal lobe (IPL) during a two-point discrimination task compared with that during an intensity discrimination task Akatsuka et al. (Neuroimage 40: 852-858, 2008). If the posterior parietal cortex (PPC), including IPL, is responsible for detecting changes in stimulus sites, PPC activity depends on the level of change at stimulus sites. The aim of this study was to clarify whether a particular site exists that could detect changes in stimulus sites using the oddball paradigm. Somatosensory-evoked magnetic fields were recorded in 10 right-handed subjects. Three oddball conditions were performed by all subjects, with the probability of deviant and standard stimuli being 20 and 80 %, respectively, under all three conditions. Deviant stimuli were always presented to the second digit of the hand and standard stimuli were presented to the first (small deviance: SD) and fifth digits (medium deviance: MD) of the hand and the first digit of the toe (large deviance: LD). Inter-stimulus intervals were set at 500 ms. A brain electrical source analysis showed that activities of areas 1 and 3b elicited by the deviant stimuli were not significantly different among the three conditions. In contrast, PPC activity was significantly greater for LD than for SD and MD. PPC activity tended to increase with greater deviance at stimulus sites, but activities of areas 1 and 3b did not differ. These findings suggest that PPC may have a functional role in automatic change detection systems with regard to deviance of stimulus sites.	[Yamashiro, Koya; Sato, Daisuke; Onishi, Hideaki; Sugawara, Kazuhiro; Nakazawa, Sho; Maruyama, Atsuo] Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata 9503198, Japan; [Kameyama, Shigeki] Nishi Niigata Chuo Natl Hosp, Dept Neurosurg, Niigata, Japan	Yamashiro, K (reprint author), Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata 9503198, Japan.	yamashiro@nuhw.ac.jp			Japan Society for the Promotion of Science (JSPS); Niigata University of Health and Welfare	This study was supported by a Grant-in-aid for young scientists (B) from the Japan Society for the Promotion of Science (JSPS) and a Grant-in-aid for Advanced Research from Niigata University of Health and Welfare.	Akatsuka K, 2007, EXP BRAIN RES, V181, P607, DOI 10.1007/s00221-007-0958-4; Akatsuka K, 2005, CLIN NEUROPHYSIOL, V116, P1930, DOI 10.1016/j.clinph.2005.04.021; Akiyama LF, 2011, NEUROSCI LETT, V488, P183, DOI 10.1016/j.neulet.2010.11.025; ANDERSEN RA, 1995, CEREB CORTEX, V5, P457, DOI 10.1093/cercor/5.5.457; Inui K, 2004, CEREB CORTEX, V14, P851, DOI 10.1093/cercor/bhh043; Downar J, 2000, NAT NEUROSCI, V3, P277; Kertzman C, 1997, EXP BRAIN RES, V114, P170, DOI 10.1007/PL00005617; Waberski TD, 2002, NEUROIMAGE, V17, P1347, DOI 10.1006/nimg.2002.1222; Kekoni J, 1997, BIOL PSYCHOL, V46, P125, DOI 10.1016/S0301-0511(97)05249-6; Mauguiere F, 1997, EVOKED POTENTIAL, V104, P290, DOI 10.1016/S0013-4694(97)00018-7; Raij T, 1997, BRAIN RES, V745, P134, DOI 10.1016/S0006-8993(96)01140-7; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Shinozaki N, 1998, COGNITIVE BRAIN RES, V7, P165, DOI 10.1016/S0926-6410(98)00020-2; Sack AT, 2009, BEHAV BRAIN RES, V202, P153, DOI 10.1016/j.bbr.2009.03.012; Akatsuka K, 2008, NEUROIMAGE, V40, P852, DOI 10.1016/j.neuroimage.2007.12.013; Barba C, 2002, CLIN NEUROPHYSIOL, V113, P981, DOI 10.1016/S1388-2457(02)00104-9; Wegner K, 2000, CLIN NEUROPHYSIOL, V111, P894, DOI 10.1016/S1388-2457(99)00319-3; Downar J, 2003, NEUROIMAGE, V20, P1540, DOI 10.1016/S1053-8119(03)00407-5; Akatsuka K, 2007, CLIN NEUROPHYSIOL, V118, P403, DOI 10.1016/j.clinph.2006.09.030; Kida T, 2006, NEUROIMAGE, V32, P1355, DOI 10.1016/j.neuroimage.2006.05.015; Pazo-Alvarez P, 2003, BIOL PSYCHOL, V63, P199, DOI 10.1016/S0301-0511(03)00049-8; Restuccia D, 2007, BRAIN, V130, P276, DOI 10.1093/brain/awl236; Omori S, 2013, CLIN NEUROPHYSIOL, V124, P1422, DOI 10.1016/j.clinph.2013.01.006; FORSS N, 1995, BRAIN RES, V685, P68, DOI 10.1016/0006-8993(95)00424-O; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Wikstrom H, 1996, EVOKED POTENTIAL, V100, P479; Nishitani N, 2002, NEURON, V36, P1211, DOI 10.1016/S0896-6273(02)01089-9; Chen TL, 2008, NEUROIMAGE, V40, P1765, DOI 10.1016/j.neuroimage.2008.01.020; HARI R, 1988, ELECTROEN CLIN NEURO, V71, P64, DOI 10.1016/0168-5597(88)90020-2; Kida T, 2004, CLIN NEUROPHYSIOL, V115, P871, DOI 10.1016/j.clinph.2003.11.037; Kida T, 2007, J NEUROPHYSIOL, V97, P3585, DOI 10.1152/jn.00007.2007; Mauguiere F, 1997, EVOKED POTENTIAL, V104, P281, DOI 10.1016/S0013-4694(97)00006-0; Nakata H, 2008, NEUROIMAGE, V42, P858, DOI 10.1016/j.neuroimage.2008.05.017; Otsuru N, 2011, NEUROSCIENCE, V182, P115, DOI 10.1016/j.neuroscience.2011.03.019; Restuccia D, 2009, DEV MED CHILD NEUROL, V51, P991, DOI 10.1111/j.1469-8749.2009.03367.x; Spackman LA, 2007, EXP BRAIN RES, V177, P21, DOI 10.1007/s00221-006-0650-0; SUPEK S, 1993, IEEE T BIO-MED ENG, V40, P529, DOI 10.1109/10.237672	37	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0896-0267	1573-6792		BRAIN TOPOGR	Brain Topogr.	MAR	2015	28	2					261	268		10.1007/s10548-014-0378-2		8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CB8BM	WOS:000349853300007		
J	Ono, T; Tomita, Y; Inose, M; Ota, T; Kimura, A; Liu, MG; Ushiba, J				Ono, Takashi; Tomita, Yutaka; Inose, Manabu; Ota, Tetsuo; Kimura, Akio; Liu, Meigen; Ushiba, Junichi			Multimodal Sensory Feedback Associated with Motor Attempts Alters BOLD Responses to Paralyzed Hand Movement in Chronic Stroke Patients	BRAIN TOPOGRAPHY			English	Article						Hemiplegia; Motor related activity; BOLD-fMRI; Event-related desynchronization	BRAIN-COMPUTER INTERFACE; TRANSCRANIAL MAGNETIC STIMULATION; CORTICOSPINAL SYSTEM INTEGRITY; CORTICAL REORGANIZATION; SUBCORTICAL STROKE; COPENHAGEN STROKE; NEURAL MECHANISMS; FUNCTIONAL MRI; EEG-ANALYSIS; RECOVERY	Electroencephalogram-based brain-computer interfaces (BCI) have been used as a potential tool for training volitional regulation of corticomuscular drive in patients who have severe hemiplegia due to stroke. However, it is unclear whether ERD observed while attempting motor execution can be regarded as a neural marker that represents M1 excitability in survivors of severe stroke. Therefore we investigated the association between ERD and the blood-oxygen-level-dependent (BOLD) fMRI signal during attempted movement of a paralyzed finger in stroke patients. Nine chronic stroke patients received BCI training for finger extension movement 1 h daily for a duration of 1 month. The sensorimotor rhythm was recorded from the sensorimotor area of the damaged hemisphere, and ongoing amplitude variations were monitored using a BCI system. Either a visual alert or the action of a motor-driven orthosis was triggered in response to ERD of the sensorimotor rhythm while patients attempted extension movements of the paralyzed fingers. Inter-subject covariance between ERD and the BOLD response in the sensorimotor areas was calculated. After BCI training, an increased ERD over the damaged hemisphere was confirmed in all participants while they attempted extension of the affected finger and this increase was associated with a BOLD response in primary sensorimotor area. Whole-brain MRI revealed that the primary sensorimotor area and supplementary motor area were activated in the damaged hemisphere after 1 month of BCI training. ERD reflects the BOLD responses of the primary motor areas in either hemisphere while patients who have severe chronic hemiplegia due to a stroke attempt an extension movement of the paralyzed fingers. One month of BCI can alter motor-related brain area activation. Combining BCI with other methods to facilitate such changes may help to implement BCI for motor rehabilitation after stroke.	[Ono, Takashi; Ushiba, Junichi] Keio Univ, Grad Sch Sci & Technol, Minato, Kanagawa, Japan; [Ono, Takashi] Saiseikai Kanagawa Prefecture Hosp, Yokohama, Kanagawa, Japan; [Tomita, Yutaka; Ushiba, Junichi] Keio Univ, Dept Biosci & Informat, Fac Sci & Technol, Minato, Kanagawa, Japan; [Tomita, Yutaka; Inose, Manabu; Ota, Tetsuo; Kimura, Akio] Keio Univ, Dept Rehabil Med, Tsukigase Rehabil Ctr, Shizuoka, Japan; [Tomita, Yutaka; Liu, Meigen] Keio Univ, Sch Med, Dept Rehabil Med, Tokyo, Japan	Ushiba, J (reprint author), Keio Univ, Dept Biosci & Informat, Fac Sci & Technol, Minato, Kanagawa, Japan.	ushiba@bio.keio.ac.jp			Strategic Research Program for Brain Sciences (SRPBS) of the Ministry of Education, Culture, Sports, Science, and Technology, Japan	This study was partially supported by the Strategic Research Program for Brain Sciences (SRPBS) of the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Ward NS, 2006, BRAIN, V129, P809, DOI 10.1093/brain/awl002; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P406, DOI 10.1016/S0003-9993(95)80568-0; Ward NS, 2007, EUR J NEUROSCI, V25, P1865, DOI 10.1111/j.1460-9568.2007.05434.x; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Caria A, 2011, PSYCHOPHYSIOLOGY, V48, P578, DOI 10.1111/j.1469-8986.2010.01117.x; Platz T, 2002, RESTOR NEUROL NEUROS, V20, P21; Foltys H, 2003, CLIN NEUROPHYSIOL, V114, P2404, DOI 10.1016/S1388-2457(03)00263-3; Halder S, 2011, NEUROIMAGE, V55, P1779, DOI 10.1016/j.neuroimage.2011.01.021; Broetz D, 2010, NEUROREHAB NEURAL RE, V24, P674, DOI 10.1177/1545968310368683; Sauseng P, 2009, NEUROPSYCHOLOGIA, V47, P284, DOI 10.1016/j.neuropsychologia.2008.07.021; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Yuan H, 2010, NEUROIMAGE, V49, P2596, DOI 10.1016/j.neuroimage.2009.10.028; NAKAYAMA H, 1994, ARCH PHYS MED REHAB, V75, P394, DOI 10.1016/0003-9993(94)90161-9; Buch E, 2008, STROKE, V39, P910, DOI 10.1161/STROKEAHA.107.505313; Aftanas LI, 2002, INT J PSYCHOPHYSIOL, V44, P67, DOI 10.1016/S0167-8760(01)00194-5; Jaillard A, 2005, BRAIN, V128, P1122, DOI 10.1093/brain/awh456; Lotze M, 2006, COGN BEHAV NEUROL, V19, P135, DOI 10.1097/01.wnn.0000209875.56060.06; Ward N, 2011, J PHYSIOL-LONDON, V589, P5625, DOI 10.1113/jphysiol.2011.220939; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Hummel F, 2002, BRAIN, V125, P404, DOI 10.1093/brain/awf030; Duncan PW, 2000, NEUROPHARMACOLOGY, V39, P835, DOI 10.1016/S0028-3908(00)00003-4; Shindo K, 2011, J REHABIL MED, V43, P951, DOI 10.2340/16501977-0859; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Takemi M, 2013, J NEUROPHYSIOL, V110, P1158, DOI 10.1152/jn.01092.2012; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Mukaino M, 2014, J REHABIL MED, V46, P378, DOI 10.2340/16501977-1785; Kaiser V, 2012, STROKE, V43, P2735, DOI 10.1161/STROKEAHA.112.665489; Delvaux V, 2003, CLIN NEUROPHYSIOL, V114, P1217, DOI 10.1016/S1388-2457(03)00070-1; Pfurtscheller G, 1997, ELECTROEN CLIN NEURO, V103, P642, DOI 10.1016/S0013-4694(97)00080-1; Neuper C, 1999, J CLIN NEUROPHYSIOL, V16, P373, DOI 10.1097/00004691-199907000-00010; Pfurtscheller G, 2008, COMPUTER, V41, P58, DOI 10.1109/MC.2008.432; Neuper C, 2009, CLIN NEUROPHYSIOL, V120, P239, DOI 10.1016/j.clinph.2008.11.015; Cramer SC, 1997, STROKE, V28, P2518; Ang KK, 2011, CLIN EEG NEUROSCI, V42, P253; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Arya Kamal Narayan, 2011, J Bodyw Mov Ther, V15, P528, DOI 10.1016/j.jbmt.2011.01.023; Braun C, 2007, EUR J NEUROSCI, V25, P2935, DOI 10.1111/j.1460-9568.2007.05526.x; Carey LM, 2006, NEUROREHAB NEURAL RE, V20, P24, DOI 10.1177/1545968305283053; Chino N, 1994, JPN J REHABIL MED, V31, P119; Diciotti S, 2007, NEUROIMAGE, V38, P402, DOI 10.1016/j.neuroimage.2007.07.045; Friston KJ, 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Hermes D, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025007; Honaga K, 2013, CLIN NEUROPHYSIOL, V124, P364, DOI 10.1016/j.clinph.2012.08.005; Levy CE, 2001, AM J PHYS MED REHAB, V80, P4, DOI 10.1097/00002060-200101000-00003; DASILVA FL, 1991, ELECTROEN CLIN NEURO, V79, P81; Park SW, 2004, NEUROREHAB NEURAL RE, V18, P95, DOI 10.1177/0888439004265113; Prasad G, 2009, 4 INT IEEE EMBS C NE, P258; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; Scherer R, 2007, INT J BIOELECTROMAGN, V9, P155; Wang Wei, 2010, Phys Med Rehabil Clin N Am, V21, P157, DOI 10.1016/j.pmr.2009.07.003; Zarkowski P, 2006, CLIN EEG NEUROSCI, V37, P247	52	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0896-0267	1573-6792		BRAIN TOPOGR	Brain Topogr.	MAR	2015	28	2					340	351		10.1007/s10548-014-0382-6		12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CB8BM	WOS:000349853300014		
J	Noguchi, M				Noguchi, Masakuni			Z-11 trial and rethinking axillary reverse mapping	BREAST CANCER			English	Editorial Material							BREAST-CANCER		Kanazawa Med Univ Hosp, Dept Breast & Endocrine Surg, Kahoku, Ishikawa 9200293, Japan	Noguchi, M (reprint author), Kanazawa Med Univ Hosp, Dept Breast & Endocrine Surg, Daigaku-1-1, Kahoku, Ishikawa 9200293, Japan.	nogumasa@kanazawa-med.ac.jp					Morrow M, 2011, ANN SURG ONCOL, V18, P2413, DOI 10.1245/s10434-011-1857-2; Deng HR, 2011, J CANCER RES CLIN, V137, P1869, DOI 10.1007/s00432-011-1064-3; Giuliano AE, 2011, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; Kodama H, 2012, J INT MED RES, V40, P2336	4	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAR	2015	22	2					99	100		10.1007/s12282-015-0582-2		2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CB8WM	WOS:000349912700001		
J	Vo, TND; Mekata, E; Umeda, T; Abe, H; Kawai, Y; Mori, T; Kubota, Y; Shiomi, H; Naka, S; Shimizu, T; Murata, S; Yamamoto, H; Ishida, M; Tani, T				Thi-Ngoc Diem Vo; Mekata, Eiji; Umeda, Tomoko; Abe, Hajime; Kawai, Yuki; Mori, Tsuyoshi; Kubota, Yoshihiro; Shiomi, Hisanori; Naka, Shigeyuki; Shimizu, Tomoharu; Murata, Satoshi; Yamamoto, Hiroshi; Ishida, Mitsuaki; Tani, Tohru			Prognostic impact of CD10 expression in clinical outcome of invasive breast carcinoma	BREAST CANCER			English	Article						CD10 +/- (negative or very weakly positive staining); CD10+(weakly positive staining); CD10++ (strongly positive staining); Invasive breast carcinoma (IBC); Lymph-node (LN)	MYOEPITHELIAL CELLS; LEUKEMIA ANTIGEN; STROMAL CELLS; NEUTRAL ENDOPEPTIDASE; TUMOR PROGRESSION; CANCER; AVAILABILITY; FIBROBLASTS; MEMBRANES; ELASTOSIS	Early diagnosis and treatment for breast cancers has greatly improved in recent years, however, subset of this disease with early recurrence have remained to be unpredictable. Several studies has addressed that strong CD10 expression in tumor stroma is associated with poor survival rate of breast cancers, but no correlation between CD10 expression and disease-free survival has been elucidated yet. For these reasons, this study with modified immunohistochemical (IHC) staining evaluated the expression of CD10 in invasive breast carcinomas (IBCs) and analyzed correlations between CD10 expression on tumor cells, stromal cells and myeloid-like cells with clinicopathological parameters and recurrence status. IHC staining method was performed on formalin-fixed paraffin-embedded sections of 73 cases of primary IBCs, with record of pathological characteristics of subjects followed up from 1998 to 2007. Stromal CD10 expression was observed in 39/73 cases (53.4 %) with strong expression in 41.0 %. Three cases stained positive for myeloid-like cells and five for carcinomatous cells, of which 6 cases had recurrence and/or regional LN status. Stromal CD10 expression was significantly higher in the unfavorable group (69.6 %; 16/23 cases) compared with the favorable group (32.1 %; 9/28 cases) (p = 0.048). The levels of CD10 expression showed significant difference among clinical outcomes (recurrence or non-recurrence), independent of regional LN status (p = 0.034), histology type (p = 0.044), ER status (p = 0.042), PgR status (p = 0.039), Her2 status (p = 0.038) and Ki67 index (p = 0.036) (partial Pearson correlations). Cox proportional-hazards regression showed that risk factors for disease-free survival were stromal CD10 expression [CD10 +/-, CD10+ versus CD10++; p = 0.003; HR 2.824 (1.427-5.591)]; regional LN status [N0, N1, N2, versus N3; p = 0.004; HR 2.107 (1.262-3.517)] and PgR status [negative versus positive, p = 0.006, HR 0.172 (0.049-0.596)]. CD10 expression on stroma with or without other positive tumor cells and/or myeloid-like cells may function as a powerful prognostic factor for IBC disease-free survival rates, predicting of potential recurrence. It can be determined by a simple modified IHC staining method, which is independent of other prognostic morphologic markers and biomarkers in IBC.	[Thi-Ngoc Diem Vo; Mekata, Eiji; Umeda, Tomoko; Abe, Hajime; Kawai, Yuki; Mori, Tsuyoshi; Kubota, Yoshihiro; Shiomi, Hisanori; Naka, Shigeyuki; Shimizu, Tomoharu; Murata, Satoshi; Yamamoto, Hiroshi; Tani, Tohru] Shiga Univ Med Sci, Dept Surg, Otsu, Shiga 5202192, Japan; [Ishida, Mitsuaki] Shiga Univ Med Sci Hosp, Dept Clin Lab Med, Otsu, Shiga 5202192, Japan; [Ishida, Mitsuaki] Shiga Univ Med Sci Hosp, Div Diagnost Pathol, Otsu, Shiga 5202192, Japan	Mekata, E (reprint author), Shiga Univ Med Sci, Dept Surg, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	mekataeiji@gmail.com					Allred DC, 2010, MODERN PATHOL, V23, pS52, DOI 10.1038/modpathol.2010.55; Khanh DT, 2011, CANCER SCI, V102, P1724, DOI 10.1111/j.1349-7006.2011.01987.x; Pandey PR, 2010, FRONT BIOSCI, V15, P226, DOI 10.2741/3617; Smollich M, 2007, BREAST CANCER RES TR, V106, P361, DOI 10.1007/s10549-007-9516-9; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Kalof AN, 2004, J CLIN PATHOL, V57, P625, DOI 10.1136/jcp.2003.013227; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; LETARTE M, 1988, J EXP MED, V168, P1247, DOI 10.1084/jem.168.4.1247; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Iwaya K, 2002, VIRCHOWS ARCH, V440, P589, DOI 10.1007/s00428-002-0639-4; Eifel P, 2001, J NATL CANCER I, V93, P979; Yada K, 2004, AM J DERMATOPATH, V26, P463, DOI 10.1097/00000372-200412000-00004; Maguer-Satta V, 2011, STEM CELLS, V29, P389, DOI 10.1002/stem.592; Terauchi M, 2005, ONCOLOGY-BASEL, V69, P52, DOI 10.1159/000087476; Huang WB, 2005, JPN J CLIN ONCOL, V35, P245, DOI 10.1093/jjcol/hyi076; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Dewar R, 2011, ARCH PATHOL LAB MED, V135, P422, DOI 10.1043/2010-0336-CP.1; Salani D, 2000, AM J PATHOL, V157, P1537, DOI 10.1016/S0002-9440(10)64791-8; Piattelli A, 2006, ORAL DIS, V12, P301, DOI 10.1111/j.1601-0825.2005.01196.x; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Braham H, 2006, VIRCHOWS ARCH, V449, P220, DOI 10.1007/s00428-006-0217-2; Deschamps L, 2006, HUM PATHOL, V37, P802, DOI 10.1016/j.humpath.2006.02.024; Desmedt C, 2012, CLIN CANC RES, V18; Edwards MJ, 1998, SURGERY, V124, P197; Ellis IO, 1992, HISTOPATHOLOGY, V19, P403; Elston WC, 1999, CRIT REV ONCOL HEMAT, V31, P209; Fasching PA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-486; Fujita S, 2010, INT J COLORECTAL DIS, V25, P681, DOI 10.1007/s00384-010-0913-x; GUSTERSON BA, 1986, J NATL CANCER I, V77, P343; HUMENIUK V, 1983, CANCER, V52, P1448, DOI 10.1002/1097-0142(19831015)52:8<1448::AID-CNCR2820520818>3.0.CO;2-Z; Kim HS, 2010, HISTOPATHOLOGY, V56, P708, DOI 10.1111/j.1365-2559.2010.03534.x; KOEHN JA, 1987, J BIOL CHEM, V262, P11623; KONDEPUDI A, 1993, AM J RESP CELL MOL, V8, P43; KONO S, 1990, MATURITAS, V12, P43, DOI 10.1016/0378-5122(90)90059-F; Makretsov NA, 2007, MODERN PATHOL, V20, P84, DOI 10.1038/modpathol.3800713; Moritani S, 2002, MODERN PATHOL, V15, P397, DOI 10.1038/modpathol.3880536; RASMUSSEN BB, 1985, CANCER RES, V45, P1428; Saika K., 2009, JMAJ - Japan Medical Association Journal, V52, P39; SHIPP MA, 1989, P NATL ACAD SCI USA, V86, P297, DOI 10.1073/pnas.86.1.297; STEPHENSON SL, 1987, BIOCHEM J, V243, P183; Tokuhara T, 2001, Jpn J Thorac Cardiovasc Surg, V49, P489, DOI 10.1007/BF02919543; Toussaint J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012100; Witkiewicz AK, 2010, CANCER BIOL THER, V10, P391; Yasuda M, 2005, ACTA HISTOCHEM CYTOC, V38, P17, DOI 10.1267/ahc.38.17	45	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAR	2015	22	2					117	128		10.1007/s12282-013-0459-1		12	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CB8WM	WOS:000349912700003		
J	Hida, AI; Oshiro, Y; Inoue, H; Kawaguchi, H; Yamashita, N; Moriya, T				Hida, Akira I.; Oshiro, Yumi; Inoue, Hiromichi; Kawaguchi, Hidetoshi; Yamashita, Natsumi; Moriya, Takuya			Visual assessment of Ki67 at a glance is an easy method to exclude many luminal-type breast cancers from counting 1000 cells	BREAST CANCER			English	Article						Ki67; MIB-1; Breast cancer; Luminal subtype; Visual assessment	KI-67 LABELING INDEX; INTERNATIONAL EXPERT CONSENSUS; ESTROGEN-RECEPTOR; ENDOCRINE THERAPY; PREDICTIVE-VALUE; PROGNOSIS; PROLIFERATION; EXPRESSION; HER2; RECOMMENDATIONS	The Ki67 labeling index (LI) reflects the proliferative activity of breast cancers and defines luminal A and B tumors; however, no detailed method to measure Ki67 has been standardized. Here, we propose a fast and easy way to evaluate Ki67. Immunohistochemical staining of estrogen receptor (ER), progesterone receptor (PgR), HER2 and Ki67 (MIB-1) was performed on 235 primary invasive ductal carcinomas. For each sample, a hot spot with many Ki67+ cells was identified using a low-power field (40x, 4x objective). Three independent areas in high-power field (400x) were selected at the hot spot, and all cancer cells in the 3 areas were manually counted to calculate LI (% Ki67+ cells). Alternatively, micrographs taken at 100x and 200x fields including the hot spot were shown to 2 pathologists, who visually assessed percentages of Ki67+ cells in 10 % intervals at a glance (Eye-10). Eye-10 and LI were strongly correlated (r = 0.9412, P < 0.0001). All cases of Eye-10 a parts per thousand yen 30 % had LI > 14 %; most of those < 10 % had LI < 14 %. Of 170 ER+/HER2- tumors, Eye-10-based subtypes matched 87 % of LI-driven subtypes, and interobserver agreement was good (kappa = 0.705). Eye-10 is far easier than counting many cancer cells and useful for classifying breast cancers. Eye-10 can exclude obviously high and low Ki67 cases, leaving a "gray zone" around a cutoff point. Combining Eye-10 and manual counting is a good candidate for a standard method to evaluate Ki67.	[Hida, Akira I.; Oshiro, Yumi] Matsuyama Red Cross Hosp, Dept Pathol, Matsuyama, Ehime 7908524, Japan; [Inoue, Hiromichi; Kawaguchi, Hidetoshi] Matsuyama Red Cross Hosp, Dept Breast Surg, Matsuyama, Ehime 7908524, Japan; [Yamashita, Natsumi] Natl Hosp Org Shikoku Canc Ctr, Clin Res Ctr, Div Clin Biostat, Shikoku, Ehime, Japan; [Moriya, Takuya] Kawasaki Med Univ, Dept Pathol 2, Kurashiki, Okayama, Japan	Hida, AI (reprint author), Matsuyama Red Cross Hosp, Dept Pathol, 1 Bunkyo, Matsuyama, Ehime 7908524, Japan.	gbears@matsuyama.jrc.or.jp					Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Cheang MCU, 2009, J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Jonat W, 2011, ANN ONCOL, V22, P500, DOI 10.1093/annonc/mdq732; Barton S, 2012, BRIT J CANCER, V106, P1760, DOI 10.1038/bjc.2012.166; Viale G, 2008, J NATL CANCER I, V100, P207, DOI 10.1093/jnci/djm289; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Allred DC, 1998, MODERN PATHOL, V11, P155; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Zabaglo L, 2010, J CLIN PATHOL, V63, P800, DOI 10.1136/jcp.2010.077578; Gudlaugsson E, 2012, HISTOPATHOLOGY, V61, P1134, DOI 10.1111/j.1365-2559.2012.04329.x; Dowsett M, 2011, J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; DeCensi A, 2011, ANN ONCOL, V22, P582, DOI 10.1093/annonc/mdq427; Ellis MJ, 2008, J NATL CANCER I, V100, P1380, DOI 10.1093/jnci/djn309; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Trihia H, 2003, CANCER, V97, P1321, DOI 10.1002/cncr.11188; Spyratos F, 2002, CANCER, V94, P2151, DOI 10.1002/cncr.10458; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Endo Y, 2011, INT J CLIN ONCOL, V16, P512, DOI 10.1007/s10147-011-0215-5; Fasanella S, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S7; Hammond ME, 2011, J CLIN ONCOL, V29, pE458, DOI 10.1200/JCO.2011.35.2245; Konsti Juho, 2011, BMC Clin Pathol, V11, P3, DOI 10.1186/1472-6890-11-3; Nishimura R, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-131; Nishimura R, 2010, BREAST CANCER-TOKYO, V17, P269, DOI 10.1007/s12282-009-0161-5; Varga Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037379	28	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAR	2015	22	2					129	134		10.1007/s12282-013-0460-8		6	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CB8WM	WOS:000349912700004		
J	Ono, M; Tsuda, H; Yunokawa, M; Yonemori, K; Shimizu, C; Tamura, K; Kinoshita, T; Fujiwara, Y				Ono, Makiko; Tsuda, Hitoshi; Yunokawa, Mayu; Yonemori, Kan; Shimizu, Chikako; Tamura, Kenji; Kinoshita, Takayuki; Fujiwara, Yasuhiro			Prognostic impact of Ki-67 labeling indices with 3 different cutoff values, histological grade, and nuclear grade in hormone-receptor-positive, HER2-negative, node-negative invasive breast cancers	BREAST CANCER			English	Article						Node-negative; Invasive breast cancer; Luminal subtype; Ki-67; Histological/nuclear grade	NATIONAL SURGICAL ADJUVANT; INTEROBSERVER AGREEMENT; MOLECULAR SUBTYPES; PREDICTIVE-VALUE; GENE-EXPRESSION; CARCINOMA; THERAPY; CHEMOTHERAPY; TRIAL; RECOMMENDATIONS	The criteria for classifying hormone receptor (HR)-positive/HER2-negative breast cancers into low-risk and high-risk subgroups remain undetermined. Supportive data for optimal criteria to identify tumors in the high-risk subgroup are necessary for Japanese patients with HR-positive/HER2-negative breast cancers. Using immunohistochemistry and fluorescence in situ hybridization, we identified 369 consecutive patients with HR-positive/HER2-negative, node-negative invasive breast cancers. We examined the prognostic impact of the Ki-67 labeling index (LI) based on 3 cutoff values, 10, 14, and 20 %, along with that of histological grade (HG) and nuclear grade (NG) by Cox's univariate and multivariate analyses. The univariate analyses clearly showed that Ki-67 LI with any cutoff value divided the patients into distinct high-risk and low-risk groups, and that HG and NG were also powerful prognostic indicators. High Ki-67 LI with any cutoff value was strongly correlated with HG and NG, and when these parameters were included in the multivariate analyses, the impact of HG/NG was stronger than Ki-67 LIs. When the 10 % cutoff value was adopted, discordance between Ki-67 LI and grades was frequent in papillotubular-type invasive ductal carcinoma, predominantly intraductal carcinoma, and mucinous carcinoma. Any of the Ki-67 LI values, regardless of cutoff value, could be applicable for the classification of high-risk and low-risk HR-positive/HER2-negative, node-negative invasive breast cancers. Luminal A/B subtyping according to Ki-67 LI, or HG/NG, in combination with histological type, appeared to be able to create an optimum risk estimation system for patients with HR-positive/HER2-negative, node-negative invasive breast cancers in Japan.	[Ono, Makiko] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Tokyo 104, Japan; [Tsuda, Hitoshi] Natl Canc Ctr, Dept Pathol & Clin Labs, Chuo Ku, Tokyo 1040045, Japan; [Yunokawa, Mayu; Yonemori, Kan; Shimizu, Chikako; Tamura, Kenji; Fujiwara, Yasuhiro] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo 1040045, Japan; [Kinoshita, Takayuki] Natl Canc Ctr, Dept Breast Surg, Tokyo 1040045, Japan	Tsuda, H (reprint author), Natl Canc Ctr, Dept Pathol & Clin Labs, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	makono@ncc.go.jp; hstsuda@gmail.com; myunokaw@ncc.go.jp; kyonemor@ncc.go.jp; cshimizu@ncc.go.jp; ketamura@ncc.go.jp; takinosh@ncc.go.jp; yfujiwar@ncc.go.jp			National Cancer Center Research and Development Fund [22-5]; Japan Society for the Promotion of Science [22501039]; Ministry of Health, Labor, and Welfare, Japan [H22-023]	This work was supported in part by the National Cancer Center Research and Development Fund (22-5), the Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (22501039), and Grant-in-Aid for the Third-Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labor, and Welfare, Japan (H22-023). We thank Sachiko Miura, M.T., Chizu Kina, M.T., Ms. Chinami Onuma (National Cancer Center Hospital), and Ms. Kozue Suzuki (National Defense Medical College) for technical support.	Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Cheang MCU, 2009, J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Viale G, 2008, J NATL CANCER I, V100, P207, DOI 10.1093/jnci/djm289; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Tsuda H, 1998, JPN J CLIN ONCOL, V28, P486, DOI 10.1093/jjco/28.8.486; Harvey JM, 1999, J CLIN ONCOL, V17, P1474; Tsuda H, 2000, JPN J CANCER RES, V91, P451; Dowsett M, 2011, J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Carlson RW, 2009, J NATL COMPR CANC NE, V7, P122; Watanabe T, 2009, J CLIN ONCOL, V27, P1368, DOI 10.1200/JCO.2008.18.3939; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Toi M, 2010, CANCER-AM CANCER SOC, V116, P3112, DOI 10.1002/cncr.25206; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; ENJOJI M, 1992, JPN J CLIN ONCOL, V22, P84; Japanese Breast Cancer Society, 2008, GEN RUL CLIN PATH RE, P18; Kurebayashi J, BREAST CANC IN PRESS; Longacre TA, 2006, MODERN PATHOL, V19, P195, DOI 10.1038/modpathol.3800496; Rakha E, 2012, WHO CLASSIFICATION T, P43; Tsuda H, 1999, JPN J CLIN ONCOL, V29, P68, DOI 10.1093/jjco/29.2.68; WHO, 1981, INT HIST CLASS TUM, P19	28	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAR	2015	22	2					141	152		10.1007/s12282-013-0464-4		12	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CB8WM	WOS:000349912700006		
J	Yamamoto-Ibusuki, M; Yamamoto, Y; Fu, PF; Yamamoto, S; Fujiwara, S; Honda, Y; Iyama, K; Iwase, H				Yamamoto-Ibusuki, Mutsuko; Yamamoto, Yutaka; Fu, Peifen; Yamamoto, Satoko; Fujiwara, Saori; Honda, Yumi; Iyama, Ken-ichi; Iwase, Hirotaka			Divisional role of quantitative HER2 testing in breast cancer	BREAST CANCER			English	Article						Breast cancer; Human epidermal growth factor 2; Real-time quantitative PCR; Gene copy number; Gene expression analysis	INTERNATIONAL EXPERT CONSENSUS; IN-SITU HYBRIDIZATION; REAL-TIME PCR; POLYMERASE CHAIN-REACTION; PRIMARY THERAPY; GENE AMPLIFICATION; GUIDELINE RECOMMENDATIONS; CLINICAL ONCOLOGY/COLLEGE; PROGESTERONE-RECEPTORS; ADJUVANT CHEMOTHERAPY	Human epidermal growth factor receptor 2 (HER2) is amplified in human breast cancers in which therapy targeted to HER2 significantly improves patient outcome. We re-visited the use of real-time quantitative polymerase chain reaction (qPCR)-based assays using formalin-fixed paraffin-embedded (FFPE) tissues as alternative methods and investigated their particular clinical relevance. DNA and RNA were isolated from FFPE specimens and HER2 status was assessed by qPCR in 249 consecutive patients with primary breast cancer. Concordance with results forg immunohistochemistry (IHC) and in situ hybridization (ISH), clinical characteristics and survival was assessed. HER2 gene copy number had a stronger correlation with clinicopathological characteristics and excellent concordance with IHC/ISH results (Sensitivity: 96.7 %; concordance: 99.2 %). HER2 gene expression showed inadequate sensitivity, rendering it unsuitable to determine HER2 status (Sensitivity: 46.7 %; concordance: 92.1 %), but lower HER2 gene expression, leading to the classification of many cases as "false negative", contributed to a prediction of better prognosis within the HER2-amplified subpopulation. Quantitative HER2 assessments are suggested to have evolved their accuracy in this decade, which can be a potential alternative for HER2 diagnosis in line with the in situ method, while HER2 gene expression levels could provide additional information regarding prognosis or therapeutic strategy within a HER2-amplified subpopulation.	[Yamamoto-Ibusuki, Mutsuko; Yamamoto, Yutaka; Yamamoto, Satoko; Fujiwara, Saori; Iwase, Hirotaka] Kumamoto Univ, Dept Breast & Endocrine Surg, Grad Sch Med Sci, Kumamoto, Kumamoto 8608556, Japan; [Fu, Peifen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gen Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Honda, Yumi; Iyama, Ken-ichi] Kumamoto Univ, Dept Surg Pathol, Grad Sch Med Sci, Kumamoto, Kumamoto 8608556, Japan	Iwase, H (reprint author), Kumamoto Univ, Dept Breast & Endocrine Surg, Grad Sch Med Sci, 1-1-1 Honjo, Kumamoto, Kumamoto 8608556, Japan.	hiwase@kumamoto-u.ac.jp					Allouche A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1851; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Susini T, 2010, GYNECOL ONCOL, V116, P234, DOI 10.1016/j.ygyno.2009.10.067; Rhodes A, 2010, AM J CLIN PATHOL, V134, P621, DOI 10.1309/AJCPOG3O3KTPZQNK; Baehner FL, 2010, J CLIN ONCOL, V28, P4300, DOI 10.1200/JCO.2009.24.8211; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Bofin AM, 2004, AM J CLIN PATHOL, V122, P110, DOI 10.1309/8A2DJFT07NE6EWHE; Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Lehmann-Che J, 2011, BRIT J CANCER, V104, P1739, DOI 10.1038/bjc.2011.135; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Goldhirsch A, 2003, J CLIN ONCOL, V21, P3357, DOI 10.1200/JCO.2003.04.576; Dabbs DJ, 2011, J CLIN ONCOL, V29, P4279, DOI 10.1200/JCO.2011.34.7963; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI 10.1043/1543-2165-134.6.907; McShane LM, 2005, NAT CLIN PRACT ONCOL, V2, P416, DOI 10.1038/ncponc0252; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Ntoulia M, 2006, CLIN BIOCHEM, V39, P942, DOI 10.1016/j.clinbiochem.2006.06.001; Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326; Middleton LP, 2009, ARCH PATHOL LAB MED, V133, P775, DOI 10.1043/1543-2165-133.5.775; Dowsett M, 2009, J CLIN ONCOL, V27, P2962, DOI 10.1200/JCO.2008.19.7939; Epis MR, 2009, J BIOL CHEM, V284, P24696, DOI 10.1074/jbc.M109.030098; Bergqvist J, 2007, ANN ONCOL, V18, P845, DOI 10.1093/annonc/mdl059; Gjerdrum LM, 2004, DIAGN MOL PATHOL, V13, P224, DOI 10.1097/01.pdm.0000134779.45353.d6; Ibusuki M, 2013, BREAST CANCER-TOKYO, V20, P159, DOI 10.1007/s12282-011-0318-x; Iwase H, 2009, SURG TODAY, V39, P374, DOI 10.1007/s00595-008-3880-x; Jan CI, 2011, J PATHOL, V225, P424, DOI 10.1002/path.2921; Joensuu H, 2011, ANN ONCOL, V22, P2007, DOI 10.1093/annonc/mdq710; Kato N, 2010, PATHOL INT, V60, P510, DOI 10.1111/j.1440-1827.2010.02553.x; Kulka J, 2006, PATHOL ONCOL RES, V12, P197; Nistor Andreea, 2006, BMC Clin Pathol, V6, P2, DOI 10.1186/1472-6890-6-2; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tse CH, 2011, J CLIN ONCOL, V29, P4168, DOI 10.1200/JCO.2011.36.0107	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAR	2015	22	2					161	171		10.1007/s12282-013-0467-1		11	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CB8WM	WOS:000349912700008		
J	Uchida, K; Ohashi, H; Kinoshita, S; Nogi, H; Kato, K; Toriumi, Y; Yamashita, A; Kamio, M; Mimoto, R; Takeyama, H				Uchida, Ken; Ohashi, Hitoshi; Kinoshita, Satoki; Nogi, Hiroko; Kato, Kumiko; Toriumi, Yasuo; Yamashita, Akinori; Kamio, Makiko; Mimoto, Rei; Takeyama, Hiroshi			Breast cancer screening and the changing population pyramid of Japan	BREAST CANCER			English	Article						Breast cancer; Mammography; Screening; Elderly women; Age	MAMMOGRAPHY	Breast cancer has been the most prevalent cancer in Japan since the 1990s. The mortality from breast cancer is increasing in Japan, whereas in other industrialized countries it has been decreasing since 1990. On the other hand, Japan faces unparalleled growth in its aging population. The aim of this study was to report the mammography screening among Japanese women and the related upcoming changes in the population pyramid of Japan. The reference data for our study were obtained from the Center for Cancer Control and Information Services, Japan Ministry of Internal Affairs and Communications, Ministry of Health, Labour and Welfare, the Japanese Cancer Society, and the National Institute of Population and Social Security. The survey data were obtained from breast cancer and mammography screenings in the Tokyo Prefecture in 2008. The following parameters were analyzed: annual breast cancer incidence, current screening rates, average life-span, and predicted demographic statistics. Our results showed that breast cancer incidence and mortality have been increasing annually in Japan. The average age of breast cancer patients increased to 58.40 years in 2010. The incidence of breast cancer in women aged 65 years and older increased from 25.3 to 32.9 % in the last 10 years and is expected to continue to increase in the future. The check-up rate was 16.0-20.0 % for women aged 65-74 years and 43.0-46.0 % for women aged 40-54 years. According to our questionnaire survey, concerns about breast cancer and mammography screening were high in the young and low in the elderly women. The Japanese population aged 65 years and older was 30,740 (24.1 %) in 2012 and is estimated to increase by 40 % over the next 20 years despite Japan's declining population size. Breast cancer incidence has increased in Japan, even among patients aged 65 years and older. Breast cancer has become increasingly prevalent in older Japanese women. As the population pyramid of Japan changes, women aged 65 years and older, who think that there is no longer need to receive mammography screening and are not educated regarding self-examinations, should be encouraged to receive regular check-ups for breast cancer.	[Uchida, Ken] Shinjuku Med Ctr, Meiji Yasuda Life Fdn Hlth & Welf, Shinjuku Ku, Tokyo 1600023, Japan; [Uchida, Ken; Ohashi, Hitoshi; Kinoshita, Satoki; Nogi, Hiroko; Kato, Kumiko; Toriumi, Yasuo; Yamashita, Akinori; Kamio, Makiko; Mimoto, Rei; Takeyama, Hiroshi] Jikei Univ, Dept Breast & Endocrine Surg, Sch Med, Tokyo, Japan	Uchida, K (reprint author), Shinjuku Med Ctr, Meiji Yasuda Life Fdn Hlth & Welf, Shinjuku Ku, 1-8-3 Nishi Shinjuku, Tokyo 1600023, Japan.	kenucd@my-zaidan.or.jp					American Cancer Society, GLOB CANC FACTS FIG; American Geriatrics Society Clinical Practice Committee, 2000, J AM GERIATR SOC, V48, P842; [Anonymous], AV LIF EXP AV REM LI; Matsuda T, 2012, JPN J CLIN ONCOL, V42, P139, DOI 10.1093/jjco/hyr184; [Anonymous], BAS PLAN PROM CANC C; [Anonymous], LIF EXP AG RAC SEX D; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Ken U, 2009, J JPN ASS BREAST CAN, V18, P346; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Ministry of Health Labour and Welfare, NAT CANC MON SUMM; Ministry of Health Labour and Welfare (MHLW), ANN REP BREAST CANC; Ministry of Health Labour and Welfare (MHLW), AV LIF SPAN JAP WOM; The Japanese Cancer Society (JBCS), 1999, REP CLIN STAT STUD R, P31; The National Institure of Population and Social Security (IPSS), POP PROJ JAP; Calonge N, 2009, ANN INTERN MED, V151, P716	16	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAR	2015	22	2					172	176		10.1007/s12282-013-0470-6		5	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CB8WM	WOS:000349912700009		
J	Nakayama, Y; Ito, Y; Tanabe, M; Takahashi, S; Hatake, K				Nakayama, Yoshie; Ito, Yoshinori; Tanabe, Masahiko; Takahashi, Shunji; Hatake, Kiyohiko			A combination of aprepitant, palonosetron, and dexamethasone prevents emesis associated with anthracycline-containing regimens for patients with breast cancer. A retrospective study	BREAST CANCER			English	Article						Aprepitant; Palonosetron; Dexamethasone; Granisetron; Anthracycline	CHEMOTHERAPY-INDUCED NAUSEA; MODERATELY EMETOGENIC CHEMOTHERAPY; PHASE-III; DOUBLE-BLIND; ANTAGONIST; TRIAL; METAANALYSIS; ONDANSETRON; ANTIEMETICS; CISPLATIN	Chemotherapy regimens for breast cancer containing anthracycline and cyclophosphamide are classified as highly emetogenic. Aprepitant (A), palonosetron (P), granisetron (G), or dexamethasone (D) are recommended antiemetic drugs. However, it is uncertain which combination is most effective. We retrospectively examined the efficacy of these antiemetic drugs. We reviewed the medical records of 454 patients with breast cancer treated in our facility with regimens containing anthracycline and cyclophosphamide between August 2009 and September 2010. The number of patients treated with GD, AGD, and APD was 147, 150, and 157, respectively. Complete response (CR) in the acute (0-24 h) and delayed (24-120 h) phases was 68.7 and 76.2 %, respectively, for GD, 90.0 and 92.7 %, respectively, for AGD, and 89.8 and 90.4 %, respectively, for APD. Complete control (CC) in the acute and delayed phases for each regimen was 60.5 and 64.6 %, respectively, for GD, 62.7 and 88.7 %, respectively, for AGD, and 84.1 and 87.3 %, respectively, for APD. In the acute and delayed phases CR for AGD or APD was significantly superior to that for GD (P < 0.01). It worth noting that CC for APD in the acute phase was significantly superior to that for AGD (P < 0.01). In the delayed phase CC for AGD or APD was significantly superior to that for GD. A combination of aprepitant, palonosetron, and dexamethasone is an antiemetic treatment of choice for patients treated with regimens containing anthracycline and cyclophosphamide.	[Nakayama, Yoshie; Ito, Yoshinori; Tanabe, Masahiko; Takahashi, Shunji; Hatake, Kiyohiko] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Oncol Ctr, Koto Ku, Tokyo 1358550, Japan	Nakayama, Y (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Breast Oncol Ctr, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	yoshie.nakayama@jfcr.or.jp					Herrington JD, 2008, CANCER, V112, P2080, DOI 10.1002/cncr.23364; Herrstedt J, 2008, NAT CLIN PRACT ONCOL, V5, P32, DOI 10.1038/ncponc1021; Roila F, 2005, SUPPORT CARE CANCER, V13, P104, DOI 10.1007/s00520-004-0700-8; Hesketh PJ, 2003, J CLIN ONCOL, V21, P4112, DOI 10.1200/JCO.2003.01.095; [Anonymous], 2012, NCCN CLIN PRACT GUID; Ioannidis JPA, 2000, J CLIN ONCOL, V18, P3409; Saito M, 2009, LANCET ONCOL, V10, P115, DOI 10.1016/S1470-2045(08)70313-9; Eisenberg P, 2003, CANCER, V98, P2473, DOI 10.1002/cncr.11817; CRAIG JB, 1987, AM J MED SCI, V293, P34, DOI 10.1097/00000441-198701000-00008; Botrel TEA, 2011, SUPPORT CARE CANCER, V19, P823, DOI 10.1007/s00520-010-0908-8; Grunberg SM, 2003, EXPERT OPIN PHARMACO, V4, P2297, DOI 10.1517/14656566.4.12.2297; Gralla R, 2003, ANN ONCOL, V14, P1570, DOI 10.1093/annonc/mdg417; Warr DG, 2005, J CLIN ONCOL, V23, P2822; CAREY MP, 1988, PSYCHOL BULL, V104, P307, DOI 10.1037//0033-2909.104.3.307; de Wit R, 2004, EUR J CANCER, V40, P403, DOI 10.1016/j.ejca.2003.08.028; Grote Thomas, 2006, J Support Oncol, V4, P403; Molassiotis A, 2002, SUPPORT CARE CANCER, V10, P139, DOI 10.1007/s00520-001-0321-4; Roila F, 2000, NEW ENGL J MED, V342, P1554	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAR	2015	22	2					177	184		10.1007/s12282-013-0472-4		8	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CB8WM	WOS:000349912700010		
J	Yoshioka, T; Hosoda, M; Yamamoto, M; Taguchi, K; Hatanaka, KC; Takakuwa, E; Hatanaka, Y; Matsuno, Y; Yamashita, H				Yoshioka, Tatsuya; Hosoda, Mitsuchika; Yamamoto, Mitsugu; Taguchi, Kazunori; Hatanaka, Kanako C.; Takakuwa, Emi; Hatanaka, Yutaka; Matsuno, Yoshihiro; Yamashita, Hiroko			Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer	BREAST CANCER			English	Article						Breast cancer; Neoadjuvant chemotherapy; Pathologic complete response; Ki67	SYSTEMIC THERAPY; RECOMMENDATIONS; SUBTYPES; DOCETAXEL; CONSENSUS; TRIAL	Recent studies have indicated that response to chemotherapy and the prognostic impact of a pathologic complete response (pCR) after neoadjuvant chemotherapy differ among breast cancer subtypes. Women with Stage I to III breast cancer treated with anthracycline and taxane-based neoadjuvant chemotherapy (four cycles of docetaxel every 3 weeks followed by four cycles of FEC every 3 weeks) between 2006 and 2011 were retrospectively analyzed. Trastuzumab was concurrently added to docetaxel for HER2-positive breast cancer. Expression of estrogen receptor (ER), progesterone receptor (PgR), HER2, and Ki67 was examined by immunohistochemistry in pre- and post-treatment specimens. Predictive factors for neoadjuvant chemotherapy and prognosis were analyzed by breast cancer subtype. Of 64 patients, 30 (47 %) were ER-positive (ER+) HER2-negative (HER2-), including eight as luminal A (Ki67 labeling index (LI) < 14 %) and 22 as luminal B (Ki67 LI a parts per thousand yen 14 %) subtypes, 11 (17 %) were ER+ HER2-positive (HER2+), 12 (19 %) were ER-negative (ER-) HER2+, and 11 (17 %) were ER- HER2-. The clinical response rates were significantly higher in luminal B, ER+ HER2+, and ER- HER2+ subtypes compared with luminal A subtype. Patients whose tumors contained high Ki67 expression effectively responded to neoadjuvant chemotherapy. Ki67 LI was a predictive marker for pCR, and all patients whose tumors achieved pCR are currently disease-free. Furthermore, high Ki67 expression in post-treatment tumors was strongly correlated with poor disease-free and overall survival regardless of subtype. It is necessary to establish additional strategies to improve survival for patients whose residual tumors show high Ki67 expression after neoadjuvant chemotherapy.	[Yoshioka, Tatsuya; Hosoda, Mitsuchika; Yamamoto, Mitsugu; Taguchi, Kazunori; Yamashita, Hiroko] Hokkaido Univ Hosp, Kita Ku, Sapporo, Hokkaido 0608648, Japan; [Yoshioka, Tatsuya] Hokkaido Univ, Dept Gastroenterol Surg 2, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Hatanaka, Kanako C.; Takakuwa, Emi; Hatanaka, Yutaka; Matsuno, Yoshihiro] Hokkaido Univ Hosp, Dept Surg Pathol, Kita Ku, Sapporo, Hokkaido 0608648, Japan; [Takakuwa, Emi; Hatanaka, Yutaka; Matsuno, Yoshihiro] Hokkaido Univ Hosp, Res Div Compan Diagnost, Kita Ku, Sapporo, Hokkaido 0608648, Japan	Yamashita, H (reprint author), Hokkaido Univ Hosp, Kita Ku, Kita 14 Nishi 5, Sapporo, Hokkaido 0608648, Japan.	hirokoy@huhp.hokudai.ac.jp					Houssami N, 2012, EUR J CANCER, V48, P3342, DOI 10.1016/j.ejca.2012.05.023; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Lips EH, 2012, BREAST CANCER RES TR, V131, P827, DOI 10.1007/s10549-011-1488-0; Viale G, 2008, J NATL CANCER I, V100, P207, DOI 10.1093/jnci/djm289; Jones RL, 2009, BREAST CANCER RES TR, V116, P53, DOI 10.1007/s10549-008-0081-7; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Jones RL, 2010, BREAST CANCER RES TR, V119, P315, DOI 10.1007/s10549-009-0329-x; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Kaufmann M, 2012, ANN SURG ONCOL, V19, P1508, DOI 10.1245/s10434-011-2108-2; Dowsett M, 2011, J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Penault-Llorca F, 2009, J CLIN ONCOL, V27, P2809, DOI 10.1200/JCO.2008.18.2808; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Montagna E, 2010, BREAST CANCER RES TR, V124, P689, DOI 10.1007/s10549-010-1027-4; Kurosumi M, 2008, BREAST CANCER-TOKYO, V15, P5, DOI 10.1007/s12282-007-0016-x; Yamashita H, 2009, CANCER SCI, V100, P2028, DOI 10.1111/j.1349-7006.2009.01274.x; Esserman LJ, 2012, J CLIN ONCOL, V30, P3242, DOI 10.1200/JCO.2011.39.2779; Burcombe R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1508; Endo Y, 2011, INT J CLIN ONCOL, V16, P512, DOI 10.1007/s10147-011-0215-5; Fasching PA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-486; Matsubara N, 2013, BREAST CANCER RES TR, V137, P203, DOI 10.1007/s10549-012-2344-6; Piccart-Gebhart MJ, 2010, ONCOLOGIST, V15, P18, DOI 10.1634/theoncologist.2010-S5-18; von Minckwitz G, 2012, BREAST CANCER-TOKYO, V19, P282, DOI 10.1007/s12282-012-0393-7	24	4	6	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAR	2015	22	2					185	191		10.1007/s12282-013-0474-2		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CB8WM	WOS:000349912700011		
J	Iwata, H; Fujii, H; Masuda, N; Mukai, H; Nishimura, Y; Katsura, K; Ellis, CE; Gagnon, RC; Nakamura, S				Iwata, Hiroji; Fujii, Hirofumi; Masuda, Norikazu; Mukai, Hirofumi; Nishimura, Yuichiro; Katsura, Koichi; Ellis, Catherine E.; Gagnon, Robert C.; Nakamura, Seigo			Efficacy, safety, pharmacokinetics and biomarker findings in patients with HER2-positive advanced or metastatic breast cancer treated with lapatinib in combination with capecitabine: results from 51 Japanese patients treated in a clinical study	BREAST CANCER			English	Article						Lapatinib; Capecitabine; HER2; Breast cancer; Biomarker	MOLECULAR PORTRAITS; PLUS CAPECITABINE; RANDOMIZED-TRIAL; BRAIN METASTASES; SOLID TUMORS; PHASE-I; EXPRESSION; RECEPTOR; HER2	The results from a phase III trial conducted outside of Japan demonstrated a significant improvement in time to progression (TTP) when lapatinib was combined with capecitabine compared with capecitabine alone in patients with HER2-positive advanced or metastatic breast cancer. In this clinical study of lapatinib in combination with capecitabine, efficacy, safety, pharmacokinetics (PK) and biomarkers were investigated in Japanese patients with HER2-positive advanced or metastatic breast cancer treated with prior trastuzumab. Eligible women received lapatinib 1250 mg once daily and capecitabine 1000 mg/m(2) twice daily on days 1 through 14 of a 21-day cycle. The primary endpoint was the clinical benefit rate (CBR: complete response, partial response or stable disease for at least 24 weeks). Lapatinib in combination with capecitabine was well tolerated in the 51 patients enrolled in this study. CBR was 59 % (95 % CI 44.2, 72.4), and the median TTP in the Kaplan-Meier estimate was 36 weeks (95 % CI 27.1, 48.0). The majority of drug-related adverse events were mild to moderate (grade 1 or 2); the most common adverse events reported were palmar-plantar erythrodysesthesia syndrome (76 %), diarrhea (67 %) and stomatitis (41 %). Lapatinib in combination with capecitabine in Japanese HER2-positive breast cancer patients was well tolerated. Overall, our findings on the efficacy, safety and PK were similar to those reported from the overseas studies.	[Iwata, Hiroji] Aichi Canc Ctr Hosp, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Fujii, Hirofumi] Jichi Med Univ Hosp, Shimotsuke, Tochigi, Japan; [Masuda, Norikazu] Natl Hosp Org Osaka Natl Hosp, Osaka, Japan; [Mukai, Hirofumi] Natl Canc Ctr Hosp East, Chiba, Japan; [Nishimura, Yuichiro; Katsura, Koichi] GlaxoSmithKline KK, Tokyo, Japan; [Ellis, Catherine E.; Gagnon, Robert C.] GlaxoSmithKline, Philadelphia, PA USA; [Nakamura, Seigo] St Lukes Int Hosp, Tokyo, Japan; [Nakamura, Seigo] Showa Univ Hosp, Tokyo, Japan	Iwata, H (reprint author), Aichi Canc Ctr Hosp, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	hiwata@aichi-cc.jp			GlaxoSmithKline K.K.	We thank all the women who participated in this study and their families; the investigators, in particular, Shigehira Saji, Yoshinori Ito, Kenjiro Aogi, Yoshiaki Rai, Yasuhiro Fujiwara, Eiichi Shiba, Kazunori Taguchi, Naoto Hara, Junichiro Watanabe, Shinji Ohno; the medical, nursing and research staff at all the study centers. This work was sponsored by GlaxoSmithKline K.K. Part of this work was previously presented at the Eighth Annual Meeting of the Japanese Society of Medical Oncology in 2010.	Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Chu QSC, 2007, J CLIN ONCOL, V25, P3753, DOI 10.1200/JCO.2007.11.1765; Herbst RS, 2002, J CLIN ONCOL, V20, P3815, DOI 10.1200/JCO.2002.03.038; Toi M, 2009, BRIT J CANCER, V101, P1676, DOI 10.1038/sj.bjc.6605343; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Metro G, 2011, ANN ONCOL, V22, P625, DOI 10.1093/annonc/mdq434; Cameron D, 2008, BREAST CANCER RES TR, V112, P533, DOI 10.1007/s10549-007-9885-0; Cameron D, 2010, ONCOLOGIST, V15, P924, DOI 10.1634/theoncologist.2009-0181; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Sutherland S, 2010, BRIT J CANCER, V102, P995, DOI 10.1038/sj.bjc.6605586; Finn RS, 2009, J CLIN ONCOL, V27, P3908, DOI 10.1200/JCO.2008.18.1925; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Fehm T, 2004, ANTICANCER RES, V24, P4205; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Xu Bing-He, 2011, Chin J Cancer, V30, P327	20	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAR	2015	22	2					192	200		10.1007/s12282-013-0475-1		9	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CB8WM	WOS:000349912700012		
J	Ikeda, T; Bando, H; Iguchi, A; Tanaka, Y; Tohno, E; Hara, H				Ikeda, Tatsuhiko; Bando, Hiroko; Iguchi, Akiko; Tanaka, Yuko; Tohno, Eriko; Hara, Hisato			Malignant lymphoma of the breast in a male patient: ultrasound imaging features	BREAST CANCER			English	Article						Non-Hodgkin lymphoma; Ultrasonography; Male; Gynecomastia	NON-HODGKIN-LYMPHOMA; B-CELL LYMPHOMA; TISSUE	Non-Hodgkin lymphoma (NHL) of the breast is a rare disease. Herein, we report a rare case of secondary involvement of the breast by NHL in a male patient and the ultrasound imaging findings. A 70-year-old man noticed an induration of the subareolar region of the right breast. He had been diagnosed as having mantle cell lymphoma 5 years before and treated with several series of chemoradiotherapy. On supine examination, palpation revealed bilateral breast enlargement, but detection of a lump was difficult. Ultrasonography showed a hypoechoic non-mass image-forming lesion in the subareolar region of the right breast. The final pathological diagnosis was recurrence of mantle cell lymphoma in the right breast. The diagnosis of malignant lymphoma of the breast by imaging modalities is difficult because there are no specific features. Breast lymphoma should be included with gynecomastia and breast cancer in the differential diagnosis of male patients with breast enlargement.	[Ikeda, Tatsuhiko] Tsukuba Univ Hosp, Dept Breast & Endocrine Surg, Tsukuba, Ibaraki 3050817, Japan; [Bando, Hiroko; Iguchi, Akiko; Tanaka, Yuko; Hara, Hisato] Univ Tsukuba, Dept Breast & Endocrine Surg, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Tohno, Eriko] Univ Tsukuba, Dept Radiol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan	Ikeda, T (reprint author), Tsukuba Univ Hosp, Dept Breast & Endocrine Surg, 2-1-1 Amakubo, Tsukuba, Ibaraki 3050817, Japan.	tatsuhikoo@gmail.com					Abbondanzo SL, 1996, PATHOL RES PRACT, V192, P37; MATTIA AR, 1993, AM J SURG PATHOL, V17, P574, DOI 10.1097/00000478-199306000-00005; ARBER DA, 1994, AM J SURG PATHOL, V18, P288, DOI 10.1097/00000478-199403000-00009; LIBERMAN L, 1994, RADIOLOGY, V192, P157; Darnell A, 1999, MAGN RESON IMAGING, V17, P479, DOI 10.1016/S0730-725X(98)00178-7; Duman BB, 2010, MED ONCOL S1, V28, pS490; Hinoshita E, 1998, BREAST CANC, V5, P309, DOI 10.1007/BF02966712; Janes SE, 2006, BREAST, V15, P273, DOI 10.1016/j.breast.2005.05.003; JEON HJ, 1992, CANCER, V70, P2451, DOI 10.1002/1097-0142(19921115)70:10<2451::AID-CNCR2820701011>3.0.CO;2-B; LAMOVEC J, 1987, CANCER, V60, P3033, DOI 10.1002/1097-0142(19871215)60:12<3033::AID-CNCR2820601230>3.0.CO;2-A; Miura Y, 2009, AM J HEMATOL, V84, P191, DOI 10.1002/ajh.21292; Mori K, 1998, BREAST CANC, V5, P93, DOI 10.1007/BF02967422; Mpallas G, 2004, BREAST, V13, P436, DOI 10.1016/j.breast.2003.11.002; Murata T, 1996, JPN J CLIN ONCOL, V26, P243; POPE TL, 1985, J CLIN ULTRASOUND, V13, P667; Sashiyama H, 1999, BREAST CANC, V6, P55, DOI 10.1007/BF02966907; Swerdlow S, 2008, WHO CLASSIFICATION T; Uesato Masaya, 2005, Breast Cancer, V12, P154, DOI 10.2325/jbcs.12.154; Wong WW, 2002, J SURG ONCOL, V80, P19, DOI 10.1002/jso.10084	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAR	2015	22	2					201	205		10.1007/s12282-012-0349-y		5	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CB8WM	WOS:000349912700013		
J	Ogiya, A; Takahashi, K; Sato, M; Kubo, Y; Nishikawa, N; Kikutani, M; Tadokoro, Y; Tanaka, K; Uematsu, T; Watanabe, J; Kasami, M; Yamasaki, S				Ogiya, Akiko; Takahashi, Kaoru; Sato, Mutsumi; Kubo, Yoshiko; Nishikawa, Noriko; Kikutani, Mariko; Tadokoro, Yukiko; Tanaka, Kumiko; Uematsu, Takayoshi; Watanabe, Junichiro; Kasami, Masako; Yamasaki, Seiji			Metastatic breast carcinoma of the abdominal wall muscle: a case report	BREAST CANCER			English	Article						Breast cancer; Skeletal muscle; Metastasis	CANCER; MASSETER	Metastasis from breast carcinoma is an uncommon occurrence in skeletal muscle, compared to local invasion into muscle from direct tumor spread. A 49-year-old woman was referred to our hospital with an 8.5-cm mass in the right breast. Core needle biopsy revealed metaplastic carcinoma with squamous metaplasia. The mass was rapidly growing and metaplastic, so mastectomy with dissection of axillary lymph nodes was performed. Pathological examination showed metaplastic carcinoma, histological grade 3, triple negative, and a MIB-1 labeling index of 80%. Six months postoperatively, during adjuvant chemotherapy treatment, she reported numbness and pain in the right lateral thigh and a mass in the right lower abdomen. Computed tomography revealed multiple lined masses in the abdominal wall and iliac muscle. Core needle biopsy showed metastatic breast carcinoma. Radio- and chemotherapy were administered, but the mass in the muscle became enlarged. To control her pain, a combined treatment with morphine, fentanyl, ketamine, antiepilepsy drug, and NSAIDs was administered. Liver metastasis appeared 9 months (15 months postoperatively) after recognition of muscle metastasis, and the patient died 16 months postoperatively. Skeletal muscle metastasis is uncommon, and therapeutic intervention is mainly palliative. The most common symptom of skeletal muscle metastasis is pain; thus, pain control is a pivotal goal of treatment.	[Ogiya, Akiko; Takahashi, Kaoru; Sato, Mutsumi; Kubo, Yoshiko; Nishikawa, Noriko; Kikutani, Mariko; Tadokoro, Yukiko; Tanaka, Kumiko] Shizuoka Canc Ctr Hosp, Dept Breast Surg, Nagaizumi, Shizuoka 4118777, Japan; [Uematsu, Takayoshi] Shizuoka Canc Ctr Hosp, Dept Breast Imaging & Breast Intervent, Nagaizumi, Shizuoka 4118777, Japan; [Watanabe, Junichiro] Shizuoka Canc Ctr Hosp, Dept Med Oncol, Nagaizumi, Shizuoka 4118777, Japan; [Kasami, Masako] Shizuoka Canc Ctr Hosp, Dept Pathol, Nagaizumi, Shizuoka 4118777, Japan; [Yamasaki, Seiji] Shizuoka Canc Ctr Hosp, Dept Multidisciplinary Therapy Breast Canc, Nagaizumi, Shizuoka 4118777, Japan	Ogiya, A (reprint author), Shizuoka Canc Ctr Hosp, Dept Breast Surg, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	a.ogiya@scchr.jp					Ahuja AT, 2000, J CLIN ULTRASOUND, V28, P299, DOI 10.1002/1097-0096(200007/08)28:6<299::AID-JCU6>3.0.CO;2-1; Tuoheti Y, 2004, JPN J CLIN ONCOL, V34, P210, DOI 10.1093/jjco/hyh036; Plaza JA, 2008, CANCER, V112, P193, DOI 10.1002/cncr.23151; DOSHI R, 1983, J NEUROL NEUROSUR PS, V46, P358, DOI 10.1136/jnnp.46.4.358; EIBER AM, 1986, CLIN NUCL MED, V11, P194, DOI 10.1097/00003072-198603000-00013; HAZELTINE M, 1990, J RHEUMATOL, V17, P1097; Liu YY, 2006, CLIN NUCL MED, V31, P266, DOI 10.1097/01.rlu.0000210518.53139.fe; Oh K, 2009, JPN J BREAST CANC, V24, P753; Peckham EL, 2005, NEUROLOGY, V65, P74, DOI 10.1212/01.WNL.0000156359.93206.99; Sahai S, 1995, Iowa Med, V85, P369; Shiina T, 1992, JPN J CLIN RADIOL, V37, P1169; Spitzer SG, 2005, J NEURO-OPHTHALMOL, V25, P37, DOI 10.1097/00041327-200503000-00010; Tanaka K, 1998, J JPN SURG ASS, V59, P89; TOSIOS K, 1992, J ORAL MAXIL SURG, V50, P304, DOI 10.1016/0278-2391(92)90334-V; YOSHY C, 1985, J COMPUT ASSIST TOMO, V9, P967, DOI 10.1097/00004728-198509000-00027	15	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAR	2015	22	2					206	209		10.1007/s12282-012-0352-3		4	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CB8WM	WOS:000349912700014		
J	Mizokawa, A; Koyasu, M				Mizokawa, Ai; Koyasu, Masuo			Digging deeper into the link between socio-cognitive ability and social relationships	BRITISH JOURNAL OF DEVELOPMENTAL PSYCHOLOGY			English	Editorial Material						theory of mind; socio-cognitive ability; social relationships; longitudinal study	CHILDRENS-MORAL-JUDGMENTS; MIND; PRESCHOOLERS; COMMISSION; EMOTION	In this commentary on Friendlessness and theory of mind: A prospective longitudinal study' by Fink, Begeer, Peterson, Slaughter, and de Rosnay (Brit. J. Dev. Psychol, 2015; 33, 1-17) we reconsider the link between early mastery of theory of mind (ToM) and social relationships by focusing on connections with other related areas of socio-cognitive ability such as emotional competence, ToM development across age, and the effect of interventions.	[Mizokawa, Ai] Meiji Gakuin Univ, Tokyo 1088636, Japan; [Koyasu, Masuo] Kyoto Univ, Kyoto, Japan	Mizokawa, A (reprint author), Meiji Gakuin Univ, Fac Psychol, Minato Ku, 1-2-37 Shirokanedai, Tokyo 1088636, Japan.	aimizokawa@gmail.com					Fahie CM, 2003, J APPL DEV PSYCHOL, V24, P51, DOI 10.1016/S0193-3973(03)00024-8; Watson AC, 1999, DEV PSYCHOL, V35, P386, DOI 10.1037//0012-1649.35.2.386; Lecce S, 2014, J EXP CHILD PSYCHOL, V126, P52, DOI 10.1016/j.jecp.2014.03.002; Slaughter V, 2002, BRIT J DEV PSYCHOL, V20, P545, DOI 10.1348/026151002760390945; Hughes C, 1998, J CHILD PSYCHOL PSYC, V39, P981, DOI 10.1017/S0021963098003059; Denham S. A., 1990, CHILD STUDY J, V20, P193; Fink E, 2015, BRIT J DEV PSYCHOL, V33, P1, DOI 10.1111/bjdp.12060; Furumi F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00817; Hayashi H, 2007, JPN PSYCHOL RES, V49, P261, DOI 10.1111/j.1468-5884.2007.00352.x; Hayashi H, 2010, INFANT CHILD DEV, V19, P187, DOI 10.1002/icd.641; Mizokawa A., 2007, JAPANESE J DEV PSYCH, V18, P174; Mizokawa A., 2011, JAPANESE J DEV PSYCH, V22, P168; Ornaghi V, 2015, SOC DEV, V24, P166, DOI 10.1111/sode.12091	13	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0261-510X	2044-835X		BRIT J DEV PSYCHOL	Br. J. Dev. Psychol.	MAR	2015	33	1					21	23		10.1111/bjdp.12072		3	Psychology, Developmental	Psychology	CC1MT	WOS:000350105800003		
J	Wong, TY; Ohno-Matsui, K; Leveziel, N; Holz, FG; Lai, TY; Yu, HG; Lanzetta, P; Chen, YX; Tufail, A				Wong, Tien Y.; Ohno-Matsui, Kyoko; Leveziel, Nicolas; Holz, Frank G.; Lai, Timothy Y.; Yu, Hyeong Gon; Lanzetta, Paolo; Chen, Youxin; Tufail, Adnan			Myopic choroidal neovascularisation: current concepts and update on clinical management	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Review							ENDOTHELIAL-GROWTH-FACTOR; TERM-FOLLOW-UP; INTRAVITREAL ANTI-VEGF; PATHOLOGICAL MYOPIA; PHOTODYNAMIC THERAPY; LONG-TERM; LASER PHOTOCOAGULATION; MACULAR DEGENERATION; PIGMENT EPITHELIUM; JAPANESE PATIENTS	Choroidal neovascularisation (CNV) is a common vision-threatening complication of myopia and pathological myopia. Despite significant advances in understanding the epidemiology, pathogenesis and natural history of myopic CNV, there is no standard definition of myopic CNV and its relationship to axial length and other myopic degenerative changes. Several treatments are available to ophthalmologists, but with the advent of new therapies there is a need for further consensus and clinical management recommendations. Verteporfin photodynamic therapy has been an established treatment for subfoveal myopic CNV for many years, but this treatment does not restore visual acuity and is associated with long-term chorioretinal atrophy. More recently, clinical trials investigating the efficacy and safety of anti-vascular endothelial growth factor agents in patients with myopic CNV have demonstrated substantial visual acuity gains and quality of life increases compared with photodynamic therapy. These enhanced outcomes provide updated evidence-based clinical management guidelines of myopic CNV, and increase the need for a generally accepted definition for myopic CNV. This review critically summarises the latest myopic CNV literature in the context of clinical experience and recommends a myopic CNV treatment algorithm.	[Wong, Tien Y.] Natl Univ Singapore, Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore 168751, Singapore; [Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Tokyo, Japan; [Leveziel, Nicolas] Fac Med Poitiers, Dept Ophthalmol, Poitiers, France; [Holz, Frank G.] Univ Bonn, Dept Ophthalmol, Bonn, Germany; [Lai, Timothy Y.] Chinese Univ Hong Kong, Hong Kong Eye Hosp, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Yu, Hyeong Gon] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Lanzetta, Paolo] Univ Udine, Dept Ophthalmol, I-33100 Udine, Italy; [Chen, Youxin] Beijing Union Med Coll Hosp, Dept Ophthalmol, Peking Union Med Coll, Beijing, Peoples R China; [Chen, Youxin] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Tufail, Adnan] Moorfields Eye Hosp, NIHR Moorfields Biomed Res Ctr, London, England	Wong, TY (reprint author), Natl Univ Singapore, Singapore Natl Eye Ctr, Singapore Eye Res Inst, 11 Third Hosp Ave, Singapore 168751, Singapore.	ophwty@nus.edu.sg			Novartis Pharma AG.	Medical writing services and publication costs were supported by Novartis Pharma AG.	Akagi-Kurashige Y, 2012, INVEST OPHTH VIS SCI, V53, P2349, DOI 10.1167/iovs.11-9405; Altan Tugrul, 2012, International Ophthalmology, V32, P119, DOI 10.1007/s10792-012-9532-6; Coutinho AM, 2011, RETINA-J RET VIT DIS, V31, P1089, DOI 10.1097/IAE.0b013e3181ff9546; Vadala M, 2011, BRIT J OPHTHALMOL, V95, P657, DOI 10.1136/bjo.2009.174243; Tufail A, 2013, OPHTHALMOLOGY, V120, P1944, DOI 10.1016/j.ophtha.2013.06.010; Miyake M, 2014, OPHTHALMOLOGY, V121, P225, DOI 10.1016/j.ophtha.2013.06.043; Curtis LH, 2010, ARCH OPHTHALMOL-CHIC, V128, P1273, DOI 10.1001/archophthalmol.2010.223; [Anonymous], 2009, AM J OPHTHALMOL; AVILA MP, 1984, OPHTHALMOLOGY, V91, P1573; Gharbiya M, 2010, AM J OPHTHALMOL, V149, P458, DOI 10.1016/j.ajo.2009.10.010; Kobayashi H, 2002, BRIT J OPHTHALMOL, V86, P1269, DOI 10.1136/bjo.86.11.1269; Ruiz-Moreno JM, 2013, BRIT J OPHTHALMOL, V97, P1447, DOI 10.1136/bjophthalmol-2012-302973; Parodi MB, 2010, ARCH OPHTHALMOL-CHIC, V128, P437, DOI 10.1001/archophthalmol.2009.408; Steidl SM, 1997, AM J OPHTHALMOL, V123, P181; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P3721, DOI 10.1167/iovs.09-3493; Ikuno Y, 2009, AM J OPHTHALMOL, V147, P94, DOI 10.1016/j.ajo.2008.07.017; Chakravarthy U, 2013, LANCET, V382, P1258, DOI 10.1016/S0140-6736(13)61501-9; Ruiz-Moreno JM, 2011, GRAEF ARCH CLIN EXP, V249, P595, DOI 10.1007/s00417-010-1599-z; WATZKE RC, 1984, AM J OPHTHALMOL, V98, P572; Chen YS, 2007, RETINA-J RET VIT DIS, V27, P839; Iacono P, 2012, RETINA-J RET VIT DIS, V32, P1539, DOI 10.1097/IAE.0b013e31826956b7; Fredrick DR, 2002, BRIT MED J, V324, P1195, DOI 10.1136/bmj.324.7347.1195; Silva RM, 2010, RETINA-J RET VIT DIS, V30, P407, DOI 10.1097/IAE.0b013e3181c9691e; Neelam K, 2012, PROG RETIN EYE RES, V31, P495, DOI 10.1016/j.preteyeres.2012.04.001; Ohno-Matsui K, 2003, BRIT J OPHTHALMOL, V87, P570, DOI 10.1136/bjo.87.5.570; Calvo-Gonzalez C, 2011, AM J OPHTHALMOL, V151, P529, DOI 10.1016/j.ajo.2010.09.021; Ruiz-Moreno JM, 2010, RETINA-J RET VIT DIS, V30, P1609, DOI 10.1097/IAE.0b013e3181e22659; Silva R, 2012, OPHTHALMOLOGICA, V228, P197, DOI 10.1159/000339893; Hayashi K, 2010, OPHTHALMOLOGY, V117, P1595, DOI 10.1016/j.ophtha.2009.11.003; HOTCHKISS ML, 1981, AM J OPHTHALMOL, V91, P177; Wong TY, 2014, AM J OPHTHALMOL, V157, P9, DOI 10.1016/j.ajo.2013.08.010; Lam DSC, 2004, BRIT J OPHTHALMOL, V88, P1315, DOI 10.1136/bjo.2004.041624; Wolf S, 2014, OPHTHALMOLOGY, V121, P682, DOI 10.1016/j.ophtha.2013.10.023; Yoshida T, 2003, OPHTHALMOLOGY, V110, P1297, DOI 10.1016/S0161-6420(03)00461-5; Tano Y, 2002, AM J OPHTHALMOL, V134, P645, DOI 10.1016/S0002-9394(02)01883-4; Hayashi K, 2008, AM J OPHTHALMOL, V145, P518, DOI 10.1016/j.ajo.2007.10.032; Hayashi K, 2012, RETINA-J RET VIT DIS, V32, P687, DOI 10.1097/IAE.0b013e3182278bae; Nakanishi H, 2011, EYE, V25, P375, DOI 10.1038/eye.2010.226; Leveziel N, 2013, AM J OPHTHALMOL, V155, P913, DOI 10.1016/j.ajo.2012.11.021; Soubrane G, 2008, SURV OPHTHALMOL, V53, P121, DOI 10.1016/j.survophthal.2007.12.004; Leveziel N, 2012, INVEST OPHTH VIS SCI, V53, P5004, DOI 10.1167/iovs.12-9538; Franqueira N, 2012, OPHTHALMOLOGICA, V227, P39, DOI 10.1159/000333213; AKIBA J, 1993, OPHTHALMOLOGY, V100, P1384; Hayashi K, 2011, AM J OPHTHALMOL, V151, P137, DOI 10.1016/j.ajo.2010.06.046; Tufail A, 2013, EYE, V27, P709, DOI 10.1038/eye.2013.8; HAMPTON GR, 1983, OPHTHALMOLOGY, V90, P923; Blinder KJ, 2003, OPHTHALMOLOGY, V110, P667, DOI 10.1016/S0161-6420(02)01998-X; Wang EQ, 2013, RETINA-J RET VIT DIS, V33, P1375, DOI 10.1097/IAE.0b013e31827d260a; Pece A, 2006, RETINA-J RET VIT DIS, V26, P746, DOI 10.1097/01.iae.0000244256.60524.c0; Chan WM, 2009, BRIT J OPHTHALMOL, V93, P150, DOI 10.1136/bjo.2008.145797; Lai TYY, 2009, RETINA-J RET VIT DIS, V29, P750, DOI 10.1097/IAE.0b013e31819ed6bd; Bayer HealthCare, 2013, POS PHAS 3 RES VEGF; Chan WM, 2007, BRIT J OPHTHALMOL, V91, P174, DOI 10.1136/bjo.2006.103606; Chan WM, 2005, BRIT J OPHTHALMOL, V89, P1522, DOI 10.1136/bjo.2005.074716; Channa Roomasa, 2012, J Ophthalmic Inflamm Infect, V2, P113, DOI 10.1007/s12348-011-0054-6; Costa RA, 2006, RETINA-J RET VIT DIS, V26, P757, DOI 10.1097/01.iae.0000244260.52901.2e; Cruess AF, 2014, OPHTHALMOLOGICA, V231, P75, DOI 10.1159/000355569; Fried M, 1981, DOC OPHTHALMOL P SER, V28, P215; Gharbiya M, 2012, BRIT J OPHTHALMOL, V96, P1068, DOI 10.1136/bjophthalmol-2012-301639; Gharbiya M, 2009, AM J OPHTHALMOL, V147, P84, DOI 10.1016/j.ajo.2008.07.022; Giansanti F, 2012, RETINA-J RET VIT DIS, V32, P1547, DOI 10.1097/IAE.0b013e3182411cee; Hayashi K, 2005, GRAEF ARCH CLIN EXP, V243, P13, DOI 10.1007/s00417-004-0960-5; Hayashi K, 2009, AM J OPHTHALMOL, V148, P396, DOI 10.1016/j.ajo.2009.03.026; Iacono P, 2011, RETINA-J RET VIT DIS, V31, P1841, DOI 10.1097/IAE.0b013e31821800a4; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Kojima A, 2006, GRAEF ARCH CLIN EXP, V244, P1474, DOI 10.1007/s00417-006-0324-4; Krebs I, 2005, AM J OPHTHALMOL, V140, P416, DOI 10.1016/j.ajo.2005.03.050; Lai TYY, 2012, EYE, V26, P1004, DOI 10.1038/eye.2012.97; Lewis H, 2003, AM J OPHTHALMOL, V136, P155, DOI 10.1016/S0002-9394(03)00144-2; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Miller DG, 2001, CURR OPIN OPHTHALMOL, V12, P222, DOI 10.1097/00055735-200106000-00014; Miyake M, 2013, INVEST OPHTH VIS SCI, V54, P4208, DOI 10.1167/iovs.13-12280; Mones JM, 2009, EYE LOND, V23, P81; Mones JM, 2009, EYE, V23, P1276, DOI 10.1038/eye.2009.88; Montero JA, 2003, BRIT J OPHTHALMOL, V87, P173, DOI 10.1136/bjo.87.2.173; Novartis, 2012, LUC SUMM PROD CHAR; OCEBM Levels of Evidence Working Group, 2011, OXF LEV EV; Pece A, 2011, OPHTHALMOLOGICA, V225, P161, DOI 10.1159/000322362; Pece A, 2007, AM J OPHTHALMOL, V143, P449, DOI 10.1016/j.ajo.2006.11.037; Ruiz-Moreno JM, 2011, OPHTHALMOLOGY, V118, P2521, DOI 10.1016/j.ophtha.2011.07.029; Ruiz-Moreno JM, 2002, EUR J OPHTHALMOL, V12, P117; Ruiz-Moreno JM, 2013, OPHTHALMOLOGY, V120, P1510, DOI 10.1016/j.ophtha.2013.03.006; Schnurrbusch UEK, 2005, GRAEF ARCH CLIN EXP, V243, P829, DOI 10.1007/s00417-005-1147-4; Secrétan M, 1997, Eur J Ophthalmol, V7, P307; Seko Y, 1999, INVEST OPHTH VIS SCI, V40, P3287; Shimada N, 2011, JPN J OPHTHALMOL, V55, P378, DOI 10.1007/s10384-011-0034-2; Tabandeh H, 1999, OPHTHALMOLOGY, V106, P2063, DOI 10.1016/S0161-6420(99)90484-0; Tang J, 2010, J OPHTHALMOL, DOI 10.1155/2010/175613; US Food and Drug Administration, 2011, POT US AV TREATM WET; Vance SK, 2011, RETINA-J RET VIT DIS, V31, P717, DOI 10.1097/IAE.0b013e318203c1ef; Arnold J, 2001, OPHTHALMOLOGY, V108, P841; Virgili G, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004765.pub2; Wakabayashi T, 2010, BRIT J OPHTHALMOL, V94, P611, DOI 10.1136/bjo.2009.163535; Yang HS, 2013, AM J OPHTHALMOL, V156; Yodoi Y, 2009, AM J OPHTHALMOL, V147, P816, DOI 10.1016/j.ajo.2008.11.020; Yoon JU, 2010, RETINA-J RET VIT DIS, V30, P418, DOI 10.1097/IAE.0b013e3181bd2fe4; Yoshida T, 2002, OPHTHALMOLOGY, V109, P712, DOI 10.1016/S0161-6420(01)01007-7	97	5	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	MAR	2015	99	3					289	296		10.1136/bjophthalmol-2014-305131		8	Ophthalmology	Ophthalmology	CC0AU	WOS:000349998000002		
J	Ohba, S; Nakao, N; Nakatani, Y; Kawasaki, T; Minamizato, T; Koga, T; Kohara, H; Yoshida, N; Asahina, I				Ohba, Seigo; Nakao, Noriko; Nakatani, Yuya; Kawasaki, Takako; Minamizato, Tokutaro; Koga, Takamitsu; Kohara, Haruka; Yoshida, Noriaki; Asahina, Izumi			The skeletal stability after maxillo-mandibular osteotomy with a "physiological positioning strategy" (vol 52, pg 965, 2014)	BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY			English	Correction									[Ohba, Seigo; Nakatani, Yuya; Kawasaki, Takako; Minamizato, Tokutaro; Koga, Takamitsu; Asahina, Izumi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Regenerat Oral Surg, Nagasaki, Japan; [Ohba, Seigo] Univ Fukui, Div Dent & Oral Surg, Dept Sensory & Locomotor Med, Fac Med Sci, Eiheiji, Fukui 9101193, Japan; [Nakao, Noriko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Special Care Dent, Nagasaki, Japan; [Kawasaki, Takako] Fujita Hlth Univ, Sch Med, Dept Rehabil Med, Toyoake, Aichi, Japan; [Kohara, Haruka; Yoshida, Noriaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Orthodont & Dentofacial Orthoped, Nagasaki, Japan	Ohba, S (reprint author), Univ Fukui, Div Dent & Oral Surg, Dept Sensory & Locomotor Med, Fac Med Sci, 23-3 Shimoaizuki, Eiheiji, Fukui 9101193, Japan.	seigoohba@gmail.com					Ohba S, 2014, BRIT J ORAL MAX SURG, V52, P965, DOI 10.1016/j.bjoms.2014.08.003	1	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0266-4356	1532-1940		BRIT J ORAL MAX SURG	Br. J. Oral Maxillofac. Surg.	MAR	2015	53	3					307	307		10.1016/j.bjoms.2014.12.007		1	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CB9RA	WOS:000349968600023		
J	Nakagami, Y; Masuda, K; Hatano, E; Inoue, T; Matsuyama, T; Iizuka, M; Ono, Y; Ohnuki, T; Murakami, Y; Iwasaki, M; Yoshida, K; Kasuya, Y; Komoriya, S				Nakagami, Yasuhiro; Masuda, Kayoko; Hatano, Emiko; Inoue, Tatsuya; Matsuyama, Takuya; Iizuka, Mayumi; Ono, Yasunori; Ohnuki, Takashi; Murakami, Yoko; Iwasaki, Masaru; Yoshida, Kazuhiro; Kasuya, Yuji; Komoriya, Satoshi			Novel Nrf2 activators from microbial transformation products inhibit blood-retinal barrier permeability in rabbits	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							MACULAR DEGENERATION; DIABETIC-RETINOPATHY; BARDOXOLONE METHYL; ARRIVE GUIDELINES; OLEANOLIC ACID; DISEASE; TRITERPENOIDS; PREMATURITY; PREVENTION; PHARMACOLOGY	Background and PurposeNuclear factor erythroid 2-related factor 2 (Nrf2) is a redox-sensitive transcription factor that binds to antioxidant response elements located in the promoter region of genes encoding many antioxidant enzymes and phase II detoxifying enzymes. Activation of the Nrf2 pathway seems protective for many organs, and although a well-known Nrf2 activator, bardoxolone methyl, was evaluated clinically for treating chronic kidney disease, it was found to induce adverse events. Many bardoxolone methyl derivatives, mostly derived by chemical modifications, have already been studied. However, we adopted a biotransformation technique to obtain a novel Nrf2 activator. Experimental ApproachThe potent novel Nrf2 activator, RS9, was obtained from microbial transformation products. Its Nrf2 activity was evaluated by determining NADPH:quinone oxidoreductase-1 induction activity in Hepa1c1c7 cells. We also investigated the effects of RS9 on oxygen-induced retinopathy in rats and glycated albumin-induced blood-retinal barrier permeability in rabbits because many ocular diseases are associated with oxidative stress and inflammation. Key ResultsBardoxolone methyl doubled the specific activity of Nrf2 in Hepa1c1c7 cells at a much higher concentration than RS9. Moreover, the induction of Nrf2-targeted genes was observed at a one-tenth lower concentration of RS9. Interestingly, the cytotoxicity of RS9 was substantially reduced compared with bardoxolone methyl. Oral and intravitreal administration of RS9 ameliorated the pathological scores and leakage in the models of retinopathy in rats and ocular inflammation in rabbits respectively. Conclusion and ImplicationsNrf2 activators are applicable for treating ocular diseases and novel Nrf2 activators have potential as a unique method for prevention and treatment of retinovascular disease.	[Nakagami, Yasuhiro; Hatano, Emiko; Inoue, Tatsuya; Matsuyama, Takuya; Yoshida, Kazuhiro; Kasuya, Yuji; Komoriya, Satoshi] Daiichi Sankyo Co Ltd, Tokyo 1408710, Japan; [Masuda, Kayoko; Iizuka, Mayumi; Ono, Yasunori; Ohnuki, Takashi; Murakami, Yoko; Iwasaki, Masaru] Daiichi Sankyo RD Novare Co Ltd, Tokyo, Japan	Nakagami, Y (reprint author), Daiichi Sankyo Co Ltd, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	nakagami.yasuhiro.y4@daiichisankyo.co.jp					Abboud HE, 2013, KIDNEY INT, V83, P785, DOI 10.1038/ki.2013.38; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Falavarjani KG, 2013, EYE, V27, P787, DOI 10.1038/eye.2013.107; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1797, DOI 10.1111/bph.12451; Wang L, 2014, FREE RADICAL BIO MED, V70, P155, DOI 10.1016/j.freeradbiomed.2014.01.015; Rushworth SA, 2008, J IMMUNOL, V181, P6730; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Kuno N, 2010, DRUG AGING, V27, P117, DOI 10.2165/11530970-000000000-00000; Zhong Q, 2013, INVEST OPHTH VIS SCI, V54, P3941, DOI 10.1167/iovs.13-11598; Firuzi O, 2011, CURR MED CHEM, V18, P3871; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Akula JD, 2007, INVEST OPHTH VIS SCI, V48, P4351, DOI 10.1167/iovs.07-0204; Nathan DM, 2014, DIABETES, V63, P282, DOI 10.2337/db13-0782; Mactier H, 2012, J PEDIATR-US, V160, P954, DOI 10.1016/j.jpeds.2011.12.013; Reisman SA, 2014, RADIAT RES, V181, P512, DOI 10.1667/RR13578.1; Kensler TW, 2013, TOP CURR CHEM, V329, P163, DOI 10.1007/128_2012_339; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Kiernan DF, 2012, EXPERT OPIN PHARMACO, V13, P1679, DOI 10.1517/14656566.2012.690736; Xu ZH, 2014, DIABETOLOGIA, V57, P204, DOI 10.1007/s00125-013-3093-8; Chin MP, 2014, AM J NEPHROL, V39, P499, DOI 10.1159/000362906; ENDO A, 1976, J ANTIBIOT, V29, P1346; Fahey JW, 2004, METHOD ENZYMOL, V382, P243; Zhang SC, 2000, INVEST OPHTH VIS SCI, V41, P887; Sporn MB, 2011, J NAT PROD, V74, P537, DOI 10.1021/np100826q; Itoh K, 2010, ANTIOXID REDOX SIGN, V13, P1665, DOI 10.1089/ars.2010.3222; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Payne AJ, 2014, INT J MOL SCI, V15, P1865, DOI 10.3390/ijms15021865; desZeeuw D, 2013, NEW ENGL J MED, V369, P2492; Gao Bifeng, 2014, Clin Pharmacol, V6, P19, DOI 10.2147/CPAA.S35078; HIKINO H, 1972, YAKUGAKU ZASSHI, V92, P1528; HIKINO H, 1969, YAKUGAKU ZASSHI, V89, P809; Komoriya S, 2013, Patent No. [WO2014/148455 A1, 2014148455]; Nguyen DH, 2013, DISCOV MED, V85, P343; Ravindran S, 2012, J BIOTECHNOL BIOMA S, V13; SERIZAWA N, 1991, BIOCHIM BIOPHYS ACTA, V1084, P35, DOI 10.1016/0005-2760(91)90052-J; Venisetty R. K., 2003, Current Pharmaceutical Biotechnology, V4, P153, DOI 10.2174/1389201033489847; Wang Y, 2012, ADV DEL SCI TECHNOL, P167, DOI 10.1007/978-1-4614-0554-2_10; Yasukawa T, 2007, GRAEF ARCH CLIN EXP, V245, P1475, DOI 10.1007/s00417-007-0571-z	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	MAR	2015	172	5					1237	1249		10.1111/bph.12999		13	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1LR	WOS:000350102700005		
J	Nakamoto, K; Nishinaka, T; Sato, N; Aizawa, F; Yamashita, T; Mankura, M; Koyama, Y; Kasuya, F; Tokuyama, S				Nakamoto, K.; Nishinaka, T.; Sato, N.; Aizawa, F.; Yamashita, T.; Mankura, M.; Koyama, Y.; Kasuya, F.; Tokuyama, S.			The activation of supraspinal GPR40/FFA1 receptor signalling regulates the descending pain control system	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							POLYUNSATURATED FATTY-ACIDS; ROSTRAL VENTROMEDIAL MEDULLA; ARRIVE GUIDELINES; EXPRESSION; NEURONS; RAT; CELLS; MICE; INVOLVEMENT; MOUSE	Background and PurposeThe -3 polyunsaturated fatty acids exert antinociceptive effects in inflammatory and neuropathic pain; however, the underlying mechanisms remain unclear. Docosahexaenoic acid-induced antinociception may be mediated by the orphan GPR40, now identified as the free fatty acid receptor 1 (FFA1 receptor). Here, we examined the involvement of supraspinal FFA1 receptor signalling in the regulation of inhibitory pain control systems consisting of serotonergic and noradrenergic neurons. Experimental ApproachFormalin-induced pain behaviours were measured in mice. Antinociception induced by FFA1 receptor agonists was examined by intrathecal injections of a catecholaminergic toxin, 5-HT lowering drug or these antagonists. The expression of FFA1 receptor protein and c-Fos was estimated by immunohistochemistry, and the levels of noradrenaline and 5-HT in the spinal cord were measured by LC-MS/MS. Key ResultsFFA1 receptors colocalized with NeuN (a neuron marker) in the medulla oblongata and with tryptophan hydroxylase (TPH; a serotonergic neuron marker) and dopamine -hydroxylase (DBH; a noradrenergic neuron marker). A single i.c.v. injection of GW9508, a FFA1 receptor agonist, increased the number of c-Fos-positive cells and the number of neurons double-labelled for c-Fos and TPH and/or DBH. It decreased formalin-induced pain behaviour. This effect was inhibited by pretreatment with 6-hydroxydopamine, DL-p-chlorophenylalanine, yohimbine or WAY100635. Furthermore, GW9508 facilitated the release of noradrenaline and 5-HT in the spinal cord. In addition, GW1100, a FFA1 receptor antagonist, significantly increased formalin-induced pain-related behaviour. Conclusion and ImplicationsActivation of the FFA1 receptor signalling pathway may play an important role in the regulation of the descending pain control system.	[Nakamoto, K.; Nishinaka, T.; Sato, N.; Aizawa, F.; Tokuyama, S.] Kobe Gakuin Univ, Sch Pharmaceut Sci, Dept Clin Pharm, Kobe, Hyogo 65085856, Japan; [Yamashita, T.; Kasuya, F.] Kobe Gakuin Univ, Sch Pharmaceut Sci, Biochem Toxicol Lab, Kobe, Hyogo 65085856, Japan; [Mankura, M.] Kurashiki Sakuyo Univ, Fac Food Culture, Kurashiki, Okayama, Japan; [Koyama, Y.] Osaka Ohtani Univ, Fac Pharm, Pharmacol Lab, Tonda Bayashi, Japan	Tokuyama, S (reprint author), Kobe Gakuin Univ, Sch Pharmaceut Sci, Dept Clin Pharm, Chuo Ku, 1-1-3 Minatojima, Kobe, Hyogo 65085856, Japan.	stoku@pharm.kobegakuin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24592364]	This work was supported by a Grant-in-Aid for Scientific Research (C) (24592364) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ochi T, 2000, EUR J PHARMACOL, V400, P199, DOI 10.1016/S0014-2999(00)00402-7; Ji RR, 2011, TRENDS NEUROSCI, V34, P599, DOI 10.1016/j.tins.2011.08.005; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Bardin L, 2011, BEHAV PHARMACOL, V22, P390, DOI 10.1097/FBP.0b013e328349aae4; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1449, DOI 10.1111/bph.12444; Yoshimura M, 2006, J PHARMACOL SCI, V101, P107, DOI 10.1254/jphys.CRJ06008X; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; HUNSKAAR S, 1985, J NEUROSCI METH, V14, P69, DOI 10.1016/0165-0270(85)90116-5; Goldberg RJ, 2007, PAIN, V129, P210, DOI 10.1016/j.pain.2007.01.020; Tokuyama S, 2011, BIOL PHARM BULL, V34, P1174; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Vines A, 2012, NEUROPHARMACOLOGY, V62, P184, DOI 10.1016/j.neuropharm.2011.06.017; Kodas E, 2004, J NEUROCHEM, V89, P695, DOI 10.1111/j.1471-4159.2004.02401.x; Stone LS, 1997, J NEUROSCI, V17, P7157; Zhang WJ, 2009, BRAIN, V132, P778, DOI 10.1093/brain/awn330; Ma D, 2007, NEUROSCI RES, V58, P394, DOI 10.1016/j.neures.2007.05.001; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; FIELDS HL, 1983, J NEUROSCI, V3, P2545; Ramsden CE, 2013, PAIN, V154, P2441, DOI 10.1016/j.pain.2013.07.028; FIELDS HL, 1995, J NEUROPHYSIOL, V74, P1742; Hunter JC, 1997, BRIT J PHARMACOL, V122, P1339, DOI 10.1038/sj.bjp.0701520; Chalon S, 2006, PROSTAG LEUKOTR ESS, V75, P259, DOI 10.1016/j.plefa.2006.07.005; Vanegas H, 2004, BRAIN RES REV, V46, P295, DOI 10.1016/j.brainresrev.2004.07; HALEY TJ, 1957, BRIT J PHARM CHEMOTH, V12, P12; Nakamoto K, 2012, BRAIN RES, V1432, P74, DOI 10.1016/j.brainres.2011.11.012; Tsunoda M, 2011, ANAL METHODS-UK, V3, P582, DOI 10.1039/c0ay00686f; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Lee YH, 2012, ARCH MED RES, V43, P356, DOI 10.1016/j.arcmed.2012.06.011; Boneva NB, 2011, HIPPOCAMPUS, V22, P896; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, P1; GAUDETTE DC, 1990, LIPIDS, V25, P166, DOI 10.1007/BF02544332; JONES SL, 1986, J NEUROPHYSIOL, V56, P1397; Khasabov SG, 2013, NEUROSCIENCE, V250, P151, DOI 10.1016/j.neuroscience.2013.06.057; Ma D, 2008, HIPPOCAMPUS, V18, P326, DOI 10.1002/hipo.20393; Mathieu Géraldine, 2010, Neurochem Int, V56, P94, DOI 10.1016/j.neuint.2009.09.006; Nakamoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081563; Nakamoto Kazuo, 2012, Japanese Journal of Neuropsychopharmacology, V32, P233; Nishinaka T, 2014, J PHARMACOL SCI, V125, P112, DOI 10.1254/jphs.14001SC; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, P1098; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Tanabe M, 2005, BRIT J PHARMACOL, V144, P703, DOI 10.1038/sj.bjp.0706109; Tanabe M, 2007, BRIT J PHARMACOL, V150, P403, DOI 10.1038/sj.bjp.0707125; Vreugdenhil M, 1996, P NATL ACAD SCI USA, V93, P12559, DOI 10.1073/pnas.93.22.12559; Winkler CW, 2006, J NEUROPHYSIOL, V96, P3465, DOI 10.1152/jn.00676.2006; XIAO YF, 1995, P NATL ACAD SCI USA, V92, P11000, DOI 10.1073/pnas.92.24.11000; Zamarbide M, 2014, HIPPOCAMPUS, V24, P733, DOI 10.1002/hipo.22263	50	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	MAR	2015	172	5					1250	1262		10.1111/bph.13003		13	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1LR	WOS:000350102700006		
J	Harada, K; Matsuoka, H; Miyata, H; Matsui, M; Inoue, M				Harada, Keita; Matsuoka, Hidetada; Miyata, Hironori; Matsui, Minoru; Inoue, Masumi			Identification of muscarinic receptor subtypes involved in catecholamine secretion in adrenal medullary chromaffin cells by genetic deletion	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							RAT SYMPATHETIC NEURONS; NERVE GROWTH-FACTOR; GUINEA-PIG; ACETYLCHOLINE-RECEPTORS; CHOLINERGIC-RECEPTORS; SYNAPTIC-TRANSMISSION; INTERNATIONAL UNION; ARRIVE GUIDELINES; ANGIOTENSIN-II; CONCISE GUIDE	Background and PurposeActivation of muscarinic receptors results in catecholamine secretion in adrenal chromaffin cells in many mammals, and muscarinic receptors partly mediate synaptic transmission from the splanchnic nerve, at least in guinea pigs. To elucidate the physiological functions of muscarinic receptors in chromaffin cells, it is necessary to identify the muscarinic receptor subtypes involved in excitation. Experimental ApproachTo identify muscarinic receptors, pharmacological tools and strains of mice where one or several muscarinic receptor subtypes were genetically deleted were used. Cellular responses to muscarinic stimulation in isolated chromaffin cells were studied with the patch clamp technique and amperometry. Key ResultsMuscarinic M-1, M-4 and M-5 receptors were immunologically detected in mouse chromaffin cells, and these receptors disappeared after the appropriate gene deletion. Mouse cells secreted catecholamines in response to muscarinic agonists, angiotensin II and a decrease in external pH. Genetic deletion of M-1, but not M-3, M-4 or M-5, receptors in mice abolished secretion in response to muscarine, but not to other stimuli. The muscarine-induced secretion was suppressed by MT7, a snake peptide toxin specific for M-1 receptors. Similarly, muscarine failed to induce an inward current in the presence of MT7 in mouse and rat chromaffin cells. The binding affinity of VU0255035 for the inhibition of muscarine-induced currents agreed with that for the M-1 receptor. Conclusions and ImplicationsBased upon the effects of genetic deletion of muscarinic receptors and MT7, it is concluded that the M-1 receptor alone is responsible for muscarine-induced catecholamine secretion.	[Harada, Keita; Matsuoka, Hidetada; Inoue, Masumi] Univ Occupat & Environm Hlth, Sch Med, Dept Cell & Syst Physiol, Kitakyushu, Fukuoka 8078555, Japan; [Miyata, Hironori] Univ Occupat & Environm Hlth, Sch Med, Animal Res Ctr, Kitakyushu, Fukuoka 8078555, Japan; [Matsui, Minoru] Fureai Higashitotsuka Hosp, Yokohama, Kanagawa, Japan	Inoue, M (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Cell & Syst Physiol, 1-1 Isseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	minoue@med.uoeh-u.ac.jp			JSPS KAKENHI [25460306, 24790228]	This work was supported in part by JSPS KAKENHI (25460306 to K. H. and 24790228 to H. M.). VU0255035 was a gift from Jeffrey Conn (Vanderbilt Center for Neuroscience Drug Discovery, Nashville, TN, USA). Thanks are also due to K. Mizuno (Tohoku University, Sendai, Japan) for providing PC12 cells. We are grateful to Takeshi Asakawa (Information Administration Center UOEH) for consultation about statistics and Kyoko Tashiro for the technical assistance.	Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1459, DOI 10.1111/bph.12445; Perry SF, 2011, AUTON NEUROSCI-BASIC, V165, P54, DOI 10.1016/j.autneu.2010.04.006; Huber K, 2006, DEV BIOL, V298, P335, DOI 10.1016/j.ydbio.2006.07.010; Oomori Y, 1998, CELL TISSUE RES, V294, P109, DOI 10.1007/s004410051161; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x; JAN LY, 1982, J PHYSIOL-LONDON, V327, P219; Oldfield S, 2009, MOL PHARMACOL, V76, P1279, DOI 10.1124/mol.109.058008; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Donoghue PCJ, 2008, BIOESSAYS, V30, P530, DOI 10.1002/bies.20767; Caulfield MP, 1998, PHARMACOL REV, V50, P279; de Gasparo M, 2000, PHARMACOL REV, V52, P415; KNIGHT DE, 1986, NEUROSCIENCE, V19, P357, DOI 10.1016/0306-4522(86)90027-8; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; Zhou CW, 2013, J BIOL CHEM, V288, P21458, DOI 10.1074/jbc.M112.444372; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1607, DOI 10.1111/bph.12447; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48; Servent D, 2009, J NEUROCHEM, V109, P1193, DOI 10.1111/j.1471-4159.2009.06092.x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P223; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Asano T, 1995, J VET MED SCI, V57, P1067; BALLESTA JJ, 1989, J PHYSIOL-LONDON, V418, P411; BERNHEIM L, 1992, P NATL ACAD SCI USA, V89, P9544, DOI 10.1073/pnas.89.20.9544; Bohme TM, 2002, J MED CHEM, V45, P3094, DOI 10.1021/jm011116o; BROWN AM, 1967, J PHYSIOL-LONDON, V191, P271; Brown DA, 2013, NEUROPHYSIOLOGY+, V45, P60, DOI 10.1007/s11062-013-9337-x; DORJE F, 1991, J PHARMACOL EXP THER, V256, P727; Guo J, 2003, EUR J PHARMACOL, V462, P25, DOI 10.1016/S0014-2999(03)01323-2; Harada K, 2011, J PHARMACOL SCI, V117, P253, DOI 10.1254/jphs.11125FP; Inoue M, 2008, J NEUROCHEM, V106, P1804, DOI 10.1111/j.1471-4159.2008.05521.x; Inoue M, 1998, J PHYSIOL-LONDON, V507, P807, DOI 10.1111/j.1469-7793.1998.807bs.x; Inoue M, 2000, J PHYSIOL-LONDON, V528, P473, DOI 10.1111/j.1469-7793.2000.00473.x; Inoue M, 2012, AM J PHYSIOL-CELL PH, V303, pC635, DOI 10.1152/ajpcell.00147.2012; INOUE M, 1995, BRIT J PHARMACOL, V114, P419; Kajiwara R, 1997, JPN J PHYSIOL, V47, P449, DOI 10.2170/jjphysiol.47.449; Krajewski JL, 2001, MOL PHARMACOL, V60, P725; Lamas JA, 2002, NEUROREPORT, V13, P585, DOI 10.1097/00001756-200204160-00010; Matsui M, 2004, LIFE SCI, V75, P2971, DOI 10.1016/j.lfs.2004.05.034; Matsuoka H, 2013, PFLUG ARCH EUR J PHY, V465, P1051, DOI 10.1007/s00424-013-1222-3; MILANO EG, 1983, J ANAT, V136, P165; NASSARGENTINA V, 1991, COMP BIOCHEM PHYS C, V100, P495, DOI 10.1016/0742-8413(91)90029-S; Olivos L, 2008, ACTA PHYSIOL, V192, P213, DOI 10.1111/j.1748-1716.2007.01816.x; RICHARDS MH, 1995, BRIT J PHARMACOL, V114, P1241; Sheffler DJ, 2009, MOL PHARM, V76, P358; Teschemacher AG, 2000, J NEUROSCI, V20, P4776; TOBIN JR, 1992, AM J PHYSIOL, V263, pH1208; WAKADE AR, 1983, NEUROSCIENCE, V10, P973, DOI 10.1016/0306-4522(83)90235-X; Warashina Akira, 2012, Journal of UOEH, V34, P163; Zholos AV, 1997, BRIT J PHARMACOL, V122, P885, DOI 10.1038/sj.bjp.0701438	53	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	MAR	2015	172	5					1348	1359		10.1111/bph.13011		12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1LR	WOS:000350102700013		
J	Kurokawa, Y; Sasako, M; Sano, T; Yoshikawa, T; Iwasaki, Y; Nashimoto, A; Ito, S; Kurita, A; Mizusawa, J; Nakamura, K				Kurokawa, Y.; Sasako, M.; Sano, T.; Yoshikawa, T.; Iwasaki, Y.; Nashimoto, A.; Ito, S.; Kurita, A.; Mizusawa, J.; Nakamura, K.		Japan Clinical Oncology Grp	Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia	BRITISH JOURNAL OF SURGERY			English	Article							LYMPH-NODE METASTASIS; CANCER; CARCINOMA; ESOPHAGUS; LYMPHADENECTOMY; RESECTION; CHEMOTHERAPY; EXPERIENCE; DISSECTION	BackgroundThe optimal surgical approach for treatment of oesophagogastric junction (OGJ) cancer is controversial. A randomized clinical trial (JCOG9502) comparing transhiatal (TH) and left thoracoabdominal (LTA) approaches was stopped after the first interim analysis owing to limited efficacy for LTA resections. Complete 10-year follow-up data are now available. MethodsPatients with histologically proven adenocarcinoma of the OGJ or gastric cardia with oesophageal invasion of 3cm or less were randomized to a TH or LTA approach. Both groups underwent total gastrectomy and splenectomy with D2 nodal dissection plus para-aortic lymphadenectomy above the left renal vein. For LTA, a thorough mediastinal lymphadenectomy below the left inferior pulmonary vein was also mandatory. The primary endpoint was overall survival. ResultsA total of 167 patients (82 TH, 85 LTA) were enrolled. The 10-year overall survival rate was 37 (95 per cent c.i. 26 to 47) per cent for the TH approach and 24 (15 to 34) per cent for the LTA technique (P=0060). The hazard ratio for death was 142 (098 to 205) for the LTA technique. Subgroup analysis based on the Siewert classification indicated non-significant survival advantages in favour of the TH approach. ConclusionLTA resections should be avoided in the treatment of adenocarcinoma of the OGJ or gastric cardia. Registration number: NCT00149266 (). No survival benefit from a more extensive operation	[Kurokawa, Y.] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan; [Sasako, M.] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan; [Sano, T.] Canc Inst Hosp, Dept Surg, Tokyo, Japan; [Iwasaki, Y.] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Surg, Tokyo, Japan; [Mizusawa, J.; Nakamura, K.] Natl Canc Ctr, Ctr Data, Japan Clin Oncol Grp, Tokyo 104, Japan; [Yoshikawa, T.] Kanagawa Canc Ctr, Dept Surg, Yokohama, Kanagawa 2410815, Japan; [Nashimoto, A.] Niigata Canc Ctr Hosp, Dept Surg, Niigata, Japan; [Ito, S.] Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Nagoya, Aichi 464, Japan; [Kurita, A.] Shikoku Canc Ctr, Natl Hosp Org, Dept Surg, Matsuyama, Ehime, Japan	Sasako, M (reprint author), Hyogo Coll Med, Dept Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	msasako@hyo-med.ac.jp			Ministry of Health, Labour and Welfare, Japan; National Cancer Centre Research and Development Fund [26-A-4]	The authors thank H. Kaba for data management, H. Katayama and K. Kataoka for their comments on drafts of the manuscript, and H. Fukuda for direction of the JCOG Data Centre and oversight of study management. The study was funded in part by Grants-in-Aid for Cancer Research and for the Second-Term Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare, Japan, and by the National Cancer Centre Research and Development Fund (26-A-4). Disclosure: The authors declare no conflict of interest.	Sasako M, 2008, NEW ENGL J MED, V359, P453, DOI 10.1056/NEJMoa0707035; Omloo JMT, 2007, ANN SURG, V246, P992, DOI 10.1097/SLA.0b013e31815c4037; Hosokawa Y, 2012, ANN SURG ONCOL, V19, P677, DOI 10.1245/s10434-011-1983-x; Yamashita H, 2011, ANN SURG, V254, P274, DOI 10.1097/SLA.0b013e3182263911; Sasako M, 2006, LANCET ONCOL, V7, P644, DOI 10.1016/S1470-2045(06)70766-5; Maruyama K, 1996, SEMIN ONCOL, V23, P360; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Mine S, 2013, BRIT J SURG, V100, P261, DOI 10.1002/bjs.8967; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Bollschweiler E, 2001, CANCER, V92, P549, DOI 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.3.CO;2-U; Hulscher JBF, 2001, ANN THORAC SURG, V72, P306, DOI 10.1016/S0003-4975(00)02570-4; Dresner SM, 2001, SURGERY, V129, P103, DOI 10.1067/msy.2001.110024; Gillies RS, 2011, DIS ESOPHAGUS, V24, P138, DOI 10.1111/j.1442-2050.2010.01107.x; HUSEMANN B, 1989, BRIT J SURG, V76, P136, DOI 10.1002/bjs.1800760210; Japanese Research Society for Gastric Cancer, 1995, JAP CLASS GASTR CARC; KAWAURA Y, 1988, ARCH SURG-CHICAGO, V123, P514; Kodama I, 1998, INT SURG, V83, P205; Kodera Y, 1999, J AM COLL SURGEONS, V189, P594, DOI 10.1016/S1072-7515(99)00201-X; Kurokawa Y, 2011, BRIT J SURG, V98, P239, DOI 10.1002/bjs.7297; Safranek PM, 2008, DIS ESOPHAGUS, V21, P201, DOI 10.1111/j.1442-2050.2007.00752.x; Siewert JR, 1996, DIS ESOPHAGUS, V9, P173; Sobin LH, 2002, TNM CLASSIFICATION M; vansHagen P, 2012, NEW ENGL J MED, V366, P2074; WANG LS, 1993, CANCER, V71, P1948, DOI 10.1002/1097-0142(19930315)71:6<1948::AID-CNCR2820710604>3.0.CO;2-S; YONEMURA Y, 1995, HEPATO-GASTROENTEROL, V42, P37	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1323	1365-2168		BRIT J SURG	Br. J. Surg.	MAR	2015	102	4					341	348		10.1002/bjs.9764		8	Surgery	Surgery	CB8OD	WOS:000349888700006		
J	Kiriyama, M; Ebata, T; Aoba, T; Kaneoka, Y; Arai, T; Shimizu, Y; Nagino, M				Kiriyama, M.; Ebata, T.; Aoba, T.; Kaneoka, Y.; Arai, T.; Shimizu, Y.; Nagino, M.		Nagoya Surg Oncology Grp	Prognostic impact of lymph node metastasis in distal cholangiocarcinoma	BRITISH JOURNAL OF SURGERY			English	Article							BILE-DUCT CANCER; RATIO; SURVIVAL; NUMBER; PANCREATICODUODENECTOMY; CARCINOMA; INVOLVEMENT; MARGIN; MIDDLE	BackgroundThe aim of the study was to investigate the prognostic impact of lymph node metastasis in cholangiocarcinoma using three different classifications. MethodsPatients who underwent pancreaticoduodenectomy for distal cholangiocarcinoma in 24 hospitals in Japan between 2001 and 2010 were included. Survival was calculated by means of the Kaplan-Meier method and differences between subgroups were assessed with the log rank test. The Cox proportional hazards model was used to identify independent predictors of survival. (2) scores were calculated to determine the cut-off value of the number of involved nodes, lymph node ratio (LNR) and total lymph node count (TLNC) for discriminating survival. ResultsSome 370 patients were included. The median (range) TLNC was 19 (3-59). Nodal metastasis occurred in 157 patients (424 per cent); the median (range) number of involved nodes and LNR were 2 (1-19) and 011 (002-080) respectively. Four or more involved nodes was associated with a significantly shorter median survival (13 versus 22years; P = 0001), as was a LNR of at least 017 (14 versus 23years; P = 0002). Involvement of nodes along the common hepatic artery, present in 21 patients (134 per cent), was also associated with a shorter survival (median 13 versus 21years; P = 0046). Multivariable analysis among 157 node-positive patients identified the number of involved nodes as an independent prognostic factor (risk ratio 187; P = 0002). ConclusionThe number of involved nodes was a strong predictor of survival in patients with distal cholangiocarcinoma. Number of involved nodes predicts survival after surgery	[Kiriyama, M.; Ebata, T.; Nagino, M.] Nagoya Univ, Dept Surg, Grad Sch Med, Div Surg Oncol, Nagoya, Aichi 4668550, Japan; [Shimizu, Y.] Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Nagoya, Aichi 464, Japan; [Aoba, T.] Toyohashi Municipal Hosp, Dept Gen Surg, Toyohashi, Aichi, Japan; [Kaneoka, Y.] Ogaki Municipal Hosp, Dept Surg, Ogaki, Japan; [Arai, T.] Anjo Kosei Hosp, Dept Surg, Anjo, Japan	Nagino, M (reprint author), Nagoya Univ, Dept Surg, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	nagino@med.nagoya-u.ac.jp					Yoshida T, 2002, ARCH SURG-CHICAGO, V137, P69, DOI 10.1001/archsurg.137.1.69; Kluge R, 2001, HEPATOLOGY, V33, P1029, DOI 10.1053/jhep.2001.23912; Jonnalagadda S, 2011, CANCER-AM CANCER SOC, V117, P4724, DOI 10.1002/cncr.26093; Oshiro Y, 2011, EJSO-EUR J SURG ONC, V37, P60, DOI 10.1016/j.ejso.2010.10.011; Horgan AM, 2012, J CLIN ONCOL, V30, P1934, DOI 10.1200/JCO.2011.40.5381; Igami T, 2009, ANN SURG, V249, P296, DOI 10.1097/SLA.0b013e318190a647; Schiffman SC, 2011, J AM COLL SURGEONS, V213, P45, DOI 10.1016/j.jamcollsurg.2011.04.024; Kayahara M, 1999, ANN SURG, V229, P76, DOI 10.1097/00000658-199901000-00010; Ito K, 2010, ANN SURG, V251, P675, DOI 10.1097/SLA.0b013e3181d3d2b2; Schwarz RE, 2007, J GASTROINTEST SURG, V11, P158, DOI 10.1007/s11605-006-0018-6; Aoba T, 2013, ANN SURG, V257, P718, DOI 10.1097/SLA.0b013e3182822277; Hong SM, 2005, AM J SURG PATHOL, V29, P1177, DOI 10.1097/01.pas.0000160978.77833.d7; DeOliveira ML, 2007, ANN SURG, V245, P755, DOI 10.1097/01.sla.0000251366.62632.d3; Rosenberg R, 2008, ANN SURG, V248, P968, DOI 10.1097/SLA.0b013e318190eddc; Adsay NV, 2009, MODERN PATHOL, V22, P107, DOI 10.1038/modpathol.2008.167; Hurtuk MG, 2009, AM J SURG, V197, P348, DOI 10.1016/j.amjsurg.2008.11.010; Murakami Y, 2007, WORLD J SURG, V31, P337, DOI 10.1007/s00268-006-0224-0; Sasaki R, 2001, SURGERY, V129, P677, DOI 10.1067/msy.2001.114555; Pomianowska E, 2013, ANN SURG ONCOL, V20, P233, DOI 10.1245/s10434-012-2592-z; Bando E, 2002, ANN SURG ONCOL, V9, P775, DOI 10.1245/ASO.2002.10.011; Compton CC, 2010, AJCC CANC STAGING AT; Connor S, 2004, BRIT J SURG, V91, P1592, DOI 10.1002/bjs.4761; Edge SB, 2010, AJCC CANC STAGING MA; Japanese Society of Biliary Surgery, 1993, GEN RUL SURG PATH ST; Kawai M, 2010, AM J SURG, V199, P447, DOI 10.1016/j.amjsurg.2009.01.019; Launois B, 2000, J Hepatobiliary Pancreat Surg, V7, P128, DOI 10.1007/s005340050166; Nakeeb A, 1996, ANN SURG, V224, P463, DOI 10.1097/00000658-199610000-00005; Noji T, 2005, J GASTROENTEROL, V40, P739, DOI 10.1007/s00535-005-1618-8; Tamandl D, 2009, BRIT J SURG, V96, P919, DOI 10.1002/bjs.6654; Wakai T, 2005, CANCER, V103, P1210, DOI 10.1002/cncr.20906	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1323	1365-2168		BRIT J SURG	Br. J. Surg.	MAR	2015	102	4					399	406		10.1002/bjs.9752		8	Surgery	Surgery	CB8OD	WOS:000349888700013		
J	Fujiwara, K; Yoshizawa, K; Sakazaki, H				Fujiwara, Keiichi; Yoshizawa, Kosuke; Sakazaki, Hisanori			Thrombus in the left atrial appendage: a case report of neonate	CARDIOLOGY IN THE YOUNG			English	Article						Neonatal thrombus; left atrial thrombus; intracardiac mass; thrombectomy	CARDIAC TUMORS; INFANCY	A Japanese girl first pointed out the mass in the left atrial appendage by the echocardiography on the 3rd day of life. At 30th day of life, the mass in the left atrial appendage was excised en bloc successfully under cardiopulmonary bypass because it appeared mobile. Its pathologic finding revealed an old organised thrombus. She is doing well with no episode of thrombus formation or thromboembolism, 2 years postoperatively.	[Fujiwara, Keiichi; Yoshizawa, Kosuke] Hyogo Kenritsu Amagasaki Hosp, Dept Cardiovasc Surg, Kobe, Hyogo 6600828, Japan; [Sakazaki, Hisanori] Hyogo Kenritsu Amagasaki Hosp, Dept Pediat Cardiol, Kobe, Hyogo 6600828, Japan	Fujiwara, K (reprint author), Hyogo Kenritsu Amagasaki Hosp, Dept Cardiovasc Surg, 1-1-1 Higashi Daimotsu, Kobe, Hyogo 6600828, Japan.	k_fujiwara@hp.pref.hyogo.jp					Isaacs H, 2004, PEDIATR CARDIOL, V25, P252, DOI 10.1007/s00246-003-0590-4; Freedom RM, 2000, PEDIATR CARDIOL, V21, P299, DOI 10.1007/s002460010070; Al-Saady NM, 1999, HEART, V82, P547; Al Dhahri KN, 2006, CARDIOL YOUNG, V16, P392, DOI 10.1017/S1047951106000436; Aswani R, 2010, PEDIATR CARDIOL, V31, P1116, DOI 10.1007/s00246-010-9777-7; Fujiwara K, 1999, ANN THORAC SURG, V67, P1492, DOI 10.1016/S0003-4975(99)00244-1; John JB, 2007, PEDIATR CARDIOL, V28, P213, DOI 10.1007/s00246-005-1068-3; MARX GR, 1984, J AM COLL CARDIOL, V3, P827; Russo G, 2008, INT J CARDIOL, V131, pE17, DOI 10.1016/j.ijcard.2007.07.049; Saxonhouse MA, 2012, CLIN PERINATOL, V39, P191, DOI 10.1016/j.clp.2011.12.018	10	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1047-9511	1467-1107		CARDIOL YOUNG	Cardiol. Young	MAR	2015	25	3					560	562		10.1017/S1047951114000390		3	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	CB6RT	WOS:000349755000025		
J	Nakayama, T; Saitoh, H				Nakayama, Tomofumi; Saitoh, Hisato			Tunicamycin-induced neutrophil extracellular trap (NET)-like structures in cultured human myeloid cell lines	CELL BIOLOGY INTERNATIONAL			English	Article						apoptosis; chromatin; myeloid cell; neutrophil extracellular trap (NET); tunicamycin	IMMUNITY	The mechanism of neutrophil extracellular trap cell death (NETosis), a regulated cell death pathway relevant to infection, autoimmunity and sepsis, is not completely known. The reason for this, at least in part, is the lack of an in vitro system that recapitulates the NETosis pathway using established human cell lines. We show that exposure of a human promyelocytic leukemia cell line HL-60 to the glycosyltransferase inhibitor tunicamycin (TM) resulted in extrusion of decompacted genomic DNAs to extracellular space, morphologically similar to NETs. Immunostaining using antibodies against NET marker proteins and bacterial trapping assay showed biochemical similarities between the TM-induced extracellular DNA structures and NETs. The NET-like structures were also generated on exposure of TM to other myeloid cell lines, such as U937 and THP-1. Thus, our findings provide an experimental setting to induce NET-like structures using cultured human myeloid cell lines, which may help our understanding of the regulation and function of NETosis.	[Nakayama, Tomofumi; Saitoh, Hisato] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto, Japan	Saitoh, H (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto, Japan.	hisa@kumamoto-u.ac.jp			KAKENHI grant from JSPS [26116517]; Astellas foundation for Research on Metabolic Disorders	We thank the members of the Saitoh Laboratory for helpful discussion. This work was supported by KAKENHI grant (Number 26116517) from JSPS and research grant from Astellas foundation for Research on Metabolic Disorders to H.S.	Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Banerjee DK, 2012, BBA-GEN SUBJECTS, V1820, P1338, DOI 10.1016/j.bbagen.2012.01.013; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; [Anonymous], 2012, J PARASITOL RES, DOI DOI 10.1155/2012/929743; Kawata J, 2013, CELLBIO, V2, P117; Kawata J, 2014, BIOTECHNOL LETT, V36, P241, DOI 10.1007/s10529-013-1364-6; Urban CF, 2009, PLOS PATHOG, V25	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-6995	1095-8355		CELL BIOL INT	Cell Biol. Int.	MAR	2015	39	3					355	359		10.1002/cbin.10396		5	Cell Biology	Cell Biology	CC1ME	WOS:000350104000016		
J	Kim, MH; Sonoda, Y; Sasaki, K; Kaminaka, H; Imai, R				Kim, Myung-Hee; Sonoda, Yutaka; Sasaki, Kentaro; Kaminaka, Hironori; Imai, Ryozo			Interactome analysis reveals versatile functions of Arabidopsis COLD SHOCK DOMAIN PROTEIN 3 in RNA processing within the nucleus and cytoplasm (vol 18, pg 517, 2013)	CELL STRESS & CHAPERONES			English	Correction									[Kim, Myung-Hee; Sonoda, Yutaka; Sasaki, Kentaro; Imai, Ryozo] Natl Agr & Food Res Org, Hokkaido Agr Res Ctr, Crop Breeding Res Div, Toyohira Ku, Sapporo, Hokkaido 0628555, Japan; [Kaminaka, Hironori] Tottori Univ, Fac Agr, Plant Mol Biol Lab, Tottori 680, Japan	Imai, R (reprint author), Natl Agr & Food Res Org, Hokkaido Agr Res Ctr, Crop Breeding Res Div, Toyohira Ku, Hitsujigaoka 1, Sapporo, Hokkaido 0628555, Japan.	rzi@affrc.go.jp					Kim MH, 2013, CELL STRESS CHAPERON, V18, P517, DOI 10.1007/s12192-012-0398-3	1	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1355-8145	1466-1268		CELL STRESS CHAPERON	Cell Stress Chaperones	MAR	2015	20	2					397	397		10.1007/s12192-014-0567-7		1	Cell Biology	Cell Biology	CB8US	WOS:000349907600020		
J	Sato, A; Yamanaka, H; Oe, K; Yokoyama, I; Yamazaki, Y; Ebina, K				Sato, Akira; Yamanaka, Hikaru; Oe, Keitaro; Yokoyama, Izumi; Yamazaki, Yoji; Ebina, Keiichi			Highly Stable, Fluorescence-Labeled Heptapeptides Substituted with a D-Amino Acid for the Specific Detection of Oxidized Low-Density Lipoprotein in Plasma	CHEMICAL BIOLOGY & DRUG DESIGN			English	Article						atherosclerosis; D-amino acid; fluorescent probe; oxidized LDL; plasma stability; synthetic peptide	ASP-HEMOLYSIN; ASPERGILLUS-FUMIGATUS; RECOGNIZES LYSOPHOSPHATIDYLCHOLINE; ATHEROSCLEROTIC LESIONS; MONOCLONAL-ANTIBODY; BINDING SPECIFICITY; PEPTIDE COMPOUNDS; CELL-DEATH; INDUCTION; APOPTOSIS	Probes that can detect oxidized low-density lipoprotein (ox-LDL) in plasma and in atherosclerotic plaques can be useful for the diagnosis, prevention, and treatment of atherosclerosis. Recently, we have reported that two heptapeptides (Lys-Trp-Tyr-Lys-Asp-Gly-Asp, KP6) coupled to fluorescein isothiocyanate (FITC) through the epsilon-amino group of N-terminus Lys in the absence/presence of 6-amino-n-caproic acid (AC) linker to FITC(FITC)KP6 and (FITC-AC)KP6can be useful as fluorescent probes for the specific detection of ox-LDL. In this study, to develop the fluorescent peptides with high plasma stability for the specific detection of ox-LDL, we investigated the interaction of (FITC)KP6 and (FITC-AC)KP6 substituted with D-Lys at the N-terminus(FITC)dKP6 and (FITC-AC)dKP6with ox-LDL, and the in vitro stability of these peptides in mouse plasma. (FITC)dKP6 and (FITC-AC)dKP6 bound with high specificity to ox-LDL in a dose-dependent manner, and also to ox-LDL in the mouse plasma. Furthermore, (FITC)dKP6 was more stable than (FITC)KP6 in mouse plasma (102.1% versus 69.0% remained after 1h). These findings strongly suggest that (FITC)dKP6 and (FITC-AC)dKP6 may be effective fluorescent probes with higher plasma stability than (FITC)KP6 and (FITC-AC)KP6 for the specific detection of ox-LDL.	[Sato, Akira; Yamanaka, Hikaru; Oe, Keitaro; Yokoyama, Izumi; Yamazaki, Yoji; Ebina, Keiichi] Iwaki Meisei Univ, Fac Pharm, Iwaki, Fukushima 9708551, Japan	Sato, A (reprint author), Iwaki Meisei Univ, Fac Pharm, 5-5-1 Chuodai Iino, Iwaki, Fukushima 9708551, Japan.	a-sato@iwakimu.ac.jp			Adaptable and Seamless Technology Transfer Program through Target-driven R&D from Japan Science and Technology Agency	This work was supported in part by the Adaptable and Seamless Technology Transfer Program through Target-driven R&D from the Japan Science and Technology Agency (to A.S.).	HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Tsutsumi H, 2006, BIOL PHARM BULL, V29, P907, DOI 10.1248/bpb.29.907; Kumagai T, 2005, BIOL PHARM BULL, V28, P1381, DOI 10.1248/bpb.28.1381; MATSUMOTO A, 1990, P NATL ACAD SCI USA, V87, P9133, DOI 10.1073/pnas.87.23.9133; EBINA K, 1994, BBA-GENE STRUCT EXPR, V1219, P148, DOI 10.1016/0167-4781(94)90258-5; Kudo Y, 2002, BIOL PHARM BULL, V25, P787, DOI 10.1248/bpb.25.787; Mitra S, 2011, AM J MED SCI, V342, P135, DOI 10.1097/MAJ.0b013e318224a147; Itabe H, 1996, J LIPID RES, V37, P45; YOKOTA K, 1977, MICROBIOL IMMUNOL, V21, P11; Sigala F, 2010, J VASC SURG, V52, P704, DOI 10.1016/j.jvs.2010.03.047; Aikawa M, 2002, CIRCULATION, V106, P1390, DOI 10.1161/01.CIR.0000028465.52694.9B; Luo ZL, 2012, CHEM SOC REV, V41, P4736, DOI 10.1039/c2cs15360b; ROSENFELD ME, 1991, CIRCULATION, V83, P2137; Itabe H, 1998, PROG LIPID RES, V37, P181, DOI 10.1016/S0163-7827(98)00009-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Esposti MD, 2003, CELL DEATH DIFFER, V10, P1300, DOI 10.1038/sj.cdd.4401306; Kumagai T, 2006, BIOL PHARM BULL, V29, P2181, DOI 10.1248/bpb.29.2181; Manara A, 2009, BBA-MOL CELL BIOL L, V1791, P997, DOI 10.1016/j.bbalip.2009.05.003; Sato A, 2012, EUR J PHARMACOL, V685, P205, DOI 10.1016/j.ejphar.2012.04.025; Caplan B. A., 1973, ATHEROSCLEROSIS, V17, P60; Crisby M, 1997, ATHEROSCLEROSIS, V130, P17, DOI 10.1016/S0021-9150(96)06037-6; Fukuchi Y, 1998, FEMS MICROBIOL LETT, V167, P275, DOI 10.1111/j.1574-6968.1998.tb13239.x; ITABE H, 1994, J BIOL CHEM, V269, P15274; JOUGASAKI M, 1992, CIRC RES, V71, P614; Kudo Y, 1999, BIOL PHARM BULL, V22, P549; Kudo Y, 2001, BBA-GEN SUBJECTS, V1568, P183, DOI 10.1016/S0304-4165(01)00217-3; Nishi K, 2002, ARTERIOSCL THROM VAS, V22, P1649, DOI 10.1161/01.ATV.0000033829.14012.18; Ramos-Arellano LE, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-54; Ross R, 1999, NEW ENGL J MED, V340, P115; Sato A, 2014, CHEM BIOL DRUG DES, V84, P443, DOI 10.1111/cbdd.12333; Sato A, 2012, CHEM BIOL DRUG DES, V80, P417, DOI 10.1111/j.1747-0285.2012.01413.x; Sternberg D., 1989, NEW ENGL J MED, V320, P915; SUGIYAMA S, 1994, CIRC RES, V74, P565; Witztum JL, 1993, BRIT HEART J, V69, P12	34	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-0277	1747-0285		CHEM BIOL DRUG DES	Chem. Biol. Drug Des.	MAR	2015	85	3					348	355		10.1111/cbdd.12399		8	Biochemistry & Molecular Biology; Chemistry, Medicinal	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CC1PE	WOS:000350112600013		
J	Gautam, SG; Komatsu, M; Nishigaki, K				Gautam, Sunita Ghimire; Komatsu, Masayuki; Nishigaki, Koichi			Strong Inhibition of Beta-Amyloid Peptide Aggregation Realized by Two-Steps Evolved Peptides	CHEMICAL BIOLOGY & DRUG DESIGN			English	Article						aggregation; aggregation inhibitors; Alzheimer's disease; amyloid; amyloid precursor protein; aptamers; fibrillization; in vitro evolution; mRNA display; peptide aptamers	IN-VITRO EVOLUTION; ALZHEIMERS-DISEASE; A-BETA; COGNITIVE DECLINE; CATHEPSIN-E; OLIGOMERS; PROTEIN; BINDING; THERAPY; THERAPEUTICS	Several decades of cumulated research evidence have proven that aggregation of beta-amyloid 42 (A42) is the main cause of neuronal death in the brains of patients with Alzheimer's disease. Therefore, inhibition of A42 aggregation holds great promise for the prevention and treatment of Alzheimer's disease. To this end, we used a systematic in vitro evolution including a paired peptide library method. We identified two peptides with high binding affinity (with K-d in the nm range) for A42. Functionally, these peptides strongly inhibited the aggregation of A42 as shown by the thioflavin T assay and atomic force microscopy. Moreover, these peptides rescued PC12 cells from the cytotoxic effect of aggregated A42 in vitro. Our results suggest that these novel peptides may be potential therapeutic seeds for the treatment of Alzheimer's disease.	[Gautam, Sunita Ghimire; Komatsu, Masayuki; Nishigaki, Koichi] Saitama Univ, Grad Sch Sci & Engn, Dept Funct Mat Sci, Sakura Ku, Saitama 3388570, Japan	Nishigaki, K (reprint author), Saitama Univ, Grad Sch Sci & Engn, Dept Funct Mat Sci, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	koichi@fms.saitama-u.ac.jp			MEXT [REDS3]	We would like to thank Dr. Ikuo Obata and Dr. Nobuhiro Saitoh of JPK AG and Dr. Manish Biyani of Tokyo University for their generous assistance in obtaining the AFM images. We are also grateful to Masaaki Fujiwara and his staffs at CHIOME Bioscience Inc. for supporting our SPR experiments. This work was partly supported by the MEXT grant for Fostering Regional Innovation (City Area Type) for the Central Saitama Area [Saitama-Bio-Project III (REDS3)].	Nemoto N, 1997, FEBS LETT, V414, P405, DOI 10.1016/S0014-5793(97)01026-0; Li J, 2011, CURR MED CHEM, V18, P4215; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Ladiwala ARA, 2012, J BIOL CHEM, V287, P24765, DOI 10.1074/jbc.M111.329763; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Selkoe DJ, 2001, PHYSIOL REV, V81, P741; Ladiwala ARA, 2011, J BIOL CHEM, V286, P3209, DOI 10.1074/jbc.M110.173856; Funke SA, 2012, CURR PHARM DESIGN, V18, P755; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Schlippe YVG, 2012, J AM CHEM SOC, V134, P10469, DOI 10.1021/ja301017y; Fradinger EA, 2008, P NATL ACAD SCI USA, V105, P14175, DOI 10.1073/pnas.0807163105; St George-Hyslop PH, 2005, CR BIOL, V328, P119, DOI 10.1016/j.crvi.2004.10.013; Gabathuler R, 2010, NEUROBIOL DIS, V37, P48, DOI 10.1016/j.nbd.2009.07.028; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Stroud JC, 2012, P NATL ACAD SCI USA, V109, P7717, DOI 10.1073/pnas.1203193109; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Baine M, 2009, J PEPT SCI, V15, P499, DOI 10.1002/psc.1150; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Chang YS, 2013, P NATL ACAD SCI USA, V110, pE3445, DOI 10.1073/pnas.1303002110; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Atwal JK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002254; Greenberg BD, 2013, ALZHEIMERS DEMENT, V9, P39, DOI 10.1016/j.jalz.2012.02.002; Kitamura K, 2002, PROTEIN ENG, V15, P843, DOI 10.1093/protein/15.10.843; Kitamura K, 2009, J MOL BIOL, V387, P1186, DOI [10.1016/j.jmb.2008.12.028, 10.1016/j.imb.2008.12.028]; Kitamura K, 2012, J PEPT SCI, V18, P711, DOI 10.1002/psc.2453; Komatsu M., 2012, INT J PEPT, V2012; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Luo Y, 2013, ACS CHEM NEUROSCI, V4, P952, DOI 10.1021/cn400011f; McKoy AF, 2012, J BIOL CHEM, V287, P38992, DOI 10.1074/jbc.M112.348037; Park SK, 2011, DIS MODEL MECH, V4, P822, DOI 10.1242/dmm.007963; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schenk D, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006387; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Sörgjerd Karin Margareta, 2013, Biochemistry, V52, P3532, DOI 10.1021/bi301705c; Tabuchi I, 2001, FEBS LETT, V508, P309, DOI 10.1016/S0014-5793(01)03075-7; Takahashi T, 2010, PROTEINS, V78, P336, DOI 10.1002/prot.22546; Tsuji-Ueno S, 2011, PROTEIN PEPTIDE LETT, V18, P642	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-0277	1747-0285		CHEM BIOL DRUG DES	Chem. Biol. Drug Des.	MAR	2015	85	3					356	368		10.1111/cbdd.12400		13	Biochemistry & Molecular Biology; Chemistry, Medicinal	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CC1PE	WOS:000350112600014		
J	Itoigawa, Y; Sperling, JW; Steinmann, SP; Chen, QS; Song, PF; Chen, SG; Itoi, E; Hatta, T; An, KN				Itoigawa, Yoshiaki; Sperling, John W.; Steinmann, Scott P.; Chen, Qingshan; Song, Pengfei; Chen, Shigao; Itoi, Eiji; Hatta, Taku; An, Kai-Nan			Feasibility Assessment of Shear Wave Elastography to Rotator Cuff Muscle	CLINICAL ANATOMY			English	Article						rotator cuff; muscle; tendon; ultrasound; shear wave elastography; imaging; supraspinatus	ULTRASOUND VIBROMETRY SDUV; FULL-THICKNESS TEARS; TISSUE ELASTICITY; MUSCULOTENDINOUS ARCHITECTURE; OPEN REPAIR; SUPRASPINATUS; DEGENERATION; VISCOSITY; RUPTURES; TENDON	Pre-surgical measurement of supraspinatus muscle extensibility is important for rotator cuff repair. The purpose of the present study was to explore the potential feasibility of a shear wave ultrasound elastography (SWE)-based method, combined with B-mode ultrasound, to measure the in vivo stiffness of the supraspinatus muscle non-invasively and thus obtain key information about supraspinatus muscle extensibility. Our investigation comprised two steps. First, we determined the orientation of the supraspinatus muscle fibers in cadaveric shoulders without rotator cuff tear in order to optimize the ultrasound probe positions for SWE imaging. Second, we investigated the feasibility of quantifying the stiffness of the normal supraspinatus muscle by SWE in vivo. The supraspinatus muscle was divided into four anatomical regions: anterior superficial (AS), posterior superficial (PS), anterior deep (AD), and posterior deep (PD). Each region was examined by SWE. The SWE stiffnesses of AD, AS, PD, and PS were 40.0 +/- 12.4, 34.0 +/- 9.9, 32.7 +/- 12.7, 39.1 +/- 15.7 kPa, respectively. SWE combined with B-Mode ultrasound imaging could be a feasible method for quantifying the local stiffness of the rotator cuff muscles. Clin. Anat. 28:213-218, 2015. (c) 2014 Wiley Periodicals, Inc.	[Itoigawa, Yoshiaki; Chen, Qingshan; Hatta, Taku; An, Kai-Nan] Mayo Clin, Div Orthoped Res, Biomech Lab, Rochester, MN USA; [Itoigawa, Yoshiaki; Chen, Qingshan; Hatta, Taku; An, Kai-Nan] Mayo Clin, Div Orthoped Res, Soft Tissue Biol Labs, Rochester, MN USA; [Sperling, John W.; Steinmann, Scott P.] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA; [Song, Pengfei; Chen, Shigao] Mayo Clin, Coll Med, Rochester, MN USA; [Itoi, Eiji] Tohoku Univ, Sch Med, Dept Orthopaed Surg, Sendai, Miyagi 980, Japan	An, KN (reprint author), 200 First St SW, Rochester, MN 55905 USA.	an@mayo.edu			Mayo Foundation; Alumni Scholarship from Juntendo University School of Medicine	Contract grant sponsors: Mayo Foundation, Alumni Scholarship from Juntendo University School of Medicine.	Arda K, 2011, AM J ROENTGENOL, V197, P532, DOI 10.2214/AJR.10.5449; Kim S, 2010, CLIN ANAT, V23, P48, DOI 10.1002/ca.20896; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Liu XH, 2011, J ORTHOP RES, V29, P588, DOI 10.1002/jor.21266; Khazzam M, 2012, AM J SPORT MED, V40, P1722, DOI 10.1177/0363546512449424; Goutallier D, 2003, J SHOULDER ELB SURG, V12, P550, DOI 10.1016/S1058-2746(03)00211-8; Tomioka T, 2009, J SHOULDER ELB SURG, V18, P955, DOI 10.1016/j.jse.2009.03.009; Mariappan YK, 2010, CLIN ANAT, V23, P497, DOI 10.1002/ca.21006; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Steinbacher P, 2010, TISSUE CELL, V42, P37, DOI 10.1016/j.tice.2009.07.001; Itoigawa Y, 2011, J ORTHOP RES, V29, P861, DOI 10.1002/jor.21317; Bartl C, 2012, INT J SHOULDER SURG, V6, P1, DOI 10.4103/0973-6042.94304; Yamamoto Atsushi, 2010, J Shoulder Elbow Surg, V19, P116, DOI 10.1016/j.jse.2009.04.006; Matthews TJW, 2006, J BONE JOINT SURG BR, V88B, P489, DOI 10.1302/0301-620X.8884.16845; Zumstein MA, 2008, J BONE JOINT SURG AM, V90A, P2423, DOI 10.2106/JBJS.G.00677; Chen SG, 2009, IEEE T ULTRASON FERR, V56, P55, DOI 10.1109/TUFFC.2009.1005; Eby SF, 2013, J BIOMECH, V46, P2381, DOI 10.1016/j.jbiomech.2013.07.033; Miller BS, 2011, AM J SPORT MED, V39, P2064, DOI 10.1177/0363546511413372; Chen SG, 2009, IEEE ENG MED BIO, P2252; Fırat Tüzün, 2012, Pathophysiology, V19, P179, DOI 10.1016/j.pathophys.2012.04.008; GOUTALLIER D, 1994, CLIN ORTHOP RELAT R, P78; Goutallier D, 2005, REV CHIR ORTHOP, V91, P109, DOI 10.1016/S0035-1040(05)84287-4; Kim SY, 2007, CLIN ANAT, V20, P648, DOI 10.1002/ca.20469; Kim SY, 2012, CLIN ANAT, V26, P228; Meyer DC, 2006, J BONE JOINT SURG BR, V88B, P1533, DOI 10.1302/0301-620X.88B11.17791; Minagawa Hiroshi, 2013, J Orthop, V10, P8, DOI 10.1016/j.jor.2013.01.008; Plagou A, 2011, ULTRASOUND MED BIOL, V37, pS140; Safran O, 2005, J BONE JOINT SURG AM, V87A, P2662, DOI 10.2106/JBJS.D.02421; Zuo JL, 2012, J ORTHOP SCI, V17, P58, DOI 10.1007/s00776-011-0176-6	29	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0897-3806	1098-2353		CLIN ANAT	Clin. Anat.	MAR	2015	28	2					213	218		10.1002/ca.22498		6	Anatomy & Morphology	Anatomy & Morphology	CC1LM	WOS:000350102200009		
J	Kobayashi, Y; Uehara, T; Kawasaki, K; Sugano, M; Matsumoto, T; Matsumoto, G; Honda, T				Kobayashi, Yukihiro; Uehara, Takeshi; Kawasaki, Kenji; Sugano, Mitsutoshi; Matsumoto, Takehisa; Matsumoto, Gou; Honda, Takayuki			Three-Dimensional Analysis of Alveolar Wall Destruction in the Early Stage of Pulmonary Emphysema	CLINICAL ANATOMY			English	Article						chronic obstructive pulmonary disease; elastic fiber; emphysema; alveolar capillary; alveolar wall	LUNG PARENCHYMAL DESTRUCTION; BRONCHIOLOALVEOLAR CARCINOMA; ELASTIC FIBERS; SMOKERS; FENESTRAE; COPD	The morphological mechanism of alveolar wall destruction during pulmonary emphysema has not been clarified. The aim of this study was to elucidate this process three-dimensionally. Lung specimens from five patients with pulmonary emphysema were used, and five controls with normal alveolar structure were also examined. Sections 150 m thick were stained with hematoxylin and eosin, elastica, and silver impregnation, and immunostained with selected antibodies. We examined these sections three-dimensionally using a laser confocal microscope and a light microscope. There were only a few Kohn's pores and no fenestrae in the normal alveoli from the controls. In the lungs of the emphysema patients a small rupture appeared in the extremely thin alveolar wall among the alveolar capillaries. This rupture enlarged to form a circle surrounded by the capillaries, which was called an alveolar fenestra. Two neighboring fenestrae fused by breakdown of the collapsed or cord-like capillary between them to form a large fenestra. The large fenestrae fused repeatedly to become larger, and these were bordered by thick elastic fibers constructing an alveolar framework. Alveolar wall destruction during emphysema could start from small ruptures of the alveolar wall that become fenestrae surrounded by capillaries, which fuse repeatedly to become larger fenestrae rimmed with elastic fibers. The alveolar capillary network could initially prevent enlargement of the fenestrae, and the thick elastic fibers constituting the alveolar framework could secondarily prevent destruction of the alveolar wall structure. Clin. Anat. 28:227-234, 2015. (c) 2014 Wiley Periodicals, Inc.	[Kobayashi, Yukihiro; Uehara, Takeshi; Kawasaki, Kenji; Sugano, Mitsutoshi; Matsumoto, Takehisa; Matsumoto, Gou; Honda, Takayuki] Shinshu Univ Hosp, Dept Lab Med, Matsumoto, Nagano, Japan; [Uehara, Takeshi; Honda, Takayuki] Shinshu Univ, Sch Med, Dept Lab Med, Matsumoto, Nagano 3908621, Japan; [Matsumoto, Gou] Shinshu Univ Hosp, Div Infect Control, Matsumoto, Nagano, Japan	Honda, T (reprint author), Shinshu Univ, Sch Med, Dept Lab Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	thondat@shinshu-u.ac.jp					Vlahovic G, 1999, AM J RESP CRIT CARE, V160, P2086; Suga M, 2000, AM J RESP CRIT CARE, V162, P1949; SAETTA M, 1985, AM REV RESPIR DIS, V131, P764; Robbesom AA, 2003, MODERN PATHOL, V16, P1, DOI 10.1097/01.MP.0000043519.29370.C2; MEAD J, 1967, J APPL PHYSIOL, V22, P95; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; BOREN HG, 1962, AM REV RESPIR DIS, V85, P328; Brusselle GG, 2006, PULM PHARMACOL THER, V19, P155, DOI 10.1016/j.pupt.2005.06.001; COSIO MG, 1986, AM REV RESPIR DIS, V133, P126; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; EIDELMAN D, 1990, AM REV RESPIR DIS, V141, P1547; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hogg JC, 2008, INT J TUBERC LUNG D, V12, P467; Honda T, 2002, LUNG CANCER-J IASLC, V36, P283, DOI 10.1016/S0169-5002(02)00002-8; Honda T, 2000, ANAT REC, V258, P34; Honda T, 2002, VIRCHOWS ARCH, V441, P47, DOI 10.1007/s00428-001-0567-8; Jacob RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006670; LEOPOLD J. G., 1957, THORAX, V12, P219, DOI 10.1136/thx.12.3.219; MERCER RR, 1992, J APPL PHYSIOL, V72, P1473; NAGAI A, 1994, AM J RESP CRIT CARE, V150, P1411; NAGAI A, 1989, AM REV RESPIR DIS, V139, P313; OTTOVERBERNE CJM, 1991, EUR RESPIR J, V4, P316; PUMP KK, 1976, AM REV RESPIR DIS, V114, P5; Uehara T, 2004, LUNG, V182, P343, DOI 10.1007/s00408-004-2515-2	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0897-3806	1098-2353		CLIN ANAT	Clin. Anat.	MAR	2015	28	2					227	234		10.1002/ca.22463		8	Anatomy & Morphology	Anatomy & Morphology	CC1LM	WOS:000350102200011		
J	Nonaka, F; Migita, K; Jiuchi, Y; Shimizu, T; Umeda, M; Iwamoto, N; Fujikawa, K; Izumi, Y; Mizokami, A; Nakashima, M; Ueki, Y; Yasunami, M; Kawakami, A; Eguchi, K				Nonaka, F.; Migita, K.; Jiuchi, Y.; Shimizu, T.; Umeda, M.; Iwamoto, N.; Fujikawa, K.; Izumi, Y.; Mizokami, A.; Nakashima, M.; Ueki, Y.; Yasunami, M.; Kawakami, A.; Eguchi, K.			Increased prevalence of MEFV exon 10 variants in Japanese patients with adult-onset Still's disease	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						adult-onset Still's disease; autoinflammatory disease; MEFV	FAMILIAL MEDITERRANEAN FEVER; AUTOINFLAMMATORY DISEASES; ANKYLOSING-SPONDYLITIS; TARGETED THERAPY; MUTATIONS; PATHOGENESIS; ASSOCIATION; SPECTRUM; DOMAIN; GENE	Autoinflammatory diseases include a large spectrum of monogenic diseases, e.g. familial Mediterranean fever (FMF), as well as complex genetic trait diseases, e.g. adult-onset Still's disease (AOSD). In populations where FMF is common, an increased MEFV mutation rate is found in patients with rheumatic diseases. The aim of this study was to examine MEFV mutations in Japanese patients with AOSD. Genomic DNA was isolated from 49 AOSD patients and 105 healthy controls, and exons 1, 2, 3 and 10 of the MEFV gene genotyped by direct sequencing. MEFV mutation frequencies in AOSD patients were compared with controls. We found no significant difference in overall allele frequencies of MEFV variants between AOSD patients and controls. However, MEFV exon 10 variants (M694I and G632S) were significantly higher in AOSD patients than controls (61 versus 0%). In addition, there was no significant difference between MEFV variant carriers and non-carriers with clinical manifestations, but the monocyclic clinical course of the AOSD disease phenotype was observed less frequently in patients without MEFV variants. AOSD patients had significantly higher frequencies of MEFV exon 10 mutations, suggesting that low-frequency variants of MEFV gene may be one of the susceptibility factors of AOSD.	[Nonaka, F.; Shimizu, T.; Eguchi, K.] Sasebo City Gen Hosp, Dept Internal Med, Sasebo, Japan; [Umeda, M.; Ueki, Y.] Sasebo Chuo Hosp, Dept Rheumatol, Sasebo, Japan; [Migita, K.; Jiuchi, Y.; Izumi, Y.] NHO Natl Nagasaki Med Ctr, Dept Rheumatol, Omura 8568562, Japan; [Iwamoto, N.; Kawakami, A.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Unit Translat Med, Nagasaki 852, Japan; [Nakashima, M.] Japanese Red Cross Nagasaki Genbaku Hosp, Dept Rheumatol, Nagasaki, Japan; [Yasunami, M.] Nagasaki Univ, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Fujikawa, K.; Mizokami, A.] Japan Community Hlth Care Org, Isahaya Gen Hosp, Dept Rheumatol, Isahaya, Japan	Migita, K (reprint author), NHO Natl Nagasaki Med Ctr, Dept Rheumatol, 2-1001-1 Kubara, Omura 8568562, Japan.	migita@nagasaki-mc.com			Ministry of Health, Labor, and Welfare of Japan	This work was supported by a Grant-in-Aid for Research on intractable diseases from the Ministry of Health, Labor, and Welfare of Japan.	Akkoc N, 2010, ARTHRITIS RHEUM-US, V62, P3059, DOI 10.1002/art.27598; Savic S, 2012, CURR OPIN RHEUMATOL, V24, P103, DOI 10.1097/BOR.0b013e32834dd2d5; YAMAGUCHI M, 1992, J RHEUMATOL, V19, P424; Migita K, 2014, MEDICINE, V93, P158, DOI 10.1097/MD.0000000000000029; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Ozkurede VU, 2012, CLIN EXP IMMUNOL, V167, P382, DOI 10.1111/j.1365-2249.2011.04535.x; Efthimiou P, 2007, NAT CLIN PRACT RHEUM, V3, P328, DOI 10.1038/ncprheum0510; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; Chae JJ, 2009, BRIT J HAEMATOL, V146, P467, DOI 10.1111/j.1365-2141.2009.07733.x; Gerfaud-Valentin M, 2014, AUTOIMMUN REV, V13, P708, DOI 10.1016/j.autrev.2014.01.058; CUSH JJ, 1987, ARTHRITIS RHEUM, V30, P186, DOI 10.1002/art.1780300209; Cosan F, 2010, ARTHRITIS RHEUM-US, V62, P3232, DOI 10.1002/art.27683; Rech J, 2012, RHEUMATOL INT, V32, P1827, DOI 10.1007/s00296-011-2020-x; Cosan F, 2013, RHEUMATOL INT, V33, P1675, DOI 10.1007/s00296-012-2609-8; Rabinovich E, 2005, ANN RHEUM DIS, V64, P1009, DOI 10.1136/ard.2004.029447; Ben-Chetrit E, 2009, RHEUMATOLOGY, V48, P1455, DOI 10.1093/rheumatology/kep296; Burkett K, 2013, CURR OPIN ALLERGY CL, V13, P470, DOI 10.1097/ACI.0b013e3283648f68; Efthimiou P, 2006, SEMIN ARTHRITIS RHEU, V36, P144, DOI 10.1016/j.semarthrit.2006.07.001; El-Shanti H, 2006, LANCET, V367, P1016, DOI 10.1016/S0140-6736(06)68430-4; French FMF Consortium, 1997, NAT GENET, V17, P25; Giampietro C, 2013, ARTHRIT CARE RES, V65, P822, DOI 10.1002/acr.21901; Grandemange S, 2011, GENES IMMUN, V12, P497, DOI 10.1038/gene.2011.53; Grutter C, 2006, FEBS LETT, V580, P99, DOI 10.1016/j.febslet.2005.11.076; Kim Jin Ju, 2013, Clin Exp Rheumatol, V31, P60; Migita K, 2008, CLIN EXP RHEUMATOL, V26, P1091; Migita K, 2014, RHEUMATOLOG IN PRESS; Shinar Y, 2007, RHEUMATOLOGY, V46, P1718, DOI 10.1093/rheumatology/kem228	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9104	1365-2249		CLIN EXP IMMUNOL	Clin. Exp. Immunol.	MAR	2015	179	3					392	397		10.1111/cei.12463		6	Immunology	Immunology	CC0PQ	WOS:000350038400003		
J	Kobuchi, S; Tanaka, R; Shintani, T; Suzuki, R; Tsutsui, H; Ohkita, M; Matsumura, Y; Ayajiki, K				Kobuchi, Shuhei; Tanaka, Ryosuke; Shintani, Takuya; Suzuki, Rie; Tsutsui, Hidenobu; Ohkita, Mamoru; Matsumura, Yasuo; Ayajiki, Kazuhide			Mechanisms underlying the renoprotective effect of GABA against ischaemia/reperfusion-induced renal injury in rats	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						acute kidney injury; GABA; ischaemia; reperfusion; renal sympathetic nerve activity	GAMMA-AMINOBUTYRIC-ACID; SPONTANEOUSLY HYPERTENSIVE-RATS; PARAVENTRICULAR NUCLEUS; ISCHEMIA/REPERFUSION; RECEPTORS; KIDNEY; RESPONSES; FAILURE; SYSTEM	Excitation of the renal sympathetic nervous system is important for the development of ischaemic acute kidney injury (AKI) in rats. We reported that intravenous treatment with GABA has preventive effects against ischaemia/reperfusion (I/R)-induced renal dysfunction with histological damage in rats; however, the mechanisms underlying these effects on renal injury remain unknown. Thus, the aim of the present study was to clarify how GABA mechanistically affects ischaemic AKI in rats. Ischaemic AKI was induced in rats by clamping the left renal artery and vein for 45min and then reperfusing the kidney to produce I/R-induced injury. Treatment with the GABA(B) receptor antagonist CGP52432 (100nmol/kg, i.v., or 1nmol/kg, i.c.v.) abolished the suppressive effects of 50mol/kg, i.v., GABA on enhanced renal sympathetic nerve activity (RSNA) during ischaemia, leading to elimination of the renoprotective effects of GABA. Intracerebroventricular treatment with 0.5mol/kg GABA or i.v. treatment with 1mol/kg baclofen, a selective GABA(B) receptor agonist, prevented the I/R-induced renal injury equivalent to i.v. treatment with GABA. Conversely, i.v. treatment with 10mol/kg bicuculline, a GABA(A) receptor antagonist, failed to affect the preventive effects of GABA against ischaemic AKI. We therefore concluded that GABA(B) receptor stimulation in the central nervous system, rather than peripheral GABA(B) receptor stimulation, mediates the preventive effect of GABA against ischaemic AKI by suppressing the enhanced RSNA induced by renal ischaemia.	[Kobuchi, Shuhei; Ayajiki, Kazuhide] Hyogo Univ Hlth Sci, Sch Pharm, Dept Pharm, Kobe, Hyogo, Japan; [Kobuchi, Shuhei; Tanaka, Ryosuke; Shintani, Takuya; Suzuki, Rie; Tsutsui, Hidenobu; Ohkita, Mamoru; Matsumura, Yasuo] Osaka Univ Pharmaceut Sci, Lab Pathol & Mol Pharmacol, Takatsuki, Osaka, Japan; [Tsutsui, Hidenobu] Osaka Ohtani Univ, Lab Clin Pharmacol, Fac Pharm, Tondabayashi, Osaka, Japan	Kobuchi, S (reprint author), Hyogo Univ Hlth Sci, Sch Pharm, Dept Pharm, Chuo Ku, 1-3-6 Minatojima, Kobe, Hyogo 6508530, Japan.	kobuchi-s@huhs.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; 'High Technology Research Center' Project for Private Universities	This study was supported, in part, by a 'High Technology Research Center' Project for Private Universities, with a matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology of Japan (2002-06 and 2007-09). The authors thank Inter-Biotech Ltd (http://www.interbiotech.com) for English language editing of the manuscript.	Li DP, 2007, J PHARMACOL EXP THER, V320, P615, DOI 10.1124/jpet.106.109538; Lien YHH, 2003, LIFE SCI, V74, P543, DOI 10.1016/j.lfs.2003.08.001; Heldt SA, 2007, NEUROSCIENCE, V150, P370, DOI 10.1016/j.neuroscience.2007.09.008; KERR DIB, 1995, PHARMACOL THERAPEUT, V67, P187, DOI 10.1016/0163-7258(95)00016-A; Hayakawa K, 2002, EUR J PHARMACOL, V438, P107, DOI 10.1016/S0014-2999(02)01294-3; Tanaka R, 2013, EUR J PHARMACOL, V714, P397, DOI 10.1016/j.ejphar.2013.07.008; Kimura M, 2002, JPN J PHARMACOL, V89, P388, DOI 10.1254/jjp.89.388; Tjen-A-Looi SC, 2009, J APPL PHYSIOL, V106, P1793, DOI 10.1152/japplphysiol.00142.2009; Kim HY, 2004, FOOD CHEM TOXICOL, V42, P2009, DOI 10.1016/j.fct.2004.06.021; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; Chatterjee PK, 2007, N-S ARCH PHARMACOL, V376, P1, DOI 10.1007/s00210-007-0183-5; Lieberthal W, 1996, AM J PHYSIOL-RENAL, V271, pF477; Coote JH, 2005, EXP PHYSIOL, V90, P169, DOI 10.1113/expphysiol.2004.029041; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; AVANZINO GL, 1994, AM J PHYSIOL, V266, pH1722; Awadi MA, 2006, LIFE SCI, V79, P847; Caramelo C, 1996, CIRC RES, V79, P1031; Durgam VR, 1999, HYPERTENSION, V33, P530; Fujimura S, 1999, BRIT J PHARMACOL, V127, P109, DOI 10.1038/sj.bjp.0702524; Gladkevich A, 2006, AUTON NEUROSCI-BASIC, V124, P1, DOI 10.1016/j.autneu.2005.11.002; Kobuchi S, 2009, EUR J PHARMACOL, V623, P113, DOI 10.1016/j.ejphar.2009.09.023; Kurata H, 2006, J PHARMACOL EXP THER, V319, P640, DOI 10.1124/jpet.106.1102122; Lattanzio Michael R, 2009, J Am Osteopath Assoc, V109, P13; Paxinos G, 1998, RAT BRAIN STEREOTAXI; Shokoji T, 2003, HYPERTENSION, V41, P266, DOI 10.1161/01.HYP.0000049621.85474.CF; Sugiura T, 2008, J CARDIOVASC PHARM, V51, P223, DOI 10.1097/FJC.0b013e318161d758; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-1681			CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	MAR	2015	42	3					278	286		10.1111/1440-1681.12350		9	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	CB9RC	WOS:000349968800007		
J	Plengsuriyakarn, T; Karbwang, J; Na-Bangchang, K				Plengsuriyakarn, Tullayakorn; Karbwang, Juntra; Na-Bangchang, Kesara			Anticancer activity using positron emission tomography-computed tomography and pharmacokinetics of beta-eudesmol in human cholangiocarcinoma xenografted nude mouse model	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						anti-CCA; beta-eudesmol; cholangiocarcinoma; pharmacokinetics; positron emission tomography-computed tomography	THAI MEDICINAL-PLANTS; BLOCKING ACTION; ANIMAL PET; IN-VITRO; MANAGEMENT; CHANNEL; CELLS; MICE	Cholangiocarcinoma (CCA) is an important public health problem in several parts of South East Asia, particularly in Thailand. The limited availability of effective diagnostic tools for early stage CCA, including chemotherapeutic options, constitutes a major problem for treatment and control of CCA. The aim of the present study was to assess the anti-CCA activity and pharmacokinetics of -eudesmol in CCA-xenografted nude mouse model and healthy mice. Positron emission tomography-computed tomography (PET-CT) with F-18-fluorodeoxyglucose was used for detecting and monitoring tumour development, and PET-CT with technetium-99m was used to investigate its pharmacokinetics property. Results support the role of PET-CT as a potential tool for detecting and monitoring the progress of lung metastasis. Tumour size and lung metastasis were significantly inhibited by 91.6% (of baseline) and 95% (of total lung mass), respectively, following treatment with high-dose -eudesmol (100mg/kg body weight for 30days). Survival time was prolonged by 64.4% compared with untreated controls. Systemic clearance of the compound was rapid, particularly during the first 60min. The compound was distributed to the vital organs at maximum levels 2h after oral administration and 15min after intravenous injection. Results from the present study suggest the potential of -eudesmol as a promising candidate for further development as an anti-CCA drug with respect to its pharmacodynamics and pharmacokinetic properties. PET-CT, with radiotracers F-18-fluorodeoxyglucose and technetium-99m, was shown to be a reliable tool in the investigation of anti-CCA and pharmacokinetic properties of -eudesmol in CCA-xenografted and healthy mice.	[Plengsuriyakarn, Tullayakorn; Na-Bangchang, Kesara] Thammasat Univ, Chulabhorn Int Coll Med, Pathum Thani 12121, Thailand; [Plengsuriyakarn, Tullayakorn; Na-Bangchang, Kesara] Thammasat Univ, Ctr Excellence Pharmacol & Mol Biol Malaria & Cho, Pathum Thani, Thailand; [Karbwang, Juntra] Nagasaki Univ, Inst Trop Med, Dept Clin Prod Dev, Nagasaki 852, Japan	Na-Bangchang, K (reprint author), Thammasat Univ, Chulabhorn Int Coll Med, Rangsit Campus, Pathum Thani 12121, Thailand.	kesaratmu@yahoo.com			National Research University Project of Thailand, Office of Higher Education Commission of Thailand; Thailand Research Fund [TRG5680040]	This study was supported by the National Research University Project of Thailand, Office of Higher Education Commission of Thailand. Tullayakorn Plengsuriyakarn received financial support from the Thailand Research Fund (Grant No. TRG5680040). We thank Associate Professor Dr. Adisak Wongkajornsilp, Department of Pharmacology, Faculty of Medicine, Siriraj Hospital, Mahidol University for providing the HubCCA1 cell line. We also thank Professor Dr. Kenji Hirayama, Department of Immunogenetics, Institute of Tropical Medicine and Professor Dr. Naoki Matsuda, Division of Radiation Biology and Protection, Radioisotope Center, Nagasaki University for kindly discussion and providing the laboratory facilities.	Deroose CM, 2007, J NUCL MED, V48, P295; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007; Mosconi S, 2009, CRIT REV ONCOL HEMAT, V69, P259, DOI 10.1016/j.critrevonc.2008.09.008; Yeh CN, 2008, MOL IMAGING BIOL, V10, P209, DOI 10.1007/s11307-008-0141-8; Sriamporn S, 2004, TROP MED INT HEALTH, V9, P588, DOI 10.1111/j.1365-3156.2004.01234.x; Sithithaworn P, 2012, PARASITOL INT, V61, P10, DOI 10.1016/j.parint.2011.08.014; Tsuneki H, 2005, EUR J PHARMACOL, V512, P105, DOI 10.1016/j.ejphar.2005.02.035; Kelloff G, 2005, CLIN CANCER RES, V11, P2785, DOI 10.1158/1078-0432.CCR-04-2626; Breitenstein S, 2008, HPB, V10, P120, DOI 10.1080/13651820801992583; Chang CH, 2006, ANTICANCER RES, V26, P159; Cherry S R, 2001, ILAR J, V42, P219; CHIOU LC, 1992, EUR J PHARMACOL, V216, P199, DOI 10.1016/0014-2999(92)90361-7; Johannsen B, 1997, TRANSIT METAL CHEM, V22, P318, DOI 10.1023/A:1018493314473; KIMURA M, 1991, NEUROPHARMACOLOGY, V30, P835, DOI 10.1016/0028-3908(91)90117-T; Laverman P, 2007, HEPATOL RES, V37, P127, DOI 10.1111/j.1872-034X.2007.00016.x; Ma EL, 2008, J ASIAN NAT PROD RES, V10, P159, DOI 10.1080/10286020701394332; Mahavorasirikul W, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-55; NOJIMA H, 1992, BRAIN RES, V575, P337, DOI 10.1016/0006-8993(92)90101-E; Plengsuriyakarn T., 2012, International Research Journal of Pharmacy and Pharmacology, V2, P52; Plengsuriyakarn T, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-23; Sacks A, 2011, AM J ROENTGENOL, V197, P260; Singh A, 2003, WORLD J NUCL MED, V2, P292; Singh MK, 2012, MT SINAI J MED, V79, P232, DOI 10.1002/msj.21298; Wongkajornsilp A, 2013, PLOS ONE, V8; Xiao P. G., 2002, MODERN CHINESE MAT M	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-1681			CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	MAR	2015	42	3					293	304		10.1111/1440-1681.12354		12	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	CB9RC	WOS:000349968800009		
J	Kurashige, M; Hanaoka, K; Imamura, M; Udagawa, T; Kawaguchi, Y; Hasegawa, T; Hosoya, T; Yokoo, T; Maeda, S				Kurashige, M.; Hanaoka, K.; Imamura, M.; Udagawa, T.; Kawaguchi, Y.; Hasegawa, T.; Hosoya, T.; Yokoo, T.; Maeda, S.			A comprehensive search for mutations in the PKD1 and PKD2 in Japanese subjects with autosomal dominant polycystic kidney disease	CLINICAL GENETICS			English	Article						ADPKD; eGFR; Japanese; PKD1; PKD2	GENE; ASSOCIATION; ENCODES; ADPKD	To elucidate the genotypic and phenotypic characteristics of autosomal dominant polycystic kidney disease (ADPKD) in Japanese populations, we performed a comprehensive search for mutations in PKD1 and PKD2 in 180 Japanese ADPKD patients from 161 unrelated families. We identified 112 (89 PKD1 and 23 PKD2) mutations within 135 families. Patients with PKD2 mutations account for 23.6% of all Japanese ADPKD families in this study. Seventy-five out of the 112 mutations have not been reported previously. The estimated glomerular filtration rate (eGFR) decline was significantly faster in patients with PKD1 mutations than in those with PKD2 mutations (-3.25 and -2.08 mlmin(-1)year(-1) for PKD1 and PKD2, respectively, p<0.01). These results indicate that mutations within PKD1 and PKD2 can be linked to most of the cases of Japanese ADPKD, and the renal function decline was faster in patients with PKD1 mutations than in those with PKD2 mutations also in the Japanese ADPKD. We also found that PKD2 mutations were more frequent in Japanese ADPKD than that in European or American ADPKD.	[Kurashige, M.; Hanaoka, K.; Udagawa, T.; Kawaguchi, Y.; Hasegawa, T.; Hosoya, T.; Yokoo, T.] Jikei Univ, Sch Med, Div Nephrol & Hypertens, Dept Internal Med,Minato Ku, Tokyo 1058461, Japan; [Kurashige, M.; Imamura, M.; Maeda, S.] RIKEN Ctr Integrat Med Sci, Lab Endocrinol Metab & Kidney Dis, Yokohama, Kanagawa, Japan; [Kawaguchi, Y.; Hasegawa, T.] Kanagawa Prefectural Shiomidai Hosp, Dept Med, Yokohama, Kanagawa, Japan	Hanaoka, K (reprint author), Jikei Univ, Sch Med, Div Nephrol & Hypertens, Dept Internal Med,Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	khanaoka@jikei.ac.jp			Ministry of Health, Labour and Welfare of Japan	We thank the technical staffs of the Laboratory for Endocrinology, Metabolism and Kidney Diseases at the RIKEN Center for Integrative Medical Sciences, and Division of Kidney and Hypertension, Department of Internal Medicine, The Jikei University, School of Medicine for their technical assistance. We also thank Dr. Diana Baralle and Dr. Michela Raponi at University of Southampton for providing hybrid minigene constructs. This study was supported in part by a Grant-in-Aid for Progressive Renal Diseases Research, Research on intractable disease, from the Ministry of Health, Labour and Welfare of Japan.	Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Neumann HPH, 2013, NEPHROL DIAL TRANSPL, V28, P1472, DOI 10.1093/ndt/gfs551; Paul BM, 2014, KIDNEY INT, V85, P383, DOI 10.1038/ki.2013.227; Cornec-Le Gall E, 2013, J AM SOC NEPHROL, V24, P1006, DOI 10.1681/ASN.2012070650; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; Audrezet MP, 2012, HUM MUTAT, V33, P1239, DOI 10.1002/humu.22103; Rossetti S, 2007, J AM SOC NEPHROL, V18, P2143, DOI 10.1681/ASN.2006121387; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Rossetti S, 2009, KIDNEY INT, V75, P848, DOI 10.1038/ki.2008.686; Bataille S, 2011, AM J KIDNEY DIS, V58, P456, DOI 10.1053/j.ajkd.2011.05.015; Johnson AM, 1997, J AM SOC NEPHROL, V8, P1560; WARD CJ, 1994, CELL, V77, P881	13	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9163	1399-0004		CLIN GENET	Clin. Genet.	MAR	2015	87	3					266	272		10.1111/cge.12372		7	Genetics & Heredity	Genetics & Heredity	CC0UG	WOS:000350052000009		
J	Hasegawa, K; Ohno, S; Kimura, H; Itoh, H; Makiyama, T; Yoshida, Y; Horie, M				Hasegawa, K.; Ohno, S.; Kimura, H.; Itoh, H.; Makiyama, T.; Yoshida, Y.; Horie, M.			Mosaic KCNJ2 mutation in Andersen-Tawil syndrome: targeted deep sequencing is useful for the detection of mosaicism	CLINICAL GENETICS			English	Article						Andersen-Tawil syndrome; KCNJ2; mosaicism; sequencing	SOMATIC MOSAICISM; GERMLINE	Andersen-Tawil syndrome (ATS) is an inherited disease characterized by ventricular arrhythmias, periodic paralysis, and dysmorphic features. It results from a heterozygous mutation of KCNJ2, but little is known about mosaicism in ATS. We performed genetic analysis of KCNJ2 in 32 ATS probands and their family members and identified KCNJ2 mutations in 25 probands, 20 families who underwent extensive genetic testing. These tests revealed that seven probands carried de novo mutations while 13 carried inherited mutations from their parents. We then specifically assessed a single proband and the respective family. The proband was a 9 year old girl who fulfilled the ATS triad and carried an insertion mutation (p.75_76insThr). We determined that the proband's mother carried a somatic mosaicism and that the proband's younger brother also carried the ATS phenotype with the same insertion mutation. The mother, who exhibited mosaicism, was asymptomatic, although she exhibited Q(T)U prolongation. Mutant allele frequency was 11% as per TA cloning and 17.3% as per targeted deep sequencing. Our observations suggest that targeted deep sequencing is useful for the detection of mosaicism and that the detection of mosaic mutations in parents of apparently sporadic ATS patients can help in the process of genetic counseling.	[Hasegawa, K.; Ohno, S.; Kimura, H.; Itoh, H.; Horie, M.] Shiga Univ Med Sci, Dept Cardiovasc & Resp Med, Otsu, Shiga 5202192, Japan; [Hasegawa, K.] Niigata Univ, Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan; [Makiyama, T.] Kyoto Univ, Grad Sch Med, Dept Cardiovasc & Med, Kyoto, Japan; [Yoshida, Y.] Osaka City Gen Hosp, Dept Pediat Electrophysiol, Osaka, Japan	Horie, M (reprint author), Shiga Univ Med Sci, Dept Cardiovasc & Resp Med, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	horie@belle.shiga-med.ac.jp			Ministry of Education, Culture, Science, and Technology of Japan; Ministry of Health, Labour and Welfare of Japan; Japan Circulation Society	The authors are grateful to the ATS families for their willingness to participate in this study. We thank Ms. Arisa Ikeda, Ms. Kazu Toyooka and Ms. Aya Umehara for their excellent technical assistance. This work was supported by Grants-in-Aid in Scientific Research from the Ministry of Education, Culture, Science, and Technology of Japan; a Health Sciences Research Grant from the Ministry of Health, Labour and Welfare of Japan; and Translational Research Funds from the Japan Circulation Society.	Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Zaritsky JJ, 2000, CIRC RES, V87, P160; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; ANDERSEN ED, 1971, ACTA PAEDIATR SCAND, V60, P559, DOI 10.1111/j.1651-2227.1971.tb06990.x; Jackson AL, 1998, GENETICS, V148, P1483; Forissier JF, 2000, J MED GENET, V37, P132, DOI 10.1136/jmg.37.2.132; Haruna Y, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9483; KIMURA H, 2012, FOLIA PHARMACOL JPN, V139, P5; Miller TE, 2004, CIRCULATION, V109, P3029, DOI 10.1161/01.CIR.0000130666.81539.9E; Roux-Buisson N, 2011, EUROPACE, V13, P130, DOI 10.1093/europace/euq331; TAWIL R, 1994, ANN NEUROL, V35, P326, DOI 10.1002/ana.410350313	12	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9163	1399-0004		CLIN GENET	Clin. Genet.	MAR	2015	87	3					279	283		10.1111/cge.12357		5	Genetics & Heredity	Genetics & Heredity	CC0UG	WOS:000350052000011		
J	Kida, K; Shibagaki, Y; Tominaga, N; Matsumoto, N; Akashi, YJ; Miyake, F; Kimura, K				Kida, Keisuke; Shibagaki, Yugo; Tominaga, Naoto; Matsumoto, Naoki; Akashi, Yoshihiro J.; Miyake, Fumihiko; Kimura, Kenjiro			Efficacy of Tolvaptan Added to Furosemide in Heart Failure Patients with Advanced Kidney Dysfunction: A Pharmacokinetic and Pharmacodynamic Study	CLINICAL PHARMACOKINETICS			English	Article							VASOPRESSIN V-2-RECEPTOR ANTAGONIST; LEFT-VENTRICULAR DYSFUNCTION; ORAL TOLVAPTAN; OUTCOMES; TRIAL; ASSOCIATION; DIURETICS; DISEASE; SINGLE; JAPAN	Background The pharmacokinetics and pharmacodynamics of tolvaptan (7.5 or 15 mg/day) in combination with furosemide have been investigated in heart failure (HF) patients with normal kidney function but not in HF patients with advanced kidney dysfunction. This study evaluated the efficacy of tolvaptan in HF patients with advanced kidney dysfunction (estimated glomerular filtration rate < 45 mL/min/1.73 m(2)) by conducting a pharmacokinetic and pharmacodynamic study in these patients. Methods Tolvaptan (15 mg once daily) was administered orally for 7 days in combination with furosemide (40-200 mg). Results The peak plasma tolvaptan concentration and area under the plasma concentration-time curve were 379.41 +/- A 149.69 ng/mL and 4,657.38 +/- A 2,741.79 ng center dot h/mL, respectively, in HF patients with advanced kidney dysfunction. These values were greater in HF patients with advanced kidney dysfunction than values reported in the literature for healthy subjects and HF patients with normal kidney function. Urine volume increased and body weight decreased significantly compared with those before tolvaptan administration in HF patients with advanced kidney dysfunction. Conclusion This study showed that adding tolvaptan to furosemide was effective in HF patients with advanced kidney dysfunction. This study also suggests that in these patients 15 mg/day of tolvaptan should be sufficient, and increasing the dose or the frequency of dosing to overcome diuretic resistance should not be necessary, and consideration should be given to using a lower dose and/or prolonging the dosing interval.	[Kida, Keisuke; Akashi, Yoshihiro J.; Miyake, Fumihiko] St Marianna Univ, Dept Internal Med, Sch Med, Div Cardiol, Kawasaki, Kanagawa 2168511, Japan; [Kida, Keisuke] St Marianna Univ, Dept Cardiol, Sch Med, Kawasaki, Kanagawa 2168511, Japan; [Shibagaki, Yugo; Tominaga, Naoto; Kimura, Kenjiro] St Marianna Univ, Div Nephrol & Hypertens, Sch Med, Dept Internal Med, Kawasaki, Kanagawa 2168511, Japan; [Matsumoto, Naoki] St Marianna Univ, Dept Pharmacol, Sch Med, Kawasaki, Kanagawa 2168511, Japan	Kida, K (reprint author), St Marianna Univ, Dept Cardiol, Sch Med, 2-16-1 Sugao Miyamae, Kawasaki, Kanagawa 2168511, Japan.	heart-kida@marianna-u.ac.jp	Akashi, Yoshihiro/E-5227-2011	Akashi, Yoshihiro/0000-0001-7670-7326			Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Vaduganathan M, 2012, J CARDIOVASC MED, V13, P415, DOI 10.2459/JCM.0b013e328355a740; Shoaf SE, 2012, EUR J CLIN PHARMACOL, V68, P1595, DOI 10.1007/s00228-012-1295-5; Watanabe K, 2012, J CARDIOL, V60, P462, DOI 10.1016/j.jjcc.2012.09.002; Eshaghian S, 2006, AM J CARDIOL, V97, P1759, DOI 10.1016/j.amjcard.2005.12.072; Yamamura Y, 1998, J PHARMACOL EXP THER, V287, P860; Hasselblad V, 2007, EUR J HEART FAIL, V9, P1064, DOI 10.1016/j.ejheart.2007.07.011; Heywood JT, 2007, J CARD FAIL, V13, P422, DOI 10.1016/j.cardfail.2007.03.011; Gheorghiade M, 2004, JAMA-J AM MED ASSOC, V291, P1963, DOI 10.1001/jama.291.16.1963; Dreisbach AW, 2008, EXPERT OPIN DRUG MET, V4, P1065, DOI [10.1517/17425255.4.8.1065 , 10.1517/17425250802273527]; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Cooper HA, 1999, CIRCULATION, V100, P1311; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Shoaf SE, 2005, J CARDIOVASC PHARM T, V10, P165, DOI 10.1177/107424840501000304; Imamura T, 2013, CIRC J, V77, P397, DOI 10.1253/circj.CJ-12-0971; FRANCIS GS, 1990, CIRCULATION, V82, P1724; Kinugawa K, 2014, CIRC J, V78, P844, DOI 10.1253/circj.CJ-14-0126; von Lueder TG, 2013, CLIN PHARMACOL THER, V94, P490, DOI 10.1038/clpt.2013.140; Costello-Boerrigter LC, 2006, AM J PHYSIOL-RENAL, V290, pF273, DOI 10.1152/ajprenal.00195.2005; Hamaguchi S, 2009, CIRC J, V73, P1442; Inomata Takayuki, 2011, Cardiovasc Drugs Ther, V25 Suppl 1, pS57, DOI 10.1007/s10557-011-6349-x; Kim Seong Ryul, 2011, Cardiovasc Drugs Ther, V25 Suppl 1, pS5, DOI 10.1007/s10557-011-6299-3; Kinugawa K, 2013, CLIN PHARMACOL THER, V94, P449, DOI 10.1038/clpt.2013.147; MATSUE Y, 2013, J CARDIOL, V61, P169; Miyazaki T, 2007, CARDIOVASC DRUG REV, V25, P1	26	0	3	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0312-5963	1179-1926		CLIN PHARMACOKINET	Clin. Pharmacokinet.	MAR	2015	54	3					273	284		10.1007/s40262-014-0194-6		12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1MD	WOS:000350103900005		
J	Nakai, K; Iida, S; Tobinai, M; Hashimoto, J; Kawanishi, T				Nakai, Kiyohiko; Iida, Satofumi; Tobinai, Masato; Hashimoto, Junko; Kawanishi, Takehiko			Application of Modeling and Simulation to a Long-Term Clinical Trial: A Direct Comparison of Simulated Data and Data Actually Observed in Japanese Osteoporosis Patients Following 3-Year Ibandronate Treatment	CLINICAL PHARMACOKINETICS			English	Article							OVARIECTOMIZED AGED RATS; POSTMENOPAUSAL OSTEOPOROSIS; INTRAVENOUS IBANDRONATE; BONE MASS; FRACTURE RISK; INJECTIONS; DIVA; BISPHOSPHONATES; ARCHITECTURE; EFFICACY	Ibandronate, a nitrogen-containing bisphosphonate, is a bone resorption inhibitor widely used to prevent and treat osteoporosis. To optimize the design for a long-term clinical study of ibandronate, modeling and simulation (M&S) was performed based on the result of population pharmacodynamic analysis using the data of a short-term clinical study. A population pharmacodynamic model was constructed by the urinary C-terminal telopeptide of type I collagen (uCTx) and the lumbar spine bone mineral density (BMD) data obtained in clinical studies, including a phase II study of Japanese osteoporosis patients treated with ibandronate for 6 months. Changes in BMD over a period of 3 years were simulated from the population pharmacodynamic parameters of the patients in this phase II study. The relationship between uCTx and BMD was well described by this modeling. The functions of disease progression and supplemental treatment were incorporated into the model to simulate a long-term clinical study with high accuracy. A long-term clinical study with a 3-year treatment was conducted after this M&S. The percentage change from baseline in observed BMD values were found to be similar to the prospectively simulated values. This study showed that M&S could be a useful and powerful tool for designing and conducting long-term clinical studies when carried out in the following sequence: (1) conduct a short-term clinical study; (2) perform M & S; and (3) conduct the long-term clinical study. Application of this procedure to various other treatment agents will establish the usefulness of M&S for long-term clinical studies and bring further efficiencies to drug development.	[Nakai, Kiyohiko; Iida, Satofumi; Tobinai, Masato; Kawanishi, Takehiko] Chugai Pharmaceut Co Ltd, Clin Res Planning Dept, Chuo Ku, Tokyo 1038324, Japan; [Hashimoto, Junko] Chugai Pharmaceut Co Ltd, Primary Lifecycle Management Dept, Chuo Ku, Tokyo 1038324, Japan	Nakai, K (reprint author), Chugai Pharmaceut Co Ltd, Clin Res Planning Dept, Chuo Ku, 2-1-1 Nihonbashi Muromachi, Tokyo 1038324, Japan.	nakaikyh@chugai-pharm.co.jp			Chugai Pharmaceutical Co. Ltd, Japan; Chugai Pharmaceutical Co. Ltd.; Taisho Pharmaceutical Co. Ltd.; Kiyohiko Nakai; Satofumi Iida; Masato Tobinai; Junko Hashimoto; Takehiko Kawanishi	The authors thank Dr. Ronald Gieschke and Dr. Bruno Reigner, F. Hoffmann-La Roche Ltd., for discussing the study results with them. The phase II study was sponsored by Chugai Pharmaceutical Co. Ltd, Japan. The phase II/III ( MOVER) study was jointly funded by Chugai Pharmaceutical Co. Ltd. and Taisho Pharmaceutical Co. Ltd. Kiyohiko Nakai, Satofumi Iida, Masato Tobinai, Junko Hashimoto, and Takehiko Kawanishi have no conflicts of interest.	Bauss F, 2002, J RHEUMATOL, V29, P990; Bauss F, 2002, J RHEUMATOL, V29, P2200; Chesnut CH, 2004, J BONE MINER RES, V19, P1241, DOI 10.1359/JBMR.040325; Schilcher J, 2011, NEW ENGL J MED, V364, P1728, DOI 10.1056/NEJMoa1010650; Eisman JA, 2008, J RHEUMATOL, V35, P488; Lemaire V, 2004, J THEOR BIOL, V229, P293, DOI 10.1016/j.jtbi.2004.03.023; Bianchi G, 2012, OSTEOPOROSIS INT, V23, P1769, DOI 10.1007/s00198-011-1793-9; Post TM, 2013, J PHARMACOKINET PHAR, V40, P143, DOI 10.1007/s10928-012-9294-9; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235; Nakamura T, 2013, CALCIFIED TISSUE INT, V93, P137, DOI 10.1007/s00223-013-9734-6; Ette E. I., 2007, PHARMACOMETRICS SCI; Gieschke R, 2003, 30 EUR S CALC TISS E, P284; Kimko HC, 2003, SIMULATION DESIGNING; Nakamura T, 2006, J BONE MINER RES, V21, pS182; Ruixo JJP, 2014, J CLIN PHARMACOL, V54, P503, DOI 10.1002/jcph.228; Pillai G, 2004, BRIT J CLIN PHARMACO, V58, P618, DOI 10.1111/j.1365-2125.2004.02224.x; Pillai G, 2006, INT J CLIN PHARM TH, V44, P655; Recker RR, 2010, BONE, V46, P660, DOI 10.1016/j.bone.2009.11.004; Reginster JY, 2005, CURR PHARM DESIGN, V11, P3711, DOI 10.2174/138161205774580750; Reginster JY, 2006, CURR DRUG METAB, V7, P827, DOI 10.2174/138920006778520624; Sambrook P, 2010, CURR MED RES OPIN, V26, P599, DOI 10.1185/03007990903512321; Thiebaud D, 1997, AM J MED, V103, P298, DOI 10.1016/S0002-9343(97)00249-0	23	1	1	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0312-5963	1179-1926		CLIN PHARMACOKINET	Clin. Pharmacokinet.	MAR	2015	54	3					295	304		10.1007/s40262-014-0206-6		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC1MD	WOS:000350103900007		
J	Morishima, T; Hasegawa, Y; Sasaki, H; Kurihara, T; Hamaoka, T; Goto, K				Morishima, Takuma; Hasegawa, Yuta; Sasaki, Hiroto; Kurihara, Toshiyuki; Hamaoka, Takafumi; Goto, Kazushige			Effects of different periods of hypoxic training on glucose metabolism and insulin sensitivity	CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING			English	Article						endurance training; insulin sensitivity; length of training period; normobaric hypoxia; short-term training	HUMAN SKELETAL-MUSCLE; ADIPOSE-TISSUE; EXERCISE; MEN; RESPONSIVENESS; STIMULATION; TOLERANCE; TRANSPORT; PROTEIN; NIDDM	This study examined the effects of different periods of hypoxic training on glucose metabolism. Sedentary subjects underwent hypoxic training (FiO(2)=150%) for either 2weeks (2-week group; n=11) or 4weeks (4-week group; n=10). The 2-week group conducted training sessions on 6days week(-1) for 2weeks, whereas the 4-week group conducted training sessions on 3days week(-1) for 4weeks. Body fat mass or abdominal fat area did not change after training period in either group. VO2max increased in both groups after training period (42 +/- 2 versus 43 +/- 2ml min(-1) kg(-1) in 2-week group, 41 +/- 1 versus 42 +/- 2ml min(-1) kg(-1) in 4-week group). Both groups showed a reduction in mean blood pressure after training period (92 +/- 3 versus 90 +/- 3mmHg in 2-week group, 91 +/- 2 versus 87 +/- 2mmHg in 4-week group, P005). No change was observed in blood glucose response after glucose ingestion after training period. However, area under the curve for serum insulin concentrations after glucose ingestion significantly decreased in only 4-week group (6910 +/- 763 versus 5812 +/- 872 IU ml(-1) 120min, P005). In conclusion, hypoxic training reduced blood pressure with independent on training duration. However, a longer period of hypoxic training led to greater improvements in insulin sensitivity compared with equivalent training over a shorter period, suggesting that hypoxic training programmes for more than 4weeks might be more beneficial for improving insulin sensitivity.	[Morishima, Takuma; Hasegawa, Yuta; Sasaki, Hiroto] Ritsumeikan Univ, Grad Sch Sport & Hlth Sci, Kusatsu, Shiga 5258577, Japan; [Kurihara, Toshiyuki; Hamaoka, Takafumi; Goto, Kazushige] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga 5258577, Japan	Goto, K (reprint author), Ritsumeikan Univ, Fac Sport & Hlth Sci, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	kagoto@fc.ritsumei.ac.jp		Kurihara, Toshiyuki/0000-0001-9726-1255	Ritsumeikan University; Japan Society for the Promotion of Science	We would like to thank all of the subjects who participated in the study. The study was supported by a research grant from Ritsumeikan University and a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science.	Haufe S, 2008, MED SCI SPORT EXER, V40, P1939, DOI 10.1249/MSS.0b013e31817f1988; Hordern MD, 2011, J SCI MED SPORT, V14, P238, DOI 10.1016/j.jsams.2010.11.003; Richards JC, 2010, J PHYSIOL-LONDON, V588, P2961, DOI 10.1113/jphysiol.2010.189886; DELA F, 1994, DIABETES, V43, P862, DOI 10.2337/diabetes.43.7.862; Kirwan JP, 2009, AM J PHYSIOL-ENDOC M, V297, pE151, DOI 10.1152/ajpendo.00210.2009; Baynard T, 2009, EUR J APPL PHYSIOL, V107, P299, DOI 10.1007/s00421-009-1126-2; Whyte LJ, 2010, METABOLISM, V59, P1421, DOI 10.1016/j.metabol.2010.01.002; Katayama K, 2010, METABOLISM, V59, P959, DOI 10.1016/j.metabol.2009.10.017; Gamboa JL, 2011, AM J PHYSIOL-REG I, V300, pR85, DOI 10.1152/ajpregu.00078.2010; DEVLIN JT, 1987, DIABETES, V36, P434, DOI 10.2337/diabetes.36.4.434; Bailey DM, 2000, MED SCI SPORT EXER, V32, P1058, DOI 10.1097/00005768-200006000-00004; DEVLIN JT, 1985, DIABETES, V34, P973, DOI 10.2337/diabetes.34.10.973; HEATH GW, 1983, J APPL PHYSIOL, V55, P512; Nishiwaki M, 2011, J PHYSIOL SCI, V61, P83, DOI 10.1007/s12576-010-0126-7; Arciero PJ, 1999, J APPL PHYSIOL, V86, P1930; CARTEE GD, 1991, J APPL PHYSIOL, V70, P1593; Dela F, 2010, AM J PHYSIOL-ENDOC M, V299, pE80, DOI 10.1152/ajpendo.00765.2009; GOODYEAR LJ, 1992, DIABETES, V41, P1091, DOI 10.2337/diabetes.41.9.1091; Houmard JA, 1999, AM J PHYSIOL-ENDOC M, V277, pE1055; Houmard JA, 2000, METABOLISM, V49, P858, DOI 10.1053/meta.2000.6751; Irving BA, 2011, J CLIN ENDOCR METAB, V96, pE1137, DOI 10.1210/jc.2010-2863; Lim S, 2008, J CLIN ENDOCR METAB, V93, P2263, DOI 10.1210/jc.2007-2028; Mackenzie R, 2011, DIABETES-METAB RES, V27, P94, DOI 10.1002/dmrr.1156; MIKINES KJ, 1988, AM J PHYSIOL, V254, pE248; Morishima T, 2013, CLIN PHYSL FUNCT IMA; Perseghin G, 1996, NEW ENGL J MED, V335, P1357, DOI 10.1056/NEJM199610313351804; RODNICK KJ, 1987, AM J PHYSIOL, V253, pE489; Schobersberger W, 2003, EUR J APPL PHYSIOL, V88, P506, DOI 10.1007/s00421-002-0736-8; Wadley GD, 2007, J APPL PHYSIOL, V102, P1624, DOI 10.1152/japplphysiol.00821.2006; Wiesner S, 2010, OBESITY, V18, P116, DOI 10.1038/oby.2009.193; Youngren JF, 2001, AM J PHYSIOL-ENDOC M, V280, pE528	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1475-0961	1475-097X		CLIN PHYSIOL FUNCT I	Clin. Physiol. Funct. Imaging	MAR	2015	35	2					104	109		10.1111/cpf.12133		6	Physiology	Physiology	CC0VG	WOS:000350055100003		
J	Nakamura, S; Asai, K; Kubota, Y; Murai, K; Takano, H; Tsukada, YT; Shimizu, W				Nakamura, Shunichi; Asai, Kuniya; Kubota, Yoshiaki; Murai, Koji; Takano, Hitoshi; Tsukada, Yayoi Tetsuou; Shimizu, Wataru			Impact of sleep-disordered breathing and efficacy of positive airway pressure on mortality in patients with chronic heart failure and sleep-disordered breathing: a meta-analysis	CLINICAL RESEARCH IN CARDIOLOGY			English	Article						Sleep-disordered breathing; Sleep apnea; Heart failure; Mortality; Positive airway pressure; Prognosis	CHEYNE-STOKES RESPIRATION; CARDIAC RESYNCHRONIZATION THERAPY; RANDOMIZED CONTROLLED-TRIAL; ADAPTIVE SERVO-VENTILATION; APNEA; RISK; SERVOVENTILATION; ACTIVATION; PROGNOSIS; OUTCOMES	To conduct a meta-analysis to investigate whether sleep-disordered breathing (SDB) is an independent risk factor for mortality and whether positive airway pressure (PAP) decreases mortality in patients with chronic heart failure (HF). The impact of SDB and the effects of PAP on mortality in patients with chronic HF remain unclear. We searched the MEDLINE, EMBASE, and Cochrane databases. Clinical trials that addressed mortality and the effect of PAP on mortality in chronic HF patients with SDB were included in this meta-analysis. Eleven studies (1,944 participants in total) that addressed mortality in chronic HF patients with SDB were included in this study. Patients with SDB showed a significantly increased mortality risk compared to those without SDB [risk ratio (RR) 1.66 (1.19-2.31)]. In sub-analyses, a significant increase in risk of mortality was observed for central sleep apnea versus no-SDB [RR 1.48 (1.15-1.91)], whereas no significant increase in risk was observed for obstructive sleep apnea versus no-SDB. Five randomized controlled studies (395 participants) that assessed the effect of PAP in chronic HF patients with SDB were analyzed. Adaptive servo-ventilation (ASV) significantly reduced all-cause mortality in chronic HF patients with SDB [RR 0.13 (0.02-0.95)], whereas continuous PAP did not significantly reduce all-cause mortality [RR 0.71 (0.32-1.57)]. The prevalence of SDB in patients with chronic HF is associated with worse survival, and ASV reduces all-cause mortality in patients with chronic HF concomitant with SDB.	[Nakamura, Shunichi; Asai, Kuniya; Kubota, Yoshiaki; Murai, Koji; Takano, Hitoshi; Tsukada, Yayoi Tetsuou; Shimizu, Wataru] Nippon Med Sch, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1130022, Japan	Nakamura, S (reprint author), Nippon Med Sch, Dept Cardiovasc Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1130022, Japan.	s-nakamura@nms.ac.jp					FRANZ MR, 1992, CIRCULATION, V86, P968; Bradley TD, 2005, NEW ENGL J MED, V353, P2025, DOI 10.1056/NEJMoa051001; Lanfranchi PA, 2003, CIRCULATION, V107, P727, DOI 10.1161/01.CIR.0000049641.11675.EE; Ferrier K, 2005, CHEST, V128, P2116, DOI 10.1378/chest.128.4.2116; NAUGHTON MT, 1995, AM J RESP CRIT CARE, V152, P473; Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; Cowie MR, 2013, EUR J HEART FAIL, V15, P937, DOI 10.1093/eurjhf/hft051; Linz D, 2011, HEART RHYTHM, V8, P1436, DOI 10.1016/j.hrthm.2011.03.053; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Wang HQ, 2007, J AM COLL CARDIOL, V49, P1625, DOI 10.1016/j.jacc.2006.12.046; Arzt M, 2007, CIRCULATION, V115, P3173, DOI 10.1161/CIRCULATIONAHA.106.683482; Sharma BK, 2012, CHEST, V142, P1211, DOI 10.1378/chest.12-0815; Javaheri S, 1998, CIRCULATION, V97, P2154; Mansfield DR, 2004, AM J RESP CRIT CARE, V169, P361, DOI 10.1164/rccm.200306-752OC; Bradley TD, 2003, CIRCULATION, V107, P1822, DOI 10.1161/01.CIR.0000061758.05044.64; Khayat R, 2012, J CARD FAIL, V18, P534, DOI 10.1016/j.cardfail.2012.05.003; Luo Q, 2010, INT J CARDIOL, V144, P420, DOI 10.1016/j.ijcard.2009.03.050; Javaheri S, 2011, AM J RESP CRIT CARE, V183, P539, DOI 10.1164/rccm.201003-0406OC; Sin DD, 1999, AM J RESP CRIT CARE, V160, P1101; Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061; Yoshihisa A, 2013, EUR J HEART FAIL, V15, P543, DOI 10.1093/eurjhf/hfs197; Sinha AM, 2004, J AM COLL CARDIOL, V44, P68, DOI 10.1016/j.jacc.2004.03.040; Hanly PJ, 1996, AM J RESP CRIT CARE, V153, P272; Sin DD, 2000, CIRCULATION, V102, P61; FRANKLIN KA, 1995, LANCET, V345, P1085, DOI 10.1016/S0140-6736(95)90820-X; Jilek C, 2011, EUR J HEART FAIL, V13, P68, DOI 10.1093/eurjhf/hfq183; Spaak J, 2005, HYPERTENSION, V46, P1327, DOI 10.1161/01.HYP.0000193497.45200.66; Yumino D, 2009, HEART, V95, P819, DOI 10.1136/hrt.2008.160952; Sampol G, 2003, AM J RESP CRIT CARE, V168, P1528, DOI 10.1164/rccm.200304-566OC; Roebuck T, 2004, EUR RESPIR J, V23, P735, DOI 10.1183/09031936.04.00060404; Arzt M, 2013, EUR RESPIR J, V42, P1244, DOI 10.1183/09031936.00083312; Bakker JP, 2012, INTERN MED J, V42, P1264, DOI 10.1111/j.1445-5994.2012.02904.x; Bradley TD, 2001, CHEST, V119, P1827, DOI 10.1378/chest.119.6.1827; Corra U, 2006, CIRCULATION, V113, P44, DOI 10.1161/CIRCULATIONAHA.105.543173; Hagenah G, 2010, LUNG, V188, P309, DOI 10.1007/s00408-009-9208-9; Hetland A, 2013, CARDIOLOGY, V126, P81, DOI 10.1159/000350826; Stanchina ML, 2007, CHEST, V132, P433, DOI 10.1378/chest.06-2509	37	4	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-0684	1861-0692		CLIN RES CARDIOL	Clin. Res. Cardiol.	MAR	2015	104	3					208	216		10.1007/s00392-014-0774-3		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CC4EW	WOS:000350304700002		
J	Hirose, Y; Mazuka, R				Hirose, Yuki; Mazuka, Reiko			Predictive processing of novel compounds: Evidence from Japanese	COGNITION			English	Article						Compound; Japanese; Compound Accent Rule; Anticipatory processing	EYE-MOVEMENTS; TIME-COURSE; ACCESS; MODEL; PROSODY; LINKING; WORDS	Our study argues that pre-head anticipatory processing operates at a level below the level of the sentence. A visual-world eye-tracking study demonstrated that, in processing of Japanese novel compounds, the compound structure can be constructed prior to the head if the prosodic information on the preceding modifier constituent signals that the Compound Accent Rule (CAR) is being applied. This prosodic cue rules out the single head analysis of the modifier noun, which would otherwise be a natural and economical choice. Once the structural representation for the head is computed in advance, the parser becomes faster in identifying the compound meaning. This poses a challenge to models maintaining that structural integration and word recognition are separate processes. At the same time, our results, together with previous findings, suggest the possibility that there is some degree of staging during the processing of different sources of information during the comprehension of compound nouns. (C) 2014 Elsevier B.V. All rights reserved.	[Hirose, Yuki] Univ Tokyo, Meguro Ku, Tokyo 1538902, Japan; [Mazuka, Reiko] RIKEN Brain Sci Inst, Wako, Saitama 35101, Japan	Hirose, Y (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	hirose@boz.c.u-tokyo.ac.jp; mazuka@brain.riken.jp			MEXT/JSPS KAKENHI [25580086]	This research was supported in part by MEXT/JSPS KAKENHI Grant Number 25580086 to the first author. We would like to thank Minako Mihara for her help with visual stimuli preparation, Rika Aoki for auditory stimuli preparation and analysis, and graduate students and post-doctorate researchers at The University of Tokyo for assisting data collection. We are greatly indebted to Manabu Arai and Douglas Roland for their valuable comments and insights on all aspects of the paper. We also thank Sumiyo Roland, Michiyo Shiomichi, Mutsuo Nishizawa for their generous logistic support. We also deeply appreciate various comments and suggestions from Nobuyuki Jincho, Remo Job, the audience at the RIKEN BSI seminar, the anonymous reviewers, and the editor of the journal.	Staub A, 2011, J EXP PSYCHOL GEN, V140, P407, DOI 10.1037/a0023517; MacGregor LJ, 2013, BRAIN LANG, V126, P217, DOI 10.1016/j.bandl.2013.04.002; Jurafsky D, 1996, COGNITIVE SCI, V20, P137, DOI 10.1016/S0364-0213(99)80005-6; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Reichle ED, 2009, PSYCHON B REV, V16, P1, DOI 10.3758/PBR.16.1.1; Kamide Y, 2003, J MEM LANG, V49, P133, DOI 10.1016/S0749-596X(03)00023-8; Gagne CL, 2009, J MEM LANG, V60, P20, DOI 10.1016/j.jml.2008.07.003; LIEBER R, 1983, LINGUIST INQ, V14, P251; Lewis RL, 2005, COGNITIVE SCI, V29, P375, DOI 10.1207/s15516709cog0000_25; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Cohen AL, 2014, Q J EXP PSYCHOL, V67, P147, DOI 10.1080/17470218.2013.796398; Fodor J. D., 1995, JAPANESE SENTENCE PR, P9; Haraguchi Shosuke, 1977, TONE PATTERN JAPANES; Hirose Y., 2013, 26 ANN CUNY C HUM SE; Holle H, 2010, NEUROREPORT, V21, P319, DOI 10.1097/WNR.0b013e328335b3e0; Isel F, 2003, J EXP PSYCHOL LEARN, V29, P277, DOI 10.1037/0278-7393.29.2.277; Ito J., 2006, MIT WORKING PAPERS L, V4, P97; Kennison SM, 2005, COGNITION, V97, P269, DOI 10.1016/j.cognition.2004.09.005; Koester D, 2004, J COGNITIVE NEUROSCI, V16, P1647, DOI 10.1162/0898929042568541; Kubozono H., 2008, OXFORD HDB JAPANESE, P165; McCawley James D., 1968, PHONOLOGICAL COMPONE; Otake T., 1997, J ACOUST SOC AM, V102, P3202, DOI 10.1121/1.420928; Poser William J., 1984, THESIS MIT; Selkirk E. O., 1982, LINGUISTIC INQUIRY M, V7; Staub A., 2007, J EXPT PSYCHOL LEARN, V33	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0010-0277	1873-7838		COGNITION	Cognition	MAR	2015	136						350	358		10.1016/j.cognition.2014.11.033		9	Psychology, Experimental	Psychology	CB8MB	WOS:000349882600030		
J	Gomi, K				Gomi, Kiyonori			A Variant of K-Theory and Topological T-Duality for Real Circle Bundles	COMMUNICATIONS IN MATHEMATICAL PHYSICS			English	Article							EQUIVARIANT CHERN CLASSES; CONJUGATION SPACES; ORBIFOLDS; MODELS; GERBES; FLUX	For a space with involutive action, there is a variant of K-theory. Motivated by T-duality in type II orbifold string theory, we establish that a twisted version of the variant enjoys a topological T-duality for Real circle bundles, i.e., circle bundles with real structure.	Shinshu Univ, Dept Math Sci, Matsumoto, Nagano 3908621, Japan	Gomi, K (reprint author), Shinshu Univ, Dept Math Sci, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	kgomi@math.shinshu-u.ac.jp			JSPS [23740051]	I would like to thank D. Tamaki for his interest in my work, valuable discussions and particularly for the way to construct a classifying space for equivariant cohomology. The author's research is supported by the Grant-in-Aid for Young Scientists (B 23740051), JSPS.	Bunke U, 2005, REV MATH PHYS, V17, P77, DOI 10.1142/S0129055X05002315; Schreiber U, 2007, COMMUN MATH PHYS, V274, P31, DOI 10.1007/s00220-007-0271-x; [Anonymous], 1981, ALGEBRAIC TOPOLOGY; Bouwknegt P, 2004, COMMUN MATH PHYS, V249, P383, DOI 10.1007/s00220-004-1115-6; Atiyah M., 2004, LONDON MATH SOC LECT, V308, P5; ATIYAH MF, 1966, Q J MATH, V17, P367, DOI 10.1093/qmath/17.1.367; Baraglia D., PURE APPL M IN PRESS; Baraglia D, 2013, INT J GEOM METHODS M, V10, DOI 10.1142/S0219887812500843; Bouwknegt P., 2013, PHYS REV LETT, V92; Braun V., ARXIVHEPTH0206158; Brown K.S., 1994, GRADUATE TEXTS MATH, V87; Brylinski J.-L., ARXIVMATH0002158; Dabholkar A., ARXIVHEPTH9804208; Deligne Pierre, 1974, I HAUTES ETUDES SCI, P5, DOI 10.1007/BF02685881; Distler J, 2011, P SYMP PURE MATH, V83, P159; Donovan P., 1970, I HAUTES ETUDES SCI, V38, P5; Doran C, 2014, LETT MATH PHYS, V104, P1333, DOI 10.1007/s11005-014-0715-0; Freed DS, 2011, J TOPOL, V4, P737, DOI 10.1112/jtopol/jtr019; Freed D.S., 2010, MANY FACETS GEOMETRY, P395; Gaberdiel MR, 2000, NUCL PHYS B, V578, P58, DOI 10.1016/S0550-3213(99)00813-5; Gawedzki K, 2011, ADV THEOR MATH PHYS, V15, P621; Grothendieck A., 1957, TOHOKU MATH J, V9, P119, DOI 10.2748/tmj/1178244839; Hattori Akio, 1976, JAPAN J MATH, V2, P13; Hausmann JC, 2005, ALGEBR GEOM TOPOL, V5, P923, DOI 10.2140/agt.2005.5.923; Hori K., 1999, ADV THEOR MATH PHYS, V3, P281; KAHN B, 1987, COMMUN ALGEBRA, V15, P695; Lawson H. B., 1989, PRINCETON MATH SERIE, V38; Mathai V., ADV THEOR M IN PRESS; Mathai V, 2012, COMMUN MATH PHYS, V316, P279, DOI 10.1007/s00220-012-1542-8; May J. Peter, 1992, CHICAGO LECT MATH; May J.P., 1996, CBMS REGIONAL C SERI, V91; Mendez-Diez S, 2012, ADV THEOR MATH PHYS, V16, P1591; Moutuou E.M., 2012, THESIS U LORRAINE ME; Pitsch W, 2013, B BELG MATH SOC-SIM, V20, P77; Rosenberg J, 2013, ALGEBR GEOM TOPOL, V13, P1225, DOI 10.2140/agt.2013.13.1225; ROSENBERG J, 1989, J AUST MATH SOC A, V47, P368; Segal G., 1968, I HAUTES ETUDES SCI, V34, P129; Sen A, 1996, NUCL PHYS B, V474, P361, DOI 10.1016/0550-3213(96)00291-X; Vafa C., LECT STRINGS DUAL; Witten E, 1998, J HIGH ENERGY PHYS	40	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0010-3616	1432-0916		COMMUN MATH PHYS	Commun. Math. Phys.	MAR	2015	334	2					923	975		10.1007/s00220-014-2153-3		53	Physics, Mathematical	Physics	CB4VY	WOS:000349627600011		
J	Kuniba, A; Okado, M				Kuniba, Atsuo; Okado, Masato			Tetrahedron Equation and Quantum R Matrices for q-oscillator Representations of U-q(A(2n)((2))), U-q(C-n((1))) and U-q(Dn+1)	COMMUNICATIONS IN MATHEMATICAL PHYSICS			English	Article							UNITARY REPRESENTATIONS; SPIN REPRESENTATIONS	The intertwiner of the quantized coordinate ring A(q) (sl(3)) is known to yield a solution to the tetrahedron equation. By evaluating their n-fold composition with special boundary vectors we generate series of solutions to the Yang-Baxter equation. Finding their origin in conventional quantum group theory is a clue to the link between two and three dimensional integrable systems. We identify them with the quantum R matrices associated with the q-oscillator representations of Uq(A(2n)((2))), Uq(C-n((1))) and Uq(D-n+1((2)))	[Kuniba, Atsuo] Univ Tokyo, Inst Phys, Grad Sch Arts & Sci, Tokyo 1538902, Japan; [Okado, Masato] Osaka City Univ, Dept Math, Sumiyoshi Ku, Osaka 5588585, Japan	Kuniba, A (reprint author), Univ Tokyo, Inst Phys, Grad Sch Arts & Sci, Tokyo 1538902, Japan.	atsuo@gokutan.c.u-tokyo.ac.jp; okado@sci.osaka-cu.ac.jp			JSPS [23340007, 24540203, 23654007]	The authors thank Takahiro Hayashi for informing the references [16,18]. This work is supported by Grants-in-Aid for Scientific Research No. 23340007, No. 24540203 and No. 23654007 from JSPS.	Kuniba A, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/46/465206; PUSZ W, 1993, COMMUN MATH PHYS, V152, P591, DOI 10.1007/BF02096620; JIMBO M, 1985, LETT MATH PHYS, V10, P63, DOI 10.1007/BF00704588; MASUDA TS, 1990, LETT MATH PHYS, V19, P195, DOI 10.1007/BF01039312; Sergeev SM, 2008, LETT MATH PHYS, V83, P231, DOI 10.1007/s11005-008-0219-x; HAYASHI T, 1990, COMMUN MATH PHYS, V127, P129, DOI 10.1007/BF02096497; Baxter R.J., 2007, EXACTLY SOLVED MODEL; Mangazeev VV, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/46/465206; Bazhanov VV, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/07/P07004; Bazhanov VV, 2006, J PHYS A-MATH GEN, V39, P3295, DOI 10.1088/0305-4470/39/13/009; Drinfeld V. G., 1987, P INT C MATH BERKELE, V1, P798; Gasper G., 1990, ENCY MATH ITS APPL, V35; KAC V. G., 1990, INFINITE DIMENSIONAL; Kapranov M. M., 1994, P S PURE MATH 2, V56, P177; KASHAEV R, 2000, AMS TRANSLATIONS SER, V201, P79; Kuniba A, 2013, SYMMETRY INTEGR GEOM, V9, DOI 10.3842/SIGMA.2013.049; Kuniba A, 2013, COMMUN MATH PHYS, V324, P695, DOI 10.1007/s00220-013-1808-9; Kuniba A, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/48/485203; OKADO M, 1990, COMMUN MATH PHYS, V134, P467, DOI 10.1007/BF02098442; Sergeev SM, 1997, MOD PHYS LETT A, V12, P1393, DOI 10.1142/S0217732397001424; Zamolodchikov A B, 1980, SOV PHYS JETP, V79, P641	21	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0010-3616	1432-0916		COMMUN MATH PHYS	Commun. Math. Phys.	MAR	2015	334	3					1219	1244		10.1007/s00220-014-2147-1		26	Physics, Mathematical	Physics	CC0MS	WOS:000350030500003		
J	Mosonyi, M; Ogawa, T				Mosonyi, Milan; Ogawa, Tomohiro			Quantum Hypothesis Testing and the Operational Interpretation of the Quantum Renyi Relative Entropies	COMMUNICATIONS IN MATHEMATICAL PHYSICS			English	Article							STRONG CONVERSE; STATISTICAL INFERENCE; STEINS LEMMA; THEOREM; SUFFICIENCY; CHANNELS; CAPACITY; RATES; LIEB	We show that the new quantum extension of Renyi's alpha-relative entropies, introduced recently by Muller-Lennert et al. (J Math Phys 54: 122203, 2013) and Wilde et al. (Commun Math Phys 331(2): 593-622, 2014), have an operational interpretation in the strong converse problem of quantum hypothesis testing. Together with related results for the direct part of quantum hypothesis testing, known as the quantum Hoeffding bound, our result suggests that the operationally relevant definition of the quantum Renyi relative entropies depends on the parameter alpha: for alpha < 1, the right choice seems to be the traditional definition D-alpha((old)) (rho parallel to sigma) := 1/alpha-1 log Tr rho(alpha)sigma(1-alpha), whereas for alpha > 1 the right choice is the newly introduced version D-alpha((new)) (rho parallel to sigma) := 1/alpha-1 log Tr (sigma 1-alpha/2 alpha rho sigma 1-alpha/2 alpha)(alpha). On the way to proving our main result, we show that the new Renyi alpha-relative entropies are asymptotically attainable by measurements for alpha > 1. From this, we obtain a new simple proof for their monotonicity under completely positive trace-preserving maps.	[Mosonyi, Milan] Univ Autonoma Barcelona, Bellaterra 08193, Barcelona, Spain; [Mosonyi, Milan] Budapest Univ Technol & Econ, Math Inst, H-1111 Budapest, Hungary; [Ogawa, Tomohiro] Univ Electrocommun, Grad Sch Informat Syst, Chofu, Tokyo 1828585, Japan	Mosonyi, M (reprint author), Univ Autonoma Barcelona, Bellaterra 08193, Barcelona, Spain.	milan.mosonyi@gmail.com; ogawa@is.uec.ac.jp			European Commission; European Research Council; MEXT [20686026]	The authors would like to thank Dr. Gen Kimura for his hospitality, and MM would further like to thank Prof. Fumio Hiai, Dr. Hiromichi Ohno and Prof. Takashi Sano for their hospitality during his visit in Japan. MM acknowledges support by the European Commission (Marie Curie Fellowship "QUANTSTAT") and by the European Research Council (Advanced Grant "IRQUAT"). Part of this work was done when MM was a Marie Curie research fellow at the School of Mathematics, University of Bristol. TO was partially supported by MEXT Grant-in-Aid (A) No. 20686026 "Project on Multi-user Quantum Network". The authors are grateful to Nilanjana Datta, Masahito Hayashi, Ke Li, Marco Tomamichel and Andreas Winter for comments and discussions, and to an anonymous referee for his/her comments. The authors are also grateful to Masahito Hayashi and Marco Tomamichel for sharing with them the manuscript [21] before publication.	Beigi S, 2013, J MATH PHYS, V54, DOI 10.1063/1.4838855; Hiai F, 2011, REV MATH PHYS, V23, P691, DOI 10.1142/S0129055X11004412; Muller-Lennert M, 2013, J MATH PHYS, V54, DOI 10.1063/1.4838856; Datta N, 2009, IEEE T INFORM THEORY, V55, P2816, DOI 10.1109/TIT.2009.2018325; PETZ D, 1986, COMMUN MATH PHYS, V105, P123, DOI 10.1007/BF01212345; PETZ D, 1988, Q J MATH, V39, P97, DOI 10.1093/qmath/39.1.97; Audenaert KMR, 2008, COMMUN MATH PHYS, V279, P251, DOI 10.1007/s00220-008-0417-5; ARAKI H, 1990, LETT MATH PHYS, V19, P167, DOI 10.1007/BF01045887; LIEB EH, 1973, ADV MATH, V11, P267, DOI 10.1016/0001-8708(73)90011-X; Frank RL, 2013, J MATH PHYS, V54, DOI 10.1063/1.4838835; Mosonyi M, 2011, IEEE T INFORM THEORY, V57, P2474, DOI 10.1109/TIT.2011.2110050; Wilde MM, 2014, COMMUN MATH PHYS, V331, P593, DOI 10.1007/s00220-014-2122-x; Petz D, 2003, REV MATH PHYS, V15, P79, DOI 10.1142/S0129055X03001576; UHLMANN A, 1977, COMMUN MATH PHYS, V54, P21, DOI 10.1007/BF01609834; Audenaert K. M. R., 2008, INT J INF SYST SCI, V4, P78; Berta M., 2011, ARXIV11075460; Bhatia R, 1997, MATRIX ANAL; Bjelakovic I, 2005, COMMUN MATH PHYS, V260, P659, DOI 10.1007/s00220-005-1426-2; Bjelakovic I, 2004, COMMUN MATH PHYS, V247, P697, DOI 10.1007/s00220-004-1054-2; Bjelakovic I, 2004, INVENT MATH, V155, P203, DOI 10.1007/s00222-003-0318-3; CSISZAR I, 1995, IEEE T INFORM THEORY, V41, P26, DOI 10.1109/18.370121; Dembo A., 1998, APPL MATH, V38; Han T.S., 2003, INFORM SPECTRUM METH; HAN TS, 1989, IEEE T INFORM THEORY, V35, P178, DOI 10.1109/18.42188; Hayashi M., 2013, COMMUNICATION; Hayashi M, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.062301; Hayashi M., ARXIV14086894; Hayashi M., 2006, QUANTUM INFORM THEOR; Hayashi M, 2002, J PHYS A-MATH GEN, V35, P10759, DOI 10.1088/0305-4470/35/50/307; Hayashi M., 2014, COMMUNICATION; Hayashi M, 2005, ASYMPTOTIC THEORY QU, P64; Hiai F, 2008, J MATH PHYS, V49, DOI 10.1063/1.2872276; Hiai F., 1994, LINEAR MULTILINEAR A, V36, P239, DOI 10.1080/03081089408818297; HIAI F, 1991, COMMUN MATH PHYS, V143, P99, DOI 10.1007/BF02100287; Jencova A, 2006, INFIN DIMENS ANAL QU, V9, P331, DOI 10.1142/S0219025706002408; Jencova A, 2006, COMMUN MATH PHYS, V263, P259, DOI 10.1007/s00220-005-1510-7; Jencova A., 2010, ACTA SCI MATH SZEGED, V76, P27; Lieb E. H., 1976, STUDIES MATH PHYS, P269; Mosonyi M., ARXIV14073567; Mosonyi M, 2013, ARXIV13107525; Nagaoka H, QUANTPH0611289; Nagaoka H, 2007, IEEE T INFORM THEORY, V53, P534, DOI 10.1109/TIT.2006.889463; Nagaoka H., 2001, P ERATO WORKSH QUANT, P33; Nielsen M. A., 2000, QUANTUM INFORM QUANT; Ogawa T, 2000, IEEE T INFORM THEORY, V46, P2428, DOI 10.1109/18.887855; Petz D., 1986, Reports on Mathematical Physics, V23, DOI 10.1016/0034-4877(86)90067-4; Renner R., 2005, THESIS SWISS FEDERAL; Renyi A., 1961, P 4 BERK S MATH STAT, V1, P547; Tomamichel M., ARXIV12032142 ETH ZU; Uhlmann A., 1976, Reports on Mathematical Physics, V9, DOI 10.1016/0034-4877(76)90060-4; Umegaki H, 1962, KODAI MATH SEM REP, V14, P59, DOI DOI 10.2996/KMJ/1138844604; Winter A., 2012, COMMUNICATION	52	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0010-3616	1432-0916		COMMUN MATH PHYS	Commun. Math. Phys.	MAR	2015	334	3					1617	1648		10.1007/s00220-014-2248-x		32	Physics, Mathematical	Physics	CC0MS	WOS:000350030500013		
J	Koyama, H; Okamoto, S; Watanabe, N; Hoshino, N; Jimbo, M; Yasumoto, K; Watabe, S				Koyama, Hirold; Okamoto, Seiji; Watanabe, Naoki; Hoshino, Naoshige; Jimbo, Mitsuru; Yasumoto, Ko; Watabe, Shugo			Dynamic changes in the accumulation of metabolites in brackish water clam Corbicula japonica associated with alternation of salinity	COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY			English	Article						Brackish water clam; Corbicula japonica; Metabolome analysis; Salinity	NMR-BASED METABOLOMICS; RUDITAPES-PHILIPPINARUM; CRASSOSTREA-VIRGINICA; CONTROL MECHANISMS; VOLUME REGULATION; BIVALVE MOLLUSKS; RIBBED MUSSEL; AMINO-ACIDS; ALANINE; OYSTER	The brackish water clam Corbicula japonica inhabits rivers and brackish waters throughout Japan where the major fishing grounds in the Ibaraki Prefecture, Japan, are located at the Hinuma Lake and Hinuma River. Water salinity in the Lake Hinuma is low and stable due to the long distance from the Pacific Ocean, whereas that in the downstream of the river varies daily due to a strong effect of tidal waters. In the present study, we dissected the gill and foot muscle of brackish water clam collected from these areas, and subjected them to metabolome analysis by capillary electrophoresis-time-of-flight mass spectrometry. More than 200 metabolites including free amino acids, peptides and organic acids were identified, and their amounts from the foot muscle tend to be higher than those from the gill. The principal component analysis revealed that the amount of each metabolite was different among sampling areas and between the gill and foot muscle, whereas no apparent differences were observed between male and female specimens. When the metabolites in the female clam at high salinity were compared with those at low salinity, concentrations of alpha-alanine, choline, gamma-aminobutyric acid, ornithine and glycine betaine were found to be changed in association with salinity. We also compared various metabolites in relation to metabolic pathways, suggesting that many enzymes were involved in their changes depending on salinity. (C) 2014 Elsevier Inc All rights reserved.	[Koyama, Hirold; Jimbo, Mitsuru; Yasumoto, Ko; Watabe, Shugo] Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 2520373, Japan; [Okamoto, Seiji; Watanabe, Naoki; Hoshino, Naoshige] Ibaraki Prefectural Fisheries Res Inst, Hitachinaka, Ibaraki 3111203, Japan; [Watabe, Shugo] Univ Tokyo, Grad Sch Agr & Life Sci, Marine Biochem Lab, Tokyo 1138657, Japan	Watabe, S (reprint author), Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 2520373, Japan.	swatabe@kitasato-u.ac.jp			JSPS KAKENHI [24658182]	This work was partly supported by a JSPS KAKENHI Grant for Challenging Exploratory Research (no. 24658182).	SHUMWAY SE, 1977, MAR BIOL, V41, P153, DOI 10.1007/BF00394023; Zhang LB, 2011, CLEAN-SOIL AIR WATER, V39, P989, DOI 10.1002/clen.201100208; Berger VJ, 1997, HYDROBIOLOGIA, V355, P115, DOI 10.1023/A:1003023322263; Liu XL, 2011, ENVIRON TOXICOL PHAR, V31, P323, DOI 10.1016/j.etap.2010.12.003; Zhang LB, 2011, MAR ENVIRON RES, V72, P33, DOI 10.1016/j.marenvres.2011.04.002; Deaton LE, 2001, J EXP MAR BIOL ECOL, V260, P185, DOI 10.1016/S0022-0981(01)00237-4; Wu HF, 2013, ECOTOX ENVIRON SAFE, V90, P1, DOI 10.1016/j.ecoenv.2012.02.022; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; SUGDEN PH, 1975, BIOCHEM J, V150, P113; MATSUSHIMA O, 1984, MAR BIOL LETT, V5, P217; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; BALLANTYNE JS, 1991, CAN J FISH AQUAT SCI, V48, P1117; BISHOP SH, 1994, J EXP ZOOL, V268, P151, DOI 10.1002/jez.1402680213; Hosoi M, 2003, FISHERIES SCI, V69, P395, DOI 10.1046/j.1444-2906.2003.00634.x; Meng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058563; Nishikawa T., 1992, J CHROMATOGR, V582, P41; Okamoto S, 2012, NIPPON SUISAN GAKK, V78, P444, DOI 10.2331/suisan.78.444; PIERCE SK, 1982, BIOL BULL, V163, P405, DOI 10.2307/1541452; PIERCE SK, 1981, J EXP ZOOL, V215, P247, DOI 10.1002/jez.1402150304; Sokolowski A, 2003, COMP BIOCHEM PHYS A, V134, P579, DOI 10.1016/S1095-6433(02)00360-4; WICKES MA, 1976, COMP BIOCHEM PHYS B, V53, P339, DOI 10.1016/0305-0491(76)90338-2; WOOD JM, 1973, BIOCHEMISTRY-US, V12, P5268, DOI 10.1021/bi00750a007; Zhang L, 2011, ENVIRON TOXICOL PHAR, V32, P218, DOI 10.1016/j.etap.2011.05.006; Zhao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046244	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1096-4959	1879-1107		COMP BIOCHEM PHYS B	Comp. Biochem. Physiol. B-Biochem. Mol. Biol.	MAR	2015	181						59	70		10.1016/j.cbpb.2014.11.007		12	Biochemistry & Molecular Biology; Zoology	Biochemistry & Molecular Biology; Zoology	CC2OH	WOS:000350184000008		
J	Koizumi, N; Hanamura, Y; Nishida, K; Mori, A; Watabe, K; Takemura, T; Man, A; Kassim, FM; Morioka, S				Koizumi, Noriyuki; Hanamura, Yukio; Nishida, Kazuya; Mori, Atsushi; Watabe, Keiji; Takemura, Takeshi; Man, Alias; Kassim, Faizul M.; Morioka, Shinsuke			Development of 18 novel polymorphic microsatellite markers for the mysid crustacean Mesopodopsis orientalis	CONSERVATION GENETICS RESOURCES			English	Article						Crustacea; Mysida; Microsatellite; Genetic diversity; Estuarine system	SEASONALITY; MALAYSIA	We have developed microsatellite DNA markers for Mesopodopsis orientalis (Tattersall 1908), a widely distributed mysid crustacean in shallow waters of the coastal and estuarine systems across India to Indonesia and the Philippines. A total of 18 novel polymorphic microsatellite markers were identified in 32 individuals from a sandy beach at Teluk Kumbar in Penang Island, Malaysia. The number of alleles per locus ranged from 3 to 17. The observed and expected heterozygosities varied from 0.031-1.000 to 0.092-0.938, respectively. These polymorphic markers could be available for future investigations of genetic diversity and structure of M. orientalis populations.	[Koizumi, Noriyuki; Mori, Atsushi; Watabe, Keiji; Takemura, Takeshi] Natl Inst Rural Engn, Tsukuba, Ibaraki 3058609, Japan; [Hanamura, Yukio] Natl Res Inst Fisheries Sci, Yokohama, Kanagawa 2368648, Japan; [Nishida, Kazuya] Natl Res Inst Far Seas Fisheries, Yokohama, Kanagawa 2368648, Japan; [Man, Alias] Fisheries Res Inst, Sitawan 32000, Perak, Malaysia; [Kassim, Faizul M.; Morioka, Shinsuke] Japan Int Res Ctr Agr Sci, Tsukuba, Ibaraki 3058686, Japan	Koizumi, N (reprint author), Natl Inst Rural Engn, Tsukuba, Ibaraki 3058609, Japan.	koizumin@affrc.go.jp			JSPS KAKENHI [26450348, 25450367, 22405030]	This study was supported in part by JSPS KAKENHI Grant Number 26450348, 25450367 and 22405030. Our thanks go to Mses. Aiko Suzuki, Kyoko Yamanoi and Ponthip Goto for their support in chemical analyses and to Mr. Philip Johnson for his English grammar correction of the manuscript.	Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Eusebio PS, 2010, AQUACULTURE, V306, P289, DOI 10.1016/j.aquaculture.2010.05.004; Hanamura Yukio, 2009, Plankton & Benthos Research, V4, P53; Hanamura Y, 2008, ESTUAR COAST SHELF S, V77, P467, DOI 10.1016/j.ecss.2007.10.015; Mantiri R, 2012, KUROSHIO SCI, V5, P137	5	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1877-7252	1877-7260		CONSERV GENET RESOUR	Conserv. Genet. Resour.	MAR	2015	7	1					133	135		10.1007/s12686-014-0311-8		3	Biodiversity Conservation; Genetics & Heredity	Biodiversity & Conservation; Genetics & Heredity	CB8UW	WOS:000349908000034		
J	Koizumi, N; Moriyama, T; Yoshino, T; Nishida, K; Mori, A; Watabe, K; Takemura, T				Koizumi, Noriyuki; Moriyama, Takumi; Yoshino, Tetsuo; Nishida, Kazuya; Mori, Atsushi; Watabe, Keiji; Takemura, Takeshi			Development and characterization of microsatellite loci for Rhinogobius sp YB (Gobiidae)	CONSERVATION GENETICS RESOURCES			English	Article						Gobiidae; Microsatellite; Genetic diversity; Ryukyu Archipelago	FRESH-WATER GOBY	Rhinogobius sp. YB (Gobiidae) distributed in the Ryukyu Archipelago is a fluvial species of gobies. We present 34 novel microsatellite loci that were tested on 32 individuals from the Okierabu-jima Island in Kagoshima Prefecture. Seventeen loci were polymorphic, while the remaining 17 were monomorphic. The number of alleles per the polymorphic loci ranged from 2 to 15. The observed heterozygosities ranged from 0.038 to 1.000 and the expected heterozygosities varied from 0.038 to 0.816. These microsatellite loci will enhance future investigations on the genetic differentiation and structure of populations of R. sp. YB.	[Koizumi, Noriyuki; Mori, Atsushi; Watabe, Keiji; Takemura, Takeshi] Natl Inst Rural Engn, Tsukuba, Ibaraki 3058609, Japan; [Moriyama, Takumi] Utsunomiya Univ, Fac Agr, Utsunomioya, Tochigi 3218505, Japan; [Yoshino, Tetsuo] Okinawa Churashima Fdn, Gen Res Ctr, Kunigami, Okinawa 9050206, Japan; [Nishida, Kazuya] Natl Res Inst Far Seas Fisheries, Kanazawa Ku, Yokohama, Kanagawa 2368648, Japan	Koizumi, N (reprint author), Natl Inst Rural Engn, Tsukuba, Ibaraki 3058609, Japan.	koizumin@affrc.go.jp			JSPS KAKENHI [26450348, 25450367]	This study was supported in part by JSPS KAKENHI Grant Nos. 26450348 and 25450367. Our thanks go to Mses. Aiko Suzuki, Kyoko Yamanoi and Ponthip Goto for their support in chemical analyses and to Mr. Philip Johnson for his English grammar correction of the manuscript.	Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Kano Y, 2012, ECOL EVOL, V2, P1805, DOI 10.1002/ece3.295; Ohara K, 2004, MOL ECOL NOTES, V4, P449, DOI 10.1111/j.1471-8286.2004.00677.x; Ohara K, 2008, ZOOL SCI, V25, P391, DOI 10.2108/zsj.25.391	4	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1877-7252	1877-7260		CONSERV GENET RESOUR	Conserv. Genet. Resour.	MAR	2015	7	1					137	141		10.1007/s12686-014-0312-7		5	Biodiversity Conservation; Genetics & Heredity	Biodiversity & Conservation; Genetics & Heredity	CB8UW	WOS:000349908000035		
J	Tsukagoshi, H; Terui, S; Abe, S				Tsukagoshi, H.; Terui, S.; Abe, S.			Characterization of sixteen polymorphic microsatellite DNA loci in the chum salmon (Oncorhynchus keta) isolated by next-generation sequencing	CONSERVATION GENETICS RESOURCES			English	Article						Chum salmon; Oncorhynchus keta; Fisheries resources; Microsatellite DNA; Next-generation sequencing		Chum salmon (Oncorhynchus keta) is an important fisheries resource around the North Pacific region. However, the genetic characteristics of this species mostly remain to be elucidated with competent molecular genetic markers for their effective resource management and sustainable use. A total of sixteen novel microsatellite markers in chum salmon were isolated using a next-generation sequencing approach. All loci were polymorphic with 6-21 alleles, with the observed and expected heterozygosities of 0.41667-0.97917 and 0.66184-0.92434, respectively. These new loci will provide a tool for examining the genetic diversity and population structure of chum salmon, which are an important information for the adaptive management of this species.	[Tsukagoshi, H.; Terui, S.; Abe, S.] Iwate Univ, Sanriku Fisheries Res Ctr, Kamaishi, Iwate 0260001, Japan	Tsukagoshi, H (reprint author), Iwate Univ, Sanriku Fisheries Res Ctr, Kamaishishi Heita 3-75-1, Kamaishi, Iwate 0260001, Japan.	tsuk@iwate-u.ac.jp			MEXT Revitalization Project for the Creation of Fisheries Research and Education Center in Sanriku; JST Revitalization Promotion Program	We thanks to Fisheries Cooperative Association of Shimoakka, Noda, Iwate, for their help in collecting samples. This study was supported by MEXT Revitalization Project for the Creation of Fisheries Research and Education Center in Sanriku, and JST Revitalization Promotion Program.	Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Seeb LW, 2011, MOL ECOL RESOUR, V11, P195, DOI 10.1111/j.1755-0998.2010.02966.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47; Oosterhout C. V., 2004, MOL ECOL NOTES, V4, P535, DOI DOI 10.1111/J.1471-8286.2004.00684.X; Rozen S, 2000, Methods Mol Biol, V132, P365	5	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1877-7252	1877-7260		CONSERV GENET RESOUR	Conserv. Genet. Resour.	MAR	2015	7	1					173	175		10.1007/s12686-014-0322-5		3	Biodiversity Conservation; Genetics & Heredity	Biodiversity & Conservation; Genetics & Heredity	CB8UW	WOS:000349908000045		
J	Yamazaki, A; Watanabe, T; Tsunogai, U; Hasegawa, H; Yamano, H				Yamazaki, A.; Watanabe, T.; Tsunogai, U.; Hasegawa, H.; Yamano, H.			The coral delta N-15 record of terrestrial nitrate loading varies with river catchment land use	CORAL REEFS			English	Article						Coral skeletons; Nitrogen isotopes; Nitrate; Land use; River discharge; Coral reefs	ISHIGAKI ISLAND; NITROGEN-SOURCES; REEF; JAPAN; OCEAN; GROUNDWATER; DELTA-O-18; DELTA-C-13; SKELETONS; SOUTHWEST	We analysed the nitrogen isotopes in two coral cores (delta N-15(coral)) from the mouth of the Todoroki River, Ishigaki Island, Japan, to examine whether the delta N-15(coral) reflects the run-off of nitrate related to the land use in the river catchment. The two coral cores were used to examine the seasonal variation in delta N-15(coral) for 14 years (CORE1; 1993-2007) and the annual variation of delta N-15(coral) for 52 years (CORE2; 1958-2010). In CORE1, the 5-month running mean of delta N-15(coral) was positively correlated with that of monthly precipitation, excluding all strong precipitation events (> 150 mm d(-1)). In CORE2, the delta N-15(coral) mean in the earlier period (1958-1980) was 1.0 aEuro degrees greater than that in the later period (1981-2010). The annual averages of delta N-15(coral) are positively correlated with the total precipitation in the rainy season (May-June) for both time periods. The difference in the delta N-15(coral) between the earlier and later periods is probably caused by the land use changed from paddy fields with N-15-rich manure to sugar cane fields in the early 1980s. Although some uncertainties still remain regarding the precision of delta N-15 coral proxy records, this study emphasises the clear potential for their use in reconstructing terrestrial nitrate discharge records from corals.	[Yamazaki, A.; Watanabe, T.] Hokkaido Univ, Grad Sch Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Yamazaki, A.] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2770882, Japan; [Tsunogai, U.] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Hasegawa, H.] Kokushikan Univ, Dept Geog & Environm Studies, Setagaya Ku, Tokyo 1548515, Japan; [Yamano, H.] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki 3058506, Japan	Yamazaki, A (reprint author), Hokkaido Univ, Grad Sch Sci, Kita Ku, N10W8, Sapporo, Hokkaido 0600810, Japan.	zaki@aori.u-tokyo.ac.jp	Tsunogai, Urumu/C-8303-2011	Tsunogai, Urumu/0000-0002-1517-3284	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [20121004]; JSPS	Coral and water sampling for this study were supported by CREES members of Hokkaido University, Toshiaki Tanaka, Teppei Sagawa, Satoshi Maekawa, and the WWF Coral Reef Conservation and Research Centre. Coral core cutting was supported by Masataka Ikeda. The research was funded by a Grant-in-Aid for Scientific Research on Innovative Areas 'Coral reef science for symbiosis and coexistence of human and ecosystem under combined stresses' (#20121004) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. A. Yamazaki was supported by Grants-in-Aid for JSPS research fellows.	Adachi H, 2003, MAR TECHNOL SOC J, V37, P31; Needoba JA, 2003, MAR ECOL PROG SER, V255, P81, DOI 10.3354/meps255081; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Umezawa Y, 2002, LIMNOL OCEANOGR, V47, P1405; Inoue M, 2014, CORAL REEFS, V33, P363, DOI 10.1007/s00338-014-1128-3; Grottoli AG, 2007, EARTH-SCI REV, V81, P67, DOI 10.1016/j.earscirev.2006.10.001; Heikoop JM, 1998, LIMNOL OCEANOGR, V43, P909; Pal M, 2003, REMOTE SENS ENVIRON, V86, P554, DOI 10.1016/S0034-4257(03)00132-9; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Gagan MK, 2000, QUATERNARY SCI REV, V19, P45, DOI 10.1016/S0277-3791(99)00054-2; Reynaud S, 2009, MAR ECOL PROG SER, V392, P103, DOI 10.3354/meps08195; Blanco AC, 2008, MAR ENVIRON RES, V66, P520, DOI 10.1016/j.marenvres.2008.08.005; Heikoop JM, 2000, CORAL REEFS, V19, P189, DOI 10.1007/s003380000092; Fukada T, 2003, WATER RES, V37, P3070, DOI 10.1016/S0043-1354(03)00176-3; Blanco AC, 2010, HYDROL PROCESS, V24, P2601, DOI 10.1002/hyp.7685; Druffel ERM, 1997, P NATL ACAD SCI USA, V94, P8354, DOI 10.1073/pnas.94.16.8354; Hasegawa H, 2011, J REMOTE SENSING SOC, V31, P73; Hirota A, 2010, RAPID COMMUN MASS SP, V24, P1085, DOI 10.1002/rcm.4483; Ikeda S, 2009, P JPN ACAD B-PHYS, V85, P374, DOI 10.2183/pjab.85.374; Ishihara M, 2014, BIODIVERSITY OBSERVA, P231; Knapp AN, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002320; Konno U, 2010, BIOGEOSCIENCES, V7, P2369, DOI 10.5194/bg-7-2369-2010; Marion GS, 2005, MAR POLLUT BULL, V50, P931, DOI 10.1016/j.marpolbul.2005.04.001; Miyajima T, 2001, MAR ECOL PROG SER, V217, P273, DOI 10.3354/meps217273; Muscatine L., 1994, Pacific Science, V48, P304; Schwarz CJ, 2011, SAMPLING REGRESSION, P57; Tsunogai U, 2008, RAPID COMMUN MASS SP, V22, P345, DOI 10.1002/rcm.3368; Uchida A, 2008, GEOCHEM J, V42, P255; Umezawa Y, 2008, J OCEANOGR, V64, P899, DOI 10.1007/s10872-008-0074-5; Umezawa Y, 2002, CORAL REEFS, V21, P346, DOI 10.1007/s00338-002-0254-5; Yamamuro M, 2003, MAR POLLUT BULL, V46, P452, DOI 10.1016/S0025-326X(02)00463-0; Yamazaki A, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049053; Yamazaki A, 2013, CHEM GEOL, V351, P276, DOI 10.1016/j.chemgeo2013.05.024; Yamazaki A, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001697	36	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0722-4028	1432-0975		CORAL REEFS	Coral Reefs	MAR	2015	34	1					353	362		10.1007/s00338-014-1235-1		10	Marine & Freshwater Biology	Marine & Freshwater Biology	CC0MY	WOS:000350031100038		
J	Zhai, ZQ; Abe, H; Miyahara, Y; Watanabe, Y				Zhai, Ziqing; Abe, Hiroshi; Miyahara, Yuichi; Watanabe, Yutaka			Effects of phosphorus segregation on stress corrosion cracking in the heat-affected zone of a dissimilar weld joint between a Ni-base alloy and a low alloy steel	CORROSION SCIENCE			English	Article						Low alloy steel; AFM; Atom probe tomography; Stress corrosion; Segregation	GRAIN-BOUNDARY SEGREGATION; HIGH-STRENGTH STEEL; CLEAVAGE INITIATION; NITRATE SOLUTIONS; ETCHING METHOD; IRON; MICROSTRUCTURE; EMBRITTLEMENT; CARBON; MANGANESE	Effects of phosphorus segregation on stress corrosion cracking (SCC) in the heat-affected zone of an Alloy 182-A533B dissimilar weld joint in high-temperature, oxygenated water doped with SO42- and CI- were evaluated by creviced bent beam test. Results indicate that step cooling and the addition of Cl- promoted SCC propagation and reactivation in the HAZ after cracks reach the fusion boundary. It is also suggested that phosphorus segregation at grain/packet boundaries and precipitate-matrix interfaces have promoted SCC, especially in coarse-grained HAZ and intercritically reheated coarse-grained HAZ. (C) 2014 Elsevier Ltd. All rights reserved.	[Zhai, Ziqing; Abe, Hiroshi; Watanabe, Yutaka] Tohoku Univ, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Miyahara, Yuichi] Cent Res Inst Elect Power Ind, Planning Grp, Chiyoda Ku, Tokyo 1008126, Japan	Zhai, ZQ (reprint author), Tohoku Univ, Grad Sch Engn, Aoba Ku, 6-6-01-2 Aoba, Sendai, Miyagi 9808579, Japan.	ziqing.zhai@gmail.com					Abe H., 2012, 15 INT C ENV DEGR MA, P791; [Anonymous], 1996, TR103515R1 EPRI; Kim S, 2001, METALL MATER TRANS A, V32, P903, DOI 10.1007/s11661-001-0347-8; [Anonymous], 2005, ASS MAN AG MAJ NUCL; [Anonymous], 2000, TR114783 EPRI; KRAKAUER BW, 1993, PHYS REV B, V48, P6724, DOI 10.1103/PhysRevB.48.6724; Hou JA, 2010, CORROS SCI, V52, P3949, DOI 10.1016/j.corsci.2010.08.002; GUTTMANN M, 1982, METALL TRANS A, V13, P1693, DOI 10.1007/BF02647825; WENG YQ, 1987, MATER SCI TECH SER, V3, P207; Im YR, 2004, J NUCL MATER, V324, P33, DOI 10.1016/j.jnucmat.2003.09.003; Peng QJ, 2011, CORROS SCI, V53, P4309, DOI 10.1016/j.corsci.2011.08.046; Liao JS, 1998, NUCL ENG DES, V183, P9, DOI 10.1016/S0029-5493(98)00151-4; GRABKE HJ, 1987, SCRIPTA METALL MATER, V21, P1329, DOI 10.1016/0036-9748(87)90108-6; KIM BC, 1991, METALL TRANS A, V22, P139; BANDYOPADHYAY N, 1983, METALL TRANS A, V14, P2005, DOI 10.1007/BF02662368; BANDYOPADHYAY N, 1985, CORROSION, V41, P274; BANDYOPADHYAY N, 1985, METALL TRANS A, V16, P1333, DOI 10.1007/BF02670337; Bandyopadhyay N., 1984, Advances in Fracture Research (Fracture 84). Proceedings of the 6th International Conference on Fracture (ICG6); BOWEN P, 1988, ACTA METALL MATER, V36, P425, DOI 10.1016/0001-6160(88)90018-1; Briant C. L., 1978, International Metals Reviews, V23; BRIANT CL, 1989, CORROS SCI, V29, P53, DOI 10.1016/0010-938X(89)90080-2; BURSTEIN GT, 1983, MET SCI, V17, P111; Davis CL, 1996, METALL MATER TRANS A, V27, P3019, DOI 10.1007/BF02663851; English C. A., 2000, EFFECTS RAD MAT, P151; Flis J, 2009, CORROS SCI, V51, P1696, DOI 10.1016/j.corsci.2009.04.020; Gibbs J, 1948, COLLECTED WORKS JW G, V1; GREEN JAS, 1968, CORROSION, V24, P66; Guttmann M., 2001, ENCY MAT SCI TECHNOL, P1; HIPPSLEY CA, 1990, MATER SCI TECH SER, V6, P735; Islam MA, 2007, J MATER ENG PERFORM, V16, P73, DOI 10.1007/s11665-006-9011-1; DAVIS CL, 1994, METALL MATER TRANS A, V25, P563, DOI 10.1007/BF02651598; Kumagai K., 2009, 14 INT C ENV DEGR MA, V1, P671; KUPPER J, 1981, CORROS SCI, V21, P227, DOI 10.1016/0010-938X(81)90032-9; Lea C., 1981, MATH PHYS SCI, V377, P477; Lea C., 1980, Metal Science, V14; Materials Reliability Program, 2003, MAT REL PROGR REV TH; Naudin C, 1999, SCRIPTA MATER, V40, P1013, DOI 10.1016/S1359-6462(99)00069-X; OGURA T, 1984, METALL TRANS A, V15, P1563, DOI 10.1007/BF02657795; OGURA T, 1980, SCRIPTA METALL MATER, V14, P887, DOI 10.1016/0036-9748(80)90314-2; Peng Q., 2005, 12 INT C ENV DEGR MA, P589; Sanchez J, 2008, CORROS SCI, V50, P1820, DOI 10.1016/j.corsci.2008.03.013; Seifert HP, 2008, J NUCL MATER, V372, P114, DOI 10.1016/j.jnucmat.2007.03.048; Takeuchi K., 2000, P ANN M JSME MMD, P437; Viswanathan R., 1988, J ENG MATER-T ASME, V110, P313; Zhai Z., 2014, METALL MATER TRANS A, P1; Zhai ZQ, 2014, J NUCL MATER, V452, P133, DOI 10.1016/j.jnucmat.2014.05.005	46	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	MAR	2015	92						32	42		10.1016/j.corsci.2014.10.037		11	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CB6LB	WOS:000349737400003		
J	Medgyes, B; Horvath, B; Illes, B; Shinohara, T; Tahara, A; Harsanyi, G; Krammer, O				Medgyes, Balint; Horvath, Barbara; Illes, Balazs; Shinohara, Tadashi; Tahara, Akira; Harsanyi, Gabor; Krammer, Oliver			Microstructure and elemental composition of electrochemically formed dendrites on lead-free micro-alloyed low Ag solder alloys used in electronics	CORROSION SCIENCE			English	Article						Alloy; STEM; Anodic dissolution; Pourbaix diagram	PRINTED-CIRCUIT BOARD; NACL SOLUTION; AQUEOUS-SOLUTION; IN-SITU; MIGRATION; CHLORIDE; SOLUBILITY; BEHAVIOR; IONS; TIN	The Electrochemical Migration (ECM) behaviour of lead-free, micro-alloyed, low Ag solder alloys was investigated using Scanning Transmission Electron Microscopy (STEM), Energy Disperse X-ray Spectroscopy (EDS) and electron diffraction methods. Different solder alloys were investigated by Water Drop (WD) tests to stimulate ECM failure mechanism. After WD tests, differently structured dendrites were formed depending on the solder alloy types. The results showed that micro-alloying components (e.g. Sb) also played role during the ECM processes. The novelty of this study is the demonstration that Sb can take part in the ECM process; the ECM model of Sb is also discussed. (C) 2014 Elsevier Ltd. All rights reserved.	[Medgyes, Balint; Illes, Balazs; Harsanyi, Gabor; Krammer, Oliver] Budapest Univ Technol & Econ, Dept Elect Technol, H-1111 Budapest, Hungary; [Horvath, Barbara; Shinohara, Tadashi; Tahara, Akira] Natl Inst Mat Sci, Mat Corros Grp, Tsukuba, Ibaraki 3050047, Japan	Medgyes, B (reprint author), Budapest Univ Technol & Econ, Dept Elect Technol, Egry Jozsef Utca 18,Bldg V1,Ground Floor, H-1111 Budapest, Hungary.	medgyes@ett.bme.hu	Illes, Balazs/G-7378-2012; 	Illes, Balazs/0000-0002-8619-5472; Harsanyi, Gabor/0000-0002-8514-8842	National Institute for Materials Science (Japan); Pro Progressio Foundation (Hungary)	The authors would like thank to the National Institute for Materials Science (Japan) and to the Pro Progressio Foundation (Hungary) for their technical and financial support.	AHRLAND S, 1974, ACTA CHEM SCAND A, VA 28, P1089, DOI 10.3891/acta.chem.scand.28a-1089; Zhong XK, 2013, ELECTROCHEM COMMUN, V27, P63, DOI 10.1016/j.elecom.2012.11.010; White ER, 2012, ACS NANO, V6, P6308, DOI 10.1021/nn3017469; Yu DQ, 2006, J MATER SCI-MATER EL, V17, P229, DOI 10.1007/s10854-006-6765-z; Kraus T, 2013, LANGMUIR, V29, P8427, DOI 10.1021/la401584z; Lee SB, 2006, THIN SOLID FILMS, V504, P294, DOI 10.1016/j.tsf.2005.09.022; MCCORMACK M, 1993, APPL PHYS LETT, V63, P15, DOI 10.1063/1.109734; He XF, 2011, J ELECTRON MATER, V40, P1921, DOI 10.1007/s11664-011-1672-3; Mohanty US, 2008, CORROS SCI, V50, P2437, DOI 10.1016/j.corsci.2008.06.042; Khireche S, 2014, CORROS SCI, V87, P504, DOI 10.1016/j.corsci.2014.07.018; Yokoyama K, 2014, CORROS SCI, V86, P142, DOI 10.1016/j.corsci.2014.05.004; Zhong XK, 2013, CORROS SCI, V74, P71, DOI 10.1016/j.corsci.2013.04.015; Osorio WR, 2014, CORROS SCI, V80, P71, DOI 10.1016/j.corsci.2013.11.010; BIERNAT J, 1975, J ELECTROANAL CHEM, V63, P444, DOI 10.1016/0368-1874(75)80082-7; BLANDAME.MJ, 1974, J CHEM SOC DALTON, P1084, DOI 10.1039/dt9740001084; BRINTZINGER H, 1948, Z ANORG CHEM, V256, P98, DOI 10.1002/zaac.622560113; CHENG F, 2012, J MATER SCI-MATER EL, V46, P3424; Fenglian S., 2011, 12 INT C 18 20 APR 2; GAYER KH, 1952, J AM CHEM SOC, V74, P2353, DOI 10.1021/ja01129a051; HARSANYI G, 1995, IEEE T COMPON PACK A, V18, P602, DOI 10.1109/95.465159; Jellesen MS, 2010, ENG FAIL ANAL, V17, P1263, DOI 10.1016/j.engfailanal.2010.02.010; Lide D.R., 2009, HDB CHEM PHYS; LINGANE JJ, 1947, J AM CHEM SOC, V69, P530, DOI 10.1021/ja01195a019; Liu Y, 2012, J MATER SCI-MATER EL, V23, P1705, DOI 10.1007/s10854-012-0649-1; Medgyes B., 2013, POLYTECH ELECT, V57, P49; Minzari D, 2011, CORROS SCI, V53, P1659, DOI 10.1016/j.corsci.2011.01.009; NEUMANN HM, 1954, J AM CHEM SOC, V76, P2611, DOI 10.1021/ja01639a004; NEUMANN HM, 1956, J AM CHEM SOC, V78, P1848, DOI 10.1021/ja01590a021; Noh BI, 2008, J MATER SCI-MATER EL, V19, P952, DOI 10.1007/s10854-007-9421-3; Pourbaix M., 1966, ATLAS ELECTROCHEMICA, P526; Sheng Zhan, 2008, IEEE Transactions on Device and Materials Reliability, V8, DOI 10.1109/TDMR.2008.922908; Shohji I, 2004, J ELECTRON MATER, V33, P923, DOI 10.1007/s11664-004-0222-7; STROHAL P, 1975, ESTUAR COAST MAR SCI, V3, P119, DOI 10.1016/0302-3524(75)90014-6; Takeno N., 2005, ATLAS EH PH DIAGRAMS, P224; TOURKY AR, 1948, J CHEM SOC, P759, DOI 10.1039/jr9480000759; Wang ZY, 2008, J PHYS CHEM SOLIDS, V69, P1296, DOI 10.1016/j.jpcs.2007.10.089; Yang S, 2006, MICROELECTRON RELIAB, V46, P1915, DOI 10.1016/j.microrel.2006.07.080; Yoo YR, 2007, MET MATER-INT, V13, P129	38	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	MAR	2015	92						43	47		10.1016/j.corsci.2014.11.004		5	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CB6LB	WOS:000349737400004		
J	Bolind, AM; Lillard, RS; Stubbins, JF				Bolind, Alan Michael; Lillard, R. Scott; Stubbins, James F.			The electrical AC impedance response of oxide scales on 9Cr-lMo steel immersed in molten lead-bismuth eutectic alloy at 200 degrees C	CORROSION SCIENCE			English	Article						Steel; EIS; High temperature corrosion; Oxidation; Passive films; Kinetic parameters	LIQUID PB-BI; OXIDATION MECHANISM; FE-9CR-1MO STEEL; CORROSION BEHAVIOR; LBE; LAYERS; TESTS	Coupons of 9Cr- lMo steel were pre-oxidized in hot air and then partially immersed in molten lead-bismuth-eutectic alloy at 200 degrees C for various durations. The oxide resistance and capacitance were measured using an AC electrical method. Impedance was found not to correlate with oxide thickness. In connection with other studies on HT-9 and 316L steels, it can be tentatively suggested that oxides on ferritic-martensitic steels may be more conductive than oxides on austenitic steels. (C) 2014 Elsevier Ltd. All rights reserved.	[Bolind, Alan Michael] Univ Calif Berkeley, Dept Nucl Engn, Berkeley, CA 94720 USA; [Bolind, Alan Michael] Los Alamos Natl Lab, Div Mat Sci & Technol, Los Alamos, NM 87545 USA; [Bolind, Alan Michael] Ibaraki Univ, Ibaraki Quantum Beam Res Ctr, Frontier Res Ctr Appl Atom Sci, Tokai, Ibaraki 3191106, Japan; [Bolind, Alan Michael; Stubbins, James F.] Univ Illinois, Dept Nucl Plasma & Radiol Engn, Urbana, IL 61801 USA; [Lillard, R. Scott] Univ Akron, Dept Biomol & Chem Engn, Engn Res Ctr 213A, Akron, OH 44325 USA	Bolind, AM (reprint author), Univ Calif Berkeley, Dept Nucl Engn, 4155 Etcheverry Hall 1730, Berkeley, CA 94720 USA.	bolind@berkeley.edu; rsl@uakron.edu; jstubbin@illinois.edu			Material Science Division of Los Alamos National Laboratory	The authors would like to thank Pat Dickerson, Kenji Kikuchi, Abu Khalid Rivai, and Peter Hosemann for their help with aspects of the microanalysis in this work. The authors also thank Stuart Maloy for providing the steel. The authors acknowledge the support of the Material Science Division of Los Alamos National Laboratory.	Pacio J, 2013, SOL ENERGY, V93, P11, DOI 10.1016/j.solener.2013.03.025; Hsu CH, 2001, CORROSION, V57, P747; Martinelli L, 2008, CORROS SCI, V50, P2549, DOI 10.1016/j.corsci.2008.06.049; Chen X, 2010, J NUCL MATER, V398, P172, DOI 10.1016/j.jnucmat.2009.10.029; Chen X, 2012, J NUCL MATER, V431, P125, DOI 10.1016/j.jnucmat.2011.11.016; Ehlers J, 2006, CORROS SCI, V48, P3428, DOI 10.1016/j.corsci.2006.02.002; Lillard RS, 2004, CORROSION, V60, P1031; Hosemann P, 2008, J NUCL MATER, V377, P201, DOI 10.1016/j.jnucmat.2008.02.073; Muller G, 2002, J NUCL MATER, V301, P40, DOI 10.1016/S0022-3115(01)00725-5; Martinelli L, 2008, CORROS SCI, V50, P2523, DOI 10.1016/j.corsci.2008.06.050; Martinelli L, 2008, CORROS SCI, V50, P2537, DOI 10.1016/j.corsci.2008.06.051; Barsoukov E, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, pXII; Fazio C, 2001, J NUCL MATER, V296, P243, DOI 10.1016/S0022-3115(01)00538-4; Jovic V.D., 2014, DETERMINATION CORREC; Kurata Y, 2005, J NUCL MATER, V343, P333, DOI 10.1016/j.jnucmat.2004.07.064; Lide D. R., 2008, CRC HDB CHEM PHYS; Lillard RS, 2004, CORROSION, V60, P1134; Nam HO, 2008, J NUCL MATER, V376, P381, DOI 10.1016/j.jnucmat.2008.02.038; Nuclear Energy Agency Organization for Economic Co-Operation and Development, 2007, HDB LEAD BISM EUT AL; Samsonov G.V., 1982, OXIDE HDB; Schroer C, 2012, J NUCL MATER, V431, P105, DOI 10.1016/j.jnucmat.2011.11.014; Stubbins JF, 2008, J NUCL MATER, V377, P243, DOI 10.1016/j.jnucmat.2008.02.091; Young DJ, 2008, ELSEV CORROS SER, V1, P1; Zhang JS, 2008, J NUCL MATER, V373, P351, DOI 10.1016/j.jnucmat.2007.06.019; Zhang JS, 2005, J NUCL MATER, V336, P1, DOI 10.1016/j.jnucmat.2004.08.002	25	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	MAR	2015	92						48	57		10.1016/j.corsci.2014.11.012		10	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CB6LB	WOS:000349737400005		
J	Ishizaki, T; Kamiyama, N; Watanabe, K; Serizawa, A				Ishizaki, Takahiro; Kamiyama, Naosumi; Watanabe, Kouhei; Serizawa, Ai			Corrosion resistance of Mg(OH)(2)/Mg-Al layered double hydroxide composite film formed directly on combustion-resistant magnesium alloy AMCa602 by steam coating	CORROSION SCIENCE			English	Article						Magnesium; Passive films; Polarization; SEM; XRD	HYDROTALCITE-LIKE COMPOUNDS; AZ31 MG ALLOY; IN-SITU GROWTH; CONVERSION FILM; ALUMINUM-ALLOYS; PURE MAGNESIUM; MECHANISM; AZ91D; PRETREATMENT; PROTECTION	Films of the Mg(OH)(2)/Mg-Al layered double hydroxide composite were formed on the combustionresistant magnesium alloy AMCa602 by steam coating and characterized by X-ray diffraction, Fourier-transform infrared spectroscopy, and scanning electron microscopy. The corrosion-resistance performances of the films in a 5 wt% NaCI solution were investigated using electrochemical measurements. The corrosion current density of the sample that was steam-coated at 433 K for 6 h using the aqueous solution containing 200 mM Al(NO3)(3) decreased significantly more than that of the bare AMCa602. The correlations between the Mg Al LDH content in the films, Al(NO3)(3) concentration in the aqueous solutions, and corrosion current densities were investigated. (C) 2014 Elsevier Ltd. All rights reserved.	[Ishizaki, Takahiro; Kamiyama, Naosumi; Watanabe, Kouhei; Serizawa, Ai] Shibaura Inst Technol, Dept Mat Sci & Engn, Fac Engn, Koto Ku, Tokyo 1358548, Japan	Ishizaki, T (reprint author), Shibaura Inst Technol, Dept Mat Sci & Engn, Fac Engn, Koto Ku, 3-7-5 Toyosu, Tokyo 1358548, Japan.	ishizaki@shibaura-it.ac.jp			Advanced Industrial Technology Development, New Energy and Industrial Technology Development Organization (NEDO) of Japan [11B06024d]; Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency [AS251Z02997K]	This research was partially supported by a Grant for Advanced Industrial Technology Development, New Energy and Industrial Technology Development Organization (NEDO) of Japan (No. 11B06024d) and the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (No. AS251Z02997K), Japan Science and Technology Agency.	Akiyama S., 2000, J JAPAN FOUNDRY ENG, V72, P521; Akiyama S., 1994, J JPN FOUNDRY ENG SO, V66, P38; Barchiche CE, 2007, ELECTROCHIM ACTA, V53, P417, DOI 10.1016/j.electacta.2007.04.030; Xia YH, 2013, MAT SCI ENG C-MATER, V33, P5044, DOI 10.1016/j.msec.2013.08.033; Pokhmurska H, 2008, SURF COAT TECH, V202, P4515, DOI 10.1016/j.surfcoat.2008.04.036; Montemor MF, 2007, ELECTROCHIM ACTA, V52, P7486, DOI 10.1016/j.electacta.2006.12.086; Lin JK, 2007, SCRIPTA MATER, V56, P927, DOI 10.1016/j.scriptamat.2007.02.020; Buchheit RG, 2003, PROG ORG COAT, V47, P174, DOI 10.1016/j.porgcoat.2003.08.003; Millange F, 2000, J MATER CHEM, V10, P1713, DOI 10.1039/b002827o; Liu ZM, 2006, SURF COAT TECH, V200, P5087, DOI 10.1016/j.surfcoat.2005.05.023; Wan TT, 2013, CORROS SCI, V66, P33, DOI 10.1016/j.corsci.2012.08.051; Lin JK, 2009, CORROS SCI, V51, P1181, DOI 10.1016/j.corsci.2009.02.007; Chen J, 2011, CORROS SCI, V53, P3281, DOI 10.1016/j.corsci.2011.06.003; Tedim J, 2012, CORROS SCI, V55, P1, DOI 10.1016/j.corsci.2011.10.003; Ishizaki T, 2013, ECS ELECTROCHEM LETT, V2, pC15, DOI 10.1149/2.006305eel; Nordlien JH, 1997, CORROS SCI, V39, P1397, DOI 10.1016/S0010-938X(97)00037-1; Chen J, 2013, CORROS SCI, V74, P130, DOI 10.1016/j.corsci.2013.04.034; Chen J, 2012, CORROS SCI, V65, P268, DOI 10.1016/j.corsci.2012.08.026; Collazo A, 2011, ELECTROCHIM ACTA, V56, P7805, DOI 10.1016/j.electacta.2011.03.067; Lin JK, 2011, CORROS SCI, V53, P3832, DOI 10.1016/j.corsci.2011.07.035; Xu ZP, 2000, CHEM MATER, V12, P2597, DOI 10.1021/cm000053f; Rives V, 1999, COORDIN CHEM REV, V181, P61, DOI 10.1016/S0010-8545(98)00216-1; Xu ZP, 2001, J PHYS CHEM B, V105, P1743, DOI 10.1021/jp0029257; Chen J, 2012, CORROS SCI, V63, P148, DOI 10.1016/j.corsci.2012.05.022; Song GL, 1999, ADV ENG MATER, V1, P11; Zheludkevich ML, 2010, CORROS SCI, V52, P602, DOI 10.1016/j.corsci.2009.10.020; REGNIER P, 1994, AM MINERAL, V79, P809; Zeng RC, 2014, CORROS SCI, V88, P452, DOI 10.1016/j.corsci.2014.08.007; Cavani F, 1991, CATAL TODAY, V11, P173, DOI 10.1016/0920-5861(91)80068-K; Baril G, 2007, J ELECTROCHEM SOC, V154, pC108, DOI 10.1149/1.2401056; Ivanou DK, 2013, CORROS SCI, V73, P300, DOI 10.1016/j.corsci.2013.04.019; Ishizaki T, 2009, CRYSTENGCOMM, V11, P2338, DOI 10.1039/b907490b; Zhang JY, 2014, CORROS SCI, V87, P452, DOI 10.1016/j.corsci.2014.07.010; Poznyak SK, 2009, ACS APPL MATER INTER, V1, P2353, DOI 10.1021/am900495r; Pardo A, 2008, CORROS SCI, V50, P823, DOI 10.1016/j.corsci.2007.11.005; Lian JS, 2006, SURF COAT TECH, V200, P5956, DOI 10.1016/j.surfcoat.2005.09.007; Cui XJ, 2013, CORROS SCI, V76, P474, DOI 10.1016/j.corsci.2013.07.024; Ghali E., 2000, UHLIGS CORROSION HDB, P793; Ishizaki T, 2013, J MATER CHEM A, V1, P8968, DOI 10.1039/c3ta11015j; Kannan MB, 2007, METALL MATER TRANS A, V38A, P2843, DOI 10.1007/s11661-007-9303-6; KUMA K, 1989, ORIGINS LIFE EVOL B, V19, P573, DOI 10.1007/BF01808119; Masaki K., 2009, MAT T, V50, P1148; Sakamamo M., 1997, J JPN FOUNDRY ENG SO, V69, P227; Shreir L. L., 1965, CORROSION, V1, P86; Syu J. H., 2012, CORROS SCI, V68, P238; Tanaka D. K., 1990, P 11 INT CORR C NAC, V4, P605; Yan TT, 2013, J ELECTROCHEM SOC, V160, pC480, DOI 10.1149/2.053310jes; Yang HY, 2014, CORROS SCI, V79, P41, DOI 10.1016/j.corsci.2013.10.024	48	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	MAR	2015	92						76	84		10.1016/j.corsci.2014.11.031		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CB6LB	WOS:000349737400008		
J	Liu, JC; Park, S; Nagao, S; Nogi, M; Koga, H; Ma, JS; Zhang, G; Suganuma, K				Liu, Jian-Chun; Park, SungWon; Nagao, Shijo; Nogi, Masaya; Koga, Hirotaka; Ma, Ju-Sheng; Zhang, Gong; Suganuma, Katsuaki			The role of Zn precipitates and Cl- anions in pitting corrosion of Sn-Zn solder alloys	CORROSION SCIENCE			English	Article						Electronic materials; Zinc; EIS; Polarization; SEM; Pitting corrosion	ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; NACL AQUEOUS-SOLUTION; LEAD-FREE SOLDERS; PVD COATED STEELS; LOCALIZED CORROSION; POLARIZATION CHARACTERISTICS; HIGH-TEMPERATURE; BINARY-ALLOYS; BEHAVIOR; TIN	Electrochemical corrosion behavior of Sn-Zn solder alloys in aerated and quiescent 0.5 M NaCl solution was investigated by electrochemical impedance spectroscopy (EIS) and potentiodynamic polarization techniques, aiming to assess the role of Zn precipitates and Cl- anions in pitting corrosion. The results reveal that increasing in Zn contents leads to increasing in pitting susceptibility, ascribed to the coarsening Zn precipitates with larger intergranular boundaries between Zn-rich precipitates and Sn matrix. The EIS results provide a quantitative description of the electrochemical interface behavior. The mechanism of pitting and the role of Cl- anions are discussed. (C) 2014 Elsevier Ltd. All rights reserved.	[Liu, Jian-Chun; Park, SungWon; Nagao, Shijo; Nogi, Masaya; Koga, Hirotaka; Suganuma, Katsuaki] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; [Liu, Jian-Chun; Ma, Ju-Sheng; Zhang, Gong] Tsinghua Univ, Dept Mech Engn, Beijing 100084, Peoples R China	Liu, JC (reprint author), Tsinghua Univ, Dept Mech Engn, Beijing 100084, Peoples R China.	jc-liu11@mails.tsinghua.edu.cn	Nagao, Shijo/E-4870-2012	Nagao, Shijo/0000-0002-2764-3458	 [24226017]	The present study was partially supported by JSPS Grant-in-Aid for Scientific Research (Grant No. 24226017). The authors wish to thank Prof. S. Tsukui for his discussion of the manuscript, to M. Ueshima for supplying the pure metals, and to Assistant Prof. J. Jiu for language modification. We also thank H. Tonomura for his help in apparatus preparation. Jian-Chun Liu would like to express gratitude to the support from the Chinese Scholars Council.	Acciari HA, 2005, CORROS SCI, V47, P635, DOI 10.1016/j.corsci.2004.07.004; Liu C, 2001, CORROS SCI, V43, P1953, DOI 10.1016/S0010-938X(00)00188-8; Wang MN, 2012, CORROS SCI, V63, P20, DOI 10.1016/j.corsci.2012.05.006; Abtew M, 2000, MAT SCI ENG R, V27, P95, DOI 10.1016/S0927-796X(00)00010-3; SATO N, 1971, ELECTROCHIM ACTA, V16, P1683, DOI 10.1016/0013-4686(71)85079-X; Wu CML, 2004, MAT SCI ENG R, V44, P1, DOI 10.1016/j.mser.2004.01.001; BRUG GJ, 1984, J ELECTROANAL CHEM, V176, P275, DOI 10.1016/S0022-0728(84)80324-1; MANSFELD F, 1990, ELECTROCHIM ACTA, V35, P1533, DOI 10.1016/0013-4686(90)80007-B; Abd El Aal EE, 2004, CORROS SCI, V46, P37, DOI 10.1016/S0010-938X(03)00110-0; WALTER GW, 1986, CORROS SCI, V26, P681, DOI 10.1016/0010-938X(86)90033-8; Frankel GS, 2008, MATER TODAY, V11, P38, DOI 10.1016/S1369-7021(08)70206-2; Liu C, 2003, CORROS SCI, V45, P1243, DOI 10.1016/S0010-938X(02)00213-5; Mohanty US, 2006, CORROS SCI, V48, P662, DOI 10.1016/j.corsci.2005.02.003; Macdonald DD, 2006, ELECTROCHIM ACTA, V51, P1376, DOI 10.1016/j.electacta.2005.02.107; Suganuma K, 2007, J MATER SCI-MATER EL, V18, P121, DOI 10.1007/s10854-006-9018-2; HOAR TP, 1967, CORROS SCI, V7, P341, DOI 10.1016/S0010-938X(67)80023-4; Mohanty US, 2008, CORROS SCI, V50, P2437, DOI 10.1016/j.corsci.2008.06.042; Prabhu KN, 2012, MAT SCI ENG A-STRUCT, V533, P64, DOI 10.1016/j.msea.2011.11.035; Mohanty US, 2007, CORROS SCI, V49, P2815, DOI 10.1016/j.corsci.2007.02.005; [Anonymous], 2006, G82 ASTM; Marcus P, 2008, CORROS SCI, V50, P2698, DOI 10.1016/j.corsci.2008.06.047; KAPUSTA SD, 1980, ELECTROCHIM ACTA, V25, P1625, DOI 10.1016/0013-4686(80)80016-8; Hu J, 2011, J ELECTRON MATER, V40, P1556, DOI 10.1007/s11664-011-1650-9; Macdonald DD, 2011, ELECTROCHIM ACTA, V56, P1761, DOI 10.1016/j.electacta.2010.11.005; Jiang JX, 2008, J ALLOY COMPD, V462, P244, DOI 10.1016/j.jallcom.2007.08.007; Suganuma K, 2001, CURR OPIN SOLID ST M, V5, P55, DOI 10.1016/S1359-0286(00)00036-X; BRETT CMA, 1994, J APPL ELECTROCHEM, V24, P1158; Chang TC, 2004, J ELECTROCHEM SOC, V151, pC484, DOI 10.1149/1.1756890; Li DZ, 2008, CORROS SCI, V50, P995, DOI 10.1016/j.corsci.2007.11.025; MANSFELD F, 1993, ELECTROCHIM ACTA, V38, P1891, DOI 10.1016/0013-4686(93)80311-M; Rosalbino F, 2009, ELECTROCHIM ACTA, V54, P7231, DOI 10.1016/j.electacta.2009.07.030; Osorio WR, 2014, CORROS SCI, V80, P71, DOI 10.1016/j.corsci.2013.11.010; Liu C, 2003, CORROS SCI, V45, P1257, DOI 10.1016/S0010-938X(02)00214-7; GALVELE JR, 1976, J ELECTROCHEM SOC, V123, P464, DOI 10.1149/1.2132857; Burstein GT, 2004, CORROS ENG SCI TECHN, V39, P25, DOI 10.1179/147842204225016859; Ter-Ovanessian B, 2014, ELECTROCHIM ACTA, V133, P373, DOI 10.1016/j.electacta.2014.04.067; BURSTEIN GT, 1993, CORROS SCI, V35, P57, DOI 10.1016/0010-938X(93)90133-2; El Din A., 1964, ELECTROCHIM ACTA, V9, P883; El-Daly AA, 2014, MATER DESIGN, V56, P594, DOI 10.1016/j.matdes.2013.11.064; ELREHIM SSA, 1992, CORROS SCI, V33, P1789; Heakal FET, 2008, CORROS SCI, V50, P1618, DOI 10.1016/j.corsci.2008.02.003; Hu CC, 2006, ELECTROCHIM ACTA, V51, P4125, DOI 10.1016/j.electacta.2005.11.031; Nazeri M. F. M., 2014, J ALLOY COMPD; Osorio WR, 2011, ELECTROCHIM ACTA, V56, P8891, DOI 10.1016/j.electacta.2011.07.114; Suganuma K, 2000, J MATER RES, V15, P884, DOI 10.1557/JMR.2000.0126; Szklarska-Smialowska Z, 2002, CORROS SCI, V44, P1143, DOI 10.1016/S0010-938X(01)00113-5; Tan YJ, 2011, CORROS SCI, V53, P1845, DOI 10.1016/j.corsci.2011.02.002; Wu BY, 2006, J MATER RES, V21, P62, DOI 10.1557/JMR.2006.0035; Yu D., 2005, 16 INT CORR C BEIJ C, P19	49	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	MAR	2015	92						263	271		10.1016/j.corsci.2014.12.014		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CB6LB	WOS:000349737400028		
J	Aibiki, M				Aibiki, Mayuki			Can Bradycardia During Therapeutic Hypothermia Help Predicting Neurologic Outcome and Be Beneficial in Post-Cardiac Arrest Patients?	CRITICAL CARE MEDICINE			English	Letter							COMATOSE SURVIVORS; MILD HYPOTHERMIA		Ehime Univ, Dept Emergency & Crit Care Med, Grad Sch Med, Tohon, Ehime, Japan	Aibiki, M (reprint author), Ehime Univ, Dept Emergency & Crit Care Med, Grad Sch Med, Tohon, Ehime, Japan.						Aibiki M, 2000, BRAIN HYPOTHERMIA: PATHOLOGY, PHARMACOLOGY, AND TREATMENT OF SEVERE BRAIN INJURY, P161; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Post H, 2010, ACTA PHYSIOL, V199, P43, DOI 10.1111/j.1748-1716.2010.02083.x; Gaieski DF, 2009, RESUSCITATION, V80, P418, DOI 10.1016/j.resuscitation.2008.12.015; KOBAYASHI M, 1985, CARDIOVASC RES, V19, P20, DOI 10.1093/cvr/19.1.20; Oda J, 2002, CRIT CARE MED, V30, P1535, DOI 10.1097/00003246-200207000-00023; Staer-Jensen H, 2014, CRIT CARE MED, V42, P2401, DOI 10.1097/CCM.0000000000000515; Xu H, 2000, CRIT CARE MED, V28, P3854, DOI 10.1097/00003246-200012000-00019	8	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	MAR	2015	43	3					E97	E97		10.1097/CCM.0000000000000785		1	Critical Care Medicine	General & Internal Medicine	CB9PI	WOS:000349963600004		
J	Hironiwa, D; Chantana, J; Sakai, N; Kato, T; Sugimoto, H; Minemoto, T				Hironiwa, Daisuke; Chantana, Jakapan; Sakai, Noriyuki; Kato, Takuya; Sugimoto, Hiroki; Minemoto, Takashi			Application of multi-buffer layer of (Zn,Mg)O/CdS in Cu2ZnSn(S,Se)(4) solar cells	CURRENT APPLIED PHYSICS			English	Article						Solar cells; Cu2ZnSn(S,Se)(4); Buffer layer; (Zn,Mg)O; Multi-buffer layer		(Zn,Mg)O (ZMO) buffer layer has attracted attention for having the potential to control the conduction band offset of buffer layer and large band-gap (Eg) Cu2ZnSn(S,Se)(4) (CZTSSe) absorber interface, where the ZMO layer is deposited by the sputtering. However, the solar cell efficiency is decreased with the ZMO layer as compared with the CdS layer. The decrease in conversion efficiency is attributed to the sputtering damage on the absorber and high light reflection from the surfaces of CZTSSe solar cells. To completely suppress the damage, a CdS layer with very thin thickness of 20 nm is inserted between the ZMO layer and the CZTSSe layer. In addition, MgF2 layers are deposited on CZTSSe solar cells as anti-reflection coating. Ultimately, the solar cell with multi-buffer layer of ZMO/thin-CdS is almost same level as that with the CdS layer. Therefore, the multi-buffer layer can be an appropriate buffer layer of the large-Eg CZTSSe layer. (C) 2015 Elsevier B.V. All rights reserved.	[Hironiwa, Daisuke] Ritsumeikan Univ, Global Innovat Res Org, Kusatsu, Shiga 5258577, Japan; [Chantana, Jakapan; Minemoto, Takashi] Ritsumeikan Univ, Dept Elect & Elect Engn, Kusatsu, Shiga 5258577, Japan; [Sakai, Noriyuki; Kato, Takuya; Sugimoto, Hiroki] Solar Frontier KK, Atsugi Res Ctr, Atsugi, Kanagawa 2430206, Japan	Hironiwa, D (reprint author), Ritsumeikan Univ, Global Innovat Res Org, Kusatsu, Shiga 5258577, Japan.	hironiwa@fc.ritsumei.ac.jp; jakapan@fc.ritsumei.ac.jp; Noriyuki.Sakai@solar-frontier.com; Takuya.Katou@solar-frontier.com; Hiroki.Sugimoto@solar-frontier.com; minemoto@se.ritsumei.ac.jp	Minemoto, Takashi/F-9342-2011; Chantana, Jakapan/O-5110-2015	Chantana, Jakapan/0000-0002-5711-4979			Walsh A, 2012, ADV ENERGY MATER, V2, P400, DOI 10.1002/aenm.201100630; Nakada T, 2012, ELECTRON MATER LETT, V8, P179, DOI 10.1007/s13391-012-2034-x; Siebentritt S, 2012, PROG PHOTOVOLTAICS, V20, P512, DOI 10.1002/pip.2156; Shin B, 2013, PROG PHOTOVOLTAICS, V21, P72, DOI 10.1002/pip.1174; Hironiwa D, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.106502; Niki S, 2010, PROG PHOTOVOLTAICS, V18, P453, DOI 10.1002/pip.969; Siebentritt S, 2013, THIN SOLID FILMS, V535, P1, DOI 10.1016/j.tsf.2012.12.089; Jackson P, 2014, PHYS STATUS SOLIDI-R, V8, P219, DOI 10.1002/pssr.201409040; Jackson P, 2011, PROG PHOTOVOLTAICS, V19, P894, DOI 10.1002/pip.1078; Chirila A, 2013, NAT MATER, V12, P1107, DOI [10.1038/nmat3789, 10.1038/NMAT3789]; Gokmen T, 2013, J APPL PHYS, V114, DOI 10.1063/1.4821841; Gokmen T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4820250; Hironiwa D., 2014, E MRS SPRING M INT C; Kato T., 2013, P 28 EUR PHOT SOL EN, P2125; Kim J., 2014, ADV ENERGY MATER, V10, P1	15	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1739	1878-1675		CURR APPL PHYS	Curr. Appl. Phys.	MAR	2015	15	3					383	388		10.1016/j.cap.2015.01.011		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CB8TT	WOS:000349904900038		
J	Donai, K; Inagaki, A; So, KH; Kuroda, K; Sone, H; Kobayashi, M; Nishimori, K; Fukuda, T				Donai, Kenichiro; Inagaki, Akane; So, Kyoung-Ha; Kuroda, Kengo; Sone, Hideko; Kobayashi, Masayuki; Nishimori, Katsuhiko; Fukuda, Tomokazu			Low-molecular-weight inhibitors of cell differentiation enable efficient growth of mouse iPS cells under feeder-free conditions	CYTOTECHNOLOGY			English	Article						Induced pluripotent stem cells; Cell culture condition; Serum-free; Feeder-free; Low-molecular-weight compounds	EMBRYONIC STEM-CELLS; LONG-TERM CULTURE; SELF-RENEWAL; FIBROBLASTS; ACTIVATION; INDUCTION; MITOGEN; LINES	Embryonic stem cells and induced pluripotent stem (iPS) cells are usually maintained on feeder cells derived from mouse embryonic fibroblasts (MEFs). In recent years, the cell culture of iPS cells under serum- and feeder-free conditions is gaining attention in overcoming the biosafety issues for clinical applications. In this study, we report on the use of multiple small-molecular inhibitors (i.e., CHIR99021, PD0325901, and Thiazovivin) to efficiently cultivate mouse iPS cells without feeder cells in a chemically-defined and serum-free condition. In this condition, we showed that mouse iPS cells are expressing the Nanog, Oct3/4, and SSEA-1 pluripotent markers, indicating that the culture condition is optimized to maintain the pluripotent status of iPS cells. Without these small-molecular inhibitors, mouse iPS cells required the adaptation period to start the stable cell proliferation. The application of these inhibitors enabled us the shortcut culture method for the cellular adaptation. This study will be useful to efficiently establish mouse iPS cell lines without MEF-derived feeder cells.	[Donai, Kenichiro; Inagaki, Akane; So, Kyoung-Ha; Kuroda, Kengo; Nishimori, Katsuhiko; Fukuda, Tomokazu] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Sone, Hideko] Natl Inst Environm Studies, Environm Exposure Res Sect, Ctr Environm Risk Res, Tsukuba, Ibaraki 3058506, Japan; [Kobayashi, Masayuki] Akita Prefectural Univ, Grad Sch Bioresource Sci, Akita 0100195, Japan	Fukuda, T (reprint author), Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	tomofukuda@bios.tohoku.ac.jp			Tojuro Iijima Foundation for Food Science and Technology; Asahi Group Foundation; JSPS grant (KAKENHI) [23650587, 25640117]	We thank Dr. Gustavo Mostoslavsky (Boston University School of Medicine) for providing the STEMCCA-loxP lentiviral vector. We also thank the technical supports and suggestion from and Dr. Takehiro Ito and Ms. Yukiko Kitamura (Cell Science and Technology Institute). This work was supported by research grants from the Tojuro Iijima Foundation for Food Science and Technology, Asahi Group Foundation and a JSPS grant (KAKENHI, #23650587 and #25640117).	Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Qin XY, 2012, CANCER BIOL THER, V13, P296, DOI [10.4161/cbt.18942, 10.4161/cbt.13.5.18942]; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Miyazaki T, 2008, BIOCHEM BIOPH RES CO, V375, P27, DOI 10.1016/j.bbrc.2008.07.111; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1172482; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Furue M, 2005, IN VITRO CELL DEV-AN, V41, P19; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Kitajima H, 2010, BIOCHEM BIOPH RES CO, V396, P933, DOI 10.1016/j.bbrc.2010.05.026; Donai K, 2013, ANAL BIOCHEM, V443, P104, DOI 10.1016/j.ab.2013.08.014; Fukusumi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055226; Hayashi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014099; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Navarro-Alvarez N, 2008, CELL TRANSPLANT, V17, P27, DOI 10.3727/000000008783906900; Polychronopoulos P, 2004, J MED CHEM, V47, P935, DOI 10.1021/jm031016d; Yamamoto A, 2003, INT J CANCER, V106, P301, DOI 10.1002/ijc.11219	27	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-9069	1573-0778		CYTOTECHNOLOGY	Cytotechnology	MAR	2015	67	2					191	197		10.1007/s10616-013-9686-8		7	Biotechnology & Applied Microbiology; Cell Biology	Biotechnology & Applied Microbiology; Cell Biology	CB6WW	WOS:000349768500002		
J	Goto, T; Hagiwara, K; Shirai, N; Yoshida, K; Hagiwara, H				Goto, Tadashi; Hagiwara, Keitaro; Shirai, Nobuaki; Yoshida, Kaoru; Hagiwara, Hiromi			Apigenin inhibits osteoblastogenesis and osteoclastogenesis and prevents bone loss in ovariectomized mice	CYTOTECHNOLOGY			English	Article						Apigenin; Polyphenol; Osteoblast; Osteoclast; Ovariectomized mice; Bone loss	ALKALINE-PHOSPHATASE; MC3T3-E1 CELLS; MESSENGER-RNAS; STROMAL CELLS; DIFFERENTIATION; EXPRESSION; MINERALIZATION; PROLIFERATION; ACTIVATION; MACROPHAGES	Polyphenol have been reported to have physiological effects with respect to alleviating diseases such as osteoporosis and osteopetrosis. We recently reported that the olive polyphenol hydroxytyrosol accelerates bone formation both in vivo and in vitro. The present study was designed to evaluate the in vivo and in vitro effects of apigenin (4',5,7-trihydroxyflavone), one of the major polyphenols in olives and parsley, on bone formation by using cultured osteoblasts and osteoclasts and ovariectomized (OVX) mice, respectively. Apigenin markedly inhibited cell proliferation and indices of osteoblast differentiation, such as collagen production, alkaline phosphatase activity, and calcium deposition in osteoblastic MC3T3-E1 cells at concentrations of 1-10 mu M. At 10 mu M, apigenin completely inhibited the formation of multinucleated osteoclasts from mouse splenic cells. Moreover, injection of apigenin at 10 mg kg(-1) body weight significantly suppressed trabecular bone loss in the femurs of OVX mice. Our findings indicate that apigenin may have critical effects on bone maintenance in vivo.	[Goto, Tadashi; Shirai, Nobuaki; Hagiwara, Hiromi] Toin Univ Yokohama, Dept Biomed Engn, Aoba Ku, Yokohama, Kanagawa 2258503, Japan; [Hagiwara, Keitaro] Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Hagiwara, Keitaro] Natl Canc Ctr, Div Mol & Cellular Med, Chuo Ku, Tokyo 1040045, Japan; [Shirai, Nobuaki] Nemoto Sci Co Ltd, Tsukuba Labs, Joso, Ibaraki 3002521, Japan; [Yoshida, Kaoru] Toin Univ Yokohama, Ctr Biomed Engn, Aoba Ku, Yokohama, Kanagawa 2258503, Japan	Hagiwara, H (reprint author), Toin Univ Yokohama, Dept Biomed Engn, Aoba Ku, 1614 Kurogane Cho, Yokohama, Kanagawa 2258503, Japan.	hagiwara@cc.toin.ac.jp			Ministry of Education, Science, Sports and Culture of Japan	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan. We would like to thank Mrs. K. Nakata for assistance with cell culture and Mrs. K. Takada for mouse maintenance.	Bharti AC, 2004, J IMMUNOL, V172, P5940; Patel D, 2007, INT J ONCOL, V30, P233; Arai M, 2007, IUBMB LIFE, V59, P27, DOI 10.1080/15216540601156188; STEIN GS, 1990, FASEB J, V4, P3111; Notoya M, 2006, EUR J PHARMACOL, V534, P55, DOI 10.1016/j.ejphar.2006.01.028; Hagiwara K, 2011, EUR J PHARMACOL, V662, P78, DOI 10.1016/j.ejphar.2011.04.023; RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649; WEI HC, 1990, CANCER RES, V50, P499; Park JA, 2008, LIFE SCI, V82, P1217, DOI 10.1016/j.lfs.2008.03.021; LIU F, 1994, DEV BIOL, V166, P220, DOI 10.1006/dbio.1994.1309; Lee DH, 2006, CELL BIOL TOXICOL, V22, P39, DOI 10.1007/s10565-006-0018-z; Kamon M, 2010, CELL BIOL INT, V34, P109, DOI 10.1042/CBI20090011; Tullberg-Reinert H, 1999, HISTOCHEM CELL BIOL, V112, P271, DOI 10.1007/s004180050447; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; Shukla S, 2007, CELL CYCLE, V6, P1102, DOI 10.4161/cc.6.9.4146; Bandyopadhyay S, 2006, BIOCHEM PHARMACOL, V72, P184, DOI 10.1016/j.bcp.2006.04.018; Liang YC, 1999, CARCINOGENESIS, V20, P1945, DOI 10.1093/carcin/20.10.1945; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Shukla S, 2010, PHARM RES-DORDR, V27, P962, DOI 10.1007/s11095-010-0089-7; Bredford JN, 1993, AM J MED GENET, V45, P163; Budhraja A, 2012, MOL CANCER THER, V11, P132, DOI 10.1158/1535-7163.MCT-11-0343; Hagiwara H, 1996, AM J PHYSIOL-CELL PH, V270, pC1311; Hosoya S, 1998, MOL GENET METAB, V65, P31, DOI 10.1006/mgme.1998.2734; Lee SF, 1997, NUTR CANCER, V28, P177; Notoya M, 2004, EUR J PHARMACOL, V485, P89, DOI 10.1016/j.ejphar.2003.11.058; Notoya M, 2007, EUR J PHARMACOL, V560, P234, DOI 10.1016/j.ejphar.2007.01.034; RIGGS BL, 1987, AM J OBSTET GYNECOL, V156, P1342; Woo JT, 2004, BIOL PHARM BULL, V27, P504, DOI 10.1248/bpb.27.504; Yamagishi T, 2001, ENDOCRINOLOGY, V142, P3632, DOI 10.1210/en.142.8.3632; Zhu Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-54	30	4	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-9069	1573-0778		CYTOTECHNOLOGY	Cytotechnology	MAR	2015	67	2					357	365		10.1007/s10616-014-9694-3		9	Biotechnology & Applied Microbiology; Cell Biology	Biotechnology & Applied Microbiology; Cell Biology	CB6WW	WOS:000349768500016		
J	Minematsu, K				Minematsu, Kazuhiko			Building blockcipher from small-block tweakable blockcipher	DESIGNS CODES AND CRYPTOGRAPHY			English	Article						Tweakable blockcipher; Mode of operation; Pseudorandomness; Format-preserving encryption	PSEUDORANDOM PERMUTATIONS; SECURITY; ENCRYPTION; CIPHERS; SYSTEMS	How to build a secure blockcipher is one of the central problems in symmetric cryptography. While the popular approach, initiated by the seminal paper of Luby and Rackoff, is based on a pseudorandom function, Minematsu (in: Dunkelman (ed.) FSE, 2009) and Minematsu and Iwata (in: Chen (ed.) IMA, 2011) proposed different schemes to efficiently achieve a better security. The point of these works is that they use tweakable blockcipher (TBC) as an internal module rather than pseudorandom function. This paper further extends the previous schemes and considers the case that the target blockcipher has much larger block size than that of the TBC we use. Assuming the tweak of TBC is long, we propose a scheme similar to unbalanced Feistel cipher that achieves stronger security than the previous schemes of Minematsu and Minematsu-Iwata. We also present a blockcipher-based instantiation of our scheme for the encryption over some unusual domains, such as decimal space, as a typical problem of format-preserving encryption.	NEC Corp Ltd, Nakahara Ku, Kawasaki, Kanagawa 2118666, Japan	Minematsu, K (reprint author), NEC Corp Ltd, Nakahara Ku, 1753 Shimonumabe, Kawasaki, Kanagawa 2118666, Japan.	k-minematsu@ah.jp.nec.com					Maurer U, 2003, LECT NOTES COMPUT SC, V2656, P544; Maurer U, 2002, LECT NOTES COMPUT SC, V2332, P110; Coron JS, 2010, LECT NOTES COMPUT SC, V5978, P273; Minematsu K, 2009, LECT NOTES COMPUT SC, V5665, P308, DOI 10.1007/978-3-642-03317-9_19; Rogaway P, 2011, LECT NOTES COMPUT SC, V6558, P237, DOI 10.1007/978-3-642-19074-2_16; Halevi S, 2003, LECT NOTES COMPUT SC, V2729, P482; Rogaway P, 2004, LECT NOTES COMPUT SC, V3329, P16; Bellare M, 1998, LECT NOTES COMPUT SC, V1403, P266; Naor M, 1999, J CRYPTOL, V12, P29; Morris B, 2009, LECT NOTES COMPUT SC, V5677, P286, DOI 10.1007/978-3-642-03356-8_17; LUBY M, 1988, SIAM J COMPUT, V17, P373, DOI 10.1137/0217022; Bellare M, 1997, ANN IEEE SYMP FOUND, P394, DOI 10.1109/SFCS.1997.646128; Patarin J, 2004, LECT NOTES COMPUT SC, V3152, P106; Liskov M, 2002, LECT NOTES COMPUT SC, V2442, P31; Bellare M., FFX MODE OPERATION F; Bellarc M, 2009, LECT NOTES COMPUT SC, V5867, P295, DOI 10.1007/978-3-642-05445-7_19; Brier E., 2010, BPS FORMAT PRESERVIN; Crowley P., 2000, LECT NOTES COMPUTER, V1978, P49; Fluhrer SR, 2002, LECT NOTES COMPUT SC, V2355, P28; Goldreich O., 1998, MODERN CRYPTOGRAPHY; Granboulan L, 2007, LECT NOTES COMPUT SC, V4593, P452; Jetchev D., 2012, LECT NOTES COMPUTER, V7658, P313; Lampe R., 2013, PREPROCEEDINGS FAST; Landecker W., 2012, LECT NOTES COMPUTER, V7417, P14; Minematsu K., 2006, LECT NOTES COMPUTER, V4356, P96; Minematsu K., 2011, LECT NOTES COMPUTER, V7089, P391; Schneier B., 1996, LNCS, V1039, P121; Schroeppel R., 1998, HASTY PUDDING CIPHER; SHANNON CE, 1949, AT&T TECH J, V28, P656; Vance J., 2011, VAES3 SCHEME FFX ADD	30	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-1022	1573-7586		DESIGN CODE CRYPTOGR	Designs Codes Cryptogr.	MAR	2015	74	3					645	663		10.1007/s10623-013-9882-8		19	Computer Science, Theory & Methods; Mathematics, Applied	Computer Science; Mathematics	CB6UK	WOS:000349762000008		
J	Matsui, H				Matsui, Hajime			On generator matrices and parity check matrices of generalized integer codes	DESIGNS CODES AND CRYPTOGRAPHY			English	Article						Codes over rings; Elementary divisors; Extended Euclidean algorithm; Bezout's identity; Integer lattices; Hecke rings	QUASI-CYCLIC CODES; ALGEBRAIC STRUCTURE; FINITE GEOMETRIES; RINGS	Generalized integer codes are defined as codes over rings of integers modulo in which individual code symbols generally have different moduli. In this paper, we use a certain type of matrix identities to derive a necessary and sufficient condition for integer matrices to be equal to the generator matrices of generalized integer codes. Moreover, it is shown that the parity check matrix is generated from this matrix identity of the generator matrix. We also show the close connection between the listing of a certain type of integer codes and Hecke rings. Finally, an efficient algorithm that enumerates theoretically all of the generator matrices of generalized integer codes is provided.	Toyota Technol Inst, Tenpa Ku, Nagoya, Aichi 4688511, Japan	Matsui, H (reprint author), Toyota Technol Inst, Tenpa Ku, Hisakata 2-12-1, Nagoya, Aichi 4688511, Japan.	matsui@toyota-ti.ac.jp			KAKENHI [23560478]	This work was partly supported by KAKENHI, Grant-in-Aid for Scientific Research C, 23560478. The author would like to thank the anonymous referees for their helpful comments which improved the final presentation of the paper.	Fossorier MPC, 2004, IEEE T INFORM THEORY, V50, P1788, DOI 10.1109/TIT.2004.831841; Lally K, 2001, DISCRETE APPL MATH, V111, P157, DOI 10.1016/S0166-218X(00)00350-4; Ling S, 2003, DESIGN CODE CRYPTOGR, V30, P113, DOI 10.1023/A:1024715527805; Ling S, 2006, DESIGN CODE CRYPTOGR, V38, P337, DOI 10.1007/s10623-005-1431-7; Heegard C, 1995, IEEE T INFORM THEORY, V41, P1752, DOI 10.1109/18.476247; Kostadinov H, 2010, IEICE T FUND ELECTR, VE93A, P1363, DOI 10.1587/transfun.E93.A.1363; Chen L, 2004, IEEE T COMMUN, V52, P1038, DOI 10.1109/TCOMM.2004.831353; Ling S, 2001, IEEE T INFORM THEORY, V47, P2751; Bhaintwal M, 2009, APPL ALGEBR ENG COMM, V20, P459, DOI 10.1007/s00200-009-0110-8; Seguin GE, 2004, IEEE T INFORM THEORY, V50, P1745, DOI 10.1109/TIT.2004.831861; Huffman WC, 2005, FINITE FIELDS TH APP, V11, P451, DOI 10.1016/j.ffa.2005.05.012; Kamiya N, 2007, IEEE T INFORM THEORY, V53, P1444, DOI 10.1109/TIT.2007.892770; Tang H, 2005, IEEE T INFORM THEORY, V51, P572, DOI 10.1109/TIT.2004.840867; BLAKE IF, 1972, INFORM CONTROL, V20, P396, DOI 10.1016/S0019-9958(72)90223-9; Kou Y, 2001, IEEE T INFORM THEORY, V47, P2711, DOI 10.1109/18.959255; BLAKE IF, 1975, INFORM CONTROL, V29, P295, DOI 10.1016/S0019-9958(75)80001-5; Calderbank A. R., 1995, Designs, Codes and Cryptography, V6, DOI 10.1007/BF01390768; Cao Y., 2010, DESIGN CODE CRYPTOGR, V60, P67; Costello Jr D.J., 2004, ERROR CONTROL CODING; Esmaeili M, 2009, APPL ALGEBR ENG COMM, V20, P159, DOI 10.1007/s00200-009-0095-3; Kamiya N, 2006, DESIGN CODE CRYPTOGR, V38, P311, DOI 10.1007/s10623-005-6685-6; Kostadinov H, 2004, IEICE T FUND ELECTR, VE87A, P3397; Kostadinov H, 2003, IEICE T FUND ELECTR, VE86A, P1843; Ling S, 2005, IEEE T INFORM THEORY, V51, P2692, DOI 10.1109/TIT.2005.850142; MacWilliams F.J., 1988, THEORY ERROR CORRECT; Matsui H., 2010, 6 AS EUR WORKSH INF; Nakamura K., 1979, IEEE INT C COMM; Nebe G., 2006, SELF DUAL CODES INVA; Roth R.M., 2005, INTRO CODING THEORY; Serre J.-P., 1973, COURSE ARITHMETIC; Shimura G., 1971, INTRO ARITHMETIC THE; Siap I., 2005, APPL MATH E NOTES, V5, P24; Sole P., 2008, P CIMP SUMM SCH ANK; SPIEGEL E, 1977, INFORM CONTROL, V35, P48, DOI 10.1016/S0019-9958(77)90526-5; Van V.T., 2010, IEEE GLOB COMM C GLO, P6; Van V.T., 2009, IEICE T FUND ELECTR, VE92-A, P2345; Vinck AJN, 1998, IEICE T FUND ELECTR, VE81A, P2013	37	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-1022	1573-7586		DESIGN CODE CRYPTOGR	Designs Codes Cryptogr.	MAR	2015	74	3					681	701		10.1007/s10623-013-9883-7		21	Computer Science, Theory & Methods; Mathematics, Applied	Computer Science; Mathematics	CB6UK	WOS:000349762000011		
J	Shonchoy, A				Shonchoy, Abu S.			SEASONAL MIGRATION AND MICROCREDIT DURING AGRICULTURAL LEAN SEASONS: EVIDENCE FROM NORTHWEST BANGLADESH	DEVELOPING ECONOMIES			English	Article						Lean season; Seasonal migration; Microcredit	CIRCULAR MIGRATION; CREDIT PROGRAMS; COOPERATIVE CAPITALISM; SUGAR FACTORIES; SOUTH-GUJARAT; LABOR; AFRICA; POOR; MICROFINANCE; HOUSEHOLDS	This paper investigates the interlinkage between microcredit and temporary seasonal migration, an issue which has been given little attention in the standard rural-urban migration literature. Seasonal migration due to agricultural downturns is a common phenomenon in developing countries. Using primary data from a cross-sectional household survey of the northwest part of Bangladesh, this paper quantifies the factors that influence such migration decisions. Our results suggest that people with prior access to microcredit are more likely to migrate during an agricultural lean season. Furthermore, we find evidence of a negative selection effect between microcredit and seasonal migration, conditional on an individual's village of residence and observed characteristics. Our results have numerous potential policy implications, including the design of typical microcredit schemes for developing countries.	[Shonchoy, Abu S.] JETRO, Inst Dev Econ, Chiba, Japan	Shonchoy, A (reprint author), Japan External Trade Org, Inst Dev Econ, Ctr Dev Studies, Microecon Anal Studies Grp,Mihama Ku, 3-2-2 Wakaba, Chiba, Chiba 2618545, Japan.	parves.shonchoy@gmail.com		Shonchoy, Abu/0000-0001-9999-2326			Afsar R. A., 2003, REG C MIGR DEV PROP; Afsar Rita, 2005, REG C MIGR DEV AS LA; Afsar Rita, 2002, HANDS NOT LAND LIVEL; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Mckenzie D, 2007, J DEV ECON, V84, P1, DOI 10.1016/j.jdeveco.2006.11.003; CHAPMAN M, 1983, INT MIGR REV, V17, P597, DOI 10.2307/2545821; Mendola M, 2008, J DEV ECON, V85, P150, DOI 10.1016/j.jdeveco.2006.07.003; Morduch J, 1999, J ECON LIT, V37, P1569, DOI 10.1257/jel.37.4.1569; Khandker SR, 2005, WORLD BANK ECON REV, V19, P263, DOI 10.1093/wber/lhi008; Deutsch CJ, 2003, WILDLIFE MONOGR, P1; Pitt MM, 2006, ECON DEV CULT CHANGE, V54, P791, DOI 10.1086/503580; Afsar R, 1999, ENVIRON URBAN, V11, P235, DOI 10.1177/095624789901100106; McKernan SM, 2002, REV ECON STAT, V84, P93, DOI 10.1162/003465302317331946; Pitt MM, 1998, J POLIT ECON, V106, P958, DOI 10.1086/250037; HECKMAN JJ, 1978, ECONOMETRICA, V46, P931, DOI 10.2307/1909757; Asiatic Society of Bangladesh, 2006, BANGL NAT ENC BANGL; Barkat Abul, 2003, DISPLACED HOMELANDS; Begum A., 1999, DESTINATION DHAKA UR; Blundell Richard W., 1993, HDB STAT, V11; Borjas George J., 2001, INT ENCY SOCIAL BEHA; BREMAN J, 1979, J PEASANT STUD, V6, P168, DOI 10.1080/03066157908438072; BREMAN J, 1978, J PEASANT STUD, V6, P41, DOI 10.1080/03066157808438065; Bryan Gharad, 2014, 20172 NBER; Chowdhury Rafiqul Huda, 1978, ORIENTAL GEOPGRAPHER, V22, P1; Deshingkar P., 2003, 220 OV DEV I; ELKAN W, 1967, INT LABOUR REV, V96, P581; ELKAN W, 1959, AM ECON REV, V49, P188; Fabbri D, 2008, APPL ECON, V40, P1411, DOI 10.1080/00036840600771395; Greene W. H., 2003, ECONOMETRIC ANAL; Guilmoto CZ, 1998, POP STUD-J DEMOG, V52, P85, DOI 10.1080/0032472031000150196; Harigaya Tomoko, 2007, AM J AGR ECON, V89, P430; Hossain Md. Zakir, 2001, BRAZ IUSSP C SALV AU; HUGO GJ, 1982, POPUL DEV REV, V8, P59, DOI 10.2307/1972690; Huq-Hussain Shanaz, 1996, FEMALE MIGRANTS ADAP; Islam Nazrul, 2003, DEMOGRAPHIC DYNAMICS; Jones A., 2007, APPL ECONOMETRICS HL; KHAN AAM, 1982, GEOGR REV, V72, P379, DOI 10.2307/214592; Khandker S., 2012, SEASONAL HUNGER PUBL; Khandker S. R., 2009, HDB IMPACT EVALUATIO; Khandker SR, 2012, J DEV ECON, V97, P244, DOI 10.1016/j.jdeveco.2011.05.001; Khandker SR, 2012, J DEV STUD, V48, P1750, DOI 10.1080/00220388.2012.720369; Kuhn Randall S., 2001, LABOR POPULATION PRO; Kuhn Randall S., 2005, POP200505 U COL I BE; Maddala G.S., 1983, LTD DEPENDENT QUALIT; Morduch J., 1998, DOES MICROFINANCE RE; Munshi K, 2003, Q J ECON, V118, P549, DOI 10.1162/003355303321675455; Park Hun Myoung, 2009, REGRESSION MODELS BI; Pitt Mark M, 1999, COMMUNICATION; Pitt MM, 1999, DEMOGRAPHY, V36, P1, DOI 10.2307/2648131; Pitt MM, 2002, J DEV STUD, V39, P1, DOI 10.1080/00220380412331322731; Rahman Hossain Zillur, 1991, TECHNICAL REPORT; Rogaly B, 2002, J DEV STUD, V38, P89, DOI 10.1080/00220380412331322521; Rogaly B., 2003, Journal of Agrarian Change, V3, P395, DOI 10.1111/1471-0366.00060; ROSENZWEIG MR, 1985, Q J ECON, V100, P961; STRETTON A, 1983, INT LABOUR REV, V122, P623; Zeba Sakiba, 2006, 007 ESS BRAC U; Zug Sebastian, 2006, J SOCIAL STUDIES, P111	57	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1533	1746-1049		DEV ECON	Dev. Econ.	MAR	2015	53	1					1	26		10.1111/deve.12063		26	Economics; Planning & Development	Business & Economics; Public Administration	CC1WF	WOS:000350135200001		
J	Ishido, H				Ishido, Hikari			Integrating Regions: Asia in Comparative Context	DEVELOPING ECONOMIES			English	Book Review									[Ishido, Hikari] Chiba Univ, Chiba, Japan	Ishido, H (reprint author), Chiba Univ, Chiba, Japan.						Gugler P, 2010, NEW HORIZ INT BUS, P1; MacIntyre A., 2013, INTEGRATING REGIONS; Stiglitz J, 2005, FAIR TRADE ALL TRADE; WILLIAMSON O.E., 1985, EC I CAPITALISM FIRM	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1533	1746-1049		DEV ECON	Dev. Econ.	MAR	2015	53	1					67	69		10.1111/deve.12067		3	Economics; Planning & Development	Business & Economics; Public Administration	CC1WF	WOS:000350135200005		
J	Horie, I; Kawasaki, E; Sakanaka, A; Takashima, M; Maeyama, M; Ando, T; Hanada, H; Kawakami, A				Horie, Ichiro; Kawasaki, Eiji; Sakanaka, Ai; Takashima, Miwa; Maeyama, Miwa; Ando, Takao; Hanada, Hirokazu; Kawakami, Atsushi			Efficacy of nutrition therapy for glucose intolerance in Japanese women diagnosed with gestational diabetes based on IADPSG criteria during early gestation	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Gestational diabetes; Nutrition; IADPSG; OGTT; Early gestation	INSULIN SENSITIVITY; PREGNANCY OUTCOMES; MELLITUS; TOLERANCE; HYPERGLYCEMIA; CLAMP	Aims: Among women with gestational diabetes mellitus (GDM), the aggravation of glucose intolerance during gestation differs substantially. We retrospectively investigated whether the glucose intolerance of women diagnosed with GDM during early gestation (i.e., early-onset GDM) improved in the mid-gestation under appropriate nutrition therapy. Methods: We conducted a longitudinal analysis of glucose tolerance derived from 75-g oral glucose tolerance test (OGTT) in 41 Japanese women with early-onset GDM defined by International Association of Diabetes and Pregnancy Study Group criteria during early gestation (<20 weeks). Glucose tolerance was also evaluated in mid-gestation (24-32 weeks) and postpartum. Insulin sensitivity, insulin secretion, and beta-cell function were assessed at each period. Results: The glucose tolerance in 18 of the 41 early-onset GDM patients normalized during mid-gestation with appropriate nutrition therapy, defined as GDM -> NGT. These women did not require insulin therapy during their pregnancies, whereas 39.1% of women who retained GDM in mid-gestation (defined as GDM -> GDM) required insulin therapy. The frequency of the postpartum development of type 2 diabetes or impaired glucose tolerance was significantly lower (5.6% vs. 39.1% in GDM -> NGT vs. GDM -> GDM, p = 0.03). Primiparity was determined as a predictive factor whether or not glucose intolerance was improved by nutrition therapy, but results of plasma glucose levels from OGTT at early gestation were not, in a multivariate logistic regression analysis. Conclusions: Appropriate nutrition therapy for women with early-onset GDM seemed effective to improve glucose tolerance during pregnancy. OGTT retesting during their mid-gestation seemed effective for predicting the appropriate treatment after the second trimester. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Horie, Ichiro; Ando, Takao; Kawakami, Atsushi] Nagasaki Univ Hosp, Dept Endocrinol & Metab, Nagasaki 8528501, Japan; [Kawasaki, Eiji; Sakanaka, Ai; Takashima, Miwa; Maeyama, Miwa; Hanada, Hirokazu] Nagasaki Univ Hosp, Dept Metab Diabet & Clin Nutr, Nagasaki 8528501, Japan; [Sakanaka, Ai; Takashima, Miwa; Maeyama, Miwa; Hanada, Hirokazu] Nagasaki Univ Hosp, Div Dietary Serv, Nagasaki 8528501, Japan	Horie, I (reprint author), Nagasaki Univ Hosp, Dept Endocrinol & Metab, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	holy197741@me.com					Bartha JL, 2003, EUR J OBSTET GYN R B, V109, P41, DOI 10.1016/S0301-2115(02)00480-3; Retnakaran R, 2009, DIABETIC MED, V26, P1198, DOI 10.1111/j.1464-5491.2009.02841.x; Seshiah V, 2008, DIABETES RES CLIN PR, V80, P199, DOI 10.1016/j.diabres.2007.12.008; SUPER DM, 1991, DIABETES CARE, V14, P288, DOI 10.2337/diacare.14.4.288; Bartha JL, 2000, AM J OBSTET GYNECOL, V182, P346, DOI 10.1016/S0002-9378(00)70222-5; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; CATALANO PM, 1991, AM J OBSTET GYNECOL, V165, P1667; Metzger BE, 2008, NEW ENGL J MED, V358, P1991; COUSINS L, 1991, DIABETES, V40, P39; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Donovan L, 2013, ANN INTERN MED, V159, P115, DOI 10.7326/0003-4819-159-2-201307160-00657; Meyer WJ, 1996, J REPROD MED, V41, P675; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Blumer I, 2013, J CLIN ENDOCR METAB, V98, P4227, DOI 10.1210/jc.2013-2465; [Anonymous], 2014, DIABETES CARE S1, V37, pS14; Kwak SH, 2013, J CLIN ENDOCR METAB, V98, pE744, DOI 10.1210/jc.2012-3324; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; DeFronzo Ralph A, 2010, Diabetes Care, V33, pe93, DOI 10.2337/dc10-0646; Ikenoue S, 2014, ENDOCR J, V61, P353; Jiwani A, 2012, J MATERN-FETAL NEO M, V25, P600, DOI 10.3109/14767058.2011.587921; Nishijima M, 2000, SANFUJINKA CHIRYO, V80, P291; Sugiyama T, 2014, ENDOCR J, V61, P373, DOI 10.1507/endocrj.EJ13-0541	24	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	MAR	2015	107	3					400	406		10.1016/j.diabres.2014.12.011		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CB9NX	WOS:000349959600015		
J	Maruta, J; Hashimoto, H; Yamashita, H; Noguchi, H; Noguchi, S; Kobayashi, TK; Tsuneoka, H; Takahashi, M				Maruta, Junko; Hashimoto, Hironobu; Yamashita, Hiroto; Noguchi, Hitoshi; Noguchi, Shiro; Kobayashi, Tadao K.; Tsuneoka, Hidehiro; Takahashi, Mutsuo			Value of Thyroid Specific Peroxidase and Ki-67 Stains in Preoperative Cytology for Thyroid Follicular Tumors	DIAGNOSTIC CYTOPATHOLOGY			English	Article						thyroid; thyroid specific peroxidase; Ki-67; follicular tumor; immuocytochemistry	FINE-NEEDLE-ASPIRATION; DIFFERENTIAL-DIAGNOSIS; EXPRESSION; NODULES; PROLIFERATION; GALECTIN-3; MALIGNANCY; CARCINOMA; LESIONS; BENIGN	BackgroundThe aim of this study was to elucidate immunocytochemically whether thyroid specific peroxidase (TPO) and Ki-67 can complement fine-needle aspiration (FNA) cytology as useful markers in order to distinguish between follicular adenoma (FA) and follicular carcinoma (FC). MethodsWe studied 40 FAs and 68 FCs obtained by surgical resection. FNA cytology smears were divided into two groups: Cytology-A (Cy-A) (94 cases) with typical benign cytology and Cytology-B (Cy-B) (14 cases) with atypical cytology. FCs were divided into two groups: FC-I (42 cases) without any poorly differentiated structures and FC-II (26 cases) with some poorly differentiated structures. Cytology smears and histology from FAs and FCs were studied immunocytochemically for thyroid specific peroxidase (TPO) and Ki-67. ResultsTPO expression was negative in 12.5% FAs, 21.4% FC-I, and 46.2% FC-II. In 68 FC cases, Cy-B were more frequently observed in TPO-negative cases (38.1%) than in TPO-positive cases (12.8%). The mean Ki-67 LI was 0.46 in FAs, 0.53 in FC-I, and 1.13 in FC-II. The high Ki-67 LI was correlated with Cy-B. Moreover, higher Ki-67 LI showed a close relationship with distant metastasis. In 94 Cy-A cases, 54 cases were FCs. When 38 cases with negative TPO or Ki-67 LI over 0.62 were extracted from them, as many as 28 cases were FCs, the rate of FCs were significantly higher than the rest. ConclusionTherefore, addition of TPO stain and Ki-67 stain to routine Papanicolaou stain could improve the diagnostic reliability of FNA cytology for FC with high degree of malignancy. Diagn. Cytopathol. 2015;43:202-209. (c) 2014 Wiley Periodicals, Inc.	[Maruta, Junko; Hashimoto, Hironobu; Yamashita, Hiroto] Noguchi Thyroid Hosp & Fdn, Dept Pathol, Oita, Japan; [Maruta, Junko; Tsuneoka, Hidehiro] Yamaguchi Univ, Grad Sch Med, Fac Hlth Sci, Dept Lab Sci, Yamaguchi, Japan; [Noguchi, Hitoshi] Noguchi Thyroid Hosp & Fdn, Dept Internal Med, Oita, Japan; [Noguchi, Shiro] Noguchi Thyroid Hosp & Fdn, Dept Surg, Oita, Japan; [Kobayashi, Tadao K.] Osaka Univ, Grad Sch Med & Hlth Sci, Canc Educ & Res Ctr, Osaka, Japan; [Takahashi, Mutsuo] Mine City Hosp, Dept Adm, Yamaguchi, Japan	Maruta, J (reprint author), Noguchi Thyroid Hosp & Fdn, Dept Pathol, Oita, Japan.	junko@noguchi-med.or.jp					Aiad HA, 2013, PATHOL ONCOL RES, V19, P167, DOI 10.1007/s12253-012-9565-1; Ali CZ, 2010, BETHESDA SYSTEM REPO, P59; Tan A, 2011, ANN DIAGN PATHOL, V15, P108, DOI 10.1016/j.anndiagpath.2010.11.005; Cui WL, 2012, CLIN LAB, V58, P419; HENRY JF, 1994, WORLD J SURG, V18, P529; CATTORETTI G, 1992, J PATHOL, V168, P357, DOI 10.1002/path.1711680404; Weber KB, 2004, AM J CLIN PATHOL, V122, P524, DOI 10.1309/UUQTE505PTN5QJ7M; Taurog A, 1996, ARCH BIOCHEM BIOPHYS, V330, P24, DOI 10.1006/abbi.1996.0222; Savin S., 2006, Experimental Oncology, V28, P70; BROWN DC, 1990, HISTOPATHOLOGY, V17, P489, DOI 10.1111/j.1365-2559.1990.tb00788.x; DesMicco C, 2008, BRIT J CANCER, V98, P818; DesMicco C, 1994, EUR J ENDOCRINOL, V131, P474; DesMicco C, 1991, CANCER, V67, P3036; DesMicco C, 1994, SURGERY, V116, P1031; DisCristofaro J, 2006, ENDOCR-RELAT CANCER, V13, P485; Erickson LA, 1998, MODERN PATHOL, V11, P169; Faroux MJ, 1997, PATHOL RES PRACT, V193, P705; Garcia S, 1998, THYROID, V8, P745, DOI 10.1089/thy.1998.8.745; Goldstein RE, 2002, ANN SURG, V235, P656, DOI 10.1097/00000658-200205000-00007; Heikkila A, 2010, APMIS, V118, P846, DOI 10.1111/j.1600-0463.2010.02668.x; Ito Y, 2010, WORLD J SURG, V34, P3015, DOI 10.1007/s00268-010-0746-3; Krolicka A, 2010, ANTICANCER RES, V30, P4945; Lacoste-Collin L, 2014, CYTOPATHOLOGY, V25, P160, DOI 10.1111/cyt.12128; Lima MA, 1999, ENDOCR PATHOL, V10, P223, DOI 10.1007/BF02738883; Mussig K, 2012, CLIN ENDOCRINOL, V77, P139, DOI 10.1111/j.1365-2265.2012.04343.x; Paunovic I, 2012, APMIS, V120, P368, DOI 10.1111/j.1600-0463.2011.02842.x; Pluot M, 1996, CANCER DETECT PREV, V20, P285; Pujani M, 2001, INDIAN J CANCER, V47, P304; Savin S, 2006, ENDOCR PATHOL, V17, P53, DOI 10.1385/EP:17:1:53; Savin S, 2008, HUM PATHOL, V39, P1656, DOI 10.1016/j.humpath.2008.04.006; Sobrinho-Simones M, 2004, WHO CLASSIFICATION T, P67; Sofiadis A, 2009, INT J ONCOL, V35, P369, DOI 10.3892/ijo_00000348; WALLIN G, 1992, ANAL QUANT CYTOL, V14, P296	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-1039	1097-0339		DIAGN CYTOPATHOL	Diagn. Cytopathol.	MAR	2015	43	3					202	209		10.1002/dc.23204		8	Medical Laboratory Technology; Pathology	Medical Laboratory Technology; Pathology	CB9PY	WOS:000349965400004		
J	Hattori, Y; Yoshida, A; Sasaki, N; Shibuki, Y; Tamura, K; Tsuta, K				Hattori, Yukinori; Yoshida, Akihiko; Sasaki, Naoshi; Shibuki, Yasuo; Tamura, Kenji; Tsuta, Koji			Desmoplastic Small Round Cell Tumor With Sphere-like Clusters Mimicking Adenocarcinoma	DIAGNOSTIC CYTOPATHOLOGY			English	Article						desmoplastic small round cell tumor; pleural effusion; cytology	FINE-NEEDLE-ASPIRATION; CYTOLOGY; DIAGNOSIS; DIFFERENTIATION; FEATURES; THINPREP	Desmoplastic small round cell tumor (DSRCT) is a rare and aggressive neoplasm that predominantly affects young men. DSRCT often presents as multiple nodules on the serosal surface and is histologically categorized as a small round cell tumor. However, the cytological spectrum of DSRCT is not fully understood because of its rarity. Here, we report an unusual case of DSRCT that showed spheres of cells without stromal cores in pleural fluid cytology material, a finding that is typically associated with metastatic adenocarcinoma and mesothelioma. The specimen from a simultaneous needle biopsy showed the classic histology of DSRCT, comprising nests of small round cells set in desmoplasia. The diagnosis of DSRCT was further supported by immunohistochemical coexpression of cytokeratin and desmin, as well as Ewing sarcoma breakpoint region 1 gene rearrangement, which was determined by fluorescence in situ hybridization. The unusual cytological finding in this case illustrates a potential pitfall of the cytological diagnosis of pleural fluid or ascites. DSRCT should not be excluded from the differential diagnosis when sphere-like round cell clusters are observed in pleural or abdominal effusion, particularly in young male patients. Diagn. Cytopathol. 2015;43:214-217. (c) 2014 Wiley Periodicals, Inc.	[Hattori, Yukinori; Yoshida, Akihiko; Sasaki, Naoshi; Shibuki, Yasuo; Tsuta, Koji] Natl Canc Ctr, Div Pathol, Tokyo 1040045, Japan; [Hattori, Yukinori; Yoshida, Akihiko; Sasaki, Naoshi; Shibuki, Yasuo; Tsuta, Koji] Natl Canc Ctr, Clin Lab, Tokyo 1040045, Japan; [Tamura, Kenji] Natl Canc Ctr, Div Breast & Med Oncol, Tokyo 1040045, Japan	Tsuta, K (reprint author), Natl Canc Ctr, Div Pathol, Chuo Ku, 1-1 Tsukiji 5 Chome, Tokyo 1040045, Japan.	ktsuta@ncc.go.jp					AKHTAR M, 1994, DIAGN CYTOPATHOL, V11, P159, DOI 10.1002/dc.2840110210; Kim HJ, 2013, KOREAN J PATHOL, V47, P182, DOI 10.4132/KoreanJPathol.2013.47.2.182; Chang FJ, 2006, ARCH PATHOL LAB MED, V130, P728; Ordonez NG, 1998, AM J SURG PATHOL, V22, P1303, DOI 10.1097/00000478-199811000-00001; Romeo S, 2010, VIRCHOWS ARCH, V456, P219, DOI 10.1007/s00428-009-0854-3; Presley AE, 2007, CANCER CYTOPATHOL, V111, P41, DOI 10.1002/cncr.22421; Antonescu CR, 2013, WHO CLASSIFICATION T, P225; BIAN YL, 1993, ACTA CYTOL, V37, P77; CARAWAY NP, 1993, DIAGN CYTOPATHOL, V9, P465, DOI 10.1002/dc.2840090419; Churg A, 2006, AFIP ATLAS TUMOR PAT, V4; Crapanzano JP, 2002, CANCER CYTOPATHOL, V96, P21, DOI 10.1002/cncr.10316; ELKATTAN I, 1995, ACTA CYTOL, V39, P514; Ferlicot S, 2001, ACTA CYTOL, V45, P617; FOOT NC, 1954, AM J PATHOL, V30, P661; GERALD W L, 1989, Pediatric Pathology, V9, P177; Granja NM, 2005, CYTOJOURNAL, V2, P6, DOI DOI 10.1186/1742-6413-2-6; Insabato L, 1999, ACTA CYTOL, V43, P641; Leca LB, 2012, ACTA CYTOL, V56, P576, DOI 10.1159/000338523; Logrono R, 1997, ACTA CYTOL, V41, P1402; Naylor B, 2008, COMPREHENSIVE CYTOPA, P515, DOI 10.1016/B978-141604208-2.10019-3; SETRAKIAN S, 1992, ACTA CYTOL, V36, P373; Shidham VB, 2010, DIAGNOSTIC CYTOPATHO, P115; Zeppa P, 2003, ACTA CYTOL, V47, P501, DOI 10.1159/000326559	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-1039	1097-0339		DIAGN CYTOPATHOL	Diagn. Cytopathol.	MAR	2015	43	3					214	217		10.1002/dc.23174		4	Medical Laboratory Technology; Pathology	Medical Laboratory Technology; Pathology	CB9PY	WOS:000349965400006		
J	Sakuma, T; Matsuo, K; Koike, S; Tagami, K				Sakuma, Takahiko; Matsuo, Koji; Koike, Shinya; Tagami, Kouichiro			Fine Needle Aspiration Cytology of Nodular Fasciitis of the Breast	DIAGNOSTIC CYTOPATHOLOGY			English	Article						breast; deep benign fibrous histiocytoma; fine needle aspiration; inflammatory myoblastic tumor; nodular fasciitis	INFLAMMATORY MYOFIBROBLASTIC TUMOR; INTRANUCLEAR CYTOPLASMIC INCLUSIONS; BENIGN FIBROUS HISTIOCYTOMA; PHYLLODES TUMOR; MAMMARY ADENOMYOEPITHELIOMA; MYOEPITHELIAL CELLS; FNA CYTOLOGY; BIOPSY; DIAGNOSIS; PSEUDOTUMOR	We report a case of nodular fasciitis (NF) of the breast, which was cytologically diagnosed as a spindle cell proliferation with undetermined malignant potential. Owing to small size of the lesion (5.9 x 3.7 x 4.1 mm), only fine needle aspiration (FNA) cytology was performed under ultrasound guidance. The FNA smears were cellular, rich in single/clustered spindle cells but mammary ductal epithelial/myoepithelial cells were absent. These cytologic findings suggested spindle cell growth of mesenchymal origin. Pattern-less arrangement of spindle cells, heterogeneous composition of the stromal matrix, lack of nuclear/cellular atypia, occasional mitosis but no aberrant mitotic figures, and lymphocyte infiltration indicated reactive rather than neoplastic nature of the lesion. Nonetheless, lumpectomy was conducted because the possibility of neoplasm was not completely ruled out. The histologic diagnosis of the resected nodule was NF. FNA specimens were reviewed thoroughly in an attempt to define the key cytomorphologic features of NF that are important for the correct diagnosis. Differential diagnoses from the lesions that show similar cytologic pictures are discussed in detail. Although NF arising from the breast is rare, cytopathologists should be aware of its clinical and cytopathologic characteristics. Knowledge of the possibility of NF in the breast and its cytologic findings may help cytopathologists to discern its reactive, not neoplastic, characteristics of the lesion. If the referring surgeon is alerted NF as a possibility along with other differential diagnoses, close observation would become a management option. In-depth discussion of cytologic features and a review of the pertinent literature are also included. Diagn. Cytopathol. 2015;43:222-229. (c) 2014 Wiley Periodicals, Inc.	[Sakuma, Takahiko] Atsumi Hosp, Dept Lab Med, Tahara, Aichi, Japan; [Matsuo, Koji] Matsuo Clin, Toyohashi, Aichi, Japan; [Koike, Shinya; Tagami, Kouichiro] Atsumi Hosp, Dept Surg, Tahara, Aichi, Japan	Sakuma, T (reprint author), Dept Lab Med, 1-1 Akaishi, Tahara, Aichi 4413415, Japan.	thsakuma@atsumi.jaaikosei.or.jp					ABENDROTH CS, 1995, ACTA CYTOL, V39, P530; AMIN MB, 1993, AM J CLIN PATHOL, V99, P593; Stoll LM, 2011, DIAGN CYTOPATHOL, V39, P663, DOI 10.1002/dc.21444; PETTINATO G, 1988, AM J CLIN PATHOL, V90, P627; Bhattarai S, 2000, ACTA CYTOL, V44, P790; Yip CH, 1997, AUST NZ J SURG, V67, P300, DOI 10.1111/j.1445-2197.1997.tb01972.x; Laforga JBM, 1998, DIAGN CYTOPATHOL, V19, P55, DOI 10.1002/(SICI)1097-0339(199807)19:1<55::AID-DC11>3.0.CO;2-7; FRIEDMAN HD, 1994, VIRCHOWS ARCH, V425, P199; Chang A, 2002, DIAGN CYTOPATHOL, V26, P191, DOI 10.1002/dc.10073; Shabb NS, 1997, ACTA CYTOL, V41, P321; Squillaci S, 2007, INT J SURG PATHOL, V15, P69, DOI 10.1177/1066896906295999; ORDI J, 1992, ACTA CYTOL, V36, P194; Zardawi IM, 2003, ACTA CYTOL, V47, P1077, DOI 10.1159/000326651; COFFIN CM, 1995, AM J SURG PATHOL, V19, P859, DOI 10.1097/00000478-199508000-00001; Al-Nafussi A, 1999, HISTOPATHOLOGY, V35, P1; STANLEY MW, 1993, DIAGN CYTOPATHOL, V9, P322, DOI 10.1002/dc.2840090316; Iyengar P, 2006, CANCER CYTOPATHOL, V108, P250, DOI 10.1002/cncr.21839; Aydin O, 2001, CYTOPATHOLOGY, V12, P346, DOI 10.1046/j.1365-2303.2001.0360b.x; BARDALES RH, 1995, DIAGN CYTOPATHOL, V12, P126, DOI 10.1002/dc.2840120207; BERNSTEIN K E, 1982, Cancer, V49, P1668, DOI 10.1002/1097-0142(19820415)49:8<1668::AID-CNCR2820490823>3.0.CO;2-9; Bharatnur SS, 2010, ACTA CYTOL, V54, P89, DOI 10.1159/000324976; BIRDSONG GG, 1993, DIAGN CYTOPATHOL, V9, P547, DOI 10.1002/dc.2840090515; Chetty R, 1997, PATHOLOGY, V29, P270; Chhieng DC, 1999, CYTOPATHOLOGY, V10, P354, DOI 10.1046/j.1365-2303.1999.00180.x; Chhieng DC, 1999, CANCER CYTOPATHOL, V87, P359, DOI 10.1002/(SICI)1097-0142(19991225)87:6<359::AID-CNCR7>3.0.CO;2-7; Chinoy RF, 1998, ACTA CYTOL, V42, P811; DAHL I, 1981, ACTA CYTOL, V25, P215; Dahlstrom J, 2001, Australas Radiol, V45, P67, DOI 10.1046/j.1440-1673.2001.00879.x; Dayan D, 2005, J ORAL PATHOL MED, V34, P426, DOI 10.1111/j.1600-0714.2005.00338.x; el-Naggar A, 1987, Diagn Cytopathol, V3, P320, DOI 10.1002/dc.2840030412; FERNANDO SSE, 1993, CYTOPATHOLOGY, V4, P305, DOI 10.1111/j.1365-2303.1993.tb00106.x; FRITSCHES HG, 1983, ACTA CYTOL, V27, P73; Gobbi H, 1999, BREAST, V8, P135, DOI 10.1054/brst.1999.0045; Green JS, 1997, CLIN RADIOL, V52, P961, DOI 10.1016/S0009-9260(97)80234-6; Gupta RK, 2000, ACTA CYTOL, V44, P1101; Gupta RK, 1998, DIAGN CYTOPATHOL, V18, P468, DOI 10.1002/(SICI)1097-0339(199806)18:6<468::AID-DC17>3.0.CO;2-F; Haj Mahmoud, 2003, Breast J, V9, P423, DOI 10.1046/j.1524-4741.2003.09516.x; Hayashi Hironori, 2007, Breast Cancer, V14, P337, DOI 10.2325/jbcs.14.337; Hikino Hajime, 2007, Breast Cancer, V14, P429, DOI 10.2325/jbcs.14.429; Ilvan S, 2005, APMIS, V113, P66, DOI 10.1111/j.1600-0463.2005.apm1130110.x; Iwatani T, 2012, BREAST CANCER-TOKYO, V19, P180, DOI 10.1007/s12282-009-0149-1; Jayaram G, 2005, ACTA CYTOL, V49, P656, DOI 10.1159/000326256; Jayaram G, 2002, DIAGN CYTOPATHOL, V26, P222, DOI 10.1002/dc.10085; KAW YT, 1993, ACTA CYTOL, V37, P957; Klijanienko J, 2004, DIAGN CYTOPATHOL, V31, P387, DOI 10.1002/dc.20140; Kong CS, 2004, ACTA CYTOL, V48, P473, DOI 10.1159/000326406; KONTOGEORGOS G, 1988, Archives d'Anatomie et de Cytologie Pathologiques, V36, P113; KONWALER BE, 1955, AM J CLIN PATHOL, V25, P241; Kurashina M, 2002, DIAGN CYTOPATHOL, V26, P29, DOI 10.1002/dc.10037; Lee WY, 2000, ACTA CYTOL, V44, P488; LopezFerrer P, 1997, DIAGN CYTOPATHOL, V17, P363, DOI 10.1002/(SICI)1097-0339(199711)17:5<363::AID-DC9>3.0.CO;2-B; Lui PCW, 2007, J CLIN PATHOL, V60, P529, DOI 10.1136/jcp.2006.039412; Maly B, 2001, ACTA CYTOL, V45, P794; McCluggage WG, 1997, CYTOPATHOLOGY, V8, P31, DOI 10.1046/j.1365-2303.1997.43975439.x; Mercado CL, 2007, DIAGN CYTOPATHOL, V35, P690, DOI 10.1002/dc.20722; Ng WK, 2002, ACTA CYTOL, V46, P317, DOI 10.1159/000326728; Nguyen G K, 1987, Diagn Cytopathol, V3, P335, DOI 10.1002/dc.2840030416; NIEMANN TH, 1995, DIAGN CYTOPATHOL, V12, P245, DOI 10.1002/dc.2840120311; NILSSON B, 1994, ACTA CYTOL, V38, P431; OConnell JX, 1997, INT J GYNECOL PATHOL, V16, P117, DOI 10.1097/00004347-199704000-00006; Paker I, 2013, CYTOPATHOLOGY, V24, P201, DOI 10.1111/j.1365-2303.2011.00947.x; PARHAM DM, 1992, CYTOPATHOLOGY, V3, P245, DOI 10.1111/j.1365-2303.1992.tb00514.x; Plaza JA, 2005, AM J CLIN PATHOL, V123, P388, DOI 10.1309/PWDOHB511L3VR56W; Pogacnik A, 1997, CYTOPATHOLOGY, V8, P45, DOI 10.1046/j.1365-2303.1997.43275432.x; Reis-Filho JS, 2012, WHO CLASSIFICATION T, P48; Saad RS, 2012, DIAGN CYTOPATHOL, V40, P1005, DOI 10.1002/dc.21705; Sastre-Garau X, 2002, J PATHOL, V196, P97, DOI 10.1002/path.1004; Shields JA, 2001, OPHTHALMIC PLAST REC, V17, P144, DOI 10.1097/00002341-200103000-00015; Shimizu K, 2002, ACTA CYTOL, V46, P332, DOI 10.1159/000326730; TAMAI M, 1994, ACTA CYTOL, V38, P435; Thompson L D, 2001, Ann Diagn Pathol, V5, P191, DOI 10.1053/adpa.2001.26969; TORLAKOVIC E, 1993, DIAGN CYTOPATHOL, V9, P655, DOI 10.1002/dc.2840090610; TORNGREN S, 1991, ACTA CHIR-EUR J SURG, V157, P155; Tse GMK, 2002, ACTA CYTOL, V46, P855, DOI 10.1159/000327059; Tulbah Asma, 2003, Breast J, V9, P223, DOI 10.1046/j.1524-4741.2003.09318.x; VALENTE PT, 1994, DIAGN CYTOPATHOL, V10, P165, DOI 10.1002/dc.2840100215; VIELH P, 1993, DIAGN CYTOPATHOL, V9, P188, DOI 10.1002/dc.2840090216; Wei XJ, 2003, DIAGN CYTOPATHOL, V29, P172, DOI 10.1002/dc.10359; Wong NL, 2002, ACTA CYTOL, V46, P1049, DOI 10.1159/000327106; Zanella M, 1999, BREAST J, V5, P264, DOI 10.1046/j.1524-4741.1999.97049.x; Zee SY, 2002, ACTA CYTOL, V46, P741, DOI 10.1159/000326988	81	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-1039	1097-0339		DIAGN CYTOPATHOL	Diagn. Cytopathol.	MAR	2015	43	3					222	229		10.1002/dc.23176		8	Medical Laboratory Technology; Pathology	Medical Laboratory Technology; Pathology	CB9PY	WOS:000349965400008		
J	Takahashi, Y; Sato, H				Takahashi, Yasuhiro; Sato, Hisao			Low-Power Supply Circuit Using Off-Chip Resonant Circuit for Adiabatic Logic	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						adiabatic logic; sinusoidal supply circuit; voltage divider; current control; low power	RECOVERY LOGIC; CMOS LOGIC	This paper presents a low-power sinusoidal supply circuit for our proposed adiabatic logic (2PC2AL). The proposed supply circuit consists of three parts: LC resonant circuit, voltage generator circuit, and peak control circuit. The proposed circuit is simulated using 0.18 m CMOS technology. The simulation results show that the power dissipation of the proposed voltage generator is 10.8 W at a 100 nA load, and that of the proposed sinusoidal supply circuit is 35.5 W at 100 kHz. The power dissipation values of the adiabatic/nonadiabatic 16-bit MPU decoders are also compared. At transition frequencies of 10 kHz to 1 MHz, the proposed decoder with a sinusoidal supply circuit shows a maximum reduction of 75% in power dissipation from to that of a static CMOS.	[Takahashi, Yasuhiro] Gifu Univ, Fac Engn, Dept Elect & Elect Engn, Gifu, Japan; [Sato, Hisao] Gifu Univ, Sch Engn, Gifu, Japan	Takahashi, Y (reprint author), Gifu Univ, Fac Engn, Dept Elect & Elect Engn, Gifu, Japan.				 [24760274]	This study was carried out in cooperation with the VLSI Design and Education Center (VDEC) and with Cadence Co., Ltd. This study was supported in part by a grant-in-aid for Scientific Research (Junior Scientists B 24760274).	Ye YB, 2001, IEEE J SOLID-ST CIRC, V36, P239; Maksimovic D, 2000, IEEE T VLSI SYST, V8, P460, DOI 10.1109/92.863629; Moon Y, 1996, IEEE J SOLID-ST CIRC, V31, P514; Anuar N, 2010, PROCEEDINGS OF THE 2010 18TH IEEE/IFIP INTERNATIONAL CONFERENCE ON VLSI AND SYSTEM-ON-CHIP, P364; Anuar N, 2010, J SEMICOND TECH SCI, V10, P1; Athas W. C., 1994, IEEE Transactions on Very Large Scale Integration (VLSI) Systems, V2, DOI 10.1109/92.335009; DICKINSON AG, 1995, IEEE J SOLID-ST CIRC, V30, P311, DOI 10.1109/4.364447; Kim S., 1998, Proceedings. 1998 International Symposium on Low Power Electronics and Design (IEEE Cat. No.98TH8379), DOI 10.1109/LPE.1998.708183; Komiyama H, 2011, P IEEE INT S INT SIG; Kuwano T, 2011, Patent Application, Patent No. [2011-134678, 2011134678]; Sato H, Patent Application, Patent No. 4905540; Takahashi Y, 2006, P IEEE APCCAS DEC, P1486; Takahashi Y, 2011, P IEEE INT EL DEV MA; Takahashi Y, 2009, FAR E J ELECT COMMUN, V3, P17; Takahashi Y, 2009, MIDWEST SYMP CIRCUIT, P1171, DOI 10.1109/MWSCAS.2009.5235943; Takahashi Y, 2007, IEICE T ELECTRON, VE90C, P2002, DOI 10.1093/ietele/e90-c.10.2002; Ye YB, 1996, IEEE T CIRCUITS-I, V43, P769; Younis S. G., 1994, P INT WORKSH LOW POW, P177	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	MAR	2015	98	3					1	8		10.1002/ecj.11605		8	Engineering, Electrical & Electronic	Engineering	CB9QH	WOS:000349966300001		
J	Uema, H; Matsumura, T; Saito, S; Murata, Y				Uema, Hideki; Matsumura, Tomokuni; Saito, Shinya; Murata, Yukio			Research and Development on Underwater Visible Light Communication Systems	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						underwater communications; visible light communications		The main subject of this investigation is to perform research and development and verification experiments on underwater communications (underwater visible light communications; VLCs) under the assumption that VLC can be used for tourism and environmental protection under the ocean conditions of the Okinawa region (Zamami village), which is one of the most popular diving spots, with the most transparent water and abundant coral and fish. Radio is rarely used as a communications tool underwater because the attenuation rate of radio signals is high. The only communications tool now available under water is sonic (ultrasonic) communications, although it has not spread among divers because it is subject to noise from reflections of the water surface or the sea floor, and its use is not simple. Another disadvantage of this mode of communication is that it is very difficult to identify the speaker when several divers are present in the same area. With the underwater VLC device, most of the underwater communications problems are already solved, for the following reasons: (1) the device is easy to move and does not involve cables; (2) it is much easier to capture another person's words because communication does not diverge as sonic communication does; (3) conversation is much easier since the other party can recognize the speaker visually.	[Uema, Hideki; Matsumura, Tomokuni; Saito, Shinya; Murata, Yukio] Marine Comms Ryukyu Inc, Tokyo, Japan	Uema, H (reprint author), Marine Comms Ryukyu Inc, Tokyo, Japan.						Ito Y, 2006, IEICE TECHNICAL REPO, V105, P127; Japan Recreational Diving Industry Association, 2006, REP 2006 SCUBA DIV T; Okinawa Prefecture Tourism Business Division, 2008, 2007 REP TOUR STAT	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	MAR	2015	98	3					9	13		10.1002/ecj.11617		5	Engineering, Electrical & Electronic	Engineering	CB9QH	WOS:000349966300002		
J	Nakaya, S; Wada, S				Nakaya, Shogo; Wada, Shigeo			Audio Watermarking Based on Vector Quantization Index Modulation Using Audio Fingerprint	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						audio watermarking; vector quantization index modulation; audio fingerprint		Development of high-quality digital audio watermarking with robustness to data compression and watermark attacks such as cropping is an important research topic. Recently, an effective watermarking method using vector quantization index modulation (VQIM) was proposed to improve the watermark performance. In this paper, a new auditory-band MDCT-based VQIM-type watermarking using audio fingerprint (AFP) is proposed to enhance the performance. The parameter values of VQIM are essential for audio quality and robustness, which are determined as individual codebook parameters. The parameters are estimated using AFP in the watermark detection process. In simulations, the effectiveness of the method was examined to show its robustness to watermark attacks. The audio quality was evaluated based on PEAQ.	[Nakaya, Shogo; Wada, Shigeo] Tokyo Denki Univ, Tokyo, Japan	Nakaya, S (reprint author), Tokyo Denki Univ, Tokyo, Japan.						Chen B, 2001, IEEE T INFORM THEORY, V47, P1423, DOI 10.1109/18.923725; Boney L, 1999, P 3 IEEE INT C MULT, P473; Goto M., 2004, P 18 INT C AC ICA 20, V1, P553; Haitsma J., 2002, ISMIR, P107; Kabal P, 2002, BS1387 ITUR MCGILL U; Kalantari NK, 2008, INT CONF ACOUST SPEE, P1741, DOI 10.1109/ICASSP.2008.4517966; Lei B, 2009, 2009 INTERNATIONAL CONFERENCE ON COMMUNICATIONS, CIRCUITS AND SYSTEMS PROCEEDINGS, VOLUMES I & II, P489, DOI 10.1109/ICCCAS.2009.5250468; Lie WN, 2006, IEEE T MULTIMEDIA, V8, P46, DOI 10.1109/TMM.2005.861292; Maha C, 2008, 2008 3RD INTERNATIONAL SYMPOSIUM ON COMMUNICATIONS, CONTROL AND SIGNAL PROCESSING, VOLS 1-3, P1138, DOI 10.1109/ISCCSP.2008.4537396; Muramatsu I., 2004, Transactions of the Institute of Electronics, Information and Communication Engineers A, VJ87-A; Muraia Harumi, 2010, Transactions of the Institute of Electronics, Information and Communication Engineers A, VJ93-A; Nishimura Ryouichi, 2009, Proceedings of the 2009 Fifth International Conference on Intelligent Information Hiding and Multimedia Signal Processing. IIH-MSP 2009, DOI 10.1109/IIH-MSP.2009.103; Sugiyama S, 2008, T IEICE A, VJ91A, P828; Tomioka A, 1999, 9882 IEICE CQ, P25; Unoki M, 2011, IEICE TECH REP, P59; Zhu KL, 2007, P IET C WIR MOB SENS, P717	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	MAR	2015	98	3					14	23		10.1002/ecj.11651		10	Engineering, Electrical & Electronic	Engineering	CB9QH	WOS:000349966300003		
J	Gion, D; Takimoto, H; Kishihara, M; Okubo, K				Gion, Daiki; Takimoto, Hironori; Kishihara, Mitsuyoshi; Okubo, Kensuke			Interactive Segmentation of Color Images Based on Color Saliency	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						image processing; foreground extraction; image segmentation; graph cuts; color saliency map	GRAPH CUTS	Efficient interactive foreground extraction from color images is of great practical importance in computer vision. In recent years, an approach based on optimization using graph-cuts has been widely used. However, an interactive foreground extraction approach, which is intuitive and efficient for users, is required for practical applications. In this paper, we propose a novel interactive foreground extraction method based on color saliency. In our method, the user provides only some foreground pixels as the initial reference. To achieve extraction of multiple target objects, the likelihoods of the foreground and background are defined by a Gaussian mixture model and a color saliency map based on the provided reference pixels. These likelihoods are added to the cost of the proposed graph. Finally, image segmentation is performed by optimizing the proposed graph using the graph-cut algorithm.	[Gion, Daiki] Okayama Prefectural Univ, Okayama, Japan; [Takimoto, Hironori; Kishihara, Mitsuyoshi; Okubo, Kensuke] Okayama Prefectural Univ, Fac Comp Sci & Syst Engn, Okayama, Japan	Gion, D (reprint author), Okayama Prefectural Univ, Okayama, Japan.				JSPS [C-24500653]	This study was supported in part by a JSPS Grant-in-Aid for Scientific Research (C-24500653, representative: Hironori Takimoto). We also express our gratitude to Professor M. Jindai and Associate Professor H. Yamauchi of Okayama Prefectural University and to Associate Professor Y. Mitsukura of Keio University for their cooperation.	Boykov Y, 2004, IEEE T PATTERN ANAL, V26, P1124, DOI 10.1109/TPAMI.2004.60; Boykov Y, 2006, INT J COMPUT VISION, V70, P109, DOI 10.1007/s11263-006-7934-5; Li Y, 2004, ACM T GRAPHIC, V23, P303, DOI 10.1145/1015706.1015719; [Anonymous], 2001, 8 IEEE INT C COMP VI; MEYER F, 1992, IEE CONF PUBL, V354, P303; Rother C, 2004, ACM T GRAPHIC, V23, P309, DOI 10.1145/1015706.1015720; Heckbert P., 1982, SIGGRAPH COMPUT GRAP, V16, P297; Inoue K, 2011, P ITE, V65, P996; Nagahashi T, 2007, P MIRU, P241; Pham V, 2011, T IEICE D, VJ94-D, P1183; Stauffer C., 1999, P IEEE C COMP VIS PA, V2, P246	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	MAR	2015	98	3					24	32		10.1002/ecj.11652		9	Engineering, Electrical & Electronic	Engineering	CB9QH	WOS:000349966300004		
J	Li, ZH; Hamashima, M; Muro, H				Li, Zhenghao; Hamashima, Mio; Muro, Hideo			Self-Sustaining Vibration Sensors Using Multiple Cantilever-Type Piezoelectric Bimorphs with Different Resonant Frequencies	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						vibration sensor; piezoelectric; bimorph; cantilever; self-sustaining	WIRELESS ELECTRONICS; MEMS	In order to realize a vibration sensor, which can operate without power supply, an optimization of the sensor configuration was studied using commercial piezoelectric bimorphs. The dependences of the energy conversion efficiency on the weight of metal mass attached to the tip of the piezoelectric bimorph and peripheral circuit components were investigated. Vibration sensors using several piezoelectric bimorphs with different weights were designed, fabricated, and tested.	[Li, Zhenghao] Automax Co Ltd, Tokyo, Japan; [Hamashima, Mio] TDK Corp, Tokyo, Japan; [Muro, Hideo] Chiba Inst Technol, Narashino, Chiba, Japan	Li, ZH (reprint author), Automax Co Ltd, Tokyo, Japan.						Renaud M, 2008, SENSOR ACTUAT A-PHYS, V145, P380, DOI 10.1016/j.sna.2007.11.005; Paradiso JA, 2005, IEEE PERVAS COMPUT, V4, P18, DOI 10.1109/MPRV.2005.9; Roundy S, 2003, COMPUT COMMUN, V26, P1131; Ashwin P, 2010, NONLINEAR DYNAM, V62, P1001; Ayala IN, 2009, POW MEMS 2009, V12, P49; Beeby S. P., 2006, MEAS SCI TECHNOL, V17, P175; Muro H, 2009, MICROSENSOR ENG, P80; Roundy S, 2004, SMART MATER STRUCT, V13, P1131, DOI 10.1088/0964-1726/13/5/018; Suzuki Y., 2009, 1 MICRONANOSCI SENSO, P13; Trolier-McKinstry S, 2004, J ELECTROCERAM, V12, P7, DOI 10.1023/B:JECR.0000033998.72845.51; Tsutsumino T, 2006, P 23 SENS S TAK JAP, P521	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	MAR	2015	98	3					33	40		10.1002/ecj.11662		8	Engineering, Electrical & Electronic	Engineering	CB9QH	WOS:000349966300005		
J	Takano, H; Takubo, C; Asai, K; Sawai, Y; Fujieda, T; Naito, T; Kurata, H; Goto, Y				Takano, Hideaki; Takubo, Chisaki; Asai, Kengo; Sawai, Yuichi; Fujieda, Tadashi; Naito, Takashi; Kurata, Hideaki; Goto, Yasushi			Printed Thermoelectric Devices Using Vanadate Glass Composite Materials	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						thermoelectric devices; printed; vanadate glass; energy harvesting; waste-heat recovery		Thermoelectric (TE) devices have emerged as one of the most promising new technologies for use as sensor module energy harvesters and as waste-heat recovery systems. Low-cost and large-area printed TE devices are suitable because heat sources are widely distributed throughout the environment. In addition, high reliability is also required of the TE materials because the devices are operated in high-temperature environments over long periods of time. In this study, we developed glass matrix TE composite materials that have a higher softening temperature than organic materials. Using low melting point vanadate glasses as the matrix materials, we fabricated n-type Bi2Te3-vanadate glass and p-type Bi0.3Sb1.7Te3-vanadate glass composites. The figure of merit (ZT) of both materials was approximately 0.2 at temperatures between 25 degrees C and 300 degrees C. We also fabricated a pair of thermocouple devices using these vanadate glass composites with simple printing process, and an output voltage of 5 mV was obtained when the thermocouple pair was placed on a hot plate heated to 90 degrees C.	[Takano, Hideaki; Takubo, Chisaki; Asai, Kengo; Kurata, Hideaki; Goto, Yasushi] Hitachi Ltd, Cent Res Lab, Tokyo, Japan; [Sawai, Yuichi; Fujieda, Tadashi; Naito, Takashi] Hitachi Ltd, Hitachi Res Lab, Tokyo, Japan	Takano, H (reprint author), Hitachi Ltd, Cent Res Lab, Tokyo, Japan.						Fujieda T, 2012, AIP ADV, V2, DOI 10.1063/1.4732311; Kim H, 2009, ENERGY HARVESTING TECHNOLOGIES, P3, DOI 10.1007/978-0-387-76464-1_1; Kaibe H., 2011, KOMATSU TECH REP, V57, P26; Kajikawa T, 2008, THERMOELECTRIC CONVE; Madan D, 2011, J APPL PHYS, V109, DOI 10.1063/1.3544501; Naito T, 2011, FC REPORT, V29, P51; Suemori K, 2012, 59 JSAP SPRING M; Tachizono S, 2009, HITACHI CHEM TECHNIC, V52, P27	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	MAR	2015	98	3					41	46		10.1002/ecj.11663		6	Engineering, Electrical & Electronic	Engineering	CB9QH	WOS:000349966300006		
J	Kano, R; Usami, K; Noda, T; Shiramatsu, TI; Kanzaki, R; Kawai, K; Takahashi, H				Kano, Ryuji; Usami, Kenichi; Noda, Takahiro; Shiramatsu, Tomoyo I.; Kanzaki, Ryohei; Kawai, Kensuke; Takahashi, Hirokazu			Vagus Nerve Stimulation-Induced Synchrony Modulation of Local Field Potential in the Rat Cerebral Cortex	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						vagus nerve stimulation; cerebral cortex; local field potential; synchronization; microelectrode array; rat	REFRACTORY EPILEPSY; ABSENCE EPILEPSY; CORTICAL RHYTHMS; SEIZURES; BRAIN; OSCILLATIONS; ACTIVATION; THERAPY; NEURONS; TRIAL	Vagus nerve stimulation (VNS) is a surgical treatment for intractable epilepsy. Although VNS has been used to treat more than 60,000 patients, the precise therapeutic mechanism of action has not been elucidated. Here, we hypothesize that VNS modulates the local synchronization of cortical activities and thus inhibits seizures. In order to verify this hypothesis, we mapped local field potentials (LFPs) with high-spatial resolution using a microelectrode array from the temporal cortices of adult rats and analyzed VNS-induced phase modulation at the local network level. VNS significantly increased the phase locking value (PLV), an index of synchronization, specifically at the gamma band. The optimal stimulation pulse of VNS was 0.5 mA delivered at 10 Hz. This PLV modulation was most effective when the interelectrode distance was about 1.6 mm. Gamma-band PLVs within the auditory cortex increased more significantly than those between the auditory and nonauditory cortices, while alpha- and low-beta PLV exhibited more synchronization between the auditory and nonauditory cortices. These results demonstrate that VNS modulates cortical synchronization in a band specific manner, and has some implications for the mechanism of action of VNS.	[Kano, Ryuji; Noda, Takahiro; Shiramatsu, Tomoyo I.] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Mechanoinformat, Tokyo 1138654, Japan; [Usami, Kenichi; Kawai, Kensuke] Univ Tokyo, Grad Sch Med, Dept Neurosurg, Tokyo 1138654, Japan; [Kanzaki, Ryohei; Takahashi, Hirokazu] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 1138654, Japan; [Takahashi, Hirokazu] Japan Sci & Technol Agcy JST, PRESTO, Tokyo, Japan	Kano, R (reprint author), Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Mechanoinformat, Tokyo 1138654, Japan.				JSPS [24650252]	This study was assisted by a JSPS Grant-in Aid (24650252) and by the MHLW Comprehensive Research on Disability Health and Welfare program. In addition, the VNS system used in the experiments was provided by Cyberonics, Inc. (USA).	Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Zagon A, 2000, EPILEPSIA, V41, P1382, DOI 10.1111/j.1528-1157.2000.tb00113.x; Schindler K, 2007, CLIN NEUROPHYSIOL, V118, P1955, DOI 10.1016/j.clinph.2007.06.006; Nichols JA, 2011, NEUROSCIENCE, V189, P207, DOI 10.1016/j.neuroscience.2011.05.024; Paz JT, 2011, NAT NEUROSCI, V14, P1167, DOI 10.1038/nn.2896; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Mooney DM, 2004, P NATL ACAD SCI USA, V101, P320, DOI 10.1073/pnas.0304445101; GEORGE R, 1995, NEUROLOGY, V45, P224; Handforth A, 1998, NEUROLOGY, V51, P48; Steriade M, 1996, J NEUROSCI, V16, P392; Mu QW, 2004, BIOL PSYCHIAT, V55, P816, DOI 10.1016/j.biopsych.2003.12.004; WOODBURY DM, 1990, EPILEPSIA, V31, pS7, DOI 10.1111/j.1528-1157.1990.tb05852.x; Pinault D, 1998, J PHYSIOL-LONDON, V509, P449, DOI 10.1111/j.1469-7793.1998.449bn.x; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; STERIADE M, 1995, J NEUROSCI, V15, P623; Krahl SE, 1998, EPILEPSIA, V39, P709, DOI 10.1111/j.1528-1157.1998.tb01155.x; Groves A, 2005, NEUROSCI BIOBEHAV R, V29, P493; HAMMOND EJ, 1992, EPILEPSIA, V33, P1013, DOI 10.1111/j.1528-1157.1992.tb01752.x; Koo B, 2001, J CLIN NEUROPHYSIOL, V18, P434, DOI 10.1097/00004691-200109000-00008; Milton J, 2003, EPILEPSY DYNAMIC DIS, P341; Morris GL, 1999, NEUROLOGY, V53, P1731; Rizzo P, 2004, CLIN NEUROPHYSIOL, V115, P658, DOI 10.1016/j.clinph.2003.10.026; RUTECKI P, 1990, EPILEPSIA, V31, pS1, DOI 10.1111/j.1528-1157.1990.tb05843.x; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	MAR	2015	98	3					47	56		10.1002/ecj.11674		10	Engineering, Electrical & Electronic	Engineering	CB9QH	WOS:000349966300007		
J	Nankaku, S; Kawakami, H; Koizumi, H; Fukuda, A				Nankaku, Shigeki; Kawakami, Hiroyuki; Koizumi, Hisao; Fukuda, Akira			A Dynamic Control Mechanism of Interrupt Stack Overflow on Real-Time Embedded Monitor (REMON)	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						embedded systems; embedded; interrupt service routine; stack; overflow; memory management unit		For embedded systems, it is important to detect changes in the real world and continuing processing properly. The changes are represented by external interrupts, and proper processes are implemented by nested interrupt service routines (hereafter ISRs). Here, a necessity of mutual exclusion arises. In a software execution environment without any real time OS (hereafter RTOS), a traditional mutual exclusion approach was to disable/enable interrupts in a CPU-specific manner. However, this method typically degrades the real time performance because it defers execution of the mutual-exclusion-free part of the system. Considering this situation, we have been studying a real-time embedded monitor (REMON) which provides a novel mutual exclusion method that can maintain real-time performance without RTOS. For in-service embedded systems, one major runtime fault is ISR stack overflow (SOF). It is extremely difficult to test all conditions where ISRs are called from various external conditions. Note that the ISR stack holds not only data but also program instruction addresses, and consequently a SOF may cause a fatal system error. In summary, ISR SOF is a significant issue, but it has not previously been addressed by REMON. This paper proposes two safety extension methods for embedded systems using REMON. The first method detects ISR overflow and safely stops the system before triggering a system-down or a malfunction. The second method reallocates the ISR stack and resumes system execution automatically.	[Nankaku, Shigeki] Osaka Electrocommun Univ, Neyagawa, Osaka, Japan; [Kawakami, Hiroyuki] Wind River KK, Tokyo, Japan; [Koizumi, Hisao] Tokyo Denki Univ, Fac Sci & Technol, Tokyo, Japan; [Fukuda, Akira] Kyushu Univ, Fac Informat Sci & Elect Engn, Fukuoka 812, Japan	Nankaku, S (reprint author), Osaka Electrocommun Univ, Neyagawa, Osaka, Japan.						Biswas S, 2006, ACM T EMBED COMPUT S, V5, P719, DOI 10.1145/1196636.1196637; Burns A, 1997, REAL TIME SYSTEMS PR; Buttazzo GC, 2011, HARD REAL-TIME COMPUTING SYSTEMS: PREDICTABLE SCHEDULING ALGORITHMS AND APPLICATIONS, THIRD EDITION, P1, DOI 10.1007/978-1-14614-0676-1; Cowan C, 1998, 7 USENIX SEC C SAN A, P63; Ishikawa T, 2012, JPN SOC SOFTWARE SCI, V29, P161; Iwahashi M, 2007, MSW TECH REP, V20, P47; Lai YC, 2011, IEICE T INF SYST, VE94D, P2129, DOI 10.1587/transinf.E94.D.2129; Laplante P. A., 2012, REAL TIME SYSTEMS DE; Laplante P. A., 2004, REAL TIME SYSTEM DES; Lipiansky E D, 2012, EMBEDDED SYSTEMS HAR; Maekawa M, 1987, OPERATING SYSTEMS AD; METI, 2009, 2008 EMB SOFTW IND S; METI, 2008, 2007 EMB SOFTW IND S; METI, 2010, 2009 EMB SOFTW IND S; Nakajima K, 2008, ENHANCING RELIABILIT, P1; Nakajima K, 2009, DESIGN EVALUATION ME, P1; Nakamori A, 2004, INTRO MICROPROCESSOR; Nankaku S, 2012, P EL INF SYST C EL I, P254; Nankaku S, 2013, IEEJ T EIS, V133, P316; Nankaku S., 2009, P EL INF SYST C EL I, P447; Ruwase O, 2004, 11 ANN NETW DISTR SY, P159; Sakamura K, 2001, HDB ITRON 4 0 SPECIF; Sanchez J, 2012, EMBEDDED SYSTEMS CIR; Silberschatz A, 2005, OPERATING SYSTEM CON; Vasudevan A, 2005, P 21 ANN COMP SEC AP	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	MAR	2015	98	3					57	69		10.1002/ecj.11675		13	Engineering, Electrical & Electronic	Engineering	CB9QH	WOS:000349966300008		
J	Yamamoto, K; Hayashi, S; Saiki, H; Indo, N; Nakabori, T; Yamamoto, M; Shibuya, M; Nishida, T; Ichiba, M; Inada, M				Yamamoto, Katsumi; Hayashi, Shiro; Saiki, Hirotsugu; Indo, Naohiko; Nakabori, Tasuku; Yamamoto, Masashi; Shibuya, Mitsuhiko; Nishida, Tsutomu; Ichiba, Makoto; Inada, Masami			Endoscopic submucosal dissection for large superficial colorectal tumors using the "clip-flap method"	ENDOSCOPY			English	Article							EARLY GASTRIC-CANCER; MUCOSAL RESECTION; LESIONS	Background and study aims: Endoscopic submucosal dissection (ESD) is technically difficult because of poor visualization and instability in the cutting area. Although mucosal flap formation improves visualization of the cutting area, it is difficult to achieve, especially in colorectal ESD. To facilitate mucosal flap formation, we developed the "clip-flap method" by substituting an endo-clip for the mucosal flap until it is formed. Patients and methods: The clip-flap method was applied to 114 of 119 large superficial colorectal tumors being treated by ESD. Therapeutic efficacy and safety were assessed. Results: Mean tumor diameter, resected specimen diameter, and procedure time were 32.5mm, 38.9mm, and 82.0 minutes, respectively. The en bloc resection rate was 97.5 %. Intraoperative perforation occurred in one patient who was treated conservatively. A single endoclip was used for 92 lesions and improved visualization of the cutting area. A cross pattern of endoclips was used for 22 lesions and further stabilized the visual field, especially near the lateral side. Conclusions: The clip-flap method is a simple, safe, and effective option for ESD of large superficial colorectal tumors.	[Yamamoto, Katsumi; Hayashi, Shiro; Saiki, Hirotsugu; Indo, Naohiko; Nakabori, Tasuku; Yamamoto, Masashi; Shibuya, Mitsuhiko; Nishida, Tsutomu; Ichiba, Makoto; Inada, Masami] Toyonaka City Hosp, Dept Gastroenterol, Osaka, Japan; [Yamamoto, Katsumi] Japan Community Healthcare Org Osaka Hosp, Endoscopy Ctr, Osaka, Osaka 5530003, Japan	Yamamoto, K (reprint author), Japan Community Healthcare Org Osaka Hosp, Endoscopy Ctr, Fukushima Ku, 4-7-28 Fukushima, Osaka, Osaka 5530003, Japan.	yamamoto-kts@umin.ac.jp		Nishida, Tsutomu/0000-0003-4037-9003			Soetikno R, 2005, J CLIN ONCOL, V23, P4490, DOI 10.1200/JCO.2005.19.935; Kudo SE, 2008, GASTROINTEST ENDOSC, V68, pS3, DOI 10.1016/j.gie.2008.07.052; Parra-Blanco A, 2011, GASTROINTEST ENDOSC, V74, P1137, DOI 10.1016/j.gie.2011.07.037; Saito Y, 2010, GASTROINTEST ENDOSC, V72, P1217, DOI 10.1016/j.gie.2010.08.004; Yamamoto H, 2005, ENDOSCOPY, V37, P764, DOI 10.1055/s-870166; Sakamoto N, 2009, GASTROINTEST ENDOSC, V69, P1370, DOI 10.1016/j.gie.2008.12.245; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Gotoda T, 2009, GASTROINTEST ENDOSC, V69, P10, DOI 10.1016/j.gie.2008.03.1127; Neuhaus H, 2006, ENDOSCOPY, V38, P1016, DOI 10.1055/s-2006-944830; Oyama Tsuneo, 2012, Clin Endosc, V45, P375, DOI 10.5946/ce.2012.45.4.375; Saito Y, 2005, GASTROINTEST ENDOSC, V62, P297, DOI 10.1016/S0016-5107(05)00546-8; Tanaka S, 2012, DIGEST ENDOSC, V24, pS73; Toyonaga Takashi, 2012, Clin Endosc, V45, P362, DOI 10.5946/ce.2012.45.4.362; Toyonaga T, 2008, ACTA CHIR IUGOSL, V55, P17; Yamamoto K, 2012, ENDOSCOPY, V44, pE334, DOI 10.1055/s-0032-1309860	15	2	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	MAR	2015	47	3					262	265		10.1055/s-0034-1390739		4	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CB8BP	WOS:000349853600014		
J	Idris, I; Selamat, A; Nguyen, NT; Omatu, S; Krejcar, O; Kuca, K; Penhaker, M				Idris, Ismaila; Selamat, Ali; Ngoc Thanh Nguyen; Omatu, Sigeru; Krejcar, Ondrej; Kuca, Kamil; Penhaker, Marek			A combined negative selection algorithm-particle swarm optimization for an email spam detection system	ENGINEERING APPLICATIONS OF ARTIFICIAL INTELLIGENCE			English	Article						Negative selection algorithm; Differential evolution; Particle swarm optimization spam detectors	CLASSIFICATION; IMMUNITY; MODEL	Email is a convenient means of communication throughout the entire world today. The increased popularity of email spam in both text and images requires a real-time protection mechanism for the media flow. The previous approach has been limited by the adaptive nature of unsolicited email spam. This research introduces an email detection system that is designed based on an improvement in the negative selection algorithm. Furthermore, particle swarm optimization (PSO) was implemented to improve the random detector generation in the negative selection algorithm (NSA). The algorithm generates detectors in the random detector generation phase of the negative selection algorithm. The combined NSA-PSO uses a local outlier factor (LOF) as the fitness function for the detector generation. The detector generation process is terminated when the expected spam coverage is reached. A distance measure and a threshold value are employed to enhance the distinctiveness between the non-spam and spam detectors after the detector generation. The implementation and evaluation of the models are analyzed. The results show that the accuracy of the proposed NSA-PSO model is better than the accuracy of the standard NSA model. The proposed model with the best accuracy is further used to differentiate between spam and non-spam in a network that is developed based on a client-server network for spam detection. (C) 2014 Elsevier Ltd. All rights reserved.	[Idris, Ismaila; Selamat, Ali] Univ Teknol Malaysia, Fac Comp, Utm Johor Bahru 81310, Johor, Malaysia; [Selamat, Ali] Univ Teknol Malaysia, IRDA Digital Media Ctr Excellence, Utm Johor Bahru 81310, Johor, Malaysia; [Ngoc Thanh Nguyen] Wroclaw Univ Technol, Knowledge Management Syst Div, PL-50370 Wroclaw, Poland; [Omatu, Sigeru] Osaka Inst Technol, Fac Engn, Dept Elect Informat & Commun Engn, Asahi Ku, Osaka 5358585, Japan; [Selamat, Ali; Krejcar, Ondrej; Kuca, Kamil] Univ Hradec Kralove, FIM, Ctr Basic & Appl Res, Hradec Kralove 50003, Czech Republic; [Penhaker, Marek] Tech Univ Ostrava, VSB, Fac Elect Engn & Comp Sci, Dept Cybernet & Biomed Engn, Ostrava 70833, Czech Republic	Selamat, A (reprint author), Univ Teknol Malaysia, Fac Comp, Utm Johor Bahru 81310, Johor, Malaysia.	aselamat@utm.my	Nguyen, Ngoc Thanh/A-5855-2008	Nguyen, Ngoc Thanh/0000-0002-3247-2948	Ministry of Education Malaysia [01G72]; Ministry of Science, Technology & Innovations Malaysia [4S062]; Moravian-Silesian Region [RRC/05/2013]; FIM excellence project; Universiti Teknologi Malaysia (UTM)	The Universiti Teknologi Malaysia (UTM) and Ministry of Education Malaysia under research Grant 01G72 and Ministry of Science, Technology & Innovations Malaysia, under research Grant 4S062 are hereby acknowledged for some of the facilities that were utilized during the course of this research work. This paper has been elaborated in the framework of the project "Support research and development in the Moravian-Silesian Region 2013 DT 1 - International research teams" (RRC/05/2013), financed from the budget of the Moravian-Silesian Region. A portion of the work is also supported from the FIM excellence project.	Abaei G., 2014, VIETNAM J COMPUT SCI, V1, P2014; Abi-Haidar A, 2008, LECT NOTES COMPUT SC, V5132, P36, DOI 10.1007/978-3-540-85072-4_4; Abu-Nimeh S., 2008, P 3 INT C AV REL SEC; Almeida TA, 2012, EXPERT SYST APPL, V39, P6557, DOI 10.1016/j.eswa.2011.12.049; Amayri O., 2012, P 2012 IEEE INT S CI; Delany SJ, 2012, EXPERT SYST APPL, V39, P9899, DOI 10.1016/j.eswa.2012.02.053; Uysal AK, 2012, KNOWL-BASED SYST, V36, P226, DOI 10.1016/j.knosys.2012.06.005; Dasgupta D, 2011, APPL SOFT COMPUT, V11, P1574, DOI 10.1016/j.asoc.2010.08.024; Ramaswamy S, 2000, SIGMOD REC, V29, P427; Dasgupta D, 2006, IEEE COMPUT INTELL M, V1, P40, DOI 10.1109/MCI.2006.329705; Mazhoud I, 2013, ENG APPL ARTIF INTEL, V26, P1263, DOI 10.1016/j.engappai.2013.02.002; Biggio B, 2011, PATTERN RECOGN LETT, V32, P1436, DOI 10.1016/j.patrec.2011.03.022; Guzella TS, 2009, EXPERT SYST APPL, V36, P10206, DOI 10.1016/j.eswa.2009.02.037; Yildiz AR, 2013, ENG APPL ARTIF INTEL, V26, P327, DOI 10.1016/j.engappai.2012.05.014; Bambauer D.E., 2005, VIRGINIA J LAW TECHN, V10, P1; Bereta M, 2007, ENG APPL ARTIF INTEL, V20, P571, DOI 10.1016/j.engappai.2006.11.004; Bezerra GB, 2006, LECT NOTES COMPUT SC, V4163, P446; Cormack G., 2007, TREC PUBLIC SPAM COR; De Castro LN., 2002, NEW COMPUTATIONAL AP, P357; Fagbola T., 2012, COMPUT ENG INTELL SY, V3, P17; Forrest S, 1994, P IEEE COMP SOC S RE, V1, P202; Gao X.Z., 2007, P IEEE INT C SYST MA; Gong T, 2013, SECUR COMMUN NETW, V6, P58, DOI 10.1002/sec.530; Guangchen R., 2007, P 3 INT C NAT COMP I; Haiyan W., 2009, P 3 INT S INT INF TE; Hamdan Mohammad Adel, 2011, APPL SOFT COMPUT, V11, P3827; Hopkins M., 1999, SPAM BASE DATASET; Knorr E. M., 1998, Proceedings of the Twenty-Fourth International Conference on Very-Large Databases; Koprinska I, 2007, INF SCI INT J ARCH, V177; Man Q., 2010, P 7 INT C FUZZ SYST; Massey B, 2003, P ANN C USENIX ANN T, P13; Oda T, 2005, LECT NOTES COMPUT SC, V3627, P276; Oda T., 2003, P 2003 C EV COMP CEC; Oda T, 2003, LECT NOTES COMPUT SC, V2723, P231; Perez-Diaz N, 2012, EXPERT SYST APPL, V39, P12487, DOI 10.1016/j.eswa.2012.04.064; Sajesh T.A., 2011, J STAT COMPUT SIM, V82, P745; Sheikhan M, 2013, SECUR COMMUN NETW, V6, P797, DOI 10.1002/sec.609; Sirisanyalak B., 2007, P IEEE C EV COMP CEC; Tenne Yoel, 2012, Engineering Applications of Artificial Intelligence, V25, DOI 10.1016/j.engappai.2012.03.009; Thonnard O., 2012, SECUR COMMUN NETW; Wamli M., 2009, P 4 INT C COMP SCI C; Wang HM, 2009, ADV SOFT COMP, V52, P13, DOI 10.1007/978-3-540-88079-0_2; Wang YZ, 2013, SECUR COMMUN NETW, V6, P89, DOI 10.1002/sec.535; Wenqing Z., 2005, P 2005 INT C ACT MED; Yevseyeva I, 2013, EXPERT SYST APPL, V40, P4010, DOI 10.1016/j.eswa.2013.01.008; Zhang L., 2004, ACM T ASIAN LANGUAGE, V3, P243, DOI 10.1145/1039621.1039625; Zhang Y, 2008, LECT NOTES COMPUT SC, V4971, P325	47	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0952-1976	1873-6769		ENG APPL ARTIF INTEL	Eng. Appl. Artif. Intell.	MAR	2015	39						33	44		10.1016/j.engappai.2014.11.001		12	Automation & Control Systems; Computer Science, Artificial Intelligence; Engineering, Multidisciplinary; Engineering, Electrical & Electronic	Automation & Control Systems; Computer Science; Engineering	CB8KL	WOS:000349878400004		
J	Liu, Z; Geng, Y; Wang, FF; Liu, ZX; Ma, ZX; Yu, XM; Tian, X; Sun, L; He, QX; Zhang, LM				Liu, Zhe; Geng, Yong; Wang, Feifeng; Liu, Zuoxi; Ma, Zhixiao; Yu, Xiaoman; Tian, Xu; Sun, Lu; He, Qiuxiang; Zhang, Liming			Emergy-Ecological Footprint Hybrid Method Analysis of Industrial Parks Using a Geographical and Regional Perspective	ENVIRONMENTAL ENGINEERING SCIENCE			English	Article						industrial park; hybrid method; local ecological capacity; energy metabolism	SOLAR TRANSFORMITY; CHINESE SOCIETY; ECONOMY; SUSTAINABILITY; KOREA	Over the past 30 years of rapid development, industrial parks have been an important sustained resource for economic development in China. However, due to economic yield-oriented policy and deficient scientific planning, excessive resource consumption and environmental pollution caused by industrial activities in industrial parks has led to ecological degradation and loss in the local areas. To respond to this issue, many researchers have focused on studying the overall efficiency of industrial parks from the perspective of metabolism of material and energy and have proposed some methods such as life cycle assessment, system of environmental economic accounting (SEEA), material flow analysis, and emergy synthesis, which indeed have improved the methods of evaluating industrial activities shift from only an economic perspective to a more comprehensive direction. However, these approaches have only focused on the efficiency of industrial activities while ignoring ecological conditions of the local areas. This article addressed this issue by proposing an emergy-ecological footprint hybrid model to show how this method could be applied to demonstrate both the energy metabolism of industrial parks' activities and ecological capacity of the local areas. We took the Shenyang economic technological development area (SETDA) and the Fuzhou Qingkou investment zone (FZQKIZ) as case studies to validate this method. Results showed that although the environmental burden of SETDA was heavier than FZQKIZ, the ecological capacity of surplus for SETDA was also stronger than FZQKIZ, which caused ecological surplus of SETDA compared with FZQKIZ. This study indicated that we should pay more attention to ecological capacity of the local areas surrounding industrial parks rather than only focusing on environmental impacts caused by industrial activities.	[Liu, Zhe; Geng, Yong; Liu, Zuoxi; Yu, Xiaoman; Tian, Xu; Sun, Lu; Zhang, Liming] Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shanghai 200240, Liaoning Provin, Peoples R China; [Liu, Zhe; Liu, Zuoxi; Yu, Xiaoman; Tian, Xu; Sun, Lu; Zhang, Liming] Univ Chinese Acad Sci, Beijing, Peoples R China; [Geng, Yong] Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, Shanghai 200030, Peoples R China; [Wang, Feifeng] Fujian Normal Univ, Coll Environm Sci & Engn, Fuzhou, Fujian Province, Peoples R China; [Ma, Zhixiao] United Nations Univ, Inst Adv Studies, Yokohama, Kanagawa, Japan; [He, Qiuxiang] Fujian Agr & Forestry Univ, Coll Resources & Environm, Fuzhou, Fujian Province, Peoples R China	Geng, Y (reprint author), Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, 800 Dongchuan Rd, Shanghai 200240, Liaoning Provin, Peoples R China.	gengyong@iae.ac.cn			Natural Science Foundation of China [71325006, 71033004, 71311140172, 31170478]; Ministry of Science and Technology [2011BAJ06B01]	This work is supported by the Natural Science Foundation of China (71325006, 71033004, 71311140172, 31170478) and the Ministry of Science and Technology (2011BAJ06B01). Especially, the authors want to thank those anonymous reviewers for their valuable comments and contributions to the revised version of this article.	Andresen N., 1999, P NJF SEM, P16; Bastianoni S, 2009, ECOL MODEL, V220, P40, DOI 10.1016/j.ecolmodel.2008.09.003; Geng Y, 2010, SCI TOTAL ENVIRON, V408, P5273, DOI 10.1016/j.scitotenv.2010.07.081; Brown MT, 2001, POPUL ENVIRON, V22, P471, DOI 10.1023/A:1010756704612; Zhao S, 2005, ECOL MODEL, V185, P65, DOI 10.1016/j.ecolmodel.2004.11.016; Chen B, 2006, ECOL MODEL, V198, P101, DOI 10.1016/j.ecolmodel.2006.04.022; Chen B, 2007, ECOL ECON, V61, P355, DOI 10.1016/j.ecolecon.2006.03.009; Bastianoni SB, 2005, ECOL MODEL, V186, P212, DOI 10.1016/j.ecolmodel.2005.01.015; Brown MT, 2002, J CLEAN PROD, V10, P321, DOI 10.1016/S0959-6526(01)00043-9; Liu GY, 2011, SCI TOTAL ENVIRON, V409, P3295, DOI 10.1016/j.scitotenv.2011.05.045; Pulselli FM, 2011, ECOL MODEL, V222, P2924, DOI 10.1016/j.ecolmodel.2011.04.022; Otsuka A, 2010, PAP REG SCI, V89, P819, DOI 10.1111/j.1435-5957.2010.00286.x; Vassallo P, 2007, ECOL INDIC, V7, P290, DOI 10.1016/j.ecolind.2006.02.003; Geng Y, 2013, SCIENCE, V339, P1526, DOI 10.1126/science.1227059; Brown MT, 1996, ECOL ECON, V19, P219, DOI 10.1016/S0921-8009(96)00046-8; Lu HF, 2011, ECOL ENG, V37, P277, DOI 10.1016/j.ecoleng.2010.11.003; Bargigli S, 2003, BIENN EM EV RES C 2; Brandt-Williams SL, 2002, HDB EMERGY EVALUATIO; Brown M. T., 1991, TRANSFORMITY WORKING; Brown MT, 2004, ENCY ENERGY, P329, DOI DOI 10.1016/B0-12-176480-X/00242-4; Brown MT, 2000, QUANTIFYING SUSTAINA, P695, DOI 10.1016/B978-012318860-1/50033-2; Buranakarn V., 1998, THESIS U FLORIDA GAI; Cindy F., 2003, ECON GEOGR, V79, P295; Comar V, 2000, P 1 BIENN EM AN RES; Dong XB, 2011, ENERGIES, V4, P1428, DOI 10.3390/en4091428; Jiang MM, 2008, COMMUN NONLINEAR SCI, V13, P2337, DOI 10.1016/j.cnsns.2007.04.025; Jorge LH, 2004, ECOL MODEL, V178, P215; Kim H, 2007, SUSTAIN DEV, V15, P357, DOI 10.1002/sd.321; Lei KP, 2008, ECOL ENG, V32, P30, DOI 10.1016/j.ecoleng.2007.08.008; Liang S., 2012, J IND ECOL, V15, P597; [刘淼 LIU Miao], 2008, [自然资源学报, Journal of Natural Resources], V23, P447; Liu Z. J., 2011, TERRITORY NAT RESOUR, V1, P5; Lu H. F., 2003, ENV SCI, V24, P150; Odum H. T., 2002, CONSTRUCTION ECOLOGY, P37; Odum H. T., 2000, HDB EMERGY EVALUATIO; Odum H. T., 1996, ENV ACCOUNTING EMERG; Odum H. T., 2000, FOLIO 1 INTRO GLOBAL, P16; ODUM HT, 1988, SCIENCE, V242, P1132, DOI 10.1126/science.242.4882.1132; Pulselli RM, 2007, ENVIRON MONIT ASSESS, V133, P1, DOI 10.1007/s10661-006-9554-5; Roberto R. M., 2010, TOURISM MANAGE, V31, P98; Sakr D, 2011, J CLEAN PROD, V19, P1158, DOI 10.1016/j.jclepro.2011.01.001; Shi L., 2010, CHINA GEOL U SOC SCI, V10, P60; Siche J. R., 2006, REV ECI PERU, V3, P22; Siche R, 2010, COMMUN NONLINEAR SCI, V15, P3182, DOI 10.1016/j.cnsns.2009.10.027; Tilley D. R., 1999, THESIS U FLORIDA GAI, P310; ULGIATI S, 1993, TRENDS IN ECOLOGICAL PHYSICAL CHEMISTRY, P187; United Nations Industrial Development Organization (UNIDO), 1997, IND EST PRINC PRACT, P47; van Vuuren DP, 2000, ECOL ECON, V34, P115, DOI 10.1016/S0921-8009(00)00155-5; Wackernagel M., 1996, OUR ECOLOGICAL FOOTP, P160; Yang G, 2011, KSCE J CIV ENG, V15, P1005, DOI 10.1007/s12205-011-1118-8; [赵志强 ZHAO ZhiQiang], 2008, [生态学报, Acta Ecologica Sinica], V28, P2220	51	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1092-8758	1557-9018		ENVIRON ENG SCI	Environ. Eng. Sci.	MAR 1	2015	32	3					193	202		10.1089/ees.2014.0003		10	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CD1AD	WOS:000350805000004		
J	Kodama, N; Sanuki, T; Kumai, Y; Yumoto, E				Kodama, Narihiro; Sanuki, Tetsuji; Kumai, Yoshihiko; Yumoto, Eiji			Long-term vocal outcomes of refined nerve-muscle pedicle flap implantation combined with arytenoid adduction	EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY			English	Article						Refined nerve-muscle pedicle flap implantation; Unilateral vocal fold paralysis; Videostroboscopy; Aerodynamic analysis; Perceptual evaluation	THYROPLASTY TYPE-I; RECURRENT LARYNGEAL NERVE; FOLD PARALYSIS; SURGICAL MEDIALIZATION; CORD PARALYSIS; REINNERVATION; VIDEOSTROBOSCOPY; RECONSTRUCTION; IMPROVEMENT; DYSPHONIA	The objective of this study is to evaluate long-term efficacy of refined nerve-muscle pedicle (NMP) flap implantation combined with arytenoid adduction (AA) for treatment of unilateral vocal fold paralysis (UVFP). The authors retrospectively reviewed 33 patients with UVFP who received refined NMP flap implantation with AA and were followed up over a 1-year period. Evaluation of vocal fold vibration (regularity, amplitude, and glottal gap), aerodynamic analysis (maximum phonation time [MPT] and mean airflow rate [MFR]), and perceptual evaluation (Grade and Breathiness) were performed preoperatively and at five different time points (1, 3, 6, 12, and 24 months) postoperatively. All voice parameters improved significantly postoperatively. All parameters except MFR also continued to improve over the course of 24 months. In the videostroboscopic analysis, the parameter for regularity 24 months after surgery was significantly improved compared with that at 1, 3, and 6 months after surgery. There were also significant improvements in amplitude and the glottal gap 24 months after surgery in comparison with values at 3 and 6 months after surgery and 3 months after surgery, respectively. Significant improvement in aerodynamic and perceptual measurements during the follow-up period together with near-normal vocal fold vibration was achieved by delayed reinnervation with refined NMP flap implantation and AA. The combined surgical technique is effective in the treatment of severe breathy dysphonia due to UVFP. Level of evidence 4.	[Kodama, Narihiro; Sanuki, Tetsuji; Kumai, Yoshihiko; Yumoto, Eiji] Kumamoto Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Kumamoto 8608556, Japan	Kumai, Y (reprint author), Kumamoto Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Kumamoto 8608556, Japan.	hurukiyokizidainootoko@yahoo.co.jp; sanuki@xa2.so-net.ne.jp; kumayoshi426yk@gmail.com; yu6167@gpo.kumamoto-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [25861568]	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 25861568, 2013.	Miyauchi A, 2009, SURGERY, V146, P1056, DOI 10.1016/j.surg.2009.09.018; McCulloch TM, 1998, ANN OTO RHINOL LARYN, V107, P427; BENNINGER MS, 1994, OTOLARYNG HEAD NECK, V111, P497; ISSHIKI N, 1989, ANN OTO RHINOL LARYN, V98, P777; ISSHIKI N, 1974, ACTA OTO-LARYNGOL, V78, P451, DOI 10.3109/00016487409126379; ISSHIKI N, 1978, ARCH OTOLARYNGOL, V104, P555; Hassan MM, 2011, LARYNGOSCOPE, V121, P1018, DOI 10.1002/lary.21657; Isshiki N, 1989, PHONOSURGERY THEORY; ISSHIKI N, 1975, ACTA OTO-LARYNGOL, V80, P465, DOI 10.3109/00016487509121353; Kimura M, 2008, AURIS NASUS LARYNX, V35, P67, DOI 10.1016/j.anl.2007.07.005; MAY M, 1986, LARYNGOSCOPE, V96, P1196; Milstein CF, 2005, LARYNGOSCOPE, V115, P1691, DOI 10.1097/01.mlg.0000173163.07828.30; MOORE DM, 1987, LARYNGOSCOPE, V97, P543; Omori K, 1996, ANN OTO RHINOL LARYN, V105, P280; Sanuki T, 2010, J ONCOL, V2010; SERCARZ JA, 1992, ANN OTO RHINOL LARYN, V101, P567; TANABE M, 1972, ACTA OTO-LARYNGOL, V74, P339, DOI 10.3109/00016487209128460; Tucker HM, 1999, J VOICE, V13, P251, DOI 10.1016/S0892-1997(99)80029-0; TUCKER HM, 1977, ANN OTO RHINOL LARYN, V86, P789; Tucker HM, 1997, J VOICE, V11, P474, DOI 10.1016/S0892-1997(97)80045-8; TUCKER HM, 1990, ANN OTO RHINOL LARYN, V99, P778; Yumoto E, 2006, LARYNGOSCOPE, V116, P1657, DOI 10.1097/01.mlg.0000233245.27582.fc; Yumoto E, 2010, ARCH OTOLARYNGOL, V136, P965, DOI 10.1001/archoto.2010.155	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-4477	1434-4726		EUR ARCH OTO-RHINO-L	Eur. Arch. Oto-Rhino-Laryn.	MAR	2015	272	3					681	688		10.1007/s00405-014-3418-3		8	Otorhinolaryngology	Otorhinolaryngology	CC0NB	WOS:000350031400023		
J	Ikeda, T; Amizuka, T; Ito, Y; Mikami, R; Matsuo, K; Kawamura, N; Fusagawa, S				Ikeda, Toshifumi; Amizuka, Takasuke; Ito, Yuya; Mikami, Ryosuke; Matsuo, Koji; Kawamura, Naoto; Fusagawa, Shintaro			Changes in the perfusion waveform of the internal cerebral vein and intraventricular hemorrhage in the acute management of extremely low-birth-weight infants	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						Internal cerebral vein; Intraventricular hemorrhage; Extremely low-birth-weight infant; Ultrasonography; Doppler	PRETERM INFANTS; NEURODEVELOPMENTAL OUTCOMES; RISK-FACTORS; NETWORK; AGE	This prospective observational study aimed to investigate the association between changes in the Doppler perfusion waveform of the internal cerebral vein and risk of intraventricular hemorrhage (IVH) in extremely low-birth-weight (ELBW) infants. We evaluated the perfusion waveform of the internal cerebral vein every 8 h from immediately after birth to 144 h post-birth in 80 ELBW infants (< 1,000 g) in our hospital. Fluctuations in the measured perfusion waveform were categorized into four patterns according to their increasing magnitude, from grade 0 (steady flow waveform) to grade 3; the IVH rate was investigated. Infants with grades 0-1 fluctuations of the perfusion waveform were classified as low grade (n = 55), and those with grades 2-3 fluctuations were classified as high grade (n = 25). The IVH rate was significantly higher in the high-grade group than the low-grade group (28 vs. 1 %, p < 0.001). The IVH group (n = 8) showed a significantly greater rate of high-grade perfusion waveform than the non-IVH group (n = 72) (87 vs. 25 %, p < 0.001). Conclusion: Changes in the perfusion waveform of the internal cerebral vein during the acute management of ELBW infants may be associated with IVH.	[Ikeda, Toshifumi; Amizuka, Takasuke; Ito, Yuya; Mikami, Ryosuke; Matsuo, Koji; Kawamura, Naoto; Fusagawa, Shintaro] Aomori Prefectural Cent Hosp, Perinatal Ctr, Dept Neonatol, Aomori 0308553, Japan	Ikeda, T (reprint author), Aomori Prefectural Cent Hosp, Perinatal Ctr, Dept Neonatol, 2-1-1 Higashitsukurimichi, Aomori 0308553, Japan.	ikecyobb@ybb.ne.jp; amizuka@nifty.com; yuuyaito@hotmail.com; ryosuke78mikami@yahoo.co.jp; koji_m_01m1070@yahoo.co.jp; ntkawamura@gmail.com; s.fusagawa0907@gmail.com					Kono Y, 2011, PEDIATR INT, V53, P930, DOI 10.1111/j.1442-200X.2011.03424.x; Bolisetty S, 2014, PEDIATRICS, V133, P55, DOI 10.1542/peds.2013-0372; Toyoshima K, 2013, J FORMOS MED ASSOC, V112, P510, DOI 10.1016/j.jfma.2013.02.011; Hintz SR, 2011, PEDIATRICS, V127, P62, DOI 10.1542/peds.2010-1150; Perrone S, 2012, J MATERN-FETAL NEO M, V25, P110, DOI 10.3109/14767058.2012.664344; Heuchan AM, 2002, ARCH DIS CHILD, V86, P86; Sherlock RL, 2005, EARLY HUM DEV, V81, P909, DOI 10.1016/j.earlhumdev.2005.07.007; Badiee Z, 2007, SAUDI MED J, V28, P1362; Crowley P, 2006, COCHRANE DB SYST REV, V2; Inder TE, 2000, SEMIN NEONATOL, V1, P3; Jodeiry B, 2012, Niger J Med, V21, P92; Kusuda S, 2006, PEDIATRICS, V118, pE1130, DOI 10.1542/peds.2005-2724; MIALLALLEN VM, 1987, ARCH DIS CHILD, V62, P1068; Patra K, 2006, J PEDIATR-US, V149, P169, DOI 10.1016/j.jpeds.2006.04.002; Practice CO, 2002, OBSTET GYNECOL, V99, P871; Roberts D, 2006, COCHRANE DATABASE SY, V3; Soraisham AS, 2008, AM J OBSTET GYNECOL, V200, pe376, DOI [10.1016/ j. ajog. 2008.11.034, DOI 10.1016/J.AJ0G.2008.11.034]; Vergani P, 2004, OBSTET GYNECOL, V104, P225, DOI 10.1097/01.AOG.0000130838.02410.b7; Volpe JJ, 2001, NEUROLOGY NEWBORN, P517; Volpe JJ, 2001, NEUROLOGY NEWBORN, P247; Volpe JJ, 2001, NEUROLOGY NEWBORN, P154; VOLPE JJ, 1981, NEW ENGL J MED, V304, P886, DOI 10.1056/NEJM198104093041506	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	MAR	2015	174	3					331	338		10.1007/s00431-014-2396-1		8	Pediatrics	Pediatrics	CC0NF	WOS:000350031800008		
J	Kubojima, Y; Yoshida, T				Kubojima, Yoshitaka; Yoshida, Takahiro			Testing method for determining water resistance of wood pellets	EUROPEAN JOURNAL OF WOOD AND WOOD PRODUCTS			English	Article							MANUFACTURING PARAMETERS; LINEAR EXPANSION	This study aimed at developing a simple, quantitative index for measuring the water resistance of wood pellets. Pellets made from various wood raw materials and other plant-based raw materials, as well as torrefied pellets, were used. Two aluminum plates with a size of 50 mm x 60 mm x 10 mm (about 76.6 g) with two dents were prepared. Two samples were laid on the plate in water and were covered with another plate. A displacement meter contacted the plate, and the rise of the plate because of sample swelling was recorded at 10-s intervals until the rise became stable. The effect of the weight of the aluminum plate and displacement meter were not significant. The temporal change in the diameter swelling of pellets was believed to be expressed by the equation developed. The suitable length of samples required for this test was obtained.	[Kubojima, Yoshitaka; Yoshida, Takahiro] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 305, Japan	Kubojima, Y (reprint author), Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 305, Japan.	kubojima@ffpri.affrc.go.jp			Forestry Agency of Japan	This work was financially supported by the programs "Development of processing and utilizing woody biomass'', by the Forestry Agency of Japan.	Suzuki S, 1998, J WOOD SCI, V44, P444, DOI 10.1007/BF00833408; Stelte W, 2011, BIOMASS BIOENERG, V35, P4690, DOI 10.1016/j.biombioe.2011.09.025; Japan Wood Pellet Association, 2011, QUAL STAND WOOD PELL; Kubojima Y, 2011, P 11 PAC RIM BIOB CO, P596; Kuroda K, 2009, 59 ANN M JAP WOOD RE; Sawabe O, 2005, 55 ANN M JAP WOOD RE; Sekino N, 2000, MOKUZAI GAKKAISHI, V46, P334; SUZUKI S, 1988, MOKUZAI GAKKAISHI, V34, P590; Suzuki S, 1985, WOOD IND, V40, P15; Yoshida T, 2012, WOOD IND, V67, P560; Yoshida T, 2011, P 19 EUR BIOM C EXH, P2015	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0018-3768	1436-736X		EUR J WOOD WOOD PROD	Eur. J. Wood Wood Prod.	MAR	2015	73	2					193	198		10.1007/s00107-014-0868-7		6	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CC0NK	WOS:000350032300006		
J	Morishita, R				Morishita, Ryuichi			New era in gene therapy: end of the beginning	EXPERT OPINION ON BIOLOGICAL THERAPY			English	Editorial Material							ALIPOGENE TIPARVOVEC		Osaka Univ, Grad Sch Med, Div Clin Gene Therapy, Suita, Osaka 5650871, Japan	Morishita, R (reprint author), Osaka Univ, Grad Sch Med, Div Clin Gene Therapy, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	morishit@cgt.med.osaka-u.ac.jp					Carpentier AC, 2012, J CLIN ENDOCR METAB, V97, P1635, DOI 10.1210/jc.2011-3002; Gaudet D, 2013, GENE THER, V20, P361, DOI 10.1038/gt.2012.43; Yla-Herttuala S, 2012, MOL THER, V20, P1831, DOI 10.1038/mt.2012.194; Deev R V, 2014, Angiol Sosud Khir, V20, P38; Haddley K, 2013, DRUG TODAY, V49, P161, DOI 10.1358/dot.2013.49.3.1937398; Santos RD, 2015, ARTERIOSCLER THROMB	6	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1471-2598	1744-7682		EXPERT OPIN BIOL TH	Expert Opin. Biol. Ther.	MAR	2015	15	3					309	310		10.1517/14712598.2015.1018002		2	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	CB7WM	WOS:000349839300001		
J	Sanada, F; Taniyama, Y; Kanbara, Y; Otsu, R; Ikeda-Iwabu, Y; Carracedo, M; Rakugi, H; Morishita, R				Sanada, Fumihiro; Taniyama, Yoshiaki; Kanbara, Yasuhiro; Otsu, Rei; Ikeda-Iwabu, Yuka; Carracedo, Miguel; Rakugi, Hiromi; Morishita, Ryuichi			Gene therapy in peripheral artery disease	EXPERT OPINION ON BIOLOGICAL THERAPY			English	Review						angiogenesis; fibroblast growth factor; gene therapy; hepatocyte growth factor; peripheral artery disease; VEGF	HEPATOCYTE GROWTH-FACTOR; CRITICAL LIMB ISCHEMIA; ENDOTHELIAL PROGENITOR CELLS; INDUCED CELLULAR SENESCENCE; MUSCLE CAPILLARY DENSITY; CLINICAL-TRIAL; DOUBLE-BLIND; OXIDATIVE STRESS; SKELETAL-MUSCLE; LOWER-EXTREMITY	Introduction: Despite the remarkable progress of medicine and endovascular procedures for revascularization, patients with critical limb ischemia (CLI) remain at high risk for amputation and often have a low quality of life due to pain and ulcers in the ischemic leg. Thus, a novel strategy for generating new blood vessels in CLI patients without treatment options is vital. Pre-clinical studies and Phase I clinical trials using VEGF and fibroblast growth factor (FGF) demonstrated promising results; however, more rigorous Phase II and III clinical trials failed to demonstrate benefits for CLI patients. Recently, two multicenter, double-blind, placebo-controlled clinical trials in Japan (Phase III) and the USA (Phase II) showed the benefits of hepatocyte growth factor (HGF) gene therapy for CLI patients. Although the number of patients included in these trials was relatively small, these results imply a distinct beneficial function for HGF over other angiogenic growth factors in a clinical setting. Areas covered: In this review, data from Phase I-III clinical trials of gene therapy for patients with peripheral artery disease (PAD) are examined. In addition, the potential mechanisms behind the success or failure of clinical trials are discussed. Expert opinion: Compared with VEGF and FGF, HGF has a unique molecular effect on inflammation, fibrosis and cell senescence under pathological conditions. These features may explain the clinical benefits of HGF in PAD patients.	[Sanada, Fumihiro; Taniyama, Yoshiaki; Kanbara, Yasuhiro; Otsu, Rei; Ikeda-Iwabu, Yuka; Carracedo, Miguel; Morishita, Ryuichi] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka 5650871, Japan; [Taniyama, Yoshiaki; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan	Morishita, R (reprint author), Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	taniyama@cgt.med.osaka-u.ac.jp; morishit@cgt.med.osaka-u.ac.jp			Novartis; Takeda; Shionogi; Astellas; Boehringer Ingelheim; Daiichi-Sankyo; Pfizer	R Morishita received honoraria, consulting fees and funds from Novartis, Takeda, Shionogi, Astellas, Boehringer Ingelheim, Daiichi-Sankyo and Pfizer. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.	Belch J, 2011, LANCET, V377, P1929, DOI 10.1016/S0140-6736(11)60394-2; Rastan A, 2011, EUR HEART J, V32, P2274, DOI 10.1093/eurheartj/ehr144; Blum A, 2012, ATHEROSCLEROSIS, V223, P269, DOI 10.1016/j.atherosclerosis.2012.03.017; Lau JF, 2011, NAT REV CARDIOL, V8, P405, DOI 10.1038/nrcardio.2011.66; Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08; NAKAMURA T, 1986, P NATL ACAD SCI USA, V83, P6489, DOI 10.1073/pnas.83.17.6489; Pipinos II, 2008, VASC ENDOVASC SURG, V42, P101, DOI 10.1177/1538574408315995; Gupta R, 2009, CIRC RES, V105, P724, DOI 10.1161/CIRCRESAHA.109.200386; Nikol S, 2008, MOL THER, V16, P972, DOI 10.1038/mt.2008.33; Makino H, 2012, ARTERIOSCL THROM VAS, V32, P2503, DOI 10.1161/ATVBAHA.111.244632; Hamada N, 2005, J IMMUNOL, V175, P1224; Van Belle E, 1998, CIRCULATION, V97, P381; Laughlin MH, 2008, J PHYSIOL PHARMACOL, V59, P71; Kalka C, 2000, ANN THORAC SURG, V70, P829, DOI 10.1016/S0003-4975(00)01633-7; Yokoi T, 2006, DIABETES, V55, P1660, DOI 10.2337/db05-1607; Powell RJ, 2008, CIRCULATION, V118, P58, DOI 10.1161/CIRCULATIONAHA.107.727347; Annex BH, 2013, NAT REV CARDIOL, V10, P387, DOI 10.1038/nrcardio.2013.70; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Brevetti G, 2010, CIRCULATION, V122, P1862, DOI 10.1161/CIRCULATIONAHA.109.918417; Chandeck C, 2010, ADV ANAT PATHOL, V17, P42, DOI 10.1097/PAP.0b013e3181c66f4e; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Burger PE, 2002, BLOOD, V100, P3527, DOI 10.1182/blood.V100.10.3527; Groen BBL, 2014, J APPL PHYSIOL, V116, P998, DOI 10.1152/japplphysiol.00919.2013; Golomb BA, 2006, CIRCULATION, V114, P688, DOI 10.1161/CIRCULATIONAHA.105.593442; Kusumanto YH, 2006, HUM GENE THER, V17, P683, DOI 10.1089/hum.2006.17.683; Monaghan-Benson E, 2009, J BIOL CHEM, V284, P25602, DOI 10.1074/jbc.M109.009894; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Belch JJF, 2003, ARCH INTERN MED, V163, P884, DOI 10.1001/archinte.163.8.884; Baumgartner I, 1998, CIRCULATION, V97, P1114; Ohtani K, 2004, CIRCULATION, V110, P2444, DOI 10.1161/01.CIR.0000145123.85083.66; [Anonymous], 2001, JAMA, V286, P1317; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Morishita R, 2011, ARTERIOSCL THROM VAS, V31, P713, DOI 10.1161/ATVBAHA.110.219550; Hirsch AT, 2006, J AM COLL CARDIOL, V47, P1239, DOI 10.1016/j.jacc.2005.10.009; Gounis MJ, 2005, GENE THER, V12, P762, DOI 10.1038/sj.gt.3302481; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; Sasaki M, 2008, FREE RADICAL RES, V42, P625, DOI 10.1080/10715760802244768; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Ueki T, 1999, NAT MED, V5, P226; Nehler MR, 2014, J VASC SURG, V60, P686, DOI 10.1016/j.jvs.2014.03.290; Yonemitsu Y, 2013, MOL THER, V21, P707, DOI 10.1038/mt.2012.279; Shigematsu H, 2010, GENE THER, V17, P1152, DOI 10.1038/gt.2010.51; Taniyama Y, 2002, CIRCULATION, V105, P1233, DOI 10.1161/hc1002.105228; Vlassara H, 2012, J GERONTOL A-BIOL, V67, P1410, DOI 10.1093/gerona/gls195; Xin XH, 2001, AM J PATHOL, V158, P1111, DOI 10.1016/S0002-9440(10)64058-8; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Chaudhary NI, 2007, EUR RESPIR J, V29, P976, DOI 10.1183/09031936.00152106; Rajagopalan S, 2003, AM HEART J, V145, P1114, DOI 10.1016/S0002-8703(03)00102-9; Kaga T, 2012, VASC PHARMACOL, V57, P3, DOI 10.1016/j.vph.2012.02.002; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Sanada F, 2014, CIRC RES, V114, P41, DOI 10.1161/CIRCRESAHA.114.302500; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Robbins JL, 2011, J APPL PHYSIOL, V111, P81, DOI 10.1152/japplphysiol.00141.2011; Shimamura M, 2013, BIOMED RES INT, DOI 10.1155/2013/186215; Makinen K, 2002, MOL THER, V6, P127, DOI 10.1006/mthe.2002.0638; Baumgartner I, 2000, ANN INTERN MED, V132, P880; Benest AV, 2006, MICROCIRCULATION, V13, P423, DOI 10.1080/10739680600775940; Comerota AJ, 2002, J VASC SURG, V35, P930, DOI 10.1067/mva.2002.123677; Fumoto S, 2008, CURR GENE THER, V8, P187, DOI 10.2174/156652308784746431; Gardner AW, 2014, INT J VASC MED, V2014; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Goncalves LM, 1998, REV PORT CARDIOL, V17, pII11; Gowdak LHW, 2000, CIRCULATION, V102, P565; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hiatt WR, 2001, NEW ENGL J MED, V344, P1608; Iekushi K, 2011, HYPERTENSION, V58, P190, DOI 10.1161/HYPERTENSIONAHA.111.173013; Imanishi Toshio, 2010, Ther Adv Cardiovasc Dis, V4, P55, DOI 10.1177/1753944709353173; Isner J M, 1996, Vasc Med, V1, P79; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Koibuchi N, 2004, BLOOD, V103, P3320, DOI 10.1182/blood-2003-02-0352; KRIZ W, 1995, KIDNEY INT, V48, P1435, DOI 10.1038/ki.1995.433; Makarevich P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038776; MANTZOURANIS EC, 1988, NEW ENGL J MED, V319, P338, DOI 10.1056/NEJM198808113190604; Matsumoto K, 2001, HYPERTENSION, V37, P270; Min JK, 2005, CIRC RES, V96, P300, DOI 10.1161/01.RES.0000155330.07887.EE; Mooi WJ, 2009, HORM RES, V71, P78, DOI 10.1159/000192442; MUHLHAUSER J, 1995, CIRC RES, V77, P1077; Nakano N, 1998, HYPERTENSION, V32, P444; Norgren L, 2007, J VASC SURG, V45, pS5; Norgren L, 2007, Eur J Vasc Endovasc Surg, V33 Suppl 1, pS1, DOI 10.1016/j.ejvs.2006.09.024; Ohnishi H, 2010, J ATHEROSCLER THROMB, V17, P751; Okayama K, 2012, HYPERTENSION, V59, P958, DOI 10.1161/HYPERTENSIONAHA.111.183905; Pipinos I, 2008, VASC ENDOVASC SURG, V41, P481, DOI 10.1177/1538574407311106; Sanada F, 2009, CIRC RES, V105, P667, DOI 10.1161/CIRCRESAHA.109.202713; Sanada F, 2009, HYPERTENSION, V53, P77, DOI 10.1161/HYPERTENSIONAHA.108.120725; Shimizu K, 2012, ARTERIOSCL THROM VAS, V32, P2687, DOI 10.1161/ATVBAHA.112.300041; Taniyama Y, 2002, HYPERTENSION, V40, P47, DOI 10.1161/01.HYP.0000020755.56955.BF; Taniyama Y, 2000, CIRCULATION, V102, P246; Walder CE, 1996, J CARDIOVASC PHARM, V27, P91, DOI 10.1097/00005344-199601000-00015; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02	93	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1471-2598	1744-7682		EXPERT OPIN BIOL TH	Expert Opin. Biol. Ther.	MAR	2015	15	3					381	390		10.1517/14712598.2015.1007039		10	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	CB7WM	WOS:000349839300008		
J	Nakagami, H; Morishita, R				Nakagami, Hironori; Morishita, Ryuichi			Development of DNA vaccines as an anti-hypertensive therapy or for anti-angiogenesis	EXPERT OPINION ON BIOLOGICAL THERAPY			English	Review						angiotensin II; hypertension; vaccine; VEGF	EXPERIMENTAL RENAL-HYPERTENSION; METASTATIC COLORECTAL-CANCER; VIRUS-LIKE PARTICLES; ALZHEIMERS-DISEASE; ACTIVE IMMUNIZATION; VEGF-TRAP; BLOOD-PRESSURE; ANGIOTENSIN-I; BETA PEPTIDE; DOUBLE-BLIND	Introduction: Vaccines are used as preventive medicine for infectious diseases worldwide; however, several recent studies have indicated the potential of therapeutic vaccines for managing Alzheimer's disease or hypertension. Areas covered: The concept and history of therapeutic vaccines for hypertension are introduced. The improvement of drug compliance associated with vaccines in hypertensive patients may assist in better control of blood pressure, leading to reduced complications. Recently, groups have attempted to develop a therapeutic vaccine against hypertension. The vaccine-induced anti-angiotensin II antibodies can efficiently ameliorate high blood pressure. DNA vaccines have also been designed via a similar strategy using a plasmid vector encoding a hepatitis B core (HBc)-angiotensin II fusion protein. The immunogenic molecule (i.e., HBc) is used to provide an antigen that supports the activation of T cells in this DNA vaccine system. The platform technology can also be applied to generate a VEGF vaccine for cancer. Expert opinion: To date, several clinical studies of DNA vaccines have been conducted, but their effectiveness has not been determined. We hope that the novel concept of DNA vaccines will contribute to promoting health and medicine in the future.	[Nakagami, Hironori] Osaka Univ, United Grad Sch Child Dev, Suita, Osaka 5650871, Japan; [Nakagami, Hironori] Kanazawa Univ, Suita, Osaka 5650871, Japan; [Nakagami, Hironori] Hamamatsu Univ Sch Med, Div Vasc Med & Epigenet, Suita, Osaka 5650871, Japan; [Morishita, Ryuichi] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka 5650871, Japan	Nakagami, H (reprint author), Osaka Univ, United Grad Sch Child Dev, Div Vasc Med & Epigenet, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	nakagami@cgt.med.osaka-u.ac.jp			AnGes MG; Novartis; Shionogi; Boehringer; Rohto; Bayer	The Department of Clinical Gene Therapy is financially supported by AnGes MG, Novartis, Shionogi, Boehringer and Rohto. The Division of Vascular Medicine and Epigenetics is financially supported by Bayer. RM is a founder of AnGes MG and is a stockholder. HN was partially supported by Grants-in-Aid for Scientific Research. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.	Valdor R, 2013, SEMIN IMMUNOL, V25, P313, DOI 10.1016/j.smim.2013.10.010; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.1440-1711.2004.01286.x; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Tissot AC, 2008, LANCET, V371, P821, DOI 10.1016/S0140-6736(08)60381-5; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Ambuhl PM, 2007, J HYPERTENS, V25, P63; Gomez-Manzano C, 2008, NEURO-ONCOLOGY, V10, P940, DOI 10.1215/15228517-2008-061; Agadjanyan MG, 2005, J IMMUNOL, V174, P1580; Orgogozo JM, 2003, NEUROLOGY, V61, P46; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Dillman RO, 2011, CANCER BIOTHER RADIO, V26, P1, DOI 10.1089/cbr.2010.0902; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Pumpens P, 2001, INTERVIROLOGY, V44, P98, DOI 10.1159/000050037; Ferrer I, 2004, BRAIN PATHOL, V14, P11; Lockhart AC, 2010, J CLIN ONCOL, V28, P207, DOI 10.1200/JCO.2009.22.9237; Kane RC, 2006, CLIN CANCER RES, V12, P7271, DOI 10.1158/1078-0432.CCR-06-1249; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Brown MJ, 2004, CLIN SCI, V107, P167; Delavallee L, 2010, SWISS MED WKLY, V140, P28, DOI 10.4414/smw.2010.13108; DEODHAR SD, 1964, J EXP MED, V119, P425, DOI 10.1084/jem.119.3.425; Downham MR, 2003, BRIT J CLIN PHARMACO, V56, P505, DOI 10.1046/j.1365-2125.2003.01926.x; FRANK MH, 1963, CIRC RES, V12, P241; Gardiner SM, 2000, BRIT J PHARMACOL, V129, P1178, DOI 10.1038/sj.bjp.0703178; Hagstrom B, 2004, FAM PRACT, V21, P46; HELMER OM, 1958, CIRCULATION, V17, P648; KATZ JI, 1957, CIRC RES, V5, P137; Kyutoku M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03380; Lechner F, 2002, INTERVIROLOGY, V45, P212, DOI 10.1159/000067912; MICHEL JB, 1987, P NATL ACAD SCI USA, V84, P4346, DOI 10.1073/pnas.84.12.4346; MICHEL JB, 1990, CIRCULATION, V81, P1899; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Nakagami F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060493; Nakagami H, 2014, INT HEART J, V55, P96; PAUL S, 1974, INT ARCH ALLER A IMM, V47, P155; Pedersen AE, 2006, CANCER LETT, V235, P229, DOI 10.1016/j.canlet.2005.04.012; Plescia OJ., 1969, MICROBIOL IMMUNOL, V50, P78; SKEGGS LT, 1975, CIRC RES, V37, P715; STRASSMANN G, 1992, J IMMUNOL, V148, P3674; Teng LS, 2010, J CHIN MED ASSOC, V73, P449, DOI 10.1016/S1726-4901(10)70097-6; Unger T, 2011, EUR HEART J, V32, P2739, DOI 10.1093/eurheartj/ehr253; Verdier F, 2002, TOXICOLOGY, V174, P37, DOI 10.1016/S0300-483X(02)00055-0; WAKERLIN GE, 1958, CIRCULATION, V17, P653	46	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1471-2598	1744-7682		EXPERT OPIN BIOL TH	Expert Opin. Biol. Ther.	MAR	2015	15	3					431	436		10.1517/14712598.2015.1014791		6	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	CB7WM	WOS:000349839300012		
J	Okuyama, H; Langsjoen, PH; Hamazaki, T; Ogushi, Y; Hama, R; Kobayashi, T; Uchino, H				Okuyama, Harumi; Langsjoen, Peter H.; Hamazaki, Tomohito; Ogushi, Yoichi; Hama, Rokuro; Kobayashi, Tetsuyuki; Uchino, Hajime			Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms	EXPERT REVIEW OF CLINICAL PHARMACOLOGY			English	Article						atherosclerosis; ATP generation; coenzyme Q10; heart failure; mitochondrial toxin; selenoprotein; statin; statin cardiomyopathy; vitamin K-2	COA-REDUCTASE INHIBITORS; CORONARY-ARTERY-DISEASE; NITRIC-OXIDE SYNTHASE; DIABETES-MELLITUS; COENZYME Q(10); CHOLESTEROL LEVELS; DOSE SIMVASTATIN; ATORVASTATIN; MORTALITY; EVENTS	In contrast to the current belief that cholesterol reduction with statins decreases atherosclerosis, we present a perspective that statins may be causative in coronary artery calcification and can function as mitochondrial toxins that impair muscle function in the heart and blood vessels through the depletion of coenzyme Q(10) and 'heme A', and thereby ATP generation. Statins inhibit the synthesis of vitamin K-2, the cofactor for matrix Gla-protein activation, which in turn protects arteries from calcification. Statins inhibit the biosynthesis of selenium containing proteins, one of which is glutathione peroxidase serving to suppress peroxidative stress. An impairment of selenoprotein biosynthesis may be a factor in congestive heart failure, reminiscent of the dilated cardiomyopathies seen with selenium deficiency. Thus, the epidemic of heart failure and atherosclerosis that plagues the modern world may paradoxically be aggravated by the pervasive use of statin drugs. We propose that current statin treatment guidelines be critically reevaluated.	[Okuyama, Harumi] Nagoya City Univ, Moriyama Ku, Nagoya, Aichi 4638521, Japan; [Okuyama, Harumi] Kinjo Gakuin Univ, Inst Consumer Sci & Human Life, Moriyama Ku, Nagoya, Aichi 4638521, Japan; [Langsjoen, Peter H.] Clin Cardiol Practice, Tyler, TX 75701 USA; [Hamazaki, Tomohito] Toyama Onsen Daini Hosp, Toyama, Toyama 9398271, Japan; [Ogushi, Yoichi] Ogushi Inst Med Informat, Hiratsuka, Kanagawa 2540807, Japan; [Hama, Rokuro] Japan Inst Pharmacovigilance, Non Profit Org, Tennoji Ku, Osaka 5430002, Japan; [Kobayashi, Tetsuyuki] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan; [Uchino, Hajime] Med Corp, Minami Ku, Kumamoto 8614113, Japan	Okuyama, H (reprint author), Nagoya City Univ, Moriyama Ku, 2-1723 Omori, Nagoya, Aichi 4638521, Japan.	okuyamah@kinjo-u.ac.jp					Schlieper G, 2011, J AM SOC NEPHROL, V22, P387, DOI 10.1681/ASN.2010040339; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Nakazato R, 2012, ATHEROSCLEROSIS, V225, P148, DOI 10.1016/j.atherosclerosis.2012.08.002; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400; Knopp RH, 2006, DIABETES CARE, V29, P1478, DOI 10.1337/dc05-2415; Hamazaki T, 2013, ANN NUTR METAB, V62, P32, DOI 10.1159/000342765; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; LENAZ G, 1991, BIOMED CLIN, V6, P11; Matsuzaki M, 2002, CIRC J, V66, P1087, DOI 10.1253/circj.66.1087; Huang KC, 2003, J BIOMED SCI, V10, P396, DOI 10.1159/000071159; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Culver AL, 2012, ARCH INTERN MED, V172, P144, DOI 10.1001/archinternmed.2011.625; Okuyama H, 2011, WORLD REV NUTR DIET, V102, P124, DOI 10.1159/000327834; Suzuki T, 2008, INT HEART J, V49, P423, DOI 10.1536/ihj.49.423; FOLKERS K, 1990, P NATL ACAD SCI USA, V87, P8931, DOI 10.1073/pnas.87.22.8931; Larsen S, 2013, J AM COLL CARDIOL, V61, P44, DOI 10.1016/j.jacc.2012.09.036; Moosmann B, 2004, LANCET, V363, P892, DOI 10.1016/S0140-6736(04)15739-5; Thambidorai SK, 2011, INT J CARDIOL, V147, P438, DOI 10.1016/j.ijcard.2010.08.016; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Laufs U, 1998, CIRCULATION, V97, P1129; Langsjoen PH, 2003, BIOFACTORS, V18, P101; Schick BA, 2007, CLIN PHARMACOL THER, V81, P650, DOI 10.1038/sj.clpt.6100124; Saremi A, 2012, DIABETES CARE, V35, P2390, DOI 10.2337/dc12-0464; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bollapragada SS, 2007, BJOG-INT J OBSTET GY, V114, P917, DOI 10.1111/j.1471-0528.2007.01415.x; Bonsu Kwadwo Osei, 2013, Vasc Health Risk Manag, V9, P303, DOI 10.2147/VHRM.S44499; Booth SL, 2001, AM J CLIN NUTR, V74, P783; Chris Kaiser Cardiology, 2012, ADA STATIN USE TIED; de Lorgeril M., 2014, CHOLESTEROL STATINS; ERNSTER L, 1993, CLIN INVESTIGATOR, V71, pS60, DOI 10.1007/BF00226842; Fuhrmeister J, 2012, TOXICOL LETT, V215, P219, DOI 10.1016/j.toxlet.2012.10.010; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hartenbach W, 2008, CHOLESTERIN LUGE DAS; Ichihara K, 1999, FOLIA PHARM JPN S1, V114, p142P; Kapusta L, 2013, HEART FAIL REV, V18, P187, DOI 10.1007/s10741-012-9302-6; KEYHANI J, 1978, FEBS LETT, V93, P271, DOI 10.1016/0014-5793(78)81119-3; KOBASHIGAWA JA, 1995, NEW ENGL J MED, V333, P621, DOI 10.1056/NEJM199509073331003; KRONMAL RA, 1993, ARCH INTERN MED, V153, P1065, DOI 10.1001/archinte.153.9.1065; Langsjoen PH, 2005, BIOFACTORS, V25, P147; Lefeber DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002427; März W, 2000, J Cardiovasc Pharmacol Ther, V5, P275, DOI 10.1054/JCPT.2000.16695; Mikus CR, 2013, J AM COLL CARDIOL, V62, P709, DOI 10.1016/j.jacc.2013.02.074; MITCHELL P, 1990, HIGHLIGHTS IN UBIQUINONE RESEARCH, P77; Moosmann B, 2004, TRENDS CARDIOVAS MED, V14, P273, DOI 10.1016/j.tcm.2004.08.003; Okuyama H, 2014, LIPID TECHNOLOGY, V26, P55, DOI [10.1002/lite.201400010, DOI 10.1002/LITE.201400010]; Okuyama H, 2013, J LIPID NUTR, V22, P173; Okuyama H., 2007, PREVENTION CORONARY; Piccinini AM, 2010, MEDIAT INFLAMM, DOI 10.1155/2010/672395; Ravnskov U, 2009, FAT CHOLESTEROL ARE; SATOH K, 1995, BRIT J PHARMACOL, V116, P1894; Satoh K, 2000, J CARDIOVASC PHARM, V35, P256, DOI 10.1097/00005344-200002000-00012; Silver MA, 2004, AM J CARDIOL, V94, P1306, DOI 10.1016/j.amjcard.2004.07.121; Villalba JM, 1997, MOL ASPECTS MED, V18, pS7	56	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1751-2433	1751-2441		EXPERT REV CLIN PHAR	Expert Rev. Clin. Pharmacol.	MAR	2015	8	2					189	199		10.1586/17512433.2015.1011125		11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC0JW	WOS:000350022600005		
J	Sacco, R; Tanaka, T; Yamamoto, T; Bresci, G; Saniabadi, AR				Sacco, Rodolfo; Tanaka, Tomotaka; Yamamoto, Takayuki; Bresci, Giampaolo; Saniabadi, Abbi R.			Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders	EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY			English	Review						colonoscopy; granulocyte and monocyte apheresis; loss of mucosal tissue; mucosal biopsy; neutrophils and monocytes; neutrophil infiltration; ulcerative colitis	INFLAMMATORY-BOWEL-DISEASE; MONOCYTE ADSORPTIVE APHERESIS; PROINFLAMMATORY CD14(+)CD16(+)DR(++) MONOCYTES; CARRIER-BASED GRANULOCYTE; STEROID NAIVE PATIENTS; TUMOR-NECROSIS-FACTOR; SELECTIVE GRANULOCYTE; CROHNS-DISEASE; T-CELLS; INTESTINAL INFLAMMATION	Cytokines such as TNF- have a validated role in the immunopathogensis of ulcerative colitis (UC), and intercepting inflammatory cytokines is currently the best option for maximizing treatment efficacy. One of the major sources of inflammatory cytokines are myeloid linage leucocytes (granulocytes, monocytes), which are present in great numbers in the colonic tissue. Their selective depletion by adsorptive granulocyte, monocyte apheresis (GMA), should be therapeutic in patients with UC, although until now efficacy outcomes have been both encouraging and disappointing. The authors' view is that in patients with UC, there is an evolving scope for therapeutic opportunity based on taking away the sources of inflammatory cytokines, also considering the favorable safety profile of GMA.	[Sacco, Rodolfo; Bresci, Giampaolo] Pisa Univ Hosp, Dept Gastroenterol, Pisa, Italy; [Tanaka, Tomotaka] Akitsu Prefectural Hosp, Dept Gastroenterol, Akitsu, Hiroshima, Japan; [Yamamoto, Takayuki] Yokkaichi Social Insurance Hosp, Ctr Inflammatory Bowel Dis, Yokaichi, Mie, Japan; [Saniabadi, Abbi R.] Hamamatsu Univ Sch Med, Dept Pharmacol, Hamamatsu, Shizuoka 4313192, Japan	Sacco, R (reprint author), Pisa Univ Hosp, Dept Gastroenterol, Pisa, Italy.	r.sacco@ao-pisa.toscana.it					Allison MC, 1998, INFLAMM BOWEL DIS, P9; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283; Schreiber S, 1999, LANCET, V353, P459, DOI 10.1016/S0140-6736(98)03339-X; Hanai H, 2011, CLIN EXP IMMUNOL, V163, P50, DOI 10.1111/j.1365-2249.2010.04279.x; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra020831; Brown SL, 2002, ARTHRITIS RHEUM, V46, P3151, DOI 10.1002/art.10679; Huber S, 2004, J IMMUNOL, V173, P6526; JARNEROT G, 1985, GASTROENTEROLOGY, V89, P1005; Brannigan AE, 2000, SHOCK, V13, P361; Hanai H, 2003, CLIN GASTROENTEROL H, V1, P28, DOI 10.1053/jcgh.2003.50005; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; TRUELOVE SC, 1974, LANCET, V1, P1067; Meagher LC, 1996, J IMMUNOL, V156, P4422; Saniabadi AR, 2007, TRANSFUS APHER SCI, V37, P191, DOI 10.1016/j.transci.2007.08.003; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Liu HY, 2003, J IMMUNOL, V171, P5012; Tibble JA, 2000, GASTROENTEROLOGY, V119, P15, DOI 10.1053/gast.2000.8523; Belge KU, 2002, J IMMUNOL, V168, P3536; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; MCCARTHY DA, 1991, CLIN EXP IMMUNOL, V86, P489; Sands BE, 2008, GASTROENTEROLOGY, V135, P400, DOI 10.1053/j.gastro.2008.04.023; VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129, DOI 10.1016/0016-5085(95)90277-5; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Yokoyama Y, 2007, DIGEST DIS SCI, V52, P2725, DOI 10.1007/s10620-006-9560-z; Saniabadi AR, 2003, THER APHER DIAL, V7, P48, DOI 10.1046/j.1526-0968.2003.00012.x; Aoki H, 2007, DIGEST DIS SCI, V52, P1427, DOI 10.1007/s10620-006-9406-8; Atzeni A, 2005, ALIMENT PHARM THER, V22, P453; Cohen Russell D, 2005, Gastroenterology, V128, P235, DOI 10.1053/j.gastro.2004.11.024; D'Arrigo C, 1993, CLIN EXP IMMUNOL, V100, P173; Habermalz B, 2010, DIGEST DIS SCI, V55, P1421, DOI 10.1007/s10620-009-0845-x; Hanai H, 2008, AM J GASTROENTEROL, V103, P1210, DOI 10.1111/j.1572-0241.2007.01714.x; Hanauer SB, 2004, GASTROENTEROLOGY, V126, P1582, DOI 10.1053/j.gastro.2004.02.071; Hanauer S B, 2001, Curr Gastroenterol Rep, V3, P455, DOI 10.1007/s11894-001-0064-x; HEIMANN TM, 1985, SURG GYNECOL OBSTET, V160, P295; Hiraishi K, 2003, THER APHER DIAL, V7, P334, DOI 10.1046/j.1526-0968.2003.00049.x; Hyde GM, 1998, EUR J GASTROEN HEPAT, V10, P411, DOI 10.1097/00042737-199805000-00010; KORNBLUTH A, 1995, J CLIN GASTROENTEROL, V20, P280, DOI 10.1097/00004836-199506000-00004; O'Keefe S J, 1996, Scand J Gastroenterol Suppl, V220, P52; Powrie Fiona, 2003, Novartis Found Symp, V252, P92; Present DH, 2000, INFLAMM BOWEL DIS, V6, P48; RACHMILEWITZ D, 1989, BRIT MED J, V298, P82; Saniabadi AR, 2005, J CLIN APHERESIS, V20, P171, DOI 10.1002/jca.20046; Saniabadi AR, 2010, GASTROEN CLIN BIOL, V34, P645, DOI 10.1016/j.gcb.2010.09.003; Sartor RB, 1997, AM J GASTROENTEROL, V92, p5S; Selby W, 1997, BAILLIERE CLIN GASTR, V11, P53, DOI 10.1016/S0950-3528(97)90053-1; Serkova N, 2004, MOL INTERV, V4, P97, DOI 10.1124/mi.4.2.7; Suzuki Y, 2006, DIGEST DIS SCI, V51, P2031, DOI 10.1007/s10620-006-9199-9; Suzuki Y, 2004, DIGEST DIS SCI, V49, P565, DOI 10.1023/B:DDAS.0000026299.43792.ae; TAFFET SL, 1983, DIGEST DIS SCI, V28, P833, DOI 10.1007/BF01296907; Tanaka T, 2010, GASTROEN CLIN BIOL, V34, P687, DOI 10.1016/j.gcb.2010.08.007; Tanaka T, 2008, DIGEST LIVER DIS, V40, P731, DOI 10.1016/j.dld.2008.02.012; Uhlig HH, 2005, SPRINGER SEMIN IMMUN, V27, P167, DOI 10.1007/s00281-005-0206-6; Yoshino T, 2014, DIGEST LIVER DIS, V46, P219, DOI 10.1016/j.dld.2013.10.011	53	0	0	EXPERT REVIEWS	LONDON	UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND	1747-4124	1747-4132		EXPERT REV GASTROENT	Expert Rev. Gastroenterol. Hepatol.	MAR	2015	9	3					327	333		10.1586/17474124.2014.953060		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB9XZ	WOS:000349989100008		
J	Tsuchikawa, T; Hirano, S; Okamura, K; Matsumoto, J; Tamoto, E; Murakami, S; Nakamura, T; Ebihara, Y; Kurashima, Y; Shichinohe, T				Tsuchikawa, Takahiro; Hirano, Satoshi; Okamura, Keisuke; Matsumoto, Joe; Tamoto, Eiji; Murakami, Soichi; Nakamura, Toru; Ebihara, Yuma; Kurashima, Yo; Shichinohe, Toshiaki			Advances in the surgical treatment of hilar cholangiocarcinoma	EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY			English	Review						bile duct drainage; hilar cholangiocarcinoma; percutaneous transhepatic portal embolization; perioperative management; residual liver function; superficial spreading biliary cancer; surgical strategy	PORTAL-VEIN EMBOLIZATION; PREOPERATIVE BILIARY DRAINAGE; BILE-DUCT CARCINOMA; ENDOSCOPIC NASOBILIARY DRAINAGE; LYMPH-NODE MICROMETASTASIS; SUPERFICIAL FLAT SPREAD; PERIHILAR CHOLANGIOCARCINOMA; EXTENDED HEPATECTOMY; PROGNOSTIC IMPACT; LIVER-FUNCTION	With the improvement of perioperative management and surgical techniques as well as the accumulation of knowledge on the oncobiological behavior of bile duct carcinoma, the long-term prognosis of hilar cholangiocarcinoma has been improving. In this article, the authors review the recent developments in surgical strategies for hilar cholangiocarcinoma, focusing on diagnosis for characteristic disease extension, perioperative management to reduce postoperative morbidity and mortality, surgical techniques for extended curative resection and postoperative adjuvant therapy.	[Tsuchikawa, Takahiro; Hirano, Satoshi; Okamura, Keisuke; Matsumoto, Joe; Tamoto, Eiji; Murakami, Soichi; Nakamura, Toru; Ebihara, Yuma; Kurashima, Yo; Shichinohe, Toshiaki] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Sapporo, Hokkaido 0608638, Japan	Tsuchikawa, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, N-15 W-7, Sapporo, Hokkaido 0608638, Japan.	tsuchi-t@med.hokudai.ac.jp					Kawakami H, 2011, J HEPATO-BIL-PAN SCI, V18, P630, DOI 10.1007/s00534-011-0404-7; Hirano S, 2010, J HEPATO-BIL-PAN SCI, V17, P455, DOI 10.1007/s00534-009-0208-1; Sakamoto E, 1998, ANN SURG, V227, P405, DOI 10.1097/00000658-199803000-00013; Liu CL, 2006, BRIT J SURG, V93, P1488, DOI 10.1002/bjs.5482; Ebata T, 2012, DIGEST SURG, V29, P23, DOI 10.1159/000335718; BISMUTH H, 1992, ANN SURG, V215, P31; KINOSHITA H, 1986, WORLD J SURG, V10, P803; Kawakami H, 2011, J GASTROENTEROL, V46, P242, DOI 10.1007/s00535-010-0298-1; Igami T, 2009, ANN SURG, V249, P296, DOI 10.1097/SLA.0b013e318190a647; Okusaka T, 2010, BRIT J CANCER, V103, P469, DOI 10.1038/sj.bjc.6605779; Murakami Y, 2009, J GASTROINTEST SURG, V13, P1470, DOI 10.1007/s11605-009-0900-0; Sakuhara Y, 2012, AM J ROENTGENOL, V198, P914, DOI 10.2214/AJR.11.6515; Nagino M, 2006, ANN SURG, V243, P364, DOI 10.1097/01.sla.0000201482.11876.14; Nagino M, 2010, ANN SURG, V252, P115, DOI 10.1097/SLA.0b013e3181e463a7; Miyakawa S, 2009, J HEPATO-BILIARY-PAN, V16, P1, DOI 10.1007/s00534-008-0015-0; Ebata T, 2014, BRIT J SURG, V101, P79, DOI 10.1002/bjs.9379; Abulkhir A, 2008, ANN SURG, V247, P49, DOI 10.1097/SLA.0b013e31815f6e5b; Kawakami H, 2009, ENDOSCOPY, V41, P959, DOI 10.1055/s-0029-1215178; Schwarz RE, 2007, J GASTROINTEST SURG, V11, P158, DOI 10.1007/s11605-006-0018-6; Aoba T, 2013, ANN SURG, V257, P718, DOI 10.1097/SLA.0b013e3182822277; Kondo S, 2004, ANN SURG, V240, P95, DOI 10.1097/01.sla.0000129491.43855.6b; Hirano S, 2009, J HEPATO-BILIARY-PAN, V16, P502, DOI 10.1007/s00534-009-0093-7; Gerhards MF, 2003, WORLD J SURG, V27, P173, DOI 10.1007/s00268-002-6434-1; Ebata T, 2012, ANN SURG, V256, P297, DOI 10.1097/SLA.0b013e31826029ca; Fan ST, 2010, J HEPATO-BIL-PAN SCI, V17, P380, DOI [10.1007/s00534-009-0229-9, 10.1007/s00534-009-0228-x]; Hirano S, 2014, J HEPATO-BIL-PAN SCI, V21, P533, DOI 10.1002/jhbp.76; MAKUUCHI M, 1990, SURGERY, V107, P521; Kawashima H, 2013, ANN SURG, V257, P121, DOI 10.1097/SLA.0b013e318262b2e9; Takahashi Y, 2010, BRIT J SURG, V97, P1860, DOI 10.1002/bjs.7228; Miyazaki M, 2007, J HEPATO-BILIARY-PAN, V14, P463, DOI 10.1007/s00534-006-1195-0; Nanashima A, 2010, J HEPATO-BIL-PAN SCI, V17, P871, DOI 10.1007/s00534-010-0281-5; Nimura Y, 2008, HPB, V10, P130, DOI 10.1080/13651820801992666; Ebata T, 2014, J HEPATO-BIL-PAN SCI, V21, P550, DOI 10.1002/jhbp.80; Hirano S, 2007, J HEPATO-BILIARY-PAN, V14, P429, DOI 10.1007/s00534-006-1190-5; Hirano S, 2009, J HEPATO-BILIARY-PAN, V16, P796, DOI 10.1007/s00534-009-0107-5; KAWARADA Y, 1995, HEPATO-GASTROENTEROL, V42, P300; Kawarada Y, 1999, J GASTROINTEST SURG, V3, P369, DOI 10.1016/S1091-255X(99)80052-3; Matsumoto N, 2014, BRIT J SURG, V101, P261, DOI 10.1002/bjs.9383; Mihara K, 2013, EUR SURG RES, V51, P118, DOI 10.1159/000356368; Nagino M, 2013, ANN SURG, V258, P129, DOI 10.1097/SLA.0b013e3182708b57; Nakanishi Y, 2006, J HEPATO-BILIARY-PAN, V13, P355, DOI 10.1007/s00534-006-1092-6; Nakanishi Y, 2008, MODERN PATHOL, V21, P807, DOI 10.1038/modpathol.2008.65; Nanashima A, 2011, J SURG RES, V169, pE119, DOI 10.1016/j.jss.2011.04.034; Nimura Y, 2000, J Hepatobiliary Pancreat Surg, V7, P155, DOI 10.1007/s005340050170; Noji T, 2014, J GASTROINTEST SURG, V18, P1131, DOI 10.1007/s11605-014-2490-8; Noji T, 2008, BRIT J SURG, V95, P92, DOI 10.1002/bjs.5920; Ojima H, 2009, CANCER SCI, V100, P62, DOI 10.1111/j.1349-7006.2008.01009.x; Pang JC, 2013, J GASTROINTEST SURG, V17, P501, DOI 10.1007/s11605-012-2133-x; Ramia José M, 2013, World J Gastrointest Oncol, V5, P113, DOI 10.4251/wjgo.v5.i7.113; Ramírez-Merino Natalia, 2013, World J Gastrointest Oncol, V5, P171, DOI 10.4251/wjgo.v5.i7.171; Sasaki R, 2007, WORLD J SURG, V31, P1788, DOI 10.1007/s00268-007-9102-7; Sasaki T, 2006, J HEPATO-BILIARY-PAN, V13, P458, DOI 10.1007/s00534-005-1096-7; Sasaki Y, 2014, DIGEST DIS SCI, V59, P2314, DOI 10.1007/s10620-014-3124-4; Senda Y, 2009, WORLD J SURG, V33, P1459, DOI 10.1007/s00268-009-0025-3; Soares Kevin C, 2014, Hepatobiliary Surg Nutr, V3, P18, DOI 10.3978/j.issn.2304-3881.2014.02.05; Stockmann M, 2009, HEPATO-GASTROENTEROL, V56, P734; TSUZUKI T, 1983, ARCH SURG-CHICAGO, V118, P1147; Yonemori A, 2010, ANN SURG, V252, P99, DOI 10.1097/SLA.0b013e3181e33c0a; Yonemori A, 2010, DIGEST SURG, V28, P315; Yonemori A, 2009, BRIT J SURG, V96, P509, DOI 10.1002/bjs.6585; Zhimin Geng, 2013, Med Sci Monit, V19, P648, DOI 10.12659/MSM.889379	61	1	1	EXPERT REVIEWS	LONDON	UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND	1747-4124	1747-4132		EXPERT REV GASTROENT	Expert Rev. Gastroenterol. Hepatol.	MAR	2015	9	3					369	374		10.1586/17474124.2015.960393		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CB9XZ	WOS:000349989100012		
J	Yeap, KH; Teh, JSM; Nisar, H; Yeong, KC; Hirasawa, K				Yeap, Kim Ho; Teh, Joyce Shu Mei; Nisar, Humaira; Yeong, Kee Choon; Hirasawa, Kazuhiro			Attenuation in Superconducting Rectangular Waveguides	FREQUENZ			English	Article						superconducting waveguide; complex conductivity; attenuation; propagation constant; cutoff frequency; gap frequency	FREQUENCY-DOMAIN; PCB TRANSIENTS; FINLINE MIXER; GAP ENERGY; CONDUCTIVITY; PROPAGATION; BOUNDARY; WALLS	We present an accurate analysis on the attenuation of waves, propagating in rectangular waveguides with superconducting walls. The wavenumbers k(x) and k(y) in the x and y directions, respectively, are first obtained as roots of a set of transcendental equations developed by matching the tangential fields at the surface of the wall with the electrical properties of the wall material. The complex conductivity of the superconducting waveguide is obtained from the extended Mattis-Bardeen theory. The propagation constant k(z) is found by substituting the values of k(x) and ky into the dispersion relation. We have computed and compared the loss in the waveguides below and above the critical temperature. At frequencies above the cutoff frequency f(c) but below the gap frequency f(g), the loss in the superconducting waveguide is significantly lower than that in a normal conducting waveguide. Above the gap frequency, however, the result indicates that the attenuation in the waveguide below the critical temperature is higher than that at room temperature. We attribute the higher loss as due to the higher surface resistance and field penetration for superconducting waveguides operating above the gap frequency.	[Yeap, Kim Ho; Teh, Joyce Shu Mei; Nisar, Humaira; Yeong, Kee Choon] Tunku Abdul Rahman Univ, Fac Engn & Green Technol, Kampar 31900, Perak, Malaysia; [Hirasawa, Kazuhiro] Univ Tsukuba, Tokyo 1660001, Japan	Yeap, KH (reprint author), Tunku Abdul Rahman Univ, Fac Engn & Green Technol, Jalan Univ, Kampar 31900, Perak, Malaysia.	yeapkh@utar.edu.my; joyce_91tsm@hotmail.com; humaira@utar.edu.my; yeongkc@utar.edu.my; hirasawa@ieee.org			FRGS grant [FRGS/2/2013/SG02/UTAR/02/1]	The authors thank Dr Takashi Noguchi for his discussion. Part of this work has been supported by the FRGS grant (project: FRGS/2/2013/SG02/UTAR/02/1).	Noguchi T, 2011, IEEE T APPL SUPERCON, V21, P756, DOI 10.1109/TASC.2010.2089033; MATTIS DC, 1958, PHYS REV, V111, P412, DOI 10.1103/PhysRev.111.412; WENGLER MJ, 1992, P IEEE, V80, P1810, DOI 10.1109/5.175257; Noguchi T, 2009, PHYSICA C, V469, P1585, DOI 10.1016/j.physc.2009.05.218; Noguchi T, 2012, PHYSCS PROC, V36, P318, DOI 10.1016/j.phpro.2012.06.166; TUCKER JR, 1985, REV MOD PHYS, V57, P1055, DOI 10.1103/RevModPhys.57.1055; Carter M, 2004, P SOC PHOTO-OPT INS, V5489, P1074, DOI 10.1117/12.552538; Cheng D. K., 1989, FIELD WAVES ELECTROM; Ciovati G., 2010, PHYS REV SPEC TOP-AC, V13, P1; Collin R. E., 1991, FIELD THEORY GUIDED; Duzer T. V., 1981, PRINCIPLES SUPERCOND; Kautz P. L., 1978, J APPL PHYS, V49, P308; Kittara P., 2004, IEEE T MICROW THEORY, V52, P2353; KOOI JW, 1994, INT J INFRARED MILLI, V15, P477, DOI 10.1007/BF02096231; Kushino A, 2013, J SUPERCOND NOV MAGN, V26, P2085, DOI 10.1007/s10948-012-2053-8; MA JG, 1995, INT J INFRARED MILLI, V16, P147, DOI 10.1007/BF02085853; Mitrovic B, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/01/015215; Noguchi T, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2013.2240761; Seida O. M. A., 2003, APPL MATH COMPUT, V136, P405; Tham CY, 2003, ENG ANAL BOUND ELEM, V27, P315, DOI 10.1016/S0955-7997(02)00119-4; Tham CY, 2001, IEEE T MAGN, V37, P3676; WANG YC, 1994, INT J ELECTRON, V76, P1151, DOI 10.1080/00207219408926024; WINTERS JH, 1991, IEEE T MICROW THEORY, V39, P617, DOI 10.1109/22.76423; Withington S, 2003, ELECTRON LETT, V39, P605, DOI 10.1049/el:20030418; Withington S., 2003, PHIL T R SOC LOND, V362, P395; Wollack E., 1996, FULL WAVEGUIDE BAND; YALAMANCHILI R, 1995, INT J ELECTRON, V78, P715, DOI 10.1080/00207219508926205; Yassin G, 2001, IEEE MICROW WIREL CO, V11, P413, DOI 10.1109/7260.959313; Yassin G, 2000, IEEE T MICROW THEORY, V48, P662, DOI 10.1109/22.841957; Yassin G., 2003, P 14 INT S SPAC TER, P516; Yassin G, 1997, ELECTRON LETT, V33, P498, DOI 10.1049/el:19970314; Yeap K. H., 2013, INT J ELECT COMPUT C, V4, P21; Yeap KH, 2013, FREQUENZ, V67, P145, DOI 10.1515/freq-2012-0117; Yeap KH, 2010, RADIOENGINEERING, V19, P320; Yeap KH, 2011, RADIOENGINEERING, V20, P472; Yeap KH, 2009, FREQUENZ, V63, P236, DOI 10.1515/FREQ.2009.63.11-12.236	36	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0016-1136	2191-6349		FREQUENZ	Frequenz	MAR	2015	69	3-4					111	117		10.1515/freq-2014-0078		7	Engineering, Electrical & Electronic	Engineering	CC2LR	WOS:000350177000005		
J	Kimori, H; Yamamoto, K; Yamachika, S; Tsurumoto, A; Kamikawa, Y; Sasao, M; Morito, M; Saito, I; Ohshima, T; Maeda, N; Nakagawa, Y				Kimori, Hisato; Yamamoto, Ken; Yamachika, Shigeo; Tsurumoto, Akihisa; Kamikawa, Yoshiaki; Sasao, Mami; Morito, Mitsuhiko; Saito, Ichiro; Ohshima, Tomoko; Maeda, Nobuko; Nakagawa, Yoichi			Factors associated with the presence of atrophic tongue in patients with dry mouth	GERODONTOLOGY			English	Article						Candida; dry mouth; atrophic tongue	CANDIDA-ALBICANS; XEROSTOMIA; INVASION; PROTEIN; LESIONS	PurposeThis study aimed to identify factors associated with atrophic tongue in patients with dry mouth. MethodsDiscriminant analysis was performed in 1265 patients with dry mouth to identify factors that might influence the risk of developing atrophic tongue. The dependent variable was the presence of atrophic tongue, while patient age, resting saliva flow rate, stimulated saliva flow rate and Candida colony-forming units (CFU) were used as the independent variables. ResultsThe standardised linear discriminant coefficients showed that Candida CFU, stimulated saliva flow rate and age were significantly associated with the presence of atrophic tongue. The following linear discriminant function was obtained: z=0.024xage-0.63x(resting saliva flow rate)-0.81x(stimulated saliva flow rate)+0.002xCandida CFU-0.611. ConclusionHigh Candida CFU, low stimulated saliva flow rate and advanced age were identified as closely associated factors for the risk of development of atrophic tongue.	[Kimori, Hisato; Yamamoto, Ken; Nakagawa, Yoichi] Tsurumi Univ, Dent Hosp, Dept Clin Pathophysiol, Yokohama, Kanagawa 2308501, Japan; [Kimori, Hisato; Yamamoto, Ken; Morito, Mitsuhiko] Tsurumi Univ, Sch Dent Med, Dept Geriatr Dent, Yokohama, Kanagawa 2308501, Japan; [Yamachika, Shigeo; Nakagawa, Yoichi] Tsurumi Univ, Sch Dent Med, Dept Oral & Maxillofacial Surg, Yokohama, Kanagawa, Japan; [Tsurumoto, Akihisa] Tsurumi Univ, Sch Dent Med, Dept Community Dent, Yokohama, Kanagawa, Japan; [Kamikawa, Yoshiaki] Kagoshima Univ Hosp, Dept Oral Surg, Kagoshima, Japan; [Sasao, Mami] Tsurumi Univ, Sch Dent Med, Dept Dent Anesthesiol, Yokohama, Kanagawa, Japan; [Saito, Ichiro] Tsurumi Univ, Sch Dent Med, Dept Pathol, Yokohama, Kanagawa, Japan; [Ohshima, Tomoko; Maeda, Nobuko] Tsurumi Univ, Sch Dent Med, Dept Oral Microbiol, Yokohama, Kanagawa, Japan	Nakagawa, Y (reprint author), Tsurumi Univ, Dent Hosp, Dept Clin Pathophysiol, 2-1-3 Tsurumi, Yokohama, Kanagawa 2308501, Japan.	nakagawa-y@tsurumi-u.ac.jp					Guggenheimer J, 2003, J AM DENT ASSOC, V134, P61; Zhao XM, 2004, MICROBIOL-SGM, V150, P2415, DOI 10.1099/mic.0.26943-0; Claveau I, 2004, MATRIX BIOL, V23, P477, DOI 10.1016/j.matbio.2004.08.006; Torres SR, 2002, ORAL SURG ORAL MED O, V93, P149, DOI 10.1067/moe.2002.119738; Albrecht A, 2006, J BIOL CHEM, V281, P688, DOI 10.1074/jbc.M509297200; Ellepola ANB, 2000, CRIT REV ORAL BIOL M, V11, P172; Bartie KL, 2004, ORAL MICROBIOL IMMUN, V19, P293, DOI 10.1111/j.1399-302X.2004.00155.x; Dawes C, 2004, CARIES RES, V38, P236, DOI 10.1159/000077760; Jayatilake JAMS, 2005, J ORAL PATHOL MED, V34, P240, DOI 10.1111/j.1600-0714.2005.00307.x; Kimori H, 2009, ORAL THERAP PHARM, V28, P17; KULLAAMIKKONEN A, 1986, INT J ORAL MAX SURG, V15, P318; Leung WK, 2000, J CLIN MICROBIOL, V38, P2219; Nakagawa Y, 2011, JPN DENT SCI REV, V47, P115; Scully C, 2004, ORAL MAXILLOFACIAL M; Terai H, 2007, CLIN EXP DERMATOL, V32, P381, DOI 10.1111/j.1365-2230.2007.02383.x; Terai H, 2005, J ORAL PATHOL MED, V34, P397, DOI 10.1111/j.1600-0714.2005.00324.x; Terai H, 2009, INT J DERMATOL, V48, P371, DOI 10.1111/j.1365-4632.2009.03925.x; WRIGHT BA, 1981, ORAL SURG ORAL MED O, V51, P55, DOI 10.1016/0030-4220(81)90126-2; Yamachika S, 2010, ORAL THERAP PHARM, V29, P15	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0734-0664	1741-2358		GERODONTOLOGY	Gerodontology	MAR	2015	32	1					13	17		10.1111/ger.12045		5	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	CC0UE	WOS:000350051800003		
J	Li, T; Hasegawa, T; Yin, XY; Zhu, Y; Boote, K; Adam, M; Bregaglio, S; Buis, S; Confalonieri, R; Fumoto, T; Gaydon, D; Marcaida, M; Nakagawa, H; Oriol, P; Ruane, AC; Ruget, F; Singh, B; Singh, U; Tang, L; Tao, FL; Wilkens, P; Yoshida, H; Zhang, Z; Bouman, B				Li, Tao; Hasegawa, Toshihiro; Yin, Xinyou; Zhu, Yan; Boote, Kenneth; Adam, Myriam; Bregaglio, Simone; Buis, Samuel; Confalonieri, Roberto; Fumoto, Tamon; Gaydon, Donald; Marcaida, Manuel, III; Nakagawa, Hiroshi; Oriol, Philippe; Ruane, Alex C.; Ruget, Francoise; Singh, Balwinder-; Singh, Upendra; Tang, Liang; Tao, Fulu; Wilkens, Paul; Yoshida, Hiroe; Zhang, Zhao; Bouman, Bas			Uncertainties in predicting rice yield by current crop models under a wide range of climatic conditions	GLOBAL CHANGE BIOLOGY			English	Article						AgMIP; climate change; crop-model ensembles; Oryza sativa; yield prediction uncertainty	AIR CO2 ENRICHMENT; HIGH-TEMPERATURE STRESS; ELEVATED CO2; SPIKELET FERTILITY; NIGHT TEMPERATURE; CARBON-DIOXIDE; GROWTH; STERILITY; FACE; PRODUCTIVITY	Predicting rice (Oryza sativa) productivity under future climates is important for global food security. Ecophysiological crop models in combination with climate model outputs are commonly used in yield prediction, but uncertainties associated with crop models remain largely unquantified. We evaluated 13 rice models against multi-year experimental yield data at four sites with diverse climatic conditions in Asia and examined whether different modeling approaches on major physiological processes attribute to the uncertainties of prediction to field measured yields and to the uncertainties of sensitivity to changes in temperature and CO2 concentration [CO2]. We also examined whether a use of an ensemble of crop models can reduce the uncertainties. Individual models did not consistently reproduce both experimental and regional yields well, and uncertainty was larger at the warmest and coolest sites. The variation in yield projections was larger among crop models than variation resulting from 16 global climate model-based scenarios. However, the mean of predictions of all crop models reproduced experimental data, with an uncertainty of less than 10% of measured yields. Using an ensemble of eight models calibrated only for phenology or five models calibrated in detail resulted in the uncertainty equivalent to that of the measured yield in well-controlled agronomic field experiments. Sensitivity analysis indicates the necessity to improve the accuracy in predicting both biomass and harvest index in response to increasing [CO2] and temperature.	[Li, Tao; Marcaida, Manuel, III; Bouman, Bas] Int Rice Res Inst, Los Banos, Philippines; [Hasegawa, Toshihiro; Fumoto, Tamon] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 305, Japan; [Yin, Xinyou] Wageningen Univ, Ctr Crop Syst Anal, NL-6700 AP Wageningen, Netherlands; [Zhu, Yan; Tang, Liang] Nanjing Agr Univ, Natl Engn & Technol Ctr Informat Agr, Nanjing, Jiangsu, Peoples R China; [Boote, Kenneth] Univ Florida, Gainesville, FL USA; [Adam, Myriam; Oriol, Philippe] CIRAD, UMR AGAP, Montpellier, France; [Bregaglio, Simone; Confalonieri, Roberto] Univ Milan, DiSAA, Cassandra Lab, Milan, Italy; [Buis, Samuel; Ruget, Francoise] INRA, EMMAH UMR1114, F-84914 Avignon, France; [Gaydon, Donald] CSIRO Agr Flagship, Brisbane, Qld, Australia; [Nakagawa, Hiroshi; Yoshida, Hiroe] Natl Agr & Food Res Org, Tsukuba, Ibaraki, Japan; [Ruane, Alex C.] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Singh, Balwinder-] CIMMYT, New Delhi 110008, India; [Singh, Upendra; Wilkens, Paul] Int Fertilizer Dev Ctr, Muscle Shoals, AL 35662 USA; [Tao, Fulu] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Zhang, Zhao] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Ruget, Francoise] UAPV, EMMAH UMR1114, F-84914 Avignon, France	Hasegawa, T (reprint author), Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 305, Japan.	thase@affrc.go.jp; Xinyou.Yin@wur.nl	Gaydon, Donald /F-4608-2012		International Rice Research Institute (IRRI) through the Global Rice Science Partnership (GRiSP); NASA Modeling, Analysis, and Prediction Program	This study was partly financed by the International Rice Research Institute (IRRI) through the Global Rice Science Partnership (GRiSP). We are grateful to the members of the AgMIP Leadership team for their support and to Senthold Asseng and Frank Ewert for sharing their insights in the AgMIP Wheat team. IRRI (via Dr. Sudhir Yadav and Dr. Roland Buresh), Nanjing Agricultural University (China), and the National Institute for Agro-Environmental Sciences (Japan) kindly provided the experimental data used in this study. We acknowledge the global climate modeling groups, the Program for Climate Model Diagnosis and Intercomparison (PCMDI), and the WCRP's Working Group on Coupled Modelling (WGCM) for making the WCRP CMIP3 multi-model dataset available. Support for this dataset is provided by the Office of Science, U.S. Department of Energy. Dr. Ruane's participation in the study was supported by the NASA Modeling, Analysis, and Prediction Program.	Tao F, 2008, AGR FOREST METEOROL, V148, P94, DOI 10.1016/j.agrformet.2007.09.012; Jagadish SVK, 2007, J EXP BOT, V58, P1627, DOI 10.1093/jxb/erm003; Cheng WG, 2009, AGR FOREST METEOROL, V149, P51, DOI 10.1016/j.agrformet.2008.07.006; Kim HY, 2003, FIELD CROP RES, V83, P261, DOI 10.1016/S0378-4290(03)00076-5; Hasegawa Toshihiro, 2011, Journal of Agricultural Meteorology, V67, P225, DOI 10.2480/agrmet.67.4.3; Rosenzweig C, 2013, AGR FOREST METEOROL, V170, P166, DOI 10.1016/j.agrformet.2012.09.011; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Hatfield JL, 2011, AGRON J, V103, P351, DOI 10.2134/agronj2010.0303; SATAKE T, 1978, JPN J CROP SCI, V47, P6; Prasad PVV, 2006, FIELD CROP RES, V95, P398, DOI 10.1016/j.fcr.2005.04.008; Ziska LH, 1997, AGRON J, V89, P45; Bassu S, 2014, GLOBAL CHANGE BIOL, V20, P2301, DOI 10.1111/gcb.12520; Adachi M, 2014, PLANT CELL PHYSIOL, V55, P370, DOI 10.1093/pcp/pcu005; Yang LX, 2006, FIELD CROP RES, V98, P141, DOI 10.1016/j.fcr.2005.12.014; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Hasegawa T, 2013, FUNCT PLANT BIOL, V40, P148, DOI 10.1071/FP12357; Ainsworth EA, 2008, GLOBAL CHANGE BIOL, V14, P1642, DOI 10.1111/j.1365-2486.2008.01594.x; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Meehl GA, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Wassmann R, 2009, ADV AGRON, V102, P91, DOI 10.1016/S0065-2113(09)01003-7; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; LONG SP, 1991, PLANT CELL ENVIRON, V14, P729, DOI 10.1111/j.1365-3040.1991.tb01439.x; Asseng S, 2013, NAT CLIM CHANGE, V3, P827, DOI [10.1038/nclimate1916, 10.1038/NCLIMATE1916]; Sudhir-Yadav, 2011, FIELD CROP RES, V120, P112, DOI 10.1016/j.fcr.2010.09.002; Belder P, 2007, AGR SYST, V92, P91, DOI 10.1016/j.agsy.2006.03.001; Cho J, 2012, RICE, V5, DOI 10.1186/1939-8433-5-10; DesWit CT, 1978, SIMULATION ASSIMILAT; Easterling W. E, 2007, CLIMATE CHANGE 2007, V4, P273; Horie T, 2000, CLIMATE CHANGE AND GLOBAL CROP PRODUCTIVITY, P81, DOI 10.1079/9780851994390.0081; Kim HY, 1996, JPN J CROP SCI, V65, P634; Lin WH, 1997, PHYSIOL PLANTARUM, V99, P178, DOI 10.1034/j.1399-3054.1997.990124.x; Maclean J. L., 2002, RICE ALMANAC; Matsui T, 1997, FIELD CROP RES, V51, P213, DOI 10.1016/S0378-4290(96)03451-X; MONTEITH JL, 1977, PHILOS T ROY SOC B, V281, P277, DOI 10.1098/rstb.1977.0140; Satake T, 1976, CLIMATE RICE, P281; Shimono H, 2008, GLOBAL CHANGE BIOL, V14, P276, DOI 10.1111/j.1365-2486.2007.01498.x; Sudhir-Yadav, 2011, FIELD CROPS RES, V122, P104; VansOort PAJ, 2011, AGR FOREST METEOROL, V151, P1545; Yin XY, 1996, ANN BOT-LONDON, V77, P203, DOI 10.1006/anbo.1996.0024; Yin XY, 2013, ANN BOT-LONDON, V112, P465, DOI 10.1093/aob/mct016; Yoshimoto M., 2005, J AGR METEOROL, V60, P597; Zhang S, 2013, EUR J AGRON, V45, P165, DOI 10.1016/j.eja.2012.10.005	42	9	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-1013	1365-2486		GLOBAL CHANGE BIOL	Glob. Change Biol.	MAR	2015	21	3					1328	1341		10.1111/gcb.12758		14	Biodiversity Conservation; Ecology; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	CB8QS	WOS:000349896400025		
J	Glowacka, K; Clark, LV; Adhikari, S; Peng, JH; Stewart, JR; Nishiwaki, A; Yamada, T; Jorgensen, U; Hodkinson, TR; Gifford, J; Juvik, JA; Sacks, EJ				Glowacka, Katarzyna; Clark, Lindsay V.; Adhikari, Shivani; Peng, Junhua; Stewart, J. Ryan; Nishiwaki, Aya; Yamada, Toshihiko; Jorgensen, Uffe; Hodkinson, Trevor R.; Gifford, Justin; Juvik, John A.; Sacks, Erik J.			Genetic variation in Miscanthus x giganteus and the importance of estimating genetic distance thresholds for differentiating clones	GLOBAL CHANGE BIOLOGY BIOENERGY			English	Article						genetic diversity; genotyping error; interspecific hybrids; Miscanthus sacchariflorus; Miscanthus sinensis; RAD-seq; SSR	MICROSATELLITE MARKERS; GENOTYPING ERRORS; SYMPATRIC POPULATIONS; GENOME SIZE; SINENSIS; POACEAE; AFLP; SACCHARIFLORUS; IDENTIFICATION; THROUGHPUT	Miscanthus x giganteus (Mxg) is an important bioenergy feedstock crop, however, genetic diversity among legacy cultivars may be severely constrained. Only one introduction from Japan to Denmark of this sterile, triploid, vegetatively propagated crop was recorded in the 1930s. We sought to determine if the Mxg cultivars in North America were all synonyms, and if they were derived from the European introduction. We used 64 nuclear and five chloroplast simple sequence repeat (SSR) markers to estimate genetic similarity for 27 Mxg accessions from North America, and compared them with six accessions from Europe, including the species' type-specimen. A subset of accessions was also evaluated by restriction-site associated DNA sequencing (RAD-seq). In addition, we assessed the potential of new crosses to increase Mxg genetic diversity by comparing eight new triploid Mxg progeny grown from seed, along with samples of the parental species M. sacchariflorus and M. sinensis. Estimates of genotyping error rates were essential for distinguishing between experimental error and true genotypic differences among accessions. Given differences in estimated error rates and costs per marker for SSRs and RAD-seq, the former is currently more cost-effective for determining if two accessions are genetically identical. We concluded that all of the Mxg legacy cultivars were derived via vegetative propagation from a single genet. In contrast with the Mxg legacy cultivars, genetic similarity to the type-specimen of eight new triploid Mxg progeny ranged from 0.46 to 0.56. Though genetic diversity among the Mxg legacy cultivars is critically low, new crosses can provide much-needed variation to growers.	[Glowacka, Katarzyna; Clark, Lindsay V.; Adhikari, Shivani; Gifford, Justin; Juvik, John A.; Sacks, Erik J.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA; [Glowacka, Katarzyna] Polish Acad Sci, Inst Plant Genet, PL-60479 Poznan, Poland; [Peng, Junhua] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Hunan, Peoples R China; [Stewart, J. Ryan] Brigham Young Univ, Provo, UT 84602 USA; [Nishiwaki, Aya] Miyazaki Univ, Field Sci Ctr, Fac Agr, Miyazaki, Miyazaki 8892192, Japan; [Yamada, Toshihiko] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Kita Ku, Sapporo, Hokkaido 0600811, Japan; [Jorgensen, Uffe] Aarhus Univ, Dept Agroecol, DK-8830 Tjele, Denmark; [Hodkinson, Trevor R.] Trinity Coll Dublin, Sch Nat Sci, Dublin D2, Ireland	Sacks, EJ (reprint author), Univ Illinois, Energy Biosci Inst, 1206 W Gregory Dr, Urbana, IL 61801 USA.	esacks@illinois.edu	Yamada, Toshihiko/A-5111-2012; Clark, Lindsay/B-3165-2008	Yamada, Toshihiko/0000-0002-7845-6556; 	Energy Biosciences Institute	We wish to thank the Energy Biosciences Institute for funding this research. We also thank Dean Tiessen and Gerald van Koeverden of New Energy Farms, Stanislaw Jezowski of the Institute of Plant Genetics, Polish Academy of Science, and Brian Baldwin of Mississippi State University for providing materials used in this study.	Adati S, 1962, B FAC AGR MIE U, V25, P1; Yu JY, 2013, EUPHYTICA, V191, P455, DOI 10.1007/s10681-013-0915-1; GREEF JM, 1993, ANGEW BOT, V67, P87; Chouvarine P, 2012, PLOS ONE, V7, P168, DOI 10.1371/journal.pone.0029850; Glowacka K, 2010, IND CROP PROD, V32, P88, DOI 10.1016/j.indcrop.2010.03.009; Greef JM, 1997, GENET RESOUR CROP EV, V44, P185, DOI 10.1023/A:1008693214629; Jiang JX, 2012, AM J BOT, V99, pE230, DOI 10.3732/ajb.1100518; Cipriani G, 2010, THEOR APPL GENET, V121, P1569, DOI 10.1007/s00122-010-1411-9; Kabelka E, 2002, PHYTOPATHOLOGY, V92, P504, DOI 10.1094/PHYTO.2002.92.5.504; LINDELAURSEN I, 1993, HEREDITAS, V119, P297, DOI 10.1111/j.1601-5223.1993.00297.x; Zhao H, 2011, J INTEGR PLANT BIOL, V53, P232, DOI 10.1111/j.1744-7909.2010.01026.x; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Hung KH, 2009, CONSERV GENET, V10, P1377, DOI 10.1007/s10592-008-9699-6; Nielsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037558; Clifton-Brown JC, 2004, GLOBAL CHANGE BIOL, V10, P509, DOI 10.1111/j.1529-8817.2003.00749.x; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Swaminathan K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-142; de Cesare M, 2010, MOL BREEDING, V26, P539, DOI 10.1007/s11032-010-9451-z; Broquet T, 2004, MOL ECOL, V13, P3601, DOI 10.1111/j.1365-294X.2004.02352.x; Jain SM, 2005, PLANT CELL TISS ORG, V82, P113, DOI 10.1007/s11240-004-7095-6; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; James BT, 2012, MOL BREEDING, V30, P661, DOI 10.1007/s11032-011-9651-1; Douhovnikoff V, 2003, THEOR APPL GENET, V106, P1307, DOI 10.1007/s00122-003-1200-9; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Hodkinson TR, 2002, AM J BOT, V89, P279, DOI 10.3732/ajb.89.2.279; Nishiwaki A, 2011, AM J BOT, V98, P154, DOI 10.3732/ajb.1000258; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Chae WB, 2013, GCB BIOENERGY, V5, P338, DOI 10.1111/j.1757-1707.2012.01206.x; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Hodkinson TR, 2002, ANN BOT-LONDON, V89, P627, DOI 10.1093/aob/mcf091; Clifton-Brown JC, 2001, AGRON J, V93, P1013; LUCKETT DJ, 1989, EUPHYTICA, V42, P177, DOI 10.1007/BF00042630; Rayburn AL, 2009, PLANT MOL BIOL REP, V27, P184, DOI 10.1007/s11105-008-0070-3; Chae WB, 2014, GLOBAL CHANGE BIOL B, DOI 10.1111/gcbb.12101; Christelova P, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr024; Dewey FE, 2012, CIRCULATION, V125, P931, DOI 10.1161/CIRCULATIONAHA.110.972828; Dwiyanti MS, 2013, BIOENERG RES, V6, P486, DOI 10.1007/s12155-012-9274-3; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P1; Hedges D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008232; Hirayoshi I, 1957, RES B FACULTY AGR GI, V8, P8; Hodkinson Trevor R., 2001, Kew Bulletin, V56, P759, DOI 10.2307/4117709; Jaccard P., 1908, B SOCIETE VAUDOISE S, V44, P223, DOI DOI 10.5169/SEALS-268384; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Lasso E, 2008, MOL ECOL RESOUR, V8, P74, DOI 10.1111/j.1471-8286.2007.01910.x; MCMURPHY LM, 1991, PLANT BREEDING, V106, P190, DOI 10.1111/j.1439-0523.1991.tb00500.x; McNeill J, 2012, INT NOM ALG FUNG PLA, V154; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Rohlf FJ, 2002, NTSYS PC NUMERICAL T; Schenck S, 2004, J HERED, V95, P327, DOI 10.1093/jhered/esh052; Scurlock JMO, 1999, TM13732 ORNL; Thurber CS, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r68; TIWARI SP, 1984, CURR SCI INDIA, V53, P1262; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; Zhang DP, 2006, CROP SCI, V46, P2084, DOI 10.2135/cropsci2006.01.0004	56	9	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1757-1693	1757-1707		GCB BIOENERGY	GCB Bioenergy	MAR	2015	7	2					386	404		10.1111/gcbb.12166		19	Agronomy; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	CB8QI	WOS:000349895300021		
J	Kurotobi, T; Shimada, Y; Kino, N; Ito, K; Tonomura, D; Yano, K; Tanaka, C; Yoshida, M; Tsuchida, T; Fukumoto, H				Kurotobi, Toshiya; Shimada, Yoshihisa; Kino, Naoto; Ito, Kazato; Tonomura, Daisuke; Yano, Kentaro; Tanaka, Chiharu; Yoshida, Masataka; Tsuchida, Takao; Fukumoto, Hitoshi			Features of intrinsic ganglionated plexi in both atria after extensive pulmonary isolation and their clinical significance after catheter ablation in patients with atrial fibrillation	HEART RHYTHM			English	Article						Autonomic nervous system; Catheter ablation; Atrial fibrillation; Pulmonary vein	STELLATE GANGLION; NERVOUS-SYSTEM; VEIN ISOLATION; STIMULATION; REFRACTORINESS; CONDUCTION; VAGAL; INDUCIBILITY; DENERVATION; RECURRENCE	BACKGROUND The features of intrinsic ganglionated plexi (GP) in both atria after extensive pulmonary vein isolation (PVI) and their clinical implications have not been clarified in patients with atrial fibrillation (AF). OBJECTIVE The purpose of this study was to assess the features of GP response after extensive PVI and to evaluate the relationship between GP responses and subsequent AF episodes. METHODS The study population consisted of 216 consecutive AF patients (104 persistent AF) who underwent an initial ablation. We searched for the GP sites in both atria after an extensive PVI. RESULTS GP responses were determined in 186 of 216 patients (85.6%). In the left atrium, GP responses were observed around the right inferior GP in 116 of 216 patients (53.7%) and around the left inferior GP in 57 of 216 (26.4%). In the right atrium, GP responses were observed around the posteroseptal area: inside the CS in 64 of 216 patients (29.6%), at the CS ostium in 150 of 216 (69.4%), and in the lower right atrium in 45 of 216 (20.8%). The presence of a positive GP response was an independent risk factor for AF recurrence (hazard ratio 4.04, confidence interval 1.48-11.0) in patients with paroxysmal, but not persistent, AF. The incidence of recurrent atrial tachyarrhythmias in patients with paroxysmal AF with a positive GP response was 51% vs 8% in those without a GP response (P =.002). CONCLUSION The presence of GP responses after extensive PVI was significantly associated with increased AF recurrence after ablation in patients with paroxysmal AF.	[Kurotobi, Toshiya; Shimada, Yoshihisa; Kino, Naoto; Ito, Kazato; Tonomura, Daisuke; Yano, Kentaro; Tanaka, Chiharu; Yoshida, Masataka; Tsuchida, Takao; Fukumoto, Hitoshi] Shiroyama Hosp, Div Cardiovasc, Habikino, Osaka 5830872, Japan	Kurotobi, T (reprint author), Shiroyama Hosp, Div Cardiovasc, 2-8-1 Habikino, Habikino, Osaka 5830872, Japan.	drk21cent@gmail.com					Lemery R, 2006, HEART RHYTHM, V3, P387, DOI 10.1016/j.hrthm.2006.01.009; Patterson E, 2005, HEART RHYTHM, V2, P624, DOI 10.1016/j.hrthm.2005.02.012; ZIPES DP, 1974, CARDIOVASC RES, V8, P647, DOI 10.1093/cvr/8.5.647; Cappato R, 2003, CIRCULATION, V108, P1599, DOI 10.1161/01.CIR.0000091081.19465.F1; Lemola K, 2008, CIRCULATION, V117, P470, DOI 10.1161/CIRCULATIONAHA.107.737023; Katritsis DG, 2013, J AM COLL CARDIOL, V62, P2318, DOI 10.1016/j.jacc.2013.06.053; Po SS, 2009, J CARDIOVASC ELECTR, V20, P1186, DOI 10.1111/j.1540-8167.2009.01515.x; Hou YL, 2007, J AM COLL CARDIOL, V50, P61, DOI 10.1016/j.jacc.2007.02.066; Nakagawa H, 2009, HEART RHYTHM, V6, pS26, DOI 10.1016/j.hrthm.2009.07.029; Armour JA, 1997, ANAT REC, V247, P289, DOI 10.1002/(SICI)1097-0185(199702)247:2<289::AID-AR15>3.0.CO;2-L; Bettoni M, 2002, CIRCULATION, V105, P2753, DOI 10.1161/01.CIR.0000018443.44005.D8; Jiang RH, 2014, HEART RHYTHM, V11, P969, DOI [10.1016/j.hrthm.2014.03.015, 10.1016/j.hrthm.2014.0.3.015]; Zhou J, 2007, J CARDIOVASC ELECTR, V18, P83, DOI 10.1111/j.1540-8167.2006.00679.x; Po SS, 2006, HEART RHYTHM, V3, P201, DOI 10.1016/j.hrthm.2005.11.008; Ogawa M, 2007, J AM COLL CARDIOL, V50, P335, DOI 10.1016/j.jacc.2007.03.045; Scherlag BJ, 2005, J INTERV CARD ELECTR, V13, P37, DOI 10.1007/s10840-005-2492-2; Lu ZB, 2009, CARDIOVASC RES, V84, P245, DOI 10.1093/cvr/cvp194; Pappone C, 2004, CIRCULATION, V109, P327, DOI 10.1161/01.CIR.0000112641.16340.C7; LAZZARA R, 1973, CIRC RES, V32, P393; Lemola K, 2004, HEART RHYTHM, V1, P197, DOI 10.1016/j.hrthm.2004.03.071; Pokushalov E, PACING CLIN ELECTROP, V20-10, P1231; Schauerte P, 2001, J CARDIOVASC ELECTR, V12, P592, DOI 10.1046/j.1540-8167.2001.00592.x	22	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	MAR	2015	12	3					470	476		10.1016/j.hrthm.2014.11.033		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CB9QF	WOS:000349966100003		
J	Watanabe, Y; Nakano, Y; Hidaka, T; Oda, N; Kajihara, K; Tokuyama, T; Uchimura, Y; Sairaku, A; Motoda, C; Fujiwara, M; Kawazoe, H; Matsumura, H; Kihara, Y				Watanabe, Yoshikazu; Nakano, Yukiko; Hidaka, Takayuki; Oda, Noboru; Kajihara, Kenta; Tokuyama, Takehito; Uchimura, Yuko; Sairaku, Akinori; Motoda, Chikaaki; Fujiwara, Mai; Kawazoe, Hiroshi; Matsumura, Hiroya; Kihara, Yasuki			Mechanical and substrate abnormalities of the left atrium assessed by 3-dimensional speckle-tracking echocardiography and electroanatomic mapping system in patients with paroxysmal atrial fibrillation	HEART RHYTHM			English	Article						Left atrium; Atrial fibrillation; Electroanatomic mapping; Speckle-tracking echocardiography; Conduction delay; Dyssynchrony; Remodeling	DELAYED-ENHANCEMENT; PULMONARY VEINS; CATHETER ABLATION; CONDUCTION; QUANTIFICATION; CORRELATE; FAILURE; VOLTAGE; STRAIN	BACKGROUND Left atrial (LA) remodeling progresses to electrical remodeling, contractile remodeling, and subsequently structural remodeling. Little is known about the relationship between LA electrical and anatomical remodeling and LA mechanical function. OBJECTIVES We aimed to clarify the relationship between LA mechanical function using 3-dimensional speckle-tracking echo-cardiography (3D-STE) and LA electrical remodeling using an electroanatomic mapping system (CART0 3) and to estimate atrial fibrillation (AF) substrate in patients with paroxysmal AF (PAF). METHODS A total of 52 patients with PAF (41 (79%) men; mean age 61 +/- 11 years) undergoing their initial pulmonary vein isolation (PVI) were examined. The standard deviation of the time to peak strain in each LA segment (%SD-TPS) was analyzed as an index of LA dyssynchrony using 3D-STE before PVI. Contact LA bipolar voltage and activation maps were constructed during sinus rhythm before PVI using CART0 3. The LA total activation time was measured and low-voltage zones (LVZs) were determined with a local bipolar electrogram amplitude of <0.5 mV. The patients were divided into those with an LVZ (LVZ group; n = 23) and those without an LVZ (non-LVZ group; n = 29). RESULTS The %SD-TPS was significantly higher (14.1 +/- 5.7 vs 8.0 +/- 5.1; P =.0002) in the LVZ group than in the non-LVZ group and was an independent determinant of the LVZ (odds ratio 1.21; 95% confidence interval 1.04-1.49; P =.01). In addition, the LA total activation time was weakly correlated with the %SD-TPS. CONCLUSION LA dyssynchrony and conduction delay exist in patients with PAF. The 3D-STE enabled noninvasive estimation of LA electrical remodeling and AF substrate.	[Watanabe, Yoshikazu; Nakano, Yukiko; Hidaka, Takayuki; Oda, Noboru; Kajihara, Kenta; Tokuyama, Takehito; Uchimura, Yuko; Sairaku, Akinori; Motoda, Chikaaki; Fujiwara, Mai; Kawazoe, Hiroshi; Matsumura, Hiroya; Kihara, Yasuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiol Med, Hiroshima 7348551, Japan	Nakano, Y (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	nakanoy@hiroshima-u.ac.jp					Lalani GG, 2012, J AM COLL CARDIOL, V59, P595, DOI 10.1016/j.jacc.2011.10.879; Miyamoto K, 2009, EUROPACE, V11, P1597, DOI 10.1093/europace/eup352; Teh AW, 2011, J CARDIOVASC ELECTR, V22, P1083, DOI 10.1111/j.1540-8167.2011.02089.x; Blume GG, 2011, EUR J ECHOCARDIOGR, V12, P421, DOI 10.1093/ejechocard/jeq175; Kuppahally SS, 2010, AM HEART J, V160, P877, DOI 10.1016/j.ahj.2010.07.003; Stiles MK, 2009, J AM COLL CARDIOL, V53, P1182, DOI 10.1016/j.jacc.2008.11.054; Vianna-Pinton R, 2009, J AM SOC ECHOCARDIOG, V22, P299, DOI 10.1016/j.echo.2008.12.017; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Kuppahally SS, 2010, CIRC-CARDIOVASC IMAG, V3, P231, DOI 10.1161/CIRCIMAGING.109.865683; Gupta DK, 2014, EUR HEART J, V35, P1457, DOI 10.1093/eurheartj/eht500; Chadaide S, 2013, ECHOCARDIOGR-J CARD, V30, P1078, DOI 10.1111/echo.12218; Mochizuki A, 2013, J AM SOC ECHOCARDIOG, V26, P165, DOI 10.1016/j.echo.2012.10.003; Verma A, 2005, J AM COLL CARDIOL, V45, P285, DOI 10.1016/j.jacc.2004.10.035; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Ouyang FF, 2004, CIRCULATION, V110, P2090, DOI 10.1161/01.CIR.0000144459.37455.EE; Pytkowski M, 2008, EUROPACE, V10, P1415, DOI 10.1093/europace/eun282; Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Lo LW, 2007, J CARDIOVASC ELECTR, V18, P258, DOI 10.1111/j.1540-8167.2007.00719.x; Kostin S, 2002, CARDIOVASC RES, V54, P361, DOI 10.1016/S0008-6363(02)00273-0; Oakes RS, 2009, CIRCULATION, V119, P1758, DOI 10.1161/CIRCULATIONAHA.108.811877; Li DS, 1999, CIRCULATION, V100, P87; Cameli M, 2012, INT J CARDIOVAS IMAG, V28, P1663, DOI 10.1007/s10554-011-9987-y; Her AY, 2012, KOREAN CIRC J, V42, P311, DOI 10.4070/kcj.2012.42.5.311; Lin YZ, 2014, J INTERV CARD ELECTR, V39, P57, DOI 10.1007/s10840-013-9838-y; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Sánchez-Quintana Damián, 2012, Curr Cardiol Rev, V8, P310; Shin SY, 2011, ECHOCARDIOGR-J CARD, V28, P44, DOI 10.1111/j.1540-8175.2010.01271.x; Sung SH, 2008, J CARDIOVASC ELECTR, V19, P165, DOI 10.1111/j.1540-8167.2007.00982.x; Tsai WC, 2009, J CARDIOVASC ELECTRO	29	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	MAR	2015	12	3					490	497		10.1016/j.hrthm.2014.12.007		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CB9QF	WOS:000349966100006		
J	Tse, HF; Turner, S; Sanders, P; Okuyama, Y; Fujiu, K; Cheung, CW; Russo, M; Green, MDS; Yiu, KH; Chen, P; Shuto, C; Lau, EOY; Siu, CW				Tse, Hung-Fat; Turner, Stuart; Sanders, Prashanthan; Okuyama, Yuji; Fujiu, Katsuhito; Cheung, Chi-Wai; Russo, Marc; Green, Matthew D. S.; Yiu, Kai-Hang; Chen, Peter; Shuto, Chika; Lau, Elizabeth O. Y.; Siu, Chung-Wah			Thoracic Spinal Cord Stimulation for Heart Failure as a Restorative Treatment (SCS HEART study): First-in-man experience	HEART RHYTHM			English	Article						Spinal cord stimulation; Heart failure	LEFT-VENTRICULAR FUNCTION; AUTONOMIC NERVOUS-SYSTEM; SEVERE ANGINA-PECTORIS; CARDIAC RESYNCHRONIZATION; MYOCARDIAL-INFARCTION; TRIAL; ARRHYTHMIAS; MODEL; THERAPY; DISEASE	BACKGROUND Preclinical studies suggest that neuromodulation with thoracic spinal cord stimulation (SCS) improves left ventricular (LV) function and remodeling in systolic heart failure (HF). OBJECTIVE The purpose of this study was to evaluate the safety and efficacy of a SCS system for the treatment of systolic HF. METHODS We performed a prospective, multicenter pilot trial in patients with New York Heart Association (NYHA) class III HF, left ventricular ejection fraction (LVEF) 20%-35%, and implanted defibrillator device who were prescribed stable optimal medical therapy. Dual thoracic SCS leads were used at the T-1-T-3 level. The device was programmed to provide SCS for 24 hours per day (50 Hz at pulse width 200 mu s). RESULTS We enrolled 22 patients from 5 centers:17 patients underwent implantation of a SCS device and 4 patients who did not fulfill the study criteria served as nontreated controls. No deaths or device-device interactions were noted during the 6-month period in the 17 SCS-treated patients. Fifteen of 17 completed the efficacy endpoint assessments: composite score improved by 4.2 +/- 1.3, and 11 patients (73%) showed improvement in >= 4 of 6 efficacy parameters. There was significant improvement in NYHA class (3.0 vs 2.1, P = .002; 13/17 improved); Minnesota Living with Heart Failure Questionnaire (42 +/- 26 vs 27 +/- 22, P = .026; 12/17 improved); peak maximum oxygen consumption (14.6 +/- 3.3 vs 16.5 +/- 3.9 mL/kg/min, P = .013; 10/15 improved); LVEF (25% +/- 6% vs 37% +/- 8%, P < .001; 14/16 improved); and LV end-systolic volume (174 +/- 57 vs 137 +/- 37 mL, P = .002; 11/16 improved) but not in N-terminal prohormone brain natriuretic peptide. No such improvements were observed in the 4 nontreated patients. CONCLUSION The results of this first-in-human trial suggest that high thoracic SCS is safe and feasible and potentially can improve symptoms, functional status, and LV function and remodeling in patients with severe, symptomatic systolic HF.	[Tse, Hung-Fat; Cheung, Chi-Wai; Yiu, Kai-Hang; Siu, Chung-Wah] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Turner, Stuart] John Hunter Hosp, Newcastle, NSW, Australia; [Sanders, Prashanthan] Univ Adelaide, Ctr Heart Rhythm Disorders, Adelaide, SA, Australia; [Okuyama, Yuji] Osaka Univ Hosp, Osaka 553, Japan; [Fujiu, Katsuhito] Tokyo Univ Hosp, Tokyo 113, Japan; [Russo, Marc] Hunter Pain Clin, Newcastle, NSW, Australia; [Green, Matthew D. S.] Ashford Private Hosp, Pain Med South Australia, Welland, Australia; [Chen, Peter; Shuto, Chika; Lau, Elizabeth O. Y.] St Jude Med Inc, Irvine, CA USA	Tse, HF (reprint author), Univ Hong Kong, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China.	hftse@hkucc.hku.hk	Siu, Chung Wah/C-6947-2011; Sanders, Prashanthan/D-7641-2013	Sanders, Prashanthan/0000-0003-3803-8429	Center for Innovation and Strategic Collaboration (CISC), St Jude Medical Inc, USA	This study was funded by the Center for Innovation and Strategic Collaboration (CISC), St Jude Medical Inc, USA. Drs. Tse, Sanders, Okuyama,Fujiu, Yiu, and Siu received an honorarium and research grant from the CISC, St Jude Medical Inc, USA. ClinicalTrials.gov identifier NCT01362725.	Lopshire JC, 2014, J CARDIOVASC TRANSL, V7, P321, DOI 10.1007/s12265-014-9547-7; Hajjar RJ, 2008, J CARD FAIL, V14, P355, DOI 10.1016/j.cardfail.2008.02.005; Lopshire JC, 2009, CIRCULATION, V120, P286, DOI 10.1161/CIRCULATIONAHA.108.812412; Schwartz PJ, 2011, HEART FAIL REV, V16, P101, DOI 10.1007/s10741-010-9179-1; De Ferrari GM, 2011, EUR HEART J, V32, P847, DOI 10.1093/eurheartj/ehq391; Shen MJ, 2014, CIRC RES, V114, P1004, DOI 10.1161/CIRCRESAHA.113.302549; Grimaldi R, 2012, HEART RHYTHM, V9, P1884, DOI 10.1016/j.hrthm.2012.08.007; Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061; Olshansky B, 2008, CIRCULATION, V118, P863, DOI 10.1161/CIRCULATIONAHA.107.760405; Liu Y, 2012, J CARDIOVASC ELECTR, V23, P534, DOI 10.1111/j.1540-8167.2011.02230.x; Cohn J, 2009, J CARD FAIL, V15, P199, DOI 10.1016/j.cardfail.2008.10.029; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Foreman RD, 2000, CARDIOVASC RES, V47, P367, DOI 10.1016/S0008-6363(00)00095-X; Issa ZF, 2005, CIRCULATION, V111, P3217, DOI 10.1161/CIRCULATIONAHA.104.507897; Schwartz PJ, 2008, EUR J HEART FAIL, V10, P884, DOI 10.1016/j.ejheart.2008.07.016; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Olgin JE, 2002, J CARDIOVASC ELECTR, V13, P475, DOI 10.1046/j.1540-8167.2002.00475.x; Lanza GA, 2012, NEUROMODULATION, V15, P542, DOI 10.1111/j.1525-1403.2012.00430.x; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Wu MY, 2008, AUTON NEUROSCI-BASIC, V138, P9, DOI 10.1016/j.autneu.2007.11.001; Brodison A, 1999, LANCET, V354, P1748, DOI 10.1016/S0140-6736(99)00296-2; CHANDLER MJ, 1993, EUR HEART J, V14, P96; Eliasson T, 1996, PAIN, V65, P169, DOI 10.1016/0304-3959(95)00238-3; Gersbach PA, 2001, ANN THORAC SURG, V72, pS1100, DOI 10.1016/S0003-4975(01)02950-2; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; KUJACIC V, 1993, EUR HEART J, V14, P1238; Lopshire JC, 2012, CURR CARDIOL REP, V14, P593, DOI 10.1007/s11886-012-0292-8; MANNHEIMER C, 1993, BRIT MED J, V307, P477; MURPHY DF, 1987, PAIN, V28, P365, DOI 10.1016/0304-3959(87)90070-4; Savoye C, 2006, AM J CARDIOL, V98, P1144, DOI 10.1016/j.amjcard.2006.06.011; Singh JP, 2014, EUR HEART J, V35, P77, DOI 10.1093/eurheartj/eht436; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685; Zhou W, 2013, AM J PHYSIOL-HEART C, V304, pH840, DOI 10.1152/ajpheart.00695.2012; Zipes DP, VENTRICULAR FUNCTION	35	7	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	MAR	2015	12	3					588	595		10.1016/j.hrthm.2014.12.014		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CB9QF	WOS:000349966100022		
J	Miyamoto, K; Aiba, T; Kimura, H; Hayashi, H; Ohno, S; Yasuoka, C; Tanioka, Y; Tsuchiya, T; Yoshida, Y; Hayashi, H; Tsuboi, I; Nakajima, I; Ishibashi, K; Okamura, H; Noda, T; Ishihara, M; Anzai, T; Yasuda, S; Miyamoto, Y; Kamakura, S; Kusano, K; Ogawa, H; Horie, M; Shimizu, W				Miyamoto, Koji; Aiba, Takeshi; Kimura, Hiromi; Hayashi, Hideki; Ohno, Seiko; Yasuoka, Chie; Tanioka, Yoshihito; Tsuchiya, Takeshi; Yoshida, Yoko; Hayashi, Hiroshi; Tsuboi, Ippei; Nakajima, Ikutaro; Ishibashi, Kohei; Okamura, Hideo; Noda, Takashi; Ishihara, Masaharu; Anzai, Toshihisa; Yasuda, Satoshi; Miyamoto, Yoshihiro; Kamakura, Shiro; Kusano, Kengo; Ogawa, Hisao; Horie, Minoru; Shimizu, Wataru			Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations	HEART RHYTHM			English	Article						Andersen-Tawil syndrome; Long QT; Flecainide; Ventricular arrhythmia; Mutation	PERIODIC PARALYSIS; CARDIAC EXCITABILITY; U-WAVE; TACHYCARDIA; KIR2.1; MODEL; CARDIOMYOPATHY; RECTIFICATION; VERAPAMIL; GENOTYPE	BACKGROUND Andersen-Tawil syndrome (ATS) is an autosomal dominant genetic or sporadic disorder characterized by ventricular arrhythmias (VAs), periodic paralyses, and dysmorphic features. The optimal pharmacological treatment of VAs in patients with ATS remains unknown. OBJECTIVE We evaluated the efficacy and safety of flecainide for VAs in patients with ATS with KCNJ2 mutations. METHODS Ten ATS probands (7 females; mean age 27 +/- 11 years) were enrolled from 6 institutions. All of them had bidirectional VAs in spite of treatment with beta-blockers (n = 6), but none of them had either aborted cardiac arrest or family history of sudden cardiac death. Twenty-four-hour Hotter recording and treadmill exercise test (TMT) were performed before (baseline) and after oral flecainide therapy (150 +/- 46 mg/d). RESULTS Twenty-four-hour Hotter recordings demonstrated that oral flecainide treatment significantly reduced the total number of VAs (from 38,407 +/- 19,956 to 11,196 +/- 14,773 per day; P = .003) and the number of the longest ventricular salvos (23 +/- 19 to 5 +/- 5; P = .01). At baseline, TMT induced nonsustained ventricular tachycardia (n = 7) or couplets of premature ventricular complex (n = 2); treatment with flecainide completely (n = 7) or partially (n = 2) suppressed these exercise-induced VAs (P = .008). In contrast, the QRS duration, QT interval, and U-wave amplitude of the electrocardiogram were not altered by flecainide therapy. During a mean follow-up of 23 +/- 11 months, no patients developed syncope or cardiac arrest after oral flecainide treatment. CONCLUSION This multicenter study suggests that oral flecainide therapy is an effective and safe means of suppressing VAs in patients with ATS with KCNJ2 mutations, though the U-wave amplitude remained unchanged by flecainide.	[Miyamoto, Koji; Aiba, Takeshi; Nakajima, Ikutaro; Ishibashi, Kohei; Okamura, Hideo; Noda, Takashi; Ishihara, Masaharu; Anzai, Toshihisa; Yasuda, Satoshi; Kamakura, Shiro; Kusano, Kengo; Ogawa, Hisao; Shimizu, Wataru] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka 5658565, Japan; [Miyamoto, Koji; Okamura, Hideo; Ishihara, Masaharu; Anzai, Toshihisa; Yasuda, Satoshi; Kusano, Kengo; Shimizu, Wataru] Kumamoto Univ, Grad Sch Med Sci, Dept Adv Cardiovasc Med, Kumamoto, Japan; [Kimura, Hiromi; Hayashi, Hideki; Ohno, Seiko; Horie, Minoru] Shiga Univ Med Sci, Dept Cardiovasc & Resp Med, Otsu, Shiga 52021, Japan; [Yasuoka, Chie; Tanioka, Yoshihito] Omura Municipal Hosp, Dept Cardiol, Omura, Japan; [Tsuchiya, Takeshi] EP Expert Doctors Team Tsuchiya, Kumamoto, Japan; [Yoshida, Yoko] Osaka City Gen Hosp, Dept Pediat Electrophysiol, Osaka, Japan; [Hayashi, Hiroshi; Tsuboi, Ippei; Shimizu, Wataru] Nippon Med Sch, Dept Cardiovasc Med, Tokyo 113, Japan; [Miyamoto, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka 5658565, Japan; [Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan	Aiba, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Div Arrhythmia & Electrophysiol, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	aiba@hsp.ncvc.go.jp; wshimizu@nms.ac.jp	Anzai, Toshihisa/J-2179-2015	Anzai, Toshihisa/0000-0003-3319-4967	Ministry of Education, Culture, Spoils, Science and Technology (MEXT) of Japan [22136011 A02, 24591086]; Research Grant for Cardiovascular Diseases from the Ministry of Health, Labor and Welfare, Japan [H24-033, H26-040]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas Want no. 22136011 A02, to Dr Aiba), a Grant-in-Aid for Scientific Research (C) (grant no. 24591086, to Dr Aiba) from the Ministry of Education, Culture, Spoils, Science and Technology (MEXT) of Japan, and a Research Grant for Cardiovascular Diseases (grant nos. H24-033 and H26-040, to Dr Aiba, Dr Miyamoto, Dr Kamakura, Dr Hone, and Dr Shimizu) from the Ministry of Health, Labor and Welfare, Japan.	Ai T, 2002, CIRCULATION, V105, P2592, DOI 10.1161/01.CIR.0000019906.35135.A3; Radwanski PB, 2011, CARDIOVASC RES, V92, P57, DOI 10.1093/cvr/cvr180; Zhang L, 2005, CIRCULATION, V111, P2720, DOI 10.1161/CIRCULATIONAHA.104.472498; Schoonderwoerd BA, 2006, HEART RHYTHM, V3, P1346, DOI 10.1016/j.hrthm.2006.07.021; Donaldson MR, 2004, ANN MED, V36, P92, DOI 10.1080/17431380410032490; Nguyen HL, 2013, INT J CARDIOL, V170, P1, DOI 10.1016/j.ijcard.2013.10.010; Caballero R, 2010, P NATL ACAD SCI USA, V107, P15631, DOI 10.1073/pnas.1004021107; Peters S, 2007, EUROPACE, V9, P162, DOI 10.1093/europace/eul188; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Nichols CG, 1996, CIRC RES, V78, P1; Dhamoon AS, 2005, HEART RHYTHM, V2, P316, DOI 10.1016/j.hrthm.2004.11.012; Silva J, 2003, CIRC RES, V92, P261, DOI 10.1161/01.RES.0000057996.20414.C6; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Kokunai Y, 2014, NEUROLOGY, V82, P1058, DOI 10.1212/WNL.0000000000000239; Watanabe H, 2013, HEART RHYTHM, V10, P542, DOI 10.1016/j.hrthm.2012.12.035; Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942; Tristani-Firouzi M, 2010, PFLUG ARCH EUR J PHY, V460, P289, DOI 10.1007/s00424-010-0820-6; Kawamura M, 2013, CIRC J, V77, P1705, DOI 10.1253/circj.CJ-12-1460; Bokenkamp R, 2007, HEART RHYTHM, V4, P508, DOI 10.1016/j.hrthm.2006.12.031; ANDERSEN ED, 1971, ACTA PAEDIATR SCAND, V60, P559, DOI 10.1111/j.1651-2227.1971.tb06990.x; Surawicz B, 1998, J CARDIOVASC ELECTR, V9, P1117, DOI 10.1111/j.1540-8167.1998.tb00890.x; Delannoy E, 2013, EUROPACE, V15, P1805, DOI 10.1093/europace/eut160; Erdogan O, 2008, J ELECTROCARDIOL, V41, P325, DOI 10.1016/j.jelectrocard.2008.02.023; Fox DJ, 2008, EUROPACE, V10, P1006, DOI 10.1093/europace/eun180; Janson CM, 2014, HEART RHYTHM, V11, P318, DOI 10.1016/j.hrthm.2013.11.003; Kannankeril PJ, 2004, J CARDIOVASC ELECTR, V15, P119, DOI 10.1046/j.1540-8167.2004.03369.x; KIMURA H, 2012, FOLIA PHARMACOL JPN, V139, P5; Lopatin AN, 2001, J MOL CELL CARDIOL, V33, P625, DOI 10.1006/jmcc.2001.1344; MCMANIS PG, 1986, MUSCLE NERVE, V9, P704, DOI 10.1002/mus.880090805; Pellizzon OA, 2008, J CARDIOVASC ELECTR, V19, P95, DOI 10.1111/j.1540-8167.2007.00910.x; Radwanski PB, 2010, HEART RHYTHM, V7, P1428, DOI 10.1016/j.hrthm.2010.03.044; Smith Andrew H, 2006, Indian Pacing Electrophysiol J, V6, P32; Sumitomo N, 2008, HEART RHYTHM, V5, P498, DOI 10.1016/j.hrthm.2007.12.012; TAWIL R, 1994, ANN NEUROL, V35, P326, DOI 10.1002/ana.410350313; Tristani-Firouzi M, 2002, J CLIN INVEST, V110, P381, DOI 10.1172/JCI200215183	35	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	MAR	2015	12	3					596	603		10.1016/j.hrthm.2014.12.009		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CB9QF	WOS:000349966100023		
J	Takahiro, T; Kou, S; Toshinobu, Y; Yuichi, H				Takahiro, Tanabe; Kou, Suzuki; Toshinobu, Yamagishi; Yuichi, Hamabe			Accidental hypothermia-induced electrical storm successfully treated with isoproterenol	HEART RHYTHM			English	Article						Accidental hypothermia; Ventricular fibrillation; Early repolarization; Electric storm; Isoproterenol	J WAVE SYNDROMES; BRUGADA-SYNDROME; VENTRICULAR-FIBRILLATION; EARLY REPOLARIZATION; MECHANISMS		[Takahiro, Tanabe; Toshinobu, Yamagishi; Yuichi, Hamabe] Tokyo Metropolitan Bokutoh Hosp, Tertiary Emergency Med Ctr, Tokyo 1308575, Japan; [Kou, Suzuki] Tokyo Metropolitan Bokutoh Hosp, Dept Cardiol, Tokyo 1308575, Japan	Takahiro, T (reprint author), Tokyo Metropolitan Bokutoh Hosp, Tertiary Emergency Med Ctr, Sumida Ku, 4-23-15 Kotobashi, Tokyo 1308575, Japan.	tanestht@yahoo.co.jp					Antzelevitch C, 2012, CIRC J, V76, P1054, DOI 10.1253/circj.CJ-12-0284; Antzelevitch C, 2010, HEART RHYTHM, V7, P549, DOI 10.1016/j.hrthm.2009.12.006; Haissaguerre M, 2009, J AM COLL CARDIOL, V53, P612, DOI 10.1016/j.jacc.2008.10.044; Maury P, 2004, EUROPACE, V6, P130, DOI 10.1016/j.eupc.2003.11.009; Soar J, 2010, RESUSCITATION, V81, P1400, DOI 10.1016/j.resuscitation.2010.08.015; ANTZELEVITCH C, 1991, CIRC RES, V69, P1427; Watanabe A, 2006, EUR HEART J, V27, P1579, DOI 10.1093/eurheartj/ehl060; Yan GX, 1999, CIRCULATION, V100, P1660; Gurabi Z, 2014, CIRC-ARRHYTHMIA ELEC, V7, P134, DOI 10.1161/CIRCEP.113.000919; OSBORN JJ, 1953, AM J PHYSIOL, V175, P389; Higuchi S, 2013, CIRC J, V78, P128; Lienhart Hannes G, 2005, Pediatr Crit Care Med, V6, P486, DOI 10.1097/01.PCC.0000163673.40424.E7; Winegard Charles, 1997, Journal of Emergency Medicine, V15, P629, DOI 10.1016/S0736-4679(97)00139-X; Wira CR, 2008, RESUSCITATION, V78, P21, DOI 10.1016/j.resuscitation.2008.01.025	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	MAR	2015	12	3					644	647		10.1016/j.hrthm.2014.11.020		4	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CB9QF	WOS:000349966100031		
J	Mitbavkar, S; Saino, T				Mitbavkar, Smita; Saino, Toshiro			Diurnal variability of Synechococcus abundance in Sagami Bay, Japan	HYDROBIOLOGIA			English	Article						Picophytoplankton; Synechococcus; Cell cycle; Sagami Bay; Diurnal variation	NORTHWESTERN MEDITERRANEAN-SEA; EQUATORIAL PACIFIC; CELL-CYCLE; SURFACE WATERS; PICOPHYTOPLANKTON ABUNDANCE; PHOTOSYNTHETIC PROKARYOTE; MARINE-PHYTOPLANKTON; PICOPLANKTON; GROWTH; PROCHLOROCOCCUS	Synechococcus, the most dominant picophytoplankton in coastal regions, exhibits diurnal variations in the open ocean. The aim of this study was to assess its short-term population dynamics and cell cycle phases through DNA analysis in a coastal region (Sagami Bay, Japan) by sampling at fixed intervals vertically across the euphotic zone. Day-to-day variations in physical processes such as mixing, induced by wind, and advective events played an important role in structuring Synechococcus population. Compared to sub-surface population, surface cells entered S phase earlier in the day and were arrested and accumulated in the S phase for a longer time suggesting an inhibitory effect by higher irradiance. Increase of G(2)-phase cells during the dark suggests progression of cells through S phase in absence of light. Although the length of G(2)-phase was not known, subsequent increase in G(1)-phase cells in the early morning and late evening suggests occurrence of two cohorts of cells which divided in the dark phase or late evening of the cycle. This study showed that the population responds differently across the euphotic zone depending on the physical structure of the water column and its cell cycle phases are controlled by the vertical irradiance availability.	[Mitbavkar, Smita] Natl Inst Oceanog, Council Sci & Ind Res, Panaji 403004, Goa, India; [Saino, Toshiro] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Res Inst Global Change, Yokosuka, Kanagawa 2370061, Japan	Mitbavkar, S (reprint author), Natl Inst Oceanog, Council Sci & Ind Res, Panaji 403004, Goa, India.	mitbavkars@nio.org			Japan Science and Technology Agency (JST)	We thank the captain and crew of the R/V Tansei Maru of Japan Agency for Marine-Earth Science and Technology (JAMSTEC) for their immense help. This study was conducted under Solution Oriented Research for Science and Technology (SORST) program funded by Japan Science and Technology Agency (JST). The first author is grateful to the Director and Dr. A.C. Anil, chief scientist, CSIR-National Institute of Oceanography, Dona Paula, Goa for support and encouragement. The authors thank the anonymous reviewers for their valuable suggestions that helped to improve the manuscript. This is the National Institute of Oceanography contribution # 5680.	Veldhuis MJW, 2001, EUR J PHYCOL, V36, P167, DOI 10.1017/S0967026201003110; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106; VAULOT D, 1995, SCIENCE, V268, P1480, DOI 10.1126/science.268.5216.1480; Tsai AY, 2005, LIMNOL OCEANOGR, V50, P1221; Mann EL, 2000, LIMNOL OCEANOGR, V45, P1067; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Kondo T, 1997, SCIENCE, V275, P224, DOI 10.1126/science.275.5297.224; VAULOT D, 1992, DEEP-SEA RES, V39, P727, DOI 10.1016/0198-0149(92)90117-C; Brussaard CPD, 1999, J PHYCOL, V35, P941, DOI 10.1046/j.1529-8817.1999.3550941.x; Marie D, 1997, APPL ENVIRON MICROB, V63, P186; Jacquet S, 1998, LIMNOL OCEANOGR, V43, P1916; Vaulot D, 1999, J GEOPHYS RES-OCEANS, V104, P3297, DOI 10.1029/98JC01333; Bouman HA, 2011, ENV MICROBIOL REP, V3, P473, DOI 10.1111/j.1758-2229.2011.00241.x; Liu H, 1998, DEEP-SEA RES PT II, V45, P2327, DOI 10.1016/S0967-0645(98)00073-3; Massana R, 2011, ANNU REV MICROBIOL, V65, P91, DOI 10.1146/annurev-micro-090110-102903; Andre JM, 1999, J GEOPHYS RES-OCEANS, V104, P3369, DOI 10.1029/1998JC900005; Liu HB, 1997, AQUAT MICROB ECOL, V12, P39, DOI 10.3354/ame012039; Jacquet S, 2002, J PLANKTON RES, V24, P635, DOI 10.1093/plankt/24.7.635; Dolan JR, 1999, LIMNOL OCEANOGR, V44, P1565; Yang Q, 2010, SCIENCE, V327, P1522, DOI 10.1126/science.1181759; ARMBRUST EV, 1989, APPL ENVIRON MICROB, V55, P425; Binder BJ, 2002, DEEP-SEA RES PT II, V49, P2601, DOI 10.1016/S0967-0645(02)00050-4; Brunet C, 2007, MAR ECOL PROG SER, V346, P15, DOI 10.3354/meps07017; Chen BZ, 2011, CONT SHELF RES, V31, P1527, DOI 10.1016/j.csr.2011.06.018; Chisholm S. W., 1986, CAN B FISH AQUAT SCI, V214, P343; Chisholm S.W., 1981, CAN B FISH AQUAT SCI, V210, P150; HAUSCHILD CA, 1991, J PHYCOL, V27, P698, DOI 10.1111/j.0022-3646.1991.00698.x; Hogetsu K., 1977, PRODUCTIVITY BIOCENO, P31; Johnson CH, 1996, MOL MICROBIOL, V21, P5, DOI 10.1046/j.1365-2958.1996.00613.x; Kanda J, 2003, PROG OCEANOGR, V57, P17, DOI 10.1016/S0079-6611(03)00048-X; Llabres M., 2011, J PHYCOL, V47, P1; Mitbavkar S, 2009, J OCEANOGR, V65, P195, DOI 10.1007/s10872-009-0019-7; NELSON DM, 1979, J PHYCOL, V15, P67, DOI 10.1111/j.0022-3646.1979.00067.x; Parsons TR, 1984, MANUAL CHEM BIOL SEA; Sarma VVSS, 2006, LIMNOL OCEANOGR, V51, P1432; SUTTLE CA, 1994, MICROBIAL ECOL, V28, P237, DOI 10.1007/BF00166813; SUZUKI R, 1990, Journal of the Oceanographical Society of Japan, V46, P190, DOI 10.1007/BF02125580; VAULOT D, 1990, LIMNOL OCEANOGR, V35, P1156; Vaulot D, 1996, APPL ENVIRON MICROB, V62, P2527; Zubkov M. V, 2000, PROGR OCEANOGRAPHY, V45, P69	40	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0018-8158	1573-5117		HYDROBIOLOGIA	Hydrobiologia	MAR	2015	747	1					133	145		10.1007/s10750-014-2125-9		13	Marine & Freshwater Biology	Marine & Freshwater Biology	CB9QR	WOS:000349967400010		
J	Atapaththu, KSS; Asaeda, T				Atapaththu, Keerthi Sri Senarathna; Asaeda, Takashi			Growth and stress responses of Nuttall's waterweed Elodea nuttallii (Planch) St. John to water movements	HYDROBIOLOGIA			English	Article						Turbulence; Main flow; Elodea nuttallii; Stress; Antioxidant	MACROPHYTE VALLISNERIA-NATANS; AQUATIC MACROPHYTES; OXIDATIVE STRESS; MECHANICAL PERTURBATION; CERATOPHYLLUM-DEMERSUM; METABOLISM; VELOCITY; CAROTENOIDS; THIGMOMORPHOGENESIS; LEAVES	Understanding the interactions between aquatic plants and environmental factors is important to clarify aquatic ecosystem functioning. The mechanisms governing the interactions between water flow and plants are not yet fully understood, and the responses of plants to main flow (without turbulence) compared to turbulence are largely unknown. Here, we compared the growth and stress responses of the aquatic macrophyte Elodea nuttallii to exposure to turbulence and main flow. Turbulence and main flow were generated using a vertically oscillating horizontal grid and a recirculating system, respectively and the experiment lasted for 3 weeks. A decrease in shoot elongation coupled with an increase in radial expansion was observed in plants exposed to water movements. These effects were further accompanied by significant increases in cellulose and lignin. Turbulence reduced total chlorophyll by approximately 40% compared to plants in the control and main flow. Mechanical stress induced by turbulence leads to increased oxidative stress and tissue rigidification. The turbulence triggered stress in E. nuttallii is more severe than that induced by main flow. Our findings can offer insights for explaining the habitat preferences of macrophytes and contribute to a better planning of the criteria that benefit in aquatic ecosystem management.	[Atapaththu, Keerthi Sri Senarathna; Asaeda, Takashi] Saitama Univ, Dept Environm Sci & Technol, Sakura Ku, Saitama 3388770, Japan	Asaeda, T (reprint author), Saitama Univ, Dept Environm Sci & Technol, Sakura Ku, 255 Shimo Okubo, Saitama 3388770, Japan.	asaeda@mail.saitama-u.ac.lk	Asaeda, Takashi/C-5278-2008		River Basin Environment Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan	This research was financially supported by a Research Grant-in-Aid from the River Basin Environment Foundation and the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors wish to acknowledge Mr. Kalum Sanjaya, Mr. T. Yoshida, and Mr. Mochizuki for their assistance during the fieldwork. Dr. Harun Rashid is gratefully acknowledged for his remarks on the manuscript.	Sraj-Krzic N, 2007, PLANT ECOL, V192, P107, DOI 10.1007/s11258-006-9230-4; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Thomaz SM, 2007, HYDROBIOLOGIA, V579, P1, DOI 10.1007/s10750-006-0285-y; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Pujol D, 2010, CONT SHELF RES, V30, P1019, DOI 10.1016/j.csr.2010.02.014; Madsen JD, 2001, HYDROBIOLOGIA, V444, P71, DOI 10.1023/A:1017520800568; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Handley RJ, 2002, AQUAT BOT, V73, P129, DOI 10.1016/S0304-3770(02)00015-3; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asaeda T, 2005, FRESHWATER BIOL, V50, P1991, DOI 10.1111/j.1365-2427.2005.01445.x; Jayakumar AR, 2006, J NEUROSCI, V26, P4774, DOI 10.1523/JNEUROSCI.0120-06.2006; YOUNG AJ, 1991, PHYSIOL PLANTARUM, V83, P702; Dybkaer R, 2001, PURE APPL CHEM, V73, P927, DOI 10.1351/pac200173060927; Wang C, 2008, AQUAT TOXICOL, V87, P88, DOI 10.1016/j.aquatox.2008.01.009; MORRISON IM, 1995, ANN BOT-LONDON, V76, P287, DOI 10.1006/anbo.1995.1097; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Delledonne M, 2001, P NATL ACAD SCI USA, V98, P13454, DOI 10.1073/pnas.231178298; Smolders AJP, 1996, AQUAT BOT, V53, P85, DOI 10.1016/0304-3770(95)01014-9; REYNOLDS CS, 1994, HYDROBIOLOGIA, V289, P9, DOI 10.1007/BF00007405; Nepf HM, 2012, J HYDRAUL RES, V50, P262, DOI 10.1080/00221686.2012.696559; BEST EPH, 1980, AQUAT BOT, V8, P197, DOI 10.1016/0304-3770(80)90051-0; Babu TS, 2003, PLANT CELL PHYSIOL, V44, P1320, DOI 10.1093/pcp/pcg160; MACADAM JW, 1992, PLANT PHYSIOL, V99, P872, DOI 10.1104/pp.99.3.872; Lin CC, 2000, PLANT GROWTH REGUL, V30, P151, DOI 10.1023/A:1006345126589; Bornette G, 2011, AQUAT SCI, V73, P1, DOI 10.1007/s00027-010-0162-7; Cao T, 2007, MAR FRESHWATER RES, V58, P581, DOI 10.1071/MF06090; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; Potters G, 2007, TRENDS PLANT SCI, V12, P98, DOI 10.1016/j.tplants.2007.01.004; Chehab EW, 2009, J EXP BOT, V60, P43, DOI 10.1093/jxb/ern315; Arnon Dl, 1938, CALIFORNIA AGR EXP S, V347, P1; Asaeda T, 2010, RIVER RES APPL, V26, P1153, DOI 10.1002/rra.1322; Asaeda T, 2010, RIVER RES APPL, V26, P960, DOI 10.1002/rra.1313; Atapaththu K. S. S., 2014, P ECOLOGY CIVIL ENG, P305; BARKO JW, 1982, CAN J BOT, V60, P877; BIDDINGTON NL, 1986, PLANT GROWTH REGUL, V4, P103, DOI 10.1007/BF00025193; Binzer T, 2005, AQUAT BOT, V83, P239, DOI 10.1016/j.aquabot.2005.07.001; CHAMBERS PA, 1991, ECOL APPL, V1, P249, DOI 10.2307/1941754; Champika Ellawala K., 2011, FLORA, V206, P1085; DALE HM, 1986, HYDROBIOLOGIA, V133, P73, DOI 10.1007/BF00010804; DeEll JR, 2003, PRACTICAL APPL CHLOR; DemmigAdams B, 1996, FASEB J, V10, P403; Ellawala C, 2011, AQUAT ECOL, V45, P417, DOI 10.1007/s10452-011-9364-x; Ellawala C, 2013, HYDROBIOLOGIA, V709, P173, DOI 10.1007/s10750-013-1447-3; ERNER Y, 1982, PLANT CELL PHYSIOL, V23, P935; ERNER Y, 1980, PHYSIOL PLANTARUM, V50, P21, DOI 10.1111/j.1399-3054.1980.tb02677.x; Folkard A.M., 2011, P I CIVIL ENG ENG CO, V164, P3, DOI DOI 10.1680/EACM.8.00006; Green JC, 2005, AQUAT ECOL, V39, P1, DOI 10.1007/s10452-004-1913-0; GRUMBACH KH, 1982, PHOTOCHEM PHOTOBIOL, V35, P209, DOI 10.1111/j.1751-1097.1982.tb03833.x; Horne AJ, 1994, LIMNOLOGY; IIYAMA K, 1988, WOOD SCI TECHNOL, V22, P271; Jaegher G., 1985, PLANT GROWTH REGUL, V3, P133, DOI 10.1007/BF01806053; JANA S, 1982, AQUAT BOT, V12, P345, DOI 10.1016/0304-3770(82)90026-2; Kadono Y., 1994, AQUATIC PLANTS JAPAN; Kawano N, 2003, ANN BOT-LONDON, V91, P465, DOI 10.1093/aob/mcg043; KRINSKY NI, 1978, PHILOS T ROY SOC B, V284, P581, DOI 10.1098/rstb.1978.0091; MADSEN TV, 1993, PLANT CELL ENVIRON, V16, P317, DOI 10.1111/j.1365-3040.1993.tb00875.x; Mitchell CA, 1996, HORTSCIENCE, V31, P31; Mony C, 2007, PLANT ECOL, V191, P109, DOI 10.1007/s11258-006-9219-z; Olson ER, 2012, AQUAT BOT, V96, P31, DOI 10.1016/j.aquabot.2011.09.007; Panda Sanjib Kumar, 2004, Brazilian Journal of Plant Physiology, V16, P115, DOI 10.1590/S1677-04202004000200007; Saidi I, 2009, PLANT SCI, V177, P1, DOI 10.1016/j.plantsci.2009.03.002; Saidi Issam, 2010, Plant Signal Behav, V5, P122, DOI 10.4161/psb.5.2.10302; Sand-Jensen K, 1999, FRESHWATER BIOL, V42, P315, DOI 10.1046/j.1365-2427.1999.444495.x; Schutten J, 2004, ANN BOT-LONDON, V93, P333, DOI 10.1093/aob/mch043; Sillanpaa M, 2005, TREE PHYSIOL, V25, P1161; Strzalka K, 2003, RUSS J PLANT PHYSL+, V50, P168, DOI 10.1023/A:1022960828050; Thomaz SM, 2006, HYDROBIOLOGIA, V570, P53, DOI 10.1007/s10750-006-0161-9; UPDEGRAF.DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307; WESTLAKE DF, 1967, J EXP BOT, V18, P187, DOI 10.1093/jxb/18.2.187; Xiong HF, 2010, AFR J BIOTECHNOL, V9, P5722; Zaman T, 2013, FLORA, V208, P211, DOI 10.1016/j.flora.2013.02.009; Zhang M, 2010, ENVIRON EXP BOT, V68, P44, DOI 10.1016/j.envexpbot.2009.09.003	75	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0018-8158	1573-5117		HYDROBIOLOGIA	Hydrobiologia	MAR	2015	747	1					217	233		10.1007/s10750-014-2141-9		17	Marine & Freshwater Biology	Marine & Freshwater Biology	CB9QR	WOS:000349967400016		
J	Currell, M; Dahlhaus, P; Ii, H				Currell, Matthew J.; Dahlhaus, Peter; Ii, Hiroyuki			Stable isotopes as indicators of water and salinity sources in a southeast Australian coastal wetland: identifying relict marine water, and implications for future change	HYDROGEOLOGY JOURNAL			English	Article						Stable isotopes; Salinity; Groundwater/surface-water relations; Wetlands; Australia	ENVIRONMENTAL ISOTOPES; MURRAY BASIN; GROUNDWATER; VARIABILITY; COASTLINE; AQUIFERS; RECHARGE; ORIGIN; OXYGEN; BORON	The Lake Connewarre Complex is an internationally protected wetland in southeast Australia, undergoing increasing environmental change due to urbanisation. Stable isotopes of water (delta O-18 and delta H-2) and other geochemical indicators were used to assess sources of water and salinity in the shallow groundwater and surface-water systems, and to better understand groundwater/surface-water interactions. While much of the shallow groundwater is saline (from 1.27 to 50.3 g/L TDS) with overlapping salinities across water groups, stable isotopes allow clear delineation of two distinct sources of water and salinity: marine water with delta O-18 between -1.4 and +1.3 aEuro degrees and ion ratios characteristic of seawater; and meteoric water with delta O-18 between -6.1 and -3.6 aEuro degrees containing cyclic salts, probably concentrated by plant transpiration. Groundwater bodies in shallow sediments beneath the wetlands have salinities and stable isotopic compositions intermediate between fresh wetland surface water and a marine water end-member. This marine-type water is likely relict seawater emplaced when the wetlands were connected to the estuary, prior to modern river regulation. Freshwater input to underlying groundwater is a recent consequence of this regulation. Future predicted changes such as increased stormwater inflow, will increase rates of freshwater leakage to shallow groundwater, favouring the proliferation of exotic reed species.	[Currell, Matthew J.] RMIT Univ, Sch Civil Environm & Chem Engn, Melbourne, Vic 3001, Australia; [Dahlhaus, Peter] Federat Univ Australia, Ctr Environm Management, Mt Helen, Australia; [Ii, Hiroyuki] Wakayama Univ, Fac Syst Engn, Wakayama, Japan	Currell, M (reprint author), RMIT Univ, Sch Civil Environm & Chem Engn, GPO Box 2476, Melbourne, Vic 3001, Australia.	matthew.currell@rmit.edu.au					Price RM, 2012, MAR FRESHWATER RES, V63, P952, DOI 10.1071/MF12042; Lerner DN, 2002, HYDROGEOL J, V10, P143, DOI 10.1007/s10040-001-0177-1; Fan Y, 2013, SCIENCE, V339, P940, DOI 10.1126/science.1229881; Hatt BE, 2004, ENVIRON MANAGE, V34, P112, DOI 10.1007/s00267-004-0221-8; Vengosh A, 1999, WATER RESOUR RES, V35, P1877, DOI 10.1029/1999WR900024; Herczeg AL, 2001, MAR FRESHWATER RES, V52, P41, DOI 10.1071/MF00040; Sloss CR, 2007, HOLOCENE, V17, P999, DOI 10.1177/0959683607082415; Cartwright I, 2006, CHEM GEOL, V231, P38, DOI 10.1016/j.chemgeo.2005.12.009; Gattacceca JC, 2009, J HYDROL, V378, P46, DOI 10.1016/j.jhydrol.2009.09.005; Lee SY, 2006, AUSTRAL ECOL, V31, P149, DOI 10.1111/j.1442-9993.2006.01581.x; Toth J, 1999, HYDROGEOL J, V7, P1, DOI 10.1007/s100400050176; Fallon SJ, 2010, NUCL INSTRUM METH B, V268, P898, DOI 10.1016/j.nimb.2009.10.059; Appelo C.A.J., 2005, GEOCHEMISTRY GROUNDW; Azous A, 2010, WETLANDS URBANIZATIO; Baker A, 2003, HYDROL PROCESS, V17, P2499, DOI 10.1002/hyp.5140; Bellio M, 2013, BIOL CONSERV, V167, P57, DOI 10.1016/j.biocon.2013.07.013; Belperio AP, 2002, SEDIMENT GEOL, V150, P153, DOI 10.1016/S0037-0738(01)00273-1; Bird ECF, 1993, COAST VITORIA SHAPIN; Carreira PM, 2014, APPL GEOCHEM, V41, P163, DOI 10.1016/j.apgeochem.2013.12.012; Chilton J, 1999, INT CONTRIBUTIONS HY, V21; Corangamite Catchment Management Authority, 2013, SEAS WAT PR IN PRESS; Dahlhaus PG, 2007, LAKE CONNEWARRE VALU; Dawson TE, 1998, ISOTOPE TRACERS CATC; Dept. of Environment and Primary Industries Victoria, 2013, VICT BIOD ATL; Ecological Assoc, 2006, BX003B EA EC ASS COR; Foster Stephen, 1998, 390 WORLD BANK; Ghassemi F., 1995, SALINISATION LAND WA; Gill ED, 1985, P ROY SOC VICTORIA, V48, P1; Herczeg A.L., 2000, ENV TRACERS SUBSURFA, P31; Holdgate GR, 2001, AUST J EARTH SCI, V48, P439, DOI 10.1046/j.1440-0952.2001.00871.x; Holdgate GR, 2003, GEOLOGICAL SOC AUSTR, V23, P289; id, 2013, WELCOME CITY GREATER; Lloyd LN, 2012, FLOW ECOLOGY RELATIO; Marsden MAH, 1988, VICTORIAN GEOLOGY EX, P169; Rosengren NJ, 1973, VICTORIAN RESOUR, V15, P19; Vengosh A, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003344; Yugovic JZ, 1985, VEGETATION LAKE CONN	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1431-2174	1435-0157		HYDROGEOL J	Hydrogeol. J.	MAR	2015	23	2					235	248		10.1007/s10040-014-1199-9		14	Geosciences, Multidisciplinary; Water Resources	Geology; Water Resources	CC0PO	WOS:000350038200003		
J	Tajima, S; Komine, K				Tajima, Satohiro; Komine, Kazuteru			Saliency-Based Color Accessibility	IEEE TRANSACTIONS ON IMAGE PROCESSING			English	Article						Visual saliency; color vision; individual difference	VISUAL-ATTENTION; NATURAL IMAGES; CAMOUFLAGED STIMULI; VISION; DICHROMATS; STATISTICS; DISCRIMINATION; POPULATION; ADVANTAGE; MODEL	Perception of color varies markedly between individuals because of differential expression of photopigments in retinal cones. However, it has been difficult to quantify the individual cognitive variation in colored scene and to predict its complex impacts on the behaviors. We developed a method for quantifying and visualizing information loss and gain resulting from individual differences in spectral sensitivity based on visual salience. We first modeled the visual salience for color-deficient observers, and found that the predicted losses and gains in local image salience derived from normal and color-blind models were correlated with the subjective judgment of image saliency in psychophysical experiments, i.e., saliency loss predicted reduced image preference in color-deficient observers. Moreover, saliency-guided image manipulations sufficiently compensated for individual differences in saliency. This visual saliency approach allows for quantification of information extracted from complex visual scenes and can be used as an image compensation to enhance visual accessibility by color-deficient individuals.	[Tajima, Satohiro] Univ Geneva, Dept Neurosci, CH-1211 Geneva, Switzerland; [Tajima, Satohiro] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Tajima, Satohiro; Komine, Kazuteru] NHK Japan Broadcasting Corp, Sci & Technol Res Labs, Tokyo 1578001, Japan	Tajima, S (reprint author), Univ Geneva, Dept Neurosci, CH-1211 Geneva, Switzerland.	satohiro.tajima@gmail.com; komine.c@nhk.or.jp			Japan Broadcasting Corporation, Tokyo, Japan	This work was supported by the Japan Broadcasting Corporation, Tokyo, Japan. The associate editor coordinating the review of this manuscript and approving it for publication was Dr. Dimitrios Tzovaras.	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Oliva A, 2000, COGNITIVE PSYCHOL, V41, P176, DOI 10.1006/cogp.1999.0728; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241; Neitz J, 1999, NAT NEUROSCI, V2, P884, DOI 10.1038/13185; Wachtler T, 2004, VISION RES, V44, P2843, DOI 10.1016/j.visres.2004.06.016; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Neitz J, 1996, SCIENCE, V274, P801, DOI 10.1126/science.274.5288.801; [Anonymous], 1940, NATURE, V146, P226; Smith AC, 2012, ANIM BEHAV, V83, P479, DOI 10.1016/j.anbehav.2011.11.023; VIENOT F, 1995, NATURE, V376, P127, DOI 10.1038/376127a0; Neitz J, 2011, VISION RES, V51, P633, DOI 10.1016/j.visres.2010.12.002; DEMARCO P, 1992, J OPT SOC AM A, V9, P1465, DOI 10.1364/JOSAA.9.001465; Caine NG, 2000, P ROY SOC B-BIOL SCI, V267, P439, DOI 10.1098/rspb.2000.1019; MORGAN MJ, 1992, P ROY SOC B-BIOL SCI, V248, P291, DOI 10.1098/rspb.1992.0074; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; Gevers T, 1999, PATTERN RECOGN, V32, P453, DOI 10.1016/S0031-3203(98)00036-3; Melin AD, 2007, ANIM BEHAV, V73, P205, DOI 10.1016/j.anbehav.2006.07.003; Yoshida M, 2012, CURR BIOL, V22, P1429, DOI 10.1016/j.cub.2012.05.046; Parraga CA, 2005, VISION RES, V45, P3145, DOI 10.1016/j.visres.2005.08.006; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Ancuti CO, 2011, PROC CVPR IEEE, P257, DOI 10.1109/CVPR.2011.5995414; Ma WJ, 2011, NAT NEUROSCI, V14, P783, DOI 10.1038/nn.2814; Brettel H, 1997, J OPT SOC AM A, V14, P2647, DOI 10.1364/JOSAA.14.002647; Bruce NDB, 2009, J VISION, V9, DOI 10.1167/9.3.5; Caywood MS, 2004, J NEUROPHYSIOL, V91, P2859, DOI 10.1152/jn.00775.2003; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181; Huang J., 2008, P IEEE C COMP VIS PA, P1; Ichikawa M, 2003, LECT NOTES COMPUT SC, V2724, P2134; Ishihara S., 1917, TESTS COLOUR BLINDNE; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Judd DB, 1943, SCIENCE, V97, P544, DOI 10.1126/science.97.2529.544; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Lowe D., 1999, P INT C COMP VIS, V2, P1150, DOI DOI 10.1109/ICCV.1999.790410; Machado GM, 2009, IEEE T VIS COMPUT GR, V15, P1291, DOI 10.1109/TVCG.2009.113; Mackay D., 2003, INFORM THEORY INFERE; Melin AD, 2012, EVOLUTIONARY BIOL ME, P225; Melin AD, 2010, CURR ZOOL, V56, P300; Moroney N., 2002, P IS T SID 10 COL IM, P23; Naor-Raz G, 2003, PERCEPTION, V32, P667, DOI 10.1068/p5050; Perez-Carpinell J, 1998, COLOR RES APPL, V23, P234, DOI 10.1002/(SICI)1520-6378(199808)23:4<234::AID-COL8>3.0.CO;2-P; Pitt F. H. G., 1944, P ROY SOC LOND B BIO, V132, P104; Rasche K, 2005, IEEE COMPUT GRAPH, V25, P22, DOI 10.1109/MCG.2005.54; Saito A, 2005, AM J PRIMATOL, V67, P425, DOI 10.1002/ajp.20197; Saito A, 2006, PERCEPT MOTOR SKILL, V102, P3, DOI 10.2466/PMS.102.1.3-12; Tajima S, 2010, NEURAL COMPUT, V22, P2586, DOI 10.1162/NECO_a_00019; Tajima S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009704; THOMSON LC, 1953, J OPT SOC AM, V43, P890, DOI 10.1364/JOSA.43.000890; Valois R. D., 1982, VISION RES, V22, P545; WALRAVEN PL, 1974, VISION RES, V14, P1339, DOI 10.1016/0042-6989(74)90007-8; Zhang L., 2008, J VIS, V8, P32	54	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1057-7149	1941-0042		IEEE T IMAGE PROCESS	IEEE Trans. Image Process.	MAR	2015	24	3					1115	1126		10.1109/TIP.2015.2393056		12	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic	Computer Science; Engineering	CB6ZD	WOS:000349774700006		
J	Wang, GJ; Musau, F; Guo, S; Abdullahi, MB				Wang, Guojun; Musau, Felix; Guo, Song; Abdullahi, Muhammad Bashir			Neighbor Similarity Trust against Sybil Attack in P2P E-Commerce	IEEE TRANSACTIONS ON PARALLEL AND DISTRIBUTED SYSTEMS			English	Article						P2P; trust; Sybil attack; collusion attack; neighbor similarity	SYSTEMS; SERVICE; NETWORK	Peer to peer (P2P) e-commerce applications exist at the edge of the Internet with vulnerabilities to passive and active attacks. These attacks have pushed away potential business firms and individuals whose aim is to get the best benefit in e-commerce with minimal losses. The attacks occur during interactions between the trading peers as a transaction takes place. In this paper, we propose how to address Sybil attack, an active attack, in which peers can have bogus and multiple identities to fake their owns. Most existing work, which concentrates on social networks and trusted certification, has not been able to prevent Sybil attack peers from doing transactions. Our work exploits the neighbor similarity trust relationship to address Sybil attack. In our approach, duplicated Sybil attack peers can be identified as the neighbor peers become acquainted and hence more trusted to each other. Security and performance analysis shows that Sybil attack can be minimized by our proposed neighbor similarity trust.	[Wang, Guojun] Cent S Univ, Sch Informat Sci & Engn, Changsha 410083, Hunan, Peoples R China; [Musau, Felix] Kenyatta Univ, Sch Engn & Technol, Nairobi 00100, Kenya; [Guo, Song] Univ Aizu, Sch Comp Sci & Engn, Aizu Wakamatsu, Fukushima 9658580, Japan; [Abdullahi, Muhammad Bashir] Fed Univ Technol, Minna, Nigeria	Wang, GJ (reprint author), Cent S Univ, Sch Informat Sci & Engn, Changsha 410083, Hunan, Peoples R China.	csgjwang@csu.edu.cn; musaunf@gmail.com; sguo@u-aizu.ac.jp; el.bashir02@gmail.com	Wang, Guojun/G-1674-2015		NSFC [61272151, 61073037]; ISTCP [2013DFB10070]; China Hunan Provincial Science & Technology Program [2012GK4106]; Ministry of Education Fund for Doctoral Disciplines in Higher Education [20110162110043]	This work was supported by NSFC grants 61272151 and 61073037, ISTCP grant 2013DFB10070, the China Hunan Provincial Science & Technology Program under Grant Number 2012GK4106, and the Ministry of Education Fund for Doctoral Disciplines in Higher Education under Grant Number 20110162110043.	Ahn L.V., 2003, P 22 INT C THEOR APP, P294; Chang S, 2012, IEEE T PARALL DISTR, V23, P1103, DOI 10.1109/TPDS.2011.263; Wei W, 2012, 2012 PROCEEDINGS IEEE INFOCOM, P1951; Yu HF, 2008, IEEE ACM T NETWORK, V16, P576, DOI 10.1109/TNET.2008.923723; Francis P, 2001, IEEE ACM T NETWORK, V9, P525, DOI 10.1109/90.958323; Mislove A, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P29; Wang JT, 2007, I C WIREL COMM NETW, P2684, DOI 10.1109/WICOM.2007.667; Stoica I, 2001, ACM SIGCOMM COMP COM, V31, P149, DOI 10.1145/964723.383071; TVERSKY A, 1977, PSYCHOL REV, V84, P327, DOI 10.1037/0033-295X.84.4.327; Yu B, 2013, J PARALLEL DISTR COM, V73, P746, DOI 10.1016/j.jpdc.2013.02.001; Ramachandran A, 2006, ACM SIGCOMM COMP COM, V36, P291, DOI 10.1145/1151659.1159947; Damiani E, 2002, P 9 ACM C COMP COMM, P207; Danezis G., 2009, P NDSS SAN DIEG CA F, P1; Douceur JR, 2002, LECT NOTES COMPUT SC, V2429, P251; Jyothi BS, 2011, PEER PEER NETW APPL, V4, P289, DOI 10.1007/s12083-010-0084-0; Kamvar S.D., 2003, P 12 INT C WORLD WID, P640, DOI DOI 10.1145/775152.775242; Mislove A., 2008, P 5 USENIX S NETW SY, P15; Mohajerzadeh A. H., 2011, P IEEE IND APPL SOC, P1; Musau Felix, 2011, Proceedings of the 2011 International Joint Conference of IEEE TrustCom-11/IEEE ICESS-11/FCST-11 (TrustCom 2011), DOI 10.1109/TrustCom.2011.111; Newsome J., 2004, P 3 INT S INF PROC S, P1; Nguyen T., 2011, P IEEE INFOCOM, P3218; Ravichandran A., 2006, P 11 ACM S ACC CONTR, P71, DOI DOI 10.1145/1133058.1133070; Tran N, 2009, P 6 USENIX S NETW SY, P15; Walsh K., 2006, P 3 C NETW SYST DES, V3, P1; Wang K., 2010, COMMUNICATIONS NETWO, P360; Xu L., 2010, P INT S APPL, P15; Yu H., 2010, IEEE ACM T NETWORK, V18, P3; Yu HF, 2009, P IEEE S SECUR PRIV, P283, DOI 10.1109/SP.2009.26	28	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1045-9219	1558-2183		IEEE T PARALL DISTR	IEEE Trans. Parallel Distrib. Syst.	MAR	2015	26	3					824	833		10.1109/TPDS.2014.2312932		10	Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CB6XG	WOS:000349769500018		
J	RamezanJamaat, S; Akimoto, Y; Aguirre, H; Tanaka, K				RamezanJamaat, Saeed; Akimoto, Youhei; Aguirre, Hernan; Tanaka, Kiyoshi			Efficient Reconfiguration of Distribution Networks Using Extended Pruning-Grafting Operators	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						distribution networks; evolutionary algorithms; extended pruning-grafting operators; loss reduction; reconfiguration	DISTRIBUTION-SYSTEM RECONFIGURATION; LOSS REDUCTION; GENETIC ALGORITHM; FLOW; RESTORATION	Network reconfiguration is a complicated, combinatorial, constrained optimization problem with many candidate switching options as well as structural and operational constraints. Introduction of evolutionary algorithms (EAs) to distribution network operation has opened many new opportunities. However, many applications of these methods suffer from high computational burden. In addition, conventional crossover/mutation operators cannot generally produce radial configurations. Performance of EAs is significantly affected by modeling of the problem and the employed operators. This paper employs a branch-based modeling of a distribution network and proposes two new EA operators that are an extension and redefinition of the preserve ancestor operator (PAO) and change ancestor operator (CAO). They are fast, exclusively produce radial configurations, and remove PAO/CAO operators' limitation. Hence, they can be utilized for a more efficient application of EAs to the network reconfiguration problem. Performance of the new operators is compared to the original PAO/CAO operators, two sets of operators in a binary representation (conventional crossover/mutation operators and an enhanced version of them), and a set of operators in an integer representation (conventional crossover and directed mutation operators). Simulations show the efficiency of the proposed method in terms of convergence speed, response time, and the quality of results. (c) 2014 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[RamezanJamaat, Saeed; Akimoto, Youhei; Aguirre, Hernan; Tanaka, Kiyoshi] Shinshu Univ, Dept Elect & Elect Engn, Nagano 3808553, Japan	RamezanJamaat, S (reprint author), Shinshu Univ, Dept Elect & Elect Engn, 4-17-1 Wakasato, Nagano 3808553, Japan.	s.ramezanjamaat@gmail.com					Su CT, 2003, IEEE T POWER DELIVER, V18, P1022, DOI 10.1109/TPWRD.2003.813641; WAGNER TP, 1991, IEEE T POWER DELIVER, V6, P1922, DOI 10.1109/61.97741; Das D, 2006, INT J ELEC POWER, V28, P331, DOI 10.1016/j.ijepes.2005.08.018; Santos AC, 2010, IEEE T POWER SYST, V25, P1254, DOI 10.1109/TPWRS.2010.2041475; Carreno EM, 2008, IEEE T POWER SYST, V23, P1542, DOI 10.1109/TPWRS.2008.2002178; NARA K, 1992, IEEE T POWER SYST, V7, P1044, DOI 10.1109/59.207317; Lavorato M, 2012, IEEE T POWER SYST, V27, P172, DOI 10.1109/TPWRS.2011.2161349; CHENG CS, 1995, IEEE T POWER SYST, V10, P671, DOI 10.1109/59.387902; Zhu JZ, 2002, ELECTR POW SYST RES, V62, P37, DOI 10.1016/S0378-7796(02)00041-X; Toune S, 2002, IEEE T POWER DELIVER, V17, P173, DOI 10.1109/61.974205; CHIANG HD, 1990, IEEE T POWER DELIVER, V5, P1568, DOI 10.1109/61.58002; Delbem ACB, 2005, IEEE T POWER SYST, V20, P425, DOI 10.1109/TPWRS.2004.840442; Hong YY, 2005, IEEE T POWER SYST, V20, P1062, DOI 10.1109/TPWRS.2005.846067; LIU CC, 1988, IEEE T POWER SYST, V3, P619, DOI 10.1109/59.192914; Liu JW, 2002, INT J ELEC ENG EDUC, V39, P371; Merlin A., 1975, P 5 POW SYST COMP C, P1; Murai M, 2011, ELECTR ENG JPN, V174, P40, DOI 10.1002/eej.21015; Nagata T, 1994, T IEE JPN B, V114, P179; RamezanJamaat S, 2013, P 3 INT C EL POW EN, P92; RamezanJamaat S, P IEEE PES AS PAC PO; Sawa T., 2001, Transactions of the Institute of Electrical Engineers of Japan, Part C, V121-C; WU JS, 1991, IEEE T POWER DELIVER, V6, P1579, DOI 10.1109/61.97695	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	MAR	2015	10	2					119	133		10.1002/tee.22044		15	Engineering, Electrical & Electronic	Engineering	CC0BQ	WOS:000350000400001		
J	Ronilaya, F; Miyauchi, H				Ronilaya, Ferdian; Miyauchi, Hajime			A New Implementation of PID-Type Fuzzy Controller for a Battery Grid-Supporting Inverter in an Autonomous Distributed Variable-Speed Wind Turbine	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						battery; PID-type fuzzy controller; inverter; permanent magnet synchronous generator; protection; variable-speed wind turbine	PARALLEL INVERTERS; ENERGY-STORAGE; POWER-SYSTEM; GENERATORS; DYNAMICS	This paper presents a new implementation of a proportional-integral-derivative (PID)-type fuzzy controller (PIDfc) for a battery grid-supporting inverter to regulate the frequency and voltage of an autonomous distributed variable-speed wind turbine (VSWT). The VSWT which drives a permanent magnet synchronous generator (PMSG) is assumed for demonstration. The PIDfc is built from a set of control rules that adopts the droop control method and uses only locally measurable frequency and voltage signals. The output control signals are determined from the knowledge base and the fuzzy inference. To ensure safe battery operating limits, we also propose a protection scheme called intelligent battery protection (IBP). Several simulation experiments are performed by using MATLAB/SimPowerSystems. Next, to verify the scheme's effectiveness, the simulation results are compared with the results of a conventional controller through some performance indices. The results demonstrate the effectiveness of the PIDfc scheme to control a grid-supporting inverter of battery in the reduction of frequency and voltage fluctuations. (c) 2014 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Ronilaya, Ferdian; Miyauchi, Hajime] Kumamoto Univ, Dept Frontier Technol Energy & Devices, Kumamoto, Japan; [Ronilaya, Ferdian] State Polytech Malang, Dept Elect Power Engn, Malang, Indonesia	Ronilaya, F (reprint author), Kumamoto Univ, Dept Frontier Technol Energy & Devices, Kumamoto, Japan.	ferdian.polinema@yahoo.com			Directorate General of Higher Education of Indonesia (DIKTI); Kumamoto University	The authors gratefully acknowledge the contributions of the Directorate General of Higher Education of Indonesia (DIKTI) and Kumamoto University for supporting this work.	YEAGER KE, 1993, IEEE T ENERGY CONVER, V8, P433, DOI 10.1109/60.257056; Muyeen SM, 2009, IEEE T ENERGY CONVER, V24, P740, DOI 10.1109/TEC.2009.2025323; Teleke S, 2009, IEEE T ENERGY CONVER, V24, P725, DOI 10.1109/TEC.2009.2016000; Verbruggen HB, 1997, FUZZY SET SYST, V90, P151, DOI 10.1016/S0165-0114(97)00081-X; De Brabandere K, 2007, IEEE T POWER ELECTR, V22, P1107, DOI 10.1109/TPEL.2007.900456; Guerrero JM, 2004, IEEE T POWER ELECTR, V19, P1205, DOI 10.1109/TPEL.2004.833451; TRIPATHY SC, 1991, IEEE T ENERGY CONVER, V6, P579, DOI 10.1109/60.103628; Abbey C, 2007, IEEE T IND APPL, V43, P769, DOI 10.1109/TIA.2007.895768; Pandey SK, 2013, RENEW SUST ENERG REV, V25, P318, DOI 10.1016/j.rser.2013.04.029; Chen Z, 1998, IEE P-ELECT POW APPL, V145, P273, DOI 10.1049/ip-epa:19981981; [Anonymous], 1992, 42151992 IEEE; Energy FW, 2013, ALIZE WIND TURBINE; Johnson G, 1990, WIND ENERGY SYSTEMS; Jong-Yul K, 2012, 3 IEEE INT S POW EL, V48, P133; Kruger T, 2001, EUR WIND EN C COP DE, P983; Matlab/Simpowersystem, 2013, PERM MAGN SYNCHR GEN; Matlab/Simpowersystem, 2013, BATT IMPL GEN BATT M; Petru T, 2000, NORD WORKSH POW IND; Ronilaya F, 2013, IEEJ ELECT POWER PE, VPE-13, P7; Slootweg JG, 2003, IEEE T POWER SYST, V18, P144, DOI 10.1109/TPWRS.2002.807113; Tremblay O, 2009, WORLD ELECT VEHICLE, V3, P1; Wu Zhi Q, 1996, FUZZY SETS SYSTEMS, V78, P23; Yoshimoto K, 2006, P IEEE POW SYST C EX, V1, P1244; Zbiniew Abbey L, 2007, IEEE T POWER SYSTEMS, V22, P985	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	MAR	2015	10	2					134	143		10.1002/tee.22045		10	Engineering, Electrical & Electronic	Engineering	CC0BQ	WOS:000350000400002		
J	Khawne, A; Attachoo, B; Hamamoto, K				Khawne, Amnach; Attachoo, Boonwat; Hamamoto, Kazuhiko			Optimum Watermark Detection of Ultrasonic Echo Medical Images	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						image watermarking; optimum detection; generalized Gaussian distribution; Cauchy distribution	ASYMPTOTICALLY OPTIMAL DETECTION; ADDITIVE WATERMARKING; DWT-DOMAIN; NOISE; MODEL; DCT	To prevent unauthorized access to a person's medical images, it is widely acknowledged that the security features of confidentiality, availability and integrity should be in place. This paper proposes the watermarking of ultrasonic echo images together with optimal watermark detection, in which pseudorandom noise is added to the images for integrity. The optimum watermark detection is the integration of the generalized Gaussian distribution (-GGD) and the Cauchy distribution. The results show that the proposed method gives good detection performance. The proposed method not merely achieves optimum detection using the Rao test but also leads to the highest detection probability with JPEG2000 compression. Compared with other detection methods, our proposed method exhibits better watermark detection performance even when the watermark-to-document ratio (WDR) is -50 dB. (c) 2014 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Khawne, Amnach; Attachoo, Boonwat] King Mongkuts Inst Technol Ladkrabang, Fac Engn, Dept Comp Engn, Bangkok 10520, Thailand; [Hamamoto, Kazuhiko] Tokai Univ, Dept Informat Media Technol, Sch Sci & Technol, Kanagawa, Tokyo 2591292, Japan	Khawne, A (reprint author), King Mongkuts Inst Technol Ladkrabang, Fac Engn, Dept Comp Engn, Ladkrabang 1,Soi Chalongkrung 1, Bangkok 10520, Thailand.	kkamnach@hotmail.com					Dowling J, 2008, LECT NOTES COMPUT SC, V5041, P454; Zeng WJ, 1999, IEEE T IMAGE PROCESS, V8, P1534, DOI 10.1109/83.799882; Khare A, 2010, SIGNAL PROCESS, V90, P428, DOI 10.1016/j.sigpro.2009.07.008; Cheng Q, 2001, IEEE T MULTIMEDIA, V3, P273, DOI 10.1109/6046.944472; Samee MK, 2008, 2008 3RD INTERNATIONAL SYMPOSIUM ON COMMUNICATIONS, CONTROL AND SIGNAL PROCESSING, VOLS 1-3, P1409, DOI 10.1109/ISCCSP.2008.4537447; Nikolaidis A, 2003, IEEE T IMAGE PROCESS, V12, P563, DOI 10.1109/TIP.2003.810586; Coatrieux G, 2000, ENG MED BIOL SOC ANN, P250; Loza A, 2010, COMPUT VIS IMAGE UND, V114, P54, DOI 10.1016/j.cviu.2009.09.002; Coatrieux G, 2008, ST HEAL T, V136, P667; Gupta S, 2004, MED BIOL ENG COMPUT, V42, P189, DOI 10.1007/BF02344630; Giakoumaki A, 2006, IEEE T INF TECHNOL B, V10, P722, DOI 10.1109/TITB.2006.875655; Barni M, 2004, WATERMARKING SYSTEMS, P307; Coatrieux G, 2006, INT C ENG MED BIOL N; Do MN, 2002, IEEE T IMAGE PROCESS, V11, P146; Eslami R, 2006, IEEE INT C MULT EXP, P1369; Gravel P, 2004, IEEE T MED IMAGING, V23, P1221, DOI 10.1109/TMI.2004.832656; Jerhotova E, 2011, APPLIED BIOMEDICAL ENGINEERING, P435; Kay S., 1998, FUNDAMENTALS STAT SI, VII; KAY SM, 1989, IEEE T ACOUST SPEECH, V37, P627, DOI 10.1109/29.17554; Khieovongphachanh V, 2008, INT S COMM INF TECHN, P160; Kwitt R, 2011, IEEE T IMAGE PROCESS, V20, P474, DOI 10.1109/TIP.2010.2064327; Kwitt R, 2009, P 17 EUR SIGN PROC C, P2072; Li MY, 2005, COMPUT MED IMAG GRAP, V29, P367, DOI 10.1016/j.compmedimag.2005.02.003; Mairgiotis AK, 2008, IEEE T INF FOREN SEC, V3, P29, DOI 10.1109/TIFS.2007.916290; Navas K. A., 2007, 4 INT C SCI EL TECHN, P1; Sahraeian SME, 2008, P EUR SIGN PROC C EU; Sudha S, 2009, J IETE, V55, P7; Tsai CY, 2008, P ICME HANN; Wang JW, 2008, SIGNAL PROCESS, V88, P117, DOI 10.1016/j.sigpro.2007.07.012; Wu HJ, 2005, ACTA AUTOMATICA SINI, V31, P683; Zha DF, 2006, INT J ADAPT CONTROL, V20, P251, DOI 10.1002/acs.893	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	MAR	2015	10	2					149	156		10.1002/tee.22047		8	Engineering, Electrical & Electronic	Engineering	CC0BQ	WOS:000350000400004		
J	Xiao, HT; Qin, JA; Ogai, H; Jiang, XC				Xiao, Haitao; Qin, Jianan; Ogai, Harutoshi; Jiang, Xiuchen			A New Standing-Wave Testing System for Bridge Structure Nondestructive Damage Detection Using Electromagnetic Wave	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						electromagnetic wave; nondestructive testing; standing wave; bridge diagnosis; system design		Several data analysis algorithms exist for detecting damages in bridges; however, such algorithms only approximately locate the damaged areas. To increase the accuracy and sensitivity, a new nondestructive, standing-wave, bridge-testing system as well as algorithm is proposed. The proposed system sends 3.8-5.8 GHz modulated sweeping waves to an object, the input and reflected waves form a standing wave, which is used to check and evaluate the state of the object under examination. In comparison with other systems, the proposed system is compact and less expensive, and offers higher sensitivity, higher resolution, and higher accuracy. Simulations and experiments verified its effectiveness. (c) 2014 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Xiao, Haitao; Qin, Jianan; Ogai, Harutoshi] Waseda Univ, Grad Sch Informat Prod & Syst, Wakamatsu Ku, Kitakyushu, Fukuoka 8080135, Japan; [Jiang, Xiuchen] Shanghai Jiao Tong Univ, Dept Elect Informat & Elect Engn, Shanghai 200240, Peoples R China	Xiao, HT (reprint author), Waseda Univ, Grad Sch Informat Prod & Syst, Wakamatsu Ku, 2-7 Hibikino, Kitakyushu, Fukuoka 8080135, Japan.	sd8015949@hotmail.com			Japan Regional Innovation Strategy Program; Health Monitoring Business limited liability partnership	This study received support from the Japan Regional Innovation Strategy Program and financial support from the Health Monitoring Business limited liability partnership.	ALQUIE C, 1981, PHYS REV LETT, V47, P1483, DOI 10.1103/PhysRevLett.47.1483; [Anonymous], 2005, HIGHW STAT ANN REP; Shah AA, 2010, J MATER CIVIL ENG, V22, P476, DOI 10.1061/(ASCE)MT.1943-5533.0000050; Sharma S, 2011, J MATER CIVIL ENG, V23, P207, DOI 10.1061/(ASCE)MT.1943-5533.0000144; Yehia S, 2007, J BRIDGE ENG, V12, P215, DOI 10.1061/(ASCE)1084-0702(2007)12:2(215); Chen DH, 2010, J GEOTECH GEOENVIRON, V136, P207, DOI 10.1061/(ASCE)GT.1943-5606.0000190; Chen H, 2008, GEOTECH TEST J, V31, P217; Cheng J, 2008, SICE ANN C 2008 U EL; HELLIER C J, 2003, HDB NONDESTRUCTIVE E, P1032, DOI DOI 10.32; Kamal ASM, 2011, J COMPOS CONSTR, V15, P473, DOI 10.1061/(ASCE)CC.1943-5614.0000168; Li T, 2011, IEEJ T ELECT INFORM, V131, P1760; Ma R, 2009, THESIS WASEDA U; Cascante G, 2008, J INFRASTRUCT SYST, V14, P117, DOI 10.1061/(ASCE)1076-0342(2008)14:2(117); Terzic AM, 2010, J MATER CIVIL ENG, V22, P853, DOI 10.1061/(ASCE)MT.1943-5533.0000083; Uebo T, 2001, P IEEE INT VEH S; Uebo T, MEASUREMENT DISTANCE; Wei Z, 2002, INDEPENDENT COMPONEN	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	MAR	2015	10	2					157	165		10.1002/tee.22048		9	Engineering, Electrical & Electronic	Engineering	CC0BQ	WOS:000350000400005		
J	Luo, X; Ohyama, W; Wakabayashi, T; Kimura, F				Luo, Xi; Ohyama, Wataru; Wakabayashi, Tetsushi; Kimura, Fumitaka			Improvement of Automatic Chinese Text Classification by Combining Multiple Features	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						Chinese text classification; categorization; feature combination; feature transformation; dimension reduction; principal component analysis; support vector machine	NAIVE BAYES; CATEGORIZATION	In this paper, we present an effective way of combining character-based (N-gram) and word-based approaches for Chinese text classification. Uni-gram and bi-gram features are considered as the baseline model, which are then combined with word features of length greater than or equal to 3. A weight coefficient that can be used to give higher weights to word features is also introduced. We further employ a serial approach based on feature transformation and dimension reduction techniques. The results of McNemar's test indicate that the performance is significantly improved by our proposed method. (c) 2014 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Luo, Xi; Ohyama, Wataru; Wakabayashi, Tetsushi; Kimura, Fumitaka] Mie Univ, Grad Sch Engn, Tsu, Mie 5148507, Japan	Luo, X (reprint author), Mie Univ, Grad Sch Engn, 1577 Kurimachiya Cho, Tsu, Mie 5148507, Japan.	luoxi@hi.info.mie-u.ac.jp					Peng FC, 2004, INFORM RETRIEVAL, V7, P317, DOI 10.1023/B:INRT.0000011209.19643.e2; Sebastiani F, 2002, ACM COMPUT SURV, V34, P1, DOI 10.1145/505282.505283; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; DAMASHEK M, 1995, SCIENCE, V267, P843, DOI 10.1126/science.267.5199.843; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Bishop C. M., 2006, PATTERN RECOGNITION, V1; Chen JN, 2009, EXPERT SYST APPL, V36, P5432, DOI 10.1016/j.eswa.2008.06.054; Dai X, 2008, P 21 INT FLAIRS C CO, P142; Fukunaga K, 1990, INTRO STAT PATTERN R, P76; Greffenstette G, 1995, P JADT 95, P85; He J., 2000, P PRICAI 2000 INT WO, P24; Joachims Thorsten, 2001, LEARNING CLASSIFY TE; Jurafsky D, 2000, INTRO NATURAL LANGUA; Lertnattee V, 2003, LECT NOTES ARTIF INT, V2773, P850; Lexicon of Common Words in Contemporary Chinese Research Team, 2009, LEX COMM WORDS CONT; Li W., 2010, P 9 IEEE INT C COGN, P484; Luo X, 2012, P 10 IAPR INT WORKSH, P271; Tan SB, 2008, EXPERT SYST APPL, V34, P2622, DOI 10.1016/j.eswa.2007.05.028; Tan S, CHINESE TEXT CATEGOR; van Rijsbergen C.J., 1979, INFORM RETRIEVAL; Yiming Yang, 1999, Information Retrieval, V1, DOI 10.1023/A:1009982220290; Yang Y., 1999, P 22 ANN INT ACM SIG, P42, DOI 10.1145/312624.312647; Zhang H, 2003, COMPUTATIONAL LINGUI, V8, P29	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	MAR	2015	10	2					166	174		10.1002/tee.22049		9	Engineering, Electrical & Electronic	Engineering	CC0BQ	WOS:000350000400006		
J	Jin, CH; Pok, G; Paik, I; Ryu, KH				Jin, Cheng Hao; Pok, Gouchol; Paik, Incheon; Ryu, Keun Ho			Short-Term Electricity Load and Price Forecasting Based on Clustering and Next Symbol Prediction	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						clustering; next symbol prediction; time series forecasting	WAVELET TRANSFORM; NEURAL-NETWORK; ALGORITHM; MODELS; MARKET	Short-term electricity load and price forecasting is an important issue in competitive electricity markets. In this paper, we propose a new direct time series forecasting method based on clustering and next symbol prediction. First, the cluster label sequence is obtained from time series clustering. Then a lossless compression algorithm of prediction by partial match version C coder (PPMC) is applied on this obtained discrete cluster label sequence to predict the next cluster label. Finally, the whole time series values of one-step-ahead can be directly forecast from the predicted cluster label. The proposed method is evaluated on electricity time series datasets, and the numerical experiments show that the proposed method can achieve promising results in day-ahead electricity load and price forecasting. (c) 2014 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Jin, Cheng Hao; Ryu, Keun Ho] Chungbuk Natl Univ, Coll Elect & Comp Engn, Dept Comp Sci, Database & Bioinformat Lab, Chungbuk, South Korea; [Pok, Gouchol] Yanbian Univ Sci & Technol, Dept Comp Sci, Yanbian, Peoples R China; [Paik, Incheon] Univ Aizu, Sch Comp Sci & Engn, Aizu Wakamatsu, Japan	Ryu, KH (reprint author), Chungbuk Natl Univ, Coll Elect & Comp Engn, Dept Comp Sci, Database & Bioinformat Lab, Chungbuk, South Korea.	khryu@dblab.chungbuk.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MEST) [2008-0062611]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2013R1A2A2A01068923]; MSIP (Ministry of Science, ICT and Future Planning), Korea under the ITRC (Information Technology Research Center) support program [NIPA-2014-H0301-14-1022]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2008-0062611), the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. 2013R1A2A2A01068923), and MSIP (Ministry of Science, ICT and Future Planning), Korea, under the ITRC (Information Technology Research Center) support program (NIPA-2014-H0301-14-1022) supervised by the NIPA (National IT Industry Promotion Agency).	Martinez-Alvarez F, 2011, PATTERN RECOGN LETT, V32, P1652, DOI 10.1016/j.patrec.2011.05.002; CLEARY JG, 1984, IEEE T COMMUN, V32, P396, DOI 10.1109/TCOM.1984.1096090; Gelper S, 2010, J FORECASTING, V29, P285, DOI 10.1002/for.1125; Catalao JPS, 2011, IEEE T POWER SYST, V26, P137, DOI 10.1109/TPWRS.2010.2049385; Aggarwal SK, 2009, INT J ELEC POWER, V31, P13, DOI 10.1016/j.ijepes.2008.09.003; MOFFAT A, 1990, IEEE T COMMUN, V38, P1917, DOI 10.1109/26.61469; Begleiter R, 2004, J ARTIF INTELL RES, V22, P385; Zhang JL, 2012, COMPUT IND ENG, V63, P695, DOI 10.1016/j.cie.2012.03.016; Amjady N, 2009, ENERGY, V34, P46, DOI 10.1016/j.energy.2008.09.020; Tan ZF, 2010, APPL ENERG, V87, P3606, DOI 10.1016/j.apenergy.2010.05.012; Kyriakides E, 2007, STUD COMPUT INTELL, V35, P391; Che JX, 2010, ENERG CONVERS MANAGE, V51, P1911, DOI 10.1016/j.enconman.2010.02.023; Anbazhagan S, 2013, IEEE SYST J, V7, P866, DOI 10.1109/JSYST.2012.2225733; Anbazhagan S, 2014, ENERG CONVERS MANAGE, V78, P711, DOI 10.1016/j.enconman.2013.11.031; Fan S, 2006, IEEE T POWER SYST, V21, P392, DOI 10.1109/TPWRS.2005.860944; Amjady N, 2010, IET GENER TRANSM DIS, V4, P432, DOI 10.1049/iet-gtd.2009.0297; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224; Hong YY, 2012, ENERGIES, V5, P4711, DOI 10.3390/en5114711; Chen J., 2007, IEEE T POWER SYST, V15, P723; Jin CH, 2014, IEEJ T ELECTR ELECTR, V9, P670, DOI 10.1002/tee.22024; Kouhi S, 2013, ENERG CONVERS MANAGE, V71, P76, DOI 10.1016/j.enconman.2013.03.014; MacQueen J., 1967, P 5 BERK S MATH STAT, V1, P14; Martinez Alvarez F, 2011, IEEE T KNOWL DATA EN, V23, P1230; Troncoso Lora A, 2004, CURRENT TOPICS ARTIF, V23, P577	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	MAR	2015	10	2					175	180		10.1002/tee.22050		6	Engineering, Electrical & Electronic	Engineering	CC0BQ	WOS:000350000400007		
J	Kumagai, S; Hotta, K				Kumagai, Shohei; Hotta, Kazuhiro			Particle Detection in Intracellular Images and Radius Estimation by Circle Fitting	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						intracellular image processing; Particle detection; Circle fitting		Detecting particles in intracellular images and estimating their radii is important for investigating the causes of clinical conditions. Presently, particles are manually counted by observers, which is time consuming and subjective. Thus, we propose an automatic particle counting and radius estimation method based on pattern recognition techniques. Particles are analyzed by a computer in two processes. During the first process, particles are detected using face recognition via a support vector machine. In the second process, the edge points of a detected particle are distinguished by the intensity difference between the particle and the background. The edge points are extracted and fitted by a circle by a voting technique. The proposed method accurately located 96.04% of the particles detected by manual counting. ImageJ, the particle detection software generally used in cell biology, detected 72.32% of the particles. Therefore, our method yields higher accuracy than ImageJ. Moreover, the effectiveness of radius estimation was also experimentally verified. (c) 2014 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Kumagai, Shohei; Hotta, Kazuhiro] Meijo Univ, Grad Sch Sci & Technol, Tempaku Ku, Nagoya, Aichi 4688508, Japan	Kumagai, S (reprint author), Meijo Univ, Grad Sch Sci & Technol, Tempaku Ku, 1-501 Shiogamaguchi, Nagoya, Aichi 4688508, Japan.	123433009@ccalumni.meijo-u.ac.jp			Support Center for Advanced Telecommunications Technology Research (SCAT)	We would like to thank Prof. Toyoshi Fujimoto and Dr. Michitaka Suzuki of Nagoya University. This work was supported by Support Center for Advanced Telecommunications Technology Research (SCAT).	Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Kumagai S, 2012, IEEE SYS MAN CYBERN, P67; Fujisaki K, 2013, 1 INT WORKSH BIOIMAG, P270; Kanade T, 2011, IEEE WORKSH APPL COM, P374; Kumagai S, 2013, 1 INT WORKSH BIOIMAG, P275; Kumagai S, 2013, IEICE T INF SYST, VJ96-D, P904; Okabe T, 2013, INT C DIG IM COMP TE, P1; Sakaushi S, 2007, BIOSCI BIOTECH BIOCH, V71, P1764, DOI 10.1271/bbb.60720; Sakaushi S, 2008, CELL CYCLE, V7, P477; Sugimoto K, 2010, METHODS MOL BIOL, V591, P135, DOI 10.1007/978-1-60761-404-3_8; Vapnik V., 1998, STAT LEARNING THEORY; Yoshizawa S, 2011, 12 INT C SYST BIOL, P212	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	MAR	2015	10	2					181	185		10.1002/tee.22051		5	Engineering, Electrical & Electronic	Engineering	CC0BQ	WOS:000350000400008		
J	Durmus, MS; Takai, S; Soylemez, MT				Durmus, Mustafa Seckin; Takai, Shigemasa; Soylemez, Mehmet Turan			Decision-Making Strategies in Fixed-Block Railway Signaling Systems: A Discrete Event Systems Approach	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						safety-related standards; fixed-block railway signaling systems; fault diagnosis; Petri nets	FAILURE DIAGNOSIS; ALGORITHM; MODELS	Ensuring the system safety at all times is most important in railway systems where small failures may result in a large number of casualties and property loss. Although there are various design methods, safety precautions, and recommendations of the railway-related safety standards, sometimes the occurrence of accidents cannot be prevented. In this paper, according to the recommendations of the railway-related safety standards, an interlocking system architecture, which consists of two controllers and a coordinator, for a fixed-block railway signaling system is studied. Based on the Petri net models of railway field components, decision-making strategies including fault diagnosis are presented. (c) 2014 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Durmus, Mustafa Seckin] Pamukkale Univ, Dept Elect & Elect Engn, TR-20070 Kinikli, Denizli, Turkey; [Takai, Shigemasa] Osaka Univ, Div Elect Elect & Informat Engn, Suita, Osaka 5650871, Japan; [Soylemez, Mehmet Turan] Istanbul Tech Univ, Dept Control Engn, TR-34469 Istanbul, Turkey	Takai, S (reprint author), Osaka Univ, Div Elect Elect & Informat Engn, Suita, Osaka 5650871, Japan.	takai@eei.eng.osaka-u.ac.jp			JSPS RONPAKU (Ph.D. dissertation) Program; Okawa Foundation for Information and Telecommunications	This work was supported by JSPS RONPAKU (Ph.D. dissertation) Program and the Okawa Foundation for Information and Telecommunications.	Sampath M, 1996, IEEE T CONTR SYST T, V4, P105, DOI 10.1109/87.486338; [Anonymous], 2001, 50128 EN; LYONS RE, 1962, IBM J RES DEV, V6, P200; Debouk R, 2000, DISCRETE EVENT DYN S, V10, P33, DOI 10.1023/A:1008335115538; PARHAMI B, 1994, IEEE T RELIAB, V43, P617, DOI 10.1109/24.370218; SAMPATH M, 1995, IEEE T AUTOMAT CONTR, V40, P1555, DOI 10.1109/9.412626; Latif-Shabgahi GR, 2004, MICROPROCESS MICROSY, V28, P357, DOI 10.1016/j.micpro.2004.02.006; Cassandras C. G., 2008, INTRO DISCRETE EVENT; Clark S, 2012, P IET PROF DEV COURS, P6; Denault A, 2014, INTRO SOFTWARE SYSTE, V18; Durmus MS, 2014, IEEJ T ELECTR ELECTR, V9, P523, DOI 10.1002/tee.22001; Durmu MS, 2013, PAMUKKALE U J ENG SC, V19, P216; Durmu MS, 2014, TURKISH J ELECT ENG; Ghazel M., 2010, FAULT DETECTION THEO, P69; Hall S, 2001, MODERN SIGNALLING HD; IEC, 2010, 615083 IEC; IEC, 2010, 615087 IEC; Latif-Shabgahi G, 2003, MICROPROCESS MICROSY, V27, P303, DOI 10.1016/S0141-9331(03)00040-1; MURATA T, 1989, P IEEE, V77, P541, DOI 10.1109/5.24143; Palmer JW, 2010, P IET PROF DEV COURS, P52; Sampath M, 2001, P AMER CONTR CONF, P2077, DOI 10.1109/ACC.2001.946050; Sengupta R, 2001, P AMER CONTR CONF, P2083, DOI 10.1109/ACC.2001.946051; Singamsetty PhaniKumar, 2011, Journal of Advances in Information Technology, V2, DOI 10.4304/jait.2.3.139-145; Sinnamohideen K, 2001, P AMER CONTR CONF, P2072, DOI 10.1109/ACC.2001.946049; S-L Chung, 2005, INT J COMPUT INTEG M, V18, P158; Ushio T, 1998, IEEE SYS MAN CYBERN, P113; White C, 2010, P IET PROF DEV COURS, P65	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	MAR	2015	10	2					186	194		10.1002/tee.22052		9	Engineering, Electrical & Electronic	Engineering	CC0BQ	WOS:000350000400009		
J	Kobayashi, M				Kobayashi, Masaki			Attractors Accompanied with a Training Pattern of Multivalued Hopfield Neural Networks	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						Hopfield neural network; multivalued neuron; complex-valued neuron; rotor neuron; rotated pattern; attractor	ASSOCIATIVE MEMORY	Recently, multivalued Hopfield neural networks, such as complex-valued Hopfield neural networks, and their applications have been studied by many researchers. In their application, low noise robustness is an important problem. Too many attractors accompanied with training patterns damage the noise robustness. Rotated patterns are well-known attractors of complex-valued Hopfield neural networks. In the present work, we reveal that any other patterns are never attractors in complex-valued Hopfield neural networks with a training pattern. We also prove a similar result for rotor Hopfield neural network. In addition, we investigate the relation between noise robustness and the number of attractors. (c) 2014 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	Univ Yamanashi, Interdisciplinary Grad Sch, Kofu, Yamanashi 4008511, Japan	Kobayashi, M (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch, 4-3-11 Takeda, Kofu, Yamanashi 4008511, Japan.	k-masaki@yamanashi.ac.jp	Kobayashi, Masaki/C-6568-2013	Kobayashi, Masaki/0000-0002-4453-0615			Aizenberg N. N., 1973, Cybernetics, V9; Aizenberg N. N., 1971, Cybernetics, V7; Isokawa T, 2008, INT J NEURAL SYST, V18, P135, DOI 10.1142/S0129065708001440; Aoki H, 2000, IEICE T FUND ELECTR, VE83A, P1824; Aoki H, 2000, INT C PATT RECOG, P626, DOI 10.1109/ICPR.2000.906153; Furusawa S., 2013, NONLINEAR THEORY ITS, V4, P299; Hertz J., 1992, INTRO THEORY NEURAL; Hirose A., 2004, SERIES INNOVATIVE IN, V5; Hirose A., 2013, IEEE PRESS SERIES CO; Hirose A., 2012, SERIES STUDIES COMPU; Isokawa T., 2010, P IEEE WORLD C COMP, P1281; Kitahara M, 2014, IEEE T NEUR NET LEAR, V25, P1298, DOI 10.1109/TNNLS.2013.2292706; Kitahara M., 2010, P 9 IEEE ACIS INT C, P497; Kitahara M., 2011, IEEJ T ELECT INF SYS, V131, P116, DOI 10.1541/ieejeiss.131.116; Kitahara M., 2012, NONLINEAR THEORY APP, V3, P426; Kitahara M, 2009, P INT S NONL THEOR I, P399; Kobayashi M, 2013, IEEE T NEUR NET LEAR, V24, P335, DOI 10.1109/TNNLS.2012.2230450; Kobayashi M, 2007, ELECTR ENG JPN, V159, P39, DOI 10.1002/eej.20387; Nitta T., 2009, COMPLEX VALUED NEURA; Noest A. J., 1988, NEURAL INFORM PROCES, P584; NOEST AJ, 1988, PHYS REV A, V38, P2196, DOI 10.1103/PhysRevA.38.2196; Suzuki Y, 2012, P IEEE WORLD C COMP, P720; Suzuki Y, 2013, P INT JOINT C NEUR N, P984; Suzuki Y, 2011, P INT C NEUR INF PRO, P509; ZEMEL RS, 1995, NEURAL NETWORKS, V8, P503, DOI 10.1016/0893-6080(94)00094-3	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	MAR	2015	10	2					195	200		10.1002/tee.22053		6	Engineering, Electrical & Electronic	Engineering	CC0BQ	WOS:000350000400010		
J	Li, WC; Wang, CY; Tian, Z; Zhang, H; Gao, YX; Zhang, Y; Yang, M; Li, YY; Nishimura, O				Li, Wei cheng; Wang, Chunyan; Tian, Zhe; Zhang, Hong; Gao, Yingxin; Zhang, Yu; Yang, Min; Li, Yu-You; Nishimura, Osamu			Anaerobic treatment of p-acetamidobenzene sulfonyl chloride (p-ASC)-containing wastewater in the presence or absence of ethanol in a UASB reactor	INTERNATIONAL BIODETERIORATION & BIODEGRADATION			English	Article						p-acetamidobenzene sulfonyl chloride; Anaerobic treatment; Aromatic sulfonates; Industrial wastewater; Microbial community structure	LINEAR ALKYLBENZENE SULFONATE; SULFATE-REDUCING BACTERIA; N-SUBSTITUTED AROMATICS; SP-NOV.; METHANOGENIC CONDITIONS; GRANULAR SLUDGE; GEN. NOV.; SP. NOV.; DEGRADATION; BIODEGRADABILITY	A lab-scale UASB reactor was operated for the treatment of p-acetamidobenzene sulfonyl chloride (p-ASC)-containing wastewater with and without ethanol for 210 days. The influence of the organic loading rate on the performance of reactor by step-decreasing HRT reduction/step-increasing the concentration of p-ASC was evaluated. Almost complete degradation of 50 mg/l p-ASC and COD removal efficiency (79.5%) was noticed with a COD removal of 79.5% at HRT of 0.5 day or longer and an applied p-ASC loading rate below 120 mg/l/day. No inhibition to the performance of this reactor was observed even at a p-ASC concentration up to 1000 mg/I. Of interest that despite the absence of sulfate in the feed, a certain quantity of sulfate and sulfide was simultaneously generated in the effluent. The trial result in the absence of ethanol demonstrated that p-ASC could be used as the sole source of carbon and energy. Clone libraries for the archaeal and bacterial communities were constructed for a biomass sample taken on day 190. The majority of bacterial clones were represented by Proteobacteria, followed by Thermotogae, Bacteroidetes and Firmicutes. Bacterial groups within the phyla Clostridia might be responsible for the desulfonation of p-ASC. (C) 2014 Elsevier Ltd. All rights reserved.	[Li, Wei cheng; Wang, Chunyan; Tian, Zhe; Zhang, Hong; Gao, Yingxin; Zhang, Yu; Yang, Min] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Aquat Chem, Beijing 100085, Peoples R China; [Li, Wei cheng; Li, Yu-You; Nishimura, Osamu] Tohoku Univ, Grad Sch Engn, Dept Civil & Environm Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan	Li, YY (reprint author), Tohoku Univ, Grad Sch Engn, Dept Civil & Environm Engn, Aoba Ku, 6-6-06 Aza Aoba, Sendai, Miyagi 9808579, Japan.	gyx@rcees.ac.cn; yyli@epl1.civil.tohoku.ac.jp			Ministry of Science and Technology of the People's Republic of China [2012AA063401, 2013DFG50150]; National Natural Science Foundation of China [51178449]; Japan Society for the Promotion of Science [CAS 11209]	This study was supported by :1)Ministry of Science and Technology of the People's Republic of China (2012AA063401, 2013DFG50150), 2)National Natural Science Foundation of China 51178449,3) Japan Society for the Promotion of Science (JSPS 2012-2015) (CAS 11209).	Duarte ICS, 2010, BIORESOURCE TECHNOL, V101, P606, DOI 10.1016/j.biortech.2008.10.065; Tamboli DP, 2010, BIORESOURCE TECHNOL, V101, P2421, DOI 10.1016/j.biortech.2009.11.094; de Lucena RM, 2011, WORLD J MICROB BIOT, V27, P2893, DOI 10.1007/s11274-011-0771-x; ODOM JM, 1981, FEMS MICROBIOL LETT, V12, P47; Sanz JL, 2003, BIODEGRADATION, V14, P57, DOI 10.1023/A:1023557915653; Rabus R, 1996, APPL ENVIRON MICROB, V62, P3605; Kunapuli U, 2010, INT J SYST EVOL MICR, V60, P686, DOI 10.1099/ijs.0.003525-0; Prats D, 1997, WATER RES, V31, P1925, DOI 10.1016/S0043-1354(97)00040-7; Liu YT, 1999, INT J SYST BACTERIOL, V49, P545; Chen SY, 2005, INT J SYST EVOL MICR, V55, P1319, DOI 10.1099/ijs.0.63565-0; Chelliapan S, 2011, DESALINATION, V271, P257, DOI 10.1016/j.desal.2010.12.045; Chen BY, 2006, PROCESS BIOCHEM, V41, P1529, DOI 10.1016/j.procbio.2006.02.014; SCHNELL S, 1991, ARCH MICROBIOL, V155, P183, DOI 10.1007/BF00248615; Tan NCG, 2005, BIODEGRADATION, V16, P527, DOI 10.1007/s10532-004-6593-x; Garcia MT, 2005, CHEMOSPHERE, V60, P1636, DOI 10.1016/j.chemosphere.2005.02.048; RazoFlores E, 1997, FEMS MICROBIOL REV, V20, P525, DOI 10.1016/S0168-6445(97)00031-4; Jackson BE, 1999, ARCH MICROBIOL, V171, P107, DOI 10.1007/s002030050685; APHA, 1998, STANDARD METHODS EXA; Bras R, 2005, J BIOTECHNOL, V115, P57, DOI 10.1016/j.jbiotec.2004.08.001; Cao XH, 2003, INT J SYST EVOL MICR, V53, P971, DOI 10.1099/ijs.0.02373-0; Carvalho MC, 2008, INT BIODETER BIODEGR, V62, P96, DOI 10.1016/j.ibiod.2007.12.008; Chang W, 2005, BIOTECHNOL PROGR, V21, P1789, DOI 10.1021/bp050250p; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Chien CC, 2005, J BASIC MICROB, V45, P274, DOI 10.1002/jobm.200410490; Denger K, 1996, APPL ENVIRON MICROB, V62, P1526; Gan HM, 2011, CHEMOSPHERE, V82, P507, DOI 10.1016/j.chemosphere.2010.10.094; Hazrati H, 2011, CHEM ENGINEER TRANS, V24, P1285, DOI 10.3303/CET1124215; Hunt CS, 1997, BIOREMED SER, V4(1), P49; Lange F.T., 1995, J HIGH RES CHROMATOG, V18, P243, DOI 10.1002/jhrc.1240180408; Lin WT, 2011, CURR MICROBIOL, V62, P374, DOI 10.1007/s00284-010-9716-0; Ma K, 2006, INT J SYST EVOL MICR, V56, P127, DOI 10.1099/ijs.0.63887-0; MAH RA, 1984, INT J SYST BACTERIOL, V34, P263; Mogensen AS, 2003, ENVIRON TOXICOL CHEM, V22, P706, DOI 10.1897/1551-5028(2003)022<0706:ADOLAS>2.0.CO;2; Okada DY, 2013, BIORESOURCE TECHNOL, V128, P125, DOI 10.1016/j.biortech.2012.10.073; de Oliveira LL, 2010, BIORESOURCE TECHNOL, V101, P5112, DOI 10.1016/j.biortech.2010.01.141; RazoFlores E, 1996, WATER SCI TECHNOL, V33, P47, DOI 10.1016/0273-1223(96)00320-4; Schloss P.D., 2005, APPL ENVIRON MICROB, V71, P1501; Sponza DT, 2007, SEP PURIF TECHNOL, V56, P108, DOI 10.1016/j.seppur.2006.07.013; Su Y.X., 2002, J HEBEI NORMAL U NAT, V26, P162; Sun D.Y., 2009, ENV SCI MANAG, V34, P124; Tan SY, 2011, CHEM PAP, V65, P510, DOI 10.2478/s11696-011-0026-1; Tanaka K, 2000, INT J SYST EVOL MICR, V50, P639; Tsuno H, 2009, WATER RES, V43, P417, DOI 10.1016/j.watres.2008.10.046; Zerbinati O, 1997, CHEMOSPHERE, V35, P2295, DOI 10.1016/S0045-6535(97)00308-1	44	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0964-8305	1879-0208		INT BIODETER BIODEGR	Int. Biodeterior. Biodegrad.	MAR	2015	98						81	88		10.1016/j.ibiod.2014.09.002		8	Biotechnology & Applied Microbiology; Environmental Sciences	Biotechnology & Applied Microbiology; Environmental Sciences & Ecology	CB6GI	WOS:000349725100011		
J	Watanabe, J; Ota, M; Suwa, Y; Suzuki, S; Suwa, H; Momiyama, M; Ishibe, A; Watanabe, K; Masui, H; Nagahori, K; Ichikawa, Y; Endo, I				Watanabe, Jun; Ota, Mitsuyoshi; Suwa, Yusuke; Suzuki, Shinsuke; Suwa, Hirokazu; Momiyama, Masasi; Ishibe, Atsushi; Watanabe, Kazuteru; Masui, Hidenobu; Nagahori, Kaoru; Ichikawa, Yasushi; Endo, Itaru			Evaluation of the intestinal blood flow near the rectosigmoid junction using the indocyanine green fluorescence method in a colorectal cancer surgery	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						Colorectal cancer; Indocyanine green; Sudeck's critical point	SHORT-TERM-OUTCOMES; PHASE-II-TRIAL; ANASTOMOTIC LEAKAGE; RECTAL-CANCER; LAPAROSCOPIC SURGERY; RESECTION; COLON; PERFUSION; ISCHEMIA; DIVISION	It has been reported that some patients do not have an anastomosis of a marginal artery near the rectosigmoid junction, but the frequency of this condition and its clinical significance so far remain unclear. The aim of this study was to evaluate the blood flow at the marginal artery near the rectosigmoid junction. From January 2013 to January 2014, we enrolled consecutive patients with a preoperative diagnosis of left-sided colon cancer or rectal cancer who underwent surgery with lymph node dissection. During the operation, the blood flow through the point of origin of the last sigmoid arterial branch, originating from the inferior mesenteric artery, was interrupted, and the rectosigmoid junction was supplied by only the marginal artery. We injected indocyanine green intravenously and observed the blood flow using a near-infrared camera system. A total of 119 consecutive patients were enrolled in this study. Sixty-eight patients (57.1 %) had a good anastomosis of the marginal artery near the rectosigmoid junction (type A). In 27 patients (22.7 %), a fluorescence border was recognized, but the fluorescence border diminished within 60 s (Type B). In 18 patients (15.1 %), delayed fluorescence was recognized over 60 s (type C), and 6 patients (5.0 %) had no fluorescence at all (type D). A mean length of 14.8 cm was found from the peritoneal reflection to fluorescence border of blood flow. This study proves that cases without the anastomosis of the marginal artery of the rectosigmoid junction truly exist, using studies in living humans (UMIN000011186).	[Watanabe, Jun; Masui, Hidenobu; Nagahori, Kaoru] Yokosuka Kyosai Hosp, Dept Surg, Yokosuka, Kanagawa 2388558, Japan; [Ota, Mitsuyoshi; Suwa, Hirokazu; Ishibe, Atsushi] Yokohama City Univ, Dept Surg, Gastroenterol Ctr, Yokohama, Kanagawa 232, Japan; [Suwa, Yusuke; Suzuki, Shinsuke; Momiyama, Masasi; Watanabe, Kazuteru; Ichikawa, Yasushi; Endo, Itaru] Yokohama City Univ, Dept Surg Gastroenterol, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan	Watanabe, J (reprint author), Yokosuka Kyosai Hosp, Dept Surg, 1-16 Yonegahama St, Yokosuka, Kanagawa 2388558, Japan.	nabe-jun@comet.ocn.ne.jp					Sherwinter DA, 2013, COLORECTAL DIS, V15, P91, DOI 10.1111/j.1463-1318.2012.03101.x; Kudszus S, 2010, LANGENBECK ARCH SURG, V395, P1025, DOI 10.1007/s00423-010-0699-x; Ito M, 2008, INT J COLORECTAL DIS, V23, P703, DOI 10.1007/s00384-008-0470-8; MacRae HM, 1998, DIS COLON RECTUM, V41, P180, DOI 10.1007/BF02238246; Hallbook O, 1996, BRIT J SURG, V83, P60, DOI 10.1002/bjs.1800830119; van der Pas MHGM, 2013, LANCET ONCOL, V14, P210, DOI 10.1016/S1470-2045(13)70016-0; Jeong SY, 2014, LANCET ONCOL, V15, P767, DOI 10.1016/S1470-2045(14)70205-0; Karliczek A, 2009, INT J COLORECTAL DIS, V24, P569, DOI 10.1007/s00384-009-0658-6; Vignali A, 2000, DIS COLON RECTUM, V43, P76, DOI 10.1007/BF02237248; Schaafsma BE, 2011, J SURG ONCOL, V104, P323, DOI 10.1002/jso.21943; Jafari MD, 2013, SURG ENDOSC, V27, P3003, DOI 10.1007/s00464-013-2832-8; Shiomi A, 2014, INT J COLORECTAL DIS, V29, P1105, DOI 10.1007/s00384-014-1921-z; Attard JAP, 2005, DIS COLON RECTUM, V48, P1460, DOI 10.1007/s10350-005-0047-3; Gendall KA, 2007, DIS COLON RECTUM, V50, P2223, DOI 10.1007/s10350-007-9051-0; ANSELINE PF, 1981, ANN SURG, V194, P716, DOI 10.1097/00000658-198112000-00010; Bacon H, 1918, ANN SURG, V127, P28; Cui Y, 2003, J CARDIOVASC SURG, V44, P775; Drummond H, 1914, P R SOC MED PROTOCOL, V7, P185; Fujii S, 2012, SURG ENDOSC, V26, P3067, DOI 10.1007/s00464-012-2317-1; GRIFFITHS J D, 1956, Ann R Coll Surg Engl, V19, P241; Holm C, 2010, J RECONSTR MICROSURG, V26, P311, DOI 10.1055/s-0030-1249314; Kang Y, 2010, MICROVASC RES, V80, P552, DOI 10.1016/j.mvr.2010.07.004; Kwon Yong Hwan, 2013, Clin Endosc, V46, P472, DOI 10.5946/ce.2013.46.5.472; Lim M, 2006, DIS COLON RECTUM, V49, P1611, DOI 10.1007/s10350-066-0663-6; LUCHTEFELD MA, 1989, DIS COLON RECTUM, V32, P733, DOI 10.1007/BF02562119; Pope C, 1929, SURG CLIN N AM, V9, P957; Reuthebuch O, 2004, CHEST, V125, P418, DOI 10.1378/chest.125.2.418; Schlegel RD, 2001, DIS COLON RECTUM, V44, P1464, DOI 10.1007/BF02234598; Sekijima M, 2004, TRANSPLANT P, V36, P2188, DOI 10.1016/j.transproceed.2004.09.001; SHIKATA JI, 1986, J SURG RES, V40, P105, DOI 10.1016/0022-4804(86)90110-1; Sudeck P, 1907, MUENCHEN MED WSCHR, V54, P1314; Toens C, 2006, INT J COLORECTAL DIS, V21, P332, DOI 10.1007/s00384-005-0017-1; Van Tonder JJ, 2007, CLIN ANAT, V20, P424, DOI 10.1002/ca.20417; WILKER D, 1988, LANGENBECK ARCH CHIR, V373, P217, DOI 10.1007/BF01261812; Yamamoto S, 2013, ANN SURG, V258, P283, DOI 10.1097/SLA.0b013e318283669c; Yamazaki T, 1997, SURG TODAY, V27, P254	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	MAR	2015	30	3					329	335		10.1007/s00384-015-2129-6		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CC0NM	WOS:000350032500005		
J	Ogura, A; Chino, A; Konishi, T; Akiyoshi, T; Kishihara, T; Tamegai, Y; Ueno, M; Igarashi, M				Ogura, Atsushi; Chino, Akiko; Konishi, Tsuyoshi; Akiyoshi, Takashi; Kishihara, Teruhito; Tamegai, Yoshiro; Ueno, Masashi; Igarashi, Masahiro			Endoscopic evaluation of clinical response after preoperative chemoradiotherapy for lower rectal cancer: the significance of endoscopic complete response	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						Rectal cancer; Chemoradiotherapy; Endoscopy; Complete response	PATHOLOGICAL COMPLETE RESPONSE; TOTAL MESORECTAL EXCISION; NEOADJUVANT CHEMORADIATION; PREDICTIVE FACTORS; RADIOTHERAPY; THERAPY; MANAGEMENT; REGRESSION; SURVIVAL; INTERVAL	The management of rectal cancer is a significant oncologic challenge because rectal cancer has a poor prognosis among the various types of colorectal cancer. There have been several recent reports on a nonoperative approach for advanced lower rectal cancer, and this may be best for local disease control. However, objective evaluation of tumor response after preoperative chemoradiotherapy has not been standardized. The purpose of this study is to evaluate our method of endoscopic evaluation of complete response. This is a retrospective chart review. All patients received a long course of preoperative chemoradiotherapy (5-fluorouracil-based chemotherapy and 45-50.4 Gy) followed by radical surgical resection from May 2005 to March 2012 in The Cancer Institute Hospital of Japanese Foundation for Cancer Research. One hundred fifty-seven patients were reviewed consecutively. Criteria for endoscopic complete response were defined with a focus on the degree of ulcer healing and pit pattern without magnification. Endoscopic CR (E-CR) evaluation with our definitions reflected histopathologic response evaluation with an accuracy of 91.7 %, sensitivity of 27.8 %, specificity of 100 %, positive predictive value (PPV) of 100 %, and negative predictive value (NPV) of 91.4 % (p < 0.001). Our criteria of E-CR led all cases of y-clinical CR (ycCR) to pathological CR. Endoscopic evaluation focused on the degree of ulcer healing, and pit pattern without magnification is useful for judging ycCR.	[Ogura, Atsushi; Konishi, Tsuyoshi; Akiyoshi, Takashi; Ueno, Masashi] Japanese Fdn Canc Res, Dept Surg Gastroenterol, Canc Inst Hosp, Koto Ku, Tokyo 1358550, Japan; [Ogura, Atsushi; Chino, Akiko; Kishihara, Teruhito; Tamegai, Yoshiro; Igarashi, Masahiro] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Koto Ku, Tokyo 1358550, Japan	Ogura, A (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	atsushi.ogura@jfcr.or.jp					Akiyoshi T, 2009, J GASTROINTEST SURG, V13, P521, DOI 10.1007/s11605-008-0744-z; Wolthuis AM, 2012, ANN SURG ONCOL, V19, P2833, DOI 10.1245/s10434-012-2327-1; Kang JH, 2010, INT J RADIAT ONCOL, V76, P1018, DOI 10.1016/j.ijrobp.2009.03.066; Smith JD, 2012, ANN SURG, V256, P965, DOI 10.1097/SLA.0b013e3182759f1c; Habr-Gama A, 2013, DIS COLON RECTUM, V56, P1109, DOI 10.1097/DCR.0b013e3182a25c4e; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Kudo SE, 1996, GASTROINTEST ENDOSC, V44, P8, DOI 10.1016/S0016-5107(96)70222-5; Kim NK, 2007, INT J RADIAT ONCOL, V67, P204, DOI 10.1016/j.ijrobp.2006.08.020; Yeo SG, 2010, INT J RADIAT ONCOL, V78, P164, DOI 10.1016/j.ijrobp.2009.07.1682; Pahlman L, 1997, NEW ENGL J MED, V336, P980; Suzuki T, 2004, JPN J CLIN ONCOL, V34, P740, DOI 10.1093/jjco/hyh140; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Kalady MF, 2009, ANN SURG, V250, P582, DOI 10.1097/SLA.0b013e3181b91e63; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Tulchinsky H, 2008, ANN SURG ONCOL, V15, P2661, DOI 10.1245/s10434-008-9892-3; GERARD A, 1988, ANN SURG, V208, P606; Inomata M, 2013, JPN J CLIN ONCOL, V43, P321, DOI 10.1093/jjco/hys219; Japanese Society for Cancer of the Colon and Rectum, 2009, JAP CLASS COL CARC; Kuriu Yoshiaki, 2012, Gan To Kagaku Ryoho, V39, P1951; Maas M, 2011, J CLIN ONCOL, V29, P4634; Moriya Y, 1997, IMPORTANCE LYMPHATIC, P153; Murata Kohei, 2013, Gan To Kagaku Ryoho, V40, P2020; Zomora O, 2004, DIS COLON RECTUM, V47, P1607	23	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	MAR	2015	30	3					367	373		10.1007/s00384-014-2105-6		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CC0NM	WOS:000350032500010		
J	Saigusa, N; Fujisaki, H; Yokoyama, T; Shinozaki, M; Kikuchi, M; Nakamura, T; Yokoyama, Y; Nonami, T				Saigusa, Naoto; Fujisaki, Hiroyuki; Yokoyama, Tadashi; Shinozaki, Masaru; Kikuchi, Manabu; Nakamura, Toshio; Yokoyama, Yasuhisa; Nonami, Toshiaki			Staged seton fistulotomy after restorative proctocolectomy with ileal pouch-anal anastomosis accompanied by a decline in anal pressure during manometry	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Letter									[Saigusa, Naoto; Yokoyama, Tadashi; Kikuchi, Manabu; Yokoyama, Yasuhisa] Yokoyama Hosp Gastroenterol Dis, Dept Surg, Nagoya, Aichi 4600012, Japan; [Fujisaki, Hiroyuki; Nonami, Toshiaki] Aichi Med Univ, Sch Med, Dept Surg, Nagakute, Aichi 4801195, Japan; [Shinozaki, Masaru] Univ Tokyo, Dept Surg, Res Hosp, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Nakamura, Toshio] Fujieda Municipal Gen Hosp, Dept Surg, Fujieda, Shizuoka 4268677, Japan	Saigusa, N (reprint author), Yokoyama Hosp Gastroenterol Dis, Dept Surg, 3-11-20 Chiyoda Naka Ku, Nagoya, Aichi 4600012, Japan.	nsanchan@hotmail.com					MARCIO J, 1993, DIS COLON RECTUM, V36, P77; Nisar PJ, 2011, DIS COLON RECTUM, V54, P446, DOI 10.1007/DCR.0b013e318206ea42; Saigusa Naoto, 2013, Clin J Gastroenterol, V6, P309, DOI 10.1007/s12328-013-0404-z; Tekkis PP, 2005, BRIT J SURG, V92, P1270, DOI 10.1002/bjs.5071	4	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	MAR	2015	30	3					421	423		10.1007/s00384-014-1989-5		3	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CC0NM	WOS:000350032500018		
J	Jones, R; Majumdar, M; Nishimura, K				Jones, Ronald; Majumdar, Mukul; Nishimura, Kazuo			Market quality, trade and dynamics: A special issue in honor of Makoto Yano Introduction	INTERNATIONAL JOURNAL OF ECONOMIC THEORY			English	Editorial Material									[Jones, Ronald] Univ Rochester, Dept Econ, Rochester, NY 14627 USA; [Majumdar, Mukul] Cornell Univ, Dept Econ, Ithaca, NY 14853 USA; [Nishimura, Kazuo] Kobe Univ, RIEB, Kobe, Hyogo, Japan; [Nishimura, Kazuo] Kyoto Univ, KIER, Kyoto 6068501, Japan	Jones, R (reprint author), Univ Rochester, Dept Econ, Rochester, NY 14627 USA.	nishimura@rieb.kobe-u.ac.jp						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-7355	1742-7363		INT J ECON THEORY	Int. J. Econ. Theory	MAR	2015	11	1								10.1111/ijet.12048		6	Economics	Business & Economics	CB9TE	WOS:000349974900001		
J	Kamihigashi, T				Kamihigashi, Takashi			Multiple interior steady states in the Ramsey model with elastic labor supply	INTERNATIONAL JOURNAL OF ECONOMIC THEORY			English	Article						multiple steady states; Ramsey model; elastic labor supply; neoclassical growth	COMPETITIVE-EQUILIBRIUM; CAPITAL ACCUMULATION; AGGREGATIVE MODEL; OPTIMAL-GROWTH; STABILITY; UTILITY; CYCLES	In this paper we show that multiple interior steady states are possible in the Ramsey model with elastic labor supply. In particular, we establish the following three results: (i) for any discount factor and production function, there is a utility function such that a continuum of interior steady states exist; (ii) the number of interior steady states can also be any finite number; and (iii) for any discount factor and production function, there is a utility function such that there is no interior steady state. Some numerical examples are provided.	[Kamihigashi, Takashi] Kobe Univ, RIEB, Nada Ku, Kobe, Hyogo 657, Japan; [Kamihigashi, Takashi] IPAG Business Sch, Paris, France	Kamihigashi, T (reprint author), Kobe Univ, RIEB, Nada Ku, Kobe, Hyogo 657, Japan.	tkamihig@rieb.kobe-u.ac.jp					Le Van C, 2007, J MATH ECON, V43, P287, DOI 10.1016/j.jmateco.2006.06.003; BROCK WA, 1972, J ECON THEORY, V4, P479, DOI 10.1016/0022-0531(72)90135-4; Keane MP, 2011, J ECON LIT, V49, P961, DOI 10.1257/jel.49.4.961; CHRISTIANO LJ, 1992, AM ECON REV, V82, P430; Barro J., 2004, EC GROWTH; Bond E. W., 2014, INT J ECON THEORY, V10, P53; Bond EW, 2012, INT J ECON THEORY, V8, P197, DOI 10.1111/j.1742-7363.2012.00186.x; Bosi S, 2005, J MATH ECON, V41, P325, DOI 10.1016/jjmateco.2003.11.010; Cai YY, 2014, J MATH ECON, V50, P167, DOI 10.1016/j.jmateco.2013.08.002; Cass D., 1965, REV ECON STUD, V3, P233, DOI 10.2307/2295827; de Hek PA, 1998, J ECON DYN CONTROL, V23, P255, DOI 10.1016/S0165-1889(97)00119-X; DIAMOND PA, 1965, AM ECON REV, V55, P1126; GALOR O, 1989, J ECON THEORY, V49, P360, DOI 10.1016/0022-0531(89)90088-4; Kamihigashi T, 2005, J ECON DYN CONTROL, V29, P1313, DOI 10.1016/j.jedc.2004.07.007; KING RG, 1988, J MONETARY ECON, V21, P195, DOI 10.1016/0304-3932(88)90030-X; Koopmans T. C., 1965, STUDY WEEK ECONOMETR, P225; Kurz M., 1968, INT ECON REV, V9, P348, DOI 10.2307/2556231; Puterman ML, 2005, MARKOV DECISION PROC; Yano M, 1999, JPN ECON REV, V50, P398, DOI 10.1111/1468-5876.00129; Yano M, 2012, INT J ECON THEORY, V8, P213, DOI 10.1111/j.1742-7363.2012.00187.x	20	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-7355	1742-7363		INT J ECON THEORY	Int. J. Econ. Theory	MAR	2015	11	1								10.1111/ijet.12050		14	Economics	Business & Economics	CB9TE	WOS:000349974900003		
J	Maruta, T; Okada, A				Maruta, Toshimasa; Okada, Akira			Formation and long-run stability of cooperative groups in a social dilemma situation	INTERNATIONAL JOURNAL OF ECONOMIC THEORY			English	Article						adaptive play; cooperation; evolution; group formation; hawk-dove game; social dilemma; stochastic stability; voluntary participation	PUBLIC-GOODS; GAMES; PARTICIPATION; EQUILIBRIA	We consider the formation and long-run stability of cooperative groups in a social dilemma situation where the pursuit of individual interests conflicts with the maximization of social welfare. The adaptive play model of Young () is applied to a group formation game where voluntary participants negotiate to create an institution that enforces cooperation. For the class of group formation games with two types, the stochastically stable equilibrium can be characterized in terms of the Nash products of the associated hawk-dove games, which summarize the strategic interaction among the individuals in the game.	[Maruta, Toshimasa] Nihon Univ, Adv Res Inst Sci & Humanities, Chiyoda Ku, Tokyo, Japan; [Okada, Akira] Hitotsubashi Univ, Grad Sch Econ, Tokyo, Japan	Maruta, T (reprint author), Nihon Univ, Adv Res Inst Sci & Humanities, Chiyoda Ku, Tokyo, Japan.	maruta.toshimasa@nihon-u.ac.jp					Kosfeld M, 2009, AM ECON REV, V99, P1335, DOI 10.1257/aer.99.4.1335; Dixit A, 2000, J PUBLIC ECON, V76, P309, DOI 10.1016/S0047-2727(99)00089-4; Harsanyi J. C., 1988, SHAPE GEN THEORY EQU; Karp L, 2013, J ENVIRON ECON MANAG, V65, P326, DOI 10.1016/j.jeem.2012.09.002; KATZ ML, 1986, RAND J ECON, V17, P527; Kohler M, 2002, J INT ECON, V56, P371, DOI 10.1016/S0022-1996(01)00128-3; Maruta T., 2014, 20143 HIT U DEP EC; Maruta T, 2012, MATH SOC SCI, V63, P31, DOI 10.1016/j.mathsocsci.2011.08.007; MCKELVEY RD, 1995, GAME ECON BEHAV, V10, P6, DOI 10.1006/game.1995.1023; Myatt DP, 2008, REV ECON STUD, V75, P499, DOI 10.1111/j.1467-937X.2008.00482.x; PALFREY TR, 1984, J PUBLIC ECON, V24, P171, DOI 10.1016/0047-2727(84)90023-9; Selten R., 1973, INT J GAME THEORY, V2, P141, DOI 10.1007/BF01737566; Young P., 1993, ECONOMETRICA, V61, P57, DOI DOI 10.2307/2951778	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-7355	1742-7363		INT J ECON THEORY	Int. J. Econ. Theory	MAR	2015	11	1								10.1111/ijet.12056		16	Economics	Business & Economics	CB9TE	WOS:000349974900009		
J	Nishimura, K; Nourry, C; Seegmuller, T; Venditti, A				Nishimura, Kazuo; Nourry, Carine; Seegmuller, Thomas; Venditti, Alain			On the ( de) stabilizing effect of public debt in a Ramsey model with heterogeneous agents	INTERNATIONAL JOURNAL OF ECONOMIC THEORY			English	Article						endogenous cycles; heterogeneous agents; public spending; public debt; borrowing constraint	EQUILIBRIUM; DYNAMICS; GROWTH; LONG	We introduce public debt in a Ramsey model with heterogeneous agents and a public spending externality affecting utility which is financed by income tax and public debt. We show that public debt considered as a fixed portion of GDP can have a stabilizing or destabilizing effect, depending on some fundamental elasticities. When the public spending externality is weak and the elasticity of capital-labor substitution is low enough, public debt can only be destabilizing, generating damped or persistent macroeconomic fluctuations. However, when the public spending externality and the elasticity of capital-labor substitution are strong enough, public debt can be stabilizing, driving to monotone convergence an economy experiencing damped or persistent fluctuations without debt.	[Nishimura, Kazuo] Kobe Univ, RIEB, Kobe, Hyogo, Japan; [Nishimura, Kazuo] Kyoto Univ, KIER, Kyoto 6068501, Japan; [Nourry, Carine] Aix Marseille Univ, Aix Marseille Sch Econ, CNRS GREQAM, EHESS, Marseille, France; [Seegmuller, Thomas; Venditti, Alain] Aix Marseille Univ, Aix Marseille Sch Econ, CNRS GREQAM, Marseille, France; [Seegmuller, Thomas; Venditti, Alain] EHESS, Paris, France	Nishimura, K (reprint author), Kobe Univ, RIEB, Kobe, Hyogo, Japan.	alain.venditti@univ-amu.fr					BECKER RA, 1987, J ECON THEORY, V41, P173, DOI 10.1016/0022-0531(87)90011-1; Bosi S, 2010, J MATH ECON, V46, P475, DOI 10.1016/j.jmateco.2010.03.002; Krusell P, 2000, ECONOMETRICA, V68, P1029, DOI 10.1111/1468-0262.00150; BECKER RA, 1991, ECONOMETRICA, V59, P441, DOI 10.2307/2938264; Ni S, 1995, J MONETARY ECON, V36, P593, DOI 10.1016/0304-3932(95)01233-8; Reinhart CM, 2010, AM ECON REV, V100, P573, DOI 10.1257/aer.100.2.573; Ilzetzki E, 2013, J MONETARY ECON, V60, P239, DOI 10.1016/j.jmoneco.2012.10.011; Ramsey FP, 1928, ECON J, V38, P543, DOI 10.2307/2224098; Leon-Ledesma MA, 2010, AM ECON REV, V100, P1330, DOI 10.1257/aer.100.4.1330; Chirinko RS, 2008, J MACROECON, V30, P671, DOI 10.1016/j.jmacro.2007.10.010; Duffy J, 2000, J ECON GROWTH, V5, P87, DOI 10.1023/A:1009830421147; Becker R., 2012, EC THEORY IN PRESS; Becker R., 1994, ECON THEOR, V4, P719, DOI 10.1007/BF01212027; BECKER RA, 1980, Q J ECON, V95, P375, DOI 10.2307/1885506; Bom PRD, 2014, J ECON DYN CONTROL, V40, P334, DOI 10.1016/j.jedc.2014.01.018; Cazzavillan G, 1996, J ECON THEORY, V71, P394, DOI 10.1006/jeth.1996.0127; de la Croix D., 2002, THEORY EC GROWTH DYN; Herndon T., 2013, 322 U MASS AMH; Nishimura K., 2013, MACROECONOM IN PRESS; Sorger G., 1994, ECON THEOR, V4, P745, DOI 10.1007/BF01212028; Sutherland D., 2012, 10003 OECD EC DEP; Zhang JX, 2000, J ECON DYN CONTROL, V24, P227, DOI 10.1016/S0165-1889(98)00088-8	22	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-7355	1742-7363		INT J ECON THEORY	Int. J. Econ. Theory	MAR	2015	11	1					7	24		10.1111/ijet.12049		18	Economics	Business & Economics	CB9TE	WOS:000349974900002		
J	Omori, M; Hashi, A; Kondo, T; Katoh, R; Hirata, S				Omori, Makiko; Hashi, Akihiko; Kondo, Tetsuo; Katoh, Ryohei; Hirata, Shuji			Dysregulation of CDK Inhibitors and p53 in HPV-negative Endocervical Adenocarcinoma	INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY			English	Article						Cervical cancer; Adenocarcinoma; Human papillomavirus; Cyclin-dependent kinase inhibitor; p53	HUMAN-PAPILLOMAVIRUS INFECTION; DEPENDENT KINASE INHIBITORS; SQUAMOUS-CELL CARCINOMA; UTERINE CERVIX; PROTEIN EXPRESSION; GENE-MUTATIONS; TP53 GENE; CANCER; P16; DNA	Human papillomavirus (HPV)-negative adenocarcinoma (AC) is a minor subset of endocervical cancer, but its pathogenesis has yet to be elucidated. This study investigated the clinicopathologic features of HPV-negative endocervical AC (n = 14) in comparison with HPV-positive endocervical AC (n = 30), and further studied aberrations of cell-cycle regulators. Expression patterns of cyclin-dependent kinase inhibitors (p16, p14, p27, and p21) and p53 were evaluated immunohistochemically, and nuclear high-risk HPV DNA signals were detected by in situ hybridization and polymerase chain reaction. Immunoexpression of p16, p14, p27, p21, and p53 were observed in 90%, 67%, 77%, 40%, and 20% of HPV-positive ACs, and in 0%, 0%, 29%, 14%, and 57% of HPV-negative ACs, respectively. A higher frequency of lymph node metastasis and worse prognosis were significantly associated with HPV-negative AC. Our findings suggest that alteration of cyclin-dependent kinase inhibitors and p53 status may contribute to carcinogenesis and the clinical behavior of HPV-negative AC of the uterine cervix.	[Omori, Makiko; Hashi, Akihiko; Hirata, Shuji] Univ Yamanashi, Dept Obstet & Gynecol, Fac Med, Chuo City, Yamanashi 4093898, Japan; [Kondo, Tetsuo; Katoh, Ryohei] Univ Yamanashi, Fac Med, Dept Pathol, Chuo City, Yamanashi 4093898, Japan	Omori, M (reprint author), Univ Yamanashi, Dept Obstet & Gynecol, Fac Med, 1110 Simokato, Chuo City, Yamanashi 4093898, Japan.	msasaki@yamanashi.ac.jp					Andersson S, 2006, MED ONCOL, V23, P113, DOI 10.1385/MO:23:1:113; LI Y, 1994, CANCER RES, V54, P6078; Pirog EC, 2000, AM J PATHOL, V157, P1055, DOI 10.1016/S0002-9440(10)64619-6; ZerfassThome K, 1996, ONCOGENE, V13, P2323; Tornesello ML, 2013, GYNECOL ONCOL, V128, P442, DOI 10.1016/j.ygyno.2012.11.017; Khleif SN, 1996, P NATL ACAD SCI USA, V93, P4350, DOI 10.1073/pnas.93.9.4350; Sano T, 1998, PATHOL INT, V48, P580, DOI 10.1111/j.1440-1827.1998.tb03954.x; Wright TC, 2004, OBSTET GYNECOL, V103, P304, DOI 10.1097/01.AOG.0000109426.82624.f8; Wang SS, 2004, CANCER, V100, P1035, DOI 10.1002/cncr.20064; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Houghton O, 2010, HISTOPATHOLOGY, V57, P342, DOI 10.1111/j.1365-2559.2010.03632.x; Andersson S, 2001, EUR J CANCER, V37, P246, DOI 10.1016/S0959-8049(00)00376-2; Zehbe I, 1999, ONCOGENE, V18, P2201, DOI 10.1038/sj.onc.1202549; Bosch FX, 2002, J CLIN PATHOL, V55, P244; zur Hausen H, 2000, J NATL CANCER I, V92, P690; Kojima A, 2007, AM J SURG PATHOL, V31, P664, DOI 10.1097/01.pas.0000213434.91868.b0; Milde-Langosch K, 2001, VIRCHOWS ARCH, V439, P55, DOI 10.1007/s004280100439; BREMER GL, 1995, EUR J OBSTET GYN R B, V63, P55, DOI 10.1016/0301-2115(95)02225-V; Cho NH, 2002, YONSEI MED J, V43, P722; CROOK T, 1992, LANCET, V339, P1070, DOI 10.1016/0140-6736(92)90662-M; Helland A, 1998, BRIT J CANCER, V78, P69, DOI 10.1038/bjc.1998.444; Howley P M, 1991, Princess Takamatsu Symp, V22, P239; IKENBERG H, 1995, CANCER, V76, P57, DOI 10.1002/1097-0142(19950701)76:1<57::AID-CNCR2820760108>3.0.CO;2-4; JIKO K, 1994, INT J CANCER, V59, P601, DOI 10.1002/ijc.2910590505; Kim JW, 1998, GYNECOL ONCOL, V70, P75, DOI 10.1006/gyno.1998.5041; KING SA, 1995, CANCER, V75, P2700, DOI 10.1002/1097-0142(19950601)75:11<2700::AID-CNCR2820751110>3.0.CO;2-I; Lizard G, 2001, DIAGN CYTOPATHOL, V24, P112, DOI 10.1002/1097-0339(200102)24:2<112::AID-DC1020>3.0.CO;2-6; MILDELANGOSCH K, 1995, INT J CANCER, V63, P639, DOI 10.1002/ijc.2910630507; Ngan HYS, 1999, EUR J CANCER, V35, P481, DOI 10.1016/S0959-8049(98)00407-9; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PARK DJ, 1994, ONCOGENE, V9, P205; Reimers LL, 2009, CANCER EPIDEM BIOMAR, V18, P792, DOI 10.1158/1055-9965.EPI-08-0965; RIOU G, 1990, LANCET, V335, P1171; Romanov VS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P575, DOI 10.1134/S000629791206003X; Ruas M, 1998, BIOCHIM BIOPHYS ACTA, V1378, P115, DOI 10.1016/S0304-419X(98)00017-1; Sano T, 2002, PATHOL INT, V52, P375, DOI 10.1046/j.1440-1827.2002.01359.x; Tavassoli FA, 2003, WHO CLASSIFICATION T, P272; Tenti P, 1998, AM J PATHOL, V152, P1057; The GlaxoSmithKline Vaccine HPV-007 Study Group, 2009, LANCET, V374, P1975; TSUDA H, 1992, JPN J CANCER RES, V83, P1184; TSUDA H, 1995, JPN J CANCER RES, V86, P1049; Uchiyama M, 1997, GYNECOL ONCOL, V65, P23, DOI 10.1006/gyno.1997.4613; WHO, GUID NOT COMPR CERV; ZurHausen H, 1996, BIOCHIM BIOPHYS ACTA, V1288, P55	44	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-1691	1538-7151		INT J GYNECOL PATHOL	Int. J. Gynecol. Pathol.	MAR	2015	34	2					196	203		10.1097/PGP.0000000000000121		8	Obstetrics & Gynecology; Pathology	Obstetrics & Gynecology; Pathology	CB7AP	WOS:000349778600015		
J	Imaizumi, K; Taniguchi, K; Ogawa, Y; Matsuzaki, K; Nagata, T; Mochimaru, M; Kouchi, M				Imaizumi, Kazuhiko; Taniguchi, Kei; Ogawa, Yoshinori; Matsuzaki, Kazutoshi; Nagata, Takeshi; Mochimaru, Masaaki; Kouchi, Makiko			Three-dimensional analyses of aging-induced alterations in facial shape: a longitudinal study of 171 Japanese males	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Facial aging; Homologous model; Procrustes superimposition; Forensic facial comparison	AGE; FACE; SUPERIMPOSITION; PORNOGRAPHY; WRINKLES; FORMS; CHILD; SKIN	We sought to generate data to facilitate forensic facial comparisons. Specifically, we conducted a longitudinal study of alterations in face shape induced by aging. We obtained two three-dimensional facial shape measurements in 171 Japanese males at intervals of approximately 10 years. With this data, we created a homologous model consisting of 10,741 data points for each face based on 33 anatomical landmarks. We averaged the movements of corresponding data points between the two homologous models for each individual and used this data to predict up to 30 years of face aging in an average Japanese male. We clearly identified aging-induced shape changes, such as drooping and denting of the facial folds, drooping of the upper lip, and projection of the lower eyelid, in the virtually aged model. A quantitative comparison of aging-induced shape alterations among three age groups (individuals in their 20's, 30's, and 40-50's) showed that these alterations accelerated more quickly as age increased. Using our predictive model, we conducted a preliminary study focused on facial shape alterations induced by reductions in body weight. Our findings indicated that our proposed method would also be valid for this purpose.	[Imaizumi, Kazuhiko; Taniguchi, Kei; Ogawa, Yoshinori] Natl Res Inst Police Sci, Forens Biol Sect 2, Kashiwa, Chiba 2770882, Japan; [Matsuzaki, Kazutoshi; Nagata, Takeshi] Mizuho Informat & Res Inst Inc, Chiyoda Ku, Tokyo 1018443, Japan; [Nagata, Takeshi] Univ Tsukuba, PhD Program Human Biol, Sch Integrat & Global Majors, Tsukuba, Ibaraki 3058577, Japan; [Mochimaru, Masaaki; Kouchi, Makiko] Natl Inst Adv Ind Sci & Technol, Digital Human Res Ctr, Tokyo 1350064, Japan	Imaizumi, K (reprint author), Natl Res Inst Police Sci, Forens Biol Sect 2, 6-3-1 Kashiwanoha, Kashiwa, Chiba 2770882, Japan.	imaizumi@nrips.go.jp			National Research Institute of Police Science	This study was supported by the research fund of the National Research Institute of Police Science.	Luebberding S, 2014, DERMATOL SURG, V40, P22, DOI 10.1111/dsu.12377; Vanezis P, 1996, SCI JUSTICE, V36, P27, DOI 10.1016/S1355-0306(96)72551-0; Mochimaru M, 2000, ERGONOMICS, V43, P1301, DOI 10.1080/001401300421752; Albert AM, 2007, FORENSIC SCI INT, V172, P1, DOI 10.1016/j.forsciint.2007.03.015; Ritz-Timme S, 2011, INT J LEGAL MED, V125, P301, DOI 10.1007/s00414-010-0446-4; Pessa JE, 2002, PLAST RECONSTR SURG, V109, P751, DOI 10.1097/00006534-200202000-00051; Wysong A, 2013, DERMATOL SURG, V39, P1895, DOI 10.1111/dsu.12362; Akgul AA, 2002, AM J ORTHOD DENTOFAC, V122, P512, DOI 10.1067/mod.2002.128861; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Davis JP, 2012, CRANIOFACIAL IDENTIFICATION, P136; Hatzis J, 2004, MICRON, V35, P201, DOI 10.1016/j.micron.2003.11.007; Richard MJ, 2009, OPHTHAL PLAST RECONS, V25, P382, DOI 10.1097/IOP.0b013e3181b2f766; Vanezis P, 1996, J FORENSIC SCI, V41, P786; Wei R, 2011, AUST DENT J, V56, P141, DOI 10.1111/j.1834-7819.2011.01315.x; Bastir M, 2007, P R SOC B, V274, P1125, DOI 10.1098/rspb.2006.0448; Bishara SE, 1998, AM J ORTHOD DENTOFAC, V114, P698, DOI 10.1016/S0889-5406(98)70203-3; BURKE PH, 1989, AM J PHYS ANTHROPOL, V79, P281, DOI 10.1002/ajpa.1330790304; Campomanes-Alvarez BR, 2015, INT J LEGAL MED, V129, P227, DOI 10.1007/s00414-014-1002-4; Coleman Sydney R, 2006, Aesthet Surg J, V26, pS4, DOI 10.1016/j.asj.2005.09.012; Cummaudo M, 2013, INT J LEGAL MED, V127, P699, DOI 10.1007/s00414-013-0850-7; Feik SA, 1998, CRANIOFACIAL IDENTIFICATION IN FORENSIC MEDICINE, P203; Forrsberg C, 1991, EUR J ORTHODONT, V13, P249; Inagaki T, 2004, P 2004 JSPE SPRING M, P271; Kahn David M, 2008, Aesthet Surg J, V28, P258, DOI 10.1016/j.asj.2008.02.007; Kato A., 2011, DENT ANTHR, V24, P1; Knussmann R, 1988, ANTHROPOLOGIE, VI, P368; Knussmann R, 1988, ANTHR HDB VERGLEICHE, VI, P232; Kouchi M, 2004, ERGONOMICS, V47, P1499, DOI 10.1080/00140130412331290907; Kouchi M, 2006, 2006012353 SAE; Krejci-Papa NC, 2006, SKIN AGING, P133; Krutmann J, 2006, SKIN AGING, P33, DOI 10.1007/3-540-32953-6_4; Liu F, 2012, PLOS GENET, V8, P1; Mayer F, 2014, INT J LEGAL MED, V128, P649, DOI 10.1007/s00414-014-1012-2; Miyasaka S, 1999, Forensic Sci Rev, V11, P51; Neave R, 1998, CRANIOFACIAL IDENTIFICATION IN FORENSIC MEDICINE, P225; Nkengne Alex, 2013, Skinmed, V11, P281; Okada HC, 2013, PLAST RECONSTR SURG, V132, P1085, DOI 10.1097/PRS.0b013e3182a4c20a; Papageorgiou KI, 2012, AESTHET SURG J, V32, P46, DOI 10.1177/1090820X11430829; Raschke GF, 2014, J CRANIO MAXILL SURG, V42, pE312, DOI 10.1016/j.jcms.2013.10.012; Ratnayake M, 2014, INT J LEGAL MED, V128, P803, DOI 10.1007/s00414-013-0875-y; Saito N, 2008, SKIN RES TECHNOL, V14, P287, DOI 10.1111/j.1600-0846.2008.00292.x; Schwidetzky I, 1988, ANTHR HDB VERGLEICHE, VI, P359; Shroeder P, 2006, SKIN AGING, P46; Taylor K., 2001, FORENSIC ART ILLUSTR; Tazoe Y, 2010, P MIRU2010; Truswell WH, 2013, FACIAL PLAST SURG, V29, P3, DOI 10.1055/s-0033-1333840; Tschachler E, 2006, SKIN AGING, P23, DOI 10.1007/3-540-32953-6_3; Tsukahara K, 2004, J COSMET SCI, V55, P373; Tsukahara K, 2000, J COSMET SCI, V51, P127; Tsukahara K, 2002, Int J Cosmet Sci, V24, P71, DOI 10.1046/j.1467-2494.2002.00122.x; Wulc AE, 2012, MIDFACIAL REJUVENATION, P15, DOI 10.1007/978-1-4614-1007-2_2; Yamazaki S, 2013, P 2 DIG HUM MOD S 20; Yoshino M, 2004, FORENSIC SCI REV, V16, P103; Yoshino M, 2005, COMPUTER GRAPHIC FAC, P347; YOUSIF NJ, 1994, PLAST RECONSTR SURG, V93, P70, DOI 10.1097/00006534-199401000-00010; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1; Zimbler M S, 2001, Facial Plast Surg Clin North Am, V9, P179	57	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	MAR	2015	129	2					385	393		10.1007/s00414-014-1114-x		9	Medicine, Legal	Legal Medicine	CC0NP	WOS:000350032800022		
J	Garrido-Vega, P; Jimenez, CHO; de los Rios, JLDP; Morita, M				Garrido-Vega, Pedro; Ortega Jimenez, Cesar H.; Perez de los Rios, Jose Luis Diez; Morita, Michiya			Implementation of technology and production strategy practices: Relationship levels in different industries	INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS			English	Article						Production strategy; Technology; Strategic focus; Strategic planning; Fit; Interdependence	JAPANESE MANUFACTURING COMPANIES; EMPIRICAL-ANALYSIS; ENVIRONMENTAL UNCERTAINTY; PLANT PERFORMANCE; FIRM PERFORMANCE; MANAGEMENT; IMPACT; FIT; PERSPECTIVE; DESIGN	Many industries face open, global markets with requirements for rapid response and low costs. Given the major role that technology plays in business competitiveness, proper technology management (T) in combination with a good production strategy (S), is important to address current challenges. This paper analyzes the nature of T & S implementation in different industrial contexts to examine whether there are differences in how T & S are implemented in different sectors, whether implementation is linked to performance, and whether contextual factors explain the differences. A database from the High Performance Manufacturing Project is used to test the research questions based on a survey of 267 plants across nine countries in three different industrial contexts (machinery, electronics and auto suppliers). The findings show some differences between the T and S practice modes in the three industries. T and S implementation is observed to be related to performance, but not in the same way. Three of the eight contextual factors are found to differ in the three sectors, which may explain the differences found in T and S implementation. The results imply that plants should consider the joint implementation of T and S as their interdependencies may affect performance, outweighing the possible differences between industries in which plants operate. However, when implementing a specific technology practice, not all plants necessarily consider the same production strategy practices across industries. Likewise, when adopting a certain production strategy, it is not necessarily influenced by the same technology practices across industries. (C) 2014 Elsevier B.V. All rights reserved.	[Ortega Jimenez, Cesar H.] UNAH, IIES, Tegucigalpa, Honduras; [Garrido-Vega, Pedro] Univ Seville, Fac Ciencias Econ & Emppresariales, Dept Econ Financiera & Direcc Operac, Grp Invest Direcc Operac Ind & Serv GIDEAO, Seville 41018, Spain; [Perez de los Rios, Jose Luis Diez] Univ Seville, Dept Econ Aplicada 1, Fac Ciencias Econ & Empresariales, Seville 41018, Spain; [Morita, Michiya] Gakushuin Univ, Fac Econ, Tokyo 171, Japan	Jimenez, CHO (reprint author), UNAH, IIES, Ciudad Univ,Blvd Suyapa, Tegucigalpa, Honduras.	pgarrido@us.es; cortega@iies-unah.org; jperez@us.es; michiya.morita@gakushuin.ac.jp					Abdel-Maksoud A., 2010, BR ACCOUNT REV, V42, P36; Adamides ED, 2009, INT J PROD ECON, V121, P301, DOI 10.1016/j.ijpe.2006.11.025; Ahmad S, 2003, J ENG TECHNOL MANAGE, V20, P161, DOI 10.1016/S0923-4748(03)00017-1; VENKATRAMAN N, 1989, ACAD MANAGE REV, V14, P423, DOI 10.5465/AMR.1989.4279078; Cua KO, 2001, J OPER MANAG, V19, P675, DOI 10.1016/S0272-6963(01)00066-3; SWAMIDASS PM, 1987, MANAGE SCI, V33, P509, DOI 10.1287/mnsc.33.4.509; Goodale JC, 2011, J OPER MANAG, V29, P116, DOI 10.1016/j.jom.2010.07.005; Boyle E, 2008, INT J PROD ECON, V114, P347, DOI 10.1016/j.ijpe.2008.01.010; Hron K, 2010, COMPUT STAT DATA AN, V54, P3095, DOI 10.1016/j.csda.2009.11.023; Morita M, 2011, INT J PROD ECON, V133, P530, DOI 10.1016/j.ijpe.2010.09.003; [Anonymous], 1951, PSYCHOMETRIKA; Yusuf YY, 1999, INT J PROD ECON, V62, P33, DOI 10.1016/S0925-5273(98)00219-9; Amoako-Gyampah K, 2008, INT J PROD ECON, V111, P575, DOI 10.1016/j.ijpe.2007.02.030; Fynes B, 2005, INT J PROD ECON, V96, P339, DOI 10.1016/j.ijpe.2004.05.008; Torkkeli M, 2002, INT J PROD ECON, V77, P271, DOI 10.1016/S0925-5273(01)00227-4; Jimenez CHO, 2011, INT J PROD ECON, V133, P508, DOI 10.1016/j.ijpe.2011.04.011; Rho BH, 2001, INT J PROD ECON, V70, P89, DOI 10.1016/S0925-5273(00)00049-9; Mohanty RP, 1998, INT J PROD ECON, V55, P295, DOI 10.1016/S0925-5273(98)00075-9; Fine CH, 2000, PROD OPER MANAG, V9, P213; Jacobs M, 2011, J PROD INNOVAT MANAG, V28, P123, DOI 10.1111/j.1540-5885.2010.00785.x; ITAMI H, 1992, STRATEGIC MANAGE J, V13, P119, DOI 10.1002/smj.4250130909; Phan AC, 2011, INT J PROD ECON, V133, P518, DOI 10.1016/j.ijpe.2011.01.024; Bozarth CC, 2009, J OPER MANAG, V27, P78, DOI 10.1016/j.jom.2008.07.003; Yarbrough L, 2011, J ACAD MARKET SCI, V39, P555, DOI 10.1007/s11747-010-0238-x; Rauniar R, 2012, INT J PROD ECON, V135, P939, DOI 10.1016/j.ijpe.2011.11.009; Trentin A, 2012, INT J PROD ECON, V135, P850, DOI 10.1016/j.ijpe.2011.10.023; Aoki K., 2013, INT J PROD EC B, V147, P373; Banerjee SK, 2000, INT J PROD ECON, V64, P79, DOI 10.1016/S0925-5273(99)00046-8; Bates K., 2001, HIGH PERFORMANCE MAN, P42; Bates KA, 1995, MANAGE SCI, V41, P1565, DOI 10.1287/mnsc.41.10.1565; Batista G., 2002, SER FRONT ARTIF INTE, V87, P251; Cua K. O., 2006, Quality Management Journal, V13; Dean JW, 1996, STRATEGIC MANAGE J, V17, P459, DOI 10.1002/(SICI)1097-0266(199606)17:6<459::AID-SMJ823>3.0.CO;2-8; Dekkers R, 2013, INT J PROD ECON, V144, P316, DOI 10.1016/j.ijpe.2013.02.020; de Vries J, 2005, INT J PROD ECON, V93-4, P273, DOI 10.1016/j.ijpe.2004.06.024; Drazin R., 1985, ADM SCI Q, V30, P514, DOI DOI 10.2307/2392695; Fang EA, 2013, INT J PROD ECON, V145, P733, DOI 10.1016/j.ijpe.2013.06.003; Flynn B. B., 1994, Journal of Operations Management, V11, DOI 10.1016/S0272-6963(97)90004-8; Gerdin J., 2005, EUROPEAN ACCOUNTING, V14, P297, DOI [10.1080/09638180500043485, DOI 10.1080/09638180500043485]; Gerdin J, 2005, ACCOUNT ORG SOC, V30, P99, DOI 10.1016/j.aos.2003.11.003; Hallgren M, 2006, INT J PROD ECON, V104, P113, DOI 10.1016/j.ijpe.2005.09.004; Hallikas J, 2014, INT J PROD ECON, V147, P53, DOI 10.1016/j.ijpe.2012.10.005; Han CD, 2012, INT J PROD ECON, V138, P159, DOI 10.1016/j.ijpe.2012.03.015; Hayes R.H., 1984, RESTORING OUR COMPET; Heim GR, 2010, J OPER MANAG, V28, P144, DOI 10.1016/j.jom.2009.09.005; Helkio P, 2013, INT J OPER PROD MAN, V33, P216, DOI 10.1108/01443571311295644; Hill T, 2000, MANUFACTURING STRATE; Hill T., 2009, MANUFACTURING STRATE; Jayaram J, 2013, INT J PROD ECON, V146, P59, DOI 10.1016/j.ijpe.2013.03.024; Jonsson P., 2004, Proceedings. 10th International Symposium on Software Metrics; Kandemir D, 2012, J PROD INNOVAT MANAG, V29, P608, DOI 10.1111/j.1540-5885.2012.00928.x; Kemppainen K, 2008, INT J PROD ECON, V111, P713, DOI 10.1016/j.ijpe.2007.03.020; Ketokivi M, 2004, INT J OPER PROD MAN, V24, P171, DOI 10.1108/01443570410514876; KOTHA S, 1989, STRATEGIC MANAGE J, V10, P211, DOI 10.1002/smj.4250100303; Lawrence P. R., 1967, ORG ENV; Machuca JAD, 2011, INT J PROD ECON, V133, P541, DOI 10.1016/j.ijpe.2010.12.010; Maier F., 2001, HIGH PERFORMANCE MAN, P93; Maier F.H, 1998, P INT SYST DYN C QUE; Maier F.H., 1998, 403398 WP MIT SOL SC; Maier F.H., 1997, SYSTEMS APPROACH LEA, V2, P667; Mallick DN, 2005, PROD OPER MANAG, V14, P142; Manthou V, 2001, INT J PROD ECON, V71, P157, DOI 10.1016/S0925-5273(00)00115-8; Matsui Y, 2007, INT J PROD ECON, V108, P153, DOI 10.1016/j.ijpe.2006.12.035; Matsui Y, 2002, INT J PROD ECON, V80, P185, DOI 10.1016/S0925-5273(02)00317-1; Matsui Y, 2007, INT J PROD ECON, V110, P16, DOI 10.1016/j.ijpe.2007.02.007; McKone KE, 2002, INT J OPER PROD MAN, V22, P772, DOI 10.1108/01443570210433544; Meilich O, 2006, ORGAN RES METHODS, V9, P161, DOI 10.1177/1094428105284915; Muyanja AW, 2013, INT J PROD ECON, V144, P533, DOI 10.1016/j.ijpe.2013.04.006; Nunnally J.C., 1967, PSYCHOMETRIC THEORY; Ortega C.H., 2009, EC POLIT EC ADM, V47, P133; Ortega CH, 2012, INT J OPER PROD MAN, V32, P958, DOI 10.1108/01443571211253146; Ortega C.H., 2010, EC ADM EC POLIT, V48, P97; RHO BH, 1994, INT J PROD ECON, V37, P27, DOI 10.1016/0925-5273(94)90005-1; Ringen G, 2012, PROC CIRP, V3, P513, DOI 10.1016/j.procir.2012.07.088; Schroeder R. G., 2001, HIGH PERFORMANCE MAN; Singh Bikram Jit, 2010, International Journal of Six Sigma and Competitive Advantage, V6, DOI 10.1504/IJSSCA.2010.034855; Singh Rajesh K, 2008, Benchmarking: An International Journal, V15, DOI 10.1108/14635770810903132; Skinner W., 1969, HARVARD BUSINESS MAY, P136; Thompson J, 1967, ORG ACTION SOCIAL SC; Thun JH, 2008, INT J PROD ECON, V113, P370, DOI 10.1016/j.ijpe.2007.09.005; UMANATH NS, 1992, DECISION SCI, V23, P819, DOI 10.1111/j.1540-5915.1992.tb00421.x; van Veen-Dirks P, 2005, INT J PROD ECON, V93-4, P263, DOI 10.1016/j.ijpe.2004.06.026; Yang MS, 2006, INT J PROD ECON, V103, P185, DOI 10.1016/j.ijpe.2005.06.003; ZAHRA SA, 1993, STRATEGIC MANAGE J, V14, P451, DOI 10.1002/smj.4250140605; Zangiski MADG, 2013, INT J PROD ECON, V144, P76, DOI 10.1016/j.ijpe.2013.01.021	85	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-5273	1873-7579		INT J PROD ECON	Int. J. Prod. Econ.	MAR	2015	161						201	216		10.1016/j.ijpe.2014.07.011		16	Engineering, Industrial; Engineering, Manufacturing; Operations Research & Management Science	Engineering; Operations Research & Management Science	CB8KT	WOS:000349879200018		
J	Matsuo, H				Matsuo, Hirofumi			Implications of the Tohoku earthquake for Toyota's coordination mechanism: Supply chain disruption of automotive semiconductors	INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS			English	Article						Supply chain management; Disruption risk management; Automotive electronics; Toyota Production System	RISK-MANAGEMENT; PRODUCT ARCHITECTURE; MITIGATION	The 2011 Tohoku Earthquake damaged severely and extensively a large geographical area and caused devastating disruptions to the industrial supply chains in Japan. This paper focuses on a case of supply disruption of the automotive microcontroller units, which were produced by Renesas Electronics and supplied to Toyota via its first tier vendors like Denso. The first purpose of this paper is to describe, from a supply chain management view point, what happened and what actions these companies took, and to understand why it took three months for Toyota to recover to its pre-earthquake production level. Since many things happened, we apply a framework of SCM hierarchy to analyze the issues from the perspective of execution, design, strategy and sustainability. The second purpose is to identify based on this case analysis what functions are missing in the supply chain coordination mechanism of Toyota Production System, where the coordination is propagating from Toyota to upstream suppliers through the close interaction between the successive layers of its multi-layered supplier network. This case analysis implies that direct control functions need to be added to alleviate the disruption risk and secure the supply of key parts and materials. The third purpose of this paper is to show by presenting a detailed case analysis that the underlying characteristics of supply chain structure and infrastructure should be linked with the resilience tactics adopted. (C) 2014 Elsevier B.V. All rights reserved.	Kobe Univ, Grad Sch Business Adm, Nada Ku, Kobe, Hyogo 6578501, Japan	Matsuo, H (reprint author), Kobe Univ, Grad Sch Business Adm, Nada Ku, 2-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	matsuoh@kobe-u.ac.jp					Craighead CW, 2007, DECISION SCI, V38, P131, DOI 10.1111/j.1540-5915.2007.00151.x; Tomlin B, 2006, MANAGE SCI, V52, P639, DOI 10.1287/mnsc.11060.0515; Tang O, 2011, INT J PROD ECON, V133, P25, DOI 10.1016/j.ijpe.2010.06.013; Ponomarov SY, 2009, INT J LOGIST MANAG, V20, P124, DOI 10.1108/09574090910954873; Sheffi Y, 2005, MIT SLOAN MANAGE REV, V47, P41; Rao S, 2009, INT J LOGIST MANAG, V20, P97, DOI 10.1108/09574090910954864; Fixson SK, 2005, J OPER MANAG, V23, P345, DOI 10.1016/j.jom.2004.08.006; Nishiguchi T, 1998, SLOAN MANAGE REV, V40, P49; Knemeyer AM, 2009, J OPER MANAG, V27, P141, DOI 10.1016/j.jom.2008.06.002; Kleindorfer PR, 2005, PROD OPER MANAG, V14, P53; Chopra S, 2004, MIT SLOAN MANAGE REV, V46, P53; Thun JH, 2011, INT J PROD ECON, V131, P242, DOI 10.1016/j.ijpe.2009.10.010; Brindley C., 2004, SUPPLY CHAIN RISK; Christopher M., 2004, INT J LOGIST MANAG, V15, P1, DOI [10.1108/09574090410700275, DOI 10.1108/09574090410700275]; Fujimoto T., 1999, EVOLUTION MANUFACTUR; Fujimoto T., 2011, DISCUSSION PAPER SER, V362; Fujimoto T., 2001, INT J AUTOMOTIVE TEC, V1, P379, DOI 10.1504/IJATM.2001.000047; IC Insights, 2012, STRAT REV 2011 12; IC Insights, 2011, STRAT REV 2010 11; Matsuo H., 2008, SYSTEMS CONTROL INFO, V52, P200; Matsuo H., 2012, P 4 PROD OP MAN WORL; McIvor R., 1997, TECHNOLOGY OPERATION, V1, P1; McMillan J., 1992, GAMES STRATEGIES MAN; METI, 2010, EMB SOFTW SOURC JAP; NIED, 2011, 2011 PAC COAST TOH E; Sheffi Y., 2005, RESILIENT ENTERPRISE; Sodhi MMS, 2012, MANAGING SUPPLY CHAI; Tang CS, 2006, INT J PROD ECON, V103, P451, DOI 10.1016/j.ijpe.2005.12.006; Tokuda A., 2008, AUTOMOTIVE ELECT ITS; Ulrich K. T., 2000, PRODUCT DESIGN DEV; ULRICH K, 1995, RES POLICY, V24, P419, DOI 10.1016/0048-7333(94)00775-3; van Hoek R. I., 1998, INT J LOGIST MANAG, V9, P35; Wiegel W., 2010, SUPPLY CHAIN RESILIE; Wu XL, 2013, M&SOM-MANUF SERV OP, V15, P458, DOI 10.1287/msom.2013.0435; Wu XL, 2014, EUR J OPER RES, V237, P887, DOI 10.1016/j.ejor.2014.02.050; Yunokami T., 2011, ELECT J          JUN, P36	36	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-5273	1873-7579		INT J PROD ECON	Int. J. Prod. Econ.	MAR	2015	161						217	227		10.1016/j.ijpe.2014.07.010		11	Engineering, Industrial; Engineering, Manufacturing; Operations Research & Management Science	Engineering; Operations Research & Management Science	CB8KT	WOS:000349879200019		
J	Morita, M; Machuca, JAD; Flynn, EJ; de los Rios, JLP				Morita, Michiya; Machuca, Jose A. D.; Flynn, E. James; Perez de los Rios, Jose Luis			Aligning product characteristics and the supply chain process - A normative perspective	INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS			English	Article						Product strategy; Supply chain strategy; Strategic linkage; Product life cycle; Little's law; Supply chain management	COMPETITIVE ADVANTAGE; LIFE-CYCLE; MANUFACTURING PERFORMANCE; STRATEGY; IMPACT; AGILE; CAPABILITIES; MANAGEMENT; ALIGNMENT; MODEL	The fit between designed product characteristics and the supply chain process has been researched in the operations and supply chain management literature as an important strategic part of operations, but how to secure this fit is still a pending issue. The aim of this study is twofold: (a) to examine the relationship between product characteristics and the supply chain process; and (b) based on the research results, to explore how their alignment should be constructed. This is done by a survey-based experimental analysis using a normative model of supply chain management, which is motivated by consideration of Little's law in a supply chain context. The study provides confirmatory results of past research as well as new results regarding the relationship between product characteristics and the supply chain process. The research introduces the concept of absolute supply chain orientation strategy (ASCOS), which focuses on perpetual improvements to lead-time, just-in-time control, quality and demand variability to ensure the fit between product characteristics and the supply chain process, as a culture or mind-set that should be encouraged in the firm. The research proposes that ASCOS leads to high competitiveness over time. The results also indicate that the inter-functional product development capability contributes to the development as well as to the implementation of the absolute supply chain strategy. (C) 2014 Elsevier B.V. All rights reserved.	[Morita, Michiya] Gakushuin Univ, Fac Econ, Toshima Ku, Tokyo 1718588, Japan; [Machuca, Jose A. D.] Univ Seville, Dept Econ Financiera & Direcc Operac FCEE, Seville 41018, Spain; [Flynn, E. James] Purdue Indiana Univ, Kelly Sch Business, Indianapolis, IN 46202 USA; [Perez de los Rios, Jose Luis] Univ Seville, Fac CienciasEcon Empresariales, Seville 41018, Spain	Morita, M (reprint author), Gakushuin Univ, Fac Econ, Toshima Ku, 1-5-1 Mejiro, Tokyo 1718588, Japan.	michiya.morita@gakushuin.ac.jp					Anderson C. R., 1984, ACAD MANAGE J, V24, P5; Swafford PM, 2006, J OPER MANAG, V24, P170, DOI 10.1016/j.jom.2005.05.002; Cua KO, 2001, J OPER MANAG, V19, P675, DOI 10.1016/S0272-6963(01)00066-3; Aitken J, 2003, INT J PROD ECON, V85, P127, DOI 10.1016/S0925-5273(03)00105-1; Lejeune MA, 2005, J OPER MANAG, V23, P81, DOI 10.1016/j.jom.2004.09.004; Kaufman A, 2000, STRATEGIC MANAGE J, V21, P649, DOI 10.1002/(SICI)1097-0266(200006)21:6<649::AID-SMJ108>3.0.CO;2-U; Stevenson M, 2007, INT J OPER PROD MAN, V27, P685, DOI 10.1108/01443570710756956; Rosenzweig ED, 2003, J OPER MANAG, V21, P437, DOI 10.1016/S0272-6963(03)00037-8; Bruce M, 2004, INT J OPER PROD MAN, V24, P151, DOI 10.1108/01443570410514867; Steckel JH, 2004, MANAGE SCI, V50, P458, DOI 10.1287/mnsc.1030.0169; Nepal B, 2012, INT J PROD ECON, V136, P318, DOI 10.1016/j.ijpe.2011.12.018; WHEELWRIGHT SC, 1985, HARVARD BUS REV, V63, P99; Kroll M, 1999, STRATEGIC MANAGE J, V20, P375, DOI 10.1002/(SICI)1097-0266(199904)20:4<375::AID-SMJ15>3.0.CO;2-Y; Khurana A, 1997, SLOAN MANAGE REV, V38, P103; Fixson SK, 2005, J OPER MANAG, V23, P345, DOI 10.1016/j.jom.2004.08.006; Li SH, 2006, OMEGA-INT J MANAGE S, V34, P107, DOI 10.1016/j.omega.2004.08.002; Salvador F, 2007, IEEE T ENG MANAGE, V54, P219, DOI 10.1109/TEM.2007.893996; Brown S, 2007, INT J OPER PROD MAN, V27, P282, DOI 10.1108/01443570710725554; Lee HL, 1997, MANAGE SCI, V43, P546, DOI 10.1287/mnsc.43.4.546; Salvador F, 2002, J OPER MANAG, V20, P549, DOI 10.1016/S0272-6963(02)00027-X; Lee HL, 2002, CALIF MANAGE REV, V44, P105; Krishnamurthy R, 2007, INT J OPER PROD MAN, V27, P588, DOI 10.1108/01443570710750277; Lee HL, 2004, HARVARD BUS REV, V82, P102; Li D, 2001, INT J PROD ECON, V73, P29, DOI 10.1016/S0925-5273(01)00094-9; Tatikonda MV, 2001, MANAGE SCI, V47, P151, DOI 10.1287/mnsc.47.1.151.10669; Little JDC, 2011, OPER RES, V59, P536, DOI 10.1287/opre.1110.0940; KEESING RM, 1974, ANNU REV ANTHROPOL, V3, P73, DOI 10.1146/annurev.an.03.100174.000445; Pero M, 2010, SUPPLY CHAIN MANAG, V15, P115, DOI 10.1108/13598541011028723; Ward PT, 2000, J OPER MANAG, V18, P123, DOI 10.1016/S0272-6963(99)00021-2; Jayaram J, 2013, INT J PROD RES, V51, P1958, DOI 10.1080/00207543.2012.700130; Naor M, 2010, J OPER MANAG, V28, P194, DOI 10.1016/j.jom.2009.11.001; LEVITT T, 1965, HARVARD BUS REV, V43, P81; MARDIA KV, 1970, BIOMETRIKA, V57, P519, DOI 10.2307/2334770; Vonderembse MA, 2006, INT J PROD ECON, V100, P223, DOI 10.1016/j.ijpe.2004.11.014; Khan O, 2009, INT J PHYS DISTR LOG, V39, P301, DOI 10.1108/09600030910962258; LAMBKIN M, 1989, J MARKETING, V53, P4, DOI 10.2307/1251339; BARNEY J, 1991, J MANAGE, V17, P99, DOI 10.1177/014920639101700108; Arana I., 2011, MANAGING GLOBAL SUPP; Banerjee A, 2012, INT J PROD RES, V50, P3051, DOI 10.1080/00207543.2011.588624; BROWN SL, 1995, ACAD MANAGE REV, V20, P343, DOI 10.2307/258850; Chopra S., 2005, SUPPLY CHAIN MANAGEM; Christopher M., 2001, INT J PHYS DISTRIB, V31, P235, DOI DOI 10.1108/09600030110394914; Christopher M, 2000, IND MARKET MANAG, V29, P37, DOI 10.1016/S0019-8501(99)00110-8; Clark K.B., 1991, PRODUCT DEV PERFORMA; Cox J., 1986, GOAL PROCESS ONGOING; Deschamps J. P., 1995, PRODUCT JUGGERNAUT C; Doha A, 2013, INT J OPER PROD MAN, V33, P470, DOI 10.1108/01443571311307352; Ferdows K., 2004, Harvard Business Review, V82; Fisher ML, 1997, HARVARD BUS REV, V75, P105; Gottschalg O, 2007, ACAD MANAGE REV, V32, P418; Hallgren M., 2009, INT J OPER PROD MAN, V29, P979; HAYES RH, 1979, HARVARD BUS REV, V57, P127; Hayes R. H., 1998, DYNAMIC MANUFACTURIN; Hill T., 1985, MANUFACTURING STRATE; Hoffer C. W., 1975, ACAD MANAGE J, V18, P784; Hopp W., 1996, FACTORY PHYS FDN MAN; Hormozi Amir M., 2001, BENCHMARKING INT J, V8, P132, DOI 10.1108/14635770110389843; Huang S. H., 2002, SUPPLY CHAIN MANAG, V7, P189, DOI 10.1108/13598540210438935; Imai K. -I., 1985, UNEASY ALLIANCE, P337; Kaipia R, 2007, SUPPLY CHAIN MANAG, V12, P3, DOI 10.1108/13598540710724347; Katayama H, 1999, INT J PROD ECON, V60-1, P43, DOI 10.1016/S0925-5273(98)00129-7; Khan O., 2012, SUPPLY CHAIN MANAG I, V17, P325; Lo SM, 2010, SUPPLY CHAIN MANAG, V15, P139, DOI [10.1108/13598541011028741, 10.1108/135985410110287411]; Machuca JAD, 2004, TRANSPORT RES E-LOG, V40, P209, DOI 10.1016/j.tre.2003.08.001; Machuca JAD, 2011, INT J PROD ECON, V133, P487, DOI 10.1016/j.ijpe.2011.06.009; MARDIA KV, 1971, BIOMETRIKA, V58, P105, DOI 10.2307/2334321; McAdam R., 2001, BUSINESS PROCESS MAN, V7, P113, DOI 10.1108/14637150110389696; Metta H, 2013, IEEE T ENG MANAGE, V60, P438, DOI 10.1109/TEM.2012.2206392; Moon Y., 2005, HARVARD BUS REV, V83, P87; Nagashima M., 2013, J JPN OPER MANAGE ST, V4, P1; Naylor JB, 1999, INT J PROD ECON, V62, P107; Pagh Janus D., 1998, J BUSINESS LOGISTICS, V19, P13; Piplani R., 2005, Journal of Manufacturing Technology Management, V16, DOI 10.1108/17410380510609465; Robertson M., 1999, International Journal of Agile Management Systems, V1, DOI 10.1108/14654659910266664; Schroeder R. G., 2001, HIGH PERFORMANCE MAN; Selldin E, 2007, SUPPLY CHAIN MANAG, V12, P42, DOI 10.1108/13598540710724392; Skinner W.G., 1978, MANUFACTURING CORPOR; Stevens J, 2002, APPL MULTIVARIATE ST; Tabachnick B. G., 2007, USING MULTIVARIATE S; Talay MB, 2014, J PROD INNOVAT MANAG, V31, P61, DOI 10.1111/jpim.12080; van Hoek RI, 2001, INT J OPER PROD MAN, V21, P126; Whitten GD, 2012, INT J OPER PROD MAN, V32, P28, DOI 10.1108/01443571211195727	82	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-5273	1873-7579		INT J PROD ECON	Int. J. Prod. Econ.	MAR	2015	161						228	241		10.1016/j.ijpe.2014.09.024		14	Engineering, Industrial; Engineering, Manufacturing; Operations Research & Management Science	Engineering; Operations Research & Management Science	CB8KT	WOS:000349879200020		
J	Keawprasert, T; Yamada, Y; Ishii, J				Keawprasert, T.; Yamada, Y.; Ishii, J.			Pilot Comparison of Radiance Temperature Scale Realization Between NIMT and NMIJ	INTERNATIONAL JOURNAL OF THERMOPHYSICS			English	Article						ITS-90 realization; Pilot bilateral comparison; Radiance temperature scale; Radiation thermometer; Spectral responsivity measurement		A pilot comparison of radiance temperature scale realizations between the National Institute of Metrology Thailand (NIMT) and the National Metrology Institute of Japan (NMIJ) was conducted. At the two national metrology institutes (NMIs), a 900 nm radiation thermometer, used as the transfer artifact, was calibrated by a means of a multiple fixed-point method using the fixed-point blackbody of Zn, Al, Ag, and Cu points, and by means of relative spectral responsivity measurements according to the International Temperature Scale of 1990 (ITS-90) definition. The Sakuma-Hattori equation is used for interpolating the radiance temperature scale between the four fixed points and also for extrapolating the ITS-90 temperature scale to 2000 C. This paper compares the calibration results in terms of fixed-point measurements, relative spectral responsivity, and finally the radiance temperature scale. Good agreement for the fixed-point measurements was found in case a correction for the change of the internal temperature of the artifact was applied using the temperature coefficient measured at the NMIJ. For the realized radiance temperature range from 400 C to 1100 C, the resulting scale differences between the two NMIs are well within the combined scale comparison uncertainty of 0.12 C (). The resulting spectral responsivity measured at the NIMT has a comparable curve to that measured at the NMIJ especially in the out-of-band region, yielding a ITS-90 scale difference within 1.0 C from the Cu point to 2000 C, whereas the realization comparison uncertainty of NIMT and NMIJ combined is 1.2 C () at 2000 C.	[Keawprasert, T.] Natl Inst Metrol Thailand, Pathum Thani, Thailand; [Yamada, Y.; Ishii, J.] AIST, Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan	Keawprasert, T (reprint author), Natl Inst Metrol Thailand, Pathum Thani, Thailand.	thada@nimt.or.th					Saunders P, 2008, INT J THERMOPHYS, V29, P1066, DOI 10.1007/s10765-008-0385-1; PRESTONTHOMAS H, 1990, METROLOGIA, V27, P3, DOI 10.1088/0026-1394/27/1/002; Fischer J., 2003, TEMP ITS MEAS, V7, P631; Keawprasert T., 2008, P NEWRAD 2008 10 INT, P287; Manoi A, 2014, INT J THERMOPHYS, V35, P485, DOI 10.1007/s10765-014-1619-z; Noulkhow N., INT J THERMOPH UNPUB; Ono A., 1987, J SICE, V23, P407; Sakuma F., 1982, TEMP ITS MEAS, V5, P535; Sakuma F., 2004, P SICE ANN C, P72; Sakuma F., 1997, P TEMPMEKO 96 6 INT, P305; Sakuma F., 2006, P SICE ICASE INT JOI, P3336; Yamada Y., INT J THERMOPH UNPUB	12	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0195-928X	1572-9567		INT J THERMOPHYS	Int. J. Thermophys.	MAR	2015	36	2-3			SI		315	326		10.1007/s10765-014-1782-2		12	Thermodynamics; Chemistry, Physical; Mechanics; Physics, Applied	Thermodynamics; Chemistry; Mechanics; Physics	CB8NS	WOS:000349887600009		
J	Ogura, H; Masuyama, S; Izuchi, M; Yamazawa, K; Arai, M				Ogura, H.; Masuyama, S.; Izuchi, M.; Yamazawa, K.; Arai, M.			Realization of Ru-C Eutectic Point for Evaluation of W-Re and IrRh/Ir Thermocouples	INTERNATIONAL JOURNAL OF THERMOPHYSICS			English	Article						Drift; Inhomogeneity; IrRh/Ir thermocouple; Ru-C eutectic point; Type C thermocouple; W-Re thermocouple	CALIBRATION; CARBON	Tungsten-rhenium (W-Re) thermocouples are widely used in industry for measurements at high temperatures, up to . Since the electromotive force (emf) of a W-Re thermocouple is known to change during exposure at high temperatures, evaluation of the emf stability is essential for measuring temperature precisely and for realizing precise temperature control used to ensure the quality of products subject to annealing processes. To evaluate precisely the thermoelectric stability around , two Ru-C cells (crucible and Ru-C eutectic alloy) were constructed in our laboratory. The key feature of the cells is that their dimensions are large to ensure there is sufficient immersion available to evaluate the homogeneity characteristics of the thermocouples. By using one of the Ru-C cells, the drift and inhomogeneity of Type C (tungsten-5 % rhenium vs tungsten-26 % rhenium) thermocouples during an exposure to high temperature around were evaluated. Furthermore, to explore possible applications of the eutectic point to other types of high-temperature thermocouples, the drift of an IrRh/Ir thermocouple (iridium-40 % rhodium vs iridium) was also evaluated using another Ru-C cell. The tests with W-Re and IrRh/Ir thermocouples demonstrate that the newly developed Ru-C cells can be used to successfully realize melting plateaux repeatedly. This enables the long-term drift measurements essential for the evaluation and improvement of high-temperature thermocouples. The results obtained in this study will also be useful for evaluating the uncertainty of thermocouple calibrations at around .	[Ogura, H.; Masuyama, S.; Izuchi, M.; Yamazawa, K.; Arai, M.] AIST, Natl Inst Adv Ind Sci & Technol NMIJ, Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan	Ogura, H (reprint author), AIST, Natl Inst Adv Ind Sci & Technol NMIJ, Natl Metrol Inst Japan, 1-1-1 Umezono, Tsukuba, Ibaraki, Japan.	h.ogura@aist.go.jp					[Anonymous], 2009, E1751E1751M09EL ASTM; Tamba J, 2011, INT J THERMOPHYS, V32, P2436, DOI 10.1007/s10765-011-1084-x; Ongrai O, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/10/105103; Burns G.W., 1972, TEMPERATURE ITS ME 3, V4, P1751; Gotoh M., 2013, AIP C P, V8, P587; Kim Y.G., 2006, P 18 IMEKO WORLD C; Massalski T.B., 1990, BINARY ALLOY PHASE D, P2355; Morice R., 2004, P TEMPMEKO 2004 9 IN, P847; Morice R., 2005, P SICE 2005 OK JAP, P678; Ogura H, 2013, AIP CONF PROC, V1552, P554, DOI 10.1063/1.4819601; Ogura H, 2011, INT J THERMOPHYS, V32, P2420, DOI 10.1007/s10765-011-1051-6; Ogura H, 2008, INT J THERMOPHYS, V29, P210, DOI 10.1007/s10765-007-0320-x; Ogura H., 2004, P TEMPMEKO 2004 9 IN, P459; Ogura H., 2009, P ICROS SICE INT JOI, P3297; Ogura Hideki, 2010, SICE Journal of Control, Measurement, and System Integration, V3; Ongrai O, 2013, AIP CONF PROC, V1552, P504, DOI 10.1063/1.4821392; Pearce JV, 2013, AIP CONF PROC, V1552, P595, DOI 10.1063/1.4821396; Pearce JV, 2009, METROLOGIA, V46, P473, DOI 10.1088/0026-1394/46/5/011; Rempe JL, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/11/115201; Yamada Y, 2000, METROLOGIA, V37, P71, DOI 10.1088/0026-1394/37/1/10	20	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0195-928X	1572-9567		INT J THERMOPHYS	Int. J. Thermophys.	MAR	2015	36	2-3			SI		385	398		10.1007/s10765-014-1825-8		14	Thermodynamics; Chemistry, Physical; Mechanics; Physics, Applied	Thermodynamics; Chemistry; Mechanics; Physics	CB8NS	WOS:000349887600015		
J	Ogura, H; Holmsten, M; Klason, P				Ogura, H.; Holmsten, M.; Klason, P.			Comparison of Co-C Eutectic-Point Cells for Thermocouple Calibration Between SP and NMIJ	INTERNATIONAL JOURNAL OF THERMOPHYSICS			English	Article						Calibration; Co-C eutectic point; Comparison; Thermocouple	COBALT-CARBON; FIXED-POINT; ITS-90	As recently reported, the metal-carbon eutectic points seem to be useful as practical reference points for calibrating thermocouples. The melting temperature of the cobalt-carbon eutectic point (Co-C, is an ideal solution for a reference point being at approximately the middle between the freezing point of copper and the melting point of palladium . In this study, a comparison of reference Co-C cells used for thermocouple calibration service was performed between the Technical Institute of Sweden (SP) and the National Metrology Institute of Japan (NMIJ) by means of two circulating Pt/Pd thermocouples and one circulating Co-C cell in order to investigate the reliability of thermocouple calibration at the Co-C eutectic point. The reference Co-C cell at SP was designed and constructed in the National Physical Laboratory (NPL), and provided to SP, while the reference Co-C cell at NMIJ as well as the circulating cell was designed and constructed at NMIJ. The melting temperature of the reference Co-C cells at SP and NMIJ were evaluated by using the calibrated radiation thermometers at NPL and NMIJ, respectively, prior to the circulation of the thermocouples and the cell between SP and NMIJ. The temperature difference between the reference cells of SP and NMIJ, as measured by means of the circulating thermocouples, was found to be within , while that measured by means of the circulating cell was found to be within . The temperature of reference cells at SP and NMIJ was found to agree within an expanded uncertainty in spite of different temperature traceability chains. This means that the calibration of thermocouples at the Co-C eutectic point was sufficiently reliable.	[Ogura, H.] AIST, Natl Inst Adv Ind Sci & Technol NMIJ, Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan; [Holmsten, M.; Klason, P.] Tech Res Inst Sweden SP, Boras, Sweden	Ogura, H (reprint author), AIST, Natl Inst Adv Ind Sci & Technol NMIJ, Natl Metrol Inst Japan, I-1-1 Umezono, Tsukuba, Ibaraki, Japan.	h.ogura@aist.go.jp					PRESTONTHOMAS H, 1990, METROLOGIA, V27, P3, DOI 10.1088/0026-1394/27/1/002; Edler F, 2005, METROLOGIA, V42, P201, DOI 10.1088/0026-1394/42/4/003; Burns GW, 1998, METROLOGIA, V35, P761, DOI 10.1088/0026-1394/35/5/6; Edler F, 2010, METROLOGIA, V47, P90, DOI 10.1088/0026-1394/47/1/010; Failleau G, 2013, AIP CONF PROC, V1552, P352, DOI 10.1063/1.4819565; Jahan F, 2013, AIP CONF PROC, V1552, P346, DOI 10.1063/1.4819564; Morice R, 2008, INT J THERMOPHYS, V29, P231, DOI 10.1007/s10765-007-0356-y; Ogura H, 2011, INT J THERMOPHYS, V32, P1811, DOI 10.1007/s10765-011-1022-y; Ogura H, 2008, INT J THERMOPHYS, V29, P210, DOI 10.1007/s10765-007-0320-x; Ogura H., 2003, TEMP ITS MEAS, V7, P485; Ogura H., 2009, P ICROS SICE INT JOI, P3297; Sadli M., 2004, P TEMPMEKO 2004 9 IN, P341	12	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0195-928X	1572-9567		INT J THERMOPHYS	Int. J. Thermophys.	MAR	2015	36	2-3			SI		399	412		10.1007/s10765-014-1750-x		14	Thermodynamics; Chemistry, Physical; Mechanics; Physics, Applied	Thermodynamics; Chemistry; Mechanics; Physics	CB8NS	WOS:000349887600016		
J	Kotera, S; Matsuda, N				Kotera, S.; Matsuda, N.			The role performance of public health nurses as clinical instructors in Japan	INTERNATIONAL NURSING REVIEW			English	Article						Clinical Instructor; Clinical Practicum; Japan; Public Health Nursing; Role Performance; Undergraduate Education	EXPERIENCES; PRECEPTOR; EDUCATION	AimTo investigate the factors associated with the role performance of public health nurses as clinical instructors in Japan. BackgroundNewly graduated public health nurses in Japan have competencies that are below the minimum requirements of the Ministry of Health, Labour and Welfare because of their limited clinical experience in undergraduate clinical education. Public health nurses play crucial roles in the clinical practicum and their role performance as clinical instructors is a key to successful learning outcomes. MethodsThis study targeted public health nurses in governmental public health centres and those who had gained experience as an undergraduate clinical instructor for nursing students. A self-administered questionnaire was distributed to a national sample of 1467 public health nurses. Data were collected from July 2011 to September 2011. ResultsIn total, 722 of 1467 questionnaires were completed (nurse age 22-64 years). Of the participants, almost half (49%) strongly disagreed (3%) or disagreed (46%) that they had confidence in their role as a clinical instructor, and preparation programmes for clinical instructors had been attended by just 262 (36.3%). Years of experience as public health nurses, previous attendance of preparation programmes, viewing their role positively, professional identity and professional competency were significantly associated with performance. Logistic regression analysis revealed that nurses with higher role performance scores had higher self-confidence, greater interests in their role and higher professional identity. ConclusionsThe self-confidence and interests of public health nurses in their role as clinical instructors as well as their professional identity were found to be significant predictors of their role performance as clinical instructors. Implications for Nursing Practice and EducationThe factors identified in our investigation can be used to predict effective clinical instructors and to develop preparation programmes to enhance their confidence and interests and potentially increase their role satisfaction.	[Kotera, S.] Kobe Univ, Grad Sch Hlth Sci, Dept Int Hlth, Kobe, Hyogo 6540142, Japan; [Matsuda, N.] Kobe Univ, Grad Sch Hlth Sci, Dept Community Hlth, Kobe, Hyogo 6540142, Japan	Kotera, S (reprint author), Kobe Univ, Grad Sch Hlth Sci, Dept Int Hlth, Suma Ku, 7-10-2 Tomogaoka, Kobe, Hyogo 6540142, Japan.	skotera@port.kobe-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [22592549]	The authors are especially grateful to all the participants who kindly agreed to participate in our survey and to the following contributors who assisted in collecting the data: Dr Kazuko Horiguchi, Dr Kimiko Nakayama and Dr Kiyomi Inoue. This article was derived from a larger study which was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (No. 22592549).	Hallin K, 2009, J ADV NURS, V65, P161, DOI 10.1111/j.1365-2648.2008.04855.x; Wade GH, 2010, PUBLIC HEALTH NURS, V27, P459, DOI 10.1111/j.1525-1446.2010.00879.x; Omansky GL, 2010, J NURS MANAGE, V18, P697, DOI 10.1111/j.1365-2834.2010.01145.x; Keller LO, 2011, PUBLIC HEALTH NURS, V28, P261, DOI 10.1111/j.1525-1446.2010.00905.x; Anzai Y., 2009, JAPANESE J PUBLIC HL, V56, P821; Gaberson KB, 2010, CLINICAL TEACHING STRATEGIES IN NURSING, THIRD EDITION, P1; Japanese Nursing Association, 2010, BAS SURV REP PUBL HL; Kazemi D, 2011, NURS EDUC TODAY, V31, P547, DOI 10.1016/j.nedt.2010.10.024; Kotera S., 2012, B HLTH SCI KOBE, V28, P1; Larsen R, 2011, PUBLIC HEALTH NURS, V28, P349, DOI 10.1111/j.1525-1446.2010.00933.x; Ministry of Health Labour and Welfare, 2011, OV HLTH ADM REP EMPL; Miyazaki M., 2006, JAPANESE J PUBLIC HL, V62, P394; Myrick F, 2011, NURS EDUC TODAY, V31, P263, DOI 10.1016/j.nedt.2010.10.026; Natan Merav Ben, 2014, Nurse Educ Today, V34, P1425, DOI 10.1016/j.nedt.2014.04.011; Negishi K., 2010, JAPANESE J PUBLIC HL, V57, P27; O'Brien A, 2014, NURS EDUC TODAY, V34, P19, DOI 10.1016/j.nedt.2013.03.015; Saeki K, 2007, PUBLIC HEALTH NURS, V24, P449, DOI 10.1111/j.1525-1446.2007.00655.x; Yamada S, 2012, NURS HEALTH SCI, V14, P229, DOI 10.1111/j.1442-2018.2012.00683.x	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0020-8132	1466-7657		INT NURS REV	Int. Nurs. Rev.	MAR	2015	62	1					21	27		10.1111/inr.12133		7	Nursing	Nursing	CB8QP	WOS:000349896100006		
J	Imanuvilov, OY; Yamamoto, M				Imanuvilov, O. Yu; Yamamoto, M.			Global uniqueness in inverse boundary value problems for the Navier-Stokes equations and Lame system in two dimensions	INVERSE PROBLEMS			English	Article						Lame system; Navier-Stokes system; Calderon problem	CAUCHY DATA; IDENTIFICATION; COEFFICIENTS; ELASTICITY; VISCOSITY	We consider inverse boundary value problems for the Navier-Stokes equations and the isotropic Lame system in two dimensions. The question of global uniqueness for these inverse problems, without any smallness assumptions on unknown coefficients, has been a longstanding open problem for the Navier-Stokes equations and the isotropic Lame system in two dimensions. We prove the global uniqueness for both inverse boundary value problems. Our methodology is the same for both systems. The key is the construction of complex geometric optics solutions after decoupling the systems into weakly coupling systems.	[Imanuvilov, O. Yu] Colorado State Univ, Dept Math, Ft Collins, CO 80523 USA; [Yamamoto, M.] Univ Tokyo, Dept Math Sci, Meguro Ku, Tokyo 153, Japan	Imanuvilov, OY (reprint author), Colorado State Univ, Dept Math, 101 Weber Bldg, Ft Collins, CO 80523 USA.	oleg@math.colostate.edu; myama@ms.u-tokyo.ac.jp					AKAMATSU M, 1991, INVERSE PROBL, V7, P335, DOI 10.1088/0266-5611/7/3/003; Uhlmann G, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/12/123011; NAKAMURA G, 1993, AM J MATH, V115, P1161, DOI 10.2307/2375069; Nachman AI, 1996, ANN MATH, V143, P71, DOI 10.2307/2118653; Bukhgeim AL, 2008, J INVERSE ILL-POSE P, V16, P19, DOI 10.1515/JIIP.2008.002; Imanuvilov OY, 2013, MILAN J MATH, V81, P187, DOI 10.1007/s00032-013-0205-3; Imanuvilov OY, 2010, J AM MATH SOC, V23, P655; Bliev N, 1997, GENERALIZED ANAL FUN; Calderon A-P, 1980, SEM NUM AN ITS APPL, P65; Eskin G, 2002, INVERSE PROBL, V18, P907, DOI 10.1088/0266-5611/18/3/324; Fursikov A, 1996, MAT SBORNIK, V187, P102; GIAQUINTA M, 1993, INTRO REGULARITY THE; Heck H, 2007, INDIANA U MATH J, V56, P2489; IKEHATA M, 1990, SIAM J APPL MATH, V50, P1635, DOI 10.1137/0150097; Imanuvilov OY, 2012, INVERSE PROBL, V28, DOI 10.1088/0266-5611/28/9/095015; Imanuvilov OY, 2011, J INVERSE ILL-POSE P, V19, P881, DOI 10.1515/JIIP.2011.060; Imanuvilov OY, 2012, INVERSE PROBL, V28, DOI 10.1088/0266-5611/28/12/125002; Kantorovich L. V., 1982, FUNCTIONAL ANAL; Li X, 2007, J DIFFER EQUATIONS, V242, P24, DOI 10.1016/j.jde.2007.07.008; NAKAMURA G, 1994, INVENT MATH, V118, P457, DOI 10.1007/BF01231541; Nakamura G, 2003, INVENT MATH, V152, P205, DOI 10.1007/s0022-002-0276-1; OLEINIK O. A., 1992, MATH PROBLEMS ELASTI; Stein E., 1993, HARMONIC ANAL REAL V; SYLVESTER J, 1987, ANN MATH, V125, P153, DOI 10.2307/1971291; Vekua I N, 1962, GEN ANAL FUNCTIONS	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0266-5611	1361-6420		INVERSE PROBL	Inverse Probl.	MAR	2015	31	3							035004	10.1088/0266-5611/31/3/035004		46	Mathematics, Applied; Physics, Mathematical	Mathematics; Physics	CB8QG	WOS:000349895100004		
J	Endo, A; Watanabe, T; Ogata, N; Nozawa, T; Aikawa, C; Arakawa, S; Maruyama, F; Izumi, Y; Nakagawa, I				Endo, Akiko; Watanabe, Takayasu; Ogata, Nachiko; Nozawa, Takashi; Aikawa, Chihiro; Arakawa, Shinichi; Maruyama, Fumito; Izumi, Yuichi; Nakagawa, Ichiro			Comparative genome analysis and identification of competitive and cooperative interactions in a polymicrobial disease	ISME JOURNAL			English	Article							OPPORTUNISTIC ORAL PATHOGEN; GAS-LIQUID-CHROMATOGRAPHY; CRISPR-CAS SYSTEMS; PORPHYROMONAS-GINGIVALIS; TREPONEMA-DENTICOLA; VIRULENCE FACTORS; PERIODONTOPATHIC BACTERIA; NATURAL TRANSFORMATION; CHRONIC PERIODONTITIS; TANNERELLA-FORSYTHIA	Polymicrobial diseases are caused by combinations of multiple bacteria, which can lead to not only mild but also life-threatening illnesses. Periodontitis represents a polymicrobial disease; Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia, called 'the red complex', have been recognized as the causative agents of periodontitis. Although molecular interactions among the three species could be responsible for progression of periodontitis, the relevant genetic mechanisms are unknown. In this study, we uncovered novel interactions in comparative genome analysis among the red complex species. Clustered regularly interspaced short palindromic repeats (CRISPRs) of T. forsythia might attack the restriction modification system of P. gingivalis, and possibly work as a defense system against DNA invasion from P. gingivalis. On the other hand, gene deficiencies were mutually compensated in metabolic pathways when the genes of all the three species were taken into account, suggesting that there are cooperative relationships among the three species. This notion was supported by the observation that each of the three species had its own virulence factors, which might facilitate persistence and manifestations of virulence of the three species. Here, we propose new mechanisms of bacterial symbiosis in periodontitis; these mechanisms consist of competitive and cooperative interactions. Our results might shed light on the pathogenesis of periodontitis and of other polymicrobial diseases.	[Endo, Akiko; Izumi, Yuichi] Tokyo Med & Dent Univ, Dept Periodontol, Grad Sch Med & Dent Sci, Tokyo, Japan; [Watanabe, Takayasu; Ogata, Nachiko; Nozawa, Takashi; Aikawa, Chihiro; Maruyama, Fumito; Nakagawa, Ichiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Bacterial Pathogenesis, Tokyo, Japan; [Nozawa, Takashi; Aikawa, Chihiro; Maruyama, Fumito; Nakagawa, Ichiro] Kyoto Univ, Dept Microbiol, Grad Sch Med, Kyoto 6068501, Japan; [Arakawa, Shinichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Lifetime Oral Hlth Care Sci, Tokyo, Japan; [Maruyama, Fumito] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Microbial Genom & Ecol, Tokyo, Japan	Maruyama, F (reprint author), Kyoto Univ, Dept Microbiol, Grad Sch Med, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	fumito-m.bac@tmd.ac.jp			Japan Society for the Promotion of Science (JSPS); Japanese Ministry of Education, Global Center of Excellence (GCOE) Program, International Research Center for Molecular Science in Tooth and Bone Diseases, MEXT (Ministry of Education, Culture, Sports, Science, and Technology), Japan; Funding Program for Next Generation World-Leading Researchers, JSPS [LS041];  [22592032];  [25293370];  [25305013];  [25670776];  [25713060];  [24117508];  [70294113]	We thank Dr M Umeda (Department of Periodontology, Osaka Dental University) for providing the T. forsythia isolates. This research was supported in part by grants-in-aid from the Japan Society for the Promotion of Science (JSPS); the Japanese Ministry of Education, Global Center of Excellence (GCOE) Program, International Research Center for Molecular Science in Tooth and Bone Diseases, MEXT (Ministry of Education, Culture, Sports, Science, and Technology), Japan; Grant-in-Aid for Scientific Research (22592032, 25293370, 25305013, 25670776 and 25713060); Grant-in-Aid for Scientific Research in Innovative Areas (24117508 and 70294113); Grant-in-Aid for Daiichi Sankyo Foundation of Life Science and the Funding Program for Next Generation World-Leading Researchers (LS041), JSPS.	Aklujkar M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-230; Mashburn LM, 2005, J BACTERIOL, V187, P554, DOI 10.1128/JB.187.2.554-566.2005; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Kesavalu L, 2007, INFECT IMMUN, V75, P1704, DOI 10.1128/IAI.00733-06; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Casarin RCV, 2013, J PERIODONTAL RES, V48, P30, DOI 10.1111/j.1600-0765.2012.01498.x; Ishihara K, 2010, PERIODONTOL 2000, V54, P117, DOI 10.1111/j.1600-0757.2009.00345.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Lopez-Sanchez MJ, 2012, MOL MICROBIOL, V85, P1057, DOI 10.1111/j.1365-2958.2012.08172.x; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Rao D, 2005, APPL ENVIRON MICROB, V71, P1729, DOI 10.1128/AEM.71.4.1729-1736.2005; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Sharma A, 2010, PERIODONTOL 2000, V54, P106, DOI 10.1111/j.1600-0757.2009.00332.x; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; KURITAOCHIAI T, 1995, J DENT RES, V74, P1367; Hament JM, 1999, FEMS IMMUNOL MED MIC, V26, P189, DOI 10.1016/S0928-8244(99)00159-5; Zhu Y, 2004, J BIOTECHNOL, V110, P143, DOI 10.1016/j.jbiotec.2004.02.006; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Watanabe T, 2013, GENOME BIOL EVOL, V5, P1099, DOI 10.1093/gbe/evt075; Zhou CE, 2007, NUCLEIC ACIDS RES, V35, pD391, DOI 10.1093/nar/gkl791; Ohara-Nemoto Y, 2014, J BIOL CHEM, V289, P5436, DOI 10.1074/jbc.M113.527333; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001; Haurat MF, 2011, J BIOL CHEM, V286, P1269, DOI 10.1074/jbc.M110.185744; Niederman R, 1997, J DENT RES, V76, P575; Grenier D, 2011, CURR DRUG TARGETS, V12, P322; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; GHARBIA SE, 1991, J GEN MICROBIOL, V137, P1201; MARGOLIS HC, 1988, J DENT RES, V67, P1476, DOI 10.1177/00220345880670120701; Kumar PS, 2003, J DENT RES, V82, P338; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Steeves CH, 2011, PROTEOMICS, V11, P2027, DOI 10.1002/pmic.201000631; Zhao YB, 2012, BIOINFORMATICS, V28, P416, DOI 10.1093/bioinformatics/btr655; Yamada T, 2011, NUCLEIC ACIDS RES, V39, pW412, DOI 10.1093/nar/gkr313; Raymond B, 2012, SCIENCE, V337, P85, DOI 10.1126/science.1218196; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; STRINGFELLOW WT, 1995, APPL ENVIRON MICROB, V61, P357; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Naito M, 2011, MICROBIOL-SGM, V157, P2022, DOI 10.1099/mic.0.047803-0; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Dashper SG, 2011, J DENT RES, V90, P691, DOI 10.1177/0022034510385242; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Loozen G, 2014, J CLIN PERIODONTOL, V41, P1, DOI 10.1111/jcpe.12167; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BOTTA GA, 1985, J PERIODONTAL RES, V20, P450, DOI 10.1111/j.1600-0765.1985.tb00827.x; Fuerst John A, 2010, Commun Integr Biol, V3, P572, DOI 10.4161/cib.3.6.13061; Ge XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065520; GILLESPIE JH, 1991, SCIENCE, V254, P1049, DOI 10.1126/science.254.5034.1049; GRENIER D, 1992, INFECT IMMUN, V60, P5298; GRENIER D, 1992, ORAL MICROBIOL IMMUN, V7, P280, DOI 10.1111/j.1399-302X.1992.tb00589.x; Hellstrom MK, 1996, J CLIN PERIODONTOL, V23, P934, DOI 10.1111/j.1600-051X.1996.tb00514.x; Honma K, 2001, INFECT IMMUN, V69, P4686, DOI 10.1128/IAI.69.7.4686-4690.2001; INGHAM HR, 1984, MICROBIOL SCI, V1, P206; Irfan U M, 2001, J Int Acad Periodontol, V3, P14; Kastenmuller G, 2008, BIOINFORMATICS, V24, pi56; KIMURA M, 1983, P NATL ACAD SCI-BIOL, V80, P6317, DOI 10.1073/pnas.80.20.6317; Kuramitsu HK, 2005, J PERIODONTOL, V76, P2047, DOI 10.1902/jop.2005.76.11-S.2047; Kurita-Ochiai T, 2010, J DENT RES, V89, P689, DOI 10.1177/0022034510365456; LADAS S, 1979, J CLIN PATHOL, V32, P1163, DOI 10.1136/jcp.32.11.1163; Mills SW, 2006, AM J VET RES, V67, P1901, DOI 10.2460/ajvr.67.11.1901; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Niu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068647; Ohta T, 1995, J MOL EVOL, V41, P717; PANOS C, 1963, ANNU REV MICROBIOL, V17, P297, DOI 10.1146/annurev.mi.17.100163.001501; Papapanou P N, 1999, N Y State Dent J, V65, P32; ROSZAK DB, 1987, MICROBIOL REV, V51, P365; Sakakibara J, 2007, MICROBIOL-SGM, V153, P866, DOI 10.1099/mic.0.29275-0; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shoaie S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02532; Soares SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053818; Sun S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042639; Tan KH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003955; Tomida S., 2013, MBIO, V4; Toyofuku M, 2010, MICROBES ENVIRON, V25, P1, DOI 10.1264/jsme2.ME09156; Tribble GD, 2012, MBIO, V3, DOI [10.1128/mBio.00231-11, DOI 10.1128/MBIO.00231-11]; Vesey PM, 2004, MICROBIOL-SGM, V150, P2401, DOI 10.1099/mic.0.26816-0; Xie H, 2007, MICROBIOL-SGM, V153, P3228, DOI 10.1099/mic.0.2007/009050-0	86	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1751-7362	1751-7370		ISME J	ISME J.	MAR	2015	9	3					629	642		10.1038/ismej.2014.155		14	Ecology; Microbiology	Environmental Sciences & Ecology; Microbiology	CB8AO	WOS:000349850600009		
J	Fukumoto, K				Fukumoto, Kentaro			Introduction to Special Issue Who Does or Does Not Respond to Whom or What in a Democracy? The Case of Japan	JAPANESE JOURNAL OF POLITICAL SCIENCE			English	Editorial Material									[Fukumoto, Kentaro] Gakushuin Univ, Tokyo 171, Japan; [Fukumoto, Kentaro] Washington Univ, St Louis, MO USA	Fukumoto, K (reprint author), Gakushuin Univ, Tokyo 171, Japan.	Kentaro.Fukumoto@gakushuin.ac.jp						0	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1468-1099	1474-0060		JPN J POLIT SCI	Jpn. J. Polit. Sci.	MAR	2015	16	1			SI		1	4		10.1017/S1468109914000358		4	Political Science	Government & Law	CB6UL	WOS:000349762100001		
J	Asako, Y; Iida, T; Matsubayashi, T; Ueda, M				Asako, Yasushi; Iida, Takeshi; Matsubayashi, Tetsuya; Ueda, Michiko			Dynastic Politicians: Theory and Evidence from Japan	JAPANESE JOURNAL OF POLITICAL SCIENCE			English	Article							DEMOCRACY; POLICY; LEGISLATURES; COMPETITION; CANDIDATES; GROWTH; MODEL	Dynastic politicians, defined as those whose family members have also served in the same position in the past, occupy a sizable portion of offices in many parts of the world. We develop a model of how dynastic politicians with inherited political advantages affect electoral outcomes and policy choices. Our model predicts that, as compared with non-dynastic legislators, dynastic legislators bring more distributions to the district, enjoy higher electoral success, and harm the economic performance of the districts, despite the larger amount of distributive benefits they bring. We test the implications of the model using data from Japan between 1997 and 2007.	[Asako, Yasushi] Waseda Univ, Sch Polit Sci & Econ, Tokyo, Japan; [Iida, Takeshi] Doshisha Univ, Fac Law, Kyoto 602, Japan; [Matsubayashi, Tetsuya] Osaka Univ, Osaka Sch Int Publ Policy, Suita, Osaka 565, Japan; [Ueda, Michiko] Syracuse Univ, Dept Polit Sci, Syracuse, NY 13244 USA	Asako, Y (reprint author), Waseda Univ, Sch Polit Sci & Econ, Tokyo, Japan.	yasushi.asako@aoni.waseda.jp; tiida@mail.doshisha.ac.jp; matsubayashi@osipp.osakau.ac.jp; michiko.uedaballmer@gmail.com			Organization for Japan-US Studies at Waseda University; JSPS [24830095]	We wish to thank Yusaku Horiuchi and Jun Saito, and Masahiko Asano for generously sharing their data, anonymous referees, Marcus Berliant, Kentaro Fukumoto, Taiji Furusawa, Scott Gehlbach, Kim Hill, Yoichi Hizen, William Leblanc, Ko Maeda, John Morrow, Salvatore Nunnari, and Motohiro Sato for their valuable comments, and Atsushi Osaki for his research assistance. This study was presented at the meetings of Public Choice Society and Japanese Economic Association, and the Workshop on the Frontiers of Statistical Analysis and Formal Theory of Political Science. We acknowledge financial support from the Organization for Japan-US Studies at Waseda University. Yasushi Asako was supported by JSPS Grants-in-Aid for Scientific Research Grant Number 24830095.	Chattopadhyay R, 2004, ECONOMETRICA, V72, P1409, DOI 10.1111/j.1468-0262.2004.00539.x; Besley T, 2010, REV ECON STUD, V77, P1329, DOI 10.1111/j.1467-937X.2010.00606.x; Horiuchi Y, 2003, AM J POLIT SCI, V47, P669, DOI 10.2307/3186126; Levitt SD, 1996, AM ECON REV, V86, P425; Gehlbach S, 2010, AM J POLIT SCI, V54, P718; Caselli F, 2004, J PUBLIC ECON, V88, P759, DOI 10.1016/S0047-2727(03)00023-9; BARON DP, 1989, AM POLIT SCI REV, V83, P1181, DOI 10.2307/1961664; Besley T, 2005, J ECON PERSPECT, V19, P43, DOI 10.1257/089533005774357761; Asano Masahiko, 2006, SHIMIN SHAKAI NI OKE; Bennedsen M, 2007, Q J ECON, V122, P647, DOI 10.1162/qjec.122.2.647; Besley T, 1997, Q J ECON, V112, P85, DOI 10.1162/003355397555136; Dal Bo E, 2009, REV ECON STUD, V76, P115, DOI 10.1111/j.1467-937X.2008.00519.x; Camp Roderic A., 1995, POLITICAL RECRUITMEN; Chirico Danilo, 2008, ONOREVOLI FIGLI DI; CLUBOK AB, 1969, J POLIT, V31, P1035, DOI 10.2307/2128357; COX GW, 1987, AM J POLIT SCI, V31, P82, DOI 10.2307/2111325; Feinstein BD, 2010, LEGIS STUD QUART, V35, P571, DOI 10.3162/036298010793322366; Hess Stephen, 1966, AM POLITICAL DYNASTI; Iida Takeshi, 2010, SENKYO KENKYU, V26, P139; ISHIBASHI M, 1992, ASIAN SURV, V32, P366, DOI 10.1525/as.1992.32.4.00p0163s; Jones BF, 2005, Q J ECON, V120, P835, DOI 10.1093/qje/120.3.835; Kabashima Ikuo, 2000, GENDAI NIHON NO SEIJ; Key V. O., 1949, SO POLITICS STATE NA; Lefort F., 1996, J ECON GROWTH, V1, P363, DOI DOI 10.1007/BF00141044; Lublin David, 1997, PARADOX REPRESENTATI; MCKELVEY RD, 1992, AM POLIT SCI REV, V86, P951, DOI 10.2307/1964347; Mendoza RU, 2012, PHILIPP POLIT SCI J, V33, P132, DOI 10.1080/01154451.2012.734094; Mizusaki Setsufumi, JED M DATABASE; Morelli M, 2004, REV ECON STUD, V71, P829, DOI 10.1111/j.1467-937X.2004.00306.x; Persson T., 2000, POLITICAL EC EXPLAIN; Osborne MJ, 1996, Q J ECON, V111, P65, DOI 10.2307/2946658; Smith Daniel M., 2012, THESIS U CALIFORNIA; Taniguchi Naoko, 2008, DEMOCRATIC REFORM JA	33	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1468-1099	1474-0060		JPN J POLIT SCI	Jpn. J. Polit. Sci.	MAR	2015	16	1			SI		5	32		10.1017/S146810991400036X		28	Political Science	Government & Law	CB6UL	WOS:000349762100002		
J	Fukumoto, K; Masuyama, M				Fukumoto, Kentaro; Masuyama, Mikitaka			Measuring Judicial Independence Reconsidered: Survival Analysis, Matching, and Average Treatment Effects	JAPANESE JOURNAL OF POLITICAL SCIENCE			English	Article							INFERENCE; JUDGES; COURT	This article reconsiders how to judge judicial independence by using the Japanese judicature, one of the allegedly-most dependent judiciary branches. In their influential work, Ramseyer and Rasmusen (2003) argue that judges who once belonged to a leftist group take longer to reach a 'moderately prestigious status' under the long-term conservative rule of Japan. Their method does not, however, deal appropriately with the possibility of judges not reaching this position because the judge dies, retires early, or is still at the early stage of her career. Ramseyer and Rasmusen also mistakenly assume that all judges will eventually obtain this position. This article develops a survival analysis model of judicial careers and attempts to solve the problems of censoring, left truncation, and split population. We also offer a way to utilize a matching procedure to estimate average treatment effects on censored time-to-event as well as event occurrence. We re-analyze a corrected version of Ramseyer and Rasmusen's data using their and our methods. One of the most important findings is that, contrary to what Ramseyer and Rasmusen argue, leftist judges are not discriminated against in terms of the timing of promotion.	[Fukumoto, Kentaro] Gakushuin Univ, Tokyo 171, Japan; [Fukumoto, Kentaro] Washington Univ, St Louis, MO USA; [Masuyama, Mikitaka] Natl Grad Inst Policy Studies, Tokyo, Japan	Fukumoto, K (reprint author), Gakushuin Univ, Tokyo 171, Japan.	Kentaro.Fukumoto@gakushuin.ac.jp; mmasuyama@grips.ac.jp			Japan Society for the Promotion of Science	An earlier version was presented at the 2006 Annual Meeting of the American Political Science Association, Philadelphia, 31 August-3 September 2006. We appreciate the Japan Society for the Promotion of Science for financial support and Mark J. Ramseyer and Eric B. Rasmusen for making their data available. Our thanks also go to Amy L. Catalinac, Jonathan Marshall, Hatsuru Morita, and Kirk A. Randazzo for their comments. The usual disclaimer is applied.	Solomon PH, 2007, WORLD POLIT, V60, P122; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; BLAND JM, 1994, BRIT MED J, V309, P1128; Hettinger VA, 2005, LEGIS STUD QUART, V30, P5, DOI 10.3162/036298005X201428; Salzberger E, 1999, J LAW ECON, V42, P831, DOI 10.1086/467444; Ramseyer JM, 2006, U PENN LAW REV, V154, P1879; Diamond A, 2013, REV ECON STAT, V95, P932; Becker R., 2004, PATTERNS PARLIAMENTA, P57; Box-Steffensmeier JM, 2005, LEGIS STUD QUART, V30, P549, DOI 10.3162/036298005X201671; Clark DH, 2003, J CONFLICT RESOLUT, V47, P94, DOI 10.1177/0022002702239513; Epstein Lee, 1998, THE CHOICES JUSTICES; Ferejohn John, 2007, THE OXFORD HANDBOOK, P727; Gibson James L., 2006, THE OXFORD HANDBOOK, P514; Ginsburg Tom, 2003, JUDICIAL REVIEW IN N; Hall Kermit L., 2005, THE JUDICIAL BRANCH, P60; Holland P, 1986, J AM STAT ASSOC, V81, P945; Jones Bradford S, 2004, EVENT HISTORY MODELI; Kenkyusho Shiso Undo, 1969, OSORUBEKI SAIBAN; King G, 2007, INT STUD QUART, V51, P183, DOI 10.1111/j.1468-2478.2007.00445.x; Maitra Pushkar, 2004, EUROPEAN J LAW EC, V17, P209, DOI 10.1023/B:EJLE.0000014577.45916.be; Martin LW, 2004, AM J POLIT SCI, V48, P445; Masuyama Mikitaka, 2005, SEIKEI HOGAKU, V61, P411; Masuyama Mikitaka, 2001, THESIS; Nihon Minshu Horituka Kyokai Shiho Seido Iinkai, 1998, ZENSAIBANKAN KEIREKI; Ramseyer J. Mark, 1993, JAPANS POLITICAL MAR; Ramseyer J. Mark, 1998, THE POLITICS OF OLIG; Ramseyer J.M., 2003, MEASURING JUDICIAL I; Shetreet Shimon, 1985, JUDICIAL INDEPENDENC	28	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1468-1099	1474-0060		JPN J POLIT SCI	Jpn. J. Polit. Sci.	MAR	2015	16	1			SI		33	51		10.1017/S1468109914000371		19	Political Science	Government & Law	CB6UL	WOS:000349762100003		
J	Kim, T				Kim, Taehee			The Effect of Direct Democracy on Political Efficacy: The Evidence from Panel Data Analysis	JAPANESE JOURNAL OF POLITICAL SCIENCE			English	Article							BALLOT INITIATIVES; DIRECT LEGISLATION; AMERICAN STATES; ATTITUDES; CITIZEN; REFERENDUMS; GOVERNMENT; ELECTIONS; MATTER; SIZE	Does direct democracy enhance political efficacy? This article examines the effect of direct democracy on political efficacy. Normative theorists have suggested that direct democracy has educative effects on citizens, such as promoting political efficacy. While a number of studies have examined the corresponding hypothesis, their empirical findings are not clear-cut. This study attributes the inconsistent results to two problems of the existing studies: the employment of cross-sectional data and the heterogeneity of popular vote issues. This study closes this gap by examining the effect of direct democracy in local politics on political efficacy in a more systematic and controlled way. More concretely, it utilizes the Japanese case: In the first decade of this century, more than 400 Japanese municipalities held a popular vote for the first time because the Japanese national government promoted municipal merger. Therefore, the Japanese case provides multiple popular votes on comparable substantive topics that can be conceived as an homogeneous treatment. By applying multilevel modeling to panel survey data, this study demonstrates the causal effect that the popular vote increases the level of internal political efficacy.	Keio Univ, Grad Sch Law, Tokyo 108, Japan	Kim, T (reprint author), Keio Univ, Grad Sch Law, Tokyo 108, Japan.	k.taehee.321@gmail.com					ACOCK A, 1985, J POLIT, V47, P1062, DOI 10.2307/2130807; Almond G., 1963, CIVIC CULTURE POLITI; Bowler S, 2002, BRIT J POLIT SCI, V32, P371; Morrell ME, 2003, PUBLIC OPIN QUART, V67, P589, DOI 10.1086/378965; NIEMI RG, 1991, AM POLIT SCI REV, V85, P1407, DOI 10.2307/1963953; CLARKE HD, 1989, BRIT J POLIT SCI, V19, P551; Hajnal ZL, 2002, J POLIT, V64, P154; Lassen DD, 2011, AM POLIT SCI REV, V105, P238, DOI 10.1017/S000305541100013X; Hero RE, 2004, BRIT J POLIT SCI, V34, P109, DOI 10.1017/S0007123403000371; Dyck JJ, 2009, POLIT BEHAV, V31, P401, DOI 10.1007/s11109-008-9081-x; Smith MA, 2002, J POLIT, V64, P892; FINIFTER AW, 1975, PUBLIC OPIN QUART, V39, P189, DOI 10.1086/268215; Balch George I., 1974, POLITICAL METHODOLOG, V1, P1; Barber B.R., 2003, STRONG DEMOCRACY PAR; BELL DA, 1978, WASH LAW REV, V54, P1; Biggers DR, 2011, POLIT BEHAV, V33, P3, DOI 10.1007/s11109-010-9113-1; BOHNET I, 1994, KYKLOS, V47, P341, DOI 10.1111/j.1467-6435.1994.tb02742.x; Campbell A., 1954, VOTER DECIDES; Clarke HD, 2010, METHODOLOGY-EUR, V6, P107, DOI 10.1027/1614-2241/a000012; Converse Philip E., 1972, HUMAN MEANING SOCIAL; CRAIG SC, 1990, POLITICAL BEHAV, V0012; Cronin Thomas E., 1989, DIRECT DEMOCRACY POL; Dahl RA, 1973, SIZE DEMOCRACY; Donovan Todd, 2000, DEMANDING CHOICES OP; Dunning T, 2012, NATURAL EXPT SOCIAL; Dyck JJ, 2012, POLIT RES QUART, V65, P615, DOI 10.1177/1065912911404562; Gamble BS, 1997, AM J POLIT SCI, V41, P245, DOI 10.2307/2111715; Gerber Alan, 2008, OXFORD HDB POLITICAL; Horiuchi Takumi, 2009, JICHI SOUKEN, V368, P86; Imai Hajime, 2000, JYUMIN TOUHYO; Macpherson CB, 1977, LIFE TIMES LIBERAL D; Mattei Franco, 2005, POLLING AM ENCY PUBL; Mendelsohn M, 2000, BRIT J POLIT SCI, V30, P685; Morton R., 2008, OXFORD HDB POLITICAL; Morton R. C., 2010, EXPT POLITICAL SCI S; Pateman Carole, 1970, PARTICIPATION DEMOCR; Schlozman D, 2008, POLIT BEHAV, V30, P469, DOI 10.1007/s11109-008-9062-0; Schuck ART, 2011, WEST EUR POLIT, V34, P181, DOI 10.1080/01402382.2011.546566; Seabrook Nicholas, 2014, POLITICAL BEHAV, P1; Shiozawa Kenichi, 2008, KEIKAKU GYOUSEI, V31, P79; Smith D. A., 1998, TAX CRUSADERS POLITI; Smith DA, 2004, ED INITIATIVE EFFECT; Smith Daniel, 2010, ANN M AM POL SCI ASS; Stadelmann-Steffen I, 2012, POLIT BEHAV, V34, P535, DOI 10.1007/s11109-011-9164-y; Tolbert CJ, 2009, AM POLIT RES, V37, P155, DOI 10.1177/1532673X08320185; Wenzel James, 1998, CITIZENS LEGISLATORS; Yano Junko, 2005, SENKYO GAKKAI KIYOU, V4, P63	47	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1468-1099	1474-0060		JPN J POLIT SCI	Jpn. J. Polit. Sci.	MAR	2015	16	1			SI		52	67		10.1017/S1468109914000383		16	Political Science	Government & Law	CB6UL	WOS:000349762100004		
J	Ono, Y				Ono, Yoshikuni			Personal Attributes of Legislators and Parliamentary Behavior: An Analysis of Parliamentary Activities among Japanese Legislators	JAPANESE JOURNAL OF POLITICAL SCIENCE			English	Article							PORK-BARREL POLITICS; PROPORTIONAL REPRESENTATION; ELECTORAL INSTITUTIONS; CONSTITUENCY FOCUS; GERMAN-BUNDESTAG; VOTE; PARTY; INCENTIVES; MPS; ORGANIZATION	This study explores the individual-level activities of legislators in parliament, which have been largely ignored in the literature on parliamentary democracies. Individual legislators are extensively involved in parliamentary activities such as drafting private members' bills and posing questions, even though these activities have only been considered to play marginal roles in parliamentary democracies. Moreover, their engagement varies significantly. By using unique data from Japan, this study demonstrates that the personal attributes of legislators affect their choice of parliamentary activities. Under electoral systems with intra-party competition, legislators use parliamentary activities as an important means to inform their constituents about what they can do for them and how they differ from other legislators. In elections, candidates cultivate personal votes by exploiting the image drawn from their personal attributes and, once elected, they behave in accordance with their attributes in order to maintain their electoral ground. Thus, they devote themselves to different activities in parliament. The data analyzed here support this argument. The results of empirical analyses show that legislators with local-level political experience engage in particularistic pork-barrel activities that will benefit their local interests, while legislators with legal-work experience allocate their time and energy to general policy-making activities that will enhance their public image and visibility as legal experts.	Tohoku Univ, Sch Law, Sendai, Miyagi 980, Japan	Ono, Y (reprint author), Tohoku Univ, Sch Law, Sendai, Miyagi 980, Japan.	onoy@law.tohoku.ac.jp		Ono, Yoshikuni/0000-0002-9222-4014	Murata Science Foundation Research Grant; Japanese Association of Electoral Studies Overseas Conference Grant; Japan Society for the Promotion of Science [26780078]	The author would like to thank Kentaro Fukumoto, Ryan Hartley, Kuniaki Nemoto, Jonson N. Porteux, and six anonymous reviewers for valuable comments on earlier drafts. This research was supported by the Murata Science Foundation Research Grant, Japanese Association of Electoral Studies Overseas Conference Grant, and the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (26780078).	Aldrich John H, 1995, WHY PARTIES ORIGIN T; AMES B, 1995, AM J POLIT SCI, V39, P406, DOI 10.2307/2111619; Andeweg Rudy B., 1995, PARLIAMENTS MAJORITY; Chattopadhyay R, 2004, ECONOMETRICA, V72, P1409, DOI 10.1111/j.1468-0262.2004.00539.x; Brauninger T, 2012, EUR J POLIT RES, V51, P607, DOI 10.1111/j.1475-6765.2011.02047.x; Tavits M, 2010, PARTY POLIT, V16, P215, DOI 10.1177/1354068809341053; Dollar D, 2001, J ECON BEHAV ORGAN, V46, P423, DOI 10.1016/S0167-2681(01)00169-X; Shugart MS, 2005, AM J POLIT SCI, V49, P437, DOI 10.1111/j.0092-5853.2005.00133.x; Martin S, 2011, LEGIS STUD QUART, V36, P339, DOI 10.1111/j.1939-9162.2011.00018.x; Carey JM, 1995, ELECT STUD, V14, P417, DOI 10.1016/0261-3794(94)00035-2; Martin LW, 2008, POLIT RES QUART, V61, P502, DOI 10.1177/1065912907308348; Quinn KM, 2010, AM J POLIT SCI, V54, P209; Ono Y, 2012, AM J POLIT SCI, V56, P553, DOI 10.1111/j.1540-5907.2012.00586.x; Heitshusen V, 2005, AM J POLIT SCI, V49, P32, DOI 10.1111/j.0092-5853.2005.00108.x; Brauninger T, 2009, EUR J POLIT RES, V48, P804, DOI 10.1111/j.1475-6765.2009.00850.x; Davis A, 2007, POLIT COMMUN, V24, P181, DOI 10.1080/10584600701313033; Carey JM, 2007, AM J POLIT SCI, V51, P92, DOI 10.1111/j.1540-5907.2007.00239.x; Van Aelst P, 2010, POLIT COMMUN, V27, P310, DOI 10.1080/10584609.2010.496711; Soroka S, 2009, CAN J POLIT SCI, V42, P563, DOI 10.1017/S0008423909990059; Heller WB, 2008, AM J POLIT SCI, V52, P910, DOI 10.1111/j.1540-5907.2008.00350.x; LANCASTER TD, 1990, COMP POLIT STUD, V22, P458, DOI 10.1177/0010414090022004004; Burden BC, 2004, BRIT J POLIT SCI, V34, P211, DOI 10.1017/S000712340400002X; Hill KQ, 2002, J POLIT, V64, P219; Plutzer E, 2002, AM POLIT SCI REV, V96, P41; Stratmann T, 2002, AM J POLIT SCI, V46, P506, DOI 10.2307/3088395; Nemoto K, 2008, BRIT J POLIT SCI, V38, P499, DOI 10.1017/S0007123408000252; Ingall RE, 2001, LEGIS STUD QUART, V26, P487, DOI 10.2307/440333; Kato J, 1998, AM POLIT SCI REV, V92, P857, DOI 10.2307/2586308; Golden MA, 2008, AM J POLIT SCI, V52, P268, DOI 10.1111/j.1540-5907.2007.00312.x; Bergman T., 2003, DELEGATION ACCOUNTAB; Blondel J., 1991, PROFESSION GOVT MINI; Bowler S., 1999, PARTY DISCIPLINE PAR; Bowler S., 2010, J LEGISLATIVE STUDIE, V16, P476, DOI DOI 10.1080/13572334.2010.519457; Brazier A, 2010, PARLIAMENT AFF, V63, P201, DOI 10.1093/pa/gsp053; Cain Bruce, 1990, PERSONAL VOTE CONSTI; Campbell A. L., 2005, POLICIES MAKE CITIZE; Cox Gary, 1993, LEGISLATIVE LEVIATHA; Cox GW, 1998, COMP POLIT STUD, V31, P267, DOI 10.1177/0010414098031003001; Crisp BF, 2004, J POLIT, V66, P136, DOI 10.1046/j.1468-2508.2004.00145.x; Epstein D, 1997, AM J POLIT SCI, V41, P965, DOI 10.2307/2111683; Fiorina P. Morris, 1989, C KEYSTONE WASHINGTO; Fukumoto Kentaro, 2000, NIHON NO KOKKAI SEIJ; Hirano S, 2006, WORLD POLIT, V59, P51, DOI 10.1353/wp.2007.0017; Hirano S, 2011, J POLIT, V73, P1081, DOI 10.1017/S002238161100079X; Hyson Stewart, 1974, PARLIAMENT AFF, V27, P262; Inoguchi Takashi, 1987, ZOKU GIIN NO KENKYU; Kam C, 2006, BRIT J POLIT SCI, V36, P561, DOI 10.1017/S0007123406000299; Kam CJ, 2009, PARTY DISCIPLINE AND PARLIAMENTARY POLITICS, P1; Kellermann Michael, 2013, POLITICAL SCI RES ME, V1, P263; Loewen PJ, 2014, AM J POLIT SCI, V58, P189, DOI 10.1111/ajps.12042; Marangoni Francesco, 2011, J LEGISLATIVE STUDIE, V17, P415; Marsh D., 1988, PRIVATE MEMBERS BILL; Martin S, 2011, POLIT STUD-LONDON, V59, P472, DOI 10.1111/j.1467-9248.2011.00885.x; Mattson Ingvar, 1995, PARLIAMENTS MAJORITY; Mayhew D. R., 1974, C ELECTORAL CONNECTI; Mershon C, 2008, COMP POLIT STUD, V41, P99, DOI 10.1177/0010414007303651; Mizusaki Tokifumi, 2007, SOSENKYO NO TOKUHYO; Nemoto K, 2013, ELECT STUD, V32, P1, DOI 10.1016/j.electstud.2012.11.005; Norton P, 1993, BACK WESTMINSTER CON; Oyama Reiko, 1997, KOKKAIGAKU NYUMON; Proksch SO, 2012, AM J POLIT SCI, V56, P520, DOI 10.1111/j.1540-5907.2011.00565.x; Sato S, 1986, JIMINTO SEIKEN; StrOm Kaare, 2003, DELEGATION ACCOUNTAB; Tatebayashi Masahiko, 2004, GIIN KODO NO SEIJIKE; Todai ho kabashima ikuo zemi, 2000, GENDAI NIHON NO SEIJ; Winter L De, 1991, PROFESSION GOVT MINI; Wood DM, 1997, LEGIS STUD QUART, V22, P217, DOI 10.2307/440383	67	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1468-1099	1474-0060		JPN J POLIT SCI	Jpn. J. Polit. Sci.	MAR	2015	16	1			SI		68	95		10.1017/S1468109914000395		28	Political Science	Government & Law	CB6UL	WOS:000349762100005		
J	Kagotani, K				Kagotani, Koji			National Security Environments, Patriotism, and Japanese Public Opinion	JAPANESE JOURNAL OF POLITICAL SCIENCE			English	Article							FRACTIONAL-INTEGRATION METHODS; PRESIDENTIAL POPULARITY; UNITED-STATES; FORCE; CONFLICT; POLICY	This study examines Japanese reactions to neighboring countries' behavior by addressing possible micro-motives, such as patriotism, the rational demand for national defense, and retrospective policy evaluation. This theoretical development leads to distinctive hypotheses from different motivations and directly tests them using macrodata (not survey data). This research will apply this framework to Japanese politics and will show that foreign threats stimulate patriotism in the public mind and enhance political support for national leaders. It will also demonstrate that the Japanese public has no optimistic view of the new prime minister and that the honeymoon effect in previous research may be confounded with the patriotic effect because the new leader is less experienced and is often challenged by foreign countries.	Osaka Univ Econ, Fac Econ, Osaka, Japan	Kagotani, K (reprint author), Osaka Univ Econ, Fac Econ, Osaka, Japan.	kagotani@osaka-ue.ac.jp			Suntory foundation; JSPS KAKENHI [26285031]	For helpful comments, I am grateful to Kentaro Fukumoto, Hatsuru Morita, Kuniaki Nemoto, and Yuki Yanai. The earlier draft was presented at the 2014 East Asian security workshop at Kobe University, sponsored by the Suntory foundation. I also appreciate the feedback from the colleagues in the workshop. This study was partially supported by JSPS KAKENHI Grant Number 26285031.	HARTLEY T, 1992, AM POLIT SCI REV, V86, P905, DOI 10.2307/1964343; MUELLER JE, 1970, AM POLIT SCI REV, V64, P18, DOI 10.2307/1955610; Lai B, 2005, INT STUD QUART, V49, P255, DOI 10.1111/j.0020-8833.2005.00344.x; King G, 2003, INT ORGAN, V57, P617, DOI 10.1017/S0020818303573064; Ghosn F, 2004, CONFLICT MANAG PEACE, V21, P133, DOI 10.1080/07388940490463861; Lebo MJ, 2000, ELECT STUD, V19, P31, DOI 10.1016/S0261-3794(99)00034-7; Klein JP, 2006, J PEACE RES, V43, P331, DOI 10.1177/0022343306063935; Izumikawa Y, 2010, INT SECURITY, V35, P123, DOI 10.1162/ISEC_a_00020; AZAR EE, 1980, J CONFLICT RESOLUT, V24, P143; Box G, 1970, TIME SERIES ANAL FOR; Box-Steffensmeier JM, 2000, ELECT STUD, V19, P63, DOI 10.1016/S0261-3794(99)00036-0; Box-Steffensmeier JM, 1998, AM J POLIT SCI, V42, P661, DOI 10.2307/2991774; Brody Richard, 1991, ASSESSING PRESIDENT; Clarke HD, 2003, BRIT J POLIT SCI, V33, P283, DOI 10.1017/S0007123403000127; Edwards GC, 1997, J POLIT, V59, P200; GOLDSTEIN JS, 1992, J CONFLICT RESOLUT, V36, P369, DOI 10.1177/0022002792036002007; Iida Takeshi, 2005, SENKYO GAKKAI KIYO, V4, P41; JAMES P, 1991, J CONFLICT RESOLUT, V35, P307, DOI 10.1177/0022002791035002008; Kagotani K, 2014, INT RELAT ASIA-PAC, V14, P91, DOI 10.1093/irap/lct017; Kagotani Koji, 2012, SCRAMBLE SECUR UNPUB; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; King Gary, 2003, 10 MILLION INT DYADI; Lind JM, 2004, INT SECURITY, V29, P92, DOI 10.1162/0162288041762968; Maeda Yukio, 2011, SYAKAI KAGAKU KENKYU, V62, P151; MARRA RF, 1990, J CONFLICT RESOLUT, V34, P588, DOI 10.1177/0022002790034004002; MCCLELLAND CA, 1983, INT STUD QUART, V27, P169, DOI 10.2307/2600544; Midford P., 2011, RETHINKING JAPANESE; Midford P, 2002, SECUR STUD, V11, P1; Midlarsky MI, 1989, HDB WAR STUDIES, P259; MORGAN TC, 1992, J CONFLICT RESOLUT, V36, P25, DOI 10.1177/0022002792036001002; Nickelsburg M, 2000, ELECT STUD, V19, P313, DOI 10.1016/S0261-3794(99)00054-2; Nishizawa Yoshitaka, 1999, DOSHISHA HOUGAKU, V51, P1; Nordhaus W, 2012, INT ORGAN, V66, P491, DOI 10.1017/S0020818312000173; Norpoth Helmut, 1991, EC POLITICS CALCULUS, P141; Ohmura Hirotaka, 2014, LEVIATHAN, V54, P77; OKAMURA M, 1991, REV ECON STAT, V73, P200, DOI 10.2307/2109509; OSTROM CW, 1986, AM POLIT SCI REV, V80, P541, DOI 10.2307/1958273; Parker SL, 1995, PUBLIC OPIN QUART, V59, P526, DOI 10.1086/269492; Russett BM, 1993, GRASPING DEMOCRATIC; Russett Bruce M, 2001, TRIANGULATING PEACE; Samuels Richard J., 2007, SECURING JAPAN TOKYO; Schultz Kenneth, 2001, DEMOCRACY COERCIVE D; Twomey CP, 2000, SECUR STUD, V9, P167; Waltz Kenneth N., 1979, THEORY INT POLITICS	44	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1468-1099	1474-0060		JPN J POLIT SCI	Jpn. J. Polit. Sci.	MAR	2015	16	1			SI		96	113		10.1017/S1468109914000401		18	Political Science	Government & Law	CB6UL	WOS:000349762100006		
J	Miwa, H				Miwa, Hirofumi			Voters' Left-Right Perception of Parties in Contemporary Japan: Removing the Noise of Misunderstanding	JAPANESE JOURNAL OF POLITICAL SCIENCE			English	Article							MODELS; INFERENCE; RESPONSES; VALUES; SAMPLE; SCALES; BIAS	The prevailing theory states that either Japanese voters have stopped ideologically distinguishing parties or that the main political parties in Japan have become more centrist in recent years. These arguments are based on survey questions asking citizens to locate parties on an ideological scale. However, these questions may suffer from noise caused by respondents who misinterpret the question wording or answer the questions inappropriately to mask their misunderstanding of the terms 'left' and 'right'. To address this problem by extracting only the views of those who know the meaning of left-right terms, this article develops a mixture model. Applying the model to an opinion poll conducted after the 2012 Japanese general election, I confirm that those who comprehend the left-right terminology - slightly over half of all voters - largely perceived parties' ideologies in the same way as experts. Additionally, I find that even these voters face difficulties in placing ambiguous or new parties on the political spectrum. This study has implications not only for understanding trends in Japanese political ideology, but also for survey design and analysis of heterogeneous survey responses.	[Miwa, Hirofumi] Univ Tokyo, Grad Sch Law & Polit, Tokyo 1138654, Japan; [Miwa, Hirofumi] Japan Soc Promot Sci, Tokyo, Japan	Miwa, H (reprint author), Univ Tokyo, Grad Sch Law & Polit, Tokyo 1138654, Japan.	miwahirofumi@gmail.com			JSPS KAKENHI [25.8571]	I wish to thank Kentaro Fukumoto, Yukio Maeda, Naoko Taniguchi, Michio Umeda, and the anonymous reviewers for their helpful comments. I also thank the participants of the workshop 'How Democracy Works in Japan: Quantitative Investigations', held at Gakushuin University of Tokyo, and especially Noriyo Isozaki, Kuniaki Nemoto, and Yoshikuni Ono for their valuable feedback. I am grateful to Masaki Taniguchi for providing access to the UTokyo-Asahi Survey data and Junko Kato for providing information on her expert survey. This work was supported by JSPS KAKENHI (Grant-in-Aid for JSPS fellow) Grant Number 25.8571.	Alvarez Michael R., 1994, J POLIT, V56, P671; Hanmer MJ, 2013, AM J POLIT SCI, V57, P263, DOI 10.1111/j.1540-5907.2012.00602.x; Katz JN, 2010, AM J POLIT SCI, V54, P815; Brambor T, 2006, POLIT ANAL, V14, P63, DOI 10.1093/pan/mpi014; Leite WL, 2010, MULTIVAR BEHAV RES, V45, P271, DOI 10.1080/00273171003680245; Bagozzi BE, 2012, POLIT ANAL, V20, P369, DOI 10.1093/pan/mps020; Brooks R, 2012, ECON LETT, V117, P683, DOI 10.1016/j.econlet.2012.08.020; SCHWARZ N, 1991, PUBLIC OPIN QUART, V55, P570, DOI 10.1086/269282; Converse Philip E., 1964, IDEOLOGY AND DISCONT; Denwood M. J., 2013, RUNJAGS INTERFACE UT; Endo Masahisa, 2014, INSTITUTE FOR RESEAR; FERBER R, 1956, J AM STAT ASSOC, V51, P576; Fortunato D, 2013, AM J POLIT SCI, V57, P459, DOI 10.1111/j.1540-5907.2012.00623.x; Imai K, 2010, AM J POLIT SCI, V54, P543; Imai K, 2012, AM J POLIT SCI, V56, P218, DOI 10.1111/j.1540-5907.2011.00555.x; Jackman S, 2000, AM J POLIT SCI, V44, P375, DOI 10.2307/2669318; Jackson John E., 1993, POLIT ANAL, V5, P39, DOI 10.1093/pan/5.1.39; Japan Audit Bureau of Circulations, 2013, SHINBUNHAKKOSHAREPOT; Jou Willy, 2014, ASUTEION, P149; Jou Willy, 2014, SENKYO KENKYU, V30, P96; Kabashima I, 1998, SEIKEN KOTAI TO YUKE; Kabashima Ikuo, 1996, GENDAI NIHONJIN NO I; Kabashima Ikuo, 2012, IDEOROGI IDEOLOGY; Kabashima Ikuo, 2010, CHANGING POLITICS IN; Kato Junko, 2014, EXPERT SURVEY RESULT; Keeter S., 1996, WHAT AMERICANS KNOW; KLINGEMA.HD, 1972, COMP POLIT STUD, V5, P93, DOI 10.1177/001041407200500105; Klingemann Hans-Dieter, 1979, POLITICAL ACTION MAS; Lemon J., 2006, R NEWS, V6, P8; Li T, 2003, SOCIOL METHOD RES, V31, P514, DOI 10.1177/0049124103251951; Miyake Ichiro, 1985, SEITO SHIJI NO BUNSE; Otake Hideo, 1999, NIHON SEIJI NO TAIRI; Plummer M, 2003, PROCEEDINGS OF THE 3; Plummer M., 2006, R NEWS, V6, P7; R Core Team, 2013, R LANG ENV STAT COMP; Rammstedt B, 2007, EUR J PSYCHOL ASSESS, V23, P32, DOI 10.1027/1015-5759.23.1.32; Reed Steven R., 2013, JAPAN DECIDES 2012 T; Strazzera E, 2003, APPL ECON, V35, P133, DOI 10.1080/0003684022000015900; Taniguchi Masaki, 2012, SEITO SHIJI NO RIRON	39	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1468-1099	1474-0060		JPN J POLIT SCI	Jpn. J. Polit. Sci.	MAR	2015	16	1			SI		114	137		10.1017/S1468109914000413		24	Political Science	Government & Law	CB6UL	WOS:000349762100007		
J	Kikukawa, H; Sakuradani, E; Nishibaba, Y; Okuda, T; Ando, A; Shima, J; Shimizu, S; Ogawa, J				Kikukawa, H.; Sakuradani, E.; Nishibaba, Y.; Okuda, T.; Ando, A.; Shima, J.; Shimizu, S.; Ogawa, J.			Production of cis-11-eicosenoic acid by Mortierella fungi	JOURNAL OF APPLIED MICROBIOLOGY			English	Article						eicosenoic acid; fatty acid elongase; Mortierella; polyunsaturated fatty acid; screening	POLYUNSATURATED FATTY-ACIDS; ARACHIDONIC-ACID; ALPINA 1S-4; HETEROLOGOUS EXPRESSION; DESATURASE; IDENTIFICATION; ASPERGILLUS; GENE	AimTo find cis-11-eicosenoic acid (20:19, EA)-producing micro-organisms. Methods and ResultsWe found EA-producing fungi by screening about 300 fungal strains and identified a major fatty acid accumulated in the Mortierella fungi as EA by means of GC-MS analysis. In particular, Mortierella chlamydospora CBS 529.75 produced a high amount of EA (363mgg(-1) of dried cells) on cultivation at 28 degrees C for 4days and then at 12 degrees C for 3days. In the result of lipid analysis, most of the EA was a component of triacylglycerols, not phospholipids. ConclusionWe found that M.chlamydospora CBS 529.75 was the best producer for the microbial production of EA. Significance and Impact of the StudyEA is beneficial as a raw material for medical supplies and a moisturizing component of cosmetic creams. This is the first report of microbial production of EA.	[Kikukawa, H.; Sakuradani, E.; Nishibaba, Y.; Okuda, T.; Ando, A.; Shimizu, S.; Ogawa, J.] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan; [Sakuradani, E.] Univ Tokushima, Inst Sci & Technol, Tokushima 7708506, Japan; [Ando, A.; Ogawa, J.] Kyoto Univ, Res Unit Physiol Chem, Kyoto, Japan; [Shima, J.] Ryukoku Univ, Fac Low, Kyoto, Japan; [Shimizu, S.] Kyoto Gakuen Univ, Fac Bioenvironm Sci, Kyoto, Japan	Sakuradani, E (reprint author), Univ Tokushima, Inst Sci & Technol, 2-1 Minami Josanjima, Tokushima 7708506, Japan.	sakuradani.eiji@tokushima-u.ac.jp			Program for the Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry of Japan; Advanced Low Carbon Technology Research and Development Program of Japan;  [22380051];  [23248014]	This work was partially supported by Grants-in-Aid for Scientific Research of Japan (No. 22380051 to E.S. and No. 23248014 to J.O.), the Program for the Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry of Japan, and the Advanced Low Carbon Technology Research and Development Program of Japan.	Abe T, 2006, APPL MICROBIOL BIOT, V70, P711, DOI 10.1007/s00253-005-0115-6; ANDERSSO.BA, 1974, LIPIDS, V9, P185, DOI 10.1007/BF02532690; Kikukawa H, 2013, J BIOSCI BIOENG, V116, P672, DOI 10.1016/j.jbiosc.2013.05.023; Sakuradani E, 2008, APPL MICROBIOL BIOT, V81, P497, DOI 10.1007/s00253-008-1675-z; Sakuradani E, 2013, J BIOSCI BIOENG, V116, P417, DOI 10.1016/j.jbiosc.2013.04.008; MIWA TK, 1971, J AM OIL CHEM SOC, V48, P259, DOI 10.1007/BF02638458; Parker-Barnes JM, 2000, P NATL ACAD SCI USA, V97, P8284, DOI 10.1073/pnas.97.15.8284; Sakuradani E, 1999, GENE, V238, P445, DOI 10.1016/S0378-1119(99)00359-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; SHINMEN Y, 1989, APPL MICROBIOL BIOT, V31, P11; Wagner L, 2013, PERSOONIA, V30, P77, DOI 10.3767/003158513X666268; Sakuradani E, 1999, EUR J BIOCHEM, V260, P208, DOI 10.1046/j.1432-1327.1999.00131.x; Sakuradani E, 2005, APPL MICROBIOL BIOT, V66, P648, DOI 10.1007/s00253-004-1760-x; Ciubota-Rosie C, 2013, BIOMASS BIOENERG, V51, P83, DOI 10.1016/j.biombioe.2013.01.008; Kawashima H, 1997, APPL ENVIRON MICROB, V63, P1820; Lee JC, 2008, BIOTECHNOL BIOPROC E, V13, P524, DOI 10.1007/s12257-008-0032-5; Michaelson LV, 1998, J BIOL CHEM, V273, P19055, DOI 10.1074/jbc.273.30.19055; NIESCHLA.HJ, 1971, J AM OIL CHEM SOC, V48, P723, DOI 10.1007/BF02638529; Sakuradani E, 2009, APPL MICROBIOL BIOT, V84, P709, DOI 10.1007/s00253-009-1999-3; Sakuradani E, 1999, EUR J BIOCHEM, V261, P812, DOI 10.1046/j.1432-1327.1999.00333.x; SHIMIZU S, 1988, BIOCHEM BIOPH RES CO, V150, P335, DOI 10.1016/0006-291X(88)90525-6; Somerville C., 2000, BIOCH MOL BIOL PLANT, P481	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1364-5072	1365-2672		J APPL MICROBIOL	J. Appl. Microbiol.	MAR	2015	118	3					641	647		10.1111/jam.12725		7	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CB9TR	WOS:000349976400011		
J	McLeod, SM; Fleming, PR; MacCormack, K; McLaughlin, RE; Whiteaker, JD; Narita, S; Mori, M; Tokuda, H; Miller, AA				McLeod, Sarah M.; Fleming, Paul R.; MacCormack, Kathleen; McLaughlin, Robert E.; Whiteaker, James D.; Narita, Shin-ichiro; Mori, Makiko; Tokuda, Hajime; Miller, Alita A.			Small-Molecule Inhibitors of Gram-Negative Lipoprotein Trafficking Discovered by Phenotypic Screening	JOURNAL OF BACTERIOLOGY			English	Article							OUTER-MEMBRANE LIPOPROTEIN; ESCHERICHIA-COLI LIPOPROTEINS; ABC TRANSPORTER LOLCDE; BACTERIAL LIPOPROTEINS; INNER MEMBRANE; CELL-SURFACE; LIPOPOLYSACCHARIDE; COMPLEX; LOCALIZATION; GLOBOMYCIN	In Gram-negative bacteria, lipoproteins are transported to the outer membrane by the Lol system. In this process, lipoproteins are released from the inner membrane by the ABC transporter LolCDE and passed to LolA, a diffusible periplasmic molecular chaperone. Lipoproteins are then transferred to the outer membrane receptor protein, LolB, for insertion in the outer membrane. Here we describe the discovery and characterization of novel pyridineimidazole compounds that inhibit this process. Escherichia coli mutants resistant to the pyridineimidazoles show no cross-resistance to other classes of antibiotics and map to either the LolC or LolE protein of the LolCDE transporter complex. The pyridineimidazoles were shown to inhibit the LolA-dependent release of the lipoprotein Lpp from E. coli spheroplasts. These results combined with bacterial cytological profiling are consistent with LolCDE-mediated disruption of lipoprotein targeting to the outer membrane as the mode of action of these pyridineimidazoles. The pyridineimidazoles are the first reported inhibitors of the LolCDE complex, a target which has never been exploited for therapeutic intervention. These compounds open the door to further interrogation of the outer membrane lipoprotein transport pathway as a target for antimicrobial therapy.	[McLeod, Sarah M.; MacCormack, Kathleen; McLaughlin, Robert E.; Whiteaker, James D.; Miller, Alita A.] AstraZeneca R&D Boston, Dept Biosci, Waltham, MA 02451 USA; [Fleming, Paul R.] AstraZeneca R&D Boston, Dept Chem, Waltham, MA USA; [Narita, Shin-ichiro; Mori, Makiko; Tokuda, Hajime] Univ Morioka, Takizawa, Iwate, Japan	McLeod, SM (reprint author), AstraZeneca R&D Boston, Dept Biosci, Waltham, MA 02451 USA.	sarah.mcleod@astrazeneca.com					Mizutani M, 2013, FEBS LETT, V587, P23, DOI 10.1016/j.febslet.2012.11.009; MATSUYAMA S, 1995, EMBO J, V14, P3365; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Tanaka K, 2001, J BACTERIOL, V183, P6538, DOI 10.1128/JB.183.22.6538-6542.2001; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Narita SI, 2007, J BIOL CHEM, V282, P13372, DOI 10.1074/jbc.M611839200; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; INOUYE M, 1972, J BIOL CHEM, V247, P8154; Tajima T, 1998, FEBS LETT, V439, P51, DOI 10.1016/S0014-5793(98)01334-9; Nikaido H, 2001, SEMIN CELL DEV BIOL, V12, P215, DOI 10.1006/scdb.2000.0247; Matsuyama S, 1997, EMBO J, V16, P6947, DOI 10.1093/emboj/16.23.6947; Okuda S, 2009, P NATL ACAD SCI USA, V106, P5877, DOI 10.1073/pnas.0900896106; Zuckert WR, 2014, BBA-MOL CELL RES, V1843, P1509, DOI 10.1016/j.bbamcr.2014.04.022; Rex JH, 2013, LANCET INFECT DIS, V13, P269, DOI 10.1016/S1473-3099(12)70293-1; Henry R, 2012, ANTIMICROB AGENTS CH, V56, P59, DOI 10.1128/AAC.05191-11; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; SHLAES DM, 1989, ANTIMICROB AGENTS CH, V33, P192; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Yakushi T, 2000, NAT CELL BIOL, V2, P212; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Nonejuie P, 2013, P NATL ACAD SCI USA, V110, P16169, DOI 10.1073/pnas.1311066110; Narita S, 2011, BIOSCI BIOTECH BIOCH, V75, P1044, DOI 10.1271/bbb.110115; Okuda S, 2011, ANNU REV MICROBIOL, V65, P239, DOI 10.1146/annurev-micro-090110-102859; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Xiao Y, 2012, ANTIMICROB AGENTS CH, V56, P2014, DOI 10.1128/AAC.06148-11; Pathania R, 2009, NAT CHEM BIOL, V5, P849, DOI 10.1038/nchembio.221; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Narita S, 2002, J BACTERIOL, V184, P1417, DOI 10.1128/JB.184.5.1417-1422.2002; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Buurman ET, 2006, ANTIMICROB AGENTS CH, V50, P385, DOI 10.1128/AAC.50.1.385-387.2006; CHOI DS, 1986, J BIOL CHEM, V261, P8953; Clinical and Laboratory Standards Institute, 2009, METH DIL ANT SUSC TE, V29, pM07; de Jonge BLM, 2013, ANTIMICROB AGENTS CH, V57, P6005, DOI 10.1128/AAC.01661-13; HUNT DE, 1969, APPL MICROBIOL, V17, P329; INUKAI M, 1978, J ANTIBIOT, V31, P1203; INUKAI M, 1979, J BACTERIOL, V140, P1098; Tanaka S, 2007, J BIOL CHEM, V282, P13379, DOI 10.1074/jbc.M611840200; Thomason LC, 2007, CURR PROTOC MOL BIOL, DOI [10.1002/0471142727.mb0116s78, DOI 10.1002/0471142727.MB0117S79]; WIENTJES FB, 1985, J BACTERIOL, V164, P331; Yakushi T, 1997, J BACTERIOL, V179, P2857; Yasuda M, 2009, BIOSCI BIOTECH BIOCH, V73, P2310, DOI 10.1271/bbb.90451; ZWIEBEL LJ, 1981, J BACTERIOL, V145, P654	46	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	MAR	2015	197	6					1075	1082		10.1128/JB.02352-14		8	Microbiology	Microbiology	CC0MK	WOS:000350029700007		
J	Oinuma, K; Takuwa, A; Taniyama, K; Doi, Y; Takaya, N				Oinuma, Ken-Ichi; Takuwa, Atsushi; Taniyama, Kosuke; Doi, Yuki; Takaya, Naoki			Hydrazidase, a Novel Amidase Signature Enzyme That Hydrolyzes Acylhydrazides	JOURNAL OF BACTERIOLOGY			English	Article							CATABOLIC GENE-CLUSTER; PSEUDOMONAS-AERUGINOSA; SUBSTRATE-SPECIFICITY; CATALYZED HYDROLYSIS; NUCLEOTIDE-SEQUENCE; AROMATIC-COMPOUNDS; AGARICUS-BISPORUS; ACID; HYDROLASE; FAMILY	The degradation mechanisms of natural and artificial hydrazides have been elucidated. Here we screened and isolated bacteria that utilize the acylhydrazide 4-hydroxybenzoic acid 1-phenylethylidene hydrazide (HBPH) from soils. Physiological and phylogenetic studies identified one bacterium as Microbacterium sp. strain HM58-2, from which we purified intracellular hydrazidase, cloned its gene, and prepared recombinant hydrazidase using an Escherichia coli expression system. The Microbacterium sp. HM58-2 hydrazidase is a 631-amino-acid monomer that was 31% identical to indoleacetamide hydrolase isolated from Bradyrhizobium japonicum. Phylogenetic studies indicated that the Microbacterium sp. HM58-2 hydrazidase constitutes a novel hydrazidase group among amidase signature proteins that are distributed within proteobacteria, actinobacteria, and firmicutes. The hydrazidase stoichiometrically hydrolyzed the acylhydrazide residue of HBPH to the corresponding acid and hydrazine derivative. Steady-state kinetics showed that the enzyme hydrolyzes structurally related 4-hydrozybenzamide to hydroxybenzoic acid at a lower rate than HBPH, indicating that the hydrazidase prefers hydrazide to amide. The hydrazidase contains the catalytic Ser-Ser-Lys motif that is conserved among members of the amidase signature family; it shares a catalytic mechanism with amidases, according to mutagenesis findings, and another hydrazidase-specific mechanism must exist that compensates for the absence of the catalytic Ser residue. The finding that an environmental bacterium produces hydrazidase implies the existence of a novel bacterial mechanism of hydrazide degradation that impacts its ecological role.	[Oinuma, Ken-Ichi; Takuwa, Atsushi; Taniyama, Kosuke; Doi, Yuki; Takaya, Naoki] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	Takaya, N (reprint author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	takaya.naoki.ge@u.tsukuba.ac.jp			Ministry of Education, Science, Culture and Sports of Japan	This study was partly supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Culture and Sports of Japan.	Blair LM, 2013, J NAT PROD, V76, P794, DOI 10.1021/np400124n; Sharma Monica, 2009, Reviews in Environmental Science and Bio/Technology, V8, P343, DOI 10.1007/s11157-009-9175-x; Toogood HS, 2004, TETRAHEDRON, V60, P711, DOI 10.1016/j.tet.2003.11.064; Hammann R, 1998, J BASIC MICROB, V38, P207, DOI 10.1002/(SICI)1521-4028(199807)38:3<207::AID-JOBM207>3.0.CO;2-R; McKinney MK, 2003, J BIOL CHEM, V278, P37393, DOI 10.1074/jbc.M303922200; Kobayashi M, 1998, FEBS LETT, V439, P325, DOI 10.1016/S0014-5793(98)01406-9; Cilia E, 2005, FEBS J, V272, P4716, DOI 10.1111/j.1742-4658.2005.04887.x; OCHMAN H, 1988, GENETICS, V120, P621; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Pollmann S, 2003, PHYTOCHEMISTRY, V62, P293, DOI 10.1016/S0031-9422(02)00563-0; Schippers A, 2005, INT J SYST EVOL MICR, V55, P655, DOI 10.1099/ijs.0.63305-0; MICHELOT D, 1991, J APPL TOXICOL, V11, P235, DOI 10.1002/jat.2550110403; Taniyama K, 2012, J BACTERIOL, V194, P1447, DOI 10.1128/JB.06590-11; Patricelli MP, 2000, J BIOL CHEM, V275, P19177, DOI 10.1074/jbc.M001607200; Becker HD, 2000, FEBS LETT, V476, P140, DOI 10.1016/S0014-5793(00)01697-5; Iwagami SG, 2000, APPL ENVIRON MICROB, V66, P1499, DOI 10.1128/AEM.66.4.1499-1508.2000; Brinkrolf K, 2006, GENET MOL RES, V5, P773; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Basso A, 2005, ADV SYNTH CATAL, V347, P963, DOI 10.1002/adsc.200505038; Doran JP, 2005, PROTEIN EXPRES PURIF, V40, P190, DOI 10.1016/j.pep.2004.12.020; Eulberg D, 1998, J BACTERIOL, V180, P1072; Fournand D, 1998, J MOL CATAL B-ENZYM, V4, P77, DOI 10.1016/S1381-1177(97)00024-6; GIGLIOTTI HJ, 1964, J BIOL CHEM, V239, P2274; GOMI K, 1991, GENE, V108, P91, DOI 10.1016/0378-1119(91)90491-S; Gopalakrishna KN, 2004, BIOCHEMISTRY-US, V43, P7725, DOI 10.1021/bi049907q; Itoh H, 2008, J BIOL CHEM, V283, P5790, DOI 10.1074/jbc.M709027200; KINOSHITA S, 1977, EUR J BIOCHEM, V80, P489, DOI 10.1111/j.1432-1033.1977.tb11904.x; Kobayashi M, 1999, BIOCHEM BIOPH RES CO, V256, P415, DOI 10.1006/bbrc.1999.0342; Komeda H, 2006, APPL MICROBIOL BIOT, V70, P412, DOI 10.1007/s00253-005-0068-9; Lavrov KV, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1006, DOI 10.1134/S0006297910080080; LEVENBERG B, 1961, J AM CHEM SOC, V83, P503, DOI 10.1021/ja01463a070; Lopez-Munoz F, 2007, J CLIN PSYCHOPHARM, V27, P555, DOI 10.1097/jcp.0b013e3181bb617; LUTWACK R, 1957, J AM CHEM SOC, V79, P5690, DOI 10.1021/ja01578a028; Neu D, 2007, FEBS J, V274, P3440, DOI 10.1111/j.1742-4658.2007.05876.x; Ohta Y., 2012, OPEN J MAR SCI, V2, P177, DOI DOI 10.4236/ojms.2012.24021; Pace HC, 2001, GENOME BIOL, V2, P1, DOI DOI 10.1186/GB-2001-2-1-REVIEWS0001; Park HJ, 2003, FEMS MICROBIOL LETT, V226, P151, DOI 10.1016/S0378-1097(03)00585-8; ROSS AE, 1982, FOOD CHEM TOXICOL, V20, P903, DOI 10.1016/S0015-6264(82)80226-5; Sambrook J., 1989, MOL CLONING LAB MANU; Schiessl HW, 2000, KIRK OTHMER ENCY CHE, V13, P562; Scior Thomas, 2002, Archiv der Pharmazie (Weinheim), V335, P511, DOI 10.1002/ardp.200290005; SEKINE M, 1989, NUCLEIC ACIDS RES, V17, P6400, DOI 10.1093/nar/17.15.6400; Shimizu T, 2012, J BIOL CHEM, V287, P40448, DOI 10.1074/jbc.M112.403055; Suzuki K, 2012, BERGEYS MANUAL SYSTE, V5, P814; TANAKA M, 1973, J BIOCHEM-TOKYO, V73, P1285; TOIDA I, 1963, J BIOCHEM-TOKYO, V53, P14; TOIDA I, 1962, AM REV RESPIR DIS, V85, P720; Toth B, 2000, IN VIVO, V14, P299; WOODS MJ, 1979, BIOCHIM BIOPHYS ACTA, V567, P225, DOI 10.1016/0005-2744(79)90189-X; Wu SJ, 1998, DNA CELL BIOL, V17, P915, DOI 10.1089/dna.1998.17.915; Zhang HJ, 2012, BIOTECHNOL LETT, V34, P1931, DOI 10.1007/s10529-012-1000-x	51	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	MAR	2015	197	6					1115	1124		10.1128/JB.02443-14		10	Microbiology	Microbiology	CC0MK	WOS:000350029700011		
J	Yanagi, T; Kajiya, H; Kawaguchi, M; Kido, H; Fukushima, T				Yanagi, Tsukasa; Kajiya, Hiroshi; Kawaguchi, Minoru; Kido, Hirofumi; Fukushima, Tadao			Photothermal stress triggered by near infrared-irradiated carbon nanotubes promotes bone deposition in rat calvarial defects	JOURNAL OF BIOMATERIALS APPLICATIONS			English	Article						Photothermal stress stimulation; DNA; protamine scaffold; bone deposition; preosteoblasts; osteogenesis	HEAT-SHOCK PROTEINS; DNA/PROTAMINE COMPLEX PASTE; IN-VIVO; GENE-EXPRESSION; CRANIAL DEFECTS; GROWTH; CELLS; HYPERTHERMIA; STIMULATION; THERAPY	The bone regenerative healing process is often prolonged, with a high risk of infection particularly in elderly and diseased patients. A reduction in healing process time usually requires mechanical stress devices, chemical cues, or laser/thermal therapies. Although these approaches have been used extensively for the reduction of bone healing time, the exact mechanisms involved in thermal stress-induced bone regeneration remain unclear. In this study, we investigated the effect of optimal hyperthermia on rat calvarial defects invivo and on osteogenesis invitro. Photothermal stress stimulation was carried out using a new photothermal device, composed of an alginate gel including in carbon nanotubes and their irradiator with near-infrared light. Photothermal stress (15min at 42?, every day), trigged by near-infrared-induced carbon nanotube, promoted bone deposition in critical-sized calvarial defects compared with nonthermal stress controls. We recently reported that our novel DNA/protamine complex scaffold induces bone regeneration in calvarial defects. In this study, photothermal stress upregulated bone deposition in DNA/protamine-engrafted calvarial defects. Furthermore, photothermal stress significantly induced expression of osteogenic related genes in a time-dependent manner, including alkaline phosphatase, osterix, and osteocalcin. This was observed in DNA/protamine cells, which were expanded from regenerated tissue engrafted into the DNA/protamine scaffold, as well as in human MG63 preosteoblasts. In summary, this novel carbon nanotube-based photothermal stress approach upregulated expression of osteogenic-related genes in preosteoblasts, resulting in promotion of mineral deposition for enhanced bone repair.	[Yanagi, Tsukasa; Kido, Hirofumi] Fukuoka Dent Coll, Dept Oral Rehabil, Fukuoka, Japan; [Yanagi, Tsukasa; Kajiya, Hiroshi; Kawaguchi, Minoru; Fukushima, Tadao] Fukuoka Dent Coll, Ctr Regenerat Med, Fukuoka, Japan; [Kajiya, Hiroshi] Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Fukuoka, Japan; [Kawaguchi, Minoru] Fukuoka Dent Coll, Dept Dent Engn, Fukuoka, Japan	Kajiya, H (reprint author), Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.	kajiya@college.fdcnet.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24592823, 23390455]; Japan Society for the Promotion of Science [S1001059]	This work was supported by a Grant-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Nos. 24592823 and 23390455) and by a Grant-in-aid for strategic study base formation support business (S1001059) from the Japan Society for the Promotion of Science.	Shinozaki Y, 2013, J HARD TISSUE BIOL, V22, P401; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Zhou FF, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3078803; Ji SR, 2010, BBA-REV CANCER, V1806, P29, DOI 10.1016/j.bbcan.2010.02.004; Mori N, 2013, J BIOMED MATER RES B, V101B, P743, DOI 10.1002/jbm.b.32877; LAVOIE JN, 1993, J BIOL CHEM, V268, P3420; Tiffee JC, 2000, TISSUE CELL, V32, P141, DOI 10.1054/tice.2000.0097; Dhar S, 2008, J AM CHEM SOC, V130, P11467, DOI 10.1021/ja803036e; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; Shui CX, 2001, J BONE MINER RES, V16, P731, DOI 10.1359/jbmr.2001.16.4.731; Fukushima T, 2010, DENT MATER J, V29, P529, DOI 10.4012/dmj.2009-131; Robinson JT, 2010, NANO RES, V3, P779, DOI 10.1007/s12274-010-0045-1; Toda M, 2014, BONE, V67, P237, DOI 10.1016/j.bone.2014.07.018; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; Tabata Y, 2003, TISSUE ENG, V9, pS5; Miyako E, 2012, P NATL ACAD SCI USA, V109, P7523, DOI 10.1073/pnas.1204391109; Liu Z, 2008, CANCER RES, V68, P6652, DOI 10.1158/0008-5472.CAN-08-1468; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; McKee MD, 1996, MICROSC RES TECHNIQ, V33, P141, DOI 10.1002/(SICI)1097-0029(19960201)33:2<141::AID-JEMT5>3.0.CO;2-W; Huang H, 2010, NAT NANOTECHNOL, V5, P602, DOI [10.1038/nnano.2010.125, 10.1038/NNANO.2010.125]; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Weissleder R, 2005, NAT BIOTECHNOL, V23, P1418, DOI 10.1038/nbt1159; Lim CL, 2008, ANN ACAD MED SINGAP, V37, P347; Carter DL, 1998, INT J RADIAT ONCOL, V40, P815, DOI 10.1016/S0360-3016(97)00855-9; Chen J, 2012, TISSUE ENG PART A, V19, P716; Doll B, 2001, CRIT REV EUKAR GENE, V11, P173; DOYLE JR, 1963, J BONE JOINT SURG AM, V45, P15; Fukushima T, 2009, J BIOMED MATER RES B, V91B, P746, DOI 10.1002/jbm.b.31451; Fukushima T, 2008, J ORAL TISSUE ENG, V6, P24; Kawaguchi M, 2006, DENT MATER J, V25, P719; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; LEON SA, 1993, INT J HYPERTHER, V9, P77, DOI 10.3109/02656739309061480; Ramos DM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-55; RICHARDS V, 1959, SURGERY, V46, P84; Rylander MN, 2010, INT J HYPERTHER, V26, P748, DOI 10.3109/02656736.2010.486778; Shinozaki Y, 2014, J BIOMED MATER RES B, V102, P1669, DOI 10.1002/jbm.b.33143; WEINBERGER A, 1990, AM J PHYS MED REHAB, V69, P239, DOI 10.1097/00002060-199010000-00003	39	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0885-3282	1530-8022		J BIOMATER APPL	J. Biomater. Appl.	MAR	2015	29	8					1109	1118		10.1177/0885328214556913		10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CB9UY	WOS:000349980100006		
J	Kuki, I; Shiomi, M; Okazaki, S; Kawawaki, H; Tomiwa, K; Amo, K; Togawa, M; Ishikawa, J; Rinka, H				Kuki, Ichiro; Shiomi, Masashi; Okazaki, Shin; Kawawaki, Hisashi; Tomiwa, Kiyotaka; Amo, Kiyoko; Togawa, Masao; Ishikawa, Junichi; Rinka, Hiroshi			Characteristic Neuroradiologic Features in Hemorrhagic Shock and Encephalopathy Syndrome	JOURNAL OF CHILD NEUROLOGY			English	Article						diffusion-weighted image; acute encephalopathy; viral infection	ACUTE NECROTIZING ENCEPHALOPATHY; CEREBRAL INFARCTION; HEAT-STROKE; CT; CHILDHOOD; DIAGNOSIS; LESIONS	Hemorrhagic shock and encephalopathy syndrome is a devastating disease, but the pathogenesis remains unclear. The aim of this study was to examine the usefulness of neuroimaging in establishing a diagnosis and elucidating the pathogenesis. We analyzed the neuroradiologic features of 22 patients who fulfilled the Levin criteria. All patients underwent brain computed tomography (CT), and 14 patients underwent brain magnetic resonance imaging (MRI) including diffusion-weighted imaging in 10 patients. Initial CT showed normal findings in 14 of 18 (78%) patients, but subsequently hypodensities appeared in bilateral watershed zones and progressed to whole brain edema. MRI revealed cytotoxic edema, showing hyperintensities in bilateral watershed zones on diffusion-weighted imaging with a low apparent diffusion coefficient. Serial neuroimaging showed characteristic features of a widespread brain ischemic event mainly in watershed zones in hemorrhagic shock and encephalopathy syndrome.	[Kuki, Ichiro; Okazaki, Shin; Kawawaki, Hisashi; Tomiwa, Kiyotaka] Osaka City Gen Hosp, Dept Pediat Neurol, Osaka 534, Japan; [Shiomi, Masashi; Amo, Kiyoko; Togawa, Masao] Osaka City Gen Hosp, Dept Pediat Emergency Med, Osaka 534, Japan; [Ishikawa, Junichi; Rinka, Hiroshi] Osaka City Gen Hosp, Emergency & Crit Care Med Ctr, Osaka 534, Japan	Kuki, I (reprint author), Osaka City Gen Hosp, Dept Pediat Neurol, Miyakojima Ku, 2-13-22 Miyakojimahondori, Osaka 534, Japan.	gpkichiro0926@yahoo.co.jp					MIZUGUCHI M, 1995, J NEUROL NEUROSUR PS, V58, P555, DOI 10.1136/jnnp.58.5.555; Albukrek D, 1997, NEURORADIOLOGY, V39, P195; Hoshino A, 2012, BRAIN DEV-JPN, V34, P337, DOI 10.1016/j.braindev.2011.07.012; Mizuguchi M, 2007, ACTA NEUROL SCAND, V115, P45, DOI 10.1111/j.1600-0404.2007.00809.x; BACON CJ, 1992, ARCH DIS CHILD, V67, P985; Bacon CJ, 1999, ARCH DIS CHILD, V81, P155; Bonnier C, 2003, PEDIATRICS, V112, P808, DOI 10.1542/peds.112.4.808; BRATTON SL, 1992, PEDIATRICS, V90, P626; Durunkan A, 2009, BRAIN RES, V14, P158; Frey B, 2000, SCHWEIZ MED WSCHR, V130, P151; IMAKITA S, 1988, NEURORADIOLOGY, V30, P372; Ince E, 2000, PEDIATR EMERG CARE, V16, P260, DOI 10.1097/00006565-200008000-00012; Jardine DS, 1997, PEDIATR RADIOL, V27, P540, DOI 10.1007/s002470050176; JARDINE DS, 1995, PEDIATRICS, V96, P1126; LEVIN M, 1983, LANCET, V2, P64; LEVIN M, 1989, J PEDIATR-US, V114, P194, DOI 10.1016/S0022-3476(89)80783-8; McLaughlin CT, 2003, AM J NEURORADIOL, V24, P1372; Mizuguchi M, 1997, BRAIN DEV-JPN, V19, P81, DOI 10.1016/S0387-7604(96)00063-0; Rinka H, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-43; Shiomi M., 2008, No To Hattatsu, V40, P122; Shiomi Masashi, 2006, Nihon Rinsho, V64, P1887; Sofer S, 1996, ARCH DIS CHILD, V75, P332; Thebaud B, 1999, INTENS CARE MED, V25, P293, DOI 10.1007/s001340050838; VLES JSH, 1992, NEUROPEDIATRICS, V23, P24, DOI 10.1055/s-2008-1071306	24	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	MAR	2015	30	4					468	475		10.1177/0883073814558119		8	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	CB9XA	WOS:000349986300010		
J	Odagiri, T; Matsuzaki, Y; Okamoto, M; Suzuki, A; Saito, M; Tamaki, R; Lupisan, SP; Sombrero, LT; Hongo, S; Oshitani, H				Odagiri, Takashi; Matsuzaki, Yoko; Okamoto, Michiko; Suzuki, Akira; Saito, Mariko; Tamaki, Raita; Lupisan, Socorro P.; Sombrero, Lydia T.; Hongo, Seiji; Oshitani, Hitoshi			Isolation and Characterization of Influenza C Viruses in the Philippines and Japan	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							PHYLOGENETIC ANALYSIS; YAMAGATA-CITY; INFECTION; CHILDREN; HEMAGGLUTININ; SEROPREVALENCE; GENE; PCR; GLYCOPROTEIN; REASSORTMENT	From November 2009 to December 2013 in the Philippines, 15 influenza C viruses were isolated, using MDCK cells, from specimens obtained from children with severe pneumonia and influenza-like illness (ILI). This is the first report of influenza C virus isolation in the Philippines. In addition, from January 2008 to December 2013, 7 influenza C viruses were isolated from specimens that were obtained from children with acute respiratory illness (ARI) in Sendai city, Japan. Antigenic analysis with monoclonal antibodies to the hemagglutinin-esterase (HE) glycoprotein showed that 19 strains (12 from the Philippines and 7 from Japan) were similar to the influenza C virus reference strain C/Sao Paulo/378/82 (SP82). Phylogenetic analysis of the HE gene showed that the strains from the Philippines and Japan formed distinct clusters within an SP82-related lineage. The clusters that included the Philippine and Japanese strains were shown to have diverged from a common ancestor around 1993. In addition, phylogenetic analysis of the internal genes showed that all strains isolated in the Philippines and Japan had emerged through reassortment events. The composition of the internal genes of the Philippine strains was different from that of the Japanese strains, although all strains were classified into an SP82-related lineage by HE gene sequence analysis. These observations suggest that the influenza C viruses analyzed here had emerged through different reassortment events; however, the time and place at which the reassortment events occurred were not determined.	[Odagiri, Takashi; Okamoto, Michiko; Suzuki, Akira; Saito, Mariko; Tamaki, Raita; Oshitani, Hitoshi] Tohoku Univ, Grad Sch Med, Dept Virol, Aoba Ku, Sendai, Miyagi 980, Japan; [Matsuzaki, Yoko; Hongo, Seiji] Yamagata Univ, Fac Med, Dept Infect Dis, Yamagata 990, Japan; [Saito, Mariko; Tamaki, Raita] RITM Tohoku Res Collaborating Ctr Emerging & Reem, Muntinlupa, Philippines; [Lupisan, Socorro P.; Sombrero, Lydia T.] Res Inst Trop Med, Muntinlupa, Philippines	Oshitani, H (reprint author), Tohoku Univ, Grad Sch Med, Dept Virol, Aoba Ku, Sendai, Miyagi 980, Japan.	oshitanih@med.tohoku.ac.jp			Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Science and Technology Research Partnership for Sustainable Development (SATREPS) from the Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA); JSPS KAKENHI [24249041]	This work was supported by a grant-in-aid from the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, the Science and Technology Research Partnership for Sustainable Development (SATREPS) from the Japan Science and Technology Agency (JST), the Japan International Cooperation Agency (JICA), and JSPS KAKENHI grant 24249041.	ANDREWS BE, 1955, BRIT MED J, V2, P992; Matsuzaki Y, 2006, J INFECT DIS, V193, P1229, DOI 10.1086/502973; Anton A, 2011, DIAGN MICR INFEC DIS, V69, P419, DOI 10.1016/j.diagmicrobio.2010.11.006; Principi N, 2013, INFLUENZA OTHER RESP, V7, P999, DOI 10.1111/irv.12062; Matsuzaki Y, 2007, J CLIN MICROBIOL, V45, P783, DOI 10.1128/JCM.01555-06; Kimura H, 1997, VIRUS RES, V48, P71, DOI 10.1016/S0168-1702(96)01427-X; Bellau-Pujol S, 2005, J VIROL METHODS, V126, P53, DOI 10.1016/j.jviromet.2005.01.020; Pabbaraju K, 2013, INFLUENZA OTHER RESP, V7, P954, DOI 10.1111/irv.12099; Matsuzaki Y, 2012, J CLIN VIROL, V54, P130, DOI 10.1016/j.jcv.2012.02.012; Gouarin S, 2008, J MED VIROL, V80, P1441, DOI 10.1002/jmv.21218; Matsuzaki Y, 2014, J CLIN VIROL, V61, P87, DOI 10.1016/j.jcv.2014.06.017; NAKADA S, 1984, J VIROL, V50, P118; Alamgir ASM, 2000, J GEN VIROL, V81, P1933; Tallo VL, 2014, INFLUENZA OTHER RESP, V8, P159, DOI 10.1111/irv.12223; BUONAGURIO DA, 1985, VIROLOGY, V146, P221, DOI 10.1016/0042-6822(85)90006-6; BUONAGURIO DA, 1986, VIROLOGY, V153, P12, DOI 10.1016/0042-6822(86)90003-6; CHAKRAVERTY P, 1978, ARCH VIROL, V58, P341, DOI 10.1007/BF01317826; CHAKRAVERTY P, 1974, J GEN VIROL, V25, P421, DOI 10.1099/0022-1317-25-3-421; Kaji M, 1983, Kurume Med J, V30, P121; Kauppila J, 2014, J MED VIROL, V86, P879, DOI 10.1002/jmv.23756; MANUGUERRA JC, 1994, EUR J EPIDEMIOL, V10, P91, DOI 10.1007/BF01717459; MATSUZAKI Y, 1994, VIROLOGY, V202, P796, DOI 10.1006/viro.1994.1401; Matsuzaki Y, 2004, EPIDEMIOL INFECT, V132, P709, DOI 10.1017/S0950268804002146; Matsuzaki Y, 2003, J VIROL, V77, P871, DOI 10.1128/JVI.77.2.871-881.2003; Matsuzaki Y, 2002, J CLIN MICROBIOL, V40, P422, DOI 10.1128/JCM.40.2.422-429.2002; Matsuzaki Y, 2000, J GEN VIROL, V81, P1447; MORIUCHI H, 1991, J PEDIATR-US, V118, P235, DOI 10.1016/S0022-3476(05)80489-5; Mukherjee TR, 2013, INFECT GENET EVOL, V16, P419, DOI 10.1016/j.meegid.2013.02.014; Muraki Y, 1996, J GEN VIROL, V77, P673, DOI 10.1099/0022-1317-77-4-673; NISHIMURA H, 1987, MICROBIOL IMMUNOL, V31, P1137; NUMAZAKI Y, 1987, MICROBIOL IMMUNOL, V31, P1085; Peng G, 1996, J GEN VIROL, V77, P1489, DOI 10.1099/0022-1317-77-7-1489; PFEIFER JB, 1984, VIRUS RES, V1, P281, DOI 10.1016/0168-1702(84)90017-0; Ramos AP, 2008, INT J INFECT DIS, V12, pE129, DOI 10.1016/j.ijid.2008.01.001; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Salez N, 2014, J INFECTION, V69, P182, DOI 10.1016/j.jinf.2014.03.016; SUGAWARA K, 1988, J GEN VIROL, V69, P537, DOI 10.1099/0022-1317-69-3-537; SUGAWARA K, 1993, J GEN VIROL, V74, P1661, DOI 10.1099/0022-1317-74-8-1661; Suzuki A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-267; Tada Y, 1997, VIRUS GENES, V15, P53, DOI 10.1023/A:1007915215958; UMETSU Y, 1992, VIROLOGY, V189, P740, DOI 10.1016/0042-6822(92)90597-I; Yano T, 2014, JPN J INFECT DIS, V67, P127, DOI 10.7883/yoken.67.127	42	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	MAR	2015	53	3					847	858		10.1128/JCM.02628-14		12	Microbiology	Microbiology	CC2WD	WOS:000350204600016		
J	Monma, C; Hatakeyama, K; Obata, H; Yokoyama, K; Konishi, N; Itoh, T; Kai, A				Monma, Chie; Hatakeyama, Kaoru; Obata, Hiromi; Yokoyama, Keiko; Konishi, Noriko; Itoh, Takeshi; Kai, Akemi			Four Foodborne Disease Outbreaks Caused by a New Type of Enterotoxin-Producing Clostridium perfringens	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							POLYMERASE-CHAIN-REACTION; ESCHERICHIA-COLI; A ENTEROTOXIN; EXPERIMENTAL DIARRHEA; RABBIT ILEUM; TOXIN GENE; CLONING; PURIFICATION; DIFFICILE; STRAINS	The epidemiological and bacteriological investigations on four foodborne outbreaks caused by a new type of enterotoxin-producing Clostridium perfringens are described. C. perfringens isolated from patients of these outbreaks did not produce any known enterotoxin and did not carry the C. perfringens enterotoxin gene. However, the culture filtrates of these isolates induced the accumulation of fluid in rabbit ileal loop tests. The molecular weight of the new enterotoxin may be between 50,000 and 100,000, although the known C. perfringens enterotoxin is ca. 35,000. This new enterotoxin was heat labile, and its biological activities were inactivated by heating for 5 min at 60 degrees C. The new enterotoxin was sensitive to pH values higher than 11.0 and protease treatment but was resistant to trypsin treatment. These results suggest that the new enterotoxin may be a protein. Although C. perfringens enterotoxin induced morphological changes in Vero cells, the changes induced by the new enterotoxin differed from those by the known C. perfringens enterotoxin. The new enterotoxin also induced morphological changes in L929 cells, whereas the known C. perfringens enterotoxin did not, because L929 cells lacked an appropriate enterotoxin receptor. Although C. perfringens enterotoxin is recognized as the only diarrheagenic toxin responsible for C. perfringens foodborne outbreaks, the results of the present study indicate that C. perfringens isolated from these four outbreaks produced a new type of enterotoxin.	[Monma, Chie; Hatakeyama, Kaoru; Obata, Hiromi; Yokoyama, Keiko; Konishi, Noriko; Itoh, Takeshi; Kai, Akemi] Tokyo Metropolitan Inst Publ Hlth, Dept Microbiol, Tokyo 1690073, Japan	Monma, C (reprint author), Tokyo Metropolitan Inst Publ Hlth, Dept Microbiol, 3-24-1 Hyakunincho, Tokyo 1690073, Japan.	Chie_Monma@member.metro.tokyo.jp					ABE A, 1992, ZBL BAKT-INT J MED M, V277, P170; CZECZULIN JR, 1993, INFECT IMMUN, V61, P3429; Kikuchi E, 2002, MICROBIOL IMMUNOL, V46, P353; KARCH H, 1989, J CLIN MICROBIOL, V27, P2751; KATO N, 1991, J CLIN MICROBIOL, V29, P33; Meer RR, 1997, AM J VET RES, V58, P702; Katahira J, 1997, J CELL BIOL, V136, P1239, DOI 10.1083/jcb.136.6.1239; DE SN, 1959, NATURE, V183, P1533, DOI 10.1038/1831533a0; DUNCAN CL, 1972, J BACTERIOL, V110, P378; DUNCAN CL, 1971, INFECT IMMUN, V3, P167; DUNCAN CL, 1973, J BACTERIOL, V113, P932; HAUSCHIL.AH, 1971, CAN J MICROBIOL, V17, P1425; HAUSCHIL.AH, 1970, CAN J MICROBIOL, V16, P339; HAUSCHIL.AH, 1971, CAN J MICROBIOL, V17, P1141; HAUSCHIL.AH, 1971, CAN J MICROBIOL, V17, P987; Ishimura K., 1997, Japanese Journal of Food Microbiology, V14, P35; Itoh T, 1979, Kansenshogaku Zasshi, V53, P409; Itoh T, 1972, ANN REP TOKYO METR R, V24, P347; IWANEJKO LA, 1989, J GEN MICROBIOL, V135, P903; KUHL SJ, 1993, CLIN INFECT DIS, V16, pS234; Labbe R, 1989, FOODBORNE BACTERIAL, P191; MCDONEL JL, 1979, BIOCHEM BIOPH RES CO, V87, P497, DOI 10.1016/0006-291X(79)91823-0; Monma C., 1995, Annual Report of Tokyo Metropolitan Research Laboratory of Public Health, V46, P8; NISHIDA S, 1962, JPN J MICROBIOL, V6, P33; OHTANI Y, 1987, J FOOD HYG SOC JPN, V28, P281; SAKAGUCH.G, 1973, APPL MICROBIOL, V26, P762; SKJELKVALE R, 1977, J APPL BACTERIOL, V43, P281, DOI 10.1111/j.1365-2672.1977.tb00752.x; STARK RL, 1971, INFECT IMMUN, V4, P89; STARK RL, 1972, INFECT IMMUN, V6, P662; STRONG DH, 1971, INFECT IMMUN, V3, P171; UEMURA T, 1975, JPN J MED SCI BIOL, V28, P165; Uzal FA, 1997, LETT APPL MICROBIOL, V25, P339, DOI 10.1046/j.1472-765X.1997.00247.x; VANDAMMEJONGSTEN M, 1989, A VAN LEEUW J MICROB, V56, P181; VICTOR T, 1991, J CLIN MICROBIOL, V29, P158; WANG RF, 1994, MOL CELL PROBE, V8, P131, DOI 10.1006/mcpr.1994.1018; WREN BW, 1993, J MED MICROBIOL, V38, P109; Yamagishi T, 1997, MICROBIOL IMMUNOL, V41, P295; Yoo HS, 1997, J CLIN MICROBIOL, V35, P228	38	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	MAR	2015	53	3					859	867		10.1128/JCM.02859-14		9	Microbiology	Microbiology	CC2WD	WOS:000350204600017		
J	Ito, R; Shindo, Y; Kobayashi, D; Ando, M; Jin, W; Wachino, J; Yamada, K; Kimura, K; Yagi, T; Hasegawa, Y; Arakawa, Y				Ito, Ryota; Shindo, Yuichiro; Kobayashi, Daisuke; Ando, Masahiko; Jin, Wanchun; Wachino, Jun-ichi; Yamada, Keiko; Kimura, Kouji; Yagi, Tetsuya; Hasegawa, Yoshinori; Arakawa, Yoshichika			Molecular Epidemiological Characteristics of Klebsiella pneumoniae Associated with Bacteremia among Patients with Pneumonia	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CARE-ASSOCIATED PNEUMONIA; BLOOD-STREAM INFECTIONS; LIVER-ABSCESS; RISK-FACTORS; VIRULENCE; MORTALITY; IDENTIFICATION; TAIWAN; CLONES	Some important virulence factors have been elucidated in Klebsiella pneumoniae infections. We investigated the relationship between virulence factors and multilocus sequence types (STs) and assessed the risk factors for bacteremia in patients with pneumonia due to K. pneumoniae. From April 2004 through April 2012, a total of 120 K. pneumoniae isolates from patients with pneumonia (23 with bacteremia and 97 without bacteremia) were collected from 10 medical institutions in Japan. Additionally, 10 strains of K. pneumoniae serotype K2 that were isolated >30 years ago were included in this study. These isolates were characterized using multilocus sequence typing (MLST), and the characteristics of their virulence factors, such as hypermucoviscosity phenotype and RmpA and aerobactin production between patients with and without bacteremia, were examined. MLST analysis was performed on the 120 isolates from patients with pneumonia, and some sequence type groups were defined as genetic lineages (GLs). GL65 was more prevalent among patients with bacteremia (21.7%) than in those without bacteremia (7.2%). The majority of the strains with serotype K2 were classified into GL14 or GL65, and rmpA and the gene for aerobactin were present in all GL65-K2 strains but absent in all GL14-K2 strains. In a multivariate analysis, the independent risk factors for bacteremia included GL65 (adjusted odds ratio [AOR], 9.46; 95% confidence interval [CI], 1.81 to 49.31), as well as neoplastic disease (AOR, 9.94; 95% CI, 2.61 to 37.92), immunosuppression (AOR, 17.85; 95% CI, 1.49 to 214.17), and hypoalbuminemia (AOR, 4.76; 95% CI, 1.29 to 17.61). GL65 was more prevalent among patients with bacteremia and was associated with the virulence factors of K. pneumoniae.	[Ito, Ryota; Shindo, Yuichiro; Kobayashi, Daisuke; Hasegawa, Yoshinori] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi 4648601, Japan; [Shindo, Yuichiro] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648601, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Jin, Wanchun; Wachino, Jun-ichi; Yamada, Keiko; Kimura, Kouji; Arakawa, Yoshichika] Nagoya Univ, Grad Sch Med, Dept Bacteriol, Nagoya, Aichi 4648601, Japan; [Yagi, Tetsuya] Nagoya Univ Hosp, Dept Infect Dis, Nagoya, Aichi, Japan	Arakawa, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Bacteriol, Nagoya, Aichi 4648601, Japan.	yarakawa@med.nagoya-u.ac.jp	Kimura, Kouji/C-1847-2015; Arakawa, Yoshichika/P-5997-2015		Ministry of Health, Labour, and Welfare of Japan [H24-Shinkou-Ippan-010]; Chugai Pharmaceutical Co., Ltd.; Shionogi Co., Ltd.; Daiichi Sankyo Co., Ltd.; Dainippon Sumitomo Pharma Co., Ltd.; Janssen Pharmaceutical; Eli Lilly Japan; Taisho Toyama Pharmaceutical Co., Ltd.; Meiji Seika Pharma Co., Ltd.; MSD; Bayer Holding Ltd.; Astellas Pharma, Inc.; Nippon Boehringer Ingelheim Co., Ltd.	Molecular analyses of the bacteria were paid for by grant H24-Shinkou-Ippan-010 from the Ministry of Health, Labour, and Welfare of Japan, and the statistical analyses of microbial and clinical data were conducted by the Central Japan Lung Study Group (CJLSG), a nonprofit organization supported by unrestricted donations from the following pharmaceutical companies: Chugai Pharmaceutical Co., Ltd.; Shionogi & Co., Ltd.; Daiichi Sankyo Co., Ltd.; Dainippon Sumitomo Pharma Co., Ltd.; Janssen Pharmaceutical K.K.; Eli Lilly Japan K.K.; Taisho Toyama Pharmaceutical Co., Ltd.; Meiji Seika Pharma Co., Ltd.; MSD K.K.; Bayer Holding Ltd.; Astellas Pharma, Inc.; and Nippon Boehringer Ingelheim Co., Ltd.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Rello J, 2010, CHEST, V137, P1138, DOI 10.1378/chest.09-2175; Falguera M, 2009, CLIN INFECT DIS, V49, P409, DOI 10.1086/600291; Zarkotou O, 2011, CLIN MICROBIOL INFEC, V17, P1798, DOI 10.1111/j.1469-0691.2011.03514.x; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; NASSIF X, 1986, INFECT IMMUN, V54, P603; Yu WL, 2006, CLIN INFECT DIS, V42, P1351, DOI 10.1086/503420; Paganin F, 2004, EUR RESPIR J, V24, P779, DOI 10.1183/09031936.04.00119503; MIZUTA K, 1983, INFECT IMMUN, V40, P56; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Williams BJ, 2010, RESPIROLOGY, V15, P1037, DOI 10.1111/j.1440-1843.2010.01819.x; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P397; Ko WC, 2002, EMERG INFECT DIS, V8, P160; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Yu WL, 2008, DIAGN MICR INFEC DIS, V62, P1, DOI 10.1016/j.diagmicrobio.2008.04.007; Meatherall BL, 2009, AM J MED, V122, P866, DOI 10.1016/j.amjmed.2009.03.034; Chung HC, 2012, ANTIMICROB AGENTS CH, V56, P618, DOI 10.1128/AAC.05753-11; Yu VL, 2007, EMERG INFECT DIS, V13, P986, DOI 10.3201/eid1307.070187; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Siu LK, 2012, LANCET INFECT DIS, V12, P881, DOI 10.1016/S1473-3099(12)70205-0; Shindo Y, 2013, AM J RESP CRIT CARE, V188, P985, DOI 10.1164/rccm.201301-0079OC; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589; Tsay RW, 2002, ARCH INTERN MED, V162, P1021, DOI 10.1001/archinte.162.9.1021; Qureshi ZA, 2012, ANTIMICROB AGENTS CH, V56, P2108, DOI 10.1128/AAC.06268-11; BATSHON BA, 1963, J IMMUNOL, V90, P121; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Clinical and Laboratory Standards Institute, 2010, M100S20 CLIN LAB STA; CRYZ SJ, 1986, J CLIN MICROBIOL, V23, P687; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; KAUFFMANN F, 1949, ACTA PATHOL MIC SC, V26, P381; Lin YT, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-307; MATSUMOT.H, 1971, JPN J MICROBIOL, V15, P11; MATSUMOT.H, 1970, JPN J MICROBIOL, V14, P129; MORI M, 1989, MICROBIOL IMMUNOL, V33, P887; NASSIF X, 1989, INFECT IMMUN, V57, P546; Russo TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026734; Siu LK, 2011, J CLIN MICROBIOL, V49, P3761, DOI 10.1128/JCM.00977-11; UZUN O, 1992, CLIN INFECT DIS, V15, P866	42	3	3	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	MAR	2015	53	3					879	886		10.1128/JCM.03067-14		8	Microbiology	Microbiology	CC2WD	WOS:000350204600020		
J	Furuse, Y; Chaimongkol, N; Okamoto, M; Imamura, T; Saito, M; Tamaki, R; Saito, M; Lupisan, SP; Oshitani, H				Furuse, Yuki; Chaimongkol, Natthawan; Okamoto, Michiko; Imamura, Tadatsugu; Saito, Mariko; Tamaki, Raita; Saito, Mayuko; Lupisan, Socorro P.; Oshitani, Hitoshi		Tohoku-RITM Collaborative Res Team	Molecular Epidemiology of Enterovirus D68 from 2013 to 2014 in Philippines	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							RESPIRATORY ILLNESS; INFECTION; CHILDREN	Enterovirus D68 (EV-D68) has been recognized as an important cause of acute respiratory infections. Here we report the molecular epidemiology of EV-D68 in Philippines from 2013 to 2014; we found cases in areas affected by Typhoon Haiyan and found new strains in the country.	[Furuse, Yuki; Chaimongkol, Natthawan; Okamoto, Michiko; Imamura, Tadatsugu; Saito, Mariko; Tamaki, Raita; Saito, Mayuko; Oshitani, Hitoshi] Tohoku Univ, Dept Virol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Saito, Mariko] Tohoku RITM Collaborating Res Ctr Emerging & Reem, Muntinlupa, Philippines; [Lupisan, Socorro P.] Res Inst Trop Med, Muntinlupa, Philippines	Oshitani, H (reprint author), Tohoku Univ, Dept Virol, Grad Sch Med, Sendai, Miyagi 980, Japan.	oshitanih@med.tohoku.ac.jp			Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Science and Technology Research Partnership for Sustainable Development (SATREPS); Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA)	This work was supported by Grants-in-Aid from the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Science and Technology Research Partnership for Sustainable Development (SATREPS); the Japan Science and Technology Agency (JST); and Japan International Cooperation Agency (JICA).	Imamura T, 2011, EMERG INFECT DIS, V17, P1430, DOI 10.3201/eid1708.101328; Wang Z, 2010, MICROB ECOL, V59, P623, DOI 10.1007/s00248-010-9636-3; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297; Hasegawa S, 2011, ALLERGY, V66, P1618, DOI 10.1111/j.1398-9995.2011.02725.x; Todd AK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-103; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Brown BA, 2014, GENOME ANNOUNC, V2; Imamura Tadatsugu, 2011, Morbidity and Mortality Weekly Report, V60, P1301; Chan EYY, 2013, LANCET, V382, P1873, DOI 10.1016/S0140-6736(13)62415-0; Ikeda T, 2012, MICROBIOL IMMUNOL, V56, P139, DOI 10.1111/j.1348-0421.2012.00411.x; Khetsuriani Nino, 2006, MMWR Surveill Summ, V55, P1; Linsuwanon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035190; Midgley Claire M, 2014, MMWR Morb Mortal Wkly Rep, V63, P798; Opanda SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102866	15	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	MAR	2015	53	3					1015	1018		10.1128/JCM.03362-14		4	Microbiology	Microbiology	CC2WD	WOS:000350204600044		
J	Gul, M; Catbas, FN; Hattori, H				Gul, Mustafa; Catbas, F. Necati; Hattori, Hiroshi			Image-Based Monitoring of Open Gears of Movable Bridges for Condition Assessment and Maintenance Decision Making	JOURNAL OF COMPUTING IN CIVIL ENGINEERING			English	Article						Structural health monitoring; Imaging techniques; Cameras; Bridges; Neural networks; Maintenance; Decision making; Structural health monitoring; Image processing; Computer vision; Video camera; Condition; Edge detection; Movable bridge; Neural network; Open gear; Maintenance	DAMAGE ASSESSMENT; INFLUENCE LINES; NETWORK; SYSTEMS; UNIT	Movable bridges are unique structures due to the complex interaction between their structural, mechanical, and electrical systems with an intricate interrelation creating several challenges related to operation and maintenance. Continuous monitoring of the critical parts of these structures is essential to track and evaluate their performance for improving maintenance operations and reducing the associated costs. Open gears are one of the most critical components of movable bridges. Proper and regular maintenance of these gears is vitally important to ensure a safe, reliable, and cost-effective operation. In this study, a practical and low-cost monitoring approach is presented to track the lubrication level in an open gear of a movable bridge by using video cameras. Two unique indices are developed for monitoring of the open gear by investigating two different image processing methods in a comparative fashion. The first methodology is based on an edge detection algorithm that utilizes a Sobel gradient operator to determine the edges in the open gear image. A lubrication index (LI) based on the edge detection results is defined and extracted to determine the lubrication level. The second methodology employs a fuzzy neural network-based approach to define a lubrication anomaly parameter (LAP) for assessing the lubrication level. The analysis results from the real-life application show that both methodologies successfully identify the lubrication level of the movable bridge's open gear.	[Gul, Mustafa] Univ Alberta, Dept Civil & Environm Engn, Edmonton, AB T6G 2W2, Canada; [Catbas, F. Necati] Univ Cent Florida, Dept Civil Environm & Construct Engn, Orlando, FL 32816 USA; [Hattori, Hiroshi] Kyoto Univ, Grad Sch Engn, Dept Civil & Earth Resources Engn, Saikyo Ku, Kyoto, Katsura 6158540, Japan	Catbas, FN (reprint author), Univ Cent Florida, Dept Civil Environm & Construct Engn, Orlando, FL 32816 USA.	catbas@ucf.edu			Florida Department of Transportation (FDOT) [BD548/RPWO 23]; Federal Highway Administration (FHWA) [DTFH61-07-H-00040]	The research project described in this paper is supported by the Florida Department of Transportation (FDOT) Contract # BD548/RPWO 23 and Federal Highway Administration (FHWA) Cooperative Agreement Award DTFH61-07-H-00040. The authors would like to thank Alberto Sardinas from FDOT for his support and feedback throughout the entire project. We would also like to acknowledge Angel Rodriguez, John Danielson, and the late Marcus Ansley in the development of this project and their input at different stages of the project. The authors would like to express their profound gratitude to Dr. Hamid Ghasemi and David Kuehn of the FHWA Exploratory Advanced Research Program for their support of this research. The support of both agencies and their engineers is greatly recognized and appreciated. Several graduate and undergraduate students, postdoctoral research associates, and research engineers also made significant contributions to the design, installation, and implementation of the SHM system; acknowledgments are also due to these individuals. The third author would like to thank the Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits supporting his stay at the University of Central Florida. The opinions, findings, and conclusions expressed in this publication are those of the authors and do not necessarily reflect the views of the sponsoring organizations.	Catbas FN, 2002, J STRUCT ENG-ASCE, V128, P1026, DOI 10.1061/(ASCE)0733-9445(2002)128:8(1026); Catbas FN, 2012, J BRIDGE ENG, V17, P662, DOI 10.1061/(ASCE)BE.1943-5592.0000288; Fraser M, 2010, J COMPUT CIVIL ENG, V24, P11, DOI 10.1061/(ASCE)CP.1943-5487.0000005; Zaurin R, 2011, STRUCT HEALTH MONIT, V10, P309, DOI 10.1177/1475921710373290; Omenzetter P, 2006, SMART MATER STRUCT, V15, P129, DOI 10.1088/0964-1726/15/1/041; Ji YF, 2008, J BRIDGE ENG, V13, P34, DOI 10.1061/(ASCE)1084-0702(2008)13:1(34); Da FP, 2010, IMAGE VISION COMPUT, V28, P1645, DOI 10.1016/j.imavis.2010.05.003; Melin P, 2010, EXPERT SYST APPL, V37, P8527, DOI 10.1016/j.eswa.2010.05.023; Lee JJ, 2006, EXP MECH, V46, P105, DOI [10.1007/s11340-006-6124-2, 10.1007/s11340-006-3124-2]; Sohn H, 2001, J DYN SYST-T ASME, V123, P706, DOI 10.1115/1.1410933; Rathinam S, 2008, J INFRASTRUCT SYST, V14, P52, DOI 10.1061/(ASCE)1076-0342(2008)14:1(52); Catbas FN, 2006, J STRUCT ENG-ASCE, V132, P1699, DOI 10.1061/(ASCE)0733-9445(2006)132:11(1699); Sun GY, 2007, PATTERN RECOGN, V40, P2766, DOI 10.1016/j.patcog.2007.01.006; Gul M, 2011, J STRUCT ENG-ASCE, V137, P1518, DOI 10.1061/(ASCE)ST.1943-541X.0000366; Brilakis I, 2011, J COMPUT CIVIL ENG, V25, P388, DOI 10.1061/(ASCE)CP.1943-5487.0000104; Catbas F. N., 2013, STRUCTURAL IDENTIFIC, P248; Catbas F. N., 2010, LONG TERM BRIDGE MAI; Catbas FN, 2013, J STRUCT ENG, V139, P1648, DOI 10.1061/(ASCE)ST.1943-541X.0000682; Chang CC, 2010, J ENG MECH-ASCE, V136, P840, DOI 10.1061/(ASCE)EM.1943-7889.0000127; Dong Q. Y., 2005, IMAGE VISION COMPUT, V23, P11, DOI 10.1016/j.imavis.2004.07.003; Duda R. O., 2001, PATTERN CLASSIFICATI; Fraser M., 2006, THESIS U CALIFORNIA; Furuta H, 2006, SOLID MECH APPL, V140, P81; Golparvar-Fard M., 2012, J COMPUT CI IN PRESS, DOI [10.1061/(ASCE)CP.1943-5487, DOI 10.1061/(ASCE)CP.1943-5487]; Gonzalez-Aguilera D, 2009, J COMPUT CIVIL ENG, V23, P319, DOI 10.1061/(ASCE)0887-3801(2009)23:6(319); Guo W, 2009, J COMPUT CIVIL ENG, V23, P160, DOI 10.1061/(ASCE)0887-3801(2009)23:3(160); Hanji T, 2003, STRUCTURAL HEALTH MONITORING AND INTELLIGENT INFRASTRUCTURE, VOLS 1 AND 2, P699; Higgins C, 2013, J BRIDGE ENG, V18, P380, DOI 10.1061/(ASCE)BE.1943-5592.0000358; Kanda K, 2005, SMART MATER STRUCT, V14, pS32, DOI 10.1088/0964-1726/14/3/005; Laefer DF, 2010, J INFRASTRUCT SYST, V16, P129, DOI 10.1061/(ASCE)1076-0342(2010)16:2(129); Li SZ, 2010, STRUCT INFRASTRUCT E, V6, P303, DOI 10.1080/15732470701492066; Lynch JP, 2004, STRUCT ENG MECH, V17, P393; Philips AA, 2009, STRUCTURAL HLTH MONI, V8, P443; Sakai K., 2002, INTRO DIGITAL IMAGE; Seul M., 2001, PRACTICAL ALGORITHMS; Tateishi K, 2005, Sensing Issues in Civil Structural Health Monitoring, P249, DOI 10.1007/1-4020-3661-2_25; Wood R.E., 2002, DIGITAL IMAGE PROCES; Yagi N., 2000, DIGITAL IMAGE PROCES; Ye J, 2011, J ENG MECH-ASCE, V137, P475, DOI 10.1061/(ASCE)EM.1943-7889.0000251; Zaurin R, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/1/015019; Zhang Z, 2009, COMPUT MATH APPL, V57, P1265, DOI 10.1016/j.camwa.2008.11.013; Zheng S, 2004, PATTERN RECOGN LETT, V25, P1143, DOI 10.1016/j.patrec.2004.03.009	42	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0887-3801	1943-5487		J COMPUT CIVIL ENG	J. Comput. Civil. Eng.	MAR	2015	29	2								10.1061/(ASCE)CP.1943-5487.0000307		11	Computer Science, Interdisciplinary Applications; Engineering, Civil	Computer Science; Engineering	CB9UK	WOS:000349978500002		
J	Guo, J; Lyaruu, DM; Takano, Y; Gibson, CW; DenBesten, PK; Bronckers, ALJJ				Guo, J.; Lyaruu, D. M.; Takano, Y.; Gibson, C. W.; DenBesten, P. K.; Bronckers, A. L. J. J.			Amelogenins as Potential Buffers during Secretory-stage Amelogenesis	JOURNAL OF DENTAL RESEARCH			English	Article						pH control; enamel; SLC4A2; mineral density; dentin; alveolar bone	ENAMEL MATRIX; APATITE CRYSTALS; EXCHANGER AE2; RAT; MATURATION; PROTEINS; AMELOBLASTS; EXPRESSION; INCISORS; GROWTH	Amelogenins are the most abundant protein species in forming dental enamel, taken to regulate crystal shape and crystal growth. Unprotonated amelogenins can bind protons, suggesting that amelogenins could regulate the pH in enamel in situ. We hypothesized that without amelogenins the enamel would acidify unless ameloblasts were buffered by alternative ways. To investigate this, we measured the mineral and chloride content in incisor enamel of amelogenin-knockout (AmelX(-/-)) mice and determined the pH of enamel by staining with methyl-red. Ameloblasts were immunostained for anion exchanger-2 (Ae2), a transmembrane pH regulator sensitive for acid that secretes bicarbonate in exchange for chloride. The enamel of AmelX(-/-) mice was 10-fold thinner, mineralized in the secretory stage 1.8-fold more than wild-type enamel and containing less chloride (suggesting more bicarbonate secretion). Enamel of AmelX(-/-) mice stained with methyl-red contained no acidic bands in the maturation stage as seen in wild-type enamel. Secretory ameloblasts of AmelX(-/-) mice, but not wild-type mice, were immunopositive for Ae2, and stained more intensely in the maturation stage compared with wild-type mice. Exposure of AmelX(-/-) mice to fluoride enhanced the mineral content in the secretory stage, lowered chloride, and intensified Ae2 immunostaining in the enamel organ in comparison with non-fluorotic mutant teeth. The results suggest that unprotonated amelogenins may regulate the pH of forming enamel in situ. Without amelogenins, Ae2 could compensate for the pH drop associated with crystal formation.	[Guo, J.; Lyaruu, D. M.; Bronckers, A. L. J. J.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral Cell Biol, Amsterdam, Netherlands; [Guo, J.; Lyaruu, D. M.; Bronckers, A. L. J. J.] Vrije Univ Amsterdam, MOVE Res Inst, Amsterdam, Netherlands; [Takano, Y.] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Biostruct Sci, Tokyo, Japan; [Gibson, C. W.] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [DenBesten, P. K.] Univ Calif San Francisco, Sch Dent, Dept Oral & Craniofacial Sci, San Francisco, CA USA	Bronckers, ALJJ (reprint author), Vrije Univ Amsterdam, Dept Oral Cell Biol, ACTA, Gustav Mahlerlaan 3004, NL-1081 LA Amsterdam, Netherlands.	a.bronckers@acta.nl			National Institutes of Health (NIH) [DE13508]; NIH [DE019629, DE011089]; JSPS [24390408]	We thank Drs. Y. Li (Anatomy and Cell Biology, University of Pennsylvania, Philadelphia, USA) and Y. Nakano (Oral Sciences, University of San Francisco, CA, USA) for help in providing mutant mice; Drs. S. Kellokumpu (Biochemistry, University of Oulu, Finland), T. Uchida (Oral Biology, Hiroshima University, Japan), and J. Simmer (Biological and Material Sciences, University of Michigan, Ann Arbor, USA) for donating antibodies; Dr. A. Kulkarni (NIDCR NIH Bethesda, MA, USA) for his help in creating the amelogenin-null mouse strain; and Mr. W. Lustenhouwer and Dr. Sergei Matveev (VU University Amsterdam) for assistance with the microprobe determinations. The authors acknowledge the assistance of Mr. T.J.M. Bervoets (Oral Cell Biology ACTA) and Dr. L. van Ruijven (Functional Anatomy ACTA) for technical support, data acquisition, and interpretation. This study was supported by National Institutes of Health (NIH) DE13508, NIH DE019629, DE011089, and JSPS 24390408. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Lee SK, 1996, INT J DEV BIOL, V40, P1141; Paine ML, 2008, J DENT RES, V87, P391; Lacruz RS, 2013, J DENT RES, V92, P122, DOI 10.1177/0022034512470954; KEREBEL B, 1979, J DENT RES, V58, P844, DOI 10.1177/00220345790580023701; Bronckers ALJJ, 2009, J EXP ZOOL PART B, V312B, P375, DOI 10.1002/jez.b.21267; Alper SL, 2009, J EXP BIOL, V212, P1672, DOI 10.1242/jeb.029454; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128; FINCHAM AG, 1995, J STRUCT BIOL, V115, P50, DOI 10.1006/jsbi.1995.1029; Smith CE, 2005, J BONE MINER RES, V20, P240, DOI 10.1359/JBMR.041002; Moradian-Oldak J, 2005, CELLS TISSUES ORGANS, V181, P202, DOI 10.1159/000091382; Margolis HC, 2006, J DENT RES, V85, P775; Simmer JP, 2012, INT J ORAL SCI, V4, P129, DOI 10.1038/ijos.2012.59; Lyaruu DM, 2014, J DENT RES, V93, P96, DOI 10.1177/0022034513510944; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; Moradian-Oldak J, 2000, J STRUCT BIOL, V131, P27, DOI 10.1006/jsbi.2000.4237; Chen X, 2011, J ORAL PATHOL MED, V40, P235, DOI 10.1111/j.1600-0714.2010.00940.x; Concepcion AR, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00413; Deutsch D, 2006, EUR J ORAL SCI, V114, P183, DOI 10.1111/j.1600-0722.2006.00301.x; Haruyama N, 2011, J ORAL BIOSCI, V53, P257; HUMPHREYS BD, 1994, AM J PHYSIOL-CELL PH, V267, pC1295; Jacques J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099626; Lu XY, 2011, EUR J ORAL SCI, V119, P254, DOI 10.1111/j.1600-0722.2011.00905.x; Lyaruu DM, 2007, MATRIX BIOL, V27, P119; Lyaruu D M, 1989, Adv Dent Res, V3, P211; MoradianOldak J, 1995, CONNECT TISSUE RES, V32, P125, DOI 10.3109/03008209509013714; Moradian-Oldak J., 2013, FRONT BIOSCI-LANDMRK, V17, P1996; NYLEN MU, 1963, J CELL BIOL, V18, P109, DOI 10.1083/jcb.18.1.109; Quentin F, 2004, J AM SOC NEPHROL, V15, P2988, DOI 10.1097/01.ASN.0000146426.93319.16; Rauth Rick J, 2009, J Calif Dent Assoc, V37, P863; ROBINSON C, 1982, J DENT RES, V61, P1490; Ryu OH, 1998, CONNECT TISSUE RES, V38, P207, DOI 10.3109/03008209809017038; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84; UCHIDA T, 1991, HISTOCHEMISTRY, V96, P129, DOI 10.1007/BF00315983; Wright JT, 2011, EUR J ORAL SCI, V119, P65, DOI 10.1111/j.1600-0722.2011.00883.x	35	2	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	MAR	2015	94	3					412	420		10.1177/0022034514564186		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CC2CB	WOS:000350151400004		
J	Urata, K; Shinoda, M; Honda, K; Lee, J; Maruno, M; Ito, R; Gionhaku, N; Iwata, K				Urata, K.; Shinoda, M.; Honda, K.; Lee, J.; Maruno, M.; Ito, R.; Gionhaku, N.; Iwata, K.			Involvement of TRPV1 and TRPA1 in Incisional Intraoral and Extraoral Pain	JOURNAL OF DENTAL RESEARCH			English	Article						whiskers; mouth mucosa; trigeminal ganglion; mechanical allodynia; transient receptor potential channels; thermal allodynia	POTENTIAL ANKYRIN 1; TRIGEMINAL GANGLION; PLANTAR INCISION; SENSORY NEURONS; RAT MODEL; RECEPTOR; CONTRIBUTES; HYPERALGESIA; HYPERSENSITIVITY; SENSITIZATION	Thermal and mechanical hypersensitivity in the injured region is a common complication. Although it is well known clinically that thermal and mechanical sensitivity of the oral mucosa is different from that of the skin, the mechanisms underlying injured pain of the oral mucosa remain poorly understood. The transient receptor potential (TRP) vanilloid 1 (TRPV1) and TRP ankyrin 1 (TRPA1) in primary afferent neurons are known to contribute to pathological pain. Therefore, we investigated whether TRPV1 and/or TRPA1 contribute to thermal and mechanical hypersensitivity following oral mucosa or whisker pad skin incision. Strong heat and mechanical and cold hypersensitivity was caused in the buccal mucosa and whisker pad skin following incisions. On day 3 after the incisions, the number of TRPV1-immunoreactive (IR) and TRPA1-IR trigeminal ganglion (TG) neurons innervating the buccal mucosa and whisker pad skin was significantly increased, and the number of TRPV1/TRPA1-IR TG neurons innervating whisker pad skin, but not the buccal mucosa, was significantly increased. Administration of the TRPV1 antagonist, SB366791, to the incised site produced a significant suppression of heat hyperalgesia in both the buccal mucosa and whisker pad skin, as well as mechanical allodynia in the whisker pad skin. Administration of the TRPA1 antagonist, HC-030031, to the incised site suppressed mechanical allodynia and cold hyperalgesia in both the buccal mucosa and whisker pad skin, as well as heat hyperalgesia in the whisker pad skin. These findings indicate that altered expressions of TRPV1 and TRPA1 in TG neurons are involved in thermal and mechanical hypersensitivity following the buccal mucosa and whisker pad skin incision. Moreover, diverse changes in the number of TRPV1 and TRPA1 coexpressed TG neurons in whisker pad skin-incised rats may contribute to the intracellular interactions of TRPV1 and TRPA1 associated with whisker pad skin incision, whereas TRPV1 and TRPA1 expression in individual TG neurons is involved in buccal mucosa-incised pain.	[Urata, K.; Lee, J.; Maruno, M.; Ito, R.; Gionhaku, N.] Nihon Univ, Dept Complete Denture Prosthodont, Sch Dent, Tokyo 1018310, Japan; [Shinoda, M.; Honda, K.; Iwata, K.] Nihon Univ, Dept Physiol, Sch Dent, Tokyo 1018310, Japan; [Shinoda, M.; Iwata, K.] Nihon Univ, Dent Res Ctr, Sch Dent, Div Funct Morphol, Tokyo 1018310, Japan; [Iwata, K.] Nihon Univ, Grad Sch Med Sci, Div Appl Syst Neurosci Adv Med Res Ctr, Tokyo 1018310, Japan	Shinoda, M (reprint author), Nihon Univ, Dept Physiol, Sch Dent, Chiyoda Ku, 1-8-13 Kandasurugadai, Tokyo 1018310, Japan.	shinoda.masamichi@nihon-u.ac.jp			Nihon University School of Dentistry; Dental Research Center, Nihon University School of Dentistry; Nihon University; KAKENHI [24593064]; MEXT	This study was supported in part by research grants from Sato and Uemura Funds from the Nihon University School of Dentistry and a grant from the Dental Research Center, Nihon University School of Dentistry; a Nihon University multidisciplinary research grant and Individual Research Grant; and KAKENHI (Grant-in-Aid for Scientific Research [C] 24593064) and MEXT-Supported Program for the Strategic Research Foundation at Private Universities 2013-2017. We also thank Dr. Dave A. Thomas and Ms. Dena C. Procaccini for correcting English usage. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Alpizar YA, 2014, PFLUG ARCH EUR J PHY, V466, P507, DOI 10.1007/s00424-013-1334-9; Shinoda M, 2011, J NEUROSCI, V31, P7145, DOI 10.1523/JNEUROSCI.0481-11.2011; Spahn V, 2014, MOL PHARMACOL, V85, P335, DOI 10.1124/mol.113.088997; Kim YS, 2010, J COMP NEUROL, V518, P687, DOI 10.1002/cne.22238; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Miura M, 2011, PAIN, V152, P888, DOI 10.1016/j.pain.2011.01.004; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004; Mizukoshi K, 2013, NEUROSCIENCE, V234, P77, DOI 10.1016/j.neuroscience.2013.01.001; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Boillat A, 2014, MOL CELL NEUROSCI, V61, P13, DOI 10.1016/j.mcn.2014.04.007; Staruschenko A, 2010, J BIOL CHEM, V285, P15167, DOI 10.1074/jbc.M110.106153; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; Wei H, 2012, ANESTHESIOLOGY, V117, P137, DOI 10.1097/ALN.0b013e31825adb0e; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Banik RK, 2009, PAIN, V141, P41, DOI 10.1016/j.pain.2008.10.004; Barabas M.E., 2013, MOL PAIN, V9, P1; da Costa DSM, 2010, PAIN, V148, P431, DOI 10.1016/j.pain.2009.12.002; GREEN BG, 1987, SOMATOSENS MOT RES, V4, P191; Honda K, 2014, EUR J ORAL SCI, V122, P391, DOI 10.1111/eos.12157; Kanai Y, 2007, J PHARM PHARMACOL, V59, P733, DOI 10.1211/jpp.59.5.0015; Katagiri A, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-23; Komiyama O, 2005, PAIN, V115, P308, DOI 10.1016/j.pain.2005.03.006; Kumar B Saravana, 2013, J Clin Diagn Res, V7, P1514, DOI 10.7860/JCDR/2013/6200.3135; Ohara K, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-139; Shimizu K, 2006, BRAIN RES, V1072, P99, DOI 10.1016/j.brainres.2005.12.040; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	29	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	MAR	2015	94	3					446	454		10.1177/0022034514565645		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CC2CB	WOS:000350151400008		
J	Takeshita, H; Ikebe, K; Kagawa, R; Okada, T; Gondo, Y; Nakagawa, T; Ishioka, Y; Inomata, C; Tada, S; Matsuda, K; Kurushima, Y; Enoki, K; Kamide, K; Masui, Y; Takahashi, R; Arai, Y; Maeda, Y				Takeshita, Hajime; Ikebe, Kazunori; Kagawa, Ryosuke; Okada, Tadashi; Gondo, Yasuyuki; Nakagawa, Takeshi; Ishioka, Yoshiko; Inomata, Chisato; Tada, Sayaka; Matsuda, Ken-ichi; Kurushima, Yuko; Enoki, Kaori; Kamide, Kei; Masui, Yukie; Takahashi, Ryutaro; Arai, Yasumichi; Maeda, Yoshinobu			Association of personality traits with oral health-related quality of life independently of objective oral health status: A study of community-dwelling elderly Japanese	JOURNAL OF DENTISTRY			English	Article						Quality of life; Personality traits; Occlusal force; Elderly people; Multivariate analysis	NECK-CANCER PATIENTS; MASTICATORY PERFORMANCE; OCCLUSAL FORCE; OLDER-ADULTS; PSYCHOLOGICAL DISTRESS; CLINICAL-VARIABLES; SALIVARY FLOW; FOLLOW-UP; IMPACT; NEUROTICISM	Objectives: Oral health-related quality of life (OHRQoL) is being increasingly used in epidemiologic studies of dentistry. However, patient-reported OHRQoL does not always coincide with clinical measures. Previous studies have shown a relationship between OHRQoL and personality, but did not concomitantly investigate oral function. We aimed to examine the association among personality traits, oral function, and OHRQoL using a large sample of community-dwelling Japanese elderly. Methods: The participants (n = 938; age, 69-71 years) were drawn from a complete enumeration of an urban area and a rural area of both the Tokyo metropolitan area and Hyogo Prefecture. The self-perceived impact of OHRQoL was measured using the Geriatric Oral Health Assessment Index (GOHAI). The oral status and socioeconomic characteristics were recorded in each participant, and personality traits (neuroticism, extraversion, openness to experience, agreeableness, and conscientiousness) were assessed with the NEO-five-factor inventory. Multiple linear regression analysis was performed to examine the relationships between OHRQoL and other factors, with p < 0.05 considered to be statistically significant. Results: Neuroticism was negatively associated with the GOHAI score in bivariate analyses (Spearman rank-order correlation coefficient (rs) = -0.20), whereas extraversion was positively associated (rs = 0.17). In the regression analyses, neuroticism (standardized partial regression coefficient(beta) = -0.179) and extraversion (beta = 0.094) were significantly associated with the GOHAI scores independently of the number of teeth, maximal occlusal force, and financial status. Conclusions: Personality traits are associated with OHRQoL independently of objective measures of oral health status in community-dwelling elderly Japanese. (C) 2015 Elsevier Ltd. All rights reserved.	[Takeshita, Hajime; Ikebe, Kazunori; Kagawa, Ryosuke; Okada, Tadashi; Inomata, Chisato; Tada, Sayaka; Matsuda, Ken-ichi; Kurushima, Yuko; Enoki, Kaori; Maeda, Yoshinobu] Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Osaka, Japan; [Gondo, Yasuyuki; Nakagawa, Takeshi] Osaka Univ, Grad Sch Human Sci, Dept Clin Thanatol & Geriatr Behav Sci, Osaka, Japan; [Ishioka, Yoshiko; Masui, Yukie; Takahashi, Ryutaro] Tokyo Metropolitan Geriatr Hosp, Tokyo 173, Japan; [Ishioka, Yoshiko; Masui, Yukie; Takahashi, Ryutaro] Inst Gerontol, Tokyo, Japan; [Kamide, Kei] Osaka Univ, Grad Sch Med, Sch Allied Hlth Sci, Osaka, Japan; [Arai, Yasumichi] Keio Univ, Sch Med, Tokyo, Japan	Ikebe, K (reprint author), Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Osaka, Japan.	ikebe@dent.osaka-u.ac.jp			Japan Society for the Promotion of Science [23390440, 25293394]	We are grateful to Tomohiro Hazeyama, Taiji Ogawa, Ken Ishida, Shunsuke Murai, Yuji Miyashita for data collection. This research was supported by A couple of Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (nos. 23390440 and 25293394).	Aarstad AKH, 2011, ACTA ONCOL, V50, P390, DOI 10.3109/0284186X.2010.504227; Al-Omiri MK, 2009, J PROSTHODONT, V19, P2; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037//0033-295X.96.2.234; Ikebe K, 2006, INT J PROSTHODONT, V19, P475; Stenman U, 2012, GERODONTOLOGY, V29, pE440, DOI 10.1111/j.1741-2358.2011.00495.x; Inomata C, 2014, J DENT, V42, P556, DOI 10.1016/j.jdent.2014.02.015; COSTA PT, 1987, J PERS, V55, P299, DOI 10.1111/j.1467-6494.1987.tb00438.x; Ikebe K, 2011, ARCH ORAL BIOL, V56, P991, DOI 10.1016/j.archoralbio.2011.03.019; Hartl K, 2010, PSYCHO-ONCOLOGY, V19, P160, DOI 10.1002/pon.1536; Siassi M, 2009, DIS COLON RECTUM, V52, P662, DOI 10.1007/DCR.0b013e31819ecf2e; Visscher CM, 2014, J ORAL REHABIL, V41, P416, DOI 10.1111/joor.12167; Fontijn-Tekamp FA, 2000, J DENT RES, V79, P1519; Iwasa H, 2008, AM J GERIAT PSYCHIAT, V16, P399, DOI 10.1097/JGP.0b013e3181662ac9; Dubayova T, 2009, QUAL LIFE RES, V18, P33, DOI 10.1007/s11136-008-9410-x; Locker D, 2007, COMMUNITY DENT ORAL, V35, P401, DOI 10.1111/j.1600-0528.2007.00418.x; Thomson WM, 2011, EUR J ORAL SCI, V119, P366, DOI 10.1111/j.1600-0722.2011.00840.x; Bal MD, 2011, MENOPAUSE, V18, P1309, DOI 10.1097/gme.0b013e31821e2494; Okiyama S, 2003, J ORAL REHABIL, V30, P278, DOI 10.1046/j.1365-2842.2003.01009.x; Paika V, 2010, PSYCHO-ONCOLOGY, V19, P273, DOI 10.1002/pon.1563; Tsakos G, 2009, EUR J ORAL SCI, V117, P286, DOI 10.1111/j.1600-0722.2009.00619.x; Hatch JP, 2001, ARCH ORAL BIOL, V46, P641, DOI 10.1016/S0003-9969(01)00023-1; Atchison K A, 1990, J Dent Educ, V54, P680; Beisland E, 2013, ACTA OTO-LARYNGOL, V133, P209, DOI 10.3109/00016489.2012.720032; Costa Jr P.T., 1992, PSYCHOL ASSESSMENT R; Duberstein PR, 2003, PSYCHOL AGING, V18, P25, DOI 10.1037/0882-7974.18.1.25; Hassel AJ, 2010, COMMUNITY DENT HLTH, V27, P242, DOI 10.1922/CDH_2464Hassel06; Herzberg PY, 2013, BONE MARROW TRANSPL, V48, P129, DOI 10.1038/bmt.2012.83; Hidaka O, 1999, J DENT RES, V78, P1336; Ikebe K, 2012, COMMUNITY DENT ORAL, V40, P406, DOI 10.1111/j.1600-0528.2012.00683.x; Ikebe K, 2007, INT J PROSTHODONT, V20, P478; Ikebe K, 2007, ORAL SURG ORAL MED O, V103, P216, DOI 10.1016/j.tripleo.2005.12.001; Karasneh J, 2009, J CONT DENT PRACTICE, V10; Kempen GIJM, 1997, HEALTH PSYCHOL, V16, P539, DOI 10.1037/0278-6133.16.6.539; Kressin NR, 2001, COMMUNITY DENT ORAL, V29, P412, DOI 10.1034/j.1600-0528.2001.290602.x; Locker David, 2003, Spec Care Dentist, V23, P86, DOI 10.1111/j.1754-4505.2003.tb01667.x; Ministry of Health Welfare Japan, 2011, REP SURV DENT DIS; Petersen LR, 2008, J PSYCHOSOC ONCOL, V26, P15, DOI 10.1080/07347330802359578; Prihodova L, 2010, TRANSPL INT, V23, P484, DOI 10.1111/j.1432-2277.2009.01003.x; Slade G D, 1994, Community Dent Health, V11, P3; van der Steeg AFW, 2007, ANN SURG ONCOL, V14, P678, DOI 10.1245/s10434-006-9175-9; VANWAAS MAJ, 1990, J PROSTHET DENT, V63, P545, DOI 10.1016/0022-3913(90)90073-L; Walter MH, 2011, EUR J ORAL SCI, V119, P481, DOI 10.1111/j.1600-0722.2011.00893.x; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Yamaoka K, 1998, QUAL LIFE RES, V7, P535, DOI 10.1023/A:1008830509237; Yiengprugsawan V, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-42	45	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0300-5712	1879-176X		J DENT	J. Dent.	MAR	2015	43	3					342	349		10.1016/j.jdent.2014.12.011		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CC2BY	WOS:000350150900006		
J	Abe, T; Takada, N; Matsumoto, R; Osawa, T; Sazawa, A; Maruyama, S; Tsuchiya, K; Harabayashi, T; Minami, K; Nagamori, S; Hatanaka, KC; Tanaka, Y; Shinohara, N; Nonomura, K				Abe, Takashige; Takada, Norikata; Matsumoto, Ryuji; Osawa, Takahiro; Sazawa, Ataru; Maruyama, Satoru; Tsuchiya, Kunihiko; Harabayashi, Toru; Minami, Keita; Nagamori, Satoshi; Hatanaka, Kanako C.; Tanaka, Yuka; Shinohara, Nobuo; Nonomura, Katsuya			The Effect of Dexmedetomidine on Intraocular Pressure Increase in Patients During Robot-Assisted Laparoscopic Radical Prostatectomy in the Steep Trendelenburg Position	JOURNAL OF ENDOUROLOGY			English	Article							UPPER URINARY-TRACT; LYMPH-NODE DISSECTION; TRANSITIONAL-CELL CARCINOMA; UROTHELIAL CARCINOMA; BLADDER-CANCER; CLINICAL-TRIAL; RENAL PELVIS; NEPHROURETERECTOMY; LYMPHADENECTOMY; MULTICENTER	Purpose: This study was to evaluate the effect of intraoperative continuous infusion of dexmedetomidine on intraocular pressure (IOP) in patients undergoing robot-assisted laparoscopic radical prostatectomy (RALRP) in the steep Trendelenburg (ST). Materials and Methods: Sixty-eight patients were randomly divided into two groups. The dexmedetomidine group (Group D, n=34) received a continuous infusion of dexmedetomidine at a rate of 0.4 mu g kg(-1) hour(-1) from the induction of anesthesia until the end of the ST position, while the control group (Group C, n=34) received an equal volume of physiologic saline at the same rate under conventional general anesthesia with sevoflurane and remifentanil. IOP was measured at 11 predefined time points for all patients. Results: Significant differences in IOP were detected between the two groups by a linear mixed model analysis (p<0.001). The highest mean IOP was 19.9 +/- 5.0 mm Hg in Group D and 25.7 +/- 5.0 mm Hg in Group C; both were measured 60 minutes after the patients had been placed in the ST position. No significant between-group differences in ocular perfusion pressure, mean blood pressure, or heart rate were observed between the two groups. No ocular or other complications were noted. Conclusion: Intraoperative continuous infusion of dexmedetomidine may help alleviate IOP increase in patients undergoing RALRP in the ST position.	[Abe, Takashige; Takada, Norikata; Matsumoto, Ryuji; Sazawa, Ataru; Maruyama, Satoru; Tsuchiya, Kunihiko; Tanaka, Yuka; Shinohara, Nobuo; Nonomura, Katsuya] Hokkaido Univ, Grad Sch Med, Dept Urol, Sapporo, Hokkaido 0608638, Japan; [Osawa, Takahiro; Harabayashi, Toru; Minami, Keita; Nagamori, Satoshi] Hokkaido Canc Ctr, Dept Urol, Sapporo, Hokkaido, Japan; [Hatanaka, Kanako C.] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido 060, Japan	Abe, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Urol, North Ward, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	takataka@rf6.so-net.ne.jp					Abe T, 2011, J ENDOUROL, V25, P803, DOI 10.1089/end.2010.0480; Abe T, 2008, BJU INT, V102, P576, DOI 10.1111/j.1464-410X.2008.07673.x; Abe T, 2010, EJSO-EUR J SURG ONC, V36, P1085, DOI 10.1016/j.ejso.2010.08.134; O'Brien T, 2011, EUR UROL, V60, P703, DOI 10.1016/j.eururo.2011.05.064; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Roscigno M, 2009, J UROLOGY, V181, P2482, DOI 10.1016/j.juro.2009.02.021; Sugihara T, 2013, INT J UROL, V20, P695, DOI 10.1111/iju.12031; Klingler HC, 2003, EUR UROL, V44, P442, DOI 10.1016/S0302-2838(03)00314-2; Abol-Enein H, 2004, J UROLOGY, V172, P1818, DOI 10.1097/01.ju.0000140457.83695.a7; Lopez-Beltran A, 2004, EUR UROL, V45, P257, DOI 10.1016/j.eururo.2003.09.018; Roscigno M, 2008, EUR UROL, V53, P794, DOI 10.1016/j.eururo.2008.01.008; Kondo T, 2012, INT J UROL, V19, P710, DOI 10.1111/j.1442-2042.2012.03009.x; Ito A, 2013, J CLIN ONCOL, V31, P1422, DOI 10.1200/JCO.2012.45.2128; Leissner J, 2004, J UROLOGY, V171, P139, DOI 10.1097/01.ju.0000102302.26806.fb; Rao SR, 2012, BJU INT, V110, pE475, DOI 10.1111/j.1464-410X.2012.11170.x; Hattori R, 2006, UROLOGY, V67, P701, DOI 10.1016/j.urology.2005.10.022; Brausi MA, 2007, EUR UROL, V52, P1414, DOI 10.1016/j.eururo.2007.04.070; Busby JE, 2008, UROLOGY, V71, P413, DOI 10.1016/j.urology.2007.10.028; Sobin L, 2009, TNM CLASSIFICATION M, P258; Vazina A, 2004, J UROLOGY, V171, P1830, DOI 10.1097/01.ju.0000121604.58067.95	20	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0892-7790	1557-900X		J ENDOUROL	J. Endourol.	MAR 1	2015	29	3					304	309		10.1089/end.2014.0381		6	Urology & Nephrology	Urology & Nephrology	CC3WX	WOS:000350283000013		
J	Asai, T; Chang, CM; Spencer, BF				Asai, Takehiko; Chang, Chia-Ming; Spencer, B. F., Jr.			Real-Time Hybrid Simulation of a Smart Base-Isolated Building	JOURNAL OF ENGINEERING MECHANICS			English	Article						Smart base isolation; Magnetorheological damper; Real-time hybrid simulation; Backward-difference method	MAGNETORHEOLOGICAL DAMPERS; ISOLATION SYSTEMS; SAMPLE CONTROLLERS; SEMIACTIVE CONTROL; SEISMIC CONTROL; VIBRATION	Traditional passive base-isolation systems provide an effective means to mitigate the responses of seismically excited structures. A challenge for these systems can be found in accommodating the large base displacements during severe earthquakes. Recently, active base-isolation systems, combining actively controlled actuators with passive isolation bearings, have been shown experimentally to produce reduced base displacements, while maintaining similar responses of the superstructure obtained by the passive base-isolation systems. The active control devices used in hybrid isolation systems are typically driven by an external power source, which may not be available during severe seismic events. Another class of isolation systems is smart base isolation, in which semiactive control devices are used in place of their active counterparts. This control strategy has been proven effective against a wide range of seismic excitation; however, there has been limited effort to experimentally validate smart base-isolation systems. In this study, the focus is on experimentally investigating and verifying a smart base-isolation system using real-time hybrid simulation (RTHS), which provides a cost-effective means to conduct such experiments because only the portion of the structure that is poorly understood needs to be represented experimentally, while the reminder of the structure can be modeled using a computer. In this paper, a prototype magnetorheological damper is physically tested, while the isolated building concurrently is simulated numerically. A model-based compensation strategy is used to carry out high-precision RTHS. The performance of the semiactive control strategies is evaluated using RTHS, and the efficacy of the smart base-isolation system is demonstrated. This smart base-isolation system is found to reduce base displacements and floor accelerations in a manner comparable with the active isolation system without the need for large external power sources. (C) 2014 American Society of Civil Engineers.	[Asai, Takehiko] Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan; [Chang, Chia-Ming] Guangzhou Univ, Earthquake Engn Res & Test Ctr, Guangzhou 510405, Guangdong, Peoples R China; [Spencer, B. F., Jr.] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA	Asai, T (reprint author), Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan.	asai.takehiko.68u@st.kyoto-u.ac.jp; bfs@illinois.edu			Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	T. A. is grateful for partial support from the Long Term Fellowship for Study Abroad by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Ramallo JC, 2002, J ENG MECH-ASCE, V128, P1088, DOI 10.1061/(ASCE)0733-9399(2002)128:10(1088); Spencer BF, 2000, JSME INT J C-MECH SY, V43, P704; [Anonymous], MATLAB R2013A COMP S; Dyke SJ, 1996, SMART MATER STRUCT, V5, P565, DOI 10.1088/0964-1726/5/5/006; Horiuchi T, 1999, EARTHQUAKE ENG STRUC, V28, P1121, DOI 10.1002/(SICI)1096-9845(199910)28:10<1121::AID-EQE858>3.3.CO;2-F; Nagarajaiah S, 2007, EARTHQ ENG STRUCT D, V36, P729, DOI 10.1002/eqe.650; Wongprasert N, 2005, J STRUCT ENG-ASCE, V131, P867, DOI 10.1061/(ASCE)0733-9445(2005)131:6(867); Sahasrabudhe S, 2005, J STRUCT ENG-ASCE, V131, P1025, DOI 10.1061/(ASCE)0733-9455(2005)131:7(1025); Yoshioka H, 2002, J ENG MECH-ASCE, V128, P540, DOI 10.1061/(ASCE)0733-9399(2002)128:5(540); Nakashima M, 1999, EARTHQUAKE ENG STRUC, V28, P393, DOI 10.1002/(SICI)1096-9845(199904)28:4<393::AID-EQE823>3.0.CO;2-C; NAKASHIMA M, 1992, EARTHQUAKE ENG STRUC, V21, P79, DOI 10.1002/eqe.4290210106; WEN YK, 1976, J ENG MECH DIV-ASCE, V102, P249; Carrion J. E., 2007, 6 U ILL URB CHAMP DE; Chang C.-M., 2012, 30 U ILL URB CHAMP D; Chang CM, 2008, STRUCT CONTROL HLTH, V15, P673, DOI 10.1002/stc.269; Hakuno M., 1969, P J SOC CIV ENG, V1969, P1; Horiuchi T., 1996, P 11 WORLD C EARTHQ; Inaudi J., 1990, P US NAT WORKSHOP ST, P125; Kim SB, 2005, J ENG MECH-ASCE, V131, P461, DOI 10.1061/(ASCE)0733-9399(2005)131;5(461); Lin PY, 2007, STRUCT CONTROL HLTH, V14, P384, DOI 10.1002/stc.163; Makris N, 1997, EARTHQUAKE ENG STRUC, V26, P571, DOI 10.1002/(SICI)1096-9845(199705)26:5<571::AID-EQE658>3.0.CO;2-6; Naeim F., 1999, DESIGN SEISMIC ISOLA; Nagarajaiah S, 2006, STRUCT CONTROL HLTH, V13, P589, DOI 10.1002/stc.100; Narasimhan S, 2008, STRUCT CONTROL HLTH, V15, P657, DOI 10.1002/stc.267; Nishimura H, 1998, JSME INT J C-MECH SY, V41, P37; Phillips B. M., 2012, 31 U ILL URB CHAMP D; Ramallo J. C., 1999, P 1999 AM CONTR C 2, V1, P515, DOI 10.1109/ACC.1999.782881; Shook D, 2007, SMART MATER STRUCT, V16, P1433, DOI 10.1088/0964-1726/16/4/058; Skinner RI, 1993, INTRO SEISMIC ISOLAT; Spencer BF, 1997, J ENG MECH-ASCE, V123, P230; Wang YM, 2013, STRUCT CONTROL HLTH, V20, P753, DOI 10.1002/stc.1490; Yang JN, 1996, J STRUCT ENG-ASCE, V122, P179, DOI 10.1061/(ASCE)0733-9445(1996)122:2(179)	32	1	1	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0733-9399	1943-7889		J ENG MECH	J. Eng. Mech.	MAR	2015	141	3							04014128	10.1061/(ASCE)EM.1943-7889.0000844		10	Engineering, Mechanical	Engineering	CB8CF	WOS:000349855200008		
J	Matsumoto, T; Miura, A; Momoyama, G; Ito, K				Matsumoto, Takumi; Miura, Ayumi; Momoyama, Gen; Ito, Katsumi			Partial Transmalleolar Approach for Lateral Impingement After Total Ankle Arthroplasty: A Case Report	JOURNAL OF FOOT & ANKLE SURGERY			English	Article						fibula osteotomy; impingement; revision; surgical complications; total ankle replacement	STANDARD RATING SYSTEM; OUTCOME MEASUREMENT; REPLACEMENT; FOOT; RELIABILITY	Advances in implant technology have made total ankle arthroplasty an increasingly popular alternative to arthrodesis for the management of ankle arthritis. However, a frequent complication of the procedure is nerve impingement related to either to heterotrophic bone growth or the prosthesis itself. Successful resolution of this complication presents a challenge to clinicians. We present a case of lateral impingement following total ankle arthroplasty that was successfully treated using a partial transmalleolar approach to effect a partial osteotomy of the lateral malleolus and create a fragment attached to the anterior talofibular and calcaneo-fibular ligaments. This approach provides a good operative field in the lateral gutter with minimal soft tissue impairment. It also facilitates curettage, and resolution of tissue impingement. The osteotomy site healed fully by 3 months postoperative, and the pain around the lateral malleolus resolved. Furthermore, the patient's score on the Japanese Society for Surgery of the Foot Ankle/Hindfoot Scale improved from 33 preoperatively to 82 at 6 months postoperative. (C) 2015 by the American College of Foot and Ankle Surgeons. All rights reserved.	[Matsumoto, Takumi; Miura, Ayumi; Momoyama, Gen] Yugawara Hosp, Dept Rheumatol, Ashigara Shimo, Kanagawa 2590396, Japan; [Miura, Ayumi] Teikyo Heisei Univ, Fac Med Sci Hlth, Tokyo, Japan; [Ito, Katsumi] Yugawara Hosp, Ashigara Shimo, Kanagawa 2590396, Japan	Matsumoto, T (reprint author), Yugawara Hosp, Dept Rheumatol, 438 Miyakami, Ashigara Shimo, Kanagawa 2590396, Japan.	matumot-tky@umin.ac.jp					Roukis TS, 2012, J FOOT ANKLE SURG, V51, P198, DOI 10.1053/j.jfas.2011.11.002; GLASGOW M, 1980, J BONE JOINT SURG BR, V62, P196; Spirt AA, 2004, J BONE JOINT SURG AM, V86A, P1172; Niki H, 2005, J ORTHOP SCI, V10, P466, DOI 10.1007/s00776-005-0937-1; Rippstein PF, 2011, J BONE JOINT SURG AM, V93A, P1426, DOI 10.2106/JBJS.J.00913; Gougoulias N, 2010, CLIN ORTHOP RELAT R, V468, P199, DOI 10.1007/s11999-009-0987-3; Shirzad K, 2011, FOOT ANKLE INT, V32, P727, DOI 10.3113/FAI.2011.0727; Niki H, 2005, J ORTHOP SCI, V10, P457, DOI 10.1007/s00776-005-0936-2; Wood PLR, 2008, J BONE JOINT SURG BR, V90B, P605, DOI 10.1302/0301-620X.90B5.19677; Besse JL, 2010, ORTHOP TRAUMATOL-SUR, V96, P291, DOI 10.1016/j.otsr.2010.03.002; Bartonicek J, 2003, SURG RADIOL ANAT, V25, P379, DOI 10.1007/s00276-003-0156-4; Lee KB, 2011, J BONE JOINT SURG AM, V93A, P751, DOI 10.2106/JBJS.J.00178; Kurup HV, 2008, INT ORTHOP, V32, P243, DOI 10.1007/s00264-006-0300-y; Roukis TS, 2013, J FOOT ANKLE SURG, V52, P728, DOI 10.1053/j.jfas.2013.08.006; Gilbert BJ, 2004, J BONE JOINT SURG AM, V86A, P1857; Kopp FJ, 2006, FOOT ANKLE INT, V27, P97; Mann Jeffrey A, 2011, Foot Ankle Int, V32, pS473, DOI 10.3113/FAI.2011.0473; Richardson Andrew B, 2012, Curr Rev Musculoskelet Med, V5, P171, DOI 10.1007/s12178-012-9121-3; Saltzman Charles L, 2010, Clin Orthop Surg, V2, P1, DOI 10.4055/cios.2010.2.1.1; TAKAKURA Y, 1990, CLIN ORTHOP RELAT R, P209	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1067-2516	1542-2224		J FOOT ANKLE SURG	J. Foot Ankle Surg.	MAR-APR	2015	54	2					233	236		10.1053/j.jfas.2014.11.006		4	Orthopedics; Surgery	Orthopedics; Surgery	CC2IA	WOS:000350167500018		
J	Nakasa, T; Adachi, N; Kato, T; Ochi, M				Nakasa, Tomoyuki; Adachi, Nobuo; Kato, Tomohiro; Ochi, Mitsuo			Distraction Arthroplasty With Arthroscopic Microfracture in a Patient With Rheumatoid Arthritis of the Ankle Joint	JOURNAL OF FOOT & ANKLE SURGERY			English	Article						arthroscope; external fixator; fibrocartilage; rheumatoid arthritis; talus; tibia	RANDOMIZED CONTROLLED-TRIAL; CLINICAL BENEFIT; KNEE-JOINT; OSTEOARTHRITIS; ARTHRODESIS	We treated a 39-year-old female who had experienced destruction of her ankle joint owing to rheumatoid arthritis. This relatively young patient wished to avoid ankle fusion and joint replacement. Therefore, distraction arthroplasty with arthroscopic microfracture was performed to improve her symptoms and preserve motion. A microfracture procedure specifically for cartilage defects of the tibial plafond and talar dome was performed with the arthroscope, after which a hinged external fixator was applied to distract the ankle joint. The ankle joint space was enlarged by the external device and joint movement allowed. After 3 months, removal of the external device and repeat arthroscopy revealed newly formed fibrocartilage on the surfaces of both the tibia and the talus. At 2 years after the surgery, a radiograph showed that the joint space enlargement of the ankle had been maintained. The American Orthopaedic Foot and Ankle Society score improved from 37 points preoperatively to 82 points at 2 years postoperatively. Our findings suggest that good clinical results can be achieved with distraction arthroplasty and arthroscopic microfracture in a relatively young patient with rheumatoid arthritis. (C) 2015 by the American College of Foot and Ankle Surgeons. All rights reserved.	[Nakasa, Tomoyuki; Adachi, Nobuo; Kato, Tomohiro; Ochi, Mitsuo] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Orthopaed Surg, Integrated Hlth Sci, Hiroshima 7348551, Japan	Nakasa, T (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Orthopaed Surg, Integrated Hlth Sci,Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	tnakasa0@gmail.com					Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Wehling N, 2009, ARTHRITIS RHEUM, V60, P801, DOI 10.1002/art.24352; Marijnissen ACA, 2002, ARTHRITIS RHEUM, V46, P2893, DOI 10.1002/art.10612; Kajiwara R, 2005, J ORTHOP RES, V23, P909, DOI 10.1016/j.orthres.2004.12.003; Deie M, 2007, ARTHROSCOPY, V23, P833, DOI 10.1016/j.arthro.2007.02.014; Roux C, 2011, OSTEOPOROSIS INT, V22, P421, DOI 10.1007/s00198-010-1319-x; VANVALBURG AA, 1995, J BONE JOINT SURG BR, V77, P720; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Jaakkola JI, 2004, FOOT ANKLE INT, V25, P866; KITAOKA HB, 1994, FOOT ANKLE INT, V15, P349; Claridge RJ, 2009, FOOT ANKLE INT, V30, P824, DOI 10.3113/FAI.2009.0824; Gardner DL, 1992, PATHOLOGICAL BASIS C, P444; Ibrahim Talal, 2007, J Foot Ankle Surg, V46, P65, DOI 10.1053/j.jfas.2006.12.002; Kokkonen A, 2011, FOOT ANKLE INT, V32, P168, DOI 10.3113/FAI.2011.0168; Marijnissen Anne C A, 2003, Foot Ankle Clin, V8, P335, DOI 10.1016/S1083-7515(03)00044-5; Nihal Aneel, 2008, Foot Ankle Surg, V14, P1, DOI 10.1016/j.fas.2007.08.004; Paley Dror, 2005, Foot Ankle Clin, V10, P685, DOI 10.1016/j.fcl.2005.06.010; Ploegmakers JJW, 2005, OSTEOARTHR CARTILAGE, V13, P582, DOI 10.1016/j.joca.2005.03.002; Rohner E, 2012, IMMUNOL RES, V52, P169, DOI 10.1007/s12026-011-8247-5; Saltzman CL, 2012, J BONE JOINT SURG AM, V94A, P961, DOI 10.2106/JBJS.K.00018; Suckel A, 2007, ACTA ORTHOP, V78, P592, DOI 10.1080/17453670710014275; Tellisi N, 2009, FOOT ANKLE INT, V30, P318, DOI 10.3113/FAI.2009.0318	22	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1067-2516	1542-2224		J FOOT ANKLE SURG	J. Foot Ankle Surg.	MAR-APR	2015	54	2					280	284		10.1053/j.jfas.2014.11.016		5	Orthopedics; Surgery	Orthopedics; Surgery	CC2IA	WOS:000350167500027		
J	Wang, LF; Lin, YS; Huang, NC; Yu, CY; Tsai, WL; Chen, JJ; Kubota, T; Matsuoka, M; Chen, SR; Yang, CS; Lu, RW; Lin, YL; Chang, TH				Wang, Li-Fong; Lin, You-Sheng; Huang, Nan-Chieh; Yu, Chia-Yi; Tsai, Wei-Lun; Chen, Jih-Jung; Kubota, Toru; Matsuoka, Mayumi; Chen, Siang-Ru; Yang, Chih-Shiang; Lu, Ruo-Wei; Lin, Yi-Ling; Chang, Tsung-Hsien			Hydroxychloroquine-Inhibited Dengue Virus Is Associated with Host Defense Machinery	JOURNAL OF INTERFERON AND CYTOKINE RESEARCH			English	Article							ENDOPLASMIC-RETICULUM STRESS; NF-KAPPA-B; INNATE IMMUNE-RESPONSES; HIV-INFECTED PATIENTS; WEST NILE VIRUS; OXIDATIVE STRESS; RIG-I; AUTOPHAGY; INTERFERON; CELLS	Hydroxychloroquine (HCQ) is an antimalarial drug also used in treating autoimmune diseases. Its antiviral activity was demonstrated in restricting HIV infection in vitro; however, the clinical implications remain controversial. Infection with dengue virus (DENV) is a global public health problem, and we lack an antiviral drug for DENV. Here, we evaluated the anti-DENV potential of treatment with HCQ. Immunofluorescence assays demonstrated that HCQ could inhibit DENV serotype 1-4 infection in vitro. RT-qPCR analysis of HCQ-treated cells showed induced expression of interferon (IFN)-related antiviral proteins and certain inflammatory cytokines. Mechanistic study suggested that HCQ activated the innate immune signaling pathways of IFN-beta, AP-1, and NF kappa B. Knocking down mitochondrial antiviral signaling protein (MAVS), inhibiting TANK binding kinase 1 (TBK1)/inhibitor-kappa B kinase e (IKKe), and blocking type I IFN receptor reduced the efficiency of HCQ against DENV-2 infection. Furthermore, HCQ significantly induced cellular production of reactive oxygen species (ROS), which was involved in the host defense system. Suppression of ROS production attenuated the innate immune activation and anti-DENV-2 effect of HCQ. In summary, HCQ triggers the host defense machinery by inducing ROS- and MAVS-mediated innate immune activation against DENV infection and may be a candidate drug for DENV infection.	[Wang, Li-Fong] Kaohsiung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Kaohsiung 813, Taiwan; [Lin, You-Sheng; Chen, Siang-Ru; Yang, Chih-Shiang; Lu, Ruo-Wei; Chang, Tsung-Hsien] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung 813, Taiwan; [Huang, Nan-Chieh] Kaohsiung Armed Forces Gen Hosp, Dept Family Med, Zuoying Branch, Kaohsiung, Taiwan; [Yu, Chia-Yi; Lin, Yi-Ling] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Tsai, Wei-Lun] Kaohsiung Vet Gen Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung 813, Taiwan; [Chen, Jih-Jung; Chang, Tsung-Hsien] Tajen Univ, Grad Inst Pharmaceut Technol, Pingtung, Taiwan; [Kubota, Toru] Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan; [Matsuoka, Mayumi] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan	Chang, TH (reprint author), Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung 813, Taiwan.	changth@vghks.gov.tw			Kaohsiung Veterans General Hospital [VGHKS102-004, VGHKS103-107]; Zuoying Branch of Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan [ZAFGH 102-16]	This work was supported by grants from Kaohsiung Veterans General Hospital (VGHKS102-004 and VGHKS103-107) and in part by the Zuoying Branch of Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan (ZAFGH 102-16). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the article.	Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Paton NI, 2012, JAMA-J AM MED ASSOC, V308, P353, DOI 10.1001/jama.2012.6936; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Lin CH, 2012, EMERG INFECT DIS, V18, P1603, DOI 10.3201/eid1810.111929; Doly J, 1998, CELL MOL LIFE SCI, V54, P1109, DOI 10.1007/s000180050240; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Aranda A, 2013, TOXICOL IN VITRO, V27, P954, DOI 10.1016/j.tiv.2013.01.016; Kohchi C, 2009, ANTICANCER RES, V29, P817; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004; Chen XQ, 2012, ANTIVIR RES, V95, P30, DOI 10.1016/j.antiviral.2012.05.001; Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Chang TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041635; Perry ST, 2009, J VIROL, V83, P8276, DOI 10.1128/JVI.00365-09; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5; Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Ben-Zvi I, 2012, CLIN REV ALLERG IMMU, V42, P145, DOI 10.1007/s12016-010-8243-x; Liu S, 2012, HEPATOLOGY, V56, P57, DOI 10.1002/hep.25642; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Li JK, 2012, MICROBES INFECT, V14, P159, DOI 10.1016/j.micinf.2011.09.001; Ke PY, 2011, AUTOPHAGY, V7, P533, DOI 10.4161/auto.7.5.14732; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JC126373; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; de Diego RP, 2010, IMMUNITY, V33, P400, DOI 10.1016/j.immuni.2010.08.014; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Nadanaka S, 2007, MOL CELL BIOL, V27, P1027, DOI 10.1128/MCB.00408-06; Zhu YZ, 2012, J VIROL, V86, P13407, DOI 10.1128/JVI.00903-12; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Simicek M, 2013, NAT CELL BIOL, V15, P1220, DOI 10.1038/ncb2847; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Dong XN, 2013, J INNATE IMMUN, V5, P480, DOI 10.1159/000346388; Lin YL, 1998, J VIROL, V72, P9729; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Lee SJ, 2011, NAT REV NEPHROL, V7, P718, DOI 10.1038/nrneph.2011.150; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; BRANDRISS MW, 1984, J GEN VIROL, V65, P791, DOI 10.1099/0022-1317-65-4-791; Chang TH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000493; Deavall D. G., 2012, J TOXICOL, V2012, DOI [DOI 10.1155/2012/645460, DOI 10.1155/2012/645460)]; Fidanboylu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025212; Gonzalez-Dosal R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002250; Hu SX, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-123; Huang YF, 2012, J IMMUNOL, V188, P358, DOI 10.4049/jimmunol.1102079; Konno H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005674; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; OCHIAI H, 1995, ANTIVIR RES, V27, P425, DOI 10.1016/0166-3542(95)00040-S; Paton NI, 2005, HIV MED, V6, P13, DOI 10.1111/j.1468-1293.2005.00259.x; RANDOLPH VB, 1990, VIROLOGY, V174, P450, DOI 10.1016/0042-6822(90)90099-D; Savarino A, 2001, J CLIN VIROL, V20, P131, DOI 10.1016/S1386-6532(00)00139-6; Savarino A, 2001, AIDS, V15, P2221, DOI 10.1097/00002030-200111230-00002; Seligman SJ, 2008, J INFECT DIS, V198, P794, DOI 10.1086/590915; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785; Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69; Wu SF, 2002, J VIROL, V76, P3596, DOI 10.1128/JVI.76.8.3596-3604.2002; Yu CY, 2010, J VIROL, V84, P2421, DOI 10.1128/JVI.02174-09; Zhao YY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003086	68	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1079-9907	1557-7465		J INTERF CYTOK RES	J. Interferon Cytokine Res.	MAR 1	2015	35	3					143	156		10.1089/jir.2014.0038		14	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	CC4YB	WOS:000350361400001		
J	Yimin; Kohanawa, M; Zhao, SJ; Li, MQ; Kuge, Y; Tamaki, N; Watanabe, M				Yimin; Kohanawa, Masashi; Zhao, Songji; Li, Minqi; Kuge, Yuji; Tamaki, Nagara; Watanabe, Masahiko			Regulatory Effect of Interleukin-4 in the Innate Inflammatory Response to Rhodococcus aurantiacus Infection in Mice	JOURNAL OF INTERFERON AND CYTOKINE RESEARCH			English	Article							TUMOR-NECROSIS-FACTOR; CANDIDA-ALBICANS; INTERFERON-GAMMA; FACTOR-ALPHA; MYCOBACTERIAL INFECTION; PERITONEAL-MACROPHAGES; MONONUCLEAR-CELLS; NATURAL-KILLER; PROTECTS MICE; IL-4 RECEPTOR	Interleukin (IL)-4 promotes the regression of granulomas during the late phase of Rhodococcus aurantiacus infection. In this study, the contribution of IL-4 to the initial response against this bacterium was investigated using IL-4-deficient mice. Compared with wild-type (WT) mice, IL-4-deficient mice displayed remarkably lower tumor necrosis factor (TNF)-alpha and IL-6 secretion in the liver, spleen, and blood at the initial phase of infection, along with improved survival. IL-4-deficient mice also showed diminished IL-10 secretion in the spleen and blood; however, hepatic IL-10 levels were similar to those observed in WT animals, and were concomitant with augmented interferon (IFN)-gamma production and decreased bacterial burden in the liver at the early infection phase. Histological examination revealed reduced hepatic granuloma formation in infected IL-4-deficient mice. On challenge with heat-killed R. aurantiacus, IL-4-deficient mouse macrophages showed reduced expression of TNF-alpha, IL-6, and IL-10 at both the gene and protein levels compared with WT mouse cells. These findings indicate that during the initiation of R. aurantiacus-induced inflammation, IL-4 deficiency attenuates cytokine responses in macrophages, which contributes to amelioration in mouse survival and reduction of granulomatous inflammation, and augments a hepatic IFN-gamma response which transiently accelerates bacterial elimination.	[Yimin; Kohanawa, Masashi; Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Adv Med, Sapporo, Hokkaido 0608638, Japan; [Zhao, Songji] Hokkaido Univ, Grad Sch Med, Dept Tracer Kinet & Bioanal, Sapporo, Hokkaido 0608638, Japan; [Li, Minqi] Shandong Univ, Dept Bone Metab, Sch Stomatol, Jinan 250100, Peoples R China; [Kuge, Yuji] Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido 0608638, Japan; [Tamaki, Nagara] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Sapporo, Hokkaido 0608638, Japan; [Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan	Yimin (reprint author), Hokkaido Univ, Grad Sch Med, Dept Adv Med, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	yimin@med.hokudai.ac.jp	WATANABE, Masahiko/A-4055-2012				CENCI E, 1993, EUR J IMMUNOL, V23, P1034, DOI 10.1002/eji.1830230508; Renna MS, 2012, INT IMMUNOL, V24, P315, DOI 10.1093/intimm/dxs001; Jarry A, 2008, J CLIN INVEST, V118, P1132, DOI 10.1172/JCI32140; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Aitken SL, 2011, J MAMMARY GLAND BIOL, V16, P291, DOI 10.1007/s10911-011-9230-4; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Cao SJ, 2005, J IMMUNOL, V174, P3484; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Bergstrom KS, 2012, CELL MICROBIOL, V14, P475, DOI 10.1111/j.1462-5822.2012.01750.x; Mencacci A, 1998, J EXP MED, V187, P307, DOI 10.1084/jem.187.3.307; Fort MM, 2001, J IMMUNOL, V166, P2793; Luzina IG, 2012, J LEUKOCYTE BIOL, V92, P753, DOI 10.1189/jlb.0412214; Asano M, 1996, IMMUNOLOGY, V88, P394, DOI 10.1046/j.1365-2567.1996.d01-660.x; ASANO M, 1995, MICROBIOL IMMUNOL, V39, P499; Baumhofer JM, 1998, EUR J IMMUNOL, V28, P610, DOI 10.1002/(SICI)1521-4141(199802)28:02<610::AID-IMMU610>3.0.CO;2-5; Cole N, 2005, CURR EYE RES, V30, P535, DOI 10.1080/02713680590968583; Crowe NY, 2005, J EXP MED, V202, P1279, DOI 10.1084/jem.20050953; DANDREA A, 1995, J EXP MED, V181, P537, DOI 10.1084/jem.181.2.537; Fujitsu Y, 2003, EXP EYE RES, V76, P107, DOI 10.1016/S0014-4835(02)00248-8; Hess DJ, 2002, J SURG RES, V104, P88, DOI 10.1006/jsre.2002.6417; Hiraki S, 2012, SHOCK, V37, P177, DOI 10.1097/SHK.0b013e31823f18ad; HO JL, 1992, J INFECT DIS, V165, P344; Ji GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053101; Major J, 2002, J IMMUNOL, V168, P2456; Murapa P, 2011, INFECT IMMUN, V79, P177, DOI 10.1128/IAI.00742-09; Pires DA, 2014, INFLAMM RES, V63, P61, DOI 10.1007/s00011-013-0671-7; Reljic R, 2010, CYTOKINE, V51, P42, DOI 10.1016/j.cyto.2010.04.005; Saeftel M, 2004, INFECT IMMUN, V72, P322, DOI 10.1128/IAI.72.1.322-331.2004; Sharma A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071872; Stegmayr B, 2012, SEMIN DIALYSIS, V25, P171, DOI 10.1111/j.1525-139X.2011.01029.x; Sugawara I, 2000, MICROBIOL IMMUNOL, V44, P971; TSUKAMURA M, 1982, J CLIN MICROBIOL, V16, P604; Woodward EA, 2012, CYTOKINE, V58, P415, DOI 10.1016/j.cyto.2012.03.009; Wu HP, 2008, J CRIT CARE, V23, P519, DOI 10.1016/j.jcrc.2007.11.008; Yimin, 2008, MICROBES INFECT, V10, P1450, DOI 10.1016/j.micinf.2008.08.013; Yimin, 2006, J IMMUNOL, V177, P642; Yimin Kohanawa M, 2001, J MED MICROBIOL, V50, P688; Yimin Kohanawa M, 2003, IMMUNOLOGY, V110, P501	39	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1079-9907	1557-7465		J INTERF CYTOK RES	J. Interferon Cytokine Res.	MAR 1	2015	35	3					222	231		10.1089/jir.2014.0107		10	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	CC4YB	WOS:000350361400008		
J	Nishid, N; Vidal, G				Nishid, Naoki; Vidal, German			A framework for computing finite SLD trees	JOURNAL OF LOGICAL AND ALGEBRAIC METHODS IN PROGRAMMING			English	Article						Logic programming; Semantics; Program analysis	LOGIC PROGRAMS; JAVA BYTECODE; TERMINATION ANALYSIS; PARTIAL DEDUCTION; FOUNDATIONS; RESOLUTION; COST; CLP	The search space of SLD resolution, usually represented by means of a so-called SLD tree, is often infinite. However, there are many applications that must deal with possibly infinite SLD trees, like partial evaluation or some static analyses. In this context, being able to construct a finite representation of an infinite SLD tree becomes useful. In this work, we introduce a framework to construct a finite data structure representing the (possibly infinite) SLD derivations for a goal. This data structure, called closed SLD tree, is built using four basic operations: unfolding, flattening, splitting, and subsumption. We prove some basic properties for closed SLD trees, namely that both computed answers and calls are preserved. We present a couple of simple strategies for constructing closed SLD trees with different levels of abstraction, together with some examples of its application. Finally, we illustrate the viability of our approach by introducing a test case generator based on exploring closed SLD trees. (C) 2014 Elsevier Inc. All rights reserved.	[Nishid, Naoki] Nagoya Univ, Grad Sch Informat Sci, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Vidal, German] Univ Politecn Valencia, MiST, DSIC, E-46022 Valencia, Spain	Vidal, G (reprint author), Univ Politecn Valencia, MiST, DSIC, Camino Vera S-N, E-46022 Valencia, Spain.	nishida@is.nagoya-u.ac.jp; gvidal@dsic.upv.es	Vidal, German/B-2217-2014	Vidal, German/0000-0002-1857-6951	EU (FEDER); Spanish Ministerio de Economia y Competitividad (Secretaria de Estado de Investigacion, Desarrollo e Innovacion) [TIN2013-44742-C4-1-R]; Generalitat Valenciana [PROMETEO/2011/052]	This work has been partially supported by the EU (FEDER) and the Spanish Ministerio de Economia y Competitividad (Secretaria de Estado de Investigacion, Desarrollo e Innovacion) under grant TIN2013-44742-C4-1-R and by the Generalitat Valenciana under grant PROMETEO/2011/052.	Albert E, 2008, LECT NOTES COMPUT SC, V5051, P2, DOI 10.1007/978-3-540-68863-1_2; Albert E., 2012, LECT NOTES COMPUTER, V7225, P25; Albert E, 2008, LECT NOTES COMPUT SC, V5382, P113, DOI 10.1007/978-3-540-92188-2_5; PETTOROSSI A, 1994, J LOGIC PROGRAM, V20, P261; Vidal G, 2012, THEOR PRACT LOG PROG, V12, P583, DOI 10.1017/S1471068412000191; LLOYD JW, 1991, J LOGIC PROGRAM, V11, P217, DOI 10.1016/0743-1066(91)90027-M; Albert E, 2012, THEOR COMPUT SCI, V413, P142, DOI 10.1016/j.tcs.2011.07.009; De Schreye D, 1999, J LOGIC PROGRAM, V41, P231, DOI 10.1016/S0743-1066(99)00030-8; Vidal G, 2011, LECT NOTES COMPUT SC, V6564, P200, DOI 10.1007/978-3-642-20551-4_13; Apt K.R., 1997, LOGIC PROGRAMMING PR; Barbuti R., 1986, LOGIC PROGRAMMING FU, P201; BOSCO PG, 1988, THEOR COMPUT SCI, V59, P3, DOI 10.1016/0304-3975(88)90095-3; Brockschmidt M., 2011, LIPICS, V10, P155; Brockschmidt M, 2010, LECT NOTES ARTIF INT, V6463, P17, DOI 10.1007/978-3-642-17172-7_2; BRUYNOOGHE M, 1992, NEW GENERAT COMPUT, V11, P47; BRUYNOOGHE M, 1991, J LOGIC PROGRAM, V10, P91, DOI 10.1016/0743-1066(91)80001-T; Bruynooghe M., 1991, P ILPS 91 SAN DIEG C, P117; DEBOER FS, 1992, THEOR COMPUT SCI, V101, P239, DOI 10.1016/0304-3975(92)90051-G; Giesl J, 2011, ACM T PROGR LANG SYS, V33, DOI 10.1145/1890028.1890030; Giesl J., 2012, PPDP 12, P1; Gomez-Zamalloa M, 2010, THEOR PRACT LOG PROG, V10, P659, DOI 10.1017/S1471068410000347; HANUS M, 1994, J LOGIC PROGRAM, V20, P583, DOI 10.1016/0743-1066(94)90034-5; Henzinger TA, 2002, ACM SIGPLAN NOTICES, V37, P58, DOI 10.1145/565816.503279; Kruskal J., 1960, T AM MATH SOC, V95, P210, DOI 10.2307/1993287; Leuschel M., 1996, P JOINT INT C S LOG, P319; Leuschel M., 2007, DPPD DOZENS PROBLEMS; LEUSCHEL M, 2002, LECT NOTES COMPUT SC, V2566, P379; Lloyd J.W., 1987, FDN LOGIC PROGRAMMIN; Nishida N, 2014, LECT NOTES COMPUT SC, V8901, P54, DOI 10.1007/978-3-319-14125-1_4; Otto C., 2010, P RTA10, V6, P259; PALAMIDESSI C, 1990, LECT NOTES COMPUT SC, V443, P386; Peralta JC, 2000, LECT NOTES COMPUT SC, V1817, P102, DOI 10.1007/10720327_7; Roychoudhury A., 2000, Proceedings of the 2nd International ACM SIGPLAN Conference on Principles and Practice of Declarative Programming (PPDP '00), DOI 10.1145/351268.351290; Schneider-Kamp P, 2010, THEOR PRACT LOG PROG, V10, P365, DOI 10.1017/S1471068410000165; Tamaki H., 1984, P 1 IEEE INT S LOG P, P259; TAMAKI H, 1986, LECT NOTES COMPUT SC, V225, P84; Vidal G, 2014, LECT NOTES COMPUT SC, V8901, P109, DOI 10.1007/978-3-319-14125-1_7; Vidal G., 2012, P 12 IEEE INT WORK C, P34	38	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2352-2208			J LOG ALGEBR METHODS	J. Log. Algebr. Methods Program	MAR	2015	84	2					197	217		10.1016/j.jlamp.2014.11.006		21	Computer Science, Theory & Methods; Logic	Computer Science; Science & Technology - Other Topics	CC1BX	WOS:000350077300001		
J	Onishi, N; Kanao, S; Kataoka, M; Iima, M; Sakaguchi, R; Kawai, M; Kataoka, TR; Mikami, Y; Toi, M; Togashi, K				Onishi, Natsuko; Kanao, Shotaro; Kataoka, Masako; Iima, Mami; Sakaguchi, Rena; Kawai, Makiko; Kataoka, Tatsuki R.; Mikami, Yoshiki; Toi, Masakazu; Togashi, Kaori			Apparent Diffusion Coefficient as a Potential Surrogate Marker for Ki-67 Index in Mucinous Breast Carcinoma	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						ADC; mucinous carcinoma; breast cancer; cellularity; Ki-67 index	INVASIVE DUCTAL CARCINOMA; PROGNOSTIC-FACTORS; CANCER; FEATURES; THERAPY; TUMORS; ADC	PurposeTo examine the association between apparent diffusion coefficient (ADC), cellularity, and Ki-67 index in mucinous breast carcinoma (MBC) compared with invasive carcinoma of no special type (NST). ADC's ability to identify lesions with highly proliferating MBC was also examined. Materials and MethodsPathologically confirmed MBCs (mucinous group, n=18) and NSTs (control group, n=18) were retrospectively analyzed. ADC was calculated from signal intensity of diffusion-weighted imaging at b values of 0 and 1000 sec/mm(2). The Ki-67 index and cellularity were histopathologically evaluated. The mucinous group was classified into high Ki-67 mucinous group (Ki-67 index 14%, highly proliferating) and low Ki-67 mucinous group. ResultsIn the mucinous group, minimum ADC (ADCmin) showed an inverse correlation with cellularity (r=-0.802, P<0.0001) and Ki-67 index (r=-0.825, P<0.0001). In the control group, ADCmin showed inverse correlation with cellularity (r=-0.537 P=0.022), but no correlation with Ki-67 index (r=0.035, P=0.892). ADCmin of high Ki-67 mucinous group was significantly lower than that of low Ki-67 mucinous group (P=0.005). ConclusionThis study demonstrates an inverse correlation between ADC and Ki-67 index in MBC and the ability of ADC to identify highly proliferating MBC. Considering that ADC can evaluate whole lesions noninvasively, ADC may be a promising noninvasive surrogate marker for Ki-67 index in the risk stratification of MBC. J. Magn. Reson. Imaging 2015;41:610-615. (c) 2014 Wiley Periodicals, Inc.	[Onishi, Natsuko; Kanao, Shotaro; Kataoka, Masako; Iima, Mami; Sakaguchi, Rena; Kawai, Makiko; Togashi, Kaori] Kyoto Univ, Dept Diagnost Imaging & Nucl Med, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan; [Kataoka, Tatsuki R.; Mikami, Yoshiki] Kyoto Univ, Dept Diagnost Pathol, Grad Sch Med, Kyoto 6068507, Japan; [Toi, Masakazu] Kyoto Univ, Dept Breast Surg, Grad Sch Med, Kyoto 6068507, Japan	Onishi, N (reprint author), Kyoto Univ, Dept Diagnost Imaging & Nucl Med, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto 6068507, Japan.	natsucom@kuhp.kyoto-u.ac.jp					Anan K, 2001, EUR J SURG ONCOL, V27, P459; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Guo Y, 2002, J MAGN RESON IMAGING, V16, P172, DOI 10.1002/jmri.10140; CLAYTON F, 1986, HUM PATHOL, V17, P34, DOI 10.1016/S0046-8177(86)80152-6; Maiorano E, 2010, BREAST CANCER RES TR, V121, P211, DOI 10.1007/s10549-009-0360-y; Jeh SK, 2011, J MAGN RESON IMAGING, V33, P102, DOI 10.1002/jmri.22400; Tsushima Y, 2009, J MAGN RESON IMAGING, V30, P249, DOI 10.1002/jmri.21854; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Dowsett M, 2011, J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Woodhams R, 2009, AM J ROENTGENOL, V193, P260, DOI 10.2214/AJR.08.1670; GERDES J, 1984, J IMMUNOL, V133, P1710; Hasebe T, 2001, MODERN PATHOL, V14, P325, DOI 10.1038/modpathol.3880310; Woodhams R, 2005, J COMPUT ASSIST TOMO, V29, P644, DOI 10.1097/01.rct.0000171913.74086.1b; Kim SH, 2009, J MAGN RESON IMAGING, V30, P615, DOI 10.1002/jmri.21884; Bussolati G, 2012, WHO CLASSIFICATION T, P60; Ellis IO, 2012, WHO CLASSIFICATION T, P34; Fentiman IS, 1997, BRIT J CANCER, V75, P1061, DOI 10.1038/bjc.1997.180; Hatakenaka Masamitsu, 2008, Magn Reson Med Sci, V7, P23, DOI 10.2463/mrms.7.23; Tozaki M, 2010, AM J ROENTGENOL, V194, P1384, DOI 10.2214/AJR.09.3431	19	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	MAR	2015	41	3					610	615		10.1002/jmri.24615		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CB9QT	WOS:000349967700005		
J	Kagei, Y; Nishida, T				Kagei, Yoshiyuki; Nishida, Takaaki			Instability of Plane Poiseuille Flow in Viscous Compressible Gas	JOURNAL OF MATHEMATICAL FLUID MECHANICS			English	Article						Compressible Navier-Stokes equation; Poiseuille flow; instability		Instability of plane Poiseuille flow in viscous compressible gas is investigated. A condition for the Reynolds and Mach numbers is given in order for plane Poiseuille flow to be unstable. It turns out that plane Poiseuille flow is unstable for Reynolds numbers much less than the critical Reynolds number for the incompressible flow when the Mach number is suitably large. It is proved by the analytic perturbation theory that the linearized operator around plane Poiseuille flow has eigenvalues with positive real part when the instability condition for the Reynolds and Mach numbers is satisfied.	[Kagei, Yoshiyuki] Kyushu Univ, Fac Math, Nishi Ku, Fukuoka 8190395, Japan; [Nishida, Takaaki] Kyoto Univ, Dept Appl Complex Syst, Sakyo Ku, Kyoto 6068317, Japan	Kagei, Y (reprint author), Kyushu Univ, Fac Math, Nishi Ku, Motooka 744, Fukuoka 8190395, Japan.	kagei@math.kyushu-u.ac.jp; tkknish@acs.i.kyoto-u.ac.jp			JSPS [24340028, 22244009, 24224003, 23540253, 26400163]	Y. Kagei was partly supported by JSPS KAKENHI Grant Number 24340028, 22244009, 24224003. T. Nishida was supported in part by JSPS KAKENHI Grant Number 23540253 and 26400163.	[Anonymous], 2010, J MATH FOR IND A, V2A, P39; [Anonymous], 2010, J MATH FOR IND B, V2B, P235; [Anonymous], 2010, PERTURBATION THEORY, V2A, P39; Kagei Y, 2012, ARCH RATION MECH AN, V205, P585, DOI 10.1007/s00205-012-0516-5; Iooss G., 1998, ANN U FERRARA, V43, P157; Kato T, 1980, PERTURBATION THEORY; Simon B., 1979, METHODS MODERN MATH	7	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1422-6928	1422-6952		J MATH FLUID MECH	J. Math. Fluid Mech.	MAR	2015	17	1					129	143		10.1007/s00021-014-0191-4		15	Mathematics, Interdisciplinary Applications; Mechanics; Physics, Fluids & Plasmas	Mathematics; Mechanics; Physics	CB8OF	WOS:000349888900007		
J	Kim, TH; Kim, JS; Kim, ZH; Huang, RB; Chae, YL; Wang, RS				Kim, Tae Hwan; Kim, Ju Sung; Kim, Zoo Haye; Huang, Ren Bin; Chae, Young Lye; Wang, Ren Sheng			Khz (Fusion Product of Ganoderma lucidum and Polyporus umbellatus Mycelia) Induces Apoptosis in Human Colon Carcinoma HCT116 Cells, Accompanied by an Increase in Reactive Oxygen Species, Activation of Caspase 3, and Increased Intracellular Ca2+	JOURNAL OF MEDICINAL FOOD			English	Article						reactive oxygen species; mitochondrial membrane potential; apoptosis; fusion; Khz; Ganoderma lucidum	OXIDATIVE STRESS; CANCER CELLS; ANTITUMOR; DEATH; MECHANISMS; MITOCHONDRIA; SENSITIVITY; CALCIUM	Khz (a fusion mycelium of Ganoderma lucidum and Polyporus umbellatus mycelia) is isolated from ganoderic acid and P. umbellatus and it exerts antiproliferative effects against malignant cells. However, no previous study has reported the inhibitory effects of Khz on the growth of human colon cancer cells. In the present study, we found that Khz suppressed cell division and induced apoptosis in HCT116 cells. Khz cytotoxicity was measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Khz reduced cell viability and mitochondrial membrane potential levels and it also induced disruption of the mitochondrial membrane potential and increased calcium concentration and reactive oxygen species generation. Khz increased caspase 3, PARP, caspase 7, and caspase 9 levels, but reduced Bcl-2 protein levels. Flow cytometry showed that the percentage of HCT116 cells in the sub-G1 phase of the cell cycle increased in response to Khz treatment.	[Kim, Tae Hwan; Wang, Ren Sheng] Guangxi Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Nanning 530021, Peoples R China; [Kim, Ju Sung] Harbin Med Univ, Harbin, Peoples R China; [Kim, Zoo Haye] Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan; [Huang, Ren Bin] Guangxi Med Univ, Dept Pharmacol, Nanning 530021, Peoples R China; [Chae, Young Lye] Korea Inst Sci & Management Career Coll, Seoul, South Korea	Wang, RS (reprint author), Guangxi Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Nanning 530021, Peoples R China.	13807806008@163.com					Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Jacobson MD, 1996, TRENDS BIOCHEM SCI, V21, P83, DOI 10.1016/0968-0004(96)20008-8; JACOBSON MD, 1995, NATURE, V374, P814, DOI 10.1038/374814a0; Lin ZB, 2004, ACTA PHARMACOL SIN, V25, P1387; Zhou Y, 2003, BLOOD, V101, P4098, DOI 10.1182/blood-2002-08-2512; Zhao YY, 2010, PLANTA MED, V76, P1755, DOI 10.1055/s-0030-1249926; Zhao SF, 2011, INT J ONCOL, V38, P1319, DOI 10.3892/ijo.2011.965; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Gao YH, 2005, IMMUNOL INVEST, V34, P171, DOI 10.1081/IMM-200055813; Yue QX, 2010, PHYTOMEDICINE, V17, P606, DOI 10.1016/j.phymed.2009.12.013; Miyajima A, 1997, BRIT J CANCER, V76, P206, DOI 10.1038/bjc.1997.363; Liu RM, 2011, PHYTOMEDICINE, V18, P349, DOI 10.1016/j.phymed.2010.08.019; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Chin-cheng S, 2010, INT J MOL MED, V25, P231; IIIana-Esteban C, 2008, REV IBEROAM MICOL, V25, P141; Jang Kyung-Jun, 2010, J Acupunct Meridian Stud, V3, P24, DOI 10.1016/S2005-2901(10)60004-0; Kim TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046208; Kim TH, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-236; Kim TH, 2014, FOOD SCI BIOTECHNOL, V23, P859, DOI 10.1007/s10068-014-0115-3; Li Lin, 2008, Zhong Yao Cai, V31, P1514; Sandodiya BS, 2009, CURR PHARM BIOTECHNO, V10, P717; Yue GGL, 2006, J ALTERN COMPLEM MED, V12, P777, DOI 10.1089/acm.2006.12.777	23	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-620X	1557-7600		J MED FOOD	J. Med. Food	MAR 1	2015	18	3					332	336		10.1089/jmf.2013.3135		5	Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics	Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics	CC4QK	WOS:000350337800009		
J	Park, CH; Xu, FH; Roh, SS; Song, YO; Uebaba, K; Noh, JS; Yokozawa, T				Park, Chan Hum; Xu, Feng Hao; Roh, Seong-Soo; Song, Yeong Ok; Uebaba, Kazuo; Noh, Jeong Sook; Yokozawa, Takako			Astaxanthin and Corni Fructus Protect Against Diabetes-Induced Oxidative Stress, Inflammation, and Advanced Glycation End Product in Livers of Streptozotocin-Induced Diabetic Rats	JOURNAL OF MEDICINAL FOOD			English	Article						astaxanthin; oxidative stress; Corni Fructus; inflammation; streptozotocin-induced diabetes; AGE	OXYGEN SPECIES FORMATION; HACHIMI-JIO-GAN; DB/DB MICE; LIPID-PEROXIDATION; ANTIOXIDANT STATUS; IN-VIVO; KAPPA-B; AMINOGUANIDINE; ACTIVATION; DISEASE	This study was conducted to compare the protective effects of astaxanthin (ASX) with Corni Fructus (CF) against diabetes-induced pathologies such as oxidative stress-induced inflammation and advanced glycation end product (AGE) formation in the liver of type 1 diabetic rats. ASX (50 mg/kg body weight/day) or CF (200 mg/kg body weight/day) was orally administered every day for 18 days to streptozotocin (STZ)-induced diabetic rats, and their effects were compared with nondiabetic and diabetic control rats. The administration of CF, but not ASX, decreased both the elevated serum and hepatic glucose concentration in diabetic rats. In diabetic rats, increased levels of AGE, reactive oxygen species, and lipid peroxidation were significantly decreased by treatment with both ASX and CF in the liver of diabetic rats. STZ treatment markedly augmented the protein expressions of AGE, and both ASX and CF efficiently attenuated these increases in hepatic protein expressions. In addition, oxidative stress and proinflammatory protein expressions were upregulated in the diabetic rats. On the contrary, these upregulations of protein expressions were decreased by the administration of ASX or CF. These results suggest that the inhibitory effect of ASX on diabetes-induced hepatic dysfunction could be derived from the blocking of AGE formation and further anti-inflammation and that CF exhibited beneficial effects through the attenuation of hyperglycemia, and thus the inhibition of AGE formation and the inflammatory responses. Therefore, ASX as well as CF may help prevent ongoing diabetes-induced hepatic injury.	[Park, Chan Hum; Roh, Seong-Soo] Daegu Haany Univ, Coll Korean Med, Taegu, South Korea; [Xu, Feng Hao] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Song, Yeong Ok] Pusan Natl Univ, Dept Food Sci Nutr, Pusan, South Korea; [Uebaba, Kazuo] Teikyo Heisei Univ, Dept Human Care, Tokyo, Japan; [Noh, Jeong Sook] Tongmyong Univ, Dept Food Sci & Nutr, Pusan, South Korea; [Yokozawa, Takako] Toyama Univ, Grad Sch Sci & Engn Res, Toyama 9308555, Japan	Yokozawa, T (reprint author), Toyama Univ, Grad Sch Sci & Engn Res, 3190 Gofuku, Toyama 9308555, Japan.	jsnoh2013@tu.ac.kr; yokozawa@inm.u-toyama.ac.jp			Toyama New Industry Organization	This study was supported, in part, by Toyama New Industry Organization.	Trombetta M, 2005, ALIMENT PHARM THERAP, V22, P24, DOI 10.1111/j.1365-2036.2005.02590.x; Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003; Uchiyama K, 2002, REDOX REP, V7, P290, DOI 10.1179/13510002125000811; Yilmaz HR, 2004, J BIOCHEM MOL TOXIC, V18, P234, DOI 10.1002/jbt.20028; EDELSTEIN D, 1992, DIABETES, V41, P26, DOI 10.2337/diabetes.41.1.26; Yamabe N, 2007, BIOL PHARM BULL, V30, P520, DOI 10.1248/bpb.30.520; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Spitaler MM, 2002, DIABETOLOGIA, V45, P476, DOI 10.1007/s00125-002-0782-0; NAKAYAMA H, 1993, DIABETES, V42, P345, DOI 10.2337/diabetes.42.2.345; Lei SQ, 2012, YONSEI MED J, V53, P294, DOI 10.3349/ymj.2012.53.2.294; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Yuan JP, 2011, MOL NUTR FOOD RES, V55, P150, DOI 10.1002/mnfr.201000414; Kim YJ, 2009, J AGR FOOD CHEM, V57, P8793, DOI 10.1021/jf9019745; ALI SF, 1992, NEUROTOXICOLOGY, V13, P637; Naguib YMA, 2000, J AGR FOOD CHEM, V48, P1150, DOI 10.1021/jf991106k; Nishigaki I, 2010, PHYTOTHER RES, V24, P54, DOI 10.1002/ptr.2867; Yamabe N, 2010, EUR J PHARMACOL, V648, P179, DOI 10.1016/j.ejphar.2010.08.044; Naito Y, 2004, BIOFACTORS, V20, P49; Manna P, 2012, FREE RADICAL RES, V46, P815, DOI 10.3109/10715762.2012.683431; SAXENA AK, 1993, BIOCHEM PHARMACOL, V45, P539, DOI 10.1016/0006-2952(93)90124-F; Griendling KK, 2003, CIRCULATION, V108, P1912, DOI 10.1161/01.CIR.0000093660.86242.BB; Ohgami K, 2003, INVEST OPHTH VIS SCI, V44, P2694, DOI 10.1167/iovs.02-0822; Mehta K, 2002, NUTR REV, V60, P289, DOI 10.1301/002966402320387224; MCLENNAN SV, 1991, DIABETES, V40, P344, DOI 10.2337/diabetes.40.3.344; Ikeuchi M, 2007, BIOSCI BIOTECH BIOCH, V71, P893, DOI 10.1271/bbb.60521; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066; Cho SY, 2002, CLIN CHIM ACTA, V317, P109, DOI 10.1016/S0009-8981(01)00762-8; Fassett Robert G, 2009, Future Cardiol, V5, P333, DOI 10.2217/fca.09.19; Giardino I, 1998, DIABETES, V47, P1114, DOI 10.2337/diabetes.47.7.1114; Haidara MA, 2010, CURR VASC PHARMACOL, V8, P661; HIRSCH J, 1992, CARBOHYD RES, V232, P125, DOI 10.1016/S0008-6215(00)90999-6; Hussein G, 2007, LIFE SCI, V80, P522, DOI 10.1016/j.lfs.2006.09.041; Iwamoto T, 2000, J Atheroscler Thromb, V7, P216; Kitada M, 2003, DIABETES, V52, P2603, DOI 10.2337/diabetes.52.10.2603; Komatsu Setsuko, 2007, V355, P73; Manabe E, 2008, J CELL BIOCHEM, V103, P1925, DOI 10.1002/jcb.21583; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Nakano M, 2008, INT J VITAM NUTR RES, V78, P175, DOI [10.1024/0300-9831.78.45.175, 10.1024/0300-9831.78.4/5.175]; Park CH, 2009, J MED FOOD, V12, P973, DOI 10.1089/jmf.2009.0037; Park CH, 2010, EUR J PHARMACOL, V640, P233, DOI 10.1016/j.ejphar.2010.04.028; Park CH, 2009, BIOL PHARM BULL, V32, P1734; Seckin D, 2006, DIABETES RES CLIN PR, V73, P191, DOI 10.1016/j.diabres.2006.01.001; Yamabe N, 2007, BIOL PHARM BULL, V30, P1289, DOI 10.1248/bpb.30.1289	44	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-620X	1557-7600		J MED FOOD	J. Med. Food	MAR 1	2015	18	3					337	344		10.1089/jmf.2014.3174		8	Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics	Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics	CC4QK	WOS:000350337800010		
J	Jung, KJ; Lee, EK; Kim, SJ; Song, CW; Maruyama, N; Ishigami, A; Kim, ND; Im, DS; Yu, BP; Chung, HY				Jung, Kyung Jin; Lee, Eun Kyeong; Kim, Su Jin; Song, Chang Woo; Maruyama, Naoki; Ishigami, Akihito; Kim, Nam Deuk; Im, Dong-Soon; Yu, Byung Pal; Chung, Hae Young			Anti-inflammatory activity of SMP30 modulates NF-kappa B through protein tyrosine kinase/phosphatase balance	JOURNAL OF MOLECULAR MEDICINE-JMM			English	Article						Senescence marker protein-30 (SMP30); Protein tyrosine kinase (PTK); Protein tyrosine phosphatase (PTP); NF-kappa B; Oxidative stress; Kidney aging	SENESCENCE MARKER PROTEIN-30; OXIDATIVE STRESS; KNOCKOUT MICE; CALORIE RESTRICTION; PHOSPHATASE 2A; SIGNAL-TRANSDUCTION; DOWN-REGULATION; RAT-KIDNEY; LIVER; ACTIVATION	Recent studies on senescence marker protein-30 (SMP30) have shown that it has an important functional role in the aging process, but its precise participation in cellular works has not been fully determined. We hypothesize that SMP30 plays crucial roles in signaling processes by modulating the balance of protein tyrosine kinase (PTK)/protein tyrosine phosphatase (PTP) and in activating proinflammatory NF-kappa B. An experimental paradigm of gain and loss of SMP30 function was established using SMP30-overexpressed YPEN-1 cells (herein referred to as "SMP30(+) cells") and SMP30 (Y/-) knockout mouse kidneys. The resulting data show that SMP30 expression suppressed oxidative stress-induced PTK/PTP dysregulation and PP1/2A inactivation in SMP30(+) cells, leading to the suppression of NF-kappa B activation. In the kidneys of SMP30 (Y/-) mice, SMP30 deficiency was found to induce NF-kappa B activation via the upstream signaling of NIK/IKK and MAPKs and to upregulate downstream NF-kappa B-responsive gene expression. In this study, we also demonstrate for the first time that SMP30 deficiency induced PTK activity in SMP30 (Y/-) kidneys, thereby significantly increasing the tyrosine phosphorylation of a catalytic subunit of PP2A (PP2Ac-Tyr307). Based on these findings, we propose that SMP30 involves NF-kappa B regulation through the PTK/PTP balance and that the age-related decrease of SMP30 causes NF-kappa B activation, which contributes to an exacerbation of the inflammatory process during aging. Key message SMP30-deficient mice induced a shorter lifespan and redox changes. Overexpression of SMP30 prevented oxidative stress insults. The depletion of SMP30 increased redox-related PTK/PTP imbalance and PP1/PP2A inactivation. The depletion of SMP30 caused an elevation of NF-kappa B-responsive inflammatory markers. SMP30 may be a potent inhibitory protein against oxidative stress and chronic inflammation.	[Jung, Kyung Jin; Kim, Su Jin; Song, Chang Woo] Korea Inst Toxicol, Taejon 305343, South Korea; [Jung, Kyung Jin; Kim, Su Jin; Song, Chang Woo] Korea Univ Sci & Technol, Dept Human & Environm Toxicol, Taejon 305333, South Korea; [Lee, Eun Kyeong; Kim, Nam Deuk; Im, Dong-Soon; Yu, Byung Pal; Chung, Hae Young] Pusan Natl Univ, Coll Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Pusan 609735, South Korea; [Maruyama, Naoki; Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Tokyo 1730015, Japan; [Yu, Byung Pal] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Jung, Kyung Jin; Lee, Eun Kyeong; Kim, Nam Deuk; Im, Dong-Soon; Chung, Hae Young] Pusan Natl Univ, Coll Pharm, Dept Pharm, Pusan 609735, South Korea	Chung, HY (reprint author), Pusan Natl Univ, Coll Pharm, Dept Pharm, Pusan 609735, South Korea.	hyjung@pusan.ac.kr		Ishigami, Akihito/0000-0001-7875-7482	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2009-0083538]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. 2009-0083538).	Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005; Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572; Chung SW, 2010, RADIAT RES, V173, P629, DOI 10.1667/RR1629.1; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Parri M, 2013, ANTIOXID REDOX SIGN, V19, P1828, DOI 10.1089/ars.2012.5040; Son TG, 2009, J NEUROSCI RES, V87, P2890, DOI 10.1002/jnr.22122; Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327; Chiarugi P, 2005, FREE RADICAL RES, V39, P353, DOI 10.1080/10715760400027987; Oruganti SR, 2011, MOL IMMUNOL, V48, P1448, DOI 10.1016/j.molimm.2011.03.020; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Yamaguchi M, 2013, CELL PROLIFERAT, V46, P243, DOI 10.1111/cpr.12036; Chong ZZ, 2007, HISTOL HISTOPATHOL, V22, P1251; Yamaguchi M, 2011, MOL CELL BIOCHEM, V353, P101, DOI 10.1007/s11010-011-0779-4; Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Luczak ED, 2014, J MOL CELL CARDIOL, V73, P112, DOI 10.1016/j.yjmcc.2014.02.004; Senmaru T, 2012, J CLIN BIOCHEM NUTR, V50, P114, DOI 10.3164/jcbn.11-52; Ando-Akatsuka Y, 1999, J CELL PHYSIOL, V179, P115, DOI 10.1002/(SICI)1097-4652(199905)179:2<115::AID-JCP1>3.0.CO;2-T; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Kim HJ, 2002, FREE RADICAL BIO MED, V32, P991, DOI 10.1016/S0891-5849(02)00798-0; Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5; Ishikawa Y, 2012, EXP EYE RES, V94, P85, DOI 10.1016/j.exer.2011.11.010; Yu BP, 2001, ANN NY ACAD SCI, V928, P39; Csiszar A, 2007, ACTA PHYSIOL HUNG, V94, P107, DOI 10.1556/APhysiol.94.2007.1-2.10; FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6; FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U; FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7; Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091; Jiang ZX, 2008, CANCER METAST REV, V27, P263, DOI 10.1007/s10555-008-9113-3; Jung KJ, 2006, ANTIOXID REDOX SIGN, V8, P671, DOI 10.1089/ars.2006.8.671; Jung KJ, 2009, FREE RADICAL BIO MED, V47, P983, DOI 10.1016/j.freeradbiomed.2009.07.009; Jung KJ, 2013, FREE RADICAL BIO MED, V61, P206, DOI 10.1016/j.freeradbiomed.2013.04.005; Kondo Y, 2004, FEBS LETT, V570, P57, DOI 10.1016/j.febslet.2004.06.028; Kondo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065698; Mori T, 2004, PATHOL INT, V54, P167, DOI 10.1111/j.1440-1827.2003.01603.x; Nakajima Y, 2000, J BIOCHEM-TOKYO, V127, P901; Sattler M, 2003, SEMIN HEMATOL, V40, P4, DOI 10.1053/shem.2003.50034; Song JH, 2003, EXP MOL MED, V35, P67; Sun WJ, 2010, J BIOL CHEM, V285, P21341, DOI 10.1074/jbc.M110.104224; Torres C, 2003, EXP CELL RES, V290, P195, DOI 10.1016/S0014-4827(03)00309-4; Witt J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-71; Zambuzzi WF, 2010, BIOCHIMIE, V92, P327, DOI 10.1016/j.biochi.2010.01.002	44	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2716	1432-1440		J MOL MED	J. Mol. Med.	MAR	2015	93	3					343	356		10.1007/s00109-014-1219-1		14	Genetics & Heredity; Medicine, Research & Experimental	Genetics & Heredity; Research & Experimental Medicine	CB9RP	WOS:000349970300013		
J	Uehara, M; Hosaka, YZ; Doi, H; Sakai, H				Uehara, Masato; Hosaka, Yoshinao Z.; Doi, Hiroyuki; Sakai, Harumi			The Shortened Spinal Cord in Tetraodontiform Fishes	JOURNAL OF MORPHOLOGY			English	Article						cauda equina; dorsal and ventral roots; filum terminale; systematic taxonomy	MITOCHONDRIAL GENOME SEQUENCES; FILUM TERMINALE; PHYLOGENY; ACANTHOMORPHA; FROG; ULTRASTRUCTURE; OSTRACIIDAE; TELEOSTEI	In teleosts, the spinal cord generally extends along the entire vertebral canal. The Tetraodontiformes, in which the spinal cord is greatly reduced in length with a distinct long filum terminale and cauda equina, have been regarded as an aberration. The aims of this study are: 1) to elucidate whether the spinal cord in all tetraodontiform fishes shorten with the filum terminale, and 2) to describe the gross anatomical and histological differences in the spinal cord among all families of the Tetraodontiformes. Representative species from all families of the Tetraodontiformes, and for comparison the carp as a common teleost, were investigated. In the Triacanthodidae, Triacanthidae, and Triodontidae, which are the more ancestral taxa of the Tetraodontiformes, the spinal cord extends through the entire vertebral canal. In the Triacanthidae and Triodontidae, the caudal half or more spinal segments of the spinal cord, however, lack gray matter and consist largely of nerve fibers. In the other tetraodontiform families, the spinal cord is shortened forming a filum terminale with the cauda equina, which is prolonged as far as the last vertebra. The shortened spinal cord is divided into three groups. In the Ostraciidae and Molidae, the spinal cord tapers abruptly at the cranium or first vertebra forming a cord-like filum terminale. In the Monacanthidae, Tetraodontidae, and Diodontidae, it abruptly flattens at the rostral vertebrae forming a flat filum terminale. The spinal cord is relatively longer in the Monacanthidae than that in the other two families. It is suggested by histological features of the flat filum terminale that shortening of the spinal cord in this group progresses in order of the Monacanthidae, Tetraodontidae, and Diodontidae. In the Balistidae and Aracanidae, the cord is relatively long and then gradually decreased in dorso-ventral thickness. J. Morphol. 276:290-300, 2015. (c) 2014 Wiley Periodicals, Inc.	[Uehara, Masato; Hosaka, Yoshinao Z.] Tottori Univ, Dept Vet Anat, Fac Agr, Tottori 6808553, Japan; [Doi, Hiroyuki] Shimonoseki Marine Sci Museum, Shimonoseki, Yamaguchi 7500036, Japan; [Sakai, Harumi] Natl Fisheries Univ, Dept Appl Aquabiol, Shimonoseki, Yamaguchi 7596595, Japan	Uehara, M (reprint author), Tottori Univ, Fac Agr, Tottori 6808553, Japan.	muehr@ncn-t.net					Santini F, 2013, MOL PHYLOGENET EVOL, V69, P177, DOI 10.1016/j.ympev.2013.05.014; Santini F, 2013, MOL PHYLOGENET EVOL, V69, P165, DOI 10.1016/j.ympev.2013.05.015; Holcroft NI, 2005, MOL PHYLOGENET EVOL, V34, P525, DOI 10.1016/j.ympev.2004.11.003; Santini F, 2003, ZOOL J LINN SOC-LOND, V139, P565, DOI 10.1111/j.1096-3642.2003.00088.x; Holcroft NI, 2004, MOL PHYLOGENET EVOL, V32, P749, DOI 10.1016/j.ympev.2004.04.002; Yamanoue Y, 2007, MOL PHYLOGENET EVOL, V45, P89, DOI 10.1016/j.ympev.2007.03.008; Arai R., 1983, Bulletin of the National Science Museum Series A (Zoology), V9, P175; Arien Kappers CU, 1960, COMP ANATOMY NERVOUS, P135; Britz R, 2005, J MORPHOL, V266, P74, DOI 10.1002/jmor.10366; Butler AB, 2005, COMP VERTEBRATE NEUR, P139; Chanet B, 2013, CYBIUM, V37, P179; CHESLER M, 1985, J COMP NEUROL, V239, P431, DOI 10.1002/cne.902390409; Chvatal A, 2001, NEUROSCI RES, V40, P23, DOI 10.1016/S0168-0102(01)00211-5; Fujita K., 1990, CAUDAL SKELETON TELE; GONZALEZROBLES A, 1979, CELL TISSUE RES, V199, P519; KLASSEN GJ, 1995, B MAR SCI, V57, P393; Kuhlenbeck H, 1975, CENTRAL NERVOUS SYST, V4, P1; MATSUURA K, 1979, Memoirs of the Faculty of Fisheries Hokkaido University, V26, P49; MILLER C, 1968, J COMP NEUROL, V132, P547, DOI 10.1002/cne.901320405; NIEUWENHUYS R., 1964, PROGR BRAIN RES, V11, P1; Ochiai A, 1987, ATLAS FISH ANATOMY; Owen R, 1866, ANATOMY VERTEBRATES, V1, P260; Rethelyi M, 2004, BRAIN RES, V1028, P133, DOI 10.1016/j.brainres.2004.08.069; Santini F, 2013, MOL PHYLOGENET EVOL, V66, P153, DOI 10.1016/j.ympev.2012.09.022; TYLER JAMES C., 1963, PROC ACAD NAT SCI PHILADELPHIA, V115, P153; Tyler JC, 1980, NOAA TECHNICAL REPOR, V434, P1; Uehara M, 2000, J MORPHOL, V244, P15, DOI 10.1002/(SICI)1097-4687(200004)244:1<15::AID-JMOR2>3.0.CO;2-X; UEHARA M, 1986, J MORPHOL, V190, P325, DOI 10.1002/jmor.1051900309; Yamanoue Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-212	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0362-2525	1097-4687		J MORPHOL	J. Morphol.	MAR	2015	276	3					290	300		10.1002/jmor.20338		11	Anatomy & Morphology	Anatomy & Morphology	CB7AY	WOS:000349779500004		
J	Lee, A; Tominaga, K; Furuya, S; Miyazaki, F; Altenmuller, E				Lee, Andre; Tominaga, Kenta; Furuya, Shinichi; Miyazaki, Fumio; Altenmueller, Eckart			Electrophysiological characteristics of task-specific tremor in 22 instrumentalists	JOURNAL OF NEURAL TRANSMISSION			English	Article						Dystonia; Coherence; EMG; Coactivation; EMG overflow	PRIMARY WRITING TREMOR; PRIMARY BOWING TREMOR; FOCAL DYSTONIA; MOVEMENT-DISORDER; WRITERS CRAMP; FREQUENCY; INHIBITION; ACTIVATION; PATHOPHYSIOLOGY; COACTIVATION	Our aim was to address three characteristics of task-specific tremor in musicians (TSTM): First, we quantified muscular activity of flexor and extensor muscles, of coactivation as well as tremor acceleration. Second, we compared muscular activity between task-dependent and position-dependent tremor. Third, we investigated, whether there is an overflow of muscular activity to muscles adjacent to the affected muscles in TSTM. Tremor acceleration and muscular activity were measured in the affected muscles and the muscles adjacent to the affected muscles in 22 patients aged 51.5 +/- 11.4 years with a task-specific tremor. We assessed power of muscular oscillatory activity and calculated the coherence between EMG activity of affected muscles and tremor acceleration as well as between adjacent muscles and tremor acceleration. This was done for task-dependent and position-dependent tremor. We found the highest power and coherence of muscular oscillatory activity in the frequency range of 3-8 Hz for affected and adjacent muscles. No difference was found between task-dependent and position-dependent tremor in neither power nor coherence measures. Our results generalize previous results of a relation between coactivation and tremor among a variety of musicians. Furthermore, we found coherence of adjacent muscles and TSTM. This indicates that overflow exists in TSTM and suggests an association of TST with dystonia.	[Lee, Andre; Tominaga, Kenta; Furuya, Shinichi; Altenmueller, Eckart] Hannover Univ Mus, Inst Mus Physiol & Musicians Med, Hannover, Germany; [Tominaga, Kenta; Miyazaki, Fumio] Osaka Univ, Dept Engn Sci, Toyonaka, Osaka 560, Japan	Lee, A (reprint author), Hannover Univ Mus, Inst Mus Physiol & Musicians Med, Hannover, Germany.	andre.lee@hmtm-hannover.de; tominaga@robotics.me.es.osaka-u.ac.jp; auditory.motor@gmail.com; miyazaki@me.es.osaka-u.ac.jp; eckart.altenmueller@hmtm-hannover.de					Berardelli A, 1998, BRAIN, V121, P1195, DOI 10.1093/brain/121.7.1195; McAuley JH, 1997, EXP BRAIN RES, V114, P525, DOI 10.1007/PL00005662; Torres-Russotto D, 2008, ANN NY ACAD SCI, V1142, P179, DOI 10.1196/annals.1444.012; Sohn YH, 2004, ANN NEUROL, V56, P595, DOI 10.1002/ana.20270; Haslinger B, 2010, NEUROLOGY, V74, P1790, DOI 10.1212/WNL.0b013e3181e0f784; Furuya S, 2012, HUM MOVEMENT SCI, V31, P26, DOI 10.1016/j.humov.2011.01.002; Elble R, 2011, MOVEMENT DISORD, V26, P1096, DOI 10.1002/mds.23579; Elble RJ, 1996, J CLIN NEUROPHYSIOL, V13, P133, DOI 10.1097/00004691-199603000-00004; Reynolds R, 2010, J NEUROPHYSIOL, V104, P2020, DOI 10.1152/jn.00513.2010; FARMER SF, 1993, J PHYSIOL-LONDON, V470, P127; Deuschl G, 1998, MOVEMENT DISORD, V13, P2; Deuschl G, 2001, MUSCLE NERVE, V24, P716, DOI 10.1002/mus.1063; Lakie M, 2012, J PHYSIOL-LONDON, V590, P2471, DOI 10.1113/jphysiol.2011.226449; Espay AJ, 2006, ANN NEUROL, V59, P825, DOI 10.1002/ana.20837; Ariga Y, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION (ICRA), P1470, DOI 10.1109/ICRA.2012.6224662; Bain Peter G, 2011, Handb Clin Neurol, V100, P711, DOI 10.1016/B978-0-444-52014-2.00050-1; Bain PG, 1995, BRAIN, V118, P1461, DOI 10.1093/brain/118.6.1461; Berg D, 2000, J NEUROL NEUROSUR PS, V69, P780, DOI 10.1136/jnnp.69.6.780; Byrnes ML, 2005, J CLIN NEUROSCI, V12, P102, DOI 10.1016/j.jocn.2004.08.004; Chen R, 1997, NEUROLOGY, V49, P1054; COHEN LG, 1988, NEUROLOGY, V38, P1005; Daneault JF, 2011, BRAIN RES, V1370, P164, DOI 10.1016/j.brainres.2010.11.047; Dresel C, 2014, J NEUROL NEUROSUR PS, V85, P1245, DOI 10.1136/jnnp-2013-307127; ELBLE RJ, 1990, MOVEMENT DISORD, V5, P118, DOI 10.1002/mds.870050205; Furuya S, 2013, NEUROSCIENCE, V247, P152, DOI 10.1016/j.neuroscience.2013.05.025; Gironell Alexandre, 2009, Ther Adv Neurol Disord, V2, P215, DOI 10.1177/1756285609104791; Inoue K, 2011, BIO WEB C, V1, DOI [10.1051/bioconf/20110100040, DOI 10.1051/BIOCONF/20110100040]; Lederman RJ, 2012, MED PROBL PERFORM AR, V27, P219; Lederman RJ, 2010, TREMULOUS BOW ARM TE; Lee A, 2013, TREMOR OTHE IN PRESS; Lee A, 2015, CLIN NEUROPHYSIOL, V126, P147, DOI 10.1016/j.clinph.2014.04.013; Lee A, 2013, MOVEMENT DISORD, V28, P1890, DOI 10.1002/mds.25569; Lee A, 2012, MED PROBL PERFORM AR, V27, P224; Lee A, 2014, J NEURAL TRANSM, V121, P739, DOI 10.1007/s00702-014-1177-3; Ljubisavljevic M, 2006, MOVEMENT DISORD, V21, P855, DOI 10.1002/mds.20807; McAuley J, 2004, MOVEMENT DISORD, V19, P253, DOI 10.1002/mds.10707; Modugno N, 2002, MOVEMENT DISORD, V17, P1336, DOI 10.1002/mds.10292; Odergren T, 1998, MOVEMENT DISORD, V13, P497, DOI 10.1002/mds.870130321; Roberts K., 2013, TREMOR OTHER HYPERKI, V3; ROSENBAUM F, 1988, NEUROLOGY, V38, P522; VANDERKAMP W, 1989, J NEUROL NEUROSUR PS, V52, P1043, DOI 10.1136/jnnp.52.9.1043	41	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	MAR	2015	122	3					393	401		10.1007/s00702-014-1275-2		9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CC0NS	WOS:000350033100007		
J	Balan, S; Iwayama, Y; Yamada, K; Toyota, T; Ohnishi, T; Toyoshima, M; Shimamoto, C; Ide, M; Iwata, Y; Suzuki, K; Kikuchi, M; Hashimoto, T; Kanahara, N; Yoshikawa, T; Maekawa, M				Balan, Shabeesh; Iwayama, Yoshimi; Yamada, Kazuo; Toyota, Tomoko; Ohnishi, Tetsuo; Toyoshima, Manabu; Shimamoto, Chie; Ide, Masayuki; Iwata, Yasuhide; Suzuki, Katsuaki; Kikuchi, Mitsuru; Hashimoto, Tasuku; Kanahara, Nobuhisa; Yoshikawa, Takeo; Maekawa, Motoko			Sequencing and expression analyses of the synaptic lipid raft adapter gene PAG1 in schizophrenia	JOURNAL OF NEURAL TRANSMISSION			English	Article						Schizophrenia; Rare variant; PAG1; Lipid raft	T-CELL DEVELOPMENT; POPULATION-STRUCTURE; ASSOCIATION ANALYSIS; 22Q11.2 DELETION; VARIANTS; CBP; MUTATIONS; KINASES	Disruption of synaptic networks has been advocated in the pathogenesis of psychiatric diseases like schizophrenia. The majority of synaptic proteins involved in neuronal communications are localized in lipid rafts. These rafts form the platform for coordinating neuronal signal transduction, by clustering interacting partners. The PAG1 protein is a transmembrane adaptor protein in the lipid raft signaling cluster that regulates Src family kinases (SFKs), a convergent point for multiple pathways regulating N-methyl-D-aspartate (NMDA) receptors. Reports of de novo missense mutations in PAG1 and SFK mediated reductions in tyrosine phosphorylation of NMDA receptor subunit proteins in schizophrenia patients, point to a putative role in schizophrenia pathogenesis. To evaluate this, we resequenced the entire coding region of PAG1 in Japanese schizophrenia patients (n = 1,140) and controls (n = 1,140). We identified eight missense variants, of which four were previously unreported. Case-control genetic association analysis of these variants in a larger cohort (n = 4,182) showed neither a statistically significant association of the individual variants with schizophrenia, nor any increased burden of the rare alleles in the patient group. Expression levels of PAG1 in post-mortem brain samples from schizophrenia patients and controls also showed no significant differences. To assess the precise role of PAG1 in schizophrenia, future studies with larger sample sizes are needed.	[Balan, Shabeesh; Iwayama, Yoshimi; Yamada, Kazuo; Toyota, Tomoko; Ohnishi, Tetsuo; Toyoshima, Manabu; Shimamoto, Chie; Yoshikawa, Takeo; Maekawa, Motoko] RIKEN Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama 3510198, Japan; [Shimamoto, Chie] Ochanomizu Univ, Grad Sch Humanities & Sci, Dept Life Sci, Tokyo 112, Japan; [Ide, Masayuki] Univ Tsukuba, Dept Psychiat, Div Clin Med, Ibaraki, Japan; [Iwata, Yasuhide; Suzuki, Katsuaki] Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Shizuoka, Japan; [Kikuchi, Mitsuru] Kanazawa Univ, Dept Psychiat & Neurobiol, Grad Sch Med, Kanazawa, Ishikawa, Japan; [Hashimoto, Tasuku; Kanahara, Nobuhisa] Chiba Univ, Dept Psychiat, Grad Sch Med, Chiba, Japan	Yoshikawa, T (reprint author), RIKEN Brain Sci Inst, Lab Mol Psychiat, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	takeo@brain.riken.jp			Japan Society for the Promotion of Science (JSPS), Japan; RIKEN Brain Science Institute	This study was supported in part by Grants-in-Aid for Scientific Research (T.Y.) and by Grant-in-Aid for Scientific Research on Innovative Areas (T.Y.), from the Japan Society for the Promotion of Science (JSPS), Japan. In addition, this study was supported by RIKEN Brain Science Institute Funds (T.Y.), and a part of this study is the result of the "Development of biomarker candidates for social behavior" project, carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan (T.Y.).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Yamada K, 2006, BIOL PSYCHIAT, V60, P192, DOI 10.1016/j.biopsych.2005.11.008; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Hattori E, 2009, AM J MED GENET B, V150B, P1110, DOI 10.1002/ajmg.b.30941; Maynard TM, 2001, SCHIZOPHRENIA BULL, V27, P457; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Toyosima M, 2011, BRIT J PSYCHIAT, V199, P245, DOI 10.1192/bjp.bp.111.093849; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Pritchard JK, 2000, GENETICS, V155, P945; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Kawabuchi M, 2000, NATURE, V404, P999; Yamada K, 2004, BIOL PSYCHIAT, V56, P683, DOI 10.1016/j.biopsych.2004.08.015; Ayalew M, 2012, MOL PSYCHIATR, V17, P887, DOI 10.1038/mp.2012.37; Dobenecker MW, 2005, MOL CELL BIOL, V25, P10533, DOI 10.1128/MCB.25.23.10533-10542.2005; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Sebastiao AM, 2013, NEUROPHARMACOLOGY, V64, P97, DOI 10.1016/j.neuropharm.2012.06.053; Sullivan PF, 2012, NAT MED, V18, P210, DOI 10.1038/nm.2670; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Grant SGN, 2012, CURR OPIN NEUROBIOL, V22, P522, DOI 10.1016/j.conb.2012.02.002; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Groveman BR, 2012, FEBS J, V279, P20, DOI 10.1111/j.1742-4658.2011.08413.x; Takata A, 2013, BIOL PSYCHIAT, V73, P532, DOI 10.1016/j.biopsych.2012.10.024; Balan S, 2014, BRIT J PSYCHIAT, V204, P398, DOI 10.1192/bjp.bp.113.138420; Bayes A., 2010, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Faludi Gábor, 2011, Int J Dev Neurosci, V29, P305, DOI 10.1016/j.ijdevneu.2011.02.013; Hrdinka M, 2014, ONCOGENE, V33, P4881, DOI 10.1038/onc.2013.485; Lindquist S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023978; Lips ES, 2011, MOL PSYCHIATR, V17, P996, DOI [10.1038/mp.2011.117, DOI 10.1038/MP.2011.117]; Sekino-Suzuki N, 2013, J NEUROCHEM, V124, P514, DOI 10.1111/jnc.12040; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI [10.1038/35036052, DOI 10.1038/35036052]; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Xu SL, 2005, MOL CELL BIOL, V25, P8486, DOI 10.1128/MCB.25.19.8486-8495.2005	36	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	MAR	2015	122	3					477	485		10.1007/s00702-014-1269-0		9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CC0NS	WOS:000350033100016		
J	Yamada, M; Tsukagoshi, M; Hashimoto, T; Oka, JI; Saitoh, A; Yamada, M				Yamada, Misa; Tsukagoshi, Mai; Hashimoto, Tomio; Oka, Jun-Ichiro; Saitoh, Akiyoshi; Yamada, Mitsuhiko			Lysophosphatidic acid induces anxiety-like behavior via its receptors in mice	JOURNAL OF NEURAL TRANSMISSION			English	Article						Lipid mediator; Emotion; Behavior; Anxiety; Receptor	HOLE-BOARD TEST; MOUSE; LYSOPHOSPHOLIPIDS; CELLS; MODEL; ROCK	Lysophosphatidic acid (LPA) is a potent bioactive lipid mediator with diverse biological properties. We previously found altered expression of the LPA-related genes in rodents after treatment with sertraline, which is widely used to treat anxiety disorders and depression. However, little is known about the behavioral effects of LPA. In the present study, we investigated the behavioral effects of intracerebroventricular injection of LPA in adult mice. LPA did not significantly affect spontaneous locomotor activity, suggesting that LPA does not induce hyperactivity, ataxia, or sedation. We next investigated the emotional effects of LPA via the hole-board test. LPA significantly increased the number of head-dips in a dose- and time-related manner. A significant induction of head-dip counts occurred 15 and 30 min after LPA administration. To clarify the involvement of LPA receptors, we examined the effect of the non-selective LPA1-4 receptor antagonist, 1-bromo-3(S)-hydroxy-4-(palmitoyloxy)butyl-phosphonate (BrP-LPA) co-administered with LPA. BrP-LPA dose-dependently inhibited LPA-induced head-dip counts. We next investigated anxiety-like behavior via the elevated plus-maze test. LPA significantly reduced the percentage of time spent in the open arms and BrP-LPA dose-dependently inhibited this anxiety-like behavior. In conclusion, LPA induced anxiety-like behavior in mice via LPA receptors. Our results suggest that LPA signaling plays an important role in regulating anxiety in mice.	[Yamada, Misa; Tsukagoshi, Mai; Hashimoto, Tomio; Saitoh, Akiyoshi; Yamada, Mitsuhiko] Natl Ctr Neurol & Psychiat, Dept Neuropsychopharmacol, Natl Inst Mental Hlth, Kodaira, Tokyo 1878553, Japan; [Tsukagoshi, Mai; Oka, Jun-Ichiro] Tokyo Univ Sci, Fac Pharmaceut Sci, Pharmacol Lab, Chiba 2788510, Japan	Saitoh, A (reprint author), Natl Ctr Neurol & Psychiat, Dept Neuropsychopharmacol, Natl Inst Mental Hlth, 4-1-1 Ogawahigashimachi, Kodaira, Tokyo 1878553, Japan.	asaitoh@ncnp.go.jp			Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; NCNP, Japan [24-2]	This work was supported by research grants from the Ministry of Health, Labour and Welfare of Japan, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Intramural Research Grant (24-2) for Neurological and Psychiatric Disorders of NCNP, Japan.	Zhang HL, 2009, CANCER RES, V69, P5441, DOI 10.1158/0008-5472.CAN-09-0302; Pedraza C, 2014, BRAIN STRUCT FUNCT, V219, P1659, DOI 10.1007/s00429-013-0592-9; Takeda H, 1998, EUR J PHARMACOL, V350, P21, DOI 10.1016/S0014-2999(98)00223-4; Reed TT, 2011, FREE RADICAL BIO MED, V51, P1302, DOI 10.1016/j.freeradbiomed.2011.06.027; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Swaney JS, 2010, BRIT J PHARMACOL, V160, P1699, DOI 10.1111/j.1476-5381.2010.00828.x; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Fedorova I, 2007, PROSTAG LEUKOTR ESS, V77, P269, DOI 10.1016/j.plefa.2007.10.013; Choi JW, 2013, BBA-MOL CELL BIOL L, V1831, P20, DOI 10.1016/j.bbalip.2012.07.015; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Saitoh A, 2007, PSYCHOPHARMACOLOGY, V191, P857, DOI 10.1007/s00213-007-0699-x; Brauer AU, 2003, NAT NEUROSCI, V6, P572, DOI 10.1038/nn1052; HALEY TJ, 1957, BRIT J PHARM CHEMOTH, V12, P12; Santin LJ, 2009, GENES BRAIN BEHAV, V8, P772, DOI 10.1111/j.1601-183X.2009.00524.x; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; BRECHER P, 1983, MOL CELL BIOCHEM, V57, P3; Callaerts-Vegh Z, 2012, GENES BRAIN BEHAV, V11, P1009, DOI 10.1111/j.1601-183X.2012.00840.x; Castilla-Ortega E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085348; Castilla-Ortega E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025522; Iwai T, 2012, J NEUROSCI RES, V90, P1359, DOI 10.1002/jnr.23029; Karliner JS, 2004, J CELL BIOCHEM, V92, P1095, DOI 10.1002/jcb.20129; OCANA M, 1993, EUR J PHARMACOL, V230, P203, DOI 10.1016/0014-2999(93)90803-P; Panupinthu N, 2010, BRIT J CANCER, V102, P941, DOI 10.1038/sj.bjc.6605588; Saitoh A, 2008, BRAIN RES, V1208, P160, DOI 10.1016/j.brainres.2007.07.095; Saitoh A, 2006, PSYCHOPHARMACOLOGY, V188, P1, DOI 10.1007/s00213-006-0466-4; Saitoh A, 2006, J PHARMACOL SCI, V102, P377, DOI 10.1254/jphs.FP0060837; Vinot N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020491; Yamada M, 2002, EUR NEUROPSYCHOPHARM, V12, P235, DOI 10.1016/S0924-977X(02)00025-1	28	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	MAR	2015	122	3					487	494		10.1007/s00702-014-1289-9		8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CC0NS	WOS:000350033100017		
J	Uenoyama, Y; Nakamura, S; Hayakawa, Y; Ikegami, K; Watanabe, Y; Deura, C; Minabe, S; Tomikawa, J; Goto, T; Ieda, N; Inoue, N; Sanbo, M; Tamura, C; Hirabayashi, M; Maeda, KI; Tsukamura, H				Uenoyama, Y.; Nakamura, S.; Hayakawa, Y.; Ikegami, K.; Watanabe, Y.; Deura, C.; Minabe, S.; Tomikawa, J.; Goto, T.; Ieda, N.; Inoue, N.; Sanbo, M.; Tamura, C.; Hirabayashi, M.; Maeda, K. -I.; Tsukamura, H.			Lack of Pulse and Surge Modes and Glutamatergic Stimulation of Luteinising Hormone Release in Kiss1 Knockout Rats	JOURNAL OF NEUROENDOCRINOLOGY			English	Article						knockout rats; GPR54; metastin; puberty; rat embryonic stem cells	FEMALE RATS; KISSPEPTIN NEURONS; ARCUATE NUCLEUS; NEUROKININ B; GONADOTROPIN-SECRETION; NERVE-TERMINALS; LH-RELEASE; ESTROGEN; MOUSE; MICE	Kisspeptin, encoded by the Kiss1 gene, has attracted attention as a key candidate neuropeptide in controlling puberty and reproduction via regulation of gonadotrophin-releasing hormone (GnRH) secretion in mammals. Pioneer studies with Kiss1 or its cognate receptor Gpr54 knockout (KO) mice showed the indispensable role of kisspeptin-GPR54 signalling in the control of animal reproduction, although detailed analyses of gonadotrophin secretion, especially pulsatile and surge-mode of luteinising hormone (LH) secretion, were limited. Thus, in the present study, we have generated Kiss1 KO rats aiming to evaluate a key role of kisspeptin in governing reproduction via pulse and surge modes of GnRH/LH secretion. Kiss1 KO male and female rats showed a complete suppression of pulsatile LH secretion, which is responsible for folliculogenesis and spermatogenesis, and an absence of puberty and atrophic gonads. Kiss1 KO female rats showed no spontaneous LH/follicle-stimulating hormone surge and an oestrogen-induced LH surge, suggesting that the GnRH surge generation system, which is responsible for ovulation, does not function without kisspeptin. Furthermore, challenge of major stimulatory neurotransmitters, such as monosodium glutamate, NMDA and norepinephrine, failed to stimulate LH secretion in Kiss1 KO rats, albeit they stimulated LH release in wild-type controls. Taken together, the results of the present study confirm that kisspeptin plays an indispensable role in generating two modes (pulse and surge) of GnRH/gonadotrophin secretion to regulate puberty onset and normal reproductive performance. In addition, the present study suggests that kisspeptin neurones play a critical role as a hub integrating major stimulatory neural inputs to GnRH neurones, using newly established Kiss1 KO rats, which serve as a useful model for detailed analysis of hormonal profiles.	[Uenoyama, Y.; Hayakawa, Y.; Ikegami, K.; Watanabe, Y.; Deura, C.; Minabe, S.; Tomikawa, J.; Goto, T.; Ieda, N.; Inoue, N.; Tsukamura, H.] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Nakamura, S.; Maeda, K. -I.] Univ Tokyo, Dept Vet Med Sci, Tokyo, Japan; [Goto, T.; Sanbo, M.; Tamura, C.; Hirabayashi, M.] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Okazaki, Aichi 444, Japan	Tsukamura, H (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	htsukamura@nagoya-u.jp			Program for Promotion of Basic Research Activities for Innovative Biosciences; Research Program on Innovative Technologies for Animal Breeding, Reproduction, and Vaccine Development (REP); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; Japan Society for the Promotion of Science [26252046, 24380157, 23580402]; Cooperative Study Program of the National Institute for Physiological Sciences, Japan	We are indebted to the National Hormone and Peptide Program for the LH assay kit, as well as to Drs G. R. Merriam and K. W. Wachter for the PULSAR software. The RIA and LH pulse analyses were performed at the Nagoya University Radioisotope Centre and the Information Technology Centre, respectively. The present study was supported in part by a grant from the Program for Promotion of Basic Research Activities for Innovative Biosciences (to K. M.); the Research Program on Innovative Technologies for Animal Breeding, Reproduction, and Vaccine Development (REP 2002, to H.T.); the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry (to H.T.); and by Grants-in Aid from the Japan Society for the Promotion of Science 26252046 (to H.T.), 24380157 (to K.M.) and 23580402 (to Y.U.). K.M. received support from the Cooperative Study Program of the National Institute for Physiological Sciences, Japan.	Kinoshita M, 2005, ENDOCRINOLOGY, V146, P4431, DOI 10.1210/en.2005-0195; Takase K, 2009, J NEUROENDOCRINOL, V21, P527, DOI 10.1111/j.1365-2826.2009.01868.x; Tomikawa J, 2010, BIOL REPROD, V82, P313, DOI 10.1095/biolreprod.109.079863; Matsui H, 2004, BIOCHEM BIOPH RES CO, V320, P383, DOI 10.1016/j.bbrc.2004.05.185; Clarkson J, 2008, J NEUROSCI, V28, P8691, DOI 10.1523/JNEUROSCI.1775-08.2008; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; Pineda R, 2010, ENDOCRINOLOGY, V151, P722, DOI 10.1210/en.2009-0803; CAGAMPANG FRA, 1991, J ENDOCRINOL, V129, P321, DOI 10.1677/joe.0.1290321; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Topaloglu AK, 2012, NEW ENGL J MED, V366, P629, DOI 10.1056/NEJMoa1111184; Cravo RM, 2011, NEUROSCIENCE, V173, P37, DOI 10.1016/j.neuroscience.2010.11.022; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Hsu MC, 2014, REPRODUCTION, V147, P835, DOI 10.1530/REP-13-0368; Garcia-Galiano D, 2012, ENDOCRINOLOGY, V153, P316, DOI 10.1210/en.2011-1260; Chan YM, 2009, J NEUROENDOCRINOL, V21, P1015, DOI 10.1111/j.1365-2826.2009.01926.x; MERRIAM GR, 1982, AM J PHYSIOL, V243, pE310; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Castellano JM, 2006, ENDOCRINOLOGY, V147, P4852, DOI 10.1210/en.2006-0117; Wakabayashi Y, 2010, J NEUROSCI, V30, P3124, DOI 10.1523/JNEUROSCI.5848-09.2010; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Kinsey-Jones JS, 2012, ENDOCRINOLOGY, V153, P307, DOI 10.1210/en.2011-1641; Adachi S, 2007, J REPROD DEVELOP, V53, P367, DOI 10.1262/jrd.18146; Kim J, 2011, ENDOCRINOLOGY, V152, P2020, DOI 10.1210/en.2010-1498; BOURGUIGNON JP, 1989, ENDOCRINOLOGY, V125, P1090; Shahab M, 2005, P NATL ACAD SCI USA, V102, P2129, DOI 10.1073/pnas.0409822102; Smith JT, 2005, ENDOCRINOLOGY, V146, P3686, DOI 10.1210/en.2005-0488; Inoue N, 2011, P NATL ACAD SCI USA, V108, P17527, DOI 10.1073/pnas.1113035108; Homma T, 2009, BIOL REPROD, V81, P1216, DOI 10.1095/biolreprod.109.078311; Tsukamura H, 2010, ANN NY ACAD SCI, V1200, P95, DOI 10.1111/j.1749-6632.2010.05645.x; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Dhillo WS, 2005, J CLIN ENDOCR METAB, V90, P6609, DOI 10.1210/jc.2005-1468; Steyn FJ, 2013, ENDOCRINOLOGY, V154, P4939, DOI 10.1210/en.2013-1502; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714; desRoux N., 2003, P NATL ACAD SCI USA, V100, P10972; de Tassigny XD, 2010, J NEUROSCI, V30, P8581, DOI 10.1523/JNEUROSCI.5486-09.2010; Gutierrez-Pascual E, 2007, J NEUROENDOCRINOL, V19, P521, DOI 10.1111/j.1365-2826.2007.01558.x; Hirabayashi M, 2012, MOL REPROD DEV, V79, P402, DOI 10.1002/mrd.22043; Kauffman AS, 2008, PEPTIDES, V30, P83; Kawakami S, 1998, GEN COMP ENDOCR, V112, P372, DOI 10.1006/gcen.1998.7140; LEUNG PCK, 1982, NEUROENDOCRINOLOGY, V34, P207, DOI 10.1159/000123301; Murahashi K, 2002, J REPROD DEVELOP, V48, P183, DOI 10.1262/jrd.48.183; Ohkura S, 2009, J NEUROENDOCRINOL, V21, P813, DOI 10.1111/j.1365-2826.2009.01909.x; OLNEY JW, 1976, BRAIN RES, V112, P420, DOI 10.1016/0006-8993(76)90298-5; ONDO JG, 1988, LIFE SCI, V43, P2283, DOI 10.1016/0024-3205(88)90422-5; Pheng V, 2009, J REPROD DEVELOP, V55, P378, DOI 10.1262/jrd.20240; Pielecka-Fortuna J, 2010, ENDOCRINOLOGY, V151, P291, DOI 10.1210/en.2009-0692; Verma S, 2014, NEUROENDOCRINOLOGY, V99, P190, DOI 10.1159/000365419; Watson C, 2007, RAT BRAIN STEREOTAXI; Xu ZF, 2012, ENDOCR J, V59, P161	50	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-8194	1365-2826		J NEUROENDOCRINOL	J. Neuroendocrinol.	MAR	2015	27	3					187	197		10.1111/jne.12257		11	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	CC2AM	WOS:000350146800002		
J	Kanda, Y; Hashiramoto, M; Shimoda, M; Hamamoto, S; Tawaramoto, K; Kimura, T; Hirukawa, H; Nakashima, K; Kaku, K				Kanda, Yukiko; Hashiramoto, Mitsuru; Shimoda, Masashi; Hamamoto, Sumiko; Tawaramoto, Kazuhito; Kimura, Tomohiko; Hirukawa, Hidenori; Nakashima, Koji; Kaku, Kohei			Dietary restriction preserves the mass and function of pancreatic beta cells via cell kinetic regulation and suppression of oxidative/ER stress in diabetic mice	JOURNAL OF NUTRITIONAL BIOCHEMISTRY			English	Article						B-cell dysfunction; Dietary restriction; Oxidative stress; Cell proliferation; Cell apoptosis	INSULIN-RESISTANCE; FOOD RESTRICTION; CALORIC RESTRICTION; INHIBITS APOPTOSIS; GLUCOSE TOXICITY; DB/DB MICE; RATS; MECHANISM; RECEPTOR; OBESITY	To assess the molecular mechanisms by which dietary restriction preserves the beta-cell mass and function in diabetic db/db mice. Male db/db mice were divided into two groups with or without diet restriction. Daily food intake of db/db mice was adjusted to that of the control db/m mice, which was determined in advance. A dietary restriction was implemented for 6 weeks from 6 weeks of age. Islet morphology, beta-cell function and gene expression profiles specific for pancreatic islet cells were compared. Food intake in db/m mice was 50% of that in db/db mice. Impaired glucose tolerance and insulin sensitivity were significantly ameliorated in db/db mice with dietary restriction. The pancreatic beta-cell mass was greater in mice with dietary restriction than that in mice without intervention. The dietary restriction significantly increased cyclin D gene expression and down-regulated CAD gene expression at 12 weeks compared with untreated db/db mice. Antiapoptotic bcl-2 gene expression was significantly increased, whereas genes related to oxidative stress, ER stress and inflammatory processes, such as NADPH oxidase, CHOP10 and TNF, were markedly down-regulated in mice with dietary restriction. Dietary restriction preserved the pancreatic beta-cell function and beta-cell mass in diabetic db/db mice, suggesting that alimentary therapy prevented a-cell loss by suppressing cellular apoptosis and antioxidative stress in the pancreatic beta cells. (C) 2015 Elsevier Inc. All right reserved.	[Kanda, Yukiko; Shimoda, Masashi; Hamamoto, Sumiko; Tawaramoto, Kazuhito; Kimura, Tomohiko; Hirukawa, Hidenori; Nakashima, Koji; Kaku, Kohei] Kawasaki Med Univ, Div Diabet Endocrinol & Metab, Kurashiki, Okayama 7010192, Japan; [Hashiramoto, Mitsuru] Yodogawa Christians Hosp, Div Diabet & Endocrinol, Osaka, Japan	Kanda, Y (reprint author), Kawasaki Med Univ, Div Diabet Endocrinol & Metab, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	kanda@med.kawasaki-m.ac.jp			Japan Society for the Promotion of Science [18591008]; Kawasaki Medical School [17-502, 18-501, 19-502]	This study was supported by a Grant-in-Aid from the Japan Society for the Promotion of Science (K.K.; 18591008) and Research Project Grants from Kawasaki Medical School (K.K.; 17-502, 18-501, 19-502).	Kanda Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE278, DOI 10.1152/ajpendo.00388.2009; TAYLOR SI, 1994, DIABETES, V43, P735; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Kawasaki F, 2005, AM J PHYSIOL-ENDOC M, V288, pE510, DOI 10.1152/ajpendo.00128.2004; Maedler K, 2004, P NATL ACAD SCI USA, V101, P8138, DOI 10.1073/pnas.0305683101; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Knowler WC, 2002, NEW ENGL J MED, V346, P393; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Shimoda M, 2011, DIABETOLOGIA, V54, P1098, DOI 10.1007/s00125-011-2069-9; Hui HX, 2003, ENDOCRINOLOGY, V144, P1444, DOI 10.1210/en.2002-220897; Gastaldelli A, 2007, AM J PHYSIOL-ENDOC M, V292, pE871, DOI 10.1152/ajpendo.00551.2006; Bantle JP, 2008, DIABETES CARE S1, V31, pS61, DOI DOI 10.2337/DC08-S061; Bates HE, 2008, AM J PHYSIOL-ENDOC M, V295, pE947, DOI 10.1152/ajpendo.90378.2008; CARTEE GD, 1994, AM J PHYSIOL, V266, pR1443; CRAIG BW, 1987, J APPL PHYSIOL, V62, P95; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Deng XQ, 2010, ACTA DIABETOL, V47, pS177, DOI 10.1007/s00592-009-0159-7; Farilla L, 2002, ENDOCRINOLOGY, V143, P4397, DOI 10.1210/en.2002-220405; Fontana L, 2007, AM J PHYSIOL-ENDOC M, V293, pE197, DOI 10.1152/ajpendo.00102.2007; Holman RR, 1998, DIABETES RES CLIN PR, V40, pS21; Ishii Y, 2011, J VET MED SCI, V73, P169, DOI 10.1292/jvms.10-0283; Kanda Y, 2009, ENDOCR J, V56, P997; Kitamura T, 2001, MOL CELL BIOL, V21, P5624, DOI 10.1128/MCB.21.16.5624-5630.2001; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Masoro EJ, 1992, J GERONTOL, V47, P202; MASORO EJ, 1993, J AM GERIATR SOC, V41, P994; OHNEDA M, 1995, DIABETOLOGIA, V38, P173, DOI 10.1007/BF00400091; Shao JQ, 2006, BIOCHEM BIOPH RES CO, V344, P1224, DOI 10.1016/j.bbrc.2006.04.011; Soeller WC, 1998, DIABETES, V47, P743, DOI 10.2337/diabetes.47.5.743; Wang J, 2008, DIABETES CARE, V31, P2120, DOI 10.2337/dc08-1085; WING RR, 1993, DIABETES CARE, V16, P193, DOI 10.2337/diacare.16.1.193; Wing RR, 2008, CURR DIABETES REP, V8, P126, DOI 10.1007/s11892-008-0023-0	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0955-2863	1873-4847		J NUTR BIOCHEM	J. Nutr. Biochem.	MAR	2015	26	3					219	226		10.1016/j.jnutbio.2014.10.007		8	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	CC1IV	WOS:000350095300003		
J	Umekawa, T; Sugiyama, T; Du, QW; Murabayashi, N; Zhang, LY; Kamimoto, Y; Yoshida, T; Sagawa, N; Ikeda, T				Umekawa, Takashi; Sugiyama, Takashi; Du, Qinwen; Murabayashi, Nao; Zhang, Lingyun; Kamimoto, Yuki; Yoshida, Toshimichi; Sagawa, Norimasa; Ikeda, Tomoaki			A maternal mouse diet with moderately high-fat levels does not lead to maternal obesity but causes mesenteric adipose tissue dysfunction in male offspring	JOURNAL OF NUTRITIONAL BIOCHEMISTRY			English	Article						Fetal programming; High-fat diet; Adipose tissue; Metabolic syndrome; Inflammation	INSULIN-RESISTANCE; METABOLIC SYNDROME; GENE-EXPRESSION; GLUCOSE-METABOLISM; ADULT MICE; IN-UTERO; PREGNANCY; LIFE; ADIPOCYTES; LACTATION	The impact of an increase in maternal fat consumption on fetal metabolic programming separately from maternal obesity remains unclear. The purpose of this study was to document the effect of in utero high-fat diet exposure on the development of metabolic syndrome characteristics in offspring. C57BL/6 female mice were fed either a control diet (10% fat) or a moderately high-fat (MHF) diet (45% fat) until delivery. All pups were fostered to mothers fed with the control diet. Pups were raised on the control diet and assessed until 35 weeks of age. The caloric intake from fat was significantly increased in the MHF dams compared with the control dams. There were no significant differences in the maternal weight at mating or at gestational Day 18 between the two groups. The MHF offspring did not become obese, but they developed hypertension and glucose intolerance. Moreover, the MHF offspring had significantly higher serum non-esterified fatty acid and triglyceride levels during the refeeding state following fasting as compared with the control offspring. Serum adiponectin levels were significantly lower, and the cell size of the mesenteric adipose tissue was significantly larger in the MHF offspring than in the control offspring. The mRNA levels of the proinflammatory macrophage markers in the mesenteric adipose tissue were significantly higher in the MHF offspring than those of the control offspring. These results suggest that in utero high-fat diet exposure causes hypertension and glucose intolerance resulting from mesenteric adipose tissue dysfunction in offspring, independently of maternal obesity. (C) 2015 Elsevier Inc. All rights reserved.	[Umekawa, Takashi; Du, Qinwen; Murabayashi, Nao; Zhang, Lingyun; Kamimoto, Yuki; Ikeda, Tomoaki] Mie Univ, Grad Sch Med, Dept Obstet & Gynecol, Tsu, Mie 514, Japan; [Yoshida, Toshimichi] Mie Univ, Grad Sch Med, Tsu, Mie 514, Japan; [Sugiyama, Takashi] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Sagawa, Norimasa] Rakuwakai Otowa Hosp, Dept Obstet & Gynecol, Kyoto, Japan; [Umekawa, Takashi] Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, SE-17176 Stockholm, Sweden	Umekawa, T (reprint author), Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Q2 07, SE-17176 Stockholm, Sweden.	umekawa.t@gmail.com	Yoshida, Toshimichi/H-6204-2013	Yoshida, Toshimichi/0000-0001-8935-8217	Ministry of Education, Science, and Culture, Japan [22591821, 23791830, 25462548]; Smoking Research Foundation	This work was partly supported by Grants-In-Aid for Scientific Research from the Ministry of Education, Science, and Culture, Japan (nos. 22591821, 23791830 and 25462548), and grant from the Smoking Research Foundation.	Amer P, 1998, LANCET, V351, P1301; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI [10.1172/JCI34260, 10.1172/JC134260]; Suganami T, 2010, J LEUKOCYTE BIOL, V88, P33, DOI 10.1189/jlb.0210072; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Shankar K, 2010, ENDOCRINOLOGY, V151, P2577, DOI 10.1210/en.2010-0017; White CL, 2009, AM J PHYSIOL-REG I, V296, pR1464, DOI 10.1152/ajpregu.91015.2008; Gustafson B, 2010, J ATHEROSCLER THROMB, V17, P332; Whitehead JP, 2006, DIABETES OBES METAB, V8, P264, DOI 10.1111/j.1463-1326.2005.00510.x; Murabayashi N, 2013, EUR J OBSTET GYN R B, V169, P39, DOI 10.1016/j.ejogrb.2013.02.003; Iwashima Y, 2004, HYPERTENSION, V43, P1318, DOI 10.1161/01.HYP.0000129281.03801.4b; Ashino NG, 2012, J NUTR BIOCHEM, V23, P341, DOI 10.1016/j.jnutbio.2010.12.011; Drazen DL, 2006, ENDOCRINOLOGY, V147, P23, DOI 10.1210/en.2005-0973; ORLAND MJ, 1987, DIABETES, V36, P341, DOI 10.2337/diabetes.36.3.341; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; DelPrado M, 1997, J NUTR, V127, P458; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Jaworski K, 2007, AM J PHYSIOL-GASTR L, V293, pG1, DOI 10.1152/ajpgi.00554.2006; Innis SM, 2011, MATERN CHILD NUTR, V7, P112, DOI 10.1111/j.1740-8709.2011.00318.x; Siemelink M, 2002, DIABETOLOGIA, V45, P1397, DOI 10.1007/s00125-002-0918-2; Fujisaka S, 2011, ENDOCRINOLOGY, V152, P1789, DOI 10.1210/en.2010-1312; Shetty PS, 2002, PUBLIC HEALTH NUTR, V5, P175, DOI 10.1079/PHN2001291; Liu YF, 2007, ENDOCRINOLOGY, V148, P683, DOI 10.1210/en.2006-0708; Dunn GA, 2009, ENDOCRINOLOGY, V150, P4999, DOI 10.1210/en.2009-0500; Ellacott KLJ, 2010, CELL METAB, V12, P10, DOI 10.1016/j.cmet.2010.06.001; BECKER G, 1977, J COMP PHYSIOL PSYCH, V91, P1432, DOI 10.1037/h0077401; Dong YM, 2011, J NUTR BIOCHEM, V22, P791, DOI 10.1016/j.jnutbio.2010.07.006; Elmadfa I, 2009, FORUM NUTR, V62, P1; Gniuli D, 2008, J LIPID RES, V49, P1936, DOI 10.1194/jlr.M800033-JLR200; Gomez-Ruiz A, 2010, J CELL PHYSIOL, V225, P206, DOI [10.1002/jcp.22241, 10.1002/jcp.2224]; Gregorio B.M., 2010, AM J OBSTET GYNECOL, V203, P1, DOI DOI 10.1016/J.AJ0G.2010.06.042); Hartil K, 2009, PEDIATR RES, V66, P368, DOI 10.1203/PDR.0b013e3181b33375; Heerwagen MJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067791; Innis Sheila M, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P359, DOI 10.1097/MED.0b013e3282be90b9; Kasbi-Chadli F, 2014, J NUTR BIOCHEM, V25, P726, DOI 10.1016/j.jnutbio.2014.03.003; Massiera F, 2003, J LIPID RES, V44, P271, DOI 10.1194/jlr.M200346-JLR200; Masuyama H, 2012, ENDOCRINOLOGY, V153, P2823, DOI 10.1210/en.2011-2161; Misra A, 2010, J AM COLL NUTR, V29, p289S; Mittelman SD, 2002, DIABETES, V51, P755, DOI 10.2337/diabetes.51.3.755; Nilsson R, 2006, CELL SIGNAL, V18, P1713, DOI 10.1016/j.cellsig.2006.01.010; Ooyama K, 2008, J NUTR SCI VITAMINOL, V54, P136, DOI 10.3177/jnsv.54.136; Tang Y, 2001, DIABETES RES CLIN PR, V54, P145, DOI 10.1016/S0168-8227(01)00271-6; Umekawa T, 2008, ENDOCRINOLOGY, V149, P3980, DOI 10.1210/en.2007-1682	45	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0955-2863	1873-4847		J NUTR BIOCHEM	J. Nutr. Biochem.	MAR	2015	26	3					259	266		10.1016/j.jnutbio.2014.10.012		8	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	CC1IV	WOS:000350095300008		
J	Yokoe, C; Hanamoto, H; Sugimura, M; Morimoto, Y; Kudo, C; Niwa, H				Yokoe, Chizuko; Hanamoto, Hiroshi; Sugimura, Mitsutaka; Morimoto, Yoshinari; Kudo, Chiho; Niwa, Hitoshi			A Prospective, Randomized Controlled Trial of Conscious Sedation Using Propofol Combined With Inhaled Nitrous Oxide for Dental Treatment	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							INTRAVENOUS MIDAZOLAM; DEEP SEDATION; HEART-RATE; ANESTHESIA; HUMANS; SEVOFLURANE; RECOVERY; MODERATE; AMNESIA; SURGERY	Purpose: Adverse reactions during propofol sedation include a decrease in arterial blood pressure, propofol-induced pain on injection, and airway complications. The purpose of this study was to investigate whether combined use of intravenous propofol and inhaled nitrous oxide could decrease the hypotensive and other adverse effects of propofol. Patients and Methods: We designed and implemented a prospective, randomized controlled trial. Patients undergoing dental procedures requiring intravenous sedation were randomly allocated to 2 groups: group P comprised those receiving sedation with propofol alone, and group N+P comprised those receiving sedation with 40% nitrous oxide inhalation and propofol. During the dental procedures, the sedation level was maintained at an Observer's Assessment of Alertness/Sedation scale score of 4 by adjusting propofol's target plasma concentration. Nitrous oxide inhalation was the predictor variable, whereas the hemodynamic changes, amount and concentration of propofol, and adverse events were the outcome variables. Results: Eighty-eight patients were successfully analyzed without any complications. The total amount of propofol was significantly less in group N+P (249.8 +/- 121.7 mg) than in group P (310.3 +/- 122.4 mg) (P = .022), and the mean concentration of propofol was significantly less in group N+P (1.81 +/- 0.34 mu g/mL) than in group P (2.05 +/- 0.44 mu g/mL) (P = .006). The mean blood pressure reduction in group N+P (11.0 +/- 8.0 mm Hg) was significantly smaller than that in group P (15.8 +/- 10.2 mm Hg) (P = .034). Pain associated with the propofol injection and memory of the procedure were less in group N+P (P = .011 and P = .048, respectively). Nitrous oxide did not affect respiratory conditions or recovery characteristics. Conclusions: The results of this study suggest that nitrous oxide inhalation combined with propofol sedation attenuates the hypotensive effect and pain associated with propofol injections, along with potentiating the amnesic effect. (C) 2015 American Association of Oral and Maxillofacial Surgeons	[Yokoe, Chizuko] Osaka Med Ctr, Dept Dent Anesthesiol, Dept Anesthesia, Osaka, Japan	Hanamoto, H (reprint author), Osaka Univ, Grad Sch Dent, Dept Dent Anesthesiol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	hanamoto@dent.osaka-u.ac.jp			Department of Dental Anesthesiology, Osaka University Graduate School of Dentistry	This work was financially supported by the Department of Dental Anesthesiology, Osaka University Graduate School of Dentistry. There was no conflict of interest for this study.	Andrzejowski J, 2000, ANAESTHESIA, V55, P761, DOI 10.1046/j.1365-2044.2000.01532.x; BRYSON HM, 1995, DRUGS, V50, P513, DOI 10.2165/00003495-199550030-00008; Cohen LB, 2004, GASTROINTEST ENDOSC, V59, P795, DOI 10.1016/S0016-5107(04)00349-9; Ryu JH, 2008, J CLIN ANESTH, V20, P328, DOI 10.1016/j.jclinane.2007.12.015; SUKHANI R, 1994, ANESTH ANALG, V78, P831; Campbell L, 2004, ANAESTHESIA, V59, P127, DOI 10.1111/j.1365-2044.2004.03580.x; CHERNIK DA, 1990, J CLIN PSYCHOPHARM, V10, P244; CLAEYS MA, 1988, BRIT J ANAESTH, V60, P3, DOI 10.1093/bja/60.1.3; Cohen LB, 2003, GASTROINTEST ENDOSC, V58, P725, DOI 10.1016/S0016-5107(03)02010-8; Duarte R, 2008, BRIT J ANAESTH, V100, P203, DOI 10.1093/bja/aem369; Amornyotin S, 2011, GASTROENT RES PRACT, DOI 10.1155/2011/134819; Averley PA, 2004, ANAESTHESIA, V59, P844, DOI 10.1111/j.1365-2044.2004.03805.x; Chun SY, 2012, GUT LIVER, V6, P464, DOI 10.5009/gnl.2012.6.4.464; DEROODE A, 1995, ANAESTHESIA, V50, P191; EBERT TJ, 1989, ANESTH ANALG, V69, P444; Ebert TJ, 2005, ANESTHESIOLOGY, V103, P20, DOI 10.1097/00000542-200507000-00007; EBERT TJ, 1990, ANESTHESIOLOGY, V72, P16, DOI 10.1097/00000542-199001000-00004; FILE SE, 1991, INT CLIN PSYCHOPHARM, V6, P169, DOI 10.1097/00004850-199100630-00005; Galinkin JL, 1997, ANESTHESIOLOGY, V87, P1082, DOI 10.1097/00000542-199711000-00012; GALLETLY DC, 1994, BRIT J ANAESTH, V72, P219, DOI 10.1093/bja/72.2.219; Klein U, 2004, PEDIATR DENT, V26, P410; Klein U, 2011, PEDIATR DENT, V33, P56; Lahoud GY, 2007, EUR J ANAESTH, V24, P116, DOI 10.1017/S0265021506001207; Larsen R, 1988, Anaesthesia, V43 Suppl, P25, DOI 10.1111/j.1365-2044.1988.tb09064.x; LINDEKAER AL, 1995, ANAESTHESIA, V50, P397, DOI 10.1111/j.1365-2044.1995.tb05991.x; Matsuki Y, 2007, ACTA ANAESTH SCAND, V51, P16, DOI 10.1111/j.1399-6576.2006.01170.x; Niwa Hitoshi, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V102, pe1, DOI 10.1016/j.tripleo.2006.03.014; SELLGREN J, 1990, ANESTHESIOLOGY, V73, P20, DOI 10.1097/00000542-199007000-00004; Sinha PK, 2005, ANAESTH INTENS CARE, V33, P235; Sosis MB, 1996, J CLIN ANESTH, V8, P110, DOI 10.1016/0952-8180(95)00193-X; Venchard GR, 2006, INT J ORAL MAX SURG, V35, P522, DOI 10.1016/j.ijom.2005.11.003; Yokoe C, 2014, OR SURG OR MED OR PA, V118, P166, DOI 10.1016/j.oooo.2013.03.020	32	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	MAR	2015	73	3					402	409		10.1016/j.joms.2014.09.014		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CB6UM	WOS:000349762200008		
J	Kanai, H; Sato, H; Takei, Y				Kanai, Hiroaki; Sato, Hiroki; Takei, Yoshichika			Autoimmune Neutropenia of Infancy With Recurrent Urinary Tract Infections: A Case Report	JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY			English	Article						autoimmune neutropenia; infant-urinary tract infection; febrile neutropenia	INVASIVE BACTERIAL-INFECTION; CLINICAL-PRACTICE GUIDELINE; ANTIBIOTIC-RESISTANCE; FEBRILE INFANTS; CHILDREN; CANCER; MANAGEMENT; FEVER; MULTICENTER; DIAGNOSIS	Autoimmune neutropenia of infancy is characterized by minor intercurrent infections despite severe neutropenia; severe bacterial infections are uncommon. An infant developed recurrent urinary tract infections at 9 and 11 months of age. The identified uropathogens were Escherichia coli and Enterococcus faecalis, respectively. Empirical treatment with carbapenems, as broad-spectrum antibiotics, promptly resolved the infection without sequelae. Febrile neutropenic children with cancer and autoimmune neutropenia can develop urinary tract infections; therefore, in such infants, urine culture should be obtained through catheterization. In febrile neutropenic infants with no apparent fever source, cephalosporin monotherapy should not be selected empirically because Enterococci can be the involved pathogens.	[Kanai, Hiroaki; Sato, Hiroki; Takei, Yoshichika] Suwa Cent Hosp, Dept Pediat, Chino City, Nagano 3918503, Japan	Kanai, H (reprint author), Suwa Cent Hosp, Dept Pediat, Tamagawa 4300, Chino City, Nagano 3918503, Japan.	hkanai@kind.ocn.ne.jp					James RM, 2006, ARCH DIS CHILD, V91, P852, DOI 10.1136/adc.2006.094706; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Santolaya ME, 2002, CLIN INFECT DIS, V35, P678, DOI 10.1086/342064; Ladhani S, 2003, ARCH DIS CHILD, V88, P444, DOI 10.1136/adc.88.5.444; Sella R, 2010, ISR MED ASSOC J, V12, P91; Bux J, 1998, BLOOD, V91, P181; HOBERMAN A, 1993, J PEDIATR-US, V123, P17, DOI 10.1016/S0022-3476(05)81531-8; Lehrnbecher T, 2012, J CLIN ONCOL, V30, P4427, DOI 10.1200/JCO.2012.42.7161; Capsoni F, 2005, ARTHRITIS RES THER, V7, P208, DOI 10.1186/ar1803; Newburger PE, 2013, SEMIN HEMATOL, V50, P198, DOI 10.1053/j.seminhematol.2013.06.010; Ismaili K, 2011, PEDIATR INFECT DIS J, V30, P371, DOI 10.1097/INF.0b013e318204dcf3; LALEZARI P, 1986, J PEDIATR-US, V109, P764, DOI 10.1016/S0022-3476(86)80690-4; Santolaya ME, 2001, J CLIN ONCOL, V19, P3415; Fioredda F, 2013, PEDIATR INFECT DIS J, V32, P410, DOI 10.1097/INF.0b013e3182814b5a; Hakim H, 2009, J PEDIAT HEMATOL ONC, V31, P623, DOI 10.1097/MPH.0b013e3181b1edc6; Haller M, 2004, PEDIATR NEPHROL, V19, P982, DOI 10.1007/s00467-004-1528-7; Klaassen ILM, 2011, PEDIATR BLOOD CANCER, V56, P868, DOI 10.1002/pbc.22799; Sandoval C, 2012, PEDIATR HEMAT ONCOL, V29, P68, DOI 10.3109/08880018.2011.617809; Senel S, 2010, MED PRIN PRACT, V19, P359, DOI 10.1159/000316373; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1077-4114	1536-3678		J PEDIAT HEMATOL ONC	J. Pediatr. Hematol. Oncol.	MAR	2015	37	2					E131	E134				4	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CB8UD	WOS:000349905900013		
J	Nakamura, J; Kamegaya, M; Saisu, T; Kakizaki, J; Hagiwara, S; Ohtori, S; Orita, S; Takahashi, K				Nakamura, Junichi; Kamegaya, Makoto; Saisu, Takashi; Kakizaki, Jun; Hagiwara, Shigeo; Ohtori, Seiji; Orita, Sumihisa; Takahashi, Kazuhisa			Outcome of Patients With Legg-Calve-Perthes Onset Before 6 Years of Age	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						Legg-Calve-Perthes disease; young patients; outcome	DISEASE; ARTHROGRAPHY; PROGNOSIS	Background: The prognosis of Legg-Calve-Perthes disease (LCPD) in young patients has been accepted as favorable. The purpose of this study was to clarify the outcome of LCPD patients with onset before 6 years of age. Methods: From 1989 to 2007, of 332 LCPD patients, 114 hips (in 100 patients) were diagnosed before 6 years of age (mean age, 4.5 y old) with subsequent repair of the epiphysis in all cases. Waldenstrom classification at presentation was initial stage in 76 hips and fragmentation stage in 38 hips. Lateral pillar classification was group A in 17 hips, group B in 22 hips, group B/C in 24 hips, and group C in 51 hips. Treatment methods were observation with restriction of activity alone in 42 hips and several containment treatments in 72 hips. Results: At the mean age of 14, Stulberg classification was class I in 26 hips, II in 46 hips, III in 28 hips, and IV in 14 hips. These data show an acceptable outcome in 72 of 114 hips (63%). Logistic regression analysis revealed that lateral pillar classification (odds ratio, 3.6) and good range of abduction without treatment (odds ratio, 4.0) were prognostic factors. Conclusions: Poor outcome was observed even in patients before 6 years of age with large necrotic area. Lateral pillar classification and good range of abduction were prognostic factors.	[Nakamura, Junichi; Hagiwara, Shigeo; Ohtori, Seiji; Orita, Sumihisa; Takahashi, Kazuhisa] Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chiba, Japan; [Kamegaya, Makoto] Chiba Children & Adult Orthopaed Clin, Chiba, Japan; [Saisu, Takashi; Kakizaki, Jun] Chiba Childrens Hosp, Div Orthopaed Surg, Chiba, Japan	Nakamura, J (reprint author), Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, 1-8-1 Inohana, Chiba, Japan.	njonedr@chiba-u.jp			Naito Foundation	J.N. received the Naito Foundation Subsidy for Dispatch of Young Researchers Abroad (2010 winter period) for this work.	Kamegaya M, 2005, CLIN ORTHOP RELAT R, P205, DOI 10.1097/01.blo.0000180601.23357.d9; Herring JA, 2004, J BONE JOINT SURG AM, V86A, P2121; STULBERG SD, 1981, J BONE JOINT SURG AM, V63, P1095; Herring JA, 2004, J BONE JOINT SURG AM, V86A, P2103; Rosenfeld SB, 2007, J BONE JOINT SURG AM, V89A, P2712, DOI 10.2106/JBJS.G.00191; Canavese F, 2008, J BONE JOINT SURG BR, V90B, P940, DOI 10.1302/0301-620X.90B7.20691; CATTERALL A, 1971, Journal of Bone and Joint Surgery British Volume, V53, P37; Fabry K, 2003, J PEDIATR ORTHOP B, V12, P222, DOI 10.1097/01.bpb.0000049583.53117.f7; Gent Edward, 2007, J Child Orthop, V1, P27, DOI 10.1007/s11832-007-0007-7; Herring JA., 2002, TACHDJIANS PEDIAT OR, P675; IPPOLITO E, 1987, J BONE JOINT SURG BR, V69, P243; KAMEGAYA M, 1989, J BONE JOINT SURG BR, V71, P413; Kamegaya M, 2004, J BONE JOINT SURG BR, V86B, P1176, DOI 10.1302/0301-620X.86B8.14458; Kamegaya Makoto, 2008, J Child Orthop, V2, P261, DOI 10.1007/s11832-008-0120-2; KELLY FB, 1980, J BONE JOINT SURG AM, V62, P400; MEYER JOHANNES, 1964, ACTA ORTHOP SCAND, V34, P183; Nakamura J, 2008, J PEDIATR ORTHOPED, V28, P614, DOI 10.1097/BPO.0b013e3181842013	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	MAR	2015	35	2					144	150				7	Orthopedics; Pediatrics	Orthopedics; Pediatrics	CB9UM	WOS:000349978700011		
J	Niwa, R; Satoh, M				Niwa, Rinpei; Satoh, Mitsuo			The Current Status and Prospects of Antibody Engineering for Therapeutic Use: Focus on Glycoengineering Technology	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Review						Therapeutic antibody; immunotherapy; glycosylation; cancer; immunology; targeted drug delivery; conjugation; biotechnology	DEPENDENT CELLULAR CYTOTOXICITY; CHRONIC LYMPHOCYTIC-LEUKEMIA; FC-GAMMA-RIIIA; ANTI-CD20 MONOCLONAL-ANTIBODY; CELLS IN-VITRO; COLORECTAL-CANCER PATIENTS; METASTATIC BREAST-CANCER; C-RECEPTOR POLYMORPHISMS; NON-HODGKIN-LYMPHOMA; HUMAN IGG-FC	Monoclonal antibodies have demonstrated enormous potential as new classes of drugs that confer great benefits to patients, and more than 40 therapeutic antibodies have already been approved for clinical use. In particular, the past 5 years might be recognized as the period guiding the new era for engineered antibodies, with the successful approval of numerous antibody-drug conjugates, bispecific antibodies, and glyco-engineered antibodies for clinical applications. In this review, we summarize the development of antibody engineering technologies that are proving their concepts in the clinic, mainly focusing on the latest trends in defucosylated antibody technologies. (c) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:930-941, 2015	[Niwa, Rinpei; Satoh, Mitsuo] Kyowa Hakko Kirin Co Ltd, Chiyoda Ku, Tokyo 1008185, Japan	Niwa, R (reprint author), Kyowa Hakko Kirin Co Ltd, Chiyoda Ku, Tokyo 1008185, Japan.	rinpei.niwa@kyowa-kirin.co.jp					AL Hussaini MH, 2013, 55 ANN M AM SOC HEM; Ikeda H, 2009, CLIN CANCER RES, V15, P4028, DOI 10.1158/1078-0432.CCR-08-2867; Preithner S, 2006, MOL IMMUNOL, V43, P1183, DOI 10.1016/j.molimm.2005.07.010; Moore GL, 2010, MABS-AUSTIN, V2, P181; Johnson S, 2010, J MOL BIOL, V399, P436, DOI 10.1016/j.jmb.2010.04.001; Coiffier B, 2008, BLOOD, V111, P1094, DOI 10.1182/blood-2007-09-111781; Schuster Manfred, 2007, Biotechnology Journal, V2, P700, DOI 10.1002/biot.200600255; Erickson HK, 2010, BIOCONJUGATE CHEM, V21, P84, DOI 10.1021/bc900315y; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Shih T, 2006, CLIN THER, V28, P1779, DOI 10.1016/j.clinthera.2006.11.015; Newland AM, 2013, PHARMACOTHERAPY, V33, P93, DOI 10.1002/phar.1170; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; Ghetie MA, 2001, BLOOD, V97, P1392, DOI 10.1182/blood.V97.5.1392; Hamann PR, 2002, BIOCONJUGATE CHEM, V13, P40, DOI 10.1021/bc0100206; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Stavenhagen JB, 2007, CANCER RES, V67, P8882, DOI 10.1158/0008-54/2.CAN-07-0696; Gerber HP, 2013, NAT PROD REP, V30, P625, DOI 10.1039/c3np20113a; Friedrich M, 2012, MOL CANCER THER, V11, P2664, DOI 10.1158/1535-7163.MCT-12-0042; Kovtun YV, 2007, CANCER LETT, V255, P232, DOI 10.1016/j.canlet.2007.04.01; WALKER MR, 1989, BIOCHEM J, V259, P347; Yu M, 2012, MABS-AUSTIN, V4, P475, DOI 10.4161/mabs.20737; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; An ZQ, 2009, MABS-AUSTIN, V1, P572; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Erickson HK, 2006, CANCER RES, V66, P4426, DOI 10.1158/0008-5472.CAN-05-4489; Idusogie EE, 2001, J IMMUNOL, V166, P2571; Kennedy AD, 2004, J IMMUNOL, V172, P3280; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; Clark MR, 1997, CHEM IMMUNOL, V65, P88; Dornan D, 2009, BLOOD, V114, P2721, DOI 10.1182/blood-2009-02-205500; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Dhodapkar KM, 2002, J EXP MED, V195, P125, DOI 10.1084/jem.20011097; Sapra P, 2005, CLIN CANCER RES, V11, P5257, DOI 10.1158/1078-0432.CCR-05-0204; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Harbers SO, 2007, J CLIN INVEST, V117, P1361, DOI 10.1172/JCI29470; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Scallon BJ, 2007, MOL IMMUNOL, V44, P1524, DOI 10.1016/j.molimm.2006.09.005; Iida S, 2006, CLIN CANCER RES, V12, P2879, DOI 10.1158/1078-0432.CCR-05-2619; Roopenian DC, 2003, J IMMUNOL, V170, P3528; Gagez AL, 2014, CURR OPIN ONCOL, V26, P484, DOI 10.1097/CCO.0000000000000107; Ferris RL, 2010, J CLIN ONCOL, V28, P4390, DOI 10.1200/JCO.2009.27.6360; MORGAN A, 1995, IMMUNOLOGY, V86, P319; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Gall JM, 2005, EXP HEMATOL, V33, P452, DOI 10.1016/j.exphem.2005.01.007; Niwa R, 2004, CANCER RES, V64, P2127, DOI 10.1158/0008-5472.CAN-03-2068; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; MIZUOCHI T, 1982, J IMMUNOL, V129, P2016; Ferrara C, 2006, BIOTECHNOL BIOENG, V93, P851, DOI 10.1002/bit.20777; Li DW, 2013, MOL CANCER THER, V12, P1255, DOI 10.1158/1535-7163.MCT-12-1173; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; Zhang W, 2007, J CLIN ONCOL, V25, P3712, DOI 10.1200/JCO.2006.08.8021; Anolik JH, 2003, ARTHRITIS RHEUM, V48, P455, DOI 10.1002/art.10764; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; KING DJ, 1994, CANCER RES, V54, P6176; Harris LJ, 1998, J MOL BIOL, V275, P861, DOI 10.1006/jmbi.1997.1508; Oganesyan V, 2008, MOL IMMUNOL, V45, P1872, DOI 10.1016/j.molimm.2007.10.042; Dall'Ozzo S, 2004, CANCER RES, V64, P4664, DOI 10.1158/0008-5472.CAN-03-2862; Rudick R, 2013, JAMA NEUROL, V70, P172, DOI 10.1001/jamaneurol.2013.598; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Naumovski L, 2010, CURR OPIN MOL THER, V12, P248; Huang S, 2013, CANCER RES, V73, P824, DOI 10.1158/0008-5472.CAN-12-1611; Hinton PR, 2006, J IMMUNOL, V176, P346; Tian F, 2014, P NATL ACAD SCI USA, V111, P1766, DOI 10.1073/pnas.1321237111; Mossner E, 2010, BLOOD, V115, P4393, DOI 10.1182/blood-2009-06-225979; Farag SS, 2004, BLOOD, V103, P1472; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Lutterbuese R, 2009, J IMMUNOTHER, V32, P341, DOI 10.1097/CJI.0b013e31819b7c70; TAO MH, 1989, J IMMUNOL, V143, P2595; Ott MG, 2012, INT J CANCER, V130, P2195, DOI 10.1002/ijc.26258; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Braghiroli MI, 2012, EXPERT REV ANTICANC, V12, P567, DOI [10.1586/era.12.13, 10.1586/ERA.12.13]; DiJoseph JF, 2006, CLIN CANCER RES, V12, P242, DOI 10.1158/1078-0432.CCR-05-1905; Kolbeck R, 2010, J ALLERGY CLIN IMMUN, V125, P1344, DOI 10.1016/j.jaci.2010.04.004; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Lin TS, 2005, BLOOD, V105, P289, DOI 10.1182/blood-2004-02-0651; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Junutula JR, 2010, CLIN CANCER RES, V16, P4769, DOI 10.1158/1078-0432.CCR-10-0987; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; McDonagh CF, 2012, MOL CANCER THER, V11, P582, DOI 10.1158/1535-7163.MCT-11-0820; Bowles JA, 2006, BLOOD, V108, P2648, DOI 10.1182/blood-2006-04-020057; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Herbst R, 2010, J PHARMACOL EXP THER, V335, P213, DOI 10.1124/jpet.110.168062; Brischwein K, 2006, MOL IMMUNOL, V43, P1129, DOI 10.1016/j.molimm.2005.07.034; Umana P, 1999, NAT BIOTECHNOL, V17, P176; Jefferis R, 2002, IMMUNOL LETT, V82, P57, DOI 10.1016/S0165-2478(02)00019-6; Beck A, 2012, MABS-AUSTIN, V4, P419, DOI 10.4161/mabs.20996; Bokemeyer C, 2010, EXPERT OPIN BIOL TH, V10, P1259, DOI 10.1517/14712598.2010.504706; Kanda Y, 2007, GLYCOBIOLOGY, V17, P104, DOI 10.1093/glycob/cwl057; Taylor C, 2007, CLIN CANCER RES, V13, P5133, DOI 10.1158/1078-0432.CCR-07-0507; Kiewe P, 2006, CLIN CANCER RES, V12, P3085, DOI 10.1158/1078-0432.CCR-05-2436; Nagorsen D, 2012, PHARMACOL THERAPEUT, V136, P334, DOI 10.1016/j.pharmthera.2012.07.013; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; Cox KM, 2006, NAT BIOTECHNOL, V24, P1591, DOI 10.1038/nbt1260; Natsume A, 2008, CANCER RES, V68, P3863, DOI 10.1158/0008-5472.CAN-07-6297; Abes R, 2010, BLOOD, V116, P926, DOI 10.1182/blood-2009-10-248609; Aronson R, 2014, DIABETES CARE, V37, P2746, DOI 10.2337/dc13-0327; Boyraz B, 2013, CURR MED RES OPIN, V29, P405, DOI 10.1185/03007995.2013.775113; Forero A, 2003, SEMIN ONCOL, V30, P1, DOI 10.1053/j.seminonco.2003.10.002; GALLINGER S, 1993, CANCER RES, V53, P271; Ghetie MA, 1997, P NATL ACAD SCI USA, V94, P7509, DOI 10.1073/pnas.94.14.7509; Grillo-López Antonio J, 2003, Expert Rev Anticancer Ther, V3, P767, DOI 10.1586/14737140.3.6.767; HARADA H, 1987, ANAL BIOCHEM, V164, P374, DOI 10.1016/0003-2697(87)90507-0; HUBER R, 1976, NATURE, V264, P415, DOI 10.1038/264415a0; Kumpel Belinda M., 1994, Human Antibodies and Hybridomas, V5, P143; Nakagawa T, 2010, LEUKEMIA RES, V34, P666, DOI 10.1016/j.leukres.2009.10.029; Nangia JR, 2012, EXPERT OPIN BIOL TH, V12, P491, DOI 10.1517/14712598.2012.664634; Niwa R, 2005, CLIN CANCER RES, V11, P2327, DOI 10.1158/1078-0432.CCR-04-2263; Olsen NJ, 2004, NEW ENGL J MED, V350, P2167, DOI 10.1056/NEJMra032906; Rao E., 2012, MABS, V4, P14; de Bono JS, 2002, TRENDS MOL MED, V8, pS19, DOI 10.1016/S1471-4914(02)02306-7; RUDD PM, 1991, MOL IMMUNOL, V28, P1369, DOI 10.1016/0161-5890(91)90039-M; Scheinberg David A., 1995, P45; SCHUMAKER VN, 1976, BIOCHEMISTRY-US, V15, P5175, DOI 10.1021/bi00668a035; Segal NH, 2013, 104 ANN M AM ASS CAN; Sen M, 2001, J HEMATOTH STEM CELL, V10, P247, DOI 10.1089/15258160151134944; Shibata-Koyama M, 2009, EXP HEMATOL, V37, P309, DOI 10.1016/j.exphem.2008.11.006; Thomas M, 2012, 103 ANN M AM ASS CAN; Topp MS, 2014, ANN M AM SOC CLIN ON; Vogel Charles L, 2003, Breast J, V9, P452, DOI 10.1046/j.1524-4741.2003.09602.x; Vugmeyster Y, 2005, J IMMUNOTHER, V28, P212, DOI 10.1097/01.cji.0000155050.03916.04; Vugmeyster YL, 2004, INT IMMUNOPHARMACOL, V4, P1117, DOI 10.1016/j.intimp.2004.04.015; Wang CY, 2014, CANCER IMMUNOL RES, V2, P846, DOI 10.1158/2326-6066.CIR-14-0040	126	5	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	MAR	2015	104	3					930	941		10.1002/jps.24316		12	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CB7BS	WOS:000349781700017		
J	Ogawa, N; Takahashi, C; Yamamoto, H				Ogawa, Noriko; Takahashi, Chisato; Yamamoto, Hiromitsu			Physicochemical Characterization of Cyclodextrin-Drug Interactions in the Solid State and the Effect of Water on These Interactions	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Review						cyclodextrins; solid state; water in solids; inclusion compounds; physicochemical properties; hydration	TRANS-CINNAMIC ACID; INCLUSION COMPLEX-FORMATION; NUCLEAR-MAGNETIC-RESONANCE; LARGE-RING CYCLODEXTRINS; X-RAY-DIFFRACTION; BETA-CYCLODEXTRIN; ALPHA-CYCLODEXTRIN; GAMMA-CYCLODEXTRIN; CRYSTAL-STRUCTURES; P-DIMETHYLAMINOBENZONITRILE	The characterization of cyclodextrin (CD)-drug interactions has encountered difficulties in the solid state, especially of amorphous state. However, recent advances in experimental techniques, such as X-ray diffraction, spectroscopy, thermal analysis, and solid-state nuclear magnetic resonance, as well as computational chemistry have provided new insights in this area. Furthermore, inclusion complexes have been found to originate from noncovalent interactions, such as van der Waals and hydrogen bonding. The formation of CD hydrates and inclusion complexes in the solid state is considered to only rely on intermolecular interactions, without any covalent bond rupture and formation in host and guest molecules. The presence of water molecules as special guests impacts on the solid-state arrangement of CD molecules, which makes this influence important to consider. Accordingly, this review presents an overview of recent work about the physicochemical characterization of CD-drug interactions in the solid state with a focus on the effect of water molecules on these interactions. (c) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:942-954, 2015	[Ogawa, Noriko; Takahashi, Chisato; Yamamoto, Hiromitsu] Aichi Gakuin Univ, Sch Pharm, Dept Pharmaceut Engn, Nagoya, Aichi 4648650, Japan	Ogawa, N (reprint author), Aichi Gakuin Univ, Sch Pharm, Dept Pharmaceut Engn, Nagoya, Aichi 4648650, Japan.	noriko30@dpc.agu.ac.jp					Akasaka H, 2000, CHEM PHARM BULL, V48, P1986; Caira MR, 2001, REV ROUM CHIM, V46, P371; Brewster ME, 2007, ADV DRUG DELIVER REV, V59, P645, DOI 10.1016/j.addr.2007.05.012; Loftsson T, 2012, J PHARM SCI-US, V101, P3019, DOI 10.1002/jps.23077; Ogawa N, 2010, J PHARM SCI-US, V99, P5019, DOI 10.1002/jps.22193; Braga D, 2004, ANGEW CHEM INT EDIT, V43, P4002, DOI 10.1002/anie.200301721; Rekharsky MV, 1997, J PHYS CHEM B, V101, P87, DOI 10.1021/jp962715n; Stella VJ, 1997, PHARMACEUT RES, V14, P556, DOI 10.1023/A:1012136608249; Grabowski ZR, 2003, CHEM REV, V103, P3899, DOI 10.1021/cr940745l; Fernandes CM, 2002, EUR J PHARM SCI, V15, P79, DOI 10.1016/S0928-0987(01)00208-1; Hapiot F, 2006, CHEM REV, V106, P767, DOI 10.1021/cr050576c; Song LX, 2009, COORDIN CHEM REV, V253, P1276, DOI 10.1016/j.ccr.2008.08.011; Uyar T, 2006, CRYST GROWTH DES, V6, P1113, DOI 10.1021/cg050500+; Lin HL, 2012, CARBOHYD POLYM, V87, P512, DOI 10.1016/j.carbpol.2011.08.010; Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576; Donald AM, 2000, COLLOID SURFACE A, V174, P37, DOI 10.1016/S0927-7757(00)00520-3; Nolasco MM, 2006, CHEMPHYSCHEM, V7, P2150, DOI 10.1002/cphc.200600308; Loftsson T, 2004, J PHARM SCI-US, V93, P1091, DOI 10.1002/jps.20047; Sinha VR, 2005, J PHARM SCI-US, V94, P676, DOI 10.1002/jps.20287; Ayala-Zavala JF, 2008, J INCL PHENOM MACRO, V60, P359, DOI 10.1007/s10847-007-9385-1; Shenderovich IG, 2003, J PHYS CHEM B, V107, P11924, DOI 10.1021/jp0349740; MATSUI Y, 1979, B CHEM SOC JPN, V52, P2808, DOI 10.1246/bcsj.52.2808; Saenger WR, 1998, CHEM REV, V98, P1787, DOI 10.1021/cr9700181; Ueda H, 2002, J INCL PHENOM MACRO, V44, P53, DOI 10.1023/A:1023055516398; Hedges AR, 1998, CHEM REV, V98, P2035, DOI 10.1021/cr970014w; Dang Z, 2011, CURR ORG CHEM, V15, P848, DOI 10.2174/138527211794518899; GIDLEY MJ, 1988, J AM CHEM SOC, V110, P3820, DOI 10.1021/ja00220a016; Szente L, 1999, ADV DRUG DELIVER REV, V36, P17, DOI 10.1016/S0169-409X(98)00092-1; Yoshioka S, 2007, J PHARM SCI-US, V96, P960, DOI 10.1002/jps.20926; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; Uekama K, 2006, J INCL PHENOM MACRO, V56, P3, DOI 10.1007/s10847-006-9052-y; Pongpeerapat A, 2004, J DRUG DELIV SCI TEC, V14, P441; Ikuta N, 2013, INT J MOL SCI, V14, P3639, DOI 10.3390/ijms14023639; TABUSHI I, 1978, J AM CHEM SOC, V100, P916, DOI 10.1021/ja00471a043; HEYES SJ, 1992, CARBOHYD RES, V233, P1, DOI 10.1016/S0008-6215(00)90916-9; Toropainen T, 2007, PHARM RES, V24, P1058, DOI 10.1007/s11095-006-9227-7; FRENCH D, 1957, ADV CARBOHYD CHEM, V12, P189; Messner M, 2010, INT J PHARMACEUT, V387, P199, DOI 10.1016/j.ijpharm.2009.11.035; Laza-Knoerr AL, 2010, J DRUG TARGET, V18, P645, DOI 10.3109/10611861003622552; LI S, 1992, CHEM REV, V92, P1457, DOI 10.1021/cr00014a009; DASILVA AMM, 1995, J CARBOHYD CHEM, V14, P677; Scharff P, 2004, CARBON, V42, P1203, DOI 10.1016/j.carbon.2003.12.053; Nolasco MM, 2009, J RAMAN SPECTROSC, V40, P394, DOI 10.1002/jrs.2138; Higashi K, 2010, J PHARM SCI-US, V99, P4192, DOI 10.1002/jps.22133; LOFTSSON T, 1994, INT J PHARM, V110, P169, DOI 10.1016/0378-5173(94)90155-4; Kuo SW, 2001, MACROMOLECULES, V34, P5224, DOI 10.1021/ma010517a; Makhlof A, 2008, INT J PHARMACEUT, V357, P280, DOI 10.1016/j.ijpharm.2008.01.025; Amado AM, 2000, J RAMAN SPECTROSC, V31, P971, DOI 10.1002/1097-4555(200011)31:11<971::AID-JRS627>3.0.CO;2-R; Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p; Ross PD, 1996, BIOPHYS J, V71, P2144; Barillaro V, 2008, INT J PHARMACEUT, V350, P155, DOI 10.1016/j.ijpharm.2007.08.048; BARONE G, 1986, J CHEM SOC FARAD T 1, V82, P2089, DOI 10.1039/f19868202089; Bender M. L., 1978, CYCLODEXTRIN CHEM; Bergeron RJ, 1984, INCLUSION COMPOUNDS, V3, P391; Bettinetti G, 2002, J THERM ANAL CALORIM, V68, P517, DOI 10.1023/A:1016043920156; Braga SS, 2006, INORG CHIM ACTA, V359, P4757, DOI 10.1016/j.ica.2006.03.017; BULEON A, 1982, STARKE, V34, P361, DOI 10.1002/star.19820341102; Chierotti MR, 2008, CHEM COMMUN, P1621, DOI 10.1039/b711551b; Cunha-Silva L, 2004, NEW J CHEM, V28, P200, DOI 10.1039/b309491j; Del VE, 2004, PROCESS BIOCHEM, V39, P1033; Endo T, 2007, HETEROCYCLES, V74, P991; Friedrich H, 2005, DRUG DEV IND PHARM, V31, P719, DOI 10.1080/03639040500216097; FUJIE T, 1973, YAKUGAKU ZASSHI, V93, P699; FUJIWARA H, 1987, B CHEM SOC JPN, V60, P3891, DOI 10.1246/bcsj.60.3891; Furuishi T, 2010, J INCL PHENOM MACRO, V67, P233, DOI 10.1007/s10847-009-9689-4; HALLEN D, 1992, J CHEM SOC FARADAY T, V88, P2859, DOI 10.1039/ft9928802859; HARA K, 1992, J PHYS CHEM-US, V96, P8307, DOI 10.1021/j100200a019; Harata K, 1998, CHEM REV, V98, P1803, DOI 10.1021/cr9700134; HARATA K, 1988, B CHEM SOC JPN, V61, P1939, DOI 10.1246/bcsj.61.1939; Harata K, 1991, INCLUSION COMPOUNDS, VV; Harata K, 1996, COMPREHENSIVE SUPRAM, VIII; HARRISON JC, 1982, BIOPOLYMERS, V21, P1153, DOI 10.1002/bip.360210611; HAYASHI S, 1991, J CHEM PHYS, V94, P4446, DOI 10.1063/1.460634; Higashi K, 2009, CRYST GROWTH DES, V9, P4243, DOI 10.1021/cg900573w; Higashi K, 2014, CRYST GROWTH DES, V14, P2773, DOI 10.1021/cg401934v; Hunt MA, 2004, CARBOHYD RES, V339, P2805, DOI 10.1016/j.carres.2004.09.012; Inoue Y, 2009, YAKUGAKU ZASSHI, V129, P253; Inoue Y, 2011, CHEM PHARM BULL, V59, P1299; Inoue Y, 2014, J INCL PHENOM MACRO, V78, P457, DOI 10.1007/s10847-013-0317-y; Iohara D, 2011, MOL PHARMACEUT, V8, P1276, DOI 10.1021/mp200204v; Jablan J, 2012, J PHARMACEUT BIOMED, V71, P35, DOI 10.1016/j.jpba.2012.07.027; Jeffrey A., 1997, INTRO HYDROGEN BONDI; Kamitori S, 2001, CARBOHYD RES, V332, P235, DOI 10.1016/S0008-6215(01)00086-6; KAWANO K, 1985, YAKUGAKU ZASSHI, V105, P1071; Kawasaki J, 2007, POLYMER, V48, P1127, DOI 10.1016/j.polymer.2006.12.007; Kokkinou A, 2000, CARBOHYD RES, V328, P135, DOI 10.1016/S0008-6215(00)00091-4; Kolbe A, 1997, J MOL STRUCT, V437, P161; Kolbe A, 2003, J MOL STRUCT, V661, P239, DOI 10.1016/S0022-2860(03)00446-0; Larsen KL, 1998, CARBOHYD RES, V309, P153, DOI 10.1016/S0008-6215(98)00130-X; LeBa G, 1987, CYCLODEXTRINS THEIR; Lehn J.-M., 1995, SUPRAMOLECULAR CHEM; Loftsson Thorsteinn, 2005, Expert Opin Drug Deliv, V2, P335, DOI 10.1517/17425247.2.1.335; MacKenzie DJK, 2002, PERGAMON MAT SERIES; MacNicol D. D., 1984, INCLUSION COMPOUNDS, V2, P231; Makedonopoulou S, 1998, CHEM COMMUN, P2133, DOI 10.1039/a804057e; Makedonopoulou S, 2000, J INCL PHENOM MACRO, V36, P191, DOI 10.1023/A:1008055904136; Mennini N, 2014, J PHARMACEUT BIOMED, V89, P142, DOI 10.1016/j.jpba.2013.11.009; MENTZAFOS D, 1991, ACTA CRYSTALLOGR B, V47, P746, DOI 10.1107/S010876819100366X; Miller LA, 2007, J PHARM SCI-US, V96, P1691, DOI 10.1002/jps.20831; Mollica G, 2006, PHARM RES, V23, P2129, DOI 10.1007/s11095-006-9044-z; Monti S, 2003, PHOTOCH PHOTOBIO SCI, V2, P203, DOI 10.1039/b211245k; MORIBE K, 1995, CHEM PHARM BULL, V43, P666; NAGAOKA S, 1983, J CHEM PHYS, V79, P4694, DOI 10.1063/1.445610; NAKAI Y, 1987, CHEM PHARM BULL, V35, P4609; NAKAI Y, 1986, CHEM PHARM BULL, V34, P2178; NAKAI Y, 1984, CHEM PHARM BULL, V32, P685; NAKAI Y, 1989, CHEM PHARM BULL, V37, P1055; NAKAI Y, 1986, YAKUGAKU ZASSHI, V106, P420; NAKAI Y, 1985, YAKUGAKU ZASSHI, V105, P801; Ndlebe VJ, 2004, J THERM ANAL CALORIM, V77, P445, DOI 10.1023/B:JTAN.0000038985.43887.48; Nishiwaki A, 2009, INT J PHARMACEUT, V378, P17, DOI 10.1016/j.ijpharm.2009.05.023; Nolasco MM, 2009, J RAMAN SPECTROSC, V40, P687, DOI 10.1002/jrs.2182; Ohmura M, 2004, POLYMER, V45, P6867; Panova IG, 2006, COLLOID J+, V68, P66, DOI 10.1134/S1061933X06010091; Pereira CCL, 2007, ORGANOMETALLICS, V26, P4220, DOI 10.1021/om7003749; Rekharsky VM, 1998, CHEM REV, V98, P1875, DOI DOI 10.1021/CR970015O; Ribeiro-Claro PJA, 2006, J RAMAN SPECTROSC, V37, P472, DOI 10.1002/jrs.1419; RibeiroClaro PJA, 1996, J RAMAN SPECTROSC, V27, P155, DOI 10.1002/(SICI)1097-4555(199602)27:2<155::AID-JRS941>3.0.CO;2-L; Saenger W, 1984, INCLUSION COMPOUNDS, VII; Saenger W., 1980, ANGEW CHEM, V92, P343, DOI 10.1002/ange.19800920505; Salgado FP, 1999, J PHYS CHEM A, V103, P3184; SANEMASA I, 1990, B CHEM SOC JPN, V63, P2814, DOI 10.1246/bcsj.63.2814; Song LX, 2007, B CHEM SOC JPN, V80, P2185, DOI 10.1246/bcsj.80.2185; Song LX, 2006, J INCL PHENOM MACRO, V54, P221, DOI 10.1007/s10847-005-7970-8; STASZCZUK P, 1983, POWDER TECHNOL, V35, P97, DOI 10.1016/0032-5910(83)85031-1; Steiner T, 1998, ACTA CRYSTALLOGR B, V54, P450, DOI 10.1107/S0108768197014547; Szejtli J., 1988, CYCLODEXTRIN TECHNOL; TAKEO K, 1970, Agricultural and Biological Chemistry, V34, P1787; TAKEO KI, 1970, AGR BIOL CHEM TOKYO, V34, P568; Teixeira LR, 2006, J INCL PHENOM MACRO, V54, P133, DOI 10.1007/s10847-005-5817-y; Tozuka Y, 2004, J INCL PHENOM MACRO, V50, P67, DOI 10.1007/s10847-004-8841-9; Turunen E, 2014, J PHARM PHARMACOL, V66, P367, DOI 10.1111/jphp.12174; Uekama K, 2008, CYCLODEXTRINS THEIR, P381; Uyar T, 2005, POLYMER, V46, P4762, DOI 10.1016/j.polymer.2005.04.002; Veiga MD, 2002, J PHARMACEUT BIOMED, V28, P973, DOI 10.1016/S0731-7085(02)00042-0; Wang EJ, 2007, CARBOHYD RES, V342, P1530, DOI 10.1016/j.carres.2007.04.008; Wang EJ, 2007, CARBOHYD RES, V342, P767, DOI 10.1016/j.carres.2006.12.004; Waree L, 2012, POWDER TECHNOL, V221, P213; Wongmekiat A, 2007, CHEM PHARM BULL, V55, P359, DOI 10.1248/cpb.55.359; Wongmekiat A, 2003, INT J PHARM, V265, P85, DOI 10.1016/S0378-5173(03)00409-5; Wongmekiat A, 2002, PHARMACEUT RES, V19, P1867, DOI 10.1023/A:1021401826554; Wongmekiat A, 2006, J INCL PHENOM MACRO, V56, P29, DOI 10.1007/s10847-006-9056-7; Yamada T, 1999, CHEM PHARM BULL, V47, P1311; Yamamoto K, 2011, CHEM PHARM BULL, V59, P147, DOI 10.1248/cpb.59.147; Yang YS, 2005, CHINESE J CHEM, V23, P775	145	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	MAR	2015	104	3					942	954		10.1002/jps.24319		13	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CB7BS	WOS:000349781700018		
J	Watanabe, A; Watari, R; Ogawa, K; Shimizu, R; Tanaka, Y; Takai, N; Nezasa, KI; Yamaguchi, Y				Watanabe, Ayahisa; Watari, Ryosuke; Ogawa, Keiko; Shimizu, Ryosuke; Tanaka, Yukari; Takai, Nozomi; Nezasa, Ken-Ichi; Yamaguchi, Yoshitaka			Using Improved Serial Blood Sampling Method of Mice to Study Pharmacokinetics and Drug-Drug Interaction	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						preclinical pharmacokinetics; drug interactions; serial sampling method	PREGNANE X RECEPTOR; CHIMERIC MICE; MASS-SPECTROMETRY; HUMANIZED LIVER; MOUSE; 1-AMINOBENZOTRIAZOLE; INHIBITION; PREDICTION; ANTIPYRINE; CLEARANCE	In pharmacokinetic evaluation of mice, using serial sampling methods rather than a terminal blood sampling method could reduce the number of animals needed and lead to more reliable data by excluding individual differences. In addition, using serial sampling methods can be valuable for evaluation of the drug-drug interaction (DDI) potential of drug candidates. In this study, we established an improved method for serially sampling the blood from one mouse by only one incision of the lateral tail vein, and investigated whether our method could be adapted to pharmacokinetic and DDI studies. After intravenous and oral administration of ibuprofen and fexofenadine (BCS class II and III), the plasma concentration and pharmacokinetic parameters were evaluated by our method and a terminal blood sampling method, with the result that both methods gave comparable results (ibuprofen: 63.8 +/- 4.0% and 64.4%, fexofenadine: 6.5 +/- 0.7% and 7.9%, respectively, in bioavailability). In addition, our method could be adapted to DDI study for cytochrome P450 and organic anion transporting polypeptide inhibition. These results demonstrate that our method can be useful for pharmacokinetic evaluation from the perspective of reliable data acquisition as well as easy handling and low stress to mice and improve the quality of pharmacokinetic and DDI studies. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:955-961, 2015	[Watanabe, Ayahisa; Watari, Ryosuke; Ogawa, Keiko; Shimizu, Ryosuke; Tanaka, Yukari; Takai, Nozomi; Nezasa, Ken-Ichi; Yamaguchi, Yoshitaka] Shionogi & Co Ltd, Res Lab Dev, Drug Metab & Pharmacokinet, Toyonaka, Osaka, Japan	Watanabe, A (reprint author), Shionogi & Co Ltd, Res Lab Dev, Drug Metab & Pharmacokinet, Toyonaka, Osaka, Japan.	ayahisa.watanabe@shionogi.co.jp					Abatan OI, 2008, J AM ASSOC LAB ANIM, V47, P8; Bateman KP, 2001, J CHROMATOGR B, V754, P245, DOI 10.1016/S0378-4347(00)00612-5; Balani SK, 2004, DRUG METAB DISPOS, V32, P1092, DOI 10.1124/dmd.104.000349; Sanoh S, 2012, DRUG METAB DISPOS, V40, P322, DOI 10.1124/dmd.111.040923; Hem A, 1998, LAB ANIM, V32, P364, DOI 10.1258/002367798780599866; Wu CY, 2005, PHARM RES, V22, P11, DOI 10.1007/s11095-004-9004-4; Christensen SD, 2009, LAB ANIM-UK, V43, P65, DOI 10.1258/la.2008.007075; Hasegawa M, 2011, MOL PHARMACOL, V80, P518, DOI 10.1124/mol.111.071845; van de Steeg E, 2012, J CLIN INVEST, V122, P519, DOI 10.1172/JCI59526; Zhang L, 2010, TOXICOL APPL PHARM, V243, P134, DOI 10.1016/j.taap.2009.12.016; Higgins JW, 2014, DRUG METAB DISPOS, V42, P182, DOI 10.1124/dmd.113.054783; HUIJZER JC, 1989, DRUG METAB DISPOS, V17, P37; Chen JW, 2006, ANAL CHEM, V78, P1212, DOI 10.1021/ac0516178; Watanabe T, 2006, ANAL CHIM ACTA, V559, P37, DOI 10.1016/j.aca.2005.11.049; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI 10.1080/00498250801986951 ; Costabile M., 2010, JOVE-J VIS EXP, V37, P1923; Hasegawa M, 2012, DRUG METAB DISPOS, V40, P474, DOI 10.1124/dmd.111.042754; Kurawattimath V, 2012, EUR J DRUG METAB PH, V37, P23, DOI 10.1007/s13318-011-0066-5; Nishimura T, 2013, J PHARMACOL EXP THER, V344, P388, DOI 10.1124/jpet.112.198697; Peng SX, 2009, J PHARM SCI-US, V98, P1877, DOI 10.1002/jps.21533; Sharer JE, 1996, DRUG METAB DISPOS, V24, P487; Shitara Y, 2002, PHARMACEUT RES, V19, P147, DOI 10.1023/A:1014264614637; Tang CY, 2010, PHARM RES-DORDR, V27, P1772, DOI 10.1007/s11095-010-0157-z; TULI JS, 1995, LAB ANIM, V29, P90, DOI 10.1258/002367795780740339; Zhuo M, 1998, EUR J PHARMACOL, V349, P211, DOI 10.1016/S0014-2999(98)00197-6	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	MAR	2015	104	3					955	961		10.1002/jps.24236		7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CB7BS	WOS:000349781700019		
J	Hiramatsu, R; Kawabata, S; Tanaka, H; Sakurai, Y; Suzuki, M; Ono, K; Miyatake, SI; Kuroiwa, T; Hao, E; Vicente, MGH				Hiramatsu, Ryo; Kawabata, Shinji; Tanaka, Hiroki; Sakurai, Yoshinori; Suzuki, Minoru; Ono, Koji; Miyatake, Shin-Ichi; Kuroiwa, Toshihiko; Hao, Erhong; Vicente, M. Graca H.			Tetrakis(p-Carboranylthio-Tetrafluorophenyl)Chlorin (TPFC): Application for Photodynamic Therapy and Boron Neutron Capture Therapy	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						absorption; blood-brain barrier; BNCT; boron-containing chlorin; CED; cell culture; CNS; osmotic pumps; PDT; TPFC	CONVECTION-ENHANCED DELIVERY; EPIDERMAL-GROWTH-FACTOR; L-ASPARTYL CHLORIN-E6; BRAIN TUMOR-MODELS; PHOTOSENSITIZING PROPERTIES; P-BORONOPHENYLALANINE; MALIGNANT GLIOMAS; CELLULAR UPTAKE; REAL-TIME; IN-VIVO	Carboranyl-containing chlorins have emerged as promising dual sensitizers for use in both photodynamic therapy (PDT) and boron neutron capture therapy (BNCT), by virtue of their known tumor affinity, low cytotoxicity in dark conditions, and their strong absorptions in the red region of the optical spectrum. Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC) is a new synthetic carboranyl-containing chlorin of high boron content (24% by weight). To evaluate TPFC's applicability as sensitizer for both PDT and BNCT, we performed an in vitro and in vivo study using F98 rat glioma cells and F98 rat glioma-bearing brain tumor models. For the in vivo BNCT study, we used boronophenylalanine (BPA), which is currently used in clinical BNCT studies, via intravenous administration (i.v.) and/or used TPFC via convection-enhanced delivery (CED), a method for local drug infusion directly into the brain. In the in vitro PDT study, the cell surviving fraction following laser irradiation (9 J/cm(2)) was 0.035 whereas in the in vitro BNCT study, the cell surviving fraction following neutron irradiation (thermal neutron = 1.73 x 10(12) n/cm(2)) was 0.04. In the in vivo BNCT study, the median survival time following concomitant administration of BPA (i.v.) and TPFC (CED) was 42 days (95% confidence interval; 37-43 days). (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:962-970, 2015	[Hiramatsu, Ryo; Kawabata, Shinji; Miyatake, Shin-Ichi; Kuroiwa, Toshihiko] Osaka Med Coll, Dept Neurosurg, Osaka 5698686, Japan; [Tanaka, Hiroki; Sakurai, Yoshinori; Suzuki, Minoru; Ono, Koji] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan; [Hao, Erhong; Vicente, M. Graca H.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA	Kawabata, S (reprint author), Osaka Med Coll, Dept Neurosurg, Osaka 5698686, Japan.	neu046@poh.osaka-med.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [20340549]; United States National Institutes of Health [R01 CA 098902]	This work was supported by Grants-in-Aid for Scientific Research (C) (20340549) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) to S.K. and by the United States National Institutes of Health, grant number R01 CA 098902 to M.G.H.V. We thank Dr. Barth (Department of Pathology, the Ohio State University) for providing the F98 rat glioma cells.	AIZAWA K, 1987, PHOTOCHEM PHOTOBIOL, V46, P789, DOI 10.1111/j.1751-1097.1987.tb04849.x; BARTH RF, 1992, CANCER-AM CANCER SOC, V70, P2995; Kawabata S, 2009, J RADIAT RES, V50, P51, DOI 10.1269/jrr.08043; Dickinson PJ, 2008, J NEUROSURG, V108, P989, DOI 10.3171/JNS/2008/108/5/0989; Barth RF, 2005, CLIN CANCER RES, V11, P3987, DOI 10.1158/1078-0432.CCR-05-0035; ROBERTS WG, 1989, LASER SURG MED, V9, P90, DOI 10.1002/lsm.1900090203; ROBERTS WG, 1989, PHOTOCHEM PHOTOBIOL, V49, P431, DOI 10.1111/j.1751-1097.1989.tb09191.x; Weaver M, 2003, J NEURO-ONCOL, V65, P3, DOI 10.1023/A:1026246500788; GOMER CJ, 1990, CANCER RES, V50, P3985; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Mukundan S, 2006, AM J ROENTGENOL, V186, P300, DOI 10.2214/AJR.05.0523; MOAN J, 1986, PHOTOCHEM PHOTOBIOL, V43, P681, DOI 10.1111/j.1751-1097.1986.tb05647.x; Stupp R, 2006, ONCOLOGIST, V11, P165, DOI 10.1634/theoncologist.11-2-165; MULLER PJ, 1986, PHYS MED BIOL, V31, P1295, DOI 10.1088/0031-9155/31/11/012; Gottumukkala V, 2006, BIOORGAN MED CHEM, V14, P1871, DOI 10.1016/j.bmc.2005.10.037; NELSON JS, 1987, CANCER RES, V47, P4681; Ol'shevskaya VA, 2009, BIOORGAN MED CHEM, V17, P1297, DOI 10.1016/j.bmc.2008.12.016; Suzuki M, 2000, JPN J CANCER RES, V91, P1058; PANDEY RK, 1991, PHOTOCHEM PHOTOBIOL, V53, P65, DOI 10.1111/j.1751-1097.1991.tb08468.x; Coderre JA, 1999, RADIAT RES, V151, P1, DOI 10.2307/3579742; Luguya R, 2006, BIOORGAN MED CHEM, V14, P5890, DOI 10.1016/j.bmc.2006.05.026; Fabris C, 2001, J PHOTOCH PHOTOBIO B, V64, P1, DOI 10.1016/S1011-1344(01)00184-1; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Miyatake SI, 2009, J NEURO-ONCOL, V91, P199, DOI 10.1007/s11060-008-9699-x; Hao E, 2008, ORG BIOMOL CHEM, V6, P3732, DOI 10.1039/b807836j; Barth RF, 1998, J NEURO-ONCOL, V36, P91, DOI 10.1023/A:1005805203044; Biston MC, 2004, CANCER RES, V64, P2317, DOI 10.1158/0008-5472.CAN-03-3600; BUCHANAN RB, 1989, EUR J SURG ONCOL, V15, P400; CODERRE JA, 1994, INT J RADIAT ONCOL, V30, P643; Dougherty TJ, 1998, J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; FAIRCHILD RG, 1990, MED PHYS, V17, P1045, DOI 10.1118/1.596455; Friso E, 2006, PHOTOCH PHOTOBIO SCI, V5, P39, DOI 10.1039/b506364g; GOMER CJ, 1989, RADIAT RES, V120, P1, DOI 10.2307/3577632; Kennedy J C, 1996, J Clin Laser Med Surg, V14, P289; KOBAYASHI N, 1980, J NEUROSURG, V53, P808, DOI 10.3171/jns.1980.53.6.0808; Kostron H, 1996, J PHOTOCH PHOTOBIO B, V36, P157, DOI 10.1016/S1011-1344(96)07364-2; MCCAUGHAN JS, 1990, CANCER INVEST, V8, P407, DOI 10.3109/07357909009012058; MORRIS GM, 1994, RADIOTHER ONCOL, V32, P144, DOI 10.1016/0167-8140(94)90101-5; MORRIS GM, 1994, RADIOTHER ONCOL, V32, P249, DOI 10.1016/0167-8140(94)90024-8; MULLER PJ, 1987, PHOTOCHEM PHOTOBIOL, V46, P929, DOI 10.1111/j.1751-1097.1987.tb04871.x; Murad GJA, 2006, CLIN CANCER RES, V12, P3145, DOI 10.1158/1078-0432.CCR-05-2583; ORIGITANO TC, 1994, MOL CHEM NEUROPATHOL, V21, P337, DOI 10.1007/BF02815360; PROFIO AE, 1987, PHOTOCHEM PHOTOBIOL, V46, P591, DOI 10.1111/j.1751-1097.1987.tb04819.x; ROBERTS WG, 1988, J NATL CANCER I, V80, P330, DOI 10.1093/jnci/80.5.330; Saito R, 2004, CANCER RES, V64, P2572, DOI 10.1158/0008-5472.CAN-03-3631; Vogelbaum MA, 2005, J NEURO-ONCOL, V73, P57, DOI 10.1007/s11060-004-2243-8; Wei QC, 2003, INT J ONCOL, V23, P1159; Wu G, 2006, MOL CANCER THER, V5, P52, DOI 10.1158/1535-7163.MCT-05-0325; Yang WL, 2002, CANCER RES, V62, P6552	49	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	MAR	2015	104	3					962	970		10.1002/jps.24317		9	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CB7BS	WOS:000349781700020		
J	Shimizu, T; Ohtake, H; Fujii, T; Tabuchi, Y; Sakai, H				Shimizu, Takahiro; Ohtake, Hironao; Fujii, Takuto; Tabuchi, Yoshiaki; Sakai, Hideki			Volume-sensitive outwardly rectifying Cl- channels contribute to butyrate-triggered apoptosis of murine colonic epithelial MCE301 cells	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						Cl- channel; Apoptosis; Butyrate; Cell shrinkage; Colon	ANTIBIOTIC COMBINATION THERAPY; CHAIN FATTY-ACIDS; ULCERATIVE-COLITIS; CISPLATIN RESISTANCE; ANION CHANNELS; MUCOSA; MECHANISMS; INDUCTION; CANCER; TRACT	Butyrate is a fatty acid with an important role in the maintenance of colonic homeostasis. It induces apoptosis in colonic epithelial cells and contributes to the pathogenesis of ulcerative colitis. However, just how how butyrate triggers apoptosis is poorly understood. In our model system of mouse colonic epithelial MCE301 cells, whole-cell patch-clamp recordings revealed the presence of swelling-activated outwardly rectifying chloride ion (Cl-) currents. These currents exhibited time-dependent inactivation upon strong depolarization, a low field strength anion selectivity (I- > Br- > Cl- > F-), and a sensitivity to 4-(2-butyl-6,7-dichloro-2-cyclopentylindan-1-on-5-yl)oxybutyric acid (DCPIB), a specific blocker of volume-sensitive outwardly rectifying (VSOR) Cl- channels. The results of flow cytometric analysis and caspase 3/7 assays demonstrated that exposure of MCE301 cells to sodium butyrate for 16 h triggered apoptotic cell shrinkage, phosphatidylserine exposure, and caspase 3/7 activation. Importantly, the VSOR Cl- channel blocker was able to inhibit sodium butyrate-induced apoptotic processes. These results suggest that activation of the VSOR Cl- channel is essential for sodium butyrate-triggered apoptosis in MCE301 cells.	[Shimizu, Takahiro; Ohtake, Hironao; Fujii, Takuto; Sakai, Hideki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pharmaceut Physiol, Toyama 9300194, Japan; [Tabuchi, Yoshiaki] Toyama Univ, Div Mol Genet Res, Life Sci Res Ctr, Toyama 9300194, Japan	Shimizu, T (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pharmaceut Physiol, 2630 Sugitani, Toyama 9300194, Japan.	takshimi@pha.u-toyama.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Tamura Science and Technology Foundation	We thank all of the members of our laboratory at University of Toyama for helpful discussion and support. This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (to H.S., T.S., T.F., and Y.T.) and the Ministry of Education, Culture, Sports, Science and Technology of Japan (to H.S.) and the grant from Tamura Science and Technology Foundation (to T.S.).	Ohkusa T, 2003, GUT, V52, P79, DOI 10.1136/gut.52.1.79; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Nomura T, 2005, ALIMENT PHARM THER, V21, P1017, DOI 10.1111/j.1365-2036.2005.02428.x; BERGMAN EN, 1990, PHYSIOL REV, V70, P567; Lang F, 1998, PHYSIOL REV, V78, P247; Ohkusa T, 2005, SCAND J GASTROENTERO, V40, P1334, DOI 10.1080/00365520510023648; Heerdt BG, 1997, CELL GROWTH DIFFER, V8, P523; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711; Lee EL, 2007, J CELL PHYSIOL, V211, P513, DOI 10.1002/jcp.20961; Ohkusa T, 2010, AM J GASTROENTEROL, V105, P1820, DOI 10.1038/ajg.2010.84; Nilius B, 1997, PROG BIOPHYS MOL BIO, V68, P69, DOI 10.1016/S0079-6107(97)00021-7; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Ohkusa T, 2002, J GASTROEN HEPATOL, V17, P849, DOI 10.1046/j.1440-1746.2002.02834.x; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755; Archer S, 1998, SURGERY, V124, P248, DOI 10.1067/msy.1998.90567; BUGAUT M, 1987, COMP BIOCHEM PHYS B, V86, P439, DOI 10.1016/0305-0491(87)90433-0; Clarke KO, 2001, CANCER LETT, V171, P57, DOI 10.1016/S0304-3835(01)00574-2; Davie James R, 2003, J Nutr, V133, p2485S; Decher Niels, 2001, British Journal of Pharmacology, V134, P1467, DOI 10.1038/sj.bjp.0704413; Fung KYC, 2012, BRIT J NUTR, V108, P820, DOI 10.1017/S0007114512001948; Litvak DA, 2000, ANTICANCER RES, V20, P779; Shimizu T, 2008, ANTICANCER RES, V28, P75; Tabuchi Y, 2000, CELL STRUCT FUNCT, V25, P297, DOI 10.1247/csf.25.297	24	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	MAR	2015	65	2					151	157		10.1007/s12576-014-0352-5		7	Physiology	Physiology	CC4DK	WOS:000350300800001		
J	Okazaki, M; Kaneko, M; Ishida, Y; Murase, N; Katsumura, T				Okazaki, Michie; Kaneko, Masaaki; Ishida, Yukisato; Murase, Norio; Katsumura, Toshihito			Gender difference in distance of tibiofibular syndesmosis to joint dynamics of lower extremities during squat	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						Tibiofibular syndesmosis; Ankle instability; Gender difference; Lower extremity injury	CHRONIC ANKLE INSTABILITY; CRUCIATE LIGAMENT INJURY; POSTURAL STABILITY; LEG DOMINANCE; BIOMECHANICS; EPIDEMIOLOGY; INDIVIDUALS; POPULATION; MECHANISMS; KINEMATICS	The incidence of lower extremity injury is greater in women than men, indicating gender difference in lower extremity function. Here we investigate the role of the ankle during squatting in young men and women by measuring the tibiofibular syndesmosis (TFS) distance and the angles of hip, ankle and knee joints. TFS distance was positively correlated to body mass in men, but not in women, suggesting some factor(s) affecting TSF distance in women. When divided into two groups with wide and narrow TFS distances, men apparently used ankle and hip joints evenly during squatting, but women, specifically those with a narrow TFS distance, used the hip joint more effectively than ankle. Estimated knee moment was positively correlated to TFS distance in women, but not in men. These results suggest that the women possessing a wider TFS distance use ankle function rather than hip junction when performing lower-extremity exercises (i.e. squatting), presumably accounting for the higher incidence of ankle injury in women during such activities.	[Okazaki, Michie; Murase, Norio; Katsumura, Toshihito] Tokyo Med Univ, Grad Sch, Course Med Sci, Shinjuku Ku, Tokyo 1608402, Japan; [Okazaki, Michie; Ishida, Yukisato] Bunkyo Gakuin Univ, Dept Phys Therapy, Fujimino, Saitama 3568533, Japan; [Kaneko, Masaaki] Tohoku Univ Hosp, Dept Rehabil, Aoba Ku, Sendai, Miyagi 9808574, Japan	Okazaki, M (reprint author), Tokyo Med Univ, Grad Sch, Course Med Sci, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	michie.o@f4.dion.ne.jp					Brown C, 2012, CLIN BIOMECH, V27, P52, DOI 10.1016/j.clinbiomech.2011.07.012; Ruedl G, 2012, AM J SPORT MED, V40, P1269, DOI 10.1177/0363546512439027; Wikstrom EA, 2007, MED SCI SPORT EXER, V39, P397, DOI 10.1249/mss0b013e31802d3460; Brophy R, 2010, BRIT J SPORT MED, V44, P694, DOI 10.1136/bjsm.2008.051243; Negrete RJ, 2007, J STRENGTH COND RES, V21, P270, DOI 10.1519/00124278-200702000-00048; Lynn SK, 2012, J STRENGTH COND RES, V26, P2417, DOI 10.1519/JSC.0b013e31823f8c2d; Ross SE, 2004, CLIN J SPORT MED, V14, P332, DOI 10.1097/00042752-200411000-00002; Beumer A, 2006, ACTA ORTHOP, V77, P531, DOI 10.1080/17453670610012557; Gribble PA, 2007, INT J SPORTS MED, V28, P236, DOI 10.1055/s-2006-924289; Shimokochi Y, 2008, J ATHL TRAINING, V43, P396, DOI 10.4085/1062-6050-43.4.396; BEIGHTON P, 1973, ANN RHEUM DIS, V32, P413, DOI 10.1136/ard.32.5.413; Gribble PA, 2009, J ATHL TRAINING, V44, P350, DOI 10.4085/1062-6050-44.4.350; GARRICK JG, 1988, CLIN SPORT MED, V7, P29; Wright RW, 2004, AM J SPORT MED, V32, P1941, DOI 10.1177/0363546504264581; Gerber JP, 1998, FOOT ANKLE INT, V19, P653; Arendt EA, 1999, J ATHL TRAINING, V34, P86; Bartonicek J, 2003, SURG RADIOL ANAT, V25, P379, DOI 10.1007/s00276-003-0156-4; Gribble PA, 2004, J ATHL TRAINING, V39, P321; Ebraheim NA, 2006, SURG RADIOL ANAT, V28, P142, DOI 10.1007/s00276-006-0077-0; OGILVIEHARRIS DJ, 1994, ARTHROSCOPY, V10, P561, DOI 10.1016/S0749-8063(05)80015-5; Myer GD, 2006, AM J SPORT MED, V34, P445, DOI 10.1177/0363546505281241; Del Buono Angelo, 2013, Curr Rev Musculoskelet Med, V6, P313, DOI 10.1007/s12178-013-9183-x; den Daas Annick, 2012, Strategies Trauma Limb Reconstr, V7, P123, DOI 10.1007/s11751-012-0147-2; Freeman M A, 1965, J Bone Joint Surg Br, V47, P669; Harris John, 2004, J Foot Ankle Surg, V43, P3, DOI 10.1053/j.jfas.2003.11.008; Hosea TM, 2000, CLIN ORTHOP RELAT R, P45; Huang PY, 2014, J ATHL TRAINING, V49, P163, DOI 10.4085/1062-6050-49.2.10; Hunt Kenneth J, 2013, Curr Rev Musculoskelet Med, V6, P304, DOI 10.1007/s12178-013-9184-9; Magan A, 2014, BRIT MED BULL, V111, P101, DOI 10.1093/bmb/ldu020; Snedden MH, 2001, CLIN ORTHOP RELAT R, P197	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	MAR	2015	65	2					165	170		10.1007/s12576-015-0355-x		6	Physiology	Physiology	CC4DK	WOS:000350300800003		
J	Takatsuru, Y; Nabekura, J; Ishikawa, T; Kohsaka, S; Koibuchi, N				Takatsuru, Yusuke; Nabekura, Junichi; Ishikawa, Tatsuya; Kohsaka, Shin-ichi; Koibuchi, Noriyuki			Early-life stress increases the motility of microglia in adulthood	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						Maternal deprivation; In vivo imaging; In vivo microdialysis; Somatosensory cortex	IN-VIVO; SOMATOSENSORY CORTEX; MATERNAL SEPARATION; PREFRONTAL CORTEX; NEURAL CIRCUITS; BRAIN; HIPPOCAMPUS; RESPONSES; SYNAPSES; FRONTIER	Early-life stress may cause several neuropsychological disorders in adulthood. Such disorders may be induced as a result of instability of neuronal circuits and/or synaptic formation. However, the mechanisms underlying such instability have not yet been clearly understood. We previously reported that the mushroom spine in the somatosensory cortex (SSC) is unstable in early-life stressed mice not only in the juvenile stage but also in adulthood. In this study, we measured the number and motility of microglial processes in early-life stressed mice to understand the mechanism further. We found that the number and motility of filopodia-like protrusions of microglial processes tended to increase in the SSC of early-life stressed mice. Interestingly, the motility of protrusions correlated significantly with the nociceptive threshold level measured by the von Frey test. These results indicated that the activity of microglia affected the neuronal function in early-life stressed mice.	[Takatsuru, Yusuke; Koibuchi, Noriyuki] Gunma Univ, Grad Sch Med, Dept Integrat Physiol, Maebashi, Gunma 3718511, Japan; [Takatsuru, Yusuke; Ishikawa, Tatsuya] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Nabekura, Junichi; Ishikawa, Tatsuya] Natl Inst Nat Sci, Natl Inst Physiol Sci, Div Homeostat Dev, Okazaki, Aichi 4448585, Japan; [Nabekura, Junichi] Grad Univ Adv Studies, Hayama, Kanagawa 2400193, Japan; [Kohsaka, Shin-ichi] Natl Inst Neurosci, Dept Neurochem, Kodaira, Tokyo 1878502, Japan	Takatsuru, Y (reprint author), Gunma Univ, Grad Sch Med, Dept Integrat Physiol, Maebashi, Gunma 3718511, Japan.	takatsur@gunma-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [23111504]; Japan Society for the Scientific of Sciences (JSPS) [21390065, 19390055, 22240042]; Core Research for Evolutional Science and Technology from Japan Science and Technology Agency	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (23111504) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) to YT, a Grant-in-Aid for Scientific Research (B) (21390065) from the Japan Society for the Scientific of Sciences (JSPS) to NK, and Core Research for Evolutional Science and Technology from Japan Science and Technology Agency and Grant-in-Aid for Scientific Research (B) (19390055) and (A) (22240042) from the Japan Society for the Scientific of Sciences (JSPS) to JN.	Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; LOWY MT, 1993, J NEUROCHEM, V61, P1957, DOI 10.1111/j.1471-4159.1993.tb09839.x; Reznikov LR, 2007, EUR J NEUROSCI, V25, P3109, DOI 10.1111/j.1460-9568.2007.05560.x; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Morris GP, 2013, NEUROBIOL LEARN MEM, V105, P40, DOI 10.1016/j.nlm.2013.07.002; Perry VH, 2010, ASN NEURO, V2, P281, DOI 10.1042/AN20100024; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Eyo UB, 2013, NEURAL PLAST, DOI 10.1155/2013/456857; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Wigger A, 1999, PHYSIOL BEHAV, V66, P293, DOI 10.1016/S0031-9384(98)00300-X; Wake H, 2013, TRENDS NEUROSCI, V36, P209, DOI 10.1016/j.tins.2012.11.007; Sanacora G, 2012, NEUROPHARMACOLOGY, V62, P63, DOI 10.1016/j.neuropharm.2011.07.036; Bock J, 2005, CEREB CORTEX, V15, P802, DOI 10.1093/cercor/bhh181; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Romeo RD, 2006, ANN NY ACAD SCI, V1094, P202, DOI 10.1196/annals.1376.022; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Crawford M. A., 1993, Nutrition and Health (Bicester), V9, P81; Hirasawa T, 2005, J NEUROSCI RES, V81, P357, DOI 10.1002/jnr.20480; Kosten TA, 2006, BRAIN RES, V1087, P142, DOI 10.1016/j.brainres.2006.03.009; Miyamoto A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00070; MOGHADDAM B, 1993, J NEUROCHEM, V60, P1650, DOI 10.1111/j.1471-4159.1993.tb13387.x; Musazzi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008566; Ovtscharoff W, 2001, NEUROSCIENCE, V104, P33, DOI 10.1016/S0306-4522(01)00059-8; Parfitt DB, 2004, BRAIN RES, V1016, P111, DOI 10.1016/j.brainres.2004.04.077; Popoli M, 2011, NAT REV NEUROSCI, V13, P22, DOI [10.1038/nrn3138, DOI 10.1038/NRN3138]; Shair HN, 2007, BEHAV BRAIN RES, V182, P180, DOI 10.1016/j.bbr.2007.02.016; Slotten HA, 2006, BRAIN RES, V1097, P123, DOI 10.1016/j.brainres.2006.04.066; Takatsuru Y, 2013, J NEUROSCI, V33, P4683, DOI 10.1523/JNEUROSCI.2657-12.2013; Takatsuru Y, 2009, BRAIN RES, V1294, P45, DOI 10.1016/j.brainres.2009.07.092; Toya S, 2014, EUR J NEUROSCI, V40, P3627, DOI 10.1111/ejn.12728; Toya ST, 2013, J PHYSIOL SCI, V63, pS152; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527	36	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	MAR	2015	65	2					187	194		10.1007/s12576-015-0361-z		8	Physiology	Physiology	CC4DK	WOS:000350300800006		
J	Kamide, T; Okumura, S; Ghosh, S; Shinoda, Y; Mototani, Y; Ohnuki, Y; Jin, HL; Cai, WQ; Suita, K; Sato, I; Umemura, M; Fujita, T; Yokoyama, U; Sato, M; Furutani, K; Kitano, H; Ishikawa, Y				Kamide, Takehisa; Okumura, Satoshi; Ghosh, Samik; Shinoda, Yoko; Mototani, Yasumasa; Ohnuki, Yoshiki; Jin, Huiling; Cai, Wenqian; Suita, Kenji; Sato, Itaru; Umemura, Masanari; Fujita, Takayuki; Yokoyama, Utako; Sato, Motohiko; Furutani, Kazuharu; Kitano, Hiroaki; Ishikawa, Yoshihiro			Oscillation of cAMP and Ca2+ in cardiac myocytes: a systems biology approach	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						Adenlyl cyclase; Subtype; Computational analysis; Oscillation; Cyclic AMP; Calcium	PROTEIN-KINASE-A; ADENYLYL-CYCLASE ISOFORM; PHOSPHORYLATION STATUS; PARABOLIC FLIGHT; HEART-FAILURE; CALCIUM; STIMULATION; DISRUPTION; DESENSITIZATION; EXPRESSION	Cyclic adenosine monophosphate (cAMP) and Ca2+ levels may oscillate in harmony within excitable cells; a mathematical oscillation loop model, the Cooper model, of these oscillations was developed two decades ago. However, in that model all adenylyl cyclase (AC) isoforms were assumed to be inhibited by Ca2+, and it is now known that the heart expresses multiple AC isoforms, among which the type 5/6 isoforms are Ca2+-inhibitable whereas the other five (AC2, 3, 4, 7, and 9) are not. We used a computational systems biology approach with CellDesigner simulation software to develop a comprehensive graphical map and oscillation loop model for cAMP and Ca2+. This model indicated that Ca2+-mediated inhibition of AC is essential to create oscillations of Ca2+ and cAMP, and the oscillations were not altered by incorporation of phosphodiesterase-mediated cAMP hydrolysis or PKA-mediated inhibition of AC into the model. More importantly, they were created but faded out immediately in the co-presence of Ca2+-noninhibitable AC isoforms. Because the subcellular locations of AC isoforms are different, spontaneous cAMP and Ca2+ oscillations may occur within microdomains containing only Ca2+-inhibitable isoforms in cardiac myocytes, which might be necessary for fine tuning of excitation-contraction coupling.	[Kamide, Takehisa; Okumura, Satoshi; Jin, Huiling; Cai, Wenqian; Suita, Kenji; Sato, Itaru; Umemura, Masanari; Fujita, Takayuki; Yokoyama, Utako; Sato, Motohiko; Ishikawa, Yoshihiro] Yokohama City Univ, Cardiovasc Res Inst, Grad Sch Med, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Okumura, Satoshi; Shinoda, Yoko; Mototani, Yasumasa; Ohnuki, Yoshiki] Tsurumi Univ, Sch Dent Med, Dept Physiol, Tsurumi Ku, Yokohama, Kanagawa 2308501, Japan; [Ghosh, Samik; Kitano, Hiroaki] Syst Biol Inst, Minato Ku, Tokyo 1080071, Japan; [Sato, Motohiko] Aichi Med Univ, Dept Physiol, Nagakute, Aichi 4801195, Japan; [Furutani, Kazuharu] Osaka Univ, Grad Sch Med, Dept Pharmacol, Osaka 5650871, Japan; [Furutani, Kazuharu] Osaka Univ, Ctr Adv Med Engn & Informat, Osaka 5650871, Japan; [Kitano, Hiroaki] Okinawa Inst Sci & Technol, Grad Sch, Onna Son, Okinawa 9040412, Japan; [Kitano, Hiroaki] RIKEN, Ctr Integrat Med Sci, Lab Dis Syst Modeling, Yokohama, Kanagawa 2300045, Japan	Ishikawa, Y (reprint author), Yokohama City Univ, Cardiovasc Res Inst, Grad Sch Med, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	okumura-s@tsuruni-u.ac.jp; yishikaw@yokohama-cu.ac.jp			Ministry of Health, Labor, and Welfare; Japanese Ministry of Education, Culture, Sports, Science, and Technology; National Cerebral and Cardiovascular Center; Takeda Science Foundation; Yokohama Foundation for Advancement of Medical Science; Yokohama Academic Foundation; Research Foundation for Community Medicine; Suzuken Memorial Foundation;  [22136009]	This study was supported in part by grants from the Ministry of Health, Labor, and Welfare (Dr Ishikawa), a Grant-in-Aid for Scientific Research on Innovative Areas (22136009), and Grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (Drs Ishikawa, Okumura, Fujita, Sato, Yokoyama, Mototani), the National Cerebral and Cardiovascular Center (Dr Ishikawa), the Takeda Science Foundation (Dr Okumura), the Yokohama Foundation for Advancement of Medical Science (Dr Okumura), the Yokohama Academic Foundation (Dr Ohnuki), the Research Foundation for Community Medicine (Dr Okumura), and the Suzuken Memorial Foundation (Dr Okumura).	Dolmetsch RE, 1998, NATURE, V392, P933; Okumura S, 2003, CIRC RES, V93, P364, DOI 10.1161/01.RES.0000086986.35568.63; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Bers DM, 2002, CIRC RES, V90, P14; Okumura S, 2014, J CLIN INVEST, V124, P2785, DOI 10.1172/JCI64784; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Matsuoka Y, 2014, METHODS MOL BIOL, V1164, P121, DOI 10.1007/978-1-4939-0805-9_11; Chen YB, 1997, P NATL ACAD SCI USA, V94, P14100, DOI 10.1073/pnas.94.25.14100; Timofeyev V, 2013, CIRC RES, V112, P1567, DOI 10.1161/CIRCRESAHA.112.300370; ESPINASSE I, 1995, J MOL CELL CARDIOL, V27, P1789, DOI 10.1016/0022-2828(95)90002-0; Tang T, 2008, CIRCULATION, V117, P61, DOI 10.1161/CIRCULATIONAHA.107.730069; IWAMI G, 1995, J BIOL CHEM, V270, P12481; Okumura S, 2003, P NATL ACAD SCI USA, V100, P9986, DOI 10.1073/pnas.1733772100; Autiero I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006226; Bai YZ, 2012, J PHARMACOL SCI, V119, P381, DOI 10.1254/jphs.12102FP; Funahashi Akira, 2007, In Silico Biology, V7, pS81; Grieco L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003286; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Ishikawa Y, 1997, CIRC RES, V80, P297; ISHIKAWA Y, 1992, J BIOL CHEM, V267, P13553; KATSUSHIKA S, 1992, P NATL ACAD SCI USA, V89, P8774, DOI 10.1073/pnas.89.18.8774; Masaki N, 2013, BIOPHYS J, V104, P1191, DOI 10.1016/j.bpj.2013.01.023; Mika D, 2014, J CELL SCI, V127, P1033, DOI 10.1242/jcs.140251; Ohnuki Y, 2014, J PHYSIOL-LONDON, V592, P5461, DOI 10.1113/jphysiol.2014.282996; Ohnuki Y, 2008, J PHYSIOL SCI, V58, P15, DOI [10.2170/physiolsci.RP012807, 10.2170/physioisci.RP012807]; Ohnuki Y, 2013, J PHARMACOL SCI, V123, P279, DOI 10.1254/jphs.13110SC; Okumura S, 2008, J APPL PHYSIOL, V105, P173, DOI 10.1152/japplphysiol.01166.2007; Okumura S, 2009, J PHARMACOL SCI, V109, P354, DOI 10.1254/jphs.08R26FM; Okumura S, 2007, CIRCULATION, V116, P1776, DOI 10.1161/CIRCULATIONAHA.107.698662; PREMONT RT, 1992, ENDOCRINOLOGY, V131, P2774, DOI 10.1210/en.131.6.2774; Sato N, 1999, AM J PHYSIOL-HEART C, V276, pH1699; TOBISE K, 1994, CIRC RES, V74, P596; Wu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010137	35	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	MAR	2015	65	2					195	200		10.1007/s12576-014-0354-3		6	Physiology	Physiology	CC4DK	WOS:000350300800007		
J	Watanabe, Y; Sasaki, R; Agawa, K; Akizuki, T				Watanabe, Yorikatsu; Sasaki, Ryo; Agawa, Kaori; Akizuki, Tanetaka			Bidirectional/double fascia grafting for simple and semi-dynamic reconstruction of lower lip deformity in facial paralysis	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Facial paralysis; Bidirectional/double fascia grafting; Semi-dynamic reconstruction; Lower lip deformity	LATISSIMUS-DORSI MUSCLE; MARGINAL MANDIBULAR BRANCH; BOTULINUM TOXIN; NERVE; REANIMATION; TRANSPLANTATION; SMILE; PALSY	Background: For the total aesthetic reconstruction of facial paralysis, treatment of lower lip deformity as "a neglected target in facial reanimation" is important. Although various dynamic reconstruction approaches have been reported for lower lip deformity, these have not been popularly performed due to aggressive surgical invasiveness, long recovery time for reinnervation, and unstable outcomes. To reconstruct the lower lip deformity more simply but semi-dynamically, we modified bidirectional/double fascia grafting methods that have been established as simple and minimally invasive treatments for pediatric congenital lower lip paralysis. Methods: Between 2009 and 2011, nine patients were treated using this procedure alone or with combinations of other procedures of facial reanimation such as one-stage free muscle transfer. For outcome assessment, patients were evaluated using a lower lip paralysis grading system, including the objective aesthetics and functional results of the lower lip at rest (score range, 0-1), during smiling (score range, 0-4), and during mouth opening (score range, 0-2). Results: The mean total scores improved from 1.43 (poor) preoperatively to 5.71 (excellent) postoperatively. In all evaluation items, the postoperative scores improved significantly compared to the preoperative scores (p < 0.01) with no severe complications. Conclusions: The procedure is simply applied to various types of extensive facial paralysis, as well as congenital lower lip paralysis in combination with other static and dynamic reconstruction methods for facial paralysis, and it is suggested that this approach significantly and semi-dynamically improves the aesthetic function of the lower lip at rest, during smiling, and during mouth opening. (C) 2014 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Watanabe, Yorikatsu; Agawa, Kaori; Akizuki, Tanetaka] Tokyo Metropolitan Police Hosp, Dept Plast Reconstruct & Aesthet Surg, Tokyo 1648541, Japan; [Sasaki, Ryo] Tokyo Metropolitan Police Hosp, Dept Oral & Maxillofacial Surg, Sch Med, Tokyo 1648541, Japan	Watanabe, Y (reprint author), Tokyo Metropolitan Police Hosp, Dept Plast Reconstruct & Aesthet Surg, Nakano Ku, 4-22-1 Nakano, Tokyo 1648541, Japan.	yorika2@hotmail.com					Yamamoto Y, 2007, J PLAST RECONSTR AES, V60, P223, DOI 10.1016/j.bjps.2006.05.012; Takushima A, 2013, J PLAST RECONSTR AES, V66, P29, DOI 10.1016/j.bjps.2012.08.004; CONLEY J, 1982, PLAST RECONSTR SURG, V70, P569, DOI 10.1097/00006534-198211000-00007; GUYURON B, 1994, PLAST RECONSTR SURG, V93, P913, DOI 10.1097/00006534-199404001-00003; Labbe D, 2000, PLAST RECONSTR SURG, V105, P1289, DOI 10.1097/00006534-200004040-00005; Harii K, 1998, PLAST RECONSTR SURG, V102, P941, DOI 10.1097/00006534-199809040-00001; Chen CK, 2007, PLAST RECONSTR SURG, V120, P1859, DOI 10.1097/01.prs.0000287136.22709.77; Watanabe Y, 2009, J PLAST RECONSTR AES, V62, P1589, DOI 10.1016/j.bjps.2008.07.025; Breslow GD, 2005, PLAST RECONSTR SURG, V116, P1223, DOI 10.1097/01.prs.0000182219.40800.56; EDGERTON MT, 1967, ANN SURG, V165, P985, DOI 10.1097/00000658-196706000-00014; Koshima I, 1997, J RECONSTR MICROSURG, V13, P157, DOI 10.1055/s-2007-1000242; Lindsay RW, 2011, AM J OTOLARYNG, V32, P1, DOI 10.1016/j.amjoto.2009.08.011; Tanaka I, 2010, FACIAL N RES JPN, V29, P114; Terzis JK, 2000, PLAST RECONSTR SURG, V105, P1917, DOI 10.1097/00006534-200005000-00001; Tulley P, 2000, BRIT J PLAST SURG, V53, P378, DOI 10.1054/bjps.2000.3318; Udagawa A, 2007, PLAST RECONSTR SURG, V120, P238, DOI 10.1097/01.prs.0000264062.64251.10; UEDA K, 1995, PLAST RECONSTR SURG, V95, P1288, DOI 10.1097/00006534-199506000-00023; Yamamoto Y, 2007, JPN PLAST RECONSTR S, V27, P543; Yamamoto Y, 2008, FACIAL NERVE RES JPN, V27, P199; Yoleri L, 2006, ANN PLAS SURG, V57, P295, DOI 10.1097/01.sap.0000221615.37105.d1	20	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	MAR	2015	68	3					321	328		10.1016/j.bjps.2014.10.044		8	Surgery	Surgery	CB9VL	WOS:000349981500013		
J	Umezawa, H; Ogawa, R; Hyakusoku, H				Umezawa, Hiroki; Ogawa, Rei; Hyakusoku, Hiko			Harvesting huge bipedicled free flaps from the anterolateral and medial thigh: Combined saphenous-anterolateral thigh (SALT) flaps	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Letter							ARTERY		[Umezawa, Hiroki; Ogawa, Rei; Hyakusoku, Hiko] Nippon Med Sch, Dept Plast Reconstruct & Aesthet Surg, Bunkyo Ku, Tokyo 1138603, Japan	Umezawa, H (reprint author), Nippon Med Sch, Dept Plast Reconstruct & Aesthet Surg, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	s8013@nms.ac.jp					ACLAND RD, 1981, PLAST RECONSTR SURG, V67, P763, DOI 10.1097/00006534-198106000-00009; Kimata Y, 1998, PLAST RECONSTR SURG, V102, P1517, DOI 10.1097/00006534-199810000-00026; Wei FC, 2002, PLAST RECONSTR SURG, V109, P2219, DOI 10.1097/00006534-200206000-00007; Miyamoto S, 2013, J PLAST RECONSTR AES, V66, P1604, DOI 10.1016/j.bjps.2013.03.028; SONG YG, 1984, BRIT J PLAST SURG, V37, P149, DOI 10.1016/0007-1226(84)90002-X	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	MAR	2015	68	3					434	436		10.1016/j.bjps.2014.10.027		4	Surgery	Surgery	CB9VL	WOS:000349981500031		
J	Mitsukawa, N; Kubota, Y; Akita, S; Saiga, A; Satoh, K				Mitsukawa, Nobuyuki; Kubota, Yoshitaka; Akita, Shinsuke; Saiga, Atsuomi; Satoh, Kaneshige			Postsurgical fixation of a buried penis	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Letter									[Mitsukawa, Nobuyuki; Kubota, Yoshitaka; Akita, Shinsuke] Chiba Univ, Fac Med, Dept Plast Reconstruct & Aesthet Surg, Chiba, Japan; [Saiga, Atsuomi] St Marys Hosp, Dept Plast & Reconstruct Surg, Fukuoka, Japan; [Satoh, Kaneshige] Chiba Univ, Fac Med, Dept Reconstruct & Aesthet Surg, Chiba, Japan	Mitsukawa, N (reprint author), Chiba Univ, Fac Med, Dept Plast Reconstruct & Aesthet Surg, Chiba, Japan.	nmitsu@air.linkclub.or.jp					Frenkl TL, 2004, J UROLOGY, V171, P826, DOI 10.1097/01.ju.0000107824.72182.95; Borsellino A, 2007, UROLOGY, V69, P1195, DOI 10.1016/j.urology.2007.01.065; Hyakusoku H, 2006, AESTHET PLAST SURG, V30, P396, DOI 10.1007/s00266-005-0018-z; Spinoit AF, 2013, UROL INT, V91, P134, DOI 10.1159/000351944; Tal MG, 2003, PLAST RECONSTR SURG, V112, P1178, DOI 10.1097/01.PRS.0000077217.55660.BE	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	MAR	2015	68	3					439	441		10.1016/j.bjps.2014.10.032		4	Surgery	Surgery	CB9VL	WOS:000349981500034		
J	Seki, Y				Seki, Yasuhiro			A simple small syringe suction drain system for septic arthritis of the finger	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Letter									Suwa Cent Hosp, Dept Orthopaed Surg, Chino, Nagano 3918503, Japan	Seki, Y (reprint author), Suwa Cent Hosp, Dept Orthopaed Surg, 4300 Tamagawa, Chino, Nagano 3918503, Japan.	yseki@suwachuo.jp					Akin S, 2004, PLAST RECONSTR SURG, V113, P2221, DOI 10.1097/01.PRS.0000123604.74180.FC; Al-Ani SA, 2004, PLAST RECONSTR SURG, V114, P614, DOI 10.1097/01.PRS.0000133456.72218.A9; SINGH A, 1992, BRIT J PLAST SURG, V45, P484, DOI 10.1016/0007-1226(92)90216-K; Sun ZY, 2009, INT J SURG, V7, P82, DOI 10.1016/j.ijsu.2008.07.003; Tan O, 2005, PLAST RECONSTR SURG, V116, P2060, DOI 10.1097/01.prs.0000192615.33036.4b	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	MAR	2015	68	3					E67	E68		10.1016/j.bjps.2014.12.012		2	Surgery	Surgery	CB9VL	WOS:000349981500008		
J	Yoshimatsu, H; Yamamoto, T; Iida, T				Yoshimatsu, Hidehiko; Yamamoto, Takumi; Iida, Takuya			Pedicle elongation technique of superficial circumflex iliac artery perforator flap	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Letter							RECONSTRUCTION; DEFECTS		[Yoshimatsu, Hidehiko; Yamamoto, Takumi; Iida, Takuya] Univ Tokyo, Grad Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138655, Japan	Yoshimatsu, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	hidehiko.yoshimatsu@gmail.com					Koshima I, 2004, PLAST RECONSTR SURG, V113, P233, DOI 10.1097/01.PRS.0000095948.03605.20; Hong JP, 2013, ANN PLAS SURG, V71, P380, DOI 10.1097/SAP.0b013e3182503ac5; Groin Flaps, 1993, ATLAS MICROVASCULAR, P120	3	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	MAR	2015	68	3					E61	E62		10.1016/j.bjps.2014.11.018		2	Surgery	Surgery	CB9VL	WOS:000349981500006		
J	Watanabe, M; Umezaki, Y; Suzuki, S; Miura, A; Shinohara, Y; Yoshikawa, T; Sakuma, T; Shitano, C; Katagiri, A; Sato, Y; Takenoshita, M; Toyofuku, A				Watanabe, Motoko; Umezaki, Yojiro; Suzuki, Spica; Miura, Anna; Shinohara, Yukiko; Yoshikawa, Tatsuya; Sakuma, Tomomi; Shitano, Chisa; Katagiri, Ayano; Sato, Yusuke; Takenoshita, Miho; Toyofuku, Akira			Psychiatric comorbidities and psychopharmacological outcomes of phantom bite syndrome	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Article						Antidepressants; Dental treatment; Phantom bite syndrome; Psychiatric disorder; Psychopharmacology; Trigger	PAIN; MANAGEMENT; DISORDERS	Objective: Phantom bite syndrome (PBS) is characterized by a persistent uncomfortable sensation of occlusion without an evident occlusal discrepancy. The aims of this retrospective cross-sectional study were to assess psychiatric comorbidities and evaluate psychopharmacological outcomes of PBS. Methods: The database of the Psychosomatic Dentistry Clinic of Tokyo Medical and Dental University Dental Hospital was reviewed for cases of PBS diagnosed between April 2009 and March 2012. Clinical Global Impression indices were used to assess psychopharmacological outcomes. Results: The review revealed 130 patients (107 women, 23 men) with a mean age of 53.0 +/- 13.1 years. They previously visited 4.4 +/- 3.4 dental clinicsand had a mean symptom duration of 5.3 +/- 5.4 years. Only 24(18.5%) of 63 (48.5%) patients with psychiatric comorbidities had schizophrenia, major depressive disorder, or bipolar disorder. The frequency of psychiatric comorbidities was significantly lower in PBS with a dental trigger than that without a specific trigger. Moreover, patients without a psychiatric comorbidity showed significantly better outcomes than those with a psychiatric comorbidity. Forty patients (30.8%) showed remarkable clinical improvement after receiving amitriptyline, mirtazapine, or aripiprazole. Conclusion: PBS is generally not associated with severe psychiatric disorders. Absence of a dental trigger predicts a psychiatric comorbidity, which affects the psychopharmacological outcome. Antidepressant or antipsychotic therapy may be effective for symptom management in PBS. (C) 2014 The Authors. Published by Elsevier Inc.	[Watanabe, Motoko; Umezaki, Yojiro; Suzuki, Spica; Miura, Anna; Shinohara, Yukiko; Katagiri, Ayano; Takenoshita, Miho; Toyofuku, Akira] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Dent, Tokyo 1138549, Japan; [Yoshikawa, Tatsuya; Sakuma, Tomomi; Shitano, Chisa] Tokyo Med & Dent Univ Dent Hosp, Psychosomat Dent Clin, Tokyo, Japan; [Sato, Yusuke] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Gerodontol, Tokyo 1138549, Japan	Watanabe, M (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Psychosomat Dent, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	totoompm@tmd.ac.jp			Japan Society for the Promotion of Science [24593141]	This study was supported in by a Grant-in-aid for Science Research from the Japan Society for the Promotion of Science (No. 24593141). The authors have no competing interests to report.	Alberts IL., 2009, INTERNET J PAIN SYMP, P6; Tsukiyama Y, 2012, J ORAL REHABIL, V39, P623, DOI 10.1111/j.1365-2842.2012.02317.x; Melzack R, 2001, ANN NY ACAD SCI, V933, P157; Davis KD, 1998, NATURE, V391, P385, DOI 10.1038/34905; MARBACH JJ, 1978, AM J PSYCHIAT, V135, P476; MARBACH JJ, 1983, J PROSTHET DENT, V49, P556, DOI 10.1016/0022-3913(83)90322-0; Hara ES, 2012, J ORAL REHABIL, V39, P630, DOI 10.1111/j.1365-2842.2012.02300.x; Miyachi H, 2007, PSYCHIAT CLIN NEUROS, V61, P313, DOI 10.1111/j.1440-1819.2007.01657.x; Jagger RG, 2004, BRIT DENT J, V197, P241, DOI 10.1038/sj.bdj.4811613; Marbach JJ, 1996, J AM DENT ASSOC, V127, P221; Leon-Salazar V, 2012, J AM DENT ASSOC, V143, P989; [Anonymous], 1985, PSYCHOPHARMACOL B, V21, P714; Clark Glenn, 2003, Alpha Omegan, V96, P33; Clark GT, 1997, ORAL SURG ORAL MED O, V83, P101, DOI 10.1016/S1079-2104(97)90099-8; HARRIS M, 1993, BRIT DENT J, V174, P129, DOI 10.1038/sj.bdj.4808098; Koga C, 2001, JAPAN J PSYCHOSOM DE, V16, P95; MARBACH JJ, 1976, AM J ORTHOD DENTOFAC, V70, P190, DOI 10.1016/S0002-9416(76)90319-5; Shetti S, 2012, J DENT ALLIED SCI, V1, P82; Tamaki K., 2009, JAPAN J PSYCHOSOM DE, V49, P1079; Tamaki K, 2013, ANN JPN PROSTHODONT, V5, P369; Toyofuku A, 1998, DELHI PSYCHIAT J, V13, P51; Toyofuku Akira, 2006, Neuropsychiatr Dis Treat, V2, P387, DOI 10.2147/nedt.2006.2.3.387; Toyofuku A, 1994, JAPAN J PSYCHOSOM DE, V9, P192; Toyofuku A, 1996, JAPAN J PSYCHOSOM DE, V11, P88; Umezaki Y, 2013, JAPAN J PSYCHOSOM DE, V28, P30; Umezaki Y, 2012, JAPAN J PSYCHOSOM DE, V27, P44; Watanabe M, 2012, JAPAN J PSYCHOSOM DE, V27, P37	27	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999	1879-1360		J PSYCHOSOM RES	J. Psychosomat. Res.	MAR	2015	78	3					255	259		10.1016/j.jpsychores.2014.11.010		5	Psychiatry	Psychiatry	CC2PE	WOS:000350186300008		
J	Nikitin, AV; Lyulin, OM; Mikhailenko, SN; Perevalov, VI; Filippov, NN; Grigoriev, IM; Morino, I; Yoshida, Y; Matsunaga, T				Nikitin, A. V.; Lyulin, O. M.; Mikhailenko, S. N.; Perevalov, V. I.; Filippov, N. N.; Grigoriev, I. M.; Morino, I.; Yoshida, Y.; Matsunaga, T.			GOSAT-2014 methane spectral line list	JOURNAL OF QUANTITATIVE SPECTROSCOPY & RADIATIVE TRANSFER			English	Article						Methane; CH4; Near infrared; Tetradecad; GOSAT; GOSAT-2	2-NU(3) BAND; REGION; CM(-1); SPECTROSCOPY; PARAMETERS; DATABASE; N-2; CH4	The updated methane spectral line list GOSAT-2014 for the 5550-6240 cm(-1) region with the intensity cutoff of 5 x 10(-25) cm/molecule at 296 K is presented. The line list is based on the extensive measurements of the methane spectral line parameters performed at different temperatures and pressures of methane without and with buffer gases N-2, O-2 and air. It contains the following spectral line parameters of about 12150 transitions: line position, line intensity, energy of lower state, air-induced and self-pressure-induced broadening and shift coefficients and temperature exponent of air-broadening coefficient. The accuracy of the line positions and intensities are considerably improved in comparison with the previous version GOSAT-2009. The improvement of the line list is done mainly due to the involving to the line position and intensity retrieval of six new spectra recorded with short path way (8.75 cm). The air-broadening and air-shift coefficients for the J-manifolds of the 2 nu(3)(F-2) band are refitted using the new more precise values of the line positions and intensities. The line assignment is considerably extended. The lower state J-value was assigned to 6397 lines representing 94.4% of integrated intensity of the considering wavenumber region. The complete assignment was done for 2750 lines. (C) 2014 Elsevier Ltd. All rights reserved.	[Nikitin, A. V.; Lyulin, O. M.; Mikhailenko, S. N.; Perevalov, V. I.] SB RAS, VE Zuev Inst Atmospher Opt, Lab Theoret Spect, Tomsk 634021, Russia; [Filippov, N. N.; Grigoriev, I. M.] St Petersburg State Univ, St Petersburg 198504, Russia; [Morino, I.; Yoshida, Y.; Matsunaga, T.] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Nikitin, A. V.] Tomsk State Univ, Tomsk 634050, Russia	Perevalov, VI (reprint author), SB RAS, VE Zuev Inst Atmospher Opt, Lab Theoret Spect, 1 Academician Zuev Sq, Tomsk 634021, Russia.	vip@lts.iao.ru	Grigoriev, Ivan/N-1800-2014; Nikitin, Andrei/K-2624-2013; Filippov, Nikolai/F-3306-2013	Grigoriev, Ivan/0000-0003-4899-7690; Nikitin, Andrei/0000-0002-4280-4096; Filippov, Nikolai/0000-0002-4776-5954			Brown LR, 2013, J QUANT SPECTROSC RA, V130, P201, DOI 10.1016/j.jqsrt.2013.06.020; Gao B, 2009, J MOL SPECTROSC, V253, P55, DOI 10.1016/j.jms.2008.09.005; Nikitin AV, 2011, J MOL SPECTROSC, V268, P93, DOI 10.1016/j.jms.2011.04.002; Campargue A, 2013, J QUANT SPECTROSC RA, V118, P49, DOI 10.1016/j.jqsrt.2012.12.004; Nikitin AV, 2013, CHEM PHYS LETT, V565, P5, DOI 10.1016/j.cplett.2013.02.022; Nikitin AV, 2010, J QUANT SPECTROSC RA, V111, P2211, DOI 10.1016/j.jqsrt.2010.05.010; Lyulin OM, 2010, J MOL SPECTROSC, V261, P91, DOI 10.1016/j.jms.2010.03.008; Frankenberg C, 2008, ATMOS CHEM PHYS, V8, P5061; Rothman LS, 2013, J QUANT SPECTROSC RA, V130, P4, DOI 10.1016/j.jqsrt.2013.07.002; Campargue A, 2013, J MOL SPECTROSC, V291, P16, DOI 10.1016/j.jms.2013.03.001; Yokota T, 2009, SOLA, V5, P160, DOI 10.2151/sola.2009-041; Yoshida Y, 2013, ATMOS MEAS TECH, V6, P1533, DOI 10.5194/amt-6-1533-2013; Nikitin AV, 2011, CHEM PHYS LETT, V501, P179, DOI 10.1016/j.cplett.2010.11.008; Lyulin OM, 2009, J QUANT SPECTROSC RA, V110, P654, DOI 10.1016/j.jqsrt.2009.02.012; Lyulin OM, 2011, J QUANT SPECTROSC RA, V112, P531, DOI 10.1016/j.jqsrt.2010.10.010; Matsunaga T, 2014, P 10 INT WORKSH GREE, P72; Nikitin AV, 2013, PHYS CHEM CHEM PHYS, V15, P10071, DOI 10.1039/c3cp50799h; Nikitin AV, 2009, J QUANT SPECTROSC RA, V110, P964, DOI 10.1016/j.jqsrt.2009.02.016; Nikitin AV, 2011, ATMOS OCEAN OPT, V24, P931; Rey M, 2013, PHYS CHEM CHEM PHYS, V15, P10049, DOI 10.1039/c3cp50275a; Suto H, 2014, P 10 INT WORKSH GREE, P23; Tran H, 2006, J QUANT SPECTROSC RA, V101, P284, DOI 10.1016/j.jqsrt.2005.11.020; Zolot AM, 2013, J QUANT SPECTROSC RA, V113, P1855	23	2	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4073	1879-1352		J QUANT SPECTROSC RA	J. Quant. Spectrosc. Radiat. Transf.	MAR	2015	154						63	71		10.1016/j.jqsrt.2014.12.003		9	Optics; Spectroscopy	Optics; Spectroscopy	CB8JY	WOS:000349877000008		
J	Videen, G; Sun, WB; Kocifaj, M; Kai, KJ; Kawamoto, K; Horvath, H; Mishchenko, M				Videen, Gorden; Sun, Wenbo; Kocifaj, Miroslav; Kai, Kenji; Kawamoto, Kazuaki; Horvath, Helmuth; Mishchenko, Michael			Topical issue on optical particle characterization and remote sensing of the atmosphere: Part II	JOURNAL OF QUANTITATIVE SPECTROSCOPY & RADIATIVE TRANSFER			English	Editorial Material							3-DIMENSIONAL DATA ASSIMILATION; SURFACE PRESSURE MEASUREMENTS; ABSORPTION RADAR SYSTEM; LIGHT-SCATTERING; VALIDATION; MORPHOLOGY; AEROSOLS; IMPACT; LIDAR; DUST		[Videen, Gorden] INTA, Madrid 28850, Spain; [Videen, Gorden] Univ Cantabria, Fac Ciencias, Dept Fis Aplicada, Grp Opt, E-39005 Santander, Spain; [Videen, Gorden] US Army Res Lab, Adelphi, MD 20783 USA; [Videen, Gorden] Space Sci Inst, Boulder, CO 80301 USA; [Sun, Wenbo] Sci Syst & Applicat Inc, Hampton, VA 23666 USA; [Kocifaj, Miroslav] Slovak Acad Sci, Bratislava 84503, Slovakia; [Kai, Kenji] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Kawamoto, Kazuaki] Nagasaki Univ, Fac Environm Studies, Nagasaki 852, Japan; [Horvath, Helmuth] Univ Vienna, Dept Phys, A-1090 Vienna, Austria; [Mishchenko, Michael] NASA, Goddard Inst Space Studies, New York, NY 10025 USA	Videen, G (reprint author), INTA, Ctra Ajalvir Km 4, Madrid 28850, Spain.	gorden.w.videen.civ@mail.mil	Mishchenko, Michael/D-4426-2012				Shimizu A, 2015, J QUANT SPECTROSC RA, V153, P77, DOI 10.1016/j.jqsrt.2014.12.005; Jin Y, 2015, J QUANT SPECTROSC RA, V153, P49, DOI 10.1016/j.jqsrt.2014.10.009; Wang CJ, 2015, J QUANT SPECTROSC RA, V153, P4, DOI 10.1016/j.jqsrt.2014.11.004; Liu JJ, 2015, J QUANT SPECTROSC RA, V153, P102, DOI 10.1016/j.jqsrt.2014.10.011; Bangsheng Yin, 2015, Journal of Quantitative Spectroscopy & Radiative Transfer, V150, DOI 10.1016/j.jqsrt.2014.08.012; Berg MJ, 2015, J QUANT SPECTROSC RA, V150, P36, DOI 10.1016/j.jqsrt.2014.05.005; Brown AJ, 2015, J QUANT SPECTROSC RA, V153, P131, DOI 10.1016/j.jqsrt.2014.10.021; Cazacu MM, 2015, J QUANT SPECTROSC RA, V153, P57, DOI 10.1016/j.jqsrt.2014.09.004; Kawamoto K, 2015, J QUANT SPECTROSC RA, V153, P38, DOI 10.1016/j.jqsrt.2014.10.012; Kemppinen O, 2015, J QUANT SPECTROSC RA, V150, P55, DOI 10.1016/j.jqsrt.2014.05.024; Kiemle C, 2015, J QUANT SPECTROSC RA, V153, P95, DOI 10.1016/j.jqsrt.2014.12.001; Kocifaj M, 2015, J QUANT SPECTROSC RA, V150, P175, DOI 10.1016/j.jqsrt.2014.03.004; Li SC, 2015, J QUANT SPECTROSC RA, V153, P113, DOI 10.1016/j.jqsrt.2014.09.018; Ma YY, 2015, J QUANT SPECTROSC RA, V153, P119, DOI 10.1016/j.jqsrt.2014.09.025; Min QL, 2015, J QUANT SPECTROSC RA, V150, P166, DOI 10.1016/j.jqsrt.2014.08.026; Min QL, 2015, J QUANT SPECTROSC RA, V150, P148, DOI 10.1016/j.jqsrt.2014.08.027; Pan YL, 2015, J QUANT SPECTROSC RA, V150, P12, DOI 10.1016/j.jqsrt.2014.06.007; Ratnesar-Shumate S, 2015, J QUANT SPECTROSC RA, V153, P13, DOI 10.1016/j.jqsrt.2014.10.003; Sugimoto N, 2015, J QUANT SPECTROSC RA, V150, P107, DOI 10.1016/j.jqsrt.2014.08.003; Sun WB, 2015, J QUANT SPECTROSC RA, V150, P121, DOI 10.1016/j.jqsrt.2014.05.013; Yan HR, 2015, J QUANT SPECTROSC RA, V153, P65, DOI 10.1016/j.jqsrt.2014.09.009; Videen G, 2015, J QUANT SPECTROSC RA, V150, P87, DOI 10.1016/j.jqsrt.2014.05.019; Videen G, 2015, J QUANT SPECTROSC RA, V150, P1, DOI 10.1016/j.jqsrt.2014.09.008; Videen G, 2015, J QUANT SPECTROSC RA, V150, P68, DOI 10.1016/j.jqsrt.2014.07.022; Wu D, 2015, J QUANT SPECTROSC RA, V153, P88, DOI 10.1016/j.jqsrt.2014.09.021; Xie CB, 2015, J QUANT SPECTROSC RA, V150, P114, DOI 10.1016/j.jqsrt.2014.08.023; Yin BS, 2015, J QUANT SPECTROSC RA, V153, P29, DOI 10.1016/j.jqsrt.2014.11.003; Zhang H, 2015, J QUANT SPECTROSC RA, V150, P76, DOI 10.1016/j.jqsrt.2014.08.024; Zhang TP, 2015, J QUANT SPECTROSC RA, V150, P134, DOI 10.1016/j.jqsrt.2014.07.013; Zhang XL, 2015, J QUANT SPECTROSC RA, V150, P3, DOI 10.1016/j.jqsrt.2014.03.006; Zubko E, 2015, J QUANT SPECTROSC RA, V150, P42, DOI 10.1016/j.jqsrt.2014.06.023	31	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4073	1879-1352		J QUANT SPECTROSC RA	J. Quant. Spectrosc. Radiat. Transf.	MAR	2015	153				SI		1	3		10.1016/j.jqsrt.2015.01.005		3	Optics; Spectroscopy	Optics; Spectroscopy	CB8MH	WOS:000349883200001		
J	Kawamoto, K; Suzuki, K				Kawamoto, Kazuaki; Suzuki, Kentaroh			Distributional correspondence of 94-GHz radar reflectivity with the variation in water cloud properties over the northwestern Pacific and China	JOURNAL OF QUANTITATIVE SPECTROSCOPY & RADIATIVE TRANSFER			English	Article						Cloud microphysics; Drizzle; Precipitation; Vertical profile; CloudSat	NOAA AVHRR; MICROPHYSICAL PROPERTIES; MODIS OBSERVATIONS; SATELLITE; LIQUID; OCEANS; RAIN; PRECIPITATION; MICROWAVE; POLLUTION	This paper studied the behavior of 94-GHz radar reflectivity (Z(e)) with variation in the properties of low-level water clouds, such as the effective droplet radius (r(e)), geometrical thickness (D-cld), and liquid water path (LWP), over the northwest Pacific and China. The changes in the distribution of maxZ(e) (the largest Z(e) within a cloud layer) were examined in terms of variation in the cloud parameters such as small, mid and large categories, while maxZ(e) had monomodal distributions regarding variation in r(e) and D-cld, that appeared bimodal in the small category of LWP. It was confirmed that the small category of LWP contained both non-precipitating clouds in the incipient stage and raining clouds in the dissipating stage. Next, optically measured particle size was combined with LWP derived from the microwave measurement to classify the precipitation type. Applying maxZ(e) and D-cld to the analysis of classified precipitation types corroborated the importance of D-cld for examining the occurrence of precipitation. Finally, the position of maxZ(e), relative to the cloud top was investigated using a measure of the probability of precipitation (POP) according to variation in r(e). The results showed that the Pacific and China had 'bow' and 'funnel' shapes, respectively. The emergence of these shapes according to the variation in r(e) was interpreted as the enhancement of Z(e), due to droplet collisional growth and the attenuation of Z(e), by the presence of large particles. Furthermore, a detailed analysis of smaller particles ( <10 mu m in radius) reinforced the idea of rapid, efficient particle growth in the lower part of the cloud. (c) 2014 Elsevier Ltd. All rights reserved.	[Kawamoto, Kazuaki] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 8528521, Japan; [Suzuki, Kentaroh] CALTECH, Jet Prop Lab, Pasadena, CA USA	Kawamoto, K (reprint author), Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	kazukawa@nagasaki-u.ac.jp	Suzuki, Kentaroh/C-3624-2011		National Aeronautics and Space Administration	K. Kawamoto is supported by Grant-in aid for Scientific Research (B), Grant-in aid for Challenging Exploratory Research and Grant-in aid for Scientific Research on Innovative Areas. The CloudSat data products of 2B-GEO-PROF, 2B-TAU, 2C-PRECIP-COLUMN and ECMWF-AUX were provided by the CloudSat Data Processing Center at CIRA/Colorado State University. Part of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration.	ALBRECHT BA, 1989, SCIENCE, V245, P1227, DOI 10.1126/science.245.4923.1227; Suzuki K, 2004, J ATMOS SCI, V61, P179, DOI 10.1175/1520-0469(2004)061<0179:ASOTAE>2.0.CO;2; Marchand R, 2008, J ATMOS OCEAN TECH, V25, P519, DOI 10.1175/2007JTECHA1006.1; Nakajima TY, 1995, J ATMOS SCI, V52, P4043, DOI 10.1175/1520-0469(1995)052<4043:WADOCM>2.0.CO;2; Stephens GL, 2002, B AM METEOROL SOC, V83, P1771, DOI 10.1175/BAMS-83-12-1771; Quaas J, 2009, ATMOS CHEM PHYS, V9, P8697; Haynes JM, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD009973; Suzuki K, 2010, J ATMOS SCI, V67, P3019, DOI 10.1175/2010JAS3463.1; Kawamoto K, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016412; HAN QY, 1994, J CLIMATE, V7, P465, DOI 10.1175/1520-0442(1994)007<0465:NGSOED>2.0.CO;2; Koren I, 2010, ATMOS CHEM PHYS, V10, P8855, DOI 10.5194/acp-10-8855-2010; Kawamoto K, 2001, J CLIMATE, V14, P2054, DOI 10.1175/1520-0442(2001)014<2054:AGDOCM>2.0.CO;2; L'Ecuyer TS, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011273; Lensky IM, 1997, J APPL METEOROL, V36, P234, DOI 10.1175/1520-0450(1997)036<0234:EOPAAR>2.0.CO;2; LIN B, 1994, J GEOPHYS RES-ATMOS, V99, P20907, DOI 10.1029/94JD01831; Kubar TL, 2009, J ATMOS SCI, V66, P2953, DOI 10.1175/2009JAS3071.1; Breon FM, 2002, SCIENCE, V295, P834, DOI 10.1126/science.1066434; TWOMEY S, 1977, J ATMOS SCI, V34, P1149, DOI 10.1175/1520-0469(1977)034<1149:TIOPOT>2.0.CO;2; Nakajima T, 2001, GEOPHYS RES LETT, V28, P1171, DOI 10.1029/2000GL012186; Platnick S, 2003, IEEE T GEOSCI REMOTE, V41, P459, DOI 10.1109/TGRS.2002.808301; Rosenfeld D, 2000, SCIENCE, V287, P1793, DOI 10.1126/science.287.5459.1793; NAKAJIMA T, 1990, J ATMOS SCI, V47, P1878, DOI 10.1175/1520-0469(1990)047<1878:DOTOTA>2.0.CO;2; Nakajima TY, 2010, J ATMOS SCI, V67, P1897, DOI 10.1175/2010JAS3276.1; Huang JP, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005101; Suzuki K, 2011, J ATMOS SCI, V68, P2655, DOI 10.1175/JAS-D-10-05026.1; Mace GG, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029017; Brenguier JL, 2000, J ATMOS SCI, V57, P803, DOI 10.1175/1520-0469(2000)057<0803:RPOBLC>2.0.CO;2; Higurashi A, 1999, J ATMOS SCI, V56, P924, DOI 10.1175/1520-0469(1999)056<0924:DOATCA>2.0.CO;2; Ho SP, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003298; Kawamoto K, 2013, J QUANT SPECTROSC RA, V122, P13, DOI 10.1016/j.jqsrt.2012.12.013; Koren I, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023187; LEBSOCK MD, 2008, J GEOPHYS RES, V113; Lin B, J GEOPHYS RES, V103, P3887; Lin B, 1996, J CLIMATE, V9, P2890, DOI 10.1175/1520-0442(1996)009<2890:SVOLAI>2.0.CO;2; Masunaga H, 2002, J GEOPHYS RES, V107; Partain P., 2007, CLOUDSAT ECMWF AUX A; Polonsky I., 2008, LEVEL 2 CLOUD OPTICA; RANDALL DA, 1984, B AM METEOROL SOC, V65, P1290, DOI 10.1175/1520-0477(1984)065<1290:OFROSM>2.0.CO;2; Rosenfeld D, 1994, J ATMOS RES, V34, P259; STEPHENS GL, 1978, J ATMOS SCI, V35, P2123, DOI 10.1175/1520-0469(1978)035<2123:RPIEWC>2.0.CO;2; Stocker T. F., 2013, CLIMATE CHANGE PHYS; Suzuki K, 2013, J GEOPHYS RES, P118	42	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4073	1879-1352		J QUANT SPECTROSC RA	J. Quant. Spectrosc. Radiat. Transf.	MAR	2015	153				SI		38	48		10.1016/j.jqsrt.2014.10.012		11	Optics; Spectroscopy	Optics; Spectroscopy	CB8MH	WOS:000349883200005		
J	Jin, Y; Kai, K; Kawai, K; Nagai, T; Sakai, T; Yamazaki, A; Uchiyama, A; Batdorj, D; Sugimoto, N; Nishizawa, T				Jin, Yoshitaka; Kai, Kenji; Kawai, Kei; Nagai, Tomohiro; Sakai, Tetsu; Yamazaki, Akihiro; Uchiyama, Akihiro; Batdorj, Dashdondog; Sugimoto, Nobuo; Nishizawa, Tomoaki			Ceilometer calibration for retrieval of aerosol optical properties	JOURNAL OF QUANTITATIVE SPECTROSCOPY & RADIATIVE TRANSFER			English	Article						Ceilometer; Lidar; Aerosol; Desert dust	ASIAN DUST; TAKLIMAKAN DESERT; LIDAR; CHINA; JAPAN; VALIDATION; TRANSPORT; CALIPSO; MODEL	Ceilometers are durable compact backscatter lidars widely used to detect cloud base height. They are also useful for measuring aerosols. We introduced a ceilometer (CL51) for observing dust in a source region in Mongolia. For retrieving aerosol profiles with a backscatter lidar, the molecular backscatter signal in the aerosol free heights or system constant of the lidar is required. Although the system constant of the ceilometer is calibrated by the manufacturer, it is not necessarily accurate,enough for the aerosol retrieval. We determined a correction factor, which is defined as the ratio of true attenuated backscattering coefficient to the measured attenuated backscattering coefficient, for the CL51 ceilometer using a dual-wavelength Mie-scattering lidar in Tsukuba, Japan before moving the ceilometer to Dalanzadgad, Mongolia. The correction factor determined by minimizing the difference between the ceilometer and lidar backscattering coefficients was approximately 1.2 +/- 0.1. Applying the correction to the CL51 signals, the aerosol optical depth (AOD) agreed well with the sky-radiometer AOD during the observation period (13-17 February 2013) in Tsukuba (9 x 10(-3) of mean square error). After moving the ceilometer to Dalanzadgad, however, the AOD observed with the CL51 (calibrated by the correction factor determined in Tsukuba) was approximately 60% of the AErosol RObotic NETwork (AERONET) sun photometer AOD. The possible causes of the lower AOD results are as follows: (1) the limited height range of extinction integration ( < 3 km); (2) change in the correction factor during the ceilometer transportation or with the window contamination in Mongolia. In both cases, on-site calibrations by dual-wavelength lidar are needed. As an alternative method, we showed that the backward inversion method was useful for retrieving extinction coefficients if the AOD was larger than 1.5. This retrieval method does not require the system constant and molecular backscatter signals, and can be applied to severe dust and air pollution aerosol cases in East Asia. (C) 2014 Elsevier Ltd. All rights reserved.	[Jin, Yoshitaka; Sugimoto, Nobuo; Nishizawa, Tomoaki] Natl Inst Environm Studies, Ctr Environm Measurement & Anal, Tsukuba, Ibaraki 3058506, Japan; [Kai, Kenji; Kawai, Kei] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Nagai, Tomohiro; Sakai, Tetsu; Yamazaki, Akihiro; Uchiyama, Akihiro] Japan Meteorol Agcy, Meteorol Res Inst, Ibaraki, Japan; [Batdorj, Dashdondog] Natl Agcy Meteorol & Environm Monitoring, Div Technol Informat & Mkt, Ulaanbaatar, Mongol Peo Rep	Jin, Y (reprint author), Natl Inst Environm Studies, Ctr Environm Measurement & Anal, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	jin.yoshitaka@nies.go.jp			 [24340111]	We thank Dr. Brent Holben for his effort in establishing and maintaining Dalanzadgad AERONET site. This study was supported by Grants-in-Aid for Scientific Research B Grant number 24340111.	Angstrom A, 1964, TELLUS, V17, P1482; Markowicz KM, 2008, J ATMOS OCEAN TECH, V25, P928, DOI 10.1175/2007JTECHA1016.1; KAI K, 1988, J METEOROL SOC JPN, V66, P457; Hess M, 1998, B AM METEOROL SOC, V79, P831, DOI 10.1175/1520-0477(1998)079<0831:OPOAAC>2.0.CO;2; Uchiyama A, 2005, J METEOROL SOC JPN, V83A, P291, DOI 10.2151/jmsj.83A.291; Lei Y, 2011, ATMOS CHEM PHYS, V11, P931, DOI 10.5194/acp-11-931-2011; FERNALD FG, 1984, APPL OPTICS, V23, P652; Sugimoto N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016349; McGowan HA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050319; Hagihara Y, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012344; Wiegner M, 2012, ATMOS MEAS TECH, V5, P1953, DOI 10.5194/amt-5-1953-2012; Holben BN, 1998, REMOTE SENS ENVIRON, V66, P1, DOI 10.1016/S0034-4257(98)00031-5; Yumimoto K, 2009, ATMOS CHEM PHYS, V9, P8545; Tesche M, 2013, J GEOPHYS RES-ATMOS, V118, P2889, DOI 10.1002/jgrd.50248; Mikami M, 2006, GLOBAL PLANET CHANGE, V52, P142, DOI 10.1016/j.gloplacha.2006.03.001; Liu ZY, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008878; Aoki T, 2005, J METEOROL SOC JPN, V83A, P315, DOI 10.2151/jmsj.83A.315; Jin Y, 2010, SOLA, V6, P121, DOI 10.2151/sola.2010-031; KLETT JD, 1981, APPL OPTICS, V20, P211, DOI 10.1364/AO.20.000211; Nishizawa T, 2007, J GEOPHYS RES-ATMOS, V112, DOI [10.1029/2006JD007435, 10.1026/2006JD007435]; Sakai T, 2013, J METEOROL SOC JPN, V91, P789, DOI 10.2151/jmsj.2013-605; Sugimoto N, 2009, J APPL METEOROL CLIM, V48, P1822, DOI 10.1175/2009JAMC2089.1; Vaughan MA, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013086; Wiegner M., 2014, ATMOS MEAS TECH DISC, V7, P2491; Xie CB, 2008, APPL OPTICS, V47, P4945, DOI 10.1364/AO.47.004945	25	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4073	1879-1352		J QUANT SPECTROSC RA	J. Quant. Spectrosc. Radiat. Transf.	MAR	2015	153				SI		49	56		10.1016/j.jqsrt.2014.10.009		8	Optics; Spectroscopy	Optics; Spectroscopy	CB8MH	WOS:000349883200006		
J	Yan, HR; Huang, JP; Minnis, P; Yi, YH; Sun-Mack, S; Wang, TH; Nakajima, TY				Yan, Hongru; Huang, Jianping; Minnis, Patrick; Yi, Yuhong; Sun-Mack, Sunny; Wang, Tianhe; Nakajima, Takashi Y.			Comparison of CERES-MODIS cloud microphysical properties with surface observations over Loess Plateau	JOURNAL OF QUANTITATIVE SPECTROSCOPY & RADIATIVE TRANSFER			English	Article						Validation; Cloud microphysical properties; Satellite	GENERAL-CIRCULATION MODELS; DROPLET EFFECTIVE RADIUS; ENERGY SYSTEM CERES; SATELLITE MEASUREMENTS; FEEDBACK PROCESSES; CLIMATE FEEDBACK; RADIATION; SENSITIVITY; GROWTH; SIZES	To enhance the utility of satellite-derived cloud properties for studying the role of clouds in climate change and the hydrological cycle in semi-arid areas, it is necessary to know their uncertainties. This paper estimates the uncertainties of several cloud properties by comparing those derived over the China Loess Plateau from the MODerate-resolution Imaging Spectroradiometer (MODIS) on Terra and Aqua by the Clouds and Earth's Radiant Energy System (CERES) with surface observations at the Semi-Arid Climate and Environment Observatory of Lanzhou University (SACOL). The comparisons use data from January 2008 to June 2010 limited to single layer and overcast stratus conditions during daytime. Cloud optical depths (tau) and liquid water paths (LWP) from both Terra and Aqua generally track the variation of the surface counterparts with modest correlation, while cloud effective radius (r(e)) is only weakly correlated with the surface retrievals. The mean differences between Terra and the SACOL retrievals are -4.7 +/- 12.9, 2.1 +/- 3.2 mu m and 30.2 +/- 85.3 g m(-2) for tau, r(e) and LWP, respectively. The corresponding differences for Aqua are 2.1 +/- 8.4, 1.2 +/- 2.9 mu m and 47.4 +/- 79.6 g m(-2), respectively. Possible causes for biases of satellite retrievals are discussed through statistical analysis and case studies. Generally, the CERES-MODIS cloud properties have a bit larger biases over the Loess Plateau than those in previous studies over other locations. (c) 2014 Elsevier Ltd. All rights reserved.	[Yan, Hongru; Huang, Jianping; Wang, Tianhe] Lanzhou Univ, Coll Atmospher Sci, Minist Educ, Key Lab Semiarid Climate Change, Lanzhou 730000, Peoples R China; [Minnis, Patrick] NASA, Langley Res Ctr, Hampton, VA 23666 USA; [Sun-Mack, Sunny] Sci Syst & Applicat Inc, Hampton, VA 23666 USA; [Nakajima, Takashi Y.] Tokai Univ, Res & Informat Ctr, Tokyo 151, Japan; [Yi, Yuhong] Lanzhou Univ, Res Sch Arid Environm & Climate Change, Minist Educ, Key Lab Western Chinas Environm Syst, Lanzhou 730000, Peoples R China	Huang, JP (reprint author), Lanzhou Univ, Coll Atmospher Sci, Minist Educ, Key Lab Semiarid Climate Change, Lanzhou 730000, Peoples R China.	hjp@lzu.edu.cn	Wang, Tianhe/F-8236-2012		Lanzhou University through the 985 Program; National Basic Research Program of China [2013CB955802, 2012CB955301]; National Natural Science Foundation of China [41375031]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1018]; China 111 Project [B13045]; NASA CERES Project	SACOL was sponsored by the Lanzhou University through the 985 Program. This study is supported by the National Basic Research Program of China (2013CB955802 and 2012CB955301), National Natural Science Foundation of China (41375031), the Program for Changjiang Scholars and Innovative Research Team in University (IRT1018), and China 111 Project (No. B13045). Support for Yuhong Yi and Sunny Sun-Mack was provided by the NASA CERES Project. Thanks to Tian Zhou, Beidou Zhang and Jianrong Bi for their efforts in providing ground-based observations.	MANABE S, 1975, J ATMOS SCI, V32, P3, DOI 10.1175/1520-0469(1975)032<0003:TEODTC>2.0.CO;2; Randall DA, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P589; Fu Q, 2006, SCIENCE, V312, P1179, DOI 10.1126/science.1125566; Dong XQ, 2002, J ATMOS SCI, V59, P3265, DOI 10.1175/1520-0469(2002)059<3265:COSCPD>2.0.CO;2; Soden BJ, 2006, J CLIMATE, V19, P3354, DOI 10.1175/JCLI3799.1; CESS RD, 1990, J GEOPHYS RES-ATMOS, V95, P16601, DOI 10.1029/JD095iD10p16601; CESS RD, 1989, SCIENCE, V245, P513, DOI 10.1126/science.245.4917.513; Webb MJ, 2006, CLIM DYNAM, V27, P17, DOI 10.1007/s00382-006-0111-2; Chang FL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003906; Minnis P, 2011, IEEE T GEOSCI REMOTE, V49, P4374, DOI 10.1109/TGRS.2011.2144601; Mace GG, 2005, J APPL METEOROL, V44, P221, DOI 10.1175/JAM2193.1; Wielicki BA, 1998, IEEE T GEOSCI REMOTE, V36, P1127, DOI 10.1109/36.701020; Zhang ZB, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016216; Bennartz R, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007547; Wielicki BA, 1996, B AM METEOROL SOC, V77, P853, DOI 10.1175/1520-0477(1996)077<0853:CATERE>2.0.CO;2; Dufresne JL, 2008, J CLIMATE, V21, P5135, DOI 10.1175/2008JCLI2239.1; Waliser DE, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010015; Stephens GL, 2005, J CLIMATE, V18, P237, DOI 10.1175/JCLI-3243.1; Wolters ELA, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012205; Chang FL, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000766; Nakajima TY, 2010, J ATMOS SCI, V67, P1884, DOI 10.1175/2009JAS3280.1; Wang TH, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009958; Wang GY, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013372; Zheng X, 2011, ATMOS CHEM PHYS, V11, P9943, DOI 10.5194/acp-11-9943-2011; Bony S, 2006, J CLIMATE, V19, P3445, DOI 10.1175/JCLI3819.1; Platnick S, 2000, J GEOPHYS RES-ATMOS, V105, P22919, DOI 10.1029/2000JD900333; Marshak A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006686; Nakajima TY, 2010, J ATMOS SCI, V67, P1897, DOI 10.1175/2010JAS3276.1; Boeke RC, 2009, THESIS OREGON STATE; Cess RD, 1996, J GEOPHYS RES-ATMOS, V101, P12791, DOI 10.1029/96JD00822; Cess RD, 1996, J GEOPHYS RES-ATMOS, V101, P23299, DOI 10.1029/96JD02156; Chen RY, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009596; Dong XQ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008438; Dong XQ, 2001, J GEOPHYS RES-ATMOS, V106, P15297, DOI 10.1029/2000JD900404; Hansen J., 1984, GEOPHYS MONOGR SER, V29, P130; Hayes CR, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012046; Heck PW, 2002, P 11 AMS C ATM RAD O, P148; Horvath A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007101; Huang J, 2008, ADV ATMOS SCI, V25, P1; Huang Jianping, 2010, Chinese Journal of Atmospheric Sciences, V34; Huang Jianping, 2008, ATMOSPHERIC OCEANIC, V1, P8; Joseph E, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002831; Kawamoto K, 2001, P 11 ARM SCI TEAM M; Liljegren JC, 2001, J GEOPHYS RES-ATMOS, V106, P14485, DOI 10.1029/2000JD900817; Loeb NG, 1998, J ATMOS SCI, V55, P2960, DOI 10.1175/1520-0469(1998)055<2960:IOSSCT>2.0.CO;2; Min QL, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004390; Min Q, 1996, J GEOPHYS LETT, V23, P1641; Min QL, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1023/2003JD003964; Minnis P, 2011, IEEE T GEOSCI REMOTE, V49, P4401, DOI 10.1109/TGRS.2011.2144602; Minnis P, 2008, J ATMOS OCEAN TECH, V25, P385, DOI 10.1175/2007JTECHA1021.1; Minnis P, 2008, IEEE T GEOSCI REMOTE, V46, P3857, DOI 10.1109/TGRS.2008.2001351; Painemal D, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017822; Seethala C, 2010, J GEOPHYS RES-ATMOS, V115, DOI [10.1029/2009JD012612, 10.1029/2009JD012662]; Spangenberg DA, 2002, P 11 AMS C CLOUD PHY; Trepte Q, 2002, P SPIE 3 INT AS PAC, V4891, P449; Uttal T, 2003, P 7 C POL MET OC JOI; WIELICKI BA, 1995, B AM METEOROL SOC, V76, P2125, DOI 10.1175/1520-0477(1995)076<2125:MTPERO>2.0.CO;2	57	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4073	1879-1352		J QUANT SPECTROSC RA	J. Quant. Spectrosc. Radiat. Transf.	MAR	2015	153				SI		65	76		10.1016/j.jqsrt.2014.09.009		12	Optics; Spectroscopy	Optics; Spectroscopy	CB8MH	WOS:000349883200008		
J	Shimizu, A; Sugimoto, N; Matsui, I; Nishizawa, T				Shimizu, Atsushi; Sugimoto, Nobuo; Matsui, Ichiro; Nishizawa, Tomoaki			Direct comparison of extinction coefficients derived from Mie-scattering lidar and number concentrations of particles, subjective weather report in Japan	JOURNAL OF QUANTITATIVE SPECTROSCOPY & RADIATIVE TRANSFER			English	Article						Lidar; Extinction; Number concentration; Meteorological observatory	ASIAN DUST; TRANSPORT; MASS	Two components of the lidar extinction coefficient, the dust extinction and the spherical particles extinction, were obtained from observations made by the National Institute for Environmental Studies lidar network in Japan. These two extinctions were compared with the number concentration of particles measured by an optical particle counter, and with subjective weather reports recorded at the nearest meteorological observatories. The dust extinction corresponded well with the number concentration of large particles with diameters as great as 5 mu m and during dry conditions with the number concentration of particles larger than 2 mu m. The relationship between the spherical particle extinction and the number of small particles was nearly constant under all conditions. Asian dust was sometimes reported by meteorological observatories in the period of lower dust extinction. This indicates contradicting relationship between human-eye based reports and optical characteristics observed by lidars in some cases. The most consistent results between lidar observation and meteorological reports were obtained in dry mist conditions, in which lidars exhibited higher spherical extinction as expected by the definition of the atmospheric phenomenon of dry mist or haze. (c) 2014 Elsevier Ltd. All rights reserved.	[Shimizu, Atsushi; Sugimoto, Nobuo; Matsui, Ichiro; Nishizawa, Tomoaki] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan	Shimizu, A (reprint author), Natl Inst Environm Studies, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	shimizua@nies.go.jp	Shimizu, Atsushi/C-2810-2009	Shimizu, Atsushi/0000-0002-7306-7412	Environmental Research and Technology Development Fund [S-7-1]	This study was partly supported by a grant from the Environmental Research and Technology Development Fund S-7-1. The authors appreciate the assistance with lidar operations by Nagasaki Prefecture, Shimane Prefecture, Toyama Prefecture, Kin'ki University, the Ministry of Environment and the Sibata corporation. SPM data were obtained from the Environmental Numerical Database at NIES website, and the meteorological data were downloaded from Japan Meteorological Agency website. Authors express sincere gratitude to two anonymous reviewers.	FERNALD FG, 1984, APPL OPTICS, V23, P652; Yumimoto K, 2008, ATMOS CHEM PHYS, V8, P2869; IWASAKA Y, 1983, TELLUS B, V35, P189; Ueda K, 2012, INHAL TOXICOL, V24, P858, DOI 10.3109/08958378.2012.724729; Sekiyama TT, 2010, ATMOS CHEM PHYS, V10, P39; ARAO K, 1986, J METEOROL SOC JPN, V64, P79; Hara Y, 2012, TENKI, V59, P702; Hara Y, 2011, SOLA, V7, DOI 10.2151/sola.2011-031; Kaneyasu N, 2012, J JPN SOC ATMOS ENV, V47, P285; Murayama T, 2001, J GEOPHYS RES-ATMOS, V106, P18345, DOI 10.1029/2000JD900554; Sakai T, 2012, ATMOS ENVIRON, V60, P419, DOI 10.1016/j.atmosenv.2012.06.068; Shimizu A, 2003, J GEOPHYS RES, V109; Shimizu A, 2011, SOLA, V7A, P1, DOI 10.2151/sola.7A-001; Sugimoto N, 2002, GEOPHYS RES LETT, V30; Yamaguchi Y, 2011, TENKI, V58, P965	15	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4073	1879-1352		J QUANT SPECTROSC RA	J. Quant. Spectrosc. Radiat. Transf.	MAR	2015	153				SI		77	87		10.1016/j.jqsrt.2014.12.005		11	Optics; Spectroscopy	Optics; Spectroscopy	CB8MH	WOS:000349883200009		
J	Tanaka, K; Okazaki, M; Yano, T; Miyashita, H; Homma, T; Tomita, M				Tanaka, Kentaro; Okazaki, Mutsumi; Yano, Tomoyuki; Miyashita, Hiroki; Homma, Tsutomu; Tomita, Makoto			Quantitative Evaluation of Blood Perfusion to Nerves Included in the Anterolateral Thigh Flap using Indocyanine Green Fluorescence Angiography: A Different Contrast Pattern between the Vastus Lateralis Motor Nerve and Femoral Cutaneous Nerve	JOURNAL OF RECONSTRUCTIVE MICROSURGERY			English	Article						vascularized nerve graft; vastus lateral's motor nerve; femoral cutaneous nerve; anterolateral thigh flap; indocyanine green fluorescent angiography	VASCULARIZED NERVE; PERFORATOR FLAP; AXONAL REGENERATION; GRAFTS; RECONSTRUCTION; EXPERIENCE; EXPRESSION; DEFECTS; RATS	Background Better postoperative results can be expected in nerve reconstruction when vascularized nerve grafts are used. Previous studies reported reconstruction with flaps including "vascularized" nerves; however, few have evaluated blood supply to these nerves. The aim of this study was to quantitatively assess blood perfusion to nerves included in anterolateral thigh (ALT) flaps by indocyanine green (ICG) fluorescence angiography. Patients and Methods Participants comprised eight patients who underwent reconstructive surgery with nerve defects using free ALT flaps, including the vastus lateralis motor nerve and/or femoral cutaneous nerve. Intraoperative ICG fluorescent angiography was performed. Time after the drug injection and the intensity of fluorescence in these nerves were analyzed as time intensity curves. Maximum intensity (Imax), time to Imax (Tmax), and time at the beginning of intensity elevation (Te) were measured at three points: Point C, the central portion of the flap-attached region of the nerve; Point P, 2 cm from the proximal flap-attached edge; and Point D, 2 cm from the distal edge. Results Imax and Te at point C and Imax/Tmax-Te at point P were significantly different between these two nerves (p = 0.03125, p = 0.02895, p = 0.03125, respectively). Fluorescence in the vastus lateralis motor nerve was slightly quicker and stronger than that in the femoral cutaneous nerve, and also exhibited an axial pattern of fluorescence. Conclusion Intraoperative ICG fluorescent angiography can be used to determine which nerve is better for nerve reconstruction. The indexes of Imax, Te, and Imax/Tmax-Te may be the suitable criteria for decision making regarding donor nerve selection.	[Tanaka, Kentaro; Okazaki, Mutsumi; Yano, Tomoyuki; Miyashita, Hiroki; Homma, Tsutomu] Tokyo Med & Dent Univ, Dept Plast & Reconstruct Surg, Grad Sch Med Sci, Tokyo 1138519, Japan; [Tomita, Makoto] Tokyo Med & Dent Univ, Hosp Med, Clin Res Ctr, Tokyo 1138519, Japan	Tanaka, K (reprint author), Tokyo Med & Dent Univ, Dept Plast & Reconstruct Surg, Grad Sch Med Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	kenta.plas@tmd.ac.jp			Ministry of Health, Labor and Welfare of Japan	This work was supported by a Grant-in-Aid for Cancer Research from Ministry of Health, Labor and Welfare of Japan.	KOSHIMA I, 1985, ANN PLAS SURG, V14, P235, DOI 10.1097/00000637-198503000-00008; Lee BT, 2010, J RECONSTR MICROSURG, V26, P59, DOI 10.1055/s-0029-1244805; Nguyen JT, 2012, J SURG RES, V177, pE83, DOI 10.1016/j.jss.2012.04.015; Betz CS, 2009, J PLAST RECONSTR AES, V62, P1602, DOI 10.1016/j.bjps.2008.07.042; Iida T, 2006, J RECONSTR MICROSURG, V22, P343, DOI 10.1055/s-2006-946711; Koshima I, 2003, J RECONSTR MICROSURG, V19, P299; Schultes G, 2001, J RECONSTR MICROSURG, V17, P637, DOI 10.1055/s-2001-18819; KOSHIMA I, 1985, J HAND SURG-AM, V10A, P64; Matsui A, 2009, PLAST RECONSTR SURG, V124, P451, DOI 10.1097/PRS.0b013e3181adcf7d; Bianchi B, 2012, MICROSURG, V32, P87, DOI 10.1002/micr.20952; Onoda S, 2013, MICROSURG, V33, P265, DOI 10.1002/micr.22079; Azuma R, 2008, PLAST RECONSTR SURG, V122, P1062, DOI 10.1097/PRS.0b013e3181858bd2; Liu DZ, 2011, J RECONSTR MICROSURG, V27, P355, DOI 10.1055/s-0031-1281515; Hyodo I, 2007, ANN PLAS SURG, V58, P677, DOI 10.1097/01.sap.0000239844.57064.ed; Pestana IA, 2009, PLAST RECONSTR SURG, V123, P1239, DOI 10.1097/PRS.0b013e31819e67c1; Ashitate Y, 2013, ANN PLAS SURG, V70, P149, DOI 10.1097/SAP.0b013e31822f9af7; Best TJ, 1999, J RECONSTR MICROSURG, V15, P183, DOI 10.1055/s-2007-1000090; Hatoko M, 2003, J RECONSTR MICROSURG, V19, P271; Hatoko M, 2001, ANN PLAS SURG, V47, P322, DOI 10.1097/00000637-200109000-00017; Iwai M, 2001, MICROSURG, V21, P43, DOI 10.1002/micr.1007; Kashiwa K, 2009, J RECONSTR MICROSURG, V25, P181, DOI 10.1055/s-0028-1103507; KOSHIMA I, 1993, PLAST RECONSTR SURG, V92, P728, DOI 10.1097/00006534-199309001-00025; Matsui A, 2010, PLAST RECONSTR SURG, V126, P1517, DOI 10.1097/PRS.0b013e3181ef8ce7; Okazaki M, 2012, J CRANIOFAC SURG, V23, P883, DOI 10.1097/SCS.0b013e31824ddf5a; Tanaka K, 2013, J PLAST RECONSTR AES, V66, P146, DOI 10.1016/j.bjps.2012.08.014	25	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0743-684X	1098-8947		J RECONSTR MICROSURG	J. Reconstr. Microsurg.	MAR	2015	31	3					163	170		10.1055/s-0034-1390382		8	Surgery	Surgery	CC2QD	WOS:000350188800001		
J	Urata, H; Mori, K; Emoto, M; Yamazaki, Y; Motoyama, K; Morioka, T; Fukumoto, S; Koyama, H; Shoji, T; Ishimura, E; Inaba, M				Urata, Hiromi; Mori, Katsuhito; Emoto, Masanori; Yamazaki, Yuko; Motoyama, Koka; Morioka, Tomoaki; Fukumoto, Shinya; Koyama, Hidenori; Shoji, Tetsuo; Ishimura, Eiji; Inaba, Masaaki			Advantage of Insulin Glulisine Over Regular Insulin in Patients With Type 2 Diabetes and Severe Renal Insufficiency	JOURNAL OF RENAL NUTRITION			English	Article							CHRONIC KIDNEY-DISEASE; BLOOD-GLUCOSE CONTROL; GLYCEMIC CONTROL; COMPLICATIONS; HEMODIALYSIS; OUTCOMES; HYPOGLYCEMIA; ASSOCIATION; MORTALITY; SURVIVAL	Objectives: To compare the efficacy and safety of insulin glulisine over regular insulin in patients with type 2 diabetes and severe renal insufficiency. Subjects: Our study included 18 patients with type 2 diabetes and a mean (range) estimated glomerular filtration rate of 13.2 mL/minute/1.73 m(2) (5.8-27.6), which corresponds to stage 4-5 chronic kidney disease. Design: After titration of doses, regular insulin was administered thrice daily on Day 1, along with continuous glucose monitoring for 24 h starting at 7 AM. Exactly equal doses of insulin glulisine were administered on Day 2. Area under the curve (AUC) for blood glucose level variation after breakfast (AUC-B 0-4), lunch (AUC-L 0-6), and dinner (AUC-D 0-6) were evaluated. Results: AUC-B 0-4 and AUC-D 0-6 were significantly lower with insulin glulisine than with regular insulin (AUC-B 0-4: 3.3 +/- 4.7 vs. 6.2 +/- 5.4 3 10 2 mmol/L$ minute, respectively, P = .028; AUC-D 0-6: 1.8 +/- 7.3 vs. 6.5 +/- 6.2 3 10(2) mmol/L. minute, respectively, P =.023). In contrast, AUC-L 0-6 was higher with insulin glulisine than with regular insulin (AUC-L 0-6: 7.6 +/- 6.4 vs. 4.2 +/- 8.7 x 10(2) mmol/L. minute, respectively, P =.099), suggesting a prolonged hypoglycemic action of regular insulin after lunch. Conclusions: Insulin glulisine effectively suppressed postprandial hyperglycemia, whereas regular insulin caused a prolonged hypoglycemic action. These findings support the effectiveness and safety of insulin glulisine in patients with type 2 diabetes and severe renal insufficiency. (C) 2015 by the National Kidney Foundation, Inc. All rights reserved.	[Urata, Hiromi; Mori, Katsuhito; Emoto, Masanori; Yamazaki, Yuko; Motoyama, Koka; Morioka, Tomoaki; Fukumoto, Shinya; Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 5458585, Japan; [Koyama, Hidenori] Hyogo Coll Med, Dept Internal Med, Div Endocrinol & Metab, Nishinomiya, Hyogo 6638501, Japan; [Shoji, Tetsuo] Osaka City Univ, Grad Sch Med, Dept Geriatr & Vasc Med, Osaka 5458585, Japan; [Ishimura, Eiji; Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Nephrol, Osaka 5458585, Japan	Mori, K (reprint author), Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	ktmori@med.osaka-cu.ac.jp			Japan Society for the Promotion of Science [25461250]; Sanofi Pharmaceutical Company; Novartis Pharmaceutical Company	This study was supported in part by a Grant-in-Aid for scientific research (25461250) from the Japan Society for the Promotion of Science (K. Mori, T.S.). K. Mori received lecture fees from Sanofi Pharmaceutical Company and Novartis Pharmaceutical Company. K. Mori and M.I. received unrestricted research grants from Sanofi Pharmaceutical Company.	Patel A, 2008, NEW ENGL J MED, V358, P2560; Aisenpreis U, 1999, NEPHROL DIAL TRA S14, V4, P5; Ramirez SPB, 2012, DIABETES CARE, V35, P2527, DOI 10.2337/dc12-0573; Heise T, 2007, DIABETES OBES METAB, V9, P746, DOI 10.1111/j.1463-1326.2007.00746.x; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Oomichi T, 2006, DIABETES CARE, V29, P1496, DOI 10.2337/dc05-1887; Ricks J, 2012, DIABETES, V61, P708, DOI 10.2337/db11-1015; Imai E, 2007, AM J KIDNEY DIS, V50, P927, DOI 10.1053/j.ajkd.2007.09.004; Shurraw S, 2011, ARCH INTERN MED, V171, P1920, DOI 10.1001/archinternmed.2011.537; Rave K, 2001, DIABETES CARE, V24, P886, DOI 10.2337/diacare.24.5.886; Iglesias P, 2008, DIABETES OBES METAB, V10, P811, DOI 10.1111/j.1463-1326.2007.00802.x; Biesenbach G, 2003, DIABETIC MED, V20, P642, DOI 10.1046/j.1464-5491.2003.01025.x; SERVICE FJ, 1970, DIABETES, V19, P644; Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480; Morioka T, 2001, DIABETES CARE, V24, P909, DOI 10.2337/diacare.24.5.909; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545; Moen MF, 2009, CLIN J AM SOC NEPHRO, V4, P1121, DOI 10.2215/CJN.00800209; Bolli GB, 2011, DIABETES OBES METAB, V13, P251, DOI 10.1111/j.1463-1326.2010.01343.x; SHAMOON H, 1993, NEW ENGL J MED, V329, P977; Garg R, 2013, MED CLIN N AM, V97, P135, DOI 10.1016/j.mcna.2012.11.001; Turner RC, 1998, LANCET, V352, P837	21	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1051-2276	1532-8503		J RENAL NUTR	J. Renal Nutr.	MAR	2015	25	2					129	134		10.1053/j.jrn.2014.07.011		6	Nutrition & Dietetics; Urology & Nephrology	Nutrition & Dietetics; Urology & Nephrology	CB9NV	WOS:000349959400009		
J	Massry, SG; Iseki, K; Niwa, T				Massry, Shaul G.; Iseki, Kunitoshi; Niwa, Toshimitsu			Uremia Research and Toxicity	JOURNAL OF RENAL NUTRITION			English	Editorial Material									[Massry, Shaul G.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Iseki, Kunitoshi] Univ Hosp Ryukus, Director Dialysis Unit, Okinawa, Japan; [Niwa, Toshimitsu] Nagoya Univ, Sch Med, Dept Adv Med Uremia, Nagoya, Aichi 4648601, Japan	Massry, SG (reprint author), 1640 Marengo St,Suite 501, Los Angeles, CA 90033 USA.	Massry@usc.edu						0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1051-2276	1532-8503		J RENAL NUTR	J. Renal Nutr.	MAR	2015	25	2					144	144		10.1053/j.jrn.2014.11.003		1	Nutrition & Dietetics; Urology & Nephrology	Nutrition & Dietetics; Urology & Nephrology	CB9NV	WOS:000349959400013		
J	Saito, S; Yisireyili, M; Shimizu, H; Ng, HY; Niwa, T				Saito, Shinichi; Yisireyili, Maimaiti; Shimizu, Hidehisa; Ng, Hwee-Yeong; Niwa, Toshimitsu			Indoxyl Sulfate Upregulates Prorenin Expression via Nuclear Factor-kappa B p65, Signal Transducer and Activator of Transcription 3, and Reactive Oxygen Species in Proximal Tubular Cells	JOURNAL OF RENAL NUTRITION			English	Article							FIBROTIC GENE-EXPRESSION; RECEPTOR-TRANSGENIC RATS; RENAL EXPRESSION; CELLULAR SENESCENCE; (PRO)RENIN RECEPTOR; HYPERTENSIVE-RATS; MESANGIAL CELLS; RENIN; PROGRESSION; TGF-BETA-1	We have recently found that indoxyl sulfate induces prorenin expression in proximal tubular cells. The present study aimed to determine whether nuclear factor-kappa B (NF-kappa B) p65, signal transducer and activator of transcription 3 (Stat3), and reactive oxygen species are involved in indoxyl sulfate-induced prorenin expression in cultured human proximal tubular cells (HK-2 cells). Effects of indoxyl sulfate on prorenin expression were determined using HK-2 cells with small interfering RNAs (siRNAs) specific to NF-kappa B p65 and Stat3, N-acetylcysteine, an antioxidant, and diphenyleneiodonium, an inhibitor of nicotinamide adenine dinucleotide phosphate oxidase. Indoxyl sulfate increased prorenin expression in HK-2 cells. siRNAs specific to NF-kappa B p65 and Stat3 inhibited indoxyl sulfate-induced prorenin expression. Both N-acetylcysteine and diphenyleneiodonium suppressed indoxyl sulfate-induced prorenin expression. Indoxyl sulfate upregulates the expression of prorenin via NF-kappa B p65, Stat3, and reactive oxygen species in proximal tubular cells. (C) 2015 by the National Kidney Foundation, Inc. All rights reserved.	[Saito, Shinichi; Yisireyili, Maimaiti; Shimizu, Hidehisa; Ng, Hwee-Yeong; Niwa, Toshimitsu] Nagoya Univ, Grad Sch Med, Dept Adv Med Uremia, Nagoya, Aichi 4648601, Japan; [Ng, Hwee-Yeong] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Ng, Hwee-Yeong] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Niwa, Toshimitsu] Shubun Univ, Fac Hlth & Nutr, Ichinomiya, Aichi 4910938, Japan	Niwa, T (reprint author), Shubun Univ, Fac Hlth & Nutr, 6 Nikko Cho, Ichinomiya, Aichi 4910938, Japan.	tniwa@med.nagoya-u.ac.jp					Adijiang A, 2008, NEPHROL DIAL TRANSPL, V23, P1892, DOI 10.1093/ndt/gfm861; Miyazaki T, 1997, KIDNEY INT, V52, pS15; Burckle CA, 2006, HYPERTENSION, V47, P552, DOI 10.1161/01.HYP.0000199912.47657.04; Niwa T, 1997, KIDNEY INT, V52, pS23; Nguyen G, 1996, KIDNEY INT, V50, P1897, DOI 10.1038/ki.1996.511; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640; Shimizu H, 2012, LIFE SCI, V90, P525, DOI 10.1016/j.lfs.2012.01.013; Navar LG, 2011, HYPERTENSION, V57, P355, DOI 10.1161/HYPERTENSIONAHA.110.163519; Kaneshiro Y, 2007, J AM SOC NEPHROL, V18, P1789, DOI 10.1681/ASN.2006091062; Huang Y, 2007, KIDNEY INT, V72, P45, DOI 10.1038/sj.ki.5002243; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Shimizu H, 2011, AM J NEPHROL, V33, P319, DOI 10.1159/000324885; NIWA T, 1994, J LAB CLIN MED, V124, P96; Shimizu H, 2011, AM J PHYSIOL-CELL PH, V301, pC1201, DOI 10.1152/ajpcell.00471.2010; Adijiang A, 2011, J RENAL NUTR, V21, P105, DOI 10.1053/j.jrn.2010.10.020; Danser AHJ, 2002, J MOL CELL CARDIOL, V34, P1463, DOI 10.1006/jmcc.2002.2078; Dikdan GS, 2004, SURGERY, V136, P677, DOI 10.1016/j.surg.2004.02.005; Miyazaki T, 1997, KIDNEY INT, pS211; Saito S, 2014, ENDOCRINOLOGY, V155, P1899, DOI 10.1210/en.2013-1937; Shimizu H, 2013, LIFE SCI, V92, P143, DOI 10.1016/j.lfs.2012.11.012; Shimizu H, 2013, AM J PHYSIOL-CELL PH, V304, pC685, DOI 10.1152/ajpcell.00236.2012; Shimizu H, 2010, AM J PHYSIOL-CELL PH, V299, pC1110, DOI 10.1152/ajpcell.00217.2010; Shimizu H, 2012, AM J NEPHROL, V36, P184, DOI 10.1159/000341515	24	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1051-2276	1532-8503		J RENAL NUTR	J. Renal Nutr.	MAR	2015	25	2					145	148		10.1053/j.jrn.2014.10.008		4	Nutrition & Dietetics; Urology & Nephrology	Nutrition & Dietetics; Urology & Nephrology	CB9NV	WOS:000349959400014		
J	Nangaku, M; Mimura, I; Yamaguchi, J; Higashijima, Y; Wada, T; Tanaka, T				Nangaku, Masaomi; Mimura, Imari; Yamaguchi, Junna; Higashijima, Yoshiki; Wada, Takehiko; Tanaka, Tetsuhiro			Role of Uremic Toxins in Erythropoiesis-Stimulating Agent Resistance in Chronic Kidney Disease and Dialysis Patients	JOURNAL OF RENAL NUTRITION			English	Article							ENDOPLASMIC-RETICULUM STRESS; HYPOXIA-INDUCIBLE FACTOR-1; STAGE RENAL-DISEASE; INDOXYL SULFATE; OXIDATIVE STRESS; EXPRESSION; ANEMIA; SUPPRESSES; ALPHA	Patients with advanced chronic kidney disease are exposed to uremic toxins. In addition to causing uremic symptoms, uremic toxins accelerate the progression of renal failure. Indoxyl sulfate (IS) increases oxygen consumption in tubules, aggravating hypoxia of the kidney, and progression of the kidney disease. IS also induces endoplasmic reticulum stress and thereby contributes the progression of cellular damages in tubular epithelial cells. Hypoxia-inducible factor (HIF) is a master transcriptional regulator of adaptive responses against hypoxia and regulates expression of erythropoietin (EPO). IS suppresses EPO expression via HIF-dependent and HIFindependent manner. IS impedes the recruitment of transcriptional coactivators to HIF via upregulation of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 through a mechanism of posttranscriptional messenger RNA stabilization. Furthermore, IS induces activating transcription factor 4 via endoplasmic reticulum stress, decreasing EPO expression. Although erythropoiesis-stimulating agent (ESA) resistance is generally defined as lack of responses to exogenous ESA administration, suppression of endogenous production of EPO under uremic conditions may aggravate ESA resistance. Uremia is associated with increased formation of advanced glycation end products (AGE). Studies of transgenic rats overexpressing glyoxalse 1 (GLO1), which detoxifies precursors of advanced glycation end products, demonstrated that glycative stress causes renal senescence and vascular endothelial dysfunction. Glycative stress also suppresses HIF activation making the kidney susceptible to hypoxia as a final common pathway to end-stage kidney disease. (C) 2015 by the National Kidney Foundation, Inc. All rights reserved.	[Nangaku, Masaomi; Mimura, Imari; Yamaguchi, Junna; Higashijima, Yoshiki; Wada, Takehiko; Tanaka, Tetsuhiro] Univ Tokyo, Grad Sch Med, Div Nephrol & Endocrinol, Bunkyo Ku, Tokyo 1138655, Japan	Nangaku, M (reprint author), Univ Tokyo, Grad Sch Med, Div Nephrol & Endocrinol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	mnangaku-tky@umin.ac.jp			Kyowa Hakko Kirin; Chugai; Tanabe Mitsubishi	M.N. received honoraria and research funding from Kyowa Hakko Kirin, Chugai, and Tanabe Mitsubishi. The other authors have nothing to declare.	Thangarajah H, 2009, P NATL ACAD SCI USA, V106, P13505, DOI 10.1073/pnas.0906670106; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Jo-Watanabe A, 2014, AGING CELL, V13, P519, DOI 10.1111/acel.12204; Kawakami T, 2010, AM J PHYSIOL-RENAL, V299, pF568, DOI 10.1152/ajprenal.00659.2009; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Fukuma S, 2012, AM J KIDNEY DIS, V59, P108, DOI 10.1053/j.ajkd.2011.07.014; Chiang CK, 2011, LAB INVEST, V91, P1564, DOI 10.1038/labinvest.2011.114; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; Ikeda Y, 2011, AM J PATHOL, V179, P2810, DOI 10.1016/j.ajpath.2011.08.023; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Chiang CK, 2013, AM J PHYSIOL-CELL PH, V304, pC342, DOI 10.1152/ajpcell.00153.2012; Chiang CK, 2012, J RENAL NUTR, V22, P77, DOI 10.1053/j.jrn.2011.10.028; Iseki K, 2003, NEPHROL DIAL TRANSPL, V18, P899, DOI 10.1093/ndt/gfg021; Mimura I, 2014, KIDNEY INT, V85, P31, DOI 10.1038/ki.2013.321; Mimura I, 2013, SEMIN NEPHROL, V33, P375, DOI 10.1016/j.semnephrol.2013.05.009; Nangaku M, 2006, SEMIN NEPHROL, V26, P261, DOI 10.1016/j.semnephrol.2006.06.001; Palm F, 2010, AM J PHYSIOL-RENAL, V299, pF380, DOI 10.1152/ajprenal.00175.2010; Shoji K, 2013, AM J PATHOL, V182, P2191, DOI 10.1016/j.ajpath.2013.02.024; Tanaka T, 2013, FASEB J, V27, P4059, DOI 10.1096/fj.13-231837; Wang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010002	22	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1051-2276	1532-8503		J RENAL NUTR	J. Renal Nutr.	MAR	2015	25	2					160	163		10.1053/j.jrn.2014.10.011		4	Nutrition & Dietetics; Urology & Nephrology	Nutrition & Dietetics; Urology & Nephrology	CB9NV	WOS:000349959400017		
J	Nagase, M				Nagase, Miki			Recent Topics on Podocytes and Aldosterone	JOURNAL OF RENAL NUTRITION			English	Article							MINERALOCORTICOID RECEPTOR ACTIVATION; SALT-SENSITIVE HYPERTENSION; KIDNEY-DISEASE; RAC1 GTPASE; NEPHROTIC SYNDROME; OXIDATIVE STRESS; INJURY; RATS; NEPHROPATHY; ARHGDIA	Podocyte injury is a major cause of proteinuria, a core component of chronic kidney disease. We reported that podocyte impairment underlied the early glomerulopathy in animal models of lifestyle-related diseases, such as hypertension and metabolic syndrome. Accumulating evidence suggests that overactivation of the aldosterone-mineralocorticoid receptor (MR) system has harmful effects on podocytes. We found that MR signaling was enhanced in such lifestyle-related diseases with podocyte injury and proteinuria, which were ameliorated by MR antagonist. Subsequent studies revealed that plasma aldosterone concentrations are not always increased in proteinuric conditions with renal MR activation, and the mechanisms of MR overactivation remained elusive. We recently identified a novel mechanism of Rac1-mediated podocyte impairment using RhoGDIa knockout mice; Rac1 potentiates the activity of MR in a ligand-independent manner, thereby accelerating podocyte injury. We demonstrated that the Rac1-MR pathway contributes to the ligand-independent aberrant MR activation in salt-sensitive hypertension and renal injury models. The importance of the RhoGDI alpha-Rac1-MR pathway in human glomerular disease is underscored by the findings that mutations in RhoGDIagene cause nephrotic syndrome. Our results provide evidence that the Rac1-MR signal cascade as a novel therapeutic target for chronic kidney disease. (C) 2015 by the National Kidney Foundation, Inc. All rights reserved.	Juntendo Univ, Dept Anat & Life Struct, Sch Med, Bunkyo Ku, Tokyo 1138421, Japan	Nagase, M (reprint author), Juntendo Univ, Dept Anat & Life Struct, Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	minagase@juntendo.ac.jp					Nagase M, 2006, HYPERTENSION, V47, P1084, DOI 10.1161/01.HYP.0000222003.28517.99; Shibata S, 2007, HYPERTENSION, V49, P355, DOI 10.1161/01.HYP.0000255636.11931.a2; Mundel P, 2010, KIDNEY INT, V77, P571, DOI 10.1038/ki.2009.424; Gupta IR, 2013, J MED GENET, V50, P330, DOI 10.1136/jmedgenet-2012-101442; Kawarazaki W, 2012, J AM SOC NEPHROL, V23, P997, DOI 10.1681/ASN.2011070734; Navaneethan SD, 2009, CLIN J AM SOC NEPHRO, V4, P542, DOI 10.2215/CJN.04750908; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Akilesh S, 2011, J CLIN INVEST, V121, P4127, DOI 10.1172/JCI46458; Greene EL, 1996, J CLIN INVEST, V98, P1063, DOI 10.1172/JCI118867; Nagase M, 2008, CLIN EXP NEPHROL, V12, P233, DOI 10.1007/s10157-008-0034-9; Nagase M, 2007, HYPERTENSION, V50, P877, DOI 10.1161/HYPERTENSIONAHA.107.091058; Nagase M, 2013, NAT REV NEPHROL, V9, P86, DOI 10.1038/nrneph.2012.282; Ueda K, 2014, BIOCHEM BIOPH RES CO, V445, P132, DOI 10.1016/j.bbrc.2014.01.125; Gee HY, 2013, J CLIN INVEST, V123, P3243, DOI 10.1172/JCI69134; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; Nagase M, 2006, J AM SOC NEPHROL, V17, P3438, DOI 10.1681/ASN.2006080944; Nagase M, 2013, CURR OPIN NEPHROL HY, V22, P148, DOI 10.1097/MNH.0b013e32835d0751; Nagase M, 2010, CLIN EXP NEPHROL, V14, P303, DOI 10.1007/s10157-010-0298-8; Selye H, 1943, ARCH PATHOL, V36, P19; Yoshida S, 2014, NEPHRON EXP NEPHROL, V126, P16, DOI 10.1159/000358758	20	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1051-2276	1532-8503		J RENAL NUTR	J. Renal Nutr.	MAR	2015	25	2					201	204		10.1053/j.jrn.2014.10.016		4	Nutrition & Dietetics; Urology & Nephrology	Nutrition & Dietetics; Urology & Nephrology	CB9NV	WOS:000349959400023		
J	Shoji, T; Emoto, M; Nishizawa, Y; Inaba, M				Shoji, Tetsuo; Emoto, Masanori; Nishizawa, Yoshiki; Inaba, Masaaki			Endocrine and Metabolic Changes Affecting Cardiovascular Disease in Dialysis Patients	JOURNAL OF RENAL NUTRITION			English	Article							CHRONIC KIDNEY-DISEASE; RANDOMIZED CONTROLLED-TRIAL; STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; INDEPENDENT PREDICTOR; DIABETIC-PATIENTS; GLYCEMIC CONTROL; RISK-FACTORS; MORTALITY; EVENTS	Protein-energy wasting plays an important role in the increased risk of mortality from cardiovascular disease in people with end-stage renal disease. Because protein-energy wasting is a condition of imbalance between anabolism and catabolism, endocrine and metabolic alterations that regulate such balance should be the possible target of intervention. Subjects with end-stage renal disease exhibit various changes in thyroid function, gonadal hormones, adrenal androgen, glucose metabolism, dyslipidemia, fatty acid composition, cholesterol absorption, and vitamin D. In this article, we briefly review the association of these alterations with mortality and cardiovascular disease in hemodialysis patients. Although some of them may be the adaptive response to the catabolic condition, these observational data are useful for risk stratification of patients and also for providing new ideas for possible prevention. (C) 2015 by the National Kidney Foundation, Inc. All rights reserved.	[Shoji, Tetsuo] Osaka City Univ, Grad Sch Med, Dept Geriatr & Vasc Med, Osaka 5458585, Japan; [Emoto, Masanori; Nishizawa, Yoshiki; Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 5458585, Japan	Shoji, T (reprint author), Osaka City Univ, Grad Sch Med, Dept Geriatr & Vasc Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	t-shoji@med.osaka-cu.ac.jp			Nikkiso; Boehringer-Ingelheim; Taisho-Toyama	Masanori Emoto: Honoraria for lectures from Boehringer-Ingelheim, Eli Lilly, Tanabe-Mitsubishi; Joint research grants from Nikkiso; Scholarship grants from Boehringer-Ingelheim, Taisho-Toyama.	Shoji T, 2013, AM J KIDNEY DIS, V62, P568, DOI 10.1053/j.ajkd.2013.02.362; Shinohara K, 2002, J AM SOC NEPHROL, V13, P1894, DOI 10.1097/01.ASN.0000019900.87535.43; Carrero JJ, 2009, J AM SOC NEPHROL, V20, P613, DOI 10.1681/ASN.2008060664; Lok CE, 2012, JAMA-J AM MED ASSOC, V307, P1809, DOI 10.1001/jama.2012.3473; Zoccali C, 2006, KIDNEY INT, V70, P523, DOI 10.1038/sj.ki.5001566; Oomichi T, 2006, DIABETES CARE, V29, P1496, DOI 10.2337/dc05-1887; LOWRIE EG, 1990, AM J KIDNEY DIS, V15, P458; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Rogacev KS, 2012, CLIN J AM SOC NEPHRO, V7, P943, DOI 10.2215/CJN.05170511; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Carrero JJ, 2007, J INTERN MED, V262, P690, DOI 10.1111/j.1365-2796.2007.01865.x; Thadhani R, 2012, JAMA-J AM MED ASSOC, V307, P674, DOI 10.1001/jama.2012.120; Svensson M, 2006, CLIN J AM SOC NEPHRO, V1, P780, DOI 10.2215/CJN.00630206; Shoji T, 2004, NEPHROL DIAL TRANSPL, V19, P179, DOI 10.1093/ndt/gfg513; Shoji T, 2011, CLIN J AM SOC NEPHRO, V6, P1112, DOI 10.2215/CJN.09961110; Morioka T, 2001, DIABETES CARE, V24, P909, DOI 10.2337/diacare.24.5.909; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Kakiya R, 2012, NEPHROL DIAL TRANSPL, V27, P3915, DOI 10.1093/ndt/gfs162; Kim Y, 2013, INT UROL NEPHROL, V45, P1079, DOI 10.1007/s11255-012-0208-y; Kovesdy CP, 2008, KIDNEY INT, V73, P1355, DOI 10.1038/ki.2008.35; Nishizawa Y, 2001, AM J KIDNEY DIS, V38, pS4, DOI 10.1053/ajkd.2001.27380; Shoji T, 2005, INTERNAL MED, V44, P179, DOI 10.2169/internalmedicine.44.179; Sonoda M, 2013, J ATHEROSCLER THROMB, V21, P346; Wang AYM, 2014, J AM SOC NEPHROL, V25, P175, DOI 10.1681/ASN.2013010103	25	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1051-2276	1532-8503		J RENAL NUTR	J. Renal Nutr.	MAR	2015	25	2					223	225		10.1053/j.jrn.2014.10.018		3	Nutrition & Dietetics; Urology & Nephrology	Nutrition & Dietetics; Urology & Nephrology	CB9NV	WOS:000349959400027		
J	Inaba, M; Okuno, S; Nagayama, H; Yamada, S; Ishimura, E; Imanishi, Y; Shoji, S				Inaba, Masaaki; Okuno, Senji; Nagayama, Harumi; Yamada, Shinsuke; Ishimura, Eiji; Imanishi, Yasuo; Shoji, Shigeichi			Restoration of Parathyroid Function After Change of Phosphate Binder From Calcium Carbonate to Lanthanum Carbonate in Hemodialysis Patients With Suppressed Serum Parathyroid Hormone	JOURNAL OF RENAL NUTRITION			English	Article							CHRONIC KIDNEY-DISEASE; MAINTENANCE HEMODIALYSIS; AORTIC CALCIFICATION; CORTICAL BONE; MINERALIZATION; ASSOCIATION; MORTALITY; MARKER; FGF-23	Control of phosphate is the most critical in the treatment of chronic kidney disease with mineral and bone disorder (CKD-MBD). Because calcium-containing phosphate binder to CKD patients is known to induce adynamic bone disease with ectopic calcification by increasing calcium load, we examined the effect of lanthanum carbonate (LaC), a non-calcium containing phosphate binder, to restore bone turnover in 27 hemodialysis patients with suppressed parathyroid function (serum intact parathyroid hormone [iPTH] <= 150 pg/mL). At the initiation of LaC administration, the dose of calcium-containing phosphate binder calcium carbonate (CaC) was withdrawn or reduced based on serum phosphate. After initiation of LaC administration, serum calcium and phosphate decreased significantly by 4 weeks, whereas whole PTH and iPTH increased. A significant and positive correlation between decreases of serum calcium, but not phosphate, with increases of whole PTH and iPTH, suggested that the decline in serum calcium with reduction of calcium load by LaC might increase parathyroid function. Serum bone resorption markers, such as serum tartrate-resistant acid phosphatase 5b, and Ntelopeptide of type I collagen increased significantly by 4 weeks after LaC administration, which was followed by increases of serum bone formation markers including serum bone alkaline phosphatase, intact procollagen N-propeptide, and osteocalcin. Therefore, it was suggested that LaC attenuated CaC-induced suppression of parathyroid function and bone turnover by decreasing calcium load. In conclusion, replacement of CaC with LaC, either partially or totally, could increase parathyroid function and resultant bone turnover in hemodialysis patients with serum iPTH <= 150 pg/mL. (C) 2015 by the National Kidney Foundation, Inc. All rights reserved.	[Inaba, Masaaki; Okuno, Senji; Nagayama, Harumi; Yamada, Shinsuke; Ishimura, Eiji; Imanishi, Yasuo; Shoji, Shigeichi] Osaka City Univ, Dept Metab Endocrinol & Mol Med, Grad Sch Med, Osaka 5458585, Japan; [Inaba, Masaaki; Okuno, Senji; Nagayama, Harumi; Yamada, Shinsuke; Ishimura, Eiji; Imanishi, Yasuo; Shoji, Shigeichi] Shirasagi Hosp, Dept Nephrol, Osaka, Japan	Inaba, M (reprint author), Osaka City Univ, Dept Metab Endocrinol & Mol Med, Grad Sch Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	inaba-m@med.osaka-cu.ac.jp					London GM, 2008, J AM SOC NEPHROL, V19, P1827, DOI 10.1681/ASN.2007050622; Jamal SA, 2013, LANCET, V382, P1268, DOI 10.1016/S0140-6736(13)60897-1; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Okuno S, 2007, AM J KIDNEY DIS, V49, P417, DOI 10.1053/j.ajkd.2006.12.017; BALSAN S, 1986, J CLIN INVEST, V77, P1661, DOI 10.1172/JCI112483; Okuno S, 2005, OSTEOPOROSIS INT, V16, P501, DOI 10.1007/s00198-004-1712-4; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Kadlec AO, 2011, UROLOGY, V78, P744, DOI 10.1016/j.urology.2011.04.007; Toussaint ND, 2011, NEPHROLOGY, V16, P290, DOI 10.1111/j.1440-1797.2010.01412.x; Finn WF, 2006, CLIN NEPHROL, V65, P191; Malluche HH, 2008, CLIN NEPHROL, V70, P284; Boivin G, 2003, J CLIN ENDOCR METAB, V88, P4199, DOI 10.1210/jc.2002-022020; Imanishi Y, 2004, KIDNEY INT, V65, P1943, DOI 10.1111/j.1523-1755.2004.00604.x; Inaba M, 2005, OSTEOPOROSIS INT, V16, P517, DOI 10.1007/s00198-004-1715-1; Kidney Disease, 2009, KIDNEY INT S, pS1, DOI DOI 10.1038/KI.2009.188; Kurajoh M, 2008, OSTEOPOROSIS INT, V19, P709, DOI 10.1007/s00198-007-0554-2; National Kidney Foundation, 2003, AM J KIDNEY DIS S, V42, pS1, DOI DOI 10.1016/S0272-6386(03)00905-3; Yajima A, 2013, THER APHER DIAL, V17, P41, DOI 10.1111/1744-9987.12038; Yamada S, 2008, CLIN ENDOCRINOL, V69, P189, DOI 10.1111/j.1365-2265.2008.03187.x; Yoda K, 2012, J CLIN ENDOCR METAB, V97, pE2036, DOI 10.1210/jc.2012-2024	20	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1051-2276	1532-8503		J RENAL NUTR	J. Renal Nutr.	MAR	2015	25	2					242	246		10.1053/j.jrn.2014.10.013		5	Nutrition & Dietetics; Urology & Nephrology	Nutrition & Dietetics; Urology & Nephrology	CB9NV	WOS:000349959400032		
J	Zhang, L; Nielson, N				Zhang, Li; Nielson, Norma			SOLVENCY ANALYSIS AND PREDICTION IN PROPERTY-CASUALTY INSURANCE: INCORPORATING ECONOMIC AND MARKET PREDICTORS	JOURNAL OF RISK AND INSURANCE			English	Article							LIABILITY INSURANCE; INSOLVENCY PREDICTION; FINANCIAL DISTRESS; INDUSTRY; MODEL; CLASSIFICATION; DETERMINANTS; SURVEILLANCE; INSURERS; RATINGS	This article extends the insolvency prediction literature by incorporating macroeconomic conditions and state-specific factors. The models achieve greater generalizability and predictive accuracy than earlier research while giving fewer false positives. At the firm level, we find insurers with less diversified business, sufficient cash flow, high return on equity, lower leverage, fewer failed Insurance Regulatory Information System ratio tests, and membership in a larger group are less likely to become insolvent. Our findings support the argument that insolvency likelihood increases for insurers domiciled in states with stricter solvency supervision and/or states with less favorable insurance market conditions, and during soft markets; insolvency risk is negatively related to the slope of the yield curve. Our findings also imply that insurers respond efficiently to changes in such market factors as market return, inflation, and catastrophic losses.	[Zhang, Li] St Cloud State Univ, GR Herberger Business Coll, Toyono, Osaka 56301, Japan; [Nielson, Norma] Univ Calgary, Haskayne Sch Business, Calgary, AB T2N 1N4, Canada	Zhang, L (reprint author), St Cloud State Univ, GR Herberger Business Coll, Toyono, Osaka 56301, Japan.	lzhang@stcloudstate.edu; norma.nielson@haskayne.ucalgary.ca			Property and Casualty Insurance Compensation Corporation (PACICC); MITACS	Li Zhang is at the G.R. Herberger Business College, St. Cloud State University. Norma Nielson is at the Haskayne School of Business, University of Calgary. The authors can be contacted via e-mail: lzhang@stcloudstate.edu, norma.nielson@haskayne.ucalgary.ca. The authors would like to thank the Property and Casualty Insurance Compensation Corporation (PACICC) and MITACS for their financial support of this research.	Aiuppa T. A., 1993, J INSURANCE ISSUES P, V16, P1; AMBROSE JM, 1988, J RISK INSUR, V55, P229, DOI 10.2307/253325; AMBROSE JM, 1994, J RISK INSUR, V61, P317, DOI 10.2307/253713; BARNIV R, 1990, J RISK INSUR, V57, P110, DOI 10.2307/252927; PINCHES GE, 1974, J RISK INSUR, V41, P563, DOI 10.2307/251955; Cummins JD, 1999, J RISK INSUR, V66, P417, DOI 10.2307/253555; Beck N, 1998, AM J POLIT SCI, V42, P1260, DOI 10.2307/2991857; Berry-Stolzle TR, 2012, J RISK INSUR, V79, P381, DOI 10.1111/j.1539-6975.2011.01423.x; Browne MJ, 1995, J RISK INSUR, V62, P309, DOI 10.2307/253794; HARRINGTON SE, 1986, J RISK INSUR, V53, P583, DOI 10.2307/252965; Baranoff EG, 2000, J RISK INSUR, V67, P369, DOI 10.2307/253834; Baranoff EG, 1999, J RISK INSUR, V66, P99, DOI 10.2307/253879; BARNIV R, 1990, ACCOUNT REV, V65, P578; BarNiv R, 1997, J RISK INSUR, V64, P89, DOI 10.2307/253913; BARNIV R, 1992, J RISK INSUR, V59, P543, DOI 10.2307/253344; Born P, 2006, J RISK UNCERTAINTY, V33, P55, DOI 10.1007/s11166-006-0171-z; Brockett L. P., 1994, J RISK INSUR, V61, P402; Brockett L. P., 2006, J RISK INSUR, V73, P397; Browne M. J., 2001, N AM ACTUARIAL J, V5, P11; Browne MJ, 1999, J RISK INSUR, V66, P643, DOI 10.2307/253868; Carson J., 2000, J MULTINATIONAL FINA, V10, P297, DOI 10.1016/S1042-444X(00)00023-2; Carson J. M., 2003, J INSURANCE ISSUES, V26, P114; Carson JM, 1995, J RISK INSUR, V62, P764, DOI 10.2307/253595; Chen RB, 2004, J RISK INSUR, V71, P469, DOI 10.1111/j.0022-4367.2004.00099.x; Cheng J, 2012, J RISK INSUR, V79, P723, DOI 10.1111/j.1539-6975.2011.01452.x; Cummins J. D., 1995, WORKING PAPER; Deleris L. A., 2012, RISK DECISION ANAL, V3, P3; DOHERTY NA, 1995, J BUS, V68, P383, DOI 10.1086/296669; Dueker Michael J., 1997, REVIEW, V79, P41; ESTRELLA A, 1991, J FINANC, V46, P555, DOI 10.2307/2328836; Gangopadhyay P., 2010, J INSURANCE ISSUES, V33, P132; Hsiao SH, 2009, EXPERT SYST APPL, V36, P6100, DOI 10.1016/j.eswa.2008.07.024; Huang C. S., 1994, J INSURANCE REGULATI, V13, P131; Klein R. W., 1998, J RISK INSUR, V65, P214; Kohonen T, 1996, A30 HELS U TECHN LAB; Lamb R. P., 1997, J INSURANCE ISSUES, V20, P10; Lee SH, 1996, J RISK INSUR, V63, P121, DOI 10.2307/253520; Pate-Cornell M. E., 2009, RISK MANAGEMENT INSU, V12, P199; Pottier S. W., 2002, J FINANCIAL SERVICES, V21, P101, DOI 10.1023/A:1014325802171; Pottier S. W., 2011, RISK MANAGEMENT INSU, V14, P73, DOI 10.1111/j.1540-6296.2011.01195.x; Sharpe G. I., 2007, J RISK INSUR, V74, P377; Shelor R. M., 1990, J REAL ESTATE RES, V5, P335; TRIESCHM.JS, 1973, J RISK INSUR, V40, P327, DOI 10.2307/252222	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4367	1539-6975		J RISK INSUR	J. Risk Insur.	MAR	2015	82	1					97	124		10.1111/j.1539-6975.2013.12012.x		28	Business, Finance; Economics	Business & Economics	CC1YG	WOS:000350140700004		
J	Park, DK; Rhee, JM; Kim, SS; Enyo, Y; Yoshiok, K				Park, Daniel K.; Rhee, John M.; Kim, Sung S.; Enyo, Yoshio; Yoshiok, Katsuhito			Do CT Scans Overestimate the Fusion Rate After Anterior Cervical Discectomy and Fusion?	JOURNAL OF SPINAL DISORDERS & TECHNIQUES			English	Article						ACDF; allograft; fusion; nonunion; pseudarthrosis; surgery; cervical spine	PLATE FIXATION; FOLLOW-UP; ARTHRODESIS; PSEUDOARTHROSIS; ALLOGRAFT; DECOMPRESSION; RADICULOPATHY; POSTERIOR; SPINE	Design: This study is a radiographic analysis. Objective: To compare the fusion rates after anterior cervical discectomy and fusion (ACDF) using x-rays versus computerized tomography (CT). Background: Although fusion status may be obvious when evaluating ACDFs performed in the remote past, determining the presence of a solid fusion at earlier time points after ACDF is often ambiguous but a necessary part of practice. Commonly used tools include radiographs and CT scans. Currently, there is no gold standard imaging modality to determine fusion status. Methods: Twenty-two patients status post-ACDF (cortical allograft with anterior plates) at 34 levels with CT scans and dynamic x-rays obtained at 3, 6, and 12 months postoperatively were included. Four spine surgeons blinded to the time point independently determined fusion status according to the criteria. Results: On the basis of the x-ray criteria, the fusion rates were 26%, 41%, and 65% at 3, 6, and 12 months, respectively, postoperatively. On the basis of CT criteria, the fusion rates were 79%, 79%, and 91% at 3, 6, and 12 months, respectively. There was a significant difference in the predicted fusion rate at each time point comparing x-ray versus CT criteria. In addition, at 3 months, 41% of the levels (11/27) thought to be fused by CT criteria demonstrated >1 mm motion on dynamic x-rays. At 6 months, 33% (9/27) of the levels thought to be fused by CT demonstrated persistent motion of >= 1 mm. At 12 months, 23% (7/31) of the levels considered fused by CT still had persistent motion. Discussion: X-ray criteria for fusion, which incorporate both static and dynamic factors, predicted lower fusion rates at each time point when compared with CT scans, which evaluate only static factors. Depending on the time point, anywhere from 23% to 41% of levels thought to be fused by CT criteria demonstrated persistent motion on dynamic x-rays. Although <1 mm motion is not a sufficient criteria for fusion by itself, levels demonstrating >1 mm motion are less likely to be solidly fused. Thus, we conclude that CT scans may overestimate the fusion rate during the early stages of ACDF healing with cortical allograft, and that CT scans alone may not accurately determine fusion status. Reliable determination of fusion may thus require dynamic information obtained from flexion-extension x-ray in association with high-resolution static information from CT.	[Park, Daniel K.] William Beaumont Hosp, Dept Orthoped Surg, Royal Oak, MI 48072 USA; [Rhee, John M.; Yoshiok, Katsuhito] Emory Univ, Emory Spine Ctr, Dept Orthoped Surg, Atlanta, GA 30322 USA; [Kim, Sung S.] Inje Univ, Sanggye Paik Hosp, Seoul Spine Inst, Dept Orthoped Surg, Seoul, South Korea; [Enyo, Yoshio] Wakayama Med Univ, Dept Orthoped Surg, Wakayama, Japan	Rhee, JM (reprint author), Emory Univ, Emory Spine Ctr, Dept Orthoped Surg, 59 Execut Pk South,Suite 3000, Atlanta, GA 30322 USA.	john.rhee@emory.org					BRODSKY AE, 1992, SPINE, V17, P1137, DOI 10.1097/00007632-199210000-00002; Bolesta MJ, 2000, SPINE, V25, P2040, DOI 10.1097/00007632-200008150-00007; Epstein NE, 2003, J SPINAL DISORD TECH, V16, P243; FAREY ID, 1990, J BONE JOINT SURG AM, V72A, P1171; MacDonald RL, 1997, J NEUROSURG, V86, P990, DOI 10.3171/jns.1997.86.6.0990; Zdeblick TA, 1997, J BONE JOINT SURG AM, V79A, P523; BOHLMAN HH, 1993, J BONE JOINT SURG AM, V75A, P1298; Buchowski JM, 2008, SPINE, V33, P1185, DOI 10.1097/BRS.0b013e318171927c; Hilibrand AS, 1998, ORTHOP CLIN N AM, V29, P591, DOI 10.1016/S0030-5898(05)70033-X; Bolesta MJ, 2000, SPINE, V25, P5; Bolesta Michael J, 2002, Spine J, V2, P197, DOI 10.1016/S1529-9430(02)00186-9; Cannada LK, 2003, SPINE, V28, P46, DOI 10.1097/00007632-200301010-00012; Phillips FM, 1997, SPINE, V22, P1585, DOI 10.1097/00007632-199707150-00012; Goldberg Edward J, 2002, Spine J, V2, P408, DOI 10.1016/S1529-9430(02)00441-2; Martin GJ, 1999, SPINE, V24, P852, DOI 10.1097/00007632-199905010-00004; Martin Jr GJ, 1999, SPINE, V24, P8; Ploumis Avraam, 2006, Acta Orthop Belg, V72, P342; Schneeberger AG, 1999, J SPINAL DISORD, V12, P215; SHINOMIYA K, 1993, J SPINAL DISORD, V6, P277; Tuli SK, 2004, SPINE, V29, P856, DOI 10.1097/00007632-200404150-00007	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1536-0652	1539-2465		J SPINAL DISORD TECH	J. Spinal Disord. Tech.	MAR	2015	28	2					41	46				6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CC1PS	WOS:000350114200002		
J	Misumi, J				Misumi, Jun			The Diameter of a Long-Range Percolation Cluster on Pre-Sierpinski Gasket	JOURNAL OF STATISTICAL PHYSICS			English	Article						Long-range percolation; Random graph; Graph diameter; Fractal lattice	GRAPH	We give several bounds for a graph diameter of a random graph created by a stochastic model called the long-range percolation, in which any pair of two distinct points is connected by a random bond independently. Such a problem is well studied on a finite subset of the -dimensional square lattice, where is a positive integer. In this manuscript, we consider the problem on a finite subset of a fractal lattice which is called the pre-Sierpinski gasket. We can observe that the Hausdorff dimension of the fractal lattice appears in the critical parameters of , where is a value determining the order of probabilities that random bonds exist.	Kochi Univ, Dept Math, Fac Sci, Kochi 7808520, Japan	Misumi, J (reprint author), Kochi Univ, Dept Math, Fac Sci, Akebono Cho, Kochi 7808520, Japan.	misumi@kochi-u.ac.jp					Benjamini I, 2004, ANN MATH, V160, P465; Benjamini I, 2001, RANDOM STRUCT ALGOR, V19, P102, DOI 10.1002/rsa.1022; Biskup M, 2004, ANN PROBAB, V32, P2938, DOI 10.1214/009117904000000577; Benjamini I, 2008, COMB PROBAB COMPUT, V17, P487, DOI 10.1017/S0963548308008948; Biskup M, 2011, RANDOM STRUCT ALGOR, V39, P210, DOI 10.1002/rsa.20349; Coppersmith D, 2002, RANDOM STRUCT ALGOR, V21, P1, DOI 10.1002/rsa.10042; Crawford N, 2013, ANN PROBAB, V41, P445, DOI 10.1214/12-AOP774; Crawford N, 2012, PROBAB THEORY REL, V154, P753, DOI 10.1007/s00440-011-0383-2; Janson S., 2000, RANDOM GRAPHS; Misumi J, 2006, J STAT PHYS, V125, P877, DOI 10.1007/s10955-006-9243-3; SCHULMAN LS, 1983, J PHYS A-MATH GEN, V16, pL639, DOI 10.1088/0305-4470/16/17/001	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-4715	1572-9613		J STAT PHYS	J. Stat. Phys.	MAR	2015	158	5					1083	1089		10.1007/s10955-014-1170-0		7	Physics, Mathematical	Physics	CB9TY	WOS:000349977200003		
J	Hosoya, T; Otsuka, F; Nakamura, E; Terasaka, T; Inagaki, K; Tsukamoto-Yamauchi, N; Hara, T; Toma, K; Komatsubara, M; Makino, H				Hosoya, Takeshi; Otsuka, Fumio; Nakamura, Eri; Terasaka, Tomohiro; Inagaki, Kenichi; Tsukamoto-Yamauchi, Naoko; Hara, Takayuki; Toma, Kishio; Komatsubara, Motoshi; Makino, Hirofumi			Regulatory role of BMP-9 in steroidogenesis by rat ovarian granulosa cells	JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Bone morphogenetic protein (BMP); Follicle-stimulating hormone (FSH); Granulosa cells; Oocyte; Steroidogenesis	BONE MORPHOGENETIC PROTEIN-9; KINASE 1 ALK1; ENDOTHELIAL-CELLS; FOLLICLE; SYSTEM; LIVER; IDENTIFICATION; HORMONE; INVOLVEMENT; RECEPTORS	BMPs expressed in the ovary differentially regulate steroidogenesis by granulosa cells. BMP-9, a circulating BMP, is associated with cell proliferation, apoptosis and differentiation in various tissues. However, the effects of BMP-9 on ovarian function have yet to be elucidated. Here we investigated BMP-9 actions on steroidogenesis using rat primary granulosa cells. BMP-9 potently suppressed FSH-induced progesterone production, whereas it did not affect FSH-induced estradiol production by granulosa cells. The effects of BMP-9 on FSH-induced steroidogenesis were not influenced by the presence of oocytes. FSH-induced cAMP synthesis and FSH-induced mRNA expression of steroidogenic factors, including StAR, P450scc, 3 beta HSD2 and FSHR, were suppressed by treatment with BMP-9. BMP-9 mRNA expression was detected in granulosa cells but not in oocytes. BMP-9 readily activated Smad1/5/8 phosphorylation and Id-1 transcription in granulosa cells. Analysis using ALK inhibitors indicated that BMP-9 actions were mediated via type-I receptors other than ALK-2, -3 and -6. Furthermore, experiments using extracellular domains (ECDs) for BMP type-I and -II receptor constructs revealed that the effects of BMP-9 were reversed by ECDs for ALK-1 and BMPRII. Thus, the functional receptors for BMP-9 in granulosa cells were most likely to be the complex of ALK-1 and BMPRII. Collectively, the results of the present study showed that BMP-9 can affect luteinization and that there are two possible sources of BMP-9, serum and granulosa cells in the ovary. (C) 2014 Elsevier Ltd. All rights reserved.	[Hosoya, Takeshi; Terasaka, Tomohiro; Inagaki, Kenichi; Tsukamoto-Yamauchi, Naoko; Hara, Takayuki; Toma, Kishio; Komatsubara, Motoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Kita Ku, Okayama 7008558, Japan; [Otsuka, Fumio; Nakamura, Eri] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Kita Ku, Okayama 7008558, Japan; [Makino, Hirofumi] Okayama Univ Hosp, Kita Ku, Okayama 7008558, Japan	Otsuka, F (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	fumiotsu@md.okayama-u.ac.jp			Foundation for Growth Science; Astellas Foundation for Research on Metabolic Disorders; Japan Foundation for Applied Enzymology (Japan);  [24591364]	This work was supported in part by Grants-in-Aid for Scientific Research (No. 24591364), Foundation for Growth Science, Astellas Foundation for Research on Metabolic Disorders, and Japan Foundation for Applied Enzymology (Japan).	Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Kidder GM, 2010, CAN J PHYSIOL PHARM, V88, P399, DOI [10.1139/y10-009, 10.1139/Y10-009]; Nakamura E, 2010, ENDOCRINOLOGY, V151, P5506, DOI 10.1210/en.2010-0265; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Inagaki K, 2009, ENDOCRINOLOGY, V150, P1921, DOI 10.1210/en.2008-0851; Moore RK, 2003, J BIOL CHEM, V278, P304, DOI 10.1074/jbc.M207362200; Otsuka F, 2002, P NATL ACAD SCI USA, V99, P8060, DOI 10.1073/pnas.122066899; Li Q, 2013, CANCER SCI, V104, P398, DOI 10.1111/cas.12093; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Miyoshi T, 2007, ENDOCRINOLOGY, V148, P337, DOI 10.1210/en.2006-0966; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; Otsuka F, 2011, MOL REPROD DEV, V78, P9, DOI 10.1002/mrd.21265; Sugimoto H, 2007, FASEB J, V21, P256, DOI 10.1096/fj.06-6837com; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Miller AF, 2000, J BIOL CHEM, V275, P17937, DOI 10.1074/jbc.275.24.17937; Herrera B, 2012, CURR PHARM DESIGN, V18, P4114; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; Gilchrist RB, 2011, REPROD FERT DEVELOP, V23, P23, DOI 10.1071/RD10225; Findlay JK, 2002, MOL CELL ENDOCRINOL, V191, P35, DOI 10.1016/S0303-7207(02)00053-9; Herrera B, 2009, CANCER RES, V69, P9254, DOI 10.1158/0008-5472.CAN-09-2912; Herrera B, 2014, INT J MOL SCI, V15, P5199, DOI 10.3390/ijms15045199; Herrera B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069535; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Kodaira K, 2006, BIOCHEM BIOPH RES CO, V345, P1224, DOI 10.1016/j.bbrc.2006.06.045; Lamplot Joseph D, 2013, Am J Stem Cells, V2, P1; Lopez-Coviella I, 2002, J PHYSIOLOGY-PARIS, V96, P53, DOI 10.1016/S0928-4257(01)00080-8; Matsumoto Y, 2012, MOL CELL ENDOCRINOL, V350, P78, DOI 10.1016/j.mce.2011.11.023; Na ICY., 2013, PATHOL RES PRACT, V209, P14; Nakamura E, 2012, ENDOCRINOLOGY, V153, P469, DOI 10.1210/en.2011-1646; Nakamura E, 2013, J STEROID BIOCHEM, V134, P67, DOI 10.1016/j.jsbmb.2012.10.018; Wagner DO, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3107mr1; Yu Paul B, 2008, Nat Chem Biol, V4, P33, DOI 10.1038/nchembio.2007.54	34	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0760			J STEROID BIOCHEM	J. Steroid Biochem. Mol. Biol.	MAR	2015	147						85	91		10.1016/j.jsbmb.2014.12.007		7	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CC1FX	WOS:000350087700011		
J	Ichioka, M; Mita, S; Shimizu, Y; Imada, K; Kiyono, T; Bono, Y; Kyo, S				Ichioka, Masayuki; Mita, Shizuka; Shimizu, Yutaka; Imada, Kazunori; Kiyono, Tohru; Bono, Yukiko; Kyo, Satoru			Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells	JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Dienogest; Progesterone receptor isoforms; Endometriosis	PROSTAGLANDIN E-2 PRODUCTION; GROWTH-FACTOR EXPRESSION; NECROSIS-FACTOR-ALPHA; LONG-TERM USE; A-FORM; OVARIAN ENDOMETRIOSIS; EPITHELIAL-CELLS; STROMAL CELLS; CYCLOOXYGENASE-2 EXPRESSION; TRANSCRIPTIONAL ACTIVITY	Dienogest (DNG) is a selective progesterone receptor (PR) agonist and oral administration of DNG is used for the treatment of endometriosis. DNG is considered to act on PR to down-regulate pathophysiological factors associated with endometriosis. PR exists as two major isoforms, PR-A and PR-B, and their physiological functions are mostly distinct. It was suggested that PR isoform expression patterns are altered in endometriosis, but it is unknown whether the pharmacological effects of DNG are exerted through PR-A, PR-B or both. In the present study, we investigated the pharmacological effects of DNG through these PR isoforms on the expression of CYP19A1 which encodes aromatase and inflammatory and neuroangiogenesis factors associated with the pain and progression of endometriosis. We used immortalized human endometriotic epithelial cell lines that specifically express PR-A or PR-B in a spheroid cell culture system, and treated them with DNG. We evaluated messenger RNA (mRNA) expression of CYP19A1, prostaglandin (PG)E2 synthase (cyclooxygenase (COX)-2 and microsomal PGE2 synthase (mPGES)-1), inflammatory cytokines (interleukin (IL)-6, IL-8, and monocyte chemoattractant protein (MCP)-1) and neuroangiogenesis factors (vascular endothelial growth factor (VEGF) and nerve growth factor (NGF)) using real-time polymerase chain reaction. In addition, PGE2 production was measured by enzyme immunoassay. We found that DNG down-regulated mRNA expression of CYP19A1, COX-2, mPGES-1, IL-6, IL-8, MCP-1, NGF and VEGF, and PGE2 production in human endometriotic epithelial cell lines that specifically express either PR-A or PR-B. These results demonstrate that DNG activates both PR-A and PR-B and down-regulates the expression of pathophysiological factors associated with pain and progression of endometriosis. Our results suggest that DNG exerts therapeutic efficacy against the pain and progression of endometriosis regardless of PR isoform expression patterns. (C) 2014 Elsevier Ltd. All rights reserved.	[Ichioka, Masayuki; Mita, Shizuka; Shimizu, Yutaka; Imada, Kazunori] Mochida Pharmaceut Co Ltd, Dev Res, Gotemba, Shizuoka 4128524, Japan; [Kiyono, Tohru] Natl Inst Canc Res, Div Virol, Chuo Ku, Tokyo 1040045, Japan; [Bono, Yukiko; Kyo, Satoru] Kanazawa Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Kanazawa, Ishikawa 9208641, Japan	Mita, S (reprint author), Mochida Pharmaceut Co Ltd, Dev Res, 722 Jimba, Gotemba, Shizuoka 4128524, Japan.	shizuka.mita@mochida.co.jp					Crosignani P, 2006, HUM REPROD UPDATE, V12, P179, DOI 10.1093/humupd/dmi049; Kalkhoven E, 1996, J BIOL CHEM, V271, P6217; Strowitzki T, 2010, HUM REPROD, V25, P633, DOI 10.1093/humrep/dep469; Matsusaki M, 2014, ADV DRUG DELIVER REV, V74, P95, DOI 10.1016/j.addr.2014.01.003; MCDONNELL DP, 1994, J STEROID BIOCHEM, V48, P425, DOI 10.1016/0960-0760(94)90190-2; Obr AE, 2012, MOL CELL ENDOCRINOL, V357, P4, DOI 10.1016/j.mce.2011.10.030; VEGETO E, 1993, MOL ENDOCRINOL, V7, P1244, DOI 10.1210/me.7.10.1244; Xue Q, 2007, BIOL REPROD, V77, P681, DOI 10.1095/biolreprod.107.061804; Bukulmez O, 2008, ENDOCRINOLOGY, V149, P1190, DOI 10.1210/en.2007-0665; Chishima F, 2002, AM J REPROD IMMUNOL, V48, P50, DOI 10.1034/j.1600-0897.2002.01101.x; Yamanaka K, 2012, FERTIL STERIL, V97, P477, DOI 10.1016/j.fertnstert.2011.11.005; Shao RJ, 2014, AM J TRANSL RES, V6, P104; Horie S, 2005, FERTIL STERIL, V83, P1530, DOI 10.1016/j.fertnstert.2004.11.042; Anaf V, 2002, HUM REPROD, V17, P1895, DOI 10.1093/humrep/17.7.1895; Bulun SE, 2010, SEMIN REPROD MED, V28, P36, DOI 10.1055/s-0029-1242991; Vaheri A, 2009, EXP CELL RES, V315, P1633, DOI 10.1016/j.yexcr.2009.03.005; Sasagawa S, 2008, STEROIDS, V73, P222, DOI 10.1016/j.steroids.2007.10.003; Kitawaki J, 2002, J STEROID BIOCHEM, V83, P149, DOI 10.1016/S0960-0760(02)00260-1; Okada H, 2011, FERTIL STERIL, V96, P786, DOI 10.1016/j.fertnstert.2011.06.048; Momoeda M, 2009, J OBSTET GYNAECOL RE, V35, P1069, DOI 10.1111/j.1447-0756.2009.01076.x; Igarashi TM, 2005, FERTIL STERIL, V84, P67, DOI 10.1016/j.fertnstert.2005.01.113; Bono Y, 2012, BRIT J CANCER, V106, P1205, DOI 10.1038/bjc.2012.26; Gazvani R, 2002, REPRODUCTION, V123, P217, DOI 10.1530/rep.0.1230217; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Hardy DB, 2006, MOL ENDOCRINOL, V20, P2724, DOI 10.1210/me.2006-0112; Irahara Minoru, 2007, Reproductive Medicine and Biology, V6, P223, DOI 10.1111/j.1447-0578.2007.00189.x; Harada T, 2009, FERTIL STERIL, V91, P675, DOI 10.1016/j.fertnstert.2007.12.080; Petraglia F, 2012, ARCH GYNECOL OBSTET, V285, P167, DOI 10.1007/s00404-011-1941-7; Attia GR, 2000, J CLIN ENDOCR METAB, V85, P2897, DOI 10.1210/jc.85.8.2897; Brueggmann D, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-17; Chishima F, 2007, AM J REPROD IMMUNOL, V57, P218, DOI 10.1111/j.1600-0897.00466.x; Dai DH, 2003, J STEROID BIOCHEM, V87, P123, DOI 10.1016/j.jsbmb.2003.08.004; de Arellano MLB, 2011, HUM REPROD, V26, P2721, DOI 10.1093/humrep/der253; Enzerink A, 2009, MOL IMMUNOL, V46, P1787, DOI 10.1016/j.molimm.2009.01.018; Gentilini D, 2010, FERTIL STERIL, V94, P1538, DOI 10.1016/j.fertnstert.2009.12.018; Hayashi A, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-31; KASTNER P, 1990, J BIOL CHEM, V265, P12163; Lim CS, 1999, MOL ENDOCRINOL, V13, P366, DOI 10.1210/me.13.3.366; McCormack PL, 2010, DRUGS, V70, P2073, DOI 10.2165/11206320-000000000-00000; MCDONNELL DP, 1994, J BIOL CHEM, V269, P11945; Mita S, 2014, FERTIL STERIL, V101, P595, DOI 10.1016/j.fertnstert.2013.10.038; Mita S, 2011, FERTIL STERIL, V96, P1485, DOI 10.1016/j.fertnstert.2011.09.040; MOBUS V, 1993, GYNECOL ONCOL, V48, P370, DOI 10.1006/gyno.1993.1065; Oettel M., 1995, Drugs of Today, V31, P499; Schweppe KW, 2007, GYNECOL ENDOCRINOL, V23, P17, DOI 10.1080/09513590701584923; Shimizu Y, 2011, STEROIDS, V76, P60, DOI 10.1016/j.steroids.2010.08.010; Triolo Onofrio, 2013, J Clin Med Res, V5, P153, DOI 10.4021/jocmr1288w	47	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0760			J STEROID BIOCHEM	J. Steroid Biochem. Mol. Biol.	MAR	2015	147						103	110		10.1016/j.jsbmb.2014.12.008		8	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CC1FX	WOS:000350087700013		
J	Ninomiya, M; Shirabe, K; Facciuto, ME; Schwartz, ME; Florman, SS; Yoshizumi, T; Harimoto, N; Ikegami, T; Uchiyama, H; Maehara, Y				Ninomiya, Mizuki; Shirabe, Ken; Facciuto, Marcelo E.; Schwartz, Myron E.; Florman, Sander S.; Yoshizumi, Tomoharu; Harimoto, Norifumi; Ikegami, Toru; Uchiyama, Hideaki; Maehara, Yoshihiko			Comparative Study of Living and Deceased Donor Liver Transplantation as a Treatment for Hepatocellular Carcinoma	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							GROWTH-FACTOR; RECURRENCE; SURVIVAL; CRITERIA; GRAFTS	BACKGROUND: Living donor liver transplantation (LDLT) is an important treatment option for unresectable hepatocellular carcinoma (HCC), but whether recurrence and survival in LDLT differ from those in deceased donor liver transplantation (DDLT) remains controversial. STUDY DESIGN: A retrospective analysis was performed between patients with HCC who underwent LDLT in a Japanese institute (n = 133) and those who underwent DDLT in a United States institute (n = 362). RESULTS: Although there was a difference in patient background characteristics (eg, body mass index, donor age, Model for End-Stage Liver Disease [MELD] score), tumor aggressiveness represented by Milan criteria and microscopic vascular invasion were comparable between the 2 groups. The cumulative 5-year recurrence rates of the LDLT group and the DDLT group were similar (14.8% vs 19.0%, p = 0.638), but overall survival in the LDLT group was significantly better than that in the DDLT group (84.2% vs 63.5%, p < 0.0001). Separate multivariate analysis identified different preoperative predictive factors for HCC recurrence (salvage transplantation and Des-gamma-carboxy prothrombin >300 in the LDLT group, beyond Milan criteria in the DDLT group). Combined multivariate analysis of the 2 groups identified recipient's body mass image >30 kg/m(2) as an independent risk factor for overall survival; the technique of transplantation (LDLT or DDLT) was not found to be a risk factor. CONCLUSIONS: When compared between the institutes where LDLT or DDLT were the first treatment choices for unresectable HCC, recurrence rates were comparable. Living donor liver trasplantation is a viable treatment option for unresectable HCC, providing recurrence rates similar to those achieved with DDLT. (C) 2015 by the American College of Surgeons	[Ninomiya, Mizuki; Shirabe, Ken; Yoshizumi, Tomoharu; Harimoto, Norifumi; Ikegami, Toru; Uchiyama, Hideaki; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Facciuto, Marcelo E.; Schwartz, Myron E.; Florman, Sander S.] Mt Sinai Med Ctr, Recanati Miller Transplantat Inst, New York, NY 10029 USA	Ninomiya, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan.	nino-m@surg2.med.kyushu-u.ac.jp			Ministry of Health, Labour and Welfare of Japan	This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare of Japan.	Fisher RA, 2007, AM J TRANSPLANT, V7, P1601, DOI 10.1111/j.1600-6143.2007.01802.x; Yang ZF, 2004, J IMMUNOL, V173, P2507; Vakili K, 2009, LIVER TRANSPLANT, V15, P1861, DOI 10.1002/lt.21940; Ninomiya M, 2010, AM J TRANSPLANT, V10, P1580, DOI 10.1111/j.1600-6143.2010.03150.x; Lo CM, 2004, LIVER TRANSPLANT, V10, P440, DOI 10.1002/lt.20097; Bhangui P, 2011, HEPATOLOGY, V53, P1570, DOI 10.1002/hep.24231; Kulik LM, 2012, AM J TRANSPLANT, V12, P2997, DOI 10.1111/j.1600-6143.2012.04272.x; Nakamuta M, 2005, TRANSPLANTATION, V80, P608, DOI 10.1097/01.tp.0000166009.77444.f3; Soejima Y, 2012, AM J TRANSPLANT, V12, P1877, DOI 10.1111/j.1600-6143.2012.04022.x; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.60016; Todo S, 2007, LIVER TRANSPLANT, V13, pS48, DOI 10.1002/lt.21334; Yonemura Y, 2005, LIVER TRANSPLANT, V11, P1556, DOI 10.1002/lt.20537; Axelrod DA, 2008, JAMA-J AM MED ASSOC, V299, P202, DOI 10.1001/jama.2007.50; Facciuto ME, 2011, TRANSPLANTATION, V92, P446, DOI 10.1097/TP.0b013e3182252733; Hwang S, 2005, LIVER TRANSPLANT, V11, P1265, DOI 10.1002/lt.20549; Lo CM, 2007, BRIT J SURG, V94, P78, DOI 10.1002/bjs.5528; Man K, 2003, LIVER TRANSPLANT, V9, P425, DOI 10.1053/jlts.2003.50066; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Ninomiya M, 2003, TRANSPLANT INT, V16, P814, DOI 10.1007/s00147-003-0628-9; Shirabe K, 2011, CLIN TRANSPLANT, V25, pE491, DOI 10.1111/j.1399-0012.2011.01463.x; Soejima Y, 2007, TRANSPLANTATION, V83, P893, DOI 10.1097/01.tp.0000259015.46798.ec; Taketomi A, 2010, J AM COLL SURGEONS, V211, P456, DOI 10.1016/j.jamcollsurg.2010.04.018; UNOS, 2002, LIV TRANSPL CAND HEP; Yoshizumi T, 2014, LIVER TRANSPLANT, V20, P323, DOI 10.1002/lt.23804	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	MAR	2015	220	3					297	U94		10.1016/j.jamcollsurg.2014.12.009		11	Surgery	Surgery	CB8WI	WOS:000349912300008		
J	Okuda, Y; Honda, G; Kurata, M; Kobayashi, S; Sakamoto, K; Takahashi, K				Okuda, Yukihiro; Honda, Goro; Kurata, Masanao; Kobayashi, Shin; Sakamoto, Katsunori; Takahashi, Keiichi			A Safe and Valid Procedure for Pure Laparoscopic Partial Hepatectomy of the Most Posterosuperior Area: The Top of Segment 7	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							LEFT LATERAL SEGMENTECTOMY; LIVER RESECTION; HEPATOCELLULAR-CARCINOMA; HEPATIC RESECTION; INCISION; TUMORS; POSITION; SIDE		[Okuda, Yukihiro; Honda, Goro; Kurata, Masanao; Kobayashi, Shin; Sakamoto, Katsunori; Takahashi, Keiichi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Surg, Tokyo 1138677, Japan	Honda, G (reprint author), Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Surg, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138677, Japan.	ghon@cick.jp					Cho JY, 2008, SURG ENDOSC, V22, P2344, DOI 10.1007/s00464-008-9966-0; Kazaryan AM, 2011, SURG ENDOSC, V25, P3881, DOI 10.1007/s00464-011-1815-x; Honda G, 2013, J HEPATO-BIL-PAN SCI, V20, P435, DOI 10.1007/s00534-012-0586-7; Ikeda T, 2014, SURG ENDOSC, V28, P2484, DOI 10.1007/s00464-014-3469-y; Ishizawa T, 2012, ANN SURG, V256, P959, DOI 10.1097/SLA.0b013e31825ffed3; D'Angelica M, 2006, WORLD J SURG, V30, P410, DOI 10.1007/s00268-005-0183-x; Dagher I, 2010, J AM COLL SURGEONS, V211, P16, DOI 10.1016/j.jamcollsurg.2010.03.012; Cho JY, 2008, SURGERY, V144, P32, DOI 10.1016/j.surg.2008.03.020; Laurent A, 2003, ARCH SURG-CHICAGO, V138, P763, DOI 10.1001/archsurg.138.7.763; Kaneko H, 1996, SURGERY, V120, P468, DOI 10.1016/S0039-6060(96)80065-1; Buell JF, 2009, ANN SURG, V250, P825, DOI 10.1097/SLA.0b013e3181b3b2d8; Lesurtel M, 2003, J AM COLL SURGEONS, V196, P236, DOI 10.1016/S1072-7515(02)01622-8; Gigot JF, 2002, ANN SURG, V236, P90, DOI 10.1097/01.SLA.0000018658.57709.09; Azagra JS, 1996, SURG ENDOSC-ULTRAS, V10, P758, DOI 10.1007/BF00193052; Yoon YS, 2010, SURG ENDOSC, V24, P1630, DOI 10.1007/s00464-009-0823-6; Couinaud C., 1992, Annali Italiani di Chirurgia, V63, P693; Honda G, 2014, J GASTROINTEST SURG, V18, P1379, DOI 10.1007/s11605-014-2538-9; Honda G, 2014, SURG ENDOSC, V28, P1331, DOI 10.1007/s00464-013-3329-1; Hüscher C G, 1998, Semin Laparosc Surg, V5, P204; Kumakiri J, 2006, ACTA OBSTET GYN SCAN, V85, P977, DOI 10.1080/00016340600607065; Okuda Yukihiro, 2013, Asian J Endosc Surg, V6, P100, DOI 10.1111/ases.12003; Otsuka Y, 2009, J HEPATO-BILIARY-PAN, V16, P720, DOI 10.1007/s00534-009-0139-x; Sato H, 2000, HEPATO-GASTROENTEROL, V47, P504; Tono T, 2003, AM J SURG, V185, P155, DOI 10.1016/S0002-9610(02)01201-1; Tsugita M, 1995, INT SURG, V80, P242	25	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	MAR	2015	220	3					E17	E21		10.1016/j.jamcollsurg.2014.11.021		5	Surgery	Surgery	CB8WI	WOS:000349912300001		
J	Kwon, J; Yoshida, Y; Yoshida, H; Kim, H; Suzuki, T; Lee, Y				Kwon, Jinhee; Yoshida, Yuko; Yoshida, Hideyo; Kim, Hunkyung; Suzuki, Takao; Lee, Yunhwan			Effects of a Combined Physical Training and Nutrition Intervention on Physical Performance and Health-Related Quality of Life in Prefrail Older Women Living in the Community: A Randomized Controlled Trial	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Article						Frail elderly; exercise; diet; quality of life; hand strength; clinical trial	FRAIL ELDERLY-PEOPLE; FUNCTIONAL PERFORMANCE; RESISTANCE EXERCISE; FOLLOW-UP; ADULTS; SUPPLEMENTATION; DISABILITY; STRENGTH; DECLINE; SERVICE	Objectives: The purpose of this study was to examine whether a 12-week combined physical exercise training and nutritional intervention improves physical performance and enhances health-related quality of life (HRQOL) among prefrail elderly women living in the community. Design: This was a randomized controlled trial in which participants were recruited and randomly assigned to the exercise and nutrition group (EN, n = 30), exercise only group (E, n = 28), and control group (C, n = 31). Setting: Group training classes were held at a research center in Itabashi Ward, Tokyo, Japan. Participants: Eighty-nine prefrail women aged 70 years or older. Intervention: The EN group participated in an exercise training and nutritional program (cooking class) once a week, and the E group participated in the exercise training program only. Measurements: Outcome measures that included physical performance (handgrip strength, balance, walking speed) and HRQOL (Medical Outcomes Study 36-Item Short Form Health Survey) were obtained at entry, the end of the 12-week intervention, and 6 months after completion of the intervention program. Results: At the end of the 12-week intervention, significant improvements in the physical component summary score and 3 (role physical, bodily pain, role emotional) of the 8 domains of the Medical Outcomes Study 36-Item Short Form Health Survey were observed in the EN group. The E group exhibited a significantly increased handgrip strength at postintervention. The positive effects, however, were not maintained at 6-month follow-up, but were reduced. Conclusions: The combined physical exercise training and nutritional intervention program has beneficial effects on several domains of HRQOL and handgrip strength in prefrail elderly women living in the community. However, further studies are needed to examine approaches that facilitate maintenance of the improved outcomes by combined exercise training and nutritional intervention. (C) 2015 AMDA - The Society for Post-Acute and Long-Term Care Medicine.	[Kwon, Jinhee] Natl Hlth Insurance Corp, Inst Hlth Insurance Policy Res, Seoul, South Korea; [Yoshida, Yuko; Yoshida, Hideyo; Kim, Hunkyung] Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Tokyo, Japan; [Suzuki, Takao] Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Aichi, Japan; [Lee, Yunhwan] Ajou Univ, Sch Med, Dept Prevent Med & Publ Hlth, Suwon 443380, South Korea; [Lee, Yunhwan] Ajou Univ, Med Ctr, Inst Aging, Suwon 443380, South Korea	Lee, Y (reprint author), Ajou Univ, Sch Med, Dept Prevent Med & Publ Hlth, 164 World Cup Ro, Suwon 443380, South Korea.	yhlee@ajou.ac.kr		Lee, Yunhwan/0000-0001-8484-4750	Ministry of Education, Science and Culture of Japan [18700570]; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1B3002939]	This study was supported in part by a Grant in Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (18700570) from April 2006 to March 2007. Yunhwan Lee was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2012R1A1B3002939).	Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; Suzuki T, 2008, J BONE MINER RES, V23, P1309, DOI [10.1359/jbmr.080328, 10.1359/JBMR.080328]; Rydwik E, 2008, AGING CLIN EXP RES, V20, P159; Benyamini Y, 2000, J GERONTOL B-PSYCHOL, V55, pP107; Faber MJ, 2006, ARCH PHYS MED REHAB, V87, P885, DOI 10.1016/j.apmr.2006.04.005; Brown M, 2000, J GERONTOL A-BIOL, V55, pM350; Bonnefoy M, 2003, BRIT J NUTR, V89, P731, DOI 10.1079/BJN2003836; Sun XJ, 2011, QUAL LIFE RES, V20, P359, DOI 10.1007/s11136-010-9752-z; Guthrie E, 2001, BRIT MED J, V323, P135, DOI 10.1136/bmj.323.7305.135; Cress ME, 1999, J GERONTOL A-BIOL, V54, pM242, DOI 10.1093/gerona/54.5.M242; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146; Kwon J, 2007, GERONTOLOGY, V53, P322, DOI 10.1159/000103257; Taaffe DR, 1999, J AM GERIATR SOC, V47, P1208; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Kwon J, 2006, EUR J CLIN NUTR, V60, P305, DOI 10.1038/sj.ejcn.1602314; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Kim CO, 2013, J GERONTOL A-BIOL, V68, P309, DOI 10.1093/gerona/gls167; Tieland M, 2012, J AM MED DIR ASSOC, V13, P720, DOI 10.1016/j.jamda.2012.07.005; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Schmitt EM, 2010, GERONTOLOGIST, V50, P531, DOI 10.1093/geront/gnp172; Muhlberg W, 2004, Z GERONTOL GERIATR, V37, P2, DOI 10.1007/s00391-004-0203-8; Bilotta C, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-56; Bunout D, 2001, J NUTR, V131, p2441S; Bunout D., 2004, Journal of Nutrition, Health & Aging, V8, P68; Cameron ID, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-65; Chin A, 2008, SPORTS MED, V38, P781, DOI DOI 10.2165/00007256-200838090-00006; Chin A Paw MJ, 2002, BRIT J SPORT MED, V36, P126, DOI [DOI 10.1136/BJSM.36.2.126], 10.1136/bjsm.36.2.126]]; Chin A Paw MJM, 2001, ARCH PHYS MED REHAB, V82, P811; Daniels R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-278; de Jong N, 1999, J NUTR, V129, P2028; Demura Shinichi, 2003, Journal of Physiological Anthropology and Applied Human Science, V22, P159, DOI 10.2114/jpa.22.159; de Vreede PL, 2007, GERONTOLOGY, V53, P12, DOI 10.1159/000095387; DiFrancisco-Donoghue J, 2007, BRIT J SPORT MED, V41, P19, DOI 10.1136/bjsm.2006.029330; GRAYDONALD K, 1995, J NUTR, V125, P2965; Kusumoto A, 2007, GERONTOLOGY, V53, P348, DOI 10.1159/000104252; Lin CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021841; Masel MC, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-70; Morley JE, 2006, MED CLIN N AM, V90, P837, DOI 10.1016/j.mcna.2006.05.019; Nagasaki H, 1995, AGING-CLIN EXP RES, V7, P451; Nash KCM, 2012, REV CLIN GERONTOL, V22, P274; Ostir GV, 2006, SOC INDIC RES, V77, P79, DOI 10.1007/s11205-005-5554-z; Rydwik E, 2010, ARCH GERONTOL GERIAT, V51, P283, DOI 10.1016/j.archger.2009.12.001; Sato D, 2009, DISABIL REHABIL, V31, P84, DOI 10.1080/09638280701817552	43	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	MAR 1	2015	16	3							263.e1	10.1016/j.jamda.2014.12.005		8	Geriatrics & Gerontology	Geriatrics & Gerontology	CC2LQ	WOS:000350176900020		
J	Sanford, AM; Orrell, M; Tolson, D; Abbatecola, AM; Arai, H; Bauer, JM; Cruz-Jentoft, AJ; Dong, BR; Ga, H; Goel, A; Hajjar, R; Holmerova, I; Katz, PR; Koopmans, RTCM; Rolland, Y; Visvanathan, R; Woo, J; Morley, JE; Vellas, B				Sanford, Angela M.; Orrell, Martin; Tolson, Debbie; Abbatecola, Angela Marie; Arai, Hidenori; Bauer, Juergen M.; Cruz-Jentoft, Alfonso J.; Dong, Birong; Ga, Hyuk; Goel, Ashish; Hajjar, Ramzi; Holmerova, Iva; Katz, Paul R.; Koopmans, Raymond T. C. M.; Rolland, Yves; Visvanathan, Renuka; Woo, Jean; Morley, John E.; Vellas, Bruno			An International Definition for "Nursing Home"	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Article						Nursing home definition; long-term care; care home	LONG-TERM-CARE	There is much ambiguity regarding the term "nursing home" in the international literature. The definition of a nursing home and the type of assistance provided in a nursing home is quite varied by country. The International Association of Gerontology and Geriatrics and AMDA foundation developed a survey to assist with an international consensus on the definition of "nursing home." (C) 2015 AMDA - The Society for Post-Acute and Long-Term Care Medicine.	[Sanford, Angela M.; Morley, John E.] St Louis Univ, Sch Med, Div Geriatr Med, St Louis, MO 63104 USA; [Orrell, Martin] UCL, London, England; [Orrell, Martin] North East London NHS Fdn Trust, London, England; [Tolson, Debbie] Univ West Scotland, Hamilton, Scotland; [Abbatecola, Angela Marie] Italian Natl Res Ctr Aging, Ancona, Italy; [Arai, Hidenori] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan; [Bauer, Juergen M.] Carl von Ossietzky Univ Oldenburg, Dept Geriatr Med, D-26111 Oldenburg, Germany; [Cruz-Jentoft, Alfonso J.] Univ Europea Madrid, Hosp Univ Ramon y Cajal, Serv Geriatria, Madrid, Spain; [Dong, Birong] Sichuan Univ, West China Hosp, Dept Geriatr, Chengdu 610064, Sichuan, Peoples R China; [Ga, Hyuk] Incheon Eun Hye Hosp, Korean Assoc Geriatr Hosp, Inchon, South Korea; [Goel, Ashish] Univ Coll Med Sci, Delhi 110095, India; [Goel, Ashish] Guru Teg Bahadur Hosp, Delhi 110095, India; [Hajjar, Ramzi] Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon; [Holmerova, Iva] Charles Univ Prague, Fac Humanities, CELLO, NT Qual Long Term Care Project 11325, Prague, Czech Republic; [Katz, Paul R.] Univ Toronto, Baycrest Med Ctr, Toronto, ON, Canada; [Koopmans, Raymond T. C. M.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands; [Rolland, Yves; Vellas, Bruno] CHU Toulouse, Gerontol Clin, INSERM 1027, Toulouse, France; [Visvanathan, Renuka] Univ Adelaide, Sch Med, Adelaide Geriatr Training & Res Aged Care Ctr, Adelaide, SA, Australia; [Visvanathan, Renuka] Queen Elizabeth Hosp, Adelaide, SA, Australia; [Woo, Jean] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Morley, John E.] St Louis Univ, Sch Med, Div Endocrinol, St Louis, MO 63104 USA	Sanford, AM (reprint author), St Louis Univ, Sch Med, Div Geriatr Med, 1402 S Grand Blvd,M238, St Louis, MO 63104 USA.	lipkaa@slu.edu	Cruz-Jentoft, Alfonso/G-2675-2015; Koopmans, R.T.C.M./H-8062-2014; Woo, Jean/K-2625-2014	Cruz-Jentoft, Alfonso/0000-0001-7628-4861; Woo, Jean/0000-0001-7593-3081			Katz PR, 2011, J AM MED DIR ASSOC, V12, P487, DOI 10.1016/j.jamda.2011.01.017; Tolson D, 2013, J AM MED DIR ASSOC, V14, P459, DOI 10.1016/j.jamda.2013.04.005; Tolson D, 2011, J AM MED DIR ASSOC, V12, P184, DOI 10.1016/j.jamda.2010.12.013; Koopmans RTCM, 2013, J AM MED DIR ASSOC, V14, P781, DOI 10.1016/j.jamda.2013.08.004; Lascaratos J, 2004, GERONTOLOGY, V50, P113, DOI 10.1159/000075563; Onder G, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-5	6	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	MAR 1	2015	16	3					181	184		10.1016/j.jamda.2014.12.013		4	Geriatrics & Gerontology	Geriatrics & Gerontology	CC2LQ	WOS:000350176900005		
J	Makizako, H; Shimada, H; Doi, T; Yoshida, D; Anan, Y; Tsutsumimoto, K; Uemura, K; Liu-Ambrose, T; Park, H; Lee, S; Suzuki, T				Makizako, Hyuma; Shimada, Hiroyuki; Doi, Takehiko; Yoshida, Daisuke; Anan, Yuya; Tsutsumimoto, Kota; Uemura, Kazuki; Liu-Ambrose, Teresa; Park, Hyuntae; Lee, Sanyoon; Suzuki, Takao			Physical Frailty Predicts Incident Depressive Symptoms in Elderly People: Prospective Findings From the Obu Study of Health Promotion for the Elderly	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Article						Geriatric Depression Scale; self-rated health; frailty cognitive function; physical performance	LATE-LIFE DEPRESSION; HIGHLY EDUCATED INDIVIDUALS; MILD COGNITIVE IMPAIRMENT; MINI-MENTAL-STATE; OLDER-ADULTS; WOMENS HEALTH; DISABILITY; MORTALITY; DEMENTIA; ASSOCIATION	Objective: The purpose of this study was to determine whether frailty is an important and independent predictor of incident depressive symptoms in elderly people without depressive symptoms at baseline. Design: Fifteen-month prospective study. Setting: General community in Japan. Participants: A total of 3025 community-dwelling elderly people aged 65 years or over without depressive symptoms at baseline. Measurements: The self-rated 15-item Geriatric Depression Scale was used to assess symptoms of depression with a score of 6 or more at baseline and 15-month follow-up. Participants underwent a structural interview designed to obtain demographic factors and frailty status, and completed cognitive testing with the Mini-Mental State Examination and physical performance testing with the Short Physical Performance Battery as potential predictors. Results: At a 15-month follow-up survey, 226 participants (7.5%) reported the development of depressive symptoms. We found that frailty and poor self-rated general health (adjusted odds ratio 1.86, 95% confidence interval 1.30-2.66, P < .01) were independent predictors of incident depressive symptoms. The odds ratio for depressive symptoms in participants with frailty compared with robust participants was 1.86 (95% confidence interval 1.05-3.28, P = .03) after adjusting for demographic factors, self-rated general health, behavior, living arrangements, Mini-Mental State Examination, Short Physical Performance Battery, and Geriatric Depression Scale scores at baseline. Conclusions: Our findings suggested that frailty and poor self-rated general health were independent predictors of depressive symptoms in community-dwelling elderly people. (C) 2015 AMDA - The Society for Post-Acute and Long-Term Care Medicine.	[Makizako, Hyuma; Shimada, Hiroyuki; Doi, Takehiko; Yoshida, Daisuke; Anan, Yuya; Tsutsumimoto, Kota; Uemura, Kazuki; Park, Hyuntae; Lee, Sanyoon] Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Functioning Activat, Aichi, Japan; [Doi, Takehiko] Japan Soc Promot Sci, Tokyo, Japan; [Liu-Ambrose, Teresa] Univ British Columbia, Dept Phys Therapy, Aging Mobil & Cognit Neurosci Lab, Vancouver, BC, Canada; [Liu-Ambrose, Teresa] Univ British Columbia, Djavad Mowafaghian Ctr, Vancouver, BC, Canada; [Liu-Ambrose, Teresa] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Suzuki, Takao] Natl Ctr Geriatr & Gerontol, Res Inst, Aichi, Japan	Makizako, H (reprint author), Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Functioning Activat, 35 Gengo,Morioka Machi, Obu, Aichi 4748511, Japan.	makizako@ncgg.go.jp			Japanese Ministry of Health, Labour and Welfare [B-3]; National Center for Geriatrics and Gerontology [22-16]	The authors thank the Obu city office for assistance with participant recruitment. This work was supported by the Japanese Ministry of Health, Labour and Welfare (Project for optimising long-term care) [grant number B-3]; and the National Center for Geriatrics and Gerontology (Research Funding for Longevity Sciences) [grant number 22-16].	Potter GG, 2007, NEUROLOGIST, V13, P105, DOI 10.1097/01.nrl.0000252947.15389.a9; Collard RM, 2014, AGING MENT HEALTH, V18, P570, DOI 10.1080/13607863.2013.827628; Xue QL, 2008, AM J EPIDEMIOL, V167, P240, DOI 10.1093/aje/kwm270; Woods NF, 2005, J AM GERIATR SOC, V53, P1321, DOI 10.1111/j.1532-5415.2005.53405.x; Ensrud KE, 2008, ARCH INTERN MED, V168, P382, DOI 10.1001/archinternmed.2007.113; Strawbridge WJ, 2002, AM J EPIDEMIOL, V156, P328, DOI 10.1093/aje/kwf047; Han B, 2002, J AM GERIATR SOC, V50, P1549, DOI 10.1046/j.1532-5415.2002.50411.x; Spering CC, 2012, J GERONTOL A-BIOL, V67, P890, DOI 10.1093/gerona/gls006; Panza F, 2010, AM J GERIAT PSYCHIAT, V18, P98, DOI 10.1097/JGP.0b013e3181b0fa13; Shimada H, 2013, J AM MED DIR ASSOC, V14, P518, DOI 10.1016/j.jamda.2013.03.010; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146; Penninx BWJH, 1998, JAMA-J AM MED ASSOC, V279, P1720, DOI 10.1001/jama.279.21.1720; Friedman B, 2005, J AM GERIATR SOC, V53, P1570, DOI 10.1111/j.1532-5415.2005.53461.x; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P963, DOI 10.1001/archneur.65.7.963; Lenze EJ, 2001, AM J GERIAT PSYCHIAT, V9, P113, DOI 10.1176/appi.ajgp.9.2.113; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Weyerer S, 2013, AGE AGEING, V42, P173, DOI 10.1093/ageing/afs184; Gustafsson TM, 1998, AGE AGEING, V27, P585, DOI 10.1093/ageing/27.5.585; GURALNIK JM, 1994, J GERONTOL, V49, pM85; Ostir GV, 2002, J CLIN EPIDEMIOL, V55, P916, DOI 10.1016/S0895-4356(02)00436-5; Djernes JK, 2006, ACTA PSYCHIAT SCAND, V113, P372, DOI 10.1111/j.1600-0447.2006.00770.x; Gine-Garriga M, 2014, ARCH PHYS MED REHAB, V95, P753, DOI 10.1016/j.apmr.2013.11.007; Espinoza SE, 2012, J AM GERIATR SOC, V60, P652, DOI 10.1111/j.1532-5415.2011.03882.x; Feng L, 2014, J AM MED DIR ASSOC, V15, p76e7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gill TM, 2006, ARCH INTERN MED, V166, P418, DOI 10.1001/.418; Harris T, 2006, AGE AGEING, V35, P25, DOI 10.1093/ageing/afi216; Shimada H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002424; Uemura K, 2012, GERONTOLOGY, V58, P413, DOI 10.1159/000336988; Yu DSF, 2012, INT J GERIATR PSYCH, V27, P119, DOI 10.1002/gps.2692	30	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	MAR 1	2015	16	3					194	199		10.1016/j.jamda.2014.08.017		6	Geriatrics & Gerontology	Geriatrics & Gerontology	CC2LQ	WOS:000350176900007		
J	Igawa, K; Konishi, M; Moriyama, Y; Fukuyama, K; Yokozeki, H				Igawa, K.; Konishi, M.; Moriyama, Y.; Fukuyama, K.; Yokozeki, H.			Erythroderma as drug eruption induced by intravesical mitomycin C therapy	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Letter							ALLERGY		[Igawa, K.; Konishi, M.; Moriyama, Y.; Fukuyama, K.; Yokozeki, H.] Tokyo Med & Dent Univ, Grad Sch Med, Dept Dermatol, Tokyo, Japan	Igawa, K (reprint author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Dermatol, Tokyo, Japan.	k.igawa.derm@tmd.ac.jp					Ebo DG, 2011, ALLERGY, V66, P1275, DOI 10.1111/j.1398-9995.2011.02661.x; Barbaud A, 2005, TOXICOLOGY, V209, P209, DOI 10.1016/j.tox.2004.12.024; Malkowicz S B, 2000, Semin Urol Oncol, V18, P280	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	MAR	2015	29	3					613	614		10.1111/jdv.12415		2	Dermatology	Dermatology	CC0QB	WOS:000350039500035		
J	Nawa, T; Nakagawa, T; Mizoue, T; Endo, K				Nawa, Takeshi; Nakagawa, Tohru; Mizoue, Tetsuya; Endo, Katsuyuki			Low-dose Computed Tomography Screening in Japan	JOURNAL OF THORACIC IMAGING			English	Review						computed tomography; cancer screening; lung cancer; mortality decline	LUNG-CANCER MORTALITY; POSITIVE TEST RESULT; SPIRAL CT; FOLLOW-UP; PROGRAM; TRIAL; SMOKERS; EFFICACY; SCANNER; COHORT	Lung cancer is a leading cause of cancer death in both male and female individuals in Japan. The effect of screening using chest radiography is assumed to be limited. In Japan, screening using low-dose computed tomography (CT) was initiated in 1993, and its dissemination has progressed with studies evaluating its efficacy, although it is not officially recommended. In addition to the academic activities of the Japanese Society of CT Screening, certification of physicians and radiologic technologists by the Japan Accreditation Council for CT Screening has been progressing. Currently, several hundred thousand low-dose CT screenings are performed annually in Japan. In Hitachi City, Ibaraki Prefecture, low-dose CT screening among employees and in communities started in 2001, and it was estimated that 40% of 50- to 69-year-old citizens had undergone screening at least once by March 2009. The lung cancer mortality rate in citizens in this age group decreased by 24% in 2005 to 2009 compared with the national statistics. Low-dose CT screening targeting the general population may be effective, but it is necessary to consider the target and interval of screening separately from those for the high-risk group. Observational study may play a role in evaluating the efficacy of screening in Japan.	[Nawa, Takeshi] Hitachi Gen Hosp, Dept Internal Med, Hitachi, Ibaraki 3170077, Japan; [Endo, Katsuyuki] Hitachi Gen Hosp, Dept Surg, Hitachi, Ibaraki 3170077, Japan; [Nakagawa, Tohru] Hitachi Hlth Care Ctr, Ibaraki, Japan; [Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan	Nawa, T (reprint author), Hitachi Gen Hosp, Dept Internal Med, 2-1-1 Jonan, Hitachi, Ibaraki 3170077, Japan.	takeshi.nawa.nw@hitachi.com					Henschke CI, 2006, NEW ENGL J MED, V355, P1763; Nawa T, 2002, CHEST, V122, P15, DOI 10.1378/chest.122.1.15; [Anonymous], 2005, PRODUCING MANUAL MUL; Aberle DR, 2013, NEW ENGL J MED, V369, P920, DOI 10.1056/NEJMoa1208962; Katanoda K, 2008, J EPIDEMIOL, V18, P251, DOI 10.2188/jea.JE2007429; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; [Anonymous], 2014, GUIDELINES MANAGEMEN; Sone S, 2007, LUNG CANCER, V58, P329, DOI 10.1016/j.lungcan.2007.06.022; Tsushima K, 2010, RESP MED, V104, P1712, DOI 10.1016/j.rmed.2010.05.014; Henschke CI, 2013, ANN INTERN MED, V158, P246, DOI 10.7326/0003-4819-158-4-201302190-00004; Sone S, 1998, LANCET, V351, P1242, DOI 10.1016/S0140-6736(97)08229-9; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Sobue T, 2002, J CLIN ONCOL, V20, P911, DOI 10.1200/JCO.20.4.911; Sagawa M, 2003, LUNG CANCER-J IASLC, V41, P29, DOI 10.1016/S0169-5002(03)00197-1; Kaneko M, 1996, RADIOLOGY, V201, P798; [Anonymous], GUID LUNG CANC SCREE; Nakazawa T, 2011, J HEPATO-BIL-PAN SCI, V18, P127, DOI 10.1007/s00534-010-0320-2; Sone S, 2001, BRIT J CANCER, V84, P25, DOI 10.1054/bjoc.2000.1531; Foy M, 2011, CANCER-AM CANCER SOC, V117, P2703, DOI 10.1002/cncr.25847; Hamashima C, 2006, JPN J CLIN ONCOL, V36, P301, DOI 10.1093/jjco/hyl022; McCarthy WJ, 2012, RISK ANAL, V32, pS69, DOI 10.1111/j.1539-6924.2012.01768.x; Ministry of Health Labour and Welfare Japan, CANC SCREEN RAT JAP; Nakayama T, 2006, JPN J LUNG CANC, V46, P871; Nawa T, 2012, LUNG CANCER, V78, P225, DOI 10.1016/j.lungcan.2012.09.012; Nawa T, 2008, J JAPANESE SOC CT SC, V15, P63; Nawa T, 2012, LUNG CANCER, V75, P197, DOI 10.1016/j.lungcan.2011.07.002; Sagawa M, 2012, JPN J CLIN ONCOL, V42, P1219, DOI 10.1093/jjco/hys157; Satoh K, 2001, CHEST, V120, P725, DOI 10.1378/chest.120.3.725; Tateno Y, 1990, SHIN IRYO, P28; Yip R, 2014, RADIOLOGY, V273, P591, DOI 10.1148/radiol.14132950	30	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0883-5993	1536-0237		J THORAC IMAG	J. Thorac. Imaging	MAR	2015	30	2					108	114				7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CC1OB	WOS:000350109500005		
J	Lu, QC; Peng, ZR; Zhang, JY				Lu, Qing-Chang; Peng, Zhong-Ren; Zhang, Junyi			Identification and Prioritization of Critical Transportation Infrastructure: Case Study of Coastal Flooding	JOURNAL OF TRANSPORTATION ENGINEERING			English	Article						Critical transportation infrastructure; Prioritization; Accessibility; Flood; Coastal area; Wood structures	VULNERABILITY ANALYSIS; NETWORKS; LINKS; PERFORMANCE; ROBUSTNESS; SEGMENTS	In order to better inform transportation decision makers of the criticality of transportation infrastructure, this paper explores an accessibility-based criticality prioritization methodology to identify and prioritize critical transportation infrastructure. In particular, the methodology evaluates the network-wide impacts of infrastructure degradation based on the increase in travel cost taking origin importance, destination attractiveness, and traffic congestion into account. The methodology is applied to the road network of Hillsborough County, Florida, threatened by flood risk from storm surge, sea-level rise, and intense precipitation. Light detection and ranging digital elevation data, transportation infrastructure and network data, and zone-based population data of the county are processed for analysis. The approach yields results of not only the criticality of transportation infrastructure under flooding impact but also the most vulnerable zones as a result of infrastructure inundation. The results show that some infrastructure is critical to adjacent areas, while some becomes important to a much broader region. The results further demonstrate that the infrastructure is more critical if it serves more people.	[Lu, Qing-Chang] Shanghai Jiao Tong Univ, Sch Naval Architecture Ocean & Civil Engn, Dept Transportat & Shipping, Shanghai 200240, Peoples R China; [Peng, Zhong-Ren] Univ Florida, Dept Urban & Reg Planning, Coll Design Construct & Planning, Gainesville, FL 32611 USA; [Zhang, Junyi] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Higashihiroshima 7398529, Japan	Lu, QC (reprint author), Shanghai Jiao Tong Univ, Sch Naval Architecture Ocean & Civil Engn, Dept Transportat & Shipping, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	qclu@sjtu.edu.cn; zpeng@ufl.edu; zjy@hiroshima-u.ac.jp			NOAA [SI20120010]; National Natural Science Foundation of China [51408356]; Key Laboratory of Road and Traffic Engineering of the Ministry of Education at Tongji University [K201209]	The writers would like to thank the NOAA for the financial support for the research reported in this paper (SI20120010). This paper is also financially supported by the National Natural Science Foundation of China (51408356). The support of the Key Laboratory of Road and Traffic Engineering of the Ministry of Education at Tongji University (K201209) is also appreciated. The writers want to give their thanks to the two anonymous reviewers for their two rounds of extensive comments and input on the paper.	Lou YY, 2011, TRANSPORT RES REC, P31, DOI 10.3141/2234-04; Taylor MAP, 2012, TRANSPORT RES A-POL, V46, P761, DOI 10.1016/j.tra.2012.02.008; Wardekker JA, 2010, TECHNOL FORECAST SOC, V77, P987, DOI 10.1016/j.techfore.2009.11.005; Chang SE, 2001, TRANSPORT RES A-POL, V35, P475, DOI 10.1016/S0965-8564(00)00003-3; [Anonymous], ARCGIS VERS 9 2 COMP; Sohn J, 2006, TRANSPORT RES A-POL, V40, P491, DOI 10.1016/j.tra.2005.08.006; [Anonymous], MATL VERS 8 0 COMP S; Lu QC, 2011, TRANSPORT RES REC, P174, DOI 10.3141/2263-19; Rosenzweig C, 2011, CLIMATIC CHANGE, V106, P93, DOI 10.1007/s10584-010-0002-8; [Anonymous], CUB VERS 5 3 COMP SO; Trucco P, 2012, RELIAB ENG SYST SAFE, V105, P51, DOI 10.1016/j.ress.2011.12.003; HANSEN WG, 1959, J AM I PLANNERS, V25, P73, DOI 10.1080/01944365908978307; MORRIS JM, 1979, TRANSPORT RES A-POL, V13, P91, DOI 10.1016/0191-2607(79)90012-8; Scott DM, 2006, J TRANSP GEOGR, V14, P215, DOI 10.1016/j.jtrangeo.2005.10.003; Seyedshohadaie SR, 2010, TRANSPORT RES A-POL, V44, P236, DOI 10.1016/j.tra.2010.01.005; Taylor MAP, 2008, GROWTH CHANGE, V39, P593, DOI 10.1111/j.1468-2257.2008.00448.x; Sullivan JL, 2010, TRANSPORT RES A-POL, V44, P323, DOI 10.1016/j.tra.2010.02.003; Chen YL, 2011, TRANSPORT RES REC, P58, DOI 10.3141/2255-07; Bremmer D, 2004, TRANSPORT RES REC, P188; Croope SV, 2011, TRANSPORT RES REC, P3, DOI 10.3141/2234-01; Dheenadayalu Y, 2004, J TRANSP ENG-ASCE, V130, P568, DOI 10.1061/(ASCE)0733-947X(2004)130:5(568); Farhan J, 2011, TRANSPORT RES REC, P11, DOI 10.3141/2225-02; Federal Highway Administration (FHWA), 2010, FED HIGHW ADM SURF T; Florida DOT, 2011, 2060 FLOR TRANSP PLA; Lambert JH, 2013, J INFRASTRUCT SYST, V19, P36, DOI 10.1061/(ASCE)IS.1943-555X.0000094; Litman T. A., 2012, EVALUATING ACCESSIBI; Lu Q.-C., 2012, EC ANAL SEA LEVEL RI, V2273, P54; National Consortium on Remote Sensing in Transportation, 2002, SPAT INF TECHN CRIT; Powell R, 2007, AM POLIT SCI REV, V101, P527, DOI 10.1017/S0003055407070244; Science Applications International Corporation, 2002, GUID HIGHW VULN ASS; Science Applications International Corporation and Parsons Brinckerhoff Consult, 2009, 525 SCI APPL INT COR; Shiomi Y, 2011, TRANSPORT RES REC, P41, DOI 10.3141/2234-05; Taylor MAP, 2006, NETW SPAT ECON, V6, P267, DOI 10.1007/s11067-006-9284-9; TRB, 2008, 290 TRB; Ukkusuri SV, 2009, J TRANSPORTATION SEC, V2, P29; U.S. Department of Homeland Security (USDHS), 2009, NAT INFR STRUCT PROT; U.S. Department of Homeland Security (USDHS), 2007, NAT STRAT HOM SEC; Walton T. L., 2006, OCEAN ENG, V34, P1832	38	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0733-947X	1943-5436		J TRANSP ENG	J. Transp. Eng.	MAR	2015	141	3							04014082	10.1061/(ASCE)TE.1943-5436.0000743		8	Engineering, Civil; Transportation Science & Technology	Engineering; Transportation	CB7YT	WOS:000349845500002		
J	Ichihara, K; Masumori, N; Fukuta, F; Tsukamoto, T; Iwasawa, A; Tanaka, Y				Ichihara, Koji; Masumori, Naoya; Fukuta, Fumimasa; Tsukamoto, Taiji; Iwasawa, Akihiko; Tanaka, Yoshinori			A Randomized Controlled Study of the Efficacy of Tamsulosin Monotherapy and its Combination with Mirabegron for Overactive Bladder Induced by Benign Prostatic Obstruction	JOURNAL OF UROLOGY			English	Article						prostatic hyperplasia; adrenergic alpha-antagonists; urinary bladder, overactive; adrenergic beta-agonists	URINARY-TRACT SYMPTOMS; MUSCARINIC RECEPTORS; OUTLET OBSTRUCTION; CONTROLLED-TRIAL; SAFETY; MEN; TOLTERODINE; THERAPY; MUSCLE	Purpose: We evaluated the efficacy and safety of add-on treatment with a beta(3)-adrenoceptor agonist (mirabegron) for overactive bladder symptoms remaining after alpha(1)-blocker (tamsulosin) treatment in men with benign prostatic obstruction. Materials and Methods: Patients with benign prostatic obstruction with urinary urgency at least once per week and a total OABSS of 3 or more points after 8 or more weeks of treatment with tamsulosin were enrolled in the study. They were randomly allocated to receive 0.2 mg tamsulosin daily or 0.2 mg tamsulosin and 50 mg mirabegron daily for 8 weeks. The primary end point was change in total OABSS. Safety assessments included change in post-void residual urine volume and adverse events. Results: From January 2012 through September 2013 a total of 94 patients were randomized. Of these patients 76 completed the protocol treatment. In the full analysis set the change in total OABSS during the treatment period was significantly greater in the combination group than in the monotherapy group (2.21 vs -0.87, p=0.012). The changes in scores for urinary urgency, daytime frequency, International Prostate Symptom Score storage symptom subscore and quality of life index at 8 weeks were significantly greater in the combination group. The change in post-void residual urine volume was significantly greater in the combination group. Although 6 patients experienced adverse events in the combination group, urinary retention was observed in only 1 patient. Conclusions: Combined tamsulosin and mirabegron treatment is effective and safe for patients with benign prostatic obstruction who have overactive bladder symptoms after tamsulosin monotherapy.	[Ichihara, Koji; Masumori, Naoya; Fukuta, Fumimasa; Tsukamoto, Taiji] Sapporo Med Univ, Sch Med, Dept Urol, Sapporo, Hokkaido 0608543, Japan; [Iwasawa, Akihiko] Hokkaido Prefectural Esashi Hosp, Iwasawa Clin, Sapporo, Hokkaido, Japan; [Tanaka, Yoshinori] Hokkaido Prefectural Esashi Hosp, Dept Urol, Sapporo, Hokkaido, Japan	Masumori, N (reprint author), Sapporo Med Univ, Sch Med, Dept Urol, Chuo Ku, S1,W16, Sapporo, Hokkaido 0608543, Japan.	masumori@sapmed.ac.jp					Lee JY, 2004, BJU INT, V94, P817, DOI 10.1111/j.1464-410X.2004.05039.x; Yamaguchi O, 2002, UROLOGY, V59, P25, DOI 10.1016/S0090-4295(01)01635-1; Nishizawa O, 2011, LUTS, V3, P29, DOI 10.1111/j.1757-5672.2010.00081.x; Kaplan SA, 2006, JAMA-J AM MED ASSOC, V296, P2319, DOI 10.1001/jama.296.19.2319; Benner JS, 2010, BJU INT, V105, P1276, DOI 10.1111/j.1464-410X.2009.09036.x; Chapple C, 2009, EUR UROL, V56, P534, DOI 10.1016/j.eururo.2008.11.026; Frazier EP, 2008, N-S ARCH PHARMACOL, V377, P449, DOI 10.1007/s00210-007-0208-0; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Homma Y, 2006, UROLOGY, V68, P318, DOI 10.1016/j.urology.2006.02.042; Kaplan SA, 2009, J UROLOGY, V182, P2825, DOI 10.1016/j.juro.2009.08.023; Abrams P, 2006, BRIT J PHARMACOL, V148, P565, DOI 10.1038/sj.bjp.0706780; Yamaguchi O, 2011, UROLOGY, V78, P126, DOI 10.1016/j.urology.2011.02.055; Fullhase C, 2013, EUR UROL, V64, P228, DOI 10.1016/j.eururo.2013.01.018; Nitti VW, 2013, J UROLOGY, V190, P1320, DOI 10.1016/j.juro.2013.05.062; Cui YS, 2014, INT UROL NEPHROL, V46, P275, DOI 10.1007/s11255-013-0509-9; Takeda M, 2013, UROLOGY, V82, P887, DOI 10.1016/j.urology.2013.05.008; Wada N, 2013, INT CONT SOC 2013 BA	17	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5347	1527-3792		J UROLOGY	J. Urol.	MAR	2015	193	3					921	926		10.1016/j.juro.2014.09.091		6	Urology & Nephrology	Urology & Nephrology	CB8IX	WOS:000349873300056		
J	Hinata, N; Murakami, G; Miyake, H; Abe, S; Fujisawa, M				Hinata, Nobuyuki; Murakami, Gen; Miyake, Hideaki; Abe, Shin-ichi; Fujisawa, Masato			Histological Study of the Cavernous Nerve Mesh Outside the Periprostatic Region: Anatomical Basis for Erectile Function after Nonnerve Sparing Radical Prostatectomy	JOURNAL OF UROLOGY			English	Article						prostate; nerves; anatomy; prostatectomy; nitric oxide synthase type I	RETROPUBIC PROSTATECTOMY; NEUROVASCULAR BUNDLES; POLYPEPTIDE; DISSECTION; OUTCOMES; POTENCY; URINARY; GRADES	Purpose: We identified the cavernous nerve mesh that exists caudal or posterior to the periprostatic region between the bilateral slings of the levator ani. We also assessed whether nonnerve sparing radical prostatectomy could be modified. Materials and Methods: Using histological sections from 24 elderly cadavers we investigated nerve anatomy by immunohistochemistry for S100 protein, neuronal nitric oxide synthase, vasoactive intestinal polypeptide and tyrosine hydroxylase. Results: The cavernous nerve mesh formed a U-shaped column attached to the lateral and posterior aspects of the rhabdosphincter. It was greater than 10 mm thick along the anteroposterior axis and 5 to 10 mm wide from the lateral margin of the rhabdosphincter. Composite neuronal nitric oxide synthase positive nerves ran obliquely with a highly tortuous course. The anterior margin of the nerve mesh corresponded to the anterior margin of the rhabdosphincter. Nerve mesh left-right communication was seen at and near the anterior margin. Bilateral periprostatic nerves joined posterior to the urethra and immediately anterior to the rectourethralis muscle, forming a midsagittal nerve mesh corresponding to the base of the U. The periprostatic nerves also formed a mesh or bundle but it was much thinner and smaller than the U-shaped mesh along the rhabdosphincter. Neuronal nitric oxide synthase positive nerves consistently contained tyrosine hydroxylase positive sympathetic nerve fibers but there were few vasoactive intestinal polypeptide positive fibers. The pudendal nerve and its branches were negative for neuronal nitric oxide synthase. Conclusions: Bilateral resection of the neurovascular bundle does not remove all cavernous nerves because these nerves cover the rhabdosphincter and perirectum caudal to the level of the apex of the prostate.	[Hinata, Nobuyuki; Miyake, Hideaki; Fujisawa, Masato] Kobe Univ, Sch Med, Dept Urol, Kobe, Hyogo 657, Japan; [Murakami, Gen] Iwamizawa Kojin Kai Hosp, Div Internal Med, Iwamizawa, Japan; [Abe, Shin-ichi] Tokyo Dent Univ, Sch Med, Dept Anat, Tokyo, Japan	Hinata, N (reprint author), Kobe Univ, Grad Sch Med, Dept Urol, 7-5-1 Kusunoki Cho, Kobe, Hyogo 657, Japan.	hinata@med.kobe-u.ac.jp	Hinata, Nobuyuki/M-9421-2015	Hinata, Nobuyuki/0000-0001-7014-6812			Costello AJ, 2004, BJU INT, V94, P1071, DOI 10.1111/j.1464-410X.2004.05106.x; Ahlering TE, 2006, J ENDOUROL, V20, P586, DOI 10.1089/end.2006.20.586; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Bernard CE, 2009, NEUROGASTROENT MOTIL, V21, P746, DOI 10.1111/j.1365-2982.2008.01245.x; MAGGI CA, 1990, EUR J PHARMACOL, V185, P169, DOI 10.1016/0014-2999(90)90637-L; Ficarra V, 2012, EUR UROL, V62, P418, DOI 10.1016/j.eururo.2012.05.046; Lunacek A, 2005, BJU INT, V95, P1226, DOI 10.1111/j.1464-410X.2005.05510.x; Alsaid B, 2010, EUR UROL, V58, P281, DOI 10.1016/j.eururo.2010.04.002; LEPOR H, 1985, J UROLOGY, V133, P207; Tewari AK, 2011, BJU INT, V108, P984, DOI 10.1111/j.1464-410X.2011.10565.x; Barre C, 2007, EUR UROL, V52, P71, DOI 10.1016/j.eururo.2006.11.057; Costello AJ, 2011, BJU INT, V107, P1210, DOI 10.1111/j.1464-410X.2010.09711.x; Eichelberg C, 2007, EUR UROL, V51, P105, DOI 10.1016/j.eururo.2006.05.038; Ganzer R, 2008, EUR UROL, V54, P353, DOI 10.1016/j.eururo.2008.04.018; Hinata Nobuyuki, 2014, Anat Cell Biol, V47, P44, DOI 10.5115/acb.2014.47.1.44; Hisasue S, 2010, J UROLOGY, V184, P2062, DOI 10.1016/j.juro.2010.06.108; Hong XR, 2008, INT UROGYNECOL J, V19, P1151, DOI 10.1007/s00192-008-0585-z; Hoyle CHV, 1996, J ANAT, V188, P633; Jacobson ED, 1994, PHYSL GASTROINTESTIN; Kim ED, 2001, UROLOGY, V58, P983, DOI 10.1016/S0090-4295(01)01403-0; Lee SB, 2008, UROLOGY, V72, P878, DOI 10.1016/j.urology.2008.05.038; Rabbani F, 2000, J UROLOGY, V164, P1929, DOI 10.1016/S0022-5347(05)66921-2; Sievert KD, 2009, J UROLOGY, V181, P1076, DOI 10.1016/j.juro.2008.10.154; Stanford JL, 2000, JAMA-J AM MED ASSOC, V283, P354, DOI 10.1001/jama.283.3.354; Takenaka A, 2005, UROLOGY, V65, P136, DOI 10.1016/j.urology.2004.08.028; Tewari A, 2006, BJU INT, V98, P314, DOI 10.1111/j.1464-410X.2006.06266.x; Tewari AK, 2013, WORLD J UROL, V31, P471, DOI 10.1007/s00345-012-1018-7; Wein AJ, 2012, CAMPBELL WALSH UROLO; Yucel S, 2004, J UROLOGY, V172, P191, DOI 10.1097/01.ju.0000128704.51870.87	29	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5347	1527-3792		J UROLOGY	J. Urol.	MAR	2015	193	3					1052	1059		10.1016/j.juro.2014.08.119		8	Urology & Nephrology	Urology & Nephrology	CB8IX	WOS:000349873300099		
J	Campbell, M				Campbell, Michael			Absolute Goodness: In Defence of the Useless and Immoral	JOURNAL OF VALUE INQUIRY			English	Article									Kyoto Univ, Dept Eth, Grad Sch Letters, Sakyo Ku, Kyoto 6068501, Japan	Campbell, M (reprint author), Kyoto Univ, Dept Eth, Grad Sch Letters, Sakyo Ku, Kyoto 6068501, Japan.	m.w.m.campbell@gmail.com					Anscombe G. E. M., RATIO, V20, P1; Aristotle, 1999, NICOMACHEAN ETHICS; Barabas Marina, 2011, PHILOSOPHY ETHICS AN; Crisp Roger, 2013, PHILOSOPHY AND PHENO, V87, p[476, 480]; Gaita R., 2000, COMMON HUMANITY THIN; Gaita Raimond, 2011, AFTER ROMULUS; Gaita Raimond, 2004, GOOD AND EVIL AN ABS, P93; Gaita Raimond, 2006, THE BEST AUSTRALIAN; Holland R. F., 1980, AGAINST EMPIRICISM, P2; Hursthouse Rosalind, 1999, ON VIRTUE ETHICS; Kierkegaard Soren, 2006, FEAR AND TREMBLIN; Kraut Richard, 2011, AGAINST ABSOLUTE GOO, P4; Levi Primo, 1991, IF THIS IS A MAN, P173; Malcolm Norman, 1958, LUDWIG WITTGENSTEIN, P81; McDowell John, 2009, HDB BIOL STAT, P33; Milton John, 2008, THE MAJOR WORKS; Moore G. E., 1903, PRINCIPIA ETHICA, P153; Stroud S, 2013, PHILOS PHENOMEN RES, V87, P459, DOI 10.1111/phpr.12057; Weil Simone, 1970, FIRST AND LAST NOTEB, P79; Winch Peter, 1977, COMMONALITY AND PART; Winch Peter, 1987, HIS TRYING TO MAKE S	21	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0022-5363	1573-0492		J VALUE INQUIRY	J. Value Inq.	MAR	2015	49	1-2					95	112		10.1007/s10790-014-9444-y		18	Ethics; Philosophy	Social Sciences - Other Topics; Philosophy	CB9UA	WOS:000349977400007		
J	Ota, Y; Ikemiyagi, Y; Takizawa, K; Yamada, C; Rikitake, R; Suzuki, M				Ota, Yasushi; Ikemiyagi, Yoshihiro; Takizawa, Katsumi; Yamada, Chikako; Rikitake, Ryoko; Suzuki, Mitsuya			Efficacy of Covering Mucosal Defects With Polyglycolic Acid Sheets After Ear or Nose Surgery	LARYNGOSCOPE			English	Article									[Ota, Yasushi; Ikemiyagi, Yoshihiro; Suzuki, Mitsuya] Toho Univ, Sakura Med Ctr, Dept Otorhinolaryngol, Chiba 2858741, Japan; [Takizawa, Katsumi; Yamada, Chikako] Japanese Red Cross Med Ctr, Dept Otorhinolaryngol, Tokyo, Japan; [Rikitake, Ryoko] Kameda Med Ctr, Dept Otorhinolaryngol, Chiba, Japan	Ota, Y (reprint author), Toho Univ, Sakura Med Ctr, Dept Otorhinolaryngol, Sakura Ku, 564-1 Shimoshizu, Chiba 2858741, Japan.	takashi160112@yahoo.co.jp					ANTHONY PF, 1982, LARYNGOSCOPE, V92, P70; Hildenbrand T, 2012, AM J RHINOL ALLERGY, V147, P1142; Ji QS, 2012, INT J OPHTHALMOL-CHI, V5, P704, DOI 10.3980/j.issn.2222-3959.2012.06.10; Kodama Satoru, 2011, Nihon Jibiinkoka Gakkai Kaiho, V114, P820; Lin XM, 2012, J CARDIOTHORAC SURG, V6, P18; Shinozaki T, 2013, JPN J CLIN ONCOL, V43, P33, DOI 10.1093/jjco/hys186; Takeuchi J, 2013, J ORAL MAXILLOFAC SU, V71, P126; Wheless SA, 2011, SKULL BASE-INTERD AP, V21, P93, DOI 10.1055/s-0030-1266763; Yano T, 2012, WORLD J SURG, V36, P463, DOI 10.1007/s00268-011-1355-5; Yonezawa H, 2012, BRIT J ORAL MAX SURG, V50, P459, DOI 10.1016/j.bjoms.2011.07.012	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	MAR	2015	125	3					567	570		10.1002/lary.24978		4	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	CB9PN	WOS:000349964100018		
J	Fujiwara, M; Yamamoto, S; Doi, H; Takada, Y; Odawara, S; Niwa, Y; Ishikura, R; Kamikonya, N; Terada, T; Uwa, N; Sagawa, K; Hirota, S				Fujiwara, Masayuki; Yamamoto, Satoshi; Doi, Hiroshi; Takada, Yasuhiro; Odawara, Soichi; Niwa, Yasue; Ishikura, Reiichi; Kamikonya, Norihiko; Terada, Tomonori; Uwa, Nobuhiro; Sagawa, Kosuke; Hirota, Shozo			Arterial Chemoradiotherapy for Carcinomas of the External Auditory Canal and Middle Ear	LARYNGOSCOPE			English	Article						Arterial chemotherapy; radiation therapy; carcinomas of the external auditory canal and middle ear	SQUAMOUS-CELL CARCINOMA; TEMPORAL BONE; INTRAARTERIAL CISPLATIN; INFUSION CHEMOTHERAPY; STAGING SYSTEM; RADIOTHERAPY; CANCER; EXPERIENCE; OUTCOMES; MEATUS	Objectives/HypothesisThe purpose of this study was to estimate the efficacy of superselective arterial chemoradiotherapy for locally advanced carcinomas of the external auditory canal and middle ear. Study DesignA retrospective study of clinical data for consecutive patients with locally advanced carcinomas of the external auditory canal and middle ear. MethodsThirteen patients with locally advanced carcinomas of the external auditory canal and middle ear (T3: one patient, T4: 12 patients) were reviewed. The median follow-up duration in the living patients was 33 months. The total dose of radiation therapy was 60 Gy using conventional fractionation. Four, five, or six courses of a superselective arterial infusion (cisplatin 50 mg) were given weekly. ResultsThe overall survival and progression-free survival rates at 2 years, calculated by the Kaplan-Meier method, were 58.7% and 53.8%, respectively. No late-phase adverse effects due to chemoradiation and no adverse effects due to catheterization were observed. ConclusionsThese results suggest that superselective arterial chemoradiation can be a treatment option for locally advanced carcinomas of the external auditory canal and middle ear.	[Fujiwara, Masayuki; Yamamoto, Satoshi; Doi, Hiroshi; Takada, Yasuhiro; Odawara, Soichi; Niwa, Yasue; Ishikura, Reiichi; Kamikonya, Norihiko; Hirota, Shozo] Hyogo Coll Med, Dept Radiol, Nishinomiya, Hyogo, Japan; [Terada, Tomonori; Uwa, Nobuhiro; Sagawa, Kosuke] Hyogo Coll Med, Dept Otolaryngol, Nishinomiya, Hyogo, Japan; [Fujiwara, Masayuki] Meiwa Canc Clin, Dept Radiat Oncol, Nishinomiya, Hyogo, Japan	Fujiwara, M (reprint author), 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	m-fuji@hyo-med.ac.jp					Nyrop M, 2002, ARCH OTOLARYNGOL, V128, P834; Ogawa K, 2007, INT J RADIAT ONCOL, V68, P1326, DOI 10.1016/j.ijrobp.2007.01.052; Moody SA, 2000, AM J OTOL, V21, P582; ARRIAGA M, 1990, ANN OTO RHINOL LARYN, V99, P714; Robbins KT, 2005, J CLIN ONCOL, V23, P1447, DOI 10.1200/JCO.2005.03.168; Gillespie MB, 2001, ARCH OTOLARYNGOL, V127, P803; Rasch CRN, 2010, CANCER-AM CANCER SOC, V116, P2159, DOI 10.1002/cncr.24916; Madsen AR, 2008, HEAD NECK-J SCI SPEC, V30, P1332, DOI 10.1002/hed.20877; Pemberton LS, 2006, CLIN ONCOL-UK, V18, P390, DOI 10.1016/j.clon.2006.03.001; STELL PM, 1985, J LARYNGOL OTOL, V99, P847, DOI 10.1017/S0022215100097796; Manolidis S, 1998, AM J OTOL, V19, pS1; ARENA S, 1988, AM J OTOL, V9, P351; Chang CH, 2009, AM J OTOLARYNG, V30, P44, DOI 10.1016/j.amjoto.2008.02.007; Cristalli G, 2009, J CRANIOFAC SURG, V20, P816, DOI 10.1097/SCS.0b013e3181a14b99; Foote RL, 2005, CANCER, V103, P559, DOI 10.1002/cncr.20803; Hirai T, 1999, CARDIOVASC INTER RAD, V22, P201, DOI 10.1007/s002709900366; Ikushima I, 2008, EUR J RADIOL, V66, P7, DOI 10.1016/j.ejrad.2007.05.019; Karasawa K, 1994, J JPN SOC THER RADIO, V6, P169; Kinebuchi Y, 2006, J JPN SOC THER RADIO, V18, P147; Leonetti JP, 2010, OTOL NEUROTOL, V31, P656, DOI 10.1097/MAO.0b013e3181d8d6e1; Lobo D, 2008, SKULL BASE-INTERD AP, V18, P167, DOI 10.1055/s-2007-994290; NADOL JB, 1984, ANN OTO RHINOL LARYN, V93, P6; Prabhu R, 2009, AM J CLIN ONCOL-CANC, V32, P401, DOI 10.1097/COC.0b013e31818f2d48; Ueda Y, 2009, J LARYNGOL OTOL, V123, P75, DOI 10.1017/S0022215109005143; Wang CC, 1976, INT J RADIAT ONCOL, V9, P881	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	MAR	2015	125	3					685	689		10.1002/lary.24908		5	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	CB9PN	WOS:000349964100039		
J	Kosaki, Y; Poulter, SL; Austen, JM; McGregor, A				Kosaki, Yutaka; Poulter, Steven L.; Austen, Joe M.; McGregor, Anthony			Dorsolateral striatal lesions impair navigation based on landmark-goal vectors but facilitate spatial learning based on a "cognitive map"	LEARNING & MEMORY			English	Article							MORRIS WATER TASK; CAUDATE-NUCLEUS LESIONS; MULTIPLE MEMORY-SYSTEMS; T-MAZE; DORSAL STRIATUM; HIPPOCAMPAL-LESIONS; PLACE NAVIGATION; CORTEX LESIONS; SWIMMING POOL; RADIAL MAZE	In three experiments, the nature of the interaction between multiple memory systems in rats solving a variation of a spatial task in the water maze was investigated. Throughout training rats were able to find a submerged platform at a fixed distance and direction from an intramaze landmark by learning a landmark-goal vector. Extramaze cues were also available for standard place learning, or "cognitive mapping," but these cues were valid only within each session, as the position of the platform moved around the pool between sessions together with the intramaze landmark. Animals could therefore learn the position of the platform by taking the consistent vector from the landmark across sessions or by rapidly encoding the new platform position on each session with reference to the extramaze cues. Excitotoxic lesions of the dorsolateral striatum impaired vector-based learning but facilitated cognitive map-based rapid place learning when the extramaze cues were relatively poor (Experiment 1) but not when they were more salient (Experiments 2 and 3). The way the lesion effects interacted with cue availability is consistent with the idea that the memory systems involved in the current navigation task are functionally cooperative yet associatively competitive in nature.	[Kosaki, Yutaka; Poulter, Steven L.; Austen, Joe M.; McGregor, Anthony] Univ Durham, Dept Psychol, Durham DH1 3LE, England	Kosaki, Y (reprint author), Keio Univ, Adv Res Ctr, Tokyo, Japan.	y.kosaki@cantab.net; anthony.mcgregor@durham.ac.uk	Austen, Joe/E-1798-2015; McGregor, Anthony/B-7682-2008	Austen, Joe/0000-0002-8509-8793; McGregor, Anthony/0000-0003-0265-828X	United Kingdom Biotechnology and Biological Sciences Research Council	This research was supported by grants from the United Kingdom Biotechnology and Biological Sciences Research Council. We are grateful to Heather Crawford and Claire Robinson for assistance in animal husbandry and Andy Long for technical assistance. We thank David Sanderson and John Pearce for their invaluable comments on an earlier version of this manuscript.	Vann SD, 2004, BEHAV BRAIN RES, V155, P97, DOI 10.1016/j.bbr.2004.04.005; Schwabe L, 2008, NEUROBIOL LEARN MEM, V90, P495, DOI 10.1016/j.nlm.2008.07.015; Asem JSA, 2013, BEHAV NEUROSCI, V127, P854, DOI 10.1037/a0034686; MACKINTOSH NJ, 1976, ANIM LEARN BEHAV, V4, P186, DOI 10.3758/BF03214033; JARRARD LE, 1989, J NEUROSCI METH, V29, P251, DOI 10.1016/0165-0270(89)90149-0; RESTLE F, 1957, PSYCHOL REV, V64, P217, DOI 10.1037/h0040678; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Chang Q, 2003, BEHAV BRAIN RES, V144, P19, DOI 10.1016/S0166-4328(03)00063-9; WIENER SI, 1993, J NEUROSCI, V13, P3802; PACKARD MG, 1992, BEHAV NEUROSCI, V106, P439, DOI 10.1037/0735-7044.106.3.439; Roberts ADL, 1999, J EXP PSYCHOL ANIM B, V25, P225, DOI 10.1037//0097-7403.25.2.225; Roberts ADL, 1998, J EXP PSYCHOL ANIM B, V24, P172, DOI 10.1037//0097-7403.24.2.172; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Chamizo VD, 2006, BEHAV PROCESS, V71, P59, DOI 10.1016/j.beproc.2005.11.003; Hamilton DA, 2007, J EXP PSYCHOL ANIM B, V33, P100, DOI 10.1037/0097-7403.33.2.100; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037//0033-295X.87.6.532; Pearce JM, 2006, J EXP PSYCHOL ANIM B, V32, P201, DOI 10.1037/0097-7403.32.3.201; Kim JJ, 2001, J NEUROSCI, V21, P5222; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5909, DOI 10.1073/pnas.0711433105; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Packard MG, 2013, HIPPOCAMPUS, V23, P1044, DOI 10.1002/hipo.22178; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; Pearce JM, 1998, NATURE, V396, P75, DOI 10.1038/23941; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; Hamilton DA, 2008, J EXP PSYCHOL ANIM B, V34, P31, DOI 10.1037/0097-7403.34.1.31; WAGNER AR, 1968, J EXP PSYCHOL, V76, P171, DOI 10.1037/h0025414; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x; Pearce JM, 2009, Q J EXP PSYCHOL, V62, P1665, DOI 10.1080/17470210902805589; Chang Q, 2004, BEHAV NEUROSCI, V118, P383, DOI 10.1177/0735-7044.118.2.383; Devan BD, 1999, J NEUROSCI, V19, P2789; BLODGETT HC, 1949, J EXP PSYCHOL, V39, P800, DOI 10.1037/h0058978; BLODGETT HC, 1947, J EXP PSYCHOL, V37, P412, DOI 10.1037/h0059305; BLODGETT HC, 1948, J COMP PHYSIOL PSYCH, V41, P17, DOI 10.1037/h0061366; Compton DM, 2004, BEHAV PROCESS, V67, P335, DOI 10.1016/j.beproc.2004.06.002; DIEZCHAMIZO V, 1985, Q J EXP PSYCHOL-B, V37, P235; Gallistel C. R, 1990, ORG LEARNING; Gibson BM, 2005, BEHAV NEUROSCI, V119, P567, DOI 10.1037/0735-7044.119.2.567; Hamilton DA, 2009, J EXP PSYCHOL ANIM B, V35, P271, DOI 10.1037/a0013260; Horne MR, 2010, BEHAV NEUROSCI, V124, P623, DOI 10.1037/a0020824; Horne MR, 2011, LEARN BEHAV, V39, P371, DOI 10.3758/s13420-011-0032-8; Kamin L.J., 1969, PUNISHMENT AVERSIVE, P279; Kosaki Y, 2013, J EXP PSYCHOL ANIM B, V39, P126, DOI [10.1037/a0031199, 10.1037/a003.1199]; Lee Anni S, 2008, Proc Natl Acad Sci U S A, V105, P17163, DOI 10.1073/pnas.0807749105; MCNAMARA HJ, 1956, J COMP PHYSIOL PSYCH, V49, P477, DOI 10.1037/h0046017; MILES C G, 1973, Learning and Motivation, V4, P11, DOI 10.1016/0023-9690(73)90036-2; MITCHELL JA, 1988, Q J EXP PSYCHOL-B, V40, P243; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; O'Keefe J., 1978, HIPPOCAMPUS COGNITIV; Oswald CJP, 2003, BEHAV NEUROSCI, V117, P588, DOI 10.1037/0735-7044.117.3.588; Pavlov I. P., 1927, CONDITIONED REFLEXES; Paxinos G, 1998, RAT BRAIN STEREOTAXI; Pych JC, 2005, LEARN MEMORY, V12, P564, DOI 10.1101/lm.33105; Redhead ES, 1997, J EXP PSYCHOL ANIM B, V23, P340, DOI 10.1037/0097-7403.23.3.340; Rescorla R. A., 1972, CLASSICAL CONDITION, V2, P64, DOI DOI 10.1016/J.COGPSYCH.2004.11.001; Skinner DM, 2003, J EXP PSYCHOL ANIM B, V29, P3, DOI 10.1037//0097-7403.29.1.3; TOLMAN EC, 1947, J EXP PSYCHOL, V37, P39, DOI 10.1037/h0062061; White NM, 2005, BEHAV NEUROSCI, V119, P1158, DOI 10.1037/0735-7044.119.4.1158	61	1	1	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1072-0502	1549-5485		LEARN MEMORY	Learn. Mem.	MAR	2015	22	3					179	191		10.1101/lm.037077.114		13	Neurosciences; Psychology, Experimental	Neurosciences & Neurology; Psychology	CB7VF	WOS:000349835900005		
J	Nakazawa, A; Nakano, N; Fukuda, A; Sakamoto, S; Imadome, KI; Kudo, T; Matsuoka, K; Kasahara, M				Nakazawa, Atsuko; Nakano, Natsuko; Fukuda, Akinari; Sakamoto, Seisuke; Imadome, Ken-Ichi; Kudo, Toyoichiro; Matsuoka, Kentaro; Kasahara, Mureo			Use of Serial Assessment of Disease Severity and Liver Biopsy for Indication for Liver Transplantation in Pediatric Epstein-Barr Virus-Induced Fulminant Hepatic Failure	LIVER TRANSPLANTATION			English	Article							INFECTION; GUIDELINES; MODEL	The decision to perform liver transplantation (LT) in patients with Epstein-Barr virus (EBV)-induced fulminant hepatic failure (FHF) relies on a precise assessment of laboratory and pathological findings. In this study, we analyzed clinical and laboratory data as well as the pathological features of the liver in order to evaluate the pathogenesis and the need for LT in 5 patients with EBV-induced FHF. According to the King's College criteria, the Acute Liver Failure Early Dynamic (ALFED) model, and the Japanese criteria (from the Acute Liver Failure Study Group of Japan), only 1 patient was considered to be a candidate for LT. However, explanted liver tissues in 3 cases exhibited massive hepatocellular necrosis together with diffuse CD8-positive T cell infiltration in both the portal area and the sinusoid. EBV was detected in the liver, plasma, and peripheral blood mononuclear cells (PBMNCs). In 2 cases indicated to be at moderate risk by the ALFED model, liver biopsy showed CD8-positive and EBV-encoded RNA signal-positive lymphocytic infiltration predominantly in the portal area, but massive hepatocellular necrosis was not observed. These patients were treated with immunosuppressants and etoposide under the diagnosis of EBV-induced hemophagocytic lymphohistiocytosis or systemic EBV-positive T cell lymphoproliferative disease of childhood. EBV DNA was detected at a high level in PBMNCs, although it was negative in plasma. On the basis of the pathological analysis of the explanted liver tissues, LT was proposed for the restoration of liver function and the removal of the EBV-infected lymphocytes concentrated in the liver. Detecting EBV DNA by a quantitative polymerase chain reaction in plasma and PBMNCs was informative. An accurate evaluation of the underlying pathogenesis is essential for developing a treatment strategy in patients with EBV-induced FHF. Liver Transpl 21:362-368, 2015. (c) 2015 AASLD.	[Nakazawa, Atsuko; Nakano, Natsuko; Matsuoka, Kentaro] Natl Res Inst Child Hlth & Dev, Dept Pathol, Tokyo, Japan; [Fukuda, Akinari; Sakamoto, Seisuke; Kasahara, Mureo] Natl Res Inst Child Hlth & Dev, Dept Transplant Surg, Tokyo, Japan; [Imadome, Ken-Ichi] Natl Res Inst Child Hlth & Dev, Dept Infect Dis, Tokyo, Japan; [Kudo, Toyoichiro] Natl Ctr Child Hlth & Dev, Div Hepatol, Tokyo 1578535, Japan; [Nakano, Natsuko] Tokai Univ, Sch Med, Dept Pathol, Tokyo 151, Japan	Nakazawa, A (reprint author), Natl Ctr Child Hlth & Dev, Dept Pathol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	nakagawa-a@ncchd.go.jp			National Center for Child Health and Development of Japan [24-4, 24-8]	This work was supported in part by a grant from the National Center for Child Health and Development of Japan (24-4, 24-8).	Langerak AW, 2012, LEUKEMIA, V26, P2159, DOI 10.1038/leu.2012.246; Mellinger JL, 2014, DIGEST DIS SCI, V59, P1630, DOI 10.1007/s10620-014-3029-2; Callan MFC, 1996, NAT MED, V2, P906, DOI 10.1038/nm0896-906; DONALDSON BW, 1993, HEPATOLOGY, V18, P1370, DOI 10.1016/0270-9139(93)90226-D; Kumar R, 2012, GUT, V61, P1068, DOI 10.1136/gutjnl-2011-301762; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Dumortier J, 2007, GASTROEN CLIN BIOL, V31, P725, DOI 10.1016/S0399-8320(07)91934-X; Feranchak AP, 1998, LIVER TRANSPLANT SUR, V4, P469, DOI 10.1002/lt.500040612; Imadome KI, 2012, PEDIATR TRANSPLANT, V16, P748, DOI 10.1111/j.1399-3046.2012.01750.x; KAWAGUCHI H, 1993, J CLIN INVEST, V92, P1444, DOI 10.1172/JCI116721; Naiki T, 2012, HEPATOL RES, V42, P68, DOI 10.1111/j.1872-034X.2011.00902.x; OGRADY JG, 1988, Q J MED, V69, P817; Okano M, 2012, AM J MED SCI, V343, P483, DOI 10.1097/MAJ.0b013e318236e02d; PAPATHEODORIDIS GV, 1995, J HEPATOL, V23, P348, DOI 10.1016/0168-8278(95)80480-3; Park HW, 2001, HPB S3, V13, P187; Sugihara J, 2001, ACTA HEPATOLOGICA JA, V42, P543; Tohyama T, 2011, LIVER TRANSPLANT, V17, pS146	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1527-6465	1527-6473		LIVER TRANSPLANT	Liver Transplant.	MAR	2015	21	3					362	368		10.1002/lt.24052		7	Gastroenterology & Hepatology; Surgery; Transplantation	Gastroenterology & Hepatology; Surgery; Transplantation	CC2BM	WOS:000350149600014		
J	Mizuno, R; Isshiki, M; Ono, N; Nishimoto, M; Fujita, T				Mizuno, Risuke; Isshiki, Masashi; Ono, Nobuyuki; Nishimoto, Mitsuhiro; Fujita, Toshiro			A High Salt Diet Alters Pressure-Induced Mechanical Activity of the Rat Lymphatics with Enhancement of Myogenic Characteristics	LYMPHATIC RESEARCH AND BIOLOGY			English	Article							HUMAN THORACIC-DUCT; CONTRACTILE ACTIVITY; INTRINSIC CONTRACTILITY; OXIDATIVE STRESS; BLOOD-PRESSURE; VESSELS; PUMP; INFLAMMATION; ENDOTHELIUM; LYMPHEDEMA	Background: The lymphatic system has become a new player for pathogenesis in salt-sensitive hypertension animals. A high salt diet (HSD) evokes accumulation of Na+ in the skin of rodents. In response to increase in Na+-proteoglycan complex, infiltrated macrophages stimulate secretion of vascular endothelial growth factor (VEGF)-C. Macrophage-derived VEGF-C increases density of the dermal lymph capillaries, indicating that lymphangiogenesis is advantageous to hypertensive animals by buffering elevated blood pressure. However, the effects of a high salt diet (HSD) on changes in mechanical activity of collecting lymph vessels, which directly connect with lymph capillaries, have not yet been determined. Methods and Results: Changes in mechanical activity of isolated collecting lymphatics in normal salt diet (NSD) and HSD rats in response to increase in intraluminal pressures were measured by video-microscopy. HSD vessels had smaller % active diameters (maximum and minimum) and higher amplitude compared with NSD vessels. The frequency of lymphatic oscillation was better maintained in HSD rats than in NSD. Lymphatic pump efficiency including stroke volume index (SVI), frequency times SVI, and amplitude times frequency in HSD rats were significantly higher than those of NSD. Thus, a HSD enhances the resistance to pressure-induced decreases in lymphatic pump efficiency. Conclusions: The present ex vivo study suggest that collecting lymphatics of rats enhance myogenic activity and lymphatic pump efficiency to compensate for increase in lymph flow and/or pressure after 2 weeks salt loading.	[Mizuno, Risuke] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pharmacol, Tokyo, Japan; [Mizuno, Risuke; Isshiki, Masashi] Univ Tokyo, Grad Sch Med, Dept Mol Vasc Endocrinol, Tokyo, Japan; [Nishimoto, Mitsuhiro; Fujita, Toshiro] Univ Tokyo, Div Clin Epigenet, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Ono, Nobuyuki] Nagano Natl Coll Technol, Dept Elect & Control Engn, Nagano, Japan	Isshiki, M (reprint author), Tokyo Univ Hosp, Dept Adv Nephrol & Regenerat Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	isshiki-tky@umin.ac.jp		Nishimoto, Mitsuhihiro/0000-0001-9542-847X	Novartis Pharma K.K.	The authors would like to thank Novartis Pharma K.K. for their financial support.	Kopp C, 2013, HYPERTENSION, V61, P635, DOI 10.1161/HYPERTENSIONAHA.111.00566; Nagai T, 2008, J PHYSIOL SCI, V58, P123, DOI 10.2170/physiolsci.RP001208; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; BENOIT JN, 1989, AM J PHYSIOL, V257, pH2059; von der Weid PY, 2014, LYMPHAT RES BIOL, V12, P66, DOI 10.1089/lrb.2013.0045; Rockson SG, 2013, LYMPHAT RES BIOL, V11, P117, DOI 10.1089/lrb.2013.1132; Frisoli TM, 2012, AM J MED, V125, P433, DOI 10.1016/j.amjmed.2011.10.023; Mizuno R, 1997, MICROCIRCULATION, V4, P413, DOI 10.3109/10739689709146805; Ono N, 2000, JPN J PHYSIOL, V50, P25, DOI 10.2170/jjphysiol.50.25; Wiig H, 2012, PHYSIOL REV, V92, P1005, DOI 10.1152/physrev.00037.2011; Gashev AA, 2004, MICROCIRCULATION, V11, P477, DOI 10.1080/10739680490476033; Wu TF, 2006, AM J PHYSIOL-GASTR L, V291, pG566, DOI 10.1152/ajpgi.00058.2006; Wiig H, 2013, J CLIN INVEST, V123, P2803, DOI 10.1172/JCI60113; Koshima I, 1996, PLAST RECONSTR SURG, V97, P397, DOI 10.1097/00006534-199602000-00018; Hosaka K, 2003, AM J PHYSIOL-HEART C, V284, pH2015, DOI 10.1152/ajpheart.00763.2002; Baker A, 2014, LYMPHAT RES BIOL, V12, P76, DOI 10.1089/lrb.2013.0036; Boedtkjer DB, 2013, CELLS TISSUES ORGANS, V197, P145, DOI 10.1159/000342437; DeLano FA, 2005, AM J PHYSIOL-HEART C, V288, pH805, DOI 10.1152/ajpheart.00696.2004; Dornyei G, 1996, AM J PHYSIOL-HEART C, V271, pH267; Gashev AA, 2006, AM J PHYSIOL-HEART C, V290, pH2295, DOI 10.1152/ajpheart.00260.2005; Kwon S, 2012, J BIOMED OPT, V17; Mizuno R, 1996, CIRCULATION, V94, P3559; OLSZEWSKI WL, 1980, AM J PHYSIOL, V239, pH775; SUN D, 1994, AM J PHYSIOL, V266, pH1177; Telinius N, 2010, AM J PHYSIOL-HEART C, V299, pH811, DOI 10.1152/ajpheart.01089.2009; Thangaswamy S, 2012, LYMPHAT RES BIOL, V10, P53, DOI 10.1089/lrb.2011.0022; Zawieja SD, 2012, AM J PHYSIOL-HEART C, V302, pH643, DOI 10.1152/ajpheart.00606.2011	27	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1539-6851	1557-8585		LYMPHAT RES BIOL	Lymphat. Res. Biol.	MAR 1	2015	13	1					2	9		10.1089/lrb.2014.0028		8	Medicine, Research & Experimental; Physiology	Research & Experimental Medicine; Physiology	CD2DH	WOS:000350883800002		
J	Adhikari, R; Joshi, B; Narro-Garcia, R; De la Rosa, E; Sekino, T; Lee, S				Adhikari, Rajesh; Joshi, Bhupendra; Narro-Garcia, R.; De la Rosa, E.; Sekino, Tohru; Lee, SooWohn			Er3+ loaded barium molybdate nanoparticles: IR to visible spectral upconversion	MATERIALS LETTERS			English	Article						Upconversion luminescence; Infrared energy; Sol-gel; 980 nm	LUMINESCENCE PROPERTIES; HYDROTHERMAL SYNTHESIS; ENHANCEMENT; GREEN; NANOCRYSTALS; FLUORESCENCE; CRYSTALS; SIZE; NIR	In this study, we report the infrared to visible upconversion luminescence behavior of Er3+ loaded barium molybdate nanoparticles synthesized by microwave induced sol-gel route. Structural and morphological properties were analyzed and the upconversion response of the Er3+ loaded samples (1 mol% and 5 mol%) was investigated by exciting the samples at 980 nm from a Continuous Wave Laser Diode (CWLD). Results showed that the green emissions around 528 and 546 and red emissions at 658 nm were observed, respectively, and the intensity of both emissions were found to be enhanced with increase in concentration from 1 mol% to 5 mol% of Er3+ ions. Upconversion mechanism is disscussed and this study gives the way to convert infrared energy to visible light in other molybdate scheelite structures. (C) 2014 Elsevier B.V. All rights reserved.	[Adhikari, Rajesh; Joshi, Bhupendra; Lee, SooWohn] Sun Moon Univ, Res Ctr Ecomultifunct Nanomat, Asan, South Korea; [Narro-Garcia, R.; De la Rosa, E.] Ctr Invest Opt, Leon 37150, Mexico; [Sekino, Tohru] Osaka Univ, SANKEN, ISIr, Osaka, Japan	Adhikari, R (reprint author), Sun Moon Univ, Res Ctr Ecomultifunct Nanomat, Asan, South Korea.	chemorajesh@gmail.com; swlee@sunmoon.ac.kr			Global Research program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST), Korea [2010-00339]	This research work has been supported by Global Research program of the National Research Foundation of Korea (NRF) funded by Ministry of Education, Science and Technology (MEST), Korea (grant number: 2010-00339).	Adhikari R, 2014, J LUMIN, V145, P866, DOI 10.1016/j.jlumin.2013.09.012; Guo H, 2007, J SOLID STATE CHEM, V180, P127, DOI 10.1016/j.jssc.2006.10.003; Chen P, 2014, MATER LETT, V128, P299, DOI 10.1016/j.matlet.2014.04.179; Bednarkiewicz A, 2011, J RARE EARTH, V29, P1152, DOI 10.1016/S1002-0721(10)60615-1; Dyck NC, 2013, ACS APPL MATER INTER, V5, P11661, DOI 10.1021/am403100t; Yi GS, 2007, CHEM MATER, V19, P341, DOI 10.1021/cm062447y; Adhikari R, 2013, MATER LETT, V91, P294, DOI 10.1016/j.matlet.2012.10.004; Chung JH, 2012, MATER CHEM PHYS, V134, P695, DOI 10.1016/j.matchemphys.2012.03.052; Liang ZQ, 2014, J ALLOY COMPD, V610, P432, DOI 10.1016/j.jallcom.2014.04.183; Balakrishnaiah R, 2010, THIN SOLID FILMS, V518, P6145, DOI 10.1016/j.tsf.2010.04.062; Adhikari R, 2014, J SOLID STATE CHEM, V216, P36, DOI 10.1016/j.jssc.2014.04.013; Pan XH, 2012, J LUMIN, V132, P1025, DOI 10.1016/j.jlumin.2011.12.026; Liang HJ, 2011, J ALLOY COMPD, V509, P409, DOI 10.1016/j.jallcom.2010.09.044; Assaaoudi H, 2013, CRYSTENGCOMM, V15, P4739, DOI 10.1039/c3ce40362a; Ding MY, 2014, MATER LETT, V128, P101, DOI 10.1016/j.matlet.2014.04.111; Feng L, 2009, SPECTROCHIM ACTA A, V73, P41, DOI 10.1016/j.saa.2009.01.022; Narro-Garcia R, 2013, J LUMIN, V134, P528, DOI 10.1016/j.jlumin.2012.07.034; Subramanian U, 2013, J LUMIN, V134, P464, DOI 10.1016/j.jlumin.2012.07.044; Wang X., 2007, SPIE, V6279, DOI [10.1117/12.725431, DOI 10.1117/12.725431]; Wu HJ, 2014, J ALLOY COMPD, V586, P485, DOI 10.1016/j.jallcom.2013.10.124	20	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-577X	1873-4979		MATER LETT	Mater. Lett.	MAR 1	2015	142						7	10		10.1016/j.matlet.2014.11.109		4	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CB6HQ	WOS:000349728500003		
J	Izumi, H; Udhayakumar, A; Kamiya, S				Izumi, Hayato; Udhayakumar, Arasu; Kamiya, Shoji			Hydrogen enhanced mechanical fatigue in single crystal silicon	MATERIALS LETTERS			English	Article						Single crystal silicon; Mechanical fatigue; Hydrogen; Humidity	ROOM-TEMPERATURE; DISLOCATIONS; FAILURE; STRESS	Silicon fatigue lifetime was examined in four different environments. Fatigue failure occurs in the range of 10(3)-10(5) cycles under the stress amplitude level of around 90% to the static fracture strength under monotonic loading, both in lab air with relative humidity (RH) 35-40% and hydrogen with RH 5%. In contrast, no specimen fractures with the same stress level up to more than 10(7) cycles in nitrogen and oxygen with RH 5%. These facts suggest that hydrogen, which could also be supplied from water adsorbed on the surface, had a significant impact on the fatigue damage accumulation in silicon. (C) 2014 Elsevier B.V. All rights reserved.	[Izumi, Hayato; Udhayakumar, Arasu; Kamiya, Shoji] Nagoya Inst Technol, Dept Mech Engn, Showa Ku, Nagoya, Aichi 4668555, Japan	Izumi, H (reprint author), Nagoya Inst Technol, Dept Mech Engn, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	izumi.hayato@nitech.nitech.ac.jp			Japan Society for the Promotion of Science [25630008]	Part of this work was supported by Grant-in-Aid for Challenging Exploratory Research #25630008 from Japan Society for the Promotion of Science.	Shima K, 2010, J APPL PHYS, V108, DOI 10.1063/1.3486465; Robertson IM, 1999, ENG FRACT MECH, V64, P649, DOI 10.1016/S0013-7944(99)00094-6; Namazu T, 2002, J MICROELECTROMECH S, V11, P125, DOI 10.1109/84.993447; Kato NI, 2001, MAT SCI SEMICON PROC, V4, P113, DOI 10.1016/S1369-8001(00)00128-1; GEORGE A, 1979, PHYS STATUS SOLIDI A, V53, P529, DOI 10.1002/pssa.2210530216; Kahn H, 2002, SCIENCE, V298, P1215; Kamiya S, 2014, SENSOR ACTUAT A-PHYS, V208, P30, DOI 10.1016/j.sna.2013.12.028; Massoud HZ, 1997, SOLID STATE ELECTRON, V41, P929, DOI 10.1016/S0038-1101(97)00001-4; Muhlstein CL, 2002, ACTA MATER, V50, P3579, DOI 10.1016/S1359-6454(02)00158-1; Oestlund F., 2009, ADV FUNCT MATER, V19, P2439; Ogawa M, 2014, MATER LETT, V120, P236, DOI 10.1016/j.matlet.2014.01.014	11	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-577X	1873-4979		MATER LETT	Mater. Lett.	MAR 1	2015	142						130	132		10.1016/j.matlet.2014.11.027		3	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CB6HQ	WOS:000349728500036		
J	Miyake, H; Harada, K; Miyazaki, A; Fujisawa, M				Miyake, Hideaki; Harada, Ken-ichi; Miyazaki, Akira; Fujisawa, Masato			Improved health-related quality of life of patients with metastatic renal cell carcinoma treated with a 2 weeks on and 1 week off schedule of sunitinib	MEDICAL ONCOLOGY			English	Article						Metastatic renal cell carcinoma; Sunitinib; Alternative dosing schedule; Quality of life	TYROSINE KINASE INHIBITOR; JAPANESE PATIENTS; INTERFERON-ALPHA; ANTITUMOR-ACTIVITY; 1ST-LINE THERAPY; DOSING SCHEDULE; PHASE-II; SAFETY; EFFICACY; CANCER	The objective of this study was to investigate the significance of changes from the standard dosing schedule of sunitinib, which is 4 weeks of treatment and 2 weeks off (schedule 4/2), to an alternative schedule with 2 weeks of treatment and 1 week off (schedule 2/1), after encountering dose-limiting toxicity in 45 consecutive Japanese patients with metastatic renal cell carcinoma (mRCC). Despite a definitively improved relative dose intensity of sunitinib by changing from schedule 4/2 to 2/1, this difference was not significant. Adverse events (AEs) occurred in all patients on both schedules 4/2 and 2/1; however, the proportion of patients experiencing AEs >= grade 3 on schedule 2/1 was significantly lower than that on schedule 4/2. Quality of life (QOL) analysis using SF-36 revealed that all eight scores during schedule 2/1 were more favorable than those during schedule 4/2, and there were significant differences in 2 of the 8 scores between these two schedules. Furthermore, multivariate analyses, which were performed to evaluate the contribution of several AEs on schedule 2/1 to the improvement of each score in SF-36, revealed that fatigue had independent impacts on two scores, despite the lack of an independent association between any scores and the remaining AEs examined. These findings suggest that schedule 2/1 is the optimal dosing schedule of sunitinib against mRCC that balances efficacy and toxicity, since treatment on schedule 2/1 resulted in a markedly improved QOL compared with that on schedule 4/2 by relieving the profile of sunitinib-related AEs.	[Miyake, Hideaki; Harada, Ken-ichi; Miyazaki, Akira; Fujisawa, Masato] Kobe Univ, Div Urol, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan	Miyake, H (reprint author), Kobe Univ, Div Urol, Grad Sch Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hideakimiyake@hotmail.com			Pfizer	H. Miyake, KI. Harada and M. Fujisawa have received lecture fees from Pfizer, while A. Miyazaki declares no conflict of interest.	Figlin R, 2012, J UROLOGY, V188, P707, DOI 10.1016/j.juro.2012.04.108; Motzer RJ, 2012, J CLIN ONCOL, V30, P1371, DOI 10.1200/JCO.2011.36.4133; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Gan HK, 2009, EXPERT OPIN INV DRUG, V18, P821, DOI 10.1517/13543780902980171; Cella D, 2008, J CLIN ONCOL, V26, P3763, DOI 10.1200/JCO.2007.13.5145; Wood L, 2012, EXPERT OPIN PHARMACO, V13, P1323, DOI 10.1517/14656566.2012.689130; Uemura H, 2010, JPN J CLIN ONCOL, V40, P194, DOI 10.1093/jjco/hyp146; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Faivre S, 2006, J CLIN ONCOL, V24, P25, DOI 10.1200/JCO.2005.02.2194; Kaptein AA, 2013, J PSYCHOSOC ONCOL, V31, P83, DOI 10.1080/07347332.2012.741092; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Gore ME, 2009, LANCET ONCOL, V10, P757, DOI 10.1016/S1470-2045(09)70162-7; Najjar YG, 2014, EUR J CANCER, V50, P1084, DOI 10.1016/j.ejca.2014.01.025; Houk BE, 2010, CANCER CHEMOTH PHARM, V66, P357, DOI 10.1007/s00280-009-1170-y; Kondo T, 2014, JPN J CLIN ONCOL, V44, P270, DOI 10.1093/jjco/hyt232; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Atkinson BJ, 2014, J UROLOGY, V191, P611, DOI 10.1016/j.juro.2013.08.090; Cella D, 2009, CANCER TREAT REV, V35, P733, DOI 10.1016/j.ctrv.2009.07.003; Cella D, 2012, BRIT J CANCER, V106, P646, DOI 10.1038/bjc.2011.589; Cella D, 2014, CANCER-AM CANCER SOC, V120, P1871, DOI 10.1002/cncr.28660; Costa-Requena G, 2009, PSYCHO-ONCOLOGY, V18, P1053, DOI 10.1002/pon.1405; George DJ, 2007, CLIN CANCER RES, V13, p753S, DOI 10.1158/1078-0432.CCR-06-2044; Goebell PJ, 2014, UROL ONCOL-SEMIN ORI, V32, P362, DOI 10.1016/j.urolonc.2013.09.009; Guida FM, 2014, CRIT REV ONCOL HEMAT, V92, P208, DOI 10.1016/j.critrevonc.2014.07.006; Miyake H, 2013, INT J CLIN ONCOL, V18, P220, DOI 10.1007/s10147-011-0364-6; Miyake H, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0190-6; Miyake H, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0978-4	28	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1357-0560	1559-131X		MED ONCOL	Med. Oncol.	MAR	2015	32	3							78	10.1007/s12032-015-0528-8		6	Oncology	Oncology	CC0WP	WOS:000350060000040		
J	Tamiya, A; Tamiya, M; Shiroyama, T; Saijo, N; Nakatani, T; Minomo, S; Tsuji, T; Takeuchi, N; Omachi, N; Kurata, K; Suzuki, H; Okamoto, N; Okishio, K; Hirashima, T; Atagi, S				Tamiya, Akihiro; Tamiya, Motohiro; Shiroyama, Takayuki; Saijo, Nobuhiko; Nakatani, Takeshi; Minomo, Shojiro; Tsuji, Taisuke; Takeuchi, Naoko; Omachi, Naoki; Kurata, Kanako; Suzuki, Hidekazu.; Okamoto, Norio; Okishio, Kyoichi; Hirashima, Tomonori; Atagi, Shinji			Phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations	MEDICAL ONCOLOGY			English	Article						Gefitinib; Carboplatin; S-1; Non-small cell lung cancer; Epidermal growth factor receptor; Phase II clinical trial	SERUM CREATININE; OPEN-LABEL; ERLOTINIB; COMBINATION; EGFR; PACLITAXEL; HETEROGENEITY; MULTICENTER; GEMCITABINE; CISPLATIN	Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), is an effective treatment for advanced non-small cell lung cancer (NSCLC) in patients with activating EGFR mutations. However, there have been little evidence-based studies of gefitinib in combination with platinum-doublet therapy in these patients. We performed a phase II trial to determine the efficacy and safety of triplet chemotherapy with gefitinib, carboplatin, and S-1 as a first-line treatment. This was a multicentre, single-arm, phase II trial of carboplatin, S-1, and gefitinib in advanced NSCLC patients with activating EGFR mutations. Patients received four courses of these drugs in 3-4 week cycles. In each cycle, carboplatin (area under curve = 5) was administered on day 1, S-1 (80 mg/m(2)) on days 1-14, and gefitinib (250 mg) every day. Subsequently, the same regimen without carboplatin was administered until disease progression or unacceptable toxicity occurred. The 1-year progression-free survival (PFS) was the primary endpoint, while response rate (RR), PFS, overall survival (OS), and safety were secondary endpoints. Thirty-five patients were enrolled into this study. The 1-year PFS was 74.3 % and the overall RR was 85.7 %. The median PFS for all patients was 17.6 months (95 % confidence interval 15.5-infinity), but the median OS was not reached, because 28 patients were still alive after a median follow-up time of 21.4 months. Haematological adverse events (grade 3 or higher) included neutropaenia (17.1 %), thrombocytopenia (14.3 %), and anaemia (5.7 %), while non-haematological adverse events (grade 3 or higher) included elevated aminotransferase (20.0 %), diarrhoea (14.3 %), and febrile neutropaenia (2.9 %). No interstitial lung disease or treatment-related deaths occurred. Combination chemotherapy with carboplatin, S-1, and gefitinib is efficacious and well tolerated as a first-line treatment in advanced NSCLC patients with activating EGFR mutations.	[Tamiya, Akihiro; Saijo, Nobuhiko; Nakatani, Takeshi; Minomo, Shojiro; Tsuji, Taisuke; Takeuchi, Naoko; Omachi, Naoki] Kinki Chuo Chest Med Ctr, Dept Internal Med, Sakai, Osaka 5918555, Japan; [Tamiya, Motohiro; Shiroyama, Takayuki; Kurata, Kanako; Suzuki, Hidekazu.; Okamoto, Norio; Hirashima, Tomonori] Osaka Prefectural Med Ctr Resp & Allerg Dis, Osaka Prefectural Hosp Org, Dept Thorac Malignancy, Osaka, Japan; [Okishio, Kyoichi; Atagi, Shinji] Kinki Chuo Chest Med Ctr, Dept Thorac Oncol, Kita Ku, Sakai, Osaka 5918555, Japan	Atagi, S (reprint author), Kinki Chuo Chest Med Ctr, Dept Thorac Oncol, Kita Ku, 1180 Nagasone Cho, Sakai, Osaka 5918555, Japan.	s-atagi@kch.hosp.go.jp					Ando M, 2000, CLIN CANCER RES, V6, P4733; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Okamoto I, 2010, J CLIN ONCOL, V28, P5240, DOI 10.1200/JCO.2010.31.0326; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Okabe T, 2008, MOL CANCER THER, V7, P599, DOI 10.1158/1535-7163.MCT-07-0567; Chen ZY, 2012, ONCOLOGIST, V17, P978, DOI 10.1634/theoncologist.2011-0385; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Wu YL, 2013, LANCET ONCOL, V14, P777, DOI 10.1016/S1470-2045(13)70254-7; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Shirasaka T, 1996, CANCER RES, V56, P2602; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Inoue A, 2014, J CLIN ONCOL S, V32, p5s; Kiyota H, 2013, CANCER CHEMOTH PHARM, V71, P859, DOI 10.1007/s00280-013-2077-1; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Okamoto I, 2009, CLIN LUNG CANCER, V10, P290, DOI 10.3816/CLC.2009.n.040	23	2	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1357-0560	1559-131X		MED ONCOL	Med. Oncol.	MAR	2015	32	3							40	10.1007/s12032-014-0474-x		7	Oncology	Oncology	CC0WP	WOS:000350060000002		
J	Chaiciwamongkol, K; Toomsan, Y; Arnanteerakul, T; Kondo, H; Hipkaeo, W				Chaiciwamongkol, Kowit; Toomsan, Yanyong; Arnanteerakul, Tansita; Kondo, Hisatake; Hipkaeo, Wiphawi			Occurrence of Fenestral Diaphragms and Knots in Renal Glomerular Endothelia of Diabetic Mutant MafA-/-MafK plus Mice as Revealed in Embedment-Free Transmission Electron Microscopy	MICROSCOPY RESEARCH AND TECHNIQUE			English	Article						kidney; glomerular capillary; ultrastructure	REPLICATION; MEMBRANE; PLATINUM	Using the advantages (high contrast and transparency and efficient 3D viewing) of embedment-free section transmission electron microscopy (TEM), the occurrence of numerous fenestral diaphragms was clearly shown in 3D en-face viewing of the renal glomerular capillary endothelium of severe overt diabetes mellitus mice, which were generally MafA-deficient and simultaneously MafK-overexpressed specifically in pancreatic -cells. This presents another example of nephritis-induced diaphragmed fenestrae in the renal glomerular endothelium. In addition, knot-/umbilicus-like structures discrete from and larger than the central knots of regular diaphragms of fenestrated endothelium were clearly demonstrated to occur randomly in the renal glomerular endothelial fenestrae of mutant mice and wild ones. The knot-structures were revealed to be protrusions of underlining basement lamina in conventional TEM by section-tilting observation. Microsc. Res. Tech. 78:207-212, 2015. (c) 2015 Wiley Periodicals, Inc.	[Chaiciwamongkol, Kowit; Toomsan, Yanyong; Arnanteerakul, Tansita; Kondo, Hisatake; Hipkaeo, Wiphawi] Khon Kaen Univ, Fac Med, Dept Anat, Khon Kaen 40002, Thailand; [Kondo, Hisatake] Keiai Kai Med Corp, Histol Lab, Mizusawa, Iwate 0294201, Japan	Hipkaeo, W (reprint author), Khon Kaen Univ, Fac Med, Dept Anat, Khon Kaen 40002, Thailand.	wiphawi@kku.ac.th			Faculty of Medicine, Khon Kaen University [G57301]	Contract grant sponsor: Faculty of Medicine, Khon Kaen University through WH; Contract grant number: G57301.	Ichimura K, 2008, J AM SOC NEPHROL, V19, P1463, DOI 10.1681/ASN.2007101138; Shimohata H, 2009, BIOCHEM BIOPH RES CO, V389, P235, DOI 10.1016/j.bbrc.2009.08.124; Stan RV, 2007, J CELL MOL MED, V11, P621, DOI 10.1111/j.1582-4934.2007.00075.x; Motohashi H, 1997, NUCLEIC ACIDS RES, V25, P2953, DOI 10.1093/nar/25.15.2953; BEARER EL, 1985, J CELL BIOL, V100, P418, DOI 10.1083/jcb.100.2.418; Kondo H, 2013, MICROSC RES TECHNIQ, V76, P1257, DOI 10.1002/jemt.22293; Kondo H, 2006, J ELECTRON MICROSC, V55, P231, DOI 10.1093/jmicro/dfl030; KONDO H, 1990, J ELECTRON MICR TECH, V14, P63, DOI 10.1002/jemt.1060140110; KONDO H, 1987, J ELECTRON MICR TECH, V7, P17, DOI 10.1002/jemt.1060070103; Kondo H, 2008, MICROSC RES TECHNIQ, V71, P418, DOI 10.1002/jemt.20572; Kondo H, 2011, MICROSC RES TECHNIQ, V74, P142, DOI 10.1002/jemt.20883; KONDO H, 1984, J ELECTRON MICR TECH, V1, P227, DOI 10.1002/jemt.1060010303; Latta H, 1973, HDB PHYSL 8, P1; Roberts WG, 2000, MORPHOGENESIS ENDOTH, V8, P23; Stan RV, 2004, MOL BIOL CELL, V15, P3615, DOI 10.1091/mbc.E03-08-0593	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-910X	1097-0029		MICROSC RES TECHNIQ	Microsc. Res. Tech.	MAR	2015	78	3					207	212		10.1002/jemt.22462		6	Anatomy & Morphology; Biology; Microscopy	Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics; Microscopy	CC1UO	WOS:000350130200003		
J	Chi, CJ; Zhou, YD; Cao, SQ; Arima, K; Chuman, Y; Okafuji, T				Chi, C. J.; Zhou, Y. D.; Cao, S. Q.; Arima, K.; Chuman, Y.; Okafuji, T.			Development of a pilot roller test machine for investigating the pulverizing performance of particle beds	MINERALS ENGINEERING			English	Article						Roller test machine; Particle bed; Breakage; Grinding; Size reduction	BREAKAGE; ATTRITION	Various types of pulverizers are commonly used in power plants for the purpose of breaking coal particles into fine powders to achieve optimum combustion for the boilers. To investigate the effects of factors that may influence the pulverizing efficiency, this study presents the development of a pilot roller test machine, which can significantly simplify the grinding conditions in actual pulverizers whilst the key variables involved in a rolling compression can be considered. The monitoring and data acquisition systems allow real-time monitoring of the pulverizing induced roller movements. Through parametric numerical analyses on an elastic feed bed of 5-30 mm in thickness and 500-1000 MPa in elastic modulus, it is found that the machine is capable of providing a maximum contact pressure stress in a range of 4.5-17.5 MPa. A series of fundamental tests have been conducted by the developed machine using a type of bituminous coal and typical bound values of roller weight and speed. The size reduction results as well as the measurements of roller movement demonstrate the capability of the machine as a suitable tool for testing grinding performance. Some discussions of the potential extension of the machine are also given in the final part. (C) 2014 Elsevier Ltd. All rights reserved.	[Chi, C. J.; Zhou, Y. D.; Cao, S. Q.] Tsinghua Univ, Dept Hydraul Engn, State Key Lab Hydrosci & Engn, Beijing 100084, Peoples R China; [Arima, K.; Chuman, Y.; Okafuji, T.] Mitsubishi Heavy Ind Co Ltd, Nagasaki Res & Dev Ctr, Nagasaki, Japan	Zhou, YD (reprint author), Tsinghua Univ, Dept Hydraul Engn, State Key Lab Hydrosci & Engn, Beijing 100084, Peoples R China.	zhouyd@mail.tsinghua.edu.cn			Mitsubishi Heavy Industries Ltd., Japan; National Natural Science Foundation of China [51479096]; State key Laboratory of Hydroscience and Engineering [2012-KY-04, 2013-KY-02, 2014-KY-1]; Tsinghua University Initiative Scientific Research Program [20131089285]	The authors are grateful for the kind support from Mitsubishi Heavy Industries Ltd., Japan. Additionally, the support from the National Natural Science Foundation of China (No. 51479096) and from State key Laboratory of Hydroscience and Engineering (Nos. 2012-KY-04, 2013-KY-02, and 2014-KY-1) as well as the support by Tsinghua University Initiative Scientific Research Program under Grant 20131089285 are gratefully acknowledged.	[Anonymous], 50741994 ISO; Liu J, 1996, INT J MINER PROCESS, V44-5, P101, DOI 10.1016/0301-7516(95)00022-4; BEMROSE CR, 1987, POWDER TECHNOL, V49, P97, DOI 10.1016/0032-5910(87)80054-2; Barrios GKP, 2011, MINER ENG, V24, P308, DOI 10.1016/j.mineng.2010.09.018; Bourgeois F.S., 1993, SINGLE PARTICLE FRAC; Eksi D, 2011, MINER ENG, V24, P216, DOI 10.1016/j.mineng.2010.08.006; Gotoh K., 1997, POWDER TECHNOLOGY HD; PARAMANATHAN BK, 1983, CHEM ENG SCI, V38, P197, DOI 10.1016/0009-2509(83)85002-7; Sankara NS, 1985, AUSTRALASIAN I MININ, V291; Schaefer HU, 2001, MINER ENG, V14, P1155, DOI 10.1016/S0892-6875(01)00133-9; Tavares LM, 1999, MINER ENG, V12, P43, DOI 10.1016/S0892-6875(98)00118-6	11	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0892-6875			MINER ENG	Miner. Eng.	MAR 1	2015	72						65	72		10.1016/j.mineng.2014.12.014		8	Engineering, Chemical; Mineralogy; Mining & Mineral Processing	Engineering; Mineralogy; Mining & Mineral Processing	CC1CL	WOS:000350078700010		
J	Hiremath, G; Hyakutake, A; Yamamoto, K; Ebisawa, T; Nakamura, T; Nishiyama, S; Homma, M; Kawagishi, I				Hiremath, Geetha; Hyakutake, Akihiro; Yamamoto, Kentaro; Ebisawa, Tatsuaki; Nakamura, Tomoyuki; Nishiyama, So-ichiro; Homma, Michio; Kawagishi, Ikuro			Hypoxia-induced localization of chemotaxis-related signaling proteins in Vibrio cholerae	MOLECULAR MICROBIOLOGY			English	Article							ESCHERICHIA-COLI CELL; BACTERIAL CHEMOTAXIS; VIRULENCE FACTORS; CHEMORECEPTOR; RECEPTOR; MOTILITY; ARRAYS; SENSITIVITY; EXPRESSION; COMPLEX	Vibrio cholerae has three sets of chemotaxis-related signaling proteins, of which only System II has been shown to be involved in chemotaxis. Here, we examined localization of green fluorescent protein (GFP)-fused components of System I. The histidine kinase (CheA1) and the adaptor (CheW0) of System I localized to polar and lateral membrane regions with standing incubation (microaerobic conditions), but their localization was lost after shaking (aerobic conditions). A transmembrane receptor of System I also showed polar and lateral localization with standing incubation. By contrast, GFP-fused components of System II localized constitutively to the flagellated pole. Nitrogen gas, sodium azide or carbonylcyanide m-chlorophenylhydrazone induced localization of CheA1-GFP even with shaking incubation, suggesting that the localization is controlled in response to changes in energy metabolism. Fluorescently labeled tetracysteine-tagged CheA1 also showed azide-induced localization, arguing against artifactual effects of GFP fusions. These results suggest that System I components are assembled into the supramolecular signaling complex in response to reduced cellular energy states, raising the possibility that the System I complex plays a role in sensing and signaling under microaerobic environments, such as in the host intestine.	[Hiremath, Geetha; Kawagishi, Ikuro] Hosei Univ, Res Ctr Micronano Technol, Tokyo 1848584, Japan; [Yamamoto, Kentaro; Ebisawa, Tatsuaki; Nakamura, Tomoyuki; Nishiyama, So-ichiro; Kawagishi, Ikuro] Hosei Univ, Dept Frontier Biosci, Tokyo 1848584, Japan; [Hyakutake, Akihiro; Homma, Michio] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nishiyama, S (reprint author), Hosei Univ, Dept Frontier Biosci, Tokyo 1848584, Japan.	soichiro.nishiyama.s3@hosei.ac.jp; ikurok@hosei.ac.jp			Japan Society for Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); MEXT	We thank Dr. Tomohiko Itoh for his help in high-intensity dark field microscopy, and Drs. Daisuke Shiomi, Yoshiyuki Sowa and Takehiko Inaba for technical advices, discussion and encouragements. This work was partially supported by Grants-in-Aid for Scientific Research from the Japan Society for Promotion of Science (JSPS) and from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (to M. H. and I. K.) and the MEXT-supported Program for the Strategic Research Foundation at Private Universities, 2008-2012 (to G. G. H. and I. K.).	ALM RA, 1990, MOL MICROBIOL, V4, P413, DOI 10.1111/j.1365-2958.1990.tb00608.x; Ames P, 2002, P NATL ACAD SCI USA, V99, P7060, DOI 10.1073/pnas.092071899; Nishiyama S, 2012, INFECT IMMUN, V80, P3170, DOI 10.1128/IAI.00039-12; Zhang PJ, 2007, P NATL ACAD SCI USA, V104, P3777, DOI 10.1073/pnas.0610106104; Butler SM, 2005, NAT REV MICROBIOL, V3, P611, DOI 10.1038/nrmicro1207; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Shiomi D, 2005, J BACTERIOL, V187, P7647, DOI 10.1128/JB.187.22.7647-7654.2005; Heidelberg JF, 2000, NATURE, V406, P477; Swulius MT, 2012, J BACTERIOL, V194, P6382, DOI 10.1128/JB.00505-12; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479; Kim SH, 2002, P NATL ACAD SCI USA, V99, P11611, DOI 10.1073/pnas.132376499; Butler SM, 2004, P NATL ACAD SCI USA, V101, P5018, DOI 10.1073/pnas.0308052101; Hang L, 2003, P NATL ACAD SCI USA, V100, P8508, DOI 10.1073/pnas.1431769100; GEGNER JA, 1992, CELL, V70, P975, DOI 10.1016/0092-8674(92)90247-A; Moorthy S, 2005, MOL MICROBIOL, V57, P1623, DOI 10.1111/j.1365-2958.2005.04797.x; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Bibikov SI, 1997, J BACTERIOL, V179, P4075; MEKALANOS JJ, 1983, NATURE, V306, P551, DOI 10.1038/306551a0; Krukonis ES, 2003, CURR OPIN MICROBIOL, V6, P186, DOI 10.1016/S1369-5274(03)00032-8; GUZMAN LM, 1995, J BACTERIOL, V177, P4121; Hoffmann C, 2010, NAT PROTOC, V5, P1666, DOI 10.1038/nprot.2010.129; MADDOCK JR, 1993, SCIENCE, V259, P1717; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Gosink KK, 2002, J BACTERIOL, V184, P1767, DOI 10.1128/JB.184.6.1767-1771.2002; Armitage JP, 1999, ADV MICROB PHYSIOL, V41, P229, DOI 10.1016/S0065-2911(08)60168-X; Banerjee R, 2002, FEBS LETT, V532, P221, DOI 10.1016/S0014-5793(02)03678-5; Banno S, 2004, MOL MICROBIOL, V53, P1051, DOI 10.1111/j.1365-2958.2004.04176.x; Boin MA, 2007, FEMS MICROBIOL LETT, V276, P193, DOI 10.1111/j.1574-6968.2007.00931.x; Briegel A, 2012, P NATL ACAD SCI USA, V109, P3766, DOI 10.1073/pnas.1115719109; Butler SM, 2006, MOL MICROBIOL, V60, P417, DOI 10.1111/j.1365-2958.2006.05096.x; EVERISS KD, 1994, INFECT IMMUN, V62, P3289; Gardel CL, 1996, INFECT IMMUN, V64, P2246; Gestwicki JE, 2002, NATURE, V415, P81, DOI 10.1038/415081a; HARKEY CW, 1994, INFECT IMMUN, V62, P2669; Hiremath G., 2013, INT J BIOSCI BIOCH B, V3, P71; Homma M, 2004, P NATL ACAD SCI USA, V101, P3462, DOI 10.1073/pnas.0306660101; Hyakutake A, 2005, J BACTERIOL, V187, P8403, DOI 10.1128/JB.187.24.8403-8410.2005; Irieda H, 2006, J BIOL CHEM, V281, P23880, DOI 10.1074/jbc.M600018200; Kan B, 2004, PROTEOMICS, V4, P3061, DOI 10.1002/pmic.200400944; Krishnan HH, 2004, INFECT IMMUN, V72, P3961, DOI 10.1128/IAI.72.7.3961-3967.2004; Lee CA, 1999, TRENDS MICROBIOL, V7, P391, DOI 10.1016/S0966-842X(99)01598-X; Lee SH, 2001, P NATL ACAD SCI USA, V98, P6889, DOI 10.1073/pnas.111581598; Merrell DS, 2002, NATURE, V417, P642, DOI 10.1038/nature00778; Rebbapragada A, 1997, P NATL ACAD SCI USA, V94, P10541, DOI 10.1073/pnas.94.20.10541; SCHUSTER SC, 1993, NATURE, V365, P343, DOI 10.1038/365343a0; Shiomi D, 2002, J BIOL CHEM, V277, P42325, DOI 10.1074/jbc.M202001200; Wu K, 2011, J BIOL CHEM, V286, P2587, DOI 10.1074/jbc.M110.188664	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-382X	1365-2958		MOL MICROBIOL	Mol. Microbiol.	MAR	2015	95	5					780	790		10.1111/mmi.12887		11	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	CC2JU	WOS:000350172100004		
J	Nindita, Y; Cao, ZS; Yang, YJ; Arakawa, K; Shiwa, Y; Yoshikawa, H; Tagami, M; Lezhava, A; Kinashi, H				Nindita, Yosi; Cao, Zhisheng; Yang, Yingjie; Arakawa, Kenji; Shiwa, Yuh; Yoshikawa, Hirofumi; Tagami, Michihira; Lezhava, Alexander; Kinashi, Haruyasu			The tap-tpg gene pair on the linear plasmid functions to maintain a linear topology of the chromosome in Streptomyces rochei	MOLECULAR MICROBIOLOGY			English	Article							TERMINAL INVERTED REPEATS; COMPLETE GENOME SEQUENCE; COELICOLOR A3(2); ESCHERICHIA-COLI; SCP1; REPLICATION; GRISEUS; TELOMERE; PROTEIN; RECOMBINATION	Streptomyces rochei 7434AN4 carries three linear plasmids, pSLA2-L (211kb), pSLA2-M (113kb) and pSLA2-S (18kb), their complete nucleotide sequences having been determined. Restriction and sequencing analysis revealed that the telomere sequences at both ends of the linear chromosome are identical to each other, are 98.5% identical to the right end sequences of pSLA2-L and pSLA2-M up to 3.1kb from the ends and have homology to those of typical Streptomyces species. Mutant 2-39, which lost all the three linear plasmids, was found to carry a circularized chromosome. Sequence comparison of the fusion junction and both deletion ends revealed that chromosomal circularization occurred by terminal deletions followed by nonhomologous recombination. Curing of pSLA2-L from strain 51252, which carries only pSLA2-L, also resulted in terminal deletions in newly obtained mutants. The tap-tpg gene pair, which encodes a telomere-associated protein and a terminal protein for end patching, is located on pSLA2-L and pSLA2-M but has not hitherto been found on the chromosome. These results led us to the idea that the tap-tpg of pSLA2-L or pSLA2-M functions to maintain a linear chromosome in strain 7434AN4. This hypothesis was finally confirmed by complementation and curing experiments of the tap-tpg of pSLA2-M.	[Nindita, Yosi; Cao, Zhisheng; Yang, Yingjie; Arakawa, Kenji; Kinashi, Haruyasu] Hiroshima Univ, Dept Mol Biotechnol, Grad Sch Adv Sci Matter, Higashihiroshima 7398530, Japan; [Shiwa, Yuh; Yoshikawa, Hirofumi] Tokyo Univ Agr, Nodai Res Inst, Genome Res Ctr, Setagaya Ku, Tokyo 1568502, Japan; [Tagami, Michihira; Lezhava, Alexander] RIKEN, Om Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Kinashi, H (reprint author), Hiroshima Univ, Dept Mol Biotechnol, Grad Sch Adv Sci Matter, 1-3-1 Kagamiyama, Higashihiroshima 7398530, Japan.	kinashi@hiroshima-u.ac.jp			Japan Society for the Promotion of Science (JSPS); MEXT [S1311017]	We thank J. Ishikawa, NIID, for the ongoing genome project of strain 7434AN4, N. Tanaka, Hiroshima University, for his helpful suggestion on complementation experiments, Center for Gene Science, Hiroshima University, for nucleotide sequencing of plasmids pCZ106 and pCZ117, and C. W. Chen, Yang-Ming University, for critical reading of the manuscript. Y. Nindita was supported by a scholarship from the Japan Society for the Promotion of Science (JSPS) and the genome sequencing of strain 2-39 was an MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1311017).	Pang XH, 2004, ANTIMICROB AGENTS CH, V48, P575, DOI 10.1128/AAC.48.2.575-588.2004; Ishikawa J, 1999, FEMS MICROBIOL LETT, V174, P251, DOI 10.1111/j.1574-6968.1999.tb13576.x; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; KINASHI H, 1994, J ANTIBIOT, V47, P1447; Kinashi H, 2011, J ANTIBIOT, V64, P19, DOI 10.1038/ja.2010.146; Zhang H, 1997, J FERMENT BIOENG, V83, P217, DOI 10.1016/S0922-338X(97)80982-8; Mochizuki S, 2003, MOL MICROBIOL, V48, P1501, DOI 10.1046/j.1365-2958.2003.03523.x; Bao K, 2001, GENE DEV, V15, P1518, DOI 10.1101/gad.896201; Bao K, 2003, GENE DEV, V17, P774, DOI 10.1101/gad.1060303; Bentley SD, 2004, MOL MICROBIOL, V51, P1615, DOI 10.1111/j.1365-2958.2003.03949.x; Chater Keith F., 2007, V7, P1, DOI 10.1007/7171_2007_097; Chen CW, 2002, TRENDS GENET, V18, P522, DOI 10.1016/S0168-9525(02)02752-X; Chen W, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-198; Goshi K, 2002, J BACTERIOL, V184, P3411, DOI 10.1128/JB.184.12.3411-3415.2002; HANAFUSA T, 1992, MOL GEN GENET, V231, P363, DOI 10.1007/BF00292704; HAYAKAWA T, 1979, J GEN APPL MICROBIOL, V25, P255, DOI 10.2323/jgam.25.255; Hiratsu K, 2000, MOL GEN GENET, V263, P1015, DOI 10.1007/PL00008689; Huang CH, 2003, MOL MICROBIOL, V47, P1563, DOI 10.1046/j.1365-2958.2003.03403.x; Huang CH, 2007, MOL MICROBIOL, V63, P1710, DOI 10.1111/j.1365-2958.2007.05616.x; Huang CH, 1998, MOL MICROBIOL, V28, P905, DOI 10.1046/j.1365-2958.1998.00856.x; Inoue S, 2003, BIOSCI BIOTECH BIOCH, V67, P1101; Ishikawa J, 1996, FEMS MICROBIOL LETT, V145, P113, DOI 10.1016/0378-1097(96)00397-7; Kameoka D, 1999, J BACTERIOL, V181, P5711; Kieser T., 2000, PRACTICAL STREPTOMYC; Kinashi H., 2008, ACTINOMYCETOL, V22, P20, DOI 10.3209/saj.SAJ220104; KINASHI H, 1991, PLASMID, V26, P123, DOI 10.1016/0147-619X(91)90052-X; KINASHI H, 1987, NATURE, V328, P454, DOI 10.1038/328454a0; Kinashi H., 1994, ACTINOMYCETOLOGICA, V8, P87, DOI 10.3209/saj.8_87; Nindita Y, 2013, FEMS MICROBIOL LETT, V347, P149, DOI 10.1111/1574-6968.12228; Novakova R, 2013, FEMS MICROBIOL LETT, V342, P130, DOI 10.1111/1574-6968.12095; Pandza S, 1998, MOL MICROBIOL, V28, P1165, DOI 10.1046/j.1365-2958.1998.00877.x; Qin ZJ, 1998, MOL MICROBIOL, V28, P893, DOI 10.1046/j.1365-2958.1998.00838.x; Sambrook J, 2001, MOL CLONING LAB MANU; Suzuki H, 2008, BIOSCI BIOTECH BIOCH, V72, P2973, DOI 10.1271/bbb.80454; Volff JN, 1998, MOL MICROBIOL, V27, P239, DOI 10.1046/j.1365-2958.1998.00652.x; WATT VM, 1985, P NATL ACAD SCI USA, V82, P4768, DOI 10.1073/pnas.82.14.4768; Yamasaki M, 2003, MICROBIOL-SGM, V149, P1351, DOI 10.1099/mic.0.26102-0; Yamasaki M, 2004, J BACTERIOL, V186, P6553, DOI 10.1128/JB.186.19.6553-6559.2004; Yamasaki M, 2001, MOL GEN GENET, V264, P634; Yang CC, 2006, APPL ENVIRON MICROB, V72, P7959, DOI 10.1128/AEM.01857-06; Yang YJ, 2011, BIOSCI BIOTECH BIOCH, V75, P1147, DOI 10.1271/bbb.110054	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-382X	1365-2958		MOL MICROBIOL	Mol. Microbiol.	MAR	2015	95	5					846	858		10.1111/mmi.12904		13	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	CC2JU	WOS:000350172100009		
J	Takeuchi, K; Noda, N; Katayose, Y; Mukai, Y; Numa, H; Yamada, K; Someya, N				Takeuchi, Kasumi; Noda, Naomi; Katayose, Yuichi; Mukai, Yoshiyuki; Numa, Hisataka; Yamada, Kosumi; Someya, Nobutaka			Rhizoxin Analogs Contribute to the Biocontrol Activity of a Newly Isolated Pseudomonas Strain	MOLECULAR PLANT-MICROBE INTERACTIONS			English	Article							FLUORESCENS CHA0; GENE-CLUSTER; BIOLOGICAL-CONTROL; RNA RECOGNITION; REGULATORY RNA; PF-5; 2,4-DIACETYLPHLOROGLUCINOL; BIOSYNTHESIS; BACTERIA; DISEASE	Two strains of Pseudomonas sp., Os17 and St29, were newly isolated from the rhizosphere of rice and potato, respectively, by screening for 2,4-diacetylphloroglucinol producers. These strains were found to be the same species and were the closest to but different from Pseudomonas protegens among the sequenced pseudomonads, based on 16S ribosomal RNA gene and whole-genome analyses. Strain Os17 was as effective a biocontrol agent as reported for P. protegens Cab57, whereas strain St29 was less effective. The whole-genome sequences of these strains were obtained: the genomes are organized into a single circular chromosome with 6,885,464 bp, 63.5% G+C content, and 6,195 coding sequences for strain Os17; and with 6,833,117 bp, 63.3% G+C content, and 6,217 coding sequences for strain St29. Comparative genome analysis of these strains revealed that the complete rhizoxin analog biosynthesis gene cluster (approximately 79 kb) found in the Os17 genome was absent from the St29 genome. In an rzxB mutant, which lacks the polyketide synthase essential for the production of rhizoxin analogs, the growth inhibition activity against fungal and oomycete pathogens and the plant protection efficacy were attenuated compared with those of wild-type Os17. These findings suggest that rhizoxin analogs are important biocontrol factors of this strain.	[Takeuchi, Kasumi; Noda, Naomi] Natl Inst Agrobiol Sci, Div Plant Sci, Tsukuba, Ibaraki 3058602, Japan; [Katayose, Yuichi; Mukai, Yoshiyuki; Numa, Hisataka] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Tsukuba, Ibaraki 3058602, Japan; [Yamada, Kosumi] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki 3058572, Japan; [Someya, Nobutaka] Natl Agr & Food Res Org, Hokkaido Agr Res Ctr, Memuro, Hokkaido 0820081, Japan	Takeuchi, K (reprint author), Natl Inst Agrobiol Sci, Div Plant Sci, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	kasumit@affrc.go.jp			Program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; JSPS KAKENHI [24780045]; NIAS Technical Support System	We thank D. Haas for providing the bacterial strains and plasmids, S. Miyashita for help with R in the plant experiments, F. Bertels for help with REALPHY, and Y. Nakamura for technical assistance. This work was supported, in part, by the Program for the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; JSPS KAKENHI Grant 24780045; and the NIAS Technical Support System.	C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Youard ZA, 2007, J BIOL CHEM, V282, P35546, DOI 10.1074/jbc.M707039200; Takeuchi K, 2012, MOL PLANT MICROBE IN, V25, P1440, DOI 10.1094/MPMI-02-12-0034-R; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Blumer C, 1999, P NATL ACAD SCI USA, V96, P14073, DOI 10.1073/pnas.96.24.14073; Lackner G, 2011, J BACTERIOL, V193, P783, DOI 10.1128/JB.01318-10; Reimmann C, 2005, J BACTERIOL, V187, P276, DOI 10.1128/JB.187.1.276-285.2005; Schnider-Keel U, 2000, J BACTERIOL, V182, P1215, DOI 10.1128/JB.182.5.1215-1225.2000; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Humair B, 2009, ISME J, V3, P955, DOI 10.1038/ismej.2009.42; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hassan KA, 2010, ENVIRON MICROBIOL, V12, P899, DOI 10.1111/j.1462-2920.2009.02134.x; Pechy-Tarr M, 2008, ENVIRON MICROBIOL, V10, P2368, DOI 10.1111/j.1462-2920.2008.01662.x; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Mao YQ, 1999, CHEM BIOL, V6, P251, DOI 10.1016/S1074-5521(99)80040-4; Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232; Valverde C, 2003, MOL MICROBIOL, V50, P1361, DOI 10.1046/j.1365-2958.2003.03774.x; Haas D, 2003, ANNU REV PHYTOPATHOL, V41, P117, DOI 10.1146/annurev.phyto.41.052002.095656; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Bertels F, 2014, MOL BIOL EVOL, V31, P1077, DOI 10.1093/molbev/msu088; Gross H, 2007, CHEM BIOL, V14, P53, DOI 10.1016/j.chembiol.2006.11.007; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Someya N, 2012, MICROBES ENVIRON, V27, P122, DOI 10.1264/jsme2.ME11237; Kay E, 2005, P NATL ACAD SCI USA, V102, P17136, DOI 10.1073/pnas.0505673102; Schubert M, 2007, NAT STRUCT MOL BIOL, V14, P807, DOI 10.1038/nsmb1285; Kim YC, 2011, APPL ENVIRON MICROB, V77, P1548, DOI 10.1128/AEM.01867-10; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Duffy BK, 1999, APPL ENVIRON MICROB, V65, P2429; IWASAKI S, 1984, J ANTIBIOT, V37, P354; Johansson PM, 2003, APPL ENVIRON MICROB, V69, P6464, DOI 10.1128/AEM.69.11.6464-6474.2003; KEEL C, 1992, MOL PLANT MICROBE IN, V5, P4, DOI 10.1094/MPMI-5-004; Kidarsa TA, 2011, MOL MICROBIOL, V81, P395, DOI 10.1111/j.1365-2958.2011.07697.x; Langille MGI, 2010, NAT REV MICROBIOL, V8, P372, DOI 10.1038/nrmicro2350; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Loper JE, 2008, APPL ENVIRON MICROB, V74, P3085, DOI 10.1128/AEM.02848-07; Maurhofer M, 1998, PHYTOPATHOLOGY, V88, P678, DOI 10.1094/PHYTO.1998.88.7.678; Miller J. H., 1972, EXPT MOL GENETICS; Sambrook J, 2001, MOL CLONING LAB MANU; Takeuchi K, 2009, J BIOL CHEM, V284, P34976, DOI 10.1074/jbc.M109.052571; Takeuchi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093683; VOISARD C, 1988, FEMS MICROBIOL LETT, V55, P9, DOI 10.1111/j.1574-6968.1988.tb02790.x; VOISARD C, 1994, MOLECULAR ECOLOGY OF RHIZOSPHERE MICROORGANISMS, P67, DOI 10.1002/9783527615810.ch6	47	0	1	AMER PHYTOPATHOLOGICAL SOC	ST PAUL	3340 PILOT KNOB ROAD, ST PAUL, MN 55121 USA	0894-0282	1943-7706		MOL PLANT MICROBE IN	Mol. Plant-Microbe Interact.	MAR	2015	28	3					333	342		10.1094/MPMI-09-14-0294-FI		10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Plant Sciences	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Plant Sciences	CB7BL	WOS:000349781000012		
J	Jia, N; Mitani, Y; Xie, MW; Tong, JX; Yang, ZH				Jia, Ning; Mitani, Yasuhiro; Xie, Mowen; Tong, Jianxing; Yang, Zhaohui			GIS deterministic model-based 3D large-scale artificial slope stability analysis along a highway using a new slope unit division method	NATURAL HAZARDS			English	Article						Geographic information system; Slope unit division; Artificial slope; Landslide hazard assessment; Deterministic model	LANDSLIDE HAZARD	The high frequency of landslide hazards has caused great human casualties and economic losses in recent years around the world. Among the current available approaches to assess landslide hazard, deterministic approach provides the best quantitative information on landslide hazard which can be used directly in the design of engineering works. However, the approach is difficult to be applied to estimate the slope stability in large scale due to two problems: (1) detailed datasets about the spatial variation of input parameters of the hydrological and slope stability models cannot be acquired easily; (2) an efficient method to divide large-scale area into small mapping units that can be used as study objects for deterministic approach is required. To solve these two problems, all the spatial data involving the physical properties of a slope are modelled in 2D planar or 3D perspective, utilizing the strong spatial data modelling and interpolation capabilities of geographic information system. In addition, a new slope unit division method is also proposed to divide an artificial slope into many small slope units as the study objects for deterministic model. The objective of this study was to propose a set of procedure to evaluate the artificial slope stability along a highway. A 3D limit equilibrium model is used to calculate stability of each slope unit in the form of safety factor. After the safety factors of all slope units are calculated, the stability of the whole area can be assessed.	[Jia, Ning; Tong, Jianxing] China Acad Bldg Res, Inst Fdn Engn, Beijing, Peoples R China; [Mitani, Yasuhiro] Kyushu Univ, Dept Civil & Struct Engn, Grad Sch Engn, Fukuoka 812, Japan; [Xie, Mowen] Univ Sci & Technol Beijing, Sch Civil & Environm Engn, Beijing 100083, Peoples R China; [Yang, Zhaohui] China Inst Water Resources & Hydropower Res, Beijing, Peoples R China	Jia, N (reprint author), China Acad Bldg Res, Inst Fdn Engn, 30 Bei San Huan Dong Lu, Beijing, Peoples R China.	ninjanin@yeah.net			West Nippon Expressway Company Limited (W-NEXCO)	The authors appreciated West Nippon Expressway Company Limited (W-NEXCO) for its support to this study.	Aleotti P., 1999, B ENG ENV, V58, P21, DOI DOI 10.1007/S100640050066; Xie MW, 2003, J GEOTECH GEOENVIRON, V129, P1109, DOI 10.1061/(ASCE)1090-0241(2003)129:12(1109); van Westen CJ, 2006, B ENG GEOL ENVIRON, V65, P167, DOI 10.1007/s10064-005-0023-0; Xie MW, 2004, COMPUT GEOTECH, V31, P267, DOI 10.1016/j.compgeo.2004.03.003; Wang CX, 2006, ENVIRON GEOL, V51, P91, DOI 10.1007/s00254-006-0307-0; Xie MW, 2004, NAT HAZARDS, V33, P265, DOI 10.1023/B:NHAZ.0000037036.01850.0d; CARRARA A, 1995, ADV NAT TECHNOL HAZ, V5, P135; Carrara A., 1983, MATH GEOL, V15, P403, DOI DOI 10.1007/BF01031290; Hansen A, 1984, SLOPE INSTABILITY, P523; Hutchinson J.N., 1995, P 6 INT S LANDSL CHR, V1, P1805; MARK RK, 1995, ADV NAT TECHNOL HAZ, V5, P93; Qiu C, 2007, THESIS KYUSHU U; Sahu KC, 2007, TXB REMOTE SENSING G; Zhou G, 2004, SOILS FOUND, V52, P26	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0921-030X	1573-0840		NAT HAZARDS	Nat. Hazards	MAR	2015	76	2					873	890		10.1007/s11069-014-1524-6		18	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Geology; Meteorology & Atmospheric Sciences; Water Resources	CC4SL	WOS:000350343600009		
J	Liu, GL; Zhang, LC; He, B; Jin, X; Zhang, Q; Razafindrabe, B; You, HL				Liu, Guilin; Zhang, Luocheng; He, Bin; Jin, Xuan; Zhang, Qian; Razafindrabe, Bam; You, Hailin			Temporal changes in extreme high temperature, heat waves and relevant disasters in Nanjing metropolitan region, China	NATURAL HAZARDS			English	Article						Extreme high temperature; Heat waves; Potential disaster; Land use; Nanjing metropolitan region	LANDSAT TM DATA; SURFACE-TEMPERATURE; RAPID URBANIZATION; PUBLIC-HEALTH; ISLAND; MORTALITY; IMPACTS; WATER; EMISSIVITY; PATTERNS	The urban heat environment in Nanjing metropolitan region is significantly affected by human activities. The days of high temperature and heat waves became increasingly obvious. Therefore, this paper aimed to reveal the temporal changes in high temperature and heat waves and analyze the relevant disasters. The results showed that the duration and average high temperature were both increasing during 1951-2013. Days of heat waves were mainly concentrated in August. The longest duration of extreme heat was in 2013 lasting 9 days. The major issues caused by high temperature and heat waves were energy consumption, power shortage, human health and human habitat deterioration. Land use change driven by human activities altered the underlying surface and accelerated urban heat island effect. These views provide scientific evidence for assisting urban planning and industrial restructuring in the future.	[Liu, Guilin; Zhang, Luocheng; He, Bin] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Guilin] Univ Trier, Dept Environm Remote Sensing & Geoinformat, D-54286 Trier, Germany; [Liu, Guilin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Jin, Xuan] Shandong Univ Art, Dept Environm Art Design, Coll Design, Jinan 250014, Peoples R China; [Zhang, Qian] Nanjing Forestry Univ, Coll Landscape Architecture, Nanjing 210037, Jiangsu, Peoples R China; [Razafindrabe, Bam] Univ Ryukyus, Nishihara, Okinawa 9030213, Japan; [You, Hailin] Jiangxi Acad Sci, Poyang Lake Res Ctr, Nanchang 330096, Peoples R China	Zhang, LC (reprint author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing 210008, Jiangsu, Peoples R China.	guilinshiwo@163.com; lchzhang@niglas.ac.cn			Public Projects of State Oceanic Administration [201005009-13]; National Natural Science Foundation of China [41130750]; Knowledge Innovation Program of the Chinese Academy of Sciences [KZZD-EW-10-04]; Program 135 from Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences [NIGLAS2012135006]	This study was supported by the Public Projects of State Oceanic Administration (201005009-13), National Natural Science Foundation of China (No. 41130750), Knowledge Innovation Program of the Chinese Academy of Sciences (KZZD-EW-10-04) and Program 135 from Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences (NIGLAS2012135006). The authors are also grateful to two anonymous reviewers.	Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Hoppe P, 1999, INT J BIOMETEOROL, V43, P71, DOI 10.1007/s004840050118; Weng QH, 2004, REMOTE SENS ENVIRON, V89, P467, DOI 10.1016/j.rse.2003.11.005; Zhang KX, 2010, ENVIRON MONIT ASSESS, V169, P101, DOI 10.1007/s10661-009-1154-8; Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; Webb BW, 2003, HYDROL PROCESS, V17, P3069, DOI 10.1002/hyp.1280; Voogt JA, 2003, REMOTE SENS ENVIRON, V86, P370, DOI 10.1016/S0034-4257(03)00079-8; Liu JY, 2005, REMOTE SENS ENVIRON, V98, P442, DOI 10.1016/j.rse.2005.08.012; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Whitehead PG, 2009, HYDROLOG SCI J, V54, P101, DOI 10.1623/hysj.54.1.101; Dessai S, 2002, INT J BIOMETEOROL, V47, P6, DOI 10.1007/s00484-002-0143-1; Whitman S, 1997, AM J PUBLIC HEALTH, V87, P1515, DOI 10.2105/AJPH.87.9.1515; Snyder WC, 1998, INT J REMOTE SENS, V19, P2753, DOI 10.1080/014311698214497; Rey G, 2007, INT ARCH OCC ENV HEA, V80, P615, DOI 10.1007/s00420-007-0173-4; Rocklov J, 2011, OCCUP ENVIRON MED, V68, P531, DOI 10.1136/oem.2010.058818; Chen XL, 2006, REMOTE SENS ENVIRON, V104, P133, DOI 10.1016/j.rse.2005.11.016; Zhou DC, 2014, REMOTE SENS ENVIRON, V152, P51, DOI 10.1016/j.rse.2014.05.017; ARTIS DA, 1982, REMOTE SENS ENVIRON, V12, P313, DOI 10.1016/0034-4257(82)90043-8; Chen X, 2013, NANJING CHILDRENS HO; China Central Television (CCTV), 2013, EL SURV SUMM EL ROS; Fouillet A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-114; Gulyas A, 2007, ACTA CLIMATOLOGICA C, V40, P37; Huang Y, 2013, 1 DEAD PATIENT CAUSE; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; Jiang Yong, 2003, Relay, V31; KENNEY WL, 1987, SPORTS MED, V4, P446, DOI 10.2165/00007256-198704060-00004; [李永红 Li Yonghong], 2005, [环境与健康杂志, Journal of Environment and Health], V22, P6; Liu GL, 2015, J SCI FOOD AGR, V95, P480, DOI 10.1002/jsfa.6745; Liu L, 2011, REMOTE SENS-BASEL, V3, P1535, DOI 10.3390/rs3071535; Lv NF, 2013, SUSTAINED HIGH TEMPE; MARKHAM BL, 1987, REMOTE SENS ENVIRON, V22, P39, DOI 10.1016/0034-4257(87)90027-7; MARKHAM BL, 1985, INT J REMOTE SENS, V6, P697; Mazon J, 2014, NAT HAZARD EARTH SYS, V14, P235, DOI 10.5194/nhess-14-235-2014; MORAN MS, 1992, REMOTE SENS ENVIRON, V41, P169, DOI 10.1016/0034-4257(92)90076-V; Ouyang XJ, 2012, INT J CARDIOL, V155, P212, DOI 10.1016/j.ijcard.2010.09.052; Paerl PW, 2008, SCIENCE, V320, P57; Pengelly LD, 2007, CAN J PUBLIC HEALTH, V98, P364; PRICE JC, 1987, REMOTE SENS ENVIRON, V22, P1, DOI 10.1016/0034-4257(87)90024-1; Rinner C, 2011, REMOTE SENS-BASEL, V3, P1251, DOI 10.3390/rs3061251; Robine J.-M., 2003, CR BIOL, V331, P171, DOI DOI 10.1016/J.CRVI.2007.12.001; Shi B, 2012, ENVIRON EARTH SCI, V67, P215, DOI 10.1007/s12665-011-1501-2; Smoyer-Tomic KE, 2003, NAT HAZARDS, V28, P463; Solheim A.L., 2010, CLIMATE CHANGE IMPAC; United Union, 2014, UN DAILY NEWS; Wang Y, 2013, SITUATIONS VARIOUS H; Wu F., 2013, J ENV HYG, V3, P288; Xu C, 2010, ENVIRON MONIT ASSESS, V171, P457, DOI 10.1007/s10661-009-1291-0; Xu TT, 2013, INCREASE PATIENTS DE; Xu Xia-zhen, 2011, Shengtaixue Zazhi, V30, P2815; Yang SG, 2013, HOSP PEAK CAUSED HIG; Yi Y, 2013, TOTAL 6 PEOPLE DIED; Yu F, 2013, SUSTAINED HIGH TEMPE; Yun Y, 2013, NANJING BUREAU PARKS; Yun Y, 2013, JIANGSU HIGH ROAST W; Zhang N, 2011, ADV ATMOS SCI, V28, P855, DOI 10.1007/s00376-010-0040-1; [张尚印 ZHANG Shangyin], 2005, [南京气象学院学报, Journal of Nanjing Institute of Meteorology], V28, P840; Zhang ZY, 2013, 100 PEOPLE WERE SUFF; Zhou F, 2013, HIGH TEMPERATURE CAU; Zhou LH, 2013, CITIZENS WERE SUFFER	61	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0921-030X	1573-0840		NAT HAZARDS	Nat. Hazards	MAR	2015	76	2					1415	1430		10.1007/s11069-014-1556-y		16	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Geology; Meteorology & Atmospheric Sciences; Water Resources	CC4SL	WOS:000350343600037		
J	Kaneko, K				Kaneko, Kastumi			GRAPHITIC NANOPORES Water capture in carbon cuboids	NATURE CHEMISTRY			English	News Item									Shinshu Univ, Ctr Energy & Environm Sci, Nagano 3808553, Japan	Kaneko, K (reprint author), Shinshu Univ, Ctr Energy & Environm Sci, Nagano 3808553, Japan.	kkaneko@shinshu-u.ac.jp					Ohba T, 2004, J AM CHEM SOC, V126, P1560, DOI 10.1021/ja038842w; Breck D. W., 1974, ZEOLITE MOL SIEVES, P600; Hao G-P., 2014, ANGEW CHEM INT EDIT, V53, P1941; McBain JW, 1933, J AM CHEM SOC, V55, P2294, DOI 10.1021/ja01333a014; Striolo A, 2011, ADSORPT SCI TECHNOL, V29, P211, DOI 10.1260/0263-6174.29.3.211	5	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1755-4330	1755-4349		NAT CHEM	Nat. Chem.	MAR	2015	7	3					194	196		10.1038/nchem.2193		4	Chemistry, Multidisciplinary	Chemistry	CC1QF	WOS:000350115700006		
J	Suzuki, S; Segawa, Y; Itami, K; Yamaguchi, J				Suzuki, Shin; Segawa, Yasutomo; Itami, Kenichiro; Yamaguchi, Junichiro			Synthesis and characterization of hexaarylbenzenes with five or six different substituents enabled by programmed synthesis	NATURE CHEMISTRY			English	Article							DIVERSITY-ORIENTED SYNTHESIS; CATALYZED DIRECT ARYLATION; EXTENDED PI-SYSTEMS; C-H ACTIVATION; SEQUENTIAL ARYLATION; OLEFIN SYNTHESIS; FUNCTIONALIZATION; STRATEGY; PLATFORM; (HETERO)ARENES	Since its discovery in 1825, benzene has served as one of the most used and indispensable building blocks of chemical compounds, ranging from pharmaceuticals and agrochemicals to plastics and those used in organic electronic devices. Benzene has six hydrogen atoms that can each be replaced by different substituents, which means that the structural diversity of benzene derivatives is intrinsically extraordinary. The number of possible substituted benzenes from n different substituents is (2n + 2n(2) + 4n(3) + 3n(4) + n(6))/12. However, owing to a lack of general synthetic methods for making multisubstituted benzenes, this potentially huge structural diversity has not been fully exploited. Here, we describe a programmed synthesis of hexaarylbenzenes using C-H activation, cross-coupling and [4+2] cycloaddition reactions. The present method allows for the isolation and structure-property characterization of hexaarylbenzenes with distinctive aryl substituents at all positions for the first time. Moreover, the established protocol can be applied to the synthesis of tetraarylnaphthalenes and pentaarylpyridines.	[Suzuki, Shin; Segawa, Yasutomo; Itami, Kenichiro; Yamaguchi, Junichiro] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Segawa, Yasutomo; Itami, Kenichiro] Nagoya Univ, Itami Mol Nanocarbon Project, JST ERATO, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Itami, Kenichiro] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Itami, K (reprint author), Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	itami@chem.nagoya-u.ac.jp; junichiro@chem.nagoya-u.ac.jp	Itami, Kenichiro/B-5110-2011; Yamaguchi, Junichiro/D-4198-2009; Segawa, Yasutomo/F-4889-2010	Yamaguchi, Junichiro/0000-0002-3896-5882; 	JST; JSPS [220GR049]; MEXT [25105720, 25708005]; World Premier International Research Center (WPI) Initiative, Japan	This work was supported by the ERATO programme from JST (K.I.), the Funding Program for Next Generation World-Leading Researchers from JSPS (220GR049 to K.I.), a Grant-in-Aid for Scientific Research on Innovative Areas 'Molecular Activation Directed toward Straightforward Synthesis' (25105720 to J.Y.) and KAKENHI (25708005 to J.Y.) from MEXT. The authors thank S. Hagihara, T. Yoshidomi, K. Muto and A. Miyazaki (Nagoya University) for discussions and critical comments. K. Kuwata (Nagoya University) is acknowledged for assistance with mass spectroscopy. ITbM is supported by the World Premier International Research Center (WPI) Initiative, Japan.	Yanagisawa S, 2009, J AM CHEM SOC, V131, P14622, DOI 10.1021/ja906215b; Itami K, 2005, J ORG CHEM, V70, P2778, DOI 10.1021/jo0477401; Wencel-Delord J, 2013, NAT CHEM, V5, P369, DOI 10.1038/nchem.1607; Kirchberg S, 2011, ANGEW CHEM INT EDIT, V50, P2387, DOI 10.1002/anie.201007060; Itami K, 2006, ANGEW CHEM INT EDIT, V45, P2404, DOI 10.1002/anie.200600063; Itami K, 2004, J AM CHEM SOC, V126, P11778, DOI 10.1021/ja045858t; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Fujiwara Y, 2012, NATURE, V492, P95, DOI 10.1038/nature11680; Steeger M, 2012, CHEM-EUR J, V18, P11937, DOI 10.1002/chem.201104020; Segawa Y, 2015, ANGEW CHEM INT EDIT, V54, P66, DOI 10.1002/anie.201403729; Campeau LC, 2008, J AM CHEM SOC, V130, P3276, DOI 10.1021/ja7107068; Traber B, 2004, CHEM-EUR J, V10, P1227, DOI 10.1002/chem.200305458; Ueda K, 2010, ANGEW CHEM INT EDIT, V49, P8946, DOI 10.1002/anie.201005082; Shibahara F, 2011, J ORG CHEM, V76, P2680, DOI 10.1021/jo200067y; Campeau LC, 2009, J AM CHEM SOC, V131, P3291, DOI 10.1021/ja808332k; Tomovic Z, 2007, J AM CHEM SOC, V129, P16190, DOI 10.1021/ja0765417; Tang RY, 2014, NATURE, V507, P215, DOI 10.1038/nature12963; Saito S, 2000, CHEM REV, V100, P2901, DOI 10.1021/cr990281x; Cheng C, 2014, SCIENCE, V343, P853, DOI 10.1126/science.1248042; Chen MS, 2010, SCIENCE, V327, P566, DOI 10.1126/science.1183602; Mckay CS, 2010, CHEM COMMUN, V46, P931, DOI 10.1039/b921630h; Chen L, 2012, ANGEW CHEM INT EDIT, V51, P7640, DOI 10.1002/anie.201201084; Itami K, 2003, J AM CHEM SOC, V125, P14670, DOI 10.1021/ja037566i; Yanagisawa S, 2006, J AM CHEM SOC, V128, P11748, DOI 10.1021/ja064500p; Tanaka Y, 2010, CHEM COMMUN, V46, P4529, DOI 10.1039/c0cc00128g; Shukla R, 2006, J AM CHEM SOC, V128, P5328, DOI 10.1021/ja060502y; Kobayashi K, 2003, J AM CHEM SOC, V125, P3035, DOI 10.1021/ja0293103; Joo JM, 2010, J ORG CHEM, V75, P4911, DOI 10.1021/jo100727j; Burke MD, 2004, ANGEW CHEM INT EDIT, V43, P46, DOI 10.1002/anie.200300626; Hiraoka S, 2010, J AM CHEM SOC, V132, P13223, DOI 10.1021/ja1069135; Ackermann L, 2009, ANGEW CHEM INT EDIT, V48, P9792, DOI 10.1002/anie.200902996; McNally A, 2014, NATURE, V510, P129, DOI 10.1038/nature13389; Zhang W, 2011, SCIENCE, V334, P340, DOI 10.1126/science.1210369; Hoye TR, 2012, NATURE, V490, P208, DOI 10.1038/nature11518; Itami K, 2001, J AM CHEM SOC, V123, P11577, DOI 10.1021/ja016790+; Taylor RD, 2014, J MED CHEM, V57, P5845, DOI 10.1021/jm4017625; Hiraoka S, 2010, ANGEW CHEM INT EDIT, V49, P1669, DOI 10.1002/anie.200905947; Itami K, 2004, J AM CHEM SOC, V126, P15396, DOI 10.1021/ja044923w; Tani S, 2014, CHEM SCI, V5, P123, DOI 10.1039/c3sc52199k; Geng YH, 2001, J MATER CHEM, V11, P1634, DOI 10.1039/b101163o; Yamaguchi J, 2012, ANGEW CHEM INT EDIT, V51, P8960, DOI 10.1002/anie.201201666; Burnside W., 1897, THEORY GROUPS FINITE; Faraday M., 1825, PHILOS T, V115, P440, DOI 10.1098/rstl.1825.0022; HIMESHIMA Y, 1983, CHEM LETT, P1211, DOI 10.1246/cl.1983.1211; Itami K, 2006, CHEM-EUR J, V12, P3966, DOI 10.1002/chem.200500958; Jandeleit B., 1999, ANGEW CHEM INT EDIT, V38, P2494; OGLIARUS.MA, 1965, CHEM REV, V65, P261, DOI 10.1021/cr60235a001; Read R.C., 1987, COMBINATORIAL ENUMER; Seyler H, 2012, PURE APPL CHEM, V84, P1047, DOI 10.1351/PAC-CON-11-09-24; Thiemann T, 2003, NEW J CHEM, V27, P1377, DOI 10.1039/b303091c	50	12	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1755-4330	1755-4349		NAT CHEM	Nat. Chem.	MAR	2015	7	3					227	233		10.1038/NCHEM.2174		7	Chemistry, Multidisciplinary	Chemistry	CC1QF	WOS:000350115700012		
J	Matano, M; Date, S; Shimokawa, M; Takano, A; Fujii, M; Ohta, Y; Watanabe, T; Kanai, T; Sato, T				Matano, Mami; Date, Shoichi; Shimokawa, Mariko; Takano, Ai; Fujii, Masayuki; Ohta, Yuki; Watanabe, Toshiaki; Kanai, Takanori; Sato, Toshiro			Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids	NATURE MEDICINE			English	Article							STEM-CELLS; HUMAN COLON; IN-VITRO; TUMORIGENESIS; MOUSE; EXPRESSION; EXPANSION; PATHWAY; GENES; NICHE	Human colorectal tumors bear recurrent mutations in genes encoding proteins operative in the WNT, MAPK, TGF-beta, TP53 and PI3K pathways(1,2). Although these pathways influence intestinal stem cell niche signaling(3-5), the extent to which mutations in these pathways contribute to human colorectal carcinogenesis remains unclear. Here we use the CRISPR-Cas9 genome-editing system(6,7) to introduce multiple such mutations into organoids derived from normal human intestinal epithelium. By modulating the culture conditions to mimic that of the intestinal niche, we selected isogenic organoids harboring mutations in the tumor suppressor genes APC, SMAD4 and TP53, and in the oncogenes KRAS and/or PIK3CA. Organoids engineered to express all five mutations grew independently of niche factors in vitro, and they formed tumors after implantation under the kidney subcapsule in mice. Although they formed micrometastases containing dormant tumor-initiating cells after injection into the spleen of mice, they failed to colonize in the liver. In contrast, engineered organoids derived from chromosome-instable human adenomas formed macrometastatic colonies. These results suggest that 'driver' pathway mutations enable stem cell maintenance in the hostile tumor microenvironment, but that additional molecular lesions are required for invasive behavior.	[Matano, Mami; Date, Shoichi; Shimokawa, Mariko; Takano, Ai; Fujii, Masayuki; Ohta, Yuki; Kanai, Takanori; Sato, Toshiro] Keio Univ, Sch Med, Dept Gastroenterol, Tokyo, Japan; [Date, Shoichi] Otsuka Pharmaceut Co Ltd, Fujii Mem Res Inst, Shiga, Japan; [Fujii, Masayuki; Watanabe, Toshiaki] Univ Tokyo, Dept Surg Oncol, Tokyo, Japan	Sato, T (reprint author), Keio Univ, Sch Med, Dept Gastroenterol, Tokyo, Japan.	t.sato@a7.keio.jp			research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct); Ministry of Education, Culture, Sports, Science and Technology of Japan; Research Grant of the Japanese Society of Gastroenterology	This work was supported by grants from a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), by a Grant-in-Aid for Scientific Research on Innovative Areas 'Stem Cell Aging and Disease', and by Grants-in-Aid for Scientific Research, Ministry of Education, Culture, Sports, Science and Technology of Japan. T.S. received a Research Grant of the Japanese Society of Gastroenterology. T.S. would like to thank H. Clevers (Hubrecht Institute) for providing discussion and comments. We also thank M. Okumura for editorial assistance, Y. Tanada for animal care and the Collaborative Research Resources, School of Medicine, Keio University for technical assistance. The R-spondin-producing cell line was a kind gift from C. Kuo (Stanford University). F. Zhang (Massachusetts Institute of Technology) kindly provided the pX330 vector.	Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Vermeulen L, 2013, SCIENCE, V342, P995, DOI 10.1126/science.1243148; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Washington MK, 2013, GASTROENTEROLOGY, V144, P705, DOI 10.1053/j.gastro.2013.01.067; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Chen XD, 2003, P NATL ACAD SCI USA, V100, P9530, DOI 10.1073/pnas.1233633100; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Noah TK, 2013, ANNU REV PHYSIOL, V75, P263, DOI 10.1146/annurev-physiol-030212-183741; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Rad R, 2013, CANCER CELL, V24, P15, DOI 10.1016/j.ccr.2013.05.014; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/nmeth.1802, 10.1038/NMETH.1802]; Baba I, 2000, CANCER RES, V60, P6886; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Carvalho B, 2012, CELL ONCOL, V35, P53, DOI 10.1007/s13402-011-0065-1; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Kreso A., 2008, CURR PROTOC STEM CEL, V7; Onuma K, 2013, P NATL ACAD SCI USA, V110, P11127, DOI 10.1073/pnas.1221926110; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589	35	17	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2015	21	3					256	+		10.1038/nm.3802		9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CC4YG	WOS:000350362000018		
J	Nishikawa, K; Iwamoto, Y; Kobayashi, Y; Katsuoka, F; Kawaguchi, S; Tsujita, T; Nakamura, T; Kato, S; Yamamoto, M; Takayanagi, H; Ishii, M				Nishikawa, Keizo; Iwamoto, Yoriko; Kobayashi, Yasuhiro; Katsuoka, Fumiki; Kawaguchi, Shin-ichi; Tsujita, Tadayuki; Nakamura, Takashi; Kato, Shigeaki; Yamamoto, Masayuki; Takayanagi, Hiroshi; Ishii, Masaru			DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine-producing metabolic pathway	NATURE MEDICINE			English	Article							MAMMALIAN DEVELOPMENT; BONE LOSS; METHYLATION; DNMT3A; GENES; CELLS; OSTEOBLAST; EFFICIENT; SYSTEM; BISPHOSPHONATES	Metabolic reprogramming occurs in response to the cellular environment to mediate differentiation(1-3), but the fundamental mechanisms linking metabolic processes to differentiation programs remain to be elucidated. During osteoclast differentiation, a shift toward more oxidative metabolic processes occurs(3). In this study we identified the de novo DNA methyltransferase 3a (Dnmt3a) as a transcription factor that couples these metabolic changes to osteoclast differentiation. We also found that receptor activator of nuclear factor-kappa B ligand (RANKL), an essential cytokine for osteoclastogenesis(4-7), induces this metabolic shift towards oxidative metabolism, which is accompanied by an increase in S-adenosylmethionine (SAM) production. We found that SAM-mediated DNA methylation by Dnmt3a regulates osteoclastogenesis via epigenetic repression of anti-osteoclastogenic genes. The importance of Dnmt3a in bone homeostasis was underscored by the observations that Dnmt3a-deficient osteoclast precursor cells do not differentiate efficiently into osteoclasts and that mice with an osteoclast-specific deficiency in Dnmt3a have elevated bone mass due to a smaller number of osteoclasts. Furthermore, inhibition of DNA methylation by theaflavin-3,3'-digallate abrogated bone loss in models of osteoporosis. Thus, this study reveals the role of epigenetic processes in the regulation of cellular metabolism and differentiation, which may provide the molecular basis for a new therapeutic strategy for a variety of bone disorders.	[Nishikawa, Keizo; Iwamoto, Yoriko; Ishii, Masaru] Osaka Univ, Grad Sch Med & Frontier Biosci, Dept Immunol & Cell Biol, Osaka, Japan; [Nishikawa, Keizo; Iwamoto, Yoriko; Ishii, Masaru] Osaka Univ, Immunol Frontier Res Ctr, WPI, Osaka, Japan; [Nishikawa, Keizo; Iwamoto, Yoriko; Ishii, Masaru] CREST, Japan Sci & Technol Agcy, Tokyo, Japan; [Iwamoto, Yoriko] Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Osaka, Japan; [Kobayashi, Yasuhiro] Matsumoto Dent Univ, Inst Oral Sci, Nagano, Japan; [Katsuoka, Fumiki] Tohoku Univ, Tohoku Med Megabank Org, Dept Integrat Gen, Sendai, Miyagi 980, Japan; [Katsuoka, Fumiki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 980, Japan; [Kawaguchi, Shin-ichi] Tohoku Univ, Grad Sch Med, Dept Mol Med & Therapy, Sendai, Miyagi 980, Japan; [Nakamura, Takashi] Keio Univ, Sch Med, Dept Biochem, Tokyo, Japan; [Kato, Shigeaki] Soma Cent Hosp, Fukushima, Japan; [Takayanagi, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo, Japan; [Takayanagi, Hiroshi] Univ Tokyo, Fac Med, Tokyo, Japan; [Takayanagi, Hiroshi] ERATO, Japan Sci & Technol Agcy, Takayanagi Osteonetwork Project, Tokyo, Japan	Nishikawa, K (reprint author), Osaka Univ, Grad Sch Med & Frontier Biosci, Dept Immunol & Cell Biol, Osaka, Japan.	nishi@ifrec.osaka-u.ac.jp; mishii@icb.med.osaka-u.ac.jp	Kawaguchi, Shin-ichi/D-1182-2012		Japan Society for the Promotion of Science (JSPS) [26116719]; JSPS [26713010, 25253070]; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Platform for Drug Discovery, Informatics, and Structural Life Science from the MEXT, Japan; Astellas Foundation for Research on Metabolic Disorders; Ichiro Kanehara Foundation; Shimadzu Science Foundation; Takeda Science Foundation; International Human Frontier Science Program [RGY0077/2011]	We thank K. Kaseda, M. Shirazaki, and Y. Maijima for technical assistance and J. Kikuta, S. Fujimori, and S. Simmons for helpful discussions. We also thank M. Okano, S. Takeda, and G. Karsenty; H. Wu, M. Takami, and K. Ozato for the gifts of Dnmt3a-deficient ESCs, Col1a1-Cre transgenic mice, the Dnmt3a expression vector, and Irf8<SUP>-/-</SUP> mice, respectively. This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas from the Japan Society for the Promotion of Science (JSPS) (26116719; K.N.); Grants-in-Aid for Creative Scientific Research and Young Scientists (A) from the JSPS (26713010; K.N.); Grants-in-Aid for Scientific Research (A) from the JSPS (25253070; M.I.); the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT; M.I.); the Platform for Drug Discovery, Informatics, and Structural Life Science from the MEXT, Japan (T.T., S. Kawaguchi and M.Y.); and grants from the Astellas Foundation for Research on Metabolic Disorders (K.N.), the Ichiro Kanehara Foundation (K.N.), the Shimadzu Science Foundation (K.N.), the Takeda Science Foundation (K.N. and M.I.), and the International Human Frontier Science Program (RGY0077/2011 to M.I.).	Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Nishikawa K, 2003, MOL CELL BIOL, V23, P8295, DOI 10.1128/MCB.23.22.8295-8305.2003; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147; Nishikawa K, 2010, J CLIN INVEST, V120, P3455, DOI 10.1172/JCI42528; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Goldring SR, 2004, ARTHRITIS RHEUM, V50, P2044, DOI 10.1002/art.20383; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; Jones D, 2011, J CLIN INVEST, V121, P2534, DOI 10.1172/JCI46262; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Teperino R, 2010, CELL METAB, V12, P321, DOI 10.1016/j.cmet.2010.09.004; Hikiji H, 2014, FASEB J, V28, P871, DOI 10.1096/fj.13-233106; Fujikawa M, 2010, BIOCHEM BIOPH RES CO, V401, P538, DOI 10.1016/j.bbrc.2010.09.089; Xing LP, 2005, IMMUNOL REV, V208, P19, DOI 10.1111/j.0105-2896.2005.00336.x; Nishikawa K, 2014, J BONE MINER METAB, V32, P331, DOI 10.1007/s00774-013-0547-5; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; de la Rica L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r99; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mund C, 2006, EPIGENETICS-US, V1, P7; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Paro R, 2000, NATURE, V406, P579, DOI 10.1038/35020675; Rajavelu A, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-16; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; SELANDER K, 1994, CALCIFIED TISSUE INT, V55, P368, DOI 10.1007/BF00299317; Teo BHD, 2012, BIOCHEM J, V447, P229, DOI 10.1042/BJ20120888; Yasui T, 2011, ANN NY ACAD SCI, V1240, P7, DOI 10.1111/j.1749-6632.2011.06245.x; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	44	9	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2015	21	3					281	+		10.1038/nm.3774		9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CC4YG	WOS:000350362000022		
J	Yamada, E; Inamori, M; Watanabe, S; Sato, T; Tagri, M; Uchida, E; Tanida, E; Izumi, M; Takeshita, K; Fujisawa, N; Komatsu, K; Hamanaka, J; Kanesaki, A; Matsuhashi, N; Nakajima, A				Yamada, E.; Inamori, M.; Watanabe, S.; Sato, T.; Tagri, M.; Uchida, E.; Tanida, E.; Izumi, M.; Takeshita, K.; Fujisawa, N.; Komatsu, K.; Hamanaka, J.; Kanesaki, A.; Matsuhashi, N.; Nakajima, A.			Constipation is not associated with colonic diverticula: a multicenter study in Japan	NEUROGASTROENTEROLOGY AND MOTILITY			English	Article						bowel habits; Bristol scale; colonic diverticula; colonoscopy; constipation; Gastrointestinal symptom rating scale	IRRITABLE-BOWEL-SYNDROME; FIBER DIET; DISEASE; EPIDEMIOLOGY	BackgroundThe association of diverticula with bowel habits is unclear. We therefore analyzed the association between diverticula and bowel habits in over 1000 Japanese individuals. MethodsJapanese subjects who underwent total colonoscopies at seven centers in Japan from June to September 2013 were analyzed. Bowel habits were evaluated using the Gastrointestinal Symptom Rating Scale, and stool form was assessed using a part of the Bristol Scale and Rome criteria. Diverticula were diagnosed by colonoscopy with a transparent soft-short hood. Key ResultsThe study evaluated 1066 subjects, 648 males and 418 females (ratio, 1.55:1), of mean age 63.913.0years. After adjusting for age and sex, the presence of constipation was associated with a significantly reduced likelihood of diverticula (odds ratio [OR]=0.70, 95% confidence interval [CI] 0.52-0.93). When assessed according to the location of diverticula, the presence of constipation was associated with a significantly decreased likelihood of left-sided (OR=0.39, 95% CI 0.16-0.93), but not right-sided (OR=1.10, 95% CI 0.48-2.53), diverticula. Furthermore, stool form was unrelated with the presence or absence of diverticula. Conclusions & InferencesThe wide-spread hypothesis that constipation was associated with colonic diverticula was not supported. Rather, we found that the absence of diverticula was associated with constipation, suggesting the need to reassess the etiology of colonic diverticula.	[Yamada, E.; Watanabe, S.] Saiseikai Yokohama Shi Nanbu Hosp, Div Gastroenterol, Yokohama, Kanagawa, Japan; [Inamori, M.; Sato, T.] Yokohama City Univ, Div Gastroenterol, Sch Med, Yokohama, Kanagawa 2360004, Japan; [Tagri, M.] Yokohama City Univ, Dept Biostat & Epidemiol, Sch Med, Yokohama, Kanagawa 2360004, Japan; [Uchida, E.; Tanida, E.; Izumi, M.; Kanesaki, A.] Machida Municipal Hosp, Dept Gastroenterol, Machida, Tokyo, Japan; [Takeshita, K.] Int Univ Hlth & Welf, Dept Gastroenterol, Atami Hosp, Atami, Shizuoka, Japan; [Fujisawa, N.] Tokyo Metropolitan, Hiroo Gen Hosp, Dept Gastroenterol, Shibuya Ku, Tokyo, Japan; [Komatsu, K.] Yokosuka City Hosp, Dept Gastroenterol, Yokosuka, Kanagawa, Japan; [Hamanaka, J.] Yokohama Minami Kyosai Hosp, Dept Gastroenterol, Yokosuka, Kanagawa, Japan; [Matsuhashi, N.] NTT Med Ctr Tokyo, Dept Gastroenterol, Tokyo, Japan; [Nakajima, A.] Yokohama City Univ, Dept Gastroenterol & Hepatol, Sch Med, Yokohama, Kanagawa 2360004, Japan	Nakajima, A (reprint author), Yokohama City Univ, Dept Gastroenterol & Hepatol, Sch Med, Kanazawa Ku, 3-9 Fuku Ura, Yokohama, Kanagawa 2360004, Japan.	nakajima-tky@umin.ac.jp					Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Law WL, 2001, INT J COLORECTAL DIS, V16, P280, DOI 10.1007/s003840100339; Peery AF, 2013, CLIN GASTROENTEROL H, V11, P1622, DOI 10.1016/j.cgh.2013.06.033; Weizman AV, 2011, CAN J GASTROENTEROL, V25, P385; Yamada E, 2013, GUT LIVER, V7, P532, DOI 10.5009/gnl.2013.7.5.532; Peery AF, 2012, GASTROENTEROLOGY, V142, P266, DOI 10.1053/j.gastro.2011.10.035; Simpson J, 2002, BRIT J SURG, V89, P546, DOI 10.1046/j.1365-2168.2002.02076.x; Jung HK, 2010, AM J GASTROENTEROL, V105, P652, DOI 10.1038/ajg.2009.621; PARKS TG, 1975, CLIN GASTROENTEROL, V4, P53; Faucheron JL, 2013, COLORECTAL DIS, V15, pE266, DOI 10.1111/codi.12137; Fukuhara S, 2004, MANUAL SF 8 JAPANESE; HAVIA T, 1971, ACTA CHIR SCAND, V137, P367; Korzenik JR, 2006, J CLIN GASTROENTEROL, V40, pS112, DOI 10.1097/01.mcg.0000225503.59923.6c; Miura S, 1996, INT J COLORECTAL DIS, V11, P71; OBrien MD, 1996, AM J GASTROENTEROL, V91, P2532; Painter N S, 1985, J R Coll Surg Edinb, V30, P118; PAINTER NS, 1982, S AFR MED J, V61, P1016; Parra-Blanco A, 2006, DIGESTION, V73, P47, DOI 10.1159/000089779; Riegler G, 2001, Tech Coloproctol, V5, P163, DOI 10.1007/s101510100019; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Yamazaki S., 1994, Journal of the Japan Society of Coloproctology, V47, P31	21	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1350-1925	1365-2982		NEUROGASTROENT MOTIL	Neurogastroenterol. Motil.	MAR	2015	27	3					333	338		10.1111/nmo.12478		6	Gastroenterology & Hepatology; Clinical Neurology; Neurosciences	Gastroenterology & Hepatology; Neurosciences & Neurology	CC2CV	WOS:000350153400004		
J	Khandaker, MU; Haba, H; Murakami, M; Otuka, N				Khandaker, Mayeen Uddin; Haba, Hiromitsu; Murakami, Masashi; Otuka, Naohiko			Production cross-sections of long-lived radionuclides in deuteron-induced reactions on natural zinc up to 23 MeV	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Natural zinc target; Stacked-foil activation; Deuteron-induced reaction cross-sections; Physical thick target yields; TENDL-2013	INDUCED NUCLEAR-REACTIONS; TARGET EXCITATION-FUNCTIONS; CARRIER-FREE GA-66; CYCLOTRON PRODUCTION; DATA SHEETS; NO-CARRIER; CU-67; ZN-65; SEPARATION; ANTIBODY	Production cross-sections of long-lived radionuclides Ga-66,Ga-67, (CU)-C-64,67, (65,69)mZn, and Co58m+g via a deuteron irradiation on a natural zinc target were measured up to 23 MeV using a stacked-foil activation technique combined with HPGe gamma-ray spectrometry. The present results showed partial agreements with the earlier experimental cross-sections and also with the theoretical data extracted from the TENDL-2013 library. Physical thick target yields of the investigated radionuclides were deduced using the measured cross-sections, and they found agreements with the directly measured ones in the literatures except for those reported by Dmitriev et al. for Zn-65. Optimal production pathways of the medically important Ga-67 radio-nuclide using a low energy cyclotron are discussed. (C) 2015 Elsevier B.V. All rights reserved.	[Khandaker, Mayeen Uddin] Univ Malaya, Dept Phys, Kuala Lumpur 50603, Malaysia; [Haba, Hiromitsu; Murakami, Masashi] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan; [Otuka, Naohiko] IAEA, Dept Nucl Sci & Applicat, Div Phys & Chem Sci, Nucl Data Sect, A-1400 Vienna, Austria	Khandaker, MU (reprint author), Univ Malaya, Dept Phys, Kuala Lumpur 50603, Malaysia.	mu_khandaker@yahoo.com	Khandaker, Mayeen /F-5376-2011	Khandaker, Mayeen /0000-0003-3772-294X	University of Malaya (Malaysia) Research Grant [RP006D-13AFR]	This work was performed at the RI Beam Factory operated by RIKEN Nishina Center and CNS, University of Tokyo, Japan. The work was partially supported by the University of Malaya (Malaysia) Research Grant (RP006D-13AFR). We would like to thank Dr. Semkova Valenitna (IAEA NDS) for discussion on the geometrical effect of the HPGe detector efficiency.	Singh B, 2007, NUCL DATA SHEETS, V108, P197, DOI 10.1016/j.nds.2007.01.003; DASGUPTA AK, 1991, APPL RADIAT ISOTOPES, V42, P371; Audi G, 1995, NUCL PHYS A, V595, P409, DOI 10.1016/0375-9474(95)00445-9; Khandaker MU, 2010, NUCL INSTRUM METH B, V268, P2303, DOI 10.1016/j.nimb.2010.04.002; Khandaker MU, 2011, NUCL INSTRUM METH B, V269, P1140, DOI 10.1016/j.nimb.2011.02.082; Browne E, 2010, NUCL DATA SHEETS, V111, P2425, DOI 10.1016/j.nds.2010.09.002; Obata A, 2005, NUCL MED BIOL, V32, P21, DOI 10.1016/j.nucmedbio.2004.08.012; BISSEM HH, 1980, PHYS REV C, V22, P1468, DOI 10.1103/PhysRevC.22.1468; Bonardi ML, 2004, J RADIOANAL NUCL CH, V259, P415, DOI 10.1023/B:JRNC.0000020910.81704.9b; McCarthy DW, 1997, NUCL MED BIOL, V24, P35, DOI 10.1016/S0969-8051(96)00157-6; Khandaker MU, 2014, NUCL INSTRUM METH B, V335, P8, DOI 10.1016/j.nimb.2014.05.020; Khandaker MU, 2013, NUCL INSTRUM METH B, V296, P14, DOI 10.1016/j.nimb.2012.12.003; Packard AB, 2002, NUCL MED BIOL, V29, P289, DOI 10.1016/S0969-8051(02)00285-8; Khandaker MU, 2007, NUCL INSTRUM METH B, V262, P171, DOI 10.1016/j.nimb.2007.05.028; Koning AJ, 2012, NUCL DATA SHEETS, V113, P2841, DOI 10.1016/j.nds.2012.11.002; Khandaker MU, 2009, NUCL INSTRUM METH B, V267, P23, DOI 10.1016/j.nimb.2008.11.017; Khandaker MU, 2013, NUCL INSTRUM METH B, V316, P33, DOI 10.1016/j.nimb.2013.08.032; Khandaker MU, 2012, NUCL INSTRUM METH B, V271, P72, DOI 10.1016/j.nimb.2011.11.009; DESHPANDE SV, 1988, J NUCL MED, V29, P217; Berglund M, 2011, PURE APPL CHEM, V83, P397, DOI 10.1351/PAC-REP-10-06-02; Engle JW, 2012, APPL RADIAT ISOTOPES, V70, P1792, DOI 10.1016/j.apradiso.2012.03.030; [Anonymous], NUDAT 2 6 SOFTW; Otuka N, 2014, NUCL DATA SHEETS, V120, P272, DOI 10.1016/j.nds.2014.07.065; BARON N, 1963, PHYS REV, V129, P2636, DOI 10.1103/PhysRev.129.2636; Nesaraja CD, 2014, NUCL DATA SHEETS, V115, P1, DOI 10.1016/j.nds.2013.12.001; Baglin CM, 2002, NUCL INSTRUM METH A, V481, P365, DOI 10.1016/S0168-9002(01)01376-6; Blower PJ, 1996, NUCL MED BIOL, V23, P957, DOI 10.1016/S0969-8051(96)00130-8; Bonardi ML, 2003, J RADIOANAL NUCL CH, V257, P229, DOI 10.1023/A:1024703022762; Browne E, 2010, NUCL DATA SHEETS, V111, P1093, DOI 10.1016/j.nds.2010.03.004; CARVER JH, 1959, NUCL PHYS, V11, P400, DOI 10.1016/0029-5582(59)90278-0; Cheng Xiao-wu, 1966, Acta Physica Sinica, V22; Daraban L, 2008, APPL RADIAT ISOTOPES, V66, P261, DOI 10.1016/j.apradiso.2007.09.006; Dmitriev P.P., 1982, VOP AT NAUKI TEKH YK, V4, P38; DMITRIEV PP, 1991, SOV ATOM ENERGY+, V71, P776, DOI 10.1007/BF01123803; GILLY LJ, 1963, PHYS REV, V131, P1727, DOI 10.1103/PhysRev.131.1727; GOETHALS P, 1988, EUR J NUCL MED, V14, P152, DOI 10.1007/BF00293540; GOETHALS P, 1990, EUR J NUCL MED, V16, P237, DOI 10.1007/BF00842774; Goethals P, 1991, Acta Radiol Suppl, V376, P61; Govindan SV, 2005, NUCL MED BIOL, V32, P513, DOI 10.1016/j.nucmedbio.2005.04.009; Groppi F, 2004, NUCL INSTRUM METH B, V213, P373, DOI 10.1016/S0168-583X(03)01632-X; Hilgers K, 2003, APPL RADIAT ISOTOPES, V59, P343, DOI 10.1016/S0969-8043(03)00199-4; Hou XL, 2002, APPL RADIAT ISOTOPES, V57, P773, DOI 10.1016/S0969-8043(02)00170-7; Ignatyuk A.V., 2013, NDS0645 INDC, P56; Junde H., 2005, Nuclear Data Sheets, V106, DOI 10.1016/j.nds.2005.10.006; Koning A. J., 2007, P INT C NUCL DAT SCI, P211; Koning A.J., TALYS BASED EVALUATE; Kozempel J, 2012, RADIOCHIM ACTA, V100, P419, DOI 10.1524/ract.2012.1939; Krasnov N. N., 1972, ISOT USSR, V27, P11; Laforest R, 2002, IEEE T NUCL SCI, V49, P2119, DOI 10.1109/TNS.2002.803685; Lahiri S, 1997, APPL RADIAT ISOTOPES, V48, P15, DOI 10.1016/S0969-8043(96)00042-5; Lucconi G, 2013, Appl Radiat Isot, V80, P27, DOI 10.1016/j.apradiso.2013.05.006; MALAGRINO W, 1994, J RADIOAN NUCL CH AR, V183, P389, DOI 10.1007/BF02038007; Mausner L.F., 1988, RADIOLABELED MONOCLO, P149; MIRZADEH S, 1986, APPL RADIAT ISOTOPES, V37, P29; Nassiff S. J., 1972, Radiochemical and Radioanalytical Letters, V12; NASSIFF SJ, 1973, RADIOCHIM ACTA, V19, P97; NEIRINCKX RD, 1977, INT J APPL RADIAT IS, V28, P802, DOI 10.1016/0020-708X(77)90118-1; Nesaraja A.D., 2010, NUCL DATA SHEETS, V111, P897; Qaim S.M., 2001, IAEATECDOC1211; Qtool: Calculation of Reaction Q-values and thresholds, QTOOL CALC REACT Q V; Sato N, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.073201; Semkova V., 22239 EUR EN; Shinde R.S., P APAC 2004 GYEONGJ; Smith S.V., 1999, J LABELLED COMPD R S, V42, P841; STEYN J, 1973, INT J APPL RADIAT IS, V24, P369, DOI 10.1016/0020-708X(73)90015-X; Szelecsényi F, 1991, Acta Radiol Suppl, V376, P62; Szelecsenyi F., 1994, P 5 INT WORKSH TARG, P234; SZELECSENYI F, 1994, APPL RADIAT ISOTOPES, V45, P473, DOI 10.1016/0969-8043(94)90114-7; TAKEDA A, 1995, NUCL MED BIOL, V22, P133, DOI 10.1016/0969-8051(94)E0063-O; Takeda A, 2001, CANCER RES, V61, P5065; Tamano H, 2002, NUCL MED BIOL, V29, P505, DOI 10.1016/S0969-8051(02)00289-5; Tarkanyi F, 2004, NUCL INSTRUM METH B, V217, P531, DOI 10.1016/j.nimb.2003.11.089; TARKANYI F, 1990, RADIOCHIM ACTA, V50, P19; Ugur O, 2002, NUCL MED BIOL, V29, P147, DOI 10.1016/S0969-8051(01)00290-6; VAKILOVA G, 1983, SOV ATOM ENERGY+, V55, P598, DOI 10.1007/BF01127995; Watson WS, 1999, J TRACE ELEM MED BIO, V13, P141; WILLIAMS DC, 1963, PHYS REV, V130, P265, DOI 10.1103/PhysRev.130.265; WILLIAMS DC, 1963, PHYS REV, V130, P259, DOI 10.1103/PhysRev.130.259; Zhou Y, 2013, ADV DRUG DELIVER REV, V65, P1098, DOI 10.1016/j.addr.2012.10.012; Ziegler J F, 2003, STOPPING RANGE IONS	80	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	MAR 1	2015	346						8	16		10.1016/j.nimb.2015.01.011		9	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CC1EK	WOS:000350083800002		
J	Tsuboya, T; Tsutsumi, A; Kawachi, I				Tsuboya, Toru; Tsutsumi, Akizumi; Kawachi, Ichiro			Change in psychological distress following change in workplace social capital: results from the panel surveys of the J-HOPE study	OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							WORKERS J-HOPE; JAPANESE WORKERS; DEPRESSIVE SYMPTOMS; JOB STRESS; SOCIOECONOMIC-STATUS; POPULATION; STRAIN; MORTALITY; EMPLOYEES; COMPANIES	Purpose Research on the longitudinal association of workplace social capital and mental health is limited. The purpose of the present study was to investigate the prospective association of social capital in the workplace with mental distress, measured by K6, adjusting for individuals factors as well as workplace-related factors among employees in Japan. Methods The participants included 6387 men and 1825 women from 12 private companies in Japan. Questionnaires, inquiring about workplace social capital, K6, job strain and effort-reward imbalance were administered at the baseline survey between October 2010 and December 2011 (response rate=77.4%). At 1-year follow-up, social capital and K6 were assessed again (follow-up rate=79.5%), and a generalised linear model was used to estimate the association between changes in workplace social capital and change in K6. Results After adjusting for baseline demographic characteristics and workplace-related factors (Job Content Questionnaire (JCQ), Effort-Reward Imbalance Questionnaire (ERIQ)), increased workplace social capital between waves was associated with improved psychological distress (beta=-0.2327, p<0.0001). An inverse association was found in both men and women, all age groups, and among employees with high or low baseline mental health. The association was stronger among those who reported higher stress at baseline. Conclusions Boosting workplace social capital may promote mental health in the workplace.	[Tsuboya, Toru; Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Tsuboya, Toru] Tohoku Univ, Grad Sch Dent, Dept Int & Community Oral Hlth, Sendai, Miyagi 980, Japan; [Tsutsumi, Akizumi] Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa 228, Japan	Tsuboya, T (reprint author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 677 Huntington Ave,Kresge Bldg,7th Floor, Boston, MA 02115 USA.	tsubo828@gmail.com			Ministry of Education, Culture, Sports, Science and Technology, Japan [4102-21119001]; JSPS KAKENHI [26253042]	This work was supported by the Grant-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Research Area) 2009-2013 (No. 4102-21119001) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and by JSPS KAKENHI Grant Number 26253042.	De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; Oksanen T, 2010, J EPIDEMIOL COMMUN H, V64, P684, DOI 10.1136/jech.2008.086074; Suzuki T, 2013, J AFFECT DISORDERS, V150, P490, DOI 10.1016/j.jad.2013.04.044; Sanderson K, 2006, CAN J PSYCHIAT, V51, P63; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; Reknes I, 2014, SCAND J PSYCHOL, V55, P45, DOI 10.1111/sjop.12092; Lindstrom M, 2008, AM J EPIDEMIOL, V167, P1152, DOI 10.1093/aje/kwn070; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kouvonen A, 2008, AM J EPIDEMIOL, V167, P1143, DOI 10.1093/aje/kwn067; Cairney J, 2007, CAN J PSYCHIAT, V52, P111; Siegrist J, 2009, INT ARCH OCC ENV HEA, V82, P1005, DOI 10.1007/s00420-008-0384-3; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Kawakami N, 1995, INT J BEHAV MED, V2, P358, DOI 10.1207/s15327558ijbm0204_5; Liukkonen V, 2004, SOC SCI MED, V59, P2447, DOI 10.1016/j.socscimed.2004.04.013; Ichiro Kawachi ST, 2013, GLOBAL PERSPECTIVES; Inoue A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091583; JOHNSON JV, 1989, SCAND J WORK ENV HEA, V15, P271; Jung J, 2012, J OCCUP ENVIRON MED, V54, P23, DOI 10.1097/JOM.0b013e318237a1b6; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kobayashi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088084; Kondo N, 2012, J EPIDEMIOL, V22, P543, DOI 10.2188/jea.JE20120025; Kurioka Sumiko, 2014, J Occup Health, V55, P340; Lin N., 2002, SOCIAL CAPITAL THEOR; Ministry of Health Labour and Welfare, 2011, SIT WORK WOM; Miyaki K, 2013, NUTRIENTS, V5, P565, DOI 10.3390/nu5020565; Miyaki K, 2013, INT J ENV RES PUB HE, V10, P980, DOI 10.3390/ijerph10030980; Miyaki K, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-33; Oshio T, 2014, IND HEALTH, V52, P313; Sapp AL, 2010, J OCCUP ENVIRON MED, V52, P740, DOI 10.1097/JOM.0b013e3181e80842; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037//1076-8998.1.1.27; Takagi D, 2013, SOC SCI MED, V83, P81, DOI 10.1016/j.socscimed.2013.01.001; Takahashi M, 2014, J SLEEP RES, V23, P458, DOI 10.1111/jsr.12136	32	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1351-0711	1470-7926		OCCUP ENVIRON MED	Occup. Environ. Med.	MAR	2015	72	3					188	194		10.1136/oemed-2014-102427		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CB7JL	WOS:000349802700006		
J	Slot, M; Kitajima, K				Slot, Martijn; Kitajima, Kaoru			General patterns of acclimation of leaf respiration to elevated temperatures across biomes and plant types	OECOLOGIA			English	Article						Climate change; Global patterns; Meta-analysis; Plant ecophysiology; Warming	PINUS-TAEDA SEEDLINGS; THERMAL-ACCLIMATION; DARK RESPIRATION; GROWTH TEMPERATURE; NIGHTTIME TEMPERATURES; SEASONAL-VARIATION; MOUNTAIN PASSES; TROPICAL FOREST; CO2 EXCHANGE; NEEDLE AGE	Respiration is instrumental for survival and growth of plants, but increasing costs of maintenance processes with warming have the potential to change the balance between photosynthetic carbon uptake and respiratory carbon release from leaves. Climate warming may cause substantial increases of leaf respiratory carbon fluxes, which would further impact the carbon balance of terrestrial vegetation. However, downregulation of respiratory physiology via thermal acclimation may mitigate this impact. We have conducted a meta-analysis with data collected from 43 independent studies to assess quantitatively the thermal acclimation capacity of leaf dark respiration to warming of terrestrial plant species from across the globe. In total, 282 temperature contrasts were included in the meta-analysis, representing 103 species of forbs, graminoids, shrubs, trees and lianas native to arctic, boreal, temperate and tropical ecosystems. Acclimation to warming was found to decrease respiration at a set temperature in the majority of the observations, regardless of the biome of origin and growth form, but respiration was not completely homeostatic across temperatures in the majority of cases. Leaves that developed at a new temperature had a greater capacity for acclimation than those transferred to a new temperature. We conclude that leaf respiration of most terrestrial plants can acclimate to gradual warming, potentially reducing the magnitude of the positive feedback between climate and the carbon cycle in a warming world. More empirical data are, however, needed to improve our understanding of interspecific variation in thermal acclimation capacity, and to better predict patterns in respiratory carbon fluxes both within and across biomes in the face of ongoing global warming.	[Slot, Martijn; Kitajima, Kaoru] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Slot, Martijn; Kitajima, Kaoru] Smithsonian Trop Res Inst, Panama City, Panama; [Kitajima, Kaoru] Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan	Slot, M (reprint author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	martijnslot78@gmail.com			National Science Foundation-Integrated Organismal Systems Grant [1051789]; Smithsonian Tropical Research Institute FOREST-GEO post-doctoral research fellowship	We gratefully acknowledge three anonymous reviewers for their comments on an earlier version of this paper. Financial support came from National Science Foundation-Integrated Organismal Systems Grant 1051789 (KK) and a Smithsonian Tropical Research Institute FOREST-GEO post-doctoral research fellowship (MS).	AMTHOR JS, 1984, PLANT CELL ENVIRON, V7, P561, DOI 10.1111/j.1365-3040.1984.tb01856.x; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Wright IJ, 2006, NEW PHYTOL, V169, P309, DOI 10.1111/j.1469-8137.2005.01590.x; Booth BBB, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024002; Bolstad PV, 2003, TREE PHYSIOL, V23, P969; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; RYAN MG, 1991, ECOL APPL, V1, P157, DOI 10.2307/1941808; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Ayub G, 2011, NEW PHYTOL, V190, P1003, DOI 10.1111/j.1469-8137.2011.03673.x; Tjoelker MG, 2009, NEW PHYTOL, V181, P218, DOI 10.1111/j.1469-8137.2008.02624.x; Lee TD, 2005, FUNCT ECOL, V19, P640, DOI 10.1111/j.1365-2435.2005.01023.x; Cunningham S, 2003, J BIOGEOGR, V30, P143, DOI 10.1046/j.1365-2699.2003.00811.x; Campbell C, 2007, NEW PHYTOL, V176, P375, DOI 10.1111/j.1469-8137.2007.02183.x; WANG KY, 1995, TREE PHYSIOL, V15, P211; Way DA, 2008, PLANT CELL ENVIRON, V31, P1250, DOI 10.1111/j.1365-3040.2008.01842.x; Corlett RT, 2012, BIOL CONSERV, V151, P22, DOI 10.1016/j.biocon.2011.11.027; Armstrong AF, 2006, PLANT CELL ENVIRON, V29, P940, DOI 10.1111/j.1365-3040.2005.01475.x; Stitt M, 2002, CURR OPIN PLANT BIOL, V5, P199, DOI 10.1016/S1369-5266(02)00258-3; Pan YD, 2013, ANNU REV ECOL EVOL S, V44, P593, DOI 10.1146/annurev-ecolsys-110512-135914; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Ow LF, 2010, GLOBAL CHANGE BIOL, V16, P288, DOI 10.1111/j.1365-2486.2009.01892.x; CHABOT BF, 1972, ECOL MONOGR, V42, P163, DOI 10.2307/1942262; Smith NG, 2013, GLOBAL CHANGE BIOL, V19, P45, DOI 10.1111/j.1365-2486.2012.02797.x; Tjoelker MG, 1999, GLOB CHANGE BIOL, V5, P679, DOI 10.1046/j.1365-2486.1999.00257.x; Wertin TM, 2012, CAN J FOREST RES, V42, P943, DOI [10.1139/X2012-050, 10.1139/x2012-050]; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Atkin OK, 2000, PLANT CELL ENVIRON, V23, P15, DOI 10.1046/j.1365-3040.2000.00511.x; King AW, 2006, SCIENCE, V312, P536, DOI 10.1126/science.1114166; Ow LF, 2008, NEW PHYTOL, V178, P123, DOI 10.1111/j.1469-8137.2007.02357.x; Cunningham SC, 2003, NEW PHYTOL, V157, P55, DOI 10.1046/j.1469-8137.2003.00652.x; Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; Yin HJ, 2008, ECOL RES, V23, P459, DOI 10.1007/s11284-007-0404-x; Lusk CH, 2000, OECOLOGIA, V123, P318, DOI 10.1007/s004420051018; Loveys BR, 2003, GLOBAL CHANGE BIOL, V9, P895, DOI 10.1046/j.1365-2486.2003.00611.x; Centritto M, 2011, TREE PHYSIOL, V31, P275, DOI 10.1093/treephys/tpq112; Searle SY, 2011, NEW PHYTOL, V189, P1027, DOI 10.1111/j.1469-8137.2010.03557.x; Wright SJ, 2009, CONSERV BIOL, V23, P1418, DOI 10.1111/j.1523-1739.2009.01337.x; Slot M, 2014, FUNCT ECOL, V28, P1074, DOI 10.1111/1365-2435.12263; Tjoelker MG, 2008, GLOBAL CHANGE BIOL, V14, P782, DOI 10.1111/j.1365-2486.2008.01548.x; Corlett RT, 2011, TRENDS ECOL EVOL, V26, P606, DOI 10.1016/j.tree.2011.06.015; Doughty CE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000632; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Arneth A, 2012, BIOGEOSCIENCES, V9, P3545; Arnone JA, 1997, ARCTIC ALPINE RES, V29, P122; Atkin OK, 2005, ADV PHOTO RESPIRAT, V18, P95; BILLINGS W D, 1971, Arctic and Alpine Research, V3, P277, DOI 10.2307/1550044; Bruhn D, 2007, GLOBAL CHANGE BIOL, V13, P1216, DOI 10.1111/j.1365-2486.2007.01351.x; Cheesman AW, 2013, NEW PHYTOL, V197, P1185, DOI 10.1111/nph.12098; Cheesman AW, 2013, J EXP BOT, V64, P3817, DOI 10.1093/jxb/ert211; Chi YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056482; Cunningham SC, 2002, OECOLOGIA, V133, P112, DOI 10.1007/s00442-002-1034-1; De Vries E P., 1975, ANN BOTANY, V39, P77; Dillaway DN, 2011, TREE PHYSIOL, V31, P1114, DOI 10.1093/treephys/tpr097; Frantz JM, 2004, ANN BOT-LONDON, V94, P155, DOI 10.1093/aob/mch122; Gandin A, 2014, PLANT CELL ENVIRON, V37, P2601, DOI 10.1111/pce.12345; Krause GH, 2013, J PLANT PHYSIOL, V170, P822, DOI 10.1016/j.jplph.2013.01.005; LARIGAUDERIE A, 1995, ANN BOT-LONDON, V76, P245, DOI 10.1006/anbo.1995.1093; Ow LF, 2008, FUNCT PLANT BIOL, V35, P448, DOI 10.1071/FP08104; Raison J. K., 1980, Adaptation of plants to water and high temperature stress., P261; Rodriguez-Calcerrada J, 2010, TREE PHYSIOL, V30, P214, DOI 10.1093/treephys/tpp104; ROOK D A, 1969, New Zealand Journal of Botany, V7, P43; Searle SY, 2011, PHYSIOL PLANTARUM, V141, P332, DOI 10.1111/j.1399-3054.2010.01442.x; Shi FS, 2010, PHOTOSYNTHETICA, V48, P437, DOI 10.1007/s11099-010-0058-8; Silim SN, 2010, PHOTOSYNTH RES, V104, P19, DOI 10.1007/s11120-010-9527-y; Slot M, 2013, TREE PHYSIOL, V33, P505, DOI 10.1093/treephys/tpt026; Slot M, 2014, GLOBAL CHANGE BIOL, V20, P2915, DOI 10.1111/gcb.12563; SMITH E M, 1974, Arctic and Alpine Research, V6, P13, DOI 10.2307/1550366; Stocker T. F., 2013, CLIMATE CHANGE 2013, P317; STRAIN BR, 1969, ECOLOGY, V50, P511, DOI 10.2307/1933911; Teskey RO, 1999, TREE PHYSIOL, V19, P519; TOBIESSEN P, 1976, AM MIDL NAT, V96, P462, DOI 10.2307/2424084; Xiong FSS, 2000, AM J BOT, V87, P700, DOI 10.2307/2656856; Zha TS, 2002, TREE PHYSIOL, V22, P1241; Zhou Z, 2007, J INTEGR PLANT BIOL, V49, P270, DOI [10.1111/j.1744-7909.2007.00374.x, DOI 10.1111/J.1744-7909.2007.00374.X]	74	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0029-8549	1432-1939		OECOLOGIA	Oecologia	MAR	2015	177	3					885	900		10.1007/s00442-014-3159-4		16	Ecology	Environmental Sciences & Ecology	CC0NV	WOS:000350033500023		
